Psyllid ID: psy6377
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 383 | 2.2.26 [Sep-21-2011] | |||||||
| Q0KHT7 | 784 | Probable serine/threonine | no | N/A | 0.571 | 0.279 | 0.467 | 2e-53 | |
| Q9GM70 | 397 | Serine/threonine-protein | no | N/A | 0.590 | 0.569 | 0.418 | 1e-49 | |
| O94768 | 372 | Serine/threonine-protein | yes | N/A | 0.590 | 0.607 | 0.416 | 4e-49 | |
| Q91XS8 | 371 | Serine/threonine-protein | yes | N/A | 0.590 | 0.609 | 0.412 | 5e-49 | |
| Q9UEE5 | 414 | Serine/threonine-protein | no | N/A | 0.590 | 0.545 | 0.418 | 9e-49 | |
| Q8BG48 | 372 | Serine/threonine-protein | yes | N/A | 0.590 | 0.607 | 0.404 | 2e-47 | |
| Q8VDF3 | 370 | Death-associated protein | no | N/A | 0.728 | 0.754 | 0.344 | 4e-45 | |
| Q9UIK4 | 370 | Death-associated protein | no | N/A | 0.728 | 0.754 | 0.341 | 3e-44 | |
| O43293 | 454 | Death-associated protein | no | N/A | 0.731 | 0.616 | 0.334 | 4e-44 | |
| O88764 | 448 | Death-associated protein | no | N/A | 0.812 | 0.694 | 0.308 | 3e-41 |
| >sp|Q0KHT7|Y2666_DROME Probable serine/threonine-protein kinase CG32666 OS=Drosophila melanogaster GN=CG32666 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 209 bits (532), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 114/244 (46%), Positives = 150/244 (61%), Gaps = 25/244 (10%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
TG FAAKFL +S+ I HEIA+L LC IV L+ V +T +T
Sbjct: 59 TGSHFAAKFLKRRRRAQSSDKEIKHEIAVLMLCEGEDNIVNLNAVHETRS-------DTA 111
Query: 68 LVVTL------QTIIDDNLVVPFES------DELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
L++ L QTI+D+ + + L +L +LH R IAHLD+KPQN+++ G+
Sbjct: 112 LLLELATGGELQTILDNEECLTEAQARHCMREVLKALKFLHDRSIAHLDLKPQNILLAGE 171
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
+K+CDF ISRV+ +GI +RE+ GTPDYVAPE+L YEP++L D+WS+GV YVLL
Sbjct: 172 RIEDGLKLCDFGISRVVCEGINVREMAGTPDYVAPEVLQYEPLSLLTDIWSVGVLTYVLL 231
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
+GFSPFGG+T ETF NIS+ L FPD LF +SP A DFI + L P +RM A L
Sbjct: 232 SGFSPFGGDTKQETFLNISQCALTFPDNLFGGVSPVAIDFIRRALRIKPNDRMNATGCLD 291
Query: 236 HPWL 239
H WL
Sbjct: 292 HIWL 295
|
Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus GN=STK17A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 100/239 (41%), Positives = 149/239 (62%), Gaps = 13/239 (5%)
Query: 14 TGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNT 66
+G+ FAAKF+ + I HEIA+L L +P ++ LH+V++T E + +
Sbjct: 66 SGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYETSSEMILVLEYAA 125
Query: 67 PLVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
++ Q + D + V L + +LH + HLD+KPQN+++ + P D
Sbjct: 126 GGEISDQCVADRDEAFNEKDVQRLMRQILEGVHFLHTHDVVHLDLKPQNILLTSESPLGD 185
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
IK+ DF +SR++ + E+RE++GTP+YVAPEIL Y+PI++A DMWS+GV YV+LTG SP
Sbjct: 186 IKIVDFGLSRIVKNSEELREIMGTPEYVAPEILSYDPISMATDMWSIGVLTYVMLTGISP 245
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F G+ ETF NIS+ L + +E F+ +S A DFI K+L+K P +R TA+E LKHPWL
Sbjct: 246 FLGDNKQETFLNISQMNLSYSEEEFDTVSESAVDFIKKLLVKKPEDRATAEECLKHPWL 304
|
Acts as a positive regulator of apoptosis. May also act as a regulator of cellular reactive oxygen species. Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O94768|ST17B_HUMAN Serine/threonine-protein kinase 17B OS=Homo sapiens GN=STK17B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 102/245 (41%), Positives = 146/245 (59%), Gaps = 19/245 (7%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQT--------- 55
S +TG+ +AAKFL+ I HEIA+L L PR++ LH+V++
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 111
Query: 56 -GEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
G S P L ++ +N V+ L + YLH I HLD+KPQN+++
Sbjct: 112 YAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 168
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+P DIK+ DF +SR I E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+L
Sbjct: 169 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 228
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
LT SPF GE + ET+ NIS+ +D+ +E F +S A DFI +L+KNP +R TA+ L
Sbjct: 229 LTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 288
Query: 235 KHPWL 239
H WL
Sbjct: 289 SHSWL 293
|
Acts as a positive regulator of apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91XS8|ST17B_RAT Serine/threonine-protein kinase 17B OS=Rattus norvegicus GN=Stk17b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 101/245 (41%), Positives = 148/245 (60%), Gaps = 19/245 (7%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-------- 56
S +TG+ +AAKFL+ I HEIA+L L P ++ LH+V++T
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVYETATEIILVLE 111
Query: 57 --EGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
G + P L ++ +N V+ L + YLH I HLD+KPQN+++
Sbjct: 112 YAAGGEIFNLCLP---ELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLKPQNILLSS 168
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+P DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+L
Sbjct: 169 IYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 228
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
LT SPF GE + ET+ NIS+ +D+ +E+F +S A DFI +L+KNP +R TA+ L
Sbjct: 229 LTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNPEKRPTAESCL 288
Query: 235 KHPWL 239
H WL
Sbjct: 289 SHSWL 293
|
Acts as a positive regulator of apoptosis. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEE5|ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 100/239 (41%), Positives = 147/239 (61%), Gaps = 13/239 (5%)
Query: 14 TGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNT 66
+G+ FAAKF+ + I HEIA+L L +P ++ LH+V++T E + +
Sbjct: 83 SGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYETASEMILVLEYAA 142
Query: 67 PLVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
+ Q + D + V L + +LH R + HLD+KPQN+++ + P D
Sbjct: 143 GGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTRDVVHLDLKPQNILLTSESPLGD 202
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
IK+ DF +SR++ + E+RE++GTP+YVAPEIL Y+PI++A DMWS+GV YV+LTG SP
Sbjct: 203 IKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMWSIGVLTYVMLTGISP 262
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F G ETF NIS+ L + +E F+ +S A DFI +L+K P +R TA+E LKHPWL
Sbjct: 263 FLGNDKQETFLNISQMNLSYSEEEFDVLSESAVDFIRTLLVKKPEDRATAEECLKHPWL 321
|
Acts as a positive regulator of apoptosis. Also acts as a regulator of cellular reactive oxygen species. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BG48|ST17B_MOUSE Serine/threonine-protein kinase 17B OS=Mus musculus GN=Stk17b PE=2 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 99/245 (40%), Positives = 146/245 (59%), Gaps = 19/245 (7%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-------- 56
S +TG+ +AAK L+ I HEIA+L L P ++ LH+V++
Sbjct: 52 SKSTGQEYAAKSLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVYENATEIILVLE 111
Query: 57 --EGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
G + P L ++ +N V+ L + YLH I HLD+KPQN+++
Sbjct: 112 YAAGGEIFNLCLP---ELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLKPQNILLSS 168
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+P DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+L
Sbjct: 169 IYPLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 228
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
LT SPF GE + ET+ NIS+ +D+ +E+F +S A DFI +L+KNP +R TA+ L
Sbjct: 229 LTHTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNPEKRPTAESCL 288
Query: 235 KHPWL 239
H WL
Sbjct: 289 SHSWL 293
|
Acts as a positive regulator of apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VDF3|DAPK2_MOUSE Death-associated protein kinase 2 OS=Mus musculus GN=Dapk2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 112/325 (34%), Positives = 173/325 (53%), Gaps = 46/325 (14%)
Query: 13 ATGEVFAAKFLESNPVR----------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
+TG +AAKF++ R I E+++L P I+ LHDV++
Sbjct: 44 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN------- 95
Query: 63 SWNTPLVVTLQTIIDDNL--------------VVPFESDELSSLAYLHHRKIAHLDIKPQ 108
T +V+ L+ + L F L + YLH +KIAH D+KP+
Sbjct: 96 --RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 153
Query: 109 NLVMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N++++ + P IK+ DF ++ I DG+E + + GTP++VAPEI++YEP+ L ADMWS+
Sbjct: 154 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 213
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y+LL+G SPF G+T ET NI+ DF +E F S AKDFI K+L+K +R
Sbjct: 214 GVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 273
Query: 228 MTAKEALKHPWL--MNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISA 285
+T +EAL+HPW+ ++ +Q M R S++ N +N +K + R L ++S
Sbjct: 274 LTIQEALRHPWITPVDTQQAMVR-----RESVV----NLENFKKQYVRRRWKLSFSIVSL 324
Query: 286 SKLQQENLRKSALLKYNKTRRLCES 310
+L K L+ ++ R CES
Sbjct: 325 CNHLTRSLMKKVHLRTSEDLRNCES 349
|
Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Capable of regulating both type I apoptotic and type II autophagic cell deaths signal. The former involves caspase activation, chromatin and mitochondrial condensation while the latter involves caspase-independent cell death in conjunction with accumulation of mature autophagic vesicles, plasma membrane blebs, and nuclear condensation without DNA degradation. Mediator of anoikis and a suppressor of beta-catenin-dependent anchorage-independent growth of malignant epithelial cells. May play a role in granulocytic maturation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UIK4|DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens GN=DAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 111/325 (34%), Positives = 172/325 (52%), Gaps = 46/325 (14%)
Query: 13 ATGEVFAAKFLESNPVR----------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
+TG +AAKF++ R I E+++L ++ LHDV++
Sbjct: 44 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYEN------- 95
Query: 63 SWNTPLVVTLQTIIDDNL--------------VVPFESDELSSLAYLHHRKIAHLDIKPQ 108
T +V+ L+ + L F L + YLH +KIAH D+KP+
Sbjct: 96 --RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 153
Query: 109 NLVMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N++++ + P IK+ DF ++ I DG+E + + GTP++VAPEI++YEP+ L ADMWS+
Sbjct: 154 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 213
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y+LL+G SPF G+T ET NI+ DF +E F S AKDFI K+L+K +R
Sbjct: 214 GVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 273
Query: 228 MTAKEALKHPWL--MNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISA 285
+T +EAL+HPW+ ++ +Q M R S++ N +N RK + R L ++S
Sbjct: 274 LTIQEALRHPWITPVDNQQAMVR-----RESVV----NLENFRKQYVRRRWKLSFSIVSL 324
Query: 286 SKLQQENLRKSALLKYNKTRRLCES 310
+L K L+ ++ R CES
Sbjct: 325 CNHLTRSLMKKVHLRPDEDLRNCES 349
|
Isoform 2 can phosphorylate MYL9. It can induce membrane blebbing and autophagic cell death. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O43293|DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 111/332 (33%), Positives = 173/332 (52%), Gaps = 52/332 (15%)
Query: 13 ATGEVFAAKFLESNPV----------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
TG+ +AAKF++ + I E+ +L P I+ LHD+F+
Sbjct: 34 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFEN------- 85
Query: 63 SWNTPLVVTLQTI--------------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQ 108
T +V+ L+ + + ++ F L + YLH ++IAH D+KP+
Sbjct: 86 --KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE 143
Query: 109 NLVMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N++++ + PN IK+ DF I+ I G E + + GTP++VAPEI++YEP+ L ADMWS+
Sbjct: 144 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y+LL+G SPF GET ET NIS DF +E F + S AKDFI ++L+K+P R
Sbjct: 204 GVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 263
Query: 228 MTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREAL--------- 278
MT ++L+H W+ ++ R G S + + L++Y KS +L
Sbjct: 264 MTIAQSLEHSWIKAIRRRNVR-GEDSGRKPERRRLKTTRLKEYTIKSHSSLPPNNSYADF 322
Query: 279 --FEKVISASKLQQENLRKSALLKYNKTRRLC 308
F KV+ + +E LR + ++RRLC
Sbjct: 323 ERFSKVLEEAAAAEEGLR-----ELQRSRRLC 349
|
Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88764|DAPK3_RAT Death-associated protein kinase 3 OS=Rattus norvegicus GN=Dapk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 110/357 (30%), Positives = 178/357 (49%), Gaps = 46/357 (12%)
Query: 13 ATGEVFAAKFLESNPV----------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
TG +AAKF++ + I E+++L P I+ LHDVF+
Sbjct: 34 GTGMEYAAKFIKKRRLPSSRRGVSREEIEREVSILREIR-HPNIITLHDVFEN------- 85
Query: 63 SWNTPLVVTLQTI--------------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQ 108
T +V+ L+ + + ++ F L + YLH ++IAH D+KP+
Sbjct: 86 --KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPE 143
Query: 109 NLVMMGDFPNC-DIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N++++ IK+ DF I+ I G E + + GTP++VAPEI++YEP+ L ADMWS+
Sbjct: 144 NIMLLDKHAASPRIKLIDFGIAHRIEAGSEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y+LL+G SPF GET ET NIS DF +E F S AKDFI ++L+K+P R
Sbjct: 204 GVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSSTSELAKDFIRRLLVKDPKRR 263
Query: 228 MTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKK---NLRKYLSKSREALFEKVIS 284
MT ++L+H W+ ++ R + P + + + +L+ + S R +
Sbjct: 264 MTIAQSLEHSWI----KVRRREDGARKPERRRLRAARLREYSLKSHSSMPRNTSYASFER 319
Query: 285 ASK-LQQENLRKSALLKYNKTRRLCESQ---MSLVSKTREKSLGDMAISLGRSKEKL 337
S+ L+ + L + + RR C + + + ++ RE D + LGR +L
Sbjct: 320 FSRVLEDVAAAEQGLRELQRGRRQCRERVCALRVAAEQREARCRDGSAGLGRDLRRL 376
|
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 383 | ||||||
| 328713083 | 654 | PREDICTED: hypothetical protein LOC10016 | 0.892 | 0.522 | 0.540 | 1e-111 | |
| 242005343 | 890 | death associated protein kinase, putativ | 0.906 | 0.389 | 0.512 | 1e-102 | |
| 332025701 | 1224 | Serine/threonine-protein kinase 17B [Acr | 0.770 | 0.241 | 0.541 | 1e-92 | |
| 156549437 | 1001 | PREDICTED: hypothetical protein LOC10011 | 0.822 | 0.314 | 0.521 | 2e-91 | |
| 380022614 | 1192 | PREDICTED: uncharacterized protein LOC10 | 0.736 | 0.236 | 0.547 | 2e-90 | |
| 328776543 | 1189 | PREDICTED: hypothetical protein LOC72679 | 0.691 | 0.222 | 0.569 | 5e-90 | |
| 350426312 | 1191 | PREDICTED: hypothetical protein LOC10074 | 0.751 | 0.241 | 0.537 | 6e-90 | |
| 383857725 | 1201 | PREDICTED: uncharacterized protein LOC10 | 0.751 | 0.239 | 0.537 | 6e-90 | |
| 340723642 | 1191 | PREDICTED: hypothetical protein LOC10064 | 0.751 | 0.241 | 0.537 | 7e-90 | |
| 307204460 | 1072 | Serine/threonine-protein kinase 17B [Har | 0.535 | 0.191 | 0.617 | 1e-77 |
| >gi|328713083|ref|XP_001942546.2| PREDICTED: hypothetical protein LOC100163198, partial [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 220/407 (54%), Positives = 274/407 (67%), Gaps = 65/407 (15%)
Query: 11 SIATGEVFAAKFLESNPVR--------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
SI TGEVFAAKF SN R IHHEIALLSLCSPSPRI KLHDVFQT + V
Sbjct: 14 SIETGEVFAAKF--SNRTRFGEDCSPDIHHEIALLSLCSPSPRITKLHDVFQTPKQLIIV 71
Query: 63 SWNTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGD 115
P LQ +IDD+ VPFE+D + LAY+H RKIAHLDIKPQNLV+MG
Sbjct: 72 MEYAP-GGDLQKVIDDD-NVPFEADVVKFIHHVVEGLAYMHQRKIAHLDIKPQNLVLMGV 129
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
FP CD+K+CDFEISRVIL+G EIRE+LGTPDYVAPEILHYEPITLAADMWSLGVT Y LL
Sbjct: 130 FPTCDVKLCDFEISRVILEGTEIREILGTPDYVAPEILHYEPITLAADMWSLGVTTYALL 189
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
TGFSPFGG+TD ETF NIS A +DFPDELFED+S EA DFI K+L+K+P ER+TAKE LK
Sbjct: 190 TGFSPFGGDTDQETFCNISNADIDFPDELFEDVSEEAVDFIRKLLVKDPKERLTAKECLK 249
Query: 236 HPWLMNKKQ----------------------------------IMTRVGCSSC----PSI 257
HPWL N ++ ++ R GC++C PSI
Sbjct: 250 HPWLANLRKSSSGSSHSVQHHQHLQQNYHQHQQPHQQQHQQPSVVKRTGCNTCAGITPSI 309
Query: 258 IQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSALLKYNK--TRRLCESQMSLV 315
+ YLSKSREALFE+++S +++ ++++S++L ++ + R+CES SLV
Sbjct: 310 SARRSGGGLQPSYLSKSREALFERIVS-KHMRESDMKRSSMLHESQYASSRMCESHTSLV 368
Query: 316 SKTREKSLGDMAISLGRSKEKLYGFKCLSKSQEVLNLYKSMKDINNI 362
S++R + + +SKEKLYG K LS+SQ+VL++ KS+KD++ +
Sbjct: 369 SRSRNGTR-----TFSKSKEKLYGLKSLSRSQDVLDMCKSIKDLSEV 410
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242005343|ref|XP_002423529.1| death associated protein kinase, putative [Pediculus humanus corporis] gi|212506643|gb|EEB10791.1| death associated protein kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 377 bits (968), Expect = e-102, Method: Compositional matrix adjust.
Identities = 218/425 (51%), Positives = 272/425 (64%), Gaps = 78/425 (18%)
Query: 11 SIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S+ TGE +AAKF E I+HEIALLSLC +PR++++HDVF+ V
Sbjct: 23 SLKTGESYAAKFTSRQRYGEDCSTEIYHEIALLSLCGSAPRVIQIHDVFENPNEIIIVME 82
Query: 65 NTPLVVTLQTIIDDNLVVPFESDELS-------SLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P LQTIID+ L+ PFESD +S L YLH RKIAHLDIKPQN+VMM D+P
Sbjct: 83 YAP-GGDLQTIIDEELI-PFESDVVSYIRQTAEGLDYLHRRKIAHLDIKPQNIVMMSDYP 140
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
NC+IK+CDFEISRVIL+G IRELLGTPDYVAPEILHY+PITLAADMWSLGVT YVLLTG
Sbjct: 141 NCEIKLCDFEISRVILEGKIIRELLGTPDYVAPEILHYDPITLAADMWSLGVTTYVLLTG 200
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
+SPFGGETD ETF NIS+ +LDFPD+LF+D+S +A DFI K+++KNP R+TA LKHP
Sbjct: 201 YSPFGGETDQETFCNISRGELDFPDDLFKDVSNDAVDFIKKLIVKNPKARLTASACLKHP 260
Query: 238 WLMNK----------------KQIMTR---VGCSSCPSIIQNQQNKKN------------ 266
WL N ++++T+ VG S ++ ++ K+N
Sbjct: 261 WLNNSTDRNKMKESKNTLVKPERVVTQNDDVG-----SNLEEEKRKENEYVDDGNRENDD 315
Query: 267 -------LRKYLSKSREALFEKVISASKLQQENLRKSALLKYN------KTRRLCESQMS 313
LRKYLSKSREALF+KV+ N S KY + R+CESQ+S
Sbjct: 316 NKNNNKKLRKYLSKSREALFDKVVQK---HNNNSTSSNFKKYTFKNHRFRKTRMCESQIS 372
Query: 314 LVSKTREKSL---GDMAISLGRSKEKLYGFKCLSKSQEVLNLYK------SMKDINNICI 364
L+SK++EK L G+ + RS EKLYG + LSKSQEVLNLYK S +++N +
Sbjct: 373 LISKSQEKLLLTGGETLNAPSRSIEKLYGLRSLSKSQEVLNLYKTGGLLTSQENLN--LV 430
Query: 365 DEIIK 369
EIIK
Sbjct: 431 SEIIK 435
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332025701|gb|EGI65859.1| Serine/threonine-protein kinase 17B [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 346 bits (887), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 182/336 (54%), Positives = 229/336 (68%), Gaps = 41/336 (12%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S +TG ++AAK+ N + HEIALLSLCS SPR+V+LHDV++T + V
Sbjct: 107 SRSTGTLYAAKYSSRNRFNADCSAELRHEIALLSLCSQSPRVVRLHDVYETPKEIILVME 166
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P LQT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 167 YAP-GGDLQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHERNIAHLDIKPQNLVMMGSFP 224
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
+CD+K+CDFEISRVIL+G E+RE+LGTPDYVAPEILHYEPITLAADMWSLGVT YVLLTG
Sbjct: 225 DCDVKLCDFEISRVILEGTEVREILGTPDYVAPEILHYEPITLAADMWSLGVTTYVLLTG 284
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELFEDIS +AKDF+AK+L+ +P RMTAK+ L+H
Sbjct: 285 FSPFGGETDQETFQNISLGEVDFPEELFEDISVQAKDFVAKLLVLDPSARMTAKQCLRHD 344
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LR+YLSKSRE L E+V+S +ENLR++A
Sbjct: 345 WLR------------GAPT-----QASPHLRRYLSKSREVLLERVVS-----RENLRRAA 382
Query: 298 LLKYNKTR-RLCESQMSL---VSKTREKSLGDMAIS 329
L+ ++ LC+ + + R++ L D +S
Sbjct: 383 LISQTTSQASLCQGDVQSDQNYQQHRQQGLQDCTLS 418
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156549437|ref|XP_001603222.1| PREDICTED: hypothetical protein LOC100119444 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 342 bits (877), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 185/355 (52%), Positives = 237/355 (66%), Gaps = 40/355 (11%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S +TG V+AAK+ N + HEIALLSLCS SPR+V+LHDV++T + V
Sbjct: 110 SRSTGIVYAAKYSSRNRFNADCSAELRHEIALLSLCSQSPRVVRLHDVYETPKEIIMVME 169
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P +QT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 170 FAP-GGDMQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHERNIAHLDIKPQNLVMMGSFP 227
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
+C++K+CDFEISRV+L+G E+RE+LGTPDYVAPEILHYEPITLAADMWSLGVT YVLLTG
Sbjct: 228 DCNVKLCDFEISRVVLEGTEVREILGTPDYVAPEILHYEPITLAADMWSLGVTTYVLLTG 287
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NI Q+DFP+ELFED+S +AKDF+AK+L+ P RM+AK+ L+H
Sbjct: 288 FSPFGGETDQETFKNIILGQVDFPEELFEDVSAQAKDFVAKLLVLEPSARMSAKQCLRHE 347
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LRKYLSKSRE L E+V+S +ENLR++A
Sbjct: 348 WLRG------------APT-----QASAHLRKYLSKSREVLLERVVS-----RENLRRAA 385
Query: 298 LLK--YNKTRRLCESQMSLVSKTREKSLGDMAISLGRSKEKLYGFKCLSKSQEVL 350
LL + + L +S+M L ++ S G +++ S++ G + S S+ L
Sbjct: 386 LLNGHHQQAMDLSQSEMCL-NRGLTGSRGSLSLPGSGSEDYESGVQDTSSSRTSL 439
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380022614|ref|XP_003695135.1| PREDICTED: uncharacterized protein LOC100870315 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 338 bits (867), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 178/325 (54%), Positives = 221/325 (68%), Gaps = 43/325 (13%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S +TG ++AAK+ N + HEIALLSLCS SPR+V+LHDV++T + V
Sbjct: 111 SRSTGILYAAKYSSRNRFNADCSAELRHEIALLSLCSQSPRVVRLHDVYETPKEIILVME 170
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P +QT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 171 YAP-GGDMQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHQRNIAHLDIKPQNLVMMGTFP 228
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+CDFEISRVIL+G E+RE+LGTPDYVAPEILHYEPITLAADMWS+GVT YVLLTG
Sbjct: 229 ECEVKLCDFEISRVILEGTEVREILGTPDYVAPEILHYEPITLAADMWSVGVTTYVLLTG 288
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELF DIS +AKDF+A++L+ +P RMTAK+ L+H
Sbjct: 289 FSPFGGETDQETFQNISLGEVDFPEELFGDISAQAKDFVARLLVLDPSARMTAKQCLRHD 348
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LR+YLSKSRE L E+V+S +ENLR++A
Sbjct: 349 WLR------------GAPT-----QASPHLRRYLSKSREVLLERVVS-----RENLRRAA 386
Query: 298 LLKYNKTRRLCESQMSLVSKTREKS 322
LL SQ +L S +E S
Sbjct: 387 LLSQ------ASSQANLSSDAQESS 405
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776543|ref|XP_001122511.2| PREDICTED: hypothetical protein LOC726790 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 172/302 (56%), Positives = 213/302 (70%), Gaps = 37/302 (12%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S +TG ++AAK+ N + HEIALLSLCS SPR+V+LHDV++T + V
Sbjct: 114 SRSTGIMYAAKYSSRNRFNADCSAELRHEIALLSLCSQSPRVVRLHDVYETPKEIILVME 173
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P +QT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 174 YAP-GGDMQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHQRNIAHLDIKPQNLVMMGTFP 231
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+CDFEISRVIL+G E+RE+LGTPDYVAPEILHYEPITLAADMWS+GVT YVLLTG
Sbjct: 232 ECEVKLCDFEISRVILEGTEVREILGTPDYVAPEILHYEPITLAADMWSVGVTTYVLLTG 291
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELF DIS +AKDF+A++L+ +P RMTAK+ L+H
Sbjct: 292 FSPFGGETDQETFQNISLGEVDFPEELFGDISAQAKDFVARLLVLDPSARMTAKQCLRHD 351
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LR+YLSKSRE L E+V+S +ENLR++A
Sbjct: 352 WLR------------GAPT-----QASPHLRRYLSKSREVLLERVVS-----RENLRRAA 389
Query: 298 LL 299
LL
Sbjct: 390 LL 391
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350426312|ref|XP_003494400.1| PREDICTED: hypothetical protein LOC100745800 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 178/331 (53%), Positives = 223/331 (67%), Gaps = 43/331 (12%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S ATG ++AAK+ N + HEIALLSLCS S R+++LHDV++T + V
Sbjct: 111 SRATGILYAAKYSSRNRFNADCSAELRHEIALLSLCSQSHRVIRLHDVYETPKEIILVME 170
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P LQT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 171 YAP-GGDLQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHQRNIAHLDIKPQNLVMMGSFP 228
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+CDFEISRVIL+G E+RE+LGTPDYVAPEILHYEPITLAADMWS+GVT YVLLTG
Sbjct: 229 ECEVKLCDFEISRVILEGTEVREILGTPDYVAPEILHYEPITLAADMWSVGVTTYVLLTG 288
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELF DIS +AKDF+AK+L+ +P RMTAK+ L+H
Sbjct: 289 FSPFGGETDQETFQNISLGEVDFPEELFGDISAQAKDFVAKLLVLDPSARMTAKQCLRHD 348
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LR+YLSKSRE L E+V+S +ENLR++A
Sbjct: 349 WLR------------GAPT-----QASPHLRRYLSKSREVLLERVVS-----RENLRRAA 386
Query: 298 LLKYNKTRRLCESQMSLVSKTREKSLGDMAI 328
LL SQ +L S ++ + D ++
Sbjct: 387 LLSQ------ASSQANLSSDVQDSNHSDQSL 411
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383857725|ref|XP_003704354.1| PREDICTED: uncharacterized protein LOC100879681 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 178/331 (53%), Positives = 224/331 (67%), Gaps = 43/331 (12%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S +TG ++AAKF + + HEIALLSLCS SPR+V+LHDV++T + V
Sbjct: 110 SRSTGILYAAKFSSRSRFNADCSAELRHEIALLSLCSQSPRVVRLHDVYETPKEIILVME 169
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P LQT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 170 YAP-GGDLQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHERNIAHLDIKPQNLVMMGSFP 227
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+CDFEISRV+L+G E+RE+LGTPDYVAPEILHYEPITLAADMWSLGVT YVLLTG
Sbjct: 228 ECEVKLCDFEISRVVLEGTEVREILGTPDYVAPEILHYEPITLAADMWSLGVTTYVLLTG 287
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELF D+S +AKDF+AK+L+ +P RMTAK+ L+H
Sbjct: 288 FSPFGGETDQETFQNISLGEVDFPEELFGDVSAQAKDFVAKLLVLDPSARMTAKQCLRHD 347
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL + P+ Q +LR+YLSKSRE L E+V+ +ENLR++A
Sbjct: 348 WLR------------AAPT-----QASPHLRRYLSKSREVLLERVVG-----RENLRRAA 385
Query: 298 LLKYNKTRRLCESQMSLVSKTREKSLGDMAI 328
LL SQ +L S +E + D ++
Sbjct: 386 LLSQ------ASSQANLSSDVQESNHRDQSL 410
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340723642|ref|XP_003400198.1| PREDICTED: hypothetical protein LOC100645687 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 337 bits (863), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 178/331 (53%), Positives = 223/331 (67%), Gaps = 43/331 (12%)
Query: 11 SIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S ATG ++AAK+ N + HEIALLSLCS S R+++LHDV++T + V
Sbjct: 111 SRATGILYAAKYSSRNRFNADCSAELRHEIALLSLCSQSHRVIRLHDVYETPKEIILVME 170
Query: 65 NTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
P LQT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMMG FP
Sbjct: 171 YAP-GGDLQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHQRNIAHLDIKPQNLVMMGSFP 228
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+CDFEISRVIL+G E+RE+LGTPDYVAPEILHYEPITLAADMWS+GVT YVLLTG
Sbjct: 229 ECEVKLCDFEISRVILEGTEVREILGTPDYVAPEILHYEPITLAADMWSVGVTTYVLLTG 288
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
FSPFGGETD ETF+NIS ++DFP+ELF DIS +AKDF+AK+L+ +P RMTAK+ L+H
Sbjct: 289 FSPFGGETDQETFQNISLGEVDFPEELFGDISAQAKDFVAKLLVLDPSARMTAKQCLRHD 348
Query: 238 WLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSA 297
WL P+ Q +LR+YLSKSRE L E+V+S +ENLR++A
Sbjct: 349 WLR------------GAPT-----QASPHLRRYLSKSREVLLERVVS-----RENLRRAA 386
Query: 298 LLKYNKTRRLCESQMSLVSKTREKSLGDMAI 328
LL SQ +L S ++ + D ++
Sbjct: 387 LLSQ------ASSQANLSSDVQDANHSDQSL 411
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307204460|gb|EFN83167.1| Serine/threonine-protein kinase 17B [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 296 bits (758), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 145/235 (61%), Positives = 174/235 (74%), Gaps = 30/235 (12%)
Query: 72 LQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
LQT+ID +LV P E D + LAYLH R IAHLDIKPQNLVMM FP CD+K+C
Sbjct: 9 LQTLIDGDLV-PLEGDVVHFVRQLVEGLAYLHERNIAHLDIKPQNLVMMSTFPECDVKLC 67
Query: 125 DFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE 184
DFEISRVIL+G EIRE+LGTPDYVAPEILHYEPITLAADMWSLGVT YVLLTGFSPFGGE
Sbjct: 68 DFEISRVILEGTEIREILGTPDYVAPEILHYEPITLAADMWSLGVTTYVLLTGFSPFGGE 127
Query: 185 TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
+D ETF+NIS ++DFP+E+FED+S +AKDF+AK+L+ +P RMTAK+ L+H WL
Sbjct: 128 SDQETFQNISLGEVDFPEEIFEDVSAQAKDFVAKLLLLDPSARMTAKQCLRHDWLR---- 183
Query: 245 IMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSALL 299
P Q +LR+YLSKSRE L E+V+S +ENLR++AL+
Sbjct: 184 --------GAP-----MQASPHLRRYLSKSREVLLERVVS-----RENLRRAALI 220
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 383 | ||||||
| FB|FBgn0052666 | 784 | Drak "Death-associated protein | 0.584 | 0.285 | 0.476 | 1.4e-49 | |
| UNIPROTKB|Q9GM70 | 397 | STK17A "Serine/threonine-prote | 0.590 | 0.569 | 0.422 | 2.6e-47 | |
| UNIPROTKB|F1MHX3 | 478 | DAPK2 "Uncharacterized protein | 0.707 | 0.566 | 0.365 | 6.8e-47 | |
| RGD|620457 | 371 | Stk17b "serine/threonine kinas | 0.595 | 0.614 | 0.419 | 8.8e-47 | |
| UNIPROTKB|Q91XS8 | 371 | Stk17b "Serine/threonine-prote | 0.595 | 0.614 | 0.419 | 8.8e-47 | |
| UNIPROTKB|Q5ZM34 | 372 | STK17B "Uncharacterized protei | 0.655 | 0.674 | 0.411 | 1.1e-46 | |
| UNIPROTKB|E2R573 | 372 | STK17B "Uncharacterized protei | 0.597 | 0.615 | 0.409 | 1.8e-46 | |
| UNIPROTKB|O94768 | 372 | STK17B "Serine/threonine-prote | 0.597 | 0.615 | 0.417 | 1.8e-46 | |
| UNIPROTKB|F1MSI1 | 372 | STK17B "Uncharacterized protei | 0.597 | 0.615 | 0.413 | 3.8e-46 | |
| UNIPROTKB|Q9UEE5 | 414 | STK17A "Serine/threonine-prote | 0.590 | 0.545 | 0.418 | 3.8e-46 |
| FB|FBgn0052666 Drak "Death-associated protein kinase related" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 1.4e-49, P = 1.4e-49
Identities = 114/239 (47%), Positives = 151/239 (63%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNT 66
TG FAAKFL +S+ I HEIA+L LC IV L+ V +T + A + T
Sbjct: 59 TGSHFAAKFLKRRRRAQSSDKEIKHEIAVLMLCEGEDNIVNLNAVHETRSDTALLLELAT 118
Query: 67 PLVVTLQTIID-DNLVVPFES-----DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
LQTI+D + + ++ + L +L +LH R IAHLD+KPQN+++ G+
Sbjct: 119 G--GELQTILDNEECLTEAQARHCMREVLKALKFLHDRSIAHLDLKPQNILLAGERIEDG 176
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
+K+CDF ISRV+ +GI +RE+ GTPDYVAPE+L YEP++L D+WS+GV YVLL+GFSP
Sbjct: 177 LKLCDFGISRVVCEGINVREMAGTPDYVAPEVLQYEPLSLLTDIWSVGVLTYVLLSGFSP 236
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
FGG+T ETF NIS+ L FPD LF +SP A DFI + L P +RM A L H WL
Sbjct: 237 FGGDTKQETFLNISQCALTFPDNLFGGVSPVAIDFIRRALRIKPNDRMNATGCLDHIWL 295
|
|
| UNIPROTKB|Q9GM70 STK17A "Serine/threonine-protein kinase 17A" [Oryctolagus cuniculus (taxid:9986)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 101/239 (42%), Positives = 149/239 (62%)
Query: 14 TGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNT 66
+G+ FAAKF+ + I HEIA+L L +P ++ LH+V++T E + +
Sbjct: 66 SGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYETSSEMILVLEYAA 125
Query: 67 PLVVTLQTIID-DNL-----VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
++ Q + D D V L + +LH + HLD+KPQN+++ + P D
Sbjct: 126 GGEISDQCVADRDEAFNEKDVQRLMRQILEGVHFLHTHDVVHLDLKPQNILLTSESPLGD 185
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
IK+ DF +SR++ + E+RE++GTP+YVAPEIL Y+PI++A DMWS+GV YV+LTG SP
Sbjct: 186 IKIVDFGLSRIVKNSEELREIMGTPEYVAPEILSYDPISMATDMWSIGVLTYVMLTGISP 245
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F G+ ETF NIS+ L + +E F+ +S A DFI K+L+K P +R TA+E LKHPWL
Sbjct: 246 FLGDNKQETFLNISQMNLSYSEEEFDTVSESAVDFIKKLLVKKPEDRATAEECLKHPWL 304
|
|
| UNIPROTKB|F1MHX3 DAPK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 462 (167.7 bits), Expect = 6.8e-47, Sum P(2) = 6.8e-47
Identities = 107/293 (36%), Positives = 163/293 (55%)
Query: 2 FALSEEMADSIATGEVFAAKFLES--NPV--------RIHHEIALLSLCSPSPRIVKLHD 51
FA+ ++ + +TG +AAKF++ +P I E+++L P ++ LHD
Sbjct: 24 FAIVKKCREK-STGLEYAAKFIKKRQSPASRRGVCREEIEREVSILRQVL-HPNVITLHD 81
Query: 52 VFQTGEGAYY----VSWNTPLVVTLQT-IIDDNLVVPFESDELSSLAYLHHRKIAHLDIK 106
VF+ VS Q + + F L + YLH +KIAH D+K
Sbjct: 82 VFENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILEGVNYLHAKKIAHFDLK 141
Query: 107 PQNLVMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMW 165
P+N++++ + P IK+ DF ++ I DG+E + + GTP++VAPEI++YEP+ L ADMW
Sbjct: 142 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 166 SLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225
S+GV Y+LL+G SPF G+T ET NI+ DF +E F S AKDFI K+L+K
Sbjct: 202 SIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETR 261
Query: 226 ERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREAL 278
+R+T +EAL+HPW+M+K +I + P NQ K LR+Y K ++
Sbjct: 262 KRLTIQEALRHPWIMSKGEIRAPEQHKAEP----NQLKTKRLREYTLKCHSSM 310
|
|
| RGD|620457 Stk17b "serine/threonine kinase 17b" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 8.8e-47, P = 8.8e-47
Identities = 102/243 (41%), Positives = 149/243 (61%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS- 63
S +TG+ +AAKFL+ I HEIA+L L P ++ LH+V++T V
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVYETATEIILVLE 111
Query: 64 -------WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+N L L ++ +N V+ L + YLH I HLD+KPQN+++ +
Sbjct: 112 YAAGGEIFNLCLP-ELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLKPQNILLSSIY 170
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
P DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+LLT
Sbjct: 171 PLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 230
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
SPF GE + ET+ NIS+ +D+ +E+F +S A DFI +L+KNP +R TA+ L H
Sbjct: 231 HTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNPEKRPTAESCLSH 290
Query: 237 PWL 239
WL
Sbjct: 291 SWL 293
|
|
| UNIPROTKB|Q91XS8 Stk17b "Serine/threonine-protein kinase 17B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 8.8e-47, P = 8.8e-47
Identities = 102/243 (41%), Positives = 149/243 (61%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS- 63
S +TG+ +AAKFL+ I HEIA+L L P ++ LH+V++T V
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELARSCPHVINLHEVYETATEIILVLE 111
Query: 64 -------WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+N L L ++ +N V+ L + YLH I HLD+KPQN+++ +
Sbjct: 112 YAAGGEIFNLCLP-ELAEMVSENDVIRLIKQILEGVHYLHQNNIVHLDLKPQNILLSSIY 170
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
P DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+LLT
Sbjct: 171 PLGDIKIVDFGMSRKIGNASELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 230
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
SPF GE + ET+ NIS+ +D+ +E+F +S A DFI +L+KNP +R TA+ L H
Sbjct: 231 HTSPFVGEDNQETYLNISQVNVDYSEEMFSSVSQLATDFIQSLLVKNPEKRPTAESCLSH 290
Query: 237 PWL 239
WL
Sbjct: 291 SWL 293
|
|
| UNIPROTKB|Q5ZM34 STK17B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 1.1e-46, P = 1.1e-46
Identities = 110/267 (41%), Positives = 156/267 (58%)
Query: 13 ATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS--- 63
+TG+ +AAKFL+ I HEIA+L L +PRIV LH+V++T V
Sbjct: 54 STGQEYAAKFLKKRRRGQDCKAEILHEIAVLELTKSNPRIVNLHEVYETANEIILVLEYA 113
Query: 64 -----WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
+N V L I ++ ++ L L LH + I HLD+KPQN+++ P
Sbjct: 114 AGGEIFNL-CVPDLDDRISESDIIRLIRQILEGLCCLHEKNIVHLDLKPQNILLSSINPL 172
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
D+K+ DF +SR I + E+R+++GT +Y+APEIL+Y+PIT A DMW++GV +Y+LLT
Sbjct: 173 GDVKIVDFGMSRKIENSTELRQIMGTTEYLAPEILNYDPITTATDMWNIGVISYMLLTQE 232
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
SPF G + ETF NIS+ +D+ +E F +S AKDFI K+LIKNP ER TA+ L H W
Sbjct: 233 SPFVGADNQETFLNISQVNVDYSEETFSSVSQPAKDFIQKLLIKNPEERPTAEACLSHFW 292
Query: 239 LMNKKQIMT-RVGCSSCPSIIQNQQNK 264
L I+ S CPS++ K
Sbjct: 293 LRQGDFILLCSPEESCCPSLMPGHATK 319
|
|
| UNIPROTKB|E2R573 STK17B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.8e-46, P = 1.8e-46
Identities = 99/242 (40%), Positives = 149/242 (61%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVS 63
S +TG+ +AAKFL+ I HEIA+L L P ++ LH+V++ T E +
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAILELAKSCPHVINLHEVYENTSEIILILE 111
Query: 64 WNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
+ + L ++ +N ++ L + YLH I HLD+KPQN+++ +P
Sbjct: 112 YAAGGEIFNLCLPELAEMVSENDIIRLIKQILEGVCYLHQNNIVHLDLKPQNILLSSIYP 171
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+LLT
Sbjct: 172 LGDIKIVDFGMSRKIGNACELREIMGTPEYLAPEILNYDPITTATDMWNVGIIAYMLLTH 231
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
SPF GE + ET+ NIS+ +D+ +E F +S A DFI ++L+KNP +R TA+ L H
Sbjct: 232 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQRLLVKNPEKRPTAEICLSHS 291
Query: 238 WL 239
WL
Sbjct: 292 WL 293
|
|
| UNIPROTKB|O94768 STK17B "Serine/threonine-protein kinase 17B" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.8e-46, P = 1.8e-46
Identities = 101/242 (41%), Positives = 148/242 (61%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVS 63
S +TG+ +AAKFL+ I HEIA+L L PR++ LH+V++ T E +
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 111
Query: 64 WNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
+ + L ++ +N V+ L + YLH I HLD+KPQN+++ +P
Sbjct: 112 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 171
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
DIK+ DF +SR I E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY+LLT
Sbjct: 172 LGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 231
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
SPF GE + ET+ NIS+ +D+ +E F +S A DFI +L+KNP +R TA+ L H
Sbjct: 232 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 291
Query: 238 WL 239
WL
Sbjct: 292 WL 293
|
|
| UNIPROTKB|F1MSI1 STK17B "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 100/242 (41%), Positives = 149/242 (61%)
Query: 11 SIATGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVS 63
S +TG+ +AAKFL+ I HEIA+L L P ++ LH+V++ T E +
Sbjct: 52 SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELTKSCPHVINLHEVYENTSEIILILE 111
Query: 64 WNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
+ + L ++ +N ++ L + YLH I HLD+KPQN+++ +P
Sbjct: 112 YAAGGEIFNLCLPELAEMVSENDIIRLIKQILEGVHYLHQNNIVHLDLKPQNILLSSIYP 171
Query: 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG 177
DIK+ DF +SR I + E+RE++GTP+Y+APEIL+Y+PIT A DMW++GV AY+LLT
Sbjct: 172 LGDIKIVDFGMSRKIGNACELREIMGTPEYLAPEILNYDPITTATDMWNVGVIAYMLLTH 231
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
SPF GE + ET+ NIS+ +D+ +E F +S A DFI ++L+KNP +R TA+ L H
Sbjct: 232 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQRLLVKNPEKRPTAEICLSHS 291
Query: 238 WL 239
WL
Sbjct: 292 WL 293
|
|
| UNIPROTKB|Q9UEE5 STK17A "Serine/threonine-protein kinase 17A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 100/239 (41%), Positives = 147/239 (61%)
Query: 14 TGEVFAAKFLESNP------VRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNT 66
+G+ FAAKF+ + I HEIA+L L +P ++ LH+V++T E + +
Sbjct: 83 SGKEFAAKFMRKRRKGQDCRMEIIHEIAVLELAQDNPWVINLHEVYETASEMILVLEYAA 142
Query: 67 PLVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
+ Q + D + V L + +LH R + HLD+KPQN+++ + P D
Sbjct: 143 GGEIFDQCVADREEAFKEKDVQRLMRQILEGVHFLHTRDVVHLDLKPQNILLTSESPLGD 202
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
IK+ DF +SR++ + E+RE++GTP+YVAPEIL Y+PI++A DMWS+GV YV+LTG SP
Sbjct: 203 IKIVDFGLSRILKNSEELREIMGTPEYVAPEILSYDPISMATDMWSIGVLTYVMLTGISP 262
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F G ETF NIS+ L + +E F+ +S A DFI +L+K P +R TA+E LKHPWL
Sbjct: 263 FLGNDKQETFLNISQMNLSYSEEEFDVLSESAVDFIRTLLVKKPEDRATAEECLKHPWL 321
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SPK4 | PPCK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3132 | 0.6109 | 0.8239 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 383 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-49 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-30 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-23 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-23 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-22 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-21 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-06 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-06 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.003 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.003 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.003 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.003 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.004 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.004 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 5e-60
Identities = 89/246 (36%), Positives = 132/246 (53%), Gaps = 30/246 (12%)
Query: 12 IATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YV 62
TG++ A K + + + RI EI +L P IV+L+DVF+ + Y Y
Sbjct: 21 KKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLYDVFEDEDKLYLVMEYC 79
Query: 63 SWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMG 114
L ++ DE LS+L YLH + I H D+KP+N+++
Sbjct: 80 EGGD-----LFDLLKKR--GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDE 132
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
D +K+ DF ++R + G ++ +GTP+Y+APE+L + A D+WSLGV Y L
Sbjct: 133 D---GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYEL 189
Query: 175 LTGFSPF-GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
LTG PF G + E F+ I K + FP DISPEAKD I K+L+K+P +R+TA+EA
Sbjct: 190 LTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
Query: 234 LKHPWL 239
L+HP+
Sbjct: 249 LQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-49
Identities = 82/249 (32%), Positives = 112/249 (44%), Gaps = 30/249 (12%)
Query: 12 IATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG++ A K L EI +L S P IV+L D F+ + Y V
Sbjct: 21 KGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNIVRLIDAFEDKDHLYLV--- 76
Query: 66 TPLVVT--LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGD 115
L + P DE L L YLH I H D+KP+N+++
Sbjct: 77 MEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLD-- 132
Query: 116 FPNCDIKVCDFEISRVILDGIEIR-ELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYV 173
N +K+ DF +++ +L +GTP Y+APE+L D+WSLGV Y
Sbjct: 133 -ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYE 191
Query: 174 LLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
LLTG PF GE + R I L+F + + S EAKD I K L K+P +R TA
Sbjct: 192 LLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTA 251
Query: 231 KEALKHPWL 239
+E L+HPW
Sbjct: 252 EEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 78/250 (31%), Positives = 127/250 (50%), Gaps = 23/250 (9%)
Query: 8 MADSIATGEVFAAKFLES------NPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A +TG+ FA K L+ N V + E A++ + SP + KL+ FQ+ + Y
Sbjct: 14 LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY 73
Query: 61 YVSWNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
V L+ TL + ++ + ++ + + LH R I H DIKP+NL++
Sbjct: 74 LVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ 132
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+K+ DF +SR G+E ++ +GTPDY+APE + +D WSLG +
Sbjct: 133 ---TGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK--- 231
L G+ PF ET F NI ++++P+E+ E SPEA D I ++L +P +R+ A
Sbjct: 187 LFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246
Query: 232 EALKHPWLMN 241
E HP+ +
Sbjct: 247 EIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 79/249 (31%), Positives = 117/249 (46%), Gaps = 36/249 (14%)
Query: 12 IATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
TG+++A K L+ + E+ +LS P IVKLH FQT E Y V
Sbjct: 15 KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLV-- 71
Query: 65 NTPLVVT--LQTIIDDNLVVP-----FESDELSS-LAYLHHRKIAHLDIKPQNLVMMGDF 116
L + + F + E+ L YLH I + D+KP+N+++
Sbjct: 72 -LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---- 126
Query: 117 PNCD---IKVCDFEISRVILDGIE-IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
IK+ DF +++ + GTP+Y+APE+L + A D WSLGV Y
Sbjct: 127 --DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+LTG PF E E + I K L FP E +SPEA+D I+ +L K+P +R+ +
Sbjct: 185 EMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGSGG 240
Query: 233 A--LK-HPW 238
A +K HP+
Sbjct: 241 AEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 44/268 (16%)
Query: 8 MADSIATGEVFAAKFLESNPVR-------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A T + +A K L+ + + E +L+ + P I+KL+ FQ E Y
Sbjct: 19 LAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78
Query: 61 YV-SW--NTPL--VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V + N L + +D+ + ++ L +L YLH + I H D+KP+N+++ D
Sbjct: 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD 138
Query: 116 FPNCDIKVCDFEISRVI----------LDGIEIRELL-----------GTPDYVAPEILH 154
IK+ DF ++V+ D I + GT +YV+PE+L+
Sbjct: 139 M---HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195
Query: 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214
+P ++D+W+LG Y +LTG PF G + TF+ I K + FP + P+AKD
Sbjct: 196 EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP----PNFPPDAKD 251
Query: 215 FIAKILIKNPMERMTAK---EALK-HPW 238
I K+L+ +P +R+ + LK HP+
Sbjct: 252 LIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 73/249 (29%), Positives = 117/249 (46%), Gaps = 35/249 (14%)
Query: 14 TGEVFAAK---FLESNPVR---IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY------Y 61
TGE+ A K + + EI +LS P IV+ + + E Y
Sbjct: 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEY 82
Query: 62 VSWNTPLVVTLQTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
VS + L +++ + ++ + L LAYLH I H DIK N+++
Sbjct: 83 VSGGS-----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV--- 134
Query: 116 FPNCDIKVCDFEISRVILDGI---EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+ +K+ DF ++ + D + GTP ++APE++ E AAD+WSLG T
Sbjct: 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVI 194
Query: 173 VLLTGFSPFG--GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
+ TG P+ G + ++ I + P E+ E +S EAKDF+ K L ++P +R TA
Sbjct: 195 EMATGKPPWSELGNPMAALYK-IGSSGE--PPEIPEHLSEEAKDFLRKCLRRDPKKRPTA 251
Query: 231 KEALKHPWL 239
E L+HP+L
Sbjct: 252 DELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 7e-35
Identities = 81/256 (31%), Positives = 136/256 (53%), Gaps = 30/256 (11%)
Query: 8 MADSIATGEVFAAK------FLESNPV-RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A +TG+++A K + N V ++ E +LS SP +VKL+ FQ + Y
Sbjct: 11 LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLY 69
Query: 61 YVSWNTP---LVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
V P L L+ + +D+++ + ++ + +L YLH I H D+KP N+++
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS- 128
Query: 116 FPNCDIKVCDFEISRVILDGIEI---------RELLGTPDYVAPEILHYEPITLAADMWS 166
N +K+ DF +S+V L +I + ++GTPDY+APE++ + + D WS
Sbjct: 129 --NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 167 LGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
LG Y L G PF GET E F+NI ++++P+ ++S EA D I+K+L+ +P +
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLISKLLVPDPEK 244
Query: 227 RMTAK---EALKHPWL 239
R+ AK E HP+
Sbjct: 245 RLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 74/246 (30%), Positives = 116/246 (47%), Gaps = 37/246 (15%)
Query: 14 TGEVFAAKFLESNPVR----IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLV 69
TG+ A K ++ I +EI +L C P IVK + G+Y + +
Sbjct: 24 TGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYY-------GSYLKK-DELWI 74
Query: 70 V-------TLQTIIDDNLVVPFES-------DELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
V +L+ ++ ES + L L YLH I H DIK N +++
Sbjct: 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN-ILLTS 133
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
+ ++K+ DF +S + D ++GTP ++APE+++ +P AD+WSLG+TA L
Sbjct: 134 --DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191
Query: 176 TGFSPFGGETDSETFRNISK-AQLDFPDELFED--ISPEAKDFIAKILIKNPMERMTAKE 232
G P+ + + + K A P L S E KDF+ K L KNP +R TA++
Sbjct: 192 EGKPPYS---ELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
Query: 233 ALKHPW 238
LKHP+
Sbjct: 248 LLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 80/248 (32%), Positives = 117/248 (47%), Gaps = 23/248 (9%)
Query: 3 ALSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
L+ E D +A ++ K E I EI LL P IVK +T + Y
Sbjct: 19 GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYII 77
Query: 61 --YVSWNTPLVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVM 112
Y + L+ II ++LV + L LAYLH + + H DIK N++
Sbjct: 78 LEYAENGS-----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132
Query: 113 MGDFPNCDIKVCDFEIS-RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
D +K+ DF ++ ++ + ++GTP ++APE++ + A+D+WSLG T
Sbjct: 133 TKD---GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
LLTG P+ I Q D P L E ISPE KDF+ + K+P R TAK
Sbjct: 190 IELLTGNPPYYDLNPMAALFRI--VQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPTAK 246
Query: 232 EALKHPWL 239
+ LKHPW+
Sbjct: 247 QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 69/241 (28%), Positives = 107/241 (44%), Gaps = 59/241 (24%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPL 68
TG+ A K + S + EI +L + P IVKL+ VF+ Y V
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLV---MEY 72
Query: 69 VV--TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
+L+ ++ +N DE L L YLH I H D+KP+N+++ D N
Sbjct: 73 CEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL--DSDN 129
Query: 119 CDIKVCDFEISRVILDGIEI-RELLGTPDYVAPEILHYEP-ITLAADMWSLGVTAYVLLT 176
+K+ DF +S+++ + + ++GTP Y+APE+L + + +D+WSLGV Y L
Sbjct: 130 GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-- 187
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
PE KD I K+L K+P +R +AKE L+H
Sbjct: 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
Query: 237 P 237
Sbjct: 215 L 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 76/254 (29%), Positives = 118/254 (46%), Gaps = 39/254 (15%)
Query: 14 TGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
FA K ++ + I E +L C+ P IVKL+ F+ Y+
Sbjct: 17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKD---KKYIYMLM 72
Query: 67 PLVV--TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+ L TI+ D F+ + + YLH+R I + D+KP+NL++
Sbjct: 73 EYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS-- 128
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
N +K+ DF ++ + G + GTP+YVAPEI+ + + D WSLG+ Y LLT
Sbjct: 129 -NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT 187
Query: 177 GFSPFGGETDS--ETFRNISKA--QLDFPDELFEDISPEAKDFIAKILIKNPMERM---- 228
G PFG + + E + +I K +L+FP+ I AKD I ++L +NP ER+
Sbjct: 188 GRPPFGEDDEDPMEIYNDILKGNGKLEFPNY----IDKAAKDLIKQLLRRNPEERLGNLK 243
Query: 229 -TAKEALKHPWLMN 241
K+ KH W
Sbjct: 244 GGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 78/257 (30%), Positives = 130/257 (50%), Gaps = 32/257 (12%)
Query: 14 TGEVFAAKFLESNPVRIHHEIAL-------LSLCSPSPRIVKLHDVFQTGEGAYYVSW-- 64
T E++A K L+ + + ++ L+L P + +LH FQT + ++V
Sbjct: 19 TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78
Query: 65 -NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
L+ +Q D+ + ++ + L +LH R I + D+K N+++ + I
Sbjct: 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHI 135
Query: 122 KVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
K+ DF + + IL G+ GTPDY+APEIL Y+P A D W+LGV Y +L G SP
Sbjct: 136 KIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM----TAKEALK- 235
F G+ + E F++I + ++ +P L S EAK + L KNP +R+ T ++ +K
Sbjct: 196 FEGDDEDELFQSILEDEVRYPRWL----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251
Query: 236 HP------W-LMNKKQI 245
HP W + +K+I
Sbjct: 252 HPFFREIDWDKLERKEI 268
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 30 IHHEIALLS-LCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTI--IDDNLVV 82
+ EIALLS L P+ IV+ + + Y V + L L+ + ++
Sbjct: 49 LEQEIALLSKLQHPN--IVQYLGTEREEDNLYIFLELVPGGS-LAKLLKKYGSFPEPVIR 105
Query: 83 PFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL 142
+ L L YLH R H DIK N+++ D N +K+ DF +++ +++ +
Sbjct: 106 LYTRQILLGLEYLHDRNTVHRDIKGANILV--D-TNGVVKLADFGMAKQVVEFSFAKSFK 162
Query: 143 GTPDYVAPE-ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP 201
G+P ++APE I LAAD+WSLG T + TG P+ I +++ + P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP 221
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ + +S EAKDFI K L ++P R TA E L+HP++
Sbjct: 222 -PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 83/286 (29%), Positives = 124/286 (43%), Gaps = 76/286 (26%)
Query: 9 ADSIATGEVFAAKFLE---------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA 59
A TGE+ A K + S +R EI+LL P IVKL DV T
Sbjct: 18 ARDKKTGEIVALKKIRLDNEEEGIPSTALR---EISLLKELK-HPNIVKLLDVIHTERKL 73
Query: 60 Y----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKP 107
Y Y + L+ +D P + L LAY H +I H D+KP
Sbjct: 74 YLVFEYCDMD------LKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP 126
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL----HYEPI 158
QN+++ D +K+ DF ++R GI +R T + Y APEIL HY
Sbjct: 127 QNILINRD---GVLKLADFGLARAF--GIPLRTY--THEVVTLWYRAPEILLGSKHYST- 178
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGET---------------DSETFRNISK---AQLDF 200
A D+WS+G ++TG F G++ E++ ++K + F
Sbjct: 179 --AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 201 P-------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P +++ + PE D ++K+L NP +R++AKEALKHP+
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 1e-27
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 29/300 (9%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-------SWNTPLVVTLQTI- 75
R EI +L+ + P IVKL+D FQ Y V S L +
Sbjct: 38 SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP 97
Query: 76 IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI--- 132
+ ++ + + LS+L YLH + I H DIKP+N+ + D +K+ DF +++++
Sbjct: 98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENI--LLDRDGRVVKLIDFGLAKLLPDP 155
Query: 133 ----LDGIEIRELLGTPDYVAPEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGET 185
+GTP Y+APE+L + ++D+WSLG+T Y LLTG PF GE
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 186 DSETFRNISK---------AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
+S K E IS A D + K+L K+P R+++ L H
Sbjct: 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 237 PWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKS 296
L + K + + P + S S KL N K
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 45/254 (17%)
Query: 11 SIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-------- 56
+ G+++ K + E +E+ +L + P I+K ++ F+
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVME 79
Query: 57 --EGAYYVSWNTPLVVTLQTIIDD--NLVVPFESDE--------LSSLAYLHHRKIAHLD 104
+G L I PF ++ +L YLH RKI H D
Sbjct: 80 YADGG-----------DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRD 128
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDYVAPEILHYEPITLAAD 163
IKPQN+ + + +K+ DF IS+V+ +++ + ++GTP Y++PE+ +P +D
Sbjct: 129 IKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSD 185
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223
+WSLG Y L T PF GE E I K Q + S E ++ ++ +L K+
Sbjct: 186 IWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPSQYSSELRNLVSSLLQKD 242
Query: 224 PMERMTAKEALKHP 237
P ER + + L+ P
Sbjct: 243 PEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 75/251 (29%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 12 IATGEVFAAK---FLESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
TG+++A K R + E+ L C SP +VK + GA+Y
Sbjct: 23 KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCY-------GAFYKEGEI 74
Query: 67 PLVV------TLQTIIDDNLVVP------FESDELSSLAYLHH-RKIAHLDIKPQNLVMM 113
+V+ +L ++ +P L L YLH R I H DIKP NL++
Sbjct: 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI- 133
Query: 114 GDFPNCD--IKVCDFEISRVILDGIEIR-ELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
N +K+ DF IS+V+ + ++ +GT Y++PE + E + AAD+WSLG+T
Sbjct: 134 ----NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED--ISPEAKDFIAKILIKNPMERM 228
G PF +F + +A D P SPE +DFI+ L K+P +R
Sbjct: 190 LLECALGKFPFLP-PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248
Query: 229 TAKEALKHPWL 239
+A E L+HP++
Sbjct: 249 SAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 79/290 (27%), Positives = 116/290 (40%), Gaps = 80/290 (27%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHH---------EIALLSLCSPSPRIVKLHDVFQTGEG 58
A TGE A K + +R EI L C P +VKL DVF G G
Sbjct: 18 KAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSG 73
Query: 59 AYYVSWNTPLVVTLQTIIDD------NLVVPFESDE--------LSSLAYLHHRKIAHLD 104
V+ ++ + D + P + L +AY+H I H D
Sbjct: 74 ---------FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYVAPEIL----HYEPI 158
+KP NL++ D +K+ DF ++R+ + + T Y APE+L Y+P
Sbjct: 125 LKPANLLISAD---GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP- 180
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGETDSE-----------------------------T 189
D+W++G LL G F GE D E T
Sbjct: 181 --GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238
Query: 190 FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F SK +E+F D SPEA D + +L+ +P +R++A EAL+HP+
Sbjct: 239 FPE-SKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+ +G+ +A K L + + +E +L P +V L+ FQ Y
Sbjct: 19 LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLY 77
Query: 61 YVSWNTPLVV--TLQTIID-----DNLVVPFESDE-LSSLAYLHHRKIAHLDIKPQNLV- 111
V V L + + V F + + + +L YLH I + D+KP+NL+
Sbjct: 78 LV---MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134
Query: 112 -MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
G IK+ DF ++ + L GTP+Y+APEI+ + A D W+LG+
Sbjct: 135 DSDGY-----IKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILSKGYGKAVDWWALGIL 187
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
Y +L G+ PF + + + I + ++ FP SP+AKD I +L + +R+
Sbjct: 188 IYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----FSPDAKDLIRNLLQVDLTKRLGN 243
Query: 229 ---TAKEALKHPW 238
+ HPW
Sbjct: 244 LKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 69/234 (29%), Positives = 119/234 (50%), Gaps = 20/234 (8%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T E++A K L+ + V ++ +L+L P + +LH FQT + Y
Sbjct: 18 LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q + + V + ++ L +LH R I + D+K N+++ D
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--D 135
Query: 116 FPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
IK+ DF + + ++DG+ R GTPDY+APEI+ Y+P + D W+ GV Y +
Sbjct: 136 SEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
L G PF GE + E F++I + + +P L S EA ++ K+P +R+
Sbjct: 195 LAGQPPFDGEDEDELFQSIMEHNVSYPKSL----SKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 82/251 (32%), Positives = 125/251 (49%), Gaps = 29/251 (11%)
Query: 11 SIATGEVFAAK---FLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
++ TGE+ A K +++P I E+ +L L P +VK + V E Y
Sbjct: 21 NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFME 79
Query: 61 YVSWNT-PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
Y S T ++ I+D++++ + L LAYLH I H DIKP N+ + D N
Sbjct: 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL--DH-NG 136
Query: 120 DIKVCDFEISRVILD-----GIEIRELLGTPDYVAPEILHYEPIT---LAADMWSLGVTA 171
IK+ DF + + + G E++ L GTP Y+APE++ AAD+WSLG
Sbjct: 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196
Query: 172 YVLLTGFSPFGGETDSE---TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
+ TG P+ E D+E F + + PD L +SPE KDF+ + L +P +R
Sbjct: 197 LEMATGKRPWS-ELDNEFQIMFHVGAGHKPPIPDSL--QLSPEGKDFLDRCLESDPKKRP 253
Query: 229 TAKEALKHPWL 239
TA E L+HP++
Sbjct: 254 TASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 60/188 (31%), Positives = 87/188 (46%), Gaps = 45/188 (23%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L YLH + H D+KP N+++ NCD+K+CDF ++R + + + L T +YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFL-T-EYV 167
Query: 149 ------APEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET------------- 185
APE+L Y T A D+WS+G LLT F G
Sbjct: 168 VTRWYRAPELLLSSSRY---TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 186 --DSETFRNISKAQ-----LDFP-------DELFEDISPEAKDFIAKILIKNPMERMTAK 231
E + I+ + P +LF SPEA D + K+L+ +P +R+TA
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284
Query: 232 EALKHPWL 239
EAL HP+L
Sbjct: 285 EALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 70/235 (29%), Positives = 116/235 (49%), Gaps = 22/235 (9%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHH--------EIALLSLCSPSPRIVKLHDVFQTGEGA 59
+A+ T E++A K L+ + V I E +L+L P + +LH FQT +
Sbjct: 18 LAERKGTDELYAIKILKKD-VIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 76
Query: 60 YYVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
Y+V L+ +Q + + V + ++ L +LH + I + D+K N+++
Sbjct: 77 YFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136
Query: 115 DFPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
+ IK+ DF + + I G R GTPDY+APEI+ Y+P + D W+ GV Y
Sbjct: 137 E---GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
+L G PF GE + E F++I + + +P L S EA +L K+P +R+
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHNVSYPKSL----SKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 53/157 (33%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L L YLH H DIK N+++ D+K+ DF +S + + R +GTP +
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTMSKRNTFVGTPFW 164
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
+APE++ AD+WSLG+TA L G P I K + P L +
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---NNPPSLEGN 221
Query: 208 -ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243
S KDF++ L K+P ER +AKE LKH ++ K
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 43 SPRIVKLHDVFQTGEGAYYVSWNTP---LVVTL--QTIIDDNLVVPFESDELSSLAYLHH 97
SP IVKL+ FQ E Y V P L+ L + + + + ++ + +L +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 98 RKIAHLDIKPQNL-------VMMGDFPNC--------DIKVCDFEISRVILDGIEIRE-- 140
H DIKP N+ + + DF C + + + D + +R
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 141 ----------LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF 190
+GTPDY+APE+L P L D WSLGV Y +L GF PF +T ET+
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 191 RNIS--KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT-AKEALKHPW 238
I K L FP + +SPEA D I + L+ +P +R+ +E HP+
Sbjct: 240 NKIINWKESLRFPPD--PPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 4e-23
Identities = 65/234 (27%), Positives = 120/234 (51%), Gaps = 20/234 (8%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T E++A K L+ + V ++ +L+L P + +LH FQT + Y
Sbjct: 18 LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q + + V + ++ L +LH + I + D+K N+++ +
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE 137
Query: 116 FPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
IK+ DF + + + DG+ + GTPDY+APEI+ Y+P + D W+ GV Y +
Sbjct: 138 ---GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
L G +PF GE + E F++I + + +P + +S EA ++ K+P +R+
Sbjct: 195 LAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-23
Identities = 72/238 (30%), Positives = 114/238 (47%), Gaps = 20/238 (8%)
Query: 14 TGEVFAAKFLESNP--VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-------SW 64
TG+V A K + I EI++L C SP IVK + + + V S
Sbjct: 27 TGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85
Query: 65 NTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
+ + +T +T+ ++ + L L YLH K H DIK N+++ + K+
Sbjct: 86 SDIMKITNKTLTEEEIAAIL-YQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLA 141
Query: 125 DFEISRVILDGI-EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
DF +S + D + + ++GTP ++APE++ AD+WSLG+TA + G P+
Sbjct: 142 DFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS- 200
Query: 184 ETDSETFRNISKAQLDFPDELF--EDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
D R I P L E SPE DF+ K L+K+P ER +A + L+HP++
Sbjct: 201 --DIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 48/270 (17%)
Query: 14 TGEVFAAKFLESNPV----RIHH---EIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
TG++FA K L+ + ++ E +L+ P + L+ FQT V
Sbjct: 25 TGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT-LDHPFLPTLYASFQTETYLCLVMDYC 83
Query: 67 P---LVVTLQT----IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNL-------VM 112
P L LQ + + + + ++ L +L YLH I + D+KP+N+ +M
Sbjct: 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIM 143
Query: 113 MGDF-----PNCDIKVCDFEISRVILDGIEIRELL---------------GTPDYVAPEI 152
+ DF + + + + GT +Y+APE+
Sbjct: 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212
+ + A D W+LG+ Y +L G +PF G ETF NI K ++ FP +S A
Sbjct: 204 ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS--PPVSSSA 261
Query: 213 KDFIAKILIKNPMERM----TAKEALKHPW 238
+D I K+L+K+P +R+ A E +HP+
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 79/252 (31%), Positives = 116/252 (46%), Gaps = 43/252 (17%)
Query: 14 TGEVFAAKF------LESNPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
T ++FA K+ +E VR + +E +L + P +V L FQ E Y
Sbjct: 24 TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY------ 76
Query: 67 PLVVTLQTIID-----------DNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQNLVMMG 114
LVV L D V F E+ +L YLH + I H DIKP N+++
Sbjct: 77 -LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL-- 133
Query: 115 DFPNCD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
D + + DF I+ + GTP Y+APE+L + ++A D WSLGVT
Sbjct: 134 -----DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVT 188
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF-EDISPEAKDFIAKILIKNPMERM- 228
AY L G P+ G S T R+ +A+ + D L+ S EA D I K+L ++P +R+
Sbjct: 189 AYECLRGKRPYRGH--SRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLG 246
Query: 229 -TAKEALKHPWL 239
K+ HP+
Sbjct: 247 DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 51/275 (18%)
Query: 8 MADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A TGE+ A K + E P EI LL P I+KL DVF+ Y
Sbjct: 17 KARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLL-KELNHPNIIKLLDVFRHKGDLYL 75
Query: 62 V-----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
V + L+ Q + ++L+ + L LA+ H I H D+KP+NL++
Sbjct: 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT-- 133
Query: 117 PNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTA 171
+K+ DF ++R + T Y APE+L Y D+WS+G
Sbjct: 134 -EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST---PVDIWSVGCIF 189
Query: 172 YVLLTGFSPFGGETD----------------------SETFRNI-----SKAQLDFPDEL 204
LL+ F G+++ + RN KA + P +L
Sbjct: 190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP-KL 248
Query: 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F + SP+A D ++++L +P +R+TA++AL HP+
Sbjct: 249 FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 43 SPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQT--IIDDNLVVPFESDELSSLAYLH 96
P IV L FQTG Y Y+S L + L+ I ++ + S+ +L +LH
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLS-GGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 97 HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR-VILDGIEIRELLGTPDYVAPEILHY 155
+ I + D+KP+N+++ +K+ DF + + I +G GT +Y+APEIL
Sbjct: 118 QQGIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215
A D WSLG Y +LTG PF E +T I K +L+ P L +PEA+D
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYL----TPEARDL 230
Query: 216 IAKILIKNPMERM-----TAKEALKHPW 238
+ K+L +NP R+ A E HP+
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 59/173 (34%), Positives = 88/173 (50%), Gaps = 19/173 (10%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L+YLH RKI H DIKP N+++ +K+CDF +S +++ + GT Y+
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVNSLA-GTFTGTSFYM 170
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--------ETFRNISKAQLDF 200
APE + +P ++ +D+WSLG+T + PF E + N+ +L
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL-- 228
Query: 201 PDELFEDI--SPEAKDFIAKILIKNPMERMTAKEALKHPWL---MNKKQIMTR 248
DE I S E KDFI + L K+P R T + L+HPW+ M KK M +
Sbjct: 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 12/158 (7%)
Query: 89 LSSLAYLHH-RKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145
L L YLH KI H D+KP N+++ G IK+CDF +S +++ + + +GT
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-----IKLCDFGVSGQLVNSLA-KTFVGTS 163
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET--FRNISKAQLDFPDE 203
Y+APE + ++ +D+WSLG++ L TG P+ E D F + + P
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR 223
Query: 204 LFEDI-SPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
L SP+ +DF+ LIK+P ER + KE L+HP++
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 27/169 (15%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVIL-----------DGIE 137
+L YLH+ I H D+KP NL++ MG IK+ DF +S++ L +
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGH-----IKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 138 IRELL-----GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN 192
RE L GTP+Y+APE++ + D W++G+ Y L G PF G+T E F
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 193 ISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPW 238
+ +++P+ E + +A+D I+++L +NP+ER+ A E +H +
Sbjct: 228 VISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 51/192 (26%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L +L Y+H + H D+KP N+++ D C +K+ DF ++R + + E E DYV
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 149 A------PEIL----HYEPITLAADMWSLGVTAYVLLTG---F----------------- 178
A PEIL Y T DMWS+G +L G F
Sbjct: 174 ATRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230
Query: 179 -----------SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
SPF + ++ DEL S +A D + K+L+ NP +R
Sbjct: 231 PPSAEDIESIKSPFA----ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286
Query: 228 MTAKEALKHPWL 239
+TA+EAL+HP++
Sbjct: 287 LTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 71/210 (33%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 44 PRIVKLHDVFQTGEGAYYVSWN--------TPLVVTLQTIIDDNLVVPFESDELS-SLAY 94
P IVKLH FQT EG Y+ + T L + +D V F EL+ +L +
Sbjct: 58 PFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLAELALALDH 113
Query: 95 LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153
LH I + D+KP+N+++ + IK+ DF +S+ +D + GT +Y+APE++
Sbjct: 114 LHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213
+ T +AD WS GV + +LTG PF G+ ET I KA+L P L SPEA+
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL----SPEAQ 226
Query: 214 DFIAKILIKNPMERMTA-----KEALKHPW 238
+ + +NP R+ A +E +HP+
Sbjct: 227 SLLRALFKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 13/159 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELLGTPDY 147
+S+L YLH R + + DIK +NL++ D IK+ DF + + I DG ++ GTP+Y
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
+APE+L A D W LGV Y ++ G PF + F I ++ FP L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL--- 218
Query: 208 ISPEAKDFIAKILIKNPMERM-----TAKEALKHPWLMN 241
SPEAK +A +L K+P +R+ AKE ++H + ++
Sbjct: 219 -SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 13 ATGEVFAAKFLESNPV----------------RIHHEIALLSLCSPSPRIVKLHDVFQTG 56
AT V+AA L +N + E+ +S C+ P +VK + F G
Sbjct: 13 ATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVG 71
Query: 57 EGAY----YVSWNTPLVVTLQTI----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQ 108
+ + Y+S + L + + +D+ ++ + L L YLH H DIK
Sbjct: 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAG 131
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-----LLGTPDYVAPEILHYEP-ITLAA 162
N +++G+ + +K+ DF +S + DG + +GTP ++APE++ A
Sbjct: 132 N-ILLGE--DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188
Query: 163 DMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP----DELFEDISPEAKDFIAK 218
D+WS G+TA L TG +P+ + Q D P ++ S + I+
Sbjct: 189 DIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQNDPPSLETGADYKKYSKSFRKMISL 246
Query: 219 ILIKNPMERMTAKEALKHP 237
L K+P +R TA+E LKH
Sbjct: 247 CLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 68/264 (25%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A +G ++A K L+ + + ++ +LSL P + +L+ FQT + +
Sbjct: 13 LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF 72
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q D+ + ++ S+L +LH + I + D+K N+++ +
Sbjct: 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132
Query: 116 FPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+C K+ DF + + I +G GTPDY+APEIL + D W++GV Y +
Sbjct: 133 -GHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA---- 230
L G +PF E + + F I ++ +P L +D A D + + KNP R+ +
Sbjct: 190 LCGHAPFEAENEDDLFEAILNDEVVYPTWLSQD----AVDILKAFMTKNPTMRLGSLTLG 245
Query: 231 --KEALKHPW-------LMNKKQI 245
+ L+HP+ +N++QI
Sbjct: 246 GEEAILRHPFFKELDWEKLNRRQI 269
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
+ S+ + +L YLH ++I + D+KP+N+++ + IK+ DF ++ + D L G
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKE---GHIKLTDFGFAKKLRD--RTWTLCG 160
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE 203
TP+Y+APE++ + A D W+LG+ Y +L G+ PF + + I +L+FP
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH 220
Query: 204 LFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPW 238
L AKD I K+L+ + R+ A + H W
Sbjct: 221 L----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 69/251 (27%), Positives = 117/251 (46%), Gaps = 38/251 (15%)
Query: 12 IATGEVFAAKFL----ESNPVR-IHHEIALLS--LCSPSPRIVKLHDVFQTGEGAYYVSW 64
+ TG V A K + + V I E+ALLS S P I K + G+Y
Sbjct: 23 VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY-------GSYLKGP 75
Query: 65 NTPLVV------TLQTI-----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLV-- 111
+++ +++T+ I + + + L +L Y+H + H DIK N++
Sbjct: 76 RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT 135
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPE-ILHYEPITLAADMWSLGV 169
G+ +K+CDF ++ ++ R +GTP ++APE I + AD+WSLG+
Sbjct: 136 NTGN-----VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED-ISPEAKDFIAKILIKNPMERM 228
T Y + TG P+ I K++ P L ++ S ++F+A L + P ER+
Sbjct: 191 TIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLLREFVAACLDEEPKERL 247
Query: 229 TAKEALKHPWL 239
+A+E LK W+
Sbjct: 248 SAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 56/160 (35%), Positives = 84/160 (52%), Gaps = 18/160 (11%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYV 148
+L +LH I + DIK +N+++ + + + DF +S+ L E R GT +Y+
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSE---GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 149 APEILHYEPI--TLAADMWSLGVTAYVLLTGFSPF----GGETDSETFRNISKAQLDFPD 202
APE++ A D WSLGV + LLTG SPF + SE R I K++ FP
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP- 232
Query: 203 ELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPWL 239
+ +S EA+DFI K+L K+P +R+ A E HP+
Sbjct: 233 ---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 21/246 (8%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T + FA K L+ + V + ++ +LSL P + L+ FQT E +
Sbjct: 13 LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF 72
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q+ D + ++ + L +LH + I + D+K N+++ D
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 116 FPNCDIKVCDFEISR-VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
IK+ DF + + +L + GTPDY+APEIL + + D WS GV Y +
Sbjct: 133 ---GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L G SPF G + E F++I +P L + EAKD + K+ ++ P R+ K +
Sbjct: 190 LIGQSPFHGHDEEELFQSIRMDNPCYPRWL----TREAKDILVKLFVREPERRLGVKGDI 245
Query: 235 K-HPWL 239
+ HP+
Sbjct: 246 RQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 6e-20
Identities = 69/246 (28%), Positives = 116/246 (47%), Gaps = 21/246 (8%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ GE FA K L+ + V I ++ +L+L +P + L+ FQT E +
Sbjct: 13 LAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF 72
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q D + ++ + L +LH + I + D+K N+++ D
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132
Query: 116 FPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
IK+ DF + + + GTPDY+APEIL T + D WS GV Y +
Sbjct: 133 ---GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L G SPF G+ + E F +I +P I+ E+KD + K+ ++P R+ +
Sbjct: 190 LIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFERDPTRRLGVVGNI 245
Query: 235 K-HPWL 239
+ HP+
Sbjct: 246 RGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 13/156 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELLGTPDY 147
+S+L YLH + + D+K +NL++ D IK+ DF + + I DG ++ GTP+Y
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
+APE+L A D W LGV Y ++ G PF + + F I ++ FP L
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL--- 218
Query: 208 ISPEAKDFIAKILIKNPMERM-----TAKEALKHPW 238
SPEAK +A +L K+P +R+ AKE ++H +
Sbjct: 219 -SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 69/251 (27%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 13 ATGEVFAAKFLESNPVRIHH-------EIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
ATG+++A K L+ ++ E +L S S IV L F+T + +
Sbjct: 16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKD-------D 67
Query: 66 TPLVVTL--------------QTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLV 111
LV+TL + + + + + + L +LH R+I + D+KP+N V
Sbjct: 68 LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPEN-V 126
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
++ D N I D ++ + G +I+ GTP Y+APE+L E + D ++LG T
Sbjct: 127 LLDDHGNVRIS--DLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTL 184
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM--- 228
Y ++ G SPF + + + L+ E + SPEAKD +L K+P +R+
Sbjct: 185 YEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCR 244
Query: 229 --TAKEALKHP 237
+A E +HP
Sbjct: 245 GGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 44/154 (28%), Positives = 82/154 (53%), Gaps = 5/154 (3%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI-SRVILDGIEIRELLGTPDY 147
L +L++LH + + H DIK ++++ D +K+ DF ++V + + L+GTP +
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
+APE++ P D+WSLG+ ++ G P+ E + + I L +
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK- 240
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241
+SP + F+ ++L+++P +R TA E L HP+L
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 76/259 (29%), Positives = 122/259 (47%), Gaps = 33/259 (12%)
Query: 14 TGEVFAAKFLESNPVRIHHEIA---------LLSLCSPSPRIVKLHDVFQTGEGAYYVS- 63
T ++A K L + E+A + +L SP IV L FQT Y V+
Sbjct: 17 TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD 76
Query: 64 --WNTPLVVTLQT--IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
L LQ ++ + ++ + +L +LH I + D+KP+N+++
Sbjct: 77 YMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA---TG 133
Query: 120 DIKVCDFEISRVIL-DGIEIRELLGTPDYVAPEILHYEP-ITLAADMWSLGVTAYVLLTG 177
I +CDF +S+ L D GT +Y+APE+L E T D WSLGV + + G
Sbjct: 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM----TAKEA 233
+SPF E + +RNI+ ++ FP + +S E + F+ +L +NP R+ A E
Sbjct: 194 WSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVEL 250
Query: 234 LKHPW-------LMNKKQI 245
+HP+ L++KKQI
Sbjct: 251 KEHPFFADIDWDLLSKKQI 269
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-19
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146
L +L LH + + D+KP+N+++ G CD +C + D + GTP+
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK----DDDKTNTFCGTPE 158
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE 206
Y+APE+L T A D W+LGV Y +LTG PF E +E +R I + L FPD
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD---- 214
Query: 207 DISPEAKDFIAKILIKNPMERM---TAKEALKHPWL 239
+AKD + +L ++P R+ A+E HP+
Sbjct: 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 14/155 (9%)
Query: 89 LSSLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELLGTPD 146
+S+L YLH + + + D+K +NL++ D IK+ DF + + I DG ++ GTP+
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPE 161
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE 206
Y+APE+L A D W LGV Y ++ G PF + + F I ++ FP L
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL-- 219
Query: 207 DISPEAKDFIAKILIKNPMERM-----TAKEALKH 236
SPEAK ++ +L K+P +R+ AKE ++H
Sbjct: 220 --SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 9/155 (5%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI-SRVILDGIEIRELLGTPDY 147
L +L YLH + + H DIK ++++ D +K+ DF +++ D + + L+GTP +
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYW 183
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL--F 205
+APE++ P D+WSLG+ ++ G P+ ++ + + + + P +L
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNA 240
Query: 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
ISP +DF+ ++L + P ER TA+E L HP+L+
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 57/159 (35%), Positives = 83/159 (52%), Gaps = 23/159 (14%)
Query: 95 LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF-EISRVILDG-IEIRELLGTPDYVAPEI 152
+H H DIKP N+++ D N I++ DF R++ DG ++ +GTPDY++PEI
Sbjct: 118 VHQLGYVHRDIKPDNVLL--DK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 153 L--------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPD 202
L Y P D WSLGV Y +L G +PF E+ ET+ I K FP
Sbjct: 175 LQAMEDGKGRYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231
Query: 203 ELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPW 238
++ D+S EAKD I + LI +P R+ ++ HP+
Sbjct: 232 DV-TDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 26/237 (10%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T E FA K L+ + V ++ +L+L P + L FQT E +
Sbjct: 13 LAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF 72
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q+ D+ + ++ + L +LH + I + D+K N+++
Sbjct: 73 FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--- 129
Query: 116 FPNCD--IKVCDFEISR--VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
+ D IK+ DF + + + +G + GTPDY+APEIL + + D WS GV
Sbjct: 130 --DKDGHIKIADFGMCKENMNGEG-KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLL 186
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
Y +L G SPF GE + E F +I + FP IS EAKD ++K+ ++P +R+
Sbjct: 187 YEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 75/244 (30%), Positives = 118/244 (48%), Gaps = 28/244 (11%)
Query: 14 TGEVFAAKFLESN---PVR--IHHEIALLSLCSPSPRIVKLHDVF-QTGEGAYYVSWNTP 67
TG ++A K + N VR I EI +L + P +VK HD+F GE + +
Sbjct: 98 TGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDG 156
Query: 68 LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127
+ I D+ + LS +AYLH R I H DIKP NL++ + ++K+ DF
Sbjct: 157 GSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI--NSAK-NVKIADFG 213
Query: 128 ISRVILDGIE-IRELLGTPDYVAPEILH-------YEPITLAADMWSLGVTAYVLLTGFS 179
+SR++ ++ +GT Y++PE ++ Y+ A D+WSLGV+ G
Sbjct: 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD--GYAGDIWSLGVSILEFYLGRF 271
Query: 180 PFG----GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
PFG G+ S I +Q P E S E + FI+ L + P +R +A + L+
Sbjct: 272 PFGVGRQGDWAS-LMCAICMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
Query: 236 HPWL 239
HP++
Sbjct: 328 HPFI 331
|
Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 72/252 (28%), Positives = 119/252 (47%), Gaps = 36/252 (14%)
Query: 13 ATGEVFAAKFL-------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
ATG+++A K + + E +LS+ S SP I +L FQ + Y V
Sbjct: 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQLQYAFQDKDNLYLVMEY 82
Query: 66 TP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
P L+ + D+++ + ++ + ++ +H H DIKP+N V++ +
Sbjct: 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN-VLIDRTGH- 140
Query: 120 DIKVCDF-EISRVILDGIEIREL-LGTPDYVAPEILH---------YEPITLAADMWSLG 168
IK+ DF +R+ + + +L +GTPDY+APE+L Y D WSLG
Sbjct: 141 -IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV---ECDWWSLG 196
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKILIKNPME 226
V AY ++ G SPF T ++T+ NI Q L FP++ +S + D I L+ E
Sbjct: 197 VIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDLIQS-LLCGQKE 253
Query: 227 RMTAKEALKHPW 238
R+ + HP+
Sbjct: 254 RLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 84/290 (28%), Positives = 121/290 (41%), Gaps = 81/290 (27%)
Query: 8 MADSIATGEVFAAKFL--------ESNPVRIHHEI-ALLSLCSPSPRIVKLHDVFQTGEG 58
+A + TGE+ A K + E +R E+ +L L + P IVKL +VF+ +
Sbjct: 17 LARNKETGELVAIKKMKKKFYSWEECMNLR---EVKSLRKL-NEHPNIVKLKEVFRENDE 72
Query: 59 AY----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIK 106
Y Y+ N L ++ D PF L LA++H H D+K
Sbjct: 73 LYFVFEYMEGN------LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLK 126
Query: 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV------APEIL----HYE 156
P+NL++ G +K+ DF ++R EIR DYV APEIL Y
Sbjct: 127 PENLLVSGPE---VVKIADFGLAR------EIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 157 -PITLAADMWSLGVTAYVLLTGFSPFGG--ETD-----------------SETFRNISKA 196
P+ D+W+LG L T F G E D E ++ SK
Sbjct: 178 SPV----DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 197 QLDFP-------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
FP +L + SPEA D I +L +P +R TA +AL+HP+
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 53/162 (32%), Positives = 86/162 (53%), Gaps = 13/162 (8%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELL 142
+ ++ +S+L YLH KI + D+K +NL++ D IK+ DF + + I D ++
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDAATMKTFC 156
Query: 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
GTP+Y+APE+L A D W LGV Y ++ G PF + + F I + FP
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR 216
Query: 203 ELFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPWL 239
L S +AK ++ +LIK+P +R+ AKE ++H +
Sbjct: 217 TL----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 8/166 (4%)
Query: 78 DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF----EISRVIL 133
+ +++ + L L+YLH +I H D+K NL++ D +++ DF ++
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI--DSTGQRLRIADFGAAARLAAKGT 159
Query: 134 DGIEIR-ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN 192
E + +LLGT ++APE+L E + D+WS+G + T P+ E S
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL 219
Query: 193 ISK-AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
I K A + E +SP +D + L P +R ++E LKHP
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 30 IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFE 85
I EI +LS C SP + K + + G + Y+ + L + D+ +
Sbjct: 49 IQQEITVLSQCD-SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML 107
Query: 86 SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGT 144
+ L L YLH K H DIK N+++ D+K+ DF ++ + D I+ +GT
Sbjct: 108 KEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL 204
P ++APE++ AD+WSLG+TA L G P +D R + + P L
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTL 221
Query: 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
+ S K+FI L K+P R TAKE LKH +++
Sbjct: 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 55/149 (36%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 95 LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH 154
LH H D+KP+N ++ IK+ DF +S+ I+ ++G+PDY+APE+L
Sbjct: 117 LHELGYIHRDLKPENFLIDAS---GHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLR 171
Query: 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS--KAQLDFP--DELFEDISP 210
+ D WSLG Y L GF PF G T +ET+ N+ K L P D+ ++S
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 211 EAKDFIAKILIKNPMERMTAKEALK-HPW 238
EA D I K LI +P R + E +K HP+
Sbjct: 232 EAWDLITK-LINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 40/266 (15%)
Query: 8 MADSIATGEVFAAKFL---------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG 58
+A+ TGE++A K L E + I + P +V L FQT +
Sbjct: 17 LAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH 76
Query: 59 AYYVSWNTP---LVVTLQTIIDDNLVVPFESDE-LSSLAYLHHRKIAHLDIKPQNLVMMG 114
+V L++ + T + F + + L YLH KI + D+K NL++
Sbjct: 77 VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRE----LLGTPDYVAPEILHYEPITLAADMWSLGVT 170
+ +K+ DF + + +G+ + GTP+++APE+L T A D W LGV
Sbjct: 137 E---GFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
Y +L G SPF G+ + E F +I ++ +P L S EA + ++L +NP R+
Sbjct: 191 IYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL----SREAISIMRRLLRRNPERRLGS 246
Query: 229 ---TAKEALKHP--------WLMNKK 243
A++ K P L+ +K
Sbjct: 247 GEKDAEDVKKQPFFRDINWDDLLARK 272
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE--- 156
I H D+KP N+++ G N +K+CDF +S ++ + + +G Y+APE +
Sbjct: 124 IIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVASLA-KTNIGCQSYMAPERIKSGGPN 179
Query: 157 ---PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213
T+ +D+WSLG++ + G P+ ET + F +S P L S +A+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239
Query: 214 DFIAKILIKNPMERMTAKEALKHPWLM 240
DF+AK L K P R T + L+HPWL+
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 33 EIALLSLCSPSPRIVKLHDVFQ-----------TGEGAYYVSWNTPLVVTLQTIIDDNLV 81
EI +LS C P IV L++ + GA +++ L+ + + +
Sbjct: 52 EIDILSECK-HPNIVGLYEAYFYENKLWILIEFCDGGAL-----DSIMLELERGLTEPQI 105
Query: 82 VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE- 140
L +L +LH K+ H D+K N+++ D D+K+ DF +S ++ R+
Sbjct: 106 RYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---GDVKLADFGVSAKNKSTLQKRDT 162
Query: 141 LLGTPDYVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK 195
+GTP ++APE++ E P AD+WSLG+T L P + R + K
Sbjct: 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLK 219
Query: 196 AQLDFPDELFED--ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN---KKQIMT 247
P L + S DF+ L+K+P +R TA E LKHP++ + K I
Sbjct: 220 ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 17/237 (7%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSW 64
T EV A K + E I EI +LS C SP I + + + G + Y+
Sbjct: 28 TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWIIMEYLGG 86
Query: 65 NTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
+ L + +++ + + L L YLH + H DIK N+++ D+K+
Sbjct: 87 GSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLA 143
Query: 125 DFEISRVILDG-IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
DF ++ + D I+ +GTP ++APE++ AD+WSLG+TA L G P
Sbjct: 144 DFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN-- 201
Query: 184 ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
+D R + + P L S K+F+ L K+P R TAKE LKH ++
Sbjct: 202 -SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 34/240 (14%)
Query: 13 ATGEVFAAKFLESNPVR-------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV--- 62
A G+ +A K L+ + I E +L P +V LH FQT + Y+V
Sbjct: 18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77
Query: 63 SWNTPLVVTLQTIIDDNLVVP---FESDELSS-LAYLHHRKIAHLDIKPQNLVM--MGDF 116
L LQ + + P F + E++S L YLH I + D+KP+N+++ G
Sbjct: 78 VNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV 135
Query: 117 PNCDIKVCDFEISRVILDGIEIRE----LLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
D +C +GIE + GTP+Y+APE+L +P D W LG Y
Sbjct: 136 VLTDFGLCK--------EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+L G PF +E + NI L+ P L +IS A+ + +L K+ +R+ AK+
Sbjct: 188 EMLYGLPPFYSRDTAEMYDNI----LNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 57/184 (30%), Positives = 89/184 (48%), Gaps = 37/184 (20%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL----DGIEIRELLGT 144
L L Y+H + H D+KP NL++ NCD+K+CDF ++R+ + E + T
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 145 PDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGE--------------TDS-E 188
Y APEI L+ + T A D+WS+G +L+ F G+ T S E
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232
Query: 189 TFRNI-------------SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
I K ++ + ++LF + P+A D + K+L NP +R+T +EAL
Sbjct: 233 DLNCIISLRARNYIKSLPFKPKVPW-NKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291
Query: 236 HPWL 239
HP+L
Sbjct: 292 HPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 58/171 (33%), Positives = 82/171 (47%), Gaps = 15/171 (8%)
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
++ LV F L L YLH+R I H DIK N+++ IK+ DF IS+ +
Sbjct: 104 EETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKLEANS 160
Query: 137 EIR-------ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET 189
L G+ ++APE++ T AD+WSLG +LTG PF T +
Sbjct: 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220
Query: 190 -FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F+ A + P +IS EA DF+ K + +R TA E LKHP+L
Sbjct: 221 IFKIGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 79 NLVVPFESDELS-SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE 137
N V F EL + YLH + I + D+KP+NL++ +KV DF ++ + D
Sbjct: 117 NDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPD--R 171
Query: 138 IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ 197
L GTP+Y+APE++ + A D W++GV Y + G+ PF +T + I +
Sbjct: 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
Query: 198 LDFPDELFEDISPEAKDFIAKILIKNPMERM 228
L FP+ A+D + +L + +R+
Sbjct: 232 LKFPNW----FDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 63/251 (25%), Positives = 115/251 (45%), Gaps = 27/251 (10%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T EV+A K L+ + + ++ +L+L + P + LH FQT + +
Sbjct: 13 LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF 72
Query: 61 YVSW---NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q D+ + ++ +L +LH + + D+K N+++ +
Sbjct: 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132
Query: 116 FPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
K+ DF + + IL+G+ GTPDY+APEIL + D W+LGV Y +
Sbjct: 133 ---GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM------ 228
+ G PF + + + F +I + +P L S EA + + KNP +R+
Sbjct: 190 MAGQPPFEADNEDDLFESILHDDVLYPVWL----SKEAVSILKAFMTKNPNKRLGCVASQ 245
Query: 229 -TAKEALKHPW 238
+HP+
Sbjct: 246 GGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 38/185 (20%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLG 143
L L Y+H + H D+KP NL++ D C++K+CDF ++R + + E +
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 144 TPDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---------------DS 187
T Y APEI L ++ T A D+WS+G LL F G+ D
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231
Query: 188 ETFRNIS--KAQ-----------LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
ET I KAQ F +F + +P A D + K+L +P +R++ +EAL
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 235 KHPWL 239
+HP+L
Sbjct: 291 EHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 14/159 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L LAYLH K+ H DIK QN+++ + ++K+ DF +S + + R +GTP +
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNA---EVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 148 VAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
+APE++ + +D+WSLG+TA L G P D R + K + P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC---DMHPMRALFKIPRNPPP 236
Query: 203 ELF--EDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
L E+ S + DFI++ LIKN +R +E L+HP++
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 74/223 (33%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 33 EIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE 88
E +L SP +V LH FQT + YVS Q V F S E
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 89 LS-SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTP 145
+ +L +LH I + DIK +N+++ + + + DF +S+ L + R GT
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 146 DYVAPEILHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGE----TDSETFRNISKAQLDF 200
+Y+APEI+ + A D WSLG+ + LLTG SPF E T SE R I K F
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230
Query: 201 PDELFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPW 238
P I PEA+D + K+L K+P +R+ A E +HP+
Sbjct: 231 PSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 73/269 (27%), Positives = 111/269 (41%), Gaps = 32/269 (11%)
Query: 82 VPFESDELSSLAY--------LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133
+PF+ E+ L Y +H RK+ H D+K N+ +M P IK+ DF S+
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYS 220
Query: 134 DGIEI---RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF 190
D + + GTP Y+APE+ + + ADMWSLGV Y LLT PF G + E
Sbjct: 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
Query: 191 RNISKAQLD-FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRV 249
+ + + D FP +S K + +L KNP R T ++ L +L + +
Sbjct: 281 QQVLYGKYDPFPC----PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI 336
Query: 250 GCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSALLKYNKTRRLCE 309
S I ++ LR+ A I + + L KY+ R
Sbjct: 337 VRHS--ETISPHDREEILRQLQESGERAPPPSSIRYGVVTSDVTHGGYLYKYSSDMRW-- 392
Query: 310 SQMSLVSKTREKSLGD--MAISLGRSKEK 336
K R +G+ + ISL + E
Sbjct: 393 -------KKRYFYIGNGQLRISLSENPEN 414
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 73/258 (28%), Positives = 120/258 (46%), Gaps = 41/258 (15%)
Query: 14 TGEVFAAKFLESNPV--------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----Y 61
+G+++A K L+ + E +L SP +V LH FQT + Y
Sbjct: 27 SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86
Query: 62 VSWNTPLVVTLQTI-IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
++ Q + V + + + +L +LH I + DIK +N+++ N
Sbjct: 87 INGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGH 143
Query: 121 IKVCDFEISRVILDGIEIR--ELLGTPDYVAPEIL------HYEPITLAADMWSLGVTAY 172
+ + DF +S+ + R GT +Y+AP+I+ H + A D WS+GV Y
Sbjct: 144 VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDK----AVDWWSMGVLMY 199
Query: 173 VLLTGFSPF--GGETDS--ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
LLTG SPF GE +S E R I K++ +P +++S AKD I ++L+K+P +R+
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDIIQRLLMKDPKKRL 255
Query: 229 -----TAKEALKHPWLMN 241
A E KHP+
Sbjct: 256 GCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 39/188 (20%)
Query: 89 LSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
L L YL KI H D+KP N+++ +IK+CDF +S ++D + +GT Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSY 164
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSP------------FGGE-TDSETFRNIS 194
++PE L T+ +D+WSLG++ + G P FG ++ E +
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 195 KAQLDFPD--------ELFEDI-------------SPEAKDFIAKILIKNPMERMTAKEA 233
PD EL + I S E +DF+ K L KNP ER KE
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284
Query: 234 LKHPWLMN 241
KHP++
Sbjct: 285 TKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 66/285 (23%)
Query: 9 ADSIATGEVFAAK--FLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEG 58
A TG++ A K LE + P EI+LL + S S IV+L DV G+
Sbjct: 20 ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79
Query: 59 AYYVSWNTPLVVTLQTIIDDN-----------LVVPFESDELSSLAYLHHRKIAHLDIKP 107
+ Y+ + L L+ +D N + F L +A+ H + H D+KP
Sbjct: 80 SLYLVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP 138
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELLGTPDYVAPEIL----HYEPI 158
QNL++ D +K+ D + R + EI L Y APE+L HY
Sbjct: 139 QNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW----YRAPEVLLGSTHY--- 189
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE--------------- 203
+ D+WS+G + F G+++ + +I K L P E
Sbjct: 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-LGTPTEQVWPGVSKLRDWHEF 248
Query: 204 ----------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
D+SPE D + K+L +P +R++AK AL HP+
Sbjct: 249 PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 53/178 (29%), Positives = 92/178 (51%), Gaps = 18/178 (10%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L +L+ LH + + H DIK ++++ D +K+ DF + + R+ L+GTP +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL--F 205
+APE++ P D+WSLG+ ++ G P+ E + + I + P +L
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNL 239
Query: 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSC--PSIIQNQ 261
+SP K F+ ++L+++P +R TA E LKHP+L + G SC P + QN+
Sbjct: 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL-------AKAGPPSCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151
L LH +I + D+KP+N+++ I++ D ++ + +G I+ +GT Y+APE
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 171
Query: 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPE 211
++ E T + D W+LG Y ++ G SPF + + + +E E SP+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD 231
Query: 212 AKDFIAKILIKNPMERM-----TAKEALKHP 237
A+ +L K+P ER+ A+E +HP
Sbjct: 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 10/176 (5%)
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
D+ V + ++ L LH +I + D+KP+N+ ++ D+ + I++ D ++ I +G
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENI-LLDDYGH--IRISDLGLAVEIPEGE 156
Query: 137 EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA 196
IR +GT Y+APE++ E T + D W LG Y ++ G SPF + + +
Sbjct: 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR 216
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPWL--MNKKQI 245
+ +E E S A+ ++L K+P R+ A+E HP+ N K++
Sbjct: 217 VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 89 LSSLAYLHHRK-IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
+ +L YL + + H D+KP N+++ + ++K+CDF IS ++D G Y
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDA---SGNVKLCDFGISGRLVDSKAKTRSAGCAAY 180
Query: 148 VAPEILHYEPIT----LAADMWSLGVTAYVLLTGFSPF-GGETDSETFRNISKAQLDFPD 202
+APE + + AD+WSLG++ L TG P+ +T+ E I Q + P
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--LQEEPPS 238
Query: 203 -ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRV 249
E SP+ F+ L K+ +R +E L+HP++ + V
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 8/170 (4%)
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
++ + + ++ L L LH + D+KP+N +++ D+ + I++ D ++ I +G
Sbjct: 100 EEERALFYAAEILCGLEDLHRENTVYRDLKPEN-ILLDDYGH--IRISDLGLAVKIPEGE 156
Query: 137 EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA 196
IR +GT Y+APE+L+ + TL+ D W LG Y ++ G SPF G + + +
Sbjct: 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 216
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK-----EALKHPWLMN 241
L+ + S EAK +L K+P +R+ + E +HP+ N
Sbjct: 217 VLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 55/156 (35%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L LAYLH H DIK N+++ D D+K+ DF +S + I R+ +GTP +
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 148 VAPEILHYE---PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--- 201
+APE+ E D+W+LG+TA L P ISK+ P
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
D+ E SP DFI K L K+P +R TA + L+HP
Sbjct: 228 DK--EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 41/241 (17%)
Query: 30 IHHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESD 87
+ HE I LL + +P+ + + +DV+ + + + +V Q + DD+ V F
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLV---THLMGADLNNIVKCQKLTDDH--VQFLIY 127
Query: 88 E-LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146
+ L L Y+H I H D+KP NL + D C++K+ DF ++R D E+ + T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDD--EMTGYVATRW 182
Query: 147 YVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGG---------------------- 183
Y APEI L++ D+WS+G LLTG + F G
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242
Query: 184 -ETDSETFRNISKAQLDFPDELFEDI----SPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ SE+ RN ++ P F ++ +P A D + K+L+ + +R+TA +AL H +
Sbjct: 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302
Query: 239 L 239
Sbjct: 303 F 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 66/253 (26%), Positives = 97/253 (38%), Gaps = 80/253 (31%)
Query: 44 PRIVKLHDVFQTGEGAYYVSWNTPLVVT-----LQTIIDDNLVVPFESD-------ELSS 91
P I+ L DVF N LV L+ +I D +V +D L
Sbjct: 62 PNIIGLLDVFGHKS-------NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD----- 146
L YLH I H D+KP NL++ + +K+ DF ++R G+P+
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF----------GSPNRKMTH 161
Query: 147 ------YVAPEIL----HYEPITLAADMWSLGVTAYVLLTG----------------FSP 180
Y APE+L HY DMWS+G LL F
Sbjct: 162 QVVTRWYRAPELLFGARHYGV---GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA 218
Query: 181 FGGETDSE-----------TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
G T+ F+ L ++F S +A D + ++L NP +R+T
Sbjct: 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPL---KQIFPAASDDALDLLQRLLTLNPNKRIT 275
Query: 230 AKEALKHPWLMNK 242
A++AL+HP+ N
Sbjct: 276 ARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 73/254 (28%), Positives = 108/254 (42%), Gaps = 55/254 (21%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGA------YYVSWNTPLV-VTLQTII----- 76
R + E+ LL ++ L DVF Y V T L+ L I+
Sbjct: 60 RTYRELRLLK-HMDHENVIGLLDVFTPASSLEDFQDVYLV---THLMGADLNNIVKCQKL 115
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
D+ + L L Y+H I H D+KP N+ + D C++K+ DF ++R D
Sbjct: 116 SDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDD-- 170
Query: 137 EIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGE-------- 184
E+ + T Y APEI+ HY D+WS+G LLTG + F G
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227
Query: 185 ---------------TDSETFRNISKAQLDFP----DELFEDISPEAKDFIAKILIKNPM 225
SE+ RN ++ P E+F +P A D + K+L+ +P
Sbjct: 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD 287
Query: 226 ERMTAKEALKHPWL 239
+R+TA EAL HP+L
Sbjct: 288 KRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTP 145
L ++ ++H + + H DIK N+++ N +K+ DF S++ + R GTP
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-FPDEL 204
YVAPEI +P + ADM+SLGV Y LLT PF GE E + D P
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS- 268
Query: 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
ISPE ++ + +L +P R ++ + L P
Sbjct: 269 ---ISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 40/101 (39%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS--KAQLDF 200
GTPDY+APE+ D WSLGV Y +L G+ PF + ET+R I K L F
Sbjct: 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF 260
Query: 201 PDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPW 238
PDE+ +SPEAKD I ++ R+ E HP+
Sbjct: 261 PDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 44 PRIVKLHDVFQTGEGAYYV---SWNTPLVVTLQTIIDDNLVVP----FESDELSSLAYLH 96
P +V LH FQT + Y+V L LQ + + P + ++ S+L YLH
Sbjct: 56 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH 113
Query: 97 HRKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH 154
I + D+KP+N+++ G D +C I GTP+Y+APE+LH
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----NGTTSTFCGTPEYLAPEVLH 169
Query: 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214
+P D W LG Y +L G PF +E + NI L+ P +L +I+ A+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI----LNKPLQLKPNITNSARH 225
Query: 215 FIAKILIKNPMERMTAKE 232
+ +L K+ +R+ AK+
Sbjct: 226 LLEGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 46 IVKLHDVFQTG-EGAYYVS--WNTPLVVTLQT-IIDDNLVVPFESDELSSLAYLHHRKIA 101
I+ L D+F + E Y+V+ T L L + ++ + F L L Y+H +
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVV 130
Query: 102 HLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI-LHYEPITL 160
H D+KP N+++ NCD+K+CDF ++R+ ++ + T Y APEI L ++ +
Sbjct: 131 HRDLKPSNILIN---ENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE----------------- 203
D+WS G +L G F G+ F I+ PD+
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245
Query: 204 ----------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F++ P A D + K+L+ +P +R++A EAL HP+L
Sbjct: 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 65/281 (23%)
Query: 9 ADSIATGEVFAAK--FLESN----PVRIHHEIALL-SLCSPSPRIVKLHDVFQTGEGAYY 61
A TGE+ A K LE+ P EI+LL L P IV+L DV + Y
Sbjct: 18 ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL--NHPNIVRLLDVVHSENKLYL 75
Query: 62 V--SWNTPLVVTLQTI----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
V + L + + +D L+ + L +AY H ++ H D+KPQNL++ D
Sbjct: 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI--D 133
Query: 116 FPNCDIKVCDFEISRVILDGIEIR----ELLGTPDYVAPEIL----HYEPITLAADMWSL 167
+K+ DF ++R G+ +R E++ T Y APEIL Y + D+WS+
Sbjct: 134 REG-ALKLADFGLARAF--GVPVRTYTHEVV-TLWYRAPEILLGSRQY---STPVDIWSI 186
Query: 168 GVTAYVLLTGFSPFGGETDSET---FRNISKAQLDFPDE--------------------- 203
G ++ F G DSE FR I + L PDE
Sbjct: 187 GCIFAEMVNRRPLFPG--DSEIDQLFR-IFRT-LGTPDEDVWPGVTSLPDYKPTFPKWAR 242
Query: 204 -----LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ ++ + D ++K+L+ +P +R++AK AL+HP+
Sbjct: 243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR----VILDGIEIRELLGT 144
L + YLH I H DIK N++ ++K+ DF S+ + G ++ + GT
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-E 203
P +++PE++ E AD+WS+G T +LT P+ + E I K + +
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPQ 227
Query: 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
L +SP+A++F+ + ++N +R +A+E L+H
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 74/254 (29%), Positives = 119/254 (46%), Gaps = 45/254 (17%)
Query: 14 TGEVFAAKFLES-NPVRIHH---EIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLV 69
TG + AAK +E+ + + EI +L+ C+ P IVKL GA+Y W+ L
Sbjct: 36 TGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLL-------GAFY--WDGKLW 85
Query: 70 VTLQTI-----------IDDNLVVP----FESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+ ++ +D L P L +L YLH KI H D+K N+++
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL 145
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYE-----PITLAADMWSLG 168
D DIK+ DF +S + ++ R+ +GTP ++APE++ E P AD+WSLG
Sbjct: 146 D---GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 202
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQ---LDFPDELFEDISPEAKDFIAKILIKNPM 225
+T + P I+K++ L P + S E +DF+ L K+P
Sbjct: 203 ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW----SMEFRDFLKTALDKHPE 258
Query: 226 ERMTAKEALKHPWL 239
R +A + L+HP++
Sbjct: 259 TRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 89 LSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
+ +L YLH + + H D+KP N+++ N +K+CDF IS ++D + G Y
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 148 VAPEIL-------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200
+APE + Y+ + +D+WSLG+T L TG P+ ++ F+ + + +
Sbjct: 170 MAPERINPELNQKGYD---VKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEP 224
Query: 201 PDELFED-ISPEAKDFIAKILIKNPMERMTAKEALKHP 237
+L + SPE +DF+ K L KN ER E L+HP
Sbjct: 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 63/252 (25%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 33 EIALL-SLCSPS-PRIVKLHDVFQTGEGAY---------YVSWNTPLVVTLQTIIDDNLV 81
EIALL L S P IV+L DV +V + L T +
Sbjct: 48 EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD------LATYLS-KCP 100
Query: 82 VPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD--IKVCDFEISR 130
P E L + +LH +I H D+KPQN+++ D +K+ DF ++R
Sbjct: 101 KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV-----TSDGQVKIADFGLAR 155
Query: 131 VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF 190
+ + + ++ T Y APE+L DMWS+G L F G ++++
Sbjct: 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL 215
Query: 191 RNISK-----AQLDFPD------------------ELFEDISPEAKDFIAKILIKNPMER 227
I ++ ++P +I E D + K+L NP +R
Sbjct: 216 DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKR 275
Query: 228 MTAKEALKHPWL 239
++A EAL+HP+
Sbjct: 276 ISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 28/244 (11%)
Query: 14 TGEVFAAKFLESNPVRIHHEIALL----SLCSP--SPRIVKLHDVFQTGEGAYYVSWNTP 67
TG A K L ++ H+ A +LC+ P IV L D + G + +
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 68 LVVTLQTIIDDNLVVPFES------DELSSLAYLHHRKIAHLDIKPQNLVM--MGDFPNC 119
TL+ ++ + +P L +LA H++ I H D+KPQN+++ G P+
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 120 DIKVCDFEISRVILDGIEI--------RELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
KV DF I ++ + E+LGTP Y APE L EP+T +D+++ G+
Sbjct: 122 --KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 172 YVLLTGFSPFGGETDSET-FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
LTG G + +E ++ +S + P + + K L K+P +R +
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI---AGHPLGQVLRKALNKDPRQRAAS 236
Query: 231 KEAL 234
AL
Sbjct: 237 APAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 39/97 (40%), Positives = 57/97 (58%), Gaps = 1/97 (1%)
Query: 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200
+LGTPDY+APE+L +P A D W+LGV + LTG PF ET + F+NI + +
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
P+ E +S A++ I +L +P +R KE +HP
Sbjct: 600 PEGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151
L LH +KI H D+K N++++ N +K+ D IS+V L + +GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPE 171
Query: 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPE 211
+ P + +D+WSLG Y + T PF + + + + + + S +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---PPIPPIYSQD 228
Query: 212 AKDFIAKILIKNPMERMTAKEALKHP 237
++FI +L P R + L P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 46/154 (29%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L +L+YLH++ + H DIK ++++ D IK+ DF + + R+ L+GTP +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE- 206
+APE++ P D+WSLG+ ++ G P+ E + R I + P + +
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDS 241
Query: 207 -DISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+S + F+ +L++ P +R TA+E L+HP+L
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 54/173 (31%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN-CDIKVCDFEISRV---I 132
++ LV F L LAYLH + I H D+K NL++ D C K+ DF IS+ I
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV--DADGIC--KISDFGISKKSDDI 161
Query: 133 LDGIEIRELLGTPDYVAPEILHYEPITLAA--DMWSLGVTAYVLLTGFSPFGGETDSETF 190
D + + G+ ++APE++H +A D+WSLG + G P+ D E
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS---DEEAI 218
Query: 191 RNI-----SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ ++ P ++ ++SP A DF+ NP R TA+E L+HP+
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 30 IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFE 85
I EI +LS C SP + K + + + Y+ + L + +D+ +
Sbjct: 49 IQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL 107
Query: 86 SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGT 144
+ L L YLH K H DIK N+++ + ++K+ DF ++ + D I+ +GT
Sbjct: 108 REILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL 204
P ++APE++ AD+WSLG+TA L G P + I K P L
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTL 221
Query: 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
+ S K+F+ L K P R TAKE LKH +++
Sbjct: 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 32/180 (17%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDY 147
L L Y+H + H D+KP NL++ NCD+K+CDF ++R + + E + T Y
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 148 VAPE-ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI-------SKAQLD 199
APE +L+ T A D+WS+G LL F G+ + I S+ L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 200 FPD--------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F LF +P A D + K+L+ +P +R+T +EAL HP+L
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L+ L +H I H DIKP N+++ IK+CDF +S +++ I +GT Y+
Sbjct: 116 LTYLYNVHR--IMHRDIKPSNILVNS---RGQIKLCDFGVSGELINSIA-DTFVGTSTYM 169
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF--- 205
+PE + T+ +D+WSLG++ L G PF S + + D L
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPF---AFSNIDDDGQDDPMGILDLLQQIV 226
Query: 206 ---------EDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
D + +DF+ L+K+P ER T ++ P
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 38/185 (20%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLG 143
L L Y+H + H D+KP NL++ D C++++ DF ++R + + E +
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNED---CELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 144 TPDYVAPEILHYEP-ITLAADMWSLG-----------------------VTAYVLLTGFS 179
T Y APE+L P T A DMWS+G + VL +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233
Query: 180 PFGGETDSETFRNI-----SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
S+ R K + + ++F SPEA D ++++L +P ER+T ++AL
Sbjct: 234 EVLNRIGSDRVRKYIQNLPRKQPVPW-SKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292
Query: 235 KHPWL 239
+HP+L
Sbjct: 293 QHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 11/158 (6%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI----LDGIE---IREL 141
L +AYLH+ + H DIK N+++M PN IK+ DF +R + L G ++ +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP 201
GTP ++APE+++ +D+WS+G T + + TG P I + P
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
L + S A DF+ L ++ ER +A + L+H +L
Sbjct: 229 -RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 9/151 (5%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVA 149
+L YLH + I H D+K QN+ + IKV D I+RV+ + ++ L+GTP Y++
Sbjct: 114 ALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKAQLDFPDELFEDI 208
PE+ +P +D+W+LG Y + T F + +S +R I P +D
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP----KDY 226
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
SPE + IA +L K P +R + K L+ P++
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 77/271 (28%), Positives = 123/271 (45%), Gaps = 57/271 (21%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV----- 62
TGEV A K + E P EI+LL + P IVKL DV T Y V
Sbjct: 24 TGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLH 82
Query: 63 -SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
+ + + I L+ + L LA+ H ++ H D+KPQNL++ + I
Sbjct: 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAI 139
Query: 122 KVCDFEISRVILDGIEIR----ELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYV 173
K+ DF ++R G+ +R E++ T Y APEIL +Y + A D+WSLG
Sbjct: 140 KLADFGLARAF--GVPVRTYTHEVV-TLWYRAPEILLGCKYY---STAVDIWSLGCIFAE 193
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDEL----------------------FEDISP- 210
++T + F G+++ + I + L PDE+ F + P
Sbjct: 194 MVTRRALFPGDSEIDQLFRIFRT-LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPP 252
Query: 211 ---EAKDFIAKILIKNPMERMTAKEALKHPW 238
+ +D ++++L +P +R++AK AL HP+
Sbjct: 253 LDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
D+ + + ++ L L +I + D+KP+N +++ D + I++ D ++ I +G
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPEN-ILLDDRGH--IRISDLGLAVQIPEGE 156
Query: 137 EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA 196
+R +GT Y+APE+++ E T + D W LG Y ++ G SPF + + +
Sbjct: 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR 216
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPWLMN 241
+ +E E S +AK +L KNP ER+ A +HP N
Sbjct: 217 VKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-15
Identities = 55/158 (34%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPD 146
L L YLH +I H DIK N V++ + +K+ DF S+ L GI GT
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDN-VLVNTYSGV-VKISDFGTSKR-LAGINPCTETFTGTLQ 174
Query: 147 YVAPEILHYEP--ITLAADMWSLGVTAYVLLTGFSPFG--GETDSETFR-NISKAQLDFP 201
Y+APE++ P AD+WSLG T + TG PF GE + F+ + K + P
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ L S EAK+FI + +P +R +A + L+ P+L
Sbjct: 235 ESL----SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 44 PRIVKLHDVFQTGEGAYYV---SWNTPLVVTLQTIIDDNLVVP----FESDELSSLAYLH 96
P +V LH FQT E Y+V L LQ + + P + ++ S+L YLH
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLH 113
Query: 97 HRKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDGIEIRE----LLGTPDYVAP 150
I + D+KP+N+++ G D +C +GI + GTP+Y+AP
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGTPEYLAP 165
Query: 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210
E++ +P D W LG Y +L G PF +E + NI L P L S
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI----LHKPLVLRPGASL 221
Query: 211 EAKDFIAKILIKNPMERMTAKE 232
A + ++L K+ R+ AKE
Sbjct: 222 TAWSILEELLEKDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 43 SPRIVKLHDVFQTGEGAYYVSWNTP--LVVTLQTIIDDNLVVP-----FESDELS-SLAY 94
S IV+LH FQ + Y V P +V L + N +P F + E+ +L
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDA 157
Query: 95 LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS-RVILDG-IEIRELLGTPDYVAPEI 152
+H H D+KP N M+ D + +K+ DF ++ +G + +GTPDY++PE+
Sbjct: 158 IHSMGFIHRDVKPDN--MLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214
Query: 153 LHYEPIT----LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDELFE 206
L + D WS+GV Y +L G +PF ++ T+ I K L FPD++
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI-- 272
Query: 207 DISPEAKDFIAKILIKNP--MERMTAKEALKHPWLMN 241
+IS +AKD I L + R E HP+ N
Sbjct: 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDY 147
L LA+LH +KI H DIK NL + ++K+ D +++++ D ++GTP Y
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYD---NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
++PE+ +P +D+W+LGV Y TG PF I + FP + +
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FP-PVSQM 224
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
S + I + L K+ +R + L++P L
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 44 PRIVKLHDVFQTGEGAYYV---SWNTPLVVTLQTIIDDNLVVP----FESDELSSLAYLH 96
P +V LH FQT E Y+V L LQ + + P + ++ S++ YLH
Sbjct: 56 PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLH 113
Query: 97 HRKIAHLDIKPQNLVMMGDFPNCD--IKVCDFEISRVILDGIEIRE----LLGTPDYVAP 150
I + D+KP+N+++ + + + DF + + +G+E E GTP+Y+AP
Sbjct: 114 SLNIIYRDLKPENILL-----DSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAP 165
Query: 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210
E+L EP D W LG Y +L G PF S+ + NI L P +
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TV 221
Query: 211 EAKDFIAKILIKNPMERMTAK 231
A D + +L K+ R+ AK
Sbjct: 222 AACDLLVGLLHKDQRRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 50/191 (26%), Positives = 73/191 (38%), Gaps = 55/191 (28%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L YLH I H DIK N+++ D +K+ DF ++R + DY
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDG---VLKLADFGLARPY-------TKRNSADYT 159
Query: 149 ---------APEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK 195
PE+L Y P DMWS+G L G F G T+ E I +
Sbjct: 160 NRVITLWYRPPELLLGATRYGP---EVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216
Query: 196 AQLDFPDE----------LFED------------------ISPEAKDFIAKILIKNPMER 227
P + FE+ I P A D + K+L +P +R
Sbjct: 217 L-CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275
Query: 228 MTAKEALKHPW 238
++A +AL+H +
Sbjct: 276 ISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 71/258 (27%), Positives = 104/258 (40%), Gaps = 68/258 (26%)
Query: 41 SPSPRIVKLHDVFQTGEGAYYVSWNTP------LVVTLQTIIDDNLVVPFESDE-LSSLA 93
S SP +V L+ FQ + Y + P +++ T +D V F E + ++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--VTRFYMAECVLAIE 115
Query: 94 YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS------------------------ 129
+H H DIKP N+++ IK+ DF +S
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRG---GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 130 -----RVILDGIEI--------------RELL-----GTPDYVAPEILHYEPITLAADMW 165
V +D I + R L+ GTPDY+APEI + D W
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 166 SLGVTAYVLLTGFSPFGGETDSETFRNIS--KAQLDFPDELFEDISPEAKDFIAKILIKN 223
SLG + L G+ PF E ET+R I + L FPD++ +S EA+D I + LI N
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRR-LITN 289
Query: 224 PMERM---TAKEALKHPW 238
R+ A E HP+
Sbjct: 290 AENRLGRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 48/259 (18%)
Query: 13 ATGEVFAA--------------KFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG 58
A+GEV+ A + + N I +EI ++ C P IV +D + G+
Sbjct: 31 ASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYLVGD- 88
Query: 59 AYYVSWNTPLVV-------TLQTIIDDNLVVPFES-------DELSSLAYLHHRKIAHLD 104
W VV +L II N V E + L L YLH + + H D
Sbjct: 89 ---ELW----VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRD 141
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAAD 163
IK N +++ + +K+ DF + + R ++GTP ++APE++ + D
Sbjct: 142 IKSDN-ILLSK--DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVD 198
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKA---QLDFPDELFEDISPEAKDFIAKIL 220
+WSLG+ + G P+ E I+ L P++ SPE KDF+ K L
Sbjct: 199 IWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW----SPEFKDFLNKCL 254
Query: 221 IKNPMERMTAKEALKHPWL 239
+K+P +R +A+E L+HP+L
Sbjct: 255 VKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 82 VPFESDELSS--------LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133
V F D++ S L ++H RKI H DIK QN+ + + K+ DF I+R +
Sbjct: 96 VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLN 153
Query: 134 DGIEI-RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN 192
D +E+ +GTP Y++PEI P D+WSLG Y L T PF G +
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 193 ISKAQLDFPDELFEDISP----EAKDFIAKILIKNPMERMTAKEALKHPWL 239
I + F ISP + + I+++ +P +R + LK P+L
Sbjct: 214 ICQGY-------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDYVA 149
+L ++H RKI H DIK QN+ + D IK+ DF I+RV+ +E+ R +GTP Y++
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPF-GGETDSETFRNISKAQLDFPDELFEDI 208
PEI P +D+W+LG Y + T F G + + I +
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY---- 225
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
S + ++ ++++ +NP +R + L+ ++
Sbjct: 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 21/221 (9%)
Query: 33 EIALLSLCSPSPRIVKLHDVFQTGEGAYYV------SWNTPLVVTLQTIIDDNLVVPFES 86
EI +L+ C P IVKL D F + + +++ L+ + + +
Sbjct: 52 EIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK 110
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTP 145
L +L YLH KI H D+K N++ D DIK+ DF +S I+ R+ +GTP
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 146 DYVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200
++APE++ E P AD+WSLG+T + P I+K++
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--- 224
Query: 201 PDELFEDI--SPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P L + S E KDF+ K L KN R T + L+HP++
Sbjct: 225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 55/204 (26%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD---IKVCDFEISRVILDGIE----IREL 141
L L Y+H + H D+KP N+ F N + +K+ DF ++R++ + E
Sbjct: 124 LRGLKYIHSANVLHRDLKPANV-----FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 142 LGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SK 195
L T Y +P +L +Y T A DMW+ G +LTG F G + E + I S
Sbjct: 179 LVTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
Query: 196 AQLDFPD------------------------ELFEDISPEAKDFIAKILIKNPMERMTAK 231
+ D +L ++PEA DF+ +IL NPM+R+TA+
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 232 EALKHPWLMNKKQIMTRVGCSSCP 255
EAL HP++ C SCP
Sbjct: 296 EALMHPYM----------SCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 3e-14
Identities = 72/270 (26%), Positives = 130/270 (48%), Gaps = 25/270 (9%)
Query: 9 ADSIATGEVFAAK--FLESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A IATG+ A K L+ P + I +EI ++ + +P IV D + G+ +
Sbjct: 38 AIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVME 96
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
Y++ + V +T +D+ + + L +L +LH ++ H DIK N+++ D
Sbjct: 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD---GS 153
Query: 121 IKVCDFEI-SRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF +++ + + ++GTP ++APE++ + D+WSLG+ A ++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 180 PFGGETDSETFRNIS---KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ E I+ +L P+ L S +DF+ + L + R +AKE L+H
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNPERL----SAVFRDFLNRCLEMDVDRRGSAKELLQH 269
Query: 237 PWLMNKKQIMTRVGCSSCPSIIQNQQNKKN 266
P+L K + S P II ++ KN
Sbjct: 270 PFLKLAKPL-----SSLTPLIIAAKEAIKN 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 41/206 (19%)
Query: 68 LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127
++V+ Q + D++ V F L L YLH I H DIKP NL++ NC +K+CDF
Sbjct: 93 IIVSPQPLSSDHVKV-FLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFG 148
Query: 128 ISRV--ILDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLG------VTAYVLL 175
++RV + + + + T Y APEIL HY T A D+WS+G + +L
Sbjct: 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHY---TSAVDIWSVGCIFAELLGRRILF 205
Query: 176 TGFSP----------FGGETDSETFRNISKAQ---LDFPDE---------LFEDISPEAK 213
SP G + A+ L P + L + EA
Sbjct: 206 QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAV 265
Query: 214 DFIAKILIKNPMERMTAKEALKHPWL 239
+ ++L+ +P +R++A +AL HP+L
Sbjct: 266 HLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 46 IVKLHDVFQTGEGAY-----YVSWNT-PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRK 99
I LH FQ Y YV + L+ + + +++ + ++ + ++ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 100 IAHLDIKPQNLVMMGDFPNCDIKVCDF-EISRVILDG-IEIRELLGTPDYVAPEILH--- 154
H DIKP N++M D N I++ DF +++ DG ++ +GTPDY++PEIL
Sbjct: 123 YVHRDIKPDNILM--DM-NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 155 -----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDELFED 207
Y P D WSLGV Y +L G +PF E+ ET+ I K + FP ++ D
Sbjct: 180 DGKGKYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV-TD 235
Query: 208 ISPEAKDFIAKILI--KNPMERMTAKEALKHPWL 239
+S +AKD I +++ ++ + + ++ +HP+
Sbjct: 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 89 LSSLAYLHHR-----KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELL 142
L +L H+R + H D+KP N+ + N ++K+ DF +++++ + +
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDA---NNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
GTP Y++PE L++ +D+WSLG Y L PF + I + +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---R 228
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
+ S E + I +L +P +R + +E L+ P
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 70/271 (25%), Positives = 115/271 (42%), Gaps = 57/271 (21%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT------------G 56
TGE+ A K + E P EI+L+ IV+LHDV T
Sbjct: 24 TGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDK 82
Query: 57 EGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+ Y+ + + +D N V F L +A+ H ++ H D+KPQNL++
Sbjct: 83 DLKKYMDTHGV-----RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR- 136
Query: 117 PNCDIKVCDFEISRVILDGIEIREL---LGTPDYVAPEIL-HYEPITLAADMWSLGVTAY 172
++K+ DF ++R GI + + T Y AP++L + + D+WS+G
Sbjct: 137 --GELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMA 192
Query: 173 VLLTGFSPFGGETDSE---------------TFRNISKA---QLDFP-------DELFED 207
++TG F G + + T+ IS+ + FP +LF
Sbjct: 193 EMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPH 252
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
P D + ++L NP R++A +AL+HPW
Sbjct: 253 ADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 8/165 (4%)
Query: 76 IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135
++ V+ + + + +LH I + D+KP+N V++ D NC ++ D ++ + DG
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPEN-VLLDDQGNC--RLSDLGLAVELKDG 148
Query: 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK 195
I + GT Y+APEIL EP + D +++G + Y ++ G +PF + + +
Sbjct: 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
Query: 196 AQLDFPDEL-FE--DISPEAKDFIAKILIKNPMERMTAKEALKHP 237
L+ DE+ FE + + E+KD L K P +R+ ++E P
Sbjct: 209 RTLE--DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 39/145 (26%), Positives = 77/145 (53%), Gaps = 4/145 (2%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDY 147
+S L +LH R+I + D+KP+N+++ D ++++ D ++ + DG + GTP +
Sbjct: 107 ISGLEHLHQRRIIYRDLKPENVLLDND---GNVRISDLGLAVELKDGQSKTKGYAGTPGF 163
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED 207
+APE+L E + D ++LGVT Y ++ PF + + + + L+ +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK 223
Query: 208 ISPEAKDFIAKILIKNPMERMTAKE 232
SP +K F +L K+P +R+ ++
Sbjct: 224 FSPASKSFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 43 SPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHR 98
+P IV D F G+ + Y++ + V +T +D+ + + L +L +LH
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 99 KIAHLDIKPQNLV--MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE 156
++ H DIK N++ M G D C +++ + + ++GTP ++APE++ +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS---KAQLDFPDELFEDISPEAK 213
D+WSLG+ A ++ G P+ E I+ +L P++L SP +
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SPIFR 246
Query: 214 DFIAKILIKNPMERMTAKEALKHPWL 239
DF+ + L + +R +AKE L+HP+L
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 40/185 (21%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPD 146
L ++AY H I H DIKP+N+++ + +K+CDF +R + + + T
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 147 YVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---------------- 186
Y APE+L +Y D+W++G LL G F G++D
Sbjct: 167 YRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 187 --SETF-RNISKAQLDFPDELFED---------ISPEAKDFIAKILIKNPMERMTAKEAL 234
E F N A + FP+ + +S A DF+ L +P ER+T E L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
Query: 235 KHPWL 239
+HP+
Sbjct: 284 QHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 19/138 (13%)
Query: 95 LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF-EISRVILDG-IEIRELLGTPDYVAPEI 152
+H H DIKP N+++ D N I++ DF ++ DG ++ +GTPDY++PEI
Sbjct: 118 IHQLHYVHRDIKPDNVLL--DM-NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 153 LH--------YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPD 202
L Y P D WSLGV Y +L G +PF E+ ET+ I + + FP
Sbjct: 175 LQAMEDGMGKYGP---ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
Query: 203 ELFEDISPEAKDFIAKIL 220
+ D+S EAKD I +++
Sbjct: 232 HI-TDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 39/164 (23%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 74 TIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133
+++D++ ++ F L +L ++H + I H D+K QN+++ D +K+ DF IS+++
Sbjct: 96 SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISKILS 153
Query: 134 DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI 193
+ ++GTP Y++PE+ +P +D+W+LG Y L + F I
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213
Query: 194 SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
+ + SP+ + I +L +P +R + + P
Sbjct: 214 MSGTF---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 80/285 (28%), Positives = 118/285 (41%), Gaps = 76/285 (26%)
Query: 9 ADSIATGEVFAAKFL--------ESNPVRIHHEIALLSLCSPSPRIVKLHDVF---QTGE 57
A S TG+ +A K + + N +R EI L SP P I++L +V +TG
Sbjct: 18 AQSRKTGKYYAIKCMKKHFKSLEQVNNLR---EIQALRRLSPHPNILRLIEVLFDRKTGR 74
Query: 58 GAYYVSWNTPLVVTLQTIIDDNL-------VVPFESDE--------LSSLAYLHHRKIAH 102
A LV L +D NL P L SL ++H I H
Sbjct: 75 LA--------LVFEL---MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPI 158
DIKP+N+++ D +K+ DF R I E + T Y APE L +Y P
Sbjct: 124 RDIKPENILIKDDI----LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP- 178
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGETD------------------SETFRNISKAQLDF 200
D+W++G + +L+ F F G + + FR +F
Sbjct: 179 --KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 201 PDE-------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
P + L + S E D + K+L +P ER+TAK+AL+HP+
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 62/251 (24%)
Query: 43 SPRIVKLHDVFQTGEGAYYVSWNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLH 96
+ +VKL+ FQ + Y+V P L++ L I +++L + ++ ++ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH 118
Query: 97 HRKIAHLDIKPQNLVMMGDFPNCDIKVCDF------------------------------ 126
H DIKP N+++ D IK+ DF
Sbjct: 119 KMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 127 ---EISRVILDGIEIR-----------ELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
EI R L +E R L+GTP+Y+APE+L T D WS+GV Y
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 173 VLLTGFSPFGGETDSETFRNIS--KAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
+L G PF +T +ET + + L P + +S EA D I + L +R+
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQA--KLSREASDLILR-LCCGAEDRLGK 292
Query: 229 -TAKEALKHPW 238
A E HP+
Sbjct: 293 NGADEIKAHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR----VILDGIEIRELLGT 144
L ++YLH I H DIK N++ ++K+ DF S+ + + G IR + GT
Sbjct: 116 LEGMSYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL 204
P +++PE++ E AD+WSLG T +LT P+ I+ + L
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--L 230
Query: 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
IS A+DF+ I ++ R +A+E L+HP+
Sbjct: 231 PSHISEHARDFLGCIFVE-ARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 2e-13
Identities = 68/270 (25%), Positives = 130/270 (48%), Gaps = 25/270 (9%)
Query: 9 ADSIATGEVFAAK--FLESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A +ATG+ A + L+ P + I +EI ++ + +P IV D + G+ +
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVME 97
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
Y++ + V +T +D+ + + L +L +LH ++ H DIK N+++ D
Sbjct: 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GS 154
Query: 121 IKVCDFEI-SRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF +++ + + ++GTP ++APE++ + D+WSLG+ A ++ G
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 180 PFGGETDSETFRNIS---KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ E I+ +L P++L S +DF+ + L + +R +AKE L+H
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDFLNRCLDMDVEKRGSAKELLQH 270
Query: 237 PWLMNKKQIMTRVGCSSCPSIIQNQQNKKN 266
+L K + S P I ++ KN
Sbjct: 271 QFLKIAKPL-----SSLTPLIAAAKEATKN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
+ L YL KI H D+KP N+++ +K+CDF +S +++ I + +GT Y+
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA-KTYVGTNAYM 160
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN-------------ISK 195
APE + E + +D+WSLG++ L G P+ + +N + +
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPY-----PQIQKNQGSLMPLQLLQCIVDE 215
Query: 196 AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P F S + FI + + K P ER + + HP++
Sbjct: 216 DPPVLPVGQF---SEKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 67/243 (27%), Positives = 118/243 (48%), Gaps = 20/243 (8%)
Query: 9 ADSIATGEVFAAK--FLESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A +ATG+ A K L+ P + I +EI L+ + P IV D + G+ +
Sbjct: 38 AIDVATGQEVAIKQMNLQQQPKKELIINEI-LVMRENKHPNIVNYLDSYLVGDELWVVME 96
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
Y++ + V +T +D+ + + L +L +LH ++ H DIK N+++ D
Sbjct: 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GS 153
Query: 121 IKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF I R ++GTP ++APE++ + D+WSLG+ A ++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 180 PFGGETDSETFRNIS---KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ E I+ +L P++L S +DF+ + L + +R +AKE L+H
Sbjct: 214 PYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDFLNRCLEMDVEKRGSAKELLQH 269
Query: 237 PWL 239
P+L
Sbjct: 270 PFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 58/274 (21%)
Query: 13 ATGEVFAAK--FLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YV 62
TG++ A K LES P EI+LL P IV L DV Y ++
Sbjct: 23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFL 81
Query: 63 SWNTPLVVTLQTI-----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
S + L L ++ +D LV + L + + H R++ H D+KPQNL++
Sbjct: 82 SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--- 136
Query: 118 NCDIKVCDFEISRVILDGIEIR----ELLGTPDYVAPEILHYEP-ITLAADMWSLGVTAY 172
IK+ DF ++R GI +R E++ T Y APE+L P + D+WS+G
Sbjct: 137 KGVIKLADFGLARAF--GIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFA 193
Query: 173 VLLTGFSPFGGETDSE------TFRNISKAQLD--------------FP-------DELF 205
+ T F G DSE FR + D FP
Sbjct: 194 EMATKKPLFHG--DSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAV 251
Query: 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+++ + D + K+LI +P +R++AK+AL HP+
Sbjct: 252 KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 40/141 (28%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYV 148
S+L ++H ++I H DIKP N+ + +K+ D + R L+GTP Y+
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--ETFRNISKAQLDFPDELFE 206
+PE +H +D+WSLG Y + SPF G+ + + I K D+P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPAD 231
Query: 207 DISPEAKDFIAKILIKNPMER 227
S E +D +++ + +P +R
Sbjct: 232 HYSEELRDLVSRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L LA+LH K+ H DIK QN+++ N ++K+ DF +S + + R +GTP +
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 148 VAPEILHYEPITLA-----ADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
+APE++ + A +D+WSLG+TA + G P D R + + P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPP 244
Query: 203 EL-FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+L + S + DFI L+KN + R + ++ LKHP++
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 43/238 (18%)
Query: 41 SPSPRIVKLHDVFQTGEGAYYVSWNTP---LVVTLQTIIDDNLVVP-----FESDELS-S 91
S P +V LH FQT ++V L+ +Q +P F S E+S +
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLA 108
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAP 150
L +LH R I + D+K N+++ + IK+ D+ + + I G GTP+Y+AP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165
Query: 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET---------FRNISKAQLDFP 201
EIL E + D W+LGV + ++ G SPF S+ F+ I + Q+ P
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAK------EALKHP------W-LMNKKQIM 246
L S +A + L K+P ER+ + HP W L+ +KQ++
Sbjct: 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVL 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 49/233 (21%)
Query: 46 IVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--------NLVVPFESDELSSLAYLHH 97
IV+L DV + + Y V L + L+ +D L+ + L +AY H
Sbjct: 63 IVRLQDVVHSEKRLYLVF--EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL---LGTPDYVAPEIL- 153
++ H D+KPQNL++ D +K+ DF ++R GI +R + T Y APEIL
Sbjct: 121 HRVLHRDLKPQNLLI--DRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176
Query: 154 ---HYEPITLAADMWSLG------VTAYVLLTGFSPFG---------GETDSETFRNISK 195
HY + D+WS+G V L G S G + ET+ ++
Sbjct: 177 GSRHY---STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 196 A---QLDFPDELFEDI-------SPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ FP +D+ P D ++K+L +P +R+TA+ AL+H +
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 33/239 (13%)
Query: 14 TGEVFAAKFLESNPVR-------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW-- 64
T ++A K ++ V + E + S P +V LH FQT ++V
Sbjct: 19 TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78
Query: 65 -NTPLVVTLQ---TIIDDNLVVPFESDELS-SLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
L+ +Q + +++ F S E+S +L YLH R I + D+K N+++ +
Sbjct: 79 NGGDLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---G 133
Query: 120 DIKVCDFEISRVIL-DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
IK+ D+ + + L G GTP+Y+APEIL E + D W+LGV + ++ G
Sbjct: 134 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
Query: 179 SPFG--GETDSET-------FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
SPF G +D+ F+ I + Q+ P +S +A + L K+P ER+
Sbjct: 194 SPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 47/189 (24%), Positives = 74/189 (39%), Gaps = 42/189 (22%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---------GIEIR 139
L + YLH I H DIK N+++ +K+ DF ++R G R
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDN---QGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 140 ELLG---TPDYVAPE-ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD--------- 186
+ T Y PE +L T A D+W +G + T G++D
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 187 ------SETFRNISK-----AQLDFPD------ELFEDISPEAKDFIAKILIKNPMERMT 229
ET+ F + E F + PE D ++K+L +P +R+T
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 230 AKEALKHPW 238
A +AL+HP+
Sbjct: 302 ASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 39/102 (38%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS--KAQLD 199
+GTPDY+APE+ D WSLGV Y +L G+ PF ET ET+R + K L
Sbjct: 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV 256
Query: 200 FPDELFEDISPEAKDFIAKILI--KNPMERMTAKEALKHPWL 239
FP E+ IS +AKD I + +N + +E HP+
Sbjct: 257 FPPEV--PISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 43 SPRIVKLHDVFQTGEGAYYVSWNTP--LVVTLQTIIDDNLVVP------FESDELSSLAY 94
SP +V+L FQ Y V P +V L + N VP + ++ + +L
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDA 157
Query: 95 LHHRKIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPE 151
+H H D+KP N+++ G D C ++ +G + +GTPDY++PE
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----MKMNKEGMVRCDTAVGTPDYISPE 213
Query: 152 ILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDELF 205
+L + D WS+GV Y +L G +PF ++ T+ I K L FPD+
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD-- 271
Query: 206 EDISPEAKDFIAKILIKNPME--RMTAKEALKHPWLMNKK 243
DIS EAK+ I L + R +E +H + N +
Sbjct: 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 30 IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLV-VTLQTIIDDNLVVPF 84
+ E + S +P +V LH FQT + YV+ + + Q + + +
Sbjct: 42 VQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY 101
Query: 85 ESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV-ILDGIEIRELLG 143
++ +L +LH R I + D+K N+++ D IK+ D+ + + + G G
Sbjct: 102 AAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGDTTSTFCG 158
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---ETFRNISKAQLDF 200
TP+Y+APEIL E + D W+LGV + ++ G SPF TD+ T + + L+
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
Query: 201 PDELFEDISPEAKDFIAKILIKNPMERM 228
P + +S +A + L K+P ER+
Sbjct: 219 PIRIPRFLSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 35/181 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC-DIKVCDFEISRVILDGI-EIRELLGTPD 146
LS +A+LH I H D+K NL++ N +K+CDF ++R + +L+ T
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICDFGLAREYGSPLKPYTQLVVTLW 171
Query: 147 YVAPEILHYEPI-TLAADMWSLG------VTAYVLLTG----------FSPFGGETDSE- 188
Y APE+L + A DMWS+G +T L G F G T+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231
Query: 189 -TFRNISKAQLDFPDELFE----------DISPEAKDFIAKILIKNPMERMTAKEALKHP 237
F + A+ + +S D + ++L +P +R++A++ALKHP
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291
Query: 238 W 238
+
Sbjct: 292 Y 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDY 147
L L++LH K+ H DIK QN+++ N ++K+ DF +S + + R +GTP +
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 148 VAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-FP 201
+APE++ + +D+WSLG+TA + G P D R + + P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPAP 234
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ S + + FI L+KN +R T ++ +KHP++
Sbjct: 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 8/150 (5%)
Query: 94 YLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152
YL I + D+KP+NL++ D F IK+ DF ++V+ L GTP+Y+APEI
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGF----IKMTDFGFAKVV--DTRTYTLCGTPEYIAPEI 199
Query: 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212
L AAD W+LG+ Y +L G PF ++ I + + FP L +
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259
Query: 213 KDFIAKILIKNPME-RMTAKEALKHPWLMN 241
K ++ L K + A+ +HPW N
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 64/206 (31%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD-IKVCDFEISRVI---------LDGIEI 138
L+ + YLH + H D+KP N+++MG+ P +K+ D ++R+ LD + +
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 139 RELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNI 193
T Y APE+L HY T A D+W++G LLT F G E +
Sbjct: 178 -----TIWYRAPELLLGARHY---TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229
Query: 194 SKAQLD-------FPDE--------------LFEDI--------------------SPEA 212
+ QL+ P E L +D +
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289
Query: 213 KDFIAKILIKNPMERMTAKEALKHPW 238
D + K+L +P +R+TA+EAL+HP+
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 60/267 (22%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL--V 81
+++ R + E+ LL C I+ L +VF T + + + LV+ L +D NL V
Sbjct: 61 QTHAKRAYRELVLLK-CVNHKNIISLLNVF-TPQKSLEEFQDVYLVMEL---MDANLCQV 115
Query: 82 VPFESDE----------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131
+ E D L + +LH I H D+KP N+V+ D C +K+ DF ++R
Sbjct: 116 IHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLART 172
Query: 132 ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD----- 186
+ + T Y APE++ D+WS+G L+ G F G TD
Sbjct: 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG-TDHIDQW 231
Query: 187 ------------------SETFRNISKAQLDFPDELFEDISP----------------EA 212
T RN + + +P FE++ P +A
Sbjct: 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQA 291
Query: 213 KDFIAKILIKNPMERMTAKEALKHPWL 239
+D ++K+L+ +P +R++ EAL+HP++
Sbjct: 292 RDLLSKMLVIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 33/179 (18%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L Y+H I H D+KP NL + D C++K+ DF ++R E+ + T Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNED---CELKILDFGLARHA--DAEMTGYVVTRWYR 181
Query: 149 APE-ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---------------------- 185
APE IL++ D+WS+G +LTG + F G+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241
Query: 186 -DSETFRNISKAQLDFPDE----LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ + ++ K+ +P + LF SP+A D + K+L + +R+TA EAL+HP+
Sbjct: 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 99 KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HY 155
KI H D+KP N+++ N +IK+CDF IS ++D I G Y+APE +
Sbjct: 128 KIIHRDVKPSNILLDR---NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA------QLDFPDELFEDIS 209
+ + +D+WSLG+T Y + TG P+ + F +++ L E E S
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPILS-NSEERE-FS 240
Query: 210 PEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSC 254
P +FI LIK+ +R KE L+HP++ + ++ V
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQ 285
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 70/295 (23%), Positives = 118/295 (40%), Gaps = 68/295 (23%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIALLSLC------SPSPRIVKLHDVFQTGEGAYY 61
+A + T ++A K L V + +++A + + + +V+L+ FQ + Y+
Sbjct: 19 LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78
Query: 62 VSWNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
V P L++ + I ++L + ++ ++ +H H DIKP N+++ D
Sbjct: 79 VMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137
Query: 116 FPNCDIKVCDFEI---------SRVILDGIEIRE-------------------------- 140
IK+ DF + S+ G +R+
Sbjct: 138 ---GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLER 194
Query: 141 -------------LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS 187
L+GTP+Y+APE+L T D WS+GV Y +L G PF +T
Sbjct: 195 RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254
Query: 188 ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPWL 239
ET + Q +SPEA D I K L + P +R+ A E HP+
Sbjct: 255 ETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 4/79 (5%)
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS--KAQLD 199
+GTPDY+APE+ D WSLGV Y +L G+ PF ET ET++ + K L
Sbjct: 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI 256
Query: 200 FPDELFEDISPEAKDFIAK 218
FP E+ IS +AKD I +
Sbjct: 257 FPPEV--PISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 67/276 (24%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
T E+ A K + E P EI LL IV+L+DV + +
Sbjct: 24 THEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHS---------DKK 73
Query: 68 LVV--------------TLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMM 113
L + + ID +V F L LA+ H + H D+KPQNL++
Sbjct: 74 LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN 133
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIR----ELLGTPDYVAPEILHYEPI-TLAADMWSLG 168
N ++K+ DF ++R GI +R E++ T Y P++L + + + DMWS G
Sbjct: 134 K---NGELKLADFGLARAF--GIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAG 187
Query: 169 VTAYVLLTGFSP-FGGETDSETFRNISK-------------AQL-DFPD----------- 202
L P F G + + I + ++L D+
Sbjct: 188 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLV 247
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ ++ +D + +L+ NP++R++A+EAL+HP+
Sbjct: 248 NVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTP 145
+ L LAYLH + H DIK N+++ N D+K+ DF ++ I I R+ +GTP
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTD---NGDVKLADFGVAAKITATIAKRKSFIGTP 170
Query: 146 DYVAPEILHYEP---ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
++APE+ E D+W++G+TA L P +SK+ P
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PP 229
Query: 203 ELFEDI--SPEAKDFIAKILIKNPMERMTAKEALKH 236
+L + S +F+ L KNP +R TA+ L H
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 8/166 (4%)
Query: 75 IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134
+ +N V + L + Y+H R+I H D+K +N+ + + +K+ DF +SR+++
Sbjct: 102 TLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMG 157
Query: 135 GIEI-RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI 193
++ GTP Y++PE L ++ +D+WSLG Y + F G+ I
Sbjct: 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
Query: 194 SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ P L E S + + +L K+P R +A E L++P++
Sbjct: 218 VEG--PTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 69/255 (27%), Positives = 106/255 (41%), Gaps = 69/255 (27%)
Query: 30 IHHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFE-- 85
+ HE I LL + +P+ I ++V+ LV L D N +V +
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVY--------------LVTNLMGA-DLNNIVKCQKL 115
Query: 86 SDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
SDE L L Y+H I H D+KP N+ + D C++++ DF ++R D
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED---CELRILDFGLARQADD-- 170
Query: 137 EIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET------- 185
E+ + T Y APEI+ HY D+WS+G LL G + F G
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQ---TVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227
Query: 186 --------DSETFRNISK-------------AQLDFPDELFEDISPEAKDFIAKILIKNP 224
E + IS Q D ++F +P A D + K+L+ +
Sbjct: 228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL-KKIFRGANPLAIDLLEKMLVLDS 286
Query: 225 MERMTAKEALKHPWL 239
+R++A EAL HP+
Sbjct: 287 DKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 63/247 (25%), Positives = 95/247 (38%), Gaps = 73/247 (29%)
Query: 46 IVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-------NLVVPFESDELSSLAYLHHR 98
IV LHD+ T + V L L+ +DD + V F L LAY H R
Sbjct: 65 IVTLHDIIHTKKTLTLVF--EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 99 KIAHLDIKPQNLVM--MGDFPNCDIKVCDFEISRVILDGIEIRE---------------L 141
++ H D+KPQNL++ G ++K+ DF ++R + + L
Sbjct: 123 RVLHRDLKPQNLLISERG-----ELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVL 175
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-------------- 187
LG+ +Y + + DMW +G Y + TG F G TD
Sbjct: 176 LGSTEY-----------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224
Query: 188 --ETFRNISK----AQLDFPDELFE---------DISPEAKDFIAKILIKNPMERMTAKE 232
ET+ +S FP D P ++ K L P +R++A E
Sbjct: 225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284
Query: 233 ALKHPWL 239
A+KHP+
Sbjct: 285 AMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 7/173 (4%)
Query: 68 LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127
+V + ++ +V+ + +S+++Y+H I H DIK N+ + IK+ DF
Sbjct: 90 IVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFG 146
Query: 128 ISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD 186
IS+++ + E ++GTP Y++PE+ +D+W+LG Y LLT F
Sbjct: 147 ISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
Query: 187 SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
I Q ++ + S E + +L ++P +R TA E L P L
Sbjct: 207 LNLVVKI--VQGNYTPVV-SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 51/179 (28%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L Y+H I H D+KP NL + D C++K+ DF ++R E+ + T Y
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQT--DSEMTGYVVTRWYR 182
Query: 149 APE-ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE---- 203
APE IL++ T D+WS+G +LTG F G + I K E
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 204 -----------------------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
L + +P A + + K+L+ + R+TA EAL HP+
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 30/176 (17%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNC-DIKVCDFEISRVILDGIEIRELLGTPDYVA 149
+LAY+H + I H D+KPQNL++ PN +K+CDF ++ +L G + + Y A
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLID---PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238
Query: 150 PEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGET-----------------DSETFR 191
PE+ L T D+WSLG ++ G+ F G++ D
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298
Query: 192 NISKAQLDFPD-------ELFEDISP-EAKDFIAKILIKNPMERMTAKEALKHPWL 239
N + A + FPD ++F +P +A +FI++ L P++R+ EAL P+
Sbjct: 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 76 IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR----V 131
+ +N+ + L ++YLH I H DIK N++ ++K+ DF S+ +
Sbjct: 103 LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS---VGNVKLGDFGASKRLQTI 159
Query: 132 ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFR 191
L G ++ + GTP +++PE++ E AD+WS+G T +LT P+ + E
Sbjct: 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMA 216
Query: 192 NISK-AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
I K A L +S +DF+ +I ++ + R +A E L+H
Sbjct: 217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKL-RPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-----LDGIEIRELLGTPD 146
L LH I H DIK +N+ + D I +CD+ + ++I DG T D
Sbjct: 122 LNDLHKHNIIHNDIKLENV--LYDRAKDRIYLCDYGLCKIIGTPSCYDG--------TLD 171
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK----AQLDFPD 202
Y +PE + ++ D W++GV Y LLTG PF + D + ++ Q P
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF--KEDEDEELDLESLLKRQQKKLP- 228
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTA-KEALKHPWL 239
+++S A DF+ +L N R+T E +KHP+L
Sbjct: 229 -FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI------KVCDFEISRVILDGIEIRELL- 142
+++ Y+H + + H D+KP N +++G F I E ++ ++ R +
Sbjct: 124 ATIEYVHSKGVLHRDLKPDN-ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 143 ----------GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN 192
GTPDY+APE L P + + D+++LGV Y +LT P+ + R
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY----RRKKGRK 238
Query: 193 IS-KAQLDFPDEL--FEDISPEAKDFIAKILIKNPMERMTAKEALK 235
IS + + P E+ + +I P K L +P ER ++ + LK
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284
|
Length = 932 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 44/191 (23%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L + +LH I H D+KP N+V+ D C +K+ DF ++R + + T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYR 184
Query: 149 APEILHYEPITLAADMWSLG------VTAYVLLTG----------FSPFGGETDS----- 187
APE++ D+WS+G + VL G G +D
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 188 -ETFRNI----------SKAQLDFPDELFEDISPE--------AKDFIAKILIKNPMERM 228
T RN S +L FPD LF S A+D ++K+L+ +P +R+
Sbjct: 245 QPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303
Query: 229 TAKEALKHPWL 239
+ +AL+HP++
Sbjct: 304 SVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 49/206 (23%)
Query: 78 DNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129
DN+ PF + L L YLH I H D+K NL++ +K+ DF ++
Sbjct: 99 DNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD---KGCLKIADFGLA 155
Query: 130 RVILDGIEIRELLGTPD-----YVAPEIL-HYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
R G+ + + TP Y APE+L T A DMW++G LL G
Sbjct: 156 RTY--GLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211
Query: 184 ETDSETFRNISKAQLDFPDE-LFEDIS--PEAKDFIAK---------------------- 218
+++ E ++ L P+E ++ S P F
Sbjct: 212 KSEIEQL-DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLL 270
Query: 219 --ILIKNPMERMTAKEALKHPWLMNK 242
+L+ +P +R TA+EAL+ + K
Sbjct: 271 NFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 86 SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145
L LAYLH + H DIK N+++ +K+ DF S ++ +GTP
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFG-SASLVS--PANSFVGTP 175
Query: 146 DYVAPEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD 199
++APE++ Y+ D+WSLG+T L P +I AQ D
Sbjct: 176 YWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQND 230
Query: 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243
P D S ++F+ L K P +R +++E LKH +++ ++
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI----LDGIEIRELLGT 144
L ++YLH I H DIK N++ ++K+ DF S+ I + G I+ + GT
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK-AQLDFPDE 203
P +++PE++ E AD+WS+ T +LT P+ + E I K A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPM 229
Query: 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237
L + +S +DF+ +I ++ R TA+ L+HP
Sbjct: 230 LPDGVSDACRDFLKQIFVEEKR-RPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 43 SPRIVKLHDVFQTGEGAYYVSWNTP--LVVTLQTIIDDNLVVP------FESDELSSLAY 94
SP +V+L FQ + Y V P +V L + N VP + ++ + +L
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDA 157
Query: 95 LHHRKIAHLDIKPQNLVM-------MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
+H + H D+KP N+++ + DF C +K+ + + R +GTPDY
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRC-------DTAVGTPDY 209
Query: 148 VAPEILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFP 201
++PE+L + D WS+GV + +L G +PF ++ T+ I K L+FP
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
Query: 202 DELFEDISPEAKDFIAKILIKNPME--RMTAKEALKHPWLMNKK 243
+++ +IS AK+ I L + R +E +HP+ N +
Sbjct: 270 EDV--EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 47/196 (23%)
Query: 89 LSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
+ L YL + KI H D+KP N+++ +IK+CDF +S ++D + +GT Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSY 168
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF-----------------GGETDSETF 190
++PE L ++ +D+WS+G++ + G P G +SET
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228
Query: 191 -------RNISKAQLDF--PDELFE----------------DISPEAKDFIAKILIKNPM 225
R +S D P +FE E +DF+ K LIKNP
Sbjct: 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288
Query: 226 ERMTAKEALKHPWLMN 241
ER K+ + H ++
Sbjct: 289 ERADLKQLMVHAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 15 GEVFAAKFLESNPVRIH-------------HEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
GEV+ + + V + E ++ ++V+L+ V E Y
Sbjct: 20 GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYI 78
Query: 62 VS---WNTPLVVTLQTIIDDNLVVP----FESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
V+ L+ L++ L +P + +AYL R H D+ +N +++G
Sbjct: 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARN-ILVG 137
Query: 115 DFPNCDIKVCDFEISRVILDGI-EIRELLGTP-DYVAPEILHYEPITLAADMWSLGVTAY 172
+ C K+ DF ++R+I D RE P + APE +Y T+ +D+WS G+
Sbjct: 138 ENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
Query: 173 VLLT-GFSPFGGETDSETFRNISK 195
++T G P+ G T+ E + +
Sbjct: 196 EIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 35/180 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI-KVCDFEISRVILDGIEIR--ELLGTP 145
+ ++ + H I H DIKP+NL++ + D+ K+CDF +R + +G E + T
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHN----DVLKLCDFGFARNLSEGSNANYTEYVATR 165
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-- 203
Y +PE+L P A DMWS+G L G F GE++ + I K P E
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
Query: 204 -LFED-------------------------ISPEAKDFIAKILIKNPMERMTAKEALKHP 237
LF +S D + +L NP +R ++ L HP
Sbjct: 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 36/183 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD----GIEIRELLGT 144
L +L Y+H + H D+KP+N++ D C +K+CDF ++RV + I + + T
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 145 PDYVAPEIL--HYEPITLAADMWSLGVTAYVLLTGFSPFGGE---------TD------S 187
Y APE+ + T A D+WS+G +LTG F G+ TD
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 188 ETF---------RNISKAQLDFP---DELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
ET R +S + P + F + P A + ++L +P +R TA+EAL
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 236 HPW 238
P+
Sbjct: 290 DPY 292
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 55/199 (27%)
Query: 89 LSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147
L LAYL + +I H D+KP N+++ +IK+CDF +S ++D + +GT Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSY 168
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF------------------GGETDSET 189
++PE L ++ +D+WS+G++ L G P G E + +
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228
Query: 190 F--------RNISKAQLD---------------------FPDELFEDISPEAKDFIAKIL 220
R +S +D P+ +F +P+ ++F+ K L
Sbjct: 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVF---TPDFQEFVNKCL 285
Query: 221 IKNPMERMTAKEALKHPWL 239
IKNP ER K + H ++
Sbjct: 286 IKNPAERADLKMLMNHTFI 304
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 7/142 (4%)
Query: 94 YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR-ELLGTPDYVAPEI 152
++H +++ H DIK +N+ + N +K+ DF +R++ +GTP YV PEI
Sbjct: 115 HIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212
P +D+WSLG Y L T PF + + + L S E
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY---KPLPSHYSYEL 228
Query: 213 KDFIAKILIKNPMERMTAKEAL 234
+ I ++ +NP R +A L
Sbjct: 229 RSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 7e-10
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ YL +K H D+ +N ++G+ K+ DF +SR + D R+ G +
Sbjct: 118 MEYLASKKFVHRDLAARN-CLVGEDLVV--KISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK-AQLDFPDELFE 206
APE L T +D+WS GV + + T G +P+ G ++ E + K +L P E
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP----E 230
Query: 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236
E + + +P +R T E ++
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 26/174 (14%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L +LH I H D+KP+N+++ +K+ DF ++R+ + + ++ T Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTS---GGQVKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF----------------RN 192
APE+L DMWS+G + F G ++++ R+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 193 ISKAQLDFP-------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
++ + F + +I + ++L NP +R++A AL+HP+
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 9e-10
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 46/244 (18%)
Query: 34 IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLA 93
I+LL++ +P + + DV+ E + L +Q +D + L +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVME-----LMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 94 YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153
+LH I H D+KP N+V+ D C +K+ DF ++R + + T Y APE++
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 154 HYEPITLAADMWSLG------VTAYVLLTGFS----------------PFGGETDSETFR 191
D+WS+G V +L G P + T R
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 192 NISKAQLD---------FPDELFEDIS-------PEAKDFIAKILIKNPMERMTAKEALK 235
N + + FPD LF S +A+D ++K+L+ +P +R++ EAL+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310
Query: 236 HPWL 239
HP++
Sbjct: 311 HPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 14/145 (9%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP-DY 147
+ YL ++ H D+ +N+++ + +K+ DF + R + + + E L P +
Sbjct: 110 MRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA--QLDFPDEL 204
APE L + A+D+W GVT + + T G P+ G + S+ + I K +L+ P
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP--- 223
Query: 205 FEDISPEAKDFIAKILIKNPMERMT 229
E + + + + NP +R T
Sbjct: 224 -EACPQDIYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 37/139 (26%), Positives = 66/139 (47%), Gaps = 4/139 (2%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYV 148
S++ ++H R++ H DIKP N+ + +K+ D + R L+GTP Y+
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI 208
+PE +H +D+WSLG Y + SPF G+ + Q D+P E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 209 SPEAKDFIAKILIKNPMER 227
S + ++ ++ + +P +R
Sbjct: 234 SEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 65/243 (26%)
Query: 46 IVKLHDVFQTGEGAYYV--SWNTPLVVTLQTI---IDDNLVVPFESDELSSLAYLHHRKI 100
IV LHD+ T E +V +T L + + V F L LAY+H + I
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 101 AHLDIKPQNLVM--MGDFPNCDIKVCDFEISR-------------VILDGIEIRELLGTP 145
H D+KPQNL++ +G ++K+ DF ++R V L LLG
Sbjct: 125 LHRDLKPQNLLISYLG-----ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD----------------SET 189
DY + A D+W G +L G F G +D +T
Sbjct: 180 DY-----------SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 190 FRNISKA-------QLDFPDELFEDI------SPEAKDFIAKILIKNPMERMTAKEALKH 236
+ +SK L + + P+A+D +++L+ P +R++A++AL H
Sbjct: 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288
Query: 237 PWL 239
P+
Sbjct: 289 PYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 8/141 (5%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDYV 148
S+L ++H R++ H DIKP N+ + +K+ D + R L+GTP Y+
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA--QLDFPDELFE 206
+PE +H +D+WSLG Y + SPF G D ++ K Q D+P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 231
Query: 207 DISPEAKDFIAKILIKNPMER 227
S E + + + +P +R
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 38/182 (20%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDY 147
L ++ + H H D+KP+N+++ IK+CDF +R++ G + + + T Y
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166
Query: 148 VAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA------- 196
APE+L Y P D+W++G LLTG + G++D + I K
Sbjct: 167 RAPELLVGDTQYGP---PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223
Query: 197 --------------QLDFPDEL------FEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
+ P+ F +IS A F+ L +P ER++ +E L+H
Sbjct: 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283
Query: 237 PW 238
P+
Sbjct: 284 PY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTP 145
+ L L YLH + H DIK N+++ N +K+ DF +S I I R+ +GTP
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTD---NGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 146 DYVAPEILHYEP---ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
++APE+ E D+W++G+TA L P ++K+ P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PP 229
Query: 203 ELFEDI--SPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+L + + S F+ L KNP +R TA++ L+HP+
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDY 147
L + + H I H DIKP+N+++ + +K+CDF +R + E+ + + T Y
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWY 166
Query: 148 VAPEILHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK----------- 195
APE+L + A D+W++G +LTG F G++D + +I K
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 196 --------AQLDFPD--------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
A + P+ + F +S D + L +P +R ++ + L H +
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L L +LH ++ H D+KPQN+++ + IK+ DF ++R+ + + ++ T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYR 176
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI-----SKAQLDFPDE 203
APE+L D+WS+G + F G +D + I + D+P +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236
Query: 204 ------------------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
DI KD + K L NP +R++A AL HP+
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 54/194 (27%), Positives = 78/194 (40%), Gaps = 45/194 (23%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR-----VILDGIEIRE--- 140
L+ L LH H D+ P N + + C K+ DF ++R D + E
Sbjct: 129 LNGLNVLHKWYFMHRDLSPAN-IFINSKGIC--KIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 141 --LLGTPD-----YVAPEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGE-------- 184
T Y APE+L E A DMWS+G LLTG F GE
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 185 ------TDSET----------FRNISKAQ-LDFPDELFEDISPEAKDFIAKILIKNPMER 227
T +E + + + D +F + S +A D + +L NP+ER
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLER 304
Query: 228 MTAKEALKHPWLMN 241
++AKEALKH + +
Sbjct: 305 ISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 44/177 (24%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 45 RIVKLHDVFQTGEGAYYVS---WNTPLVVTLQTIIDDNLVVP----FESDELSSLAYLHH 97
++V+L+ V E Y ++ L+ L++ +++P F + +AY+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP-DYVAPEILHY 155
+ H D++ N V++ + C K+ DF ++RVI D RE P + APE +++
Sbjct: 122 KNYIHRDLRAAN-VLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 156 EPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL-----DFPDELFE 206
T+ +D+WS G+ Y ++T G P+ G ++S+ + + + PDEL++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL-LGTP 145
+ L L +LH K H D+K N+++ + +K+ DF +S + R +GTP
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 146 DYVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200
++APE++ E D+WSLG+TA L G P D R + K +
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---DLHPMRALFKIPRNP 245
Query: 201 PDELF--EDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P L E S E DFI K L K+ +R T + L+H ++
Sbjct: 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 29 RIHHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFES 86
R+ H+ I+L ++CS + + ++ + G ++ V+ + ++ID
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID------MAC 111
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP- 145
+AYL + H D+ +N +++G+ C KV DF ++R+I + + + P
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARN-ILVGEDLVC--KVADFGLARLIKEDVYLSSDKKIPY 168
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNI 193
+ APE + + +D+WS G+ Y + T G P+ G + E + I
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 62/251 (24%)
Query: 46 IVKLHDVFQTGEGAYYVSWNTP----LVVTLQTIIDDNLVVPFESDELS-SLAYLHHRKI 100
+VKL+ FQ + Y+V P + + ++ + ++ F EL+ ++ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 101 AHLDIKPQNLVMMGDFPNCDIKVCDFEI---------SRVILDGIEIRE----------- 140
H DIKP N+++ D IK+ DF + S+ G IR+
Sbjct: 123 IHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 141 ----------------------------LLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
L+GTP+Y+APE+L + T D WS+GV +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 173 VLLTGFSPFGGETDSETFRNIS--KAQLDFPDELFEDISPEAKDFIAKILI--KNPMERM 228
+L G PF T +ET + + L P ++ +SPEA D I K+ + + R
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV--KLSPEAVDLITKLCCSAEERLGRN 297
Query: 229 TAKEALKHPWL 239
A + HP+
Sbjct: 298 GADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 14/172 (8%)
Query: 29 RIHHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFES 86
++ H I L ++C+ I + ++ + G Y+ + L +ID V
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVA--- 113
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP 145
S +AYL + H D+ +N V++G+ C KV DF ++RVI + I E RE P
Sbjct: 114 ---SGMAYLEAQNYIHRDLAARN-VLVGENNIC--KVADFGLARVIKEDIYEAREGAKFP 167
Query: 146 -DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ APE Y ++ +D+WS G+ ++T G P+ G T++E + + +
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 54/245 (22%), Positives = 102/245 (41%), Gaps = 48/245 (19%)
Query: 34 IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLA 93
I LL++ +P + + DV+ E + L +Q +D + L +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVME-----LMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 94 YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153
+LH I H D+KP N+V+ D C +K+ DF ++R + + T Y APE++
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------ 201
D+WS+G ++ G F G + + + + QL P
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-QLGTPCPEFMKKLQPTV 256
Query: 202 ---------------DELFEDI------------SPEAKDFIAKILIKNPMERMTAKEAL 234
++LF D+ + +A+D ++K+L+ + +R++ EAL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 235 KHPWL 239
+HP++
Sbjct: 317 QHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE--LLGTPD 146
L L +LH+ +I H D+K N+++ + +K+ DF +S L +R +GTP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVS-AQLTSTRLRRNTSVGTPF 193
Query: 147 YVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP 201
++APE++ E D+WSLG+TA L G P D + + K + P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKIPRNPP 250
Query: 202 DELF--EDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
L E FI++ LIK+ R + L+HP++
Sbjct: 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 3e-08
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 8/116 (6%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD---YV 148
+ YL + H D+ +N ++ + K+ DF +SR I + R+ G ++
Sbjct: 115 MEYLESKNFVHRDLAARN-CLVTENLVV--KISDFGLSRDIYEDDYYRKRGGGKLPIKWM 171
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK-AQLDFPD 202
APE L T +D+WS GV + + T G P+ G ++ E + +L P+
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPE 227
|
Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 91 SLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149
+L YLH ++I H D+ P N +M+G+ + + + DF +++ ++ ++GT Y
Sbjct: 125 ALRYLHKEKRIVHRDLTPNN-IMLGE--DDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-FPDELFEDI 208
PEI+ EP AD+W+ G Y + T PF I +A + P+ ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY--- 238
Query: 209 SPEAKDFIAKILIKNPMER 227
S + D I L + R
Sbjct: 239 SEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 61/261 (23%), Positives = 113/261 (43%), Gaps = 55/261 (21%)
Query: 14 TGEVFAAKFLESNPVRIH-------HEIALLSLCSPS--PRIVKLHDVFQT--------- 55
TG+++A K L+ +++ +E +LSL S P IV + F T
Sbjct: 18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77
Query: 56 ----GEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLV 111
G+ Y++S + + + + + ++ + L ++H+R + + D+KP N +
Sbjct: 78 LMNGGDLHYHLSQHG--------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN-I 128
Query: 112 MMGDFPNCDIK----VCDFEISRVILDGIEIRELLGTPDYVAPEILH----YEPITLAAD 163
++ + + I CDF + +GT Y+APE+L Y+ +AD
Sbjct: 129 LLDEHGHVRISDLGLACDFSKKKP-------HASVGTHGYMAPEVLQKGVAYDS---SAD 178
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223
+SLG + LL G SPF + I + L EL + SPE + + +L ++
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRD 237
Query: 224 PMERM-----TAKEALKHPWL 239
R+ A+E +HP+
Sbjct: 238 VNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L LAYLH + H DIK N+++ P +K+ DF + + +GTP ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTE--PG-QVKLADFGSASIASPA---NSFVGTPYWM 188
Query: 149 APEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
APE++ Y+ D+WSLG+T L P +I AQ + P
Sbjct: 189 APEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPT 243
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243
+ S ++F+ L K P +R T++E LKH +++ ++
Sbjct: 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 9e-08
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 76 IDDNLVVPFESDELSSLAYLHHRK-------IAHLDIKPQNLVMMGDFPNCD-------- 120
I+++ +V L +LAY H+ K + H D+KPQN+ + +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 121 ------IKVCDFEISRVILDGIE--IRELLGTPDYVAPEILHYEPITL--AADMWSLGVT 170
K+ DF +S+ I GIE +GTP Y +PE+L +E + +DMW+LG
Sbjct: 175 LNGRPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y L +G +PF + F + PD + S E I +L + ER +A
Sbjct: 233 IYELCSGKTPF---HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA 289
Query: 231 KEALKHPWLMNKKQIMTRVG 250
+ L + QI+ VG
Sbjct: 290 LQCLGY-------QIIKNVG 302
|
Length = 1021 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 73/282 (25%), Positives = 108/282 (38%), Gaps = 66/282 (23%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDV---------FQTGEG 58
TGE+ A K + E P+ EI +L + IV L ++ F+ +G
Sbjct: 31 TGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKG 89
Query: 59 AYYVSWNTPLVVTLQTIIDDNLVVPFESDELSS--------LAYLHHRKIAHLDIKPQNL 110
A+Y+ + + L +++ LV F D + S L Y H + H DIK N+
Sbjct: 90 AFYLVFEY-MDHDLMGLLESGLV-HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNI 147
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLG---TPDYVAPEIL----HYEPITLAAD 163
++ IK+ DF ++R+ E R T Y PE+L Y P A D
Sbjct: 148 LLNN---KGQIKLADFGLARLYNSE-ESRPYTNKVITLWYRPPELLLGEERYGP---AID 200
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISK-----AQLDFPD---------------- 202
+WS G L T F + IS+ +PD
Sbjct: 201 VWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY 260
Query: 203 -----ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
E F I A D + +L +P +R TA+EAL PWL
Sbjct: 261 RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 66/262 (25%), Positives = 99/262 (37%), Gaps = 63/262 (24%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--NL- 80
E P E++LL + IV LHD+ T V L L+ +D+ NL
Sbjct: 44 EGAPCTAIREVSLLKNLKHA-NIVTLHDIIHTERCLTLVF--EYLDSDLKQYLDNCGNLM 100
Query: 81 ----VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR------ 130
V F L L+Y H RKI H D+KPQNL++ ++K+ DF ++R
Sbjct: 101 SMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPT 157
Query: 131 -------VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
V L LLG+ +Y P DMW +G Y + TG F G
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTP-----------IDMWGVGCILYEMATGRPMFPG 206
Query: 184 ETDSETFRNISK--------------AQLDFPDELFEDISP------------EAKDFIA 217
T E I + + +F LF + D ++
Sbjct: 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLS 266
Query: 218 KILIKNPMERMTAKEALKHPWL 239
+L+ R++A+ AL+H +
Sbjct: 267 SLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 43/253 (16%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--NL- 80
E P E++LL + IV LHD+ T + V L L+ +DD N
Sbjct: 45 EGAPCTAIREVSLLKDLKHA-NIVTLHDIIHTEKSLTLVF--EYLDKDLKQYLDDCGNSI 101
Query: 81 ----VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV--ILD 134
V F L L Y H RK+ H D+KPQNL++ ++K+ DF ++R I
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPT 158
Query: 135 GIEIRELLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI 193
E++ T Y P+I L + DMW +G Y + TG F G T E I
Sbjct: 159 KTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
Query: 194 SK-------------------AQLDFPDELFEDISPEAK-------DFIAKILIKNPMER 227
+ ++P + + A + ++K+L +R
Sbjct: 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277
Query: 228 MTAKEALKHPWLM 240
++A+EA+KHP+
Sbjct: 278 ISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 56/236 (23%), Positives = 109/236 (46%), Gaps = 32/236 (13%)
Query: 14 TGEVFAAKFLESNPVRIH-------HEIALLSLCSPS--PRIVKLHDVFQTGEGAYYV-- 62
TG+++A K L+ +++ +E +LSL S P IV + F T + ++
Sbjct: 18 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77
Query: 63 ---SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVM--MGDFP 117
+ ++ + + + + ++ + L ++H+R + + D+KP N+++ G
Sbjct: 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137
Query: 118 NCDIKV-CDFEISRVILDGIEIRELLGTPDYVAPEILH----YEPITLAADMWSLGVTAY 172
D+ + CDF + +GT Y+APE+L Y+ +AD +SLG +
Sbjct: 138 ISDLGLACDFSKKKP-------HASVGTHGYMAPEVLQKGTAYDS---SADWFSLGCMLF 187
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
LL G SPF + ++ I + L EL + SPE K + +L ++ +R+
Sbjct: 188 KLLRGHSPF-RQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 44 PRIVKLHDVFQTGEGAYYVS---WNTPLVVTLQTIIDDNLVVPFESDELSS----LAYLH 96
PR+V+L+ V T E Y ++ N LV L+T L + D + +A++
Sbjct: 61 PRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 97 HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP-DYVAPEILH 154
+ H D++ N +++ + C K+ DF ++R+I D RE P + APE ++
Sbjct: 120 RKNYIHRDLRAAN-ILVSETLCC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 155 YEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDFPDELFEDISPEA 212
Y T+ +D+WS G+ ++T G P+ G T+ E +N+ + ++ PD E E
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE----EL 232
Query: 213 KDFIAKILIKNPMERMT 229
+ + + P ER T
Sbjct: 233 YELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 55/203 (27%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPN-CDIKVCDFEISRVILDGI----EIRELLG 143
L + YLH + H D+KP N+++MG+ P +K+ D +R+ + ++ ++
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 144 TPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFG-GETDSETFRNISKAQL 198
T Y APE+L HY T A D+W++G LLT F + D +T QL
Sbjct: 178 TFWYRAPELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
Query: 199 D-------FP-DELFEDI--------------------------------SPEAKDF--I 216
D FP D+ +EDI P++K F +
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 217 AKILIKNPMERMTAKEALKHPWL 239
K+L +P++R+T+++A++ P+
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 18/149 (12%)
Query: 67 PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126
P + LQT++ F D S + YL + H D+ +N ++ + C V DF
Sbjct: 107 PFTLPLQTLVR------FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC---VADF 157
Query: 127 EISRVILDGIEIRELLGTP---DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFG 182
+S+ I G R+ + ++A E L T +D+W+ GVT + ++T G +P+
Sbjct: 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 183 GETDSETFR-----NISKAQLDFPDELFE 206
G +SE + N K D ++++E
Sbjct: 218 GVENSEIYNYLIKGNRLKQPPDCLEDVYE 246
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 55/203 (27%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPN-CDIKVCDFEISRVILDGI----EIRELLG 143
L + YLH + H D+KP N+++MG+ P +K+ D +R+ + ++ ++
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 144 TPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFG-GETDSETFRNISKAQL 198
T Y APE+L HY T A D+W++G LLT F + D +T QL
Sbjct: 178 TFWYRAPELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234
Query: 199 D-------FP-DELFEDI--------------------------------SPEAKDF--I 216
D FP D+ +EDI P++K F +
Sbjct: 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLL 294
Query: 217 AKILIKNPMERMTAKEALKHPWL 239
K+L +P +R+T+++AL+ P+
Sbjct: 295 QKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 31/119 (26%), Positives = 60/119 (50%), Gaps = 6/119 (5%)
Query: 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-R 139
++ F + +A++ R H D++ N +++ C K+ DF ++RVI D R
Sbjct: 104 LIDFSAQIAEGMAFIEQRNYIHRDLRAAN-ILVSASLVC--KIADFGLARVIEDNEYTAR 160
Query: 140 ELLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA 196
E P + APE +++ T+ +D+WS G+ ++T G P+ G ++ E R + +
Sbjct: 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L LAYLH + H DIK N+++ P +K+ DF + +GTP ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTE--PG-QVKLADFGSASKSSPA---NSFVGTPYWM 184
Query: 149 APEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
APE++ Y+ D+WSLG+T L P +I AQ D P
Sbjct: 185 APEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNDSPT 239
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
+ + + F+ L K P ER + E L+H
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 25/131 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNL-------VMMGDF-PNCDIKVCDFEISRVILDGIEIRE 140
LS++ Y+H I H DIK +N+ + +GDF C + S GI
Sbjct: 270 LSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS---WSTPFHYGIA--- 323
Query: 141 LLGTPDYVAPEILHYEPITLAADMWSLGV--------TAYVLLTGFSPFGGETDSETFRN 192
GT D APE+L +P T + D+WS G+ TA + D++ R
Sbjct: 324 --GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI 381
Query: 193 ISKAQLDFPDE 203
I +AQ+ DE
Sbjct: 382 IRQAQVH-VDE 391
|
Length = 461 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 34/131 (25%), Positives = 71/131 (54%), Gaps = 13/131 (9%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
F +D + YL ++ H D+ +N +++G+ N K+ DF +SR + +++ +G
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARN-ILVGE--NYVAKIADFGLSRG--QEVYVKKTMG 171
Query: 144 --TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLD 199
++A E L+Y T +D+WS GV + +++ G +P+ G T +E + + + +L+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
Query: 200 FP----DELFE 206
P DE+++
Sbjct: 232 KPLNCDDEVYD 242
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIR 139
+V + S +AY+ H D++ N +++G+ N KV DF ++R+I D R
Sbjct: 104 LVDMAAQIASGMAYVERMNYVHRDLRAAN-ILVGE--NLVCKVADFGLARLIEDNEYTAR 160
Query: 140 ELLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA- 196
+ P + APE Y T+ +D+WS G+ L T G P+ G + E + +
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 220
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
++ P E E + D + + K P ER T
Sbjct: 221 RMPCPPECPESL----HDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 65 NTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
+ P + Q + V F +D S + YL + H D+ +N M+ + N ++ V
Sbjct: 104 DCPQYLPTQML------VKFMTDIASGMEYLSSKSFIHRDLAARN-CMLNE--NMNVCVA 154
Query: 125 DFEISRVILDGIEIRE--LLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSP 180
DF +S+ I +G R+ + P ++A E L T +D+WS GVT + + T G +P
Sbjct: 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
Query: 181 FGGETDSETF 190
+ G +SE +
Sbjct: 215 YPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 36/131 (27%), Positives = 73/131 (55%), Gaps = 13/131 (9%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
F SD + + YL ++ H D+ +N V++G+ N K+ DF +SR + + +++ +G
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARN-VLVGE--NLASKIADFGLSRG--EEVYVKKTMG 178
Query: 144 --TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLD 199
++A E L+Y T +D+WS GV + +++ G +P+ G T +E + + + +++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 200 FP----DELFE 206
P DE++E
Sbjct: 239 KPRNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 6/108 (5%)
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT-P-DYV 148
+LAYL ++ H DI +N+++ P+C +K+ DF +SR + D + G P ++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSS--PDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWM 175
Query: 149 APEILHYEPITLAADMWSLGVTAY-VLLTGFSPFGGETDSETFRNISK 195
APE +++ T A+D+W GV + +L+ G PF G +++ I
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140
+V F D + +AYL + H D+ +N ++G+ N +K+ DF +SR DGI
Sbjct: 95 LVKFALDAAAGMAYLESKNCIHRDLAARN-CLVGE--NNVLKISDFGMSRQEDDGIYSSS 151
Query: 141 -LLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA- 196
L P + APE L+Y + +D+WS G+ + + G P+ G T+ + + K
Sbjct: 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211
Query: 197 QLDFPDELFEDIS 209
++ P + +D+
Sbjct: 212 RMSCPQKCPDDVY 224
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 22/131 (16%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-------LDGIEIRELL 142
++YLH R + H DI +N V+ + +K+ D +SR + L E R +
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEEL---QVKITDNALSRDLFPMDYHCLGDNENRPV- 183
Query: 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK-----A 196
++A E L + + A+D+WS GV + L+T G +P+ E D K A
Sbjct: 184 ---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY-VEIDPFEMAAYLKDGYRLA 239
Query: 197 Q-LDFPDELFE 206
Q ++ PDELF
Sbjct: 240 QPINCPDELFA 250
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
L LAYLH + H D+K N+++ P +K+ DF + ++ +GTP ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSE--PG-LVKLGDFGSASIMAPA---NXFVGTPYWM 178
Query: 149 APEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202
APE++ Y+ D+WSLG+T L P +I AQ + P
Sbjct: 179 APEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPA 233
Query: 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243
S ++F+ L K P +R T++ LKH +++ ++
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT-P-DYVA 149
+ YL + H D+ +N ++G+ N +K+ DF +SR + D + G P ++A
Sbjct: 116 MEYLESKNFIHRDLAARN-CLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFPDELFED 207
PE L T +D+WS GV + + T G P+ G +++E + K L P +
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP----PN 228
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALK 235
PE + + ++P +R T E ++
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT-P-DYVA 149
+ YL + H D+ +N ++G+ N +K+ DF +SR + D R+ G P ++A
Sbjct: 115 MEYLESKNFIHRDLAARN-CLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFPDELFED 207
PE L T +D+WS GV + + T G P+ G ++ E + L P +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP----PN 227
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALK 235
PE D + + ++P +R T E ++
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 18/152 (11%)
Query: 67 PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126
P + LQT+ + F D + YL +R H D+ +N ++ D C V DF
Sbjct: 107 PEKLPLQTL------LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC---VADF 157
Query: 127 EISRVILDGIEIRE--LLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFG 182
+S+ I G R+ + P ++A E L T +D+W+ GVT + + T G +P+
Sbjct: 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217
Query: 183 GETDSETFR-----NISKAQLDFPDELFEDIS 209
G + E + N K D DEL++ +
Sbjct: 218 GVENHEIYDYLRHGNRLKQPEDCLDELYDLMY 249
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 9/121 (7%)
Query: 86 SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145
SD ++ YL H D+ +N ++G+ + +KV DF ++R +LD + GT
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARN-CLVGE--DNVVKVSDFGLARYVLDD-QYTSSQGTK 162
Query: 146 ---DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDF 200
+ PE+ Y + +D+WS GV + + + G P+ ++SE ++S +L
Sbjct: 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR 222
Query: 201 P 201
P
Sbjct: 223 P 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP-DY 147
+ +AY+ H D++ N +++GD C K+ DF ++R+I D R+ P +
Sbjct: 113 AGMAYIERMNYIHRDLRSAN-ILVGDGLVC--KIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDFPDELF 205
APE Y T+ +D+WS G+ L+T G P+ G + E + + ++ P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP---- 225
Query: 206 EDISPEAKDFIAKILIKNPMERMT 229
+D + + + K+P ER T
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDY- 147
+AYLH + H D+ +N+++ D +K+ DF +++ + +G E +RE +P +
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT 176
A E L + A+D+WS GVT Y LLT
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP-----D 146
+ YL R++ H D+ +N+++ PN +K+ DF ++R +L+G E +E
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKS--PN-HVKITDFGLAR-LLEGDE-KEYNADGGKMPIK 176
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGG 183
++A E +HY T +D+WS GVT + L+T G P+ G
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL----------DGIEIREL 141
+AYL RK H D+ +N ++ N +K+ DF +SR I D I IR
Sbjct: 143 MAYLSERKFVHRDLATRNCLVGE---NMVVKIADFGLSRNIYSADYYKASENDAIPIR-- 197
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSE 188
++ PE + Y T +D+W+ GV + + + G P+ G E
Sbjct: 198 -----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 14/125 (11%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE----LLGTPDY 147
+AYL+ K H D+ +N ++ DF +K+ DF ++R I + R+ LL +
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 187
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL-----DFP 201
++PE L T +D+WS GV + + T P+ G ++ + R + + L + P
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCP 247
Query: 202 DELFE 206
D LFE
Sbjct: 248 DMLFE 252
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP- 145
D +AYL ++ H D+ +N ++ +KV DF +SR +LD E +G+
Sbjct: 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDD-EYTSSVGSKF 163
Query: 146 --DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ PE+L Y + +D+W+ GV + + + G P+ +SET +S+
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 45/253 (17%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD----- 78
E P E++LL + IV LHD+ T + V L L+ +DD
Sbjct: 45 EGAPCTAIREVSLLKDLKHA-NIVTLHDIVHTDKSLTLVF--EYLDKDLKQYMDDCGNIM 101
Query: 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV--ILD 134
+ V F L LAY H RK+ H D+KPQNL++ ++K+ DF ++R +
Sbjct: 102 SMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPT 158
Query: 135 GIEIRELLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGET-------- 185
E++ T Y P++ L + DMW +G + + +G F G T
Sbjct: 159 KTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
Query: 186 -------DSETFRNISKAQLDFPDELFEDISP------------EAKDFIAKILIKNPME 226
ET+ IS +F + F P E + + K L +
Sbjct: 218 FRLLGTPTEETWPGISSND-EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK 276
Query: 227 RMTAKEALKHPWL 239
R++A+EA+KH +
Sbjct: 277 RISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 8/112 (7%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP- 145
D +AYL + H D+ +N ++G+ N +KV DF ++R +LD + GT
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARN-CLVGE--NQVVKVSDFGMTRFVLDD-QYTSSTGTKF 163
Query: 146 --DYVAPEILHYEPITLAADMWSLGVTAY-VLLTGFSPFGGETDSETFRNIS 194
+ +PE+ + + +D+WS GV + V G +P+ ++SE I+
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 31/92 (33%), Positives = 42/92 (45%), Gaps = 18/92 (19%)
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFS-----PFGGETDSETFRNISKAQLDFP 201
Y APE+ T A D WSLG + LLTG + P G T + L+ P
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT---------TLNIP 198
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
E +S EA+ + ++L NP ER+ A A
Sbjct: 199 ----EWVSEEARSLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 11 SIATGEVFAAKFLESNPV--RIHHE--IALLSLCSPSPRIV--------KLHDVFQTGEG 58
++ G + FL+ + ++ H+ + L ++ S P + L D + G+G
Sbjct: 37 TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDG 96
Query: 59 AYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
Y P +V + I D +AY+ H D++ N +++GD N
Sbjct: 97 KYL---KLPQLVDMAAQIAD------------GMAYIERMNYIHRDLRAAN-ILVGD--N 138
Query: 119 CDIKVCDFEISRVILDG-IEIRELLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
K+ DF ++R+I D R+ P + APE Y T+ +D+WS G+ L+T
Sbjct: 139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
Query: 177 -GFSPFGGETDSETFRNISKA 196
G P+ G + E + +
Sbjct: 199 KGRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 28/105 (26%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 76 IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135
I+ ++ F S + YL ++ H D+ +N+++ + + +K+ DF +++V+ +
Sbjct: 106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV--ESEDL-VKISDFGLAKVLPED 162
Query: 136 IE---IRELLGTP-DYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
+ ++E +P + APE L + A+D+WS GVT Y L T
Sbjct: 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ +L RK H D+ +N+++ N +K+CDF ++R ++ PDYV
Sbjct: 192 MEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLAR---------DIYKDPDYVRKG 239
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGG-ETDSETFRNISKA- 196
APE + T+ +D+WS GV + + + G SP+ G + D E R + +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
++ PD +PE + P +R T E ++H
Sbjct: 300 RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 34/131 (25%), Positives = 71/131 (54%), Gaps = 13/131 (9%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
F +D + YL ++ H D+ +N +++G+ N K+ DF +SR + +++ +G
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARN-ILVGE--NYVAKIADFGLSRG--QEVYVKKTMG 183
Query: 144 --TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLD 199
++A E L+Y T +D+WS GV + +++ G +P+ G T +E + + + +L+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243
Query: 200 FP----DELFE 206
P DE+++
Sbjct: 244 KPLNCDDEVYD 254
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV--ILDGIEIRELLGTPD 146
L L+Y+H R I H D+KPQNL++ ++K+ DF ++R + E++ T
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISD---TGELKLADFGLARAKSVPSHTYSNEVV-TLW 168
Query: 147 YVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD-----SETFRNISKAQLD- 199
Y P++ L + DMW +G ++ G + F G D F + D
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228
Query: 200 ---------FPDELFEDISPE--------------AKDFIAKILIKNPMERMTAKEALKH 236
F E F SP+ A+D +K+L P R++A+ AL H
Sbjct: 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288
Query: 237 PWL 239
+
Sbjct: 289 EYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 34/134 (25%), Positives = 62/134 (46%), Gaps = 27/134 (20%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-----------GIEI 138
+ + YL H D+ +N+++ N + KV DF +SRV+ D I I
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK-- 195
R + APE + Y T A+D+WS G+ + +++ G P+ ++ E + I+
Sbjct: 175 R-------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 196 ---AQLDFPDELFE 206
A +D P +++
Sbjct: 228 RLPAPMDCPSAVYQ 241
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 41 SPSPRIVKLHDVFQTGEGAYYV-----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYL 95
S SP IV L+ Q+ Y V + ++ + D+ + V + S+ +L YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 96 HHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150
H I H D+KP N+++ + IK+ DF +S+V L+ + + ++L TP P
Sbjct: 121 HRHGIIHRDLKPDNMLISNE---GHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 76 IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC--DFEISRVIL 133
ID L++ E L L YLH ++I H D+K +N+ F N +VC D ++ +
Sbjct: 156 IDQALII--EKQILEGLRYLHAQRIIHRDVKTENI-----FINDVDQVCIGDLGAAQFPV 208
Query: 134 DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
L GT + APE+L + AD+WS G+ + +L
Sbjct: 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 9/119 (7%)
Query: 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140
++ E L ++ YLH +I H DIK +N+ + + P D+ + DF + +D +
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFI--NHPG-DVCLGDFGAACFPVDINANKY 240
Query: 141 L--LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG----FSPFGGETDSETFRNI 193
GT APE+L +P A D+WS G+ + + T F G + D ++ R I
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 36/140 (25%), Positives = 63/140 (45%), Gaps = 33/140 (23%)
Query: 64 WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
W +PL ++D + F+ + +L RK H D+ +N+++ N +K+
Sbjct: 167 WKSPLT------MEDLICYSFQVAR--GMEFLASRKCIHRDLAARNILLS---ENNVVKI 215
Query: 124 CDFEISRVILDGIEIRELLGTPDYV------------APEILHYEPITLAADMWSLGVTA 171
CDF ++R ++ PDYV APE + + T +D+WS GV
Sbjct: 216 CDFGLAR---------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 266
Query: 172 YVLLT-GFSPFGGETDSETF 190
+ + + G SP+ G +E F
Sbjct: 267 WEIFSLGASPYPGVQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 36/129 (27%), Positives = 54/129 (41%), Gaps = 24/129 (18%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIK--------VCDFEISRVILDGIEIRE 140
L ++ Y+H +K+ H DIK +N+ F NCD K FE R D
Sbjct: 277 LCAVEYIHDKKLIHRDIKLENI-----FLNCDGKIVLGDFGTAMPFEKEREAFD----YG 327
Query: 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDS------ETFRNI 193
+GT +PEIL + D+WS G+ +L+ F P G + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387
Query: 194 SKAQLDFPD 202
S +FPD
Sbjct: 388 SVCDEEFPD 396
|
Length = 501 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 7/87 (8%)
Query: 94 YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDY-VA 149
YL R+ H D+ +N+++ + +K+ DF +++ I E +++ L +P + A
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLT 176
PE L +A+D+WS GVT Y LLT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 37/167 (22%)
Query: 50 HDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQN 109
D+F YV + PL L+ I + L +LAYLH R I H D+K +N
Sbjct: 170 CDLFT------YVDRSGPL--PLEQAI------TIQRRLLEALAYLHGRGIIHRDVKTEN 215
Query: 110 L-------VMMGDF-PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLA 161
+ ++GDF C + D + GT + +PE+L +P
Sbjct: 216 IFLDEPENAVLGDFGAACKLDAHP--------DTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 162 ADMWSLGVTAYVLLTGFSPFGG---ETDSETFRNISKA----QLDFP 201
D+WS G+ + + G ++ S R+I + L+FP
Sbjct: 268 TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314
|
Length = 392 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 47/187 (25%), Positives = 71/187 (37%), Gaps = 43/187 (22%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-- 146
L+ L Y+H KI H D+K N+++ D +K+ DF ++R + T
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 147 ---YVAPEIL----HYEPITLAADMWSLGV------TAYVLLTG---------FSPFGGE 184
Y PE+L Y P DMW G T ++ G S G
Sbjct: 186 TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242
Query: 185 TDSETFRNISKAQLDFPDELFEDI-------------SPEAKDFIAKILIKNPMERMTAK 231
E + + K +L EL + P A D I K+L+ +P +R+ A
Sbjct: 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302
Query: 232 EALKHPW 238
AL H +
Sbjct: 303 TALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP- 145
D + YL H D+ +N ++ +KV DF ++R +LD E G
Sbjct: 108 DVCEGMEYLERNSFIHRDLAARNCLVSS---TGVVKVSDFGMTRYVLDD-EYTSSSGAKF 163
Query: 146 --DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ PE+ ++ + +D+WS GV + + T G PF +++ E IS+
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE--LLGT 144
D + + YL + H D+ +N ++G+ N +K+ DF +SR GI L
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARN-CLVGE--NNVLKISDFGMSREEEGGIYTVSDGLKQI 157
Query: 145 P-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSET 189
P + APE L+Y T +D+WS G+ + + G +P+ G ++ +T
Sbjct: 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 29 RIHHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFES 86
+ H + LL +C+ L + G+ ++ N+P D+ + +
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 87 DELSSLA--------YLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI 138
+ +A YL H D+ +N ++G+ +K+ DF +SR I
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARN-CLVGEGLT--VKISDFGLSRDIYSADYY 180
Query: 139 RELLGTP---DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNIS 194
R + ++ PE + Y T +D+WS GV + + + G P+ G ++ E I
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240
Query: 195 KAQL 198
QL
Sbjct: 241 SRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 34/117 (29%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE----LLGTPDY 147
+AYL+ +K H D+ +N ++ DF +K+ DF ++R I + R+ LL +
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYETDYYRKGGKGLLPV-RW 187
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNI-SKAQLDFPD 202
+APE L T ++DMWS GV + + + P+ G ++ + + + LD PD
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 36/134 (26%), Positives = 59/134 (44%), Gaps = 27/134 (20%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----------IEI 138
S + YL H D+ +N+++ N KV DF +SRV+ D I I
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAY-VLLTGFSPFGGETDSETFRNISK-- 195
R + APE + Y T A+D+WS G+ + V+ G P+ ++ + + I +
Sbjct: 174 R-------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226
Query: 196 ---AQLDFPDELFE 206
A +D P L +
Sbjct: 227 RLPAPMDCPAALHQ 240
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 32/125 (25%), Positives = 56/125 (44%), Gaps = 22/125 (17%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-------DG---IEIREL 141
+AYL +K H D+ +N ++ D +K+ DF ++R I G + +R
Sbjct: 132 MAYLAAKKFVHRDLAARNCMVAEDL---TVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LD 199
++APE L T +D+WS GV + + T P+ G ++ E + + LD
Sbjct: 187 -----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241
Query: 200 FPDEL 204
P+
Sbjct: 242 LPENC 246
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 10/109 (9%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----IEIRELLGTP 145
S + YL H D+ +N ++ + IK+ DF +SR + G I+ R +L
Sbjct: 149 SGMKYLSSLNFVHRDLATRNCLVGENL---TIKIADFGMSRNLYAGDYYRIQGRAVLPI- 204
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAY--VLLTGFSPFGGETDSETFRN 192
++A E + T A+D+W+ GVT + ++L P+G TD + N
Sbjct: 205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 31/122 (25%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
F D + YL +K+ H D+ +N+++ D KV DF ++RV G++ +L
Sbjct: 105 FSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV---AKVSDFGLARVGSMGVDNSKL-- 159
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDFP 201
+ APE L ++ + +D+WS GV + + + G +P+ + E + K +++ P
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
Query: 202 DE 203
+
Sbjct: 220 EG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 25/112 (22%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ +L RK H D+ +N+++ N +K+CDF ++R ++ PDYV
Sbjct: 186 MEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLAR---------DIYKDPDYVRKG 233
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETF 190
APE + + T +D+WS GV + + + G SP+ G E F
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP---D 146
S++ YL + H D+ +N ++G+ N +KV DF +SR++ G
Sbjct: 115 SAMEYLEKKNFIHRDLAARN-CLVGE--NHLVKVADFGLSRLMTGDTYTAHA-GAKFPIK 170
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELF 205
+ APE L Y ++ +D+W+ GV + + T G SP+ G S+ + + K + E
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---GYRMERP 227
Query: 206 EDISPEAKDFIAKILIKNPMERMTAKE 232
E P+ + + NP +R + E
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAE 254
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 30/126 (23%), Positives = 61/126 (48%), Gaps = 12/126 (9%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPD 146
+ + YL + H D+ +N ++G+ N +K+ DF +SR + R +
Sbjct: 131 AGMVYLASQHFVHRDLATRN-CLVGE--NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL-----DF 200
++ PE + Y T +D+WSLGV + + T G P+ +++E I++ ++
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247
Query: 201 PDELFE 206
P E+++
Sbjct: 248 PKEVYD 253
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 14/159 (8%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPD 146
S + YL + H D+ +N ++G N +K+ DF +SR + R +
Sbjct: 134 SGMVYLASQHFVHRDLATRN-CLVGA--NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFPDEL 204
++ PE + Y T +D+WS GV + + T G P+ +++E I++ + L+ P
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP--- 247
Query: 205 FEDISP-EAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242
+ P E D + + P +R+ KE K + K
Sbjct: 248 --RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 46/204 (22%)
Query: 15 GEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNTPLVVTLQ 73
G V+ ++S+ +IH + L+ RI L +V Q EG ++ P V++L
Sbjct: 9 GCVYHGTLIDSDGQKIHCAVKSLN------RITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 74 TIIDDN-----LVVPF--ESDELS-----------------------SLAYLHHRKIAHL 103
I + +V+P+ D + + YL +K H
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--IEIRELLGTP---DYVAPEILHYEPI 158
D+ +N ++ F +KV DF ++R I D + G ++A E L +
Sbjct: 123 DLAARNCMLDESF---TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 159 TLAADMWSLGVTAYVLLT-GFSPF 181
T +D+WS GV + L+T G P+
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 9/97 (9%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP-DY 147
++YL +++ H D+ +N+++ P +K+ DF +++ +LD E E P +
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKT--PQ-HVKITDFGLAK-LLDVDEKEYHAEGGKVPIKW 177
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGG 183
+A E + + T +D+WS GVT + L+T G P+ G
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 33/133 (24%), Positives = 58/133 (43%), Gaps = 26/133 (19%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----------IEIR 139
S + YL H D+ +N+++ + C KV DF +SR + D I IR
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNL-VC--KVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 140 ELLGTPDYVAPEILHYEPITLAADMWSLGVTAY-VLLTGFSPFGGETDSETFRNISK--- 195
+ APE + Y T A+D+WS G+ + V+ G P+ ++ + + +
Sbjct: 174 -------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
Query: 196 --AQLDFPDELFE 206
+D P L++
Sbjct: 227 LPPPMDCPSALYQ 239
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----IEIRELLGTP 145
+ + YL H D+ +N +++G+ +K+ D +SR I ++ + LL
Sbjct: 135 AGMEYLSSHFFVHKDLAARN-ILIGE--QLHVKISDLGLSREIYSADYYRVQPKSLLPI- 190
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL 198
++ PE + Y + +D+WS GV + + + G P+ G ++ E + K QL
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 28/127 (22%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE--LLGT 144
+ + + YL + H D+ +N ++ +K+ DF +SR DG+ +
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 145 P-DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDFP 201
P + APE L+Y + +D+WS G+ + + G P+ ++ +T I + +L P
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP 218
Query: 202 DELFEDI 208
+ + +
Sbjct: 219 ELCPDAV 225
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 26/120 (21%), Positives = 59/120 (49%), Gaps = 10/120 (8%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP---- 145
+ + +L + H D+ +N+++ F ++K+ D + R + + +L+G
Sbjct: 135 AGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAA-DYYKLMGNSLLPI 190
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFPDE 203
+++PE + Y ++ +D+WS GV + + + G P+ G ++ + I Q L PD+
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDD 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 29/103 (28%), Positives = 55/103 (53%), Gaps = 11/103 (10%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG----TP-D 146
+ YL R++ H D+ +N+++ P +K+ DF +++++ G + +E P
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKT--PQ-HVKITDFGLAKLL--GADEKEYHAEGGKVPIK 176
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSE 188
++A E + + T +D+WS GVT + L+T G P+ G SE
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 383 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| KOG1095|consensus | 1025 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4257|consensus | 974 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG4278|consensus | 1157 | 99.96 | ||
| KOG0984|consensus | 282 | 99.96 | ||
| KOG0199|consensus | 1039 | 99.96 | ||
| KOG0196|consensus | 996 | 99.96 | ||
| KOG0576|consensus | 829 | 99.96 | ||
| KOG1152|consensus | 772 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| KOG0200|consensus | 609 | 99.96 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345|consensus | 378 | 99.95 | ||
| KOG3653|consensus | 534 | 99.95 | ||
| KOG2052|consensus | 513 | 99.94 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1025|consensus | 1177 | 99.93 | ||
| KOG0590|consensus | 601 | 99.92 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0603|consensus | 612 | 99.9 | ||
| KOG0606|consensus | 1205 | 99.89 | ||
| KOG1024|consensus | 563 | 99.87 | ||
| KOG1164|consensus | 322 | 99.87 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1163|consensus | 341 | 99.84 | ||
| KOG1165|consensus | 449 | 99.83 | ||
| KOG1240|consensus | 1431 | 99.83 | ||
| KOG4158|consensus | 598 | 99.82 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| KOG1033|consensus | 516 | 99.77 | ||
| KOG0195|consensus | 448 | 99.73 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG0590|consensus | 601 | 99.68 | ||
| KOG1023|consensus | 484 | 99.65 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG1166|consensus | 974 | 99.59 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0606|consensus | 1205 | 99.49 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.48 | |
| KOG0601|consensus | 524 | 99.48 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| KOG1243|consensus | 690 | 99.29 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG1266|consensus | 458 | 99.18 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG0601|consensus | 524 | 99.08 | ||
| KOG2137|consensus | 700 | 98.95 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG3741|consensus | 655 | 98.93 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| KOG3087|consensus | 229 | 98.71 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.6 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.33 | |
| KOG1035|consensus | 1351 | 98.32 | ||
| KOG0576|consensus | 829 | 98.3 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.96 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| KOG1235|consensus | 538 | 97.68 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 97.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.12 | |
| KOG1826|consensus | 2724 | 97.06 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.97 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.51 | |
| PLN02236 | 344 | choline kinase | 96.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.39 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.37 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.36 | |
| KOG1093|consensus | 725 | 96.35 | ||
| KOG2268|consensus | 465 | 95.93 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.57 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.88 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.11 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.02 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.8 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 91.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.76 | |
| KOG2270|consensus | 520 | 90.77 | ||
| PTZ00296 | 442 | choline kinase; Provisional | 90.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 88.81 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 88.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 88.08 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 86.77 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.81 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-58 Score=435.98 Aligned_cols=237 Identities=32% Similarity=0.541 Sum_probs=216.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.|++|.++.||+.||||++.+ ....+.+|+++|+ .++|||||+++++|+..+..|+||||+. ||+|+
T Consensus 187 ~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILk-kL~HP~IV~~~d~f~~~ds~YmVlE~v~-GGeLf 264 (475)
T KOG0615|consen 187 LVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILK-KLSHPNIVRIKDFFEVPDSSYMVLEYVE-GGELF 264 (475)
T ss_pred EEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHH-hcCCCCEEEEeeeeecCCceEEEEEEec-CccHH
Confidence 589999999999999999987 1234679999999 8899999999999999999999999999 99999
Q ss_pred Hhh------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 74 TII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 74 ~~l------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
+.+ .+.....+++|++.||.|||++||+||||||+|||+..+.....+||+|||+|+..+.+.-+.+.||||.|
T Consensus 265 d~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 265 DKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSY 344 (475)
T ss_pred HHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccc
Confidence 943 44555688899999999999999999999999999988867789999999999999888889999999999
Q ss_pred CCCcccccCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 148 VAPEILHYEPI---TLAADMWSLGVTAYVLLTGFSPFGGETDSE-TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 148 ~aPE~l~~~~~---~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
.|||++.+.++ ..++|+||+||+||.+|+|.+||.+..... ..++|..|.+.+.+..|..+|+++.+||.+||..|
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~Vd 424 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVD 424 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeC
Confidence 99999987653 457899999999999999999999887776 88899999999999999999999999999999999
Q ss_pred CCCCCCHHHHHcCcccCCcc
Q psy6377 224 PMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~~ 243 (383)
|+.|||++|+|+||||+...
T Consensus 425 P~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 425 PENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccCcCHHHHhcChhhhccc
Confidence 99999999999999998643
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=389.18 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=232.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH-hhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT-IID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~-~l~ 77 (383)
+||.|.++.||+.||+|++.. +.+.+.+|++|.+ .++|||||++++.+.+....|+|+|++. |++|.. +..
T Consensus 26 vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~-~LqHP~IvrL~~ti~~~~~~ylvFe~m~-G~dl~~eIV~ 103 (355)
T KOG0033|consen 26 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYLVFDLVT-GGELFEDIVA 103 (355)
T ss_pred HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHH-hcCCCcEeehhhhhcccceeEEEEeccc-chHHHHHHHH
Confidence 578999999999999999975 5678999999999 8899999999999999999999999999 999987 443
Q ss_pred c-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 78 D-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 78 ~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
+ ..+-...+||++||.|||.+||||||+||+|+++.+......+||+|||+|....++......+|||.|+|||+
T Consensus 104 R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEv 183 (355)
T KOG0033|consen 104 REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEV 183 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHH
Confidence 3 22233449999999999999999999999999998877778999999999999988888888999999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+...+|+.++|||+.|||||.||.|++||++.+...+++.|+.+.+.+|++.|+++++++++||++||..||.+|.|+.|
T Consensus 184 vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~E 263 (355)
T KOG0033|consen 184 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADE 263 (355)
T ss_pred hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHcCcccCCcchhhcccCCCCCCchhhhhhhHHHHHHHHHHH
Q psy6377 233 ALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS 274 (383)
Q Consensus 233 ~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (383)
+|+|||+.+..... +....++....+++|..++
T Consensus 264 AL~HpWi~~r~~~A---------s~~H~~dtvd~lrkfNarR 296 (355)
T KOG0033|consen 264 ALKHPWICNRERVA---------SAIHRQDTVDCLKKFNARR 296 (355)
T ss_pred HhCCchhcchHHHH---------HHhhhHHHHHHHHHhhHHH
Confidence 99999998765432 3344555666778876543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=416.23 Aligned_cols=230 Identities=31% Similarity=0.487 Sum_probs=214.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||.+++..||+.||+|++++ ..+.+.+||+|.+ .++|||||++|++|+|.+++|+|+|+|. .++|..+++
T Consensus 33 ~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr-~L~HpnIV~f~~~FEDs~nVYivLELC~-~~sL~el~K 110 (592)
T KOG0575|consen 33 RCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHR-SLKHPNIVQFYHFFEDSNNVYIVLELCH-RGSLMELLK 110 (592)
T ss_pred EEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHH-hcCCCcEEeeeeEeecCCceEEEEEecC-CccHHHHHH
Confidence 579999999999999999998 4678999999999 8899999999999999999999999999 999999765
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
+.+++++.+||+.||.|||++||+|||||..|+|++.+ .+|||+|||||...... +...+.||||.|+||
T Consensus 111 rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~---~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAP 187 (592)
T KOG0575|consen 111 RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN---MNVKIGDFGLATQLEYDGERKKTLCGTPNYIAP 187 (592)
T ss_pred hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc---CcEEecccceeeeecCcccccceecCCCcccCh
Confidence 44567888999999999999999999999999999876 58999999999998744 667889999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++...+++..+||||+||++|.||.|+|||...+..+++.+|....+.+|. .+|.++++||.+||.+||.+|||+
T Consensus 188 EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl 263 (592)
T KOG0575|consen 188 EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSL 263 (592)
T ss_pred hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCH
Confidence 9999999999999999999999999999999999999999999999999986 679999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
+++|.|+||....
T Consensus 264 ~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 264 DEVLDHPFFKSGF 276 (592)
T ss_pred HHHhcCHhhhCCC
Confidence 9999999995443
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=379.81 Aligned_cols=241 Identities=30% Similarity=0.490 Sum_probs=220.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
.+|..|.++.||+.+|+|++.- -.+...+|+.||++..+||+|+++.|+|+++..+++|+++++ .|+
T Consensus 31 s~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~p-rGE 109 (411)
T KOG0599|consen 31 SVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMP-RGE 109 (411)
T ss_pred hhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcc-cch
Confidence 4678899999999999999964 135567899999999999999999999999999999999999 999
Q ss_pred HHHhhc------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 72 LQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 72 L~~~l~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
|++++. +.....+++|+++|++|||.++||||||||+|||++++ .+++|+|||+|+...++..+...||||
T Consensus 110 LFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn---~~i~isDFGFa~~l~~GekLrelCGTP 186 (411)
T KOG0599|consen 110 LFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN---MNIKISDFGFACQLEPGEKLRELCGTP 186 (411)
T ss_pred HHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc---cceEEeccceeeccCCchhHHHhcCCC
Confidence 999864 44566888999999999999999999999999999876 689999999999999999999999999
Q ss_pred CcCCCcccc------cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 146 DYVAPEILH------YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 146 ~y~aPE~l~------~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
+|.|||.+. ..+|+..+|+|++|||+|.||.|.+||+.....-+++.|+.|++.|..+.|.++|...++||.+|
T Consensus 187 gYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrl 266 (411)
T KOG0599|consen 187 GYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRL 266 (411)
T ss_pred cccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHH
Confidence 999999985 34689999999999999999999999999988899999999999999999999999999999999
Q ss_pred cccCCCCCCCHHHHHcCcccCCcchhhcc
Q psy6377 220 LIKNPMERMTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~ 248 (383)
|+.||.+|.|++|+|.||||....+...+
T Consensus 267 LqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 267 LQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred HeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 99999999999999999999765544443
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=385.46 Aligned_cols=232 Identities=29% Similarity=0.457 Sum_probs=203.7
Q ss_pred cceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-EEEEEecCCCcCcHHHhh
Q psy6377 3 ALSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-AYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 3 ~~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-~~lv~e~~~~g~~L~~~l 76 (383)
+..|++|+|+.||+.+|+|++.- ...++.+|+++++. .+||+||++|++|..+.. ++++||||+ ||+|.+++
T Consensus 92 gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~-~~spyIV~~ygaF~~~~~~isI~mEYMD-gGSLd~~~ 169 (364)
T KOG0581|consen 92 GGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRS-CQSPYIVGFYGAFYSNGEEISICMEYMD-GGSLDDIL 169 (364)
T ss_pred CcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhh-CCCCCeeeEeEEEEeCCceEEeehhhcC-CCCHHHHH
Confidence 56899999999999999999943 46789999999994 499999999999999995 999999999 99999976
Q ss_pred c------cCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 77 D------DNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~------~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. +.....++.++++||.|||. ++||||||||+|||+++. |.|||||||.+...... ...+++||..|||
T Consensus 170 k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk---GeVKicDFGVS~~lvnS-~a~tfvGT~~YMs 245 (364)
T KOG0581|consen 170 KRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK---GEVKICDFGVSGILVNS-IANTFVGTSAYMS 245 (364)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC---CCEEeccccccHHhhhh-hcccccccccccC
Confidence 5 34445677999999999995 999999999999999875 79999999999987655 5678999999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHhccCCCCcchhcC-CCHHHHHHHHHhcccC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE-----TDSETFRNISKAQLDFPDELFED-ISPEAKDFIAKILIKN 223 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~d 223 (383)
||.+.++.|+.++||||||+.+.|+++|+.||... +..+++..|..+. |+..... +|+++++||..||++|
T Consensus 246 PERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---pP~lP~~~fS~ef~~FV~~CL~Kd 322 (364)
T KOG0581|consen 246 PERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---PPRLPEGEFSPEFRSFVSCCLRKD 322 (364)
T ss_pred hhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---CCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999999999999999999999999999875 4456666666543 3334444 8999999999999999
Q ss_pred CCCCCCHHHHHcCcccCCcc
Q psy6377 224 PMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~~ 243 (383)
|.+|||+.|+|+|||+....
T Consensus 323 p~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 323 PSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cccCCCHHHHhcCHHHhhcc
Confidence 99999999999999998643
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=405.60 Aligned_cols=234 Identities=29% Similarity=0.504 Sum_probs=217.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..|++|+|..||+.+|||++.+. ...+.+||-||+ ++.|||++++||++++..++|+|+||++ ||+|++++
T Consensus 26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMk-Li~HpnVl~LydVwe~~~~lylvlEyv~-gGELFdyl 103 (786)
T KOG0588|consen 26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMK-LIEHPNVLRLYDVWENKQHLYLVLEYVP-GGELFDYL 103 (786)
T ss_pred ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHH-HhcCCCeeeeeeeeccCceEEEEEEecC-CchhHHHH
Confidence 46899999999999999999984 788999999999 9999999999999999999999999999 99999954
Q ss_pred ------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 ------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.+.....+++||+.|+.|||..+|+||||||+|+|++.. ..|||+|||+|....++..+.+.||+|.|.||
T Consensus 104 v~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~---~nIKIADFGMAsLe~~gklLeTSCGSPHYA~P 180 (786)
T KOG0588|consen 104 VRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK---NNIKIADFGMASLEVPGKLLETSCGSPHYAAP 180 (786)
T ss_pred HhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc---cCEeeeccceeecccCCccccccCCCcccCCc
Confidence 334456888999999999999999999999999999876 46999999999998888889999999999999
Q ss_pred cccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+.+| +.++||||+|||||.||+|..||.+++...++.++..|.+.+| .++|.++++||++||..||++|.|
T Consensus 181 EIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~ml~VDp~~RiT 256 (786)
T KOG0588|consen 181 EIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLRRMLDVDPSTRIT 256 (786)
T ss_pred hhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHHHHhccCcccccc
Confidence 99999999 5899999999999999999999999999999999999999998 478999999999999999999999
Q ss_pred HHHHHcCcccCCcchhh
Q psy6377 230 AKEALKHPWLMNKKQIM 246 (383)
Q Consensus 230 ~~e~L~hp~~~~~~~~~ 246 (383)
.+|+++|||+.......
T Consensus 257 ~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 257 TEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHHhhCchhhcCCCCC
Confidence 99999999998766443
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=391.78 Aligned_cols=232 Identities=30% Similarity=0.546 Sum_probs=210.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.|++|+++.|++.||||++.+ -..-+.+|-.+|.++.+||.|++||..|+|+..+|+|+||++ +|+|.++|.
T Consensus 88 tV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~-nGdll~~i~ 166 (604)
T KOG0592|consen 88 TVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP-NGDLLDLIK 166 (604)
T ss_pred eEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC-CCcHHHHHH
Confidence 489999999999999999988 245577888888867799999999999999999999999999 999999865
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------------
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-------------- 137 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-------------- 137 (383)
+ ...++++.||+.||+|||++|||||||||||||+++| ++++|+|||.|+.+.+...
T Consensus 167 K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d---mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~ 243 (604)
T KOG0592|consen 167 KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD---GHIKITDFGSAKILSPSQKSQENPVDPNQASSR 243 (604)
T ss_pred HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC---CcEEEeeccccccCChhhccccCccCcccccCc
Confidence 4 4566888999999999999999999999999999887 7999999999997654211
Q ss_pred cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 138 IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
..+++||..|.+||++.....++.+|+|+||||+|+|+.|.+||.+.++.-++++|+...+.||+ +.++.+++||+
T Consensus 244 ~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~----~fp~~a~dLv~ 319 (604)
T KOG0592|consen 244 RSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE----GFPEDARDLIK 319 (604)
T ss_pred ccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC----CCCHHHHHHHH
Confidence 14579999999999999999999999999999999999999999999999999999999999986 55899999999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
++|..||.+|+|++++.+||||.....
T Consensus 320 KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 320 KLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHccCccccccHHHHhhCcccccCCh
Confidence 999999999999999999999987653
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=386.24 Aligned_cols=239 Identities=35% Similarity=0.563 Sum_probs=219.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||.|+++.||+.+|+|++.+ ....+.+|+.+|+.+.+|||||.++++|++.+.+|+|||++. ||+|++.+
T Consensus 49 g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~-GGeLfd~i 127 (382)
T KOG0032|consen 49 GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE-GGELFDRI 127 (382)
T ss_pred eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC-CchHHHHH
Confidence 3689999999999999999988 125899999999966569999999999999999999999999 99999954
Q ss_pred cc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-CCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-NCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
-. .....+..|++.|++|||+.||+||||||+|+|+..... .+.+|++|||+|.....+....+.+|||.|+||
T Consensus 128 ~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 128 VKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAP 207 (382)
T ss_pred HHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCc
Confidence 33 334455699999999999999999999999999876543 468999999999998887778899999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++...+|+..+||||+||++|.|++|.+||.+.+..+.+.+|..+.+.++.+.|..+|..+++||++||..||.+|+|+
T Consensus 208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
.++|+|||+....
T Consensus 288 ~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 288 AQALQHPWIKSIG 300 (382)
T ss_pred HHHhcCccccCCc
Confidence 9999999998753
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=374.92 Aligned_cols=234 Identities=32% Similarity=0.456 Sum_probs=211.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.|+.++.+.||+.||+|+++| +...+..|..||. ..+||+||+++..|++...+|||++|+. ||+|+..|+
T Consensus 40 kV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~-~v~hPFiv~l~ysFQt~~kLylVld~~~-GGeLf~hL~ 117 (357)
T KOG0598|consen 40 KVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILS-KIKHPFIVKLIYSFQTEEKLYLVLDYLN-GGELFYHLQ 117 (357)
T ss_pred eEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHH-hCCCCcEeeeEEecccCCeEEEEEeccC-CccHHHHHH
Confidence 689999999999999999998 4677899999999 6999999999999999999999999999 999999776
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
+ ..+.+++..|+.||.|||++|||||||||+|||++.+ |+++|+|||+++... .+....+.|||+.||||
T Consensus 118 ~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~---GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAP 194 (357)
T KOG0598|consen 118 REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ---GHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAP 194 (357)
T ss_pred hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC---CcEEEeccccchhcccCCCccccccCCccccCh
Confidence 4 3456777999999999999999999999999999876 799999999999644 44556778999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+.+|+..+|.||||+++|+|++|.+||.+.+.....++|..+....++. -++.+++++|+++|..||++|.
T Consensus 195 Eil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll~~LL~rdp~~RLg~ 271 (357)
T KOG0598|consen 195 EILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDLLKKLLKRDPRQRLGG 271 (357)
T ss_pred HHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHHHHHHhccCHHHhcCC
Confidence 99999999999999999999999999999999999999999999988555543 3699999999999999999996
Q ss_pred --CHHHHHcCcccCCcchhh
Q psy6377 229 --TAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 229 --t~~e~L~hp~~~~~~~~~ 246 (383)
++.++-+||||.......
T Consensus 272 ~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 272 PGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred CCChHHhhcCcccccCCHHH
Confidence 688999999999766543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=358.57 Aligned_cols=231 Identities=27% Similarity=0.491 Sum_probs=212.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.|.+++++.+|..||+|++.+ ..+...+|..+|+ ...||+++++++.|.+.+.+|+||||++ ||+|+.++.
T Consensus 59 rV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~-~v~~PFlv~l~~t~~d~~~lymvmeyv~-GGElFS~Lr 136 (355)
T KOG0616|consen 59 RVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLK-AVSHPFLVKLYGTFKDNSNLYMVMEYVP-GGELFSYLR 136 (355)
T ss_pred eEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHh-hccCceeEEEEEeeccCCeEEEEEeccC-CccHHHHHH
Confidence 589999999999999999998 3456789999999 7789999999999999999999999999 999999764
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
+..+++++.||+.||+|||+++|++|||||||||++++ |.+||+|||+|+..... ..+.||||.|+|||
T Consensus 137 k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~---G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 137 KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN---GHIKITDFGFAKRVSGR--TWTLCGTPEYLAPE 211 (355)
T ss_pred hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC---CcEEEEeccceEEecCc--EEEecCCccccChH
Confidence 45577889999999999999999999999999999876 79999999999987543 67889999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC---
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM--- 228 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--- 228 (383)
++...+|+.++|.|||||++|||+.|.+||.+.+...++++|..+.+.+|. ..+.++++||+++|+.|-.+|.
T Consensus 212 ii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnl 287 (355)
T KOG0616|consen 212 IIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLKKLLQVDLTKRFGNL 287 (355)
T ss_pred HhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHHHHHhhhhHhhhcCc
Confidence 999999999999999999999999999999999999999999999999986 4599999999999999999994
Q ss_pred --CHHHHHcCcccCCcchhh
Q psy6377 229 --TAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 229 --t~~e~L~hp~~~~~~~~~ 246 (383)
...++..||||+......
T Consensus 288 knG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 288 KNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred CCCccccccCcccccccHHH
Confidence 578999999999765443
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=365.77 Aligned_cols=239 Identities=32% Similarity=0.465 Sum_probs=216.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeC----CeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTG----EGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~----~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..|..|.++.||+.||+|++. +.....||+++.-+..+|||||.++|+|++. .-+.+|||.+. ||+|+..|++.
T Consensus 76 GkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me-GGeLfsriq~~ 153 (400)
T KOG0604|consen 76 GKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME-GGELFSRIQDR 153 (400)
T ss_pred CceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc-chHHHHHHHHc
Confidence 468899999999999999987 6778899999998888999999999999753 44788999999 99999976543
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
++..+.+||..|+.|||+.+|.||||||+|+|+.....+..+||+|||+|+.......+.+.|.||.|.|||
T Consensus 154 g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPe 233 (400)
T KOG0604|consen 154 GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPE 233 (400)
T ss_pred ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHH
Confidence 334555899999999999999999999999999988888999999999999987777889999999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET----DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
++..+.|+..+|+||+|||+|.||+|++||.... ...+..+|..+++.||.+.|..+|+.++++|+.+|..+|.+|
T Consensus 234 vlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteR 313 (400)
T KOG0604|consen 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTER 313 (400)
T ss_pred HhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhh
Confidence 9999999999999999999999999999997654 345778899999999999999999999999999999999999
Q ss_pred CCHHHHHcCcccCCcch
Q psy6377 228 MTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~~ 244 (383)
.|+++++.|||+.....
T Consensus 314 lTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 314 LTIEEVMDHPWINQYEA 330 (400)
T ss_pred eeHHHhhcCchhccccc
Confidence 99999999999987543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=363.91 Aligned_cols=235 Identities=24% Similarity=0.347 Sum_probs=204.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--C----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--N----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI-- 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~-- 75 (383)
.+|++|+++.||+.||||.+.. + .+-..|||++|+ .+.|||+|.++++|.....++||+|||+ ..-|.++
T Consensus 16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLK-qLkH~NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~ 93 (396)
T KOG0593|consen 16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLK-QLKHENLVNLIEVFRRKRKLHLVFEYCD-HTVLHELER 93 (396)
T ss_pred eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHH-hcccchHHHHHHHHHhcceeEEEeeecc-hHHHHHHHh
Confidence 3689999999999999999875 1 345789999999 8899999999999999999999999999 5656553
Q ss_pred ----hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 76 ----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 76 ----l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
+....+..+.+|++.|+.|||+++++||||||||||++.+ |.+||||||+|+... ++...+.++.|.||+||
T Consensus 94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~---gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 94 YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN---GVVKLCDFGFARTLSAPGDNYTDYVATRWYRAP 170 (396)
T ss_pred ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC---CcEEeccchhhHhhcCCcchhhhhhhhhhccCh
Confidence 2334566788999999999999999999999999999876 699999999999887 66667789999999999
Q ss_pred ccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------------
Q psy6377 151 EILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------- 202 (383)
Q Consensus 151 E~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------- 202 (383)
|.+.+ ..|+.++||||+||++.||++|.+.|.|.++.+++..|...-..+++
T Consensus 171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe 250 (396)
T KOG0593|consen 171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE 250 (396)
T ss_pred hhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchh
Confidence 99877 78999999999999999999999999999999988888665443322
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..+++++.-+.+|+++||..||.+|++.+|+|.||||.+..
T Consensus 251 ~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 251 RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred hhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 12456778899999999999999999999999999996543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=379.32 Aligned_cols=232 Identities=34% Similarity=0.552 Sum_probs=209.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC---------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN---------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..|+.|.+..+|+.||+|++.+. ...+.+|+.+++.+..||||+++++++++...+|+||||+. ||+|++
T Consensus 31 gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~-gGdL~~ 109 (370)
T KOG0583|consen 31 GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCS-GGDLFD 109 (370)
T ss_pred eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecC-CccHHH
Confidence 46899999999999999988762 34677999999955559999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe-ecCcccccccCCCCc
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDY 147 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~gt~~y 147 (383)
.+.. ..+..+++|++.||+|||++||+||||||+|||++.+. +.+||+|||++... .......+.||||.|
T Consensus 110 ~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y 187 (370)
T KOG0583|consen 110 YIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAISPGEDGLLKTFCGSPAY 187 (370)
T ss_pred HHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEeccccccccCCCCCcccCCCCCccc
Confidence 6544 34556779999999999999999999999999998763 68999999999987 466678899999999
Q ss_pred CCCcccccCC-CC-hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 148 VAPEILHYEP-IT-LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 148 ~aPE~l~~~~-~~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
+|||++.+.+ |+ .++||||+||+||.|++|+.||...+...++..|..+.+.+|.... |.++++|+.+||..||.
T Consensus 188 ~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~ 264 (370)
T KOG0583|consen 188 AAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPS 264 (370)
T ss_pred CCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcc
Confidence 9999999988 85 8899999999999999999999999999999999999999886432 99999999999999999
Q ss_pred CCCCHHHHHcCcccCC
Q psy6377 226 ERMTAKEALKHPWLMN 241 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~ 241 (383)
+|+|+.++++||||+.
T Consensus 265 ~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 265 TRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCHHHHhhChhhcc
Confidence 9999999999999997
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=362.97 Aligned_cols=243 Identities=30% Similarity=0.445 Sum_probs=211.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe-----CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-----GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~~L~ 73 (383)
.|+.|.++.||+.||+|.+.. ...+..||+.+|+ .++|+||+.++|++.. -+.+|+|+|++. .+|.
T Consensus 37 vVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr-~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe--tDL~ 113 (359)
T KOG0660|consen 37 VVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLR-HLRHENIIGLLDIFRPPSRDKFNDVYLVFELME--TDLH 113 (359)
T ss_pred eEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHH-HhcCCCcceEEeecccccccccceeEEehhHHh--hHHH
Confidence 789999999999999999885 5788999999999 7779999999999976 356999999996 9999
Q ss_pred HhhccCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec---CcccccccCC
Q psy6377 74 TIIDDNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---GIEIRELLGT 144 (383)
Q Consensus 74 ~~l~~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---~~~~~~~~gt 144 (383)
.+++.+. +.++.+||+.||+|+||.||+||||||.|+|++.+ +.+||+|||+|+.... ...++.++.|
T Consensus 114 ~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~---c~lKI~DFGLAR~~~~~~~~~~mTeYVaT 190 (359)
T KOG0660|consen 114 QIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD---CDLKICDFGLARYLDKFFEDGFMTEYVAT 190 (359)
T ss_pred HHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---CCEEeccccceeeccccCcccchhcceee
Confidence 9877654 56777999999999999999999999999999876 7899999999998753 4557889999
Q ss_pred CCcCCCccc-ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Q psy6377 145 PDYVAPEIL-HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------- 202 (383)
Q Consensus 145 ~~y~aPE~l-~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------- 202 (383)
.+|+|||++ ....|+.+.||||+|||+.||++|++.|.|.+..+++..|....+.+++
T Consensus 191 RWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~ 270 (359)
T KOG0660|consen 191 RWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQI 270 (359)
T ss_pred eeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCC
Confidence 999999986 5678999999999999999999999999999887777766554333321
Q ss_pred ------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcccCCCC
Q psy6377 203 ------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSS 253 (383)
Q Consensus 203 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~~~~~ 253 (383)
..+++.++.+.+|+.+||..||.+|+|++|+|+|||+.....+..++.+..
T Consensus 271 p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~ 327 (359)
T KOG0660|consen 271 PKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP 327 (359)
T ss_pred CCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence 235678999999999999999999999999999999999888777775544
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=366.98 Aligned_cols=236 Identities=28% Similarity=0.421 Sum_probs=212.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
+||+|+++.+|..||||.+.+ ..+.+..||.+|+ .++|||||.++|++++++.+|||||||. ||+|..++..
T Consensus 25 vVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLk-el~H~nIV~l~d~~~~~~~i~lVMEyC~-gGDLs~yi~~ 102 (429)
T KOG0595|consen 25 VVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILK-ELKHPNIVRLLDCIEDDDFIYLVMEYCN-GGDLSDYIRR 102 (429)
T ss_pred EEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHH-hcCCcceeeEEEEEecCCeEEEEEEeCC-CCCHHHHHHH
Confidence 689999999999999999987 3566789999999 7889999999999999999999999999 9999998754
Q ss_pred C------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC---CcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 79 N------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN---CDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~---~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. .++.++.||+.||++||+++||||||||+|||++..... ..+||+|||+|+...++....+.||+|.|||
T Consensus 103 ~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMA 182 (429)
T KOG0595|consen 103 RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMA 182 (429)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccC
Confidence 3 456778999999999999999999999999999875222 6799999999999998888899999999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++..+.|+.|+|+||+|+|+|+|++|++||...+..+.+..+..+....| .....++....+++..+|..+|.+|.+
T Consensus 183 PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-~~~~~~s~~~~~Ll~~ll~~~~~~~~~ 261 (429)
T KOG0595|consen 183 PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-VLPAELSNPLRELLISLLQRNPKDRIS 261 (429)
T ss_pred HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-chhhhccCchhhhhhHHHhcCccccCc
Confidence 9999999999999999999999999999999999999999998887765443 233456788889999999999999999
Q ss_pred HHHHHcCcccCCcc
Q psy6377 230 AKEALKHPWLMNKK 243 (383)
Q Consensus 230 ~~e~L~hp~~~~~~ 243 (383)
..+.+.|+++....
T Consensus 262 ~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 262 FEDFFDHPFLAANP 275 (429)
T ss_pred hHHhhhhhhcccCc
Confidence 99999999997654
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=374.92 Aligned_cols=238 Identities=33% Similarity=0.504 Sum_probs=207.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+.+.||..||+|++++ ....+..|-.+|. -..+|.||+||..|++.+++||||||++ ||++..+|
T Consensus 155 GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~-~~ds~~vVKLyYsFQD~~~LYLiMEylP-GGD~mTLL 232 (550)
T KOG0605|consen 155 GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILA-EVDSPWVVKLYYSFQDKEYLYLIMEYLP-GGDMMTLL 232 (550)
T ss_pred eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhh-hcCCCcEEEEEEEecCCCeeEEEEEecC-CccHHHHH
Confidence 3799999999999999999998 3456788889998 6899999999999999999999999999 99999964
Q ss_pred ------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec----------------
Q psy6377 77 ------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---------------- 134 (383)
Q Consensus 77 ------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---------------- 134 (383)
.++.+.+++.+++.|++.+|..|++||||||+|+|++.. |++||+||||+.....
T Consensus 233 ~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~---GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~ 309 (550)
T KOG0605|consen 233 MRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK---GHIKLSDFGLSTGLDKKHRIESYRLDEQMQIN 309 (550)
T ss_pred HhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC---CCEeeccccccchhhhhhhhhhhcchhhhhhh
Confidence 455667888999999999999999999999999999876 8999999999864311
Q ss_pred ------C--c----c--------------------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCC
Q psy6377 135 ------G--I----E--------------------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFG 182 (383)
Q Consensus 135 ------~--~----~--------------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~ 182 (383)
. . . ....+|||-|+|||++.+.+|+..+|+||||||+||||.|.|||.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 310 LSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred hccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 0 0 0 012379999999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccCCcchhhccc
Q psy6377 183 GETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKILIKNPMERMT---AKEALKHPWLMNKKQIMTRV 249 (383)
Q Consensus 183 ~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hp~~~~~~~~~~~~ 249 (383)
+.+..+++++|.... ..+|.+ ..++++++|||.+||. ||++|.. ++|+.+||||........+.
T Consensus 390 s~tp~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 390 SETPQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLRE 458 (550)
T ss_pred CCCHHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhc
Confidence 999999999999877 455544 4678999999999999 9999985 89999999999876554443
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.27 Aligned_cols=235 Identities=28% Similarity=0.472 Sum_probs=216.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.+|++|+|..||+.||||++.+ ....+++|++.++ +.+|||||+||++..+...+|||+|+-+ +|+|+++|
T Consensus 32 AVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMK-LVQHpNiVRLYEViDTQTKlyLiLELGD-~GDl~DyIm 109 (864)
T KOG4717|consen 32 AVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMK-LVQHPNIVRLYEVIDTQTKLYLILELGD-GGDLFDYIM 109 (864)
T ss_pred ehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHH-HhcCcCeeeeeehhcccceEEEEEEecC-CchHHHHHH
Confidence 3689999999999999999998 3567999999999 9999999999999999999999999999 99999964
Q ss_pred c------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 D------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
+ +.....++.||+.|+.|||..++|||||||+|+.+... .|.|||+|||++..+.++..+.+.||+..|.||
T Consensus 110 KHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAP 187 (864)
T KOG4717|consen 110 KHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAP 187 (864)
T ss_pred hhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee--cCceEeeeccccccCCCcchhhcccchhhccCc
Confidence 2 33455777999999999999999999999999987654 489999999999999999999999999999999
Q ss_pred cccccCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPIT-LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..|+ +++||||||||||.|.+|++||+..++.+.+..|+...+..|. .+|.++++||..||..||.+|.|
T Consensus 188 EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAs 263 (864)
T KOG4717|consen 188 EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKECRDLIQSMLVRDPKKRAS 263 (864)
T ss_pred hhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHHHHHHHHHHhcCchhhcc
Confidence 999999996 7789999999999999999999999999999999999999885 67999999999999999999999
Q ss_pred HHHHHcCcccCCcchhh
Q psy6377 230 AKEALKHPWLMNKKQIM 246 (383)
Q Consensus 230 ~~e~L~hp~~~~~~~~~ 246 (383)
.+++..|+|++......
T Consensus 264 lEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 264 LEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHhccccccCCCCCc
Confidence 99999999999876543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.21 Aligned_cols=237 Identities=27% Similarity=0.380 Sum_probs=206.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-eEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-GAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-~~~lv~e~~~~g~~L~~~l~ 77 (383)
.+||+|+.+.+|+.||||.+++ ....-.||+..|+++..|||||++.+++.+.+ .+|+|||||+ .+|+++++
T Consensus 24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md--~NLYqLmK 101 (538)
T KOG0661|consen 24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD--CNLYQLMK 101 (538)
T ss_pred eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh--hhHHHHHh
Confidence 3799999999999999999987 34456799999995656999999999999988 9999999998 99999876
Q ss_pred cCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 DNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.+. +..+++||++||+|+|.+|+.||||||||||+... ..|||+|||+|+......+.+.++.|.||+||
T Consensus 102 ~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~---~~iKiaDFGLARev~SkpPYTeYVSTRWYRAP 178 (538)
T KOG0661|consen 102 DRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN---DVIKIADFGLAREVRSKPPYTEYVSTRWYRAP 178 (538)
T ss_pred hcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc---ceeEecccccccccccCCCcchhhhcccccch
Confidence 543 45566999999999999999999999999999854 38999999999999988889999999999999
Q ss_pred cccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------------c
Q psy6377 151 EILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------E 203 (383)
Q Consensus 151 E~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~ 203 (383)
|++. ..-|+.+.||||+|||++|+.+-++.|.|.++.+++.+|......+.. .
T Consensus 179 EvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~ 258 (538)
T KOG0661|consen 179 EVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKD 258 (538)
T ss_pred HHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHH
Confidence 9875 456899999999999999999999999999999888888664433321 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..++.+.++.++|.+||.+||++||||.|+|+||||+.....
T Consensus 259 L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 259 LLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred hCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 234578999999999999999999999999999999876543
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=338.81 Aligned_cols=234 Identities=30% Similarity=0.398 Sum_probs=205.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..||+.||+|.+.- -.....|||+.|+ .++||||+.++|+|...+++.+|+||++ .+|...++
T Consensus 16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lq-el~h~nIi~LiD~F~~~~~l~lVfEfm~--tdLe~vIk 92 (318)
T KOG0659|consen 16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQ-ELKHPNIIELIDVFPHKSNLSLVFEFMP--TDLEVVIK 92 (318)
T ss_pred EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHH-HccCcchhhhhhhccCCCceEEEEEecc--ccHHHHhc
Confidence 3689999999999999999976 2456889999999 7789999999999999999999999998 99999876
Q ss_pred cCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc-cccCCCCcCC
Q psy6377 78 DNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR-ELLGTPDYVA 149 (383)
Q Consensus 78 ~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~-~~~gt~~y~a 149 (383)
... +..+..+++.||+|||++.|+||||||.|+|++++ |.+||+|||+|+.+....... ..+.|.+|+|
T Consensus 93 d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~---g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRA 169 (318)
T KOG0659|consen 93 DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD---GQLKIADFGLARFFGSPNRIQTHQVVTRWYRA 169 (318)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC---CcEEeecccchhccCCCCcccccceeeeeccC
Confidence 643 55677999999999999999999999999999876 799999999999987655433 3488999999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh-----------------------
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF----------------------- 205 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------- 205 (383)
||.+.+ ..|+..+||||+|||+.||+.|.|.|.|.++.+++..|...-.++.+..|
T Consensus 170 PELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~l 249 (318)
T KOG0659|consen 170 PELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNL 249 (318)
T ss_pred hHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccc
Confidence 998866 56999999999999999999999999999999999988776555544333
Q ss_pred -cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 206 -EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 206 -~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+.++.+|+.+||.+||.+|+|+.|+|+|+||....
T Consensus 250 f~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 250 FPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred cccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 34578899999999999999999999999999998643
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.62 Aligned_cols=241 Identities=29% Similarity=0.544 Sum_probs=212.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
.+|-.|+...||..||||++.+ .+.++.||++++..+.+|+||+.|+++|+++..+|||||-+. ||.|...|.
T Consensus 92 asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~-GGplLshI~~~ 170 (463)
T KOG0607|consen 92 ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR-GGPLLSHIQKR 170 (463)
T ss_pred eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc-CchHHHHHHHh
Confidence 3688899999999999999998 578999999999999999999999999999999999999999 999988543
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC--------cccccccCCC
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--------IEIRELLGTP 145 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~--------~~~~~~~gt~ 145 (383)
+.....+.+.|..||.|||.+||.||||||+|||...-+.-..||||||.++...... ..+.+.+|+.
T Consensus 171 ~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSA 250 (463)
T KOG0607|consen 171 KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSA 250 (463)
T ss_pred hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccch
Confidence 3344456689999999999999999999999999877666678999999987654322 2345678999
Q ss_pred CcCCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------------cHHHHHHHHhccCCCCcchh
Q psy6377 146 DYVAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGET---------------DSETFRNISKAQLDFPDELF 205 (383)
Q Consensus 146 ~y~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---------------~~~~~~~i~~~~~~~~~~~~ 205 (383)
.|||||+.. ...|+.++|.||||||+|.||+|++||.|.- ...++..|..|.+.||+..|
T Consensus 251 EfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW 330 (463)
T KOG0607|consen 251 EFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW 330 (463)
T ss_pred hhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh
Confidence 999999863 3458999999999999999999999998753 24678899999999999999
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..+|.+++++|+.+|..+|.+|.++.++++|||++.....
T Consensus 331 ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 331 AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 9999999999999999999999999999999999876544
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=371.84 Aligned_cols=234 Identities=28% Similarity=0.455 Sum_probs=213.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI- 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~- 75 (383)
..|+++..+.|++.||||+++| +.+..+.|-+|+....+||.++.++..|++.+++|+||||+. ||++..+
T Consensus 382 GkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~-Ggdm~~~~ 460 (694)
T KOG0694|consen 382 GKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA-GGDLMHHI 460 (694)
T ss_pred ceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC-CCcEEEEE
Confidence 3689999999999999999998 467899999999977789999999999999999999999999 9997764
Q ss_pred ----hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 76 ----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 76 ----l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
+++..+.+++..|+.||+|||++||||||||.+|||++.+ |++||+|||+++... .+....+.||||.|+||
T Consensus 461 ~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e---Gh~kiADFGlcKe~m~~g~~TsTfCGTpey~aP 537 (694)
T KOG0694|consen 461 HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE---GHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAP 537 (694)
T ss_pred ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc---CcEEecccccccccCCCCCccccccCChhhcCh
Confidence 3455677888999999999999999999999999999876 799999999999765 45567889999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.++.|+.++|.|||||+||+||.|++||.|++..+.+..|....+.+|. .+|.++.++++++|++||++|..
T Consensus 538 Eil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 538 EVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCC
Confidence 9999999999999999999999999999999999999999999998887774 67999999999999999999995
Q ss_pred ----HHHHHcCcccCCcchh
Q psy6377 230 ----AKEALKHPWLMNKKQI 245 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~~ 245 (383)
++++..||||+.....
T Consensus 614 ~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 614 GERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CCCCchhhhhCCccccCCHH
Confidence 5899999999976543
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=366.72 Aligned_cols=232 Identities=27% Similarity=0.411 Sum_probs=206.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
..||.|+...+++.||+|.+.. ..+-+.+|+.+|+ ...|+|||.+++.|.-.+.+|.||||++ ||+|.+++.
T Consensus 287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~-~~~H~NiVnfl~Sylv~deLWVVMEym~-ggsLTDvVt~~ 364 (550)
T KOG0578|consen 287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMR-DLHHPNIVNFLDSYLVGDELWVVMEYME-GGSLTDVVTKT 364 (550)
T ss_pred cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHH-hccchHHHHHHHHhcccceeEEEEeecC-CCchhhhhhcc
Confidence 5799999999999999999986 4677999999999 8899999999999999999999999999 999999754
Q ss_pred ---cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 78 ---DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 78 ---~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
+.++..+.++++.||+|||.+||+|||||.+|||++.+ |.+||+|||++..+.... ...+.+|||+|||||++
T Consensus 365 ~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~---g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVv 441 (550)
T KOG0578|consen 365 RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD---GSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVV 441 (550)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC---CcEEEeeeeeeeccccccCccccccCCCCccchhhh
Confidence 45666777999999999999999999999999999876 689999999999876654 46678999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
....|++++||||||+++.||+.|++||-.++....+..|.. ...+.-..++.+|+.+++|+.+||+.|+++|++|.++
T Consensus 442 trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eL 520 (550)
T KOG0578|consen 442 TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKEL 520 (550)
T ss_pred hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence 999999999999999999999999999998777666665543 3333344557899999999999999999999999999
Q ss_pred HcCcccCC
Q psy6377 234 LKHPWLMN 241 (383)
Q Consensus 234 L~hp~~~~ 241 (383)
|+||||+.
T Consensus 521 L~HpFl~~ 528 (550)
T KOG0578|consen 521 LEHPFLKM 528 (550)
T ss_pred hcChhhhh
Confidence 99999953
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.24 Aligned_cols=238 Identities=30% Similarity=0.471 Sum_probs=212.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+.+.++..||+|++.+ ...++..|-+||+ .++||.++.||..|++++..||+||||+ ||+|..+.
T Consensus 91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~-~lDHPFlPTLYa~fet~~~~cl~meyCp-GGdL~~Lr 168 (459)
T KOG0610|consen 91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILS-LLDHPFLPTLYASFETDKYSCLVMEYCP-GGDLHSLR 168 (459)
T ss_pred eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHH-hcCCCccchhhheeeccceeEEEEecCC-CccHHHHH
Confidence 4799999999999999999988 2456778889999 8899999999999999999999999999 99999875
Q ss_pred c--------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec--------------
Q psy6377 77 D--------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-------------- 134 (383)
Q Consensus 77 ~--------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-------------- 134 (383)
+ +..+.+++..++.||+|||-.|||+|||||||||+.++ |+|.|+||.|+.....
T Consensus 169 qkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred---GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~ 245 (459)
T KOG0610|consen 169 QKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED---GHIMLSDFDLSLRCPVSPTLVKSSSPRSSG 245 (459)
T ss_pred hhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC---CcEEeeeccccccCCCCCeeeccCCCCCCC
Confidence 4 34567888999999999999999999999999999877 7999999998764310
Q ss_pred -------------------C-c-----------------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHH
Q psy6377 135 -------------------G-I-----------------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171 (383)
Q Consensus 135 -------------------~-~-----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil 171 (383)
. . .....+||-.|+|||++.+.+.+.++|+|+|||++
T Consensus 246 ~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIfl 325 (459)
T KOG0610|consen 246 SQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFL 325 (459)
T ss_pred CCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHH
Confidence 0 0 00124799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC----HHHHHcCcccCCcchhhc
Q psy6377 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT----AKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 172 yelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~L~hp~~~~~~~~~~ 247 (383)
||||.|..||.|.+..+++.+|......||... .++..++|||+++|.+||.+|.. |+|+-+||||++.+....
T Consensus 326 YEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 326 YEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALI 403 (459)
T ss_pred HHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhe
Confidence 999999999999999999999999999998753 78999999999999999999998 999999999999877644
Q ss_pred c
Q psy6377 248 R 248 (383)
Q Consensus 248 ~ 248 (383)
+
T Consensus 404 r 404 (459)
T KOG0610|consen 404 R 404 (459)
T ss_pred e
Confidence 4
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=366.24 Aligned_cols=232 Identities=30% Similarity=0.501 Sum_probs=209.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
+.||+++.+.|.+.||+|++.+ +...+.+|++|++ .++|||||.++++|++..++|+|.||+. |+|+.+++
T Consensus 16 g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r-~lkHpniv~m~esfEt~~~~~vVte~a~--g~L~~il~ 92 (808)
T KOG0597|consen 16 GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILR-SLKHPNIVEMLESFETSAHLWVVTEYAV--GDLFTILE 92 (808)
T ss_pred ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHH-hcCCcchhhHHHhhcccceEEEEehhhh--hhHHHHHH
Confidence 4799999999999999999988 2345899999999 8899999999999999999999999998 59999875
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
. +.+..+..|++.||.|||+.+|+|||+||.|||+.+. |.+|+||||+|+....+.. .+...|||.||||
T Consensus 93 ~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~---~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAP 169 (808)
T KOG0597|consen 93 QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG---GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAP 169 (808)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC---CceeechhhhhhhcccCceeeeeccCcccccCH
Confidence 4 4456777999999999999999999999999999765 7999999999998765443 4567899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+++|+..+|+||+|||+|||+.|+|||......+..+.|......+|. ..|..+.+|+..+|.+||.+|.|+
T Consensus 170 Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 170 ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHHHHHhhcChhhcccH
Confidence 9999999999999999999999999999999999999999999988777765 679999999999999999999999
Q ss_pred HHHHcCcccCCcchh
Q psy6377 231 KEALKHPWLMNKKQI 245 (383)
Q Consensus 231 ~e~L~hp~~~~~~~~ 245 (383)
.+++.|||.+..-..
T Consensus 246 ~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 246 TDLLGHPFWKGKINI 260 (808)
T ss_pred HHHhcChHHhhhhhh
Confidence 999999999865433
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=353.98 Aligned_cols=231 Identities=25% Similarity=0.352 Sum_probs=202.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|++..||+.||+|.++. ...-..|||.||+ .++||||++|.++..+. ..+|||+|||+ -+|.-++
T Consensus 132 ~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr-~l~HpNIikL~eivt~~~~~siYlVFeYMd--hDL~GLl 208 (560)
T KOG0600|consen 132 QVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILR-RLDHPNIIKLEEIVTSKLSGSIYLVFEYMD--HDLSGLL 208 (560)
T ss_pred heeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHH-hcCCCcccceeeEEEecCCceEEEEEeccc--chhhhhh
Confidence 699999999999999999986 2345789999999 88999999999998876 68999999998 6777654
Q ss_pred c-------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCc
Q psy6377 77 D-------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDY 147 (383)
Q Consensus 77 ~-------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y 147 (383)
. +.++.-+++||+.||+|||++||+|||||..|||++.+ |.+||+|||||+.+.... .++..+-|+||
T Consensus 209 ~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~---G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWY 285 (560)
T KOG0600|consen 209 SSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN---GVLKIADFGLARFYTPSGSAPYTSRVVTLWY 285 (560)
T ss_pred cCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC---CCEEeccccceeeccCCCCcccccceEEeec
Confidence 4 45566777999999999999999999999999999876 799999999999765543 46778899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc--------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE-------------------- 206 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------------- 206 (383)
+|||++.+ ..|+.++|+||+||||.||+.|++.|+|.+..+++..|.+.-..+.+.+|+
T Consensus 286 RpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l 365 (560)
T KOG0600|consen 286 RPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRL 365 (560)
T ss_pred cChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchH
Confidence 99999876 569999999999999999999999999999999999998776655555544
Q ss_pred -----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 207 -----DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 207 -----~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
.++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 366 ~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 366 RETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 35788999999999999999999999999999943
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=338.33 Aligned_cols=235 Identities=27% Similarity=0.346 Sum_probs=200.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~ 75 (383)
.+||+|+++.|++.||+|.++. ..-...|||.+|. ..+|||||.+-++.... +.+|+|||||. .+|..+
T Consensus 90 GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl-~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E--hDLksl 166 (419)
T KOG0663|consen 90 GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILL-KARHPNIVEVKEVVVGSNMDKIYIVMEYVE--HDLKSL 166 (419)
T ss_pred eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHH-hcCCCCeeeeEEEEeccccceeeeeHHHHH--hhHHHH
Confidence 3699999999999999999987 2345789999999 66799999999998744 56999999998 788877
Q ss_pred hcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCc
Q psy6377 76 IDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDY 147 (383)
Q Consensus 76 l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y 147 (383)
++. ..+..+..|++.||+|||.+.|+||||||+|+|++.. |.+||+|||+|+.++... .++..+-|.+|
T Consensus 167 ~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~---G~lKiaDFGLAR~ygsp~k~~T~lVVTLWY 243 (419)
T KOG0663|consen 167 METMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK---GILKIADFGLAREYGSPLKPYTPLVVTLWY 243 (419)
T ss_pred HHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC---CcEEecccchhhhhcCCcccCcceEEEeee
Confidence 643 3345566999999999999999999999999999866 799999999999987653 35667899999
Q ss_pred CCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcC-------------------
Q psy6377 148 VAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED------------------- 207 (383)
Q Consensus 148 ~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~------------------- 207 (383)
+|||++.+. .|+.+.|+||+|||+.||+++.|.|.|.+..+++.+|...-..+....|++
T Consensus 244 RaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~ 323 (419)
T KOG0663|consen 244 RAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNN 323 (419)
T ss_pred cCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchh
Confidence 999998764 599999999999999999999999999999999999877554443333322
Q ss_pred ---------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 208 ---------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 208 ---------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
+++...+|+..+|.+||.+|.||+|+|+|+||.....
T Consensus 324 lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 324 LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 4588999999999999999999999999999987543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=351.27 Aligned_cols=231 Identities=31% Similarity=0.533 Sum_probs=202.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------------------CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEe
Q psy6377 5 SEEMADSIATGEVFAAKFLES------------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSW 64 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e 64 (383)
.|++|++..+|+.||+|++.+ ..+.+.+||.||+ .+.|||||+|+++..+ .+.+|||+|
T Consensus 112 kVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK-kl~H~nVV~LiEvLDDP~s~~~YlVle 190 (576)
T KOG0585|consen 112 KVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK-KLHHPNVVKLIEVLDDPESDKLYLVLE 190 (576)
T ss_pred eEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH-hcCCcCeeEEEEeecCcccCceEEEEE
Confidence 689999999999999999987 1247899999999 7789999999999976 467999999
Q ss_pred cCCCcCcHHHh------hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec----
Q psy6377 65 NTPLVVTLQTI------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---- 134 (383)
Q Consensus 65 ~~~~g~~L~~~------l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---- 134 (383)
||. .|.+... +.+...+.+++.++.||+|||.+||+||||||.|+|++++ |.|||+|||.+.....
T Consensus 191 y~s-~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~---g~VKIsDFGVs~~~~~~~~~ 266 (576)
T KOG0585|consen 191 YCS-KGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD---GTVKISDFGVSNEFPQGSDE 266 (576)
T ss_pred ecc-CCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC---CcEEeeccceeeecccCCcc
Confidence 999 6666542 5566677888999999999999999999999999999876 7999999999987622
Q ss_pred --CcccccccCCCCcCCCcccccC---C-CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 135 --GIEIRELLGTPDYVAPEILHYE---P-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 135 --~~~~~~~~gt~~y~aPE~l~~~---~-~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
...+...+|||.|+|||.+.++ . .+.+.||||+||+||.|+.|+.||.+....+++.+|......+|.. +.+
T Consensus 267 ~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~--pe~ 344 (576)
T KOG0585|consen 267 GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN--PEI 344 (576)
T ss_pred ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc--ccc
Confidence 2234557899999999998763 2 3688999999999999999999999999999999999998888764 367
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+.+++||.+||.+||++|+++.++..|||....
T Consensus 345 ~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 345 NEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 8999999999999999999999999999999765
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=345.45 Aligned_cols=226 Identities=27% Similarity=0.458 Sum_probs=209.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.|.+|.+...|+.||||.+++ +...+.|||+|+. .++||||+.+|++|+..+.+.+||||.. +|+|+++++
T Consensus 68 KVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMS-sLNHPhII~IyEVFENkdKIvivMEYaS-~GeLYDYiS 145 (668)
T KOG0611|consen 68 KVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMS-SLNHPHIIQIYEVFENKDKIVIVMEYAS-GGELYDYIS 145 (668)
T ss_pred ceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHh-hcCCCceeehhhhhcCCceEEEEEEecC-CccHHHHHH
Confidence 688999999999999999988 4567899999999 8999999999999999999999999999 999999876
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
+ .....+++||+.|+.|||.++++|||||.+|||++.+ +++||+|||++..+....-++++||+|.|.+||
T Consensus 146 er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N---~NiKIADFGLSNly~~~kfLqTFCGSPLYASPE 222 (668)
T KOG0611|consen 146 ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN---NNIKIADFGLSNLYADKKFLQTFCGSPLYASPE 222 (668)
T ss_pred HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC---CCeeeeccchhhhhccccHHHHhcCCcccCCcc
Confidence 5 3456788999999999999999999999999999876 699999999999998888899999999999999
Q ss_pred ccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+.+| ++.+|.|||||+||.|..|..||.|.+-..++++|..|.+.-|. .+..+.-||+.||..||++|.|+
T Consensus 223 IvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 223 IVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred ccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHHHHHHHHHhcCcccchhH
Confidence 9999998 68899999999999999999999999999999999999887664 47789999999999999999999
Q ss_pred HHHHcCcccC
Q psy6377 231 KEALKHPWLM 240 (383)
Q Consensus 231 ~e~L~hp~~~ 240 (383)
+++-.|=|++
T Consensus 298 eDiAsHWWvN 307 (668)
T KOG0611|consen 298 EDIASHWWVN 307 (668)
T ss_pred HHHhhhheee
Confidence 9999998775
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=342.69 Aligned_cols=237 Identities=27% Similarity=0.402 Sum_probs=203.5
Q ss_pred cceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 3 ALSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 3 ~~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
...||+|+.+.+|+.||||++.- +...+.+|+..++ +.+||||++++..|..++.+|+||.++. +|++.++++
T Consensus 39 sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~ms-l~~HPNIv~~~~sFvv~~~LWvVmpfMa-~GS~ldIik 116 (516)
T KOG0582|consen 39 SAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMS-LIDHPNIVTYHCSFVVDSELWVVMPFMA-GGSLLDIIK 116 (516)
T ss_pred eeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhh-hcCCCCcceEEEEEEecceeEEeehhhc-CCcHHHHHH
Confidence 46899999999999999999975 3477999999999 8999999999999999999999999999 999999764
Q ss_pred --------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cccccCC
Q psy6377 78 --------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLGT 144 (383)
Q Consensus 78 --------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~gt 144 (383)
+..+..+.++++.||.|||.+|.||||||+.|||++++ |.|||+|||.+........ +.+.+||
T Consensus 117 ~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d---G~VkLadFgvsa~l~~~G~R~~~rf~tfvgt 193 (516)
T KOG0582|consen 117 TYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD---GTVKLADFGVSASLFDSGDRQVTRFNTFVGT 193 (516)
T ss_pred HHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC---CcEEEcCceeeeeecccCceeeEeeccccCc
Confidence 34455667999999999999999999999999999877 7999999998765543221 2456899
Q ss_pred CCcCCCcccc--cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC------CcchhcCCCHHHHHHH
Q psy6377 145 PDYVAPEILH--YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF------PDELFEDISPEAKDFI 216 (383)
Q Consensus 145 ~~y~aPE~l~--~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~------~~~~~~~~s~~~~~li 216 (383)
|+|||||++. ..+|+.|+||||||++..||.+|..||.......++..-.++.++. +.+.....+..++.+|
T Consensus 194 p~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i 273 (516)
T KOG0582|consen 194 PCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMI 273 (516)
T ss_pred ccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHH
Confidence 9999999963 4679999999999999999999999999888777666555555542 2333455788999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 217 AKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
..||++||.+||||+++|+|+||+....
T Consensus 274 ~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 274 ALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 9999999999999999999999987543
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=324.41 Aligned_cols=229 Identities=31% Similarity=0.530 Sum_probs=210.7
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
|| .||+|+.++++-.||+|++.+ -..++.||++|-. .+.||||+++|++|.+...+||++||.. .|+++.
T Consensus 35 FG-~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs-~L~hpnilrlY~~fhd~~riyLilEya~-~gel~k 111 (281)
T KOG0580|consen 35 FG-NVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQS-HLRHPNILRLYGYFHDSKRIYLILEYAP-RGELYK 111 (281)
T ss_pred cc-cEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeec-ccCCccHHhhhhheeccceeEEEEEecC-CchHHH
Confidence 66 899999999999999999988 4678999999998 8899999999999999999999999999 888888
Q ss_pred hhc--------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 75 IID--------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 75 ~l~--------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
.+. +.....+.+|++.||.|||.++|+||||||+|+|++.+ +.+||+|||-+-... .....+.|||.-
T Consensus 112 ~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~---~~lkiAdfGwsV~~p-~~kR~tlcgt~d 187 (281)
T KOG0580|consen 112 DLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAP-SNKRKTLCGTLD 187 (281)
T ss_pred HHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC---CCeeccCCCceeecC-CCCceeeecccc
Confidence 654 33445666999999999999999999999999999776 689999999988754 455678999999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|.|||...+..++..+|+|++|++.||++.|.+||...+..+.+++|.+....+| ..++.+++|+|.+||.++|.+
T Consensus 188 yl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~ 263 (281)
T KOG0580|consen 188 YLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADLISRLLVKNPIE 263 (281)
T ss_pred cCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHHHHHHhccCccc
Confidence 9999999999999999999999999999999999999999999999999999988 478999999999999999999
Q ss_pred CCCHHHHHcCcccCC
Q psy6377 227 RMTAKEALKHPWLMN 241 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~ 241 (383)
|.+..|++.|||+..
T Consensus 264 r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 264 RLALTEVMDHPWIVA 278 (281)
T ss_pred cccHHHHhhhHHHHh
Confidence 999999999999864
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=335.21 Aligned_cols=235 Identities=28% Similarity=0.388 Sum_probs=202.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCC-cccceEEEEeCC------eEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPR-IVKLHDVFQTGE------GAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpn-Ivkl~~~~~~~~------~~~lv~e~~~~g~~ 71 (383)
.||.|+.+.+|+.||+|.++-. .....||+.+|+ .++|+| ||.++|++.+.+ .+++|+|++. .+
T Consensus 26 ~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk-~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d--~D 102 (323)
T KOG0594|consen 26 VVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLK-RLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD--RD 102 (323)
T ss_pred EEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHH-HhCCCcceEEEEeeeeecccccccceEEEEEEeec--cc
Confidence 6999999999999999999762 345689999999 888999 999999999888 8999999998 88
Q ss_pred HHHhhccCC----------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCccccc
Q psy6377 72 LQTIIDDNL----------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRE 140 (383)
Q Consensus 72 L~~~l~~~~----------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~ 140 (383)
|.++++... +..+.+||+.||+|||++||+||||||+|||++++ |.+||+|||+|+... +....+.
T Consensus 103 L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~---G~lKlaDFGlAra~~ip~~~yt~ 179 (323)
T KOG0594|consen 103 LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS---GVLKLADFGLARAFSIPMRTYTP 179 (323)
T ss_pred HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC---CcEeeeccchHHHhcCCcccccc
Confidence 888765433 56777999999999999999999999999999875 799999999999766 3344677
Q ss_pred ccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcC------------
Q psy6377 141 LLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED------------ 207 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~------------ 207 (383)
.++|.+|+|||++.+. .|+...||||+|||++||+++++.|.|..+.+++..|......+....|+.
T Consensus 180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~ 259 (323)
T KOG0594|consen 180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFP 259 (323)
T ss_pred cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCc
Confidence 8899999999998776 799999999999999999999999999999998888876544443333322
Q ss_pred --------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 208 --------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 208 --------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
.++...+++.+||+.+|.+|.|++.+|.||||......
T Consensus 260 ~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 260 KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 34589999999999999999999999999999876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=344.90 Aligned_cols=230 Identities=29% Similarity=0.467 Sum_probs=200.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ .+.||||++++++|++++.+|+||||+. |++|.+.+.
T Consensus 10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 87 (323)
T cd05571 10 KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-NTRHPFLTALKYSFQTHDRLCFVMEYAN-GGELFFHLS 87 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCCEEEEEEcCCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999976 2245778999998 7789999999999999999999999999 999988664
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... +......+||+.|+||
T Consensus 88 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aP 164 (323)
T cd05571 88 RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164 (323)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEeeCCCCcccccCCCcccceecCccccCh
Confidence 3 2344566899999999999999999999999999765 6899999999886422 2334456899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+..++.++||||+||++|+|++|..||.+.+.......+......+|. .+++++.+||.+||..||++||
T Consensus 165 E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred hhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCC
Confidence 9999999999999999999999999999999988887777777776666553 5799999999999999999999
Q ss_pred ---CHHHHHcCcccCCcc
Q psy6377 229 ---TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ---t~~e~L~hp~~~~~~ 243 (383)
++.++++||||....
T Consensus 241 ~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 241 GPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.33 Aligned_cols=235 Identities=26% Similarity=0.370 Sum_probs=196.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|+.||+|.+.+ ....+.+|+.+++ .++||||++++++|.+++..++||||++ +++|...+.
T Consensus 15 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~~~ 92 (285)
T cd05631 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILE-KVNSRFVVSLAYAYETKDALCLVLTIMN-GGDLKFHIY 92 (285)
T ss_pred EEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHH-hcCCCcEEEEEEEEccCCeEEEEEEecC-CCcHHHHHH
Confidence 689999999999999999875 1235678999999 7799999999999999999999999999 999987542
Q ss_pred --------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 --------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 --------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
+..+..++.|++.||+|||++||+||||||+|||++++ +.++|+|||++.............||+.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~a 169 (285)
T cd05631 93 NMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR---GHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169 (285)
T ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeCCCcEEcCCCCeecCCCCCCCccC
Confidence 22345666899999999999999999999999999765 5899999999987654444556689999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++||||+||++|+|++|++||.+.........+.......+..+...++.++.+||++||..||.+|||
T Consensus 170 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLG 249 (285)
T ss_pred HhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcC
Confidence 99999999999999999999999999999999887654333333222222223344568999999999999999999997
Q ss_pred -----HHHHHcCcccCCcch
Q psy6377 230 -----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 -----~~e~L~hp~~~~~~~ 244 (383)
++++++||||.....
T Consensus 250 ~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 250 CRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred CCCCCHHHHhcCHhhcCCCH
Confidence 899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.35 Aligned_cols=234 Identities=32% Similarity=0.497 Sum_probs=192.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEeCC--eEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||++.++.+|+.+|||.+... ...+.+|+.+|. .+.|||||++++...... .++++|||++ ||+|.+++.
T Consensus 31 G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~-~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~-~GsL~~~~~ 108 (313)
T KOG0198|consen 31 GSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILS-RLNHPNIVQYYGSSSSRENDEYNIFMEYAP-GGSLSDLIK 108 (313)
T ss_pred eEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHH-hCCCCCEEeeCCccccccCeeeEeeeeccC-CCcHHHHHH
Confidence 36899999999999999998874 456899999999 556999999999855544 6999999999 999999765
Q ss_pred cC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec----CcccccccCCCC
Q psy6377 78 DN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD----GIEIRELLGTPD 146 (383)
Q Consensus 78 ~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~----~~~~~~~~gt~~ 146 (383)
.. .+..+.+||+.||+|||++|||||||||+|||++.. .+.+||+|||++..... ........|||.
T Consensus 109 ~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~ 186 (313)
T KOG0198|consen 109 RYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLESKGTKSDSELSVQGTPN 186 (313)
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCccccccccccccccccccccCCcc
Confidence 43 355666999999999999999999999999999763 26899999999987653 122345789999
Q ss_pred cCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 147 YVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 147 y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|||||++... ....++|||||||++.||+||.+||.. ....+.+-.+.... ..| .+...+|+++++||.+||..||
T Consensus 187 ~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~ls~~a~~Fl~~C~~~~p 264 (313)
T KOG0198|consen 187 YMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDSLSDEAKDFLRKCFKRDP 264 (313)
T ss_pred ccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcccCHHHHHHHHHHhhcCc
Confidence 9999999852 234599999999999999999999987 33334334443333 222 5556799999999999999999
Q ss_pred CCCCCHHHHHcCcccCCcc
Q psy6377 225 MERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 225 ~~Rpt~~e~L~hp~~~~~~ 243 (383)
++||||+++|.|||+....
T Consensus 265 ~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 265 EKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ccCcCHHHHhhChhhhccc
Confidence 9999999999999997644
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=333.52 Aligned_cols=229 Identities=27% Similarity=0.359 Sum_probs=190.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+++..|+|||++. ++|.+.+..
T Consensus 20 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~ 96 (288)
T cd07871 20 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-NLKHANIVTLHDIIHTERCLTLVFEYLD--SDLKQYLDNC 96 (288)
T ss_pred EEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEEEEEeCCC--cCHHHHHHhc
Confidence 689999999999999999875 2346779999999 7799999999999999999999999998 488876532
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......|++.|+|||
T Consensus 97 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE 173 (288)
T cd07871 97 GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEECcCcceeeccCCCccccCceecccccChH
Confidence 2234566899999999999999999999999999765 689999999998653322 234457899999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch--------------------------
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL-------------------------- 204 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------------------- 204 (383)
++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+......++...
T Consensus 174 ~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07871 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH 253 (288)
T ss_pred HhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHh
Confidence 8865 5689999999999999999999999999887776666544332222111
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
...++.++++||.+||.+||.+|||++|+|+||||
T Consensus 254 ~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 254 APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 13467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=337.04 Aligned_cols=230 Identities=25% Similarity=0.451 Sum_probs=201.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+++..|+||||++ +++|.+++
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 92 (291)
T cd05612 15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK-EVSHPFIIRLFWTEHDQRFLYMLMEYVP-GGELFSYL 92 (291)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHH-hCCCCcHhhhHhhhccCCeEEEEEeCCC-CCCHHHHH
Confidence 3799999999999999999864 2345788999999 7899999999999999999999999999 99999876
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... ....+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... ....+||+.|+||
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~---~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aP 167 (291)
T cd05612 93 RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE---GHIKLTDFGFAKKLRDR--TWTLCGTPEYLAP 167 (291)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEEecCcchhccCC--cccccCChhhcCH
Confidence 432 344666999999999999999999999999999765 68999999999875432 3346799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.+..++.++|||||||++|+|++|..||.+.+..+....+..+...+|. .++..+++||++||..||.+||+
T Consensus 168 E~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~ 243 (291)
T cd05612 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGN 243 (291)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHHHcCCCHHHccCC
Confidence 9999999999999999999999999999999999888888888887766654 45899999999999999999995
Q ss_pred ----HHHHHcCcccCCcch
Q psy6377 230 ----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~ 244 (383)
++++++||||.....
T Consensus 244 ~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 244 MKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ccCCHHHHhcCccccCCCH
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=331.40 Aligned_cols=218 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceE-EEEeCC-eEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHD-VFQTGE-GAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~-~~~~~~-~~~lv~e~~~~g~~L~~~l 76 (383)
.||++++..+|..+|.|.+.- .++....|+.+|+ .++|||||++|+ -|.++. -++++||+|. +|+|...+
T Consensus 34 ~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLk-QL~HpNIVqYy~~~f~~~~evlnivmE~c~-~GDLsqmI 111 (375)
T KOG0591|consen 34 EVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLK-QLNHPNIVQYYAHSFIEDNEVLNIVMELCD-AGDLSQMI 111 (375)
T ss_pred heEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHH-hcCCchHHHHHHHhhhccchhhHHHHHhhc-ccCHHHHH
Confidence 589999999999999998875 4577889999999 899999999998 454444 4999999999 99999864
Q ss_pred ----------ccCCchhhHHHHHHHHHHHHh--CC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccc
Q psy6377 77 ----------DDNLVVPFESDELSSLAYLHH--RK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IREL 141 (383)
Q Consensus 77 ----------~~~~~~~~~~qil~aL~yLHs--~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~ 141 (383)
.+..+|.++.|++.||..||+ .+ |+||||||.||+++.+ |.+||+|||+++.+..... ..++
T Consensus 112 k~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~---gvvKLGDfGL~r~l~s~~tfA~S~ 188 (375)
T KOG0591|consen 112 KHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN---GVVKLGDFGLGRFLSSKTTFAHSL 188 (375)
T ss_pred HHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC---CceeeccchhHhHhcchhHHHHhh
Confidence 445678888999999999999 55 9999999999999866 7999999999998765443 4568
Q ss_pred cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-CCcchhcCCCHHHHHHHHHhc
Q psy6377 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-FPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L 220 (383)
+|||.||+||++...+|+.++||||+||++|||+.-++||.|.+-.++..+|..+.++ .|. ..+|.++..+|..|+
T Consensus 189 VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~---~~YS~~l~~li~~ci 265 (375)
T KOG0591|consen 189 VGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD---EHYSTDLRELINMCI 265 (375)
T ss_pred cCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH---HHhhhHHHHHHHHHc
Confidence 9999999999999999999999999999999999999999999999999999988765 332 457999999999999
Q ss_pred ccCCCCCCCH
Q psy6377 221 IKNPMERMTA 230 (383)
Q Consensus 221 ~~dP~~Rpt~ 230 (383)
..||+.||+.
T Consensus 266 ~vd~~~RP~t 275 (375)
T KOG0591|consen 266 AVDPEQRPDT 275 (375)
T ss_pred cCCcccCCCc
Confidence 9999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=341.84 Aligned_cols=228 Identities=26% Similarity=0.453 Sum_probs=200.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+++..|+||||+. |++|.+.+
T Consensus 32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 109 (329)
T PTZ00263 32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM-ELSHPFIVNMMCSFQDENRVYFLLEFVV-GGELFTHL 109 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEcCCEEEEEEcCCC-CChHHHHH
Confidence 3799999999999999999875 2345789999999 7799999999999999999999999999 99999876
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++...... ....+||+.|+||
T Consensus 110 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aP 184 (329)
T PTZ00263 110 RKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPDR--TFTLCGTPEYLAP 184 (329)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC---CCEEEeeccCceEcCCC--cceecCChhhcCH
Confidence 432 234556899999999999999999999999999765 68999999999876432 3346799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.+..++.++|||||||++|+|++|..||.+.+..+....+..+...+|. .++..+++||.+||..||.+|++
T Consensus 185 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred HHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9999999999999999999999999999999998888888888877666553 47899999999999999999997
Q ss_pred ----HHHHHcCcccCCc
Q psy6377 230 ----AKEALKHPWLMNK 242 (383)
Q Consensus 230 ----~~e~L~hp~~~~~ 242 (383)
+++++.||||...
T Consensus 261 ~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 261 LKGGVADVKNHPYFHGA 277 (329)
T ss_pred CCCCHHHHhcCCccCCC
Confidence 7999999999864
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.16 Aligned_cols=232 Identities=27% Similarity=0.426 Sum_probs=201.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.++.....||||++++++|.+.+.+|+||||++ |++|.+.+
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~-~g~L~~~i 87 (320)
T cd05590 9 GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN-GGDLMFHI 87 (320)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC-CchHHHHH
Confidence 3689999999999999999875 234567888888866789999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++..... .......+||+.|+|
T Consensus 88 ~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 164 (320)
T cd05590 88 QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164 (320)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCCCcccccccCccccC
Confidence 43 2345667999999999999999999999999999765 6899999999886432 223445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+||+
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred HHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHCCC
Confidence 99999999999999999999999999999999999988888888776665553 57899999999999999999999
Q ss_pred H------HHHHcCcccCCcc
Q psy6377 230 A------KEALKHPWLMNKK 243 (383)
Q Consensus 230 ~------~e~L~hp~~~~~~ 243 (383)
+ +++++||||....
T Consensus 241 ~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 241 SLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 8 9999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=337.86 Aligned_cols=229 Identities=28% Similarity=0.450 Sum_probs=198.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+.+..|+||||++ |++|.+.+.
T Consensus 8 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 85 (312)
T cd05585 8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLA-QVNCPFIVPLKFSFQSPEKLYLVLAFIN-GGELFHHLQ 85 (312)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCcEeceeeEEecCCeEEEEEcCCC-CCcHHHHHH
Confidence 689999999999999999875 2345678999999 7799999999999999999999999999 999998764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
.. .+..+..|++.||.|||++||+||||||+|||++.+ +.++|+|||+++..... ......+||+.|+||
T Consensus 86 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 162 (312)
T cd05585 86 REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAP 162 (312)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC---CcEEEEECcccccCccCCCccccccCCcccCCH
Confidence 33 344566899999999999999999999999999765 68999999998864322 223456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+..++.++||||+||++|+|++|.+||.+.+..+.+..+......+| ..+++++.+||.+||..||.+||
T Consensus 163 E~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred HHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999999999999999999999999999999999888888888777665555 46799999999999999999997
Q ss_pred -CHHHHHcCcccCCc
Q psy6377 229 -TAKEALKHPWLMNK 242 (383)
Q Consensus 229 -t~~e~L~hp~~~~~ 242 (383)
++.++|.||||...
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=331.70 Aligned_cols=230 Identities=26% Similarity=0.374 Sum_probs=190.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+++..|+||||+. ++.+..+..
T Consensus 16 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~ 93 (287)
T cd07848 16 VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLR-TLKQENIVELKEAFRRRGKLYLVFEYVE-KNMLELLEEM 93 (287)
T ss_pred EEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHH-hCCCccccchhhhEecCCEEEEEEecCC-CCHHHHHHhc
Confidence 589999999999999999875 2356789999999 7899999999999999999999999999 776665432
Q ss_pred -----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCCC
Q psy6377 78 -----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVAP 150 (383)
Q Consensus 78 -----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~aP 150 (383)
...+..+..|++.||.|||+.||+||||||+||+++.+ +.+||+|||++....... ......||+.|+||
T Consensus 94 ~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 170 (287)
T cd07848 94 PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccCcccccccccccccccccccccCCc
Confidence 22345677999999999999999999999999999765 689999999998764322 23345799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc----------------------------
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD---------------------------- 202 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------- 202 (383)
|++.+..++.++|+||+||++|+|++|++||.+.+..+....+.....+.|.
T Consensus 171 E~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T cd07848 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLER 250 (287)
T ss_pred HHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHH
Confidence 9999888999999999999999999999999988766555444332221111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.....+|.++.+||++||.+||++|||++++|+||||
T Consensus 251 ~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 251 RYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1122368889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.06 Aligned_cols=231 Identities=28% Similarity=0.451 Sum_probs=200.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .+.||||+++++++.+.+.+|+||||++ +++|...+
T Consensus 9 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~Ey~~-~g~L~~~l 86 (328)
T cd05593 9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK-NTRHPFLTSLKYSFQTKDRLCFVMEYVN-GGELFFHL 86 (328)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCEEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999976 2346778999998 7899999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|
T Consensus 87 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 163 (328)
T cd05593 87 SRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163 (328)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC---CcEEEecCcCCccCCCcccccccccCCcCccC
Confidence 43 2345667999999999999999999999999999765 6899999999876432 223345679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|. .++.++.+||.+||.+||++|+
T Consensus 164 PE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred hhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCCCHHHcCC
Confidence 99999889999999999999999999999999988877777777666665553 5799999999999999999997
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
++.++++||||....
T Consensus 240 ~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.87 Aligned_cols=231 Identities=26% Similarity=0.424 Sum_probs=201.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+..|++++....+||||++++++|++.+.+|+||||+. +++|...+.
T Consensus 10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~-~~~L~~~l~ 88 (321)
T cd05591 10 KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN-GGDLMFQIQ 88 (321)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999876 224567889999866789999999999999999999999999 999988654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
. ..+..++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++..... .......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (321)
T cd05591 89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165 (321)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeecccceecccCCccccccccCccccCH
Confidence 3 2345667999999999999999999999999999765 6899999999886432 2234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+..++.++|||||||++|+|++|++||.+.+..+.+..+......+|. .++.++.++|.+||..||++|+
T Consensus 166 E~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999999999999999999999999999988888888877666553 4689999999999999999999
Q ss_pred -----CHHHHHcCcccCCcc
Q psy6377 229 -----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 -----t~~e~L~hp~~~~~~ 243 (383)
+++++++||||....
T Consensus 242 ~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 242 VASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCHHHHhcCCccCCCC
Confidence 899999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.69 Aligned_cols=232 Identities=27% Similarity=0.401 Sum_probs=195.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.++. ..+||||+++++.+++...+|+||||++ |++|.+++.
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~~~~~~iv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 93 (363)
T cd05628 16 EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV-EADSLWVVKMFYSFQDKLNLYLIMEFLP-GGDMMTLLM 93 (363)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCeEEEEEcCCC-CCcHHHHHH
Confidence 689999999999999999976 1245778999998 7799999999999999999999999999 999999764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------------
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------------- 136 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------------- 136 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 94 ~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 170 (363)
T cd05628 94 KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170 (363)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CCEEEeeccCccccccccccccccccccccccc
Confidence 3 3345667999999999999999999999999999765 689999999987542210
Q ss_pred ---------------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Q psy6377 137 ---------------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK 195 (383)
Q Consensus 137 ---------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~ 195 (383)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMN 250 (363)
T ss_pred ccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 01235799999999999999999999999999999999999999999988888888876
Q ss_pred cc--CCCCcchhcCCCHHHHHHHHHhcccCCC---CCCCHHHHHcCcccCCcch
Q psy6377 196 AQ--LDFPDELFEDISPEAKDFIAKILIKNPM---ERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 196 ~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpt~~e~L~hp~~~~~~~ 244 (383)
.. ..+|+. ..+++++++||.+|+. +|. .||+++|+++||||+....
T Consensus 251 ~~~~~~~p~~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 251 WKETLIFPPE--VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CcCcccCCCc--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 43 334432 3578999999999875 444 4689999999999987644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.52 Aligned_cols=233 Identities=27% Similarity=0.439 Sum_probs=199.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.+ ....+.+|+.++. ..+||||+++++++++.+..|+||||++ |++|.+++
T Consensus 15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~lv~e~~~-g~~L~~~l 92 (333)
T cd05600 15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILT-TTKSEWLVKLLYAFQDDEYLYLAMEYVP-GGDFRTLL 92 (333)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHH-hCCCCCCccEEEEEEcCCEEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999975 2345778999999 7789999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ......||+.|+||
T Consensus 93 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aP 167 (333)
T cd05600 93 NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS---GHIKLTDFGLSKGIVT--YANSVVGSPDYMAP 167 (333)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEEEeCcCCccccc--ccCCcccCccccCh
Confidence 43 2344566999999999999999999999999999765 6899999999986543 33456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh----cCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF----EDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......+..+.+ ..++.++.+||.+||..+|.+
T Consensus 168 E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~r 247 (333)
T cd05600 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRR 247 (333)
T ss_pred hHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhh
Confidence 9999999999999999999999999999999998888877776654322211111 257899999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||++++++||||....
T Consensus 248 r~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 248 FGSLEDIKNHPFFKEVD 264 (333)
T ss_pred cCCHHHHHhCcccCCCC
Confidence 99999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.49 Aligned_cols=231 Identities=29% Similarity=0.472 Sum_probs=200.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .+.||||++++++|.+.+..|+||||+. +++|...+
T Consensus 9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~E~~~-~~~L~~~l 86 (323)
T cd05595 9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYAN-GGELFFHL 86 (323)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCEEEEEEeCCC-CCcHHHHH
Confidence 3689999999999999999875 2235668999998 7799999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++..... ........||+.|+|
T Consensus 87 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 163 (323)
T cd05595 87 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC---CCEEecccHHhccccCCCCccccccCCcCcCC
Confidence 43 3345666999999999999999999999999999765 6899999999876422 223345679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|. .+++++.+||.+||..||++|+
T Consensus 164 PE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccCCHHHhCC
Confidence 99999999999999999999999999999999988888888877766666553 5799999999999999999998
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
++.++++||||....
T Consensus 240 ~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.88 Aligned_cols=233 Identities=27% Similarity=0.421 Sum_probs=196.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+++ .++||||++++++|.+++.+|+||||+. |++|.+++.
T Consensus 16 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv~E~~~-~g~L~~~l~ 93 (364)
T cd05599 16 EVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA-EADNPWVVKLYYSFQDENYLYLIMEYLP-GGDMMTLLM 93 (364)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCeEEEEECCCC-CcHHHHHHH
Confidence 689999999999999999975 1234678999999 7789999999999999999999999999 999999654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------------
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------------- 136 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------------- 136 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 94 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 170 (364)
T cd05599 94 KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170 (364)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEeecccceecccccccccccccccccccc
Confidence 3 3345667999999999999999999999999999765 689999999987643211
Q ss_pred ------------------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q psy6377 137 ------------------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN 192 (383)
Q Consensus 137 ------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~ 192 (383)
.....+||+.|+|||++....++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~ 250 (364)
T cd05599 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRK 250 (364)
T ss_pred ccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHH
Confidence 01124699999999999999999999999999999999999999999888887777
Q ss_pred HHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccCCcc
Q psy6377 193 ISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT---AKEALKHPWLMNKK 243 (383)
Q Consensus 193 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hp~~~~~~ 243 (383)
+......++......+++++++||.+||. +|.+|++ +++++.||||....
T Consensus 251 i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 251 IINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 76554333222223579999999999997 9999998 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=332.24 Aligned_cols=231 Identities=29% Similarity=0.446 Sum_probs=198.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ .......|..++....+||||++++++|.+.+..|+||||+. |++|...+.
T Consensus 10 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~-~g~L~~~i~ 88 (316)
T cd05620 10 KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN-GGDLMFHIQ 88 (316)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC-CCcHHHHHH
Confidence 689999999999999999975 234567788888867799999999999999999999999999 999988664
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
.. .+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.... .......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05620 89 DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165 (316)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEeCccCCCeecccCCCceeccCCCcCccCH
Confidence 42 234566899999999999999999999999999765 6899999999875322 2234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++||||+||++|+|++|..||.+.+..+....+......+|. .++.++++||.+||..||++||++
T Consensus 166 E~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~ 241 (316)
T cd05620 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFERDPTRRLGV 241 (316)
T ss_pred HHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCC
Confidence 9999999999999999999999999999999998888888877766554443 578999999999999999999998
Q ss_pred -HHHHcCcccCCcc
Q psy6377 231 -KEALKHPWLMNKK 243 (383)
Q Consensus 231 -~e~L~hp~~~~~~ 243 (383)
+++++||||....
T Consensus 242 ~~~~~~h~~f~~~~ 255 (316)
T cd05620 242 VGNIRGHPFFKTIN 255 (316)
T ss_pred hHHHHcCCCcCCCC
Confidence 5889999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.12 Aligned_cols=234 Identities=25% Similarity=0.382 Sum_probs=198.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ ..+||||+++++++.+++..|+||||++ |++|.+++.
T Consensus 58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~-~~~h~~iv~~~~~~~~~~~~~lv~Ey~~-gg~L~~~l~ 135 (370)
T cd05596 58 EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-HANSEWIVQLHYAFQDDKYLYMVMEYMP-GGDLVNLMS 135 (370)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCEEEEEEcCCC-CCcHHHHHH
Confidence 689999999999999999975 2234678999999 7899999999999999999999999999 999999765
Q ss_pred cC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCCC
Q psy6377 78 DN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~aP 150 (383)
.. ....+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....+||+.|+||
T Consensus 136 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aP 212 (370)
T cd05596 136 NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC---CCEEEEeccceeeccCCCcccCCCCCCCcCeECH
Confidence 42 344566899999999999999999999999999765 689999999998764332 22356799999999
Q ss_pred cccccC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILHYE----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~~~----~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++.+. .++.++|+|||||++|+|++|.+||.+.+....+..+......+..+....+|.++++||.+||..+|.+
T Consensus 213 E~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r 292 (370)
T cd05596 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVR 292 (370)
T ss_pred HHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhc
Confidence 998653 3789999999999999999999999999888888888765433322223467999999999999999988
Q ss_pred --CCCHHHHHcCcccCCcc
Q psy6377 227 --RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 --Rpt~~e~L~hp~~~~~~ 243 (383)
|+|++++++||||.+..
T Consensus 293 ~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 293 LGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred cCCCCHHHHhcCcccCCCC
Confidence 99999999999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=329.51 Aligned_cols=236 Identities=28% Similarity=0.400 Sum_probs=205.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCC-----eEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||.|+-..+++.||||....+..---+|+.+|+ .+.|||||++..+|.... ...|||||++ .+|.+.+..
T Consensus 39 ~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~-~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP--~tL~~~~r~~ 115 (364)
T KOG0658|consen 39 VVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMR-KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP--ETLYRVIRHY 115 (364)
T ss_pred eEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHH-hcCCcCeeeEEEEEEecCCCchhHHHHHHHhch--HHHHHHHHHH
Confidence 5899999999999999999887777889999999 889999999999997543 2458899998 899987652
Q ss_pred ---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 79 ---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 79 ---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
-.++.+.+||++||.|||+.||+||||||+|||++.+ .|.+||||||.|+....+++..++..|..|+|
T Consensus 116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKicDFGSAK~L~~~epniSYicSRyYRa 193 (364)
T KOG0658|consen 116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKICDFGSAKVLVKGEPNISYICSRYYRA 193 (364)
T ss_pred hhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEeccCCcceeeccCCCceeEEEeccccC
Confidence 1345666999999999999999999999999999876 48999999999999998888889999999999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------c-----
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------E----- 203 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------~----- 203 (383)
||.+.+ ..|+.+.||||.||++.||+-|++.|.|.+..+++..|.+.-..+.. .
T Consensus 194 PELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~ 273 (364)
T KOG0658|consen 194 PELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKV 273 (364)
T ss_pred HHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceee
Confidence 998765 57999999999999999999999999999998888887654333321 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
+...+++++.+|+.++|.++|.+|.++.|+|.||||+.....
T Consensus 274 ~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 274 FFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 234578999999999999999999999999999999876654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=326.98 Aligned_cols=232 Identities=26% Similarity=0.345 Sum_probs=184.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.++...|+||||+. ++|.+.+..
T Consensus 20 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~ 96 (303)
T cd07869 20 TVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTLVFEYVH--TDLCQYMDKH 96 (303)
T ss_pred EEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHh-hCCCCCcCeEEEEEecCCeEEEEEECCC--cCHHHHHHhC
Confidence 699999999999999999875 2345788999999 7799999999999999999999999997 567664432
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE 151 (383)
..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+|||
T Consensus 97 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 173 (303)
T cd07869 97 PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT---GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173 (303)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECCCCcceeccCCCccCCCCcccCCCCChH
Confidence 2345667999999999999999999999999999765 68999999998764322 2234567899999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCC-----------------------cc---
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFP-----------------------DE--- 203 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~-----------------------~~--- 203 (383)
++.+ ..++.++||||+||++|+|++|.+||.+.... +.+..+........ ..
T Consensus 174 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (303)
T cd07869 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQ 253 (303)
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHH
Confidence 9865 45899999999999999999999999876442 23332221110000 00
Q ss_pred hh--cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 204 LF--EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 204 ~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+ ...++.+.+||.+||+.||++|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 254 AWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 01 1245789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.04 Aligned_cols=228 Identities=27% Similarity=0.377 Sum_probs=198.4
Q ss_pred eEEEEEEcCCC-cEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATG-EVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg-~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.++ ..||+|.+.+ ....+.+|+.+++ .++||||+++++++.+++..|+||||+. |++|.+++
T Consensus 45 ~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~-~g~L~~~i 122 (340)
T PTZ00426 45 RVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN-YINHPFCVNLYGSFKDESYLYLVLEFVI-GGEFFTFL 122 (340)
T ss_pred EEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCCcceEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 58999877665 7899999865 2345778999999 7789999999999999999999999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... .+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ...+.+||+.|+||
T Consensus 123 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~---~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aP 197 (340)
T PTZ00426 123 RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD---GFIKMTDFGFAKVVDT--RTYTLCGTPEYIAP 197 (340)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---CCEEEecCCCCeecCC--CcceecCChhhcCH
Confidence 543 234566999999999999999999999999999765 6899999999987532 23456899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+..++.++|+||+||++|+|++|.+||.+.+.......+..+...+|. .+++.+.++|++||..||.+|+
T Consensus 198 E~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~dp~~R~~~ 273 (340)
T PTZ00426 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGN 273 (340)
T ss_pred HHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHcCCC
Confidence 9999888999999999999999999999999998888888888877766653 5689999999999999999995
Q ss_pred ---CHHHHHcCcccCCcc
Q psy6377 229 ---TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ---t~~e~L~hp~~~~~~ 243 (383)
|++++++||||.+..
T Consensus 274 ~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 274 LKKGAQNVKEHPWFGNID 291 (340)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 899999999998743
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=325.79 Aligned_cols=234 Identities=25% Similarity=0.374 Sum_probs=192.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.||+|.++.+|+.||+|.+.+ ....+..|+.+++ .++||||++++++|.+.+..|+||||++ |++|...+
T Consensus 8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~g~L~~~~~ 85 (280)
T cd05608 8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA-KVHSRFIVSLAYAFQTKTDLCLVMTIMN-GGDLRYHIY 85 (280)
T ss_pred eEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHH-hCCCCcEeeeeEEEcCCCeEEEEEeCCC-CCCHHHHHH
Confidence 689999999999999999875 1245678999999 7799999999999999999999999999 99998754
Q ss_pred ---------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCC
Q psy6377 77 ---------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPD 146 (383)
Q Consensus 77 ---------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~ 146 (383)
.+..+..+..||+.||+|||++||+||||||+||+++.+ +.++|+|||++........ .....||+.
T Consensus 86 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~g~~~ 162 (280)
T cd05608 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND---GNVRISDLGLAVELKDGQSKTKGYAGTPG 162 (280)
T ss_pred hccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCccceecCCCCccccccCCCcC
Confidence 223345667999999999999999999999999999765 6899999999987644322 334579999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+..++.++|+||+||++|+|++|+.||.+.........+.......+......++..+.+++.+||..||++
T Consensus 163 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 242 (280)
T cd05608 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEK 242 (280)
T ss_pred ccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHH
Confidence 99999999999999999999999999999999999876543222222222222222334568999999999999999999
Q ss_pred CC-----CHHHHHcCcccCCcc
Q psy6377 227 RM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rp-----t~~e~L~hp~~~~~~ 243 (383)
|| |++++++||||+...
T Consensus 243 R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 243 RLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred hcCCCCCCHHHHhcChhhhcCC
Confidence 99 889999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.80 Aligned_cols=230 Identities=29% Similarity=0.466 Sum_probs=199.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+++++ ...||||++++++|.+.+..|+||||+. |++|...+.
T Consensus 10 ~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~~~hp~i~~~~~~~~~~~~~~lv~E~~~-~~~L~~~l~ 87 (325)
T cd05594 10 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLCFVMEYAN-GGELFFHLS 87 (325)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCCceEEEEEcCCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999976 2345678889898 7789999999999999999999999999 999988654
Q ss_pred cC------CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. .+..+..||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|
T Consensus 88 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (325)
T cd05594 88 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164 (325)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC---CCEEEecCCCCeecCCCCcccccccCCcccCC
Confidence 33 345666999999999998 799999999999999765 6899999999876432 233445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|. .+++++.+||.+||..||++|+
T Consensus 165 PE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhCC
Confidence 99999899999999999999999999999999998887787777766666553 5789999999999999999997
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
++.++++||||....
T Consensus 241 ~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 241 GGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=330.76 Aligned_cols=231 Identities=31% Similarity=0.469 Sum_probs=197.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ .......|..++....+||||+++++++.++...|+||||+. |++|...+.
T Consensus 10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-gg~L~~~~~ 88 (316)
T cd05592 10 KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN-GGDLMFHIQ 88 (316)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC-CCcHHHHHH
Confidence 689999999999999999875 234456778888766799999999999999999999999999 999988664
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
. ..+..+..||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... ......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05592 89 SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---GHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165 (316)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC---CCEEEccCcCCeECCCCCCccccccCCccccCH
Confidence 3 2345667999999999999999999999999999765 68999999999865332 223456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+| ..++.++.+||.+||..||.+||++
T Consensus 166 E~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~ 241 (316)
T cd05592 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGV 241 (316)
T ss_pred HHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999988888877766554444 3578999999999999999999986
Q ss_pred -HHHHcCcccCCcc
Q psy6377 231 -KEALKHPWLMNKK 243 (383)
Q Consensus 231 -~e~L~hp~~~~~~ 243 (383)
.+++.||||....
T Consensus 242 ~~~l~~h~~~~~~~ 255 (316)
T cd05592 242 DGDIRQHPFFRGID 255 (316)
T ss_pred hHHHHcCcccCCCC
Confidence 5888999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=341.63 Aligned_cols=233 Identities=27% Similarity=0.401 Sum_probs=195.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+++.||+|++.+ ....+.+|+.+++ ..+||||+++++.|.+++.+|+||||++ ||+|.+++.
T Consensus 16 ~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~~~h~~iv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 93 (382)
T cd05625 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA-EADNEWVVRLYYSFQDKDNLYFVMDYIP-GGDMMSLLI 93 (382)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hCCCCcCCeEEEEEEeCCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999976 1346788999999 7799999999999999999999999999 999999764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC----------------
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---------------- 135 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---------------- 135 (383)
.. .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 94 ~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~---g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 170 (382)
T cd05625 94 RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170 (382)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEeECCCCcccccccccccccccccccccc
Confidence 32 344566899999999999999999999999999765 68999999997532100
Q ss_pred --------------------------------cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q psy6377 136 --------------------------------IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183 (383)
Q Consensus 136 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~ 183 (383)
....+.+||+.|+|||++.+.+|+.++||||+||++|+|++|++||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred ccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 001234799999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccCCcc
Q psy6377 184 ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT---AKEALKHPWLMNKK 243 (383)
Q Consensus 184 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hp~~~~~~ 243 (383)
.+..+....+.......+.+....+++++.++|.+|+ .+|.+|++ ++++++||||....
T Consensus 251 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 251 QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 8877777776654433333334568999999999986 59999997 99999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=330.12 Aligned_cols=231 Identities=31% Similarity=0.522 Sum_probs=199.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++...+||||++++++|++.+.+|+||||+. |++|...+.
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 88 (318)
T cd05570 10 KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN-GGDLMFHIQ 88 (318)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC-CCCHHHHHH
Confidence 699999999999999999986 234567888999866689999999999999999999999999 999988654
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
.. .+..+..|++.||.|||++||+||||||+|||++.+ +.++|+|||+++.... .......+||+.|+||
T Consensus 89 ~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aP 165 (318)
T cd05570 89 RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAP 165 (318)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---CcEEecccCCCeecCcCCCcccceecCccccCH
Confidence 33 345666999999999999999999999999999765 6899999999875322 2233446799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|+|||||++|+|++|..||.+.+..+....+......+| ..++.++.+||.+||..||++|||+
T Consensus 166 E~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999888888887776665554 3578999999999999999999999
Q ss_pred -----HHHHcCcccCCcc
Q psy6377 231 -----KEALKHPWLMNKK 243 (383)
Q Consensus 231 -----~e~L~hp~~~~~~ 243 (383)
.+++.||||....
T Consensus 242 ~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 242 LPTGEQDIKGHPFFREID 259 (318)
T ss_pred CCCCHHHHhcCCCcCCCC
Confidence 9999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=333.13 Aligned_cols=232 Identities=25% Similarity=0.404 Sum_probs=193.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.++....+||||++++++|.+.+.+|+||||++ |++|...+
T Consensus 9 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~~ 87 (329)
T cd05588 9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS-GGDLMFHM 87 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999986 123477899999866689999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++... ........+||+.|+|
T Consensus 88 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (329)
T cd05588 88 QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164 (329)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEECcCccccccccCCCccccccCCccccC
Confidence 33 3455667999999999999999999999999999765 689999999987532 2333455789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---------SETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
||++.+..++.++|+|||||++|+|++|+.||..... ......+.......| ..++..+.++|.+||
T Consensus 165 PE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L 240 (329)
T cd05588 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKASSVLKGFL 240 (329)
T ss_pred HHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999963221 123344444444444 357899999999999
Q ss_pred ccCCCCCCC------HHHHHcCcccCCcc
Q psy6377 221 IKNPMERMT------AKEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rpt------~~e~L~hp~~~~~~ 243 (383)
..||.+|+| ++++++||||....
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 999999997 78999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=345.95 Aligned_cols=235 Identities=26% Similarity=0.383 Sum_probs=191.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeC--------CeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--------EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--------~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|++..+|+.||||.+........+|+.+++ .++||||++++++|... ..+++||||++ ++|.+.+
T Consensus 81 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~-~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~--~~l~~~~ 157 (440)
T PTZ00036 81 VVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMK-NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYM 157 (440)
T ss_pred EEEEEEECCCCCEEEEEEEecCcchHHHHHHHHH-hcCCCCCcceeeeEeecccccCCCceEEEEEEecCC--ccHHHHH
Confidence 6899999999999999998776666778999999 77999999999987542 24678999998 5666543
Q ss_pred c----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 77 D----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 77 ~----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
. ...++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+............||+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~~~~~~t~~ 235 (440)
T PTZ00036 158 KHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKLCDFGSAKNLLAGQRSVSYICSRF 235 (440)
T ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--CceeeeccccchhccCCCCcccCCCCcC
Confidence 2 123445668999999999999999999999999997542 4699999999987765555556789999
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-----------------CCc------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-----------------FPD------ 202 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~------ 202 (383)
|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...... +|.
T Consensus 236 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l 315 (440)
T PTZ00036 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDL 315 (440)
T ss_pred ccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhH
Confidence 999999865 46899999999999999999999999998877766665442211 111
Q ss_pred --chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 203 --ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 203 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.+....++++++||.+||.+||.+|||+.|+|+||||.....
T Consensus 316 ~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 316 KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 011246789999999999999999999999999999986543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.41 Aligned_cols=232 Identities=29% Similarity=0.498 Sum_probs=198.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+++.||+|++.+ ....+..|++++.....|++|++++++|.+.+..|+||||+. |++|.+.+
T Consensus 14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~-~g~L~~~~ 92 (324)
T cd05587 14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN-GGDLMYHI 92 (324)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC-CCcHHHHH
Confidence 3689999999999999999875 234577888998855556679999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. .....++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++.... ........+||+.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 169 (324)
T cd05587 93 QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE---GHIKIADFGMCKENIFGGKTTRTFCGTPDYIA 169 (324)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC---CCEEEeecCcceecCCCCCceeeecCCccccC
Confidence 33 3345667999999999999999999999999999765 689999999987532 2223445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+.+++.++||||+||++|+|++|++||.+.+..+.+..+......+| ..++.++.+++.+||.+||.+|++
T Consensus 170 PE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~ 245 (324)
T cd05587 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLLTKHPAKRLG 245 (324)
T ss_pred hhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 9999999999999999999999999999999999988888888877766555 357999999999999999999998
Q ss_pred H-----HHHHcCcccCCcc
Q psy6377 230 A-----KEALKHPWLMNKK 243 (383)
Q Consensus 230 ~-----~e~L~hp~~~~~~ 243 (383)
+ +++++||||....
T Consensus 246 ~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 246 CGPTGERDIREHAFFRRID 264 (324)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 6 8999999998643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=340.32 Aligned_cols=233 Identities=26% Similarity=0.376 Sum_probs=195.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+++++ .++||||+++++.|++++.+|+||||++ |++|.+++.
T Consensus 16 ~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv~E~~~-~g~L~~~i~ 93 (376)
T cd05598 16 EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVMDYIP-GGDMMSLLI 93 (376)
T ss_pred EEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCEEEEEEeCCC-CCcHHHHHH
Confidence 589999999999999999975 2355788999999 7799999999999999999999999999 999999764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC----------------
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---------------- 135 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---------------- 135 (383)
.. .+..+..||+.||+|||++||+||||||+|||++.+ +.++|+|||+|......
T Consensus 94 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~---~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 170 (376)
T cd05598 94 RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170 (376)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC---CCEEEEeCCCCcccccccccccccccccccccc
Confidence 43 234566899999999999999999999999999765 68999999997532100
Q ss_pred ----------------------------cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH
Q psy6377 136 ----------------------------IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS 187 (383)
Q Consensus 136 ----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~ 187 (383)
......+||+.|+|||++.+.+++.++|||||||++|+|++|.+||.+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 250 (376)
T cd05598 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPA 250 (376)
T ss_pred ccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHH
Confidence 0012347999999999999999999999999999999999999999998877
Q ss_pred HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcccCCcc
Q psy6377 188 ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPWLMNKK 243 (383)
Q Consensus 188 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hp~~~~~~ 243 (383)
+....+.......+...+..++.++.++|.+|+ .+|.+|+ |+.++++||||....
T Consensus 251 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 251 ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 776666554443333334578999999999976 5999999 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.59 Aligned_cols=238 Identities=28% Similarity=0.394 Sum_probs=189.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+.||+|.+.. ...++.+|+.+++ .++||||+++++++... ...|+||||+. ++|
T Consensus 14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~--~~L 90 (338)
T cd07859 14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDL 90 (338)
T ss_pred eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHH-hCCCCCEeeecceEeccCCCCCceEEEEEecCC--CCH
Confidence 3689999999999999999864 2346789999999 77999999999998643 34899999996 688
Q ss_pred HHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----cccccc
Q psy6377 73 QTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI----EIRELL 142 (383)
Q Consensus 73 ~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~----~~~~~~ 142 (383)
.+.+.. ..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... ......
T Consensus 91 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd07859 91 HQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFWTDYV 167 (338)
T ss_pred HHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEccCccccccccccCccccccCCC
Confidence 886543 3345666999999999999999999999999999765 689999999998643221 123467
Q ss_pred CCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC---------------------
Q psy6377 143 GTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD--------------------- 199 (383)
Q Consensus 143 gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~--------------------- 199 (383)
||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......
T Consensus 168 ~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (338)
T cd07859 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSM 247 (338)
T ss_pred CCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhh
Confidence 9999999999865 67899999999999999999999999887654443332221111
Q ss_pred ------CCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhc
Q psy6377 200 ------FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 200 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~ 247 (383)
.....++.+++.+.++|.+||..||++|||++++|+||||........
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~ 301 (338)
T cd07859 248 RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVER 301 (338)
T ss_pred cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccc
Confidence 111223467889999999999999999999999999999987655433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=338.48 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=196.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ ..+||||++++++|.+++.+|+||||++ |++|.+++.
T Consensus 58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~~~lv~Ey~~-gg~L~~~l~ 135 (370)
T cd05621 58 EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFCAFQDDKYLYMVMEYMP-GGDLVNLMS 135 (370)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEEEcCCC-CCcHHHHHH
Confidence 689999999999999999875 2345778999998 8899999999999999999999999999 999999775
Q ss_pred cC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 78 DN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
.. .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|........ ..+.+||+.|+||
T Consensus 136 ~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~---~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aP 212 (370)
T cd05621 136 NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212 (370)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEEecccceecccCCceecccCCCCcccCCH
Confidence 42 345566999999999999999999999999999765 6899999999987643322 2456799999999
Q ss_pred cccccCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~~~~----~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++.+.+ ++.++|+||+||++|+|++|.+||.+.+....+..+......+..+....++..++++|.+||..+|.+
T Consensus 213 E~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r 292 (370)
T cd05621 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVR 292 (370)
T ss_pred HHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhc
Confidence 9987643 789999999999999999999999999888888888765433222222467999999999999865544
Q ss_pred --CCCHHHHHcCcccCCc
Q psy6377 227 --RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 --Rpt~~e~L~hp~~~~~ 242 (383)
|+|++++++||||+..
T Consensus 293 ~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 293 LGRNGVEEIKQHPFFKND 310 (370)
T ss_pred cCCCCHHHHhcCcccCCC
Confidence 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=331.28 Aligned_cols=231 Identities=27% Similarity=0.428 Sum_probs=196.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|..++...++||||+++++++++.+..|+||||+. |++|...+.
T Consensus 10 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 88 (323)
T cd05575 10 KVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN-GGELFFHLQ 88 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC-CCCHHHHHH
Confidence 689999999999999999975 123455666655447899999999999999999999999999 999988664
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
.. .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..... .......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (323)
T cd05575 89 RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165 (323)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeccCCCcccccCCCccccccCChhhcCh
Confidence 43 334566999999999999999999999999999765 6899999999875432 2223456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......+ +.++..+.++|.+||..||.+||++
T Consensus 166 E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~ 241 (323)
T cd05575 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGA 241 (323)
T ss_pred hhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCC
Confidence 999999999999999999999999999999999888888888776655444 4579999999999999999999987
Q ss_pred ----HHHHcCcccCCcc
Q psy6377 231 ----KEALKHPWLMNKK 243 (383)
Q Consensus 231 ----~e~L~hp~~~~~~ 243 (383)
.+++.||||....
T Consensus 242 ~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 242 KDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCHHHHHcCCCcCCCC
Confidence 6999999998644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.26 Aligned_cols=230 Identities=26% Similarity=0.382 Sum_probs=188.4
Q ss_pred eEEEEEEcC-CCcEEEEEEccC------CcccHHHHHHHHHhc--CCCCCcccceEEEE-----eCCeEEEEEecCCCcC
Q psy6377 5 SEEMADSIA-TGEVFAAKFLES------NPVRIHHEIALLSLC--SPSPRIVKLHDVFQ-----TGEGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~-tg~~vAvK~i~~------~~~~~~~Ei~il~~~--~~hpnIvkl~~~~~-----~~~~~~lv~e~~~~g~ 70 (383)
.||+|++.. +|+.||+|.+.. ......+|+.+++.+ ..||||+++++++. ....+++|||++. +
T Consensus 16 ~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~--~ 93 (290)
T cd07862 16 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--Q 93 (290)
T ss_pred EEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC--C
Confidence 689999865 478899999875 123567888888743 36999999999985 3456899999997 5
Q ss_pred cHHHhhcc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccccc
Q psy6377 71 TLQTIIDD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL 142 (383)
Q Consensus 71 ~L~~~l~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~ 142 (383)
+|.+++.. ..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.............
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (290)
T cd07862 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVV 170 (290)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---CCEEEccccceEeccCCccccccc
Confidence 78776532 2345677999999999999999999999999999765 689999999998765544445567
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-------------------- 202 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------- 202 (383)
||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+.+..+........+
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T cd07862 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 250 (290)
T ss_pred ccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCC
Confidence 999999999998889999999999999999999999999998887777777543221111
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
...+.+++.+++||.+||..||++|||+.++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 251 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1224578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=340.25 Aligned_cols=233 Identities=27% Similarity=0.394 Sum_probs=193.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ ..+||||++++++|.+.+.+|+||||++ |++|.+++.
T Consensus 16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 93 (377)
T cd05629 16 EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA-ESDSPWVVSLYYSFQDAQYLYLIMEFLP-GGDLMTMLI 93 (377)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCeeEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999865 1345778999998 7899999999999999999999999999 999998764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------------
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-------------- 137 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-------------- 137 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.......
T Consensus 94 ~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~ 170 (377)
T cd05629 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG---GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170 (377)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---CCEEEeecccccccccccccccccccccccccc
Confidence 3 2345567999999999999999999999999999765 6899999999863211000
Q ss_pred ----------------------------------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q psy6377 138 ----------------------------------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183 (383)
Q Consensus 138 ----------------------------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~ 183 (383)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred cccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 0124699999999999999999999999999999999999999998
Q ss_pred CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcccCCcc
Q psy6377 184 ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER---MTAKEALKHPWLMNKK 243 (383)
Q Consensus 184 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~L~hp~~~~~~ 243 (383)
.+..+.+..+......+.-+....++.++++||.+||. +|.+| +|+.+++.||||....
T Consensus 251 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 251 ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 88877777776533222211223578999999999997 77765 5999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.70 Aligned_cols=231 Identities=29% Similarity=0.456 Sum_probs=198.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ .......|..++....+||||+++++++.+.+.+|+||||++ |++|.+.+.
T Consensus 10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~-~g~L~~~l~ 88 (316)
T cd05619 10 KVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN-GGDLMFHIQ 88 (316)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999875 234566788888866799999999999999999999999999 999998764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
.. ....++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++...... .......||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05619 89 SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165 (316)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEccCCcceECCCCCCceeeecCCccccCH
Confidence 42 234666999999999999999999999999999765 68999999998864322 233456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|+||+||++|+|++|..||.+.+..+.+..+......+| ..++.++++||.+||..||++||++
T Consensus 166 E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~ 241 (316)
T cd05619 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVREPERRLGV 241 (316)
T ss_pred HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhccCHhhcCCC
Confidence 999999999999999999999999999999999888888877766554444 3478999999999999999999999
Q ss_pred H-HHHcCcccCCcc
Q psy6377 231 K-EALKHPWLMNKK 243 (383)
Q Consensus 231 ~-e~L~hp~~~~~~ 243 (383)
. +++.||||....
T Consensus 242 ~~~l~~h~~~~~~~ 255 (316)
T cd05619 242 KGDIRQHPFFREID 255 (316)
T ss_pred hHHHHcCcccCCCC
Confidence 6 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=339.60 Aligned_cols=234 Identities=26% Similarity=0.357 Sum_probs=192.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+.+.+|+||||++ |++|.+++.
T Consensus 16 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 93 (381)
T cd05626 16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVMDYIP-GGDMMSLLI 93 (381)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hcCCCCeeeeEEEEecCCEEEEEEecCC-CCcHHHHHH
Confidence 689999999999999999975 1345788999999 7899999999999999999999999999 999998764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------------
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------------- 136 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------------- 136 (383)
. ..+..++.||+.||+|||+.||+||||||+|||++.+ +.++|+|||++.......
T Consensus 94 ~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~---~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~ 170 (381)
T cd05626 94 RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170 (381)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC---CCEEEeeCcCCcccccccccccccccccccccc
Confidence 3 2345666899999999999999999999999999765 689999999975321000
Q ss_pred ---------------------------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCC
Q psy6377 137 ---------------------------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183 (383)
Q Consensus 137 ---------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~ 183 (383)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred cCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcC
Confidence 01235799999999999999999999999999999999999999998
Q ss_pred CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc--CCCCCCCHHHHHcCcccCCcc
Q psy6377 184 ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK--NPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 184 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.+..+....+.........+.+..+++++++||.+|+.. +|..|+|+++++.||||....
T Consensus 251 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 251 PTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred CCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 887776666654332222223346899999999996654 555599999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=330.62 Aligned_cols=231 Identities=29% Similarity=0.466 Sum_probs=198.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHh--cCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSL--CSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~--~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.++.+|+.||||++.+ ....+.+|++++.. ..+||||++++++|.+.+..|+||||+. |++|...
T Consensus 14 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~-~~~L~~~ 92 (324)
T cd05589 14 KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA-GGDLMMH 92 (324)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC-CCcHHHH
Confidence 689999999999999999975 23456777776642 4579999999999999999999999999 9999886
Q ss_pred hcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 76 IDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 76 l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
+.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++..... .......+||+.|+|
T Consensus 93 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~a 169 (324)
T cd05589 93 IHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169 (324)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CcEEeCcccCCccCCCCCCcccccccCccccC
Confidence 544 3345677999999999999999999999999999875 6899999999875432 223445689999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|. .++..+.+||.+||..||.+||
T Consensus 170 PE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred HhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCC
Confidence 99999999999999999999999999999999999888888888777665553 5799999999999999999999
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
++.++++||||.+..
T Consensus 246 ~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 246 SGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCCCCHHHHhhCCCcCCCC
Confidence 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.09 Aligned_cols=230 Identities=30% Similarity=0.465 Sum_probs=197.6
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++. .+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+++..|+||||+. |++|.
T Consensus 11 ~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 88 (323)
T cd05584 11 KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-AVKHPFIVDLIYAFQTGGKLYLILEYLS-GGELF 88 (323)
T ss_pred EEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHH-hCCCCchhceeeEEecCCeEEEEEeCCC-CchHH
Confidence 57888763 5789999999875 2245678999999 7899999999999999999999999999 99999
Q ss_pred HhhccCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 74 TIIDDNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 74 ~~l~~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
+.+.... +..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ......+||+.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 165 (323)
T cd05584 89 MHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165 (323)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEeeCcCCeecccCCCcccccCCCcc
Confidence 8765432 34566899999999999999999999999999765 68999999998754322 22344679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..+....|+ .+++.+.+||.+||.+||++
T Consensus 166 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~ 241 (323)
T cd05584 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKKLLKRNPSS 241 (323)
T ss_pred ccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHcccCHhH
Confidence 99999999888999999999999999999999999998888888888777666553 56899999999999999999
Q ss_pred CC-----CHHHHHcCcccCCcc
Q psy6377 227 RM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rp-----t~~e~L~hp~~~~~~ 243 (383)
|| ++++++.||||....
T Consensus 242 R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 242 RLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred cCCCCCCCHHHHhcCCCcCCCC
Confidence 99 899999999998643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.34 Aligned_cols=233 Identities=26% Similarity=0.397 Sum_probs=188.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||++++++|.... ..|+||||+. ++|
T Consensus 36 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l 112 (359)
T cd07876 36 IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK-CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD--ANL 112 (359)
T ss_pred EEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCCccccceeEEEEeCCC--cCH
Confidence 589999999999999999865 2456778999998 789999999999997543 4799999998 455
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
...+ ....+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||+++............||+.|+
T Consensus 113 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~ 189 (359)
T cd07876 113 CQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYR 189 (359)
T ss_pred HHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEecCCCccccccCccCCCCcccCCCC
Confidence 5543 334455677999999999999999999999999999765 689999999998755444455668999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC----------------------CCc----
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD----------------------FPD---- 202 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~---- 202 (383)
|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+...... .+.
T Consensus 190 aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (359)
T cd07876 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFE 269 (359)
T ss_pred CchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchh
Confidence 999999999999999999999999999999999987655444333221111 000
Q ss_pred ------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 ------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
......++++++||.+||.+||++|||+.|+|+|||+....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 270 ELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred hhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 01112467899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.17 Aligned_cols=232 Identities=33% Similarity=0.509 Sum_probs=199.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.+ ....+.+|+.++. ...||||+++++++.+++..|+||||+. |++|.+++
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 92 (350)
T cd05573 15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA-DADSPWIVKLYYSFQDEEHLYLVMEYMP-GGDLMNLL 92 (350)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH-hcCCCCccchhhheecCCeEEEEEcCCC-CCCHHHHH
Confidence 3689999999999999999975 2345778999998 7789999999999999999999999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--------------
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-------------- 136 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-------------- 136 (383)
... .+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 93 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (350)
T cd05573 93 IRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169 (350)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEeecCCCCccCcccCcccccccccccccc
Confidence 543 344566999999999999999999999999999765 689999999998654432
Q ss_pred ----------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--ccC
Q psy6377 137 ----------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK--AQL 198 (383)
Q Consensus 137 ----------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~--~~~ 198 (383)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 249 (350)
T cd05573 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL 249 (350)
T ss_pred cccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcc
Confidence 22345799999999999999999999999999999999999999999888777777776 333
Q ss_pred CCCcchhcCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcccCCcc
Q psy6377 199 DFPDELFEDISPEAKDFIAKILIKNPMERMT-AKEALKHPWLMNKK 243 (383)
Q Consensus 199 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~L~hp~~~~~~ 243 (383)
.+|. ...+++++.+||.+||. ||.+||+ ++++++||||....
T Consensus 250 ~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 250 RFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred cCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 3332 23479999999999997 9999999 99999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=332.12 Aligned_cols=234 Identities=24% Similarity=0.339 Sum_probs=191.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||.|.+..+++.||||++.. ....+.+|+.+++ .++||||++++++|... ...|+||||+. ++|
T Consensus 39 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l 115 (364)
T cd07875 39 IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD--ANL 115 (364)
T ss_pred EEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHH-hcCCCCccccceeecccccccccCeEEEEEeCCC--CCH
Confidence 589999999999999999975 2356788999998 78999999999998654 35799999998 566
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
...+ ....+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++............||+.|+
T Consensus 116 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~ 192 (364)
T cd07875 116 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYR 192 (364)
T ss_pred HHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC---CcEEEEeCCCccccCCCCcccCCcccCCcC
Confidence 6644 334455677999999999999999999999999999765 689999999998765544445678999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE------------------------- 203 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------- 203 (383)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+++.
T Consensus 193 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (364)
T cd07875 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE 272 (364)
T ss_pred CHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChH
Confidence 9999999999999999999999999999999999888776666554322211110
Q ss_pred -------------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 -------------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 -------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.....+..+++||.+||..||.+|||+.++|+||||.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 273 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred hhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 11123567899999999999999999999999999986433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.68 Aligned_cols=231 Identities=28% Similarity=0.496 Sum_probs=200.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+++.||+|++.+ .......|..++.....||+|+++++++++.+..|+||||++ +++|.+.+.
T Consensus 15 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~-~g~L~~~~~ 93 (323)
T cd05616 15 KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN-GGDLMYQIQ 93 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC-CCCHHHHHH
Confidence 689999999999999999876 123466788888866679999999999999999999999999 999988653
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+||
T Consensus 94 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aP 170 (323)
T cd05616 94 QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAP 170 (323)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC---CcEEEccCCCceecCCCCCccccCCCChhhcCH
Confidence 3 3355677999999999999999999999999999876 6899999999986432 2234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+.+++.++|||||||++|+|++|++||.+.+..+....+......+|. .++.++.+++.+||..||.+|+++
T Consensus 171 E~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 9999999999999999999999999999999999888888888877766653 579999999999999999999984
Q ss_pred -----HHHHcCcccCCcc
Q psy6377 231 -----KEALKHPWLMNKK 243 (383)
Q Consensus 231 -----~e~L~hp~~~~~~ 243 (383)
.++++||||....
T Consensus 247 ~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 247 GPEGERDIKEHAFFRYID 264 (323)
T ss_pred CCCCHHHHhcCCCcCCCC
Confidence 8999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.28 Aligned_cols=234 Identities=28% Similarity=0.418 Sum_probs=190.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh--h
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI--I 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~--l 76 (383)
..||+|++..+|+.||+|++.. ....+.+|+++++ .++||||++++++|.+++.+|+||||+. +++|... .
T Consensus 88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 165 (353)
T PLN00034 88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR-DVNHPNVVKCHDMFDHNGEIQVLLEFMD-GGSLEGTHIA 165 (353)
T ss_pred eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHH-hCCCCCcceeeeEeccCCeEEEEEecCC-CCcccccccC
Confidence 3689999999999999999865 2356889999999 7789999999999999999999999999 9999763 3
Q ss_pred ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccccc
Q psy6377 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEILHY 155 (383)
Q Consensus 77 ~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~~ 155 (383)
.+..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++..
T Consensus 166 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242 (353)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEcccccceecccccccccccccCccccCcccccc
Confidence 444455778999999999999999999999999999765 689999999998764332 2345679999999998743
Q ss_pred -----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 156 -----EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 156 -----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
...+.++|||||||++|+|++|+.||......+....+.......+......++.++++||.+||..||++|||+
T Consensus 243 ~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~ 322 (353)
T PLN00034 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSA 322 (353)
T ss_pred ccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCH
Confidence 234578999999999999999999997544333222222222222233345679999999999999999999999
Q ss_pred HHHHcCcccCCc
Q psy6377 231 KEALKHPWLMNK 242 (383)
Q Consensus 231 ~e~L~hp~~~~~ 242 (383)
.|+|+||||...
T Consensus 323 ~ell~hp~~~~~ 334 (353)
T PLN00034 323 MQLLQHPFILRA 334 (353)
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.93 Aligned_cols=231 Identities=26% Similarity=0.412 Sum_probs=192.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.++....+||||++++++|.+.+..|+||||++ +++|...+.
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~-~~~L~~~~~ 88 (329)
T cd05618 10 KVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN-GGDLMFHMQ 88 (329)
T ss_pred EEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC-CCCHHHHHH
Confidence 689999999999999999986 123467888888867799999999999999999999999999 999988654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........+||+.|+||
T Consensus 89 ~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aP 165 (329)
T cd05618 89 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 165 (329)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CCEEEeeCCccccccCCCCccccccCCccccCH
Confidence 3 2345667999999999999999999999999999765 689999999987532 22334456899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---------DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|++.+..++.++|+|||||++|+|++|..||.... .......+......+| ..++..+.++|.+||.
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~ 241 (329)
T cd05618 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLN 241 (329)
T ss_pred HHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999995311 1123334444444444 4678999999999999
Q ss_pred cCCCCCCC------HHHHHcCcccCCcc
Q psy6377 222 KNPMERMT------AKEALKHPWLMNKK 243 (383)
Q Consensus 222 ~dP~~Rpt------~~e~L~hp~~~~~~ 243 (383)
.||++||| ++++++||||.+..
T Consensus 242 ~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 242 KDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred CCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=331.79 Aligned_cols=233 Identities=27% Similarity=0.404 Sum_probs=196.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ ..+||||+++++++.+.+..|+||||++ |++|.+++.
T Consensus 16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 93 (330)
T cd05601 16 EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQYAFQDKDNLYLVMEYQP-GGDLLSLLN 93 (330)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCeEEEEECCCC-CCCHHHHHH
Confidence 689999999999999999986 2345778899998 7899999999999999999999999999 999999765
Q ss_pred cC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcC
Q psy6377 78 DN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYV 148 (383)
Q Consensus 78 ~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~ 148 (383)
.. .+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....||+.|+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 170 (330)
T cd05601 94 RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT---GHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170 (330)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC---CCEEeccCCCCeECCCCCceeeecccCCcccc
Confidence 43 234566899999999999999999999999999765 6899999999987644332 22357999999
Q ss_pred CCcccc------cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 149 APEILH------YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 149 aPE~l~------~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|||++. ...++.++|||||||++|+|++|..||.+.+....+.++.........+....++.++.+||.+||.
T Consensus 171 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~- 249 (330)
T cd05601 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC- 249 (330)
T ss_pred CHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-
Confidence 999986 4567899999999999999999999999888877777776543222111224579999999999998
Q ss_pred CCCCCCCHHHHHcCcccCCcc
Q psy6377 223 NPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+|.+|||+++++.||||....
T Consensus 250 ~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 250 GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ChhhCCCHHHHhCCCCcCCCC
Confidence 999999999999999998644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.49 Aligned_cols=234 Identities=26% Similarity=0.370 Sum_probs=195.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||++.+..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..++||||+. |++|.+.+.
T Consensus 15 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 92 (285)
T cd05605 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVLTLMN-GGDLKFHIY 92 (285)
T ss_pred EEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHH-hcCCCCEeeeeeeecCCCeEEEEEeccC-CCcHHHHHH
Confidence 589999999999999999875 1245678999999 7799999999999999999999999999 999987542
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. ..+..+..|++.||.|||+.||+||||||+||+++++ +.++|+|||++.............|++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~a 169 (285)
T cd05605 93 NMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY---GHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169 (285)
T ss_pred hcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC---CCEEEeeCCCceecCCCCccccccCCCCccC
Confidence 2 2244566999999999999999999999999999765 6899999999987654444445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|+||+||++|+|++|..||.+.+.......+.......+..+...++..+.+||.+||..||.+||
T Consensus 170 PE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred cHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcC
Confidence 9999988899999999999999999999999998766544433332222222333456799999999999999999999
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
+++++++||||....
T Consensus 250 ~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 250 CRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred CCCCCHHHHhcCcCccCCC
Confidence 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=343.16 Aligned_cols=234 Identities=28% Similarity=0.368 Sum_probs=199.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCC-----CCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSP-----SPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~-----hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.|-+|.+..||+.||||++++ ...+...||.+|..+.+ --|||+++|+|...+++|||+|++. .+|.+++
T Consensus 201 QVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~--~NLYell 278 (586)
T KOG0667|consen 201 QVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS--TNLYELL 278 (586)
T ss_pred eeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh--hhHHHHH
Confidence 577899999999999999998 34677789999995542 3579999999999999999999997 9999998
Q ss_pred ccCC--------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 77 DDNL--------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 77 ~~~~--------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
+.+. +..+..||+.||.+||..||||+||||||||+..-.. ..|||+|||.|+..... ..+++.+..|+
T Consensus 279 K~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVIDFGSSc~~~q~--vytYiQSRfYR 355 (586)
T KOG0667|consen 279 KNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVIDFGSSCFESQR--VYTYIQSRFYR 355 (586)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEecccccccCCc--ceeeeeccccc
Confidence 7754 3456699999999999999999999999999976543 58999999999986443 44889999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh-----------------------
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF----------------------- 205 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------- 205 (383)
|||++.+.+|+.+.||||||||++||++|.|.|.|.+..+++..|......+|....
T Consensus 356 APEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~ 435 (586)
T KOG0667|consen 356 APEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVET 435 (586)
T ss_pred cchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeee
Confidence 999999999999999999999999999999999999999999988765443331100
Q ss_pred ------------------------c------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 206 ------------------------E------------DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 206 ------------------------~------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+ .-...+.+||++||.+||.+|+|+.++|+|||+....
T Consensus 436 ~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 436 SAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred cccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 0 0124579999999999999999999999999998543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=332.06 Aligned_cols=232 Identities=29% Similarity=0.443 Sum_probs=196.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcC--CCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCS--PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+++.+|+.||+|++.+ .......|..++.... +||||++++++|.+.+..|+||||+. +++|...
T Consensus 8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~-~g~L~~~ 86 (330)
T cd05586 8 QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS-GGELFWH 86 (330)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC-CChHHHH
Confidence 689999999999999999975 1223455667776444 89999999999999999999999999 9999886
Q ss_pred hcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
+.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++...... ......+||+.|+
T Consensus 87 l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~ 163 (330)
T cd05586 87 LQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163 (330)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEecCCcCcCCCCCCCCccCccCCcccc
Confidence 543 3345667999999999999999999999999999765 68999999998764322 2334568999999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..+...+|. ..+++++.+||.+||..||.+|
T Consensus 164 aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred CHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCCHHHC
Confidence 99998654 5899999999999999999999999999888888888777766654 2468999999999999999999
Q ss_pred C----CHHHHHcCcccCCcc
Q psy6377 228 M----TAKEALKHPWLMNKK 243 (383)
Q Consensus 228 p----t~~e~L~hp~~~~~~ 243 (383)
| +++++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=333.87 Aligned_cols=233 Identities=25% Similarity=0.382 Sum_probs=195.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+++.||+|++.+ ....+.+|+.+++ ..+||||+++++++.+++..|+||||++ |++|.+++.
T Consensus 58 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~~~lv~Ey~~-gg~L~~~~~ 135 (371)
T cd05622 58 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMP-GGDLVNLMS 135 (371)
T ss_pred EEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCEEEEEEcCCC-CCcHHHHHH
Confidence 589999999999999999875 2344678899998 7899999999999999999999999999 999999765
Q ss_pred cC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 78 DN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
.. .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++........ ....+||+.|+||
T Consensus 136 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~---~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aP 212 (371)
T cd05622 136 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212 (371)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC---CCEEEEeCCceeEcCcCCcccccCcccCccccCH
Confidence 43 344566899999999999999999999999999765 6899999999987643322 2356799999999
Q ss_pred cccccCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~~~~----~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++.... ++.++|||||||++|+|++|.+||.+.+....+..+......++.+....++..++++|.+||..++.+
T Consensus 213 E~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r 292 (371)
T cd05622 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVR 292 (371)
T ss_pred HHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhh
Confidence 9987543 789999999999999999999999999888888888765433332334578999999999999844443
Q ss_pred --CCCHHHHHcCcccCCc
Q psy6377 227 --RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 --Rpt~~e~L~hp~~~~~ 242 (383)
|++++++++||||.+.
T Consensus 293 ~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 293 LGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cCCCCHHHHhcCcccCCC
Confidence 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.49 Aligned_cols=232 Identities=28% Similarity=0.454 Sum_probs=195.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.++. ..+||||+++++.|++.+.+|+||||++ |++|.+++.
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 93 (360)
T cd05627 16 EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV-EADGAWVVKMFYSFQDKRNLYLIMEFLP-GGDMMTLLM 93 (360)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEEEeCCC-CccHHHHHH
Confidence 689999999999999999975 2345778999998 7799999999999999999999999999 999999764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------------
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------------- 136 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------------- 136 (383)
.. .+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 94 ~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~---~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~ 170 (360)
T cd05627 94 KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170 (360)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC---CCEEEeeccCCcccccccccccccccccCCccc
Confidence 32 345667999999999999999999999999999765 689999999987542110
Q ss_pred ---------------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Q psy6377 137 ---------------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK 195 (383)
Q Consensus 137 ---------------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~ 195 (383)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~ 250 (360)
T cd05627 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250 (360)
T ss_pred ccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHc
Confidence 01235799999999999999999999999999999999999999999988888877765
Q ss_pred cc--CCCCcchhcCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcccCCcch
Q psy6377 196 AQ--LDFPDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPWLMNKKQ 244 (383)
Q Consensus 196 ~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hp~~~~~~~ 244 (383)
.. ..+|+. ..+++++++||.+|+ .||.+|+ ++++++.||||.+...
T Consensus 251 ~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 251 WKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 33 333332 247899999999987 5999998 4899999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=316.36 Aligned_cols=231 Identities=24% Similarity=0.376 Sum_probs=191.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+++++.+|+.||+|.+.. .......|+++++ .++||||++++++|+++...|+||||+. |++|.+.+.
T Consensus 8 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~~~~ 85 (277)
T cd05607 8 EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE-KVNSPFIVNLAYAFESKTHLCLVMSLMN-GGDLKYHIY 85 (277)
T ss_pred EEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHH-hcCCCcEEEEEEEEecCCeEEEEEecCC-CCCHHHHHH
Confidence 689999999999999999865 1234567999999 7799999999999999999999999999 999988653
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. ..+..+..|++.||+|||+.||+||||||+||+++.+ +.++|+|||++.............|++.|+|
T Consensus 86 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~a 162 (277)
T cd05607 86 NVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162 (277)
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC---CCEEEeeceeeeecCCCceeeccCCCCCccC
Confidence 2 2234566899999999999999999999999999765 5899999999987655444445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
||++.+..++.++|+||+||++|+|++|..||.+.... +....+......++ ...+++++++||.+||.+||+
T Consensus 163 PE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred HHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHHhccCHh
Confidence 99998888999999999999999999999999765432 22233332222222 246799999999999999999
Q ss_pred CCCCH----HHHHcCcccCCcc
Q psy6377 226 ERMTA----KEALKHPWLMNKK 243 (383)
Q Consensus 226 ~Rpt~----~e~L~hp~~~~~~ 243 (383)
+|||+ ++++.||||+...
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hCCCCccchhhhhcChhhcCCC
Confidence 99999 7788999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.83 Aligned_cols=232 Identities=26% Similarity=0.380 Sum_probs=196.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|..++....+||||++++++|++++..|+||||+. |++|...+
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 87 (325)
T cd05604 9 GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN-GGELFFHL 87 (325)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC-CCCHHHHH
Confidence 3689999999999999999975 123455666654447899999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|
T Consensus 88 ~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 164 (325)
T cd05604 88 QRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164 (325)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEeecCCcccCCCCCCCcccccCChhhCC
Confidence 43 2345677999999999999999999999999999765 6899999999875432 223345679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+ +..+..+.++|.+||..+|.+||+
T Consensus 165 PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred HHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCC
Confidence 9999999999999999999999999999999999888888887776654443 357899999999999999999997
Q ss_pred H----HHHHcCcccCCcc
Q psy6377 230 A----KEALKHPWLMNKK 243 (383)
Q Consensus 230 ~----~e~L~hp~~~~~~ 243 (383)
+ .++++||||....
T Consensus 241 ~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 241 AKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCHHHHhcCCCcCCCC
Confidence 6 5999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=325.31 Aligned_cols=232 Identities=28% Similarity=0.492 Sum_probs=199.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+..|+.++....+||+|++++++|++.+.+|+||||++ |++|.+.+
T Consensus 14 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~-~g~L~~~i 92 (323)
T cd05615 14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN-GGDLMYHI 92 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC-CCcHHHHH
Confidence 3689999999999999999976 123567888888866678899999999999999999999999 99999865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~a 149 (383)
.. ..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++..... ......+||+.|+|
T Consensus 93 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 169 (323)
T cd05615 93 QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIA 169 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeccccccccCCCCccccCccCCccccC
Confidence 43 3455677999999999999999999999999999865 68999999998864322 22345679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|+||+||++|+|++|.+||.+.+.......+......+| ..++.++.+++.+||..+|.+|++
T Consensus 170 PE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~p~~R~~ 245 (323)
T cd05615 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLMTKHPSKRLG 245 (323)
T ss_pred HHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHcccCHhhCCC
Confidence 9999999999999999999999999999999999988888888887766655 357899999999999999999997
Q ss_pred -----HHHHHcCcccCCcc
Q psy6377 230 -----AKEALKHPWLMNKK 243 (383)
Q Consensus 230 -----~~e~L~hp~~~~~~ 243 (383)
.+++++||||....
T Consensus 246 ~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 246 CGPEGERDIREHAFFRRID 264 (323)
T ss_pred CCCCCHHHHhcCcccCCCC
Confidence 57999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=322.44 Aligned_cols=232 Identities=24% Similarity=0.341 Sum_probs=178.8
Q ss_pred eEEEEEEc--CCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSI--ATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++ .+++.||+|.+.. ....+.+|+.+++ .++||||++++++|.+ +...|++||++. ++|.+++..
T Consensus 16 ~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 92 (317)
T cd07868 16 HVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLR-ELKHPNVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIKF 92 (317)
T ss_pred EEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHH-hcCCCCCcceeeeEecCCCcEEEEEEeccC--CCHHHHHHh
Confidence 68999976 4789999999876 2456789999999 7799999999999964 456899999986 677775432
Q ss_pred ---------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc-CCCCcEEEEeccceeEeecCc----cc
Q psy6377 79 ---------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDGI----EI 138 (383)
Q Consensus 79 ---------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~~~~~~~----~~ 138 (383)
..+..+..||+.||+|||++||+||||||+|||+..+ ...+.+||+|||+++...... ..
T Consensus 93 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 172 (317)
T cd07868 93 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172 (317)
T ss_pred cccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccccc
Confidence 2244667999999999999999999999999999543 234689999999998754321 23
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhccCCCCcch----
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETD---------SETFRNISKAQLDFPDEL---- 204 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~---- 204 (383)
....||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+... ...+..+......++...
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd07868 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 252 (317)
T ss_pred CCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHH
Confidence 45678999999999876 4589999999999999999999999975432 122222222111110000
Q ss_pred ------------------------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 205 ------------------------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 205 ------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
....+..+.+||.+||.+||.+|||++|+|+||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 253 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=317.13 Aligned_cols=230 Identities=25% Similarity=0.368 Sum_probs=187.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhc--CCCCCcccceEEEEe-----CCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLC--SPSPRIVKLHDVFQT-----GEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~--~~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~~ 71 (383)
.||+|+++.+|+.||+|.+.. ......+|+.+++.+ .+||||+++++++.+ ....+++||++. ++
T Consensus 15 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 92 (288)
T cd07863 15 TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD--QD 92 (288)
T ss_pred EEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc--cC
Confidence 689999999999999999875 123567888888743 379999999999875 345899999998 57
Q ss_pred HHHhhcc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 72 LQTIIDD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 72 L~~~l~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
|.+++.. ..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.............|
T Consensus 93 l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~ 169 (288)
T cd07863 93 LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVV 169 (288)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccCccccccCcccCCCccc
Confidence 7775533 2345667999999999999999999999999999765 6899999999987654444455678
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-----------------------
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF----------------------- 200 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 200 (383)
|+.|+|||++.+..++.++||||+||++|+|++|.+||.+....+.+..+.......
T Consensus 170 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07863 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRP 249 (288)
T ss_pred cccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCc
Confidence 999999999998899999999999999999999999998887766665554321100
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.....+.++..+.++|.+||.+||++|||+.+++.||||
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 250 VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011234678889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=331.58 Aligned_cols=231 Identities=28% Similarity=0.391 Sum_probs=201.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|.+..|++.||+|++.- ....+.+|+.+|. +.++|||.++|+.|-.+..++++||||. ||++.+.++.
T Consensus 27 G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls-~~~~~~it~yygsyl~g~~LwiiMey~~-gGsv~~lL~~ 104 (467)
T KOG0201|consen 27 GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLS-QCDSPNITEYYGSYLKGTKLWIIMEYCG-GGSVLDLLKS 104 (467)
T ss_pred ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHH-hcCcchHHhhhhheeecccHHHHHHHhc-Ccchhhhhcc
Confidence 3799999999999999999976 3567889999999 8889999999999999999999999999 9999997654
Q ss_pred C------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCc
Q psy6377 79 N------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPE 151 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE 151 (383)
. .+..+.++++.||.|||+++.+|||||+.|||+..+ |.+|++|||++........ ..+.+|||.|||||
T Consensus 105 ~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 105 GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPE 181 (467)
T ss_pred CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechhhccccccccccccchh
Confidence 3 444566999999999999999999999999999876 7999999999988765443 36789999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+..|+.++||||||++.|||++|.|||........+-.| ....|+.+-..+|+.+++||..||.+||+.||||.
T Consensus 182 VI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~ 258 (467)
T KOG0201|consen 182 VIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAK 258 (467)
T ss_pred hhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHH
Confidence 999999999999999999999999999999887763332222 22344555557899999999999999999999999
Q ss_pred HHHcCcccCCc
Q psy6377 232 EALKHPWLMNK 242 (383)
Q Consensus 232 e~L~hp~~~~~ 242 (383)
++|+|+|++..
T Consensus 259 ~LLKh~FIk~a 269 (467)
T KOG0201|consen 259 ELLKHKFIKRA 269 (467)
T ss_pred HHhhhHHHHhc
Confidence 99999999863
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=332.86 Aligned_cols=231 Identities=20% Similarity=0.247 Sum_probs=184.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc------
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD------ 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~------ 78 (383)
.||+|+++.+++.||+|... ...+.+|+.+++ .++||||++++++|......++++|++. ++|...+..
T Consensus 107 ~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~ 181 (391)
T PHA03212 107 FAFACIDNKTCEHVVIKAGQ--RGGTATEAHILR-AINHPSIIQLKGTFTYNKFTCLILPRYK--TDLYCYLAAKRNIAI 181 (391)
T ss_pred EEEEEEECCCCCEEEEechh--hhhhHHHHHHHH-hCCCCCCCCEeEEEEECCeeEEEEecCC--CCHHHHHHhcCCCCH
Confidence 68999999999999999764 346789999999 7899999999999999999999999986 678776533
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC--cccccccCCCCcCCCcccccC
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--IEIRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~--~~~~~~~gt~~y~aPE~l~~~ 156 (383)
..++.+..||+.||.|||++||+||||||+|||++.+ +.++|+|||+|+..... ......+||+.|+|||++.+.
T Consensus 182 ~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 258 (391)
T PHA03212 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD 258 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---CCEEEEeCCcccccccccccccccccCccCCCChhhhcCC
Confidence 2345666999999999999999999999999999765 68999999999753221 223446799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCc---------------------------
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFSPFGGET-------DSETFRNISKAQLDFPD--------------------------- 202 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~--------------------------- 202 (383)
.|+.++|||||||++|+|++|..||.+.. ....+..+.......|.
T Consensus 259 ~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (391)
T PHA03212 259 PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS 338 (391)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC
Confidence 99999999999999999999998875432 11222222211111110
Q ss_pred -chh---cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 -ELF---EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 -~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..| ..++.++.+||.+||.+||.+|||++|+|+||||+...
T Consensus 339 ~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 001 13567899999999999999999999999999998754
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.81 Aligned_cols=231 Identities=27% Similarity=0.407 Sum_probs=194.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+..+....+||||++++++|.+.+..|+||||++ |++|...+.
T Consensus 10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 88 (321)
T cd05603 10 KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN-GGELFFHLQ 88 (321)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC-CCCHHHHHH
Confidence 699999999999999999875 223455666543337899999999999999999999999999 999988654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (321)
T cd05603 89 RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165 (321)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEccCCCCccCCCCCCccccccCCcccCCH
Confidence 3 2344567999999999999999999999999999765 6899999999875322 2223456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|||||||++|+|++|.+||.+.+.......+......+| ...+..+.++|.+||..||.+|+++
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred HHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCC
Confidence 999988999999999999999999999999999888777777776655544 3568899999999999999999975
Q ss_pred ----HHHHcCcccCCcc
Q psy6377 231 ----KEALKHPWLMNKK 243 (383)
Q Consensus 231 ----~e~L~hp~~~~~~ 243 (383)
.++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 242 KADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCHHHHhCCCCcCCCC
Confidence 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.68 Aligned_cols=229 Identities=31% Similarity=0.458 Sum_probs=197.9
Q ss_pred eEEEEEE---cCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADS---IATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~---~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||++++ ..+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+++.+|+||||+. +++|.+.
T Consensus 11 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 88 (318)
T cd05582 11 KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA-EVNHPFIVKLHYAFQTEGKLYLILDFLR-GGDLFTR 88 (318)
T ss_pred EEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCEEEEEEcCCC-CCcHHHH
Confidence 5787765 46899999999976 2345778999998 7789999999999999999999999999 9999887
Q ss_pred hcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
+.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.++|+|||++...... ......+||+.|+
T Consensus 89 l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~ 165 (318)
T cd05582 89 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165 (318)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---CcEEEeeccCCcccCCCCCceecccCChhhc
Confidence 643 3345677999999999999999999999999999765 68999999999865443 2334567999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+|. .+++.+.+||++||..||++||
T Consensus 166 aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~~P~~R~ 241 (318)
T cd05582 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRALFKRNPANRL 241 (318)
T ss_pred CHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHhHcC
Confidence 999999888999999999999999999999999998888888888777666553 5789999999999999999999
Q ss_pred C-----HHHHHcCcccCCc
Q psy6377 229 T-----AKEALKHPWLMNK 242 (383)
Q Consensus 229 t-----~~e~L~hp~~~~~ 242 (383)
| +++++.||||...
T Consensus 242 ~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 242 GAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred CCCCCCHHHHhCCCCcCCC
Confidence 9 7789999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=326.29 Aligned_cols=231 Identities=27% Similarity=0.430 Sum_probs=195.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+++.||+|++.+ ....+..|...+....+||||++++++|.+.+..|+||||+. |++|.+.+.
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 88 (325)
T cd05602 10 KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN-GGELFYHLQ 88 (325)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999975 123445555544337799999999999999999999999999 999998764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
.. .+..+..||+.||.|||++||+||||||+|||++.+ +.++|+|||+++.... .......+||+.|+||
T Consensus 89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aP 165 (325)
T cd05602 89 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165 (325)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEEccCCCCcccccCCCCcccccCCccccCH
Confidence 32 234566999999999999999999999999999765 6899999999876432 2234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++ +.++..+.++|.+||..||.+|+++
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~ 241 (325)
T cd05602 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGA 241 (325)
T ss_pred HHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 999999999999999999999999999999999888888887766544433 4679999999999999999999987
Q ss_pred H----HHHcCcccCCcc
Q psy6377 231 K----EALKHPWLMNKK 243 (383)
Q Consensus 231 ~----e~L~hp~~~~~~ 243 (383)
. ++++|+|+....
T Consensus 242 ~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 242 KDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCHHHHhcCcccCCCC
Confidence 6 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=325.45 Aligned_cols=232 Identities=25% Similarity=0.379 Sum_probs=192.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+++.||+|++.+ ....+.+|+.++....+||||++++++|++.+.+|+||||++ |++|...+
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 87 (327)
T cd05617 9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN-GGDLMFHM 87 (327)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 3689999999999999999986 124477899998867789999999999999999999999999 99998865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... ........+||+.|+|
T Consensus 88 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (327)
T cd05617 88 QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164 (327)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---CCEEEeccccceeccCCCCceecccCCcccCC
Confidence 33 3455677999999999999999999999999999876 689999999988632 2333455789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC------c-HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET------D-SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~------~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
||++.+..++.++|||||||++|+|++|..||.... . ......+......+| ..++..+.++|.+||..
T Consensus 165 PE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHVLKGFLNK 240 (327)
T ss_pred HHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhcc
Confidence 999999999999999999999999999999996422 1 223333333333333 45789999999999999
Q ss_pred CCCCCCC------HHHHHcCcccCCcc
Q psy6377 223 NPMERMT------AKEALKHPWLMNKK 243 (383)
Q Consensus 223 dP~~Rpt------~~e~L~hp~~~~~~ 243 (383)
||.+|++ +++++.||||....
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.86 Aligned_cols=231 Identities=30% Similarity=0.413 Sum_probs=188.3
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++. .+|+.||+|++.+ ....+.+|+.+++.+.+||||++++++|.+++.+|+||||+. |++|.
T Consensus 15 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~-~g~L~ 93 (332)
T cd05614 15 KVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVS-GGEMF 93 (332)
T ss_pred EEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCC-CCcHH
Confidence 47887764 5899999999875 134577899999966679999999999999999999999999 99999
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTP 145 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~ 145 (383)
+.+.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .....+||+
T Consensus 94 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---~~~kl~DfG~~~~~~~~~~~~~~~~~gt~ 170 (332)
T cd05614 94 THLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEEKERTYSFCGTI 170 (332)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---CCEEEeeCcCCccccccCCCccccccCCc
Confidence 86533 3345566899999999999999999999999999765 689999999998653322 233467999
Q ss_pred CcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 146 DYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETD----SETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 146 ~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+......+ ...++..+.+||.+||
T Consensus 171 ~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l 246 (332)
T cd05614 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSFIGPEAQDLLHKLL 246 (332)
T ss_pred cccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHc
Confidence 99999998765 478999999999999999999999975432 22333343333333 3467999999999999
Q ss_pred ccCCCCCC-----CHHHHHcCcccCCcc
Q psy6377 221 IKNPMERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rp-----t~~e~L~hp~~~~~~ 243 (383)
..||++|| +++++++||||....
T Consensus 247 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 247 RKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999 888999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=336.64 Aligned_cols=235 Identities=31% Similarity=0.537 Sum_probs=212.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||.++|++||+.||||++.+ ...++..|+.||+ .+.||.||.+.-+|++.+.++.|||-+. |.-|.=+++.
T Consensus 579 ~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq-~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSs 656 (888)
T KOG4236|consen 579 TVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQ-NLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSS 656 (888)
T ss_pred eeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHH-hcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHh
Confidence 589999999999999999988 3578999999999 8899999999999999999999999998 5544445543
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
....+...||+.||.|||-+||+|+||||+|||+.+..+...+||||||+|+.+++..-..+.+|||.|.|||
T Consensus 657 EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPE 736 (888)
T KOG4236|consen 657 EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPE 736 (888)
T ss_pred hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHH
Confidence 2334666999999999999999999999999999988888899999999999998877777889999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++..++|+..-|+||+|||+|.-|+|..||..+ +++-.+|.+..+-+|+..|..+++++.+||..+|+..-.+|.|.+
T Consensus 737 VLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 737 VLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 999999999999999999999999999999654 456677888888899999999999999999999999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
+.|.|||+++..
T Consensus 815 k~lsh~Wlq~yq 826 (888)
T KOG4236|consen 815 KSLSHPWLQDYQ 826 (888)
T ss_pred hhccchhhhcch
Confidence 999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=328.47 Aligned_cols=233 Identities=24% Similarity=0.357 Sum_probs=188.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|.+..+|+.||+|.+.. ....+.+|+.+++ .++||||++++++|.... ..|++||++. ++|
T Consensus 32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l 108 (355)
T cd07874 32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD--ANL 108 (355)
T ss_pred EEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHH-HhCCCchhceeeeeeccccccccceeEEEhhhhc--ccH
Confidence 589999999999999999875 2356778999998 789999999999987543 5799999998 456
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.+.+ ....+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++............||+.|+
T Consensus 109 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~ 185 (355)
T cd07874 109 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYR 185 (355)
T ss_pred HHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC---CCEEEeeCcccccCCCccccCCccccCCcc
Confidence 5543 334455677999999999999999999999999999765 689999999998765544455678999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC---------------------------C
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF---------------------------P 201 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~ 201 (383)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....... +
T Consensus 186 aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (355)
T cd07874 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265 (355)
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccch
Confidence 9999999999999999999999999999999998877555444332211110 0
Q ss_pred -----------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 202 -----------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 202 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.......+.++++||.+||..||++|||+.|+|+||||....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred hhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 011122457889999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.72 Aligned_cols=233 Identities=26% Similarity=0.337 Sum_probs=190.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|+++.+++.||+|.+.. ....+.+|+.+++ .++||||+++++++.+++..|+||||+. ++|.+.+..
T Consensus 21 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~ 97 (309)
T cd07872 21 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-DLKHANIVTLHDIVHTDKSLTLVFEYLD--KDLKQYMDDC 97 (309)
T ss_pred EEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHH-hCCCCCcceEEEEEeeCCeEEEEEeCCC--CCHHHHHHhc
Confidence 589999999999999999875 2345778999999 7789999999999999999999999998 477775432
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... ......+|+.|+|||
T Consensus 98 ~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 174 (309)
T cd07872 98 GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174 (309)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECccccceecCCCccccccccccccccCCH
Confidence 2244566899999999999999999999999999765 689999999998653322 233457899999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------------ch
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------EL 204 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~ 204 (383)
++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+.......+. ..
T Consensus 175 ~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (309)
T cd07872 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH 254 (309)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh
Confidence 8865 56899999999999999999999999988776655554432211111 11
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 255 APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 235688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.17 Aligned_cols=231 Identities=29% Similarity=0.453 Sum_probs=208.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.|-+|+.+.||+.||+|++++ .......|-++|+ ...||.+..+...|++.+.+++||||.. ||+|+-.++
T Consensus 183 KVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~-~~~HPFLt~LKYsFQt~drlCFVMeyan-GGeLf~HLs 260 (516)
T KOG0690|consen 183 KVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQ-NCRHPFLTSLKYSFQTQDRLCFVMEYAN-GGELFFHLS 260 (516)
T ss_pred eEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHH-hccCcHHHHhhhhhccCceEEEEEEEcc-CceEeeehh
Confidence 578999999999999999998 3455667888998 7789999999999999999999999999 999987654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe-ecCcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~gt~~y~aP 150 (383)
+ ....++-..|+.||.|||+++||+||||.+|+|+++| |+|||+|||+++.. ..+....+.||||.|.||
T Consensus 261 rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD---GHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 261 RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD---GHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAP 337 (516)
T ss_pred hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC---CceEeeecccchhcccccceeccccCChhhcCc
Confidence 3 4455666999999999999999999999999999887 79999999999864 345668889999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++....|+.++|.|.+||++|||++|+.||...+...++.-|......||. .++++++.|+..+|.+||.+|..
T Consensus 338 EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 338 EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred hhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHHHHHHhhcChHhhcCC
Confidence 9999999999999999999999999999999999999999999999999986 56999999999999999999984
Q ss_pred ----HHHHHcCcccCCcch
Q psy6377 230 ----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~ 244 (383)
+.|+++|+||.....
T Consensus 414 GpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 414 GPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred CchhHHHHHhhhhhccCCH
Confidence 789999999987654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=321.54 Aligned_cols=232 Identities=25% Similarity=0.397 Sum_probs=190.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|+++.+|..+|+|++... ...+.+|+++++ .++||||+++++++.+++..++||||++ |++|.+++...
T Consensus 20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 97 (331)
T cd06649 20 VVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEISICMEHMD-GGSLDQVLKEA 97 (331)
T ss_pred EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEEEEeecCC-CCcHHHHHHHc
Confidence 6899999999999999998752 356889999999 7789999999999999999999999999 99999977543
Q ss_pred ------CchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 80 ------LVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||.|||++ +|+||||||+|||++.+ +.++|+|||++...... ......||+.|+|||+
T Consensus 98 ~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~ 173 (331)
T cd06649 98 KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPER 173 (331)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---CcEEEccCccccccccc-ccccCCCCcCcCCHhH
Confidence 2346668999999999986 69999999999999765 68999999998865432 3345679999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-----------------------------------
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ----------------------------------- 197 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~----------------------------------- 197 (383)
+.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 174 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T cd06649 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAI 253 (331)
T ss_pred hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhH
Confidence 999899999999999999999999999997765544322211100
Q ss_pred ---------CCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 198 ---------LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 198 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
...+......+++++++||.+||.+||++|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 254 FELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000111112468899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.69 Aligned_cols=233 Identities=28% Similarity=0.384 Sum_probs=190.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-----eEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L~ 73 (383)
.||+|.+..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+ ..|+|+||+. ++|.
T Consensus 15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~ 91 (372)
T cd07853 15 VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC-FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ--SDLH 91 (372)
T ss_pred EEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHH-hCCCCCcCCHhheecCCCccccceEEEEeeccc--cCHH
Confidence 689999999999999999865 2346789999999 778999999999998877 7899999987 5777
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTP 145 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~ 145 (383)
+.+.. ..+..+..||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... ......+|+
T Consensus 92 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 168 (372)
T cd07853 92 KIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDESKHMTQEVVTQ 168 (372)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC---CCEEeccccceeecccCccccCCCCCcCC
Confidence 75432 3345667999999999999999999999999999765 689999999998754322 233457899
Q ss_pred CcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-----------------------CC
Q psy6377 146 DYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-----------------------FP 201 (383)
Q Consensus 146 ~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~-----------------------~~ 201 (383)
.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..+...... .+
T Consensus 169 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (372)
T cd07853 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPP 248 (372)
T ss_pred CcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCC
Confidence 99999998764 4799999999999999999999999988877666555432111 11
Q ss_pred c-----chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 202 D-----ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 202 ~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
. ......++++.+||.+||..||.+|||+.|+|+||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 249 SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred chHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 11234688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.76 Aligned_cols=234 Identities=26% Similarity=0.394 Sum_probs=192.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|+.||+|.+... ...+.+|+.+++ .++|++|+.+++.+.+.+..|+||||+. |++|.+.+.
T Consensus 15 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~~l~ 92 (285)
T cd05630 15 EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVLTLMN-GGDLKFHIY 92 (285)
T ss_pred EEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHH-hCCCCCeeeeeEEEecCCEEEEEEEecC-CCcHHHHHH
Confidence 5899999999999999998751 234678999998 7799999999999999999999999999 999988652
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. ..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++.............|++.|+|
T Consensus 93 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~a 169 (285)
T cd05630 93 HMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169 (285)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeccceeecCCCccccCCCCCccccC
Confidence 2 2345667999999999999999999999999999765 5899999999987654444445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|+||+||++|+|++|.+||.+.................+......+++++.+|+.+||+.||++|||
T Consensus 170 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred hHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccC
Confidence 99999889999999999999999999999999875532221111111111122334567899999999999999999999
Q ss_pred -----HHHHHcCcccCCcc
Q psy6377 230 -----AKEALKHPWLMNKK 243 (383)
Q Consensus 230 -----~~e~L~hp~~~~~~ 243 (383)
++++++||||+...
T Consensus 250 ~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 250 CQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred CCCCchHHHHcChhhhccC
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=321.05 Aligned_cols=232 Identities=28% Similarity=0.416 Sum_probs=189.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|.+..+++.||||.+.. ....+.+|+.+++ .++||||++++++|... ...|++++++ +++|
T Consensus 30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l 106 (343)
T cd07878 30 SVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK-HMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADL 106 (343)
T ss_pred EEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHH-hcCCCchhhhhhhhcccccccccCcEEEEeecC--CCCH
Confidence 589999999999999999875 2345778999999 77899999999998643 3478888887 5888
Q ss_pred HHhhc-----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTIID-----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l~-----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.+++. ...+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ......||+.|
T Consensus 107 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~--~~~~~~~t~~y 181 (343)
T cd07878 107 NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED---CELRILDFGLARQADD--EMTGYVATRWY 181 (343)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC---CCEEEcCCccceecCC--CcCCccccccc
Confidence 88654 33455677999999999999999999999999999865 6899999999987543 34556899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------ 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 202 (383)
+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......+.
T Consensus 182 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07878 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQ 261 (343)
T ss_pred cCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccch
Confidence 99999876 56899999999999999999999999887766555554332211111
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
..+...++.+.+||.+||..||.+|||+.|+|.||||.....
T Consensus 262 ~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 262 DLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 112345778899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=336.83 Aligned_cols=230 Identities=28% Similarity=0.352 Sum_probs=196.7
Q ss_pred ceEEEEEEcCC-CcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 4 LSEEMADSIAT-GEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 4 ~~V~~~~~~~t-g~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
..||+|.+..+ ++.||+|.+.. ....+.+|+.+++ .++|||||+++++|.+++..|+||||++ |++|.+.+.
T Consensus 81 g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~~ 158 (478)
T PTZ00267 81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLA-ACDHFGIVKHFDDFKSDDKLLLIMEYGS-GGDLNKQIKQ 158 (478)
T ss_pred cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEEECCEEEEEEECCC-CCCHHHHHHH
Confidence 46899988888 88899998754 2345678999999 7899999999999999999999999999 999987543
Q ss_pred ---------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCC
Q psy6377 78 ---------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP 145 (383)
Q Consensus 78 ---------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~ 145 (383)
+..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....... ....+||+
T Consensus 159 ~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~---~~~kL~DFgla~~~~~~~~~~~~~~~~gt~ 235 (478)
T PTZ00267 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235 (478)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC---CcEEEEeCcCceecCCccccccccccCCCc
Confidence 22344566899999999999999999999999999765 6899999999987644322 34467999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+.... ....++.++.+||.+||..||+
T Consensus 236 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~ 312 (478)
T PTZ00267 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPA 312 (478)
T ss_pred cccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChh
Confidence 9999999999999999999999999999999999999988888888777665432 2246789999999999999999
Q ss_pred CCCCHHHHHcCcccCC
Q psy6377 226 ERMTAKEALKHPWLMN 241 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~ 241 (383)
+|||+++++.|||+..
T Consensus 313 ~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 313 LRPTTQQLLHTEFLKY 328 (478)
T ss_pred hCcCHHHHHhCHHHHH
Confidence 9999999999999864
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.03 Aligned_cols=225 Identities=29% Similarity=0.436 Sum_probs=197.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-cc----
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII-DD---- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l-~~---- 78 (383)
.+|..|.++.|++.+++|++.+......+|+.++.+..+||||+++++++.++.+.|+|||++. |+.+.+.+ ..
T Consensus 336 s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~-g~ell~ri~~~~~~~ 414 (612)
T KOG0603|consen 336 SAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD-GGELLRRIRSKPEFC 414 (612)
T ss_pred cceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc-ccHHHHHHHhcchhH
Confidence 4688999999999999999998777788999888878899999999999999999999999999 77777743 22
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCC
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI 158 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 158 (383)
..+..|+.+|+.|+.|||++|||||||||+|||+.+ ..++++|+|||.++..... ..+.+.|..|.|||++...+|
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~--~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~y 490 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDG--SAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEY 490 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecC--CCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCC
Confidence 233458899999999999999999999999999962 2378999999999986544 556788999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6377 159 TLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237 (383)
Q Consensus 159 ~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 237 (383)
+++||+||||++||+||+|+.||...... ++..+|..+... ..+|..+++||++||+.||.+|+++.+++.||
T Consensus 491 t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 491 TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 99999999999999999999999887766 555555544333 67899999999999999999999999999999
Q ss_pred cc
Q psy6377 238 WL 239 (383)
Q Consensus 238 ~~ 239 (383)
|+
T Consensus 565 w~ 566 (612)
T KOG0603|consen 565 WF 566 (612)
T ss_pred ch
Confidence 99
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.98 Aligned_cols=231 Identities=25% Similarity=0.359 Sum_probs=207.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-EEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-AYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-~~lv~e~~~~g~~L~~~l~ 77 (383)
++++++++..++.||+|.+.- .+....+|+.+++ .+.|||||.++|.|..++. .++||+||+ ||++.+.+.
T Consensus 19 ~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis-~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e-Gg~l~~~i~ 96 (426)
T KOG0589|consen 19 SALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLS-KLLHPNIVEYKDSFEEDGQLLCIVMEYCE-GGDLAQLIK 96 (426)
T ss_pred hhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHH-hccCCCeeeeccchhcCCceEEEEEeecC-CCCHHHHHH
Confidence 567889999999999999875 3457889999999 5889999999999998888 999999999 999999765
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYV 148 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~ 148 (383)
+ +.+..|+.|++.||.|||+++|+|||||+.|||++++ +.|+|+|||+|+...+.. ...+.+|||.|+
T Consensus 97 ~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~---~~VkLgDfGlaK~l~~~~~~a~tvvGTp~Ym 173 (426)
T KOG0589|consen 97 EQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD---KKVKLGDFGLAKILNPEDSLASTVVGTPYYM 173 (426)
T ss_pred HHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc---CceeecchhhhhhcCCchhhhheecCCCccc
Confidence 4 3455677999999999999999999999999999987 578999999999987766 567889999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
+||++.+.+|+.++|||||||++|||++-+++|.+.+......+|..+.+.+.+ ..++.+++.+|+.||..+|..||
T Consensus 174 cPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~~lv~~~l~~~P~~RP 250 (426)
T KOG0589|consen 174 CPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELRSLVKSMLRKNPEHRP 250 (426)
T ss_pred CHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHHHHHHHHhhcCCccCC
Confidence 999999999999999999999999999999999999999999999998854433 46799999999999999999999
Q ss_pred CHHHHHcCcccCCcc
Q psy6377 229 TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 t~~e~L~hp~~~~~~ 243 (383)
++.++|.+|.++...
T Consensus 251 sa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 251 SALELLRRPHLLRYL 265 (426)
T ss_pred CHHHHhhChhhhhHH
Confidence 999999999887544
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=332.80 Aligned_cols=233 Identities=26% Similarity=0.432 Sum_probs=211.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..|.++++.-||..||+|++.+ ..+.+.+|+++++ .++|||||+++.++++...+|+||||+. +|++++++.
T Consensus 70 ~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk-~l~HPnIvkl~~v~~t~~~lylV~eya~-~ge~~~yl~ 147 (596)
T KOG0586|consen 70 AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMK-SLNHPNIVKLFSVIETEATLYLVMEYAS-GGELFDYLV 147 (596)
T ss_pred EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHH-hcCCcceeeeeeeeeecceeEEEEEecc-CchhHHHHH
Confidence 4799999999999999999998 2455899999999 8899999999999999999999999999 999999764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .....+.|++.|++|||+++|+|||||++|||++.+ .++||+|||++..+..+....+.||+|.|.|||
T Consensus 148 ~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~---mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 148 KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN---MNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPE 224 (596)
T ss_pred hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc---cceeeeccccceeecccccccccCCCCCccChH
Confidence 33 334556899999999999999999999999999876 479999999999999888899999999999999
Q ss_pred ccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..| ++.+|+||+|+++|.|+.|..||.|.+..+.-.....+.+..|. -++.++.++|+++|.++|.+|+++
T Consensus 225 l~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~ 300 (596)
T KOG0586|consen 225 LFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPC 300 (596)
T ss_pred hhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHHHHHhhccCccccCCH
Confidence 9999887 58899999999999999999999999998888888888877764 468999999999999999999999
Q ss_pred HHHHcCcccCCcchh
Q psy6377 231 KEALKHPWLMNKKQI 245 (383)
Q Consensus 231 ~e~L~hp~~~~~~~~ 245 (383)
+++++|.|+......
T Consensus 301 dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 301 DQIMKDRWRNDLLEA 315 (596)
T ss_pred HHhhhhcccchhhhh
Confidence 999999999876544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.73 Aligned_cols=233 Identities=27% Similarity=0.348 Sum_probs=190.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|+++.+++.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||+. ++|...+..
T Consensus 21 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~nI~~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~ 97 (301)
T cd07873 21 TVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLTLVFEYLD--KDLKQYLDDC 97 (301)
T ss_pred EEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHH-hcCCCCcceEEEEEecCCeEEEEEeccc--cCHHHHHHhc
Confidence 689999999999999999875 2345778999999 7799999999999999999999999997 578775533
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... ......+++.|+|||
T Consensus 98 ~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 174 (301)
T cd07873 98 GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174 (301)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---CcEEECcCcchhccCCCCCcccccceeecccCcH
Confidence 2244566899999999999999999999999999765 589999999987643322 233456789999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--------------------------ch
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------EL 204 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~ 204 (383)
++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.......+. ..
T Consensus 175 ~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (301)
T cd07873 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254 (301)
T ss_pred HHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhh
Confidence 8865 45789999999999999999999999988776665544332211111 11
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+++.+++||.+||..||.+|||++|+|+||||....
T Consensus 255 ~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 255 APRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 235788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=317.73 Aligned_cols=233 Identities=27% Similarity=0.436 Sum_probs=193.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.++. ..+||||++++++|.+++.+|+||||+. |++|.+++.
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~~l~ 93 (331)
T cd05597 16 EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV-NGDRRWITNLHYAFQDENNLYLVMDYYV-GGDLLTLLS 93 (331)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCceEEEEecCCeEEEEEecCC-CCcHHHHHH
Confidence 689999999999999999875 2345778899988 7799999999999999999999999999 999999764
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYV 148 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~ 148 (383)
. ..+..+..||+.||+|||++||+||||||+|||++.+ +.++|+|||++......... ...+||+.|+
T Consensus 94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 170 (331)
T cd05597 94 KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN---GHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170 (331)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC---CCEEEEECCceeecCCCCCccccceecccccc
Confidence 3 2345667999999999999999999999999999765 68999999999875443222 2346999999
Q ss_pred CCccccc-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 149 APEILHY-----EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 149 aPE~l~~-----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|||++.. ..++.++||||+||++|+|++|+.||.+.+..+....+.... ..++.. ...++..+++||++||.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~li~~ll~ 249 (331)
T cd05597 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-VTDVSEEAKDLIRRLIC 249 (331)
T ss_pred CHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc-cCCCCHHHHHHHHHHcc
Confidence 9999863 457889999999999999999999999888777777776533 333322 34589999999999997
Q ss_pred cCCCC--CCCHHHHHcCcccCCcc
Q psy6377 222 KNPME--RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 222 ~dP~~--Rpt~~e~L~hp~~~~~~ 243 (383)
.++++ |++++++++||||....
T Consensus 250 ~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 250 SPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CcccccCCCCHHHHhcCCCCCCCC
Confidence 65544 78999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=301.71 Aligned_cols=229 Identities=24% Similarity=0.349 Sum_probs=192.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||.|.+..+|+.||+|.+.. ....+.+|+.+++ .++||||++++++++++...++++|+++ |++|.+
T Consensus 16 ~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~l~~ 93 (263)
T cd06625 16 GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK-NLQHERIVQYYGCLRDDETLSIFMEYMP-GGSVKD 93 (263)
T ss_pred eEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEccCCeEEEEEEECC-CCcHHH
Confidence 3689999999999999998864 1245788999998 7799999999999999999999999999 999998
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----ccccCC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELLGT 144 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~gt 144 (383)
.+.. .....++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++......... ....|+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T cd06625 94 QLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICSSGTGMKSVTGT 170 (263)
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceeccccccccccccCCCcC
Confidence 7643 3345666999999999999999999999999999765 68999999998865432111 235688
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
+.|+|||++.+..++.++||||+|+++|+|++|++||.+.........+..... .......++..+.++|.+||..+|
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p 248 (263)
T cd06625 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPQLPSHVSPDARNFLRRTFVENA 248 (263)
T ss_pred ccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--CCCCCccCCHHHHHHHHHHhhcCc
Confidence 899999999988899999999999999999999999987766555554443322 223345679999999999999999
Q ss_pred CCCCCHHHHHcCccc
Q psy6377 225 MERMTAKEALKHPWL 239 (383)
Q Consensus 225 ~~Rpt~~e~L~hp~~ 239 (383)
++|||+.++++||||
T Consensus 249 ~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 249 KKRPSAEELLRHFFV 263 (263)
T ss_pred ccCCCHHHHhhCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=308.26 Aligned_cols=234 Identities=27% Similarity=0.401 Sum_probs=196.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||.+.+..+|+.||+|.+.. ....+.+|+.+++ .++|+||+.+++.|.+++..+++|||+. +++|.+.+.
T Consensus 15 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 92 (285)
T cd05632 15 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQFVVNLAYAYETKDALCLVLTIMN-GGDLKFHIY 92 (285)
T ss_pred EEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-HcCCcCceeEEEEEecCCEEEEEEEecc-CccHHHHHH
Confidence 589999999999999999865 1234678999999 7799999999999999999999999999 999987543
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. ..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++.............|++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~a 169 (285)
T cd05632 93 NMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169 (285)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---CCEEEecCCcceecCCCCcccCCCCCcCccC
Confidence 2 2345667999999999999999999999999999765 5899999999987544444445679999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|+||+||++|+|++|..||.+.........+..........+...++.++.+|+.+||..||++|||
T Consensus 170 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05632 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLG 249 (285)
T ss_pred hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCC
Confidence 99999889999999999999999999999999887665544444333333333344568899999999999999999999
Q ss_pred -----HHHHHcCcccCCcc
Q psy6377 230 -----AKEALKHPWLMNKK 243 (383)
Q Consensus 230 -----~~e~L~hp~~~~~~ 243 (383)
+.+++.||||....
T Consensus 250 ~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 250 CQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred CcccChHHHHcChhhhcCC
Confidence 88999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=316.23 Aligned_cols=224 Identities=22% Similarity=0.326 Sum_probs=187.8
Q ss_pred ceEEEEEEcCCCcE-EEEEEccC-C-----cccHHHHHHHHHhcCCCCCcccceEEEEeCC-eEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEV-FAAKFLES-N-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-GAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~-vAvK~i~~-~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-~~~lv~e~~~~g~~L~~~ 75 (383)
..||.+..+ |+. ||+|++.. + ...+.+|+.+|. .++|||||++++++.+.. .+.+||||++ +|+|.++
T Consensus 55 g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~-~l~HpNIV~f~G~~~~~~~~~~iVtEy~~-~GsL~~~ 130 (362)
T KOG0192|consen 55 GTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLS-RLRHPNIVQFYGACTSPPGSLCIVTEYMP-GGSLSVL 130 (362)
T ss_pred eeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCceEEEEEeCC-CCcHHHH
Confidence 357777765 666 99999987 1 348999999999 789999999999999887 7999999999 9999998
Q ss_pred hcc--C------CchhhHHHHHHHHHHHHhCC-ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCC
Q psy6377 76 IDD--N------LVVPFESDELSSLAYLHHRK-IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP 145 (383)
Q Consensus 76 l~~--~------~~~~~~~qil~aL~yLHs~g-ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~ 145 (383)
+.. . .++.++.||+.|+.|||+++ ||||||||+|||++.+. .++||+|||+++..... ...+...||+
T Consensus 131 l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~~~~~~~~~~~GT~ 208 (362)
T KOG0192|consen 131 LHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKVISKTSMTSVAGTY 208 (362)
T ss_pred HhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeeccccccccCCCCCc
Confidence 754 1 23566699999999999999 99999999999998762 38999999999987654 3445578999
Q ss_pred CcCCCcccc--cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 146 DYVAPEILH--YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 146 ~y~aPE~l~--~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
.|||||++. ..+|+.++||||||+++|||+||..||.+....+....+......++ ....+++.+..++.+||..|
T Consensus 209 ~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--~p~~~~~~l~~l~~~CW~~d 286 (362)
T KOG0192|consen 209 RWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--IPKECPPHLSSLMERCWLVD 286 (362)
T ss_pred cccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCCHHHHHHHHHhCCCC
Confidence 999999999 66999999999999999999999999999988665555543332221 22348999999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|.+||+..+++.
T Consensus 287 p~~RP~f~ei~~ 298 (362)
T KOG0192|consen 287 PSRRPSFLEIVS 298 (362)
T ss_pred CCcCCCHHHHHH
Confidence 999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.14 Aligned_cols=233 Identities=26% Similarity=0.404 Sum_probs=193.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+++++.+++.||+|++.+ ....+.+|+.++. ..+||||+++++++++.+.+|+||||+. +|+|.+++.
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~ey~~-~g~L~~~l~ 93 (332)
T cd05623 16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDNQWITTLHYAFQDENNLYLVMDYYV-GGDLLTLLS 93 (332)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCEEEEEEeccC-CCcHHHHHH
Confidence 589999999999999999875 2234678888888 7899999999999999999999999999 999999775
Q ss_pred cC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcC
Q psy6377 78 DN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYV 148 (383)
Q Consensus 78 ~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~ 148 (383)
.. .+..+..||+.||.|||++||+||||||+|||++.+ +.++|+|||++........ ....+||+.|+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~ 170 (332)
T cd05623 94 KFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170 (332)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEeecchheecccCCcceecccccCcccc
Confidence 41 244666899999999999999999999999999765 6899999999876533222 22357999999
Q ss_pred CCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC--CCCcchhcCCCHHHHHHHHHhcc
Q psy6377 149 APEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL--DFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 149 aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|||++. ...++.++|||||||++|+|++|+.||.+.+..+.+..+..... .+|. ....+++++++||++||.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~~li~~ll~ 249 (332)
T cd05623 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPA-QVTDVSEDAKDLIRRLIC 249 (332)
T ss_pred CHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC-ccccCCHHHHHHHHHHcc
Confidence 999986 34688999999999999999999999999888888887765442 2332 235689999999999997
Q ss_pred cCCCC--CCCHHHHHcCcccCCcc
Q psy6377 222 KNPME--RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 222 ~dP~~--Rpt~~e~L~hp~~~~~~ 243 (383)
.++++ |++++++++||||.+..
T Consensus 250 ~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 250 SREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred ChhhhcCCCCHHHHhCCCCcCCCC
Confidence 65554 68999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.19 Aligned_cols=232 Identities=24% Similarity=0.363 Sum_probs=187.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|.+..+|..+|+|++... ...+.+|+++++ .++||||++++++|.+++..|+||||+. |++|.+++...
T Consensus 20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 97 (333)
T cd06650 20 VVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEISICMEHMD-GGSLDQVLKKA 97 (333)
T ss_pred EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHH-HCCCCcccceeEEEEECCEEEEEEecCC-CCcHHHHHHHc
Confidence 6899999999999999998752 346889999999 7789999999999999999999999999 99999977543
Q ss_pred C------chhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 80 L------VVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 ~------~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
. +..+..|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++...... ......||+.|+|||+
T Consensus 98 ~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~ 173 (333)
T cd06650 98 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPER 173 (333)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---CCEEEeeCCcchhhhhh-ccccCCCCccccCHHH
Confidence 2 345668999999999985 79999999999999765 58999999998765322 2344579999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---c---------------------------------
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK---A--------------------------------- 196 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~---~--------------------------------- 196 (383)
+.+..++.++|+|||||++|+|++|+.||......+....+.. +
T Consensus 174 ~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (333)
T cd06650 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFE 253 (333)
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHH
Confidence 9988899999999999999999999999976554332211100 0
Q ss_pred ------cCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 197 ------QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 197 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
....+......++.++++||.+||.+||++|||+.|++.||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 254 LLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000011357889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=301.02 Aligned_cols=231 Identities=32% Similarity=0.500 Sum_probs=197.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+..+|+.||+|++.+. ...+..|..++....+||||+++++++.+++..|+|+||+. |++|.+++.
T Consensus 11 ~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 89 (260)
T cd05611 11 SVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN-GGDCASLIK 89 (260)
T ss_pred eEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC-CCCHHHHHH
Confidence 6999999999999999998761 12345566666556789999999999999999999999999 999999764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..+..+..|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++..... .....|++.|+|||
T Consensus 90 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe 163 (260)
T cd05611 90 TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPE 163 (260)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEeecccceeccc---cccCCCCcCccChh
Confidence 4 3345666999999999999999999999999999765 6899999999886433 23456889999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC--
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT-- 229 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-- 229 (383)
.+.+..++.++|+||+|+++|+|++|.+||.+.+....+..+......++......+++.+.++|.+||..+|++|||
T Consensus 164 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred hhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence 998888899999999999999999999999988888888777777666666666678999999999999999999995
Q ss_pred -HHHHHcCcccCCc
Q psy6377 230 -AKEALKHPWLMNK 242 (383)
Q Consensus 230 -~~e~L~hp~~~~~ 242 (383)
++|+|.||||.+.
T Consensus 244 ~~~~~l~~~~~~~~ 257 (260)
T cd05611 244 GYQEIKSHPFFKSI 257 (260)
T ss_pred cHHHHHcChHhhcC
Confidence 4799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.20 Aligned_cols=232 Identities=24% Similarity=0.339 Sum_probs=176.0
Q ss_pred eEEEEEEcC--CCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSIA--TGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~~--tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|+++. ++..||+|.+.. ....+.+|+.+++ .++||||+++++++.. +...+++|||+. ++|.+.+.
T Consensus 16 ~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 92 (317)
T cd07867 16 HVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLR-ELKHPNVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIKF 92 (317)
T ss_pred eEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHH-hCCCCCeeeEEEEEeccCCCeEEEEEeeeC--CcHHHHHHh
Confidence 689998654 678999999876 2346789999999 7899999999999853 567899999987 57766542
Q ss_pred --------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc-CCCCcEEEEeccceeEeecCc----cc
Q psy6377 78 --------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDGI----EI 138 (383)
Q Consensus 78 --------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~~~~~~~----~~ 138 (383)
+..+..+..||+.||.|||++||+||||||+|||+..+ ...+.+||+|||+++...... ..
T Consensus 93 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 172 (317)
T cd07867 93 HRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172 (317)
T ss_pred hhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccccc
Confidence 11234566899999999999999999999999999543 234689999999998754322 23
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHHHHhccCCCCc------
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDS---------ETFRNISKAQLDFPD------ 202 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---------~~~~~i~~~~~~~~~------ 202 (383)
....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.... ..+..+.........
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd07867 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDI 252 (317)
T ss_pred CcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhh
Confidence 34578999999999876 45899999999999999999999999754321 111111111000000
Q ss_pred ----------------------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ----------------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
......+..+.+||.+||..||.+|||++|+|+||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 253 RKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0011235678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.24 Aligned_cols=229 Identities=27% Similarity=0.393 Sum_probs=184.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.++...|+|||++. ++|.+.+..
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~--~~l~~~~~~ 91 (285)
T cd07861 15 VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK-ELQHPNIVCLQDVLMQESRLYLIFEFLS--MDLKKYLDS 91 (285)
T ss_pred EEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHH-hcCCCCEeeeEEEEeeCCeEEEEEecCC--CCHHHHHhc
Confidence 689999999999999999865 1346789999999 7789999999999999999999999997 577765432
Q ss_pred ---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcC
Q psy6377 79 ---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYV 148 (383)
Q Consensus 79 ---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~ 148 (383)
..+..+..|++.||.|||++||+||||+|+||+++.+ +.++|+|||++........ .....+++.|+
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 168 (285)
T cd07861 92 LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168 (285)
T ss_pred CCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---CcEEECcccceeecCCCcccccCCccccccc
Confidence 2334567999999999999999999999999999765 6899999999986543222 23346789999
Q ss_pred CCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------c
Q psy6377 149 APEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP-------------------------D 202 (383)
Q Consensus 149 aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~ 202 (383)
|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+........ .
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T cd07861 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR 248 (285)
T ss_pred ChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH
Confidence 9998865 4578999999999999999999999988765443332221111000 1
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.....+++++.+||.+||..||.+|||+.+++.||||
T Consensus 249 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=304.65 Aligned_cols=235 Identities=27% Similarity=0.408 Sum_probs=194.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|+.||+|.+.+ ....+.+|+.+++ .++||||++++++|+..+..|+||||++ +++|.+.+.
T Consensus 8 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 85 (277)
T cd05577 8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLAYAFETKDDLCLVMTLMN-GGDLKYHIY 85 (277)
T ss_pred eEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHH-hCCCCCEeeeeeEEecCCeEEEEEecCC-CCcHHHHHH
Confidence 589999999999999999865 2345678999999 7789999999999999999999999999 999998654
Q ss_pred cC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 DN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
.. .+..+..|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.............++..|+|
T Consensus 86 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~ 162 (277)
T cd05577 86 NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162 (277)
T ss_pred HcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEccCcchhhhccCCccccccCCCCcCC
Confidence 32 234456899999999999999999999999999765 5899999999886544444445678899999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..++.++|+||+||++|+|++|+.||.+.........+.......+......+++.+.++|.+||..||.+||
T Consensus 163 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 242 (277)
T cd05577 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLG 242 (277)
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccC
Confidence 9999888899999999999999999999999987655333333333333333444456799999999999999999999
Q ss_pred ----CHHHHHcCcccCCcch
Q psy6377 229 ----TAKEALKHPWLMNKKQ 244 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~~ 244 (383)
++.+++.||||.....
T Consensus 243 ~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 243 CRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CCcccHHHHHhChhhhcCCh
Confidence 8999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.66 Aligned_cols=234 Identities=21% Similarity=0.259 Sum_probs=182.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhc-----CCCCCcccceEEEEeC-CeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLC-----SPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~-----~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.+..+++.||||++.. .......|+.+++.. ..|++|++++++|... ..+|+||+++ |++|.++
T Consensus 144 ~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~--g~~l~~~ 221 (467)
T PTZ00284 144 KVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDW 221 (467)
T ss_pred EEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc--CCCHHHH
Confidence 689999999999999999965 223455677766632 2456799999999865 4678888877 5778775
Q ss_pred hcc------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCC-------------CCcEEEEeccceeEeecC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFP-------------NCDIKVCDFEISRVILDG 135 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~-------------~~~ikL~DFGla~~~~~~ 135 (383)
+.. ..+..+..||+.||+|||+ .||+||||||+|||++.++. .+.+||+|||++....
T Consensus 222 l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-- 299 (467)
T PTZ00284 222 IMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-- 299 (467)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--
Confidence 533 2345677999999999998 59999999999999976531 1259999999876432
Q ss_pred cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc---------
Q psy6377 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE--------- 206 (383)
Q Consensus 136 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--------- 206 (383)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+......+|..+..
T Consensus 300 ~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~ 379 (467)
T PTZ00284 300 HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARL 379 (467)
T ss_pred cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHH
Confidence 23345789999999999999999999999999999999999999999888776666554443333322110
Q ss_pred -----------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 207 -----------------------------DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 207 -----------------------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..++.+.+||.+||.+||.+|||++|+|+||||...
T Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 380 LYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred HhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 013557899999999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.41 Aligned_cols=235 Identities=18% Similarity=0.297 Sum_probs=186.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+++++.+|+.||+|.+... ...+.+|+.+++ .++||||++++++|.+++..|+||||++ +++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~ 91 (327)
T cd08227 14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSK-LFNHPNIVPYRATFIADNELWVVTSFMA-YGSAKDLIC 91 (327)
T ss_pred EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEECCEEEEEEeccC-CCcHHHHHH
Confidence 36899999999999999999751 245778999998 7799999999999999999999999999 999998764
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cc-------cccc
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IE-------IREL 141 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~-------~~~~ 141 (383)
. ..++.+..|++.||+|||++||+||||||+|||++.+ +.++++|||.+...... .. ....
T Consensus 92 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (327)
T cd08227 92 THFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168 (327)
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---CcEEEcccchhhccccccccccccccccccc
Confidence 2 2245566999999999999999999999999999865 58999999865433211 10 1123
Q ss_pred cCCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------C-----------
Q psy6377 142 LGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------P----------- 201 (383)
Q Consensus 142 ~gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------~----------- 201 (383)
.++..|+|||++.+ .+|+.++||||+||++|+|++|..||.+............+..+. +
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T cd08227 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRS 248 (327)
T ss_pred cceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCccc
Confidence 56778999999875 468999999999999999999999998765544433332221110 0
Q ss_pred ------------------------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 202 ------------------------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 202 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
......+++.+.+||.+||..||++|||++++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 249 GANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred CCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 011223577899999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.25 Aligned_cols=230 Identities=21% Similarity=0.272 Sum_probs=181.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-----
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD----- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~----- 78 (383)
..||+|++..+++.||+|+..+ .....|+.+++ .++||||+++++++.+....++||+++. ++|.+++..
T Consensus 80 g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~ 154 (357)
T PHA03209 80 GRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQ-NVNHPSVIRMKDTLVSGAITCMVLPHYS--SDLYTYLTKRSRPL 154 (357)
T ss_pred eEEEEEEECCCCceEEEEeCCc--cccHHHHHHHH-hCCCCCCcChhheEEeCCeeEEEEEccC--CcHHHHHHhccCCC
Confidence 3699999999999999998654 34567999999 7899999999999999999999999997 677775432
Q ss_pred --CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccC
Q psy6377 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 79 --~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~ 156 (383)
..+..++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++............||+.|+|||++.+.
T Consensus 155 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 231 (357)
T PHA03209 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231 (357)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEecCccccccccCcccccccccccccCCeecCCC
Confidence 2345666999999999999999999999999999765 58999999999864443344556799999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCC-CCCCCCcH---------HHHHHHHhccCCCCcch----------------------
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFS-PFGGETDS---------ETFRNISKAQLDFPDEL---------------------- 204 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~-Pf~~~~~~---------~~~~~i~~~~~~~~~~~---------------------- 204 (383)
.++.++|||||||++|+|+++.. +|.+.... ..+..+.......|..+
T Consensus 232 ~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (357)
T PHA03209 232 KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQP 311 (357)
T ss_pred CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCc
Confidence 99999999999999999998544 44432211 11111111111001100
Q ss_pred --------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 205 --------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 205 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
..+++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 312 YTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1245778889999999999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.24 Aligned_cols=233 Identities=26% Similarity=0.395 Sum_probs=193.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+++.||+|++.+ ....+.+|+.++. ..+||||+++++++++.+..|+||||+. |++|.+++.
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~l~~~~~~~~~~~lv~Ey~~-gg~L~~~l~ 93 (331)
T cd05624 16 EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLV-NGDCQWITTLHYAFQDENYLYLVMDYYV-GGDLLTLLS 93 (331)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEEEeCCC-CCcHHHHHH
Confidence 589999999999999999875 2234677888887 7899999999999999999999999999 999999764
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYV 148 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~ 148 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++......... ...+||+.|+
T Consensus 94 ~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ 170 (331)
T cd05624 94 KFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170 (331)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC---CCEEEEeccceeeccCCCceeeccccCCcccC
Confidence 4 1234566899999999999999999999999999765 68999999999876443222 2357999999
Q ss_pred CCccccc-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 149 APEILHY-----EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 149 aPE~l~~-----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|||++.+ ..++.++|+||+||++|+|++|+.||.+.+..+.+..+.... ..+|. ....++.+++++|.+||.
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~~li~~ll~ 249 (331)
T cd05624 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS-HITDVSEEAKDLIQRLIC 249 (331)
T ss_pred CHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC-ccccCCHHHHHHHHHHcc
Confidence 9999875 467899999999999999999999999888878777776543 23332 335679999999999998
Q ss_pred cCCCC--CCCHHHHHcCcccCCcc
Q psy6377 222 KNPME--RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 222 ~dP~~--Rpt~~e~L~hp~~~~~~ 243 (383)
.++.+ |++++++++||||....
T Consensus 250 ~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 250 SRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred CchhhcCCCCHHHHhcCCCcCCCC
Confidence 76654 56999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=297.73 Aligned_cols=227 Identities=24% Similarity=0.312 Sum_probs=195.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||++ |++|.+++..
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 92 (256)
T cd08529 15 VVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLA-KLDSSYIIRYYESFLDKGKLNIVMEYAE-NGDLHKLLKM 92 (256)
T ss_pred EEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHH-hcCCCCeehheeeeccCCEEEEEEEeCC-CCcHHHHHHH
Confidence 699999999999999999864 3566888999998 7789999999999999999999999999 9999997644
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCC
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVA 149 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~a 149 (383)
. .++.+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........ .....|++.|+|
T Consensus 93 ~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08529 93 QRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169 (256)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---CCEEEcccccceeccCccchhhccccCccccC
Confidence 2 234556899999999999999999999999999875 6899999999887654322 234578999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|+|||||++|+|++|..||...+..+....+..+..... ...++..+.+++.+||..+|++||+
T Consensus 170 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (256)
T cd08529 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQLIDQCLTKDYRQRPD 246 (256)
T ss_pred HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHHHHHHccCCcccCcC
Confidence 9999988899999999999999999999999998887776666665543322 2367899999999999999999999
Q ss_pred HHHHHcCccc
Q psy6377 230 AKEALKHPWL 239 (383)
Q Consensus 230 ~~e~L~hp~~ 239 (383)
+.++++|||+
T Consensus 247 ~~~ll~~~~~ 256 (256)
T cd08529 247 TFQLLRNPSL 256 (256)
T ss_pred HHHHhhCCCC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.61 Aligned_cols=239 Identities=27% Similarity=0.410 Sum_probs=209.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..|+.|+-+.||+.||+|.+.+ ......+|-.+|. ..+.+.||.+-..|++.+.++|||..|. ||+|.-.|
T Consensus 199 GEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~-kV~s~FiVslaYAfeTkd~LClVLtlMN-GGDLkfHi 276 (591)
T KOG0986|consen 199 GEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILE-KVSSPFIVSLAYAFETKDALCLVLTLMN-GGDLKFHI 276 (591)
T ss_pred cceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHH-HhccCcEEEEeeeecCCCceEEEEEeec-CCceeEEe
Confidence 3689999999999999999876 3456778999998 7889999999999999999999999999 99998743
Q ss_pred --------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 77 --------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 77 --------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
++..+.+++.+|+.||++||..+||+|||||+|||+++. |+|+|+|.|||..+..+......+||.+||
T Consensus 277 yn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~---GhvRISDLGLAvei~~g~~~~~rvGT~GYM 353 (591)
T KOG0986|consen 277 YNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH---GHVRISDLGLAVEIPEGKPIRGRVGTVGYM 353 (591)
T ss_pred eccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC---CCeEeeccceEEecCCCCccccccCccccc
Confidence 455677889999999999999999999999999999865 899999999999999998888889999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++..+.|+.+.|.|||||++|+|+.|+.||.......-.+.+......-+.++....|++++++.+.+|.+||++|.
T Consensus 354 APEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 354 APEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred CHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 99999999999999999999999999999999987665544444444444445555677899999999999999999998
Q ss_pred -----CHHHHHcCcccCCcchhhc
Q psy6377 229 -----TAKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 229 -----t~~e~L~hp~~~~~~~~~~ 247 (383)
+++++.+||||+..+...-
T Consensus 434 Gcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 434 GCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred cCCCcCcchhhhCcccccCCHhHH
Confidence 4679999999998664433
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=305.20 Aligned_cols=231 Identities=23% Similarity=0.365 Sum_probs=190.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh--h
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI--I 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~--l 76 (383)
..||+|++..+|+.||+|.+..+ ...+.+|+.+++ .++||||+++++.+.+.+..++||||++ +++|... +
T Consensus 15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~ 92 (279)
T cd06619 15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY-KCDSPYIIGFYGAFFVENRISICTEFMD-GGSLDVYRKI 92 (279)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEECCEEEEEEecCC-CCChHHhhcC
Confidence 36999999999999999998752 345778999998 7789999999999999999999999999 8988764 3
Q ss_pred ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccC
Q psy6377 77 DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 77 ~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~ 156 (383)
.+..+..+..|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++...... .....+||+.|+|||++.+.
T Consensus 93 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 93 PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE 168 (279)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC---CCEEEeeCCcceecccc-cccCCCCChhhcCceeecCC
Confidence 444556778999999999999999999999999999765 68999999999875432 33456899999999999988
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDS-------ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
.++.++|+|||||++|+|++|..||...... .....+.... .+.......++++.+||.+||..+|++||+
T Consensus 169 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 246 (279)
T cd06619 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEKFVHFITQCMRKQPKERPA 246 (279)
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHHHHHHHHHHhhCChhhCCC
Confidence 8999999999999999999999999653321 1222222111 111122457889999999999999999999
Q ss_pred HHHHHcCcccCCc
Q psy6377 230 AKEALKHPWLMNK 242 (383)
Q Consensus 230 ~~e~L~hp~~~~~ 242 (383)
++++++||||...
T Consensus 247 ~~eil~~~~~~~~ 259 (279)
T cd06619 247 PENLMDHPFIVQY 259 (279)
T ss_pred HHHHhcCcccccc
Confidence 9999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.80 Aligned_cols=230 Identities=29% Similarity=0.357 Sum_probs=194.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC--------eEEEEEecCCCcC
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--------GAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--------~~~lv~e~~~~g~ 70 (383)
.||+|+++.+|+.||||++.. ....+.+|+.++. ...|+||+++++.|...+ .+++||||+. +|
T Consensus 47 ~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~-~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~-~g 124 (496)
T PTZ00283 47 TVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL-NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYAN-AG 124 (496)
T ss_pred EEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHh-cCCCCcEEEeecceecccccCcccceEEEEEEeCCC-CC
Confidence 589999999999999999865 2345778999998 779999999998876432 3789999999 99
Q ss_pred cHHHhhcc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---cc
Q psy6377 71 TLQTIIDD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IE 137 (383)
Q Consensus 71 ~L~~~l~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~ 137 (383)
+|.+.+.. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 125 sL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~---~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN---GLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred cHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC---CCEEEEecccCeeccccccccc
Confidence 99986643 2234566899999999999999999999999999875 68999999999875432 12
Q ss_pred cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 138 IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..+..+.... ....+++++.+++.
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~ 278 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---LPPSISPEMQEIVT 278 (496)
T ss_pred cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHH
Confidence 345679999999999999999999999999999999999999999988888877776655432 33567999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
+||..||.+|||+.++++|||++..
T Consensus 279 ~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 279 ALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHcccChhhCcCHHHHHhCHHHHHh
Confidence 9999999999999999999998754
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=301.46 Aligned_cols=230 Identities=26% Similarity=0.401 Sum_probs=189.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ ...||||+++++++++....++||||++ ++.|..++..
T Consensus 16 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~l~~~~~~ 93 (286)
T cd07847 16 VVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLK-QLKHPNLVNLIEVFRRKRKLHLVFEYCD-HTVLNELEKN 93 (286)
T ss_pred EEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHH-hCCCCCEeeeeeEEeeCCEEEEEEeccC-ccHHHHHHhC
Confidence 689999999999999998865 1234678999999 7789999999999999999999999999 8888776532
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....... ......++..|+|||
T Consensus 94 ~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE 170 (286)
T cd07847 94 PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170 (286)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---CcEEECccccceecCCCcccccCcccccccCCHH
Confidence 2355677999999999999999999999999999765 589999999998765433 233456889999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC-------------------CCCc--------c
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL-------------------DFPD--------E 203 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~-------------------~~~~--------~ 203 (383)
++.+ ..++.++|+||+|+++|+|++|.+||.+.+..+....+..... ..|. .
T Consensus 171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd07847 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLES 250 (286)
T ss_pred HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHH
Confidence 9865 5578999999999999999999999998776555444322110 0011 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.++.++..+.+||.+||.++|++|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 251 KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 235678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=324.70 Aligned_cols=232 Identities=26% Similarity=0.344 Sum_probs=199.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh-----
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI----- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~----- 75 (383)
.||+|+++.|+-..|.|+|.. ..+.+.-||+||. ..+||+||+|++.|..++.+|++.|||. ||-...+
T Consensus 47 KVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa-~CdHP~ivkLl~ayy~enkLwiliEFC~-GGAVDaimlEL~ 124 (1187)
T KOG0579|consen 47 KVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILA-ECDHPVIVKLLSAYYFENKLWILIEFCG-GGAVDAIMLELG 124 (1187)
T ss_pred hhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhh-cCCChHHHHHHHHHhccCceEEEEeecC-CchHhHHHHHhc
Confidence 689999999999999999987 4677889999999 6679999999999999999999999999 9988774
Q ss_pred --hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCcc
Q psy6377 76 --IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEI 152 (383)
Q Consensus 76 --l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~ 152 (383)
+.+.++..+.+|++.||.|||+++|+|||||..|||++.+ |.|+|+|||.+...... ....++.|||+|||||+
T Consensus 125 r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld---GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEV 201 (1187)
T KOG0579|consen 125 RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD---GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEV 201 (1187)
T ss_pred cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec---CcEeeecccccccchhHHhhhccccCCcccccchh
Confidence 3456666777999999999999999999999999999987 79999999998764332 23456899999999998
Q ss_pred c-----ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 153 L-----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 153 l-----~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+ ...||++++||||||++|.+|..+.||-...+....+-+|.+...+- --.+..++..+.||+.+||.+||..|
T Consensus 202 vmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT-LlqPS~Ws~~F~DfLk~cL~Knp~~R 280 (1187)
T KOG0579|consen 202 VMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LLQPSHWSRSFSDFLKRCLVKNPRNR 280 (1187)
T ss_pred eeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc-ccCcchhhhHHHHHHHHHHhcCCccC
Confidence 6 45789999999999999999999999998888777777766543221 01124568999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
|++.++|+|||+.+.
T Consensus 281 p~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 281 PPAAQLLKHPFVQNA 295 (1187)
T ss_pred CCHHHHhhCcccccC
Confidence 999999999999864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.69 Aligned_cols=229 Identities=26% Similarity=0.369 Sum_probs=183.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+....|+++||+. ++|.+.+..
T Consensus 15 ~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 91 (284)
T cd07839 15 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDS 91 (284)
T ss_pred EEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHH-hcCCCCeeeHHHHhccCCceEEEEecCC--CCHHHHHHh
Confidence 689999999999999999875 1346788999999 7799999999999999999999999997 567665432
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aP 150 (383)
..++.+..||+.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......+++.|+||
T Consensus 92 ~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 168 (284)
T cd07839 92 CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168 (284)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---CcEEECccchhhccCCCCCCcCCCccccCCcCh
Confidence 2345667999999999999999999999999999865 689999999988654332 23345678999999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHhccCCCC-------------------------cc
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLTGFSPF-GGETDSETFRNISKAQLDFP-------------------------DE 203 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyelltg~~Pf-~~~~~~~~~~~i~~~~~~~~-------------------------~~ 203 (383)
|++.+. .++.++||||+||++|+|++|..|| .+.+..+.+..+.......+ ..
T Consensus 169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
T cd07839 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVN 248 (284)
T ss_pred HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhh
Confidence 998664 4789999999999999999988775 45544444444332111000 01
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+.+++++++||.+||..||.+|||+++++.||||
T Consensus 249 ~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 249 VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.19 Aligned_cols=231 Identities=33% Similarity=0.520 Sum_probs=187.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++... .....+|+.+++ .+.||||+++++++.+....+++|+++. +++|.+++.
T Consensus 13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~~v~~~~~-~~~L~~~l~ 90 (260)
T PF00069_consen 13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILR-RLRHPNIVQILDVFQDDNYLYIVMEYCP-GGSLQDYLQ 90 (260)
T ss_dssp EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHH-HHTBTTBCHEEEEEEESSEEEEEEEEET-TEBHHHHHH
T ss_pred EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccc-cccccccccccccccccccccccccccc-ccccccccc
Confidence 47899999999999999999872 122345899999 4489999999999999999999999999 889998765
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe-ecCcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||++||++||+|+||||+||+++.+ +.++|+|||.+... ..........+++.|+||
T Consensus 91 ~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 167 (260)
T PF00069_consen 91 KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN---GEVKLIDFGSSVKLSENNENFNPFVGTPEYMAP 167 (260)
T ss_dssp HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT---SEEEESSGTTTEESTSTTSEBSSSSSSGGGSCH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 2 3345666999999999999999999999999999855 68999999999863 233445567899999999
Q ss_pred cccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET---FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++. +..++.++|+||+|+++|+|++|..||........ ...........+.......+..+.++|.+||..||++
T Consensus 168 E~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 247 (260)
T PF00069_consen 168 EVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQ 247 (260)
T ss_dssp HHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGG
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhH
Confidence 9998 78899999999999999999999999998733332 3222221111111111222489999999999999999
Q ss_pred CCCHHHHHcCccc
Q psy6377 227 RMTAKEALKHPWL 239 (383)
Q Consensus 227 Rpt~~e~L~hp~~ 239 (383)
|||+.++++||||
T Consensus 248 R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 248 RPSAEELLKHPWF 260 (260)
T ss_dssp STTHHHHHTSGGG
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.34 Aligned_cols=235 Identities=29% Similarity=0.469 Sum_probs=199.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+..+|+.||+|.+... ...+.+|+.+++ .++||||+++++.+.++...|+|||++. |++|.+++.
T Consensus 16 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 93 (316)
T cd05574 16 RVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA-TLDHPFLPTLYASFQTETYLCLVMDYCP-GGELFRLLQ 93 (316)
T ss_pred EEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHH-hCCCCCchhheeeeecCCEEEEEEEecC-CCCHHHHHH
Confidence 6999999999999999999762 235788999999 7789999999999999999999999999 999999765
Q ss_pred cC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc------------
Q psy6377 78 DN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE------------ 137 (383)
Q Consensus 78 ~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~------------ 137 (383)
.. ....++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus 94 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 170 (316)
T cd05574 94 RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---GHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170 (316)
T ss_pred hCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---CCEEEeecchhhccccccccccccccccccc
Confidence 32 234556899999999999999999999999999865 6899999999875432111
Q ss_pred ------------------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC
Q psy6377 138 ------------------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD 199 (383)
Q Consensus 138 ------------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~ 199 (383)
.....||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....+.++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 250 (316)
T cd05574 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVT 250 (316)
T ss_pred ccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCcc
Confidence 11246889999999999888999999999999999999999999998888887777665555
Q ss_pred CCcchhcCCCHHHHHHHHHhcccCCCCCCC----HHHHHcCcccCCcchhh
Q psy6377 200 FPDELFEDISPEAKDFIAKILIKNPMERMT----AKEALKHPWLMNKKQIM 246 (383)
Q Consensus 200 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~L~hp~~~~~~~~~ 246 (383)
++.. ..++..+.++|.+||..||++||| ++++|.||||+......
T Consensus 251 ~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 251 FPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred CCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 4432 237899999999999999999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.61 Aligned_cols=229 Identities=32% Similarity=0.515 Sum_probs=195.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++.+.++...|+++|+++ +++|.+.+.
T Consensus 8 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 85 (262)
T cd05572 8 RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLYRTFKDKKYIYMLMEYCL-GGELWTILR 85 (262)
T ss_pred EEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHH-hCCCCCEeeeeeeEEcCCccEEEEecCC-CCcHHHHHh
Confidence 699999999999999999875 2356888999998 7799999999999999999999999999 999999765
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.............|++.|+|||
T Consensus 86 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE 162 (262)
T cd05572 86 DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162 (262)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---CCEEEeeCCcccccCcccccccccCCcCccChh
Confidence 43 233456899999999999999999999999999775 689999999998765443334457899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh--ccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET--DSETFRNISK--AQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
.+....++.++|+||+|+++|+|++|..||.+.. ..+....+.. ....+| ...++++.++|.+||..+|++|
T Consensus 163 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHccCChhhC
Confidence 9988889999999999999999999999998776 5555666553 223333 3448899999999999999999
Q ss_pred CC-----HHHHHcCcccCCc
Q psy6377 228 MT-----AKEALKHPWLMNK 242 (383)
Q Consensus 228 pt-----~~e~L~hp~~~~~ 242 (383)
|| ++|+++||||.+.
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.91 Aligned_cols=229 Identities=24% Similarity=0.341 Sum_probs=187.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|++..+++.||+|++.. ....+.+|+.+++ .++||||+++++.+.+.+..|++|||+. +++|.+++..
T Consensus 24 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~-~l~h~~ii~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 101 (267)
T cd06645 24 DVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK-DCKHSNIVAYFGSYLRRDKLWICMEFCG-GGSLQDIYHVTG 101 (267)
T ss_pred EEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCEEEEEEeccC-CCcHHHHHHhcC
Confidence 589999999999999999875 2345678999998 7799999999999999999999999999 9999987643
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
..++.+..|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....... ......|++.|+|||++
T Consensus 102 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 102 PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN---GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECcceeeeEccCcccccccccCcccccChhhh
Confidence 3345666999999999999999999999999999765 689999999987654322 22345789999999987
Q ss_pred c---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-hhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 154 H---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-LFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 154 ~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
. ...++.++|+||+||++|+|++|.+||...........+.......+.. ....++..+.+||.+||..+|++|||
T Consensus 179 ~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred ccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC
Confidence 4 4568899999999999999999999997665544444333333322211 11246889999999999999999999
Q ss_pred HHHHHcCcc
Q psy6377 230 AKEALKHPW 238 (383)
Q Consensus 230 ~~e~L~hp~ 238 (383)
++++++|||
T Consensus 259 ~~~ll~~~~ 267 (267)
T cd06645 259 AEKLLQHPF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=304.63 Aligned_cols=233 Identities=24% Similarity=0.354 Sum_probs=194.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||++++..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++.|.++...|+||||++ |++|.+++...
T Consensus 34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~-~~~h~~v~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 111 (296)
T cd06654 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVMEYLA-GGSLTDVVTET 111 (296)
T ss_pred eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHH-hCCCCCEeeEEEEEEeCCEEEEeecccC-CCCHHHHHHhc
Confidence 3689999999999999998876 2456788999998 7899999999999999999999999999 99999976442
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l 153 (383)
....+..|++.||.|||++||+||||||+|||++.+ +.++|+|||++........ .....|++.|+|||.+
T Consensus 112 ~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (296)
T cd06654 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEECccccchhccccccccCcccCCccccCHHHH
Confidence 345666899999999999999999999999999765 5899999999886543222 2345789999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+|||||++|+|++|++||.+.+.......+.... ..+......++..+.++|.+||.++|++|||+.++
T Consensus 189 ~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 88889999999999999999999999998877654443333222 11222234678999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
+.|||+...
T Consensus 268 l~~~~~~~~ 276 (296)
T cd06654 268 LQHQFLKIA 276 (296)
T ss_pred hhChhhhcc
Confidence 999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.09 Aligned_cols=229 Identities=28% Similarity=0.482 Sum_probs=198.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||++.+..+++.||+|.+.+ ....+.+|+++++ .++||||+++++++.+++..|+|||+++ +++|.+.+
T Consensus 15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~ 92 (290)
T cd05580 15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ-SIRHPFLVNLYGSFQDDSNLYLVMEYVP-GGELFSHL 92 (290)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCccceeeEEEcCCeEEEEEecCC-CCCHHHHH
Confidence 3689999999999999999865 2356788999999 7779999999999999999999999999 89999876
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... .+..+..|++.||.|||++|++||||+|.|||++.+ +.++|+|||++...... .....|++.|+||
T Consensus 93 ~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aP 167 (290)
T cd05580 93 RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---GYIKITDFGFAKRVKGR--TYTLCGTPEYLAP 167 (290)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEeeCCCccccCCC--CCCCCCCccccCh
Confidence 433 344566899999999999999999999999999765 68999999999876443 3445789999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|.+.+..++.++|+||||+++|+|++|..||.+.+.......+..+...+|. .++..++++|.+||..||.+|+
T Consensus 168 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHHHccCCHHHccCc
Confidence 9998888899999999999999999999999888876777777766655543 4589999999999999999999
Q ss_pred ---CHHHHHcCcccCCcc
Q psy6377 229 ---TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ---t~~e~L~hp~~~~~~ 243 (383)
+++++++||||....
T Consensus 244 ~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 244 LKNGVNDIKNHPWFAGID 261 (290)
T ss_pred ccCCHHHHHcCcccccCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=293.21 Aligned_cols=227 Identities=28% Similarity=0.408 Sum_probs=191.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC-CeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+++++.+|+.||+|.+.. ....+.+|+.+++ .++|||++++++.+... ...|++||+++ +++|.+.+.
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~l~ 92 (257)
T cd08223 15 EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS-QLKHPNIVAYRESWEGEDGLLYIVMGFCE-GGDLYHKLK 92 (257)
T ss_pred EEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHH-hCCCCCeeeeeeeecCCCCEEEEEecccC-CCcHHHHHH
Confidence 689999999999999999865 2345788999998 77899999999998754 46899999999 999988664
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYV 148 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~ 148 (383)
. ..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....... ......|++.|+
T Consensus 93 ~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~ 169 (257)
T cd08223 93 EQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT---NIIKVGDLGIARVLENQCDMASTLIGTPYYM 169 (257)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC---CcEEEecccceEEecccCCccccccCCcCcc
Confidence 3 2235667999999999999999999999999999765 689999999998764322 233457899999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+..++.++|+||+|+++|+|++|..||.+.+.......+..+.... ....+++.+.+|+.+||..+|++||
T Consensus 170 aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd08223 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELIATMLSKRPEKRP 246 (257)
T ss_pred ChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHHHhccCcccCC
Confidence 9999998889999999999999999999999998877666666655544321 2346789999999999999999999
Q ss_pred CHHHHHcCccc
Q psy6377 229 TAKEALKHPWL 239 (383)
Q Consensus 229 t~~e~L~hp~~ 239 (383)
|+.++++||||
T Consensus 247 ~~~~~l~~~~~ 257 (257)
T cd08223 247 SVKSILRQPYI 257 (257)
T ss_pred CHHHHhcCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.00 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=189.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|++..+|+.||+|.+.+ ....+.+|+.+++ .++||||++++++|... ...|+|||++. ++|
T Consensus 31 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l 107 (353)
T cd07850 31 IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD--ANL 107 (353)
T ss_pred EEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHH-hcCCCCCcceeeeeccCCCccccCcEEEEEeccC--CCH
Confidence 589999999999999999865 1345778999999 77999999999998654 35799999997 577
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.+.+ ....+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||+++............+++.|+
T Consensus 108 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~ 184 (353)
T cd07850 108 CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYR 184 (353)
T ss_pred HHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCccceeCCCCCCCCCCccccccc
Confidence 7754 334455677999999999999999999999999999765 689999999998765544444567899999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE------------------------- 203 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------- 203 (383)
|||.+.+..++.++|||||||++|+|++|..||.+.+....+..+......++..
T Consensus 185 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T cd07850 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFE 264 (353)
T ss_pred CHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchh
Confidence 9999999999999999999999999999999998877655555443321111100
Q ss_pred ------h--------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 ------L--------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 ------~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
. ....++.+++||.+||..||++|||+.|+|.||||..+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 1134667899999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=308.63 Aligned_cols=234 Identities=29% Similarity=0.515 Sum_probs=210.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.|-+|..+.|.+.||||++++ +.+-.+.|-++|.....-|.+++++.+|++-+.+|+||||+. ||+|--.+
T Consensus 364 KVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn-GGDLMyhiQ 442 (683)
T KOG0696|consen 364 KVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN-GGDLMYHIQ 442 (683)
T ss_pred eeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec-CchhhhHHH
Confidence 578899999999999999998 455677888899866678999999999999999999999999 99998754
Q ss_pred -----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 77 -----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 -----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
++..+.+++..|+-||=|||++||++||||.+|||++.+ |+|||+|||+++... ++....+.||||.|+||
T Consensus 443 Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e---GHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAP 519 (683)
T KOG0696|consen 443 QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIFDGVTTKTFCGTPDYIAP 519 (683)
T ss_pred HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC---CceEeeecccccccccCCcceeeecCCCccccc
Confidence 455677888999999999999999999999999999876 799999999998643 44556789999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+++|+.++|.||+||+||||+.|++||.|++..++++.|+.....+|. .+|.++.++++.+|.+.|.+|..+
T Consensus 520 EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 520 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHHHHHhhcCCccccCC
Confidence 9999999999999999999999999999999999999999999999888875 679999999999999999999864
Q ss_pred -----HHHHcCcccCCcchhh
Q psy6377 231 -----KEALKHPWLMNKKQIM 246 (383)
Q Consensus 231 -----~e~L~hp~~~~~~~~~ 246 (383)
.++-.||||.......
T Consensus 596 g~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 596 GPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred CCccccchhhCcchhhccHHH
Confidence 5899999998766443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.37 Aligned_cols=229 Identities=24% Similarity=0.385 Sum_probs=186.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.+..+++.||+|++.. ....+.+|+.+++...+||||++++++|... ...|++||++. +++|.++
T Consensus 21 ~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~~L~~~ 99 (272)
T cd06637 21 QVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG-AGSVTDL 99 (272)
T ss_pred EEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCC-CCcHHHH
Confidence 589999999999999999876 3456889999998666899999999999753 46899999999 9999997
Q ss_pred hccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 76 IDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 76 l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
+... .+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++...... .......|++.
T Consensus 100 l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~ 176 (272)
T cd06637 100 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176 (272)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC---CCEEEccCCCceecccccccCCccccccc
Confidence 6532 123466899999999999999999999999999865 58999999999865332 22344678999
Q ss_pred cCCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 147 YVAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 147 y~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|+|||++. ...++.++|+||+||++|+|++|..||...........+.... .+......++..+.+|+.+||.
T Consensus 177 y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 254 (272)
T cd06637 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLV 254 (272)
T ss_pred ccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCCCCCCCcCHHHHHHHHHHcC
Confidence 99999985 3468889999999999999999999997665544443332221 2222234578999999999999
Q ss_pred cCCCCCCCHHHHHcCccc
Q psy6377 222 KNPMERMTAKEALKHPWL 239 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~hp~~ 239 (383)
.+|.+|||+.++++||||
T Consensus 255 ~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 255 KNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.13 Aligned_cols=231 Identities=29% Similarity=0.383 Sum_probs=195.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||++++..+|+.||+|.+... ...+.+|+.+++ .++||||+++++++.++...|+|+|++. +++|.+.+...
T Consensus 16 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~ 93 (274)
T cd06609 16 EVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLS-QCRSPYITKYYGSFLKGSKLWIIMEYCG-GGSCLDLLKPG 93 (274)
T ss_pred EEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHH-HcCCCCeeeeeEEEEECCeEEEEEEeeC-CCcHHHHHhhc
Confidence 6899999999999999998752 245788999999 7789999999999999999999999999 99999976543
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l 153 (383)
.+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++...... .......|++.|+|||.+
T Consensus 94 ~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~ 170 (274)
T cd06609 94 KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170 (274)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEcccccceeecccccccccccCCccccChhhh
Confidence 345666999999999999999999999999999875 68999999999876543 223445788999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcC-CCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED-ISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
.+..++.++|+|||||++|+|++|.+||.+.+.......+.....+ ..... ++.++.+++.+||..+|++|||+++
T Consensus 171 ~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP---SLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC---CCcccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 9888999999999999999999999999877665555544443222 12222 7899999999999999999999999
Q ss_pred HHcCcccCCcc
Q psy6377 233 ALKHPWLMNKK 243 (383)
Q Consensus 233 ~L~hp~~~~~~ 243 (383)
+++||||....
T Consensus 248 il~~~~~~~~~ 258 (274)
T cd06609 248 LLKHKFIKKAK 258 (274)
T ss_pred HhhChhhcCCC
Confidence 99999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=302.75 Aligned_cols=235 Identities=26% Similarity=0.328 Sum_probs=189.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|.++.+|+.||+|.+... .....+|+.+++ .++||||+++++++.+. +..|+|||++. ++|.++
T Consensus 21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~ 97 (309)
T cd07845 21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLL-NLRHPNIVELKEVVVGKHLDSIFLVMEYCE--QDLASL 97 (309)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHH-hCCCCCCcceEEEEecCCCCeEEEEEecCC--CCHHHH
Confidence 37899999999999999998641 234668999999 78899999999999765 56899999997 477765
Q ss_pred hcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCc
Q psy6377 76 IDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDY 147 (383)
Q Consensus 76 l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y 147 (383)
+.. ..+..+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....... ......+++.|
T Consensus 98 l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y 174 (309)
T cd07845 98 LDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWY 174 (309)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccceeeecCCccCCCCcccccccc
Confidence 432 3345677999999999999999999999999999765 689999999998765432 22334568889
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch----------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL---------------------- 204 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------------- 204 (383)
+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 175 ~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (309)
T cd07845 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNN 254 (309)
T ss_pred cChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCc
Confidence 99999865 5689999999999999999999999998888777766654322111111
Q ss_pred ----hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 205 ----FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 205 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
....++.+.+||.+||.+||++|||+.+++.||||.....
T Consensus 255 ~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 255 LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 1235889999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.88 Aligned_cols=229 Identities=30% Similarity=0.421 Sum_probs=186.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|+.||+|.+.+ ......+|+.++++..+||||+++++++.++ +..++|||++. ++|.+.+.
T Consensus 14 ~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~l~ 91 (282)
T cd07831 14 EVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD--MNLYELIK 91 (282)
T ss_pred eEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC--ccHHHHHH
Confidence 699999999999999999876 1233457888888666799999999999988 88999999997 46666543
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||.|||+.|++||||+|+||+++. +.++|+|||++.............+++.|+||
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP 167 (282)
T cd07831 92 GRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167 (282)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCCCcCCCCCCcccCCh
Confidence 2 234566699999999999999999999999999976 58999999999876554444556789999999
Q ss_pred cccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC------------------CCc-------ch
Q psy6377 151 EILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD------------------FPD-------EL 204 (383)
Q Consensus 151 E~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~------------------~~~-------~~ 204 (383)
|.+. +..++.++|+||+||++|+|++|.+||.+.+..+.+..+...... +|. ..
T Consensus 168 E~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd07831 168 ECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKL 247 (282)
T ss_pred hHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHH
Confidence 9764 455789999999999999999999999988776665555432211 111 11
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
...++..+.++|.+||.++|++|||++++++||||
T Consensus 248 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 248 LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 23568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=296.81 Aligned_cols=229 Identities=26% Similarity=0.345 Sum_probs=183.9
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-----
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN----- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~----- 79 (383)
.||+|+++.+|..+|+|++..... ...|+.......+||||+++++.|...+..|+||||++ +++|.+++...
T Consensus 31 ~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~-~~~L~~~l~~~~~l~~ 108 (267)
T PHA03390 31 KVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK-DGDLFDLLKKEGKLSE 108 (267)
T ss_pred EEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC-CCcHHHHHHhcCCCCH
Confidence 689999999999999999876211 11244444433479999999999999999999999999 99999876543
Q ss_pred -CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCC
Q psy6377 80 -LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI 158 (383)
Q Consensus 80 -~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 158 (383)
.+..+..|++.||.|||+.|++||||||+||+++.+. +.++|+|||++...... ....|++.|+|||++.+..+
T Consensus 109 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 109 AEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCC
Confidence 3456669999999999999999999999999998752 37999999998865332 23568999999999998899
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-HHHHHcC
Q psy6377 159 TLAADMWSLGVTAYVLLTGFSPFGGETDSETF-RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT-AKEALKH 236 (383)
Q Consensus 159 ~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~L~h 236 (383)
+.++|+||+|+++|+|++|..||........- ..+.... ..+...+..+++.+.+||.+||+++|.+||+ ++++|+|
T Consensus 184 ~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 184 DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999999999999866543321 1111111 2223344578999999999999999999996 6999999
Q ss_pred cccCC
Q psy6377 237 PWLMN 241 (383)
Q Consensus 237 p~~~~ 241 (383)
|||.+
T Consensus 263 ~~~~~ 267 (267)
T PHA03390 263 PFLKI 267 (267)
T ss_pred CcccC
Confidence 99964
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=302.94 Aligned_cols=233 Identities=27% Similarity=0.382 Sum_probs=195.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||++++..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+++..|+|+|++. +++|..++..
T Consensus 34 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 111 (296)
T cd06655 34 TVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK-ELKNPNIVNFLDSFLVGDELFVVMEYLA-GGSLTDVVTETC 111 (296)
T ss_pred EEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHH-hcCCCceeeeeeeEecCceEEEEEEecC-CCcHHHHHHhcC
Confidence 689999999999999998875 2456788999998 7799999999999999999999999999 9999987654
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~ 154 (383)
..+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++........ .....|++.|+|||.+.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccchhcccccccCCCcCCCccccCcchhc
Confidence 3344566899999999999999999999999999765 6899999999886543322 23457899999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..++.++|+|||||++|+|++|..||.+.+.......+..... .+...+..+++.+.+||.+||..||.+|||+.+++
T Consensus 189 ~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 88899999999999999999999999988876655554443321 12223356789999999999999999999999999
Q ss_pred cCcccCCcc
Q psy6377 235 KHPWLMNKK 243 (383)
Q Consensus 235 ~hp~~~~~~ 243 (383)
.||||....
T Consensus 268 ~~~~~~~~~ 276 (296)
T cd06655 268 QHPFLKLAK 276 (296)
T ss_pred hChHhhhcc
Confidence 999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=315.58 Aligned_cols=231 Identities=21% Similarity=0.282 Sum_probs=184.1
Q ss_pred eEEEEEEc--CCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSI--ATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
.||+|... .++..||+|.+.. .....+|+.+++ .++||||++++++|......|++|+++. ++|.+++..
T Consensus 107 ~Vy~~~~~~~~~~~~v~vK~~~~-~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~l 182 (392)
T PHA03207 107 EVFVCTKHGDEQRKKVIVKAVTG-GKTPGREIDILK-TISHRAIINLIHAYRWKSTVCMVMPKYK--CDLFTYVDRSGPL 182 (392)
T ss_pred EEEEEEEcCCccceeEEEEeccc-cccHHHHHHHHH-hcCCCCccceeeeEeeCCEEEEEehhcC--CCHHHHHHhcCCC
Confidence 68888754 4678899998875 345679999999 7799999999999999999999999986 677776533
Q ss_pred --CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcCCCccc
Q psy6377 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 --~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l 153 (383)
..++.+..||+.||.|||++||+||||||+|||++.+ +.++|+|||++........ .....||+.|+|||++
T Consensus 183 ~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~---~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 259 (392)
T PHA03207 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP---ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259 (392)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEccCccccccCcccccccccccccccCccCHhHh
Confidence 2345667999999999999999999999999999765 6899999999986543322 2345799999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhcc----CCCCc------------------------
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---ETFRNISKAQ----LDFPD------------------------ 202 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~i~~~~----~~~~~------------------------ 202 (383)
.+..|+.++|||||||++|+|++|+.||.+.... ..+..+.... ..++.
T Consensus 260 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (392)
T PHA03207 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339 (392)
T ss_pred cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcccc
Confidence 9999999999999999999999999999875432 2222222111 01110
Q ss_pred ch--hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 203 EL--FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 203 ~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.. ...++.++.+||.+||..||++|||+.++|.||||...
T Consensus 340 ~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 340 PVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 12356789999999999999999999999999999764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=299.23 Aligned_cols=232 Identities=28% Similarity=0.342 Sum_probs=186.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-----EEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-----AYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-----~~lv~e~~~~g~~L~ 73 (383)
.||+|.+..+|+.||+|.+.. ....+.+|+.+++.+.+||||+++++++...+. .|++|||+. + +|.
T Consensus 16 ~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~-~l~ 93 (295)
T cd07837 16 KVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-S-DLK 93 (295)
T ss_pred EEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccC-c-CHH
Confidence 689999999999999998875 124678899999966678999999999987666 899999998 4 777
Q ss_pred Hhhc-----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccc
Q psy6377 74 TIID-----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIREL 141 (383)
Q Consensus 74 ~~l~-----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~ 141 (383)
+.+. ...++.+..||+.||.|||++||+||||+|+||+++.+ .+.++|+|||++...... ......
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg~~~~~~~~~~~~~~~ 171 (295)
T cd07837 94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLGLGRAFSIPVKSYTHE 171 (295)
T ss_pred HHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecccceecCCCccccCCc
Confidence 7542 22345566999999999999999999999999999863 268999999998865332 122334
Q ss_pred cCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------
Q psy6377 142 LGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------- 201 (383)
Q Consensus 142 ~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------- 201 (383)
.+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+.......+
T Consensus 172 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (295)
T cd07837 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW 251 (295)
T ss_pred ccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcc
Confidence 67889999998764 4578999999999999999999999998876665555433211111
Q ss_pred -----cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 202 -----DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 202 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
....+.++.++.+||.+||.+||.+|||+.++|.||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 252 KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111245789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=292.62 Aligned_cols=228 Identities=21% Similarity=0.332 Sum_probs=195.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|.+..+++.+|+|.+.. ....+.+|+.+++ ..+||||+++++.+..++..++|||+++ |++|.+++..
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 92 (256)
T cd08220 15 IVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLK-LLSHPNIIEYYENFLEDKALMIVMEYAP-GGTLAEYIQK 92 (256)
T ss_pred EEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHh-hCCCCchhheeeeEecCCEEEEEEecCC-CCCHHHHHHH
Confidence 689999999999999999875 2346889999999 7789999999999999999999999999 9999987643
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
. .+..+..|++.||+|||++|++|+||+|+||+++.++ +.++|+|||++.............|++.|+||
T Consensus 93 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aP 170 (256)
T cd08220 93 RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170 (256)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEccCCCceecCCCccccccccCCcccCc
Confidence 2 2345568999999999999999999999999997542 46899999999887655444556789999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|.+.+..++.++|+||+|+++|+|++|..||.+.+.......+....... ....++..+.+++.+||..+|++|||+
T Consensus 171 E~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~ 247 (256)
T cd08220 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQL 247 (256)
T ss_pred hhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHHHHHccCChhhCCCH
Confidence 99998888999999999999999999999999888777776665543321 223578999999999999999999999
Q ss_pred HHHHcCccc
Q psy6377 231 KEALKHPWL 239 (383)
Q Consensus 231 ~e~L~hp~~ 239 (383)
.+++.|||+
T Consensus 248 ~~ll~~p~~ 256 (256)
T cd08220 248 SQIMAQPIC 256 (256)
T ss_pred HHHhhCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.58 Aligned_cols=233 Identities=28% Similarity=0.415 Sum_probs=192.2
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|++..+|+.||+|.+... ...+.+|+.+++ ...||||+++++.+...+..|+||||++ |++|..++...
T Consensus 16 ~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~ 93 (286)
T cd06622 16 SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH-KAVSPYIVDFYGAFFIEGAVYMCMEYMD-AGSLDKLYAGG 93 (286)
T ss_pred EEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHH-hcCCCcHHhhhhheecCCeEEEEEeecC-CCCHHHHHHhc
Confidence 6899999999999999988651 346888999999 6799999999999999999999999999 99998876542
Q ss_pred ---------CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 80 ---------LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 80 ---------~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
.+..+..|++.||.|||+ .||+||||||+||+++.+ +.++|+|||++...... ......|++.|+|
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~a 169 (286)
T cd06622 94 VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMA 169 (286)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC---CCEEEeecCCcccccCC-ccccCCCccCccC
Confidence 234566899999999997 599999999999999764 68999999998765332 2344568899999
Q ss_pred CcccccC------CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 150 PEILHYE------PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 150 PE~l~~~------~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
||.+.+. .++.++|+||+||++|+|++|..||...........+.......+...+..++.++.+||.+||..+
T Consensus 170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 249 (286)
T cd06622 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKI 249 (286)
T ss_pred cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccC
Confidence 9998543 3588999999999999999999999876655544443332222333444568999999999999999
Q ss_pred CCCCCCHHHHHcCcccCCcc
Q psy6377 224 PMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~~ 243 (383)
|++||++++++.||||....
T Consensus 250 p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 250 PNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCCCHHHHhcChhhhhcc
Confidence 99999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=292.32 Aligned_cols=227 Identities=24% Similarity=0.305 Sum_probs=196.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.|+.+++..+|+.+++|.+.. ....+.+|+.+++ ..+||||+++++++.+.+..+++|||++ +++|.+.+..
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~~~e~~~-~~~L~~~~~~ 92 (256)
T cd08221 15 EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILS-LLQHPNIIAYYNHFMDDNTLLIEMEYAN-GGTLYDKIVR 92 (256)
T ss_pred eEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHH-hCCCCCeeEEEeEEecCCeEEEEEEecC-CCcHHHHHHh
Confidence 579999999999999998765 2346889999999 6799999999999999999999999999 9999997754
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCC
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVA 149 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~a 149 (383)
. .+..+..|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++....... ......|++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08221 93 QKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFGISKILGSEYSMAETVVGTPYYMS 169 (256)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---CCEEECcCcceEEcccccccccccCCCccccC
Confidence 3 234556899999999999999999999999999875 589999999998764433 2344678999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||.+.+..++.++|+||+|+++|+|++|..||.+.+..+....+..+...... ..++.++.++|.+||..+|.+|||
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~s 246 (256)
T cd08221 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISLVHSLLQQDPEKRPT 246 (256)
T ss_pred HhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHHHHHcccCcccCCC
Confidence 99998888899999999999999999999999988888888777665544322 567899999999999999999999
Q ss_pred HHHHHcCccc
Q psy6377 230 AKEALKHPWL 239 (383)
Q Consensus 230 ~~e~L~hp~~ 239 (383)
+.++|+|||+
T Consensus 247 ~~~ll~~~~l 256 (256)
T cd08221 247 ADEVLDQPLL 256 (256)
T ss_pred HHHHhhCcCC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.83 Aligned_cols=234 Identities=26% Similarity=0.371 Sum_probs=194.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||++.+..+|+.||+|.+.. ....+.+|+.+++ ..+||||++++++|..++..|+||||++ +++|.+++.+
T Consensus 34 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 111 (297)
T cd06656 34 TVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVMEYLA-GGSLTDVVTETC 111 (297)
T ss_pred EEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCEEEEeecccC-CCCHHHHHHhCC
Confidence 689999999999999999875 3456788999998 7899999999999999999999999999 9999997644
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~ 154 (383)
..+..+..|++.||.|||+.|++||||||+|||++.+ +.++|+|||++........ .....+++.|+|||.+.
T Consensus 112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (297)
T cd06656 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEECcCccceEccCCccCcCcccCCccccCHHHHc
Confidence 2345666899999999999999999999999999765 6899999999887543322 23457899999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..++.++|+||+||++|+|++|.+||.+.+.......+.... ..+......++..+.+|+.+||..+|++|||+++++
T Consensus 189 ~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 8889999999999999999999999998776544333222211 112223346788999999999999999999999999
Q ss_pred cCcccCCcch
Q psy6377 235 KHPWLMNKKQ 244 (383)
Q Consensus 235 ~hp~~~~~~~ 244 (383)
+||||.....
T Consensus 268 ~~~~~~~~~~ 277 (297)
T cd06656 268 QHPFLKLAKP 277 (297)
T ss_pred cCchhccccc
Confidence 9999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=293.60 Aligned_cols=229 Identities=29% Similarity=0.404 Sum_probs=191.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
.||+|+++.+++.+|+|.+.. ....+.+|+++++ .++||||+++++++.++...|+++|++. +++|.+++..
T Consensus 18 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l~~e~~~-~~~L~~~l~~~~~~ 95 (256)
T cd06612 18 SVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK-QCDSPYIVKYYGSYFKNTDLWIVMEYCG-AGSVSDIMKITNKT 95 (256)
T ss_pred EEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHH-hCCCCcEeeeeeeeecCCcEEEEEecCC-CCcHHHHHHhCccC
Confidence 789999999999999999886 3567899999999 6699999999999999999999999999 9999987643
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~ 154 (383)
..+..+..|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....... ......|+..|+|||++.
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 172 (256)
T cd06612 96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---CcEEEcccccchhcccCccccccccCCccccCHHHHh
Confidence 2344666999999999999999999999999999875 589999999988765433 223346889999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..++.++||||+|+++|+|++|.+||...........+...... .......++..+.++|.+||..||++|||+.++|
T Consensus 173 ~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 889999999999999999999999999877655544433222111 1112235688999999999999999999999999
Q ss_pred cCccc
Q psy6377 235 KHPWL 239 (383)
Q Consensus 235 ~hp~~ 239 (383)
.||||
T Consensus 252 ~~~~~ 256 (256)
T cd06612 252 QHPFI 256 (256)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=300.92 Aligned_cols=221 Identities=16% Similarity=0.138 Sum_probs=184.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---C----cccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---N----PVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L 72 (383)
..||+|+. +|+.||||.+.+ . ...+.+|+.+++ .+.||||+++++++.+ ...+++||||+. ||+|
T Consensus 34 ~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~-~g~L 109 (283)
T PHA02988 34 NSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLR-RIDSNNILKIYGFIIDIVDDLPRLSLILEYCT-RGYL 109 (283)
T ss_pred eEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHH-hcCCCCEEEEeeeEEecccCCCceEEEEEeCC-CCcH
Confidence 35788875 799999999986 1 245669999999 7799999999999977 457899999999 9999
Q ss_pred HHhhccCC------chhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 73 QTIIDDNL------VVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 73 ~~~l~~~~------~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
.+++.... ...++.|++.||.|||+ .+++||||||+|||++.+ +.+||+|||+++..... .....|++
T Consensus 110 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~---~~~kl~dfg~~~~~~~~--~~~~~~~~ 184 (283)
T PHA02988 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN---YKLKIICHGLEKILSSP--PFKNVNFM 184 (283)
T ss_pred HHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC---CcEEEcccchHhhhccc--cccccCcc
Confidence 99875533 34566899999999998 499999999999999875 68999999998865332 23457899
Q ss_pred CcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 146 DYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 146 ~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++ ....+++.+++|+.+||+.|
T Consensus 185 ~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 185 VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred cccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--CCCcCcHHHHHHHHHHhcCC
Confidence 9999999976 6799999999999999999999999999888787777755443332 22357899999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|++|||+++++.
T Consensus 263 p~~Rps~~ell~ 274 (283)
T PHA02988 263 SIKRPNIKEILY 274 (283)
T ss_pred cccCcCHHHHHH
Confidence 999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=298.59 Aligned_cols=232 Identities=28% Similarity=0.368 Sum_probs=192.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||++.+..++..+|+|.+.. ....+.+|+.+++ .++||||+++++++..++..|+++||++ +++|...+..
T Consensus 20 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~~v~e~~~-~~~l~~~~~~~~ 97 (282)
T cd06643 20 KVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWILIEFCA-GGAVDAVMLELE 97 (282)
T ss_pred EEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHH-HCCCCCeeeEEEEEeeCCEEEEEEEecC-CCcHHHHHHhcC
Confidence 689999999999999999875 2346788999998 7789999999999999999999999999 9999885432
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~ 152 (383)
..+..+..|++.||.|||+.|++||||||+||+++.+ +.++|+|||++....... ......|++.|+|||+
T Consensus 98 ~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 174 (282)
T cd06643 98 RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174 (282)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---CCEEEccccccccccccccccccccccccccCHhh
Confidence 2345566999999999999999999999999999765 589999999987653321 2234578999999999
Q ss_pred cc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 153 LH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 153 l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+. +..++.++|+||+||++|+|++|.+||.+.+..+....+....... ......++.++.+||.+||..||.+|
T Consensus 175 ~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R 253 (282)
T cd06643 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKDFLKKCLEKNVDAR 253 (282)
T ss_pred ccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHHHHHHHHHccCChhhC
Confidence 73 4557889999999999999999999999887766666665443221 11234578999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||++++++|||+...
T Consensus 254 p~~~~il~~~~~~~~ 268 (282)
T cd06643 254 WTTTQLLQHPFVTVN 268 (282)
T ss_pred cCHHHHhcCCCEecc
Confidence 999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=297.58 Aligned_cols=230 Identities=32% Similarity=0.474 Sum_probs=189.9
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++..+|+.||+|++... ...+.+|+.+++ ..+||||+++++++.++...|+|+|++ +++|.+.+..
T Consensus 15 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e~~--~~~L~~~~~~ 91 (286)
T cd07832 15 IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ-ACQHPYVVKLLDVFPHGSGFVLVMEYM--PSDLSEVLRD 91 (286)
T ss_pred EEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHH-hCCCCCCcceeeEEecCCeeEEEeccc--CCCHHHHHHh
Confidence 5899999999999999998761 356889999999 667999999999999999999999999 6999986532
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVA 149 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~a 149 (383)
..++.++.||+.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... ......|++.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a 168 (286)
T cd07832 92 EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD---GVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168 (286)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC---CcEEEeeeeecccccCCCCCccccccCcccccC
Confidence 3345667999999999999999999999999999865 689999999988764432 1344578999999
Q ss_pred CcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------C-------c
Q psy6377 150 PEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------------------P-------D 202 (383)
Q Consensus 150 PE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------~-------~ 202 (383)
||.+.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+....... + .
T Consensus 169 PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd07832 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE 248 (286)
T ss_pred ceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHH
Confidence 9998654 46899999999999999999999998887666655544321111 0 1
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
...++.+..+.+||++||.++|++|||++++|.||||.
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 249 EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 12245678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=298.67 Aligned_cols=235 Identities=29% Similarity=0.394 Sum_probs=192.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.++.+|+.||+|.+... ...+.+|+.+++ ..+||||+++++++.+.+..++|||++ +++|.++
T Consensus 15 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~--~~~L~~~ 91 (298)
T cd07841 15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ-ELKHPNIIGLLDVFGHKSNINLVFEFM--ETDLEKV 91 (298)
T ss_pred EEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHh-hcCCCCChhhhheeecCCEEEEEEccc--CCCHHHH
Confidence 7899999999999999999762 124568999998 778999999999999999999999999 5899987
Q ss_pred hccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCc
Q psy6377 76 IDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDY 147 (383)
Q Consensus 76 l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y 147 (383)
+.... +..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++....... ......+++.|
T Consensus 92 i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 168 (298)
T cd07841 92 IKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSPNRKMTHQVVTRWY 168 (298)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---CCEEEccceeeeeccCCCccccccccceee
Confidence 75543 45666999999999999999999999999999865 689999999998765432 23344678899
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------------------------c
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------------D 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~ 202 (383)
+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+........ .
T Consensus 169 ~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T cd07841 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLK 248 (298)
T ss_pred eCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchh
Confidence 99998854 5678999999999999999999999988877666655543211111 1
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..+...+..+.+||.+||.++|++|||+.++|.||||.+....
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 1224567899999999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=298.66 Aligned_cols=234 Identities=28% Similarity=0.361 Sum_probs=192.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
..||++++..+|+.+|+|.+.. ....+.+|+.+++ .++||||+++++.+..+...|+||||++ |++|..++.
T Consensus 26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~ 103 (292)
T cd06644 26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILA-TCNHPYIVKLLGAFYWDGKLWIMIEFCP-GGAVDAIMLEL 103 (292)
T ss_pred eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHH-hCCCCcEeeeEEEEEeCCeEEEEEecCC-CCcHHHHHHhh
Confidence 3689999999999999999876 2356778999998 7789999999999999999999999999 999987542
Q ss_pred -----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 78 -----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 78 -----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
...+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||
T Consensus 104 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 180 (292)
T cd06644 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC---CCEEEccCccceeccccccccceecCCccccCce
Confidence 23345667999999999999999999999999999764 689999999987643321 223456889999999
Q ss_pred ccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 152 ILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 152 ~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
++. ...++.++|+|||||++|+|++|.+||...+.......+.....+ +......++.++.++|.+||..+|++
T Consensus 181 ~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (292)
T cd06644 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPET 259 (292)
T ss_pred eeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCccc
Confidence 984 345788999999999999999999999887766555555433221 11223467889999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
||+++++++|||+....
T Consensus 260 Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 260 RPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CcCHHHHhcCccccccc
Confidence 99999999999997644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=300.73 Aligned_cols=234 Identities=26% Similarity=0.452 Sum_probs=196.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+++++.+++.||+|.+.. ....+.+|+.+++ ..+||||+++++.+.+++..|+|||++. |++|.+++.
T Consensus 16 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~~l~ 93 (305)
T cd05609 16 AVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSFETKRHLCMVMEYVE-GGDCATLLK 93 (305)
T ss_pred eEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEecCCEEEEEEecCC-CCcHHHHHH
Confidence 689999999999999999875 1345778999999 7799999999999999999999999999 999999775
Q ss_pred cCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------------
Q psy6377 78 DNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------------- 136 (383)
Q Consensus 78 ~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------------- 136 (383)
... +..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||+++......
T Consensus 94 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 170 (305)
T cd05609 94 NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170 (305)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC---CCEEEeeCCCccccCcCccccccccccccchhh
Confidence 432 34556899999999999999999999999999765 689999999987421100
Q ss_pred -ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHH
Q psy6377 137 -EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215 (383)
Q Consensus 137 -~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 215 (383)
......|++.|+|||.+....++.++|+|||||++|+|++|..||.+.+..+....+..+....|... ..++.++.++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 249 (305)
T cd05609 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD-EALPADAQDL 249 (305)
T ss_pred ccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc-ccCCHHHHHH
Confidence 01123578899999999888899999999999999999999999998888887877776655554432 2678999999
Q ss_pred HHHhcccCCCCCCC---HHHHHcCcccCCcch
Q psy6377 216 IAKILIKNPMERMT---AKEALKHPWLMNKKQ 244 (383)
Q Consensus 216 i~~~L~~dP~~Rpt---~~e~L~hp~~~~~~~ 244 (383)
|.+||..+|++||| +.++|+||||.....
T Consensus 250 i~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 250 ISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred HHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 99999999999998 799999999976443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=298.01 Aligned_cols=230 Identities=30% Similarity=0.400 Sum_probs=185.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||+|.+.. ....+.+|+++++ .++||||+++++++.+++..+++|||+. ++|...+.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~--~~l~~~~~ 90 (284)
T cd07860 14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMD 90 (284)
T ss_pred eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHH-hcCCCCCcchhhhcccCCcEEEEeeccc--cCHHHHHH
Confidence 3689999999999999998875 1246889999999 7799999999999999999999999997 57777553
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYV 148 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~ 148 (383)
. ..+..+..|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++....... ......+++.|+
T Consensus 91 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 167 (284)
T cd07860 91 ASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167 (284)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEeeccchhhcccCcccccccccccccc
Confidence 2 2244566899999999999999999999999999876 589999999987654322 223346788999
Q ss_pred CCcccccCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------
Q psy6377 149 APEILHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------- 202 (383)
Q Consensus 149 aPE~l~~~~-~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------- 202 (383)
|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+.......+.
T Consensus 168 aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd07860 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS 247 (284)
T ss_pred CCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHH
Confidence 999886544 688999999999999999999999887765544443322111111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
...+.++.+++++|.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 248 KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.31 Aligned_cols=233 Identities=24% Similarity=0.397 Sum_probs=195.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||++.+..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++.+..++..|+|||+++ +++|.+++..
T Consensus 37 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 114 (292)
T cd06658 37 IVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMR-DYHHENVVDMYNSYLVGDELWVVMEFLE-GGALTDIVTHTR 114 (292)
T ss_pred EEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHH-hCCCCcHHHHHHheecCCeEEEEEeCCC-CCcHHHHHhcCC
Confidence 589999999999999999865 2456889999998 7799999999999999999999999999 9999987643
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~ 154 (383)
..+..+..||+.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......|++.|+|||.+.
T Consensus 115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (292)
T cd06658 115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEccCcchhhcccccccCceeecCccccCHHHHc
Confidence 3345666999999999999999999999999999765 589999999987543222 223457899999999998
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..++.++|+||+|+++|+|++|..||.+.+....+..+..... ........++..+.+|+.+||..||.+|||+++++
T Consensus 192 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 88899999999999999999999999988777666655543321 11122235788999999999999999999999999
Q ss_pred cCcccCCcc
Q psy6377 235 KHPWLMNKK 243 (383)
Q Consensus 235 ~hp~~~~~~ 243 (383)
+||||....
T Consensus 271 ~~~~~~~~~ 279 (292)
T cd06658 271 QHPFLKLAG 279 (292)
T ss_pred hChhhhccC
Confidence 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.25 Aligned_cols=234 Identities=29% Similarity=0.406 Sum_probs=204.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..|.+++++.|++.||+|++++ +..-|..|-.+|. ..+.+=|+.++-.|+|+.++|+||+|++ ||+|-.++
T Consensus 89 GEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv-~~ns~Wiv~LhyAFQD~~~LYlVMdY~p-GGDlltLl 166 (1317)
T KOG0612|consen 89 GEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMV-FGNSEWIVQLHYAFQDERYLYLVMDYMP-GGDLLTLL 166 (1317)
T ss_pred ceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHH-cCCcHHHHHHHHHhcCccceEEEEeccc-CchHHHHH
Confidence 3689999999999999999998 3456778888888 7789999999999999999999999999 99999987
Q ss_pred ccCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcC
Q psy6377 77 DDNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYV 148 (383)
Q Consensus 77 ~~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~ 148 (383)
+.-. +.++...|+.||.-+|+.|+|||||||+|||++.. |+|||+|||.+........ ....+|||-|+
T Consensus 167 Sk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~---GHikLADFGsClkm~~dG~V~s~~aVGTPDYI 243 (1317)
T KOG0612|consen 167 SKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS---GHIKLADFGSCLKMDADGTVRSSVAVGTPDYI 243 (1317)
T ss_pred hhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc---CcEeeccchhHHhcCCCCcEEeccccCCCCcc
Confidence 6543 56777999999999999999999999999999766 8999999998877653333 45678999999
Q ss_pred CCcccc----c-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc--cCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 149 APEILH----Y-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA--QLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 149 aPE~l~----~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
+||++. + +.|+..||+||+||++|||+.|..||..++-.+++.+|+.- .+.||+.. .+|+++++||.+++.
T Consensus 244 SPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~--~VSeeakdLI~~ll~ 321 (1317)
T KOG0612|consen 244 SPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET--DVSEEAKDLIEALLC 321 (1317)
T ss_pred CHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc--ccCHHHHHHHHHHhc
Confidence 999984 2 45899999999999999999999999999999999999886 67788443 599999999999876
Q ss_pred cCCCCCCC---HHHHHcCcccCCcchh
Q psy6377 222 KNPMERMT---AKEALKHPWLMNKKQI 245 (383)
Q Consensus 222 ~dP~~Rpt---~~e~L~hp~~~~~~~~ 245 (383)
+|+.|.+ ++++..||||.+....
T Consensus 322 -~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 322 -DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred -ChhhhcccccHHHHHhCccccCCChh
Confidence 5778887 9999999999987653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=303.14 Aligned_cols=232 Identities=27% Similarity=0.394 Sum_probs=189.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||++++..+|..+|+|.+... ..++.+|+++++ .++||||++++++|.+++..|++|||++ |++|.+++...
T Consensus 16 ~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ey~~-~~~L~~~l~~~ 93 (308)
T cd06615 16 VVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH-ECNSPYIVGFYGAFYSDGEISICMEHMD-GGSLDQVLKKA 93 (308)
T ss_pred EEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCEEEEEeeccC-CCcHHHHHHhc
Confidence 6899999999999999998752 345889999999 6799999999999999999999999999 99999976442
Q ss_pred ------CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 80 ------LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
....++.|++.||.|||+ .|++||||||+|||++.+ +.++|+|||++...... ......|++.|+|||+
T Consensus 94 ~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~ 169 (308)
T cd06615 94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPER 169 (308)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---CcEEEccCCCccccccc-ccccCCCCcCccChhH
Confidence 345666999999999998 599999999999999765 58999999998765332 2345678999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--------------------------------
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------------------------------- 200 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------------------- 200 (383)
+.+..++.++|+|||||++|+|++|..||.+.+.......+.......
T Consensus 170 ~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (308)
T cd06615 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE 249 (308)
T ss_pred hcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcC
Confidence 988889999999999999999999999997665333222221110000
Q ss_pred --CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 201 --PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 201 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
|......++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus 250 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 250 PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000112367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.31 Aligned_cols=224 Identities=19% Similarity=0.285 Sum_probs=177.7
Q ss_pred eEEEEEE-----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC-CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADS-----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~ 73 (383)
.||+|.+ ..+++.||+|++.. ....+.+|+.+++.+.+||||+++++++... ..++++|||++ +|+|.
T Consensus 22 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~-~g~L~ 100 (338)
T cd05102 22 KVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCK-YGNLS 100 (338)
T ss_pred eEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCC-CCcHH
Confidence 5788874 35567899999975 2346889999999565899999999988764 45899999999 99999
Q ss_pred HhhccCC--------------------------------------------------------------------chhhH
Q psy6377 74 TIIDDNL--------------------------------------------------------------------VVPFE 85 (383)
Q Consensus 74 ~~l~~~~--------------------------------------------------------------------~~~~~ 85 (383)
+++.... +..++
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 180 (338)
T cd05102 101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180 (338)
T ss_pred HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence 8764321 12355
Q ss_pred HHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcCCCcccccCCCChhh
Q psy6377 86 SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAA 162 (383)
Q Consensus 86 ~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~ 162 (383)
.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+++.|+|||++.+..++.++
T Consensus 181 ~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 257 (338)
T cd05102 181 FQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQS 257 (338)
T ss_pred HHHHHHHHHHHHCCEECCCCccceEEEcCC---CcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCccc
Confidence 799999999999999999999999999765 5899999999986533221 1223466889999999989999999
Q ss_pred HHHHHHHHHHHHHh-CCCCCCCCCcHHHH-HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 163 DMWSLGVTAYVLLT-GFSPFGGETDSETF-RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 163 DiwSlGvilyellt-g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
|||||||++|+|++ |.+||.+....+.+ ..+..+.... ....+++.+.+++.+||..||.+|||+.++++
T Consensus 258 DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 258 DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999997 99999886654433 3333332211 22467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=298.03 Aligned_cols=232 Identities=27% Similarity=0.363 Sum_probs=193.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||++.+..+++.+|+|++.. ....+.+|+.+++ .++||||+++++++.++...|+||||++ +++|.+++..
T Consensus 20 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 97 (280)
T cd06611 20 KVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS-ECKHPNIVGLYEAYFYENKLWILIEFCD-GGALDSIMLELE 97 (280)
T ss_pred eEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHH-hCCCCceeEEEEEEecCCeEEEEeeccC-CCcHHHHHHHhc
Confidence 689999999999999999875 2346778999999 6779999999999999999999999999 9999987543
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~ 152 (383)
..+..++.|++.||.|||++||+|+||+|+||+++.+ +.++|+|||++....... ......|++.|+|||.
T Consensus 98 ~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~ 174 (280)
T cd06611 98 RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174 (280)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC---CCEEEccCccchhhcccccccceeecchhhcCHHH
Confidence 3345677999999999999999999999999999765 689999999987653322 2234568999999999
Q ss_pred cc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 153 LH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 153 l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+. ..+++.++|+||+|+++|+|++|.+||.+.+..+....+..+.... ......++.++.+||.+||..+|.+|
T Consensus 175 ~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred HhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccCCHHHHHHHHHHhccChhhC
Confidence 74 3457889999999999999999999998887666666655443211 11224578999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+.++++|||+...
T Consensus 254 ps~~~il~~~~~~~~ 268 (280)
T cd06611 254 PTAAELLKHPFVSDQ 268 (280)
T ss_pred cCHHHHhcChhhccc
Confidence 999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=317.71 Aligned_cols=230 Identities=24% Similarity=0.280 Sum_probs=183.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-----
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD----- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~----- 78 (383)
..||+|++..+++.||+|... ...+.+|+++++ .++|||||++++++..+...++||+++. ++|...+..
T Consensus 183 G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~-~L~HpnIv~l~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~l 257 (461)
T PHA03211 183 GCVFESSHPDYPQRVVVKAGW--YASSVHEARLLR-RLSHPAVLALLDVRVVGGLTCLVLPKYR--SDLYTYLGARLRPL 257 (461)
T ss_pred eEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHH-HCCCCCCCcEEEEEEECCEEEEEEEccC--CCHHHHHHhcCCCC
Confidence 468999999999999999643 346789999999 7899999999999999999999999996 677775432
Q ss_pred --CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcCCCccc
Q psy6377 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 --~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l 153 (383)
..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++....... .....||+.|+|||++
T Consensus 258 ~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~ 334 (461)
T PHA03211 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334 (461)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---CCEEEcccCCceecccccccccccccCCCcCCcCHHHH
Confidence 2345677999999999999999999999999999765 5899999999986543221 2235799999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHhccCC---CC---------------------
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGET--------DSETFRNISKAQLD---FP--------------------- 201 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~--------~~~~~~~i~~~~~~---~~--------------------- 201 (383)
.+..++.++|||||||++|+|++|..|+.+.. ..+..+.+...... ++
T Consensus 335 ~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 414 (461)
T PHA03211 335 AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRP 414 (461)
T ss_pred cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCC
Confidence 99999999999999999999999876553322 12233333322211 11
Q ss_pred ---cchh---cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 202 ---DELF---EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 202 ---~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
...| ..++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 415 ~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 415 AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 245678999999999999999999999999999974
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=292.35 Aligned_cols=229 Identities=31% Similarity=0.416 Sum_probs=192.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
.||+|++..+++.+|+|++.. ....+.+|+.+++ ..+||||+++++++.+.+.+|++||++. +++|.+++...
T Consensus 18 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l~~e~~~-~~~l~~~~~~~~ 95 (262)
T cd06613 18 DVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLK-ECRHPNIVAYFGSYLRRDKLWIVMEYCG-GGSLQDIYQVTR 95 (262)
T ss_pred EEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHH-hCCCCChhceEEEEEeCCEEEEEEeCCC-CCcHHHHHHhhc
Confidence 689999999999999999886 2457889999999 7799999999999999999999999999 99999876442
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.
T Consensus 96 ~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~ 172 (262)
T cd06613 96 GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---CCEEECccccchhhhhhhhccccccCCccccCchh
Confidence 334566999999999999999999999999999865 689999999988654322 2334578899999999
Q ss_pred cccC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-chhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 153 LHYE---PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-ELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 153 l~~~---~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
+... .++.++|+||+|+++|+|++|.+||.+.+.......+....+..+. .....++.++.+|+.+||..+|..||
T Consensus 173 ~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd06613 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252 (262)
T ss_pred hcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC
Confidence 8776 7899999999999999999999999887766655555444332221 11234678899999999999999999
Q ss_pred CHHHHHcCcc
Q psy6377 229 TAKEALKHPW 238 (383)
Q Consensus 229 t~~e~L~hp~ 238 (383)
|+.+++.|||
T Consensus 253 t~~~il~~~~ 262 (262)
T cd06613 253 TATKLLQHPF 262 (262)
T ss_pred CHHHHhcCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.80 Aligned_cols=235 Identities=25% Similarity=0.311 Sum_probs=191.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+++.||+|++.. ....+.+|+.+++ .+.|||||+++++|.+ ...+|+||||+. +++|.++|
T Consensus 28 tVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~-~L~HPNIVrl~d~f~de~~~~lyIVMEY~~-gGSL~~lL 105 (1021)
T PTZ00266 28 EVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR-ELKHKNIVRYIDRFLNKANQKLYILMEFCD-AGDLSRNI 105 (1021)
T ss_pred EEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEecCCCEEEEEEeCCC-CCcHHHHH
Confidence 589999999999999999875 2456889999999 7899999999999864 456899999999 99999865
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhC-------CceecCCCCCcEEEeccC--------------CCCcEEEEe
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHR-------KIAHLDIKPQNLVMMGDF--------------PNCDIKVCD 125 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~-------givHrDLKp~NILl~~~~--------------~~~~ikL~D 125 (383)
.. ..++.++.||+.||.|||+. +|+||||||+|||++.+. ..+.+||+|
T Consensus 106 ~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsD 185 (1021)
T PTZ00266 106 QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185 (1021)
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEcc
Confidence 32 33556779999999999984 499999999999996531 124589999
Q ss_pred ccceeEeecCcccccccCCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc
Q psy6377 126 FEISRVILDGIEIRELLGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE 203 (383)
Q Consensus 126 FGla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 203 (383)
||++.............||+.|+|||++.+ ..++.++||||||||+|+|++|.+||...+....+.........+|
T Consensus 186 FGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-- 263 (1021)
T PTZ00266 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-- 263 (1021)
T ss_pred CCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--
Confidence 999987654444455679999999999854 4588999999999999999999999987665544443333322222
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
....+.++.+||..||.++|.+|||+.|+|.|||+.....
T Consensus 264 -i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 264 -IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred -cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 2456899999999999999999999999999999976543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.14 Aligned_cols=229 Identities=26% Similarity=0.330 Sum_probs=186.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+++++.+|+.||+|++.. ....+.+|+.+++ ..+||||+++++++..+...|+||||++ +++|.+++..
T Consensus 24 ~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~-~~~h~~ii~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~ 101 (267)
T cd06646 24 DVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK-ECKHCNIVAYFGSYLSREKLWICMEYCG-GGSLQDIYHVTG 101 (267)
T ss_pred EEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHH-hcCCCCeeeeeEEEEeCCEEEEEEeCCC-CCcHHHHHHhcC
Confidence 689999999999999999875 2345778999998 7899999999999999999999999999 9999987643
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++....... ......|++.|+|||.+
T Consensus 102 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~ 178 (267)
T cd06646 102 PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEECcCccceeecccccccCccccCccccCHhHc
Confidence 2344566999999999999999999999999999765 579999999998764322 12345789999999987
Q ss_pred c---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-hhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 154 H---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-LFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 154 ~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
. ...++.++|+||+||++|+|++|++||......+....+.......+.. ....++..+.+||++||..+|++|||
T Consensus 179 ~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred ccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC
Confidence 4 4557889999999999999999999997655443333333332222211 12356899999999999999999999
Q ss_pred HHHHHcCcc
Q psy6377 230 AKEALKHPW 238 (383)
Q Consensus 230 ~~e~L~hp~ 238 (383)
++++|+|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.42 Aligned_cols=233 Identities=26% Similarity=0.351 Sum_probs=198.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||.|+++.|...+|||-++- ..+.+..||.+.+ .+.|.|||++++.+..+..+-++||-++ ||+|..++..
T Consensus 590 ~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~-~LrHkNIVrYLGs~senGf~kIFMEqVP-GGSLSsLLrskW 667 (1226)
T KOG4279|consen 590 TVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHS-TLRHKNIVRYLGSVSENGFFKIFMEQVP-GGSLSSLLRSKW 667 (1226)
T ss_pred EEEeeccccceeEEEeeecccccchhhccHHHHHHHHH-HHhhHhHHHHhhccCCCCeEEEEeecCC-CCcHHHHHHhcc
Confidence 589999999999999999976 4677889999988 8889999999999998888999999999 9999998642
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
..+-++-+||++||.|||.+.|||||||-+|+|++.- .|.+||+|||.+++... .....++.||..||||
T Consensus 668 GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy--SGvlKISDFGTsKRLAginP~TETFTGTLQYMAP 745 (1226)
T KOG4279|consen 668 GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 745 (1226)
T ss_pred CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec--cceEEecccccchhhccCCccccccccchhhhCh
Confidence 3455667999999999999999999999999999765 38999999999987643 3335568899999999
Q ss_pred cccccC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 151 EILHYE--PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 151 E~l~~~--~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|++..+ +|+.++|||||||++.||.||+|||........ ....-|.+..-++.+..+|.++++||.+|+.+||.+||
T Consensus 746 EvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~ 824 (1226)
T KOG4279|consen 746 EVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRP 824 (1226)
T ss_pred HhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCc
Confidence 999764 589999999999999999999999975543322 11222444444555677899999999999999999999
Q ss_pred CHHHHHcCcccCCc
Q psy6377 229 TAKEALKHPWLMNK 242 (383)
Q Consensus 229 t~~e~L~hp~~~~~ 242 (383)
+|.++|..||++..
T Consensus 825 sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 825 SAKDLLQDPFLQHN 838 (1226)
T ss_pred cHHHhccCcccccC
Confidence 99999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=302.73 Aligned_cols=235 Identities=18% Similarity=0.298 Sum_probs=187.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..|++++++.+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+.+..|++|||++ +++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~e~~~-~~~l~~~l~ 91 (314)
T cd08216 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSR-QLQHPNILPYVTSFIVDSELYVVSPLMA-YGSCEDLLK 91 (314)
T ss_pred ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHH-hcCCcchhhhhheeecCCeEEEEEeccC-CCCHHHHHH
Confidence 4689999999999999999865 2357889999999 7789999999999999999999999999 999998765
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccc
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IREL 141 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~ 141 (383)
. ..+..+++|++.||+|||++||+||||||+||+++.+ +.++|+|||.+........ ....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeeccccccccccccccccc
Confidence 3 2244566999999999999999999999999999865 6899999999876533211 1234
Q ss_pred cCCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-------C------------
Q psy6377 142 LGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD-------F------------ 200 (383)
Q Consensus 142 ~gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~-------~------------ 200 (383)
.++..|+|||++.. ..|+.++|+||+||++|+|++|..||..............+... .
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 57788999999865 45889999999999999999999999876544333222111100 0
Q ss_pred -----------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 201 -----------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 201 -----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+......++.++.+|+.+||.+||++|||++++|+||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0001122356889999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.34 Aligned_cols=227 Identities=31% Similarity=0.407 Sum_probs=190.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
.||.|.+..+++.+|+|.+... ...+.+|+.+++ .++||||+++++++.+.+..+++||+++ +++
T Consensus 15 ~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~ 92 (267)
T cd06628 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK-ELQHENIVQYLGSSLDADHLNIFLEYVP-GGS 92 (267)
T ss_pred EEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCccEEEEEecC-CCC
Confidence 6899999999999999988651 135778999999 7799999999999999999999999999 999
Q ss_pred HHHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-------cc
Q psy6377 72 LQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-------EI 138 (383)
Q Consensus 72 L~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-------~~ 138 (383)
|.+++... .+..+..|++.||+|||++|++||||+|+||+++.+ +.++|+|||+++...... ..
T Consensus 93 L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (267)
T cd06628 93 VAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGAR 169 (267)
T ss_pred HHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC---CCEEecccCCCcccccccccCCccccc
Confidence 99876442 344666999999999999999999999999999765 689999999988764211 11
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 218 (383)
....|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.... .+.....++..+.++|.+
T Consensus 170 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~ 246 (267)
T cd06628 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIPSNISSEAIDFLEK 246 (267)
T ss_pred cccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCCcccCHHHHHHHHH
Confidence 23458899999999988889999999999999999999999998876655544443321 122334678999999999
Q ss_pred hcccCCCCCCCHHHHHcCccc
Q psy6377 219 ILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
||.+||.+||++.++++||||
T Consensus 247 ~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 247 TFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HccCCchhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=296.47 Aligned_cols=235 Identities=26% Similarity=0.359 Sum_probs=188.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||++.++.+|+.||+|.+... ...+.+|+.+++ .++||||+++++++.++...|+||||+. ++|.+.+.
T Consensus 16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~ 92 (294)
T PLN00009 16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK-EMQHGNIVRLQDVVHSEKRLYLVFEYLD--LDLKKHMD 92 (294)
T ss_pred EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHH-hccCCCEeeEEEEEecCCeEEEEEeccc--ccHHHHHH
Confidence 36899999999999999998651 245788999999 6799999999999999999999999997 57777543
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYV 148 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~ 148 (383)
. ..+..++.||+.||+|||++|++||||+|+||+++.++ +.+||+|||++....... ......+++.|+
T Consensus 93 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 170 (294)
T PLN00009 93 SSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEVVTLWYR 170 (294)
T ss_pred hCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCCccccccCceeeccc
Confidence 2 12335668999999999999999999999999998542 479999999997653322 233456789999
Q ss_pred CCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------
Q psy6377 149 APEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------- 202 (383)
Q Consensus 149 aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------- 202 (383)
|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+...++.........
T Consensus 171 ~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (294)
T PLN00009 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA 250 (294)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH
Confidence 9998865 45789999999999999999999999887766555554322111111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+.+++++.++|.+||..+|++||++.++++||||.+..
T Consensus 251 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 251 TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11245788999999999999999999999999999998643
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=296.87 Aligned_cols=229 Identities=25% Similarity=0.376 Sum_probs=185.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEe------CCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQT------GEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~------~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+++.+++.+|+|++.. ....+..|+.+++...+||||++++++|.. .+..|++|||+. +++|.++
T Consensus 31 ~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~-~~~L~~~ 109 (282)
T cd06636 31 QVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCG-AGSVTDL 109 (282)
T ss_pred EEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCC-CCcHHHH
Confidence 689999999999999999876 345678899999866689999999999853 467899999999 8999987
Q ss_pred hccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 76 IDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 76 l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
+... .+..+..|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++...... .......|++.
T Consensus 110 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 186 (282)
T cd06636 110 VKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186 (282)
T ss_pred HHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCcchhhhhccccCCCccccccc
Confidence 6431 234556899999999999999999999999999765 58999999998765322 12334578999
Q ss_pred cCCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 147 YVAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 147 y~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
|+|||.+. ...++.++|+|||||++|+|++|.+||...........+.... .+......++.++.+||.+||.
T Consensus 187 y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~ 264 (282)
T cd06636 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPKLKSKKWSKKFIDFIEGCLV 264 (282)
T ss_pred ccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCCCcccccCHHHHHHHHHHhC
Confidence 99999875 3568889999999999999999999997766544443332221 1222234578999999999999
Q ss_pred cCCCCCCCHHHHHcCccc
Q psy6377 222 KNPMERMTAKEALKHPWL 239 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~hp~~ 239 (383)
.||.+|||+.|+|+||||
T Consensus 265 ~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 265 KNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=293.14 Aligned_cols=230 Identities=27% Similarity=0.401 Sum_probs=186.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.++.+++.+|+|++.. ....+.+|+.+++...+||||+++++++.+.. ..|++||++. +++|.++
T Consensus 21 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 99 (275)
T cd06608 21 KVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCG-GGSVTDL 99 (275)
T ss_pred EEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCC-CCcHHHH
Confidence 589999999999999999886 34578899999996668999999999997644 4899999999 9999886
Q ss_pred hcc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCC
Q psy6377 76 IDD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGT 144 (383)
Q Consensus 76 l~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt 144 (383)
+.. ..+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... ......|+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~ 176 (275)
T cd06608 100 VKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDFGVSAQLDSTLGRRNTFIGT 176 (275)
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC---CeEEECCCccceecccchhhhcCcccc
Confidence 532 2234566899999999999999999999999999865 689999999988654322 23345689
Q ss_pred CCcCCCccccc-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 145 PDYVAPEILHY-----EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 145 ~~y~aPE~l~~-----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.........+....... -.....++..+++||.+|
T Consensus 177 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 255 (275)
T cd06608 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT-LKSPENWSKKFNDFISEC 255 (275)
T ss_pred ccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC-CCchhhcCHHHHHHHHHH
Confidence 99999998753 346789999999999999999999998766555555554432211 111123688999999999
Q ss_pred cccCCCCCCCHHHHHcCccc
Q psy6377 220 LIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~ 239 (383)
|..||++|||+.++++|||+
T Consensus 256 l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 256 LIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=299.06 Aligned_cols=233 Identities=26% Similarity=0.419 Sum_probs=185.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh----
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI---- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~---- 75 (383)
.||+++++.+|+.+|+|.+.. ....+.+|+.++.+..+||||+++++++.++...+++||++. +++.++
T Consensus 19 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~--~~l~~l~~~~ 96 (288)
T cd06616 19 TVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYV 96 (288)
T ss_pred EEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc--CCHHHHHHHH
Confidence 689999999999999999875 234678899999866679999999999999999999999987 454432
Q ss_pred -------hccCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 76 -------IDDNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 76 -------l~~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
+.+..+..+..|++.||+|||+. |++||||||+||+++.+ +.++|+|||++.............|++.|
T Consensus 97 ~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y 173 (288)
T cd06616 97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQLVDSIAKTRDAGCRPY 173 (288)
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC---CcEEEeecchhHHhccCCccccccCccCc
Confidence 12233456679999999999985 99999999999999765 58999999999765444333445789999
Q ss_pred CCCcccccC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhcc-CCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 148 VAPEILHYE---PITLAADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQ-LDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 148 ~aPE~l~~~---~~~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+|||++... .++.++||||+||++|+|++|.+||..... .+....+..+. ...+...+..++.++.+||.+||..
T Consensus 174 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 253 (288)
T cd06616 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIK 253 (288)
T ss_pred cCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccC
Confidence 999998765 689999999999999999999999976542 12222222222 1222223345899999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCc
Q psy6377 223 NPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~ 242 (383)
+|++|||++++++||||...
T Consensus 254 ~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 254 DESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ChhhCcCHHHHhcChhhhch
Confidence 99999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=295.81 Aligned_cols=229 Identities=28% Similarity=0.390 Sum_probs=181.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|.++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+++..|+||||+. + +|.+++..
T Consensus 20 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~L~~~~~~~ 96 (291)
T cd07844 20 TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLK-DLKHANIVTLHDIIHTKKTLTLVFEYLD-T-DLKQYMDDC 96 (291)
T ss_pred EEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHh-hCCCcceeeEEEEEecCCeEEEEEecCC-C-CHHHHHHhC
Confidence 689999999999999999865 1345678999999 7799999999999999999999999998 4 88876533
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||+++..... .......+++.|+|||
T Consensus 97 ~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE 173 (291)
T cd07844 97 GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPD 173 (291)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---CCEEECccccccccCCCCccccccccccccCCcH
Confidence 2344566899999999999999999999999999765 68999999998764321 1122345788999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCc--------------------------c
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGET-DSETFRNISKAQLDFPD--------------------------E 203 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~i~~~~~~~~~--------------------------~ 203 (383)
++.+ ..++.++||||+|+++|+|++|.+||.+.. ..+.+..+........+ .
T Consensus 174 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd07844 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLIN 253 (291)
T ss_pred HhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHH
Confidence 8865 568999999999999999999999997765 23333322211111000 0
Q ss_pred hhcCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDIS--PEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
....++ .++.++|.+||..+|++|||+.++|.||||
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 254 HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 112344 888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=295.67 Aligned_cols=230 Identities=27% Similarity=0.402 Sum_probs=189.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|.++.+|+.||+|.+.. ....+.+|+++++ .+.||||+++++++.+++..+++|||+. ++.+..+..
T Consensus 16 ~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv~e~~~-~~~l~~~~~~ 93 (288)
T cd07833 16 VVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLR-QLRHENIVNLKEAFRRKGRLYLVFEYVE-RTLLELLEAS 93 (288)
T ss_pred eEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHH-hcCCCCeeehhheEEECCEEEEEEecCC-CCHHHHHHhc
Confidence 689999999999999998865 2457889999999 7789999999999999999999999999 776665443
Q ss_pred -----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCCC
Q psy6377 78 -----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVAP 150 (383)
Q Consensus 78 -----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~aP 150 (383)
...+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....... ......+++.|+||
T Consensus 94 ~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~P 170 (288)
T cd07833 94 PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES---GVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEEeeecccccCCCccccccCcccccCCcCC
Confidence 23345666999999999999999999999999999865 689999999988765443 33456789999999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------------
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------- 202 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------- 202 (383)
|++.+. .++.++|+||+|+++|+|++|.+||.+.+..+....+......+++
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T cd07833 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLE 250 (288)
T ss_pred chhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHH
Confidence 999877 8899999999999999999999999877665544433221111110
Q ss_pred -chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 -ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.+...++.++.+||++||..+|++|||++++++||||
T Consensus 251 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 251 RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0112348899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=300.27 Aligned_cols=233 Identities=24% Similarity=0.441 Sum_probs=196.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|.+..+|+.||+|.+.. ....+.+|+.+++ .++||||++++++|..++..|+++|+++ +++|..++..
T Consensus 36 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~ 113 (297)
T cd06659 36 IVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-DYQHQNVVEMYKSYLVGEELWVLMEFLQ-GGALTDIVSQTR 113 (297)
T ss_pred eEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHH-hCCCCchhhhhhheeeCCeEEEEEecCC-CCCHHHHHhhcC
Confidence 589999999999999999865 3456889999998 7789999999999999999999999999 9999987643
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~ 154 (383)
..++.+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....... ......|++.|+|||++.
T Consensus 114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (297)
T cd06659 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---CcEEEeechhHhhcccccccccceecCccccCHHHHc
Confidence 3345667999999999999999999999999999765 689999999987543322 233467899999999998
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..++.++|+||+||++|+|++|..||...+..+....+...... ....+..++..+.++|.+||..+|.+|||+.+++
T Consensus 191 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 888999999999999999999999999887776666655433222 2223456789999999999999999999999999
Q ss_pred cCcccCCcc
Q psy6377 235 KHPWLMNKK 243 (383)
Q Consensus 235 ~hp~~~~~~ 243 (383)
+||||....
T Consensus 270 ~~~~~~~~~ 278 (297)
T cd06659 270 DHPFLLQTG 278 (297)
T ss_pred hChhhccCC
Confidence 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=292.43 Aligned_cols=232 Identities=24% Similarity=0.339 Sum_probs=189.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCC----------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLESN----------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~----------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.+.+..+|+.||+|.+... ...+.+|+.+++ .++||||+++++++.+.+..++|+|++. |++|.+
T Consensus 15 ~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~v~e~~~-~~~L~~ 92 (268)
T cd06630 15 SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA-RLNHPHIIRMLGATCEDSHFNLFVEWMA-GGSVSH 92 (268)
T ss_pred EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHH-HcCCCceehhhceeccCCeEEEEEeccC-CCcHHH
Confidence 6899999999999999999751 246788999999 6799999999999999999999999999 999998
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----ccccccC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELLG 143 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~g 143 (383)
++.. ..+..+..|++.||.|||++|++|+||+|+||+++.++ ..++|+|||++....... ......|
T Consensus 93 ~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 170 (268)
T cd06630 93 LLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAKGTGAGEFQGQLLG 170 (268)
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccccccCCcccccccc
Confidence 7644 23356669999999999999999999999999997542 369999999987654321 1123468
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-cCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-QLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+... ....+......+++++.+++.+||..
T Consensus 171 ~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 250 (268)
T cd06630 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLEL 250 (268)
T ss_pred ccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCC
Confidence 89999999998888999999999999999999999999765543333322211 11122233346789999999999999
Q ss_pred CCCCCCCHHHHHcCcccC
Q psy6377 223 NPMERMTAKEALKHPWLM 240 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~ 240 (383)
+|.+|||+.++++||||.
T Consensus 251 ~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 251 QPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CcccCcCHHHHhcCcccC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=296.49 Aligned_cols=230 Identities=24% Similarity=0.355 Sum_probs=188.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|.++.+|+.||+|.+.+ ....+.+|+++++ ..+||||+++++++.++...|+|+||+. ++.|..+..
T Consensus 16 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~ 93 (286)
T cd07846 16 MVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLK-QLRHENLVNLIEVFRRKKRLYLVFEFVD-HTVLDDLEKY 93 (286)
T ss_pred EEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHH-hcCCcchhhHHHhcccCCeEEEEEecCC-ccHHHHHHhc
Confidence 589999999999999999875 1345778999999 7799999999999999999999999999 888887643
Q ss_pred -----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 78 -----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 78 -----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
...++.+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||
T Consensus 94 ~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 170 (286)
T cd07846 94 PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170 (286)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CcEEEEeeeeeeeccCCccccCcccceeeccCcH
Confidence 33445666899999999999999999999999999765 689999999988754332 234456889999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------Cc--------c
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------------------PD--------E 203 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------~~--------~ 203 (383)
++.+ ..++.++||||||+++|+|++|.+||.+....+....+......+ +. .
T Consensus 171 ~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd07846 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEK 250 (286)
T ss_pred HhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHH
Confidence 9865 457889999999999999999999998777655444433211111 00 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.++.++..+.+|+.+||..+|++|||+.++++||||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 251 RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=294.33 Aligned_cols=226 Identities=29% Similarity=0.426 Sum_probs=192.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++.++++...++|+|++. |++|.+.+.
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 92 (258)
T cd05578 15 KVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ-ELNHPFLVNLWYSFQDEENMYLVVDLLL-GGDLRYHLS 92 (258)
T ss_pred eEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHH-hCCCCChHHHHHhhcCCCeEEEEEeCCC-CCCHHHHHH
Confidence 689999999999999999975 2357888999999 7799999999999999999999999999 999998765
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .+..+..|++.||.|||++|++|+||+|+||+++++ +.++|+|||++.............|+..|+|||
T Consensus 93 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE 169 (258)
T cd05578 93 QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169 (258)
T ss_pred hcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---CCEEEeecccccccCCCccccccCCChhhcCHH
Confidence 43 345667999999999999999999999999999865 689999999998765554445567899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
++....++.++|+||+|+++|+|++|..||...+. ............. ....++..+.++|.+||..||.+||
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~ 245 (258)
T cd05578 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTEAIDAINKLLERDPQKRL 245 (258)
T ss_pred HHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHHHHHHHHHHccCChhHcC
Confidence 99888899999999999999999999999988774 3333222222222 3345789999999999999999999
Q ss_pred CH--HHHHcCccc
Q psy6377 229 TA--KEALKHPWL 239 (383)
Q Consensus 229 t~--~e~L~hp~~ 239 (383)
++ .|+++||||
T Consensus 246 ~~~~~~l~~~~~~ 258 (258)
T cd05578 246 GDNLKDLKNHPYF 258 (258)
T ss_pred CccHHHHhcCCCC
Confidence 99 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=293.99 Aligned_cols=230 Identities=29% Similarity=0.447 Sum_probs=189.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|.++.+|+.+|+|.+... ...+.+|+.+++ ...||||+++++++.+++..++++|++. +++|.+++..
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 92 (265)
T cd06605 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH-KCNSPYIVGFYGAFYNNGDISICMEYMD-GGSLDKILKE 92 (265)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHH-HCCCCchhhhheeeecCCEEEEEEEecC-CCcHHHHHHH
Confidence 36899999999999999998762 346789999998 5679999999999999999999999999 9999997754
Q ss_pred C-------CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 79 N-------LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 79 ~-------~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
. .+..+..|++.||+|||+ .|++|+||+|+||+++.+ +.++|+|||.+........ ....+++.|+||
T Consensus 93 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~---~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~P 168 (265)
T cd06605 93 VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR---GQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAP 168 (265)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC---CCEEEeecccchhhHHHHh-hcccCChhccCH
Confidence 3 234566999999999999 999999999999999875 6899999999876543222 226789999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCCCcchhc-CCCHHHHHHHHHhcccCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET-----DSETFRNISKAQLDFPDELFE-DISPEAKDFIAKILIKNP 224 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP 224 (383)
|.+.+..++.++|+||+|+++|+|++|..||.... ..+....+.... . +.... .++.++.++|.+||..||
T Consensus 169 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li~~~l~~~p 245 (265)
T cd06605 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--P-PRLPSGKFSPDFQDFVNLCLIKDP 245 (265)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--C-CCCChhhcCHHHHHHHHHHcCCCc
Confidence 99998899999999999999999999999997652 223333333221 1 11112 278999999999999999
Q ss_pred CCCCCHHHHHcCcccCCc
Q psy6377 225 MERMTAKEALKHPWLMNK 242 (383)
Q Consensus 225 ~~Rpt~~e~L~hp~~~~~ 242 (383)
++|||+.+++.||||+..
T Consensus 246 ~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 246 RERPSYKELLEHPFIKKY 263 (265)
T ss_pred hhCcCHHHHhhCchhhcc
Confidence 999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.43 Aligned_cols=230 Identities=26% Similarity=0.395 Sum_probs=191.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|....+|..+|+|++.. ....+.+|+.+++ .+.||||+++++.+.+++..|+++|++. |++|.+.+...
T Consensus 16 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv~e~~~-~~~l~~~~~~~ 93 (267)
T cd06610 16 VVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS-QCNHPNVVKYYTSFVVGDELWLVMPYLS-GGSLLDIMKSS 93 (267)
T ss_pred EEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHH-hcCCCCEEEEEEEEeeCCEEEEEEeccC-CCcHHHHHHHh
Confidence 689999999999999999875 2356889999998 7799999999999999999999999999 99999876432
Q ss_pred ---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc-----ccccCCC
Q psy6377 80 ---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-----RELLGTP 145 (383)
Q Consensus 80 ---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~-----~~~~gt~ 145 (383)
.+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++......... ....|++
T Consensus 94 ~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (267)
T cd06610 94 YPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170 (267)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccchHHHhccCccccccccccccCCh
Confidence 234566999999999999999999999999999865 58999999998765443221 3346899
Q ss_pred CcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--hhcCCCHHHHHHHHHhccc
Q psy6377 146 DYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE--LFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 146 ~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~ 222 (383)
.|+|||++... .++.++|+|||||++|+|++|..||...+..+.+..+.......... .+..+++.+.+++.+||..
T Consensus 171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (267)
T cd06610 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQK 250 (267)
T ss_pred hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCC
Confidence 99999998766 78999999999999999999999998877666555554432211111 1246789999999999999
Q ss_pred CCCCCCCHHHHHcCccc
Q psy6377 223 NPMERMTAKEALKHPWL 239 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~ 239 (383)
||++|||+.++++||||
T Consensus 251 ~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 251 DPSKRPTAEELLKHKFF 267 (267)
T ss_pred ChhhCcCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=292.05 Aligned_cols=230 Identities=26% Similarity=0.330 Sum_probs=185.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
.||++++..++..||+|.+.. ....+.+|+.+++ .++||||+++++++.+++..++++|+++ +++|.+.+...
T Consensus 23 ~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~ 100 (268)
T cd06624 23 IVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS-YLKHRNIVQYLGSDSENGFFKIFMEQVP-GGSLSALLRSKW 100 (268)
T ss_pred EEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHH-hcCCCCeeeeeeeeccCCEEEEEEecCC-CCCHHHHHHHhc
Confidence 589999999999999998876 3456889999999 7799999999999999999999999999 99999976432
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
.+..+..|++.||+|||++||+||||||+||+++.+. +.++|+|||++........ .....|++.|+||
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 178 (268)
T cd06624 101 GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178 (268)
T ss_pred ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CeEEEecchhheecccCCCccccCCCCccccCh
Confidence 1234568999999999999999999999999997532 5899999999876543222 3335689999999
Q ss_pred cccccC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 151 EILHYE--PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 151 E~l~~~--~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|.+... .++.++|+||+|+++|+|++|.+||............. ......+.....+++++.+|+.+||..+|.+||
T Consensus 179 E~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 257 (268)
T cd06624 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRA 257 (268)
T ss_pred hhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCCCcccCHHHHHHHHHHcCCCchhCC
Confidence 998654 37899999999999999999999997654322211111 111111223346789999999999999999999
Q ss_pred CHHHHHcCccc
Q psy6377 229 TAKEALKHPWL 239 (383)
Q Consensus 229 t~~e~L~hp~~ 239 (383)
|+.+++.||||
T Consensus 258 t~~~ll~~~~~ 268 (268)
T cd06624 258 SAHDLLQDPFL 268 (268)
T ss_pred CHHHHHhCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.99 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHh--cCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSL--CSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~--~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||++.+..+|+.+|+|.+.+. .....+|..+++. ...||||+.+++++.+++..++||||++ |++|.+.
T Consensus 9 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 87 (279)
T cd05633 9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN-GGDLHYH 87 (279)
T ss_pred EEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC-CCCHHHH
Confidence 6999999999999999998751 1223455544442 3479999999999999999999999999 9999886
Q ss_pred hcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
+.. ..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++...... ......||+.|+|
T Consensus 88 i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~a 163 (279)
T cd05633 88 LSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-KPHASVGTHGYMA 163 (279)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---CCEEEccCCcceecccc-CccCcCCCcCccC
Confidence 543 3345667999999999999999999999999999765 58999999998765432 2234579999999
Q ss_pred Ccccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 150 PEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 150 PE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
||.+. +..++.++|+||+||++|+|++|..||.+...... ..+.......+......++.++.++|.+||..||.+||
T Consensus 164 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 242 (279)
T cd05633 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242 (279)
T ss_pred HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhc
Confidence 99986 46689999999999999999999999976543221 11222222233334456899999999999999999999
Q ss_pred -----CHHHHHcCcccCCcc
Q psy6377 229 -----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 -----t~~e~L~hp~~~~~~ 243 (383)
|+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 243 GCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCCCCCHHHHHhCccccCCC
Confidence 699999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=291.37 Aligned_cols=231 Identities=32% Similarity=0.579 Sum_probs=197.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.+|+|++... ...+.+|+.+++ ..+||||+++++.+.++...|+++|++. +++|.+++.
T Consensus 8 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 85 (265)
T cd05579 8 RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS-QAQSPYVVKLYYSFQGKKNLYLVMEYLP-GGDLASLLE 85 (265)
T ss_pred EEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHH-hCCCcchhHHHHheecCcEEEEEEecCC-CCcHHHHHH
Confidence 6999999999999999998762 346888999998 6689999999999999999999999999 899988764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---------cccccc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---------EIRELL 142 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---------~~~~~~ 142 (383)
. ..+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....... ......
T Consensus 86 ~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 162 (265)
T cd05579 86 NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162 (265)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccccccccccccCcc
Confidence 4 2344567999999999999999999999999999876 689999999988654331 122346
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+++.|+|||.+....++.++|+||||+++|+|++|..||......+....+..+...++... .++..+.+|+.+||..
T Consensus 163 ~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~ 240 (265)
T cd05579 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKLLVP 240 (265)
T ss_pred cCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccc--cCCHHHHHHHHHHhcC
Confidence 88899999999888889999999999999999999999998888888877776665555432 3589999999999999
Q ss_pred CCCCCCCH---HHHHcCcccCCc
Q psy6377 223 NPMERMTA---KEALKHPWLMNK 242 (383)
Q Consensus 223 dP~~Rpt~---~e~L~hp~~~~~ 242 (383)
+|.+|||+ .++|+||||...
T Consensus 241 ~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 241 DPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CHhhcCCCccHHHHhcCccccCC
Confidence 99999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=295.89 Aligned_cols=234 Identities=24% Similarity=0.426 Sum_probs=196.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||++.+..+|+.+|+|.+.. ....+.+|+.+++ ..+||||+++++++...+..++++|++. |++|.+++..
T Consensus 33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~-~~~h~~vv~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~ 110 (285)
T cd06648 33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR-DYQHPNIVEMYSSYLVGDELWVVMEFLE-GGALTDIVTHT 110 (285)
T ss_pred eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHH-HcCCCChheEEEEEEcCCeEEEEEeccC-CCCHHHHHHhC
Confidence 4689999999999999998864 2345788999998 7799999999999999999999999999 9999997644
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....... ......|++.|+|||.+
T Consensus 111 ~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (285)
T cd06648 111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC---CcEEEcccccchhhccCCcccccccCCccccCHHHh
Confidence 2334567999999999999999999999999999765 689999999887543322 12335689999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+||+||++|+|++|..||.+.+..+....+........ .....++..+.+|+.+||..+|++|||+.++
T Consensus 188 ~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 188 SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 888899999999999999999999999988777666666655432221 1223478999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
++|||+....
T Consensus 267 l~~~~~~~~~ 276 (285)
T cd06648 267 LNHPFLAKAG 276 (285)
T ss_pred ccCcccccCC
Confidence 9999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=304.83 Aligned_cols=235 Identities=20% Similarity=0.294 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++..+|+.||+|++... .+.+.+|+.+++ .++||||++++++|..++..++++|++. +++|.+++..
T Consensus 15 ~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~~~~~~v~e~~~-~~~l~~~l~~ 92 (328)
T cd08226 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSH-FFRHPNIMTSWTVFTTGSWLWVISPFMA-YGSANSLLKT 92 (328)
T ss_pred eEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCcceEeeeEecCCceEEEEeccc-CCCHHHHHHh
Confidence 6999999999999999998751 356788888887 7889999999999999999999999999 9999987653
Q ss_pred --------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-c-------ccccc
Q psy6377 79 --------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-E-------IRELL 142 (383)
Q Consensus 79 --------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~-------~~~~~ 142 (383)
..+..++.|++.||+|||++||+||||||+|||++.+ +.++++|||.+....... . .....
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (328)
T cd08226 93 YFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169 (328)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCcccccccccccccc
Confidence 2233566999999999999999999999999999865 589999998654321110 0 01123
Q ss_pred CCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------
Q psy6377 143 GTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------- 201 (383)
Q Consensus 143 gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------- 201 (383)
++..|+|||++.+ ..++.++||||+||++|+|++|.+||.+....+....+.......|
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd08226 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSG 249 (328)
T ss_pred CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhh
Confidence 4667999999876 3478999999999999999999999988765555444332211111
Q ss_pred ------------------------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 202 ------------------------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 202 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
......++..+.+||++||..||++|||++++|+||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 250 VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0111235678999999999999999999999999999976544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.24 Aligned_cols=229 Identities=29% Similarity=0.400 Sum_probs=186.2
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|.++.+|+.+|+|.+... ...+.+|+.+++ .+.||||+++++++.+. +..|+|||++. ++|.+++
T Consensus 20 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~~ 96 (293)
T cd07843 20 VVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILL-KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE--HDLKSLM 96 (293)
T ss_pred EEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHH-hcCCCCEEEEEEEEEecCCCcEEEEehhcC--cCHHHHH
Confidence 6899999999999999999751 224678999998 66799999999999887 88999999997 4887755
Q ss_pred cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 77 DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 77 ~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
.. ..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++...... .......+++.|+
T Consensus 97 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 173 (293)
T cd07843 97 ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYR 173 (293)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CcEEEeecCceeeccCCcccccccccccccc
Confidence 33 2345677999999999999999999999999999765 68999999999876543 2334456889999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------- 202 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------- 202 (383)
|||.+.+. .++.++|+||+|+++|+|++|.+||.+.+..+....+.......++
T Consensus 174 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (293)
T cd07843 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253 (293)
T ss_pred CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhh
Confidence 99988654 4689999999999999999999999988776665554432111100
Q ss_pred -chhcC--CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 -ELFED--ISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 -~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..++. +++.+.++|++||..+|++|||+.|+|.||||
T Consensus 254 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 254 RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11122 48889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.48 Aligned_cols=230 Identities=24% Similarity=0.317 Sum_probs=184.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEE-----eCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQ-----TGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~-----~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+|+.+|+|++.. ....+.+|+.+++.+.+||||+++++++. ++...|+||||++ |++|.+++
T Consensus 33 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 111 (286)
T cd06638 33 KVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN-GGSVTDLV 111 (286)
T ss_pred EEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecC-CCCHHHHH
Confidence 589999999999999999875 23567889999985558999999999883 4567899999999 99998865
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCC
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP 145 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~ 145 (383)
.. ..+..+..|++.||.|||+.+++||||||+||+++.+ +.++|+|||++....... ......|++
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 188 (286)
T cd06638 112 KGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 188 (286)
T ss_pred HHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEEEccCCceeecccCCCccccccCCC
Confidence 31 1233466999999999999999999999999999765 579999999998764322 223457899
Q ss_pred CcCCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 146 DYVAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 146 ~y~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.|+|||++. ...++.++|+||+||++|+|++|+.||.+.........+..... ........++..+.++|.+||
T Consensus 189 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd06638 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-PTLHQPELWSNEFNDFIRKCL 267 (286)
T ss_pred cccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC-CcccCCCCcCHHHHHHHHHHc
Confidence 999999875 34578999999999999999999999987765444443322211 111112345788999999999
Q ss_pred ccCCCCCCCHHHHHcCccc
Q psy6377 221 IKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~ 239 (383)
..||++|||+.++++|+||
T Consensus 268 ~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 268 TKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCcccCCCHHHHhhcccC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=288.61 Aligned_cols=227 Identities=25% Similarity=0.392 Sum_probs=194.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||++++..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++++.+..|+|+|++. +++|.+.+..
T Consensus 15 ~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~ 92 (256)
T cd08218 15 KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS-NMKHPNIVQYQESFEENGNLYIVMDYCE-GGDLYKKINA 92 (256)
T ss_pred EEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHH-hCCCCCeeeeEeeecCCCeEEEEEecCC-CCcHHHHHHh
Confidence 588999999999999998864 2346889999999 7889999999999999999999999999 9999987643
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCC
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVA 149 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~a 149 (383)
. ....+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ .....|++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (256)
T cd08218 93 QRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169 (256)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEEeeccceeecCcchhhhhhccCCccccC
Confidence 2 235667999999999999999999999999999765 5899999999987644322 223468899999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..++.++|+|||||++|+|++|..||...+..+....+..+.... ....++.++.++|.+||..+|.+||+
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (256)
T cd08218 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNLVSQLFKRNPRDRPS 246 (256)
T ss_pred HHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHHHHHHhhCChhhCcC
Confidence 999988889999999999999999999999998888777777776555332 22467899999999999999999999
Q ss_pred HHHHHcCccc
Q psy6377 230 AKEALKHPWL 239 (383)
Q Consensus 230 ~~e~L~hp~~ 239 (383)
+.++++||||
T Consensus 247 ~~~vl~~~~~ 256 (256)
T cd08218 247 VNSILEKNFI 256 (256)
T ss_pred HHHHhhCcCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.86 Aligned_cols=230 Identities=25% Similarity=0.316 Sum_probs=181.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCC--------eEEEEEecCCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--------GAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--------~~~lv~e~~~~g 69 (383)
..||+|+++.+|+.||+|.+... ...+.+|+.+++ .+.||||+++++++.+.. ..++|||++.
T Consensus 26 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-- 102 (310)
T cd07865 26 GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-- 102 (310)
T ss_pred EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHH-hCCCCCccceEEEEecccccccCCCceEEEEEcCCC--
Confidence 36899999999999999988651 234568999998 779999999999987654 4599999997
Q ss_pred CcHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----c
Q psy6377 70 VTLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----E 137 (383)
Q Consensus 70 ~~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~ 137 (383)
++|.+.+.. ..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....... .
T Consensus 103 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~ 179 (310)
T cd07865 103 HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGLARAFSLSKNSKPNR 179 (310)
T ss_pred cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CcEEECcCCCcccccCCcccCCCC
Confidence 577765432 3345666999999999999999999999999999765 689999999998653322 1
Q ss_pred cccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc----------
Q psy6377 138 IRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE---------- 206 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---------- 206 (383)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|++||.+.+.......+......+++..++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T cd07865 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKK 259 (310)
T ss_pred ccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhh
Confidence 2234678899999987654 47889999999999999999999998887665554444322222221111
Q ss_pred ------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 207 ------------------DISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 207 ------------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+..+.+||.+||..||.+|||++++|+||||
T Consensus 260 ~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 260 MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 125678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.39 Aligned_cols=235 Identities=24% Similarity=0.378 Sum_probs=196.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
..|++++.++||...|||.+++ +..++.+.++++..+.++|+||+.+++|..+..+++.||.+. .-+..++.
T Consensus 106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs--~C~ekLlkr 183 (391)
T KOG0983|consen 106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS--TCAEKLLKR 183 (391)
T ss_pred cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH--HHHHHHHHH
Confidence 4699999999999999999988 457888899988877789999999999999999999999985 33444432
Q ss_pred ------cCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 ------DNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
+..+-.+...++.||.||-. +||+|||+||+|||++.. |.|||||||++.+..+....+...|-+.||||
T Consensus 184 ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~---GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaP 260 (391)
T KOG0983|consen 184 IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAP 260 (391)
T ss_pred hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC---CCEEeecccccceeecccccccccCCccccCc
Confidence 22222344788999999986 589999999999999865 79999999999998888777778899999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|.+. ...|+.++||||||+.++||.||+.||.+. ++.+.+..+.+...+.- ..-...|+.+.+|+..||++|+.+
T Consensus 261 ERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L-~~~~gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 261 ERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL-PGHMGFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred cccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC-CcccCcCHHHHHHHHHHhhcCccc
Confidence 9985 346999999999999999999999999884 45677777776433211 122348999999999999999999
Q ss_pred CCCHHHHHcCcccCCcch
Q psy6377 227 RMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~~ 244 (383)
||...++|+|||+.....
T Consensus 340 RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 340 RPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CcchHHHhcCcceeecch
Confidence 999999999999987654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=289.09 Aligned_cols=228 Identities=21% Similarity=0.341 Sum_probs=193.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|.+..+|+.||+|.+.. ....+.+|+.+++ .+.||||+++++++.. +...|++||+++ +++|.++
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~-~~~L~~~ 91 (265)
T cd08217 14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR-ELKHPNIVRYYDRIIDRSNQTLYIVMEYCE-GGDLAQL 91 (265)
T ss_pred eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHH-hcCCCccceeeeeeecCCCCEEEEEehhcc-CCCHHHH
Confidence 3789999999999999999864 2346778999998 7889999999998764 456899999999 9999987
Q ss_pred hcc----------CCchhhHHHHHHHHHHHH-----hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cc
Q psy6377 76 IDD----------NLVVPFESDELSSLAYLH-----HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IR 139 (383)
Q Consensus 76 l~~----------~~~~~~~~qil~aL~yLH-----s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~ 139 (383)
+.. ..++.+..|++.||.||| +.+++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus 92 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~---~~~kl~d~g~~~~~~~~~~~~~ 168 (265)
T cd08217 92 IQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFGLAKILGHDSSFAK 168 (265)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---CCEEEecccccccccCCccccc
Confidence 643 234566799999999999 9999999999999999865 6899999999987654433 34
Q ss_pred cccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 140 ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
...|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+..+... .....++..+.+++.+|
T Consensus 169 ~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~ 245 (265)
T cd08217 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPYRYSSELNEVIKSM 245 (265)
T ss_pred ccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCccccCHHHHHHHHHH
Confidence 567899999999998888999999999999999999999999988866666666655432 22346789999999999
Q ss_pred cccCCCCCCCHHHHHcCccc
Q psy6377 220 LIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~ 239 (383)
|..+|++|||+.++++|||+
T Consensus 246 l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 246 LNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.71 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=186.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|.+..+|+.+|+|++.. ....+.+|+.+++.+.+||||+++++++... ...|+||||+. |++|.+++
T Consensus 37 ~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~-~~sL~~~~ 115 (291)
T cd06639 37 KVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN-GGSVTELV 115 (291)
T ss_pred EEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC-CCcHHHHH
Confidence 689999999999999999875 2356778999998666899999999998754 35899999999 99998865
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCC
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTP 145 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~ 145 (383)
.. ..++.+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....|++
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 192 (291)
T cd06639 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 192 (291)
T ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEeecccchhcccccccccCccCCc
Confidence 31 2234566899999999999999999999999999765 5799999999886543221 23456889
Q ss_pred CcCCCcccccC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 146 DYVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 146 ~y~aPE~l~~~-----~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.|+|||++... .++.++|+||+||++|+|++|++||......+....+....... -.....++..+.+||.+||
T Consensus 193 ~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 271 (291)
T cd06639 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT-LLHPEKWCRSFNHFISQCL 271 (291)
T ss_pred cccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC-CCcccccCHHHHHHHHHHh
Confidence 99999998543 36889999999999999999999998877655555554332211 1112346788999999999
Q ss_pred ccCCCCCCCHHHHHcCcccC
Q psy6377 221 IKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~ 240 (383)
..+|++||++.+++.||||+
T Consensus 272 ~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 272 IKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred hcChhhCcCHHHHhcCcccC
Confidence 99999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.34 Aligned_cols=231 Identities=28% Similarity=0.384 Sum_probs=194.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||.|.+..+++.||+|++... ...+.+|+.+++ .+.||||+++++++.++...|+|||+++ |++|.+++...
T Consensus 19 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~i~~~ 96 (277)
T cd06640 19 EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKGTKLWIIMEYLG-GGSALDLLRAG 96 (277)
T ss_pred EEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEEEEEecCC-CCcHHHHHhcC
Confidence 6899999999999999998752 346788999998 7789999999999999999999999999 99999976543
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l 153 (383)
.+..+..|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++........ .....++..|+|||++
T Consensus 97 ~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~ 173 (277)
T cd06640 97 PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---CCEEEcccccceeccCCccccccccCcccccCHhHh
Confidence 234556899999999999999999999999999865 5899999999987644322 2334688899999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+|||||++|+|++|.+||.+.........+.... ++.....++..+.+++.+||..+|++|||+.++
T Consensus 174 ~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 88889999999999999999999999998877665554443222 233445678899999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
+.|||+....
T Consensus 251 l~~~~~~~~~ 260 (277)
T cd06640 251 LKHKFIVKNA 260 (277)
T ss_pred HhChHhhhcc
Confidence 9999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=296.04 Aligned_cols=231 Identities=28% Similarity=0.370 Sum_probs=192.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||++.+..+|+.||+|.+... ...+.+|+.+++ .++||||+++++++.+++..|+||||++ +++|.+++..
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 95 (277)
T cd06642 18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLS-QCDSPYITRYYGSYLKGTKLWIIMEYLG-GGSALDLLKP 95 (277)
T ss_pred eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHH-cCCCCccHhhhcccccCCceEEEEEccC-CCcHHHHhhc
Confidence 36899999999999999998751 246889999998 7789999999999999999999999999 9999987643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCcc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEI 152 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~ 152 (383)
..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ .....|+..|+|||.
T Consensus 96 ~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 172 (277)
T cd06642 96 GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---CCEEEccccccccccCcchhhhcccCcccccCHHH
Confidence 2344566999999999999999999999999999765 5899999999876543221 223468889999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+..++.++|+|||||++|+|++|..||...........+.... ++.....++.++.++|.+||..+|++|||+.+
T Consensus 173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred hCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 998889999999999999999999999998766555544433222 22223457889999999999999999999999
Q ss_pred HHcCcccCCc
Q psy6377 233 ALKHPWLMNK 242 (383)
Q Consensus 233 ~L~hp~~~~~ 242 (383)
++.|||+...
T Consensus 250 il~~~~~~~~ 259 (277)
T cd06642 250 LLKHKFITRY 259 (277)
T ss_pred HHHhHHHHHH
Confidence 9999998654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=294.83 Aligned_cols=231 Identities=25% Similarity=0.419 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
.||+++++.+|+.||+|.+... ...+..|+.++.+..+||||+++++++..++..|++|||++ ++|.+++.
T Consensus 16 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~ 93 (283)
T cd06617 16 VVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD--TSLDKFYKKV 93 (283)
T ss_pred EEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc--ccHHHHHHHh
Confidence 6899999999999999998762 34566777765558899999999999999999999999997 66666442
Q ss_pred --------cCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 78 --------DNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 78 --------~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
+..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++.............|+..|+
T Consensus 94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~ 170 (283)
T cd06617 94 YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN---GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170 (283)
T ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeecccccccccccccccccCCcccc
Confidence 233456679999999999998 99999999999999765 689999999998764433333356889999
Q ss_pred CCccccc----CCCChhhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhcc-CCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 149 APEILHY----EPITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQ-LDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 149 aPE~l~~----~~~~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|||.+.+ ..++.++|+||+||++|+|++|+.||... ...+....+.... ...+ ...+|.++.+||.+||..
T Consensus 171 aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~ 247 (283)
T cd06617 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AEKFSPEFQDFVNKCLKK 247 (283)
T ss_pred ChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccC
Confidence 9998864 55789999999999999999999999653 2333333333221 2222 134789999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCcc
Q psy6377 223 NPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+|.+|||+++++.||||....
T Consensus 248 ~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 248 NYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ChhhCcCHHHHhcCchhhhcc
Confidence 999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.40 Aligned_cols=228 Identities=24% Similarity=0.363 Sum_probs=188.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC----------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLESN----------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~----------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||++.. .+|+.+|+|.+... ...+.+|+.+++ ..+||||+++++++.+.+..++++|+++ |++|.+
T Consensus 15 ~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 91 (265)
T cd06631 15 TVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK-SLKHVNIVQYLGTCLDDNTISIFMEFVP-GGSISS 91 (265)
T ss_pred EEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHH-hcCCCCEeeEeeEeecCCeEEEEEecCC-CCcHHH
Confidence 6888876 58999999988641 245788999999 7789999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-------Ccccccc
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-------GIEIREL 141 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-------~~~~~~~ 141 (383)
++.. ..+..+..|++.||+|||+.||+|+||+|+||+++++ +.++|+|||++..... .......
T Consensus 92 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 168 (265)
T cd06631 92 ILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168 (265)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC---CeEEeccchhhHhhhhcccccccccccccc
Confidence 7644 2334566999999999999999999999999999765 6899999999875421 1122345
Q ss_pred cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....... +.....++.++.+||.+||.
T Consensus 169 ~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06631 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSFSAAAIDFVTSCLT 247 (265)
T ss_pred CCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCCCHHHHHHHHHHhc
Confidence 68999999999998889999999999999999999999998766555444443332222 22335679999999999999
Q ss_pred cCCCCCCCHHHHHcCccc
Q psy6377 222 KNPMERMTAKEALKHPWL 239 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~hp~~ 239 (383)
.+|++|||+.+++.||||
T Consensus 248 ~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 248 RDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.22 Aligned_cols=240 Identities=27% Similarity=0.382 Sum_probs=191.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||++++++|.. ....|+||||+. ++|.+
T Consensus 20 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~ 96 (334)
T cd07855 20 VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR-HFKHDNIIAIRDILRPPGADFKDVYVVMDLME--SDLHH 96 (334)
T ss_pred EEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHH-hcCCCCccCHHHhccccCCCCceEEEEEehhh--hhHHH
Confidence 589999999999999999876 2345778999999 7789999999999863 356899999996 57888
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cccccC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLG 143 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~g 143 (383)
.+.. ..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++........ .....|
T Consensus 97 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 173 (334)
T cd07855 97 IIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED---CELRIGDFGMARGLSSSPTEHKYFMTEYVA 173 (334)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEecccccceeecccCcCCCcccccccc
Confidence 6643 2345666999999999999999999999999999865 6899999999986543221 234578
Q ss_pred CCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------------------
Q psy6377 144 TPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--------------------- 201 (383)
Q Consensus 144 t~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 201 (383)
+..|+|||.+.+ ..++.++|+||+||++|+|++|++||.+.+....+..+.......+
T Consensus 174 ~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 253 (334)
T cd07855 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPR 253 (334)
T ss_pred cccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhccc
Confidence 999999999865 4588999999999999999999999988766554433332111111
Q ss_pred ------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcccC
Q psy6377 202 ------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVG 250 (383)
Q Consensus 202 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~~ 250 (383)
....+..+.++.++|.+||..+|.+|||+++++.||||.........+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~ 308 (334)
T cd07855 254 KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT 308 (334)
T ss_pred CCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence 1123457899999999999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.60 Aligned_cols=229 Identities=28% Similarity=0.439 Sum_probs=186.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|++..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++.+.+.+..++|||++. + +|.+++..
T Consensus 15 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~ 91 (284)
T cd07836 15 TVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMK-ELKHENIVRLHDVIHTENKLMLVFEYMD-K-DLKKYMDTH 91 (284)
T ss_pred EEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHH-hhcCCCEeeeeeeEeeCCcEEEEEecCC-c-cHHHHHHhc
Confidence 689999999999999999876 2356778999999 6689999999999999999999999998 4 77775432
Q ss_pred --------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCC
Q psy6377 79 --------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVA 149 (383)
Q Consensus 79 --------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~a 149 (383)
..+..+..|++.||.|||+.|++||||+|+||+++++ +.++|+|||++....... ......+++.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~ 168 (284)
T cd07836 92 GVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIPVNTFSNEVVTLWYRA 168 (284)
T ss_pred CCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CcEEEeecchhhhhcCCccccccccccccccC
Confidence 2334566999999999999999999999999999765 689999999987653321 2234567899999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------c
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-------------------------E 203 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~ 203 (383)
||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+....+......... .
T Consensus 169 PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (284)
T cd07836 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQ 248 (284)
T ss_pred hHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHH
Confidence 998865 45789999999999999999999999988776665554432111100 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 249 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 249 LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=291.61 Aligned_cols=229 Identities=27% Similarity=0.419 Sum_probs=186.2
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|.++.+|+.||+|++... ...+.+|+.+++ ..+||||+++++++.+++..|++|||+. ++|.+++..
T Consensus 14 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~iv~~~~~~~~~~~~~iv~e~~~--~~l~~~~~~ 90 (283)
T cd07835 14 VVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLK-ELNHPNIVRLLDVVHSENKLYLVFEFLD--LDLKKYMDS 90 (283)
T ss_pred EEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHH-hcCCCCccCHhheeccCCeEEEEEeccC--cCHHHHHhh
Confidence 6899999999999999998752 245788999999 7789999999999999999999999996 578886543
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCC
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVA 149 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~a 149 (383)
. .+..+..|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....... ......+++.|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~a 167 (283)
T cd07835 91 SPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE---GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167 (283)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CcEEEeecccccccCCCccccCccccccCCCC
Confidence 2 234566999999999999999999999999999874 689999999987653222 2233467889999
Q ss_pred CcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------------Ccc
Q psy6377 150 PEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------------------------PDE 203 (383)
Q Consensus 150 PE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~ 203 (383)
||++.+. .++.++|+||||+++|+|++|.+||.+.+.......+......+ ...
T Consensus 168 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd07835 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSK 247 (283)
T ss_pred CceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhh
Confidence 9987654 57899999999999999999999998877655444443321111 112
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+.++..+.++|.+||..+|.+|||+++++.||||
T Consensus 248 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 248 VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 235678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.97 Aligned_cols=236 Identities=32% Similarity=0.445 Sum_probs=197.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-----eEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L~ 73 (383)
.||+|++..+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.. ..|++|+++. ++|.
T Consensus 15 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~ 91 (330)
T cd07834 15 VVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR-HLRHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLH 91 (330)
T ss_pred EEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHH-hcCCcchhhhhhhhcccCcccccceEEEecchh--hhHH
Confidence 689999999999999998876 2457889999999 778999999999998875 7899999997 5788
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----ccccccC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI----EIRELLG 143 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~----~~~~~~g 143 (383)
+.+... .+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... ......+
T Consensus 92 ~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---~~~~L~dfg~~~~~~~~~~~~~~~~~~~~ 168 (330)
T cd07834 92 KVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---CDLKICDFGLARGVDPDEDEKGFLTEYVV 168 (330)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccCceEeeccccccccccccccc
Confidence 866543 344567999999999999999999999999999876 689999999999865543 2445678
Q ss_pred CCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------
Q psy6377 144 TPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE------------------- 203 (383)
Q Consensus 144 t~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------- 203 (383)
++.|+|||++.+. .++.++|+||+|+++|+|++|.+||.+.+..+.+..+......++..
T Consensus 169 ~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (330)
T cd07834 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPK 248 (330)
T ss_pred ccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhccc
Confidence 9999999999877 78999999999999999999999999988777766665533222211
Q ss_pred --------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 204 --------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 204 --------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
....++..+.+||.+||.++|++|||+++++.||||+......
T Consensus 249 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 249 KPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred CCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 1234688999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=300.49 Aligned_cols=236 Identities=28% Similarity=0.410 Sum_probs=186.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-----eEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L~ 73 (383)
..||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.... ..|+++|++. ++|.
T Consensus 19 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~ 95 (336)
T cd07849 19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILR-RFKHENIIGILDIIRPPSFESFNDVYIVQELME--TDLY 95 (336)
T ss_pred eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHH-hCCCCCcCchhheeecccccccceEEEEehhcc--cCHH
Confidence 3689999999999999999864 2345778999999 778999999999876543 5899999997 5787
Q ss_pred Hhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCC
Q psy6377 74 TIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGT 144 (383)
Q Consensus 74 ~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt 144 (383)
..+.. ..+..++.|++.||.|||+.||+||||||+|||++.+ +.++|+|||++........ .....||
T Consensus 96 ~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 172 (336)
T cd07849 96 KLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTEYVAT 172 (336)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---CCEEECcccceeeccccccccCCcCCcCcC
Confidence 76543 3345667999999999999999999999999999765 6899999999987543221 2335789
Q ss_pred CCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Q psy6377 145 PDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP---------------------- 201 (383)
Q Consensus 145 ~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 201 (383)
+.|+|||.+.+ ..++.++|+||+||++|+|++|++||.+.+.......+.......+
T Consensus 173 ~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T cd07849 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK 252 (336)
T ss_pred CCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcC
Confidence 99999998654 5689999999999999999999999987665443333221111000
Q ss_pred -----cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 202 -----DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 202 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
....+.++.++.+||.+||..+|++|||+.++++||||......
T Consensus 253 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 253 PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred CcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 01124568899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=288.94 Aligned_cols=228 Identities=25% Similarity=0.362 Sum_probs=185.2
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~ 73 (383)
.||+|.+..+|..||+|.+... ...+.+|+.+++ .++||||+++++++.+. ...++++|+++ +++|.
T Consensus 17 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~-~~~L~ 94 (266)
T cd06651 17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK-NLQHERIVQYYGCLRDRAEKTLTIFMEYMP-GGSVK 94 (266)
T ss_pred EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHH-HcCCCCeeeEEEEEEcCCCCEEEEEEeCCC-CCcHH
Confidence 6899999999999999988641 235778999999 67899999999998763 57889999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC----cccccccC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----IEIRELLG 143 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----~~~~~~~g 143 (383)
+.+... ..+.+..|++.||+|||++||+||||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 95 ~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (266)
T cd06651 95 DQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMSGTGIRSVTG 171 (266)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCCCccccccccccCCccccCCc
Confidence 876432 334567999999999999999999999999999765 58999999998764321 11233568
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+..|+|||.+.+..++.++|+||+||++|+|++|++||...........+..... .+.....+++.++++| +||..+
T Consensus 172 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li-~~~~~~ 248 (266)
T cd06651 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHISEHARDFL-GCIFVE 248 (266)
T ss_pred cccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcCHHHHHHH-HHhcCC
Confidence 8999999999988899999999999999999999999987765555444332221 2223345788999999 577789
Q ss_pred CCCCCCHHHHHcCcccC
Q psy6377 224 PMERMTAKEALKHPWLM 240 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~ 240 (383)
|++|||++|+++||||+
T Consensus 249 p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 249 ARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhhCcCHHHHhcCcccc
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=285.37 Aligned_cols=228 Identities=29% Similarity=0.443 Sum_probs=190.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|....+|+.||+|.+... ...+.+|+.+++ ..+||||+++++++.++...|+++||++ +++|.++
T Consensus 15 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 92 (258)
T cd06632 15 SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS-KLQHPNIVQYLGTEREEDNLYIFLELVP-GGSLAKL 92 (258)
T ss_pred eEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHH-hcCCCCchheeeeEecCCeEEEEEEecC-CCcHHHH
Confidence 7899999999999999988651 245788999998 6799999999999999999999999999 9999987
Q ss_pred hccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 76 IDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 76 l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
+... .+..+..|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++.............|++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~---~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~ 169 (258)
T cd06632 93 LKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169 (258)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccceeccccccccccCCCcceeC
Confidence 6432 234566899999999999999999999999999765 6899999999887654443455678999999
Q ss_pred CcccccCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 150 PEILHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 150 PE~l~~~~-~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
||.+.... ++.++|+||+||++|+|++|.+||...........+.... . .+.....+++.+.+|+.+||..+|++||
T Consensus 170 pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp 247 (258)
T cd06632 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-E-LPPIPDHLSDEAKDFILKCLQRDPSLRP 247 (258)
T ss_pred HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-c-CCCcCCCcCHHHHHHHHHHhhcCcccCc
Confidence 99987666 8999999999999999999999998766544444433311 1 1223456789999999999999999999
Q ss_pred CHHHHHcCccc
Q psy6377 229 TAKEALKHPWL 239 (383)
Q Consensus 229 t~~e~L~hp~~ 239 (383)
|+.+++.|||+
T Consensus 248 ~~~~~l~~~~~ 258 (258)
T cd06632 248 TAAELLEHPFV 258 (258)
T ss_pred CHHHHhcCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=289.19 Aligned_cols=231 Identities=28% Similarity=0.379 Sum_probs=189.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----C---------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----N---------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g 69 (383)
..||++.+..+|+.+|+|.+.. . .+.+.+|+.+++ .++||||+++++++...+..++|||+++ +
T Consensus 15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 92 (272)
T cd06629 15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK-DLDHLNIVQYLGFETTEEYLSIFLEYVP-G 92 (272)
T ss_pred eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHH-hcCCCCcceEEEEeccCCceEEEEecCC-C
Confidence 3789999999999999998753 0 134678999998 7789999999999999999999999999 9
Q ss_pred CcHHHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---cccc
Q psy6377 70 VTLQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRE 140 (383)
Q Consensus 70 ~~L~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~ 140 (383)
++|.+.+... .+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....... ....
T Consensus 93 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~ 169 (272)
T cd06629 93 GSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD---GICKISDFGISKKSDDIYDNDQNMS 169 (272)
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC---CeEEEeecccccccccccccccccc
Confidence 9999876443 234556899999999999999999999999999765 689999999987643211 1223
Q ss_pred ccCCCCcCCCcccccCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc--cCCCCcchhcCCCHHHHHHH
Q psy6377 141 LLGTPDYVAPEILHYEP--ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA--QLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li 216 (383)
..|+..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+... ...++......++..+.++|
T Consensus 170 ~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (272)
T cd06629 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249 (272)
T ss_pred ccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHH
Confidence 46889999999987654 789999999999999999999999766555444433222 33444455567899999999
Q ss_pred HHhcccCCCCCCCHHHHHcCccc
Q psy6377 217 AKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.+||.++|++|||++++|+|||+
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 250 NACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHhcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=286.83 Aligned_cols=229 Identities=26% Similarity=0.370 Sum_probs=193.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||++..+.+|+.+|+|.+.. ....+.+|+.+++ ..+||||+++++.+.+....|+|+|+++ +++|.+.+.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 91 (257)
T cd08225 14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA-KMKHPNIVTFFASFQENGRLFIVMEYCD-GGDLMKRIN 91 (257)
T ss_pred ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHH-hCCCCChhhhhheeccCCeEEEEEecCC-CCcHHHHHH
Confidence 3799999999999999999865 3456789999999 7789999999999999999999999999 999998664
Q ss_pred c--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcC
Q psy6377 78 D--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYV 148 (383)
Q Consensus 78 ~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~ 148 (383)
. .....+..|++.||.|||+.|++|+||+|+||+++++. ..++|+|||.+........ .....|++.|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 169 (257)
T cd08225 92 RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSMELAYTCVGTPYYL 169 (257)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCcccccccCCCcccc
Confidence 3 22445668999999999999999999999999997652 3579999999887654332 23346899999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++....++.++|+||+|+++|+|++|..||.+.+..+....+...... .....++..+.++|.+||..+|++||
T Consensus 170 ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp 246 (257)
T cd08225 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLFKVSPRDRP 246 (257)
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHHHHHHhccChhhCc
Confidence 999998888999999999999999999999999887776666655544332 22245788999999999999999999
Q ss_pred CHHHHHcCccc
Q psy6377 229 TAKEALKHPWL 239 (383)
Q Consensus 229 t~~e~L~hp~~ 239 (383)
|+.++++||||
T Consensus 247 t~~~ll~~~~~ 257 (257)
T cd08225 247 SITSILKRPFL 257 (257)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=290.65 Aligned_cols=230 Identities=27% Similarity=0.374 Sum_probs=179.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-c
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII-D 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l-~ 77 (383)
..||+|.++.+|+.||+|.+... ...+.+|+.+++ .++|+||+++++++.++...|+|+|++. ++|.+.+ .
T Consensus 19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 95 (291)
T cd07870 19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTFVFEYMH--TDLAQYMIQ 95 (291)
T ss_pred EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHH-hcCCCCEeEEEEEEecCCeEEEEEeccc--CCHHHHHHh
Confidence 37899999999999999998751 235778999999 6789999999999999999999999997 4555533 2
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||.|||+.||+|+||||+|||++.+ +.++|+|||+++..... .......+++.|+||
T Consensus 96 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 172 (291)
T cd07870 96 HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172 (291)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---CcEEEeccccccccCCCCCCCCCccccccccCC
Confidence 1 2344566899999999999999999999999999765 68999999998764322 122334678999999
Q ss_pred ccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCC-----------------------Cc---
Q psy6377 151 EILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDF-----------------------PD--- 202 (383)
Q Consensus 151 E~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~-----------------------~~--- 202 (383)
|.+.+ ..++.++|+|||||++|+|++|.+||.+.... +.+..+......+ +.
T Consensus 173 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd07870 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLR 252 (291)
T ss_pred ceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchh
Confidence 99865 45789999999999999999999999765532 2222221110000 00
Q ss_pred chhc--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 ELFE--DISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 ~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+. ..+..+.+++.+||..||.+|||+.|++.||||
T Consensus 253 ~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 253 VVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0011 125689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=293.75 Aligned_cols=234 Identities=23% Similarity=0.402 Sum_probs=195.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||++..+.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++.|.+++..+++|||++ +++|.+++..
T Consensus 34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 111 (292)
T cd06657 34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEFLE-GGALTDIVTHT 111 (292)
T ss_pred eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHH-hcCCcchhheeeEEEeCCEEEEEEecCC-CCcHHHHHhcC
Confidence 3789999999999999998864 3346888999998 7889999999999999999999999999 8999987643
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++....... ......|++.|+|||.+
T Consensus 112 ~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~ 188 (292)
T cd06657 112 RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188 (292)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEcccccceecccccccccccccCccccCHHHh
Confidence 2344666999999999999999999999999999865 589999999987654322 22335689999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+||+|+++|+|++|.+||.+....+....+....... ......++..+.+++.+||..+|.+||++.++
T Consensus 189 ~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~l 267 (292)
T cd06657 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267 (292)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHH
Confidence 88888999999999999999999999998877666655544332211 11234578999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
+.||||....
T Consensus 268 l~~~~~~~~~ 277 (292)
T cd06657 268 LKHPFLAKAG 277 (292)
T ss_pred hcChHHhccC
Confidence 9999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=301.08 Aligned_cols=232 Identities=28% Similarity=0.375 Sum_probs=197.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc----
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID---- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~---- 77 (383)
.+||+|.|+.+|+.+|+|.++- +.+.+..||.|++ +.+.|++|++|+.|-....+|+|||||. .|+..+++.
T Consensus 47 GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQ-QC~S~yVVKYYGSYFK~sDLWIVMEYCG-AGSiSDI~R~R~K 124 (502)
T KOG0574|consen 47 GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQ-QCKSKYVVKYYGSYFKHSDLWIVMEYCG-AGSISDIMRARRK 124 (502)
T ss_pred hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHH-HcCCchhhhhhhhhccCCceEeehhhcC-CCcHHHHHHHhcC
Confidence 3689999999999999999987 6788999999999 7789999999999999999999999999 999999753
Q ss_pred ---cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCccc
Q psy6377 78 ---DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEIL 153 (383)
Q Consensus 78 ---~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l 153 (383)
++.+..+++..+.||+|||...-+|||||..|||++.+ |..||+|||.|....+.-. ..+..|||.|||||++
T Consensus 125 ~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~---G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 125 PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD---GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 201 (502)
T ss_pred CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---chhhhhhccccchhhhhHHhhCccccCcccccHHHH
Confidence 34455666889999999999999999999999999765 7999999999998765432 4567899999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch--hcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL--FEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
..-+|+.++||||||++..||..|++||.+.... +.|.-..-.+|+.+ .+.+|.++.+||++||.++|++|.||.
T Consensus 202 ~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 202 EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred HHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 9999999999999999999999999999765432 22222222222222 245689999999999999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
++++|||+++..
T Consensus 279 ~L~~H~FiknA~ 290 (502)
T KOG0574|consen 279 RLCEHTFIKNAP 290 (502)
T ss_pred HHhhhhhhcCCC
Confidence 999999998754
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=286.53 Aligned_cols=231 Identities=29% Similarity=0.431 Sum_probs=194.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|++..+|+.||+|.+... ...+.+|+..+. .+.||||+++++++......++++|+++ +++|.+++..
T Consensus 15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 92 (264)
T cd06623 15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLR-SCESPYVVKCYGAFYKEGEISIVLEYMD-GGSLADLLKK 92 (264)
T ss_pred eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHH-hcCCCCeeeEEEEEccCCeEEEEEEecC-CCcHHHHHHH
Confidence 36899999999999999998762 457889999998 6679999999999999999999999999 9999997653
Q ss_pred ------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc-ccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~-~~~~gt~~y~aP 150 (383)
...+.+..|++.||+|||+ .|++||||+|+||+++.+ +.++|+|||++......... ....++..|+||
T Consensus 93 ~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~p 169 (264)
T cd06623 93 VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169 (264)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC---CCEEEccCccceecccCCCcccceeecccccCH
Confidence 3345677999999999999 999999999999999765 68999999999876543332 245788999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCCCcchhcC-CCHHHHHHHHHhcccCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---DSETFRNISKAQLDFPDELFED-ISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~ 226 (383)
|.+....++.++|+||||+++|+|++|..||.... ..+....+..... ...... ++..+.++|.+||..+|++
T Consensus 170 E~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~ 246 (264)
T cd06623 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPEFRDFISACLQKDPKK 246 (264)
T ss_pred hhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHHHHHHHHHHccCChhh
Confidence 99998889999999999999999999999998774 3344444442221 122234 7899999999999999999
Q ss_pred CCCHHHHHcCcccCCc
Q psy6377 227 RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~ 242 (383)
|||+.++++|||++..
T Consensus 247 R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 247 RPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCHHHHHhCHHHHhc
Confidence 9999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=286.65 Aligned_cols=223 Identities=21% Similarity=0.283 Sum_probs=186.9
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|..+.+++.||+|++..+ ...+.+|+++++ .+.||||+++++++..+..++++||+++ +++|.+.+...
T Consensus 21 ~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~ 98 (263)
T cd05052 21 EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYIITEFMT-YGNLLDYLRECNR 98 (263)
T ss_pred eEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHH-hCCCCChhheEEEEcCCCCcEEEEEeCC-CCcHHHHHHhCCC
Confidence 5899999999999999998763 356889999999 6799999999999999999999999999 99999976432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aPE 151 (383)
.++.+..|++.||+|||++|++||||||+||+++.+ +.++|+|||++......... ....+++.|+|||
T Consensus 99 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE 175 (263)
T cd05052 99 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175 (263)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---CcEEeCCCccccccccceeeccCCCCCccccCCHH
Confidence 234556899999999999999999999999999765 68999999999875433211 1123456899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..+. +......++.++.++|.+||..+|++|||+
T Consensus 176 ~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 252 (263)
T cd05052 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKVYELMRACWQWNPSDRPSF 252 (263)
T ss_pred HhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 9998999999999999999999998 999999887777766665432 222335678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
.++++
T Consensus 253 ~~l~~ 257 (263)
T cd05052 253 AEIHQ 257 (263)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=285.65 Aligned_cols=224 Identities=22% Similarity=0.324 Sum_probs=190.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||++.++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++.+++++..|++|||++ +++|.+.+..
T Consensus 15 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~ 92 (255)
T cd08219 15 RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLA-KMKHPNIVAFKESFEADGHLYIVMEYCD-GGDLMQKIKLQ 92 (255)
T ss_pred EEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEEeeCC-CCcHHHHHHhc
Confidence 589999999999999998864 3456788999998 7799999999999999999999999999 8999886532
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
.....+..|++.||.|||++||+|+||||+||+++.+ +.++++|||++........ .....|++.|+||
T Consensus 93 ~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 169 (255)
T cd08219 93 RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169 (255)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC---CcEEEcccCcceeecccccccccccCCccccCH
Confidence 2234667999999999999999999999999999765 6899999999987643222 2345789999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++|+||+|+++|+|++|..||.+.+.......+..+..... ...++..+.+||.+||..||++|||+
T Consensus 170 E~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~ 246 (255)
T cd08219 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSLIKQMFKRNPRSRPSA 246 (255)
T ss_pred HHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHHHHHHHhCCcccCCCH
Confidence 999988899999999999999999999999998877766666655544322 24578899999999999999999999
Q ss_pred HHHHcC
Q psy6377 231 KEALKH 236 (383)
Q Consensus 231 ~e~L~h 236 (383)
.+++.-
T Consensus 247 ~~il~~ 252 (255)
T cd08219 247 TTILSR 252 (255)
T ss_pred HHHhhc
Confidence 999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=289.19 Aligned_cols=224 Identities=21% Similarity=0.270 Sum_probs=187.7
Q ss_pred eEEEEEEcCCC-----cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATG-----EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg-----~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.....+ ..||+|.+... ...+.+|+.+++ .++||||+++++++.+....|++||+++ +++|.+
T Consensus 20 ~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~e~~~-~~~L~~ 97 (283)
T cd05048 20 KVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS-DLQHPNIVCLLGVCTKEQPTCMLFEYLA-HGDLHE 97 (283)
T ss_pred cEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHH-hcCCcccceEEEEEcCCCceEEEEecCC-CCcHHH
Confidence 68888876655 78999998751 345789999998 7789999999999999999999999999 999998
Q ss_pred hhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 75 IIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 75 ~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
++... .++.+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~---~~~~L~dfg~~~~~ 174 (283)
T cd05048 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG---LTVKISDFGLSRDI 174 (283)
T ss_pred HHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC---CcEEECCCcceeec
Confidence 76432 123566999999999999999999999999999765 58999999999865
Q ss_pred ecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+....... ....+
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~ 251 (283)
T cd05048 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP---CPEDC 251 (283)
T ss_pred cccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CcccC
Confidence 33221 223456889999999988889999999999999999998 999999988888777766544322 23567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+.++.+|+.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 252 PARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=288.03 Aligned_cols=223 Identities=21% Similarity=0.304 Sum_probs=188.0
Q ss_pred eEEEEEEc-----CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+. .+++.||+|++... ...+.+|+++++ .++||||+++++++.+....+++|||++ +++|.+
T Consensus 20 ~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 97 (280)
T cd05049 20 KVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT-NFQHENIVKFYGVCTEGDPPIMVFEYME-HGDLNK 97 (280)
T ss_pred eEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHH-hcCCCCchheeeEEecCCCeEEEEecCC-CCCHHH
Confidence 68888775 44689999998761 357889999999 6789999999999999999999999999 999999
Q ss_pred hhccC--------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec
Q psy6377 75 IIDDN--------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134 (383)
Q Consensus 75 ~l~~~--------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~ 134 (383)
++... .+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 98 ~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---~~~kl~d~g~~~~~~~ 174 (280)
T cd05049 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD---LVVKIGDFGMSRDVYT 174 (280)
T ss_pred HHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC---CeEEECCcccceeccc
Confidence 76532 224456899999999999999999999999999876 6899999999986533
Q ss_pred Ccc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 135 GIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 135 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+....++ ..++.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 251 (280)
T cd05049 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRP---RTCPS 251 (280)
T ss_pred CcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCC---CCCCH
Confidence 221 123346788999999999999999999999999999998 99999988888888877765544332 46789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+.+++.+||..||++|||+.|+++
T Consensus 252 ~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 252 EVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=289.13 Aligned_cols=234 Identities=26% Similarity=0.438 Sum_probs=190.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcC--CCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCS--PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|.+..+|+.||+|.+.. ....+.+|+.+++.+. .|||++++++++.++...|++|||+. |++|.+++
T Consensus 15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 93 (277)
T cd06917 15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE-GGSVRTLM 93 (277)
T ss_pred ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC-CCcHHHHH
Confidence 3689999999999999999865 2356788999998443 49999999999999999999999999 99999876
Q ss_pred ccC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 77 DDN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
... ..+.++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .....|++.|+||
T Consensus 94 ~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 170 (277)
T cd06917 94 KAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT---GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170 (277)
T ss_pred HccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC---CCEEEccCCceeecCCCccccccccCCcceeCH
Confidence 543 234566899999999999999999999999999865 6899999999987654332 3345789999999
Q ss_pred ccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|.+.+ ..++.++|+|||||++|+|++|.+||.+.........+... ..+......++.++.+++.+||..||++|||
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 248 (277)
T cd06917 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS 248 (277)
T ss_pred HHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC
Confidence 98764 45789999999999999999999999877654444333222 1121112237889999999999999999999
Q ss_pred HHHHHcCcccCCcc
Q psy6377 230 AKEALKHPWLMNKK 243 (383)
Q Consensus 230 ~~e~L~hp~~~~~~ 243 (383)
+.+++.|||++...
T Consensus 249 ~~~il~~~~~~~~~ 262 (277)
T cd06917 249 AEELLKSKWIKAHS 262 (277)
T ss_pred HHHHhhChHhhccc
Confidence 99999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=290.36 Aligned_cols=230 Identities=23% Similarity=0.344 Sum_probs=184.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHh--cCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSL--CSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~--~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++..+|+.||+|.+.+. ......|..+++. ...||+|++++++|.+.+..|+||||+. |++|...
T Consensus 9 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-g~~L~~~ 87 (278)
T cd05606 9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN-GGDLHYH 87 (278)
T ss_pred EEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC-CCcHHHH
Confidence 6999999999999999998751 1123344433331 3579999999999999999999999999 9999886
Q ss_pred hcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
+.. ..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++...... ......|++.|+|
T Consensus 88 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~---~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~a 163 (278)
T cd05606 88 LSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-KPHASVGTHGYMA 163 (278)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC---CCEEEccCcCccccCcc-CCcCcCCCcCCcC
Confidence 643 3445677999999999999999999999999999765 58999999998765332 2234579999999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
||++.+ ..++.++|+||+||++|+|++|..||.+... ......+...... .+..++.++.+++.+||..+|.
T Consensus 164 PE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred cHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHHHHhhcCHH
Confidence 999874 4689999999999999999999999987632 2222222222222 3345699999999999999999
Q ss_pred CCC-----CHHHHHcCcccCCcc
Q psy6377 226 ERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 226 ~Rp-----t~~e~L~hp~~~~~~ 243 (383)
+|| ++.++++||||....
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred hccCCCCCCHHHHHhCccccCCC
Confidence 999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.88 Aligned_cols=233 Identities=28% Similarity=0.348 Sum_probs=189.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---c---------------ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---P---------------VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~---------------~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~ 66 (383)
.||+|+++.+|+.||+|.+... . ..+.+|+++++ .+.||||+++++++..++..+++||++
T Consensus 24 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 102 (335)
T PTZ00024 24 KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN-EIKHENIMGLVDVYVEGDFINLVMDIM 102 (335)
T ss_pred eEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH-hCCCcceeeeeEEEecCCcEEEEEecc
Confidence 5899999999999999998751 1 13778999999 778999999999999999999999999
Q ss_pred CCcCcHHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec------
Q psy6377 67 PLVVTLQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD------ 134 (383)
Q Consensus 67 ~~g~~L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~------ 134 (383)
. ++|.+.+.. .....++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 103 ~--~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~---~~~kl~dfg~~~~~~~~~~~~~ 177 (335)
T PTZ00024 103 A--SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYSDT 177 (335)
T ss_pred c--cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC---CCEEECCccceeeccccccccc
Confidence 7 588886643 2344566999999999999999999999999999765 6899999999986541
Q ss_pred ---------CcccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc--
Q psy6377 135 ---------GIEIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-- 202 (383)
Q Consensus 135 ---------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 202 (383)
........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+.......+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 257 (335)
T PTZ00024 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDN 257 (335)
T ss_pred ccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhh
Confidence 1112234578899999998654 4789999999999999999999999988877766655432211111
Q ss_pred ----------------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 ----------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
......+..+.++|.+||..+|++|||++|+|.||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 258 WPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred CcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 11234578899999999999999999999999999998654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=290.48 Aligned_cols=233 Identities=30% Similarity=0.440 Sum_probs=186.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|.+..+++.+|+|++... ...+.+|+++++ .++||||++++++|.+. ..+|+||||++ |++|.+++
T Consensus 15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 92 (287)
T cd06621 15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINK-SCKSPYIVKYYGAFLDESSSSIGIAMEYCE-GGSLDSIY 92 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEccCCCeEEEEEEecC-CCCHHHHH
Confidence 36899999999999999998762 346889999998 67899999999998654 46899999999 99998764
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
.. ..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... .....++..
T Consensus 93 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 168 (287)
T cd06621 93 KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGELVNSL-AGTFTGTSF 168 (287)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---CeEEEeeccccccccccc-cccccCCcc
Confidence 32 2234577999999999999999999999999999765 579999999987654322 223467889
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCC-CCcchh--cCCCHHHHHHHHH
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET-----DSETFRNISKAQLD-FPDELF--EDISPEAKDFIAK 218 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~i~~~~~~-~~~~~~--~~~s~~~~~li~~ 218 (383)
|+|||.+.+..++.++|+||+||++|+|++|..||.... ..+....+...... .+.... ...++.+.+||.+
T Consensus 169 y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (287)
T cd06621 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ 248 (287)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHH
Confidence 999999998899999999999999999999999998662 22333333321111 111111 2346789999999
Q ss_pred hcccCCCCCCCHHHHHcCcccCCc
Q psy6377 219 ILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
||.++|++|||+.|+++|||+.+.
T Consensus 249 ~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 249 CLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HcCCCcccCCCHHHHHhCcccccc
Confidence 999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.31 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=194.0
Q ss_pred ceEEEEEEcCC--CcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIAT--GEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~t--g~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~ 71 (383)
..||++++..+ |+.||+|.+.. ....+.+|+.+++...+||||+++++.... ....|++++++. ++
T Consensus 14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~--~~ 91 (332)
T cd07857 14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME--AD 91 (332)
T ss_pred eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc--CC
Confidence 37899999988 99999999875 134578899999866689999999997543 245788888886 68
Q ss_pred HHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----cccc
Q psy6377 72 LQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRE 140 (383)
Q Consensus 72 L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~ 140 (383)
|.+.+.. ..+..+..||+.||.|||++||+||||||+|||++.+ +.++|+|||++....... ....
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 168 (332)
T cd07857 92 LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGFSENPGENAGFMTE 168 (332)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---CCEEeCcCCCceecccccccccccccC
Confidence 8886543 3345666999999999999999999999999999765 689999999998654321 1234
Q ss_pred ccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------------------
Q psy6377 141 LLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------ 201 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 201 (383)
..||+.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+......++
T Consensus 169 ~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (332)
T cd07857 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRS 248 (332)
T ss_pred cccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHh
Confidence 578999999998765 5789999999999999999999999987765544443332211111
Q ss_pred ---------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcccCCCCCCch
Q psy6377 202 ---------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSI 257 (383)
Q Consensus 202 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~~~~~~~~~ 257 (383)
...++.++..+.+|+.+||..||.+|||+.+++.|||+....+....+.|...+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 313 (332)
T cd07857 249 LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDF 313 (332)
T ss_pred ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccC
Confidence 11234568899999999999999999999999999999887766555556554443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.01 Aligned_cols=229 Identities=30% Similarity=0.426 Sum_probs=187.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||.+++..+|+.||+|.+... ...+.+|+.+++ ..+||||+++++++.+.+..++++|++. +++|.+++..
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 92 (264)
T cd06626 15 KVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLE-LLKHPNLVKYYGVEVHREKVYIFMEYCS-GGTLEELLEH 92 (264)
T ss_pred EEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHH-hCCCCChhheeeeEecCCEEEEEEecCC-CCcHHHHHhh
Confidence 6899999999999999998762 346789999999 7799999999999999999999999999 9999997654
Q ss_pred C------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cccccCCCCc
Q psy6377 79 N------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLGTPDY 147 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~gt~~y 147 (383)
. ....+..|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .....+++.|
T Consensus 93 ~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T cd06626 93 GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169 (264)
T ss_pred cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEcccccccccCCCCCcccccccCCcCCcCc
Confidence 3 234566899999999999999999999999999865 6899999999887643322 1235688999
Q ss_pred CCCcccccCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 148 VAPEILHYEP---ITLAADMWSLGVTAYVLLTGFSPFGGETDSE-TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 148 ~aPE~l~~~~---~~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+|||++.+.. ++.++||||+|+++|++++|+.||.+..... ....+... ....-+.+..++..+.+||.+||..+
T Consensus 170 ~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 248 (264)
T cd06626 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPEGKDFLDRCLESD 248 (264)
T ss_pred cChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC-CCCCCCcccccCHHHHHHHHHHccCC
Confidence 9999988765 8899999999999999999999997664332 22222221 11111223346899999999999999
Q ss_pred CCCCCCHHHHHcCccc
Q psy6377 224 PMERMTAKEALKHPWL 239 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~ 239 (383)
|.+|||+.+++.|||+
T Consensus 249 p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 249 PKKRPTASELLQHPFV 264 (264)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=269.32 Aligned_cols=232 Identities=26% Similarity=0.375 Sum_probs=198.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
-|++++++.|++.||+|.++- -.....|||-+|+ -+.|.|||+++|+...+..+-+|+|+|. .+|..++..
T Consensus 17 tvfkarn~~t~eivalkrvrlddddegvpssalreicllk-elkhknivrl~dvlhsdkkltlvfe~cd--qdlkkyfds 93 (292)
T KOG0662|consen 17 TVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVFEFCD--QDLKKYFDS 93 (292)
T ss_pred eeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHH-HhhhcceeehhhhhccCceeEEeHHHhh--HHHHHHHHh
Confidence 378999999999999999876 2456899999999 8899999999999999999999999997 778776543
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
.....++.|++.||.|||++++.||||||+|+|++.+ |.+|++|||+|+.++-+.. .+..+.|.+|++|
T Consensus 94 lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n---gelkladfglarafgipvrcysaevvtlwyrpp 170 (292)
T KOG0662|consen 94 LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN---GELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_pred cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC---CcEEecccchhhhcCCceEeeeceeeeeeccCc
Confidence 3355777999999999999999999999999999765 7999999999998765543 4556789999999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc----------------------
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE---------------------- 206 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---------------------- 206 (383)
.++.+. -|+...|+||.|||+.|+.. |++.|.|.+..+++.+|...-..+....|+
T Consensus 171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsq 250 (292)
T KOG0662|consen 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQ 250 (292)
T ss_pred ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHH
Confidence 998775 48999999999999999986 999999999999999887654443333222
Q ss_pred ---CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 207 ---DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 207 ---~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.++...+++++++|.-+|.+|.+++++|+||||.+.
T Consensus 251 ivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 251 IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 335568899999999999999999999999999753
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=286.15 Aligned_cols=225 Identities=23% Similarity=0.330 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..++++|+++ +++|.+++.
T Consensus 17 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~ 94 (267)
T cd08228 17 EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK-QLNHPNVIKYLDSFIEDNELNIVLELAD-AGDLSQMIK 94 (267)
T ss_pred eEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCcceeeeeeeEEECCeEEEEEEecC-CCcHHHHHH
Confidence 699999999999999998764 1245788999999 7799999999999999999999999999 999988653
Q ss_pred ----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCC
Q psy6377 78 ----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPD 146 (383)
Q Consensus 78 ----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~ 146 (383)
+..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........ .....|++.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08228 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---CCEEECccccceeccchhHHHhcCCCCcc
Confidence 12334666899999999999999999999999999765 5899999999887643322 234568899
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD--SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+... .+++.....++..+.+++.+||..+|
T Consensus 172 ~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p 249 (267)
T cd08228 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSEKLRELVSMCIYPDP 249 (267)
T ss_pred ccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCHHHHHHHHHHCCCCc
Confidence 9999999888899999999999999999999999976543 2333333322 23333334578899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy6377 225 MERMTAKEALKH 236 (383)
Q Consensus 225 ~~Rpt~~e~L~h 236 (383)
++|||+.++++.
T Consensus 250 ~~Rp~~~~vl~~ 261 (267)
T cd08228 250 DQRPDIGYVHQI 261 (267)
T ss_pred ccCcCHHHHHHH
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=293.20 Aligned_cols=233 Identities=27% Similarity=0.377 Sum_probs=181.1
Q ss_pred ceEEEEEEcC--CCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIA--TGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~--tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L 72 (383)
..||+|.++. +|+.||+|.+... ...+.+|+.+++ .++||||+++++++.+. ..+++|||++. ++|
T Consensus 14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~--~~l 90 (316)
T cd07842 14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR-ELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDL 90 (316)
T ss_pred EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHH-hcCCCCccceEEEEeCCCCceEEEEEeCCC--cCH
Confidence 3689999988 8999999998762 356788999999 77899999999999988 88999999997 456
Q ss_pred HHhhc-----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC-CCCcEEEEeccceeEeecCcc---
Q psy6377 73 QTIID-----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF-PNCDIKVCDFEISRVILDGIE--- 137 (383)
Q Consensus 73 ~~~l~-----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~-~~~~ikL~DFGla~~~~~~~~--- 137 (383)
.+.+. +..++.++.|++.||+|||++||+||||||+||+++.++ ..+.+||+|||++........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 170 (316)
T cd07842 91 WQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170 (316)
T ss_pred HHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccccc
Confidence 65432 223446679999999999999999999999999998721 147899999999886543221
Q ss_pred -cccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHHHhc----------
Q psy6377 138 -IRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSE---------TFRNISKA---------- 196 (383)
Q Consensus 138 -~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~---------~~~~i~~~---------- 196 (383)
.....+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+..... .+..+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 250 (316)
T cd07842 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250 (316)
T ss_pred ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHH
Confidence 233468899999998765 458999999999999999999999998665432 11111100
Q ss_pred ----------------cCCCC-cc------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 197 ----------------QLDFP-DE------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 197 ----------------~~~~~-~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
...++ .. .+...+..+.++|.+||..||++|||+.+++.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 251 DIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00111 00 011567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=283.97 Aligned_cols=227 Identities=24% Similarity=0.358 Sum_probs=193.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+++++.+|+.+|+|.+.. ....+.+|+.+++ .++||||+++++++.+....|+|+|+++ +++|.+.+.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~ 91 (256)
T cd08530 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILA-SVNHPNIISYKEAFLDGNKLCIVMEYAP-FGDLSKAIS 91 (256)
T ss_pred eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHH-hCCCCCchhhhhhhccCCEEEEEehhcC-CCCHHHHHH
Confidence 3689999999999999999875 2345678999998 6789999999999999999999999999 999998654
Q ss_pred c----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 78 D----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 78 ~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
. ..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... ......+++.|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~---~~~kl~d~g~~~~~~~~-~~~~~~~~~~~ 167 (256)
T cd08530 92 KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN---DLVKIGDLGISKVLKKN-MAKTQIGTPHY 167 (256)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC---CcEEEeeccchhhhccC-CcccccCCccc
Confidence 3 2344666899999999999999999999999999875 58999999999876544 33345689999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+........ ....+.++++++.+||..+|++|
T Consensus 168 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08530 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQNFIRSMLQVKPKLR 244 (256)
T ss_pred cCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHHHHHHHcCCCcccC
Confidence 999999988899999999999999999999999998887766666655443322 23678999999999999999999
Q ss_pred CCHHHHHcCccc
Q psy6377 228 MTAKEALKHPWL 239 (383)
Q Consensus 228 pt~~e~L~hp~~ 239 (383)
||+.++++||++
T Consensus 245 p~~~~~l~~p~~ 256 (256)
T cd08530 245 PNCDKILASPAV 256 (256)
T ss_pred CCHHHHhcCCCC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.25 Aligned_cols=223 Identities=18% Similarity=0.237 Sum_probs=183.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|+++.+|+.+|+|.+.. ....+.+|+++++ .++||||+++++++.+....|+||||+. +++|.+++...
T Consensus 10 ~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 87 (252)
T cd05084 10 EVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIVMELVQ-GGDFLTFLRTE 87 (252)
T ss_pred cEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEcCCCCeEEEEeecc-CCcHHHHHHhC
Confidence 589999999999999998765 1356889999999 7799999999999999999999999999 99999976432
Q ss_pred -------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc---cccCCCCcCC
Q psy6377 80 -------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPDYVA 149 (383)
Q Consensus 80 -------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~---~~~gt~~y~a 149 (383)
.++.+..|++.||.|||++|++||||||+|||++.+ +.++|+|||++.......... ...++..|+|
T Consensus 88 ~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 164 (252)
T cd05084 88 GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA 164 (252)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC---CcEEECccccCcccccccccccCCCCCCceeecC
Confidence 234566999999999999999999999999999765 589999999987643321111 1123456999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
||.+.+..++.++|+|||||++|+|++ |.+||...+.......+.... +......++..+.+|+.+||..+|++||
T Consensus 165 PE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 999988889999999999999999998 999998777665555554322 1123346789999999999999999999
Q ss_pred CHHHHHc
Q psy6377 229 TAKEALK 235 (383)
Q Consensus 229 t~~e~L~ 235 (383)
|+.++++
T Consensus 242 s~~~~~~ 248 (252)
T cd05084 242 SFSTVHQ 248 (252)
T ss_pred CHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=292.24 Aligned_cols=217 Identities=19% Similarity=0.230 Sum_probs=173.9
Q ss_pred CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC---------
Q psy6377 14 TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN--------- 79 (383)
Q Consensus 14 tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~--------- 79 (383)
++..||+|++... ...+.+|+.++. .++||||+++++++.+.+..++||||+. +++|.+++...
T Consensus 45 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~ 122 (304)
T cd05096 45 RPLLVAVKILRPDANKNARNDFLKEVKILS-RLKDPNIIRLLGVCVDEDPLCMITEYME-NGDLNQFLSSHHLDDKEENG 122 (304)
T ss_pred cceEEEEEEecCCCCHHHHHHHHHHHHHHh-hcCCCCeeEEEEEEecCCceEEEEecCC-CCcHHHHHHhcccccccccc
Confidence 4557999998762 346889999999 6799999999999999999999999999 99999876432
Q ss_pred ----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---ccc
Q psy6377 80 ----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRE 140 (383)
Q Consensus 80 ----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~ 140 (383)
.++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++....... ...
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kl~DfG~~~~~~~~~~~~~~~~ 199 (304)
T cd05096 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN---LTIKIADFGMSRNLYAGDYYRIQGR 199 (304)
T ss_pred ccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCC---ccEEECCCccceecccCceeEecCc
Confidence 134577999999999999999999999999999865 6899999999986543322 122
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHhcc----CCCCcchhcCCCHHHHH
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT--GFSPFGGETDSETFRNISKAQ----LDFPDELFEDISPEAKD 214 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt--g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~ 214 (383)
..+++.|+|||++....++.++|||||||++|+|++ +..||.+.+..+....+.... ........+.++..+.+
T Consensus 200 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (304)
T cd05096 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYE 279 (304)
T ss_pred CCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHH
Confidence 345788999999988889999999999999999986 678888877666555443211 11111122456889999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6377 215 FIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~ 235 (383)
|+.+||..||++|||+.++.+
T Consensus 280 li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCchhCcCHHHHHH
Confidence 999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.62 Aligned_cols=229 Identities=30% Similarity=0.416 Sum_probs=191.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||++.+..+|+.+++|++... ...+.+|+++++ .+.||||+++++++..+...++++|+++ |++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l~~e~~~-~~~L~~~~~~~ 91 (253)
T cd05122 14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNIVKYYGSYLKKDELWIVMEFCS-GGSLKDLLKST 91 (253)
T ss_pred eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEEecCC-CCcHHHHHhhc
Confidence 47899999999999999999773 357889999999 7779999999999999999999999999 99999976543
Q ss_pred -------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 80 -------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 -------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||.+.............++..|+|||.
T Consensus 92 ~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~ 168 (253)
T cd05122 92 NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168 (253)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC---CeEEEeeccccccccccccccceecCCcccCHHH
Confidence 234566999999999999999999999999999865 6899999999987655433345678999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+..++.++|+||||+++|+|++|..||...+.......+....... ......++..+.++|.+||..||++|||+.+
T Consensus 169 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred HcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 988888999999999999999999999998876555544443321111 1111224889999999999999999999999
Q ss_pred HHcCcc
Q psy6377 233 ALKHPW 238 (383)
Q Consensus 233 ~L~hp~ 238 (383)
+++|||
T Consensus 248 ~l~~~~ 253 (253)
T cd05122 248 LLKHPF 253 (253)
T ss_pred HhcCCC
Confidence 999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.40 Aligned_cols=228 Identities=23% Similarity=0.330 Sum_probs=185.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~ 73 (383)
.||.+.+..+|..||+|.+.. ....+.+|+.+++ .+.||||+++++++.+. ..++++||+++ |++|.
T Consensus 17 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~-~~~L~ 94 (265)
T cd06652 17 RVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK-NLLHERIVQYYGCLRDPMERTLSIFMEHMP-GGSIK 94 (265)
T ss_pred EEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHH-hcCCCCeeeEEeEeccCCCceEEEEEEecC-CCcHH
Confidence 589999999999999998753 1235778999999 77899999999998764 46889999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC----cccccccC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----IEIRELLG 143 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----~~~~~~~g 143 (383)
+++... ....++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++...... .......|
T Consensus 95 ~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 171 (265)
T cd06652 95 DQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLSGTGMKSVTG 171 (265)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC---CCEEECcCccccccccccccccccccCCC
Confidence 876432 345667999999999999999999999999999765 68999999998864321 12233568
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+..|+|||++.+..++.++|+|||||++|+|++|+.||.+.........+..... .+.....++..+.++|.+|+. +
T Consensus 172 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~-~ 248 (265)
T cd06652 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVSDHCRDFLKRIFV-E 248 (265)
T ss_pred CccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhCHHHHHHHHHHhc-C
Confidence 8999999999888899999999999999999999999987765555444332211 122334568899999999995 9
Q ss_pred CCCCCCHHHHHcCcccC
Q psy6377 224 PMERMTAKEALKHPWLM 240 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~ 240 (383)
|++|||++++++|||+.
T Consensus 249 p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 249 AKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=304.08 Aligned_cols=225 Identities=20% Similarity=0.295 Sum_probs=180.6
Q ss_pred eEEEEEEcCCC-----cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATG-----EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg-----~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|++..+| ..||+|++... ...+.+|+.+++.+.+||||+++++++.+....|+||||++ +|+|.+
T Consensus 53 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~-~g~L~~ 131 (374)
T cd05106 53 KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCC-YGDLLN 131 (374)
T ss_pred cEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhcc-CCcHHH
Confidence 57888865544 57999999751 34578999999955589999999999999999999999999 999998
Q ss_pred hhccC---------------------------------------------------------------------------
Q psy6377 75 IIDDN--------------------------------------------------------------------------- 79 (383)
Q Consensus 75 ~l~~~--------------------------------------------------------------------------- 79 (383)
++...
T Consensus 132 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 211 (374)
T cd05106 132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDL 211 (374)
T ss_pred HHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCH
Confidence 65321
Q ss_pred -CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCCCcCCCccccc
Q psy6377 80 -LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTPDYVAPEILHY 155 (383)
Q Consensus 80 -~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~l~~ 155 (383)
.++.+..||+.||.|||++||+||||||+|||++.+ +.++|+|||+++........ ....+++.|+|||++..
T Consensus 212 ~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~---~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG---RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC---CeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 124566999999999999999999999999999865 58999999999865433221 12235568999999988
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 156 EPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 156 ~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
..++.++|||||||++|+|++ |..||.+.........+.......+ ....+++++.+++.+||..||.+|||+.+++
T Consensus 289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 899999999999999999997 9999987765554444444332222 2234689999999999999999999999987
Q ss_pred c
Q psy6377 235 K 235 (383)
Q Consensus 235 ~ 235 (383)
+
T Consensus 367 ~ 367 (374)
T cd05106 367 Q 367 (374)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=298.88 Aligned_cols=235 Identities=29% Similarity=0.417 Sum_probs=187.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++++... ...|+++|++. ++|.
T Consensus 20 ~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~--~~L~ 96 (337)
T cd07858 20 IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-HLDHENVIAIKDIMPPPHREAFNDVYIVYELMD--TDLH 96 (337)
T ss_pred EEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHH-hcCCCCccchHHheecccccccCcEEEEEeCCC--CCHH
Confidence 689999999999999998865 2346778999999 67899999999998754 34899999996 6787
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
+.+.. ..+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++...... .......++..
T Consensus 97 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 173 (337)
T cd07858 97 QIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTEYVVTRW 173 (337)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECcCccccccCCCcccccccccccC
Confidence 76543 3345667999999999999999999999999999765 68999999999876433 22344578999
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF------------------------- 200 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~------------------------- 200 (383)
|+|||.+.. ..++.++|+|||||++|+|++|++||.+.+.......+.......
T Consensus 174 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (337)
T cd07858 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPR 253 (337)
T ss_pred ccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccc
Confidence 999998764 468899999999999999999999998776444333322111000
Q ss_pred --CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 201 --PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 201 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
....++.+++++.+||++||..+|++|||++++|+||||......
T Consensus 254 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 254 QSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 012235688999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.44 Aligned_cols=228 Identities=26% Similarity=0.385 Sum_probs=180.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
-.||++.. ...+.||+|.+.- ....+.+||..|.++.+|.+||+|||+=..++.+|+|||+-+ .+|..+|.
T Consensus 375 SkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd--~DL~kiL~ 451 (677)
T KOG0596|consen 375 SKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD--IDLNKILK 451 (677)
T ss_pred ceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc--ccHHHHHH
Confidence 36888875 4455666665543 246788999999999999999999999889999999999987 89999876
Q ss_pred cCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCc
Q psy6377 78 DNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDY 147 (383)
Q Consensus 78 ~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y 147 (383)
... ++++.+|+|.|+.++|..||||.||||.|+|+-+ |.+||+|||+|..+..... ..+.+||+.|
T Consensus 452 k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NY 527 (677)
T KOG0596|consen 452 KKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNY 527 (677)
T ss_pred hccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCccccceeeccccCcccc
Confidence 532 3455599999999999999999999999999864 6899999999998765432 3457999999
Q ss_pred CCCcccccC-----------CCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhcc--CCCCcchhcCCCHHHH
Q psy6377 148 VAPEILHYE-----------PITLAADMWSLGVTAYVLLTGFSPFGGET-DSETFRNISKAQ--LDFPDELFEDISPEAK 213 (383)
Q Consensus 148 ~aPE~l~~~-----------~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~i~~~~--~~~~~~~~~~~s~~~~ 213 (383)
||||.+... ..+.++||||||||||+|+.|++||.... ...-+..|.... .+||... -..++.
T Consensus 528 MsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~---~~~~li 604 (677)
T KOG0596|consen 528 MSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP---ENDELI 604 (677)
T ss_pred cCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC---CchHHH
Confidence 999988432 25688999999999999999999996543 233334444332 2333211 122399
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 214 DFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
++++.||.+||++|||+.++|+|||++.
T Consensus 605 ~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 605 DVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 9999999999999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=298.56 Aligned_cols=234 Identities=30% Similarity=0.437 Sum_probs=192.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe------EEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG------AYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~------~~lv~e~~~~g~~ 71 (383)
..||+|++..+|+.||+|.+.. ....+.+|+.+++ ...||||+++++++...+. .|+|++++. ++
T Consensus 29 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 105 (343)
T cd07851 29 GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLK-HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG--AD 105 (343)
T ss_pred eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHH-hccCCCHHHHHHHhhccccccccccEEEEEecCC--CC
Confidence 4789999999999999999865 2345778999999 6799999999999876655 899999984 79
Q ss_pred HHHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 72 LQTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 72 L~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
|.+++.. ..+..+..|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++..... ......+++.
T Consensus 106 L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~---~~~kL~dfg~~~~~~~--~~~~~~~~~~ 180 (343)
T cd07851 106 LNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDD--EMTGYVATRW 180 (343)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEccccccccccc--cccCCccccc
Confidence 9887644 3345667999999999999999999999999999865 6899999999987533 2445678999
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-----------------------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD----------------------- 202 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------------------- 202 (383)
|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......++
T Consensus 181 y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07851 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPK 260 (343)
T ss_pred ccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCC
Confidence 999999865 46789999999999999999999999888776666665443222211
Q ss_pred ----chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 ----ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..+...+..+.+||.+||..+|.+|||+.+++.||||......
T Consensus 261 ~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 261 KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1123468999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=284.30 Aligned_cols=219 Identities=24% Similarity=0.314 Sum_probs=177.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc------
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD------ 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~------ 78 (383)
.||+|+++.+|+.||+|.+.... ...+|...+. ...||||+++++++.+.+..+++|||+. |++|.+.+..
T Consensus 8 ~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~l~~ 84 (237)
T cd05576 8 KVLLVMDTRTQQTFILKGLRKSS-EYSRERLTII-PHCVPNMVCLHKYIVSEDSVFLVLQHAE-GGKLWSHISKFLNIPE 84 (237)
T ss_pred eEEEEEEccCCcEEEEEeecchh-hhhhHHHHHH-hcCCCceeehhhheecCCeEEEEEecCC-CCCHHHHHHHhcCCCH
Confidence 48999999999999999998632 2344544444 4569999999999999999999999999 9999886533
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCC
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI 158 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 158 (383)
..+..+..|++.||+|||++||+||||||+||+++.+ +.++++|||.+...... .....++..|+|||.+.+.++
T Consensus 85 ~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 85 ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEecccchhccccc--cccCCcCccccCCcccCCCCC
Confidence 3345666999999999999999999999999999876 58999999987665332 234556788999999988889
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH-----HHH
Q psy6377 159 TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA-----KEA 233 (383)
Q Consensus 159 ~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~ 233 (383)
+.++|+||+|+++|+|++|..||........ .......| ..+++.++++|.+||..||++|||+ +++
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIP----EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCc----ccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 9999999999999999999998864422100 00111222 3578999999999999999999986 999
Q ss_pred HcCccc
Q psy6377 234 LKHPWL 239 (383)
Q Consensus 234 L~hp~~ 239 (383)
++||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.53 Aligned_cols=230 Identities=29% Similarity=0.399 Sum_probs=188.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++..+|+.+|+|.+... ...+.+|+.+++ .++|||++++++++.+. ...++|++|++ ++|.++
T Consensus 13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~ 89 (287)
T cd07840 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQ-KLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--HDLTGL 89 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHH-hccCCCeeeheeeEecCCCCcEEEEecccc--ccHHHH
Confidence 37999999999999999999762 235778999999 77899999999999988 88999999998 478876
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPD 146 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~ 146 (383)
+... .++.+..|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++..
T Consensus 90 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 166 (287)
T cd07840 90 LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---GVLKLADFGLARPYTKRNSADYTNRVITLW 166 (287)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC---CCEEEccccceeeccCCCcccccccccccc
Confidence 5432 344666999999999999999999999999999875 689999999998765433 2334567889
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch---------------------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL--------------------- 204 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------------------- 204 (383)
|+|||.+.+ ..++.++||||||+++|+|++|.+||.+.+....+..+.......+...
T Consensus 167 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07840 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKR 246 (287)
T ss_pred cCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchh
Confidence 999997764 4678999999999999999999999998887666665544322211111
Q ss_pred -----hcC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 205 -----FED-ISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 205 -----~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
... ++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 247 RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 122 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=298.45 Aligned_cols=233 Identities=31% Similarity=0.422 Sum_probs=187.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||+|.+.+ ....+.+|+.+++ .+.||||++++++|.... .+|++++++. .+|
T Consensus 30 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l 106 (342)
T cd07879 30 SVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK-HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ--TDL 106 (342)
T ss_pred EEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHH-hcCCCCccchhheecccccCCCCceEEEEecccc--cCH
Confidence 689999999999999999875 1245789999999 779999999999997543 4699999987 577
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.... ....+..+..|++.||+|||++|++||||||+||+++.+ +.++|+|||+++.... ......+++.|+
T Consensus 107 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~---~~~kL~dfg~~~~~~~--~~~~~~~~~~y~ 181 (342)
T cd07879 107 QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED---CELKILDFGLARHADA--EMTGYVVTRWYR 181 (342)
T ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCCCCcCCCC--CCCCceeeeccc
Confidence 7643 334455677999999999999999999999999999765 6899999999876422 234457889999
Q ss_pred CCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-----------------------Cc--
Q psy6377 149 APEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-----------------------PD-- 202 (383)
Q Consensus 149 aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-----------------------~~-- 202 (383)
|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....... +.
T Consensus 182 aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (342)
T cd07879 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKD 261 (342)
T ss_pred ChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccch
Confidence 9999865 468899999999999999999999999877655554443321110 10
Q ss_pred --chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 --ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..++..+..+.+||.+||+.||++|||+++++.||||......
T Consensus 262 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 262 FSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 1124578889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=285.39 Aligned_cols=230 Identities=28% Similarity=0.405 Sum_probs=188.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhc--CCCCCcccceEEEEeCCe-----EEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLC--SPSPRIVKLHDVFQTGEG-----AYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~--~~hpnIvkl~~~~~~~~~-----~~lv~e~~~~g~~ 71 (383)
.||+++++.+|+.||+|.+... ...+.+|+.+++.. ..||||+++++++.+.+. .+++||++. ++
T Consensus 14 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~--~~ 91 (287)
T cd07838 14 TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QD 91 (287)
T ss_pred EEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc--cC
Confidence 6899999999999999999751 23466788877644 369999999999998877 999999997 47
Q ss_pred HHHhhcc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 72 LQTIIDD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 72 L~~~l~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
|.+.+.. ..++.+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.............+
T Consensus 92 l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~ 168 (287)
T cd07838 92 LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLARIYSFEMALTSVVV 168 (287)
T ss_pred HHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcceeccCCcccccccc
Confidence 8775533 2334566999999999999999999999999999876 6899999999988655444445568
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-----------------------
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF----------------------- 200 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 200 (383)
++.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+..+.+.++.......
T Consensus 169 ~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T cd07838 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS 248 (287)
T ss_pred cccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccc
Confidence 899999999998889999999999999999999999999888777766664421100
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
+....+.++..+.++|.+||..||.+||++.+++.||||
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 011123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=290.81 Aligned_cols=229 Identities=27% Similarity=0.405 Sum_probs=194.2
Q ss_pred EEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcHH
Q psy6377 6 EEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L~ 73 (383)
|..|-+.-++++||+|.+.. ...+.++|..++. +..|+||++++.+|... ..+|+|||++. .+|.
T Consensus 32 v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~-~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~--~nl~ 108 (369)
T KOG0665|consen 32 VVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMK-CVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD--ANLC 108 (369)
T ss_pred EEecchhhccCceehhhhcCccccCccchhhhhhhhhhh-hhcccceeeeeeccCccccHHHHHhHHHHHHhhh--hHHH
Confidence 66777888999999998866 4678999999998 99999999999999644 35899999998 8888
Q ss_pred Hhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 74 TII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 74 ~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
..+ +...+.++.+|+++|++|||+.||+||||||+||++..+ +.+||.|||+|+.....-.++.++.|..|+|
T Consensus 109 ~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~---~~lKi~dfg~ar~e~~~~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 109 QVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD---CTLKILDFGLARTEDTDFMMTPYVVTRYYRA 185 (369)
T ss_pred HHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch---hheeeccchhhcccCcccccCchhheeeccC
Confidence 843 334566778999999999999999999999999999776 7999999999998766656788999999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------------
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP---------------------------- 201 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------- 201 (383)
||++.+-+|...+||||+|||+.||++|...|.|.+..+++.++......+.
T Consensus 186 pevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~ 265 (369)
T KOG0665|consen 186 PEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSE 265 (369)
T ss_pred chheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhh
Confidence 9999998899999999999999999999999999887777766654333222
Q ss_pred ---cchhcC-------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 202 ---DELFED-------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 202 ---~~~~~~-------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
+..|.. -+..+++++.+||..||++|.+++++|+|||++
T Consensus 266 ~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 266 LFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111211 235689999999999999999999999999998
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.14 Aligned_cols=224 Identities=24% Similarity=0.341 Sum_probs=184.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.+|||.+.. ....+.+|+.+++ ..+||||++++++|.+++..+++||++. |++|.+++.
T Consensus 17 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~ 94 (267)
T cd08229 17 EVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNELNIVLELAD-AGDLSRMIK 94 (267)
T ss_pred EEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHH-HccCCchhhhhheeEeCCeEEEEEEecC-CCCHHHHHH
Confidence 699999999999999998764 2346788999999 7799999999999999999999999999 999998654
Q ss_pred c----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCC
Q psy6377 78 D----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPD 146 (383)
Q Consensus 78 ~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~ 146 (383)
. ..++.+..|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........ .....|++.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08229 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEECcchhhhccccCCcccccccCCcC
Confidence 2 2234556899999999999999999999999999765 5899999999876543322 234578999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|+|||.+.+..++.++|+||+|+++|+|++|..||.+.... +....+... ..++..+..++..+.++|.+||..||
T Consensus 172 ~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p 249 (267)
T cd08229 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDP 249 (267)
T ss_pred ccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccHHHHHHHHHhcCCCc
Confidence 99999998888999999999999999999999999765432 333333322 22333334678999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++++
T Consensus 250 ~~Rpt~~~i~~ 260 (267)
T cd08229 250 EKRPDITYVYD 260 (267)
T ss_pred ccCCCHHHHHH
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=280.37 Aligned_cols=228 Identities=28% Similarity=0.425 Sum_probs=194.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||++.+..+|+.||+|.+.. ....+.+|+++++ ..+|||++++++.+..+...++++|+++ +++|.+.+.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 91 (258)
T cd08215 14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILK-KLNHPNIIKYYESFEEKGKLCIVMEYAD-GGDLSQKIK 91 (258)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHH-hcCCCChhheEEEEecCCEEEEEEEecC-CCcHHHHHH
Confidence 3789999999999999999875 2346889999999 7789999999999999999999999999 999998765
Q ss_pred cC----------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCC
Q psy6377 78 DN----------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPD 146 (383)
Q Consensus 78 ~~----------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~ 146 (383)
.. .+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... ......|++.
T Consensus 92 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 168 (258)
T cd08215 92 KQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN---GLVKLGDFGISKVLSSTVDLAKTVVGTPY 168 (258)
T ss_pred HhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC---CcEEECCccceeecccCcceecceeeeec
Confidence 42 234566999999999999999999999999999765 689999999998765443 2334578999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+...... .....++..+.+++.+||..+|++
T Consensus 169 y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~ 245 (258)
T cd08215 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP---PIPSQYSSELRNLVSSLLQKDPEE 245 (258)
T ss_pred ccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999998888999999999999999999999999888766666665544322 222367899999999999999999
Q ss_pred CCCHHHHHcCccc
Q psy6377 227 RMTAKEALKHPWL 239 (383)
Q Consensus 227 Rpt~~e~L~hp~~ 239 (383)
|||+.++|+||||
T Consensus 246 Rp~~~~ll~~~~~ 258 (258)
T cd08215 246 RPSIAQILQSPFI 258 (258)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=291.15 Aligned_cols=233 Identities=26% Similarity=0.374 Sum_probs=193.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
.||++.+..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++.+...+..|+|+|++. +++|.+++...
T Consensus 34 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~ 111 (293)
T cd06647 34 TVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR-ENKHPNIVNYLDSYLVGDELWVVMEYLA-GGSLTDVVTETC 111 (293)
T ss_pred EEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHh-hcCCCCeeehhheeeeCCcEEEEEecCC-CCcHHHHHhhcC
Confidence 689999999999999999865 3456788999998 6789999999999999999999999999 99999876543
Q ss_pred ----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCcccc
Q psy6377 80 ----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEILH 154 (383)
Q Consensus 80 ----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~ 154 (383)
.+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++........ .....|++.|+|||.+.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 188 (293)
T cd06647 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC---CCEEEccCcceecccccccccccccCChhhcCchhhc
Confidence 345666899999999999999999999999999765 5899999999876543322 23356889999999998
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
...++.++|+|||||++|++++|..||.+.+..+....+.... ......+..++..++++|.+||..+|++||++.+++
T Consensus 189 ~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 8889999999999999999999999998776554443332221 111112345688999999999999999999999999
Q ss_pred cCcccCCcc
Q psy6377 235 KHPWLMNKK 243 (383)
Q Consensus 235 ~hp~~~~~~ 243 (383)
.||||....
T Consensus 268 ~h~~~~~~~ 276 (293)
T cd06647 268 QHPFLKIAK 276 (293)
T ss_pred cCHHHhcCc
Confidence 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.40 Aligned_cols=232 Identities=25% Similarity=0.399 Sum_probs=188.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||++.+..+|+.||+|++.. ....+.+|+++++ .++||||+++++.+.+....|+||||++ +++|.+++..
T Consensus 19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 96 (284)
T cd06620 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH-ECRSPYIVSFYGAFLNENNICMCMEFMD-CGSLDRIYKK 96 (284)
T ss_pred eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHH-HcCCCCcceEeeeEecCCEEEEEEecCC-CCCHHHHHHh
Confidence 3689999999999999998865 2356889999998 6789999999999999999999999999 9999987654
Q ss_pred C------CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 79 N------LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ....+..|++.||.|||+ .|++||||+|+||+++.+ +.++|+|||++...... ......|+..|+|||
T Consensus 97 ~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~---~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE 172 (284)
T cd06620 97 GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR---GQIKLCDFGVSGELINS-IADTFVGTSTYMSPE 172 (284)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC---CcEEEccCCcccchhhh-ccCccccCcccCCHH
Confidence 3 234566899999999997 699999999999999765 68999999998754322 223457899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-----------HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-----------ETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
++.+..++.++|+||+||++|+|++|..||...... +....+..... +......++.++.+|+.+||
T Consensus 173 ~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l 250 (284)
T cd06620 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACL 250 (284)
T ss_pred HHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHh
Confidence 998888999999999999999999999999865542 22222222211 11111237889999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCcc
Q psy6377 221 IKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.+||++|||+.|+++||||....
T Consensus 251 ~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 251 LKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=279.83 Aligned_cols=226 Identities=35% Similarity=0.526 Sum_probs=194.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||.|.+..+|+.||+|++.+. ...+.+|+.+++ ...||||+++++.++++...|++||++. +++|.+.+.
T Consensus 8 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~l~ 85 (250)
T cd05123 8 KVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS-RINHPFIVKLHYAFQTEEKLYLVLEYAP-GGELFSHLS 85 (250)
T ss_pred EEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHH-HcCCCcHHHHHHHeecCCeeEEEEecCC-CCcHHHHHH
Confidence 7899999999999999998761 236888999998 7789999999999999999999999999 899998764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
.. ....+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... .......++..|+||
T Consensus 86 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~P 162 (250)
T cd05123 86 KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162 (250)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---CcEEEeecCcceecccCCCcccCCcCCccccCh
Confidence 43 345566999999999999999999999999999765 58999999999876443 233456788999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|.+.+..++.++|+||||+++|+|++|..||...+.......+......+| ...+..+.+++.+||..||++|||+
T Consensus 163 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred HHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 999888889999999999999999999999988776666666665444444 3458999999999999999999999
Q ss_pred ---HHHHcCccc
Q psy6377 231 ---KEALKHPWL 239 (383)
Q Consensus 231 ---~e~L~hp~~ 239 (383)
++++.||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.84 Aligned_cols=229 Identities=30% Similarity=0.438 Sum_probs=188.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|.+..+|+.+|+|.+... ...+.+|+.+++ .++||||+++++++.+++..++++||+. ++|.+.+..
T Consensus 14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~--~~l~~~l~~ 90 (283)
T cd05118 14 VVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK-ELNHPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKD 90 (283)
T ss_pred eEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHH-HhcCCCcchHHHhhccCCCEEEEEeccC--CCHHHHHHh
Confidence 6899999999999999998762 346788999999 6679999999999999999999999998 477775533
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aP 150 (383)
..+..+..|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||.+....... ......++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~P 167 (283)
T cd05118 91 RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE---GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167 (283)
T ss_pred hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC---CcEEEeeeeeeEecCCCcccccCccCcccccCc
Confidence 2234566999999999999999999999999999765 689999999998765543 23345688899999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------------cc
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--------------------------DE 203 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 203 (383)
|.+.+. .++.++|+||+|+++|+|++|++||.+.+..+.+..+........ ..
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK 247 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH
Confidence 998776 789999999999999999999999988876665555433211110 11
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.++.++.++.+||.+||.+||.+||++.+++.||||
T Consensus 248 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 248 LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.22 Aligned_cols=227 Identities=18% Similarity=0.195 Sum_probs=186.2
Q ss_pred eEEEEEEcC-----CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA-----TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~-----tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|.++. ++..||+|.+... ...+.+|+.+++ .++||||+++++++.+.+..+++||++. |++|.+
T Consensus 21 ~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-g~~L~~ 98 (277)
T cd05036 21 EVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS-KFNHQNIVRLIGVSFERLPRFILLELMA-GGDLKS 98 (277)
T ss_pred cEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCcEEEEecCC-CCCHHH
Confidence 689999887 7889999998752 345888999998 7799999999999999999999999999 999999
Q ss_pred hhccCC-------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---c
Q psy6377 75 IIDDNL-------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---I 138 (383)
Q Consensus 75 ~l~~~~-------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~ 138 (383)
++.... +..++.||+.||+|||++|++||||||+||+++.++....++|+|||+++....... .
T Consensus 99 ~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~ 178 (277)
T cd05036 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178 (277)
T ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecC
Confidence 765431 234668999999999999999999999999998754445799999999987532211 1
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... ......++..+.+++.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~ 255 (277)
T cd05036 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR---LDPPKGCPGPVYRIMT 255 (277)
T ss_pred CCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHH
Confidence 12233567999999988889999999999999999997 9999998887776665543321 1223467899999999
Q ss_pred HhcccCCCCCCCHHHHHcC
Q psy6377 218 KILIKNPMERMTAKEALKH 236 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~h 236 (383)
+||..+|++|||+.++++|
T Consensus 256 ~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 256 DCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=285.04 Aligned_cols=230 Identities=27% Similarity=0.369 Sum_probs=193.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||++.+..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++.+.+++..|+||||+. +++|.+++...
T Consensus 19 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~l~~~i~~~ 96 (277)
T cd06641 19 EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWIIMEYLG-GGSALDLLEPG 96 (277)
T ss_pred EEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHH-hcCCCCEeEEEEEEEeCCeEEEEEEeCC-CCcHHHHHhcC
Confidence 789999999999999999865 2346788999998 7789999999999999999999999999 99999876532
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
.+..+..|++.|+.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......|+..|+|||.+
T Consensus 97 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 97 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---CCEEEeecccceecccchhhhccccCCccccChhhh
Confidence 345666999999999999999999999999999765 689999999987654322 12335688999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+||+||++|+|++|..||...........+.... ++.....++.++.++|.+||..+|.+||++.++
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 88888999999999999999999999998776655555443322 222334678999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
++||||...
T Consensus 251 l~~~~~~~~ 259 (277)
T cd06641 251 LKHKFIVRF 259 (277)
T ss_pred HhCHHHhhh
Confidence 999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.59 Aligned_cols=226 Identities=19% Similarity=0.287 Sum_probs=179.7
Q ss_pred eEEEEEE-----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADS-----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+. ..++..||||++.. ....+.+|+.+++.+..||||+++++++.+.+..++||||++ ||+|.+
T Consensus 50 ~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-~g~L~~ 128 (375)
T cd05104 50 KVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCC-YGDLLN 128 (375)
T ss_pred eEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhcc-CCcHHH
Confidence 4677753 45778999999875 235688999999955489999999999999999999999999 999988
Q ss_pred hhccCC--------------------------------------------------------------------------
Q psy6377 75 IIDDNL-------------------------------------------------------------------------- 80 (383)
Q Consensus 75 ~l~~~~-------------------------------------------------------------------------- 80 (383)
++....
T Consensus 129 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (375)
T cd05104 129 FLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE 208 (375)
T ss_pred HHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC
Confidence 764321
Q ss_pred -------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCCCcCCC
Q psy6377 81 -------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTPDYVAP 150 (383)
Q Consensus 81 -------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~~y~aP 150 (383)
+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........ ....+++.|+||
T Consensus 209 ~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 285 (375)
T cd05104 209 LALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG---RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP 285 (375)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC---CcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence 22455899999999999999999999999999765 58999999999876433221 123345679999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++|||||||++|+|++ |..||.+.................+ .....+.++.+||.+||..||++|||
T Consensus 286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs 363 (375)
T cd05104 286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMYDIMKSCWDADPLKRPT 363 (375)
T ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999999999999999998 8999987665444333333322211 12346889999999999999999999
Q ss_pred HHHHHcC
Q psy6377 230 AKEALKH 236 (383)
Q Consensus 230 ~~e~L~h 236 (383)
+.++++.
T Consensus 364 ~~eil~~ 370 (375)
T cd05104 364 FKQIVQL 370 (375)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.75 Aligned_cols=228 Identities=32% Similarity=0.563 Sum_probs=194.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+++++.+|+.||+|++.+ ....+.+|+.+++...+||||+++++++.+++..+++||++. +++|.+.+
T Consensus 15 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 93 (280)
T cd05581 15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP-NGELLQYI 93 (280)
T ss_pred eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC-CCcHHHHH
Confidence 3699999999999999999875 235678889999844349999999999999999999999999 99999876
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-------------
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE------------- 137 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~------------- 137 (383)
... .+..+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 94 ~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (280)
T cd05581 94 RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170 (280)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEecCCccccccCCccccccCCCCCccccc
Confidence 543 345666999999999999999999999999999765 6899999999886543221
Q ss_pred --------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCC
Q psy6377 138 --------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDIS 209 (383)
Q Consensus 138 --------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 209 (383)
.....|+..|+|||++....++.++|+||||++++++++|+.||...+....+..+......+|. .++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 246 (280)
T cd05581 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP----NFP 246 (280)
T ss_pred cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC----ccC
Confidence 12245788999999998888999999999999999999999999988877777777666655553 558
Q ss_pred HHHHHHHHHhcccCCCCCCCH----HHHHcCccc
Q psy6377 210 PEAKDFIAKILIKNPMERMTA----KEALKHPWL 239 (383)
Q Consensus 210 ~~~~~li~~~L~~dP~~Rpt~----~e~L~hp~~ 239 (383)
+.+.+||.+||..+|++|||+ +++|+||||
T Consensus 247 ~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 247 PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.50 Aligned_cols=231 Identities=29% Similarity=0.435 Sum_probs=194.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||.+.+..+++.||+|++... ...+.+|+++++ .++||||+++++.+...+..|+++|++. |++|.+++...
T Consensus 34 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 111 (286)
T cd06614 34 EVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK-DCKHPNIVDYYDSYLVGDELWVVMEYMD-GGSLTDIITQNFV 111 (286)
T ss_pred EEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHH-HCCCCCeeEEEEEEEECCEEEEEEeccC-CCcHHHHHHHhcc
Confidence 6899999999999999999862 457889999998 7789999999999999999999999999 99999977654
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
....++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+
T Consensus 112 ~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 188 (286)
T cd06614 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD---GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC---CCEEECccchhhhhccchhhhccccCCcccCCHhHh
Confidence 234566999999999999999999999999999865 689999999877543321 12334578899999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|+|||||++|+|++|..||.+.........+...... +......++..+.+||.+||..+|.+|||+.++
T Consensus 189 ~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 8888999999999999999999999999887766555555433222 112223478999999999999999999999999
Q ss_pred HcCcccCC
Q psy6377 234 LKHPWLMN 241 (383)
Q Consensus 234 L~hp~~~~ 241 (383)
++||||..
T Consensus 268 l~~~~~~~ 275 (286)
T cd06614 268 LQHPFLKK 275 (286)
T ss_pred hhChHhhc
Confidence 99999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=306.89 Aligned_cols=232 Identities=30% Similarity=0.448 Sum_probs=204.9
Q ss_pred EEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 6 EEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
|-++.-+.....||+|++++ ..+.+..|-.||. ....|.||++|-.|.++..+|+.||-|- ||+|+.++..
T Consensus 436 VELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~-~~~s~fIvrLYrTfrd~kyvYmLmEaCl-GGElWTiLrd 513 (732)
T KOG0614|consen 436 VELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMM-ECRSDFIVRLYRTFRDSKYVYMLMEACL-GGELWTILRD 513 (732)
T ss_pred EEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHH-hcCchHHHHHHHHhccchhhhhhHHhhc-Cchhhhhhhh
Confidence 34444444444699999988 3456888899998 5669999999999999999999999999 9999997654
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
....++...+++|++|||++|||+|||||+|+|++.+ |-+||.|||+|+.+..+....++||||.|.|||+
T Consensus 514 Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~---Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEI 590 (732)
T KOG0614|consen 514 RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR---GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEI 590 (732)
T ss_pred cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC---CceEEeehhhHHHhccCCceeeecCCcccccchh
Confidence 3456777999999999999999999999999999766 7999999999999999999999999999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
+...+.+.++|.||||+++||||+|.|||.+.++..++..|.++. ..+| ..++..+.+||+++...+|.+|..
T Consensus 591 ILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P----r~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 591 ILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP----RRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred hhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc----cccchhHHHHHHHHHhcCcHhhhcc
Confidence 999999999999999999999999999999999999999998875 4444 467999999999999999999996
Q ss_pred ----HHHHHcCcccCCcchhh
Q psy6377 230 ----AKEALKHPWLMNKKQIM 246 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~~~ 246 (383)
+.++-+|-||.+....-
T Consensus 667 ~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 667 QKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred ccCChHHHHhhhhhhcCChhh
Confidence 88999999999866543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.12 Aligned_cols=224 Identities=18% Similarity=0.226 Sum_probs=183.1
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|+++ .++..||+|.+.. ....+.+|+.+++ .++||||+++++++.++...++||||++ +++|.+
T Consensus 21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 98 (277)
T cd05062 21 MVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPTLVIMELMT-RGDLKS 98 (277)
T ss_pred eEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCeEEEEecCC-CCCHHH
Confidence 68888764 3467899999865 2335778999998 7899999999999999999999999999 999999
Q ss_pred hhccC----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 75 IIDDN----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 75 ~l~~~----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
++... .+..++.|++.||.|||+.|++||||||+||+++++ +.++|+|||+++.......
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~---~~~~l~dfg~~~~~~~~~~~ 175 (277)
T cd05062 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC---CCEEECCCCCccccCCccee
Confidence 76431 123456899999999999999999999999999865 6899999999876533221
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+....... ....++..+.+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 252 (277)
T cd05062 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD---KPDNCPDMLFE 252 (277)
T ss_pred ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHHH
Confidence 112345778999999998889999999999999999998 789999888777776665544322 12457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++.+||..||++|||+.+++++
T Consensus 253 li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 253 LMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.86 Aligned_cols=221 Identities=22% Similarity=0.307 Sum_probs=188.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||.|..+. ...||+|.+.. ....+.+|+.+|+ .+.|+|||++++++..+..+||||||++ .|+|.+++...
T Consensus 221 ~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk-~L~H~~lV~l~gV~~~~~piyIVtE~m~-~GsLl~yLr~~~~ 297 (468)
T KOG0197|consen 221 EVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMK-KLRHEKLVKLYGVCTKQEPIYIVTEYMP-KGSLLDYLRTREG 297 (468)
T ss_pred eEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHH-hCcccCeEEEEEEEecCCceEEEEEecc-cCcHHHHhhhcCC
Confidence 689998753 33789999876 4578889999999 8899999999999999889999999999 99999988751
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~gt~~y~aPE 151 (383)
..+.+..||++|++||+++++|||||-..||||+.+ ..+||+|||+|+...++.... ....+..|.|||
T Consensus 298 ~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~---~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPE 374 (468)
T KOG0197|consen 298 GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED---LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPE 374 (468)
T ss_pred CccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC---ceEEEcccccccccCCCceeecCCCCCCceecCHH
Confidence 234566999999999999999999999999999876 589999999999654433321 122345799999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+....|+.++|||||||+||||+| |+.||.+.+..+.++.+..|..=+. +..+|+++-+++..||..+|++|||+
T Consensus 375 a~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 375 ALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PEGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CCCCCHHHHHHHHHHhhCCcccCCCH
Confidence 9999999999999999999999999 9999999999999999988753222 24689999999999999999999999
Q ss_pred HHHH
Q psy6377 231 KEAL 234 (383)
Q Consensus 231 ~e~L 234 (383)
+.+.
T Consensus 452 ~~L~ 455 (468)
T KOG0197|consen 452 ETLR 455 (468)
T ss_pred HHHH
Confidence 9664
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=289.92 Aligned_cols=227 Identities=24% Similarity=0.356 Sum_probs=186.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||++.+..+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++++.+++..|+|+||+. +++.+.+.
T Consensus 30 ~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~--g~l~~~~~ 106 (307)
T cd06607 30 AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-QLRHPNTIEYKGCYLREHTAWLVMEYCL--GSASDILE 106 (307)
T ss_pred EEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEEeCCeEEEEHHhhC--CCHHHHHH
Confidence 689999999999999999864 1245789999999 7789999999999999999999999997 56655432
Q ss_pred -------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 -------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 -------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
...+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++...... ....|++.|+||
T Consensus 107 ~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~---~~~kL~dfg~~~~~~~~---~~~~~~~~y~aP 180 (307)
T cd06607 107 VHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP---GTVKLADFGSASLVSPA---NSFVGTPYWMAP 180 (307)
T ss_pred HcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC---CCEEEeecCcceecCCC---CCccCCccccCc
Confidence 23344566899999999999999999999999999765 68999999998765332 345688999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|++. ...++.++||||||+++|+|++|.+||.+.+.......+.... .+......++..+.++|.+||..+|++|
T Consensus 181 E~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (307)
T cd06607 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLSSNDWSDYFRNFVDSCLQKIPQDR 258 (307)
T ss_pred eeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--CCCCCchhhCHHHHHHHHHHhcCChhhC
Confidence 9874 4568899999999999999999999998877665554443322 1111123468899999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+.+++.|||+...
T Consensus 259 p~~~~il~~~~~~~~ 273 (307)
T cd06607 259 PSSEELLKHRFVLRE 273 (307)
T ss_pred cCHHHHhcChhhccc
Confidence 999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.23 Aligned_cols=234 Identities=24% Similarity=0.371 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|.+..+|+.||||.+.. ....+.+|+.++....+||||+++++++.++...|++||++. +.|..++..
T Consensus 30 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~--~~l~~l~~~~ 107 (296)
T cd06618 30 QVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRI 107 (296)
T ss_pred EEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC--cCHHHHHHHh
Confidence 689999999999999999975 223456778777657679999999999999999999999986 566664422
Q ss_pred ------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||+|||+ .||+||||+|+||+++.+ +.++|+|||++.............+++.|+|||
T Consensus 108 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE 184 (296)
T cd06618 108 QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS---GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184 (296)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC---CCEEECccccchhccCCCcccCCCCCccccCHh
Confidence 2334677999999999997 599999999999999765 689999999988664433334446788999999
Q ss_pred ccccCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 152 ILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 152 ~l~~~~----~~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+..+........ .....++.++.+|+.+||..||++
T Consensus 185 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~ 263 (296)
T cd06618 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFSPDFCSFVDLCLTKDHRK 263 (296)
T ss_pred hcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHHccCChhh
Confidence 987553 78999999999999999999999976433 333444433322111 111247889999999999999999
Q ss_pred CCCHHHHHcCcccCCcch
Q psy6377 227 RMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~~ 244 (383)
|||+++++.|||+.....
T Consensus 264 Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 264 RPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCCHHHHhcChhhhccch
Confidence 999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.11 Aligned_cols=222 Identities=25% Similarity=0.331 Sum_probs=187.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEE-EEe--C----CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDV-FQT--G----EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~-~~~--~----~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++...|..||+|.+.. ....+.+||++++++.+|||||.++|. ... . -.++|.||||. ||.|-
T Consensus 52 ~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~-gg~Lv 130 (738)
T KOG1989|consen 52 QVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCK-GGSLV 130 (738)
T ss_pred EEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhcc-CCcHH
Confidence 589999999989999998876 346688999999988899999999993 221 1 24678899999 99999
Q ss_pred Hhhc--------cCCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-c----
Q psy6377 74 TIID--------DNLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-I---- 138 (383)
Q Consensus 74 ~~l~--------~~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~---- 138 (383)
+++. +.+++.+++|+++||.+||... |||||||-||||+..+ +.+||||||-|........ .
T Consensus 131 d~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~---g~~KLCDFGSatt~~~~~~~~~e~~ 207 (738)
T KOG1989|consen 131 DFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD---GNYKLCDFGSATTKILSPTSAQEVN 207 (738)
T ss_pred HHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC---CCEEeCcccccccccCCCccHHHHH
Confidence 9754 6678899999999999999998 9999999999999876 6899999999875433221 0
Q ss_pred -----ccccCCCCcCCCccc---ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 139 -----RELLGTPDYVAPEIL---HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 139 -----~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
-...-|+.|+|||++ .+.+++.|+|||+|||+||-|+....||.+... ..|..+.+.+|+. +.++.
T Consensus 208 ~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~--p~ys~ 281 (738)
T KOG1989|consen 208 YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPF--PNYSD 281 (738)
T ss_pred HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCC--ccHHH
Confidence 012479999999986 578899999999999999999999999987643 3466789998864 67899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+++||+.||+.||++||++.|++.+
T Consensus 282 ~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 282 RLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHHhccCcccCCCHHHHHHH
Confidence 99999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=293.23 Aligned_cols=237 Identities=30% Similarity=0.407 Sum_probs=188.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|.+..+|+.+|+|.+.+ ....+.+|+.+++.+.+||||+++++++... ...|+|||++. ++|...+
T Consensus 22 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~--~~L~~~~ 99 (337)
T cd07852 22 IVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME--TDLHAVI 99 (337)
T ss_pred eEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc--cCHHHHH
Confidence 589999999999999998854 2345778999999443999999999998654 36899999997 5888866
Q ss_pred ccC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc------ccccccCCC
Q psy6377 77 DDN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI------EIRELLGTP 145 (383)
Q Consensus 77 ~~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~------~~~~~~gt~ 145 (383)
... ....++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++....... ......||+
T Consensus 100 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 176 (337)
T cd07852 100 RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDYVATR 176 (337)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccchhccccccccccCcchhcccccc
Confidence 442 334566999999999999999999999999999866 689999999988654322 233457899
Q ss_pred CcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-------------------------
Q psy6377 146 DYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLD------------------------- 199 (383)
Q Consensus 146 ~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~------------------------- 199 (383)
.|+|||.+.+ ..++.++|+||||+++|+|++|++||.+....+....+......
T Consensus 177 ~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (337)
T cd07852 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP 256 (337)
T ss_pred cccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccccc
Confidence 9999998754 55789999999999999999999999877665554443322111
Q ss_pred --CCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 200 --FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 200 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
......+.++.++.+||.+||..||++|||+.++++|||+....+..
T Consensus 257 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~ 305 (337)
T cd07852 257 RKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS 305 (337)
T ss_pred ccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence 11122345789999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=285.84 Aligned_cols=224 Identities=19% Similarity=0.271 Sum_probs=184.2
Q ss_pred eEEEEEE----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADS----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+. ..++..+|+|.+.. ....+.+|+.+++ .++||||+++++++..++..|++|||++ +++|.++
T Consensus 20 ~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 97 (283)
T cd05090 20 KIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA-ELHHPNIVCLLGVVTQEQPVCMLFEYLN-QGDLHEF 97 (283)
T ss_pred ceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHh-hCCCCCeeeEEEEEecCCceEEEEEcCC-CCcHHHH
Confidence 5888875 35668999999975 1246789999999 7789999999999999999999999999 9999987
Q ss_pred hcc-----------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 76 IDD-----------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 76 l~~-----------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+.. .....+..|++.||+|||++|++||||||+|||++.+ +.++|+|||+++..
T Consensus 98 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~ 174 (283)
T cd05090 98 LIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ---LHVKISDLGLSREI 174 (283)
T ss_pred HHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC---CcEEeccccccccc
Confidence 631 1224566899999999999999999999999999865 57999999999875
Q ss_pred ecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....+...... ..+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 251 (283)
T cd05090 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL---PCSEDC 251 (283)
T ss_pred cCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---CCCCCC
Confidence 43221 223446678999999988889999999999999999998 99999888776666655543322 233567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++.+.+++.+||..||.+||++.+++++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 252 PPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.05 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=182.1
Q ss_pred eEEEEEEcCCCcE--EEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEV--FAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~--vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|.. +|+|.+.. ....+.+|+.++..+.+||||+++++++.+++..|++|||++ +++|.+++.
T Consensus 22 ~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 100 (303)
T cd05088 22 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP-HGNLLDFLR 100 (303)
T ss_pred eEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC-CCcHHHHHH
Confidence 6899999888865 57776654 124577899999856589999999999999999999999999 999999764
Q ss_pred cC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 78 DN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 78 ~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
.. .++.+..|++.||+|||++|++||||||+|||++.+ +.++|+|||++......
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~ 177 (303)
T cd05088 101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVY 177 (303)
T ss_pred hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC---CcEEeCccccCcccchh
Confidence 32 234566999999999999999999999999999765 58999999998743221
Q ss_pred cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 136 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ....+..++.++.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 254 (303)
T cd05088 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYD 254 (303)
T ss_pred hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC---cCCCCCCCCHHHHH
Confidence 11112234667999999988889999999999999999998 999998887777666554321 11223457899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
|+.+||..+|++|||+++++.+
T Consensus 255 li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 255 LMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=294.92 Aligned_cols=237 Identities=29% Similarity=0.391 Sum_probs=188.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|.+..+|+.||+|.+.+ ....+.+|+.+++ .++||||+++++++... ...|++++++ |++|
T Consensus 32 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~--~~~L 108 (345)
T cd07877 32 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADL 108 (345)
T ss_pred EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHH-HcCCCcccceeeeeeecccccccccEEEEehhc--ccCH
Confidence 589999999999999999875 1346778999999 77899999999998654 3467777776 6888
Q ss_pred HHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.+++.. ..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++..... ......|++.|
T Consensus 109 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~dfg~~~~~~~--~~~~~~~~~~y 183 (345)
T cd07877 109 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTDD--EMTGYVATRWY 183 (345)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---CCEEEecccccccccc--cccccccCCCc
Confidence 876543 3445667999999999999999999999999999865 6899999999886432 33456789999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------ 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 202 (383)
+|||++.+ ..++.++|+||+||++|+|++|++||.+.+....+..+.......++
T Consensus 184 ~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (345)
T cd07877 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 263 (345)
T ss_pred cCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCc
Confidence 99999865 56889999999999999999999999877665555444332221111
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhccc
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRV 249 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~ 249 (383)
..+...++++.+||.+||..||.+|||+.+++.||||.........+
T Consensus 264 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~ 313 (345)
T cd07877 264 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 313 (345)
T ss_pred chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence 11224578899999999999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=288.87 Aligned_cols=230 Identities=27% Similarity=0.383 Sum_probs=181.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC--------eEEEEEecCCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--------GAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--------~~~lv~e~~~~g 69 (383)
..||+|+++.+|+.+|+|.+.. ......+|+++++ .++||||+++++++.+.. .+|++++|+.
T Consensus 22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-- 98 (311)
T cd07866 22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK-KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-- 98 (311)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHH-hcCCCCccchhhheecccccccccCceEEEEEecCC--
Confidence 3799999999999999998864 1245788999999 779999999999885443 4699999987
Q ss_pred CcHHHhh-------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----
Q psy6377 70 VTLQTII-------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----- 137 (383)
Q Consensus 70 ~~L~~~l-------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----- 137 (383)
++|...+ ....+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++........
T Consensus 99 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~ 175 (311)
T cd07866 99 HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGG 175 (311)
T ss_pred cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECcCccchhccCCCcccccC
Confidence 4566543 233455677999999999999999999999999999765 6899999999986533211
Q ss_pred -------cccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------
Q psy6377 138 -------IRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------- 202 (383)
Q Consensus 138 -------~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------- 202 (383)
.....|++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+.......+.......++
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T cd07866 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWR 255 (311)
T ss_pred CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 122357889999998765 45889999999999999999999999988776665554432111110
Q ss_pred -------------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 -------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+...++.+.+||.+||..||.+|||+.+++.||||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 256 SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1123456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=278.95 Aligned_cols=222 Identities=19% Similarity=0.271 Sum_probs=185.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||++..+ .+..+|+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..+++|||++ +++|.+.+...
T Consensus 19 ~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~~ 95 (256)
T cd05114 19 VVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMM-KLSHPKLVQLYGVCTQQKPLYIVTEFME-NGCLLNYLRQRQG 95 (256)
T ss_pred eEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHH-HCCCCCceeEEEEEccCCCEEEEEEcCC-CCcHHHHHHhCcc
Confidence 68888775 456899998876 3467889999999 7789999999999999999999999999 99999976432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~gt~~y~aPE~ 152 (383)
....+..|++.||+|||++|++||||||+||+++.+ +.++|+|||+++......... ...++..|+|||.
T Consensus 96 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~ 172 (256)
T cd05114 96 KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC---CeEEECCCCCccccCCCceeccCCCCCchhhCChhh
Confidence 234556899999999999999999999999999765 589999999988653322221 2235568999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++|+||+|+++|+|++ |++||.+.+..+....+..+.....+ ...+..+.+++.+||..+|++|||++
T Consensus 173 ~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~ 249 (256)
T cd05114 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFA 249 (256)
T ss_pred cccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHH
Confidence 998889999999999999999999 99999998888888877765433222 34578899999999999999999999
Q ss_pred HHHc
Q psy6377 232 EALK 235 (383)
Q Consensus 232 e~L~ 235 (383)
++++
T Consensus 250 ~l~~ 253 (256)
T cd05114 250 ELLR 253 (256)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.36 Aligned_cols=236 Identities=28% Similarity=0.407 Sum_probs=189.9
Q ss_pred eEEEEEEcCCCc----EEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGE----VFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~----~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+.+.++. .||+|.++. -....-||+.+++ -+.|||++.+..+|-+ +..++++++|.+ -+|.
T Consensus 39 ~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~R-El~h~nvi~Lv~Vfl~~d~~v~l~fdYAE--hDL~ 115 (438)
T KOG0666|consen 39 KVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLR-ELKHPNVISLVKVFLSHDKKVWLLFDYAE--HDLW 115 (438)
T ss_pred eeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHH-HhcCCcchhHHHHHhccCceEEEEehhhh--hhHH
Confidence 588997776654 689999876 2456789999999 8899999999999987 778999999998 8888
Q ss_pred Hhhc-----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-CCcEEEEeccceeEeecCcc----
Q psy6377 74 TIID-----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-NCDIKVCDFEISRVILDGIE---- 137 (383)
Q Consensus 74 ~~l~-----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-~~~ikL~DFGla~~~~~~~~---- 137 (383)
.+|. ...+..++.||+.|+.|||++-|+||||||.|||+..+.+ .|.|||+|||+|+.+...-.
T Consensus 116 ~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s 195 (438)
T KOG0666|consen 116 HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLAS 195 (438)
T ss_pred HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccccc
Confidence 8753 2234567799999999999999999999999999987643 48999999999998754322
Q ss_pred cccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhccCCCCcchhcC
Q psy6377 138 IRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETD---------SETFRNISKAQLDFPDELFED 207 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~ 207 (383)
....+.|.+|+|||.+.+ ..|+.+.|+||+|||+.||++-.|.|.|... .+++.+|...-..+....|+.
T Consensus 196 ~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~ 275 (438)
T KOG0666|consen 196 LDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPD 275 (438)
T ss_pred CCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchh
Confidence 233567999999999876 4599999999999999999999999977532 345566655443333222221
Q ss_pred ---------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 208 ---------------------------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 208 ---------------------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
-++.+.+|+.+||++||-+|.|++++|+|+||....
T Consensus 276 lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 276 LKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred hhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 245689999999999999999999999999998754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=276.52 Aligned_cols=229 Identities=31% Similarity=0.422 Sum_probs=191.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~ 75 (383)
..||.|.+..+|+.|++|++... ...+.+|+.+++ .++||||+++++.+.+. ...++++|++. +++|.++
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 91 (260)
T cd06606 14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILS-SLQHPNIVRYYGSERDEEKNTLNIFLEYVS-GGSLSSL 91 (260)
T ss_pred eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-HcCCCCEeeEEEEEecCCCCeEEEEEEecC-CCcHHHH
Confidence 37899999999999999998762 456889999999 77899999999999988 89999999998 8999997
Q ss_pred hccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCC
Q psy6377 76 IDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPD 146 (383)
Q Consensus 76 l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~ 146 (383)
+... .++.+..|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+........ .....++..
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (260)
T cd06606 92 LKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168 (260)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEcccccEEecccccccccccCCCCCcc
Confidence 6543 334667999999999999999999999999999875 6899999999988765443 345678999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||.+....++.++|+||||+++|+|++|..||..... ......+.. ..........++..+.+||.+||..+|+
T Consensus 169 y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~ 246 (260)
T cd06606 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEAKDFLRKCLRRDPK 246 (260)
T ss_pred ccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHHHHHHHHhCcCChh
Confidence 9999999888899999999999999999999999987762 222222221 1112223345689999999999999999
Q ss_pred CCCCHHHHHcCccc
Q psy6377 226 ERMTAKEALKHPWL 239 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~ 239 (383)
+||++.+++.||||
T Consensus 247 ~Rp~~~~ll~~~~~ 260 (260)
T cd06606 247 KRPTADELLQHPFL 260 (260)
T ss_pred hCCCHHHHhhCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=293.16 Aligned_cols=233 Identities=28% Similarity=0.371 Sum_probs=189.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|.+..+|+.||||.+.. ....+.+|+.+++ .++||||++++++|..+. .+++||+++ |++|
T Consensus 30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~--~~~l 106 (343)
T cd07880 30 TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDL 106 (343)
T ss_pred EEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCCccceeeeecCCccccccceEEEEEecC--CCCH
Confidence 589999999999999999865 1245778999999 779999999999998654 358999988 5788
Q ss_pred HHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.+++.. ..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++..... ......+++.|
T Consensus 107 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~--~~~~~~~~~~y 181 (343)
T cd07880 107 GKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQTDS--EMTGYVVTRWY 181 (343)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeccccccccc--CccccccCCcc
Confidence 876543 3455677999999999999999999999999999765 6899999999986533 23345689999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------ 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 202 (383)
+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+.......+.
T Consensus 182 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07880 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK 261 (343)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcc
Confidence 99999865 45889999999999999999999999887765555554433222111
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..+..++..+.++|.+||..||++|||+.+++.||||+.....
T Consensus 262 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 262 DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 1234678899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=294.61 Aligned_cols=235 Identities=27% Similarity=0.367 Sum_probs=186.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeC--------------CeEEEEEec
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--------------EGAYYVSWN 65 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--------------~~~~lv~e~ 65 (383)
..||+|.++.+|+.||+|.+.. ....+.+|+++++ ..+||||+++++++... ...|++||+
T Consensus 19 g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 97 (342)
T cd07854 19 GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIR-RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY 97 (342)
T ss_pred EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHH-hcCCCcchhhHhhhcccccccccccccccccceEEEEeec
Confidence 3689999999999999999865 2456889999999 77999999999887654 357899999
Q ss_pred CCCcCcHHHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---
Q psy6377 66 TPLVVTLQTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--- 137 (383)
Q Consensus 66 ~~~g~~L~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--- 137 (383)
+. ++|.+.+.. ..+..++.||+.||.|||+.||+||||||+||+++.++ +.++|+|||++........
T Consensus 98 ~~--~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--~~~kl~dfg~~~~~~~~~~~~~ 173 (342)
T cd07854 98 ME--TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--LVLKIGDFGLARIVDPHYSHKG 173 (342)
T ss_pred cc--ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--ceEEECCcccceecCCcccccc
Confidence 97 588876543 34556779999999999999999999999999997542 5789999999986532211
Q ss_pred -cccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC---------------
Q psy6377 138 -IRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF--------------- 200 (383)
Q Consensus 138 -~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~--------------- 200 (383)
.....|++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (342)
T cd07854 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSF 253 (342)
T ss_pred ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 123467889999998654 568899999999999999999999998877655544433221000
Q ss_pred -----------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 201 -----------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 201 -----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.....+.++.++.+||.+||..||.+|||+.++|.||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 254 VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 0112245788999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.70 Aligned_cols=224 Identities=22% Similarity=0.305 Sum_probs=187.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC---
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL--- 80 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~--- 80 (383)
..||+++- -++.||||.++ +.-..+|+.|+ .++||||+.+.+++....-+++|||||. .|.|..+++...
T Consensus 138 GAVF~Grl--~netVAVKKV~---elkETdIKHLR-kLkH~NII~FkGVCtqsPcyCIiMEfCa-~GqL~~VLka~~~it 210 (904)
T KOG4721|consen 138 GAVFLGRL--HNETVAVKKVR---ELKETDIKHLR-KLKHPNIITFKGVCTQSPCYCIIMEFCA-QGQLYEVLKAGRPIT 210 (904)
T ss_pred cceeeeec--cCceehhHHHh---hhhhhhHHHHH-hccCcceeeEeeeecCCceeEEeeeccc-cccHHHHHhccCccC
Confidence 46888874 48899999865 45567899999 8899999999999999999999999999 999999887654
Q ss_pred ---chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCC
Q psy6377 81 ---VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEP 157 (383)
Q Consensus 81 ---~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 157 (383)
...|..+|+.|+.|||.+.|||||||.-|||++.++ .|||+|||.++...+....-.++||..|||||++..++
T Consensus 211 p~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP 287 (904)
T KOG4721|consen 211 PSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP 287 (904)
T ss_pred HHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC
Confidence 235569999999999999999999999999998774 89999999999876655555689999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6377 158 ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237 (383)
Q Consensus 158 ~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 237 (383)
.+.|+|||||||+|||||||..||.+-+...++--+-.....+| ....+++.++-||+.||.-.|..||++.++|.|-
T Consensus 288 csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 288 CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999999999987665433322222222222 2346788999999999999999999999999984
Q ss_pred cc
Q psy6377 238 WL 239 (383)
Q Consensus 238 ~~ 239 (383)
=+
T Consensus 366 dI 367 (904)
T KOG4721|consen 366 DI 367 (904)
T ss_pred hh
Confidence 33
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.83 Aligned_cols=231 Identities=29% Similarity=0.414 Sum_probs=186.3
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||.|.+. .+|+.||+|++.. ....+.+|+.+++...+||||++++++|+.+...|+|+|+++ +++|.
T Consensus 15 ~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~ 93 (290)
T cd05613 15 KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYIN-GGELF 93 (290)
T ss_pred eEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCC-CCcHH
Confidence 58888875 4899999999875 135577899999966689999999999999999999999999 99999
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTP 145 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~ 145 (383)
+.+.. ..+..+..|++.||.|||+.|++||||+|+|||++.+ +.++|+|||++....... ......|++
T Consensus 94 ~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 170 (290)
T cd05613 94 THLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFHEDEVERAYSFCGTI 170 (290)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC---CCEEEeeCccceecccccccccccccCCc
Confidence 97543 2334455799999999999999999999999999765 689999999998754322 223456899
Q ss_pred CcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 146 DYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 146 ~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
.|+|||.+.. ..++.++|+||||+++|+|++|..||...... +....+.....++ ...++..+.+++.+|
T Consensus 171 ~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~ 246 (290)
T cd05613 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDIIQRL 246 (290)
T ss_pred ccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----CccCCHHHHHHHHHH
Confidence 9999999865 34688999999999999999999999754332 2233333333222 345789999999999
Q ss_pred cccCCCCCC-----CHHHHHcCcccCCcc
Q psy6377 220 LIKNPMERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 220 L~~dP~~Rp-----t~~e~L~hp~~~~~~ 243 (383)
|..||++|| ++++++.||||+...
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=284.89 Aligned_cols=227 Identities=22% Similarity=0.325 Sum_probs=187.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.||+|.+.. ....+.+|+.+++ ..+|||++++++++.+.+..|+|||++. +++.+.+.
T Consensus 36 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~ 112 (313)
T cd06633 36 AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ-QLKHPNTIEYKGCYLKEHTAWLVMEYCL--GSASDLLE 112 (313)
T ss_pred EEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEEEecCC--CCHHHHHH
Confidence 689999999999999999875 1245778999999 7789999999999999999999999997 56666443
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.... ......|++.|+||
T Consensus 113 ~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~---~~~kL~dfg~~~~~~---~~~~~~~~~~y~aP 186 (313)
T cd06633 113 VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASKSS---PANSFVGTPYWMAP 186 (313)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC---CCEEEeecCCCcccC---CCCCccccccccCh
Confidence 2 2234566899999999999999999999999999765 689999999986532 23345789999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|.+. ...++.++|+|||||++|+|++|.+||.+.+.......+.... .+......++..+++|+.+||.++|.+|
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~P~~R 264 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQSNEWTDSFRGFVDYCLQKIPQER 264 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCccccCHHHHHHHHHHccCChhhC
Confidence 9974 4568899999999999999999999998877666665554432 2222334567889999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+.+++.||||...
T Consensus 265 p~~~~~l~~~~~~~~ 279 (313)
T cd06633 265 PASAELLRHDFVRRD 279 (313)
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.65 Aligned_cols=232 Identities=27% Similarity=0.370 Sum_probs=198.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||.|.+..||+..|+|-+.. ....+.+|..+|. .++|||+|++|++=.+.+..++.||||. ||+|.++++
T Consensus 1249 G~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE-~lnHpNlV~YyGVEvHRekv~IFMEyC~-~GsLa~ll~ 1326 (1509)
T KOG4645|consen 1249 GKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLE-GLNHPNLVRYYGVEVHREKVYIFMEYCE-GGSLASLLE 1326 (1509)
T ss_pred eeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHH-hccCccccccCceeecHHHHHHHHHHhc-cCcHHHHHH
Confidence 4799999999999999998875 3567889999999 8999999999999989999999999999 999999876
Q ss_pred cCCch------hhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----cccccccCCCC
Q psy6377 78 DNLVV------PFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----IEIRELLGTPD 146 (383)
Q Consensus 78 ~~~~~------~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-----~~~~~~~gt~~ 146 (383)
...+. .+..|++.|+.|||+.|||||||||+||+++.+ |.+|++|||.|..+... ..+....|||.
T Consensus 1327 ~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~---g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~ 1403 (1509)
T KOG4645|consen 1327 HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN---GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPM 1403 (1509)
T ss_pred hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC---CcEEeecccceeEecCchhcCCHHHHhhcCCch
Confidence 65432 333899999999999999999999999999865 69999999999987543 23556789999
Q ss_pred cCCCccccc---CCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 147 YVAPEILHY---EPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 147 y~aPE~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|||||++.+ ++..-+.|||||||++.||+||+.||.. ++.+.++..+-.|..+.. +..+|++.++||.+||..
T Consensus 1404 YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P~~ls~~g~dFle~Cl~~ 1480 (1509)
T KOG4645|consen 1404 YMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---PERLSSEGRDFLEHCLEQ 1480 (1509)
T ss_pred hcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---chhhhHhHHHHHHHHHhc
Confidence 999999965 4567899999999999999999999965 455677777766654332 245899999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCcc
Q psy6377 223 NPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
||++|+++.|+|+|.|-+...
T Consensus 1481 dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1481 DPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred CchhhhHHHHHHHhhcccccc
Confidence 999999999999999876543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=285.36 Aligned_cols=223 Identities=21% Similarity=0.273 Sum_probs=184.4
Q ss_pred eEEEEEE-----cCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADS-----IATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||++.. ..++..+|+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..+++|||+. +++|.++
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 97 (288)
T cd05093 20 KVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT-NLQHEHIVKFYGVCVEGDPLIMVFEYMK-HGDLNKF 97 (288)
T ss_pred eEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCccEEEEEcCC-CCCHHHH
Confidence 5777764 34567799999876 2446889999999 7789999999999999999999999999 9999987
Q ss_pred hcc-------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 76 IDD-------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 76 l~~-------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
+.. ..++.+..|++.||+|||++|++||||||+|||++.+ +.++|+|||++.......
T Consensus 98 i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~~ 174 (288)
T cd05093 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMSRDVYSTD 174 (288)
T ss_pred HHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC---CcEEeccCCccccccCCc
Confidence 642 2234566999999999999999999999999999765 689999999998653322
Q ss_pred c---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHH
Q psy6377 137 E---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212 (383)
Q Consensus 137 ~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 212 (383)
. .....+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.+....+....+..+..... ...++.++
T Consensus 175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l 251 (288)
T cd05093 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR---PRTCPKEV 251 (288)
T ss_pred eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHH
Confidence 1 122345778999999998889999999999999999998 9999998887777777776653221 23578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6377 213 KDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+|+.+||..||.+|||+.+++.
T Consensus 252 ~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 252 YDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=284.68 Aligned_cols=224 Identities=17% Similarity=0.264 Sum_probs=185.8
Q ss_pred eEEEEEEcCC-----CcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIAT-----GEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~t-----g~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+..+ ++.||+|++... ...+.+|+.++. .++||||+++++++.+....+++++++. +++|.+
T Consensus 20 ~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~~~~e~~~-~~~l~~ 97 (283)
T cd05091 20 KVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRS-RLQHPNIVCLLGVVTKEQPLSMIFSYCS-HSDLHE 97 (283)
T ss_pred eEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEcCCCceEEEEEcCC-CCcHHH
Confidence 5899987543 688999999862 245778998888 7899999999999999999999999999 999998
Q ss_pred hhcc----------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 75 IIDD----------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 75 ~l~~----------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
++.. ..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~ 174 (283)
T cd05091 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK---LNVKISDLGLFREV 174 (283)
T ss_pred HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC---CceEeccccccccc
Confidence 7531 1133566899999999999999999999999999765 57999999998865
Q ss_pred ecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.+....+....+....... ....+
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~ 251 (283)
T cd05091 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP---CPDDC 251 (283)
T ss_pred ccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCC
Confidence 43222 223456789999999988889999999999999999998 899999888888887777665432 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+..+.+|+.+||+.+|.+||++++++..
T Consensus 252 ~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 252 PAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=286.77 Aligned_cols=225 Identities=20% Similarity=0.265 Sum_probs=182.5
Q ss_pred eEEEEEEcCCCc--EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGE--VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~--~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+.+.+|. .+++|.+.. ....+.+|+.++.++.+||||+++++++.+.+..|+++|+++ +++|.+++.
T Consensus 17 ~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 95 (297)
T cd05089 17 QVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP-YGNLLDFLR 95 (297)
T ss_pred eEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC-CCcHHHHHH
Confidence 689998887775 468888764 234688899999856589999999999999999999999999 899998764
Q ss_pred cC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 78 DN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 78 ~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
.. .+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~ 172 (297)
T cd05089 96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN---LASKIADFGLSRGEEVY 172 (297)
T ss_pred hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC---CeEEECCcCCCccccce
Confidence 32 234566999999999999999999999999999765 58999999998643221
Q ss_pred cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 136 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..+... .....++..+.+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 249 (297)
T cd05089 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM---EKPRNCDDEVYE 249 (297)
T ss_pred eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHHH
Confidence 11111223557999999998899999999999999999997 99999988877777766543211 122467899999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
|+.+||..+|.+|||++++++.
T Consensus 250 li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 250 LMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=282.63 Aligned_cols=223 Identities=15% Similarity=0.161 Sum_probs=183.0
Q ss_pred eEEEEEEc---CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSI---ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||++..+ ..+..||+|.+... ...+.+|+.+++ .++||||+++++++..++..++||||++ +++|.+++
T Consensus 20 ~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 97 (266)
T cd05064 20 ELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG-QFDHSNIVRLEGVITRGNTMMIVTEYMS-NGALDSFL 97 (266)
T ss_pred eEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEecCCCcEEEEEeCC-CCcHHHHH
Confidence 46787665 45779999998862 245778999998 6799999999999999999999999999 99999876
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccCCCCc
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDY 147 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~gt~~y 147 (383)
... .++.++.|++.||+|||++|++||||||+|||++.+ +.++++|||.+.......... ...+++.|
T Consensus 98 ~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 174 (266)
T cd05064 98 RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD---LVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174 (266)
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC---CcEEECCCcccccccccchhcccCCCCceee
Confidence 442 234666899999999999999999999999999765 689999999876543222111 22356789
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+|||.+.+..++.++|||||||++|++++ |..||.+.+..+....+..+... | ....++..+.+++.+||..+|.+
T Consensus 175 ~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-P--APRNCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred cCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHHHHHcCCCchh
Confidence 99999999999999999999999999775 99999998887777776654322 1 23567899999999999999999
Q ss_pred CCCHHHHHc
Q psy6377 227 RMTAKEALK 235 (383)
Q Consensus 227 Rpt~~e~L~ 235 (383)
|||++++++
T Consensus 252 RP~~~~i~~ 260 (266)
T cd05064 252 RPRFSQIHS 260 (266)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=302.39 Aligned_cols=226 Identities=23% Similarity=0.356 Sum_probs=195.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||-|++..|.+.||||.+.. -+..+..|++.|+ .+.|||++.+.++|-.+...|||||||- |+-.++++
T Consensus 41 AVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~-~l~HPntieYkgCyLre~TaWLVMEYCl--GSAsDlle 117 (948)
T KOG0577|consen 41 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLR-QLRHPNTIEYKGCYLREHTAWLVMEYCL--GSASDLLE 117 (948)
T ss_pred eeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHH-hccCCCcccccceeeccchHHHHHHHHh--ccHHHHHH
Confidence 589999999999999999976 3678999999999 8899999999999999999999999997 77777653
Q ss_pred -------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 -------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 -------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
+-.+..+..+.+.||+|||+.+.||||||..|||++.. |.|||+|||.|.... +..+++|||+||||
T Consensus 118 VhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~---g~VKLaDFGSAsi~~---PAnsFvGTPywMAP 191 (948)
T KOG0577|consen 118 VHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP---GLVKLADFGSASIMA---PANSFVGTPYWMAP 191 (948)
T ss_pred HHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC---CeeeeccccchhhcC---chhcccCCccccch
Confidence 23344555899999999999999999999999999865 799999999988754 34568999999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ-LDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|++. .+.|+-++||||||++..+|...+||+...+....+..|.... +.++. ..+|..+..||..||.+-|.+
T Consensus 192 EVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqe 268 (948)
T KOG0577|consen 192 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQE 268 (948)
T ss_pred hHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCccc
Confidence 9874 5679999999999999999999999999988877777776543 33333 456899999999999999999
Q ss_pred CCCHHHHHcCcccCCc
Q psy6377 227 RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~ 242 (383)
|||.+++|+|+|+...
T Consensus 269 Rptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 269 RPTSEELLKHRFVLRE 284 (948)
T ss_pred CCcHHHHhhcchhccC
Confidence 9999999999999754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=283.24 Aligned_cols=230 Identities=32% Similarity=0.449 Sum_probs=188.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ ...||||+++++++.+....++|+|++. ++|.+++.
T Consensus 13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~--~~l~~~i~ 89 (282)
T cd07829 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLK-ELKHPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLD 89 (282)
T ss_pred ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHH-hcCCCCHHHHHhhhhcCCceEEEecCcC--cCHHHHHH
Confidence 36899999999999999998862 245678999999 7789999999999999999999999998 48988765
Q ss_pred cC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCC
Q psy6377 78 DN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVA 149 (383)
Q Consensus 78 ~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~a 149 (383)
.. .+..++.|++.||+|||++||+||||+|+||+++.+ +.++|+|||++....... ......+++.|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~a 166 (282)
T cd07829 90 KRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD---GVLKLADFGLARAFGIPLRTYTHEVVTLWYRA 166 (282)
T ss_pred hhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC---CCEEEecCCcccccCCCccccCccccCcCcCC
Confidence 43 234566999999999999999999999999999875 689999999988764432 2334456788999
Q ss_pred CcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------c
Q psy6377 150 PEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-------------------------E 203 (383)
Q Consensus 150 PE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~ 203 (383)
||.+... .++.++|+|||||++|+|++|.+||.+.+..+.+..+........+ .
T Consensus 167 PE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd07829 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEK 246 (282)
T ss_pred hHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHH
Confidence 9998766 7899999999999999999999999988766665554332111111 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.++.++..+.++|.+||..+|++||++.+++.||||
T Consensus 247 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 247 VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 223457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=279.25 Aligned_cols=224 Identities=25% Similarity=0.348 Sum_probs=184.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+..+|+.||+|.+.. ....+.+|+.+++ ..+|+||+++++++.+.+..+++|||++ +++|..++.
T Consensus 17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 94 (267)
T cd08224 17 VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK-QLDHPNVIKYLASFIENNELNIVLELAD-AGDLSRMIK 94 (267)
T ss_pred EEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCeeeeeeeeecCCeEEEEEecCC-CCCHHHHHH
Confidence 689999999999999998864 2457889999999 7799999999999999999999999999 999998663
Q ss_pred c----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCC
Q psy6377 78 D----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPD 146 (383)
Q Consensus 78 ~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~ 146 (383)
. ..+..+..|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....... ......|++.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08224 95 HFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---CcEEEeccceeeeccCCCcccceecCCcc
Confidence 2 2345666899999999999999999999999999765 689999999988654322 2234568999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD--SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|+|||.+.+..++.++|+||+||++|+|++|..||.+... .+....+..+.. ++.....++..+.++|.+||..+|
T Consensus 172 y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p 249 (267)
T cd08224 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDP 249 (267)
T ss_pred ccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCc
Confidence 9999999888899999999999999999999999966542 233334333322 222223678899999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++++
T Consensus 250 ~~Rp~~~~il~ 260 (267)
T cd08224 250 EKRPDISYVLQ 260 (267)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=277.31 Aligned_cols=224 Identities=21% Similarity=0.259 Sum_probs=190.9
Q ss_pred eEEEEEEcCC---CcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIAT---GEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~t---g~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||.|..... +..||+|++... ...+.+|+++++ .++||||+++++++.+...++++||+++ +++|.+.+
T Consensus 10 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 87 (262)
T cd00192 10 EVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMK-KLGHPNVVRLLGVCTEEEPLYLVLEYME-GGDLLDYL 87 (262)
T ss_pred EEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHh-hcCCCChheeeeeecCCCceEEEEEecc-CCcHHHHH
Confidence 6899998866 999999999871 467889999999 6679999999999999999999999999 99999977
Q ss_pred ccC---------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---cc
Q psy6377 77 DDN---------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EI 138 (383)
Q Consensus 77 ~~~---------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~ 138 (383)
... ..+.++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~ 164 (262)
T cd00192 88 RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---LVVKISDFGLSRDVYDDDYYRKK 164 (262)
T ss_pred hhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---CcEEEcccccccccccccccccc
Confidence 553 234566999999999999999999999999999876 689999999998765432 23
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
....+++.|+|||.+....++.++|+||+|+++|+|++ |..||.+....+....+..+.. ......++.++.+++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~ 241 (262)
T cd00192 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEYCPDELYELML 241 (262)
T ss_pred cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCccCChHHHHHHH
Confidence 34567889999999988889999999999999999999 6999999887777777765322 1223466899999999
Q ss_pred HhcccCCCCCCCHHHHHcC
Q psy6377 218 KILIKNPMERMTAKEALKH 236 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~h 236 (383)
+||..+|.+|||+.|++++
T Consensus 242 ~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 242 SCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHccCCcccCcCHHHHHHh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.80 Aligned_cols=228 Identities=33% Similarity=0.473 Sum_probs=192.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||++++..+|+.||+|.+... ...+.+|+++++ .+.|||++++++++.++...+++|+++. +++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~ 91 (254)
T cd06627 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLK-NLKHPNIVKYIGSIETSDSLYIILEYAE-NGSLRQIIK 91 (254)
T ss_pred eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHH-hCCCCCccEEEEEEEeCCEEEEEEecCC-CCcHHHHHH
Confidence 47899999999999999999772 246889999998 6789999999999999999999999999 899998764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
. .....++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++........ .....+++.|+||
T Consensus 92 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~p 168 (254)
T cd06627 92 KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD---GVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168 (254)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC---CCEEEeccccceecCCCcccccccccchhhcCH
Confidence 4 2335666999999999999999999999999999864 6899999999987654332 2345688999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|.+.+..++.++|+||+|+++|+|++|..||...+.......+..... ......++..+.+++.+||..+|++|||+
T Consensus 169 e~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 245 (254)
T cd06627 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDFLMQCFQKDPNLRPTA 245 (254)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHHHhCChhhCcCH
Confidence 999888889999999999999999999999987765544444432221 12335678999999999999999999999
Q ss_pred HHHHcCccc
Q psy6377 231 KEALKHPWL 239 (383)
Q Consensus 231 ~e~L~hp~~ 239 (383)
.+++.||||
T Consensus 246 ~~~l~~~~~ 254 (254)
T cd06627 246 KQLLKHPWI 254 (254)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=279.36 Aligned_cols=223 Identities=19% Similarity=0.254 Sum_probs=184.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+++++ ++..+|+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||+++ |++|.+++...
T Consensus 19 ~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 95 (256)
T cd05059 19 VVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMM-KLSHPNLVQLYGVCTKQRPIFIVTEYMA-NGCLLNYLRERKG 95 (256)
T ss_pred eEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHH-hCCCCCEEEEEEEEcCCCceEEEEecCC-CCCHHHHHHhccc
Confidence 68999875 567899999876 3456889999999 7799999999999999999999999999 99999976432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||+|||++|++||||||+||+++.+ +.+||+|||+++......... ...++..|+|||.
T Consensus 96 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~ 172 (256)
T cd05059 96 KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED---NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEV 172 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC---CcEEECCcccceecccccccccCCCCCCccccCHHH
Confidence 234566999999999999999999999999999765 689999999998654332211 1223457999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++|+||||+++|+|++ |.+||.+.+..+....+..+.. ......++..+.+++.+||..+|++|||+.
T Consensus 173 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 249 (256)
T cd05059 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFK 249 (256)
T ss_pred hccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 998899999999999999999998 8999988877777766654421 122245799999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
++++.
T Consensus 250 ~~l~~ 254 (256)
T cd05059 250 KLLSQ 254 (256)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=281.69 Aligned_cols=224 Identities=21% Similarity=0.273 Sum_probs=181.6
Q ss_pred eEEEEEEcCCCc--EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGE--VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~--~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+++...+|. .+|+|.+.. ....+.+|+.++..+.+||||+++++++...+..|++||+++ +++|.+++.
T Consensus 10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~i~ 88 (270)
T cd05047 10 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP-HGNLLDFLR 88 (270)
T ss_pred eEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC-CCcHHHHHH
Confidence 689999988886 468888874 234677899999856589999999999999999999999999 999998764
Q ss_pred cC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 78 DN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 78 ~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
.. .+..+..|++.||+|||++|++||||||+|||++.+ +.++|+|||++......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~---~~~kl~dfgl~~~~~~~ 165 (270)
T cd05047 89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVY 165 (270)
T ss_pred hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC---CeEEECCCCCccccchh
Confidence 32 224566899999999999999999999999999765 68999999998643221
Q ss_pred cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 136 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
........++.|+|||++....++.++|+|||||++|+|++ |..||.+.+..+.+..+.... .. .....++.++.+
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~ 242 (270)
T cd05047 166 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--EKPLNCDDEVYD 242 (270)
T ss_pred hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--CCCCcCCHHHHH
Confidence 11112234567999999988889999999999999999997 999998887777666654432 11 122357889999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6377 215 FIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~ 235 (383)
++.+||..+|.+|||+.+++.
T Consensus 243 li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 243 LMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHcccChhhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.61 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=162.6
Q ss_pred ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-----------CchhhHHHHHHHHHHHH
Q psy6377 28 VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-----------LVVPFESDELSSLAYLH 96 (383)
Q Consensus 28 ~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-----------~~~~~~~qil~aL~yLH 96 (383)
..+.+|+.+++ .++||||+++++++.+.+..|++++++. ++|.+.+... .+..++.||+.||+|||
T Consensus 208 ~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 208 IQLENEILALG-RLNHENILKIEEILRSEANTYMITQKYD--FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHH-hCCCCCcCcEeEEEEECCeeEEEEeccc--cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 45789999999 7799999999999999999999999986 5666643221 13356799999999999
Q ss_pred hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHH
Q psy6377 97 HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174 (383)
Q Consensus 97 s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyel 174 (383)
++||+||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|
T Consensus 285 ~~gIiHrDLKP~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DKKLIHRDIKLENIFLNCD---GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hCCeecCCCCHHHEEECCC---CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999765 6899999999987654322 2346799999999999999999999999999999999
Q ss_pred HhCCCC-CCCCC--cHHHHHHHHhcc----CCCCcc----------------------h--hcCCCHHHHHHHHHhcccC
Q psy6377 175 LTGFSP-FGGET--DSETFRNISKAQ----LDFPDE----------------------L--FEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 175 ltg~~P-f~~~~--~~~~~~~i~~~~----~~~~~~----------------------~--~~~~s~~~~~li~~~L~~d 223 (383)
++|..+ |.+.. ....+..+.... ..+|.. . ...++.++.++|.+||.+|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 998754 43322 122222222111 111110 0 1135677889999999999
Q ss_pred CCCCCCHHHHHcCcccCCc
Q psy6377 224 PMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~ 242 (383)
|.+|||+.|+|.||||...
T Consensus 442 P~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 442 WHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccCcCHHHHhhChhhhcC
Confidence 9999999999999999753
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=283.62 Aligned_cols=230 Identities=19% Similarity=0.261 Sum_probs=186.2
Q ss_pred eEEEEEEcC-----CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA-----TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~-----tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|..+. .+..||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||++ +++|.+
T Consensus 21 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~g~L~~ 98 (288)
T cd05061 21 MVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMK-GFTCHHVVRLLGVVSKGQPTLVVMELMA-HGDLKS 98 (288)
T ss_pred EEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCcEEEEeCCC-CCCHHH
Confidence 688886552 355899999875 2235678999998 7789999999999999999999999999 999999
Q ss_pred hhccC----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 75 IIDDN----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 75 ~l~~~----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
++... .+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||+++.......
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~---~~~~L~Dfg~~~~~~~~~~~ 175 (288)
T cd05061 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD---FTVKIGDFGMTRDIYETDYY 175 (288)
T ss_pred HHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC---CcEEECcCCccccccccccc
Confidence 87431 123466899999999999999999999999999865 6899999999886533221
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+....+....+..+.... .....++.+.+
T Consensus 176 ~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 252 (288)
T cd05061 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD---QPDNCPERVTD 252 (288)
T ss_pred cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 112245678999999988889999999999999999998 899999887777666665443221 12356889999
Q ss_pred HHHHhcccCCCCCCCHHHHHc------CcccCCc
Q psy6377 215 FIAKILIKNPMERMTAKEALK------HPWLMNK 242 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~------hp~~~~~ 242 (383)
++.+||..||++|||+.++++ ||||...
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 253 LMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 999999999999999999987 8888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=285.24 Aligned_cols=230 Identities=27% Similarity=0.335 Sum_probs=184.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC----------eEEEEEecCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE----------GAYYVSWNTP 67 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~----------~~~lv~e~~~ 67 (383)
..||+|.++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.. .+++++|+++
T Consensus 21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T cd07864 21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR-QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD 99 (302)
T ss_pred EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHH-hCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC
Confidence 3689999999999999999975 1245678999999 778999999999997655 7999999998
Q ss_pred CcCcHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--cc
Q psy6377 68 LVVTLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EI 138 (383)
Q Consensus 68 ~g~~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~ 138 (383)
+ ++...+.. ..+..+..|++.||+|||+.||+||||+|+||+++++ +.+||+|||++....... ..
T Consensus 100 -~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~~~~~~ 174 (302)
T cd07864 100 -H-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRPY 174 (302)
T ss_pred -c-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CcEEeCcccccccccCCccccc
Confidence 5 66664432 2345667999999999999999999999999999765 689999999998754332 12
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------- 202 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 202 (383)
....+++.|+|||.+.+ ..++.++||||+||++|+|++|++||...+..+.+..+.......++
T Consensus 175 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T cd07864 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 254 (302)
T ss_pred ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccc
Confidence 22356788999998764 45789999999999999999999999887776666555443221111
Q ss_pred -----------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 203 -----------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 203 -----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+..++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 255 KPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1233578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=278.71 Aligned_cols=222 Identities=18% Similarity=0.247 Sum_probs=182.1
Q ss_pred eEEEEEE--cCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADS--IATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~--~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|.. +.++..+|+|++... ...+.+|+.+++ ..+||||++++++++ .+..++|||+++ +++|.+++
T Consensus 10 ~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~-~~~~~lv~e~~~-~~~L~~~l 86 (257)
T cd05116 10 TVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQ-QLDNPYIVRMIGICE-AESWMLVMELAE-LGPLNKFL 86 (257)
T ss_pred ceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHH-hCCCCCcceEEEEEc-CCCcEEEEecCC-CCcHHHHH
Confidence 5788854 567899999998751 346788999999 779999999999885 457799999999 89999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----ccccCCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELLGTPD 146 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~gt~~ 146 (383)
.. .....+..|++.||+|||++||+||||||.||+++.+ +.++|+|||++......... ....+++.
T Consensus 87 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05116 87 QKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVK 163 (257)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC---CeEEECCCccccccCCCCCeeeecCCCCCCcc
Confidence 43 2345667999999999999999999999999999865 58999999999875433221 12234578
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||.+....++.++|+|||||++|+|++ |.+||.+.+..+....+..+... .....+++++.++|.+||..||+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~~~~~p~ 240 (257)
T cd05116 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYDLMKLCWTYGVD 240 (257)
T ss_pred ccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHHHHHhccCch
Confidence 999999988889999999999999999998 99999988877777777655431 12346799999999999999999
Q ss_pred CCCCHHHHHc
Q psy6377 226 ERMTAKEALK 235 (383)
Q Consensus 226 ~Rpt~~e~L~ 235 (383)
+||+++++..
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05116 241 ERPGFAVVEL 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.66 Aligned_cols=227 Identities=24% Similarity=0.351 Sum_probs=186.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~ 73 (383)
.||+|.++.+|+.||+|.+.. ....+.+|+.+++ .++||||+++++++.+. ..+++++|+++ +++|.
T Consensus 17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~-~~~L~ 94 (264)
T cd06653 17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK-NLRHDRIVQYYGCLRDPEEKKLSIFVEYMP-GGSIK 94 (264)
T ss_pred EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHH-HcCCCCcceEEEEEEcCCCCEEEEEEEeCC-CCcHH
Confidence 689999999999999998753 1246788999999 77899999999999764 45889999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec----CcccccccC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD----GIEIRELLG 143 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~----~~~~~~~~g 143 (383)
+.+... ....+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||+++.... ........|
T Consensus 95 ~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (264)
T cd06653 95 DQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICMSGTGIKSVTG 171 (264)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECccccccccccccccCccccccCC
Confidence 876432 334566899999999999999999999999999765 5899999999986532 112234568
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+... +.++..+..+++.+.++|.+||. +
T Consensus 172 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~~i~~~l~-~ 248 (264)
T cd06653 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPDGVSDACRDFLKQIFV-E 248 (264)
T ss_pred cccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC--CCCCCCCcccCHHHHHHHHHHhc-C
Confidence 99999999998888999999999999999999999999877655555444322 22233456789999999999999 5
Q ss_pred CCCCCCHHHHHcCccc
Q psy6377 224 PMERMTAKEALKHPWL 239 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~ 239 (383)
|..|||+.+++.|||.
T Consensus 249 ~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 249 EKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCccHHHHhcCCCC
Confidence 7999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=292.36 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=191.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCC-----CcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSP-----RIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hp-----nIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.|-.|.+..++..||+|+++. -++...-||++|++...+. -+|.+.++|+-.++.++|+|.+ |.++++++
T Consensus 104 kV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell--G~S~~dFl 181 (415)
T KOG0671|consen 104 KVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL--GLSTFDFL 181 (415)
T ss_pred ceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc--ChhHHHHh
Confidence 466788889999999999987 4667788999999664443 4889999999999999999999 58999998
Q ss_pred ccCC--------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC-----------------CCCcEEEEeccceeE
Q psy6377 77 DDNL--------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF-----------------PNCDIKVCDFEISRV 131 (383)
Q Consensus 77 ~~~~--------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~-----------------~~~~ikL~DFGla~~ 131 (383)
.++. +..+.+|++.+++|||+.+++|-||||||||+.+.. ....|+++|||.|+.
T Consensus 182 k~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 182 KENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATF 261 (415)
T ss_pred ccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcce
Confidence 8754 334448999999999999999999999999985421 135799999999997
Q ss_pred eecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch-------
Q psy6377 132 ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL------- 204 (383)
Q Consensus 132 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 204 (383)
.. ....+.+.|..|+|||++.+-+++.++||||+||||+||++|...|++.++.|.+..+.....++|...
T Consensus 262 ~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~ 339 (415)
T KOG0671|consen 262 DH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKE 339 (415)
T ss_pred ec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhH
Confidence 54 344677899999999999999999999999999999999999999999998886544433333443211
Q ss_pred ---------hcC--------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 205 ---------FED--------------------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 205 ---------~~~--------------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
|++ .-.++.+||++||.+||.+|+|+.|+|.||||+..
T Consensus 340 Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 340 KYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred hhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 111 01358899999999999999999999999999754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=287.73 Aligned_cols=236 Identities=28% Similarity=0.448 Sum_probs=188.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+|+.||+|.+.+ ....+.+|+.+++ .+.||||++++++|.. ....|+++|++. ++|..++.
T Consensus 25 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~lv~e~~~--~~L~~~~~ 101 (328)
T cd07856 25 LVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK-HLRHENIISLSDIFISPLEDIYFVTELLG--TDLHRLLT 101 (328)
T ss_pred EEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHH-hcCCCCeeeEeeeEecCCCcEEEEeehhc--cCHHHHHh
Confidence 689999999999999998764 2456889999999 7789999999999976 567899999985 68888765
Q ss_pred cC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 78 DN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
.. .+..+..|++.||.|||++||+||||+|.||+++.+ +.++|+|||++..... ......+++.|+|||.
T Consensus 102 ~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~---~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~ 176 (328)
T cd07856 102 SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN---CDLKICDFGLARIQDP--QMTGYVSTRYYRAPEI 176 (328)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC---CCEEeCccccccccCC--CcCCCcccccccCcee
Confidence 42 234566999999999999999999999999999764 6899999999886432 2344578899999998
Q ss_pred ccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC--------------------------C-CCcch
Q psy6377 153 LHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL--------------------------D-FPDEL 204 (383)
Q Consensus 153 l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~--------------------------~-~~~~~ 204 (383)
+.+ ..++.++|+||+||++|+|++|.+||.+.........+..... . .....
T Consensus 177 ~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (328)
T cd07856 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK 256 (328)
T ss_pred eeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH
Confidence 765 5689999999999999999999999987664333222211100 0 11122
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~ 248 (383)
.+.++..+.++|.+||..+|++|||+++++.|||+........+
T Consensus 257 ~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 34578999999999999999999999999999999876665444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=278.38 Aligned_cols=232 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--------CCeEEEEEecCCCcC
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--------GEGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--------~~~~~lv~e~~~~g~ 70 (383)
.|++|+.+.+|+.||+|++-. ......+|+++|. ++.|+|++.+++++.+ ...+|+|+.+|. .
T Consensus 32 eVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~-~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce--h 108 (376)
T KOG0669|consen 32 EVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE--H 108 (376)
T ss_pred HHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHH-HhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh--h
Confidence 588999999999999987654 3456789999999 8899999999999753 235899999998 8
Q ss_pred cHHHhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----c
Q psy6377 71 TLQTIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----I 138 (383)
Q Consensus 71 ~L~~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~ 138 (383)
+|+-+++... +..+..+++.||.|+|...|+|||+||+|+|++.+ |.+||+|||+++.+..... .
T Consensus 109 DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d---gilklADFGlar~fs~~~n~~kpry 185 (376)
T KOG0669|consen 109 DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD---GILKLADFGLARAFSTSKNVVKPRY 185 (376)
T ss_pred hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC---ceEEeeccccccceecccccCCCCc
Confidence 8888776543 44555899999999999999999999999999887 7999999999987643222 3
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCC---------
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI--------- 208 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--------- 208 (383)
+..+.|.+|++||.+.+ ..|+++.|||+.|||+.+|++|.+.|++.+...++.-|...-..+.++.|+++
T Consensus 186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si 265 (376)
T KOG0669|consen 186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI 265 (376)
T ss_pred ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence 34567999999998765 56999999999999999999999999999999998888776666655555543
Q ss_pred ----------------------CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 209 ----------------------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 209 ----------------------s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+++.+|+.+||..||.+|++++++|+|.||...
T Consensus 266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 3478899999999999999999999999999653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=283.73 Aligned_cols=223 Identities=21% Similarity=0.276 Sum_probs=185.3
Q ss_pred eEEEEEEc-----CCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+.. .++..+++|.+... ...+.+|+.+++ ..+||||+++++++.+.+..++||||++ +++|.++
T Consensus 20 ~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 97 (291)
T cd05094 20 KVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT-NLQHEHIVKFYGVCGDGDPLIMVFEYMK-HGDLNKF 97 (291)
T ss_pred eEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHh-cCCCCCcceEEEEEccCCceEEEEecCC-CCcHHHH
Confidence 57888753 45677999998762 356889999999 7789999999999999999999999999 9999997
Q ss_pred hccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee
Q psy6377 76 IDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133 (383)
Q Consensus 76 l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~ 133 (383)
+... .++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++....
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~dfg~a~~~~ 174 (291)
T cd05094 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMSRDVY 174 (291)
T ss_pred HHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC---CcEEECCCCcccccC
Confidence 6432 235667999999999999999999999999999865 589999999997654
Q ss_pred cCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCC
Q psy6377 134 DGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDIS 209 (383)
Q Consensus 134 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 209 (383)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..+.... .....+
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 251 (291)
T cd05094 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE---RPRVCP 251 (291)
T ss_pred CCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC---CCccCC
Confidence 3221 123456788999999998899999999999999999998 999998888777777665544332 223568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 210 PEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 210 ~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
..+.+++.+||..+|++|||+.++++
T Consensus 252 ~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 252 KEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHH
Confidence 89999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=278.30 Aligned_cols=222 Identities=20% Similarity=0.316 Sum_probs=184.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|... +++.||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..|++||+++ +++|.+++...
T Consensus 21 ~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 97 (261)
T cd05072 21 EVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMK-TLQHDKLVRLYAVVTKEEPIYIITEYMA-KGSLLDFLKSDEG 97 (261)
T ss_pred eEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCcEEEEecCC-CCcHHHHHHHhcC
Confidence 68999864 667899998875 3457889999999 7789999999999999999999999999 99999976432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.+..+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....++..|+|||
T Consensus 98 ~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 174 (261)
T cd05072 98 GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES---LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC---CcEEECCCccceecCCCceeccCCCccceecCCHH
Confidence 234566899999999999999999999999999865 6899999999987643321 12234567899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+....++.++|+|||||++|+|++ |..||.+.+..+....+..+. .. +....++.++.+++.+||..+|++|||+
T Consensus 175 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 251 (261)
T cd05072 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM--PRMENCPDELYDIMKTCWKEKAEERPTF 251 (261)
T ss_pred HhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence 9988889999999999999999998 999999887777776665442 22 2234678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
+++++
T Consensus 252 ~~i~~ 256 (261)
T cd05072 252 DYLQS 256 (261)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=281.10 Aligned_cols=230 Identities=30% Similarity=0.422 Sum_probs=186.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|+...+|+.||+|.+... .....+|+..++...+||||+++++++.+++..|+|||++. ++|.+.+...
T Consensus 14 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~ 91 (283)
T cd07830 14 SVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME--GNLYQLMKDR 91 (283)
T ss_pred EEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCC--CCHHHHHHhc
Confidence 6999999999999999998762 23456789999845449999999999999999999999994 7787755432
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.............++..|+|||
T Consensus 92 ~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE 168 (283)
T cd07830 92 KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP---EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPE 168 (283)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CCEEEeecccceeccCCCCcCCCCCcccccCce
Confidence 234566899999999999999999999999999865 689999999998775544455567899999999
Q ss_pred ccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------------cch
Q psy6377 152 ILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--------------------------DEL 204 (383)
Q Consensus 152 ~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~ 204 (383)
++. ...++.++|+||||+++|+|++|.+||.+.+..+.+..+.......+ ...
T Consensus 169 ~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd07830 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248 (283)
T ss_pred eeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHH
Confidence 874 45578999999999999999999999988876665554433211111 111
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.+..+..+.+||++||..+|++|||+.|++.||||
T Consensus 249 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 249 IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 22346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.72 Aligned_cols=223 Identities=19% Similarity=0.274 Sum_probs=187.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|.++. ++.+|+|++.. ....+.+|+.+++ .++||||+++++++.+....++||||++ +++|.+++...
T Consensus 20 ~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 96 (261)
T cd05148 20 GEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALK-RLRHKHLISLFAVCSVGEPVYIITELME-KGSLLAFLRSP 96 (261)
T ss_pred ccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHh-cCCCcchhheeeeEecCCCeEEEEeecc-cCCHHHHHhcC
Confidence 3689999887 89999999987 2457889999999 7799999999999999999999999999 99999976532
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCC
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAP 150 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aP 150 (383)
.+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++........ .....+++.|+||
T Consensus 97 ~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~P 173 (261)
T cd05148 97 EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173 (261)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---ceEEEccccchhhcCCccccccCCCCceEecCH
Confidence 234566899999999999999999999999999876 5899999999986543221 1223456789999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|.+....++.++|+||||+++|+|++ |..||.+.+..+.+..+..+. .. ......++.+.+++.+||..||.+|||
T Consensus 174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RM--PCPAKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cC--CCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 99988889999999999999999998 899999888777777766432 11 223467899999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
+.++++
T Consensus 251 ~~~l~~ 256 (261)
T cd05148 251 FKALRE 256 (261)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.74 Aligned_cols=224 Identities=20% Similarity=0.232 Sum_probs=181.1
Q ss_pred eEEEEEEcCCCc--EEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcC
Q psy6377 5 SEEMADSIATGE--VFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~--~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~ 70 (383)
.||+|+...+++ .+|+|.+.. ....+.+|+.+++ .++||||+++++++... ...+++|||+. ++
T Consensus 14 ~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~-~~ 91 (272)
T cd05075 14 SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMK-EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK-HG 91 (272)
T ss_pred eEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEccCCcccCCCCcEEEEEeCC-CC
Confidence 689999888876 599998865 2356788999998 67999999999976432 24689999999 89
Q ss_pred cHHHhhc------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 71 TLQTIID------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 71 ~L~~~l~------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
+|.+.+. ......+..|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.......
T Consensus 92 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~ 168 (272)
T cd05075 92 DLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVCVADFGLSKKIYNGDYY 168 (272)
T ss_pred cHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC---CCEEECCCCcccccCcccce
Confidence 9988542 12234566899999999999999999999999999765 6899999999987643322
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||.+....+....+..+.... ....++..+.+
T Consensus 169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 245 (272)
T cd05075 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---QPPDCLDGLYS 245 (272)
T ss_pred ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence 112346778999999998899999999999999999999 899999887777777666554321 22467889999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+|.+||..||++|||+.+++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=280.64 Aligned_cols=223 Identities=21% Similarity=0.261 Sum_probs=184.4
Q ss_pred eEEEEEEcCC-----CcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIAT-----GEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~t-----g~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||++..+.. +..||+|.+... ...+.+|+.+++ ..+||||+++++++.+....|++||+++ +++|.+
T Consensus 21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~ 98 (277)
T cd05032 21 MVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK-EFNCHHVVRLLGVVSTGQPTLVVMELMA-KGDLKS 98 (277)
T ss_pred eEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHH-hCCCCceeEEEEEEcCCCCcEEEEecCC-CCCHHH
Confidence 5788887644 489999998752 345778999998 6789999999999999999999999999 999999
Q ss_pred hhccC----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 75 IIDDN----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 75 ~l~~~----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
++... .+..++.|++.||.|||+.|++||||||+|||++.+ +.++|+|||+++.......
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~---~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05032 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED---LTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC---CCEEECCcccchhhccCccc
Confidence 76431 234566899999999999999999999999999876 6899999999886543321
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....++..|+|||.+.+..++.++|||||||++|++++ |.+||.+.+..+....+..+... .....++.++.+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 252 (277)
T cd05032 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL---DLPENCPDKLLE 252 (277)
T ss_pred ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC---CCCCCCCHHHHH
Confidence 223456788999999988889999999999999999998 99999988877777766643221 122346899999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6377 215 FIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~ 235 (383)
++.+||..+|++|||+.+++.
T Consensus 253 li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 253 LMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.80 Aligned_cols=225 Identities=22% Similarity=0.293 Sum_probs=182.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++... ..++.+|+++++ .+.||||+++++++.+++..|++|||++ |++|.+++
T Consensus 16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs-~L~HPNIVkl~~v~~d~~~lyLVMEY~e-GGSL~~lL 93 (932)
T PRK13184 16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAA-DLIHPGIVPVYSICSDGDPVYYTMPYIE-GYTLKSLL 93 (932)
T ss_pred EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHH-hCCCcCcCeEEEEEeeCCEEEEEEEcCC-CCCHHHHH
Confidence 36999999999999999998751 346889999999 7789999999999999999999999999 99999876
Q ss_pred ccC-----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---
Q psy6377 77 DDN-----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--- 136 (383)
Q Consensus 77 ~~~-----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--- 136 (383)
... .++.+..||+.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 94 ~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d---g~vKLiDFGLAk~i~~~~~~~ 170 (932)
T PRK13184 94 KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF---GEVVILDWGAAIFKKLEEEDL 170 (932)
T ss_pred HHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC---CCEEEEecCcceecccccccc
Confidence 421 123456899999999999999999999999999765 689999999998652110
Q ss_pred ----------------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC
Q psy6377 137 ----------------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 137 ----------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
.....+||+.|+|||++.+.+++.++||||+||++|+|++|..||.+.......... ....
T Consensus 171 ~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~---~i~~ 247 (932)
T PRK13184 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD---VILS 247 (932)
T ss_pred cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh---hccC
Confidence 011246999999999999999999999999999999999999999876544333221 1111
Q ss_pred Cc--chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 201 PD--ELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 201 ~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
|. ..+..+++.+.+++.+||..||++|++..+.+.+
T Consensus 248 P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 1234688999999999999999999887666544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.28 Aligned_cols=226 Identities=21% Similarity=0.304 Sum_probs=177.7
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~ 73 (383)
.||.|+.. .+++.||+|++.. ....+.+|+.+++....||||+++++++.. +..++++|||++ +++|.
T Consensus 22 ~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~-~~~L~ 100 (337)
T cd05054 22 KVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK-FGNLS 100 (337)
T ss_pred eEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCC-CCCHH
Confidence 58888643 4568999999875 124577899999956589999999998764 456889999999 99999
Q ss_pred HhhccC-------------------------------------------------------------------CchhhHH
Q psy6377 74 TIIDDN-------------------------------------------------------------------LVVPFES 86 (383)
Q Consensus 74 ~~l~~~-------------------------------------------------------------------~~~~~~~ 86 (383)
+++... .+..++.
T Consensus 101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 180 (337)
T cd05054 101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF 180 (337)
T ss_pred HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence 866321 1234558
Q ss_pred HHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhH
Q psy6377 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAAD 163 (383)
Q Consensus 87 qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~D 163 (383)
||+.||+|||++||+||||||+|||++.+ +.++|+|||++........ .....++..|+|||++.+..++.++|
T Consensus 181 qi~~aL~~lH~~~ivHrDikp~Nill~~~---~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 257 (337)
T cd05054 181 QVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSD 257 (337)
T ss_pred HHHHHHHHHHhCCeecCCCCcceEEEeCC---CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcccc
Confidence 99999999999999999999999999865 5899999999987533221 12234567899999999999999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 164 MWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 164 iwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
||||||++|+|++ |..||.+....+.+.......... ......++++.+++.+||+.+|++|||+.++++|
T Consensus 258 i~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 258 VWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999998 999998765544443333222111 1123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=275.05 Aligned_cols=223 Identities=19% Similarity=0.252 Sum_probs=184.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||.+... .+..+|+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..|++||++. +++|.+++...
T Consensus 19 ~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~i~~~~~ 95 (256)
T cd05113 19 VVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMM-KLSHEKLVQLYGVCTKQRPIYIVTEYMS-NGCLLNYLREHGK 95 (256)
T ss_pred eEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHh-cCCCCCeeeEEEEEccCCCcEEEEEcCC-CCcHHHHHHhcCC
Confidence 57888765 355699998876 2456889999999 7789999999999999999999999999 89999876432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~gt~~y~aPE~ 152 (383)
.++.++.||+.||+|||+.|++|+||||+||+++.+ +.+||+|||.++......... ...++..|+|||.
T Consensus 96 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~ 172 (256)
T cd05113 96 RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ---GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CCEEECCCccceecCCCceeecCCCccChhhCCHHH
Confidence 235666999999999999999999999999999765 589999999988654432211 1235567999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++|+|||||++|+|++ |..||...+..+....+..+.....+ ...+..+.+++.+||..+|.+|||+.
T Consensus 173 ~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ 249 (256)
T cd05113 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQ 249 (256)
T ss_pred HhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 988889999999999999999998 99999888777777777665433222 34689999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
+++.+
T Consensus 250 ~ll~~ 254 (256)
T cd05113 250 QLLSS 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=274.29 Aligned_cols=221 Identities=21% Similarity=0.295 Sum_probs=181.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|... ++..+|+|.+.. ....+.+|+.+++ .++||||+++++++. ....|++||++. +++|.+++...
T Consensus 21 ~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~-~~~~~lv~e~~~-~~~L~~~~~~~~~ 96 (260)
T cd05070 21 EVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMK-KLRHDKLVQLYAVVS-EEPIYIVTEYMS-KGSLLDFLKDGEG 96 (260)
T ss_pred eEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHH-hcCCCceEEEEeEEC-CCCcEEEEEecC-CCcHHHHHHhcCC
Confidence 68999765 667799999876 3467889999999 779999999999885 456899999999 99999976432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aPE 151 (383)
.+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++......... ....++..|+|||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 173 (260)
T cd05070 97 RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG---LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC---ceEEeCCceeeeeccCcccccccCCCCCccccChH
Confidence 245666999999999999999999999999999865 68999999999875433221 1223556799999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+.+..++.++|+||||+++|+|++ |.+||.+.+..+....+.... . .+.....+..+.+|+.+||.++|++|||+
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-R--MPCPQDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred HHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--CCCCCcCCHHHHHHHHHHcccCcccCcCH
Confidence 9988889999999999999999999 999999888777777665432 1 12234678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
+++.+
T Consensus 251 ~~l~~ 255 (260)
T cd05070 251 EYLQS 255 (260)
T ss_pred HHHHH
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=273.74 Aligned_cols=222 Identities=21% Similarity=0.295 Sum_probs=183.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL- 80 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~- 80 (383)
.||+|... +++.||+|.+.. ....+.+|+.+++ .++||||+++++++...+..|++||++. +++|.+++....
T Consensus 21 ~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~ 97 (261)
T cd05068 21 EVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMK-KLRHPKLIQLYAVCTLEEPIYIVTELMK-YGSLLEYLQGGAG 97 (261)
T ss_pred cEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHH-HCCCCCccceeEEEecCCCeeeeeeccc-CCcHHHHHhccCC
Confidence 68888865 457899999876 3456889999999 6789999999999999999999999998 999999765422
Q ss_pred -------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCCc
Q psy6377 81 -------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAPE 151 (383)
Q Consensus 81 -------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aPE 151 (383)
+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++......... ....++..|+|||
T Consensus 98 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 174 (261)
T cd05068 98 RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN---NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---CCEEECCcceEEEccCCcccccCCCcCceeccCcc
Confidence 34556899999999999999999999999999875 68999999999876532211 1112345799999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+.... ..+ ....++..+.+++.+||..+|++||++
T Consensus 175 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMP--CPPGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred ccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHhhcCcccCCCH
Confidence 9998899999999999999999999 999999888777777665432 221 224678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
.+++.
T Consensus 252 ~~l~~ 256 (261)
T cd05068 252 ETLQW 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.67 Aligned_cols=225 Identities=21% Similarity=0.289 Sum_probs=183.5
Q ss_pred eEEEEEEcCCC-----cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATG-----EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg-----~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||++..+..+ ..+|+|.+... ...+.+|+.+++.+.+||||+++++++..+...+++|||++ +++|..
T Consensus 27 ~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~-~~~L~~ 105 (293)
T cd05053 27 QVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA-HGNLRD 105 (293)
T ss_pred cEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCC-CCcHHH
Confidence 67888876443 78999998762 23577899999855589999999999999999999999999 999998
Q ss_pred hhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 75 IIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 75 ~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
++... .++.+..|++.||+|||++||+||||||+|||++.+ +.++|+|||+++..
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~---~~~kL~Dfg~~~~~ 182 (293)
T cd05053 106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADFGLARDI 182 (293)
T ss_pred HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC---CeEEeCcccccccc
Confidence 77432 123467999999999999999999999999999765 68999999999865
Q ss_pred ecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+...... ......
T Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 259 (293)
T cd05053 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM---EKPQNC 259 (293)
T ss_pred ccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---CCCCCC
Confidence 43221 122234678999999988889999999999999999997 99999988877777666544321 122456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+..+.+|+.+||..||++|||+.+++++
T Consensus 260 ~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 260 TQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=277.45 Aligned_cols=224 Identities=21% Similarity=0.236 Sum_probs=181.6
Q ss_pred eEEEEEEcC---CCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCe------EEEEEecCCCc
Q psy6377 5 SEEMADSIA---TGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG------AYYVSWNTPLV 69 (383)
Q Consensus 5 ~V~~~~~~~---tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~------~~lv~e~~~~g 69 (383)
.||.|.... ++..||+|.+... ...+.+|+..++ .++||||+++++++.+... .++++||++ +
T Consensus 14 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~-~ 91 (273)
T cd05035 14 SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMK-DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMK-H 91 (273)
T ss_pred eEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHH-hCCCCCeeeEEeeeccCCccccCcccEEEEeccC-C
Confidence 678887664 4588999998752 246788999999 7789999999998865544 799999999 9
Q ss_pred CcHHHhhcc------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc
Q psy6377 70 VTLQTIIDD------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 70 ~~L~~~l~~------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~ 137 (383)
++|..++.. .....+..|++.||.|||++|++||||||+||+++++ +.+||+|||+++.......
T Consensus 92 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05035 92 GDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED---MTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred CCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC---CeEEECCccceeecccccc
Confidence 999886522 1234566999999999999999999999999999765 6899999999987643321
Q ss_pred c---ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHH
Q psy6377 138 I---RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213 (383)
Q Consensus 138 ~---~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 213 (383)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+....+....+..+... .....++..+.
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 245 (273)
T cd05035 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---KQPEDCLDELY 245 (273)
T ss_pred ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcCCCHHHH
Confidence 1 11235678999999988889999999999999999999 99999988877777766654322 22346789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6377 214 DFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+++.+||..||++|||+.+++++
T Consensus 246 ~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 246 DLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=272.19 Aligned_cols=223 Identities=22% Similarity=0.271 Sum_probs=187.8
Q ss_pred eEEEEEEcCCC----cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATG----EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg----~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++..++ ..+|+|.+... ...+.+|+.+++ .++||||+++++++.+.+..|++||+++ +++|.+.
T Consensus 14 ~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~i~e~~~-~~~l~~~ 91 (258)
T smart00219 14 EVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMR-KLDHPNIVKLLGVCTEEEPLMIVMEYME-GGDLLDY 91 (258)
T ss_pred ceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHH-hcCCCchheEEEEEcCCCeeEEEEeccC-CCCHHHH
Confidence 68999998877 99999999762 347889999999 5599999999999999999999999999 9999987
Q ss_pred hccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc--ccCCC
Q psy6377 76 IDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE--LLGTP 145 (383)
Q Consensus 76 l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~--~~gt~ 145 (383)
+... .+..+..|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++........... ..+++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 168 (258)
T smart00219 92 LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKKKGGKLPI 168 (258)
T ss_pred HHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC---CeEEEcccCCceecccccccccccCCCcc
Confidence 6432 234566999999999999999999999999999876 5899999999987654422221 23678
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|+||+|+++|+|++ |.+||.+.+.......+....... ....++.++.+++.+||..+|
T Consensus 169 ~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p 245 (258)
T smart00219 169 RWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENCPPEIYKLMLQCWAEDP 245 (258)
T ss_pred cccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHHHHHHHHHCcCCh
Confidence 9999999988889999999999999999998 899999888777777776554322 223479999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++++
T Consensus 246 ~~Rpt~~~ll~ 256 (258)
T smart00219 246 EDRPTFSELVE 256 (258)
T ss_pred hhCcCHHHHHh
Confidence 99999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.62 Aligned_cols=121 Identities=25% Similarity=0.378 Sum_probs=107.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+.+|+||||+. |++|.+++.
T Consensus 19 ~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~~lVmEy~~-g~~L~~li~ 96 (669)
T cd05610 19 KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYSLQSANNVYLVMEYLI-GGDVKSLLH 96 (669)
T ss_pred EEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHH-hcCCCCcCeEEEEEEECCEEEEEEeCCC-CCCHHHHHH
Confidence 6999999999999999999762 257888999998 7899999999999999999999999999 999998764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
. ..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++
T Consensus 97 ~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~---g~vkL~DFGls~ 152 (669)
T cd05610 97 IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE---GHIKLTDFGLSK 152 (669)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC---CCEEEEeCCCCc
Confidence 3 3356777999999999999999999999999999765 689999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=285.22 Aligned_cols=223 Identities=19% Similarity=0.258 Sum_probs=180.3
Q ss_pred eEEEEEEcCCCcE----EEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEV----FAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~----vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++..+|+. ||+|.+.. ....+.+|+.+++ .+.||||+++++++... ..++++++++ +|+|.+.
T Consensus 22 ~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~g~~~~~-~~~~v~e~~~-~g~l~~~ 98 (316)
T cd05108 22 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTS-TVQLITQLMP-FGCLLDY 98 (316)
T ss_pred eEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEcCC-CceeeeecCC-CCCHHHH
Confidence 6899988777765 89999865 2356788999998 77999999999998764 6789999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTP 145 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~ 145 (383)
+... ..+.+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........ ....++.
T Consensus 99 l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 175 (316)
T cd05108 99 VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGADEKEYHAEGGKVPI 175 (316)
T ss_pred HHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC---CcEEEccccccccccCCCcceeccCCccce
Confidence 6543 234666899999999999999999999999999765 58999999999876543221 1223466
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+. ....+|. ...++..+.+++.+||..+|
T Consensus 176 ~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~li~~cl~~~p 252 (316)
T cd05108 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQ--PPICTIDVYMIMVKCWMIDA 252 (316)
T ss_pred eecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCC--CCCCCHHHHHHHHHHccCCh
Confidence 8999999999999999999999999999997 999998876655444333 3222222 23568899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy6377 225 MERMTAKEALKH 236 (383)
Q Consensus 225 ~~Rpt~~e~L~h 236 (383)
.+|||+.+++.+
T Consensus 253 ~~Rps~~~l~~~ 264 (316)
T cd05108 253 DSRPKFRELIIE 264 (316)
T ss_pred hhCcCHHHHHHH
Confidence 999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=283.37 Aligned_cols=227 Identities=23% Similarity=0.345 Sum_probs=187.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||++++..+|+.+|+|.+... ...+.+|+++++ ..+|||++++++++.+++..|+||||+. | +|.+.+.
T Consensus 40 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g-~l~~~~~ 116 (317)
T cd06635 40 AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ-RIKHPNSIEYKGCYLREHTAWLVMEYCL-G-SASDLLE 116 (317)
T ss_pred EEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCeEEEEEeCCC-C-CHHHHHH
Confidence 6899999999999999998751 235788999999 7789999999999999999999999998 4 6666442
Q ss_pred -------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 -------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 -------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
...+..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||++..... .....|++.|+||
T Consensus 117 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~---~~~kl~dfg~~~~~~~---~~~~~~~~~y~aP 190 (317)
T cd06635 117 VHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASIASP---ANSFVGTPYWMAP 190 (317)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC---CCEEEecCCCccccCC---cccccCCccccCh
Confidence 22344566899999999999999999999999999765 6899999999875432 2345789999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|.+. ...++.++|+||+||++|+|++|.+||.+.........+........ ....+++.+++++.+||..+|.+|
T Consensus 191 E~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R 268 (317)
T cd06635 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQDR 268 (317)
T ss_pred hhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHHHHHHHHccCCcccC
Confidence 9873 45688999999999999999999999988776666666554433221 224568899999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+.++++|+|+...
T Consensus 269 pt~~~il~~~~~~~~ 283 (317)
T cd06635 269 PTSEELLKHMFVLRE 283 (317)
T ss_pred cCHHHHHhChhhhcc
Confidence 999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=278.85 Aligned_cols=223 Identities=21% Similarity=0.280 Sum_probs=183.1
Q ss_pred eEEEEEE-----cCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADS-----IATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||++.. ..++..+|+|.+.. ....+.+|+++++ .++||||+++++++.+.+..+++||+++ +++|.++
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 97 (280)
T cd05092 20 KVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT-VLQHQHIVRFYGVCTEGRPLLMVFEYMR-HGDLNRF 97 (280)
T ss_pred eEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHh-cCCCCCCceEEEEEecCCceEEEEecCC-CCCHHHH
Confidence 5777753 34677899998876 2457889999999 7799999999999999999999999999 9999987
Q ss_pred hcc---------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec
Q psy6377 76 IDD---------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134 (383)
Q Consensus 76 l~~---------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~ 134 (383)
+.. ..++.+..|++.||+|||++|++||||||+|||++++ +.++|+|||++.....
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~---~~~kL~dfg~~~~~~~ 174 (280)
T cd05092 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG---LVVKIGDFGMSRDIYS 174 (280)
T ss_pred HHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC---CCEEECCCCceeEcCC
Confidence 643 2234556899999999999999999999999999765 5899999999986543
Q ss_pred Ccc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 135 GIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 135 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+..+... .....+++
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 251 (280)
T cd05092 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL---ERPRTCPP 251 (280)
T ss_pred CceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC---CCCCCCCH
Confidence 221 122345678999999998999999999999999999998 99999887777777666554322 12246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+.++|.+||..||.+||++.+++.
T Consensus 252 ~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 252 EVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=304.05 Aligned_cols=229 Identities=23% Similarity=0.398 Sum_probs=193.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe--EEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG--AYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~--~~lv~e~~~~g~~L~~ 74 (383)
.||+|-+..+|-.||=--++. ..++++.|+++|+ .++||||+++|+.+.+... +.+|+|++. .|+|..
T Consensus 55 tVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLK-sL~H~NIirfy~SW~d~~n~~in~iTEL~T-SGtLr~ 132 (632)
T KOG0584|consen 55 TVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLK-SLKHPNIIRFYDSWVDTDNKTINFITELFT-SGTLRE 132 (632)
T ss_pred eeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHc-cCCCCceeeeeeheecCCCceeeeeeeccc-CCcHHH
Confidence 478888888887776322221 3488999999999 8999999999999998766 889999999 999999
Q ss_pred hhccC------CchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 75 IIDDN------LVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 75 ~l~~~------~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
++++. .+..|.+|||.||.|||++. |+|||||.+|||++++ .|.|||+|+|||....... ....+|||.
T Consensus 133 Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~--~G~VKIGDLGLAtl~r~s~-aksvIGTPE 209 (632)
T KOG0584|consen 133 YRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN--LGEVKIGDLGLATLLRKSH-AKSVIGTPE 209 (632)
T ss_pred HHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC--cCceeecchhHHHHhhccc-cceeccCcc
Confidence 86552 35678899999999999986 9999999999999865 5899999999999865443 344789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|||||++. ..|+..+||||||+.+.||.|+..||.. .+..++++++..|.. |..+..--.+++++||.+||.. .+
T Consensus 210 FMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK--P~sl~kV~dPevr~fIekCl~~-~~ 285 (632)
T KOG0584|consen 210 FMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK--PAALSKVKDPEVREFIEKCLAT-KS 285 (632)
T ss_pred ccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC--HHHhhccCCHHHHHHHHHHhcC-ch
Confidence 99999998 7899999999999999999999999964 566677888877653 3333333478999999999999 99
Q ss_pred CCCCHHHHHcCcccCCc
Q psy6377 226 ERMTAKEALKHPWLMNK 242 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~~ 242 (383)
.|||+.|+|+||||+..
T Consensus 286 ~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 286 ERLSAKELLKDPFFDED 302 (632)
T ss_pred hccCHHHHhhChhhccc
Confidence 99999999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=275.37 Aligned_cols=221 Identities=22% Similarity=0.296 Sum_probs=181.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|++..++ .||+|++.. ....+.+|+.+++ .++||||+++++++.+ ...|++||++. +++|.+++...
T Consensus 21 ~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~-~~~~lv~e~~~-~~~L~~~~~~~~~ 96 (262)
T cd05071 21 EVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYIVTEYMS-KGSLLDFLKGEMG 96 (262)
T ss_pred cEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHH-hCCCCCcceEEEEECC-CCcEEEEEcCC-CCcHHHHHhhccc
Confidence 68999887664 599999986 2456889999999 6789999999998854 56899999999 99999977542
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aPE 151 (383)
.+..+..|++.||+|||++|++||||||+||+++.+ +.++|+|||.+......... ....++..|+|||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~---~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE 173 (262)
T cd05071 97 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC---CcEEeccCCceeeccccccccccCCcccceecCHh
Confidence 234566999999999999999999999999999765 68999999999876433221 1234667899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+.+..++.++|+|||||++|+|++ |.+||.+....+....+..+. .. .....++..+.+++.+||.++|++|||+
T Consensus 174 ~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 250 (262)
T cd05071 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM--PCPPECPESLHDLMCQCWRKEPEERPTF 250 (262)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CC--CCccccCHHHHHHHHHHccCCcccCCCH
Confidence 9988889999999999999999999 899998888777776665432 11 1234678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
.++++
T Consensus 251 ~~~~~ 255 (262)
T cd05071 251 EYLQA 255 (262)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=280.30 Aligned_cols=232 Identities=30% Similarity=0.413 Sum_probs=184.5
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||++++. .+++.||+|++.+ ....+.+|+.++....+||||+++++.+..+...|+||||+. +++|.
T Consensus 15 ~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~ 93 (288)
T cd05583 15 KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVN-GGELF 93 (288)
T ss_pred eEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCC-CCcHH
Confidence 57877753 5788999999875 234577899999966689999999999999999999999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTP 145 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~ 145 (383)
+.+... .+..+..|++.||.|||+.|++||||+|.||+++.+ +.++|+|||+++....... .....|++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 170 (288)
T cd05583 94 THLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE---GHVVLTDFGLSKEFLAEEEERAYSFCGTI 170 (288)
T ss_pred HHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEEECccccccccccccccccccCCc
Confidence 865432 344556899999999999999999999999999765 6899999999886543322 12346899
Q ss_pred CcCCCcccccCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 146 DYVAPEILHYEP--ITLAADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 146 ~y~aPE~l~~~~--~~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
.|+|||.+.+.. .+.++|+||+|+++|+|++|..||...... +....+....... ...++..+.++|.+|
T Consensus 171 ~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~ 246 (288)
T cd05583 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PKTMSAEARDFIQKL 246 (288)
T ss_pred cccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----CcccCHHHHHHHHHH
Confidence 999999987654 788999999999999999999999654322 2223333333222 245788999999999
Q ss_pred cccCCCCCCC---HHHHHcCcccCCcch
Q psy6377 220 LIKNPMERMT---AKEALKHPWLMNKKQ 244 (383)
Q Consensus 220 L~~dP~~Rpt---~~e~L~hp~~~~~~~ 244 (383)
|..||++||| +.++|+||||+....
T Consensus 247 l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 247 LEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred hcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999999998 567799999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=283.04 Aligned_cols=227 Identities=22% Similarity=0.337 Sum_probs=186.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.||+++++.+|+.+|+|.+.. ....+.+|+.+++ .++|||++++++++...+..|+||||+. | ++.+.+
T Consensus 30 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~ 106 (308)
T cd06634 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVMEYCL-G-SASDLLE 106 (308)
T ss_pred EEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCeeEEEEEccC-C-CHHHHHH
Confidence 699999999999999999864 1235678999999 6789999999999999999999999997 4 666643
Q ss_pred ------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 ------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
....+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++...... ....|++.|+||
T Consensus 107 ~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~---~~~~~~~~y~aP 180 (308)
T cd06634 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPA---NXFVGTPYWMAP 180 (308)
T ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC---CcEEECCcccceeecCc---ccccCCccccCH
Confidence 223344566899999999999999999999999999765 68999999998865432 345689999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|.+. ...++.++|||||||++|+|++|..||...+..+....+..... +......++..+.+||.+||..+|++|
T Consensus 181 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~P~~R 258 (308)
T cd06634 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDR 258 (308)
T ss_pred HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccccHHHHHHHHHHhhCCcccC
Confidence 9874 35578899999999999999999999987766555555444332 222223578899999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+++++.|||+...
T Consensus 259 p~~~~ll~~~~~~~~ 273 (308)
T cd06634 259 PTSEVLLKHRFVLRE 273 (308)
T ss_pred CCHHHHhhCcccccc
Confidence 999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=280.79 Aligned_cols=225 Identities=19% Similarity=0.267 Sum_probs=184.0
Q ss_pred eEEEEEEc-------CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSI-------ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~-------~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||.|+.. .++..+|+|.+.. ....+.+|+.+++.+.+||||+++++++......|++|||+. +++|
T Consensus 30 ~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L 108 (304)
T cd05101 30 QVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGNL 108 (304)
T ss_pred eEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCC-CCcH
Confidence 67888643 3456899999875 235688999999955489999999999999999999999999 9999
Q ss_pred HHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++.... +..+..||+.||.|||++|++||||||+||+++.+ +.++|+|||+++
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~---~~~kl~D~g~~~ 185 (304)
T cd05101 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLAR 185 (304)
T ss_pred HHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC---CcEEECCCccce
Confidence 99765421 23456899999999999999999999999999765 689999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+...... ....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 262 (304)
T cd05101 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPA 262 (304)
T ss_pred ecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCC
Confidence 7643221 122345678999999988889999999999999999998 88999988877777776544321 1224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++..+.+|+.+||..+|.+|||+.++++.
T Consensus 263 ~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 263 NCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=280.62 Aligned_cols=225 Identities=19% Similarity=0.295 Sum_probs=181.7
Q ss_pred eEEEEEE-----cCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADS-----IATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||++.+ ..++..+|+|.+... ...+.+|+.+++.+.+||||+++++++...+..|++|||+. +++|.+
T Consensus 50 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 128 (302)
T cd05055 50 KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCC-YGDLLN 128 (302)
T ss_pred eEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCC-CCcHHH
Confidence 4677764 345678999998762 24578899999955589999999999999999999999999 999998
Q ss_pred hhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccC
Q psy6377 75 IIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLG 143 (383)
Q Consensus 75 ~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~g 143 (383)
++... ....+..|++.||.|||++||+|+||||+|||++.+ +.++|+|||++........ .....+
T Consensus 129 ~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 205 (302)
T cd05055 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG---KIVKICDFGLARDIMNDSNYVVKGNARL 205 (302)
T ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC---CeEEECCCcccccccCCCceeecCCCCc
Confidence 76432 234566899999999999999999999999999754 5899999999986543221 112345
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
++.|+|||.+.+..++.++||||+||++|+|++ |.+||.+....+.+..........+ .....++++.+|+.+||.+
T Consensus 206 ~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~ 283 (302)
T cd05055 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPEHAPAEIYDIMKTCWDA 283 (302)
T ss_pred ccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCC
Confidence 778999999998889999999999999999998 9999988776665554443332221 2245689999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
+|++|||+.+++.
T Consensus 284 ~p~~Rpt~~ell~ 296 (302)
T cd05055 284 DPLKRPTFKQIVQ 296 (302)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=276.33 Aligned_cols=226 Identities=25% Similarity=0.386 Sum_probs=187.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||++++..++..+++|++.. ....+.+|+.+++ .++||||+++++++.+....++++||++ +++|.+.
T Consensus 15 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~ 92 (260)
T cd08222 15 TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS-KLDHPAIVKFHASFLERDAFCIITEYCE-GRDLDCK 92 (260)
T ss_pred eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHH-hCCCCcHHHHHHHHhcCCceEEEEEeCC-CCCHHHH
Confidence 689999998888888887764 1234667888888 7799999999999999999999999999 8999876
Q ss_pred hc----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCC
Q psy6377 76 ID----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGT 144 (383)
Q Consensus 76 l~----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt 144 (383)
+. +..++.+..|++.||.|||+.|++|+||+|+||+++. +.++|+|||++........ .....|+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~~~~~~~~~~~~~~ 168 (260)
T cd08222 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLLMGSCDLATTFTGT 168 (260)
T ss_pred HHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeecCCCcccccCCCCC
Confidence 53 2334566799999999999999999999999999964 3699999999887644322 2345688
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+..+.. +.....++.++.++|.+||..+|
T Consensus 169 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p 245 (260)
T cd08222 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPETYSRQLNSIMQSMLNKDP 245 (260)
T ss_pred cCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC---CCCcchhcHHHHHHHHHHhcCCh
Confidence 999999999888889999999999999999999999987776666555544322 22234678999999999999999
Q ss_pred CCCCCHHHHHcCccc
Q psy6377 225 MERMTAKEALKHPWL 239 (383)
Q Consensus 225 ~~Rpt~~e~L~hp~~ 239 (383)
++||++.++++||||
T Consensus 246 ~~Rp~~~~il~~~~~ 260 (260)
T cd08222 246 SLRPSAAEILRNPFI 260 (260)
T ss_pred hhCcCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=279.28 Aligned_cols=226 Identities=18% Similarity=0.218 Sum_probs=182.1
Q ss_pred eEEEEEEcCCC----------------cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEE
Q psy6377 5 SEEMADSIATG----------------EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS 63 (383)
Q Consensus 5 ~V~~~~~~~tg----------------~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~ 63 (383)
.||+|.+..++ ..||+|.+... ...+.+|+++++ .+.||||+++++++.+++..+++|
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~ 98 (296)
T cd05051 20 EVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILS-RLSDPNIARLLGVCTVDPPLCMIM 98 (296)
T ss_pred cEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHH-hcCCCCEeEEEEEEecCCCcEEEE
Confidence 57777765544 56899998762 456788999999 778999999999999999999999
Q ss_pred ecCCCcCcHHHhhccC-----------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEec
Q psy6377 64 WNTPLVVTLQTIIDDN-----------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126 (383)
Q Consensus 64 e~~~~g~~L~~~l~~~-----------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DF 126 (383)
|++. +++|.+++... .++.+..|++.||+|||++||+||||||+||+++.+ +.++|+||
T Consensus 99 e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~---~~~~l~df 174 (296)
T cd05051 99 EYME-NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADF 174 (296)
T ss_pred ecCC-CCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCC---CceEEccc
Confidence 9999 99999876432 234566999999999999999999999999999876 68999999
Q ss_pred cceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHhc----c
Q psy6377 127 EISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT--GFSPFGGETDSETFRNISKA----Q 197 (383)
Q Consensus 127 Gla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt--g~~Pf~~~~~~~~~~~i~~~----~ 197 (383)
|+++....... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..+... .
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05051 175 GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254 (296)
T ss_pred cceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc
Confidence 99986543321 223456788999999988889999999999999999998 78899887777766665433 1
Q ss_pred CCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 198 LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 198 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
..........++.++.+++.+||..||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11111122456789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=271.94 Aligned_cols=219 Identities=21% Similarity=0.309 Sum_probs=183.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||.|... |+.||+|.+... ..++.+|+.+++ .++||||+++++++.+.+..++|||+++ +++|.+++...
T Consensus 21 ~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~~~ 96 (256)
T cd05039 21 DVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMT-TLRHPNLVQLLGVVLQGNPLYIVTEYMA-KGSLVDYLRSRGR 96 (256)
T ss_pred eEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHH-hcCCcceeeeEEEEcCCCCeEEEEEecC-CCcHHHHHHhcCC
Confidence 68888764 899999999873 357889999999 7789999999999999999999999999 99999976443
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.+..+..|++.||.|||++|++||||||+||+++.+ +.++|+|||+++...... ....++..|+|||.+
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~---~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~ 171 (256)
T cd05039 97 AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED---LVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEAL 171 (256)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC---CCEEEccccccccccccc--ccCCCcccccCchhh
Confidence 245666999999999999999999999999999765 689999999998763322 233456679999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
....++.++|+||||+++|+|++ |..||...+..+....+..... ......+++.+.++|.+||..+|++|||+.+
T Consensus 172 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 88889999999999999999997 9999988877666665554321 1223467899999999999999999999999
Q ss_pred HHc
Q psy6377 233 ALK 235 (383)
Q Consensus 233 ~L~ 235 (383)
+++
T Consensus 249 l~~ 251 (256)
T cd05039 249 LRE 251 (256)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=274.45 Aligned_cols=222 Identities=17% Similarity=0.237 Sum_probs=180.0
Q ss_pred eEEEEEEc--CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSI--ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||.|+.+ .++..+|+|++... ...+.+|+.+++ .++||||++++++++ ....++||||++ +++|.+++.
T Consensus 10 ~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~-~~~~~lv~e~~~-~~~L~~~l~ 86 (257)
T cd05115 10 CVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH-QLDNPYIVRMIGVCE-AEALMLVMEMAS-GGPLNKFLS 86 (257)
T ss_pred cEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHH-hcCCCCeEEEEEEEc-CCCeEEEEEeCC-CCCHHHHHH
Confidence 58888664 45667999998762 345789999999 679999999999986 457899999999 999998764
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----ccccCCCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELLGTPD 146 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~gt~~ 146 (383)
. ..++.+..|++.||.|||++|++||||||+|||++.+ +.+||+|||++......... ....+++.
T Consensus 87 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05115 87 GKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADDSYYKARSAGKWPLK 163 (257)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC---CcEEeccCCccccccCCccceeccCCCCCCcc
Confidence 3 2345667999999999999999999999999999765 58999999999865432221 11223578
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||.+....++.++|+|||||++|++++ |..||.+....+....+..+... ......++++.++|.+||..+|+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred cCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCChh
Confidence 999999988889999999999999999996 99999988877776666554321 22246789999999999999999
Q ss_pred CCCCHHHHHc
Q psy6377 226 ERMTAKEALK 235 (383)
Q Consensus 226 ~Rpt~~e~L~ 235 (383)
+||++.++.+
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05115 241 DRPNFAKVEE 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=272.75 Aligned_cols=219 Identities=17% Similarity=0.264 Sum_probs=180.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEE-EeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVF-QTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~-~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||++.. .|..+|+|.+.. ....+.+|+.+++ ..+||||+++++++ .+++..|++||+++ +++|.+++...
T Consensus 21 ~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~ 96 (256)
T cd05082 21 DVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTEYMA-KGSLVDYLRSRGR 96 (256)
T ss_pred eEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHH-hCCCCCeeeEEEEEEcCCCceEEEEECCC-CCcHHHHHHhcCC
Confidence 5788865 488899999876 3446889999999 77999999999975 45567999999999 99999976542
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
....+..|++.||+|||++|++||||||+||+++.+ +.+||+|||++....... ....++..|+|||++
T Consensus 97 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~ 171 (256)
T cd05082 97 SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEAL 171 (256)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC---CcEEecCCccceeccccC--CCCccceeecCHHHH
Confidence 234566899999999999999999999999999765 689999999988653322 233456789999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
.+..++.++|||||||++|+|++ |.+||...+..+....+..+. +......+++.+.+++.+||..+|++|||+.+
T Consensus 172 ~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 248 (256)
T cd05082 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQ 248 (256)
T ss_pred ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 98889999999999999999997 999998877766666665432 22333567899999999999999999999999
Q ss_pred HHc
Q psy6377 233 ALK 235 (383)
Q Consensus 233 ~L~ 235 (383)
+++
T Consensus 249 l~~ 251 (256)
T cd05082 249 LRE 251 (256)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=278.06 Aligned_cols=223 Identities=20% Similarity=0.274 Sum_probs=184.8
Q ss_pred eEEEEEEc-----CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+. .++..+|+|.+... ...+.+|+.+++ .++||||+++++++.++...+++||+++ +++|.+
T Consensus 20 ~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 97 (288)
T cd05050 20 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA-EFDHPNIVKLLGVCAVGKPMCLLFEYMA-YGDLNE 97 (288)
T ss_pred cEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHH-hcCCCchheEEEEEcCCCccEEEEecCC-CCCHHH
Confidence 57888875 37889999998762 345888999999 7799999999999999999999999999 999998
Q ss_pred hhccC----------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEec
Q psy6377 75 IIDDN----------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126 (383)
Q Consensus 75 ~l~~~----------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DF 126 (383)
++... .++.++.|++.||.|||++|++||||||+||+++.+ +.++|+||
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~df 174 (288)
T cd05050 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVVKIADF 174 (288)
T ss_pred HHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCC---CceEECcc
Confidence 76432 124677999999999999999999999999999765 68999999
Q ss_pred cceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCc
Q psy6377 127 EISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPD 202 (383)
Q Consensus 127 Gla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 202 (383)
|++........ .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+..+....
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-- 252 (288)
T cd05050 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS-- 252 (288)
T ss_pred ccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC--
Confidence 99886543221 122345667999999988899999999999999999997 889998888777777776554322
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
....++.++.+||.+||..+|.+|||+.|+++
T Consensus 253 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 253 -CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 12357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=272.45 Aligned_cols=221 Identities=21% Similarity=0.273 Sum_probs=180.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|.+..++ .+|+|.+.. ....+.+|+.+++ .++||||+++++++. .+..+++||++. +++|.+++...
T Consensus 21 ~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~v~e~~~-~~~L~~~~~~~~~ 96 (260)
T cd05069 21 EVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMK-KLRHDKLVPLYAVVS-EEPIYIVTEFMG-KGSLLDFLKEGDG 96 (260)
T ss_pred eEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHH-hCCCCCeeeEEEEEc-CCCcEEEEEcCC-CCCHHHHHhhCCC
Confidence 68999876554 599998875 2356789999999 778999999999885 456899999999 89999976432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.+..+..|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe 173 (260)
T cd05069 97 KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN---LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC---CeEEECCCccceEccCCcccccCCCccchhhCCHH
Confidence 134566899999999999999999999999999765 6899999999987543321 11234567899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
.+.+..++.++|+||||+++|+|++ |.+||.+....+....+.... . .......+..+.+++.+||.+||++||++
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05069 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R--MPCPQGCPESLHELMKLCWKKDPDERPTF 250 (260)
T ss_pred HhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C--CCCCcccCHHHHHHHHHHccCCcccCcCH
Confidence 9988889999999999999999999 999999888777776665432 2 12234678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
+++++
T Consensus 251 ~~i~~ 255 (260)
T cd05069 251 EYIQS 255 (260)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=274.68 Aligned_cols=224 Identities=18% Similarity=0.252 Sum_probs=184.6
Q ss_pred eEEEEEEcCC---CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIAT---GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~t---g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+.+.+ ...||+|.+.. ....+.+|+.+++ .++||||+++++++.+.+..+++||++. +++|.+++
T Consensus 19 ~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~ 96 (266)
T cd05033 19 EVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMG-QFDHPNIIRLEGVVTKSRPVMIITEYME-NGSLDKFL 96 (266)
T ss_pred eEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHH-hCCCCCcceEeEEEecCCceEEEEEcCC-CCCHHHHH
Confidence 6899988654 46899999876 2345778999998 7789999999999999999999999999 99999976
Q ss_pred cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccc--cccCCCC
Q psy6377 77 DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIR--ELLGTPD 146 (383)
Q Consensus 77 ~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~--~~~gt~~ 146 (383)
.. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... ... ...+++.
T Consensus 97 ~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (266)
T cd05033 97 RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN---LVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173 (266)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CCEEECccchhhcccccccceeccCCCCCcc
Confidence 43 2234566899999999999999999999999999765 589999999998764211 111 2234678
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..+... + ....++..+.+++.+||..+|+
T Consensus 174 y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred ccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCCcc
Confidence 999999998889999999999999999998 99999888777777766554322 2 1246789999999999999999
Q ss_pred CCCCHHHHHcC
Q psy6377 226 ERMTAKEALKH 236 (383)
Q Consensus 226 ~Rpt~~e~L~h 236 (383)
+||++.+++++
T Consensus 251 ~Rp~~~ei~~~ 261 (266)
T cd05033 251 ERPTFSQIVST 261 (266)
T ss_pred cCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=271.70 Aligned_cols=222 Identities=22% Similarity=0.264 Sum_probs=182.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|.+.. |+.||+|.+.. ....+.+|+.+++ .+.||||+++++++.+....|++||++. |++|.+++...
T Consensus 10 ~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~l~~~l~~~ 86 (251)
T cd05041 10 DVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILK-QYDHPNIVKLIGVCVQKQPIYIVMELVP-GGSLLTFLRKK 86 (251)
T ss_pred eEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCeEEEEEEEecCCCeEEEEEcCC-CCcHHHHHHhc
Confidence 689999877 99999999876 2346889999999 7789999999999999999999999999 99999876432
Q ss_pred -------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCCCcCC
Q psy6377 80 -------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTPDYVA 149 (383)
Q Consensus 80 -------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~~y~a 149 (383)
.+..+..|++.||+|||++|++||||+|+|||++.+ +.++|+|||++......... ....++..|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~ 163 (251)
T cd05041 87 KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163 (251)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC---CcEEEeeccccccccCCcceeccccCcceeccCC
Confidence 234555899999999999999999999999999765 68999999999865422111 11233567999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
||.+.+..++.++|+|||||++|+|++ |..||.+.........+.... .. ......+.++.+++.+||..+|.+||
T Consensus 164 PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHHHHHHhccChhhCc
Confidence 999988889999999999999999999 899998887666666554432 11 12245789999999999999999999
Q ss_pred CHHHHHc
Q psy6377 229 TAKEALK 235 (383)
Q Consensus 229 t~~e~L~ 235 (383)
|+.++++
T Consensus 241 ~~~ell~ 247 (251)
T cd05041 241 SFSEIYN 247 (251)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=292.56 Aligned_cols=225 Identities=19% Similarity=0.287 Sum_probs=179.3
Q ss_pred eEEEEEEcCC-----CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIAT-----GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~t-----g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|++... +..||+|++.. ..+.+.+|+.+++.+..||||+++++++.+....|+||||++ +|+|.+
T Consensus 52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~-~g~L~~ 130 (400)
T cd05105 52 KVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCF-YGDLVN 130 (400)
T ss_pred eEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecC-CCcHHH
Confidence 5788886543 45799999975 235688999999955469999999999999999999999999 999988
Q ss_pred hhccCC--------------------------------------------------------------------------
Q psy6377 75 IIDDNL-------------------------------------------------------------------------- 80 (383)
Q Consensus 75 ~l~~~~-------------------------------------------------------------------------- 80 (383)
++....
T Consensus 131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (400)
T cd05105 131 YLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDR 210 (400)
T ss_pred HHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccc
Confidence 653311
Q ss_pred ----------------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 81 ----------------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 81 ----------------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 211 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~---~~~kL~DfGla~~~ 287 (400)
T cd05105 211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG---KIVKICDFGLARDI 287 (400)
T ss_pred cccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC---CEEEEEeCCcceec
Confidence 12455899999999999999999999999999865 57999999999875
Q ss_pred ecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+......+.........++ ....+
T Consensus 288 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~ 365 (400)
T cd05105 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA--KPDHA 365 (400)
T ss_pred cccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC--CCccC
Confidence 43222 122356788999999988889999999999999999997 9999987654444333333322222 23467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+..+.+++.+||..||++|||+.++.+
T Consensus 366 ~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 366 TQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=270.31 Aligned_cols=222 Identities=22% Similarity=0.286 Sum_probs=182.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||++.. .+++.+|+|.+... ...+.+|+.+++ .++||||+++++++.+.+..++|||+++ +++|.+++..
T Consensus 10 ~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 86 (250)
T cd05085 10 EVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILK-QYDHPNIVKLIGVCTQRQPIYIVMELVP-GGDFLSFLRKK 86 (250)
T ss_pred eEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHH-hCCCCCcCeEEEEEecCCccEEEEECCC-CCcHHHHHHhc
Confidence 6899985 47889999998762 235788999998 6799999999999999999999999999 9999986643
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aP 150 (383)
..+..+..|++.||.|||++|++||||+|+||+++.+ +.++|+|||++......... ....+++.|+||
T Consensus 87 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aP 163 (250)
T cd05085 87 KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163 (250)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC---CeEEECCCccceeccccccccCCCCCCcccccCH
Confidence 2234556899999999999999999999999999765 58999999998764332211 112345679999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++|+||||+++|++++ |..||.+.........+..+.. ......++..+.+++.+||..+|++|||
T Consensus 164 E~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 99988889999999999999999998 9999998877766666554321 1223467899999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
+.++++
T Consensus 241 ~~~l~~ 246 (250)
T cd05085 241 FSELQK 246 (250)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=273.54 Aligned_cols=223 Identities=19% Similarity=0.272 Sum_probs=184.2
Q ss_pred eEEEEEEcCCCc---EEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGE---VFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~---~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+.+.+++ .+|+|.+... ...+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++
T Consensus 20 ~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 97 (268)
T cd05063 20 EVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG-QFSHHNIIRLEGVVTKFKPAMIITEYME-NGALDKYL 97 (268)
T ss_pred cEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHh-cCCCCCeeEEEEEEccCCCcEEEEEcCC-CCCHHHHH
Confidence 699999887665 7999998752 346788999998 7799999999999999999999999999 99999876
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--c--cccCCC
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--R--ELLGTP 145 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~--~~~gt~ 145 (383)
... ....+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++......... . ....++
T Consensus 98 ~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 174 (268)
T cd05063 98 RDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN---LECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174 (268)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC---CcEEECCCccceecccccccceeccCCCcCc
Confidence 432 234566999999999999999999999999999765 58999999998865432211 1 112345
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+..+. ..| ....++..+.+++.+||..+|
T Consensus 175 ~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~~~li~~c~~~~p 251 (268)
T cd05063 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP--APMDCPSAVYQLMLQCWQQDR 251 (268)
T ss_pred eecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC--CCCCCCHHHHHHHHHHcCCCc
Confidence 7999999988889999999999999999997 999999888777777776542 222 224578999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++||++.++++
T Consensus 252 ~~Rp~~~~i~~ 262 (268)
T cd05063 252 ARRPRFVDIVN 262 (268)
T ss_pred ccCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=266.94 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=197.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh---hcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI---IDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~---l~~ 78 (383)
.|+.+++..+++.++||+++. ....+.|||.||+-+.+||||++++|+..+. ...-||+|++. ..+...+ +..
T Consensus 53 EVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~-n~Dfk~ly~tl~d 131 (338)
T KOG0668|consen 53 EVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN-NTDFKQLYPTLTD 131 (338)
T ss_pred hHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc-cccHHHHhhhhch
Confidence 477788889999999999987 6788999999999777899999999999765 45789999998 7776664 455
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc-cCC
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH-YEP 157 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~-~~~ 157 (383)
-.+.++..+++.||.||||+||+|||+||.|++++... ..++|+|+|+|....++......+.+..|-.||.+. .+.
T Consensus 132 ~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~ 209 (338)
T KOG0668|consen 132 YDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQM 209 (338)
T ss_pred hhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--ceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechh
Confidence 66778889999999999999999999999999998653 589999999999998888888888999999999874 567
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHhc-------------cCCCCcch-----------h-------
Q psy6377 158 ITLAADMWSLGVTAYVLLTGFSPF-GGETDSETFRNISKA-------------QLDFPDEL-----------F------- 205 (383)
Q Consensus 158 ~~~~~DiwSlGvilyelltg~~Pf-~~~~~~~~~~~i~~~-------------~~~~~~~~-----------~------- 205 (383)
|+.+-|+|||||++..|+..+.|| .|.+..+++-+|.+. ....++.+ |
T Consensus 210 YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~ 289 (338)
T KOG0668|consen 210 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSE 289 (338)
T ss_pred ccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcc
Confidence 999999999999999999977665 677766666555332 22333221 1
Q ss_pred --cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 206 --EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 206 --~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.-+++++.||+.++|..|..+|+||.|++.||||.....
T Consensus 290 n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 290 NQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred ccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 114799999999999999999999999999999976543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=281.04 Aligned_cols=224 Identities=21% Similarity=0.285 Sum_probs=181.2
Q ss_pred eEEEEEEcC-------CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIA-------TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~-------tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||+|++.. .+..+|+|.+... ...+.+|+.+++...+||||+++++++.+.+..|++|||++ +++|
T Consensus 27 ~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L 105 (314)
T cd05099 27 QVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAA-KGNL 105 (314)
T ss_pred cEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCC-CCcH
Confidence 678887642 3557999998752 24577899999855579999999999999999999999999 9999
Q ss_pred HHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++.... +..+..|++.||.|||++|++||||||+|||++.+ +.+||+|||+++
T Consensus 106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~---~~~kL~Dfg~~~ 182 (314)
T cd05099 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED---NVMKIADFGLAR 182 (314)
T ss_pred HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC---CcEEEccccccc
Confidence 99764321 23456899999999999999999999999999765 589999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+...... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 259 (314)
T cd05099 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM---DKPS 259 (314)
T ss_pred cccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6543211 112234567999999988889999999999999999999 89999888877777766544321 1234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.++.++.+++.+||..+|++|||+.++++
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 260 NCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=272.97 Aligned_cols=221 Identities=21% Similarity=0.307 Sum_probs=181.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|.. .+++.||+|.+.. ....+.+|+.+++ .++||||+++++++. .+..+++||++. +++|.+.+..
T Consensus 21 ~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~v~e~~~-~~~L~~~~~~~~~ 96 (260)
T cd05067 21 EVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMK-QLQHPRLVRLYAVVT-QEPIYIITEYME-NGSLVDFLKTPEG 96 (260)
T ss_pred eEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHH-hcCCcCeeeEEEEEc-cCCcEEEEEcCC-CCCHHHHHHhcCC
Confidence 6899985 4678899999886 3467889999999 778999999999875 467899999999 9999987643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.....+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....++..|+|||
T Consensus 97 ~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe 173 (260)
T cd05067 97 IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET---LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC---CCEEEccCcceeecCCCCcccccCCcccccccCHH
Confidence 1234556899999999999999999999999999875 5899999999987642221 12234567899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++....++.++|+||||+++|+|++ |.+||.+.+..+....+..... .+.....+.++.+++.+||..+|++|||+
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred HhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9988889999999999999999998 9999998887777666654322 12334678899999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
++++.
T Consensus 251 ~~l~~ 255 (260)
T cd05067 251 EYLRS 255 (260)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=275.94 Aligned_cols=226 Identities=22% Similarity=0.239 Sum_probs=183.3
Q ss_pred eEEEEEEcCCC------cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATG------EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg------~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+.+.++ +.+|+|.+.. ....+.+|+.+++ .++||||+++++++.+....+++||+++ +++|.
T Consensus 10 ~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~ 87 (269)
T cd05044 10 EVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMS-NFNHPNIVKLLGVCLLNEPQYIIMELME-GGDLL 87 (269)
T ss_pred eEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHH-hcCCCCeeeEeeeecCCCCeEEEEeccC-CCcHH
Confidence 68998876544 7899998865 2456789999999 7799999999999999999999999999 99999
Q ss_pred Hhhcc-------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecCcc-
Q psy6377 74 TIIDD-------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 74 ~~l~~-------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~~~- 137 (383)
+++.. ..+..++.|++.||.|||+.|++|+||+|+||+++.+. ....++|+|||++........
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~ 167 (269)
T cd05044 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167 (269)
T ss_pred HHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc
Confidence 97643 12334668999999999999999999999999998753 223799999999876543221
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..+... .....++..+.+
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 244 (269)
T cd05044 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKPENCPDKIYQ 244 (269)
T ss_pred ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCcccchHHHHH
Confidence 122345788999999998889999999999999999998 99999887776666655433211 223457899999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6377 215 FIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+|.+||.++|.+|||++++++
T Consensus 245 li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 245 LMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=275.32 Aligned_cols=222 Identities=20% Similarity=0.243 Sum_probs=180.0
Q ss_pred eEEEEEEcCCCc----EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGE----VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~----~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++..+|+ .||+|++.. ....+.+|+.+++ ..+||||+++++++.. ...++++++++ +|+|.+.
T Consensus 22 ~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~-~~~~l~~~~~~-~g~l~~~ 98 (279)
T cd05109 22 TVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA-GVGSPYVCRLLGICLT-STVQLVTQLMP-YGCLLDY 98 (279)
T ss_pred eEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHH-hcCCCCCceEEEEEcC-CCcEEEEEcCC-CCCHHHH
Confidence 689999888887 489999875 2346778898988 7789999999999875 55789999999 8999987
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTP 145 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~ 145 (383)
+... .++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........ ....+++
T Consensus 99 l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~---~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05109 99 VRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP---NHVKITDFGLARLLDIDETEYHADGGKVPI 175 (279)
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCCCceeecccccceeecCCCccch
Confidence 6442 234567999999999999999999999999999765 57999999999876432221 1223467
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.........+..+... + ....++..+.+++.+||..||
T Consensus 176 ~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P--QPPICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred hhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--CCccCCHHHHHHHHHHcCCCh
Confidence 8999999988899999999999999999998 99999877766655545443322 1 224678999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.+++.
T Consensus 253 ~~Rp~~~~l~~ 263 (279)
T cd05109 253 ECRPRFRELVD 263 (279)
T ss_pred hhCcCHHHHHH
Confidence 99999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=281.42 Aligned_cols=225 Identities=21% Similarity=0.272 Sum_probs=182.0
Q ss_pred eEEEEEEcC-------CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIA-------TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~-------tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||.+++.. ++..+|+|.+... ...+.+|+.+++.+.+||||+++++++.+.+..|+||||+. +++|
T Consensus 33 ~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L 111 (307)
T cd05098 33 QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGNL 111 (307)
T ss_pred eEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCC-CCcH
Confidence 578887643 3457999999752 23577899999955589999999999999999999999999 9999
Q ss_pred HHhhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++... .++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 112 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~---~~~kL~dfg~a~ 188 (307)
T cd05098 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLAR 188 (307)
T ss_pred HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC---CcEEECCCcccc
Confidence 9977532 123456999999999999999999999999999765 589999999988
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..+....+..... .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 265 (307)
T cd05098 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR---MDKPS 265 (307)
T ss_pred cccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC---CCCCC
Confidence 6543211 111234568999999988889999999999999999998 8999988777666666554432 12234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++.++.+++.+||..+|.+|||+.+++++
T Consensus 266 ~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=274.10 Aligned_cols=223 Identities=21% Similarity=0.295 Sum_probs=183.1
Q ss_pred eEEEEEEcCCCc---EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGE---VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~---~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.++. .+|+|.+.. ....+.+|+.+++ ..+||||+++++++.+++..|+|||+++ +++|.+++
T Consensus 19 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 96 (267)
T cd05066 19 EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSKPVMIVTEYME-NGSLDAFL 96 (267)
T ss_pred ceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCccEEEEEcCC-CCCHHHHH
Confidence 689998875554 799999875 2356888999998 7789999999999999999999999999 99999976
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-c---ccccCCC
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-I---RELLGTP 145 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~---~~~~gt~ 145 (383)
... .+..+..|++.||.|||++|++||||||+|||++.+ +.++|+|||++........ . ....++.
T Consensus 97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (267)
T cd05066 97 RKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173 (267)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC---CeEEeCCCCcccccccccceeeecCCCccce
Confidence 543 234566899999999999999999999999999765 6899999999986543221 1 1122356
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|+|||||++|++++ |..||.+....+....+..+. .+| ....+++.+.+++.+||..+|
T Consensus 174 ~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred eecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCCCHHHHHHHHHHcccCc
Confidence 7999999998889999999999999999886 999998887777766665542 222 224678999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
.+|||+.++++
T Consensus 251 ~~Rp~~~~i~~ 261 (267)
T cd05066 251 NERPKFEQIVS 261 (267)
T ss_pred hhCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.42 Aligned_cols=229 Identities=38% Similarity=0.593 Sum_probs=194.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|++..+|+.+|+|++... ...+.+|+..++ .++|+||+++++.+......++++|++. +++|.+++..
T Consensus 4 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l~~e~~~-~~~L~~~~~~~ 81 (244)
T smart00220 4 KVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILK-KLKHPNIVRLYDVFEDEDKLYLVMEYCD-GGDLFDLLKKR 81 (244)
T ss_pred EEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH-hCCCCcHHHHHhheeeCCEEEEEEeCCC-CCCHHHHHHhc
Confidence 7899999999999999999862 468899999999 6699999999999999999999999999 8899997643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.....+..+++.++.|||+.|++|+||+|.||+++.+ +.++|+|||.+.............+++.|+|||.+
T Consensus 82 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 82 GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 3344666999999999999999999999999999865 68999999999987655455667789999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
....++.++|+||+|+++|+|++|..||.. .........+........ ..+..++.++.+++.+||..+|++||++.+
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 888899999999999999999999999987 444444444443333322 222227899999999999999999999999
Q ss_pred HHcCccc
Q psy6377 233 ALKHPWL 239 (383)
Q Consensus 233 ~L~hp~~ 239 (383)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=269.30 Aligned_cols=223 Identities=21% Similarity=0.326 Sum_probs=183.6
Q ss_pred eEEEEEEcC-CCc--EEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIA-TGE--VFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~-tg~--~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||++.+.. +++ .||+|.+... ...+.+|+.+++ .+.||||+++++++.+ ...+++||+++ +++|.+.+
T Consensus 10 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~-~~~~~v~e~~~-~~~L~~~l 86 (257)
T cd05040 10 VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMH-SLDHENLIRLYGVVLT-HPLMMVTELAP-LGSLLDRL 86 (257)
T ss_pred cEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHh-hcCCCCccceeEEEcC-CeEEEEEEecC-CCcHHHHH
Confidence 688888765 333 6999999873 346788999999 7789999999999998 88999999999 99999976
Q ss_pred ccCC--------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCC
Q psy6377 77 DDNL--------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGT 144 (383)
Q Consensus 77 ~~~~--------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt 144 (383)
.... ++.+..|++.||+|||++|++||||+|+||+++.+ +.+||+|||++........ .....++
T Consensus 87 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05040 87 RKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163 (257)
T ss_pred HhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccceecccCCCCC
Confidence 4432 23455899999999999999999999999999876 6899999999987644221 1124567
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.......+ .....+..+.+++.+||..+
T Consensus 164 ~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd05040 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIYNVMLQCWAHN 241 (257)
T ss_pred ceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHHHHHHHHCCCC
Confidence 88999999998889999999999999999998 9999988877777766654322222 22356899999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|++|||+.++++
T Consensus 242 p~~Rps~~~~~~ 253 (257)
T cd05040 242 PADRPTFAALRE 253 (257)
T ss_pred cccCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=269.36 Aligned_cols=223 Identities=22% Similarity=0.288 Sum_probs=184.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
..||+|... .++.+|+|.+.. ....+.+|+.+++ .++||||+++++++.+....+++||+++ +++|.+++...
T Consensus 20 ~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~i~~~~ 96 (261)
T cd05034 20 GEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMK-KLRHDKLVQLYAVCSEEEPIYIVTEYMS-KGSLLDFLKSGE 96 (261)
T ss_pred eEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHh-hCCCCCEeeeeeeeecCCceEEEEeccC-CCCHHHHHhccc
Confidence 368999875 567899999876 3467889999999 7789999999999999899999999999 99999976442
Q ss_pred -------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 80 -------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 80 -------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
.+..+..|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ .....++..|+||
T Consensus 97 ~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~P 173 (261)
T cd05034 97 GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173 (261)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC---CCEEECccccceeccchhhhhhhccCCCccccCH
Confidence 234666999999999999999999999999999876 6899999999987643211 1122345689999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|.+.+..++.++|+||+|+++|+|++ |+.||.+.+.......+..+.. . ......+.++.+++.+||..+|++||+
T Consensus 174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-M--PRPPNCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 99998889999999999999999998 9999998887777777654321 1 122356889999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
+++++.
T Consensus 251 ~~~l~~ 256 (261)
T cd05034 251 FEYLQS 256 (261)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=276.75 Aligned_cols=223 Identities=20% Similarity=0.271 Sum_probs=181.7
Q ss_pred eEEEEEEcC-----CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA-----TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~-----tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+.. .+..+|+|.+... ...+.+|+.+++ .+.||||+++++.+..++..++++||+. +++|.+
T Consensus 15 ~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 92 (290)
T cd05045 15 KVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLK-QVNHPHVIKLYGACSQDGPLLLIVEYAK-YGSLRS 92 (290)
T ss_pred ceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCCcEEEEEecC-CCCHHH
Confidence 588887653 3367999988762 346889999999 7789999999999999999999999999 999998
Q ss_pred hhccC------------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEE
Q psy6377 75 IIDDN------------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124 (383)
Q Consensus 75 ~l~~~------------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~ 124 (383)
++... .++.+..|++.||.|||++|++||||||+|||++++ +.++|+
T Consensus 93 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~---~~~kl~ 169 (290)
T cd05045 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG---RKMKIS 169 (290)
T ss_pred HHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCC---CcEEec
Confidence 76431 124566899999999999999999999999999765 589999
Q ss_pred eccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCC
Q psy6377 125 DFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 125 DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+... ...
T Consensus 170 dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~ 248 (290)
T cd05045 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM 248 (290)
T ss_pred cccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC
Confidence 9999986533221 122345678999999988889999999999999999998 99999888776666654433 222
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+ ....++.++.+|+.+||..+|++||++.++++
T Consensus 249 ~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 249 E--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred C--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1 23467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.87 Aligned_cols=223 Identities=17% Similarity=0.248 Sum_probs=184.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||++.+. .++.+|+|.+.. ....+.+|+++++ .++||||+++++++.+....+++||++. +++|.+++...
T Consensus 19 ~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~~~ 95 (256)
T cd05112 19 LVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMM-KLSHPKLVQLYGVCTERSPICLVFEFME-HGCLSDYLRAQRG 95 (256)
T ss_pred eEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHH-hCCCCCeeeEEEEEccCCceEEEEEcCC-CCcHHHHHHhCcc
Confidence 68898775 577899999876 3467899999999 7799999999999999999999999999 99999876432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....++..|+|||.
T Consensus 96 ~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~ 172 (256)
T cd05112 96 KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN---QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC---CeEEECCCcceeecccCcccccCCCccchhhcCHhH
Confidence 234556899999999999999999999999999765 5899999999886543221 112235678999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++|+||+|+++|+|++ |.+||......+....+..+...+.+ ...+..+.+|+.+||..+|++|||+.
T Consensus 173 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~ 249 (256)
T cd05112 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFS 249 (256)
T ss_pred hccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHH
Confidence 988889999999999999999998 99999988877777776654322222 23588999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
+++++
T Consensus 250 ~~l~~ 254 (256)
T cd05112 250 LLLHQ 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=272.10 Aligned_cols=225 Identities=18% Similarity=0.235 Sum_probs=175.6
Q ss_pred eEEEEEEc--CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSI--ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|... .....+|+|.+.. ....+.+|+.+++ .++||||+++++.+.+....|+|||+++ +++|.+++.
T Consensus 10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~-~l~h~nii~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 87 (269)
T cd05042 10 KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYR-ELNHPNVLQCLGQCIESIPYLLVLEFCP-LGDLKNYLR 87 (269)
T ss_pred eEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHH-hCCCCCcceEEEEECCCCceEEEEEeCC-CCcHHHHHH
Confidence 57777543 3456789998764 1345778999998 7799999999999999999999999999 999999764
Q ss_pred cCC-----------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccC
Q psy6377 78 DNL-----------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLG 143 (383)
Q Consensus 78 ~~~-----------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~g 143 (383)
... ...++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........ .....+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05042 88 SNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLALEQYPEDYYITKDCHAV 164 (269)
T ss_pred hccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---CcEEEeccccccccccchheeccCCCCC
Confidence 421 23566899999999999999999999999999875 5899999999875432211 122345
Q ss_pred CCCcCCCcccc-------cCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhc-cCCCCcc-hhcCCCHHHH
Q psy6377 144 TPDYVAPEILH-------YEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA-QLDFPDE-LFEDISPEAK 213 (383)
Q Consensus 144 t~~y~aPE~l~-------~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~-~~~~~s~~~~ 213 (383)
++.|+|||++. ...++.++|||||||++|+|++ |.+||......+....+... ...++.. ....++..+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05042 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWY 244 (269)
T ss_pred cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHH
Confidence 67899999874 2456889999999999999999 88999887766665554433 2333322 3346788899
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6377 214 DFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+++..|+ .||++|||++++++
T Consensus 245 ~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 245 EVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHh-cCcccccCHHHHHH
Confidence 9999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=269.17 Aligned_cols=222 Identities=21% Similarity=0.290 Sum_probs=181.3
Q ss_pred eEEEEEEcCCC---cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATG---EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg---~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+...++ ..+|+|.+... ...+.+|+.+++ .++||||+++++++. .+..+++|+++. +++|.+++
T Consensus 10 ~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~~~~~v~e~~~-~~~L~~~l 86 (257)
T cd05060 10 SVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMA-QLDHPCIVRLIGVCK-GEPLMLVMELAP-LGPLLKYL 86 (257)
T ss_pred eEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHH-hcCCCCeeeEEEEEc-CCceEEEEEeCC-CCcHHHHH
Confidence 67888766555 78999998862 346788999999 678999999999876 456899999999 89999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc----cccCCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR----ELLGTPD 146 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~----~~~gt~~ 146 (383)
... .+..+..|++.||+|||+.|++||||||+|||++.+ +.++|+|||+++......... ...++..
T Consensus 87 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05060 87 KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---HQAKISDFGMSRALGAGSDYYRATTAGRWPLK 163 (257)
T ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---CcEEeccccccceeecCCcccccccCcccccc
Confidence 442 345666999999999999999999999999999765 689999999998765433211 1123467
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+...... .....++..+.++|.+||..+|+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~ 240 (257)
T cd05060 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSIMLSCWKYRPE 240 (257)
T ss_pred ccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChh
Confidence 999999988889999999999999999998 99999888776666666544321 23346789999999999999999
Q ss_pred CCCCHHHHHc
Q psy6377 226 ERMTAKEALK 235 (383)
Q Consensus 226 ~Rpt~~e~L~ 235 (383)
+|||+.++++
T Consensus 241 ~Rp~~~~l~~ 250 (257)
T cd05060 241 DRPTFSELES 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=273.41 Aligned_cols=222 Identities=18% Similarity=0.257 Sum_probs=176.3
Q ss_pred eEEEEEEcCCCcE-------EEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEV-------FAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~-------vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|.++.++.. +|+|.+.. ....+.+|+.+++ ...||||+++++++.++...++||||+. +++|.
T Consensus 10 ~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~ 87 (258)
T cd05078 10 KIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMS-QLSHKHLVLNYGVCVCGDESIMVQEYVK-FGSLD 87 (258)
T ss_pred hheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHH-hCCCCChhheeeEEEeCCCcEEEEecCC-CCcHH
Confidence 6899988766554 88888865 2346788899998 7789999999999999999999999999 99999
Q ss_pred HhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-----CCcEEEEeccceeEeecCcccccc
Q psy6377 74 TIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-----NCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 74 ~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-----~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
.++... ....+..||+.||+|||++||+||||||+||+++.++. .+.++++|||++...... ...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~ 164 (258)
T cd05078 88 TYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EIL 164 (258)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhc
Confidence 977542 22345699999999999999999999999999976531 134799999998765332 335
Q ss_pred cCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 142 LGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 142 ~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
.+++.|+|||++.+ ..++.++|+|||||++|+|++| .+||...+...... +......+|. ..+.++.+++.+|
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~li~~~ 239 (258)
T cd05078 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PKWTELANLINQC 239 (258)
T ss_pred cccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CCcHHHHHHHHHH
Confidence 68899999999876 4579999999999999999998 56766555443332 3333333333 3467899999999
Q ss_pred cccCCCCCCCHHHHHcC
Q psy6377 220 LIKNPMERMTAKEALKH 236 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~h 236 (383)
|..||++|||++++++.
T Consensus 240 l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 240 MDYEPDFRPSFRAIIRD 256 (258)
T ss_pred hccChhhCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.89 Aligned_cols=223 Identities=19% Similarity=0.283 Sum_probs=182.7
Q ss_pred eEEEEEEcCCCc---EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGE---VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~---~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+.+.+|. .||+|++.. ....+..|+.+++ ...||||+++++++.++...+++||++. +++|.+++
T Consensus 19 ~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 96 (269)
T cd05065 19 EVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSRPVMIITEFME-NGALDSFL 96 (269)
T ss_pred eEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHH-hCCCcCcceEEEEECCCCceEEEEecCC-CCcHHHHH
Confidence 689999887765 699999876 2356889999999 7799999999999999999999999999 99999876
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc---cc---C
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE---LL---G 143 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~---~~---g 143 (383)
... .++.+..|++.||.|||++|++||||||+||+++.+ +.++|+|||++........... .. +
T Consensus 97 ~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (269)
T cd05065 97 RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173 (269)
T ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC---CcEEECCCccccccccCccccccccccCCCc
Confidence 532 234566899999999999999999999999999765 6899999999876543222111 11 2
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+..|+|||.+.+..++.++||||+||++|++++ |..||.+.+..+....+... ...| ....++..+.+++.+||..
T Consensus 174 ~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~--~~~~~~~~~~~li~~~l~~ 250 (269)
T cd05065 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLP--PPMDCPTALHQLMLDCWQK 250 (269)
T ss_pred ceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCC--CcccCCHHHHHHHHHHcCC
Confidence 357999999998899999999999999999886 99999888777766666433 2222 2246788999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
+|.+||++.+++.
T Consensus 251 ~p~~Rp~~~~i~~ 263 (269)
T cd05065 251 DRNARPKFGQIVS 263 (269)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=274.66 Aligned_cols=225 Identities=24% Similarity=0.324 Sum_probs=180.7
Q ss_pred ccceEEEEEEc----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 2 FALSEEMADSI----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 2 f~~~V~~~~~~----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
|| .||.|... ..+..|+||.+.. ....+.+|++.++ .++||||+++++++......++|+|+++ +++|
T Consensus 12 fg-~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~g~~~~~~~~~lv~e~~~-~g~L 88 (259)
T PF07714_consen 12 FG-KVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILR-KLRHPNIVKLYGFCIENEPLFLVMEYCP-GGSL 88 (259)
T ss_dssp SE-EEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHH-THSBTTBE-EEEEEESSSSEEEEEE--T-TEBH
T ss_pred Cc-EEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccc-cccccccccccccccccccccccccccc-cccc
Confidence 44 58888877 5678899999965 2468899999999 5599999999999998888999999999 8999
Q ss_pred HHhhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccc
Q psy6377 73 QTIIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IREL 141 (383)
Q Consensus 73 ~~~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~ 141 (383)
.+++... ....++.||+.||.|||+++++|++|+|.||+++++ +.+||+|||++........ ....
T Consensus 89 ~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~---~~~Kl~~f~~~~~~~~~~~~~~~~~~ 165 (259)
T PF07714_consen 89 DDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN---GQVKLSDFGLSRPISEKSKYKNDSSQ 165 (259)
T ss_dssp HHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT---TEEEEESTTTGEETTTSSSEEESTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 9976553 234566999999999999999999999999999876 6999999999987632211 2234
Q ss_pred cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.+...|+|||.+....++.++||||||+++||+++ |..||...+..+....+..+..... ...++..+.++|..||
T Consensus 166 ~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~C~ 242 (259)
T PF07714_consen 166 QLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPKDIYSLIQQCW 242 (259)
T ss_dssp ESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhHHHHHHHHHHc
Confidence 56778999999998889999999999999999999 7899999888887877755544322 2457899999999999
Q ss_pred ccCCCCCCCHHHHHc
Q psy6377 221 IKNPMERMTAKEALK 235 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~ 235 (383)
..||++|||+.++++
T Consensus 243 ~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 243 SHDPEKRPSFQEILQ 257 (259)
T ss_dssp -SSGGGS--HHHHHH
T ss_pred CCChhhCcCHHHHHh
Confidence 999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=281.46 Aligned_cols=225 Identities=20% Similarity=0.272 Sum_probs=182.5
Q ss_pred eEEEEEEcCC-------CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIAT-------GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~t-------g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||.|++... +..+|+|.+.. ....+.+|+.+++.+.+||||+++++++..++..++++||++ +++|
T Consensus 27 ~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L 105 (334)
T cd05100 27 QVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYAS-KGNL 105 (334)
T ss_pred cEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCC-CCcH
Confidence 5788876432 23789998875 235688999999955589999999999999999999999999 9999
Q ss_pred HHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++.... +..+..|++.||.|||++|++||||||+|||++.+ +.++|+|||+++
T Consensus 106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~---~~~kL~Dfg~~~ 182 (334)
T cd05100 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED---NVMKIADFGLAR 182 (334)
T ss_pred HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCcccce
Confidence 99765321 12356899999999999999999999999999765 589999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...... ....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 259 (334)
T cd05100 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPA 259 (334)
T ss_pred ecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6543221 112234567999999998899999999999999999998 89999988877777766544321 1224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++.++.+++.+||..+|.+|||+.+++.+
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 260 NCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=276.50 Aligned_cols=225 Identities=17% Similarity=0.239 Sum_probs=178.8
Q ss_pred eEEEEEEcCCC--------------cEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEec
Q psy6377 5 SEEMADSIATG--------------EVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65 (383)
Q Consensus 5 ~V~~~~~~~tg--------------~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~ 65 (383)
.||+|++..++ ..||+|.+... ...+.+|+++++ .++||||+++++++...+..++||||
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~ 98 (295)
T cd05097 20 EVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS-RLKNPNIIRLLGVCVSDDPLCMITEY 98 (295)
T ss_pred eEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHH-hCCCCCcCeEEEEEcCCCccEEEEec
Confidence 58888775433 35999998762 345788999999 78999999999999999999999999
Q ss_pred CCCcCcHHHhhccC------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 66 TPLVVTLQTIIDDN------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 66 ~~~g~~L~~~l~~~------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
+. +++|.+++... ..+.+..|++.||+|||++|++||||||+||+++.+ +.+||+|||
T Consensus 99 ~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~---~~~kl~dfg 174 (295)
T cd05097 99 ME-NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH---YTIKIADFG 174 (295)
T ss_pred CC-CCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCC---CcEEecccc
Confidence 99 99999976432 123456899999999999999999999999999765 589999999
Q ss_pred ceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHhc-----c
Q psy6377 128 ISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT--GFSPFGGETDSETFRNISKA-----Q 197 (383)
Q Consensus 128 la~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt--g~~Pf~~~~~~~~~~~i~~~-----~ 197 (383)
++........ .....+++.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd05097 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR 254 (295)
T ss_pred cccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccc
Confidence 9886543221 122345678999999988889999999999999999988 67899887766655544321 1
Q ss_pred CCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 198 LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 198 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
..+ ....+..++.+.+|+.+||..||++|||++++++
T Consensus 255 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 255 QIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111 1122356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=269.60 Aligned_cols=224 Identities=19% Similarity=0.207 Sum_probs=177.5
Q ss_pred eEEEEEEcC---CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEE-eCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIA---TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~---tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~-~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|.... ++..+|+|.+.. ....+.+|+.+++ .++||||+++++++. .++..+++|+++. +++|.++
T Consensus 10 ~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 87 (262)
T cd05058 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMK-DFSHPNVLSLLGICLPSEGSPLVVLPYMK-HGDLRNF 87 (262)
T ss_pred eEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHc-cCCCCCcceEEEEeecCCCCcEEEEecCC-CCCHHHH
Confidence 588888653 446799998864 2346778999998 789999999999765 4556899999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----ccccccC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELLG 143 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~g 143 (383)
+... ....++.|++.||.|||+.|++||||||+|||++.+ +.+||+|||+++...... ......+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 164 (262)
T cd05058 88 IRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES---FTVKVADFGLARDIYDKEYYSVHNHTGAKL 164 (262)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC---CcEEECCccccccccCCcceeecccccCcC
Confidence 6432 123455899999999999999999999999999765 589999999998653321 1123346
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+..+..... ...++..+.+++.+||..
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~ 241 (262)
T cd05058 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLYEVMLSCWHP 241 (262)
T ss_pred CccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCC
Confidence 778999999988889999999999999999999 5778877776666665554432221 134688999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
+|++||++.+++..
T Consensus 242 ~p~~Rp~~~~il~~ 255 (262)
T cd05058 242 KPEMRPTFSELVSR 255 (262)
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.64 Aligned_cols=219 Identities=21% Similarity=0.289 Sum_probs=170.7
Q ss_pred EEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhhcc----
Q psy6377 10 DSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 10 ~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
....+++.||+|++... ...+.+|+++++ .++||||+++++++... ...+++||++. +++|.+++..
T Consensus 28 ~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~l~ 105 (283)
T cd05080 28 ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK-TLYHENIVKYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLN 105 (283)
T ss_pred ccCCCCceEEEEEeccccChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCCceEEEEecCCC-CCCHHHHHHHcCCC
Confidence 34568899999998752 346788999999 77999999999988753 46899999999 9999987643
Q ss_pred -CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCCcCCCccc
Q psy6377 79 -NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||.|||++||+||||||+|||++.+ +.++|+|||++.....+.. .....++..|+|||.+
T Consensus 106 ~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC---CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHh
Confidence 3445667999999999999999999999999999765 5899999999987643322 1122456679999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH--HH------------HHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--ET------------FRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
....++.++||||||+++|+|++|..||...... +. ........... +....++.++.+++.+|
T Consensus 183 ~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c 260 (283)
T cd05080 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL--PCPKNCPQEVYILMKNC 260 (283)
T ss_pred cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHH
Confidence 8888999999999999999999999998654321 00 00011011111 12245688999999999
Q ss_pred cccCCCCCCCHHHHHc
Q psy6377 220 LIKNPMERMTAKEALK 235 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~ 235 (383)
|..+|++|||+++++.
T Consensus 261 l~~~p~~Rps~~~i~~ 276 (283)
T cd05080 261 WETEAKFRPTFRSLIP 276 (283)
T ss_pred hccChhhCCCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=272.11 Aligned_cols=222 Identities=18% Similarity=0.265 Sum_probs=177.1
Q ss_pred eEEEEEEcCCCcE----EEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEV----FAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~----vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+...+|+. +++|.+... ...+..|+.+++ ..+||||+++++++. +...++++|+++ +++|.++
T Consensus 22 ~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~-~l~h~~iv~~~~~~~-~~~~~~i~e~~~-~gsL~~~ 98 (279)
T cd05111 22 TVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG-SLDHAYIVRLLGICP-GASLQLVTQLSP-LGSLLDH 98 (279)
T ss_pred ceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHh-cCCCCCcceEEEEEC-CCccEEEEEeCC-CCcHHHH
Confidence 5899999888874 677777541 234566676777 778999999999875 456789999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP 145 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~ 145 (383)
+... ....++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++....... .....++.
T Consensus 99 l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05111 99 VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD---SIVQIADFGVADLLYPDDKKYFYSEHKTPI 175 (279)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---CcEEEcCCccceeccCCCcccccCCCCCcc
Confidence 6432 234567999999999999999999999999999765 6899999999987643322 22345677
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+..+..... ...++..+.+++.+||..||
T Consensus 176 ~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred cccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCCHHHHHHHHHHcCCCc
Confidence 8999999988889999999999999999998 9999988876655554444332222 23457889999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++++
T Consensus 253 ~~Rps~~el~~ 263 (279)
T cd05111 253 NVRPTFKELAN 263 (279)
T ss_pred ccCcCHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.63 Aligned_cols=233 Identities=26% Similarity=0.393 Sum_probs=195.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.|.+++...|...||+|.+++ ....+.-|-.||. -.+.+-||+||-.|+|.+.+|+||+|++ ||++-.+|
T Consensus 644 eV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILA-EADn~WVVrLyySFQDkdnLYFVMdYIP-GGDmMSLLI 721 (1034)
T KOG0608|consen 644 EVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILA-EADNEWVVRLYYSFQDKDNLYFVMDYIP-GGDMMSLLI 721 (1034)
T ss_pred eeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHh-hcCCcceEEEEEEeccCCceEEEEeccC-CccHHHHHH
Confidence 577788889999999999988 2455778888998 7789999999999999999999999999 99999853
Q ss_pred -----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec---------Ccc-----
Q psy6377 77 -----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---------GIE----- 137 (383)
Q Consensus 77 -----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---------~~~----- 137 (383)
++....++...+.+|+++.|..|+|||||||+|||++.+ |+|||+||||+..+.- +..
T Consensus 722 rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd---GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDS 798 (1034)
T KOG0608|consen 722 RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDS 798 (1034)
T ss_pred HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC---CceeeeeccccccceeccccccccCCCcccccc
Confidence 455566778999999999999999999999999999887 7999999999875421 100
Q ss_pred -----------------------------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH
Q psy6377 138 -----------------------------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE 188 (383)
Q Consensus 138 -----------------------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~ 188 (383)
....+||+.|+|||++...+|+..||.||.|||||+|+.|++||.+.+..+
T Consensus 799 mep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 799 MEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred CCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 012469999999999999999999999999999999999999999988887
Q ss_pred HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcccCCcc
Q psy6377 189 TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM---TAKEALKHPWLMNKK 243 (383)
Q Consensus 189 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hp~~~~~~ 243 (383)
.-.++.+-.-.+.-.+..++|.++.++|.++ .-+++.|+ .++|+..||||...+
T Consensus 879 tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 879 TQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred ceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence 7666655443333344568899999999985 66788888 478899999998765
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=269.50 Aligned_cols=226 Identities=20% Similarity=0.259 Sum_probs=187.3
Q ss_pred eEEEEEEcC-CCcEEEEEEccC--------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCc
Q psy6377 5 SEEMADSIA-TGEVFAAKFLES--------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLV 69 (383)
Q Consensus 5 ~V~~~~~~~-tg~~vAvK~i~~--------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g 69 (383)
.||.+.+.. +++.+|+|.+.. ....+.+|+.++....+||||+++++++.+++..+++|||+. |
T Consensus 15 ~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 93 (269)
T cd08528 15 CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIE-G 93 (269)
T ss_pred eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCC-C
Confidence 789999887 789999998753 123466788888767899999999999999999999999999 9
Q ss_pred CcHHHhhcc----------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc
Q psy6377 70 VTLQTIIDD----------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI 138 (383)
Q Consensus 70 ~~L~~~l~~----------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~ 138 (383)
++|.+++.. ..++.+..|++.||.|||+ .|++|+||+|+||+++.+ +.++|+|||++.........
T Consensus 94 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~ 170 (269)
T cd08528 94 APLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITDFGLAKQKQPESKL 170 (269)
T ss_pred CcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC---CcEEEecccceeeccccccc
Confidence 999886521 2344566899999999996 789999999999999765 68999999999876554444
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 218 (383)
....|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...........+......... ...+++.+.++|.+
T Consensus 171 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 248 (269)
T cd08528 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--EGMYSEDVTDVITS 248 (269)
T ss_pred ccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--cccCCHHHHHHHHH
Confidence 5567899999999999888999999999999999999999999877766666666554433222 23568999999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q psy6377 219 ILIKNPMERMTAKEALKH 236 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~h 236 (383)
||..||++|||+.|+..+
T Consensus 249 cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 249 CLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HCCCCCccCCCHHHHHHH
Confidence 999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=286.52 Aligned_cols=226 Identities=20% Similarity=0.279 Sum_probs=181.6
Q ss_pred eEEEEEEc-----CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++ .++..||+|++... ...+.+|+.++..+..||||+++++++.+....++||||+. +|+|.+
T Consensus 52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~-~g~L~~ 130 (401)
T cd05107 52 RVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCR-YGDLVD 130 (401)
T ss_pred eEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccC-CCcHHH
Confidence 47889854 45678999999862 23678899999955459999999999999999999999999 999999
Q ss_pred hhccCC--------------------------------------------------------------------------
Q psy6377 75 IIDDNL-------------------------------------------------------------------------- 80 (383)
Q Consensus 75 ~l~~~~-------------------------------------------------------------------------- 80 (383)
++....
T Consensus 131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (401)
T cd05107 131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE 210 (401)
T ss_pred HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence 764321
Q ss_pred ------------------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 81 ------------------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 81 ------------------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+.+..|++.||.|||++||+||||||+|||++.+ +.++|+|||+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~---~~~kL~DfGla~ 287 (401)
T cd05107 211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG---KLVKICDFGLAR 287 (401)
T ss_pred CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC---CEEEEEecCcce
Confidence 12345799999999999999999999999999765 589999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||......+...........+ ..+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~p~ 365 (401)
T cd05107 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM--AKPA 365 (401)
T ss_pred ecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC--CCCC
Confidence 6533221 123457789999999998889999999999999999998 899998766655544443333222 1234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++.++.+++.+||..+|.+||++.++++.
T Consensus 366 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 366 HASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=280.61 Aligned_cols=225 Identities=21% Similarity=0.313 Sum_probs=176.1
Q ss_pred eEEEEEE-----cCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeC-CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADS-----IATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++ ..+++.||||++... ...+.+|+.++..+.+||||+++++++... ...+++|||++ +++|.
T Consensus 22 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~-~g~L~ 100 (343)
T cd05103 22 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK-FGNLS 100 (343)
T ss_pred eEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccC-CCcHH
Confidence 5888874 467889999999751 245778999999666899999999987654 56889999999 99999
Q ss_pred HhhccCC-------------------------------------------------------------------------
Q psy6377 74 TIIDDNL------------------------------------------------------------------------- 80 (383)
Q Consensus 74 ~~l~~~~------------------------------------------------------------------------- 80 (383)
+++....
T Consensus 101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (343)
T cd05103 101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED 180 (343)
T ss_pred HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence 8654211
Q ss_pred chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcCCCcccccCC
Q psy6377 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEILHYEP 157 (383)
Q Consensus 81 ~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~ 157 (383)
...+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++........ .....+++.|+|||.+.+..
T Consensus 181 ~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 181 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257 (343)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC---CcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC
Confidence 12345799999999999999999999999999765 5899999999986533221 11234567899999998888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHH-HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 158 ITLAADMWSLGVTAYVLLT-GFSPFGGETDSETF-RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 158 ~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
++.++|+||||+++|+|++ |..||.+....+.. ..+..+... +. ...+++++.+++..||..||++|||+.++++
T Consensus 258 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~ 334 (343)
T cd05103 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334 (343)
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999997 99999876543333 333333221 11 1246789999999999999999999999997
Q ss_pred C
Q psy6377 236 H 236 (383)
Q Consensus 236 h 236 (383)
|
T Consensus 335 ~ 335 (343)
T cd05103 335 H 335 (343)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=269.55 Aligned_cols=225 Identities=19% Similarity=0.317 Sum_probs=185.2
Q ss_pred eEEEEEEcC-----CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA-----TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~-----tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+.+. +.+.+|+|.+... ...+.+|+++++ .++||||+++++++.+.+..|++||+++ +++|.+
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 97 (275)
T cd05046 20 EVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFR-KLSHKNVVRLLGLCREAEPHYMILEYTD-LGDLKQ 97 (275)
T ss_pred EEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHH-hcCCcceeeeEEEECCCCcceEEEEecC-CCcHHH
Confidence 688888654 4578999998762 245889999999 6799999999999999999999999999 999999
Q ss_pred hhccCC---------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--c
Q psy6377 75 IIDDNL---------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--E 137 (383)
Q Consensus 75 ~l~~~~---------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~ 137 (383)
++.... +..+..|++.||+|||+.||+||||||+||+++.+ +.++++|||++....... .
T Consensus 98 ~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~~~~~~~~~~~~~~~~ 174 (275)
T cd05046 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---REVKVSLLSLSKDVYNSEYYK 174 (275)
T ss_pred HHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC---CcEEEcccccccccCcccccc
Confidence 765322 34556899999999999999999999999999775 689999999987543221 1
Q ss_pred cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHH
Q psy6377 138 IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 216 (383)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..+...++. ...++..+.+++
T Consensus 175 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~i 252 (275)
T cd05046 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--PEGCPSRLYKLM 252 (275)
T ss_pred cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC--CCCCCHHHHHHH
Confidence 233456778999999988888999999999999999998 88999887777777766655544332 246789999999
Q ss_pred HHhcccCCCCCCCHHHHHcC
Q psy6377 217 AKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+||..+|.+|||+.+++.+
T Consensus 253 ~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 253 TRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHcCCCcccCCCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=265.82 Aligned_cols=220 Identities=21% Similarity=0.243 Sum_probs=175.1
Q ss_pred eEEEEEEcCCC----------cEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATG----------EVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg----------~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
.||++.+..++ ..+++|.+... ...+.+|+.+++ .++||||+++++++.. ...++||||+. +++
T Consensus 10 ~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~-~~~~lv~e~~~-~~~ 86 (259)
T cd05037 10 NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMS-QLSHKHLVKLYGVCVR-DENIMVEEYVK-FGP 86 (259)
T ss_pred eEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHH-cCCCcchhheeeEEec-CCcEEEEEcCC-CCc
Confidence 57999998877 45888887652 457889999998 7799999999999988 78899999999 999
Q ss_pred HHHhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC----CCCcEEEEeccceeEeecCccccc
Q psy6377 72 LQTIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF----PNCDIKVCDFEISRVILDGIEIRE 140 (383)
Q Consensus 72 L~~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~----~~~~ikL~DFGla~~~~~~~~~~~ 140 (383)
|.+++.... +..+..||+.||+|||++||+||||||+|||++.+. ..+.++|+|||++..... ...
T Consensus 87 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~ 163 (259)
T cd05037 87 LDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REE 163 (259)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccc
Confidence 998765422 345568999999999999999999999999998753 123699999999987543 223
Q ss_pred ccCCCCcCCCcccccC--CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 141 LLGTPDYVAPEILHYE--PITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
..++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+..+....... ....+ ...+..+.++|.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~li~ 238 (259)
T cd05037 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP----MPDCAELANLIN 238 (259)
T ss_pred cccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC----CCCchHHHHHHH
Confidence 4577889999998776 78999999999999999999 6888877654433332221 11111 122478999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q psy6377 218 KILIKNPMERMTAKEALK 235 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~ 235 (383)
+||..+|.+|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 239 QCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHhccChhhCCCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=273.51 Aligned_cols=215 Identities=20% Similarity=0.284 Sum_probs=172.3
Q ss_pred CCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC---------
Q psy6377 14 TGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN--------- 79 (383)
Q Consensus 14 tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~--------- 79 (383)
++..+|+|.+... ...+.+|+.+++ .++||||+++++++.+++..+++||++. +++|.+++...
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~ 122 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMS-RLKDPNIIRLLAVCITSDPLCMITEYME-NGDLNQFLSRHEPQEAAEKA 122 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCccEEEEEeCC-CCcHHHHHHhcCcccccccc
Confidence 4557999999752 346889999999 7799999999999999999999999999 99999976442
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcC
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYV 148 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~ 148 (383)
.+..++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++........ .....+++.|+
T Consensus 123 ~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 199 (296)
T cd05095 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN---YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWM 199 (296)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCC---CCEEeccCcccccccCCcceeccCcCcCccccC
Confidence 245667999999999999999999999999999765 6899999999986533221 11233467899
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHh-----c-cCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLT--GFSPFGGETDSETFRNISK-----A-QLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyellt--g~~Pf~~~~~~~~~~~i~~-----~-~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
|||...+..++.++|+|||||++|+|++ |..||...+..+....... . ....+ ....+++.+.+|+.+||
T Consensus 200 ~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl 277 (296)
T cd05095 200 SWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLP--KPALCPDSLYKLMLSCW 277 (296)
T ss_pred CHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCC--CCCCCCHHHHHHHHHHc
Confidence 9999888889999999999999999998 7899987766555443321 0 11111 12356789999999999
Q ss_pred ccCCCCCCCHHHHHc
Q psy6377 221 IKNPMERMTAKEALK 235 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~ 235 (383)
..||++|||+.++++
T Consensus 278 ~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 278 RRNAKERPSFQEIHA 292 (296)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.25 Aligned_cols=232 Identities=29% Similarity=0.325 Sum_probs=191.1
Q ss_pred cceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 3 ALSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 3 ~~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
||.||.+.- .|+.||||.+-. ......|||..|+..-.|||||++|+.=.+....|+..|+|. .+|.++++..
T Consensus 523 Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~--~sL~dlie~~~~ 598 (903)
T KOG1027|consen 523 GTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA--CSLQDLIESSGL 598 (903)
T ss_pred CcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh--hhHHHHHhcccc
Confidence 689999984 689999998876 455789999999988899999999999999999999999997 9999988662
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecCcc----cccccCCC
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDGIE----IRELLGTP 145 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~~~----~~~~~gt~ 145 (383)
..+....|++.||++||+.+||||||||+|||++..+ ....++|+|||+++....+.. ..+..||-
T Consensus 599 d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~ 678 (903)
T KOG1027|consen 599 DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTS 678 (903)
T ss_pred chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcc
Confidence 1234459999999999999999999999999998642 235789999999998765433 34567999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
+|+|||++....-..++||+|+||++|+.++| .+||...- +.-.+|..+.+..-.-. +....++.+||.+|+.++|
T Consensus 679 GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP 755 (903)
T KOG1027|consen 679 GWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDP 755 (903)
T ss_pred cccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeec-cCchHHHHHHHHHhcCCCc
Confidence 99999999988888899999999999999985 89996543 33345666665543211 1112289999999999999
Q ss_pred CCCCCHHHHHcCcccCC
Q psy6377 225 MERMTAKEALKHPWLMN 241 (383)
Q Consensus 225 ~~Rpt~~e~L~hp~~~~ 241 (383)
..||+|.++|.||+|=.
T Consensus 756 ~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 756 QLRPSATDVLNHPLFWD 772 (903)
T ss_pred ccCCCHHHHhCCCccCC
Confidence 99999999999999854
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=272.39 Aligned_cols=224 Identities=22% Similarity=0.310 Sum_probs=175.5
Q ss_pred eEEEEE----EcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMAD----SIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~----~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+ .+.++..||+|.+.. ....+.+|+.+++ .+.||||+++++++.+. ...+++|||++ |++|.
T Consensus 19 ~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-g~~L~ 96 (284)
T cd05079 19 KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR-NLYHENIVKYKGICTEDGGNGIKLIMEFLP-SGSLK 96 (284)
T ss_pred eEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEecCCCCceEEEEEccC-CCCHH
Confidence 578876 357899999999875 2356889999999 77999999999999875 56899999999 99999
Q ss_pred HhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----ccccc
Q psy6377 74 TIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELL 142 (383)
Q Consensus 74 ~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~ 142 (383)
+++.+. .+..+..|++.||+|||++|++||||||+||+++.+ +.++|+|||+++....... .....
T Consensus 97 ~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05079 97 EYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEYYTVKDDLD 173 (284)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC---CCEEECCCccccccccCccceeecCCCC
Confidence 976442 234566899999999999999999999999999765 6899999999987543322 12345
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHhccCCCCcchhcC
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---------------SETFRNISKAQLDFPDELFED 207 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~ 207 (383)
++..|+|||++.+..++.++|||||||++|+|+++..|+..... ......+..+. .. +.+..
T Consensus 174 ~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 250 (284)
T cd05079 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK-RL--PRPPN 250 (284)
T ss_pred CCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc-cC--CCCCC
Confidence 67789999999888899999999999999999998776532110 01111111111 11 12346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 208 ISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 208 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++..+.+|+.+||..+|++|||+++++++
T Consensus 251 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 251 CPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 78999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=268.12 Aligned_cols=222 Identities=18% Similarity=0.207 Sum_probs=172.7
Q ss_pred eEEEEEEcC------------CCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCC
Q psy6377 5 SEEMADSIA------------TGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPL 68 (383)
Q Consensus 5 ~V~~~~~~~------------tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~ 68 (383)
.||.+.... .+..+|+|.+.. ....+.+|+.+++ .++||||+++++++.++...+++|||++
T Consensus 10 ~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 87 (262)
T cd05077 10 QIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMR-QVSHKHIVLLYGVCVRDVENIMVEEFVE- 87 (262)
T ss_pred eEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCCCEEEEeccc-
Confidence 678887432 233689998765 2346778888888 7899999999999999999999999999
Q ss_pred cCcHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC----CCcEEEEeccceeEeecCcc
Q psy6377 69 VVTLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP----NCDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 69 g~~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~----~~~ikL~DFGla~~~~~~~~ 137 (383)
+++|..++.. ...+.++.||+.||+|||++||+||||||+|||++.+.. ...++++|||++......
T Consensus 88 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-- 165 (262)
T cd05077 88 FGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-- 165 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--
Confidence 8998876543 223466799999999999999999999999999975421 123899999998764322
Q ss_pred cccccCCCCcCCCcccc-cCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHH
Q psy6377 138 IRELLGTPDYVAPEILH-YEPITLAADMWSLGVTAYVLL-TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvilyell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 215 (383)
....++..|+|||.+. +..++.++|||||||++|+|+ .|..||.+....+... ......... ...+.++.+|
T Consensus 166 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~l 239 (262)
T cd05077 166 -QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV----TPSCKELADL 239 (262)
T ss_pred -ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC----CCChHHHHHH
Confidence 2346788999999886 567899999999999999998 5889987765444322 222222221 2346789999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q psy6377 216 IAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 216 i~~~L~~dP~~Rpt~~e~L~h 236 (383)
|.+||..||.+||++.+++++
T Consensus 240 i~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 240 MTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHcCCChhhCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=268.06 Aligned_cols=223 Identities=21% Similarity=0.312 Sum_probs=181.0
Q ss_pred eEEEEEEcCC---CcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIAT---GEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~t---g~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|.+..+ ...+|+|..... .+.+.+|+.+++ ..+||||+++++++.+ ...|+|||+++ +++|.+++
T Consensus 21 ~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~-~~~~lv~e~~~-~~~L~~~l 97 (270)
T cd05056 21 DVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR-QFDHPHIVKLIGVITE-NPVWIVMELAP-LGELRSYL 97 (270)
T ss_pred eEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHH-hCCCCchhceeEEEcC-CCcEEEEEcCC-CCcHHHHH
Confidence 6889887654 457999988762 346888999999 7789999999999876 55789999999 99999976
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCc
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDY 147 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y 147 (383)
... .+..+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||+++........ ....+++.|
T Consensus 98 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 174 (270)
T cd05056 98 QVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174 (270)
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC---CCeEEccCceeeecccccceecCCCCccccc
Confidence 542 234556899999999999999999999999999865 58999999999875433211 122345689
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+|||.+....++.++||||||+++|+|++ |..||.+.+..+....+..+... ..+..++..+.+++.+||..+|++
T Consensus 175 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred cChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999988889999999999999999986 99999988877777666554322 123467899999999999999999
Q ss_pred CCCHHHHHcC
Q psy6377 227 RMTAKEALKH 236 (383)
Q Consensus 227 Rpt~~e~L~h 236 (383)
|||+.+++..
T Consensus 252 Rpt~~~~~~~ 261 (270)
T cd05056 252 RPRFTELKAQ 261 (270)
T ss_pred CcCHHHHHHH
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=268.66 Aligned_cols=225 Identities=18% Similarity=0.217 Sum_probs=175.4
Q ss_pred eEEEEEEc--CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSI--ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||++... .++..+|+|.+... ...+.+|+.+++ .++||||+++++++.+....++||||++ +++|.+++.
T Consensus 10 ~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 87 (269)
T cd05087 10 KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYR-SLQHSNLLQCLGQCTEVTPYLLVMEFCP-LGDLKGYLR 87 (269)
T ss_pred eEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCCcEEEEECCC-CCcHHHHHH
Confidence 57888754 46678999988761 246788999999 7799999999999999999999999999 999998764
Q ss_pred cC-----------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccC
Q psy6377 78 DN-----------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLG 143 (383)
Q Consensus 78 ~~-----------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~g 143 (383)
.. .+..+..|++.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05087 88 SCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD---LTVKIGDYGLSHNKYKEDYYVTPDQLWV 164 (269)
T ss_pred HhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC---CcEEECCccccccccCcceeecCCCcCC
Confidence 31 123456899999999999999999999999999765 6899999999875432211 123457
Q ss_pred CCCcCCCcccccC-------CCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH-hccCCCCcc-hhcCCCHHHH
Q psy6377 144 TPDYVAPEILHYE-------PITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNIS-KAQLDFPDE-LFEDISPEAK 213 (383)
Q Consensus 144 t~~y~aPE~l~~~-------~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~-~~~~~~~~~-~~~~~s~~~~ 213 (383)
++.|+|||++.+. .++.++|+||||+++|+|++ |..||......+...... ......+.. .....++.+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05087 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWY 244 (269)
T ss_pred cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHH
Confidence 7889999998642 35789999999999999996 999998776655544332 222333322 2234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6377 214 DFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+++.+|+ .+|++|||+++++.
T Consensus 245 ~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 245 EVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHh-cCcccCCCHHHHHH
Confidence 9999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=268.10 Aligned_cols=222 Identities=19% Similarity=0.251 Sum_probs=182.3
Q ss_pred eEEEEEEcCCCc----EEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGE----VFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~----~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|..+.+|+ .+|+|.+... ...+.+|+.+++ .++||||+++++++.+ ...+++||+++ +++|.+.
T Consensus 22 ~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~-~~~~~v~e~~~-~g~L~~~ 98 (279)
T cd05057 22 TVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA-SVDHPHVVRLLGICLS-SQVQLITQLMP-LGCLLDY 98 (279)
T ss_pred cEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEec-CceEEEEecCC-CCcHHHH
Confidence 588998877775 5899988762 346778999999 6799999999999987 78999999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc---ccCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE---LLGTP 145 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~---~~gt~ 145 (383)
+... .+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++.......... ..++.
T Consensus 99 l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05057 99 VRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175 (279)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---CeEEECCCcccccccCcccceecCCCcccc
Confidence 6442 345666999999999999999999999999999765 5899999999987654332111 22356
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+....++.++|+||||+++|++++ |..||.+....+....+..+..... ....+..+.+++.+||..+|
T Consensus 176 ~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~p 252 (279)
T cd05057 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICTIDVYMVLVKCWMIDA 252 (279)
T ss_pred cccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHcCCCh
Confidence 7999999988889999999999999999998 9999998887777766665432211 23467899999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
+.|||+.++++
T Consensus 253 ~~Rp~~~~l~~ 263 (279)
T cd05057 253 ESRPTFKELIN 263 (279)
T ss_pred hhCCCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=265.48 Aligned_cols=221 Identities=21% Similarity=0.323 Sum_probs=181.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||++... .+..+|+|.+.. ....+.+|+.+++ ..+|+||+++++++.+ ...+++||+++ +++|.+++...
T Consensus 21 ~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~-~~~~~v~e~~~-~~~L~~~~~~~~~ 96 (260)
T cd05073 21 EVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMK-TLQHDKLVKLHAVVTK-EPIYIITEFMA-KGSLLDFLKSDEG 96 (260)
T ss_pred EEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHH-hcCCCCcceEEEEEcC-CCeEEEEEeCC-CCcHHHHHHhCCc
Confidence 68999754 556799998876 2456889999999 6789999999999987 78899999999 89999977542
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.+..+..|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++........ .....++..|+|||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE 173 (260)
T cd05073 97 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173 (260)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC---CcEEECCCcceeeccCCCcccccCCcccccccCHh
Confidence 234566899999999999999999999999999765 6899999999987643322 11234567799999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++....++.++|+|||||++|++++ |.+||.+.+.......+..+.. . +.....+.++.+++.+||.++|++||++
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 250 (260)
T cd05073 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-M--PRPENCPEELYNIMMRCWKNRPEERPTF 250 (260)
T ss_pred HhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-C--CCcccCCHHHHHHHHHHcccCcccCcCH
Confidence 9988889999999999999999998 9999998877766666554322 1 2235678999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
.+++.
T Consensus 251 ~~l~~ 255 (260)
T cd05073 251 EYIQS 255 (260)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=264.05 Aligned_cols=218 Identities=21% Similarity=0.279 Sum_probs=179.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC---
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN--- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~--- 79 (383)
.||.+. .+|+.||+|.+.. ....+.+|+.+++ ..+||||+++++++.. +..+++|||+. +++|.+++...
T Consensus 21 ~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~-~~~~~v~e~~~-~~~L~~~l~~~~~~ 95 (254)
T cd05083 21 AVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMT-KLHHKNLVRLLGVILH-NGLYIVMELMS-KGNLVNFLRTRGRA 95 (254)
T ss_pred ceEecc--cCCCceEEEeecCcchHHHHHHHHHHHH-hCCCCCcCeEEEEEcC-CCcEEEEECCC-CCCHHHHHHhcCcC
Confidence 467765 5788999999876 3456889999998 7899999999999875 45799999999 99999876432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH 154 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~ 154 (383)
.+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++...... ......+..|+|||.+.
T Consensus 96 ~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~ 170 (254)
T cd05083 96 LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---GVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALK 170 (254)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CcEEECCCccceecccc--CCCCCCCceecCHHHhc
Confidence 123456899999999999999999999999999765 58999999998865332 22234467899999998
Q ss_pred cCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
+..++.++|+|||||++|+|++ |.+||.+.+..+....+..+.... ....++..+.+++.+||..+|++|||++++
T Consensus 171 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKL 247 (254)
T ss_pred cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8889999999999999999997 999999888777666665442211 224678999999999999999999999998
Q ss_pred Hc
Q psy6377 234 LK 235 (383)
Q Consensus 234 L~ 235 (383)
+.
T Consensus 248 ~~ 249 (254)
T cd05083 248 RE 249 (254)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.61 Aligned_cols=223 Identities=28% Similarity=0.342 Sum_probs=179.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
..||.++++.||+.||||.+++ ..++.-+|+++|+ .++|||||++.++=++.. ...++||||. ||+|
T Consensus 27 g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eieilk-KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~-gGsL 104 (732)
T KOG4250|consen 27 GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILK-KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCS-GGSL 104 (732)
T ss_pred ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHH-HcCchhhhhhcccCCccccCcccccceEEEeecC-CCcH
Confidence 4799999999999999999987 5788999999999 666999999999966543 4689999999 9999
Q ss_pred HHhhcc---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc-CCCCcEEEEeccceeEeecCccccccc
Q psy6377 73 QTIIDD---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDGIEIRELL 142 (383)
Q Consensus 73 ~~~l~~---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~~~~~~~~~~~~~ 142 (383)
...+.+ ..++.+...+..||.|||.+||+||||||+||++... ++....||+|||.|+...++..+.+.+
T Consensus 105 ~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~v 184 (732)
T KOG4250|consen 105 RKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLV 184 (732)
T ss_pred HHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeec
Confidence 998653 4456666899999999999999999999999996432 234567999999999999988899999
Q ss_pred CCCCcCCCcccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhcc--------------------
Q psy6377 143 GTPDYVAPEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQ-------------------- 197 (383)
Q Consensus 143 gt~~y~aPE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~-------------------- 197 (383)
||+.|.+||++. ...|+..+|.|||||++|++.||..||...... +....+....
T Consensus 185 GT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~ 264 (732)
T KOG4250|consen 185 GTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSS 264 (732)
T ss_pred CchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeec
Confidence 999999999998 488999999999999999999999999654332 2332222111
Q ss_pred -CCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 198 -LDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 198 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
.++|.......-..+-.++..+|..+|.+|.
T Consensus 265 ~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 265 TLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111111122223466788899999999998
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.38 Aligned_cols=225 Identities=17% Similarity=0.206 Sum_probs=174.3
Q ss_pred eEEEEEEcCC--CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIAT--GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~t--g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||++..... ...+++|.+.. ....+.+|+.+++ .++||||+++++.+.+....|++|||+. +++|.+++.
T Consensus 10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 87 (268)
T cd05086 10 KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR-ILQHPNILQCLGQCVEAIPYLLVFEYCE-LGDLKSYLS 87 (268)
T ss_pred eEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHh-ccCCcchhheEEEecCCCccEEEEecCC-CCcHHHHHH
Confidence 4788865433 34567777664 2356888999998 7799999999999999999999999999 999999765
Q ss_pred cC----------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCC
Q psy6377 78 DN----------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGT 144 (383)
Q Consensus 78 ~~----------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt 144 (383)
.. .+..+..||+.||+|||+.|++||||||+|||++.+ +.++|+|||++....... ......|+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 164 (268)
T cd05086 88 QEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD---LTVKVGDYGIGPSRYKEDYIETEDDKCVP 164 (268)
T ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC---ccEEecccccccccCcchhhhcccCCcCc
Confidence 32 123456899999999999999999999999999765 689999999986432211 12235688
Q ss_pred CCcCCCccccc-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhcc-CCCC-cchhcCCCHHHHH
Q psy6377 145 PDYVAPEILHY-------EPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFP-DELFEDISPEAKD 214 (383)
Q Consensus 145 ~~y~aPE~l~~-------~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~~s~~~~~ 214 (383)
+.|+|||++.. ..++.++|||||||++|+|++ |.+||...+..+.+..+.... ...+ +.....+++.+.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYE 244 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHH
Confidence 99999998743 245789999999999999997 678998777767666654432 2222 2233457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHc
Q psy6377 215 FIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~ 235 (383)
++..|+ .+|++|||++++++
T Consensus 245 l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 245 VLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHh-hCcccCCCHHHHHH
Confidence 999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=268.02 Aligned_cols=223 Identities=20% Similarity=0.205 Sum_probs=180.4
Q ss_pred eEEEEEEcC----CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA----TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~----tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|.+.. ++..+|+|.+.. ....+.+|+.+++ .++||||+++++++.. +...++++++++ +++|.+
T Consensus 21 ~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ 98 (280)
T cd05043 21 RIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLY-GLSHQNILPILHVCIEDGEPPFVLYPYMN-WGNLKL 98 (280)
T ss_pred eEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCCCCEEEEEcCC-CCcHHH
Confidence 588998876 368899998875 2355788999998 6799999999998665 567889999999 999998
Q ss_pred hhccC--------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--
Q psy6377 75 IIDDN--------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-- 138 (383)
Q Consensus 75 ~l~~~--------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~-- 138 (383)
++... .+..++.|++.||+|||++|++||||||+||+++++ +.+||+|||+++........
T Consensus 99 ~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kl~d~g~~~~~~~~~~~~~ 175 (280)
T cd05043 99 FLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE---LQVKITDNALSRDLFPMDYHCL 175 (280)
T ss_pred HHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC---CcEEECCCCCcccccCCceEEe
Confidence 76432 234566899999999999999999999999999765 68999999999865432211
Q ss_pred -ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHH
Q psy6377 139 -RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 139 -~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 216 (383)
....++..|+|||++.+..++.++|||||||++|++++ |.+||.+.+..+....+..+ ..++ ....+++++.+++
T Consensus 176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~li 252 (280)
T cd05043 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA--QPINCPDELFAVM 252 (280)
T ss_pred CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCCC--CCCcCCHHHHHHH
Confidence 12345678999999988889999999999999999998 99999887766665555443 2222 2345789999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q psy6377 217 AKILIKNPMERMTAKEALK 235 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+||..||++|||+.++++
T Consensus 253 ~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 253 ACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=271.21 Aligned_cols=223 Identities=22% Similarity=0.318 Sum_probs=178.5
Q ss_pred eEEEEEEcCCCc----EEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGE----VFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~----~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+++++.+|+ .+|+|.+... ...+.+|+.+++ .++||||+++++++... ..++++++++ +|+|.+.
T Consensus 22 ~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~-~~~~v~e~~~-~g~l~~~ 98 (303)
T cd05110 22 TVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA-SMDHPHLVRLLGVCLSP-TIQLVTQLMP-HGCLLDY 98 (303)
T ss_pred cEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCcccEEEEEcCC-CceeeehhcC-CCCHHHH
Confidence 689999988887 4688888762 225778999998 77999999999998754 5778999999 8999987
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP 145 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~ 145 (383)
+... .+..+..|++.||.|||++||+||||||+||+++.+ +.+||+|||+++....... .....++.
T Consensus 99 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 175 (303)
T cd05110 99 VHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPI 175 (303)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC---CceEEccccccccccCcccccccCCCcccc
Confidence 6442 335666899999999999999999999999999765 5799999999987543222 12234577
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..+. .++. ....+..+.+++.+||..+|
T Consensus 176 ~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred ccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCCCHHHHHHHHHHcCCCh
Confidence 8999999998999999999999999999997 999998876555444443322 2221 24568899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy6377 225 MERMTAKEALKH 236 (383)
Q Consensus 225 ~~Rpt~~e~L~h 236 (383)
++||++.++++.
T Consensus 253 ~~Rp~~~~l~~~ 264 (303)
T cd05110 253 DSRPKFKELAAE 264 (303)
T ss_pred hhCcCHHHHHHH
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.68 Aligned_cols=211 Identities=21% Similarity=0.264 Sum_probs=167.5
Q ss_pred cEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-------Cchhh
Q psy6377 16 EVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-------LVVPF 84 (383)
Q Consensus 16 ~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-------~~~~~ 84 (383)
..+|+|++.. ....+.+|+.+++ .++||||+++++++.++...++||||++ +++|..++... ....+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~-~l~h~niv~~~~~~~~~~~~~lv~ey~~-~g~L~~~l~~~~~~~~~~~~~~i 122 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMS-QVSHIHLAFVHGVCVRGSENIMVEEFVE-HGPLDVCLRKEKGRVPVAWKITV 122 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHh-cCCCCCeeeEEEEEEeCCceEEEEecCC-CCcHHHHHHhcCCCCCHHHHHHH
Confidence 4689998865 2345778888888 8899999999999999999999999999 99998876432 23456
Q ss_pred HHHHHHHHHHHHhCCceecCCCCCcEEEeccC----CCCcEEEEeccceeEeecCcccccccCCCCcCCCccccc-CCCC
Q psy6377 85 ESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF----PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY-EPIT 159 (383)
Q Consensus 85 ~~qil~aL~yLHs~givHrDLKp~NILl~~~~----~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~ 159 (383)
..||+.||+|||++||+||||||+|||++... ..+.++++|||++...... ....+++.|+|||.+.+ ..++
T Consensus 123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~ 199 (274)
T cd05076 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLS 199 (274)
T ss_pred HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCC
Confidence 69999999999999999999999999997532 2235899999998654322 23457888999998865 5689
Q ss_pred hhhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 160 LAADMWSLGVTAYVLL-TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 160 ~~~DiwSlGvilyell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++|+|||||++|+|+ +|.+||.+....+.... .......|. ..++.+.++|.+||..+|++|||+.++|++
T Consensus 200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 9999999999999985 69999987765544332 222223332 346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=270.04 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=195.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh---
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII--- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l--- 76 (383)
.|++-.|+.+|+..|||.++. +..++..|++...+..+.||||++|+..-.+..-|+.||+++ .+|..+.
T Consensus 79 ~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd--~SlDklYk~v 156 (361)
T KOG1006|consen 79 TVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD--ISLDKLYKRV 156 (361)
T ss_pred hhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh--hhHHHHHHHH
Confidence 467888999999999999986 567899999988878899999999999988999999999998 6776642
Q ss_pred --------ccCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 77 --------DDNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 77 --------~~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.++-.-.+..-++.||.||-. .+|+|||+||+|||++.. |.|||||||++....++...+...|-..|
T Consensus 157 y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~---G~vKLCDFGIcGqLv~SiAkT~daGCrpY 233 (361)
T KOG1006|consen 157 YSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH---GDVKLCDFGICGQLVDSIAKTVDAGCRPY 233 (361)
T ss_pred HHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC---CCEeeecccchHhHHHHHHhhhccCCccc
Confidence 222223333566899999975 589999999999999765 79999999999888777667777899999
Q ss_pred CCCcccc--cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCC--cchhcCCCHHHHHHHHHhccc
Q psy6377 148 VAPEILH--YEPITLAADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQLDFP--DELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 148 ~aPE~l~--~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~ 222 (383)
||||.+. +.+|+.++|+||||++|||+.||..||.+-+. .+++..+..+..+.- +...-+++..+..||.-||.+
T Consensus 234 mAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~K 313 (361)
T KOG1006|consen 234 MAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIK 313 (361)
T ss_pred cChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhc
Confidence 9999985 45699999999999999999999999987654 345555555543321 111235799999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCcchhhcc
Q psy6377 223 NPMERMTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~~~~~~ 248 (383)
|-+.||...+++++||+....+..++
T Consensus 314 d~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 314 DRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred ccccCcchhhhhcCchhhhhhhcCCc
Confidence 99999999999999999877655443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.67 Aligned_cols=230 Identities=27% Similarity=0.384 Sum_probs=188.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC----------------------
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG---------------------- 56 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~---------------------- 56 (383)
.+|++|+++-+|+.||||.|+- ....+.+|+..|. .++|||||++|..+.+.
T Consensus 493 G~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LA-rLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s 571 (1351)
T KOG1035|consen 493 GSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLA-RLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSAS 571 (1351)
T ss_pred ceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHh-hcCCcceeeeehhhhccCCccccccccccchhhhcccCC
Confidence 3799999999999999999986 2456899999999 88999999999765210
Q ss_pred --------------------------------------------------------------------------------
Q psy6377 57 -------------------------------------------------------------------------------- 56 (383)
Q Consensus 57 -------------------------------------------------------------------------------- 56 (383)
T Consensus 572 ~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s 651 (1351)
T KOG1035|consen 572 KYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSES 651 (1351)
T ss_pred CcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhh
Confidence
Q ss_pred -----------------CeEEEEEecCCCcCcHHHhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy6377 57 -----------------EGAYYVSWNTPLVVTLQTIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVM 112 (383)
Q Consensus 57 -----------------~~~~lv~e~~~~g~~L~~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl 112 (383)
..+|+-||||+ ...+.+++.++. .+.+++||++||.|+|++|||||||||.||++
T Consensus 652 ~~~~~n~~e~~~~~q~~~~LYIQMEyCE-~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL 730 (1351)
T KOG1035|consen 652 IPKTENSSEPMVPVQKPLILYIQMEYCE-KTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL 730 (1351)
T ss_pred ccccCCccccccccccceEEEEEHhhhh-hhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE
Confidence 12577799999 677777776543 45677999999999999999999999999999
Q ss_pred eccCCCCcEEEEeccceeEee-------------------cCcccccccCCCCcCCCcccccCC---CChhhHHHHHHHH
Q psy6377 113 MGDFPNCDIKVCDFEISRVIL-------------------DGIEIRELLGTPDYVAPEILHYEP---ITLAADMWSLGVT 170 (383)
Q Consensus 113 ~~~~~~~~ikL~DFGla~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvi 170 (383)
+.+ +.|||+|||+|+... .....++.+||..|+|||++.+.. |+.|+|+||||+|
T Consensus 731 d~~---~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIV 807 (1351)
T KOG1035|consen 731 DSR---NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIV 807 (1351)
T ss_pred cCC---CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHH
Confidence 865 689999999998721 012356678999999999997654 9999999999999
Q ss_pred HHHHHhCCCCCC-CCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 171 AYVLLTGFSPFG-GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 171 lyelltg~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
++||+. ||. +......+.++..+..+.|..++.+--+.-..+|++||..||++||||.|+|++.|+..
T Consensus 808 lFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 808 LFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999974 564 33445667777778877776666666667788999999999999999999999999974
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=286.54 Aligned_cols=235 Identities=26% Similarity=0.426 Sum_probs=198.5
Q ss_pred CccceEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcC-----CCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 1 MFALSEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCS-----PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 1 ~f~~~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~-----~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
||+++| .|.+..-|+.||||||..+ ...=..|++||+.+. +--|+++|+-.|...+++|||+|.+. .+|
T Consensus 444 vFs~Vv-ra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls--lNL 520 (752)
T KOG0670|consen 444 VFSTVV-RARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS--LNL 520 (752)
T ss_pred eeeeee-eccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh--chH
Confidence 577665 4778888999999999983 455678999999665 35689999999999999999999986 888
Q ss_pred HHhhcc---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 73 QTIIDD---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 73 ~~~l~~---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
.++++. ..+..++.|++.||..|-..||+|.||||+|||++... ..+||||||.|...... .++.+..
T Consensus 521 RevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k--~iLKLCDfGSA~~~~en-eitPYLV 597 (752)
T KOG0670|consen 521 REVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK--NILKLCDFGSASFASEN-EITPYLV 597 (752)
T ss_pred HHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc--ceeeeccCccccccccc-cccHHHH
Confidence 887654 23456779999999999999999999999999998653 47999999999876543 4666777
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc-----------------
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE----------------- 206 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------- 206 (383)
+..|.|||++.+.+|++..|+||+||+||||.||+..|.|.+...++.-.+.....||.....
T Consensus 598 SRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~ 677 (752)
T KOG0670|consen 598 SRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLY 677 (752)
T ss_pred HHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEE
Confidence 889999999999999999999999999999999999999999999988887777777632110
Q ss_pred --------------------------------CC-------CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 207 --------------------------------DI-------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 207 --------------------------------~~-------s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
.+ -..+++|+.+||..||++|.|+.++|.||||..
T Consensus 678 ~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 678 IEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred EeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 01 135889999999999999999999999999964
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.05 Aligned_cols=224 Identities=21% Similarity=0.234 Sum_probs=177.7
Q ss_pred eEEEEEEc---CCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCc
Q psy6377 5 SEEMADSI---ATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLV 69 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g 69 (383)
.||+|..+ .+|+.||+|++... ...+.+|+.+++ .++||||+++++++.... ..+++++++. +
T Consensus 14 ~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 91 (273)
T cd05074 14 SVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMK-EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMK-H 91 (273)
T ss_pred CEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHh-cCCCCCcceEEEEEccCCCCCcccceEEEEecCC-C
Confidence 68888754 46899999998762 335788999999 778999999999986542 2467889998 8
Q ss_pred CcHHHhhcc------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc
Q psy6377 70 VTLQTIIDD------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 70 ~~L~~~l~~------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~ 137 (383)
++|..++.. .....++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||+++.......
T Consensus 92 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~---~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05074 92 GDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN---MTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred CcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC---CCEEECcccccccccCCcc
Confidence 999875421 1235666999999999999999999999999999765 6899999999986543221
Q ss_pred ---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHH
Q psy6377 138 ---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213 (383)
Q Consensus 138 ---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 213 (383)
.....+++.|++||.+....++.++|||||||++|+|++ |.+||.+.+..+....+....... .....+..+.
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 245 (273)
T cd05074 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK---QPPDCLEDVY 245 (273)
T ss_pred eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHHHH
Confidence 122345678999999998889999999999999999999 899998887766666655443211 1135688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6377 214 DFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+++.+||..+|++|||+.+++.+
T Consensus 246 ~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 246 ELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=268.78 Aligned_cols=235 Identities=25% Similarity=0.380 Sum_probs=198.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh--
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI-- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~-- 75 (383)
.|-++++++|.+.||+|++++ +..=+..|-.+.....+||.+|-++.+|+++..+++|.||++ ||+|--.
T Consensus 265 kvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~-ggdlmfhmq 343 (593)
T KOG0695|consen 265 KVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN-GGDLMFHMQ 343 (593)
T ss_pred hhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec-Ccceeeehh
Confidence 467789999999999999998 234467788888878899999999999999999999999999 9998654
Q ss_pred ----hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe-ecCcccccccCCCCcCCC
Q psy6377 76 ----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 76 ----l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~gt~~y~aP 150 (383)
+.++...++...|+.||.|||++||++||||.+|+|++.. |++||+|+|+.+.. .++...++.||||.|+||
T Consensus 344 rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae---ghikltdygmcke~l~~gd~tstfcgtpnyiap 420 (593)
T KOG0695|consen 344 RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 420 (593)
T ss_pred hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC---CceeecccchhhcCCCCCcccccccCCCcccch
Confidence 3445566777999999999999999999999999999876 79999999998864 455667889999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCC--C------CcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGG--E------TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~--~------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|++.+..|+.++|.|+|||+++||+.|+.||.- . +..-+++-|...+...|. .+|-.+..+++..|.+
T Consensus 421 eilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----slsvkas~vlkgflnk 496 (593)
T KOG0695|consen 421 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SLSVKASHVLKGFLNK 496 (593)
T ss_pred hhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----eeehhhHHHHHHhhcC
Confidence 999999999999999999999999999999942 1 122245555666666664 5688889999999999
Q ss_pred CCCCCCC------HHHHHcCcccCCcchhhc
Q psy6377 223 NPMERMT------AKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 223 dP~~Rpt------~~e~L~hp~~~~~~~~~~ 247 (383)
||.+|.. ..++-.|+||......+-
T Consensus 497 dp~erlgc~~~~g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 497 DPKERLGCRPQTGFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred CcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence 9999984 579999999987654443
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=263.92 Aligned_cols=225 Identities=25% Similarity=0.296 Sum_probs=181.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~~~ 75 (383)
-|+++++.+|+..||+|.+.. +.+...+|++..+ ..+|||+++++++.-.+ ...|+++.|+. .|+|.+.
T Consensus 36 fv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~r-kf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~-~Gsl~d~ 113 (302)
T KOG2345|consen 36 FVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHR-KFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK-RGSLLDE 113 (302)
T ss_pred eeeeecccCcccchhhheeeccchHHHHHHHHHHHHHH-hhCCcchHHHHHHHHHhhccCceeEEEEeehhc-cccHHHH
Confidence 378999999999999998876 5678999999999 88999999999886433 34999999999 8888885
Q ss_pred hc----------cCCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeec---Cc----
Q psy6377 76 ID----------DNLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---GI---- 136 (383)
Q Consensus 76 l~----------~~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---~~---- 136 (383)
++ +..++.+..+|++||++||+.. ++||||||.|||+.++ +.++|.|||.++...- +.
T Consensus 114 i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~---~~~vl~D~GS~~~a~i~i~~~~~a~ 190 (302)
T KOG2345|consen 114 IERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS---GLPVLMDLGSATQAPIQIEGSRQAL 190 (302)
T ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC---CceEEEeccCccccceEeechHHHH
Confidence 43 3446677799999999999999 9999999999999874 6899999998875421 11
Q ss_pred ---ccccccCCCCcCCCccccc---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCcchhcCC
Q psy6377 137 ---EIRELLGTPDYVAPEILHY---EPITLAADMWSLGVTAYVLLTGFSPFGGETD--SETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 137 ---~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
.......|..|+|||.+.- ...+.++|||||||+||.|+.|..||...-. ....-.+..+++.+|..- .+
T Consensus 191 ~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~--~y 268 (302)
T KOG2345|consen 191 RLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS--RY 268 (302)
T ss_pred HHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC--Cc
Confidence 1122357899999999854 4568999999999999999999999953211 112223455677777654 38
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
|+.+.++|+.||+.||.+||++.+++.+
T Consensus 269 se~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 269 SEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=265.21 Aligned_cols=224 Identities=22% Similarity=0.282 Sum_probs=172.4
Q ss_pred eEEEEE----EcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMAD----SIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~----~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.|. +..+|..||+|.+... ...+.+|+++++ .++||||+++++++.. ...+++|+||++ +++|.+
T Consensus 19 ~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 96 (284)
T cd05081 19 SVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK-SLQHDNIVKYKGVCYSAGRRNLRLVMEYLP-YGSLRD 96 (284)
T ss_pred eEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHH-hCCCCCeeEEEEEEccCCCCceEEEEEecC-CCCHHH
Confidence 478876 4568999999998762 346789999999 7799999999998753 356899999999 999999
Q ss_pred hhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----ccccC
Q psy6377 75 IIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELLG 143 (383)
Q Consensus 75 ~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~g 143 (383)
++... ....++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++......... ....+
T Consensus 97 ~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05081 97 YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGES 173 (284)
T ss_pred HHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC---CeEEECCCcccccccCCCcceeecCCCCC
Confidence 76432 234566999999999999999999999999999765 58999999999876433221 11123
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH---------------HHHHHHhccCCCCcchhcCC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE---------------TFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~ 208 (383)
+..|+|||.+.+..++.++|+|||||++|+|++|..|+....... .+..+......++ ....+
T Consensus 174 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 251 (284)
T cd05081 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP--APPGC 251 (284)
T ss_pred ceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC--CCCCC
Confidence 456999999988889999999999999999999887764332110 0111111111111 22467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+.++.+|+.+||..+|++|||+.++++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 252 PAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=262.89 Aligned_cols=224 Identities=22% Similarity=0.296 Sum_probs=177.0
Q ss_pred eEEEEEEc----CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI----ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~----~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~ 73 (383)
.||+++.. .+++.+|+|.+... ...+.+|+.+++ .+.||||+++++++.. ....+++||+++ +++|.
T Consensus 19 ~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~l~ 96 (284)
T cd05038 19 KVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR-TLDHENIVKYKGVCEKPGGRSLRLIMEYLP-SGSLR 96 (284)
T ss_pred eEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHH-hCCCCChheEEeeeecCCCCceEEEEecCC-CCCHH
Confidence 57888754 45899999999872 346889999998 6799999999999887 567999999999 99999
Q ss_pred HhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----cccc
Q psy6377 74 TIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELL 142 (383)
Q Consensus 74 ~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~ 142 (383)
+++.... +..+..|++.||+|||++|++||||||+||+++.+ +.++|+|||++......... ....
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05038 97 DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---DLVKISDFGLAKVLPEDKDYYYVKEPGE 173 (284)
T ss_pred HHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccccccccccCCcceeccCCCC
Confidence 9764422 34666999999999999999999999999999876 68999999999876532221 1123
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH--------------HHHHHHhccCCCCcchhcCC
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE--------------TFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~--------------~~~~i~~~~~~~~~~~~~~~ 208 (383)
++..|+|||.+....++.++|+||||+++|+|++|..||....... .+..........+ ....+
T Consensus 174 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 251 (284)
T cd05038 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP--RPPSC 251 (284)
T ss_pred CcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCC--CCccC
Confidence 4567999999988889999999999999999999999986543221 1112222222222 12356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+.++.+++.+||..+|++|||+.++++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 252 PDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=288.95 Aligned_cols=232 Identities=25% Similarity=0.401 Sum_probs=196.4
Q ss_pred cceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEE-----eCCeEEEEEecCCCcCcHHH
Q psy6377 3 ALSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQ-----TGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 3 ~~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~-----~~~~~~lv~e~~~~g~~L~~ 74 (383)
.+.||+++++.+|+..|+||... ..+.++-|.++|+....|||++.+|++|. .++.+|||||||. ||+.-+
T Consensus 32 ygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~-gGSVTD 110 (953)
T KOG0587|consen 32 YGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG-GGSVTD 110 (953)
T ss_pred ceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC-CccHHH
Confidence 36799999999999999999987 45778888999998889999999999996 3578999999999 999999
Q ss_pred hhc--------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCC
Q psy6377 75 IID--------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTP 145 (383)
Q Consensus 75 ~l~--------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~ 145 (383)
+++ +..+.++.+.++.||.+||.+.++|||+|-.|||++.+ +.|||+|||++........ ..+.+|||
T Consensus 111 LVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e---~~VKLvDFGvSaQldsT~grRnT~iGtP 187 (953)
T KOG0587|consen 111 LVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDSTVGRRNTFIGTP 187 (953)
T ss_pred HHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc---CcEEEeeeeeeeeeecccccccCcCCCc
Confidence 753 34456677999999999999999999999999999876 7899999999998765433 45678999
Q ss_pred CcCCCcccccC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--hhcCCCHHHHHHHHH
Q psy6377 146 DYVAPEILHYE-----PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE--LFEDISPEAKDFIAK 218 (383)
Q Consensus 146 ~y~aPE~l~~~-----~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~ 218 (383)
.|||||++... .|+..+|+||||++..||..|.||+.+.-....+-.| ...+|+. .|...++++.+||..
T Consensus 188 ~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLkrp~kWs~~FndFIs~ 264 (953)
T KOG0587|consen 188 YWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLKRPKKWSKKFNDFIST 264 (953)
T ss_pred ccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCccccchhhHHHHHHHHHHH
Confidence 99999999643 4788999999999999999999999776554433322 2222322 356789999999999
Q ss_pred hcccCCCCCCCHHHHHcCcccCC
Q psy6377 219 ILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
||.+|-.+||+..++|+|||+..
T Consensus 265 cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 265 CLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHhhccccCcchhhhccCCcccc
Confidence 99999999999999999999973
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=263.38 Aligned_cols=220 Identities=17% Similarity=0.142 Sum_probs=164.7
Q ss_pred eEEEEEEcCC---CcEEEEEEccCCcccHHHH---------------HHHHHhcCCCCCcccceEEEEeCC----eEEEE
Q psy6377 5 SEEMADSIAT---GEVFAAKFLESNPVRIHHE---------------IALLSLCSPSPRIVKLHDVFQTGE----GAYYV 62 (383)
Q Consensus 5 ~V~~~~~~~t---g~~vAvK~i~~~~~~~~~E---------------i~il~~~~~hpnIvkl~~~~~~~~----~~~lv 62 (383)
.||+|++..+ +..+|+|+.......+..| +..+. ...|++|++++++..... ..+++
T Consensus 27 ~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~~~h~~i~~~~~~~~~~~~~~~~~~~~ 105 (294)
T PHA02882 27 CVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH-NIDHLGIPKYYGCGSFKRCRMYYRFIL 105 (294)
T ss_pred eEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhc-cCCCCCCCcEEEeeeEecCCceEEEEE
Confidence 6899998888 7788888754422222222 22333 568999999999866543 34677
Q ss_pred EecCCCcCcHHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 63 SWNTPLVVTLQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 63 ~e~~~~g~~L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
++++. .++.+.++. ..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+|+......
T Consensus 106 ~~~~~--~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~---~~~~l~DFGla~~~~~~~ 180 (294)
T PHA02882 106 LEKLV--ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN---NRGYIIDYGIASHFIIHG 180 (294)
T ss_pred Eehhc--cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CcEEEEEcCCceeeccCC
Confidence 77764 455554432 2245677999999999999999999999999999764 689999999998764321
Q ss_pred --------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HH--------HHHHHhccCC
Q psy6377 137 --------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ET--------FRNISKAQLD 199 (383)
Q Consensus 137 --------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~--------~~~i~~~~~~ 199 (383)
......||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.... .. ...+..+...
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (294)
T PHA02882 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK 260 (294)
T ss_pred cccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc
Confidence 112346999999999999999999999999999999999999999877432 22 2222222222
Q ss_pred CCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 200 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
..+.++++.+++..|+..+|++||+++++++
T Consensus 261 -----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 261 -----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2456889999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.68 Aligned_cols=233 Identities=18% Similarity=0.200 Sum_probs=159.4
Q ss_pred eEEEEEEcCC----CcEEEEEEccCCcc-cHHHHHHHHHhcCCCCCcccceEEE------EeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIAT----GEVFAAKFLESNPV-RIHHEIALLSLCSPSPRIVKLHDVF------QTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~t----g~~vAvK~i~~~~~-~~~~Ei~il~~~~~hpnIvkl~~~~------~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++..+ |..||+|.+..... ....+. .++ ...+.++..+...| .++...++|+||+. +++|.
T Consensus 147 ~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~-~gsL~ 223 (566)
T PLN03225 147 VVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVR-RACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEG-ESTLA 223 (566)
T ss_pred EEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHH-hhchhhHHHHHHhhhcccccccCCceEEEEEecC-CCcHH
Confidence 6899999999 99999998765211 111111 122 11233333333322 35667999999999 99999
Q ss_pred HhhccCC--------------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 74 TIIDDNL--------------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 74 ~~l~~~~--------------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
+++.... +..++.||+.||+|||++||+||||||+|||++.+. +.+||+|||
T Consensus 224 ~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~--~~~KL~DFG 301 (566)
T PLN03225 224 DLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS--GSFKIIDLG 301 (566)
T ss_pred HHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC--CcEEEEeCC
Confidence 8765432 224668999999999999999999999999998542 589999999
Q ss_pred ceeEeecCc--ccccccCCCCcCCCcccccC----------------------CCChhhHHHHHHHHHHHHHhCCCCCCC
Q psy6377 128 ISRVILDGI--EIRELLGTPDYVAPEILHYE----------------------PITLAADMWSLGVTAYVLLTGFSPFGG 183 (383)
Q Consensus 128 la~~~~~~~--~~~~~~gt~~y~aPE~l~~~----------------------~~~~~~DiwSlGvilyelltg~~Pf~~ 183 (383)
+|+....+. .....++|+.|+|||.+... .++.++||||+||++|+|+++..|+.
T Consensus 302 lA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~- 380 (566)
T PLN03225 302 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD- 380 (566)
T ss_pred CccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc-
Confidence 998653322 23456899999999965322 23456799999999999998766543
Q ss_pred CCcHHHHHHH-HhccCCC-----------Ccc------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 184 ETDSETFRNI-SKAQLDF-----------PDE------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 184 ~~~~~~~~~i-~~~~~~~-----------~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
+....+..+ ....... .+. .....+..+.+||.+||.+||++|||+.++|+||||.....
T Consensus 381 -~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 381 -SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred -hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 222222221 1111110 000 01112334669999999999999999999999999987544
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=264.87 Aligned_cols=235 Identities=29% Similarity=0.392 Sum_probs=195.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-----eEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L 72 (383)
.+||.+.+..+|+.||+|.+.. ...++.+|+.+|. ..+|.|++..+|+.+..+ .+|.+.|++. .+|
T Consensus 67 GVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLc-fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ--SDL 143 (449)
T KOG0664|consen 67 GVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLS-SFRHDNVLSLLDILQPANPSFFQELYVLTELMQ--SDL 143 (449)
T ss_pred eEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHH-hhccccHHHHHHhcCCCCchHHHHHHHHHHHHH--hhh
Confidence 3789999999999999999887 4678999999999 889999999999987654 3677888886 888
Q ss_pred HHhh------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC--cccccccCC
Q psy6377 73 QTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--IEIRELLGT 144 (383)
Q Consensus 73 ~~~l------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~--~~~~~~~gt 144 (383)
.++| +...+.-+.+||+.||+|||+.||+||||||.|+|++++ +.+||||||+|+..... ..++..+.|
T Consensus 144 HKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN---CvLKICDFGLARvee~d~~~hMTqEVVT 220 (449)
T KOG0664|consen 144 HKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN---CILKICDFGLARTWDQRDRLNMTHEVVT 220 (449)
T ss_pred hheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC---ceEEecccccccccchhhhhhhHHHHHH
Confidence 8854 445667788999999999999999999999999999766 89999999999986543 335667789
Q ss_pred CCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--------------------
Q psy6377 145 PDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-------------------- 203 (383)
Q Consensus 145 ~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------- 203 (383)
..|+|||++.+. .|+.+.||||+|||+.||+..+..|+..+..+.+..|...-.++..+
T Consensus 221 QYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~ 300 (449)
T KOG0664|consen 221 QYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA 300 (449)
T ss_pred HHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC
Confidence 999999998764 58999999999999999999999999999888877775543332211
Q ss_pred -----hh-----cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 -----LF-----EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 -----~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.+ ..-..+..+++..||.+||++|.+.++++.|+++...+-
T Consensus 301 Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 301 PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 00 112356889999999999999999999999999977653
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.84 Aligned_cols=221 Identities=19% Similarity=0.268 Sum_probs=180.6
Q ss_pred EEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 6 EEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
||++++- | .||||++.. ..+.|.+|+..|+ ...|.||+-+.+++..... -+|..+|. |.+|+.++..
T Consensus 408 V~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lk-kTRH~NIlLFMG~~~~p~~-AIiTqwCe-GsSLY~hlHv~ 481 (678)
T KOG0193|consen 408 VYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLK-KTRHENILLFMGACMNPPL-AIITQWCE-GSSLYTHLHVQ 481 (678)
T ss_pred eeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHh-hcchhhheeeehhhcCCce-eeeehhcc-Cchhhhhccch
Confidence 6777763 3 699999987 2467999999999 8899999999999977665 88999999 9999996532
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec---CcccccccCCCCcCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---GIEIRELLGTPDYVA 149 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---~~~~~~~~gt~~y~a 149 (383)
...+.+++||++|+.|||.++|||||||..|||+.++ +.|||+|||++..-.. ........|...|||
T Consensus 482 etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~---~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA 558 (678)
T KOG0193|consen 482 ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED---LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA 558 (678)
T ss_pred hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC---CcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence 3445777999999999999999999999999999876 6899999999886432 223445678899999
Q ss_pred Ccccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 150 PEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-PDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 150 PE~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
||++. ..+|++.+||||||+++|||++|..||.......++-.+-.|..-. ......+.++++++|+..||.++++
T Consensus 559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~ 638 (678)
T KOG0193|consen 559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDRE 638 (678)
T ss_pred HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcc
Confidence 99985 4579999999999999999999999999666555554444442221 1233456788999999999999999
Q ss_pred CCCCHHHHHc
Q psy6377 226 ERMTAKEALK 235 (383)
Q Consensus 226 ~Rpt~~e~L~ 235 (383)
+||.+.++|.
T Consensus 639 eRP~F~~il~ 648 (678)
T KOG0193|consen 639 ERPLFPQLLS 648 (678)
T ss_pred cCccHHHHHH
Confidence 9999999886
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.06 Aligned_cols=213 Identities=23% Similarity=0.342 Sum_probs=186.2
Q ss_pred CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----------
Q psy6377 14 TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---------- 78 (383)
Q Consensus 14 tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---------- 78 (383)
..+.||||.++. .+..|.||++++. .++|||||+|++++..++-+|+|+||+. .|+|.++|..
T Consensus 515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla-~l~H~nIVrLlGVC~~~~P~~MvFEYm~-~GDL~eFLra~sP~a~~~~~ 592 (774)
T KOG1026|consen 515 DEQLVAVKALKDKAENQARQDFRREAELLA-ELQHPNIVRLLGVCREGDPLCMVFEYMD-HGDLHEFLRARSPKADKLAS 592 (774)
T ss_pred cceehhHhhhcccccHHHHHHHHHHHHHHH-hccCCCeEEEEEEEccCCeeEEEEEecc-cccHHHHHHhhCCccccccC
Confidence 447899999987 3567999999999 8899999999999999999999999999 9999997521
Q ss_pred ----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc---ccCCC
Q psy6377 79 ----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE---LLGTP 145 (383)
Q Consensus 79 ----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~---~~gt~ 145 (383)
.+.+.++.||+.|+.||-++.+|||||-..|.|+..+ -.|||+|||+++..-..+.... ..-..
T Consensus 593 g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~---l~VKIsDfGLsRdiYssDYYk~~~~t~lPI 669 (774)
T KOG1026|consen 593 GQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN---LVVKISDFGLSRDIYSSDYYKVRGNTLLPI 669 (774)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc---eEEEecccccchhhhhhhhhcccCCceeee
Confidence 1245667999999999999999999999999999776 5899999999997654433221 12356
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|||||.+.+..|+.++||||+||+|||+++ |..||.|.+.++.++.|..++. ++ ..++++.++.+|+..||..+|
T Consensus 670 RWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~--~Pe~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 670 RWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS--CPENCPTEVYSLMLECWNENP 746 (774)
T ss_pred ecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-cc--CCCCCCHHHHHHHHHHhhcCc
Confidence 8999999999999999999999999999998 9999999999999999999887 43 236899999999999999999
Q ss_pred CCCCCHHHHH
Q psy6377 225 MERMTAKEAL 234 (383)
Q Consensus 225 ~~Rpt~~e~L 234 (383)
.+||++.|+-
T Consensus 747 ~~RPsF~eI~ 756 (774)
T KOG1026|consen 747 KRRPSFKEIH 756 (774)
T ss_pred ccCCCHHHHH
Confidence 9999999973
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=276.24 Aligned_cols=224 Identities=22% Similarity=0.258 Sum_probs=185.7
Q ss_pred eEEEEEEcCCCc---E-EEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGE---V-FAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~---~-vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+++-+..+. . ||+|.... ....+.+|.++++ .++|||||++|++.....-+++|||+|. ||+|.
T Consensus 172 eV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr-~l~H~NVVr~yGVa~~~~Pl~ivmEl~~-gGsL~ 249 (474)
T KOG0194|consen 172 EVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMR-QLNHPNVVRFYGVAVLEEPLMLVMELCN-GGSLD 249 (474)
T ss_pred EEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEcCCCccEEEEEecC-CCcHH
Confidence 467776665433 3 89998873 3467899999999 7999999999999999999999999999 99999
Q ss_pred HhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccc-cCCC
Q psy6377 74 TIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL-LGTP 145 (383)
Q Consensus 74 ~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~-~gt~ 145 (383)
+++.+.. ...+..+.+.||+|||+++++||||-..|+|++.+ +.+||+|||+++........... .-..
T Consensus 250 ~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~---~~vKISDFGLs~~~~~~~~~~~~~klPi 326 (474)
T KOG0194|consen 250 DYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK---GVVKISDFGLSRAGSQYVMKKFLKKLPI 326 (474)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC---CeEEeCccccccCCcceeeccccccCcc
Confidence 9887654 23445899999999999999999999999999876 36799999998875421111112 2456
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||.+...-|++++||||+||++||+++ |..||.+....+....|....+..+.+ ...+.++..++.+|+..+|
T Consensus 327 rWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 327 RWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred eecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCCh
Confidence 8999999999999999999999999999998 899999999999999985555444332 3668899999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++.+
T Consensus 405 ~~R~tm~~i~~ 415 (474)
T KOG0194|consen 405 EDRPTMSTIKK 415 (474)
T ss_pred hhccCHHHHHH
Confidence 99999998864
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=266.62 Aligned_cols=226 Identities=23% Similarity=0.304 Sum_probs=172.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--C--cccHHHHHHHHHhcCCCCCcccceEEEEeCC-eEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--N--PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-GAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~--~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||++.- .+|+.||||.+.. . ...+.+|+.++. .+.|||+|+|++++.+.+ ..+||+||++ .|+|.+.+..
T Consensus 89 g~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls-~l~H~Nlv~LlGyC~e~~~~~~LVYEym~-nGsL~d~L~~ 165 (361)
T KOG1187|consen 89 GTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILS-RLRHPNLVKLLGYCLEGGEHRLLVYEYMP-NGSLEDHLHG 165 (361)
T ss_pred eEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHh-cCCCcCcccEEEEEecCCceEEEEEEccC-CCCHHHHhCC
Confidence 35888875 4559999998877 2 356999999999 667999999999999988 5999999999 7899996543
Q ss_pred CC--------chhhHHHHHHHHHHHHhCC---ceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-Ccccccc-cCCC
Q psy6377 79 NL--------VVPFESDELSSLAYLHHRK---IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIREL-LGTP 145 (383)
Q Consensus 79 ~~--------~~~~~~qil~aL~yLHs~g---ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~-~gt~ 145 (383)
.. ...++.+++.||+|||... |+||||||+|||++.+ ...||+|||+|+.... .....+. .||.
T Consensus 166 ~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~---~~aKlsDFGLa~~~~~~~~~~~~~~~gt~ 242 (361)
T KOG1187|consen 166 KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED---FNAKLSDFGLAKLGPEGDTSVSTTVMGTF 242 (361)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC---CCEEccCccCcccCCccccceeeecCCCC
Confidence 32 3466689999999999854 9999999999999977 4899999999976544 3333333 8999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---cHHHH----HHHHhcc-CCCC-cchh-cCCC-----H
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---DSETF----RNISKAQ-LDFP-DELF-EDIS-----P 210 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~----~~i~~~~-~~~~-~~~~-~~~s-----~ 210 (383)
+|+|||.+.....+.++|||||||+|.||++|+.|..... ..... ..+..+. .... +... ...+ .
T Consensus 243 gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~ 322 (361)
T KOG1187|consen 243 GYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVK 322 (361)
T ss_pred ccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHH
Confidence 9999999988889999999999999999999998876432 11111 1111111 0111 1111 1222 2
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+..+..+|+..+|..||++.|+++
T Consensus 323 ~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 323 KLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 3567888999999999999999754
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=261.79 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=191.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC--C---------cccHHHHHHHHHhcCCCCCcccceEEEE-eCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES--N---------PVRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~---------~~~~~~Ei~il~~~~~hpnIvkl~~~~~-~~~~~~lv~e~~~~g~~L 72 (383)
.||+|-+..-+++||||+-.- + .....||.+|.+ .++||.||++||+|. +.+.++-|+|||+ |.+|
T Consensus 478 EVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHK-eLDHpRIVKlYDyfslDtdsFCTVLEYce-GNDL 555 (775)
T KOG1151|consen 478 EVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHK-ELDHPRIVKLYDYFSLDTDSFCTVLEYCE-GNDL 555 (775)
T ss_pred HHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhh-ccCcceeeeeeeeeeeccccceeeeeecC-CCch
Confidence 478899998999999998542 1 234678999999 889999999999997 5567899999999 9999
Q ss_pred HHhh------ccCCchhhHHHHHHHHHHHHhC--CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-------
Q psy6377 73 QTII------DDNLVVPFESDELSSLAYLHHR--KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE------- 137 (383)
Q Consensus 73 ~~~l------~~~~~~~~~~qil~aL~yLHs~--givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~------- 137 (383)
.-++ ++.....+..||+.||.||... -|+|-||||.|||+.+....|.|||+|||+++...+...
T Consensus 556 DFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGme 635 (775)
T KOG1151|consen 556 DFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGME 635 (775)
T ss_pred hHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCccccee
Confidence 8664 4556678889999999999976 499999999999987777789999999999998754321
Q ss_pred -cccccCCCCcCCCcccccC----CCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHH--H-HhccCCCCcchhcCC
Q psy6377 138 -IRELLGTPDYVAPEILHYE----PITLAADMWSLGVTAYVLLTGFSPFGGET-DSETFRN--I-SKAQLDFPDELFEDI 208 (383)
Q Consensus 138 -~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~--i-~~~~~~~~~~~~~~~ 208 (383)
.....||.||++||.+.-. ..+.++||||+|||+|.++.|+-||...- ..+++.. | ....+.||+. +-+
T Consensus 636 LTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvV 713 (775)
T KOG1151|consen 636 LTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVV 713 (775)
T ss_pred eecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--Ccc
Confidence 2335799999999986432 36889999999999999999999996543 3333332 2 2334566553 468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
+.++++||++||.+--++|..+.++-.||+|.....
T Consensus 714 sseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 714 SSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred CHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 999999999999999999999999999999987543
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=283.20 Aligned_cols=222 Identities=19% Similarity=0.273 Sum_probs=187.5
Q ss_pred eEEEEEEcCCCc-----EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGE-----VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~-----~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.+.-..-.. .||+|.+.+ ....+.+|..+++ ..+|||||+++++.-+....++++|||. ||+|..
T Consensus 707 ~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~-~f~HpNiv~liGv~l~~~~~~i~leyM~-gGDL~s 784 (1025)
T KOG1095|consen 707 EVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMS-KFDHPNIVSLIGVCLDSGPPLILLEYME-GGDLLS 784 (1025)
T ss_pred ceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHh-cCCCcceeeEEEeecCCCCcEEEehhcc-cCcHHH
Confidence 577777664433 399999987 3567899999999 8899999999999999999999999999 999999
Q ss_pred hhccC-------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc-
Q psy6377 75 IIDDN-------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE- 140 (383)
Q Consensus 75 ~l~~~-------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~- 140 (383)
+|.+. ..+.+..||+.|+.||++++.|||||...|.|++.. ..+||+|||+|+.+......+.
T Consensus 785 flr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaDFGlArDiy~~~yyr~~ 861 (1025)
T KOG1095|consen 785 FLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIADFGLARDIYDKDYYRKH 861 (1025)
T ss_pred HHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcccchhHhhhhchheecc
Confidence 88764 134555999999999999999999999999999876 6899999999995443322111
Q ss_pred -c-cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhcc-CCCCcchhcCCCHHHHHHH
Q psy6377 141 -L-LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQ-LDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 141 -~-~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li 216 (383)
. .-...|||||.+....|+.++|||||||++||+++ |..||.+.+..+.+.....+. .+.| ..+++.+.+++
T Consensus 862 ~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P----~~CP~~ly~lM 937 (1025)
T KOG1095|consen 862 GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP----SYCPEKLYQLM 937 (1025)
T ss_pred CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC----CCCChHHHHHH
Confidence 1 23457999999999999999999999999999998 999999999999988666554 3333 46789999999
Q ss_pred HHhcccCCCCCCCHHHHHc
Q psy6377 217 AKILIKNPMERMTAKEALK 235 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~ 235 (383)
..||..+|++||++..+++
T Consensus 938 ~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 938 LQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHccCChhhCccHHHHHh
Confidence 9999999999999999987
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=256.32 Aligned_cols=236 Identities=27% Similarity=0.346 Sum_probs=182.9
Q ss_pred EEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCC-------CCCcccceEEEEe----CCeEEEEEecCCCcCc
Q psy6377 6 EEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSP-------SPRIVKLHDVFQT----GEGAYYVSWNTPLVVT 71 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~-------hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~ 71 (383)
||+|.+..+.+.||+|+.+. -.+....||++|+.... ..+||+|+|.|.. +.++++|+|++ |.+
T Consensus 94 VWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL--Gdn 171 (590)
T KOG1290|consen 94 VWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL--GDN 171 (590)
T ss_pred eEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh--hhH
Confidence 89999999999999999987 35678899999995443 3479999999974 56789999988 689
Q ss_pred HHHhhccC--------CchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccC--------------------------
Q psy6377 72 LQTIIDDN--------LVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDF-------------------------- 116 (383)
Q Consensus 72 L~~~l~~~--------~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~-------------------------- 116 (383)
|..+|... .+..+.+|||.||.|||.. ||+|-||||+|||+..+.
T Consensus 172 LLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~ 251 (590)
T KOG1290|consen 172 LLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVS 251 (590)
T ss_pred HHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCccccc
Confidence 99876542 3556779999999999975 999999999999983100
Q ss_pred --------------------------------------------------------------------------------
Q psy6377 117 -------------------------------------------------------------------------------- 116 (383)
Q Consensus 117 -------------------------------------------------------------------------------- 116 (383)
T Consensus 252 t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~ 331 (590)
T KOG1290|consen 252 TRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNR 331 (590)
T ss_pred ccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCC
Confidence
Q ss_pred -----C----------------------------------------------------CCcEEEEeccceeEeecCcccc
Q psy6377 117 -----P----------------------------------------------------NCDIKVCDFEISRVILDGIEIR 139 (383)
Q Consensus 117 -----~----------------------------------------------------~~~ikL~DFGla~~~~~~~~~~ 139 (383)
+ ...+||+|||-|+-.. ..++
T Consensus 332 ~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT 409 (590)
T KOG1290|consen 332 ENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFT 409 (590)
T ss_pred ccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhc
Confidence 0 0136788888777542 3455
Q ss_pred cccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHhccCCCCcch---------
Q psy6377 140 ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET------DSETFRNISKAQLDFPDEL--------- 204 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~i~~~~~~~~~~~--------- 204 (383)
..+.|..|+||||+.+.+|+..+||||++|++|||+||...|.... +.+.+..|+..-...|..+
T Consensus 410 ~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRd 489 (590)
T KOG1290|consen 410 EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRD 489 (590)
T ss_pred hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHh
Confidence 5678999999999999999999999999999999999999986543 2344444544333333210
Q ss_pred ----------------h-------------cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 205 ----------------F-------------EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 205 ----------------~-------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
| ..-..++.+|+.-||+.+|++||||.++|+|||+.+....
T Consensus 490 FFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 490 FFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred hhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 0 0113568899999999999999999999999999976543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=291.26 Aligned_cols=223 Identities=20% Similarity=0.264 Sum_probs=170.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---CCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---NLV 81 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---~~~ 81 (383)
.||+|+++.+|..||||.+.........|+++++ .++|||||++++++.+.+..|+||||++ +++|.+++.. ...
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~-~l~HpnIv~~~~~~~~~~~~~lv~Ey~~-~g~L~~~l~~l~~~~~ 782 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-KLQHPNIVKLIGLCRSEKGAYLIHEYIE-GKNLSEVLRNLSWERR 782 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCccccHHHHHHHh-hCCCCCcceEEEEEEcCCCCEEEEeCCC-CCcHHHHHhcCCHHHH
Confidence 6999999999999999999764445567899998 7799999999999999999999999999 9999997643 445
Q ss_pred hhhHHHHHHHHHHHH---hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCC
Q psy6377 82 VPFESDELSSLAYLH---HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI 158 (383)
Q Consensus 82 ~~~~~qil~aL~yLH---s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 158 (383)
..++.|++.||+||| +.+|+||||||+||+++.+ +..++. ||.+..... .....||+.|+|||++.+..|
T Consensus 783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~---~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK---DEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDI 855 (968)
T ss_pred HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC---CceEEE-ecccccccc---CCCccccccccCcccccCCCC
Confidence 577799999999999 6799999999999999865 344443 565443221 123468999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHH--HHHhcc--------CCCCc--chhcCCCHHHHHHHHHhcccCC
Q psy6377 159 TLAADMWSLGVTAYVLLTGFSPFGGETDS--ETFR--NISKAQ--------LDFPD--ELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 159 ~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~--~i~~~~--------~~~~~--~~~~~~s~~~~~li~~~L~~dP 224 (383)
+.++||||+||++|||++|+.||...... .... ...... ..... ........++.+++.+||..||
T Consensus 856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P 935 (968)
T PLN00113 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935 (968)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCc
Confidence 99999999999999999999999543211 1111 000000 00000 0001122357789999999999
Q ss_pred CCCCCHHHHHcC
Q psy6377 225 MERMTAKEALKH 236 (383)
Q Consensus 225 ~~Rpt~~e~L~h 236 (383)
++|||+.|+++.
T Consensus 936 ~~RPt~~evl~~ 947 (968)
T PLN00113 936 TARPCANDVLKT 947 (968)
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=263.56 Aligned_cols=222 Identities=21% Similarity=0.265 Sum_probs=157.8
Q ss_pred CCCcEEEEEEccCCc------------------ccHHHHHHHHHhcCCCC-----CcccceEEEEe--------CCeEEE
Q psy6377 13 ATGEVFAAKFLESNP------------------VRIHHEIALLSLCSPSP-----RIVKLHDVFQT--------GEGAYY 61 (383)
Q Consensus 13 ~tg~~vAvK~i~~~~------------------~~~~~Ei~il~~~~~hp-----nIvkl~~~~~~--------~~~~~l 61 (383)
..++.||||.+.... +....|+.++. .+.|. ++++++++|.. ....++
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~-~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~L 262 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA-KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWL 262 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH-HhhcccchhhhhhhhhhhcccccccccccCCceEE
Confidence 345789999986421 12223555555 23333 34677777653 356899
Q ss_pred EEecCCCcCcHHHhhccC------------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy6377 62 VSWNTPLVVTLQTIIDDN------------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLV 111 (383)
Q Consensus 62 v~e~~~~g~~L~~~l~~~------------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NIL 111 (383)
|+||+. +++|.+++... .+..+..|++.||.|||++||+||||||+|||
T Consensus 263 V~Ey~~-~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NIL 341 (507)
T PLN03224 263 VWKFES-DATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLL 341 (507)
T ss_pred EEEcCC-CCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEE
Confidence 999999 99998876421 12235589999999999999999999999999
Q ss_pred EeccCCCCcEEEEeccceeEeecCcccccc--cCCCCcCCCcccccCC--------------------CC--hhhHHHHH
Q psy6377 112 MMGDFPNCDIKVCDFEISRVILDGIEIREL--LGTPDYVAPEILHYEP--------------------IT--LAADMWSL 167 (383)
Q Consensus 112 l~~~~~~~~ikL~DFGla~~~~~~~~~~~~--~gt~~y~aPE~l~~~~--------------------~~--~~~DiwSl 167 (383)
++.+ +.+||+|||++.....+...... .+|+.|+|||.+.... |+ .+.|+||+
T Consensus 342 l~~~---~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 342 VTVD---GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred ECCC---CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 9865 58999999999765433332222 3489999999875321 11 34799999
Q ss_pred HHHHHHHHhCCC-CCCCCC-----------cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC---CCCCCHHH
Q psy6377 168 GVTAYVLLTGFS-PFGGET-----------DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP---MERMTAKE 232 (383)
Q Consensus 168 Gvilyelltg~~-Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpt~~e 232 (383)
||++|+|++|.. ||.+.. ....++.+....+.++ .+...++.+++|+.+||..+| .+|+|++|
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 999999999875 775421 1112222233334443 456789999999999999866 68999999
Q ss_pred HHcCcccCC
Q psy6377 233 ALKHPWLMN 241 (383)
Q Consensus 233 ~L~hp~~~~ 241 (383)
+|+||||.+
T Consensus 497 aL~Hp~f~~ 505 (507)
T PLN03224 497 ALSHRFFLP 505 (507)
T ss_pred HhCCCCcCC
Confidence 999999964
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=257.17 Aligned_cols=222 Identities=22% Similarity=0.330 Sum_probs=183.9
Q ss_pred ceEEEEEEcCC----CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIAT----GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~t----g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.+||.++-..- .-.||||..+. +.+.+..|..+++ ..+|||||++++++.+ .-.|+|||+++ .|+|..
T Consensus 403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMr-nfdHphIikLIGv~~e-~P~WivmEL~~-~GELr~ 479 (974)
T KOG4257|consen 403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMR-NFDHPHIIKLIGVCVE-QPMWIVMELAP-LGELRE 479 (974)
T ss_pred cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHH-hCCCcchhheeeeeec-cceeEEEeccc-chhHHH
Confidence 35777764322 33589999887 4678999999999 9999999999999865 67999999999 999999
Q ss_pred hhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC--CC
Q psy6377 75 IIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG--TP 145 (383)
Q Consensus 75 ~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g--t~ 145 (383)
+++.+. ...+.+||+.||+|||+.+.|||||-..|||+.+. .-|||+|||+++...+........| +.
T Consensus 480 yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp---~CVKLaDFGLSR~~ed~~yYkaS~~kLPI 556 (974)
T KOG4257|consen 480 YLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP---QCVKLADFGLSRYLEDDAYYKASRGKLPI 556 (974)
T ss_pred HHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc---ceeeecccchhhhccccchhhccccccce
Confidence 887643 22444999999999999999999999999999865 4799999999998766544333333 44
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|||||-+....++.++|||-|||.+||++. |--||.|-...+.+..|.+|...+ .++++++.+..++.+||.++|
T Consensus 557 KWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---~P~nCPp~LYslmskcWayeP 633 (974)
T KOG4257|consen 557 KWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---CPPNCPPALYSLMSKCWAYEP 633 (974)
T ss_pred eecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---CCCCCChHHHHHHHHHhccCc
Confidence 7999999999999999999999999999886 999999998888877777765332 235789999999999999999
Q ss_pred CCCCCHHHHH
Q psy6377 225 MERMTAKEAL 234 (383)
Q Consensus 225 ~~Rpt~~e~L 234 (383)
.+||++.++.
T Consensus 634 ~kRPrftei~ 643 (974)
T KOG4257|consen 634 SKRPRFTEIK 643 (974)
T ss_pred ccCCcHHHHH
Confidence 9999887653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=277.12 Aligned_cols=194 Identities=16% Similarity=0.140 Sum_probs=144.8
Q ss_pred CC-CCcccceEEE-------EeCCeEEEEEecCCCcCcHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCC
Q psy6377 42 PS-PRIVKLHDVF-------QTGEGAYYVSWNTPLVVTLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIK 106 (383)
Q Consensus 42 ~h-pnIvkl~~~~-------~~~~~~~lv~e~~~~g~~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLK 106 (383)
.| +||++++|.| .....+++++|++. ++|.+++.. ..++.+++||+.||+|||++||+|||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~--~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED--VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccCC--ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 45 6899999988 23345777788775 799998743 2345667999999999999999999999
Q ss_pred CCcEEEecc----------------CCCCcEEEEeccceeEeecC-----------------cccccccCCCCcCCCccc
Q psy6377 107 PQNLVMMGD----------------FPNCDIKVCDFEISRVILDG-----------------IEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 107 p~NILl~~~----------------~~~~~ikL~DFGla~~~~~~-----------------~~~~~~~gt~~y~aPE~l 153 (383)
|+|||++.. +..+.+|++|||+++..... ......+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999541 12356788888888753210 001124689999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..|+.++|||||||+||||++|.+|+.... ..+..+.... .|+.. ........+++.+||.++|.+|||+.|+
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 99999999999999999999999999876432 2222222221 12211 1224567889999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
|+||||...
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999764
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=253.18 Aligned_cols=223 Identities=20% Similarity=0.255 Sum_probs=189.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL 80 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~ 80 (383)
..||.+.+++..-.||||.++. ..+.|..|..+++ -+.|||+|+|++++..+.-+|+|.|||. .|+|.+++.+..
T Consensus 281 GeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMK-eikHpNLVqLLGVCT~EpPFYIiTEfM~-yGNLLdYLRecn 358 (1157)
T KOG4278|consen 281 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTHEPPFYIITEFMC-YGNLLDYLRECN 358 (1157)
T ss_pred cceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHH-hhcCccHHHHhhhhccCCCeEEEEeccc-CccHHHHHHHhc
Confidence 3689999999999999999987 4678999999999 8899999999999999999999999999 899999876532
Q ss_pred --------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--ccccCCCCcCCC
Q psy6377 81 --------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RELLGTPDYVAP 150 (383)
Q Consensus 81 --------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~~~gt~~y~aP 150 (383)
.++.+.||..|++||..+++|||||-..|.|+..+ ..||++||||++........ ........|.||
T Consensus 359 r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn---hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAP 435 (1157)
T KOG4278|consen 359 RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 435 (1157)
T ss_pred hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc---ceEEeeccchhhhhcCCceecccCccCcccccCc
Confidence 23455899999999999999999999999999765 58999999999987543221 112345679999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|-+....++.++|||+|||+|||+.| |..||.|.+....+.-+.++ +... ..+++++.+..|++.||.++|.+||+
T Consensus 436 EsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~--~PeGCPpkVYeLMraCW~WsPsDRPs 512 (1157)
T KOG4278|consen 436 ESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMD--GPEGCPPKVYELMRACWNWSPSDRPS 512 (1157)
T ss_pred ccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-cccc--CCCCCCHHHHHHHHHHhcCCcccCcc
Confidence 99999999999999999999999998 99999999877776655443 2222 23578999999999999999999999
Q ss_pred HHHHH
Q psy6377 230 AKEAL 234 (383)
Q Consensus 230 ~~e~L 234 (383)
+.|+-
T Consensus 513 FaeiH 517 (1157)
T KOG4278|consen 513 FAEIH 517 (1157)
T ss_pred HHHHH
Confidence 98874
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=225.93 Aligned_cols=187 Identities=21% Similarity=0.390 Sum_probs=157.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh----
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI---- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~---- 75 (383)
.|-+.++..+|+..|+|.+.. ...+..+|+.+......+|.+|.+|+.+......++.||.+. .+|..+
T Consensus 61 ~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~--tSldkfy~~v 138 (282)
T KOG0984|consen 61 VVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD--TSLDKFYRKV 138 (282)
T ss_pred hhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh--hhHHHHHHHH
Confidence 355678999999999999976 467889999999889999999999999999999999999998 777764
Q ss_pred hc------cCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 76 ID------DNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 76 l~------~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
++ +..+-.++..++.||.|||++ .++|||+||+|||++.+ |++|+||||++....++...+...|-..|+
T Consensus 139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~---GqVKiCDFGIsG~L~dSiAkt~daGCkpYm 215 (282)
T KOG0984|consen 139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD---GQVKICDFGISGYLVDSIAKTMDAGCKPYM 215 (282)
T ss_pred HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC---CcEEEcccccceeehhhhHHHHhcCCCccC
Confidence 33 233345668999999999986 89999999999999876 799999999999887766666577888999
Q ss_pred CCcccc----cCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHhc
Q psy6377 149 APEILH----YEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDSETFRNISKA 196 (383)
Q Consensus 149 aPE~l~----~~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~i~~~ 196 (383)
|||.+. ..+|+.++||||||+.+.||.+++.||.. .+..+++.++...
T Consensus 216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 999884 34799999999999999999999999964 4555666666543
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=256.19 Aligned_cols=226 Identities=20% Similarity=0.288 Sum_probs=188.2
Q ss_pred eEEEEEEcCC-Cc--EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIAT-GE--VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~t-g~--~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
+||.+.++.. |+ .||||++.. ....|.+|+.++- .++|||+++||++.-+ .-+-+|+|+++ +|+|.+.+
T Consensus 125 vV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~-~L~H~hliRLyGvVl~-qp~mMV~ELap-lGSLldrL 201 (1039)
T KOG0199|consen 125 VVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHML-KLQHPHLIRLYGVVLD-QPAMMVFELAP-LGSLLDRL 201 (1039)
T ss_pred eEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHH-hccCcceeEEeeeecc-chhhHHhhhcc-cchHHHHH
Confidence 5666666543 33 589999987 3467999999998 8899999999999987 77889999999 99999976
Q ss_pred ccCC--------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccccc----CC
Q psy6377 77 DDNL--------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GT 144 (383)
Q Consensus 77 ~~~~--------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~----gt 144 (383)
.... .-.++.||+.|+.||.++++|||||-..|+|+... ..|||+||||.+....++...... -.
T Consensus 202 rka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp---rtVKI~DFGLmRaLg~ned~Yvm~p~rkvP 278 (1039)
T KOG0199|consen 202 RKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP---RTVKICDFGLMRALGENEDMYVMAPQRKVP 278 (1039)
T ss_pred hhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc---ceeeeecccceeccCCCCcceEecCCCcCc
Confidence 5521 12445899999999999999999999999999664 589999999999887776655432 23
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
..|+|||.+....++.++|+|++||++|||++ |+.||.|-....++++|..+..-.. .+.+++++.+++..||..+
T Consensus 279 fAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 279 FAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred ccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCCChHHHHHHHHHhccCC
Confidence 47999999999999999999999999999998 8999999999999999885543221 2467999999999999999
Q ss_pred CCCCCCHHHHHcCccc
Q psy6377 224 PMERMTAKEALKHPWL 239 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~ 239 (383)
|.+|||+..+.+.-++
T Consensus 356 paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 356 PADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccccHHHHHHhHHH
Confidence 9999999988654444
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=260.93 Aligned_cols=224 Identities=21% Similarity=0.290 Sum_probs=191.5
Q ss_pred eEEEEEEcCCC---cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATG---EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg---~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.|+.++-+..| ..||||.++. .+..|..|..|+. +.+||||++|.++.....-+.+|.|||+ .|+|+.+|
T Consensus 644 EVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG-QFdHPNIIrLEGVVTks~PvMIiTEyME-NGsLDsFL 721 (996)
T KOG0196|consen 644 EVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG-QFDHPNIIRLEGVVTKSKPVMIITEYME-NGSLDSFL 721 (996)
T ss_pred ceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc-cCCCCcEEEEEEEEecCceeEEEhhhhh-CCcHHHHH
Confidence 57778777666 5799999986 4667999999999 8899999999999999999999999999 99999988
Q ss_pred ccCCc-------hhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccC--CC
Q psy6377 77 DDNLV-------VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLG--TP 145 (383)
Q Consensus 77 ~~~~~-------~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~g--t~ 145 (383)
..+.. .-.++.|+.|++||-+.|+|||||-..|||++++ -..|++|||+++...++.. .++..| ..
T Consensus 722 R~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn---LvCKVsDFGLSRvledd~~~~ytt~GGKIPi 798 (996)
T KOG0196|consen 722 RQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEAAYTTLGGKIPI 798 (996)
T ss_pred hhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc---eEEEeccccceeecccCCCccccccCCccce
Confidence 76432 2333889999999999999999999999999876 4789999999998765542 222223 35
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|.|||.+...+++.++||||+|+++||.++ |.-||+..+.++.+..|..+-.-+|+ .+++..+-+|+..||++|-
T Consensus 799 RWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---mDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 799 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---MDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred eecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---CCCcHHHHHHHHHHHHHHh
Confidence 7999999999999999999999999999886 99999999999999999876533333 4789999999999999999
Q ss_pred CCCCCHHHHHcC
Q psy6377 225 MERMTAKEALKH 236 (383)
Q Consensus 225 ~~Rpt~~e~L~h 236 (383)
..||++.|++.+
T Consensus 876 ~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 876 NRRPKFAQIVST 887 (996)
T ss_pred hcCCCHHHHHHH
Confidence 999999998764
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=259.36 Aligned_cols=234 Identities=26% Similarity=0.345 Sum_probs=197.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh----
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI---- 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~---- 75 (383)
.+||+|+++.+|+..|+|+++- +...+..||-+++ -.+|||||.+++-|.-.+.+|+.||||. ||+|+++
T Consensus 29 gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~-dc~h~nivay~gsylr~dklwicMEycg-ggslQdiy~~T 106 (829)
T KOG0576|consen 29 GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLR-DCRHPNIVAYFGSYLRRDKLWICMEYCG-GGSLQDIYHVT 106 (829)
T ss_pred cchhhhcccccCchhhheeeeccCCccccccccceeeee-cCCCcChHHHHhhhhhhcCcEEEEEecC-CCcccceeeec
Confidence 3799999999999999999986 5677889999998 7789999999999999999999999999 9999995
Q ss_pred --hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcc
Q psy6377 76 --IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEI 152 (383)
Q Consensus 76 --l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~ 152 (383)
+++.++.+.-+..+.||+|||++|-+|||||-.|||+++. |.+|++|||.+..+.... ......|||.|||||+
T Consensus 107 gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~---gDvklaDfgvsaqitati~KrksfiGtpywmapEv 183 (829)
T KOG0576|consen 107 GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE---GDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 183 (829)
T ss_pred ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc---CceeecccCchhhhhhhhhhhhcccCCccccchhH
Confidence 4556666666899999999999999999999999999876 799999999988765432 2456789999999998
Q ss_pred c---ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-hhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 153 L---HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-LFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 153 l---~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
. ...+|...+|+|++|+...++---++|....-....+.-+.+..+.+|.- .....++.+-+|++.+|.++|++||
T Consensus 184 aaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp 263 (829)
T KOG0576|consen 184 AAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP 263 (829)
T ss_pred HHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC
Confidence 6 45679999999999999999998888876665555555555555554421 1234688999999999999999999
Q ss_pred CHHHHHcCcccCCc
Q psy6377 229 TAKEALKHPWLMNK 242 (383)
Q Consensus 229 t~~e~L~hp~~~~~ 242 (383)
|++.+|.|||+...
T Consensus 264 taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 264 TAEKLLQHPFVSQT 277 (829)
T ss_pred Chhhheeceeeccc
Confidence 99999999999643
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=251.21 Aligned_cols=174 Identities=22% Similarity=0.301 Sum_probs=155.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC------------CcccHHHHHHHHHhcCC---CCCcccceEEEEeCCeEEEEEecCCCc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------------NPVRIHHEIALLSLCSP---SPRIVKLHDVFQTGEGAYYVSWNTPLV 69 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------------~~~~~~~Ei~il~~~~~---hpnIvkl~~~~~~~~~~~lv~e~~~~g 69 (383)
.|++|.++++...|++|.+.| ....+..||.||. .++ |+||++++++|++++.+||+||-...|
T Consensus 576 kV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla-~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~g 654 (772)
T KOG1152|consen 576 KVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILA-TLNKHSHENILKLLDFFEDDDYYYLETEVHGEG 654 (772)
T ss_pred eEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHH-HhhhcCccchhhhhheeecCCeeEEEecCCCCC
Confidence 689999999999999999988 2345789999998 444 999999999999999999999999889
Q ss_pred CcHHHhhc------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 70 VTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 70 ~~L~~~l~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
.+|+++|+ +.....+++|++.|+++||++||||||||-+|+.++++ |.+||+|||.|..... .++...+|
T Consensus 655 IDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~---g~~klidfgsaa~~ks-gpfd~f~g 730 (772)
T KOG1152|consen 655 IDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN---GFVKLIDFGSAAYTKS-GPFDVFVG 730 (772)
T ss_pred cchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC---CeEEEeeccchhhhcC-CCcceeee
Confidence 99999864 34556778999999999999999999999999999876 7999999999886543 46788899
Q ss_pred CCCcCCCcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCC
Q psy6377 144 TPDYVAPEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGG 183 (383)
Q Consensus 144 t~~y~aPE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~ 183 (383)
|..|.|||++.+.+| +..-|||++|++||.+.....||..
T Consensus 731 tv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 731 TVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999988 6779999999999999999999864
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=245.59 Aligned_cols=226 Identities=20% Similarity=0.235 Sum_probs=186.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
+.|++|.- ..+..||||+++. .+..+.+||++|. .++||||+.+++++..++-+++|+||+. .|+|..++.+
T Consensus 552 GEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLs-qLkhPNIveLvGVC~~DePicmI~EYmE-nGDLnqFl~a 628 (807)
T KOG1094|consen 552 GEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILS-RLKHPNIVELLGVCVQDDPLCMITEYME-NGDLNQFLSA 628 (807)
T ss_pred ceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHh-ccCCCCeeEEEeeeecCCchHHHHHHHh-cCcHHHHHHh
Confidence 35788874 3479999999987 3578999999999 6699999999999999999999999999 8999997755
Q ss_pred CC--------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc---cccCCCCc
Q psy6377 79 NL--------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPDY 147 (383)
Q Consensus 79 ~~--------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~---~~~gt~~y 147 (383)
.. ...+..||+.|++||.+.++|||||.+.|+|++++ .++||+|||+++..-.+.... ..+-+..|
T Consensus 629 heapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e---~~iKiadfgmsR~lysg~yy~vqgr~vlpiRw 705 (807)
T KOG1094|consen 629 HELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE---FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRW 705 (807)
T ss_pred ccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc---ccEEecCcccccccccCCceeeecceeeeeee
Confidence 42 23566999999999999999999999999999876 589999999999765544322 23456789
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHhccCCCCc----chhcCCCHHHHHHHHHhcc
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLL--TGFSPFGGETDSETFRNISKAQLDFPD----ELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyell--tg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~ 221 (383)
||||.+.-.+++.++|+|+||+++||++ +...||...++.+..++........+. ..+.-++..+.+++.+|+.
T Consensus 706 mawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~ 785 (807)
T KOG1094|consen 706 MAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWR 785 (807)
T ss_pred hhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhc
Confidence 9999998899999999999999999976 588999988888777765433222221 1224568899999999999
Q ss_pred cCCCCCCCHHHHHc
Q psy6377 222 KNPMERMTAKEALK 235 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~ 235 (383)
.|.++|||.+++..
T Consensus 786 ~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 786 RESEQRPSFEQLHL 799 (807)
T ss_pred hhhhcCCCHHHHHH
Confidence 99999999999854
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=254.33 Aligned_cols=213 Identities=22% Similarity=0.333 Sum_probs=178.6
Q ss_pred CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC---------
Q psy6377 15 GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL--------- 80 (383)
Q Consensus 15 g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~--------- 80 (383)
...||||.++. +...+..|+.+++....||||+.+++++.....+++|+||+. .|+|.+++....
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~-~G~L~~~Lr~~r~~~~~~~~~ 406 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAE-HGDLLEFLRKKRVTESIDGSG 406 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEecc-CCcHHHHHHhccccccccccC
Confidence 56799999986 357899999999988889999999999999899999999999 999999765444
Q ss_pred -------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc--cccC--
Q psy6377 81 -------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLG-- 143 (383)
Q Consensus 81 -------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~--~~~g-- 143 (383)
.+.++.||+.|++||++.++|||||-..|||+..+ ..+||+|||+|+......... ...|
T Consensus 407 ~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~---~~~kIaDFGlar~~~~~~~y~~~~~~~~L 483 (609)
T KOG0200|consen 407 VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN---KVIKIADFGLARDHYNKDYYRTKSSAGTL 483 (609)
T ss_pred CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC---CEEEEccccceeccCCCCceEecCCCCcc
Confidence 23555999999999999999999999999999876 489999999999654433322 1222
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC-cHHHHHHHHhccC-CCCcchhcCCCHHHHHHHHHhc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGET-DSETFRNISKAQL-DFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~-~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L 220 (383)
...|||||.+....|+.++||||+|++|||+++ |..||.+.. ..+.++.+..|.. ..| ..+++++.++++.||
T Consensus 484 P~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P----~~c~~eiY~iM~~CW 559 (609)
T KOG0200|consen 484 PVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQP----EHCSDEIYDLMKSCW 559 (609)
T ss_pred ceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHh
Confidence 335999999999999999999999999999998 999999865 5566666666653 222 467999999999999
Q ss_pred ccCCCCCCCHHHHHc
Q psy6377 221 IKNPMERMTAKEALK 235 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~ 235 (383)
..+|++||+..++.+
T Consensus 560 ~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 560 NADPEDRPTFSECVE 574 (609)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999864
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=240.83 Aligned_cols=236 Identities=27% Similarity=0.328 Sum_probs=180.0
Q ss_pred eEEEEEEcC---CCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIA---TGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~---tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
+||++.... .+..||+|.+.. ...++..|+++|..+.++.||+++.+++..++...+|++|++ ..+..++...
T Consensus 51 sv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~-H~~f~~l~~~l 129 (418)
T KOG1167|consen 51 SVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE-HDRFRDLYRSL 129 (418)
T ss_pred hhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC-ccCHHHHHhcC
Confidence 456666655 788999999887 578899999999989999999999999999999999999999 7777776433
Q ss_pred --CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-----------------c--Cc-
Q psy6377 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-----------------D--GI- 136 (383)
Q Consensus 79 --~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-----------------~--~~- 136 (383)
..+..+.+.++.||.++|.+|||||||||.|+|++... +.-.|+|||+|.... . +.
T Consensus 130 ~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t--~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~ 207 (418)
T KOG1167|consen 130 SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT--QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKD 207 (418)
T ss_pred CHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc--CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCc
Confidence 34556779999999999999999999999999997653 567999999998210 0 00
Q ss_pred -----------c--------------cccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHH
Q psy6377 137 -----------E--------------IRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGET-DSET 189 (383)
Q Consensus 137 -----------~--------------~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~ 189 (383)
. .-...|||+|+|||++..- .-+.++||||.|||+..+++++.||.-.. +.+.
T Consensus 208 ~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~a 287 (418)
T KOG1167|consen 208 VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADA 287 (418)
T ss_pred ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccch
Confidence 0 0013599999999998654 45789999999999999999999984322 1111
Q ss_pred HHHHH--------------hcc---------------------------CC------CCcchhcCCCHHHHHHHHHhccc
Q psy6377 190 FRNIS--------------KAQ---------------------------LD------FPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 190 ~~~i~--------------~~~---------------------------~~------~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+..|. .+. .. .+.......+..+.+|+.+||..
T Consensus 288 l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~ 367 (418)
T KOG1167|consen 288 LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLEL 367 (418)
T ss_pred HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccC
Confidence 11110 000 00 00011122355899999999999
Q ss_pred CCCCCCCHHHHHcCcccCCcc
Q psy6377 223 NPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
||.+|.||+++|+||||....
T Consensus 368 np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 368 NPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ChhhcccHHHHhcCcCCcchh
Confidence 999999999999999998544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=210.00 Aligned_cols=195 Identities=34% Similarity=0.541 Sum_probs=169.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCc-----ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNP-----VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~-----~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||++....+|+.+++|++.... ..+.+|+..++ .+.|++|+++++++......++++|++. |++|.+++..
T Consensus 7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~~~~e~~~-~~~l~~~~~~ 84 (215)
T cd00180 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILK-KLNHPNIVKLYGVFEDENHLYLVMEYCE-GGSLKDLLKE 84 (215)
T ss_pred eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHH-hcCCCCeeeEeeeeecCCeEEEEEecCC-CCcHHHHHHh
Confidence 478999998889999999998732 57999999999 7789999999999999999999999999 9999998754
Q ss_pred C-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCC
Q psy6377 79 N-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAP 150 (383)
Q Consensus 79 ~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aP 150 (383)
. ....+..+++.+|.+||+.|++|+||+|.||+++.. .+.++|+|||.+....... ......+...|++|
T Consensus 85 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p 162 (215)
T cd00180 85 NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162 (215)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccCCCCccCh
Confidence 3 234556899999999999999999999999999872 2589999999998764432 13345678899999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|.+... .++.+.|+|++|+++++| ..+.+++.+|+..+|++||+
T Consensus 163 e~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 163 EVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred hHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 998876 788999999999999999 57889999999999999999
Q ss_pred HHHHHcCc
Q psy6377 230 AKEALKHP 237 (383)
Q Consensus 230 ~~e~L~hp 237 (383)
+.++++|+
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=224.25 Aligned_cols=231 Identities=22% Similarity=0.330 Sum_probs=176.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEE-EEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDV-FQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~-~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
.+.+|.|+.+++.+|+|.+++ ....+.+|...--.+..|.||+.-|++ |++.+.+++++|+++ .|+|..-+...
T Consensus 39 kIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP-~gdL~snv~~~G 117 (378)
T KOG1345|consen 39 KILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP-RGDLRSNVEAAG 117 (378)
T ss_pred eEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc-cchhhhhcCccc
Confidence 578999999999999999998 467788888755446679999999987 788888899999999 89999865443
Q ss_pred ----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccccc
Q psy6377 80 ----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY 155 (383)
Q Consensus 80 ----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~ 155 (383)
....+..|+++|+.|||++++||||||.+|||+-..+- -.|||||||+.+..+.. ....-.+..|.|||+...
T Consensus 118 igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df-~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 118 IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF-YRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDT 194 (378)
T ss_pred ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc-cEEEeeecccccccCce--ehhhhhhcccCCcHHHhh
Confidence 34567799999999999999999999999999644322 48999999998875432 222335667999997643
Q ss_pred ---CC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 156 ---EP--ITLAADMWSLGVTAYVLLTGFSPFGGETDSE----TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 156 ---~~--~~~~~DiwSlGvilyelltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+. ..+.+|+|.||+|+|.+|+|.+||+.....+ .+.....+...--+..+...|+.+..+.++-|.++|++
T Consensus 195 ~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~d 274 (378)
T KOG1345|consen 195 VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKD 274 (378)
T ss_pred ccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccc
Confidence 22 4688999999999999999999998543221 12222223222334455678999999999999999999
Q ss_pred C---CCHHHHHcCccc
Q psy6377 227 R---MTAKEALKHPWL 239 (383)
Q Consensus 227 R---pt~~e~L~hp~~ 239 (383)
| .++......-|.
T Consensus 275 rcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 275 RCKIWTAKKMRKCLWK 290 (378)
T ss_pred cchhHHHHHHHHHHHH
Confidence 9 455555555554
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=229.35 Aligned_cols=222 Identities=21% Similarity=0.270 Sum_probs=168.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHh-cCCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSL-CSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~-~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+ -+++.||||+++. +.+.+..|-+|++. .+.|+||++++..=+... .++||++|.+ .|+|.++++.
T Consensus 225 ~V~Kaq--L~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~-kGsL~dyL~~ 301 (534)
T KOG3653|consen 225 CVWKAQ--LDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP-KGSLCDYLKA 301 (534)
T ss_pred eeehhh--ccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc-CCcHHHHHHh
Confidence 578887 4679999999997 67788888888873 347999999999876555 7999999999 9999999877
Q ss_pred CCc-----hhhHHHHHHHHHHHHhC---------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccc
Q psy6377 79 NLV-----VPFESDELSSLAYLHHR---------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IREL 141 (383)
Q Consensus 79 ~~~-----~~~~~qil~aL~yLHs~---------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~ 141 (383)
+.+ ..++..++.||+|||+- .|+|||||..|||+.+| +...|+|||+|..+.++.. ....
T Consensus 302 ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D---lTccIaDFGLAl~~~p~~~~~d~~~q 378 (534)
T KOG3653|consen 302 NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND---LTCCIADFGLALRLEPGKPQGDTHGQ 378 (534)
T ss_pred ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC---CcEEeeccceeEEecCCCCCcchhhh
Confidence 654 34458899999999973 59999999999999887 6899999999999876543 3447
Q ss_pred cCCCCcCCCcccccCC-CC-----hhhHHHHHHHHHHHHHhCCC------------CCCC-----CCcHHHHHHH--Hhc
Q psy6377 142 LGTPDYVAPEILHYEP-IT-----LAADMWSLGVTAYVLLTGFS------------PFGG-----ETDSETFRNI--SKA 196 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~-~~-----~~~DiwSlGvilyelltg~~------------Pf~~-----~~~~~~~~~i--~~~ 196 (383)
+||..|||||++.+.- +. .+.||||+|.+||||+++-. ||.. .+..++...+ .+.
T Consensus 379 VGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~ 458 (534)
T KOG3653|consen 379 VGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ 458 (534)
T ss_pred hhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc
Confidence 8999999999996532 21 45899999999999998633 3321 1112222222 223
Q ss_pred cCCCCcchhcC-CCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 197 QLDFPDELFED-ISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 197 ~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
...+|+.+..+ ....+++.+..||..||+.|.|+.=
T Consensus 459 RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 459 RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 44555444333 2345789999999999999999863
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=224.97 Aligned_cols=225 Identities=19% Similarity=0.204 Sum_probs=171.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHh-cCCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSL-CSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~-~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||.++.+ |+.||||+|.. +.....||.+|++. +++|+||+.++..=-.++ .+|||.+|.+ .|+|++++.+
T Consensus 226 EVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe-~GSL~DyL~r 302 (513)
T KOG2052|consen 226 EVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE-HGSLYDYLNR 302 (513)
T ss_pred ceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc-CCcHHHHHhh
Confidence 58888876 99999999998 78889999998875 458999999998744332 4899999999 9999999876
Q ss_pred CC-----chhhHHHHHHHHHHHHhC--------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----ccccc
Q psy6377 79 NL-----VVPFESDELSSLAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----IEIRE 140 (383)
Q Consensus 79 ~~-----~~~~~~qil~aL~yLHs~--------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-----~~~~~ 140 (383)
.. .+.++..++.||++||.. .|.|||||..|||+.++ +..-|+|+|||-..... .....
T Consensus 303 ~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn---~~C~IADLGLAv~h~~~t~~idi~~N~ 379 (513)
T KOG2052|consen 303 NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSDTDTIDIPPNP 379 (513)
T ss_pred ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC---CcEEEeeceeeEEecccCCcccCCCCC
Confidence 43 345568999999999963 49999999999999876 68999999999876443 12345
Q ss_pred ccCCCCcCCCcccccCC----C--ChhhHHHHHHHHHHHHHhC----------CCCCCCC----CcHHHHHHHHhcc--C
Q psy6377 141 LLGTPDYVAPEILHYEP----I--TLAADMWSLGVTAYVLLTG----------FSPFGGE----TDSETFRNISKAQ--L 198 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~----~--~~~~DiwSlGvilyelltg----------~~Pf~~~----~~~~~~~~i~~~~--~ 198 (383)
.+||..|||||++...- + -..+||||||.|+||++.. ++||.+- ...+.++++...+ .
T Consensus 380 rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R 459 (513)
T KOG2052|consen 380 RVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR 459 (513)
T ss_pred ccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC
Confidence 78999999999996432 1 2458999999999999864 5788643 3344455443322 1
Q ss_pred CCCcchhcCCC--HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 199 DFPDELFEDIS--PEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 199 ~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+.++..|...+ ..+..+++.||..||.-|.||-.+-+
T Consensus 460 P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 460 PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 22233444332 24667899999999999999877643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=207.59 Aligned_cols=156 Identities=22% Similarity=0.260 Sum_probs=119.8
Q ss_pred CcHHHhhc-------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccccc
Q psy6377 70 VTLQTIID-------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL 142 (383)
Q Consensus 70 ~~L~~~l~-------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~ 142 (383)
|+|.+++. +..++.++.|++.||+|||++| ||+|||++.+ +.+++ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~---~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD---GLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc---cceee--ccceEeecccc----CC
Confidence 45555543 3445677799999999999998 9999999765 57888 99998764422 36
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCc---chhcCCCH--HHHHHH
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPD---ELFEDISP--EAKDFI 216 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 216 (383)
||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... ..+..+......... .....++. .+.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 333333322221110 11123344 699999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccC
Q psy6377 217 AKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
.+||..+|.+|||+.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=205.83 Aligned_cols=189 Identities=32% Similarity=0.403 Sum_probs=159.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||++.+..+++.+|+|.+... ...+.+|++.++ ...|+|++++++.+......++++|+++ +++|.+.+..
T Consensus 13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~ 90 (225)
T smart00221 13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILK-KLKHPNIVKLYGVFEDPEPLYLVMEYCE-GGDLFDYLRK 90 (225)
T ss_pred eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHH-hCCCCChhhheeeeecCCceEEEEeccC-CCCHHHHHHh
Confidence 36899999999999999999872 457888999998 6689999999999999999999999999 8899997654
Q ss_pred CC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCC
Q psy6377 79 NL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVA 149 (383)
Q Consensus 79 ~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~a 149 (383)
.. ...+..|++.++.|||+.|++|+||+|.||+++.+ +.++|+|||.+....... ......++..|++
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 167 (225)
T smart00221 91 KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLAALLKTVKGTPFYLA 167 (225)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCcccccccceeccCCcCC
Confidence 32 34566899999999999999999999999999865 689999999998875543 3345678889999
Q ss_pred Cccc-ccCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcH-HHHHHHHhcc
Q psy6377 150 PEIL-HYEPITLAADMWSLGVTAYVLLTGFSPFGG-ETDS-ETFRNISKAQ 197 (383)
Q Consensus 150 PE~l-~~~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~-~~~~~i~~~~ 197 (383)
||.+ ...+++.++|+|+||+++|+|++|+.||.+ .... +..+.+..+.
T Consensus 168 pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 168 PEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred HhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 9998 677788899999999999999999999987 4444 5555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=230.10 Aligned_cols=224 Identities=19% Similarity=0.260 Sum_probs=181.2
Q ss_pred ccceEEEEEEcCCC----cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 2 FALSEEMADSIATG----EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 2 f~~~V~~~~~~~tg----~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
|||+ |++..---| -+||+|++.. ....+.+|.-++. .++|||+++|++++.... +-||++|++ +|.|
T Consensus 709 fGtV-~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~ma-sldHpnl~RLLgvc~~s~-~qlvtq~mP-~G~L 784 (1177)
T KOG1025|consen 709 FGTV-YKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMA-SLDHPNLLRLLGVCMLST-LQLVTQLMP-LGCL 784 (1177)
T ss_pred ceeE-EeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHh-cCCCchHHHHhhhcccch-HHHHHHhcc-cchH
Confidence 4543 444443334 4689998876 2456888888998 889999999999998765 888899999 9999
Q ss_pred HHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc-cc--c
Q psy6377 73 QTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR-EL--L 142 (383)
Q Consensus 73 ~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~-~~--~ 142 (383)
.+++.. +..+.|.+||++|+.|||.+++|||||-..|||+.+- .++||+|||+|+...+..... .. .
T Consensus 785 lDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---~hvkitdfgla~ll~~d~~ey~~~~gK 861 (1177)
T KOG1025|consen 785 LDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---NHVKITDFGLAKLLAPDEKEYSAPGGK 861 (1177)
T ss_pred HHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---CeEEEEecchhhccCcccccccccccc
Confidence 997644 2345666999999999999999999999999999764 489999999999876543322 22 2
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
..+.|||-|.+....|+.++||||+||++||++| |..|+.+....++-.-+..+.. ++. .+..+-++..++.+||.
T Consensus 862 ~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 862 VPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICTIDVYMVMVKCWM 938 (1177)
T ss_pred cCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCccHHHHHHHHHHhc
Confidence 3567999999999999999999999999999998 9999999998888777666653 222 24678899999999999
Q ss_pred cCCCCCCCHHHHHc
Q psy6377 222 KNPMERMTAKEALK 235 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~ 235 (383)
.|+..||+++++-.
T Consensus 939 id~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 939 IDADSRPTFKELAE 952 (1177)
T ss_pred cCcccCccHHHHHH
Confidence 99999999988753
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-26 Score=238.36 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=177.3
Q ss_pred eEEEEEEcCCCcEEEEEEcc----C-C-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLE----S-N-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~----~-~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
+|+.+.....++.++.|.+. . + ...+..|.-+-. .+.|||++...+.+.+....+-+||||+ + +|+.
T Consensus 333 ~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~-~l~h~~~~e~l~~~~~~~~~~~~mE~~~-~-Dlf~ 409 (601)
T KOG0590|consen 333 SVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGS-SLSHPNIIETLDIVQEIDGILQSMEYCP-Y-DLFS 409 (601)
T ss_pred ceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecc-cccCCchhhhHHHHhhcccchhhhhccc-H-HHHH
Confidence 45666666666666666543 2 0 111334444444 5689999999998888888887799999 7 9999
Q ss_pred hhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----ccccccC
Q psy6377 75 IIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELLG 143 (383)
Q Consensus 75 ~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~g 143 (383)
++... .+--+.+|++.||+|||+.||.||||||+|++++.+ |.+||+|||.+..+.-+. .....+|
T Consensus 410 ~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~~~~e~~~~~~~g~~g 486 (601)
T KOG0590|consen 410 LVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFRYPWEKNIHESSGIVG 486 (601)
T ss_pred HHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeeccCcchhhhhhcCccc
Confidence 77664 222344999999999999999999999999999876 699999999988764322 2445789
Q ss_pred CCCcCCCcccccCCCCh-hhHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHh----ccCCCCcchhcCCCHHHHHHHH
Q psy6377 144 TPDYVAPEILHYEPITL-AADMWSLGVTAYVLLTGFSPFGGETDSETF-RNISK----AQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~-~~DiwSlGvilyelltg~~Pf~~~~~~~~~-~~i~~----~~~~~~~~~~~~~s~~~~~li~ 217 (383)
+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+.. ..... ....-+...+..++...+.+|.
T Consensus 487 S~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~ 566 (601)
T KOG0590|consen 487 SDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIY 566 (601)
T ss_pred CCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHH
Confidence 99999999999999875 589999999999999999999765544321 11111 1122234556778999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+||++||.+|.|++++++.+||+...
T Consensus 567 ~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 567 RMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHccCChhheecHHHHhhChHhhhcc
Confidence 99999999999999999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-23 Score=191.30 Aligned_cols=234 Identities=33% Similarity=0.480 Sum_probs=184.9
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC--C-----cccHHHHHHHHHhcCCCC-CcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES--N-----PVRIHHEIALLSLCSPSP-RIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~--~-----~~~~~~Ei~il~~~~~hp-nIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
| ..||.+.+. ..+|+|.+.. . ...+.+|+.+++ .+.|+ +|+++++++......+++++++. ++++.
T Consensus 13 ~-~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~l~ 86 (384)
T COG0515 13 F-GEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILA-SLNHPPNIVKLYDFFQDEGSLYLVMEYVD-GGSLE 86 (384)
T ss_pred C-eEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHH-HccCCcceeeEEEEEecCCEEEEEEecCC-CCcHH
Confidence 5 678888887 8899999987 1 456889999998 55555 89999999988888899999999 99999
Q ss_pred HhhccC---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-------c
Q psy6377 74 TIIDDN---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-------E 137 (383)
Q Consensus 74 ~~l~~~---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-------~ 137 (383)
+++... ....+..|++.++.|+|+.|++|||+||+||+++... ..++++|||++....... .
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (384)
T COG0515 87 DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG--RVVKLIDFGLAKLLPDPGSTSSIPAL 164 (384)
T ss_pred HHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC--CeEEEeccCcceecCCCCcccccccc
Confidence 765543 2345559999999999999999999999999998652 169999999998654432 2
Q ss_pred cccccCCCCcCCCccccc---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhccCC-CCcchhcCC-
Q psy6377 138 IRELLGTPDYVAPEILHY---EPITLAADMWSLGVTAYVLLTGFSPFGGETD----SETFRNISKAQLD-FPDELFEDI- 208 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~- 208 (383)
.....||+.|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+...... .........
T Consensus 165 ~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (384)
T COG0515 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP 244 (384)
T ss_pred ccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCcccc
Confidence 456789999999999987 5788999999999999999999999887764 3444444444333 222222222
Q ss_pred ---CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 209 ---SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 209 ---s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+.+++.+++..+|..|.+..+...++|.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 245 ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 25789999999999999999999999887665543
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-25 Score=222.29 Aligned_cols=222 Identities=31% Similarity=0.468 Sum_probs=188.6
Q ss_pred EEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 6 EEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
|.++.....|..||+|+..+ .......|-.++....+||.+|+++..|+++...++++++.. |++|+..+...
T Consensus 13 vrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r-gg~lft~l~~~ 91 (612)
T KOG0603|consen 13 VRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR-GGDLFTRLSKE 91 (612)
T ss_pred HHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc-cchhhhccccC
Confidence 44555667889999999987 334667788888856669999999999999999999999999 99999976554
Q ss_pred Cc------hhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 LV------VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ~~------~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.. ..+...++.|++++|+.||+|||+|++||+++.+ |++++.|||+++...... ..|||..|||||++
T Consensus 92 ~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~---Ghi~~tdfglske~v~~~---~~cgt~eymApEI~ 165 (612)
T KOG0603|consen 92 VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE---GHIKLTDFGLSKEAVKEK---IACGTYEYRAPEII 165 (612)
T ss_pred CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc---CccccCCchhhhHhHhhh---hcccchhhhhhHhh
Confidence 32 2344788999999999999999999999999776 799999999998764432 23999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC----
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT---- 229 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---- 229 (383)
. +....+|.||+|+++++|++|..||.+ +....|......+|.. .+..+++++..++..+|..|..
T Consensus 166 ~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~----l~~~a~~~~~~l~~r~p~nrLg~~~~ 235 (612)
T KOG0603|consen 166 N--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE----LSAEARSLFRQLFKRNPENRLGAGPD 235 (612)
T ss_pred h--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh----hhHHHHHHHHHHHhhCHHHHhccCcc
Confidence 8 678899999999999999999999988 7888888888888764 5789999999999999999985
Q ss_pred -HHHHHcCcccCCcch
Q psy6377 230 -AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 -~~e~L~hp~~~~~~~ 244 (383)
+.++++|+||+....
T Consensus 236 ~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 236 GVDEIKQHEFFQSIDW 251 (612)
T ss_pred hhHHHhccchheeeeH
Confidence 479999999986543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=220.27 Aligned_cols=207 Identities=30% Similarity=0.519 Sum_probs=163.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCchhh
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPF 84 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~~~~ 84 (383)
.||+++|+.|-+.||+|+=++. .+.|- ++. ..+.|.+| |+-..+++.-. ..
T Consensus 98 avylvrh~~trqrfa~kiNkq~--lilRn--ilt-~a~npfvv----------------------gDc~tllk~~g--~l 148 (1205)
T KOG0606|consen 98 AVYLVRHKETRQRFAMKINKQN--LILRN--ILT-FAGNPFVV----------------------GDCATLLKNIG--PL 148 (1205)
T ss_pred ceeeeeccccccchhhcccccc--hhhhc--ccc-ccCCccee----------------------chhhhhcccCC--CC
Confidence 5899999999999999653221 11111 444 44566555 22222232211 22
Q ss_pred HHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----------------cccccCCCCcC
Q psy6377 85 ESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----------------IRELLGTPDYV 148 (383)
Q Consensus 85 ~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----------------~~~~~gt~~y~ 148 (383)
-.+++.+++|+|+.||+|||+||+|++++.- |++|++|||+++....... -...||||.|+
T Consensus 149 Pvdmvla~Eylh~ygivhrdlkpdnllIT~m---GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyi 225 (1205)
T KOG0606|consen 149 PVDMVLAVEYLHSYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYI 225 (1205)
T ss_pred cchhhHHhHhhccCCeecCCCCCCcceeeec---ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcccc
Confidence 2344889999999999999999999999865 7999999999886532110 12348999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++..++|+..+|+|++|+|+|+.+-|..||.|++..+++..+......+|+. -..++++++++|.++|+.+|..|.
T Consensus 226 aPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 226 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 9999999999999999999999999999999999999999999999988888887 467899999999999999999997
Q ss_pred ---CHHHHHcCcccCCcch
Q psy6377 229 ---TAKEALKHPWLMNKKQ 244 (383)
Q Consensus 229 ---t~~e~L~hp~~~~~~~ 244 (383)
++-++.+|+||+..+.
T Consensus 305 gt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 305 GTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred ccchhhhhhhccceeeccc
Confidence 4678899999986543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=185.68 Aligned_cols=210 Identities=20% Similarity=0.229 Sum_probs=165.1
Q ss_pred EEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHHHhhc-----c-------
Q psy6377 17 VFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQTIID-----D------- 78 (383)
Q Consensus 17 ~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~~~l~-----~------- 78 (383)
.+-+|.++.. ...+..|--.+. -..|||+..+.++..+ ....+.++.+.. -|+|..++. +
T Consensus 316 ~v~vKTvk~~AS~iQv~~~L~es~lly-~~sH~nll~V~~V~ie~~~~P~V~y~~~~-~gNLK~FL~~Cr~~~~~~aqtv 393 (563)
T KOG1024|consen 316 EVLVKTVKQHASQIQVNLLLQESMLLY-GASHPNLLSVLGVSIEDYATPFVLYPATG-VGNLKSFLQICRGDDPSYAQTV 393 (563)
T ss_pred HHHHHHHHhcccHHHHHHHHHHHHHHh-cCcCCCccceeEEEeeccCcceEEEeccC-cchHHHHHHHhccCCCccccch
Confidence 3455555441 233556666666 6679999999999754 445666677777 899998764 1
Q ss_pred --CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cc-cccCCCCcCCCccc
Q psy6377 79 --NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IR-ELLGTPDYVAPEIL 153 (383)
Q Consensus 79 --~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~-~~~gt~~y~aPE~l 153 (383)
.+....+.|+..|++|||+.||||.||-..|.++++. -.+||+|=.+++..-+... +. ....+..||+||.+
T Consensus 394 tt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~---LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 394 TTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ---LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---eeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 1223445899999999999999999999999999876 5899999999997655432 11 12345689999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
....|+.++|+|||||++|||+| |+.||...++.|+..-+.+|.. ..++ .++++++..++.-||...|++||+.+|
T Consensus 471 ~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-laQP--~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 471 QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-LAQP--FNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 99999999999999999999998 9999999999888887776642 2221 478999999999999999999999999
Q ss_pred HH
Q psy6377 233 AL 234 (383)
Q Consensus 233 ~L 234 (383)
+.
T Consensus 548 lv 549 (563)
T KOG1024|consen 548 LV 549 (563)
T ss_pred HH
Confidence 75
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-21 Score=184.91 Aligned_cols=231 Identities=17% Similarity=0.133 Sum_probs=174.2
Q ss_pred ceEEEEEEcCCC-cEEEEEEccC----CcccHHHHHHHHHhcC---CCCCcccceEEE-EeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATG-EVFAAKFLES----NPVRIHHEIALLSLCS---PSPRIVKLHDVF-QTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg-~~vAvK~i~~----~~~~~~~Ei~il~~~~---~hpnIvkl~~~~-~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||.|.+..++ ..+|+|+... ....+..|+.++..+. +.+++..+++.+ ..+...|+||+.+ |.+|.+
T Consensus 32 G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~--G~sL~d 109 (322)
T KOG1164|consen 32 GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL--GPSLED 109 (322)
T ss_pred ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc--CccHHH
Confidence 368999988775 6899998876 1227999999999555 347999999999 5778899999998 599998
Q ss_pred hhc--------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEecccee--EeecCc------
Q psy6377 75 IID--------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISR--VILDGI------ 136 (383)
Q Consensus 75 ~l~--------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~--~~~~~~------ 136 (383)
+.. ......++.|++.+|++||+.|++||||||+|+++.... ....+.|.|||+|+ ......
T Consensus 110 l~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~ 189 (322)
T KOG1164|consen 110 LRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRP 189 (322)
T ss_pred HHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCccccc
Confidence 653 234556669999999999999999999999999997542 12479999999999 421111
Q ss_pred --c-cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-hhcCCCHHH
Q psy6377 137 --E-IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-LFEDISPEA 212 (383)
Q Consensus 137 --~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~ 212 (383)
. .....||..|+++.+..+...+.+.|+||++.++.+++.|..||.+.........+.......... .....+.++
T Consensus 190 ~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (322)
T KOG1164|consen 190 PRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEF 269 (322)
T ss_pred CCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHH
Confidence 1 123459999999999999999999999999999999999999998776543333332222111111 223346778
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 213 KDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..+...+-..+...+|....+...
T Consensus 270 ~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 270 AKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHHHhhccCCcCCCCHHHHHHH
Confidence 888887777888899988776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=188.62 Aligned_cols=141 Identities=25% Similarity=0.183 Sum_probs=111.8
Q ss_pred eEEEEEEcC-CCcEEEEEEccCC---------cccHHHHHHHHHhcCCCCCccc-ceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIA-TGEVFAAKFLESN---------PVRIHHEIALLSLCSPSPRIVK-LHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~-tg~~vAvK~i~~~---------~~~~~~Ei~il~~~~~hpnIvk-l~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+++. +|+.+|||.+... ...+.+|+++|+ .+.|+||+. +++. ...|+||||++ |++|.
T Consensus 33 ~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~-~L~h~~iv~~l~~~----~~~~LVmE~~~-G~~L~ 106 (365)
T PRK09188 33 TVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALK-TVRGIGVVPQLLAT----GKDGLVRGWTE-GVPLH 106 (365)
T ss_pred EEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHH-hccCCCCCcEEEEc----CCcEEEEEccC-CCCHH
Confidence 689999886 7888899986531 345889999999 778999985 5442 46899999999 99997
Q ss_pred HhhccCCchhhHHHHHHHHHHHHhCCceecCC-CCCcEEEeccCCCCcEEEEeccceeEeecCc---------ccccccC
Q psy6377 74 TIIDDNLVVPFESDELSSLAYLHHRKIAHLDI-KPQNLVMMGDFPNCDIKVCDFEISRVILDGI---------EIRELLG 143 (383)
Q Consensus 74 ~~l~~~~~~~~~~qil~aL~yLHs~givHrDL-Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~---------~~~~~~g 143 (383)
..... ....+..|++.||.|||++||+|||| ||+|||++.+ +.++|+|||+|+...... ......+
T Consensus 107 ~~~~~-~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~---~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~ 182 (365)
T PRK09188 107 LARPH-GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD---GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLK 182 (365)
T ss_pred HhCcc-chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC---CCEEEEECccceecccCcchhhhhhhhhhhhhhc
Confidence 53222 22467899999999999999999999 9999999654 589999999999764432 2234578
Q ss_pred CCCcCCCccccc
Q psy6377 144 TPDYVAPEILHY 155 (383)
Q Consensus 144 t~~y~aPE~l~~ 155 (383)
++.|+|||.+..
T Consensus 183 ~~~~~~pe~~~~ 194 (365)
T PRK09188 183 HKRTYAPDALTP 194 (365)
T ss_pred cCccCCcccCCh
Confidence 899999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=180.84 Aligned_cols=209 Identities=23% Similarity=0.313 Sum_probs=134.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCC---------CCCcccceEEEEeC---------C-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSP---------SPRIVKLHDVFQTG---------E- 57 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~---------hpnIvkl~~~~~~~---------~- 57 (383)
..||.+++..||+.+|+|++.. ..+.+.+|.-......+ |-.++..+|...-. .
T Consensus 26 ~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~ 105 (288)
T PF14531_consen 26 SIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPG 105 (288)
T ss_dssp EEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECET
T ss_pred eEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCC
Confidence 4689999999999999999875 23445555433332222 45566666665421 1
Q ss_pred -------eEEEEEecCCCcCcHHHhhcc----CC---------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC
Q psy6377 58 -------GAYYVSWNTPLVVTLQTIIDD----NL---------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 58 -------~~~lv~e~~~~g~~L~~~l~~----~~---------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~ 117 (383)
+.+++|..+. ++|.++++. .. .+.+-.|++..+++||+.|++|+||+|+|++++.+
T Consensus 106 ~~~~~v~n~~~l~P~~~--~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~-- 181 (288)
T PF14531_consen 106 QSIYWVLNRFLLMPRAQ--GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQD-- 181 (288)
T ss_dssp TEEEEEESEEEEEE--S--EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TT--
T ss_pred Cccceeehhhhccchhh--hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCC--
Confidence 2356677775 888886432 11 11222899999999999999999999999999876
Q ss_pred CCcEEEEeccceeEeecCcccccccCCCCcCCCccccc--------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH
Q psy6377 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY--------EPITLAADMWSLGVTAYVLLTGFSPFGGETDSET 189 (383)
Q Consensus 118 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~ 189 (383)
|.+.|+||+.....+... .....+..|.|||.... -.++.+.|.|+||+++|.|+||..||........
T Consensus 182 -G~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 182 -GGVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD 258 (288)
T ss_dssp -S-EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST
T ss_pred -CCEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc
Confidence 799999999887654322 22455678999998743 2578999999999999999999999976543211
Q ss_pred HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 190 FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 190 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
... .+ ....++++.++.||..||++||.+|
T Consensus 259 ~~~------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 259 PEW------DF--SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SGG------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccc------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence 110 11 1123779999999999999999988
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=167.47 Aligned_cols=226 Identities=20% Similarity=0.184 Sum_probs=182.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
++|++....+|+.||+|+-++ ...++..|..+.+.+.+-..|+.+..++.+.+.-.+||++. |.+|.+++.-
T Consensus 30 dIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL--GPsLEdLfnfC~R~ 107 (341)
T KOG1163|consen 30 DIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL--GPSLEDLFNFCSRR 107 (341)
T ss_pred heeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc--CccHHHHHHHHhhh
Confidence 689999999999999999887 46788999999997778899999999999999999999999 5999987532
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccccCCCCc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IRELLGTPDY 147 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~~gt~~y 147 (383)
..++..+-|++.-++|+|.++.+||||||+|+|+.-+.....+.++|||+|+...+... -....||..|
T Consensus 108 ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY 187 (341)
T KOG1163|consen 108 FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY 187 (341)
T ss_pred hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence 34455668999999999999999999999999986554455799999999998754321 1234799999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCC-cchhcCCCHHHHHHHHHhcccC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFP-DELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~d 223 (383)
.+--...+..-+...|+-|+|.+|.+...|..||+|... .+-.++|.......| .....+.|.++...+.-|-..-
T Consensus 188 ASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~ 267 (341)
T KOG1163|consen 188 ASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLG 267 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcC
Confidence 987777666678889999999999999999999998654 344555665554444 4466788999998888887777
Q ss_pred CCCCCCHHH
Q psy6377 224 PMERMTAKE 232 (383)
Q Consensus 224 P~~Rpt~~e 232 (383)
-++-|...-
T Consensus 268 F~E~Pdy~y 276 (341)
T KOG1163|consen 268 FEEKPDYMY 276 (341)
T ss_pred CCCCCcHHH
Confidence 777776543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=172.94 Aligned_cols=225 Identities=19% Similarity=0.206 Sum_probs=184.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
+++.+++.-+|++||||+-+. +..++..|.+..+.+.+.+.|+.+|-+-+++-+-.||++++ |.+|.++++.
T Consensus 43 ~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL--GPSLEDLFD~CgR~ 120 (449)
T KOG1165|consen 43 VLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL--GPSLEDLFDLCGRR 120 (449)
T ss_pred eeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh--CcCHHHHHHHhcCc
Confidence 568889999999999999887 67889999999998889999999999999999999999998 5888887654
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecCcc--------cccccCCC
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDGIE--------IRELLGTP 145 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~~~--------~~~~~gt~ 145 (383)
..+..++.|++.-++|+|++.+|+|||||+|+|+..-. ....|.++|||+|+...+... .....||.
T Consensus 121 FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA 200 (449)
T KOG1165|consen 121 FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA 200 (449)
T ss_pred ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence 34456669999999999999999999999999995421 124689999999998765432 33457999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhcc-CCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE---TDSETFRNISKAQ-LDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~---~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.||+--...+..-+...|+=|||-++++.|.|..||+|. +..+-+++|-... .+....+..+++.++..-+.-.-.
T Consensus 201 RYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 201 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred eeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 999988888888889999999999999999999999875 4455666665544 333455667888888888877777
Q ss_pred cCCCCCCCHH
Q psy6377 222 KNPMERMTAK 231 (383)
Q Consensus 222 ~dP~~Rpt~~ 231 (383)
.+-.+-|..+
T Consensus 281 L~F~E~PDYd 290 (449)
T KOG1165|consen 281 LDFFETPDYD 290 (449)
T ss_pred cCcccCCCHH
Confidence 7777777754
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=204.32 Aligned_cols=218 Identities=20% Similarity=0.240 Sum_probs=157.0
Q ss_pred EEEEEEcCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 6 EEMADSIATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
|.+|++ ....|+||++-+ ...+...|++ .. +.+|||.+.+.-+..++...|+|-+|+. .+|++.++
T Consensus 39 v~r~k~--~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAylvRqyvk--hnLyDRlS 112 (1431)
T KOG1240|consen 39 VARAKD--REGLVVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAYLVRQYVK--HNLYDRLS 112 (1431)
T ss_pred hhhccC--CCceEEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHHHHHHHHh--hhhhhhhc
Confidence 344444 344599999876 1234445555 33 6789999999999999999999999997 88998766
Q ss_pred cCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----cc----ccccC
Q psy6377 78 DNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI----EI----RELLG 143 (383)
Q Consensus 78 ~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~----~~----~~~~g 143 (383)
.+. .+.++.|++.||.-||..||+|+|||.||||+++.+ .+.|+||.--+..--+. .. .+...
T Consensus 113 TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN---W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrR 189 (1431)
T KOG1240|consen 113 TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN---WLYLTDFASFKPTYLPEDNPADFTFFFDTSRR 189 (1431)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec---hhhhhcccccCCccCCCCCcccceEEEecCCc
Confidence 543 335669999999999999999999999999999874 89999998655432111 11 12233
Q ss_pred CCCcCCCccccc----------CC-CChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcC-CCH
Q psy6377 144 TPDYVAPEILHY----------EP-ITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFED-ISP 210 (383)
Q Consensus 144 t~~y~aPE~l~~----------~~-~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~ 210 (383)
-.+|+|||.+.. .+ .+++-||||+||+++||++ |+|||.-. ++-....+.-..++...+. -+.
T Consensus 190 RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ied~ 265 (1431)
T KOG1240|consen 190 RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDPEQLLEKIEDV 265 (1431)
T ss_pred eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCHHHHHHhCcCc
Confidence 458999998743 12 5688899999999999998 89999421 1222222221222222222 245
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++.+|..|++.||++|.+|++.|+.
T Consensus 266 ~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 266 SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cHHHHHHHHHccCchhccCHHHHHHh
Confidence 78999999999999999999999974
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-20 Score=175.32 Aligned_cols=187 Identities=23% Similarity=0.318 Sum_probs=137.9
Q ss_pred cCCCCCcccceEEEEeC---------------------------CeEEEEEecCCCcCcHHHhhccCC-----chhhHHH
Q psy6377 40 CSPSPRIVKLHDVFQTG---------------------------EGAYYVSWNTPLVVTLQTIIDDNL-----VVPFESD 87 (383)
Q Consensus 40 ~~~hpnIvkl~~~~~~~---------------------------~~~~lv~e~~~~g~~L~~~l~~~~-----~~~~~~q 87 (383)
+..|||||++..+|.++ ..+|+||-.++ .+|..++..+. ...+..|
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~--~tLr~yl~~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR--QTLREYLWTRHRSYRTGRVILAQ 349 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch--hhHHHHHhcCCCchHHHHHHHHH
Confidence 34799999999998652 45899999987 88888765433 2355599
Q ss_pred HHHHHHHHHhCCceecCCCCCcEEEecc-CCCCcEEEEeccceeEeecC-------cccccccCCCCcCCCcccccCC--
Q psy6377 88 ELSSLAYLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDG-------IEIRELLGTPDYVAPEILHYEP-- 157 (383)
Q Consensus 88 il~aL~yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~-- 157 (383)
+++|+.|||.+||.|||||.+|||+.-+ +....+.++|||.+--.... ...-...|....||||+...-+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999999999999999997543 34467899999976542210 1112245788899999986433
Q ss_pred ----CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 158 ----ITLAADMWSLGVTAYVLLTGFSPFGGETDSET-FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 158 ----~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
--.++|.|+.|.+.||++....||.+...... .+.....+ . +.....+++.+++++..+|..||++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--L-Palp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--L-PALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--C-CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 13579999999999999999999988432211 11111112 1 234467899999999999999999999854
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=160.96 Aligned_cols=173 Identities=15% Similarity=0.085 Sum_probs=131.5
Q ss_pred ccceEEEEEEcCCCcEEEEEEccCC--------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 2 FALSEEMADSIATGEVFAAKFLESN--------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~~--------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
||++. .+. ..+..++.+.+.-. ...+.+|+++|+.+.+|++|++++++ +..|++|+|+. |.+|.
T Consensus 15 f~~v~-~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~-G~~L~ 86 (218)
T PRK12274 15 FGRIL-LVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA-GAAMY 86 (218)
T ss_pred cceEE-Eee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec-CccHH
Confidence 55554 333 26778887766651 12578999999966678999999996 45799999999 99998
Q ss_pred HhhccCCchhhHHHHHHHHHHHHhCCceecCC-CCCcEEEeccCCCCcEEEEeccceeEeecCccc----c---------
Q psy6377 74 TIIDDNLVVPFESDELSSLAYLHHRKIAHLDI-KPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----R--------- 139 (383)
Q Consensus 74 ~~l~~~~~~~~~~qil~aL~yLHs~givHrDL-Kp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~--------- 139 (383)
....... ..+..|++.+|.++|++||+|||| ||+|||++.+ +.++|+|||+|......... .
T Consensus 87 ~~~~~~~-~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~---g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk 162 (218)
T PRK12274 87 QRPPRGD-LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED---GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLK 162 (218)
T ss_pred hhhhhhh-HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC---CCEEEEECCCceecCCcchHHHHHHHHHHHHHHH
Confidence 7654433 367789999999999999999999 7999999754 68999999999865443321 0
Q ss_pred -cccCCCCcCCCcccc--cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q psy6377 140 -ELLGTPDYVAPEILH--YEPITLAADMWSLGVTAYVLLTGFSPFGGETD 186 (383)
Q Consensus 140 -~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~ 186 (383)
-..+++.|+.|+--. ..+--...+.++.|+-+|.++|+..|+.+++.
T Consensus 163 ~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 163 HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 123688888888543 23323678889999999999999999877653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=161.74 Aligned_cols=150 Identities=12% Similarity=0.097 Sum_probs=113.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC----Ccc---c------HHHHHHHHHhcCCCCCcccceEEEEeC--------CeEEEEE
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPV---R------IHHEIALLSLCSPSPRIVKLHDVFQTG--------EGAYYVS 63 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~---~------~~~Ei~il~~~~~hpnIvkl~~~~~~~--------~~~~lv~ 63 (383)
.||++.. ++..+|+|++.. ... . +.+|+..+. .+.||+|+.+.+++.+. ...+++|
T Consensus 46 ~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~-rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvm 122 (232)
T PRK10359 46 KVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD-RVRSEGLASLNDFYLLAERKTLRYAHTYIMLI 122 (232)
T ss_pred EEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH-HHHHCCCCcceEeeeecccccccccCCeEEEE
Confidence 5777544 577899999975 111 1 578888888 55899999999997754 3578999
Q ss_pred ecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 64 WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 64 e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
||++ |.+|.+...... ....+++.+|..||..|++|||+||+||+++.+ | ++|+|||............
T Consensus 123 Eyi~-G~tL~~~~~~~~--~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g-i~liDfg~~~~~~e~~a~d---- 191 (232)
T PRK10359 123 EYIE-GVELNDMPEISE--DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G-LRIIDLSGKRCTAQRKAKD---- 191 (232)
T ss_pred EEEC-CccHHHhhhccH--HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C-EEEEECCCcccccchhhHH----
Confidence 9999 999988643222 445799999999999999999999999999765 5 9999999877643221111
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHH
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyell 175 (383)
.++....|+.++|+|+||+++....
T Consensus 192 -------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 192 -------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -------HHHHHhHhcccccccceeEeehHHH
Confidence 1334455778999999999887653
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=179.16 Aligned_cols=170 Identities=22% Similarity=0.326 Sum_probs=132.9
Q ss_pred eEEEEEecCCCcCcHHHhhcc---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccc
Q psy6377 58 GAYYVSWNTPLVVTLQTIIDD---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI 128 (383)
Q Consensus 58 ~~~lv~e~~~~g~~L~~~l~~---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGl 128 (383)
.+|+.|++|. ..+|.+++.. ...+.++.|+..|++| +|.+|||+||.||++..+ +.+||.|||+
T Consensus 330 ~lyI~Mn~c~-~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d---~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCE-KETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD---DQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhh-hhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc---hhhhhhhhhh
Confidence 5788999999 8999998742 2245666999999999 999999999999998776 4799999999
Q ss_pred eeEeecCc-------ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCC
Q psy6377 129 SRVILDGI-------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 129 a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
........ ..+...||++||+||.+.++.|+.++||||||+||+||+. =..+|. ....+..+..+. +
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~--i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGI--I 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCC--C
Confidence 88765444 3556789999999999999999999999999999999987 222221 112333444443 4
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
|+.++.+++. -..|+.+||...|.+||++.+.-.|+|.+
T Consensus 478 p~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 478 PPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred ChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 4455555444 45799999999999999888887777753
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.1e-18 Score=154.15 Aligned_cols=216 Identities=20% Similarity=0.263 Sum_probs=167.3
Q ss_pred EEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 6 EEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.|+++. .|..+++|++.- -...+..|.-.|+ ...||||+.+++.+....++.+|..|++ .|+|+.++.+
T Consensus 206 lwrgrw--qgndivakil~vr~~t~risrdfneefp~lr-ifshpnilpvlgacnsppnlv~isq~mp-~gslynvlhe~ 281 (448)
T KOG0195|consen 206 LWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALR-IFSHPNILPVLGACNSPPNLVIISQYMP-FGSLYNVLHEQ 281 (448)
T ss_pred cccccc--cCcchhhhhhhhhhcchhhcchhhhhCccee-eecCCchhhhhhhccCCCCceEeeeecc-chHHHHHHhcC
Confidence 455554 355677888765 2356777888888 7889999999999999999999999999 8999997654
Q ss_pred -------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
.+...++..++.|++|||+.. |.-.-|....++++.+. ...+-.+|-.++... ......|.|++
T Consensus 282 t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfqe------~gr~y~pawms 354 (448)
T KOG0195|consen 282 TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQE------VGRAYSPAWMS 354 (448)
T ss_pred ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeeec------cccccCcccCC
Confidence 345688899999999999975 44456788889998763 234555565554432 23456899999
Q ss_pred CcccccCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 150 PEILHYEPIT---LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 150 PE~l~~~~~~---~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
||.++..+-+ .++|+|||++++|||-|...||..-...+.-.+|.-.... ....++++..+..|+.-|+.-||.+
T Consensus 355 pealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~hm~klm~icmnedpgk 432 (448)
T KOG0195|consen 355 PEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRHMNKLMNICMNEDPGK 432 (448)
T ss_pred HHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHHHHHHHHHHhcCCCCc
Confidence 9999876643 6799999999999999999999988877766665433221 2334578999999999999999999
Q ss_pred CCCHHHHH
Q psy6377 227 RMTAKEAL 234 (383)
Q Consensus 227 Rpt~~e~L 234 (383)
||.++.++
T Consensus 433 rpkfdmiv 440 (448)
T KOG0195|consen 433 RPKFDMIV 440 (448)
T ss_pred CCCcceeh
Confidence 99987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=150.35 Aligned_cols=120 Identities=14% Similarity=0.086 Sum_probs=89.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------------cccH-----------------HHHHHHHHhcCCCCCcccceEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------------PVRI-----------------HHEIALLSLCSPSPRIVKLHDVF 53 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------------~~~~-----------------~~Ei~il~~~~~hpnIvkl~~~~ 53 (383)
..||.|.+. +|+.||+|+++.. ..++ .+|+.++. .+.++++.....+.
T Consensus 11 ~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~v~~p~~~~ 88 (190)
T cd05147 11 ANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK-RLVTAGIPCPEPIL 88 (190)
T ss_pred eEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH-HHHHCCCCCCcEEE
Confidence 469999986 9999999999752 1122 23889888 55677765444432
Q ss_pred EeCCeEEEEEecCCCcCcHHHh-hc-----cCCchhhHHHHHHHHHHH-HhCCceecCCCCCcEEEeccCCCCcEEEEec
Q psy6377 54 QTGEGAYYVSWNTPLVVTLQTI-ID-----DNLVVPFESDELSSLAYL-HHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126 (383)
Q Consensus 54 ~~~~~~~lv~e~~~~g~~L~~~-l~-----~~~~~~~~~qil~aL~yL-Hs~givHrDLKp~NILl~~~~~~~~ikL~DF 126 (383)
.. ..++||||++ |+++... +. ...+..++.|++.+|.|+ |+.||+||||||+|||++. +.++|+||
T Consensus 89 ~~--~~~iVmE~i~-g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~----~~v~LiDF 161 (190)
T cd05147 89 LK--SHVLVMEFIG-DDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD----GKLYIIDV 161 (190)
T ss_pred ec--CCEEEEEEeC-CCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----CcEEEEEc
Confidence 22 2389999999 7766543 22 233456679999999999 7999999999999999973 47999999
Q ss_pred cceeEe
Q psy6377 127 EISRVI 132 (383)
Q Consensus 127 Gla~~~ 132 (383)
|+|...
T Consensus 162 G~a~~~ 167 (190)
T cd05147 162 SQSVEH 167 (190)
T ss_pred cccccC
Confidence 998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.4e-17 Score=146.44 Aligned_cols=121 Identities=12% Similarity=0.029 Sum_probs=92.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCc------------------------------ccHHHHHHHHHhcCCCCCcccceEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNP------------------------------VRIHHEIALLSLCSPSPRIVKLHDVF 53 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~------------------------------~~~~~Ei~il~~~~~hpnIvkl~~~~ 53 (383)
..||+|++. +|+.||||+++... ....+|.+.+. .+.|++|.....+.
T Consensus 11 ~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~ 88 (190)
T cd05145 11 ANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK-RLYEAGVPVPEPIL 88 (190)
T ss_pred cEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH-HHHhCCCCCceEEE
Confidence 479999987 99999999988621 01257788887 56788876655554
Q ss_pred EeCCeEEEEEecCCCcCcHHH-hhc-----cCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEec
Q psy6377 54 QTGEGAYYVSWNTPLVVTLQT-IID-----DNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126 (383)
Q Consensus 54 ~~~~~~~lv~e~~~~g~~L~~-~l~-----~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DF 126 (383)
.. ..|+||||++ |+++.. .+. ......+..|++.+|.++|+ +||+||||||+|||++ + +.++|+||
T Consensus 89 ~~--~~~lVmE~~~-g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~---~~~~liDF 161 (190)
T cd05145 89 LK--KNVLVMEFIG-DDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D---GKPYIIDV 161 (190)
T ss_pred ec--CCEEEEEEec-CCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C---CCEEEEEc
Confidence 33 2489999998 765433 232 23345677999999999999 9999999999999997 3 58999999
Q ss_pred cceeEee
Q psy6377 127 EISRVIL 133 (383)
Q Consensus 127 Gla~~~~ 133 (383)
|+|....
T Consensus 162 G~a~~~~ 168 (190)
T cd05145 162 SQAVELD 168 (190)
T ss_pred ccceecC
Confidence 9998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=147.16 Aligned_cols=122 Identities=19% Similarity=0.168 Sum_probs=93.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcC----CCCCcccceEEEEeCC---eEE-EEEec--CCCcC
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCS----PSPRIVKLHDVFQTGE---GAY-YVSWN--TPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~----~hpnIvkl~~~~~~~~---~~~-lv~e~--~~~g~ 70 (383)
.||. +..++.. +||++.. ....+.+|+.+++.+. .||||+++|++++++. .++ +|+|+ +. ++
T Consensus 17 ~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~-~~ 92 (210)
T PRK10345 17 KCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKP-SI 92 (210)
T ss_pred EEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCc-ch
Confidence 4563 7777776 6998875 3567999999999542 5899999999999875 333 67999 55 79
Q ss_pred cHHHhhccCCc---hhhHHHHHHHH-HHHHhCCceecCCCCCcEEEeccC-CCCcEEEEecccee
Q psy6377 71 TLQTIIDDNLV---VPFESDELSSL-AYLHHRKIAHLDIKPQNLVMMGDF-PNCDIKVCDFEISR 130 (383)
Q Consensus 71 ~L~~~l~~~~~---~~~~~qil~aL-~yLHs~givHrDLKp~NILl~~~~-~~~~ikL~DFGla~ 130 (383)
+|.+++++... .....|++.++ +|||+++|+||||||+|||++... ....++|+||+.+.
T Consensus 93 tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 93 TLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred hHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99998865321 22357888888 999999999999999999997643 23579999955443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-18 Score=178.28 Aligned_cols=226 Identities=23% Similarity=0.317 Sum_probs=177.1
Q ss_pred CCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-ccC------
Q psy6377 13 ATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII-DDN------ 79 (383)
Q Consensus 13 ~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l-~~~------ 79 (383)
.+...+|+|.+.. ...++..|..+-+.+.+|+|++.+++...+.+..++++++.. |+++++.+ ...
T Consensus 44 ~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~-g~~~f~~i~~~~~~~~~~ 122 (601)
T KOG0590|consen 44 DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD-GGSLFSKISHPDSTGTSS 122 (601)
T ss_pred CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc-ccccccccccCCccCCCC
Confidence 3445567776654 233445577777755569999999999999999999999977 99999966 322
Q ss_pred -CchhhHHHHHHHHHHHH-hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-Cc---ccccccC-CCCcCCCcc
Q psy6377 80 -LVVPFESDELSSLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GI---EIRELLG-TPDYVAPEI 152 (383)
Q Consensus 80 -~~~~~~~qil~aL~yLH-s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~---~~~~~~g-t~~y~aPE~ 152 (383)
....+..|+..++.|+| ..++.|||+||+|.+++..+. .+++.|||+|..... .. .....+| ++.|+|||.
T Consensus 123 ~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 123 SSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred cchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 23466699999999999 999999999999999987632 799999999987655 22 2345688 999999999
Q ss_pred cccCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 153 LHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETF-RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 153 l~~~~-~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
..+.. ..+..|+||.|+++.-+++|..||......... .........+....|..++..+.+++.++|..+|..|.+.
T Consensus 201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred ccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccc
Confidence 88754 468899999999999999999999765543321 1111122222345678899999999999999999999999
Q ss_pred HHHHcCcccCC
Q psy6377 231 KEALKHPWLMN 241 (383)
Q Consensus 231 ~e~L~hp~~~~ 241 (383)
+++-.+||+..
T Consensus 281 ~~~~~d~~~~~ 291 (601)
T KOG0590|consen 281 EELKLDNWLSS 291 (601)
T ss_pred ccccccccccc
Confidence 99999999987
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=5e-16 Score=155.94 Aligned_cols=192 Identities=20% Similarity=0.265 Sum_probs=146.9
Q ss_pred cCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC-------chhhHHHHHHHHHHHHhCCc-eecCCCCCcEE
Q psy6377 40 CSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL-------VVPFESDELSSLAYLHHRKI-AHLDIKPQNLV 111 (383)
Q Consensus 40 ~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~-------~~~~~~qil~aL~yLHs~gi-vHrDLKp~NIL 111 (383)
.+.|.|+.++++..-++...+.|-++|. .|+|.+.+.... ...+.+.|+.||.|+|+--| .|+.|++.|-+
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~-rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCS-RGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeec-CccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 5679999999999999999999999999 999999765532 12333899999999998766 99999999999
Q ss_pred EeccCCCCcEEEEeccceeEeecC---cccccccCCCCcCCCcccccCC-------CChhhHHHHHHHHHHHHHhCCCCC
Q psy6377 112 MMGDFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYVAPEILHYEP-------ITLAADMWSLGVTAYVLLTGFSPF 181 (383)
Q Consensus 112 l~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-------~~~~~DiwSlGvilyelltg~~Pf 181 (383)
++.. -.+||+|||+....... .......-...|.|||.+.... .+.+.|+||+|+++||+++...||
T Consensus 82 vd~~---w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 82 VDSR---WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeee---EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9876 48999999998765321 1111122345799999987632 367799999999999999999999
Q ss_pred CCCC----cHHHHHHHHh-ccCCCCcchh--cCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 182 GGET----DSETFRNISK-AQLDFPDELF--EDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 182 ~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.... ..+....+.. +...+-+..+ ....+++..++..|+..+|..||+++++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 7532 2345555555 3222222222 145668999999999999999999998854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.1e-15 Score=135.03 Aligned_cols=120 Identities=18% Similarity=0.151 Sum_probs=99.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||.|.. +|..+++|+.... ...+.+|++++. .+.|++|+....++.+.+..+++||+++ |++
T Consensus 10 ~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv~e~~~-G~~ 85 (211)
T PRK14879 10 AEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS-RARKAGVNVPAVYFVDPENFIIVMEYIE-GEP 85 (211)
T ss_pred EEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHH-HHHHCCCCCCeEEEEeCCCCEEEEEEeC-CcC
Confidence 46899986 7888999976531 135778999998 6678999888888888888999999999 999
Q ss_pred HHHhhccCC--chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 72 LQTIIDDNL--VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 72 L~~~l~~~~--~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
|.+.+.... ...+..+++.+|.++|+.|++|+|++|.|||++ + +.++|+|||.+..
T Consensus 86 L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~---~~~~liDf~~a~~ 143 (211)
T PRK14879 86 LKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G---GKIYLIDFGLAEF 143 (211)
T ss_pred HHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C---CCEEEEECCcccC
Confidence 999775432 346668999999999999999999999999998 2 5799999999876
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.7e-15 Score=158.61 Aligned_cols=173 Identities=26% Similarity=0.284 Sum_probs=135.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-CcccHH--HHH-HHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-NPVRIH--HEI-ALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-~~~~~~--~Ei-~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.+||+|.+.. |+.||+|+-.. ..-.++ .++ ..|+ ..--+-|..+...+.-.+.-+||++|.+ .|+|.+++..
T Consensus 712 ~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~lv~ey~~-~Gtlld~~N~~ 788 (974)
T KOG1166|consen 712 GSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQMLPSIMHISSAHVFQNASVLVSEYSP-YGTLLDLINTN 788 (974)
T ss_pred eEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhhhcchHHHHHHHccCCcceeeeeccc-cccHHHhhccC
Confidence 3689999876 99999998765 111111 111 1222 2234667777777777888999999999 9999998653
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEec----cCCCCcEEEEeccceeEe---ecCcccccccCCCC
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG----DFPNCDIKVCDFEISRVI---LDGIEIRELLGTPD 146 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~----~~~~~~ikL~DFGla~~~---~~~~~~~~~~gt~~ 146 (383)
..+.++..|++..|+.||..||||+||||+|.|+.. +.....++|+|||-|.-. .++..+...++|-.
T Consensus 789 ~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~ 868 (974)
T KOG1166|consen 789 KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDL 868 (974)
T ss_pred CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeecccc
Confidence 335567799999999999999999999999999853 222356999999988643 34556777889999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~ 179 (383)
+-.+|...+.+|++.+|.|.|+.++|.||.|+.
T Consensus 869 f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 869 FDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred chhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999853
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.4e-15 Score=131.87 Aligned_cols=120 Identities=17% Similarity=0.096 Sum_probs=96.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||++. .+|..+++|..... ..++.+|+++++ .+.|+++....-++.+.+..+++||+++ |++
T Consensus 8 ~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv~e~~~-g~~ 83 (199)
T TIGR03724 8 AIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLS-RARKAGVNTPVVYDVDPDNKTIVMEYIE-GKP 83 (199)
T ss_pred EEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHH-HHHHCCCCCCEEEEEECCCCEEEEEEEC-Ccc
Confidence 3588997 46888999985431 144668999998 5667776666656666777899999999 999
Q ss_pred HHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 72 LQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 72 L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
|.+.+..... .+..|++.+|.+||+.|++|+|++|.||+++ + +.++++|||++...
T Consensus 84 l~~~~~~~~~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~---~~~~liDfg~a~~~ 139 (199)
T TIGR03724 84 LKDVIEEGND-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D---DKLYLIDFGLGKYS 139 (199)
T ss_pred HHHHHhhcHH-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C---CcEEEEECCCCcCC
Confidence 9997765433 6789999999999999999999999999998 3 58999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.4e-15 Score=136.30 Aligned_cols=121 Identities=16% Similarity=0.036 Sum_probs=90.2
Q ss_pred ceEEEEE-EcCCCcEEEEEEccCCc----------------------------ccHHHHHHHHHhcCCCCCcccceEEEE
Q psy6377 4 LSEEMAD-SIATGEVFAAKFLESNP----------------------------VRIHHEIALLSLCSPSPRIVKLHDVFQ 54 (383)
Q Consensus 4 ~~V~~~~-~~~tg~~vAvK~i~~~~----------------------------~~~~~Ei~il~~~~~hpnIvkl~~~~~ 54 (383)
..||.|. +..+|+.||+|++.... ..+.+|+.++..+ .+ +++.+..++.
T Consensus 42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~-~~i~~p~~~~ 119 (237)
T smart00090 42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YE-AGVPVPKPIA 119 (237)
T ss_pred eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-Hh-cCCCCCeeeE
Confidence 4699998 77899999999987521 1246899999844 33 2333333443
Q ss_pred eCCeEEEEEecCCCcCcHHHhh-cc-----CCchhhHHHHHHHHHHHHhCC-ceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 55 TGEGAYYVSWNTPLVVTLQTII-DD-----NLVVPFESDELSSLAYLHHRK-IAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 55 ~~~~~~lv~e~~~~g~~L~~~l-~~-----~~~~~~~~qil~aL~yLHs~g-ivHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
.. ..++|||++. |.+|.... .. .....+..|++.+|.+||+.| |+||||||+||+++ + +.++|+|||
T Consensus 120 ~~-~~~lV~E~~~-g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~---~~i~LiDFg 193 (237)
T smart00090 120 WR-RNVLVMEFIG-GDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D---GKVVIIDVS 193 (237)
T ss_pred ec-CceEEEEEec-CCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C---CCEEEEECh
Confidence 33 3589999999 87776633 22 123466799999999999999 99999999999997 3 589999999
Q ss_pred ceeEe
Q psy6377 128 ISRVI 132 (383)
Q Consensus 128 la~~~ 132 (383)
.|...
T Consensus 194 ~a~~~ 198 (237)
T smart00090 194 QSVEL 198 (237)
T ss_pred hhhcc
Confidence 98754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-14 Score=128.64 Aligned_cols=119 Identities=18% Similarity=0.040 Sum_probs=92.4
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc--------------------------ccHHHHHHHHHhcCCCC--CcccceEEEEeC
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP--------------------------VRIHHEIALLSLCSPSP--RIVKLHDVFQTG 56 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~--------------------------~~~~~Ei~il~~~~~hp--nIvkl~~~~~~~ 56 (383)
.||.|.+. +|+.||||+++... ....+|+.++. .+.|+ .++..++ .
T Consensus 30 ~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~v~~~~~----~ 103 (198)
T cd05144 30 DVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK-ALYEEGFPVPKPID----W 103 (198)
T ss_pred EEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH-HHHHcCCCCCceee----c
Confidence 58999874 89999999865411 12567888887 44565 3444443 2
Q ss_pred CeEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee
Q psy6377 57 EGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133 (383)
Q Consensus 57 ~~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~ 133 (383)
...+++||+++ |++|...........+..+++.++.++|+.||+||||+|+||+++.+ +.++|+|||++....
T Consensus 104 ~~~~lv~e~~~-g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~---~~~~liDfg~~~~~~ 176 (198)
T cd05144 104 NRHAVVMEYID-GVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD---EKIYIIDWPQMVSTD 176 (198)
T ss_pred CCceEEEEEeC-CcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC---CcEEEEECCccccCC
Confidence 45689999999 99998866534455777999999999999999999999999999764 689999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=127.13 Aligned_cols=121 Identities=13% Similarity=0.118 Sum_probs=90.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----------------CcccHHHHHHHHHhcCCCCCc--ccceEEEEeCCe----EEE
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----------------NPVRIHHEIALLSLCSPSPRI--VKLHDVFQTGEG----AYY 61 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----------------~~~~~~~Ei~il~~~~~hpnI--vkl~~~~~~~~~----~~l 61 (383)
.||.+.. .|..+|||.+.. ...++.+|++++. .+.|++| +..+++...... .++
T Consensus 47 tv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~-~L~~~gi~vP~pl~~~~~~~~~~~~~~l 123 (239)
T PRK01723 47 TTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLA-QLYEAGLPVPRPIAARVVRHGLFYRADI 123 (239)
T ss_pred cEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHH-HHHhCCCCCceeEeeeeeecCcceeeeE
Confidence 4566654 377899987753 1245778999998 6667664 677776543322 259
Q ss_pred EEecCCCc-CcHHHhhccCC-chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 62 VSWNTPLV-VTLQTIIDDNL-VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 62 v~e~~~~g-~~L~~~l~~~~-~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
|||+++ | .+|.+++.... ......|++.+|.+||++||+||||||+|||++.+ +.++|+|||.+...
T Consensus 124 V~e~l~-G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~---~~v~LIDfg~~~~~ 192 (239)
T PRK01723 124 LIERIE-GARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPD---GKFWLIDFDRGELR 192 (239)
T ss_pred EEEecC-CCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC---CCEEEEECCCcccC
Confidence 999998 6 68988775543 22345899999999999999999999999999765 47999999988763
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-14 Score=153.89 Aligned_cols=233 Identities=28% Similarity=0.365 Sum_probs=178.1
Q ss_pred EEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 6 EEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
++.+.-..+|..++.|+... +......+-.++- ...+|.++...--|......+|++++.. |++|...+.
T Consensus 820 s~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP~~L~~~~~~-~~~~~Skl~~ 897 (1205)
T KOG0606|consen 820 SFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSPLPLVGHYLN-GGDLPSKLHN 897 (1205)
T ss_pred cccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCCcchhhHHhc-cCCchhhhhc
Confidence 34445556666666665543 2233333333332 2345667766655667788999999999 899988743
Q ss_pred -----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----------------
Q psy6377 78 -----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----------------- 135 (383)
Q Consensus 78 -----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----------------- 135 (383)
..........+..+++|||+..+.|||++|.|++...+ ++.+++|||.......-
T Consensus 898 ~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~---gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~ 974 (1205)
T KOG0606|consen 898 SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD---GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRR 974 (1205)
T ss_pred CCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc---CCcccCccccccccccccCcCCcccccccCcccc
Confidence 33444566888999999999999999999999998765 68999999843322100
Q ss_pred ---------------cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC
Q psy6377 136 ---------------IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 136 ---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
.......||+.|.+||.+.+......+|+|++|+++++.++|.+||...+....+++|..+...+
T Consensus 975 ~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~ 1054 (1205)
T KOG0606|consen 975 LSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW 1054 (1205)
T ss_pred ccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC
Confidence 00112368999999999999989999999999999999999999999999999999999888877
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHH---HHHcCcccCCcch
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAK---EALKHPWLMNKKQ 244 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~L~hp~~~~~~~ 244 (383)
|.. ....+.++++++.++|..+|.+|.++. ++-.||||+....
T Consensus 1055 p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1055 PEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 643 346789999999999999999999887 8899999987553
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=142.26 Aligned_cols=97 Identities=18% Similarity=0.111 Sum_probs=84.6
Q ss_pred ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCC
Q psy6377 28 VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKP 107 (383)
Q Consensus 28 ~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp 107 (383)
.++.+|+++++ .+.|++|+..+.++.+....++||||++ |++|.+.+.. ...+..|++.+|.|||+.|++||||||
T Consensus 381 ~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv~E~~~-g~~L~~~l~~--~~~~~~~i~~~L~~lH~~giiHrDlkp 456 (535)
T PRK09605 381 ERTRAEARLLS-EARRAGVPTPVIYDVDPEEKTIVMEYIG-GKDLKDVLEG--NPELVRKVGEIVAKLHKAGIVHGDLTT 456 (535)
T ss_pred HHHHHHHHHHH-hhcccCCCeeEEEEEeCCCCEEEEEecC-CCcHHHHHHH--HHHHHHHHHHHHHHHHhCCCccCCCCh
Confidence 45789999999 7789999988888777788899999999 9999997752 347789999999999999999999999
Q ss_pred CcEEEeccCCCCcEEEEeccceeEe
Q psy6377 108 QNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 108 ~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+|||++. +.++|+|||+++..
T Consensus 457 ~NILl~~----~~~~liDFGla~~~ 477 (535)
T PRK09605 457 SNFIVRD----DRLYLIDFGLGKYS 477 (535)
T ss_pred HHEEEEC----CcEEEEeCcccccC
Confidence 9999942 47999999998863
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.6e-14 Score=142.13 Aligned_cols=227 Identities=23% Similarity=0.214 Sum_probs=181.9
Q ss_pred eEEEEEE--cCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh-
Q psy6377 5 SEEMADS--IATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI- 75 (383)
Q Consensus 5 ~V~~~~~--~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~- 75 (383)
+||.++. +.++..+|+|.-.. ...+-.+|+......-.|++.++.+..+++.+..|+-+|++. .+|..+
T Consensus 131 s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~--~sl~~~~ 208 (524)
T KOG0601|consen 131 SVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG--ESLQSYC 208 (524)
T ss_pred eeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc--chhHHhh
Confidence 4566666 88999999997433 455677888877767789999999999999999999999996 777764
Q ss_pred ------hccCCchhhHHHHHH----HHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc------c
Q psy6377 76 ------IDDNLVVPFESDELS----SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI------R 139 (383)
Q Consensus 76 ------l~~~~~~~~~~qil~----aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~------~ 139 (383)
+.....+....+... ||..+|+.+++|-|+||+||+..++. ...+++|||+...+.++... .
T Consensus 209 ~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~df~~v~~i~~~~~~~~~~~~~ 286 (524)
T KOG0601|consen 209 HTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTDFGLVSKISDGNFSSVFKVSK 286 (524)
T ss_pred hcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCCcceeEEccCCccccceeeee
Confidence 334455666677778 99999999999999999999998763 57899999999987665421 1
Q ss_pred cccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 140 ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE--TDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
...|...|++||.+.+- ++...|++++|.+..+..+|..++... +.+..+++ ...|.++....+..+...+.
T Consensus 287 r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-----~~ip~e~~~~~s~~l~~~~~ 360 (524)
T KOG0601|consen 287 RPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-----GYIPLEFCEGGSSSLRSVTS 360 (524)
T ss_pred cCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-----ccCchhhhcCcchhhhhHHH
Confidence 22577889999998744 689999999999999999888777555 44444432 22567777788888888999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCC
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
.|+..+|-.|++++.+++|+++..
T Consensus 361 ~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 361 QMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred HhcCcchhhhhHHHHHhccccccc
Confidence 999999999999999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.9e-13 Score=117.68 Aligned_cols=119 Identities=17% Similarity=0.049 Sum_probs=84.4
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc------ccH----------------------HHHHHHHHhcCCC-CCcccceEEEEe
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP------VRI----------------------HHEIALLSLCSPS-PRIVKLHDVFQT 55 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~------~~~----------------------~~Ei~il~~~~~h-pnIvkl~~~~~~ 55 (383)
.||.|.+. +|+.||||++.... ... ..|...+.....+ -.+++++.+
T Consensus 12 ~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--- 87 (187)
T cd05119 12 DVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL--- 87 (187)
T ss_pred eEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence 58899876 89999999987511 111 2444444422211 224444443
Q ss_pred CCeEEEEEecCCCc-----CcHHHhhccCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 56 GEGAYYVSWNTPLV-----VTLQTIIDDNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 56 ~~~~~lv~e~~~~g-----~~L~~~l~~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
...+++||+++ | ..|.+.........+..+++.++.++|+ .||+||||||+||+++ + +.++|+|||.+
T Consensus 88 -~~~~lv~e~~~-g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~---~~~~liDfg~a 161 (187)
T cd05119 88 -NRHVLVMEFIG-GDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D---GKVYIIDVPQA 161 (187)
T ss_pred -CCCEEEEEEeC-CCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C---CcEEEEECccc
Confidence 34689999999 7 3454443324556788999999999999 9999999999999998 3 58999999999
Q ss_pred eEee
Q psy6377 130 RVIL 133 (383)
Q Consensus 130 ~~~~ 133 (383)
....
T Consensus 162 ~~~~ 165 (187)
T cd05119 162 VEID 165 (187)
T ss_pred cccc
Confidence 7653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.4e-13 Score=113.97 Aligned_cols=121 Identities=17% Similarity=0.156 Sum_probs=97.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCc--ccHHHHHHHHHhcCCC-CCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNP--VRIHHEIALLSLCSPS-PRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL 80 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~--~~~~~Ei~il~~~~~h-pnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~ 80 (383)
..||++... +..+++|...... ..+.+|+.+++.+..+ +++++++.++...+..+++||++. |+.+..+ ....
T Consensus 12 ~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~-g~~~~~~-~~~~ 87 (155)
T cd05120 12 NRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE-GETLDEV-SEEE 87 (155)
T ss_pred cceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC-CeecccC-CHHH
Confidence 357888864 3789999987643 4789999999955444 699999999988889999999998 7777654 2223
Q ss_pred chhhHHHHHHHHHHHHhC---CceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 81 VVPFESDELSSLAYLHHR---KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 81 ~~~~~~qil~aL~yLHs~---givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
......+++.+|+++|.. +++|+|++|+||++++. +.++++|||.+..
T Consensus 88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~---~~~~l~Df~~~~~ 138 (155)
T cd05120 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG---KILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC---cEEEEEecccccC
Confidence 335668999999999985 79999999999999863 5899999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.9e-11 Score=120.29 Aligned_cols=168 Identities=15% Similarity=0.138 Sum_probs=122.0
Q ss_pred ceEE-EEEEcCCCcEEEEEEccCC-c---ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEE-MADSIATGEVFAAKFLESN-P---VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~-~~~~~~tg~~vAvK~i~~~-~---~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..+| .+..+.+|.++.|...... . ..+.+=++.|+ -++||||+++++.++.+..+|+|.|-+.--++-.+-+.+
T Consensus 25 ~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lK-tlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~ 103 (690)
T KOG1243|consen 25 EALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLK-TLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGK 103 (690)
T ss_pred cccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhh-hccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHH
Confidence 3456 3667889999999988762 2 34566677787 778999999999999999999999998622222222333
Q ss_pred CCchhhHHHHHHHHHHHH-hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCcccccC
Q psy6377 79 NLVVPFESDELSSLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLH-s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE~l~~~ 156 (383)
..+..-+.||+.||.||| ..+++|++|....|+++.. |..||++|.++........ .....---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~---GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES---GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC---CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 333355599999999998 5789999999999999876 7999999998765432221 1111112235666654433
Q ss_pred CCChhhHHHHHHHHHHHHHhC
Q psy6377 157 PITLAADMWSLGVTAYVLLTG 177 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg 177 (383)
. -..|.|-|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=8e-11 Score=102.81 Aligned_cols=116 Identities=15% Similarity=0.070 Sum_probs=87.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLV 81 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~ 81 (383)
.||.+.. .|+.|++|+.... .....+|..+++.+.+...+++++.+.. ...++|||+++ |.++... ....
T Consensus 13 ~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~-G~~l~~~--~~~~ 85 (170)
T cd05151 13 KNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE-GSELLTE--DFSD 85 (170)
T ss_pred ceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC-CCccccc--cccC
Confidence 5777775 3888999998663 3457899999995444444556666543 34589999999 8888754 1112
Q ss_pred hhhHHHHHHHHHHHHhCCc-----eecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 82 VPFESDELSSLAYLHHRKI-----AHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 82 ~~~~~qil~aL~yLHs~gi-----vHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
.....+++.+|..||+.++ +|+|++|.||+++. +.++++|||.+..
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~----~~~~liDf~~a~~ 136 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD----GRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC----CeEEEEecccccC
Confidence 3556899999999999985 99999999999983 3799999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=115.31 Aligned_cols=191 Identities=20% Similarity=0.226 Sum_probs=134.3
Q ss_pred CCCCCcccceEEEEeCC-----eEEEEEecCCCcCcHHHhhccC----------CchhhHHHHHHHHHHHHhCC--ceec
Q psy6377 41 SPSPRIVKLHDVFQTGE-----GAYYVSWNTPLVVTLQTIIDDN----------LVVPFESDELSSLAYLHHRK--IAHL 103 (383)
Q Consensus 41 ~~hpnIvkl~~~~~~~~-----~~~lv~e~~~~g~~L~~~l~~~----------~~~~~~~qil~aL~yLHs~g--ivHr 103 (383)
+.|.|||+++.++.+.. ...++.||+. .|++..++++. ....|.-||+.||.|||+-. |+|+
T Consensus 124 lvHsnlvkfH~yw~d~K~~e~~rviFiteyms-sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMS-SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHhhcccccccccceEEEEeccc-chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 45999999999986543 4788999999 99999987642 12345589999999999875 9999
Q ss_pred CCCCCcEEEeccCCCCcEEEEeccceeEeec-----CcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCC
Q psy6377 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILD-----GIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178 (383)
Q Consensus 104 DLKp~NILl~~~~~~~~ikL~DFGla~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~ 178 (383)
.+...-|++..+ |.||+.--.-...-.. ........+-++|.|||.=.....+.++|||++|....+|..|.
T Consensus 203 nlTc~tifiq~n---gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 203 NLTCDTIFIQHN---GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred CcchhheeecCC---ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999744 5666543221111000 00111235678999999766566678899999999999998887
Q ss_pred CC-CCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 179 SP-FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 179 ~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.- -.+....+.-.+|....+...+ ..-++++.+||+..|..||++.++|.||.+-+.
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred eccCCCcceeehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 54 3333333333333333322221 223568999999999999999999999987553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=118.20 Aligned_cols=74 Identities=16% Similarity=0.118 Sum_probs=57.3
Q ss_pred CCeEEEEEecCCCcCcHHHhhccC----CchhhHHHHHH-HHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 56 GEGAYYVSWNTPLVVTLQTIIDDN----LVVPFESDELS-SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 56 ~~~~~lv~e~~~~g~~L~~~l~~~----~~~~~~~qil~-aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
....+++|||++ |++|.++.... ....+..+++. .+..+|..|++|+|+||.||++..+ +.++++|||++.
T Consensus 230 ~~~~vLvmE~i~-G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~---g~i~liDfG~~~ 305 (437)
T TIGR01982 230 TSERVLTMEWID-GIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD---GKIIALDFGIVG 305 (437)
T ss_pred cCCceEEEEeEC-CcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC---CcEEEEeCCCee
Confidence 345789999999 99998864321 12234455555 4788999999999999999999765 689999999988
Q ss_pred Eee
Q psy6377 131 VIL 133 (383)
Q Consensus 131 ~~~ 133 (383)
...
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=103.57 Aligned_cols=120 Identities=13% Similarity=0.028 Sum_probs=86.2
Q ss_pred eEEEEEEcC------CCcEEEEEEccC--------------C------------cccHH----HHHHHHHhcCCC-CCcc
Q psy6377 5 SEEMADSIA------TGEVFAAKFLES--------------N------------PVRIH----HEIALLSLCSPS-PRIV 47 (383)
Q Consensus 5 ~V~~~~~~~------tg~~vAvK~i~~--------------~------------~~~~~----~Ei~il~~~~~h-pnIv 47 (383)
.||.|.... .+..+|||+.+. + ...+. +|.+.|+++... -+++
T Consensus 12 ~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~Gv~vP 91 (197)
T cd05146 12 VVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAGIPCP 91 (197)
T ss_pred EEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 688887543 357999999875 1 01122 788888866543 6777
Q ss_pred cceEEEEeCCeEEEEEecCCCcCcH-----HHh-hccCCchhhHHHHHHHHHHH-HhCCceecCCCCCcEEEeccCCCCc
Q psy6377 48 KLHDVFQTGEGAYYVSWNTPLVVTL-----QTI-IDDNLVVPFESDELSSLAYL-HHRKIAHLDIKPQNLVMMGDFPNCD 120 (383)
Q Consensus 48 kl~~~~~~~~~~~lv~e~~~~g~~L-----~~~-l~~~~~~~~~~qil~aL~yL-Hs~givHrDLKp~NILl~~~~~~~~ 120 (383)
+++++ ...++|||++. ++.+ .+. ++......+..+++.+|..| |..||+|+||+|.|||+.. +.
T Consensus 92 ~pi~~----~~~~lvME~Ig-~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~----~~ 162 (197)
T cd05146 92 EVVVL----KKHVLVMSFIG-DDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD----GK 162 (197)
T ss_pred eEEEe----cCCEEEEEEcC-CCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC----Cc
Confidence 77775 56788999997 5433 221 22222334568999999999 8999999999999999974 47
Q ss_pred EEEEeccceeEee
Q psy6377 121 IKVCDFEISRVIL 133 (383)
Q Consensus 121 ikL~DFGla~~~~ 133 (383)
+.|+|||.|....
T Consensus 163 v~iIDF~qav~~~ 175 (197)
T cd05146 163 VWFIDVSQSVEPT 175 (197)
T ss_pred EEEEECCCceeCC
Confidence 9999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-10 Score=118.96 Aligned_cols=130 Identities=14% Similarity=0.127 Sum_probs=81.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCc--------------------------------------ccHHHHHHHHHh------
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNP--------------------------------------VRIHHEIALLSL------ 39 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~--------------------------------------~~~~~Ei~il~~------ 39 (383)
..||.|+.+.+|+.||||+.+... ..+.+|++..+-
T Consensus 133 aQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~ 212 (537)
T PRK04750 133 AQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQ 212 (537)
T ss_pred cEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHH
Confidence 469999998889999999997511 112233332221
Q ss_pred ---cCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHHHh--hccCCc--hhhH-HHHHHHHHHHHhCCceecCCCCCcE
Q psy6377 40 ---CSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQTI--IDDNLV--VPFE-SDELSSLAYLHHRKIAHLDIKPQNL 110 (383)
Q Consensus 40 ---~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~~~--l~~~~~--~~~~-~qil~aL~yLHs~givHrDLKp~NI 110 (383)
...+.+.+.+-++|.+ ....++||||+. |+.+.++ +..... ..+. ..+-.-+..++..|++|+|+||.||
T Consensus 213 ~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~-G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~GffHaDpHPGNI 291 (537)
T PRK04750 213 LRRNFEDSDMLYVPEVYWDYCSETVMVMERMY-GIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDGFFHADMHPGNI 291 (537)
T ss_pred HHHHccCCCCeecceeecccCCCceEEEeeec-CccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCeeeCCCChHHe
Confidence 1123333333333332 344569999999 9999874 333221 1222 2222234456679999999999999
Q ss_pred EEeccC-CCCcEEEEeccceeEeec
Q psy6377 111 VMMGDF-PNCDIKVCDFEISRVILD 134 (383)
Q Consensus 111 Ll~~~~-~~~~ikL~DFGla~~~~~ 134 (383)
+++.++ ..+.++++|||++.....
T Consensus 292 lv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 292 FVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred EEecCCCCCCeEEEEecceEEECCH
Confidence 998652 124899999999987643
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.2e-11 Score=118.81 Aligned_cols=219 Identities=17% Similarity=0.136 Sum_probs=161.1
Q ss_pred EEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh------hc
Q psy6377 10 DSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI------ID 77 (383)
Q Consensus 10 ~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~------l~ 77 (383)
++..++..|++|-..+ ....-..|+-+...+..|.+++..+..+...++.|+-.|||. ++++... ++
T Consensus 286 ~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~-~~s~~l~~~~~~~~d 364 (524)
T KOG0601|consen 286 KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE-GGSSSLRSVTSQMLD 364 (524)
T ss_pred ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc-CcchhhhhHHHHhcC
Confidence 3336788899998776 233445666666666789999999999888888889999998 7777663 45
Q ss_pred cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccccc-CCCCc-CCCccccc
Q psy6377 78 DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL-GTPDY-VAPEILHY 155 (383)
Q Consensus 78 ~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~-gt~~y-~aPE~l~~ 155 (383)
+...+....|++.++.++|+..++|+|+||+||++..++ +..++.|||.+....-. ..... ++..| .+|.....
T Consensus 365 ~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~ 440 (524)
T KOG0601|consen 365 EDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLED 440 (524)
T ss_pred cchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccccee--cccccccccccccchhhccc
Confidence 566667779999999999999999999999999998753 57899999998752211 11122 23334 35555666
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 156 ~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
..+..+.|++|||.-+++..+|.+.-.... ....|..+.....+ ....++..+.+.++..++..|+.+.++..
T Consensus 441 ~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 441 YPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLP----GLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred cccccccccccccccccccccCcccCcccc---cceeeecccccCCC----chHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 778899999999999999999875543332 23334444443332 33478888999999999999999999988
Q ss_pred CcccC
Q psy6377 236 HPWLM 240 (383)
Q Consensus 236 hp~~~ 240 (383)
|+-+.
T Consensus 514 ~~~~~ 518 (524)
T KOG0601|consen 514 HSEFY 518 (524)
T ss_pred cchhh
Confidence 86553
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.3e-10 Score=116.23 Aligned_cols=156 Identities=24% Similarity=0.330 Sum_probs=116.6
Q ss_pred HHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--cc--------ccCCCCcCCCcccc
Q psy6377 86 SDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI--RE--------LLGTPDYVAPEILH 154 (383)
Q Consensus 86 ~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~--~~--------~~gt~~y~aPE~l~ 154 (383)
.++..|+.|+|. .++||+.|.|++|.++.. +.+||+.|+++....++... .. ..-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~---~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNAN---GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccC---cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 566689999996 589999999999999765 78999999987655442211 11 12456799999999
Q ss_pred cCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHhccCCCC-cchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLL-TGFSPFGGETDSETFRNISKAQLDFP-DELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyell-tg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
....+.++|++|+||++|.+. .|...+.+.+...... ......... ..+..++++++++=+.++|..++.-||++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 888889999999999999999 5666665554332222 221211111 1222578999999999999999999999999
Q ss_pred HHcCcccCCcchh
Q psy6377 233 ALKHPWLMNKKQI 245 (383)
Q Consensus 233 ~L~hp~~~~~~~~ 245 (383)
++..|||.+....
T Consensus 262 l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 262 LLSIPFFSDPGLK 274 (700)
T ss_pred hhcccccCCchhh
Confidence 9999999876543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5e-09 Score=92.37 Aligned_cols=100 Identities=15% Similarity=0.137 Sum_probs=79.3
Q ss_pred CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCC
Q psy6377 26 NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDI 105 (383)
Q Consensus 26 ~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDL 105 (383)
...+..+|.+++..+. --.|...+=++.+.+...++|||++ |..|.+.+.+.. ..+.+.+=.-+.-||..||+|+||
T Consensus 42 rr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~me~I~-G~~lkd~l~~~~-~~~~r~vG~~vg~lH~~givHGDL 118 (204)
T COG3642 42 RRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVMEYIE-GELLKDALEEAR-PDLLREVGRLVGKLHKAGIVHGDL 118 (204)
T ss_pred HHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEEEEeC-ChhHHHHHHhcc-hHHHHHHHHHHHHHHhcCeecCCC
Confidence 3567888999988443 3345444445557788899999999 888888887763 366778888899999999999999
Q ss_pred CCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 106 KPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 106 Kp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.++||++.++ .+.++|||++...
T Consensus 119 TtsNiIl~~~----~i~~IDfGLg~~s 141 (204)
T COG3642 119 TTSNIILSGG----RIYFIDFGLGEFS 141 (204)
T ss_pred ccceEEEeCC----cEEEEECCccccc
Confidence 9999999865 5999999998853
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.6e-08 Score=99.47 Aligned_cols=204 Identities=17% Similarity=0.212 Sum_probs=151.1
Q ss_pred CccceEEEEEEcCCCcEEEEEEccCCc----ccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcH
Q psy6377 1 MFALSEEMADSIATGEVFAAKFLESNP----VRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 1 ~f~~~V~~~~~~~tg~~vAvK~i~~~~----~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L 72 (383)
+|.+-.|+|....+|..|++|.+..++ .....-++.++ .+.|+|||++.++|.+ +..+++|++|++..++|
T Consensus 287 ~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wk-kl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 287 LFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWK-KLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHH-HhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 356678999999999999999994422 23344577787 7789999999999983 45689999999988899
Q ss_pred HHh-h--------------------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 73 QTI-I--------------------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 73 ~~~-l--------------------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
.++ + .+..+|.++.|+..||.++|+.|+.-+-|.|.+||++++ .+|+|..-|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---MRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---ceEEEecccceee
Confidence 884 2 123456777999999999999999999999999999876 4788877776665
Q ss_pred eecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCcHHH-HHHHHhccCCCCcchhcCCC
Q psy6377 132 ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSP-FGGETDSET-FRNISKAQLDFPDELFEDIS 209 (383)
Q Consensus 132 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~s 209 (383)
..... + +.+.. -.+-|.-.||.++.-|.||..- +......+. +..| ...+|
T Consensus 443 l~~d~------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~yS 495 (655)
T KOG3741|consen 443 LQEDP------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTTYS 495 (655)
T ss_pred ecCCC------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhhhh
Confidence 43322 0 11111 2467899999999999998543 222222222 2222 23568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 210 PEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 210 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+++++|.-+..-++++ -++.++|.+
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999999987 688998865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=9e-09 Score=92.29 Aligned_cols=119 Identities=18% Similarity=0.097 Sum_probs=79.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC----------------C--------------cccHHHHHHHHHhcCCC-CCcccceEEE
Q psy6377 5 SEEMADSIATGEVFAAKFLES----------------N--------------PVRIHHEIALLSLCSPS-PRIVKLHDVF 53 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----------------~--------------~~~~~~Ei~il~~~~~h-pnIvkl~~~~ 53 (383)
+||.|.. ..|..+|+|+.+. . .....+|.+.|..+... -++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 5899986 5788999999865 0 12466899999966554 3678887662
Q ss_pred EeCCeEEEEEecCCC-cCcHHHhhc----cCCchhhHHHHHHHHHH-HHhCCceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 54 QTGEGAYYVSWNTPL-VVTLQTIID----DNLVVPFESDELSSLAY-LHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 54 ~~~~~~~lv~e~~~~-g~~L~~~l~----~~~~~~~~~qil~aL~y-LHs~givHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
...+||||+.. |..+..+.. ......+..+++..+.. +|..||+|+||.+.|||++.+ .+.++|||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iIDf~ 151 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIIDFG 151 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--GT
T ss_pred ----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEecC
Confidence 45799999973 333333322 23445666888886555 579999999999999999864 79999999
Q ss_pred ceeEe
Q psy6377 128 ISRVI 132 (383)
Q Consensus 128 la~~~ 132 (383)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.6e-07 Score=82.79 Aligned_cols=120 Identities=20% Similarity=0.179 Sum_probs=90.1
Q ss_pred EcCCCcEEEEEE-ccC-----------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCc-CcHHHhhc
Q psy6377 11 SIATGEVFAAKF-LES-----------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLV-VTLQTIID 77 (383)
Q Consensus 11 ~~~tg~~vAvK~-i~~-----------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g-~~L~~~l~ 77 (383)
-...|+.++||. +.+ ...+..+|.++|.++.. -.|.-..=+|.|...-.++||+++ | .++.+++.
T Consensus 26 ~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~-~GI~~P~l~~~D~~~~~i~ME~~~-g~~~vk~~i~ 103 (229)
T KOG3087|consen 26 GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRA-LGIPAPRLIFIDTYGGQIYMEFID-GASTVKDFIL 103 (229)
T ss_pred eccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHH-hCCCCceEEEEecCCCeEEEEecc-chhHHHHHHH
Confidence 346788888874 333 45778899999985543 366666666778888889999998 5 35555432
Q ss_pred c-------CC-chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 78 D-------NL-VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 78 ~-------~~-~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+ .. ...+.++|=..+.-||.++|+|+||..+||++..++..-.+.++|||++...
T Consensus 104 ~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 104 STMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred HHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 1 11 2355688888999999999999999999999988876666799999998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.1e-07 Score=91.15 Aligned_cols=146 Identities=18% Similarity=0.273 Sum_probs=106.5
Q ss_pred hhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc-----cCC
Q psy6377 83 PFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH-----YEP 157 (383)
Q Consensus 83 ~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~ 157 (383)
...+.++.+.+-||..|.+-+|+.++|+|++++ +.|.|.|-..-.....+......+|.+.|.+||.-. +..
T Consensus 121 rvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~---~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~ 197 (637)
T COG4248 121 RVARNLASAFATLHEHGHVVGDVNQNSFLVSDD---SKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFE 197 (637)
T ss_pred HHHHHHHHHHHHHHhcCCcccccCccceeeecC---ceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccC
Confidence 444899999999999999999999999999876 688998876544444455566678999999999753 334
Q ss_pred CChhhHHHHHHHHHHHHHhC-CCCCCCCCcH----HHHH-HHHhccC-----------CCC-cchhcCCCHHHHHHHHHh
Q psy6377 158 ITLAADMWSLGVTAYVLLTG-FSPFGGETDS----ETFR-NISKAQL-----------DFP-DELFEDISPEAKDFIAKI 219 (383)
Q Consensus 158 ~~~~~DiwSlGvilyelltg-~~Pf~~~~~~----~~~~-~i~~~~~-----------~~~-~~~~~~~s~~~~~li~~~ 219 (383)
-+...|.|.||++++++|.| ++||.|.... .-++ .|..+.+ +.| ..-|.-+++.+..|..+|
T Consensus 198 r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qa 277 (637)
T COG4248 198 RTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQA 277 (637)
T ss_pred CCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHH
Confidence 56789999999999999986 9999764311 0111 2322221 112 123456789999999999
Q ss_pred ccc--CCCCCCCHH
Q psy6377 220 LIK--NPMERMTAK 231 (383)
Q Consensus 220 L~~--dP~~Rpt~~ 231 (383)
+.. ++.-|||++
T Consensus 278 F~~~~~~~~RP~a~ 291 (637)
T COG4248 278 FTESGVATPRPTAK 291 (637)
T ss_pred hcccCCCCCCCCHH
Confidence 864 356899875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.1e-07 Score=86.15 Aligned_cols=118 Identities=11% Similarity=0.098 Sum_probs=81.8
Q ss_pred CCCcEEEEEEccC-C--------------cccHHHHHHHHHhcCC-CCCcccceEEEEe-----CCeEEEEEecCCCcC-
Q psy6377 13 ATGEVFAAKFLES-N--------------PVRIHHEIALLSLCSP-SPRIVKLHDVFQT-----GEGAYYVSWNTPLVV- 70 (383)
Q Consensus 13 ~tg~~vAvK~i~~-~--------------~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~- 70 (383)
-.|+.|.||.... . .....+|...+..+.. --..+.+..+++. ....+||+|+++ +.
T Consensus 43 ~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~-~~~ 121 (268)
T PRK15123 43 LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLA-PTI 121 (268)
T ss_pred ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCC-CCc
Confidence 4678899996643 1 0137799888874431 2223344444443 234789999998 54
Q ss_pred cHHHhhcc---C-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc----CCCCcEEEEeccceeE
Q psy6377 71 TLQTIIDD---N-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD----FPNCDIKVCDFEISRV 131 (383)
Q Consensus 71 ~L~~~l~~---~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~----~~~~~ikL~DFGla~~ 131 (383)
+|.+++.. . ....+..++...+.-||..||+|+||+|.|||++.+ .....+.++||+.+..
T Consensus 122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 78887632 1 122455789999999999999999999999999752 2246799999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.2e-07 Score=84.19 Aligned_cols=125 Identities=14% Similarity=0.123 Sum_probs=87.9
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCC-CCCcccceEEEEeCC---eEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSP-SPRIVKLHDVFQTGE---GAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~~~---~~~lv~e~~~~g~~L~~~ 75 (383)
.||++... .|+.+++|+.... ...+.+|.++++.+.. +.++++++.+..... ..+++|++++ |.++.+.
T Consensus 13 ~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~-G~~l~~~ 90 (223)
T cd05154 13 LTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD-GRVLRDR 90 (223)
T ss_pred eEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC-CEecCCC
Confidence 57777653 3689999998762 4678999999994433 245677888766542 5689999999 8888774
Q ss_pred hc-----cCCchhhHHHHHHHHHHHHh-----------------------------------------------------
Q psy6377 76 ID-----DNLVVPFESDELSSLAYLHH----------------------------------------------------- 97 (383)
Q Consensus 76 l~-----~~~~~~~~~qil~aL~yLHs----------------------------------------------------- 97 (383)
+. ......+..+++.+|..||+
T Consensus 91 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (223)
T cd05154 91 LLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPA 170 (223)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCC
Confidence 32 11222445666666666663
Q ss_pred ---CCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 98 ---RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 98 ---~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
..++|+|++|.||+++.+ ..+.+.|+||+.+...
T Consensus 171 ~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~g 207 (223)
T cd05154 171 DSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATLG 207 (223)
T ss_pred CCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccccC
Confidence 246899999999999863 1246899999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=79.63 Aligned_cols=106 Identities=16% Similarity=0.127 Sum_probs=78.4
Q ss_pred cccHHHHHHHHHhcC-CCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhcc------CCchhhHHHHHHHHHHH
Q psy6377 27 PVRIHHEIALLSLCS-PSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIIDD------NLVVPFESDELSSLAYL 95 (383)
Q Consensus 27 ~~~~~~Ei~il~~~~-~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~~------~~~~~~~~qil~aL~yL 95 (383)
..+..+|...+..+. ..=.+++.+.+.+... ..++|+|.++...+|.+++.. .....+..++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 446788888766333 2333566666665532 358999999823578887754 23346668999999999
Q ss_pred HhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 96 HHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 96 Hs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
|.+||+|+|++|.|||+..+.....+.++||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999988754457999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-06 Score=78.23 Aligned_cols=116 Identities=15% Similarity=0.080 Sum_probs=76.2
Q ss_pred EEEEcCCCcEEEEEEccCC-------------cccHHHHHH---HHHhcCCCCCcccceEEEE-----eCCeEEEEEecC
Q psy6377 8 MADSIATGEVFAAKFLESN-------------PVRIHHEIA---LLSLCSPSPRIVKLHDVFQ-----TGEGAYYVSWNT 66 (383)
Q Consensus 8 ~~~~~~tg~~vAvK~i~~~-------------~~~~~~Ei~---il~~~~~hpnIvkl~~~~~-----~~~~~~lv~e~~ 66 (383)
++.=.-.|+.+++|..+.. .....+++. .++ ..+--.+..++-+.+ -....+++|||+
T Consensus 47 ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~-~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI 125 (229)
T PF06176_consen 47 VALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIR-NEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI 125 (229)
T ss_pred EEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHH-HcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence 3333456788899987651 111222222 232 223444444444433 234567899999
Q ss_pred CCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 67 PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 67 ~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+ |..|.+...-.. .....+..++.-+|..|++|+|.+|.|++++.+ .++++||+..+.
T Consensus 126 e-G~~l~d~~~i~e--~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~----~i~iID~~~k~~ 183 (229)
T PF06176_consen 126 E-GVELNDIEDIDE--DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN----GIRIIDTQGKRM 183 (229)
T ss_pred c-CeecccchhcCH--HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC----cEEEEECccccc
Confidence 9 999887543221 344678889999999999999999999999864 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.1e-06 Score=79.13 Aligned_cols=119 Identities=20% Similarity=0.110 Sum_probs=92.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--------------------------CcccHHHHHHHHHhcCCC-CCcccceEEEEeC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--------------------------NPVRIHHEIALLSLCSPS-PRIVKLHDVFQTG 56 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--------------------------~~~~~~~Ei~il~~~~~h-pnIvkl~~~~~~~ 56 (383)
.+||.|... .|..+|||+=+- .+....+|.++|..+..+ -.+++.+++
T Consensus 105 sdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~---- 179 (304)
T COG0478 105 SDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW---- 179 (304)
T ss_pred ceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----
Confidence 368999864 789999997542 234577999999955444 467777775
Q ss_pred CeEEEEEecCCCcCcHHHhh-ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 57 EGAYYVSWNTPLVVTLQTII-DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 57 ~~~~lv~e~~~~g~~L~~~l-~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+...+|||++. |..|...- .......+...|+.-+.-+-..||||+|+.+=||+++.+ |.+.++||--+..
T Consensus 180 nRHaVvMe~ie-G~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d---g~~~vIDwPQ~v~ 251 (304)
T COG0478 180 NRHAVVMEYIE-GVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED---GDIVVIDWPQAVP 251 (304)
T ss_pred ccceeeeehcc-cceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC---CCEEEEeCccccc
Confidence 56788999999 98888843 455555667778888877779999999999999999886 6899999976554
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.3e-06 Score=91.66 Aligned_cols=228 Identities=19% Similarity=0.165 Sum_probs=146.3
Q ss_pred ccceEEE-EEEcCCCcEEEEEEccC----------------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe
Q psy6377 2 FALSEEM-ADSIATGEVFAAKFLES----------------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG 58 (383)
Q Consensus 2 f~~~V~~-~~~~~tg~~vAvK~i~~----------------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~ 58 (383)
|+-.||- +-+..+|+.+.+|-... ......-|+..+. ...|+|++.++.+--....
T Consensus 178 ~~~~vy~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~-k~~~~n~~~~~~~~le~~~ 256 (1351)
T KOG1035|consen 178 YGKRVYPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLS-KIAHDNLGGYFVYGLERLF 256 (1351)
T ss_pred ecceeeeeeccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHH-hhccccccceeEEeehhhc
Confidence 3444555 56667788888886543 1122334455555 5689999999998654332
Q ss_pred EE----EEEecCCCcCcHHHhhccCC------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEE--ec
Q psy6377 59 AY----YVSWNTPLVVTLQTIIDDNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC--DF 126 (383)
Q Consensus 59 ~~----lv~e~~~~g~~L~~~l~~~~------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~--DF 126 (383)
.. +..+++. +.++...+..-. .+.+..++++||.|+|+....|.-|...-..-....+.+.+.++ ||
T Consensus 257 ~g~~~~v~~~~~s-~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~ 335 (1351)
T KOG1035|consen 257 RGIVLDVLQEICS-KVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDF 335 (1351)
T ss_pred chHHHHHHHhhcC-ccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhh
Confidence 22 2246666 667776554422 33445889999999999865555444332221111223455666 88
Q ss_pred cceeEeecCcccccccCCCCcCCCcccccCCCChh--hHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch
Q psy6377 127 EISRVILDGIEIRELLGTPDYVAPEILHYEPITLA--ADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL 204 (383)
Q Consensus 127 Gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 204 (383)
+.+.............-+..+.+||......+..+ .|+|.+|.....+..|..+-.-.. . +..+
T Consensus 336 ~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~---~-----------~~~~ 401 (1351)
T KOG1035|consen 336 DSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA---V-----------PVSL 401 (1351)
T ss_pred cccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc---c-----------hhhh
Confidence 88887766555555556777889998877666554 799999999999988765432111 1 1111
Q ss_pred hcCCC-HHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 205 FEDIS-PEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 205 ~~~~s-~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
....+ ....+++.+|+.-++++|+++.+++.|||.......
T Consensus 402 l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 402 LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 11112 267889999999999999999999999999765443
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.6e-07 Score=96.11 Aligned_cols=224 Identities=18% Similarity=0.176 Sum_probs=151.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCC-cccceEEEEeCCeEEEEEecCCCcC-cHHHhhc----
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPR-IVKLHDVFQTGEGAYYVSWNTPLVV-TLQTIID---- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpn-Ivkl~~~~~~~~~~~lv~e~~~~g~-~L~~~l~---- 77 (383)
|++++.+...+.... .+++... ....-++++|. ..+||| .+..++-++.++..++.++++. ++ +-.....
T Consensus 256 tknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLd-K~n~P~~~v~~~~d~~~E~~~~i~~~i~s-~~rs~~~~~~~se~ 331 (829)
T KOG0576|consen 256 TKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLD-KVNNPNPVVRYLEDYDGEDYLWIPMRICS-TGRSSALEMTVSEI 331 (829)
T ss_pred cCCCccCCChhhhee-ceeeccc-hhhHHHHHHHH-HccCCCCcccccccCCcccccchhhhhhc-CCccccccCChhhH
Confidence 445555555555444 5655532 44556788898 778999 6677777777788899999998 44 3322221
Q ss_pred ---cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc
Q psy6377 78 ---DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH 154 (383)
Q Consensus 78 ---~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~ 154 (383)
.-.+....+.-..+++++|+--=+||| ||+..+ +..+..||+............+..+|+.++|||+..
T Consensus 332 ~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~ 403 (829)
T KOG0576|consen 332 ALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQ 403 (829)
T ss_pred hhhhhhhhhhhhhhcccccccccccccCcc----cccccc----cccccccccCCcccCcccccccCCCCCCCCCchhhc
Confidence 112222335557789999998778998 888765 478999999988876665567788999999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--Cc-chhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF--PD-ELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~--~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
...+....|.|++|+--.++.-|-+|-.... .....+-.+.-.+ .+ ..|.. ..-.++...|+...|..|++..
T Consensus 404 ~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~--~~~~~~~~~~~~g~P~~pkv~m 479 (829)
T KOG0576|consen 404 ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSP--VFHRDFPAPCLNGLPPTPKVHM 479 (829)
T ss_pred ccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCc--ccccCCcccccCCCCCCCcchh
Confidence 9999999999999987777877777754411 0100111111000 00 11111 1122588889999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
.++.|.+|+.-.
T Consensus 480 gacfsKvfngCp 491 (829)
T KOG0576|consen 480 GACFSKVFNGCP 491 (829)
T ss_pred hHHHHHHhccCc
Confidence 999998887644
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=3e-05 Score=72.02 Aligned_cols=69 Identities=13% Similarity=0.058 Sum_probs=52.8
Q ss_pred cceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 3 ALSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 3 ~~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
+..||.+.. .+..+++|+... ....+.+|+++++.+.++-.+++++++...++..++||++++ |.++..
T Consensus 12 ~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~-G~~l~~ 81 (244)
T cd05150 12 GATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP-GVPAAA 81 (244)
T ss_pred cCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC-CccHhH
Confidence 346777764 347899998865 234688999999866666667788888877777899999999 887775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.3e-05 Score=78.58 Aligned_cols=76 Identities=16% Similarity=0.116 Sum_probs=55.4
Q ss_pred eCCeEEEEEecCCCcCcHHHh--hccCCch--hhHHHHHHH-HHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 55 TGEGAYYVSWNTPLVVTLQTI--IDDNLVV--PFESDELSS-LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 55 ~~~~~~lv~e~~~~g~~L~~~--l~~~~~~--~~~~qil~a-L~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
-.+.-.|+|||+. |..+.++ ++....- .+...++.+ +..+-..|+.|.|.+|.||++..+ |.+.+.|||+.
T Consensus 237 ~t~~~VLtmE~i~-Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~---g~i~~lDfGi~ 312 (517)
T COG0661 237 YTTRRVLTMEWID-GIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSD---GRIVLLDFGIV 312 (517)
T ss_pred ccCCcEEEEEeeC-CEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccCCCccceEEecC---CcEEEEcCcce
Confidence 3566789999999 9999996 4443321 233333322 344445899999999999999877 79999999998
Q ss_pred eEeec
Q psy6377 130 RVILD 134 (383)
Q Consensus 130 ~~~~~ 134 (383)
....+
T Consensus 313 g~l~~ 317 (517)
T COG0661 313 GRLDP 317 (517)
T ss_pred ecCCH
Confidence 87654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00013 Score=65.96 Aligned_cols=118 Identities=14% Similarity=0.075 Sum_probs=84.1
Q ss_pred EEEEcCCCcEEEEEEccCC--------------------cccHHHHHHHHHhc-----CCCCCcccceEEEEeCCeEEEE
Q psy6377 8 MADSIATGEVFAAKFLESN--------------------PVRIHHEIALLSLC-----SPSPRIVKLHDVFQTGEGAYYV 62 (383)
Q Consensus 8 ~~~~~~tg~~vAvK~i~~~--------------------~~~~~~Ei~il~~~-----~~hpnIvkl~~~~~~~~~~~lv 62 (383)
.|-....+....||+.... ..+..+|+.-...+ ..+.+|.++|++.+++.+..+|
T Consensus 16 ~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv 95 (199)
T PF10707_consen 16 DCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLV 95 (199)
T ss_pred eEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEE
Confidence 3444445556778888763 36677887766522 2489999999999999999999
Q ss_pred EecCC-----CcCcHHHhhccCCchhhH-HHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC-cEEEEe
Q psy6377 63 SWNTP-----LVVTLQTIIDDNLVVPFE-SDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC-DIKVCD 125 (383)
Q Consensus 63 ~e~~~-----~g~~L~~~l~~~~~~~~~-~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~-~ikL~D 125 (383)
+|.+. ...+|.+++.++....-. ..+-.-..||-..+|+.+||+|.||++....... .+.|+|
T Consensus 96 ~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 96 VELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 98874 245677777665543322 3333445689999999999999999998765444 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.68 E-value=7.9e-05 Score=76.59 Aligned_cols=76 Identities=13% Similarity=0.138 Sum_probs=53.3
Q ss_pred CeEEEEEecCCCcCcHHHh--hccCCch--hhHHHHHHHHH-HHHhCCceecCCCCCcEEEecc-CCCCcEEEEecccee
Q psy6377 57 EGAYYVSWNTPLVVTLQTI--IDDNLVV--PFESDELSSLA-YLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISR 130 (383)
Q Consensus 57 ~~~~lv~e~~~~g~~L~~~--l~~~~~~--~~~~qil~aL~-yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~ 130 (383)
..-.|+|||++ |..+.++ +++..+- .+...+.++.. -+-..|.+|.|=+|.||++..+ ...+.+.+.|||+..
T Consensus 275 t~RVLtME~~~-G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 275 TKRVLTMEYVD-GIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred cceEEEEEecC-CccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 45789999999 9998884 5554432 22233333322 2335789999999999999854 235789999999987
Q ss_pred Eee
Q psy6377 131 VIL 133 (383)
Q Consensus 131 ~~~ 133 (383)
.+.
T Consensus 354 ~is 356 (538)
T KOG1235|consen 354 VIS 356 (538)
T ss_pred ccc
Confidence 653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00051 Score=62.54 Aligned_cols=115 Identities=13% Similarity=0.067 Sum_probs=81.5
Q ss_pred CcEEEEEEccC----------CcccHHHHHHHHHhcC--CCCCcccceEEEEe-----CCeEEEEEecCCCcCcHHHhhc
Q psy6377 15 GEVFAAKFLES----------NPVRIHHEIALLSLCS--PSPRIVKLHDVFQT-----GEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 15 g~~vAvK~i~~----------~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
|+.|-+|.-.. ....+.+|+..|..+. +-| ++++. ++.. .-..+||+|.+..-.+|.+++.
T Consensus 41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~ 118 (216)
T PRK09902 41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYA 118 (216)
T ss_pred CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHh
Confidence 44677776552 4567999999888443 233 55555 3321 1236789997764678888765
Q ss_pred cCCc--------hhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 78 DNLV--------VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 78 ~~~~--------~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.... ..+..++...+.-||+.|+.|+|+-+.||+++.++ .-.+.++||.-++..
T Consensus 119 ~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 119 QHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRRR 180 (216)
T ss_pred cCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccchh
Confidence 4322 35668999999999999999999999999997543 235999999977653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00051 Score=63.45 Aligned_cols=118 Identities=14% Similarity=0.067 Sum_probs=74.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCC-CcccceEEEEeCCeEEEEEecCCCcCc-HHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSP-RIVKLHDVFQTGEGAYYVSWNTPLVVT-LQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hp-nIvkl~~~~~~~~~~~lv~e~~~~g~~-L~~~l~~~- 79 (383)
.||.+ .|..+++|+... ....+.+|.++++.+.... .+++.+++.++.+..+++|+++. |.. +...+...
T Consensus 16 ~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~-G~~~~~~~~~~~~ 90 (226)
T TIGR02172 16 ESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV-GKRSFSRIISDNP 90 (226)
T ss_pred ceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC-CccchhhhhcCCH
Confidence 46653 255688998876 3456899999998555443 36888888888888899999999 763 22111100
Q ss_pred -----------------------C-ch-----hhH----------HHHHHH-HHHHHh----CCceecCCCCCcEEEecc
Q psy6377 80 -----------------------L-VV-----PFE----------SDELSS-LAYLHH----RKIAHLDIKPQNLVMMGD 115 (383)
Q Consensus 80 -----------------------~-~~-----~~~----------~qil~a-L~yLHs----~givHrDLKp~NILl~~~ 115 (383)
. .. .+. ..+... ..+|.+ ..++|+|+.|.||+++.+
T Consensus 91 ~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~ 170 (226)
T TIGR02172 91 SRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGK 170 (226)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCC
Confidence 0 00 000 011111 222221 247899999999999764
Q ss_pred CCCCcEEEEeccceeE
Q psy6377 116 FPNCDIKVCDFEISRV 131 (383)
Q Consensus 116 ~~~~~ikL~DFGla~~ 131 (383)
+ +.++||+.+..
T Consensus 171 ---~-~~iIDwe~a~~ 182 (226)
T TIGR02172 171 ---G-TYWIDLGDFGY 182 (226)
T ss_pred ---C-cEEEechhcCc
Confidence 4 88999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00061 Score=63.24 Aligned_cols=120 Identities=13% Similarity=0.045 Sum_probs=80.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc-----------------------c-----cHHHHHHHHHhcC-CCCCcccceEEEEe
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP-----------------------V-----RIHHEIALLSLCS-PSPRIVKLHDVFQT 55 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~-----------------------~-----~~~~Ei~il~~~~-~hpnIvkl~~~~~~ 55 (383)
.||.|.. .++..+|+|++.... . =...|..-|+++. .+-.+++.+.++
T Consensus 63 ~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~-- 139 (268)
T COG1718 63 NVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR-- 139 (268)
T ss_pred EEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec--
Confidence 5788864 678999999997500 0 0234555555443 245666666664
Q ss_pred CCeEEEEEecCCCcCcHHHhhccC-----CchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 56 GEGAYYVSWNTPLVVTLQTIIDDN-----LVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 56 ~~~~~lv~e~~~~g~~L~~~l~~~-----~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
...||||++...|.=...|+.- .......++++.+.-|-. .|+||+||..=|||+.. +.+.|+|||-|
T Consensus 140 --~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~----~~p~iID~~Qa 213 (268)
T COG1718 140 --NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD----GEPYIIDVSQA 213 (268)
T ss_pred --CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC----CeEEEEECccc
Confidence 4578999997322111133322 233445788888888877 89999999999999973 47899999987
Q ss_pred eEee
Q psy6377 130 RVIL 133 (383)
Q Consensus 130 ~~~~ 133 (383)
....
T Consensus 214 V~~~ 217 (268)
T COG1718 214 VTID 217 (268)
T ss_pred cccC
Confidence 7543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0023 Score=58.85 Aligned_cols=63 Identities=16% Similarity=0.081 Sum_probs=40.3
Q ss_pred eEEEEEEcC-CCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIA-TGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~-tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.+|++.... .++.|++|+.... .....+|+.+++.+..+.-.++++..+. + .++||+++ |.++
T Consensus 13 ~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~-G~~l 79 (235)
T cd05157 13 KLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP-GRTL 79 (235)
T ss_pred eEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC-CCcC
Confidence 466665332 3578999987652 2344689998885545555666665543 2 37999998 7665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0017 Score=60.80 Aligned_cols=117 Identities=15% Similarity=0.051 Sum_probs=69.0
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc----ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh-----
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP----VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI----- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~----~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~----- 75 (383)
.+|+.. .+|+.+++|+..... ....+|..+++.+..+.-.++++.... -++|+++++ |..+...
T Consensus 11 ~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~-G~~~~~~~~~~~ 83 (256)
T TIGR02721 11 RSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE-GEVITLDQFVAL 83 (256)
T ss_pred CeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc-CcccccccccCc
Confidence 356555 567789999876521 246889999995554433455555432 368999998 7665421
Q ss_pred ---------hc------c-CCchhhH-------HH---------HHHHHHHHHh--------CCceecCCCCCcEEEecc
Q psy6377 76 ---------ID------D-NLVVPFE-------SD---------ELSSLAYLHH--------RKIAHLDIKPQNLVMMGD 115 (383)
Q Consensus 76 ---------l~------~-~~~~~~~-------~q---------il~aL~yLHs--------~givHrDLKp~NILl~~~ 115 (383)
+. . ....... .+ +...+..+-. ..++|+|+.|.||+++++
T Consensus 84 ~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~ 163 (256)
T TIGR02721 84 DLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQ 163 (256)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCC
Confidence 00 0 0000000 01 1111222222 248999999999999865
Q ss_pred CCCCcEEEEeccceeEe
Q psy6377 116 FPNCDIKVCDFEISRVI 132 (383)
Q Consensus 116 ~~~~~ikL~DFGla~~~ 132 (383)
.+.++||+.|...
T Consensus 164 ----~~~lIDwE~a~~g 176 (256)
T TIGR02721 164 ----GLKLIDWEYASDG 176 (256)
T ss_pred ----CCEEEeccccCcC
Confidence 3789999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0018 Score=59.85 Aligned_cols=57 Identities=12% Similarity=0.042 Sum_probs=36.5
Q ss_pred cEEEEEEccC--CcccHHHHHHHHHhcCCC--CCcccceEEEEeCC---eEEEEEecCCCcCcHH
Q psy6377 16 EVFAAKFLES--NPVRIHHEIALLSLCSPS--PRIVKLHDVFQTGE---GAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 16 ~~vAvK~i~~--~~~~~~~Ei~il~~~~~h--pnIvkl~~~~~~~~---~~~lv~e~~~~g~~L~ 73 (383)
..+++|+... ....+.+|.++++.+.++ -.++++++.....+ ..+++|++++ |.++.
T Consensus 19 ~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~-G~~l~ 82 (235)
T cd05155 19 DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE-GETAT 82 (235)
T ss_pred CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec-CCCCC
Confidence 4578888665 234789999999855443 23455555433322 3488999998 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0033 Score=59.99 Aligned_cols=120 Identities=13% Similarity=0.072 Sum_probs=71.6
Q ss_pred EEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCC-CcccceEE------EEeCCeEEEEEecCCCcCcHHH---
Q psy6377 6 EEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSP-RIVKLHDV------FQTGEGAYYVSWNTPLVVTLQT--- 74 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hp-nIvkl~~~------~~~~~~~~lv~e~~~~g~~L~~--- 74 (383)
+|.+.. .+..+++|+... ....+..|++++..+..+- .+++++.. ...++..++++++++ |..+..
T Consensus 30 ~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~-G~~~~~~~~ 106 (296)
T cd05153 30 NYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA-GEHLTRPTA 106 (296)
T ss_pred eEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC-CCCCCCCCH
Confidence 566542 445799999875 4556778888887543321 24555442 233456788999998 766532
Q ss_pred -h-------h------ccC--------CchhhH----------------HHHHHHHHHHHh-------CCceecCCCCCc
Q psy6377 75 -I-------I------DDN--------LVVPFE----------------SDELSSLAYLHH-------RKIAHLDIKPQN 109 (383)
Q Consensus 75 -~-------l------~~~--------~~~~~~----------------~qil~aL~yLHs-------~givHrDLKp~N 109 (383)
. + ... ....+. ..+..++.++.. .+++|+|+.|.|
T Consensus 107 ~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~N 186 (296)
T cd05153 107 AHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDN 186 (296)
T ss_pred HHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCccc
Confidence 0 0 000 000000 112234445443 479999999999
Q ss_pred EEEeccCCCCcEEEEeccceeE
Q psy6377 110 LVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 110 ILl~~~~~~~~ikL~DFGla~~ 131 (383)
|+++++ +.+.|+||+.+..
T Consensus 187 il~~~~---~~~~iIDfe~a~~ 205 (296)
T cd05153 187 VLFDGD---ELSGVIDFYFACT 205 (296)
T ss_pred EEEeCC---ceEEEeehhhhcC
Confidence 999865 3467999997664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0025 Score=69.79 Aligned_cols=65 Identities=9% Similarity=0.065 Sum_probs=43.3
Q ss_pred EEEEEEcCCC--cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCc--ccceEEEEeC---CeEEEEEecCCCcCc
Q psy6377 6 EEMADSIATG--EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRI--VKLHDVFQTG---EGAYYVSWNTPLVVT 71 (383)
Q Consensus 6 V~~~~~~~tg--~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnI--vkl~~~~~~~---~~~~lv~e~~~~g~~ 71 (383)
+|+......+ ..+++|+.+. ....+.+|.++++.+..|+++ ++++.++.+. ...|+|||+++ |..
T Consensus 54 ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~-G~~ 130 (822)
T PLN02876 54 TFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLE-GRI 130 (822)
T ss_pred eEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecC-Ccc
Confidence 4554433222 4678887654 234688999999955446654 7777777654 35789999998 664
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.06 E-value=3e-05 Score=86.36 Aligned_cols=194 Identities=14% Similarity=-0.004 Sum_probs=129.2
Q ss_pred cCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhhccC---------CchhhHHHH-HHHHHHHHhCC-----cee
Q psy6377 40 CSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTIIDDN---------LVVPFESDE-LSSLAYLHHRK-----IAH 102 (383)
Q Consensus 40 ~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l~~~---------~~~~~~~qi-l~aL~yLHs~g-----ivH 102 (383)
-..|+++...+.-.+.. ...|..++++. +|.++.++-++ .......++ +.+..-+|+.. .+|
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~-~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVE-FGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHH-HhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence 34699998888777643 45788899999 99999964221 111122344 77777777642 789
Q ss_pred cCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCC
Q psy6377 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF 181 (383)
Q Consensus 103 rDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf 181 (383)
++||+-|.++..+ -.+++.++|+.+...+ ........+++.|++|++...-.++.++|+|..|+-+|.+..|..+|
T Consensus 1364 ~~Lkf~lpmIVtn---y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTN---YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhhccceecC---CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999998765 4799999999994333 23345567899999999998888999999999999999999998887
Q ss_pred CCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 182 GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 182 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
...........+..+.. +.-+ .-.|.++-.....+|-+.-..||.-...+.-+.+.
T Consensus 1441 i~flq~~Lkgiidn~tf-~sIe--~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1441 IFFLQPALKGIIDNHTF-FSIE--KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHcCccccccc-cccc--ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 43222111111111111 1001 11234444455556666666788877777766554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0045 Score=55.98 Aligned_cols=67 Identities=13% Similarity=0.095 Sum_probs=45.1
Q ss_pred eEEEEEEcCCCcEEEEEEccCC--cccHHHHHHHHHhcCCC-CCcccceEEEEe---CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLESN--PVRIHHEIALLSLCSPS-PRIVKLHDVFQT---GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~--~~~~~~Ei~il~~~~~h-pnIvkl~~~~~~---~~~~~lv~e~~~~g~~L~~ 74 (383)
.||.+.... ..+++|+.... ...+.+|..+++.+..+ ..+++++..... ....+++|++++ |..+..
T Consensus 12 ~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~-g~~~~~ 84 (239)
T PF01636_consen 12 RVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP-GRPLDD 84 (239)
T ss_dssp EEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES-SEEHHH
T ss_pred eEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec-cccccc
Confidence 477777543 58999998753 46788888888754444 246677764432 334789999999 887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0052 Score=61.53 Aligned_cols=61 Identities=15% Similarity=-0.025 Sum_probs=42.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCC--CCCcccceEEEEeCCeEEEEEecCC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSP--SPRIVKLHDVFQTGEGAYYVSWNTP 67 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~--hpnIvkl~~~~~~~~~~~lv~e~~~ 67 (383)
.||.+.....++.++||.-.. ...+...|.+.|+.... ..++++++.+ +....++|||+++
T Consensus 41 ~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~ 114 (401)
T PRK09550 41 LVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLS 114 (401)
T ss_pred EEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCC
Confidence 467777653335899998442 23456788888885433 3567888887 4566889999998
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0056 Score=54.15 Aligned_cols=118 Identities=14% Similarity=0.049 Sum_probs=82.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLV 81 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~ 81 (383)
..||+|.. .|..+|+|+-.. .+..+..|.++|..+.+----+++|.+-+ .++.|||.. |..|.+.......
T Consensus 36 s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~-G~~L~~~~~~~~r 108 (201)
T COG2112 36 SVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID-GRPLGKLEIGGDR 108 (201)
T ss_pred cEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc-CcchhhhhhcccH
Confidence 46888885 477999998776 46789999999996655555666776633 234499999 8899986543221
Q ss_pred hhhHHHHHHHHHHHHhCCceecCCC-CCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 82 VPFESDELSSLAYLHHRKIAHLDIK-PQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 82 ~~~~~qil~aL~yLHs~givHrDLK-p~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.-...++++---|-..||-|..|. |...++.++ ..+.|+||.-|+.-
T Consensus 109 -k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~---~~~~iIDFd~At~k 156 (201)
T COG2112 109 -KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND---RDVYIIDFDSATFK 156 (201)
T ss_pred -HHHHHHHHHHHHHHHhccchhhhcCCceeEEecC---CcEEEEEccchhhc
Confidence 333445555445667899999998 544444333 37999999988853
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0064 Score=58.25 Aligned_cols=64 Identities=13% Similarity=0.000 Sum_probs=41.4
Q ss_pred eEEEEEEcC------CCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIA------TGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~------tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.+|++.... +++.|++|+... ......+|.++++.+..+--.++++..+.. ..|+++++ |..+.
T Consensus 13 ~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~-G~~l~ 85 (302)
T cd05156 13 AVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP-SRTLT 85 (302)
T ss_pred eeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC-CCcCC
Confidence 356665332 368899999776 235678898888855554445667766642 35788887 66654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.028 Score=53.81 Aligned_cols=65 Identities=9% Similarity=-0.024 Sum_probs=38.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCC-CCcccceEE------EEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPS-PRIVKLHDV------FQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~h-pnIvkl~~~------~~~~~~~~lv~e~~~~g~~L 72 (383)
.||++.. ++..+++|++......+..|+.++..+..+ -.+++++.. ...++..+.++++++ |..+
T Consensus 11 ~v~~v~t--~~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~-G~~~ 82 (313)
T TIGR02906 11 NVYKVET--DSGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIE-GREC 82 (313)
T ss_pred cEEEEEe--CCCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhcc-CcCC
Confidence 4777763 344689999875545566677666533221 134444432 223556889999998 6554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.025 Score=54.49 Aligned_cols=121 Identities=16% Similarity=0.180 Sum_probs=69.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCC-CCcccceEE------EEeCCeEEEEEecCCCcCcHHH-
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPS-PRIVKLHDV------FQTGEGAYYVSWNTPLVVTLQT- 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~h-pnIvkl~~~------~~~~~~~~lv~e~~~~g~~L~~- 74 (383)
.+|.+.. . +..+++|+... ....+..|++++..+..+ -.+++++.. ....+..++++++++ |..+..
T Consensus 37 ~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~-G~~~~~~ 113 (307)
T TIGR00938 37 SNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ-GLSVGRP 113 (307)
T ss_pred ceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC-CCCCCCC
Confidence 4676653 3 44688898765 245667778777644321 124444432 122345788999988 654321
Q ss_pred ----------hh-------c---cC--C---chhhH------------------HHHHHHHHHHHh-------CCceecC
Q psy6377 75 ----------II-------D---DN--L---VVPFE------------------SDELSSLAYLHH-------RKIAHLD 104 (383)
Q Consensus 75 ----------~l-------~---~~--~---~~~~~------------------~qil~aL~yLHs-------~givHrD 104 (383)
.+ . .. . ...+. ..+...++++.. .+++|+|
T Consensus 114 ~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD 193 (307)
T TIGR00938 114 TAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHAD 193 (307)
T ss_pred CHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCC
Confidence 00 0 00 0 00000 112234555542 6899999
Q ss_pred CCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 105 IKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 105 LKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+.+.||+++.+ +.+.++||+.+..
T Consensus 194 ~~~~Nvl~~~~---~~~~vIDfd~~~~ 217 (307)
T TIGR00938 194 LFPDNVLFDGD---SVKGVIDFYFACT 217 (307)
T ss_pred CCcCcEEEECC---ceEEEeecccccC
Confidence 99999999865 3568999997654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.032 Score=54.84 Aligned_cols=54 Identities=19% Similarity=0.105 Sum_probs=36.2
Q ss_pred CcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 15 GEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 15 g~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
++.|++|+.... .-...+|..+++.+..+.--+++++.+..+ .|.+|++ |.++.
T Consensus 65 ~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~-g~~l~ 121 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH-ARTLS 121 (344)
T ss_pred CCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC-CCCCC
Confidence 478999988652 223467899988665665566777777443 4678876 66654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.039 Score=49.99 Aligned_cols=107 Identities=21% Similarity=0.170 Sum_probs=72.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------------C------------cccHHHHHHHHHhc--CCCCCc--ccceEEEEe
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------------N------------PVRIHHEIALLSLC--SPSPRI--VKLHDVFQT 55 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------------~------------~~~~~~Ei~il~~~--~~hpnI--vkl~~~~~~ 55 (383)
.|++++ -.|+.||+|++.. . ...+..|-+...++ .++.++ |++|+++--
T Consensus 53 ~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L 130 (207)
T PF13095_consen 53 YVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLL 130 (207)
T ss_pred EEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEE
Confidence 456665 5688999999432 0 12456776665533 356667 999999732
Q ss_pred C------------------CeEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC
Q psy6377 56 G------------------EGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 56 ~------------------~~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~ 117 (383)
. ...-+|.|+++ ... .....-+.+|++-+..+|..||+-+|+++.|..
T Consensus 131 ~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~-~~~-------~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~------ 196 (207)
T PF13095_consen 131 TEDQQFEQLRQRGSDHRPLPIRAIVKDFVP-DDP-------PLQIRDIPQMLRDLKILHKLGIVPRDVKPRNYR------ 196 (207)
T ss_pred chHHHHHHhhcccccCCCCccEEEEEeecC-Ccc-------ccchhHHHHHHHHHHHHHHCCeeeccCcccccc------
Confidence 2 11345667666 222 112245588999999999999999999999987
Q ss_pred CCcEEEEeccce
Q psy6377 118 NCDIKVCDFEIS 129 (383)
Q Consensus 118 ~~~ikL~DFGla 129 (383)
.-+|+|||.+
T Consensus 197 --~G~lvDfs~~ 206 (207)
T PF13095_consen 197 --GGKLVDFSSS 206 (207)
T ss_pred --CCEEEecccC
Confidence 1289999964
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.0082 Score=53.85 Aligned_cols=93 Identities=24% Similarity=0.210 Sum_probs=70.1
Q ss_pred HHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH-------HHhhc--cCCchhhHHHHHHHHHHHHh---CC
Q psy6377 32 HEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL-------QTIID--DNLVVPFESDELSSLAYLHH---RK 99 (383)
Q Consensus 32 ~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L-------~~~l~--~~~~~~~~~qil~aL~yLHs---~g 99 (383)
.|.-+++.+.+.++++++++.+ +.+++.|+.. .+++ ..++. ......++.+++..+.+++. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~-~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVG-AGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeec-CccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4777777555668999999987 3466788888 5544 33332 23445777999999999987 45
Q ss_pred ceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 100 ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+.-.|++|+|+-++++ +.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~---~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDD---GRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCC---CcEEEEechhcchh
Confidence 7789999999999866 68999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.034 Score=54.31 Aligned_cols=30 Identities=30% Similarity=0.369 Sum_probs=25.0
Q ss_pred ceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 100 ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
..|.|+.|.|||++.++ +.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~--~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDE--GKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCC--CcEEEEcccccCC
Confidence 68999999999997532 4799999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.015 Score=57.33 Aligned_cols=68 Identities=12% Similarity=-0.090 Sum_probs=43.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCCC-C-CcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSPS-P-RIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~h-p-nIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
-||++.....++.++||.-.. ...+...|.+.|+..... | .++++|.+ +.....+|||+++....
T Consensus 10 ~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vMEdL~~~~i 87 (370)
T TIGR01767 10 LVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVMEDLSHHKI 87 (370)
T ss_pred EEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHhhCccchH
Confidence 377887654446899986543 345667788888754442 3 46667665 55667789999974444
Q ss_pred HHH
Q psy6377 72 LQT 74 (383)
Q Consensus 72 L~~ 74 (383)
|.+
T Consensus 88 lR~ 90 (370)
T TIGR01767 88 ARK 90 (370)
T ss_pred HHH
Confidence 433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.007 Score=61.61 Aligned_cols=165 Identities=22% Similarity=0.214 Sum_probs=106.7
Q ss_pred ccHHHHHHHHHhcCCCCCcccceEEEEeCCe-EEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCC
Q psy6377 28 VRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-AYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIK 106 (383)
Q Consensus 28 ~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLK 106 (383)
.++.--..+++ ...|+|....+++-..... ..+|||++. .+|.+++..+.. ..+ +++ +||=+
T Consensus 27 ~~ilgr~~~lk-tl~~~~l~~yl~~~r~~~~r~IVV~e~~~--~Sled~~~~~~l-~~~-s~~-----------~~~~~- 89 (725)
T KOG1093|consen 27 IQILGRFQYLK-SLQHDNLCQYLDFSRGKHERVIVVMEHYT--MSLEDILKTGNL-KDE-SLL-----------AHGVL- 89 (725)
T ss_pred HHHhhhhHHHH-hhcCccceeeEeeecCccceEEEEehhhc--cchHHHHHhccc-chh-hhc-----------ccccc-
Confidence 34444556666 6679999999999876543 667788885 999997765542 221 111 22211
Q ss_pred CCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q psy6377 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD 186 (383)
Q Consensus 107 p~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~ 186 (383)
+-|+ ++++| -++.. | | .+..+++||||+|.++.++.-|...+.....
T Consensus 90 ~~~~----------~~~td-~~~t~---------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~ 136 (725)
T KOG1093|consen 90 HLNI----------IYITD-HFLTK---------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELTE 136 (725)
T ss_pred eehh----------hhccc-ccccc---------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence 1222 23334 00000 0 1 1112499999999999999999988887777
Q ss_pred HHHHHHHHhccCCCCc--------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 187 SETFRNISKAQLDFPD--------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 187 ~~~~~~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+....+.+....... .....++....++..+|+-..|..||...++++++-|...
T Consensus 137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7766665543221110 1223456778899999999999999999999999988654
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.01 Score=57.38 Aligned_cols=115 Identities=16% Similarity=0.098 Sum_probs=82.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC--------------------------CcccHHHHHHHHHhcCCCCC-cccceEEEEeCC
Q psy6377 5 SEEMADSIATGEVFAAKFLES--------------------------NPVRIHHEIALLSLCSPSPR-IVKLHDVFQTGE 57 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--------------------------~~~~~~~Ei~il~~~~~hpn-Ivkl~~~~~~~~ 57 (383)
+||.+-+ ..|+++++|+=+- .+-...+|...++.+..|-. +++.+|+ +
T Consensus 107 DIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~----~ 181 (465)
T KOG2268|consen 107 DIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDH----N 181 (465)
T ss_pred ceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccc----c
Confidence 5677765 4678888885431 12345678888885555433 5555554 5
Q ss_pred eEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccc
Q psy6377 58 GAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI 128 (383)
Q Consensus 58 ~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGl 128 (383)
..++|||++. |-.|...-.-.....+...++.-+--|-.+|+||+|..-=||++..+ +.++++||--
T Consensus 182 RH~Vvmelv~-g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd---~~i~vIDFPQ 248 (465)
T KOG2268|consen 182 RHCVVMELVD-GYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD---DKIVVIDFPQ 248 (465)
T ss_pred ceeeHHHhhc-ccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecC---CCEEEeechH
Confidence 6788999999 88888865444444555666777778889999999999999999865 5899999974
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.12 Score=49.29 Aligned_cols=32 Identities=19% Similarity=0.298 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 99 KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 99 givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.++|+|++|.|||++.+ ....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~--~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDED--ARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCC--CCEEEEECcHhcccC
Confidence 37999999999999853 123569999988763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.026 Score=51.17 Aligned_cols=55 Identities=20% Similarity=0.089 Sum_probs=32.9
Q ss_pred CcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 15 GEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 15 g~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
++.|++++.... .....+|..+++.+..+-.-++++..+.+ + .|.+|+. |..|..
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~--g--~v~e~i~-g~~l~~ 59 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN--G--RVEEFIE-GRTLSP 59 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT--E--EEEE--S-SEE--C
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC--C--cEEEEec-ccccCh
Confidence 467888887762 34566788888866566666777777643 2 4558886 666543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.094 Score=52.42 Aligned_cols=67 Identities=16% Similarity=-0.021 Sum_probs=43.1
Q ss_pred EEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcCC-CC-CcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 6 EEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCSP-SP-RIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~~-hp-nIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
||++.+...++.++||.-.. ...+...|.++|+.... .| +++++|.+ +.....+|||+++....|.
T Consensus 45 VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vMEdL~~~~ilR 122 (409)
T PRK12396 45 VFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVMEDLSDHTILR 122 (409)
T ss_pred EEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHHhCcccHHHH
Confidence 77777643456788886543 34667788888885443 23 57777766 5566778888886333344
Q ss_pred H
Q psy6377 74 T 74 (383)
Q Consensus 74 ~ 74 (383)
+
T Consensus 123 ~ 123 (409)
T PRK12396 123 T 123 (409)
T ss_pred H
Confidence 3
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.23 Score=48.24 Aligned_cols=118 Identities=13% Similarity=0.146 Sum_probs=70.8
Q ss_pred CCCcEEEEEEccC------CcccHHHHHHHHHhcCC-CCCcccceEEEEeCC--eEEEEEecCCCcCcHHHhhccCC---
Q psy6377 13 ATGEVFAAKFLES------NPVRIHHEIALLSLCSP-SPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQTIIDDNL--- 80 (383)
Q Consensus 13 ~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~~~l~~~~--- 80 (383)
.+++.+++. .+. ......+|..+++.+.. ---+...+.++.++. ..|.||+++. |......+....
T Consensus 46 ~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve-Ge~~~~~~~~~~~~~ 123 (321)
T COG3173 46 DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE-GEVVWSALPPESLGR 123 (321)
T ss_pred cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec-ceeccCcCCcccchH
Confidence 348889998 442 34567788888885544 233444555555444 5699999998 633333111000
Q ss_pred -----------------------------------chhhHH--------------HHHHHHHHHHhC--------Cceec
Q psy6377 81 -----------------------------------VVPFES--------------DELSSLAYLHHR--------KIAHL 103 (383)
Q Consensus 81 -----------------------------------~~~~~~--------------qil~aL~yLHs~--------givHr 103 (383)
+..+.. ....-..+++.+ .++|+
T Consensus 124 ~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHG 203 (321)
T COG3173 124 QFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHG 203 (321)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeC
Confidence 000001 111224455543 37999
Q ss_pred CCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 104 DLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
|+.+.||+++.+. .+=++||+++....+.
T Consensus 204 D~~~gNlii~~~~---~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 204 DYRPGNLIIDPGR---PTGVLDWELATLGDPL 232 (321)
T ss_pred CcccCCEEEeCCC---eeEEEeccccccCCcH
Confidence 9999999998763 4889999998875443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.56 Score=44.97 Aligned_cols=56 Identities=13% Similarity=0.038 Sum_probs=38.8
Q ss_pred CCCcEEEEEEccC-CcccHHHHHHHHHhc--CCCCCcccceEEEEeCCeEEEEEecCCC
Q psy6377 13 ATGEVFAAKFLES-NPVRIHHEIALLSLC--SPSPRIVKLHDVFQTGEGAYYVSWNTPL 68 (383)
Q Consensus 13 ~tg~~vAvK~i~~-~~~~~~~Ei~il~~~--~~hpnIvkl~~~~~~~~~~~lv~e~~~~ 68 (383)
.+++.|.||+-.. ....+.-|.+-|+.+ ...-.+++++.+....+..||+||+++.
T Consensus 38 ~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 38 TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 6788999998775 456788998888855 2466788999999888888999999983
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.54 Score=45.27 Aligned_cols=30 Identities=10% Similarity=0.081 Sum_probs=26.1
Q ss_pred CceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 99 KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 99 givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+++|+|+.+.|+|++++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~---~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET---RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC---CCEEEEEhhhccc
Confidence 79999999999999765 4688999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.80 E-value=0.2 Score=46.14 Aligned_cols=96 Identities=15% Similarity=0.081 Sum_probs=60.2
Q ss_pred EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCchhhHHHHHHH
Q psy6377 17 VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSS 91 (383)
Q Consensus 17 ~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~a 91 (383)
+..+|.++. ....+..+.+++.+. -.|+++..= +...+.+|+|.|..-..+.- -+..-=+.+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~ND--n~~~yGvIlE~Cy~~~i~~~--------N~i~agi~~ 153 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARM---HGILRLKND--NNYKYGVILERCYKIKINFS--------NFITAGIKD 153 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHh---hheeEeecC--CCceeEEEEeeccCcccchh--------HHHHHhHHH
Confidence 344455544 234567788888733 245665522 44557789999871111111 011111456
Q ss_pred HHHHHh--CCceecCCCCCcEEEeccCCCCcEEEEeccc
Q psy6377 92 LAYLHH--RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI 128 (383)
Q Consensus 92 L~yLHs--~givHrDLKp~NILl~~~~~~~~ikL~DFGl 128 (383)
|.-.|+ .+.+|+|-.|+|||-++. |.+||.|-+.
T Consensus 154 L~~fH~~~~~~lHGD~np~NiM~D~~---G~lKlVDP~~ 189 (308)
T PF07387_consen 154 LMDFHSENQHCLHGDCNPDNIMCDKF---GYLKLVDPVC 189 (308)
T ss_pred HHHhhccCCCeecCCCChhheeecCC---CCEEecChhh
Confidence 777884 579999999999999776 7999999774
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.56 Score=52.76 Aligned_cols=33 Identities=21% Similarity=0.246 Sum_probs=26.2
Q ss_pred CCceecCCCCCcEEEeccCCCCcEE-EEeccceeE
Q psy6377 98 RKIAHLDIKPQNLVMMGDFPNCDIK-VCDFEISRV 131 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~~~~ik-L~DFGla~~ 131 (383)
.++||.|+.+.|||++.+... .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGE-RISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCc-ceEEEEECccccc
Confidence 579999999999999876322 444 999998765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.25 E-value=0.72 Score=46.08 Aligned_cols=39 Identities=10% Similarity=-0.035 Sum_probs=29.6
Q ss_pred HHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 30 IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 30 ~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
-.+|+.+++.+..+--=+++++.|.. +++.|+++ |.+|.
T Consensus 99 R~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe-Gr~l~ 137 (383)
T PTZ00384 99 NDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE-GNTMG 137 (383)
T ss_pred cHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec-cccCC
Confidence 46789999966677777888888753 58888988 76664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.86 E-value=0.13 Score=49.65 Aligned_cols=31 Identities=26% Similarity=0.322 Sum_probs=25.3
Q ss_pred CCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
.|++|+|+.|.||+++++ ...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~---~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD---RLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECC---ceEEEEecccccC
Confidence 489999999999999854 2347999997764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.76 E-value=1.1 Score=45.06 Aligned_cols=58 Identities=12% Similarity=-0.054 Sum_probs=38.5
Q ss_pred EEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCC--CCCcccceEEEEeCCeEEEEEecCC
Q psy6377 6 EEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSP--SPRIVKLHDVFQTGEGAYYVSWNTP 67 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~--hpnIvkl~~~~~~~~~~~lv~e~~~ 67 (383)
||+... .++.++||.-.. ...+...|.+.|+.... ..+++++|.+.+ +..+++||+++
T Consensus 48 VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~ 118 (418)
T PLN02756 48 VYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLE 118 (418)
T ss_pred EEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecC
Confidence 566554 345688997762 34455677777773332 257888888865 55678899997
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=90.77 E-value=1.2 Score=44.29 Aligned_cols=120 Identities=14% Similarity=0.086 Sum_probs=71.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------Cc-------cc-----------------HHHHHHHHHhcCCCCCcccceEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NP-------VR-----------------IHHEIALLSLCSPSPRIVKLHDVF 53 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~-------~~-----------------~~~Ei~il~~~~~hpnIvkl~~~~ 53 (383)
..||-|.. .+|..||||+++. ++ .+ ...|++-|.++. .-.|+-.--+.
T Consensus 158 ANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~aGIP~PePIl 235 (520)
T KOG2270|consen 158 ANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NAGIPCPEPIL 235 (520)
T ss_pred ceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hcCCCCCCcee
Confidence 36888874 6888999999875 10 01 235566555332 22222221111
Q ss_pred EeCCeEEEEEecCCCcCcHHHhhc-----cCCchhhHHHHHHHHHHH-HhCCceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 54 QTGEGAYYVSWNTPLVVTLQTIID-----DNLVVPFESDELSSLAYL-HHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 54 ~~~~~~~lv~e~~~~g~~L~~~l~-----~~~~~~~~~qil~aL~yL-Hs~givHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
- ....|||+++...|--...|+ ...+.....|++.-+.-| |..++||.||.-=|+|+.. |.+.++|-+
T Consensus 236 L--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd----G~lyiIDVS 309 (520)
T KOG2270|consen 236 L--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD----GKLYIIDVS 309 (520)
T ss_pred e--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC----CEEEEEEcc
Confidence 1 345789999962222222333 223323335666666655 4578999999999999864 589999988
Q ss_pred ceeE
Q psy6377 128 ISRV 131 (383)
Q Consensus 128 la~~ 131 (383)
-+-.
T Consensus 310 QSVE 313 (520)
T KOG2270|consen 310 QSVE 313 (520)
T ss_pred cccc
Confidence 6654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.39 E-value=2.4 Score=43.14 Aligned_cols=29 Identities=24% Similarity=0.432 Sum_probs=23.7
Q ss_pred CceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 99 KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 99 givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
...|.|+.+.|||...+ .++++||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~----~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK----CLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCC----CEEEEeeccccc
Confidence 47899999999997543 599999987654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.81 E-value=1.6 Score=41.87 Aligned_cols=82 Identities=13% Similarity=0.029 Sum_probs=56.3
Q ss_pred cEEEEEEccC--CcccHHHHHHHHHhcCCC--CCcccceEEEEeC---CeEEEEEecCCCcCcHHHhhcc-CCchhhHHH
Q psy6377 16 EVFAAKFLES--NPVRIHHEIALLSLCSPS--PRIVKLHDVFQTG---EGAYYVSWNTPLVVTLQTIIDD-NLVVPFESD 87 (383)
Q Consensus 16 ~~vAvK~i~~--~~~~~~~Ei~il~~~~~h--pnIvkl~~~~~~~---~~~~lv~e~~~~g~~L~~~l~~-~~~~~~~~q 87 (383)
..+++|+.+. ....+..|.+.|+.+.++ -.++++++++.++ +..++|||+++ |.++.+.... ........+
T Consensus 38 ~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~-G~~~~~~~~~~~~~~~l~~~ 116 (297)
T PRK10593 38 GNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR-GVSVEAPARTPERWEQLKDQ 116 (297)
T ss_pred CCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC-CEecCCCCCCHHHHHHHHHH
Confidence 3577788654 235889999999866554 4788999887653 56899999999 8877652111 011233356
Q ss_pred HHHHHHHHHhC
Q psy6377 88 ELSSLAYLHHR 98 (383)
Q Consensus 88 il~aL~yLHs~ 98 (383)
++.+|.-||+.
T Consensus 117 l~~~La~LH~~ 127 (297)
T PRK10593 117 IVEGLLAWHRI 127 (297)
T ss_pred HHHHHHHHhCC
Confidence 77899999975
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.58 E-value=0.4 Score=42.93 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=24.7
Q ss_pred ceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 100 ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.+|+|+.|.||+++++ .++++||+.|...
T Consensus 79 p~H~D~~~~N~~~~~~----~~~lIDwe~a~~g 107 (188)
T PRK10271 79 PLHMDVHAGNLVHSAS----GLRLIDWEYAGDG 107 (188)
T ss_pred eecCCCCCccEEEECC----CEEEEeCCcccCC
Confidence 5899999999998764 4899999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.08 E-value=1.2 Score=44.22 Aligned_cols=84 Identities=17% Similarity=0.174 Sum_probs=51.1
Q ss_pred CCCCcccceEEE-EeCCeEEEEEecCCCcCcHHH--hhccCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCC
Q psy6377 42 PSPRIVKLHDVF-QTGEGAYYVSWNTPLVVTLQT--IIDDNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 42 ~hpnIvkl~~~~-~~~~~~~lv~e~~~~g~~L~~--~l~~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~ 117 (383)
+-++..+.+-+- ......|++|++. |+.+.- .....++..++.+-+..++-+..+ ..-||+|...|||++ +
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh--gt~is~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-- 357 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH--GTPISIIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-- 357 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC--CceeeeeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c--
Confidence 344444444333 2233456666665 466554 223333445555554444444433 478999999999998 3
Q ss_pred CCcEEEEeccceeE
Q psy6377 118 NCDIKVCDFEISRV 131 (383)
Q Consensus 118 ~~~ikL~DFGla~~ 131 (383)
|+|-|+||-+++.
T Consensus 358 -GnvtLIDfklsRl 370 (488)
T COG5072 358 -GNVTLIDFKLSRL 370 (488)
T ss_pred -CceEEEEeeeeec
Confidence 6999999999985
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=86.77 E-value=0.56 Score=42.06 Aligned_cols=35 Identities=23% Similarity=0.282 Sum_probs=27.0
Q ss_pred CCceecCCCCCcEEEeccCC--CCcEEEEeccceeEe
Q psy6377 98 RKIAHLDIKPQNLVMMGDFP--NCDIKVCDFEISRVI 132 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~--~~~ikL~DFGla~~~ 132 (383)
..++|||+.+.||++..+.. ...+.++||..++..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g 156 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG 156 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence 46899999999999975421 126899999987753
|
subfamily of choline kinases |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.81 E-value=1.7 Score=42.52 Aligned_cols=33 Identities=15% Similarity=0.212 Sum_probs=22.3
Q ss_pred hhHHHHHHHHHHHH----hCCceecCCCCCcEEEecc
Q psy6377 83 PFESDELSSLAYLH----HRKIAHLDIKPQNLVMMGD 115 (383)
Q Consensus 83 ~~~~qil~aL~yLH----s~givHrDLKp~NILl~~~ 115 (383)
++..||+.-.-.+- -.+.+|-||||+|||+-..
T Consensus 283 fifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 283 FIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 44467665543332 2468999999999997544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 383 | ||||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-50 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-46 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-44 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-43 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-43 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-43 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-43 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-42 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-42 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-42 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-42 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-42 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-42 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-41 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-41 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-41 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-41 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-41 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-41 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-41 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-41 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-41 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-35 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-35 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-35 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-34 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-34 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-34 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-34 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-34 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-34 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-33 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-33 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-31 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-31 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-30 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-30 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-30 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-30 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-30 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-29 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-29 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-28 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-28 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-28 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-26 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-24 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-24 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-24 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-22 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-22 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-21 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-21 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-04 |
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-89
Identities = 102/282 (36%), Positives = 152/282 (53%), Gaps = 27/282 (9%)
Query: 13 ATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+TG+ +AAKFL + I HEIA+L L PR++ LH+V++
Sbjct: 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII------ 105
Query: 67 PLVVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVM 112
L++ + + + E+D L + YLH I HLD+KPQN+++
Sbjct: 106 -LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164
Query: 113 MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+P DIK+ DF +SR I E+RE++GTP+Y+APEIL+Y+PIT A DMW++G+ AY
Sbjct: 165 SSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+LLT SPF GE + ET+ NIS+ +D+ +E F +S A DFI +L+KNP +R TA+
Sbjct: 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284
Query: 233 ALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS 274
L H WL + S + ++ SKS
Sbjct: 285 CLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKS 326
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 8e-84
Identities = 107/331 (32%), Positives = 166/331 (50%), Gaps = 38/331 (11%)
Query: 13 ATGEVFAAKFLESNPVR----------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
+TG +AAKF++ R I E+++L P I+ LHDV++
Sbjct: 35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENRTDVV-- 91
Query: 63 SWNTPLVVTLQT-------IIDDNL-----VVPFESDELSSLAYLHHRKIAHLDIKPQNL 110
L++ L + + F L + YLH +KIAH D+KP+N+
Sbjct: 92 -----LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 111 VMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGV 169
+++ + P IK+ DF ++ I DG+E + + GTP++VAPEI++YEP+ L ADMWS+GV
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
Y+LL+G SPF G+T ET NI+ DF +E F S AKDFI K+L+K +R+T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
Query: 230 AKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQ 289
+EAL+HPW+ ++ N +N +K + R L ++S
Sbjct: 267 IQEALRHPWITPVDT-------QQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHL 319
Query: 290 QENLRKSALLKYNKTRRLCESQMSLVSKTRE 320
+L K L+ ++ R CES R+
Sbjct: 320 TRSLMKKVHLRTSEDLRNCESDTEENIARRK 350
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-82
Identities = 98/296 (33%), Positives = 152/296 (51%), Gaps = 38/296 (12%)
Query: 13 ATGEVFAAKFLESNPVR----------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
+TG +AAKF++ R I E+++L ++ LHDV++
Sbjct: 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENRTDVV-- 91
Query: 63 SWNTPLVVTLQT-------IIDDNL-----VVPFESDELSSLAYLHHRKIAHLDIKPQNL 110
L++ L + + F L + YLH +KIAH D+KP+N+
Sbjct: 92 -----LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146
Query: 111 VMMG-DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGV 169
+++ + P IK+ DF ++ I DG+E + + GTP++VAPEI++YEP+ L ADMWS+GV
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
Y+LL+G SPF G+T ET NI+ DF +E F S AKDFI K+L+K +R+T
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT 266
Query: 230 AKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISA 285
+EAL+HPW+ ++ N +N RK + R L ++S
Sbjct: 267 IQEALRHPWITPVDN-------QQAMVRRESVVNLENFRKQYVRRRWKLSFSIVSL 315
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 3e-82
Identities = 92/257 (35%), Positives = 143/257 (55%), Gaps = 35/257 (13%)
Query: 13 ATGEVFAAKFLESNPVR----------IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
TG+ +AAKF++ + I E+ +L P I+ LHD+F+
Sbjct: 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTDVV-- 84
Query: 63 SWNTPLVVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQ 108
L++ L + + + + E + L + YLH ++IAH D+KP+
Sbjct: 85 -----LILELVSGGELFDFLAEKESLT--EDEATQFLKQILDGVHYLHSKRIAHFDLKPE 137
Query: 109 NLVMM-GDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N++++ + PN IK+ DF I+ I G E + + GTP++VAPEI++YEP+ L ADMWS+
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 197
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y+LL+G SPF GET ET NIS DF +E F + S AKDFI ++L+K+P R
Sbjct: 198 GVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257
Query: 228 MTAKEALKHPWLMNKKQ 244
MT ++L+H W+ ++
Sbjct: 258 MTIAQSLEHSWIKAIRR 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 8e-81
Identities = 88/279 (31%), Positives = 150/279 (53%), Gaps = 35/279 (12%)
Query: 13 ATGEVFAAKFLE----SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPL 68
ATG AAK ++ + + +EI++++ +++L+D F++ L
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIV-------L 163
Query: 69 VVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMG 114
V+ IID++ + E D + ++H I HLD+KP+N+ +
Sbjct: 164 VMEYVDGGELFDRIIDESYNLT-ELDTILFMKQICEGIRHMHQMYILHLDLKPENI-LCV 221
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+ IK+ DF ++R +++ GTP+++APE+++Y+ ++ DMWS+GV AY+L
Sbjct: 222 NRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYML 281
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L+G SPF G+ D+ET NI + D DE F+DIS EAK+FI+K+LIK R++A EAL
Sbjct: 282 LSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 235 KHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSK 273
KHPWL + K S S + + + + +++K
Sbjct: 342 KHPWLSDHKL-------HSRLSAQKKKNRGSDAQDFVTK 373
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 5e-80
Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 38/302 (12%)
Query: 12 IATGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPL 68
++ + + AKF++ + EI++L++ I+ LH+ F++ E +
Sbjct: 27 TSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESMEELV-------M 78
Query: 69 VVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMG 114
+ + I + E + +L +LH I H DI+P+N+ +
Sbjct: 79 IFEFISGLDIFERINTSAFELN-EREIVSYVHQVCEALQFLHSHNIGHFDIRPENI-IYQ 136
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+ IK+ +F +R + G R L P+Y APE+ ++ ++ A DMWSLG YVL
Sbjct: 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L+G +PF ET+ + NI A+ F +E F++IS EA DF+ ++L+K RMTA EAL
Sbjct: 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 235 KHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLR 294
+HPWL K + R+Y + V+SA+++
Sbjct: 257 QHPWLKQKI-----------ERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAI 305
Query: 295 KS 296
+S
Sbjct: 306 RS 307
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 5e-80
Identities = 86/304 (28%), Positives = 145/304 (47%), Gaps = 28/304 (9%)
Query: 12 IATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
ATG VF AKF+ + + +EI++++ P+++ LHD F+
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV------- 124
Query: 68 LVVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMM 113
L++ + I ++ + E++ L ++H I HLDIKP+N+ M
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMS-EAEVINYMRQACEGLKHMHEHSIVHLDIKPENI-MC 182
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
+K+ DF ++ + ++ T ++ APEI+ EP+ DMW++GV YV
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
LL+G SPF GE D ET +N+ + +F ++ F +SPEAKDFI +L K P +R+T +A
Sbjct: 243 LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
Query: 234 LKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENL 293
L+HPWL +T SS + I+ + +K + S K + +
Sbjct: 303 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 362
Query: 294 RKSA 297
+
Sbjct: 363 QIYD 366
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 6e-80
Identities = 91/300 (30%), Positives = 154/300 (51%), Gaps = 43/300 (14%)
Query: 12 IATGEVFAAKFL----------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
+TG +AAKF+ + I E+++L P ++ LH+V++
Sbjct: 33 KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVI- 90
Query: 62 VSWNTPLVVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKP 107
L++ L + + + E + L+ + YLH +IAH D+KP
Sbjct: 91 ------LILELVAGGELFDFLAEKESLT--EEEATEFLKQILNGVYYLHSLQIAHFDLKP 142
Query: 108 QN-LVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWS 166
+N +++ + P IK+ DF ++ I G E + + GTP++VAPEI++YEP+ L ADMWS
Sbjct: 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS 202
Query: 167 LGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
+GV Y+LL+G SPF G+T ET N+S +F DE F + S AKDFI ++L+K+P +
Sbjct: 203 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 262
Query: 227 RMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSR-EALFEKVISA 285
RMT +++L+HPW+ K S + N + +K+ ++ + ++
Sbjct: 263 RMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKKFAARKKSNNGSGGGLND 315
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 6e-77
Identities = 87/339 (25%), Positives = 144/339 (42%), Gaps = 35/339 (10%)
Query: 12 IATGEVFAAKFLE----SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
ATG FAAKF+ S+ + EI +S+ P +V LHD F+
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV------- 230
Query: 68 LVVTLQT-------IIDDNL------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
++ + + D++ V + L ++H HLD+KP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
N ++K+ DF ++ + ++ GT ++ APE+ +P+ DMWS+GV +Y+L
Sbjct: 291 KRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L+G SPFGGE D ET RN+ + D F IS + KDFI K+L+ +P RMT +AL
Sbjct: 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 409
Query: 235 KHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLR 294
+HPWL S +R + +A E + ++ +
Sbjct: 410 EHPWLTPGNAPGRDSQIPS--------SRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSL 461
Query: 295 KSALLKYNKTRRLCESQMSLVSKTREKSLGDMAISLGRS 333
+ + + R S + G+S
Sbjct: 462 RKHRPQ-EYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQS 499
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-66
Identities = 87/313 (27%), Positives = 141/313 (45%), Gaps = 44/313 (14%)
Query: 12 IATGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG FAAK + + + ++ E + P IV+LHD Q E +Y
Sbjct: 51 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE-ESFHY---- 104
Query: 66 TPLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNL 110
LV L T I+ + E+D L S+AY H I H ++KP+NL
Sbjct: 105 --LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
++ +K+ DF ++ + D GTP Y++PE+L +P + D+W+ GV
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y+LL G+ PF E + I D+P ++ ++PEAK I +L NP +R+TA
Sbjct: 220 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 279
Query: 231 KEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQ 290
+ALK PW+ N++++ S I Q L+K+ ++ + + I + +
Sbjct: 280 DQALKVPWICNRERV---------ASAIHRQDTVDCLKKFNARRK---LKGAILTTMIAT 327
Query: 291 ENLRKSALLKYNK 303
NL NK
Sbjct: 328 RNLSNLGRNLLNK 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-65
Identities = 77/254 (30%), Positives = 121/254 (47%), Gaps = 32/254 (12%)
Query: 12 IATGEVFAAKFLE------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG FAAK + + ++ E + P IV+LHD Q E +Y
Sbjct: 28 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE-ESFHY---- 81
Query: 66 TPLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNL 110
LV L T I+ + E+D L S+AY H I H ++KP+NL
Sbjct: 82 --LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
++ +K+ DF ++ + D GTP Y++PE+L +P + D+W+ GV
Sbjct: 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 196
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y+LL G+ PF E + I D+P ++ ++PEAK I +L NP +R+TA
Sbjct: 197 LYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 256
Query: 231 KEALKHPWLMNKKQ 244
+ALK PW+ N+++
Sbjct: 257 DQALKVPWICNRER 270
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-65
Identities = 85/299 (28%), Positives = 148/299 (49%), Gaps = 41/299 (13%)
Query: 9 ADSIATGEVFAAKFLE--SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
T + +A K L+ + + EI +L S P I+KL ++F+T
Sbjct: 72 CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFET-PTEIS----- 124
Query: 67 PLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNLV 111
LV+ L T I++ + E D L ++AYLH I H D+KP+NL+
Sbjct: 125 -LVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
P+ +K+ DF +S+++ + ++ + GTP Y APEIL DMWS+G+
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
Query: 172 YVLLTGFSPFGGET-DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y+LL GF PF E D FR I + F ++++S AKD + K+++ +P +R+T
Sbjct: 241 YILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTT 300
Query: 231 KEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSR-EALFEKVISASKL 288
+AL+HPW+ K + + +K L+++ ++ + +A + V+++S+L
Sbjct: 301 FQALQHPWVTGK-----------AANFVHMDTAQKKLQEFNARRKLKAAVKAVVASSRL 348
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-64
Identities = 62/254 (24%), Positives = 110/254 (43%), Gaps = 31/254 (12%)
Query: 9 ADSIATGEVFAAKF-----LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS 63
+ ++G K + +I EI +L P I+K+ +VF+ Y
Sbjct: 41 VEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMY--- 96
Query: 64 WNTPLVVTLQT-------IIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKP 107
+V+ I+ S+ +++LAY H + + H D+KP
Sbjct: 97 ----IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP 152
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
+N++ P+ IK+ DF ++ + GT Y+APE+ + +T D+WS
Sbjct: 153 ENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSA 211
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV Y LLTG PF G + E + + + ++ E ++P+A D + ++L K+P R
Sbjct: 212 GVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERR 270
Query: 228 MTAKEALKHPWLMN 241
+A + L H W
Sbjct: 271 PSAAQVLHHEWFKQ 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-64
Identities = 73/316 (23%), Positives = 129/316 (40%), Gaps = 45/316 (14%)
Query: 12 IATGEVFAAKFL---------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
TG+ FA K + + + E ++ + P IV+L + + + +G Y
Sbjct: 46 RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS-DGMLY- 102
Query: 63 SWNTPLVVTLQT-------IIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIK 106
+V I+ S+ L +L Y H I H D+K
Sbjct: 103 -----MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK 157
Query: 107 PQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAPEILHYEPITLAADMW 165
P +++ + +K+ F ++ + + G+ +GTP ++APE++ EP D+W
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVW 217
Query: 166 SLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225
GV ++LL+G PF G T F I K + + IS AKD + ++L+ +P
Sbjct: 218 GCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPA 276
Query: 226 ERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSR-EALFEKVIS 284
ER+T EAL HPWL + + I + + LRK+ ++ + + +S
Sbjct: 277 ERITVYEALNHPWLKERDR---------YAYKIHLPETVEQLRKFNARRKLKGAVLAAVS 327
Query: 285 ASKLQQENLRKSALLK 300
+ K L
Sbjct: 328 SHKFNSFYGDPPEELP 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-63
Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 47/264 (17%)
Query: 8 MADSIATGEVFAAKFLE----SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS 63
+A T AAK + + R EI ++ P I++L++ F+ Y V
Sbjct: 27 IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDIYLV- 84
Query: 64 WNTPLV---------------------VTLQTIIDDNLVVPFESDELSSLAYLHHRKIAH 102
L ++ + LS++AY H +AH
Sbjct: 85 --MELCTGGELFERVVHKRVFRESDAARIMKDV-------------LSAVAYCHKLNVAH 129
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH--YEPITL 160
D+KP+N + + D P+ +K+ DF ++ G +R +GTP YV+P++L Y P
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGP--- 186
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220
D WS GV YVLL G+ PF TDSE I + FP++ + ++SP+A+ I ++L
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLL 246
Query: 221 IKNPMERMTAKEALKHPWLMNKKQ 244
K+P +R+T+ +AL+H W +
Sbjct: 247 TKSPKQRITSLQALEHEWFEKQLS 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 6e-62
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 63/294 (21%)
Query: 12 IATGEVFAAKFLESNPVR---------IHHEIALLSLCSPSPRIVKLHDVFQT------- 55
T + A K + N +R I E+ L+ P I +L++V++
Sbjct: 48 NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLV 106
Query: 56 ------GE--------GAYYVSWNTPLVVTLQTIIDDNLVVPFESDE------------- 88
G VV Q +
Sbjct: 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR 166
Query: 89 -----------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL---- 133
S+L YLH++ I H DIKP+N + + + +IK+ DF +S+
Sbjct: 167 EKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNN 225
Query: 134 -DGIEIRELLGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF 190
+ + GTP +VAPE+L+ E D WS GV ++LL G PF G D++T
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285
Query: 191 RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
+ +L F + + +SP A+D ++ +L +N ER A AL+HPW+
Sbjct: 286 SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-62
Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 33/253 (13%)
Query: 13 ATGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
T + +A K + I E+ LL P I+KL ++ + Y
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFY------ 97
Query: 67 PLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNLV 111
+V L T II F E D S + Y+H I H D+KP+N++
Sbjct: 98 -IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
+ +CDIK+ DF +S ++++ +GT Y+APE+L D+WS GV
Sbjct: 154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
Y+LL+G PF G+ + + + + + F + IS +AKD I K+L +P R+TA
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 232 EALKHPWLMNKKQ 244
+ L+HPW+
Sbjct: 273 QCLEHPWIQKYSS 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 7e-62
Identities = 71/262 (27%), Positives = 109/262 (41%), Gaps = 47/262 (17%)
Query: 12 IATGEVFAAKF-------------LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG 58
T + +A K ++ E+ +L S P I++L D ++T
Sbjct: 39 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98
Query: 59 AYYVSWNTPLVVTLQT-------IIDDNLVVPFESDE--------LSSLAYLHHRKIAHL 103
+ LV L + + V E L + LH I H
Sbjct: 99 FF-------LVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHR 148
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL------HYEP 157
D+KP+N+++ D +IK+ DF S + G ++RE+ GTP Y+APEI+ ++
Sbjct: 149 DLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 158 ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217
DMWS GV Y LL G PF R I F ++D S KD ++
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS 265
Query: 218 KILIKNPMERMTAKEALKHPWL 239
+ L+ P +R TA+EAL HP+
Sbjct: 266 RFLVVQPQKRYTAEEALAHPFF 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-62
Identities = 76/307 (24%), Positives = 134/307 (43%), Gaps = 43/307 (14%)
Query: 13 ATGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
T + +A K + I E+ LL P I+KL ++ + Y
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFY------ 97
Query: 67 PLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNLV 111
+V L T II F E D S + Y+H I H D+KP+N++
Sbjct: 98 -IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
+ +CDIK+ DF +S ++++ +GT Y+APE+L D+WS GV
Sbjct: 154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
Y+LL+G PF G+ + + + + + F + IS +AKD I K+L +P R+TA
Sbjct: 213 YILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272
Query: 232 EALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS---REALFEKVISASKL 288
+ L+HPW+ + + + N+R++ ++ + AL +++
Sbjct: 273 QCLEHPWIQKYSSE-----TPTISDLPSLESAMTNIRQFQAEKKLAQAAL--LYMASKLT 325
Query: 289 QQENLRK 295
+ ++
Sbjct: 326 TLDETKQ 332
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-61
Identities = 78/312 (25%), Positives = 136/312 (43%), Gaps = 45/312 (14%)
Query: 9 ADSIATGEVFAAKFL-------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
TG+ A K + +++ + E+ LL P I+KL++ F+ Y
Sbjct: 45 CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFY- 102
Query: 62 VSWNTPLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIK 106
LV + T II F E D LS + Y+H KI H D+K
Sbjct: 103 ------LVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWS 166
P+NL++ + +I++ DF +S ++++ +GT Y+APE+LH D+WS
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWS 212
Query: 167 LGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
GV Y+LL+G PF G + + + + K + F ++ +S AKD I K+L P
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
Query: 227 RMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS---REALFEKVI 283
R++A++AL H W+ + + N+R++ + AL +
Sbjct: 273 RISARDALDHEWIQTYTKE------QISVDVPSLDNAILNIRQFQGTQKLAQAAL--LYM 324
Query: 284 SASKLQQENLRK 295
+ Q+ ++
Sbjct: 325 GSKLTSQDETKE 336
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-61
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 47/317 (14%)
Query: 12 IATGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
+ G+ +AA + + + ++ E + L P IV+LHD EG +Y
Sbjct: 33 VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISE-EGHHY---- 86
Query: 66 TPLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNL 110
L+ L T I+ + E+D L ++ + H + H ++KP+NL
Sbjct: 87 --LIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141
Query: 111 VMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGV 169
++ +K+ DF ++ + + GTP Y++PE+L +P D+W+ GV
Sbjct: 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
Y+LL G+ PF E ++ I DFP ++ ++PEAKD I K+L NP +R+T
Sbjct: 202 ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
Query: 230 AKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQ 289
A EALKHPW+ ++ S+ S + Q+ L+K+ ++ + + I L
Sbjct: 262 AAEALKHPWISHR---------STVASCMHRQETVDCLKKFNARRK---LKGAILTVMLA 309
Query: 290 QENL--RKSALLKYNKT 304
N RK ++K +
Sbjct: 310 TRNFSVRKQEIIKVTEQ 326
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-61
Identities = 84/331 (25%), Positives = 135/331 (40%), Gaps = 46/331 (13%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT---GEGAYYVSWNTPLV 69
T E FA K L+ P + E+ L S P IV++ DV++ G +V
Sbjct: 85 RTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL------IV 137
Query: 70 VTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+ I D E + ++ YLH IAH D+KP+NL+
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 197
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
PN +K+ DF ++ + TP YVAPE+L E + DMWSLGV Y+LL
Sbjct: 198 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257
Query: 176 TGFSPFGGE----TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
G+ PF I Q +FP+ + ++S E K I +L P +RMT
Sbjct: 258 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 317
Query: 232 EALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQE 291
E + HPW+M ++ P + K + + ++ ++ E
Sbjct: 318 EFMNHPWIMQSTKV---------PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 368
Query: 292 NLRKSALLKYNKTRRLCESQMSLVSKTREKS 322
+ K +++ ++ L+ K R+K+
Sbjct: 369 QI---------KIKKIEDASNPLLLKRRKKA 390
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 80/324 (24%), Positives = 143/324 (44%), Gaps = 48/324 (14%)
Query: 12 IATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71
AT FA K ++ + EI +L P I+ L DV+ G+ Y +V
Sbjct: 44 KATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVY-------VVTE 96
Query: 72 LQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
L I+ F E + ++ YLH + + H D+KP N++ + +
Sbjct: 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES 153
Query: 117 PNCD-IKVCDFEISRVILDGIEI-RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
N + I++CDF ++ + + T ++VAPE+L + A D+WSLGV Y +
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 175 LTGFSPF---GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
LTG++PF +T E I + + +S AKD ++K+L +P +R+TA
Sbjct: 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 232 EALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQE 291
L+HPW+++ Q+ P N+Q+ +L K A+ + ++ Q
Sbjct: 274 LVLRHPWIVHWDQL---------PQYQLNRQDAPHLVK------GAMAATYSALNRNQSP 318
Query: 292 NLR---KSALLKYNKTRRLCESQM 312
L +S L + +++ + +
Sbjct: 319 VLEPVGRSTLAQRRGIKKITSTAL 342
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-61
Identities = 87/311 (27%), Positives = 143/311 (45%), Gaps = 43/311 (13%)
Query: 9 ADSIATGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
T A K + V ++ E+A+L L P I+KL+D F+ Y
Sbjct: 56 CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNYY-- 112
Query: 63 SWNTPLVVTLQT-------IIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKP 107
LV+ II F E D LS + YLH I H D+KP
Sbjct: 113 -----LVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
+NL++ + IK+ DF +S V + +++E LGT Y+APE+L + D+WS+
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI 223
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
GV ++LL G+ PFGG+TD E R + K + F ++++S AKD I ++L + R
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283
Query: 228 MTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS---REALFEKVIS 284
++A++AL+HPW+ + +N+RK+ + + AL ++
Sbjct: 284 ISAQQALEHPWIKEMCSKKESG-----IELPSLANAIENMRKFQNSQKLAQAAL--LYMA 336
Query: 285 ASKLQQENLRK 295
+ QE ++
Sbjct: 337 SKLTSQEETKE 347
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 38/303 (12%)
Query: 12 IATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT---GEGAYYVSWNTPL 68
TG+ A K L +P + E+ S P IV + DV++ G+ +
Sbjct: 51 RRTGQKCALKLLYDSP-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL------I 103
Query: 69 VVTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMG 114
++ I + E + +++ +LH IAH D+KP+NL+
Sbjct: 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS 163
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+ +K+ DF ++ ++ TP YVAPE+L E + DMWSLGV Y+L
Sbjct: 164 KEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222
Query: 175 LTGFSPFGGETDSET----FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
L GF PF T R I Q FP+ + ++S +AK I +L +P ER+T
Sbjct: 223 LCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
Query: 231 KEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQ 290
+ + HPW+ + ++ + Q K+ + + ++ ++
Sbjct: 283 TQFMNHPWINQSMVVPQTPLHTA-----RVLQEDKDHWDEVKE----EMTSALATMRVDY 333
Query: 291 ENL 293
+ +
Sbjct: 334 DQV 336
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 26/278 (9%)
Query: 12 IATGEVFAAKFLESNPV-RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70
+ + FA K + EI L LC P IVKLH+VF + V L+
Sbjct: 33 KKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV---MELLN 89
Query: 71 ---TLQTIIDDNLVVPF-ESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
+ I F E++ +S+++++H + H D+KP+NL+ + N
Sbjct: 90 GGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146
Query: 120 DIKVCDFEISRVIL-DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
+IK+ DF +R+ D ++ T Y APE+L+ + D+WSLGV Y +L+G
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 179 SPFGGETDS-------ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
PF S E + I K F E ++++S EAKD I +L +P +R+
Sbjct: 207 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266
Query: 232 EALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRK 269
+ WL + Q+ + + ++
Sbjct: 267 GLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-60
Identities = 69/267 (25%), Positives = 113/267 (42%), Gaps = 58/267 (21%)
Query: 12 IATGEVFAAK------------FLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA 59
ATG FA K LE E +L + P I+ L D +++
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 60 YYVSWNTPLV---------------------VTLQTIIDDNLVVPFESDELSSLAYLHHR 98
+ V L+ ++++ L ++++LH
Sbjct: 176 FLV---FDLMRKGELFDYLTEKVALSEKETRSIMRSL-------------LEAVSFLHAN 219
Query: 99 KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----- 153
I H D+KP+N+++ + I++ DF S + G ++REL GTP Y+APEIL
Sbjct: 220 NIVHRDLKPENILLDDNMQ---IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD 276
Query: 154 -HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212
+ D+W+ GV + LL G PF R I + Q F ++D S
Sbjct: 277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTV 336
Query: 213 KDFIAKILIKNPMERMTAKEALKHPWL 239
KD I+++L +P R+TA++AL+HP+
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-59
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
LS + YLH I H DIKP+N+++ +IK+ DF +S ++R+ LGT Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI 208
APE+L + D+WS GV Y+LL G+ PFGG+ D + + + K + F +++I
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLR 268
S EAK+ I +L + +R TA+EAL W+ + N+R
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN------INKSDQKTLCGALSNMR 328
Query: 269 KYLSKS---REALFEKVISASKLQQENLRK 295
K+ + A+ I + E ++
Sbjct: 329 KFEGSQKLAQAAI--LFIGSKLTTLEERKE 356
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 49/293 (16%)
Query: 12 IATGEVFAAK------------FLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA 59
T + A K + + EI +L + P I+K+ + F +
Sbjct: 32 RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAED-- 88
Query: 60 YYVSWNTPLVVTLQT-------IIDDNLVVPFESDE--------LSSLAYLHHRKIAHLD 104
YY +V+ L ++ + + L ++ YLH I H D
Sbjct: 89 YY------IVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRD 139
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITLA 161
+KP+N+++ +C IK+ DF S+++ + +R L GTP Y+APE+L A
Sbjct: 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 162 ADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220
D WSLGV ++ L+G+ PF T I+ + +F E++ ++S +A D + K+L
Sbjct: 200 VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 259
Query: 221 IKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSK 273
+ +P R T +EAL+HPWL ++ ++ + L + L++
Sbjct: 260 VVDPKARFTTEEALRHPWLQDEDMK------RKFQDLLSEENESTALPQVLAQ 306
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 4e-57
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 43/266 (16%)
Query: 8 MADSIATGEVFAAKFLE------------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQT 55
+A T + A + + + + EI +L + P I+K+ + F
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDA 211
Query: 56 GEGAYYVSWNTPLVVTLQT-------IIDDNLVVPFESDE--------LSSLAYLHHRKI 100
+ YY +V+ L ++ + + L ++ YLH I
Sbjct: 212 ED--YY------IVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGI 260
Query: 101 AHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEP 157
H D+KP+N+++ +C IK+ DF S+++ + +R L GTP Y+APE+L
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 320
Query: 158 ITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQLDFPDELFEDISPEAKDFI 216
A D WSLGV ++ L+G+ PF T I+ + +F E++ ++S +A D +
Sbjct: 321 YNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLV 380
Query: 217 AKILIKNPMERMTAKEALKHPWLMNK 242
K+L+ +P R T +EAL+HPWL ++
Sbjct: 381 KKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 69/284 (24%)
Query: 12 IATGEVFAAKFLESNPV----RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
+ T + +A K +E P R+ E+ +L C +++L + F+ + Y V
Sbjct: 35 LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV---FE 91
Query: 68 LV---------------------VTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIK 106
+ V +Q + S+L +LH++ IAH D+K
Sbjct: 92 KMRGGSILSHIHKRRHFNELEASVVVQDV-------------ASALDFLHNKGIAHRDLK 138
Query: 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL--------GTPDYVAPEILHYEPI 158
P+N++ +K+CDF++ I + + G+ +Y+APE++
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 159 TL-----AADMWSLGVTAYVLLTGFSPFGGETDSET---------------FRNISKAQL 198
D+WSLGV Y+LL+G+ PF G S+ F +I + +
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 199 DFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242
+FPD+ + IS AKD I+K+L+++ +R++A + L+HPW+
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-52
Identities = 63/318 (19%), Positives = 114/318 (35%), Gaps = 33/318 (10%)
Query: 14 TGEVFAAKFLESNPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV-- 70
A K + E+ LL P +++ + + Y + +
Sbjct: 47 DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQY-------IAIEL 99
Query: 71 ---TLQTIIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQN--LVMMGDFPN 118
TLQ ++ + S LA+LH I H D+KP N + M
Sbjct: 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGK 159
Query: 119 CDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEIL---HYEPITLAADMWSLGVTA 171
+ DF + + + G GT ++APE+L E T D++S G
Sbjct: 160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
Query: 172 YVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y +++ G PFG + + LD + A++ I K++ +P +R +A
Sbjct: 220 YYVISEGSHPFGKSLQRQANILLGACSLDCLHP-EKHEDVIARELIEKMIAMDPQKRPSA 278
Query: 231 KEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISA-SKLQ 289
K LKHP+ + ++ + + I + + +++ R + +
Sbjct: 279 KHVLKHPFFWSLEKQL-QFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPL 337
Query: 290 QENLRKSALLKYNKTRRL 307
Q +LRK K R L
Sbjct: 338 QTDLRKFRTYKGGSVRDL 355
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 48/276 (17%)
Query: 9 ADSIATGEVFAAKFL---ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
A + +A K + E I E+ LL+ + +V+ + +
Sbjct: 25 ARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTA 83
Query: 66 TPLVVTL-------------QTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLD 104
TL I +NL + DE L +L+Y+H + I H D
Sbjct: 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQGIIHRD 141
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL---------------GTPDYVA 149
+KP N+ + + ++K+ DF +++ + ++I +L GT YVA
Sbjct: 142 LKPMNIFIDE---SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 150 PEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI 208
E+L DM+SLG+ + ++ G + + ++FP + ++
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNK 256
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
K I ++ +P +R A+ L WL K Q
Sbjct: 257 MKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 55/267 (20%), Positives = 106/267 (39%), Gaps = 52/267 (19%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALL-SLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+++A K++ +EIA L L S +I++L+D T + Y
Sbjct: 51 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY------ 104
Query: 67 PLVVT------LQTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+V L + + D + + L ++ +H I H D+KP N +
Sbjct: 105 --MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL--- 159
Query: 115 DFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYVAPEILHYEP-----------ITL 160
+ +K+ DF I+ + + +GT +Y+ PE + I+
Sbjct: 160 -IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNI--SKAQLDFPDELFEDISPEAKDFIA 217
+D+WSLG Y + G +PF + I +++FPD + +D +
Sbjct: 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD----IPEKDLQDVLK 274
Query: 218 KILIKNPMERMTAKEALKHPWLMNKKQ 244
L ++P +R++ E L HP++ +
Sbjct: 275 CCLKRDPKQRISIPELLAHPYVQIQTH 301
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 73/296 (24%), Positives = 110/296 (37%), Gaps = 58/296 (19%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT---GEGAYYVSWNTPLV 69
T E FA K L+ P + E+ L S P IV++ DV++ G +V
Sbjct: 41 RTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL------IV 93
Query: 70 VTLQT-------IIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+ I D E + ++ YLH IAH D+KP+NL+
Sbjct: 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 153
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
PN +K+ DF G A E E + DMWSLGV Y+LL
Sbjct: 154 RPNAILKLTDF--------GF------------AKETTG-EKYDKSCDMWSLGVIMYILL 192
Query: 176 TGFSPFGGE----TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
G+ PF I Q +FP+ + ++S E K I +L P +RMT
Sbjct: 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
Query: 232 EALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASK 287
E + HPW+M ++ P + K + + ++ +
Sbjct: 253 EFMNHPWIMQSTKV---------PQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-49
Identities = 66/345 (19%), Positives = 124/345 (35%), Gaps = 69/345 (20%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLS-LCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+++A K++ +EIA L+ L S +I++L+D T + Y+
Sbjct: 32 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM---- 86
Query: 67 PLVVT------LQTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
V L + + D + + L ++ +H I H D+KP N +++
Sbjct: 87 ---VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV- 142
Query: 115 DFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYVAPEIL-----------HYEPITL 160
+ +K+ DF I+ + + +GT +Y+ PE + I+
Sbjct: 143 ---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219
+D+WSLG Y + G +PF + I + + + +D +
Sbjct: 200 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCC 257
Query: 220 LIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALF 279
L ++P +R++ E L HP++ Q + + + E +
Sbjct: 258 LKRDPKQRISIPELLAHPYV---------------------QIQTHPVNQMAKGTTEEMK 296
Query: 280 EKVISASKLQQENLRKSALLKYNKTRRLCESQMSLVSKTREKSLG 324
+ L N A + ES S SKT EK G
Sbjct: 297 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 23/244 (9%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A + + A K L + ++ E+ + S P I++L+ F Y
Sbjct: 27 LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 85
Query: 61 ----YVSWNTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
Y + LQ + D+ + ++ ++L+Y H +++ H DIKP+NL ++G
Sbjct: 86 LILEYAP-LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL-LLG 143
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
++K+ DF S V +L GT DY+ PE++ D+WSLGV Y
Sbjct: 144 S--AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L G PF T ET++ IS+ + FPD ++ A+D I+++L NP +R +E L
Sbjct: 201 LVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVL 256
Query: 235 KHPW 238
+HPW
Sbjct: 257 EHPW 260
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-48
Identities = 65/276 (23%), Positives = 110/276 (39%), Gaps = 54/276 (19%)
Query: 14 TGEVFAAK-FLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV-- 70
G A K L EI LL+ P +++ + T Y + +
Sbjct: 38 QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY-------IALEL 90
Query: 71 ---TLQTII------DDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNL---- 110
LQ ++ D+NL + E + S +A+LH KI H D+KPQN+
Sbjct: 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 111 ------VMMGDFPNCDIKVCDFEISRVILDG-----IEIRELLGTPDYVAPEIL------ 153
N I + DF + + + G + GT + APE+L
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 154 -HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELF---EDI 208
+T + D++S+G Y +L+ G PFG + E+ NI + + +
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSL 268
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
EA D I++++ +P++R TA + L+HP K +
Sbjct: 269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-48
Identities = 60/328 (18%), Positives = 127/328 (38%), Gaps = 54/328 (16%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLS-LCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+++A K++ +EIA L+ L S +I++L+D T + Y+
Sbjct: 79 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM---- 133
Query: 67 PLVVT------LQTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
V L + + D + + L ++ +H I H D+KP N +++
Sbjct: 134 ---VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV- 189
Query: 115 DFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYVAPEIL-----------HYEPITL 160
+ +K+ DF I+ + + +G +Y+ PE + I+
Sbjct: 190 ---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNI--SKAQLDFPDELFEDISPEAKDFIA 217
+D+WSLG Y + G +PF + I +++FPD + +D +
Sbjct: 247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD----IPEKDLQDVLK 302
Query: 218 KILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSI--IQNQQNKKNLRKYLSKSR 275
L ++P +R++ E L HP++ + + ++ + + + Q N + K+
Sbjct: 303 CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362
Query: 276 EALFEKVISASKLQQENLRKSALLKYNK 303
+ L+E + + + K
Sbjct: 363 KTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 24/254 (9%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A + A K L + + ++ EI + S P I+++++ F + Y
Sbjct: 32 LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIY 90
Query: 61 ----YVSWNTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+ L LQ D+ F + +L Y H RK+ H DIKP+NL+M
Sbjct: 91 LMLEFAP-RGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM-- 147
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+ ++K+ DF S V + R + GT DY+ PE++ + D+W GV Y
Sbjct: 148 GY-KGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L G PF + +ET R I L FP +S +KD I+K+L +P +R+ K +
Sbjct: 206 LVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVM 261
Query: 235 KHPW-LMNKKQIMT 247
+HPW N ++++
Sbjct: 262 EHPWVKANSRRVLP 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-46
Identities = 51/289 (17%), Positives = 92/289 (31%), Gaps = 60/289 (20%)
Query: 12 IATGEVFAAKF-----LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
TG++FA K E +L + IVKL + + + V
Sbjct: 31 KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV---- 85
Query: 67 PLVVTLQT-------IIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQN-L 110
L++ + + + E + + +L I H +IKP N +
Sbjct: 86 -LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL--------HYEPITLAA 162
++G+ K+ DF +R + D + L GT +Y+ P++ H +
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 163 DMWSLGVTAYVLLTGFSPF----GGETDSETFRNISKAQ--------------------- 197
D+WS+GVT Y TG PF G + E I +
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
Query: 198 LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246
+ L + +A IL + + + + +
Sbjct: 265 MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-46
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 35/251 (13%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
T EVFA K + + + ++ EI++ + +V H F+ + +
Sbjct: 33 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 91
Query: 61 ----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
+ L + E + YLH ++ H D+K
Sbjct: 92 VVLELCRRRS-----LLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 144
Query: 109 NLVMMGDFPNCDIKVCDFEIS-RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
NL + + + ++K+ DF ++ +V DG + L GTP+Y+APE+L + + D+WS+
Sbjct: 145 NL-FLNE--DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
G Y LL G PF ET+ I K + P I+P A I K+L +P R
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTAR 257
Query: 228 MTAKEALKHPW 238
T E L +
Sbjct: 258 PTINELLNDEF 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 22/248 (8%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
A+SI TG A K ++ + R+ +E+ + P I++L++ F+ Y
Sbjct: 29 RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVY 87
Query: 61 ----YVSWNT--PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+ +N F ++ + YLH I H D+ NL ++
Sbjct: 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL-LLT 146
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELL-GTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
N +IK+ DF ++ + E L GTP+Y++PEI L +D+WSLG Y
Sbjct: 147 R--NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYT 204
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
LL G PF +T T + A + P +S EAKD I ++L +NP +R++
Sbjct: 205 LLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 234 LKHPWLMN 241
L HP++
Sbjct: 261 LDHPFMSR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-45
Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
T EVFA K + + + ++ EI++ + +V H F+ + +
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117
Query: 61 ----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
+ L + E + YLH ++ H D+K
Sbjct: 118 VVLELCRRRS-----LLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 109 NLVMMGDFPNCDIKVCDFEIS-RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
NL + + + ++K+ DF ++ +V DG + L GTP+Y+APE+L + + D+WS+
Sbjct: 171 NL-FLNE--DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
G Y LL G PF ET+ I K + P I+P A I K+L +P R
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTAR 283
Query: 228 MTAKEALKHPWLMNKKQIMTRVGCSSCPS 256
T E L + I R+ +
Sbjct: 284 PTINELLNDEF-FTSGYIPARLPITCLTI 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 40/247 (16%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
G ++A K + R E+ P V+L ++ G Y
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY------- 133
Query: 68 LVVT------LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMM 113
+ T LQ + + L +LA+LH + + HLD+KP N+ +
Sbjct: 134 -LQTELCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
P K+ DF + + G P Y+APE+L AAD++SLG+T
Sbjct: 192 ---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILE 247
Query: 174 LLTGFS-PFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+ P GGE + + P E +S E + + +L +P R TA+
Sbjct: 248 VACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEA 301
Query: 233 ALKHPWL 239
L P L
Sbjct: 302 LLALPVL 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 154 bits (389), Expect = 2e-43
Identities = 33/163 (20%), Positives = 55/163 (33%), Gaps = 12/163 (7%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
+ A L + + H P NL +M P+ + + D G Y
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVSALWK--VGTRGPASSVPVTYA 258
Query: 149 APEIL--HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--ETFRNISKAQLDFPDEL 204
E L T A + W LG++ Y + F PFG T +++ S
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 205 FE---DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
F + K I + L + R+ EA++ P + +
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 37/245 (15%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQT-------------GEGAYYVSWNTPLVVTLQTI 75
+E+ +++ + + + + + L
Sbjct: 89 DFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 76 IDDNLVVPFESDELSSLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134
I ++ L+S +Y+H + I H D+KP N++M D N +K+ DF S ++D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM--DK-NGRVKLSDFGESEYMVD 204
Query: 135 GIEIRELLGTPDYVAPEILHYEPIT--LAADMWSLGVTAYVLLTGFSPFGGETD-SETFR 191
+I+ GT +++ PE E D+WSLG+ YV+ PF + E F
Sbjct: 205 K-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 192 NISKAQLDFPDELFED---------------ISPEAKDFIAKILIKNPMERMTAKEALKH 236
NI +++P + +S E DF+ L KNP ER+T+++ALKH
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 237 PWLMN 241
WL +
Sbjct: 324 EWLAD 328
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 47/307 (15%)
Query: 8 MADSIATGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQT--------- 55
+ T E+ A K++E + EI P IV+ +V T
Sbjct: 38 LMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIME 96
Query: 56 ----GEGAYYVSWNTPLVVT-----LQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIK 106
GE + Q ++ S ++Y H +I H D+K
Sbjct: 97 YASGGELYERICNAGRFSEDEARFFFQQLL-------------SGVSYCHSMQICHRDLK 143
Query: 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITLAAD 163
+N ++ G P +K+CDF S+ + + + +GTP Y+APE+L Y+ AD
Sbjct: 144 LENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG--KIAD 200
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRN----ISKAQLDFPDELFEDISPEAKDFIAKI 219
+WS GVT YV+L G PF + +R I + PD++ ISPE I++I
Sbjct: 201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRI 258
Query: 220 LIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALF 279
+ +P R++ E H W + ++ + +Q ++L + EA
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318
Query: 280 EKVISAS 286
V +
Sbjct: 319 PAVRNRC 325
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 70/238 (29%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 24 ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVV------TLQTII 76
+++ EIA+L P +VKL +V E Y +V + +
Sbjct: 77 RGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLY------MVFELVNQGPVMEVP 129
Query: 77 DDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEI 128
P D+ + + YLH++KI H DIKP NL++ + IK+ DF +
Sbjct: 130 TLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE---DGHIKIADFGV 183
Query: 129 SRVILDGIEIRELL----GTPDYVAPEILHYEPIT---LAADMWSLGVTAYVLLTGFSPF 181
S LL GTP ++APE L A D+W++GVT Y + G PF
Sbjct: 184 SNEFKGS---DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 182 GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
E I L+FPD DI+ + KD I ++L KNP R+ E HPW+
Sbjct: 241 MDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-42
Identities = 43/257 (16%), Positives = 89/257 (34%), Gaps = 35/257 (13%)
Query: 11 SIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70
G+ + K ++ N + E+ L+ IV + + + S
Sbjct: 32 HRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 71 ---------------TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKP 107
TL+ I+ + + Y+H +K+ + D+KP
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSL 167
N + + D +K+ DF + + + + GT Y++PE + + D+++L
Sbjct: 151 SN-IFLVD--TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
G+ LL S+ F ++ + + + K + K+L K P +R
Sbjct: 208 GLILAELLHVCDTA--FETSKFFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDR 259
Query: 228 MTAKEALKHPWLMNKKQ 244
E L+ + K
Sbjct: 260 PNTSEILRTLTVWKKSP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 2e-41
Identities = 27/162 (16%), Positives = 56/162 (34%), Gaps = 25/162 (15%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
+ LA LHH + H ++P ++V+ + + FE DG + +
Sbjct: 216 IRLLASLHHYGLVHTYLRPVDIVLDQR---GGVFLTGFEHLV--RDG-ARVVSSVSRGFE 269
Query: 149 APEILHYE-----------PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ 197
PE+ +T + D W+LG+ Y + P + I ++
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 198 LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
++I + + L +R+ +A++ P
Sbjct: 330 --------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 50/260 (19%)
Query: 8 MADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT------ 55
+A I TG A K + ++ ++ E+ ++ + + P IVKL +V +T
Sbjct: 33 LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL 91
Query: 56 -------GEGAYYVSWNTPL-----VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHL 103
GE Y+ + + + I+ S++ Y H ++I H
Sbjct: 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV-------------SAVQYCHQKRIVHR 138
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITL 160
D+K +NL++ + +IK+ DF S G ++ G P Y APE+ Y+
Sbjct: 139 DLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG--P 193
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220
D+WSLGV Y L++G PF G+ E + + + P + S + ++ + + L
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM----STDCENLLKRFL 249
Query: 221 IKNPMERMTAKEALKHPWLM 240
+ NP++R T ++ +K W+
Sbjct: 250 VLNPIKRGTLEQIMKDRWIN 269
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 59/265 (22%)
Query: 8 MADSIATGEVFAAKFLE-------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----- 55
+ + TG A K L +I EI L L P I+KL+ V T
Sbjct: 29 IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF 87
Query: 56 --------GEGAYYVSWNTPL-----VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAH 102
GE Y+ + + Q I+ S++ Y H + H
Sbjct: 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL-------------SAVDYCHRHMVVH 134
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEILH---Y 155
D+KP+N+++ D + + K+ DF +S ++ DG E L G+P+Y APE++ Y
Sbjct: 135 RDLKPENVLL--D-AHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLY 187
Query: 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215
D+WS GV Y LL G PF E F+ I P+ L +
Sbjct: 188 AG--PEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL----NRSVATL 241
Query: 216 IAKILIKNPMERMTAKEALKHPWLM 240
+ +L +P++R T K+ +H W
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFK 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 63/289 (21%), Positives = 114/289 (39%), Gaps = 43/289 (14%)
Query: 11 SIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
S G + K + E+A+L+ P IV+ + F+ Y
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLY---- 99
Query: 65 NTPLVVT-------LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQN 109
+V L I+ V F+ D+ +L ++H RKI H DIK QN
Sbjct: 100 ----IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155
Query: 110 LVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLG 168
+ + D +++ DF I+RV+ +E+ +GTP Y++PEI +P +D+W+LG
Sbjct: 156 IFLTKDG---TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
Y L T F + I + S + + ++++ +NP +R
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 229 TAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREA 277
+ L+ ++ + + P +I + K K+ S+ A
Sbjct: 270 SVNSILEKGFIAKRIEKFLS------PQLIAEEFCLKTFSKFGSQPIPA 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 53/319 (16%), Positives = 100/319 (31%), Gaps = 63/319 (19%)
Query: 12 IATGEVFAAKF-----LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
TG++FA K E +L + IVKL + + + V
Sbjct: 31 KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKV---- 85
Query: 67 PLVVTLQT-------IIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQN-L 110
L++ + + + E + + +L I H +IKP N +
Sbjct: 86 -LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL--------HYEPITLAA 162
++G+ K+ DF +R + D + L GT +Y+ P++ H +
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 163 DMWSLGVTAYVLLTGFSPF----GGETDSETFRNISKAQ--------------------- 197
D+WS+GVT Y TG PF G + E I +
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
Query: 198 LDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSI 257
+ L + +A IL + + + + + ++ +
Sbjct: 265 MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAH 324
Query: 258 ---IQNQQNKKNLRKYLSK 273
I + + + K
Sbjct: 325 KIYIHSYNTATIFHELVYK 343
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 43/257 (16%)
Query: 8 MADSIATGEVFAAKFLE-----SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
+A + T E A K ++ P I EI + + + +VK + + G Y
Sbjct: 25 LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLF 83
Query: 61 --YVSWNTPLVVTLQTIIDDNLV--VPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
Y S L D + + + ++ + YLH I H DIKP+
Sbjct: 84 LEYCS-GGELF--------DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL---GTPDYVAPEIL---HYEPITLAA 162
NL++ D ++K+ DF ++ V R L GT YVAPE+L +
Sbjct: 135 NLLL--D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA--EPV 189
Query: 163 DMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221
D+WS G+ +L G P+ +DS + + + + + ++ I + KIL+
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILV 247
Query: 222 KNPMERMTAKEALKHPW 238
+NP R+T + K W
Sbjct: 248 ENPSARITIPDIKKDRW 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 61/261 (23%), Positives = 99/261 (37%), Gaps = 51/261 (19%)
Query: 8 MADSIATGEVFAAKFLE----------SNPVRIHHEIALLSLCSPS---PRIVKLHDVFQ 54
+ A K + S+ V E+ALL P +++L D F+
Sbjct: 49 AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108
Query: 55 TGEGAYYVSWNTPLVVT---LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHL 103
T EG V + L I + P ++++ + H R + H
Sbjct: 109 TQEGFMLV---LERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHR 163
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEILHYEPIT 159
DIK +N+++ D K+ DF ++ D GT Y PE +
Sbjct: 164 DIKDENILI--DLRRGCAKLIDFGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYH 216
Query: 160 -LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218
L A +WSLG+ Y ++ G PF + + I +A+L FP + SP+ I +
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHV----SPDCCALIRR 266
Query: 219 ILIKNPMERMTAKEALKHPWL 239
L P R + +E L PW+
Sbjct: 267 CLAPKPSSRPSLEEILLDPWM 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 8e-40
Identities = 28/158 (17%), Positives = 54/158 (34%), Gaps = 18/158 (11%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR--ELLGTPD 146
+ LA LHH + H ++P ++V+ + + FE P+
Sbjct: 221 IRLLASLHHYGLVHTYLRPVDIVLDQR---GGVFLTGFEHLVRDGASAVSPIGRGFAPPE 277
Query: 147 YVAPEILHYEP-----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP 201
A +L + +T A D W+LG+ Y + P + I F
Sbjct: 278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------FR 331
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
++I + + L +R+ +A++ P
Sbjct: 332 SC--KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 73/259 (28%), Positives = 117/259 (45%), Gaps = 50/259 (19%)
Query: 8 MADSIATGEVFAAKFLE-------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----- 55
+A T + A KF+ +R+ EI+ L L P I+KL+DV T
Sbjct: 27 LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV 85
Query: 56 -------GEGAYYVSWNTPL-----VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHL 103
GE Y+ + Q II ++ Y H KI H
Sbjct: 86 MVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII-------------CAIEYCHRHKIVHR 132
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITL 160
D+KP+NL++ N ++K+ DF +S ++ DG ++ G+P+Y APE++ Y
Sbjct: 133 DLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG--P 187
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220
D+WS G+ YV+L G PF E F+ ++ PD L SP A+ I +++
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL----SPGAQSLIRRMI 243
Query: 221 IKNPMERMTAKEALKHPWL 239
+ +PM+R+T +E + PW
Sbjct: 244 VADPMQRITIQEIRRDPWF 262
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 49/255 (19%)
Query: 12 IATGEVFAAKFLE----------SNPVRIHHEIALLSLCS-PSPRIVKLHDVFQTGEGAY 60
++ A K +E N R+ E+ LL S +++L D F+ +
Sbjct: 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124
Query: 61 YVSWNTPLVVTLQTIIDDNLVV---PFESDE--------LSSLAYLHHRKIAHLDIKPQN 109
+ +Q + D + + + L ++ + H+ + H DIK +N
Sbjct: 125 LI---LERPEPVQDLFD--FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 110 LVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEILHYEPIT-LAADM 164
+++ D ++K+ DF ++ D + GT Y PE + Y +A +
Sbjct: 180 ILI--DLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 165 WSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224
WSLG+ Y ++ G PF + I + Q+ F + S E + I L P
Sbjct: 233 WSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV----SSECQHLIRWCLALRP 282
Query: 225 MERMTAKEALKHPWL 239
+R T +E HPW+
Sbjct: 283 SDRPTFEEIQNHPWM 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 43/257 (16%)
Query: 8 MADSIATGEVFAAKFLE-----SNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
+A + T E A K ++ P I EI + + + +VK + + G Y
Sbjct: 25 LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLF 83
Query: 61 --YVSWNTPLVVTLQTIIDDNLV--VPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
Y S L D + + + ++ + YLH I H DIKP+
Sbjct: 84 LEYCS-GGELF--------DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL---GTPDYVAPEIL---HYEPITLAA 162
NL++ D ++K+ DF ++ V R L GT YVAPE+L +
Sbjct: 135 NLLL--D-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA--EPV 189
Query: 163 DMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221
D+WS G+ +L G P+ +DS + + + + + ++ I + KIL+
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILV 247
Query: 222 KNPMERMTAKEALKHPW 238
+NP R+T + K W
Sbjct: 248 ENPSARITIPDIKKDRW 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 59/264 (22%), Positives = 92/264 (34%), Gaps = 49/264 (18%)
Query: 8 MADSIATGEVFAAKFL--------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA 59
T A K L + + EI LL +++L DV E
Sbjct: 23 EVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81
Query: 60 Y------YVSWNTPLVVTLQTIIDDNLVV-PFESDE--------LSSLAYLHHRKIAHLD 104
Y ++ D++ F + + L YLH + I H D
Sbjct: 82 KMYMVMEYCVCGMQEML-------DSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKD 134
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEIL----HYE 156
IKP NL++ +K+ ++ L + G+P + PEI +
Sbjct: 135 IKPGNLLL--T-TGGTLKISALGVAE-ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFI 216
D+WS GVT Y + TG PF G+ + F NI K P D P D +
Sbjct: 191 G--FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG----DCGPPLSDLL 244
Query: 217 AKILIKNPMERMTAKEALKHPWLM 240
+L P +R + ++ +H W
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 82/363 (22%), Positives = 137/363 (37%), Gaps = 66/363 (18%)
Query: 8 MADSIATGEVFAAKFLE-------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----- 55
+ TG A K L +I EI L L P I+KL+ V T
Sbjct: 34 VGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF 92
Query: 56 --------GEGAYYVSWNTPL-----VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAH 102
GE Y+ N L Q I+ S + Y H + H
Sbjct: 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL-------------SGVDYCHRHMVVH 139
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----GTPDYVAPEILH---Y 155
D+KP+N+++ D + + K+ DF +S ++ DG E L G+P+Y APE++ Y
Sbjct: 140 RDLKPENVLL--D-AHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLY 192
Query: 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215
D+WS GV Y LL G PF + F+ I P L +P
Sbjct: 193 AG--PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL----NPSVISL 246
Query: 216 IAKILIKNPMERMTAKEALKHPWL-MNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKS 274
+ +L +PM+R T K+ +H W + + + S ++I ++ K + + S
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEAL-KEVCEKFECS 305
Query: 275 REALFEKVISASKLQQENLRKSA--LLKYNKTRRLCESQMSLVSKTREKSLGDMAISLGR 332
E + + + + ++ A L+ N+ L + + L D ++
Sbjct: 306 EEEVLSCLYNRNH---QDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPH 362
Query: 333 SKE 335
+
Sbjct: 363 PER 365
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-38
Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 43/257 (16%)
Query: 8 MADSIATGEVFAAKFLE------------SNPVRIHHEIALLSLCSPSPRIVKLHDVFQT 55
A + KF++ ++ EIA+LS I+K+ D+F+
Sbjct: 42 TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFEN 100
Query: 56 GEGAYYVSWNTPLVVT---LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLD 104
V + L ID + + +S++ YL + I H D
Sbjct: 101 QGFFQLV---MEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRD 155
Query: 105 IKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEP-ITLAAD 163
IK +N+V+ + IK+ DF + + G GT +Y APE+L P +
Sbjct: 156 IKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223
MWSLGVT Y L+ +PF +A + P + S E ++ +L
Sbjct: 213 MWSLGVTLYTLVFEENPF------CELEETVEAAIHPPYLV----SKELMSLVSGLLQPV 262
Query: 224 PMERMTAKEALKHPWLM 240
P R T ++ + PW+
Sbjct: 263 PERRTTLEKLVTDPWVT 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 22/246 (8%)
Query: 14 TGEVFAAK--FLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTP 67
TG A K LE V E+ + S SPRIV L+ + G +
Sbjct: 82 TGFQCAVKKVRLEVFRVE---ELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLE-GGS 136
Query: 68 LVVTLQT--IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCD 125
L ++ + ++ + + L L YLH R+I H D+K N+++ D +CD
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD--GSRAALCD 194
Query: 126 FEISRVILDGIEIRELL------GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
F + + + LL GT ++APE++ +P D+WS +L G
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 180 PFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P+ I+ E+ +P I + L K P+ R +A E +
Sbjct: 255 PWTQYFRGPLCLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313
Query: 240 MNKKQI 245
++
Sbjct: 314 ALQEVG 319
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-38
Identities = 52/263 (19%), Positives = 98/263 (37%), Gaps = 42/263 (15%)
Query: 11 SIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
+ G++ K L E+ + E+ LL P IV+ +D
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY-- 83
Query: 65 NTPLVVT-------LQTIIDDNLV--VPFESDE--------LSSLAYLHHRK-----IAH 102
+V L ++I + + +L H R + H
Sbjct: 84 ----IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLA 161
D+KP N+ + G ++K+ DF ++R++ + +GTP Y++PE ++
Sbjct: 140 RDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 162 ADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221
+D+WSLG Y L PF + E I + + + S E + I ++L
Sbjct: 197 SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIPYRYSDELNEIITRMLN 253
Query: 222 KNPMERMTAKEALKHPWLMNKKQ 244
R + +E L++P ++
Sbjct: 254 LKDYHRPSVEEILENPLILEHHH 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 49/266 (18%), Positives = 87/266 (32%), Gaps = 43/266 (16%)
Query: 9 ADSIATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
+ + G +A K + + + E + L P I++L GA + +W
Sbjct: 48 VEGLHDGHFYALKRILCHEQQDREEAQREADMHRL-FNHPNILRLVAYCLRERGAKHEAW 106
Query: 65 NTPLVV------TLQTIIDDNLV--VPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
L++ TL I+ D+ L +H + AH D+KP
Sbjct: 107 ---LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPT 163
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL----------GTPDYVAPEILH---Y 155
N +++GD + D +E T Y APE+ +
Sbjct: 164 N-ILLGD--EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH 220
Query: 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKD 214
I D+WSLG Y ++ G P+ ++ + QL P S
Sbjct: 221 CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ--SPRHSSALWQ 278
Query: 215 FIAKILIKNPMERMTAKEALKHPWLM 240
+ ++ +P +R L +
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 56/269 (20%), Positives = 101/269 (37%), Gaps = 44/269 (16%)
Query: 12 IATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
TGE A K N R EI ++ + P +V +V + +
Sbjct: 36 QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQ--KLAPNDL 92
Query: 67 PLVVT-------LQTIIDDN---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNL 110
PL+ L+ ++ + SD S+L YLH +I H D+KP+N+
Sbjct: 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 152
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
V+ K+ D ++ + G E +GT Y+APE+L + T+ D WS G
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDF--------------------PDELFEDISP 210
A+ +TGF PF + + + + P+ L ++
Sbjct: 213 AFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 211 EAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ + ++ +L+ + +R T +
Sbjct: 273 KLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 67/251 (26%), Positives = 98/251 (39%), Gaps = 29/251 (11%)
Query: 14 TGEVFAAK---FLESNPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWN 65
A K +S + +H EIAL IV+ F V
Sbjct: 46 NQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVP-G 103
Query: 66 TPLVVTLQTI-----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQN-LVMMGDFPNC 119
L L++ ++ + + L L YLH +I H DIK N L+ + +
Sbjct: 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI---NTYSG 160
Query: 120 DIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPI--TLAADMWSLGVTAYVLLT 176
+K+ DF S+ + E GT Y+APEI+ P AAD+WSLG T + T
Sbjct: 161 VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220
Query: 177 GFSPFGGETDSET---FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
G PF E F+ + E+ E +S EAK FI K +P +R A +
Sbjct: 221 GKPPFY-ELGEPQAAMFK-V--GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
Query: 234 LKHPWLMNKKQ 244
L +L +
Sbjct: 277 LVDEFLKVSSK 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 52/256 (20%), Positives = 87/256 (33%), Gaps = 35/256 (13%)
Query: 11 SIATGEVFAAKF--LESNP-----VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY--- 60
+ G A K + EI LL + P ++K + F
Sbjct: 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVL 111
Query: 61 -YVSWNTPLVVTLQTIIDD--NLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQN 109
L +I S+L ++H R++ H DIKP N
Sbjct: 112 ELADAGD-----LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 110 LVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLG 168
V + +K+ D + R L+GTP Y++PE +H +D+WSLG
Sbjct: 167 -VFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 169 VTAYVLLTGFSPFGGETDS--ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
Y + SPF G+ + + I + D+P + S E + + + +P +
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEK 281
Query: 227 RMTAKEALKHPWLMNK 242
R M+
Sbjct: 282 RPDVTYVYDVAKRMHA 297
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 49/256 (19%)
Query: 14 TGEVFAAKFL------ESNPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
T +++A K++ E N VR + E+ ++ P +V L FQ E +
Sbjct: 39 TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF------ 91
Query: 67 PLVVTL-----------QTIIDDNLVVPFESDELSS-LAYLHHRKIAHLDIKPQNLVMMG 114
+VV L Q + V EL L YL +++I H D+KP N+++
Sbjct: 92 -MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL-- 148
Query: 115 DFPNCD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI---TLAADMWSL 167
D + + DF I+ ++ +I + GT Y+APE+ + A D WSL
Sbjct: 149 -----DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL 203
Query: 168 GVTAYVLLTGFSPFGGETDS---ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224
GVTAY LL G P+ + + E + +P S E + K+L NP
Sbjct: 204 GVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPNP 259
Query: 225 MERMTAKEALK-HPWL 239
+R + ++ P++
Sbjct: 260 DQRFSQLSDVQNFPYM 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 41/264 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A+ T + FA K L+ + V + ++ +LSL P + + FQT E +
Sbjct: 35 LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94
Query: 61 YVSWNTP---LVVTLQTIIDDNLVVP---FESDELSS-LAYLHHRKIAHLDIKPQNLVMM 113
+V L+ +Q+ + F + E+ L +LH + I + D+K N+++
Sbjct: 95 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL- 151
Query: 114 GDFPNCD----IKVCDFEISR-VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLG 168
D IK+ DF + + +L + GTPDY+APEIL + + D WS G
Sbjct: 152 ------DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG 205
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
V Y +L G SPF G+ + E F +I +P L EAKD + K+ ++ P +R+
Sbjct: 206 VLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL----EKEAKDLLVKLFVREPEKRL 261
Query: 229 TAKEALK-HPW--------LMNKK 243
+ ++ HP L K+
Sbjct: 262 GVRGDIRQHPLFREINWEELERKE 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 35/255 (13%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+A +AT +A K LE + + E ++S P VKL+ FQ E Y
Sbjct: 48 LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLY 106
Query: 61 ----YVSWNTPLVVTLQTIID-DNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQNLVMMG 114
Y N L+ ++ I D F + E+ S+L YLH + I H D+KP+N+++
Sbjct: 107 FGLSYAK-NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL-- 163
Query: 115 DFPNCD--IKVCDFEISRVILDGIEIRE---LLGTPDYVAPEILHYEPITLAADMWSLGV 169
N D I++ DF ++V+ + +GT YV+PE+L + ++D+W+LG
Sbjct: 164 ---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
Y L+ G PF + F+ I K + DFP++ P+A+D + K+L+ + +R+
Sbjct: 221 IIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRLG 276
Query: 230 ------AKEALKHPW 238
HP+
Sbjct: 277 CEEMEGYGPLKAHPF 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 50/272 (18%), Positives = 100/272 (36%), Gaps = 49/272 (18%)
Query: 11 SIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
+ +A K + E ++ E+ L+ P IV+ + + + +
Sbjct: 26 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPS 84
Query: 66 TPLVV-----------TLQTIIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDI 105
+P V L+ ++ + ++ +LH + + H D+
Sbjct: 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDL 144
Query: 106 KPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL-------------GTPDYVAPEI 152
KP N + + +KV DF + + E + +L GT Y++PE
Sbjct: 145 KPSN-IFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQLDFPDELFEDISPE 211
+H + D++SLG+ + LL PF + + T ++ + FP LF P
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK--FP-PLFTQKYPC 255
Query: 212 AKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243
+ +L +PMER A +++ +
Sbjct: 256 EYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 41/266 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+++ T E++A K L+ + V ++ +L+L P + +LH FQT + Y
Sbjct: 359 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418
Query: 61 YVSWNTP---LVVTLQ--TIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q + V + ++ L +L + I + D+K N+++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--- 475
Query: 116 FPNCD----IKVCDFEISR-VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
D IK+ DF + + I DG+ + GTPDY+APEI+ Y+P + D W+ GV
Sbjct: 476 ----DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
Y +L G +PF GE + E F++I + + +P + S EA ++ K+P +R+
Sbjct: 532 LYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGC 587
Query: 229 ---TAKEALKHPW--------LMNKK 243
++ +H + L K+
Sbjct: 588 GPEGERDIKEHAFFRYIDWEKLERKE 613
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 39/268 (14%), Positives = 83/268 (30%), Gaps = 51/268 (19%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVS 63
G ++A K + E+ ++ +V+ + + Y +
Sbjct: 35 DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94
Query: 64 WNTPLVVTLQTIIDDNLVVPFESDE----------LSSLAYLHHRKIAHLDIKPQN---- 109
+ L I +N + E L Y+H + H+DIKP N
Sbjct: 95 GGS-----LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149
Query: 110 ------------LVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE- 156
K+ D I + G ++A E+L
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENY 206
Query: 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFI 216
AD+++L +T + + + I + + + + +S E + +
Sbjct: 207 THLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGR---LPRIPQVLSQEFTELL 260
Query: 217 AKILIKNPMERMTAKEALKHPWLMNKKQ 244
++ +P R +A +KH L++ +
Sbjct: 261 KVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 67/264 (25%), Positives = 126/264 (47%), Gaps = 37/264 (14%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+++ T E++A K L+ + V ++ +L+L P + +LH FQT + Y
Sbjct: 38 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97
Query: 61 YVSWNTP---LVVTLQ--TIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q + V + ++ L +L + I + D+K N+++
Sbjct: 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--- 154
Query: 116 FPNCD--IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+ + IK+ DF + + I DG+ + GTPDY+APEI+ Y+P + D W+ GV Y
Sbjct: 155 --DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM---- 228
+L G +PF GE + E F++I + + +P + S EA ++ K+P +R+
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHPGKRLGCGP 268
Query: 229 -TAKEALKHPW--------LMNKK 243
++ +H + L K+
Sbjct: 269 EGERDIKEHAFFRYIDWEKLERKE 292
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 66/267 (24%), Positives = 121/267 (45%), Gaps = 42/267 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A TG+++A K L+ + + ++ +LSL P + +L FQT + +
Sbjct: 41 LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100
Query: 61 YVSWNTP---LVVTLQ--TIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L+ +Q D+ + ++ +S+L +LH + I + D+K N+++
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--- 157
Query: 116 FPNCD----IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
D K+ DF + + I +G+ GTPDY+APEIL A D W++GV
Sbjct: 158 ----DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
Y +L G +PF E + + F I ++ +P L +A + + KNP R+
Sbjct: 214 LYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL----HEDATGILKSFMTKNPTMRLGS 269
Query: 229 ---TAKEALK-HPW--------LMNKK 243
+ A+ HP+ L +++
Sbjct: 270 LTQGGEHAILRHPFFKEIDWAQLNHRQ 296
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 39/253 (15%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
ATG+++A K LE ++ A +L + S +V L ++T + V
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTL 265
Query: 66 TP---LVVTLQTIIDDNLVVP---FESDEL-SSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
L + + F + E+ L LH +I + D+KP+N+++
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL------ 319
Query: 119 CD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
D I++ D ++ + +G I+ +GT Y+APE++ E T + D W+LG Y +
Sbjct: 320 -DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 175 LTGFSPFGGE----TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
+ G SPF E R + + ++ + SP+A+ +++L K+P ER+
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF----SPQARSLCSQLLCKDPAERLGC 434
Query: 229 ---TAKEALKHPW 238
+A+E +HP
Sbjct: 435 RGGSAREVKEHPL 447
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 58/273 (21%), Positives = 94/273 (34%), Gaps = 46/273 (16%)
Query: 9 ADSIATGEVFAAKFLESNPV----RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
A + +G +A K L SN I E+ + S P IV+ G+
Sbjct: 47 AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106
Query: 65 NTPLVVT-------LQTIIDDNLVVPFESDE--------LSSLAYLHHRK--IAHLDIKP 107
L++T ++ + P D ++ ++H +K I H D+K
Sbjct: 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKV 166
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGI-------------EIRELLGTPDYVAPEILH 154
+NL++ IK+CDF + I E TP Y PEI+
Sbjct: 167 ENLLLSN---QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 155 ---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPE 211
PI D+W+LG Y+L PF + I + P +
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGKYSIPP--HDTQYTV 277
Query: 212 AKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
I +L NP ER++ E + + +
Sbjct: 278 FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 27/250 (10%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+ ATG +A K L+ + E+A +L P + L FQT +
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLC 224
Query: 61 YVSWNTP---LVVTLQT--IIDDNLVVPFESDELSSLAYLHHRK-IAHLDIKPQNLVMMG 114
+V L L + ++ + ++ +S+L YLH K + + D+K +NL++
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 115 DFPNCDIKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
D IK+ DF + + I DG ++ GTP+Y+APE+L A D W LGV Y
Sbjct: 285 D---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM----- 228
++ G PF + + F I ++ FP L PEAK ++ +L K+P +R+
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIRFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 229 TAKEALKHPW 238
AKE ++H +
Sbjct: 398 DAKEIMQHRF 407
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 71/250 (28%), Positives = 112/250 (44%), Gaps = 41/250 (16%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
+++A K L + VR E +L + P IVKLH FQT Y +
Sbjct: 51 ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLR 109
Query: 68 ---LVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
L L V F ++ +L +LH I + D+KP+N+++
Sbjct: 110 GGDLFTRLSK------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---- 159
Query: 117 PNCD--IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
+ + IK+ DF +S+ I + GT +Y+APE+++ T +AD WS GV +
Sbjct: 160 -DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM----- 228
+LTG PF G+ ET I KA+L P L SPEA+ + + +NP R+
Sbjct: 219 MLTGTLPFQGKDRKETMTMILKAKLGMPQFL----SPEAQSLLRMLFKRNPANRLGAGPD 274
Query: 229 TAKEALKHPW 238
+E +H +
Sbjct: 275 GVEEIKRHSF 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 75/266 (28%), Positives = 118/266 (44%), Gaps = 42/266 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+ ATG +A K L + E+A +L P + L FQT +
Sbjct: 23 LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLC 81
Query: 61 YVSWNTP---LVVTLQT--IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+V L L + + + ++ +S+L YLH R + + DIK +NL++
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--- 138
Query: 116 FPNCD----IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
D IK+ DF + + I DG ++ GTP+Y+APE+L A D W LGV
Sbjct: 139 ----DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228
Y ++ G PF + F I ++ FP L SPEAK +A +L K+P +R+
Sbjct: 195 MYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGG 250
Query: 229 ---TAKEALKHPW--------LMNKK 243
AKE ++H + ++ KK
Sbjct: 251 GPSDAKEVMEHRFFLSINWQDVVQKK 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD----IKVCDFEISRV-ILDGIEIRELLG 143
+L +LH + I + D+KP+N+++ + +K+ DF + + I DG G
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIML-------NHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE 203
T +Y+APEIL A D WSLG Y +LTG PF GE +T I K +L+ P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
Query: 204 LFEDISPEAKDFIAKILIKNPMERM-----TAKEALKHPW 238
L + EA+D + K+L +N R+ A E HP+
Sbjct: 244 L----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 69/266 (25%), Positives = 106/266 (39%), Gaps = 42/266 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+A A +A K L+ + E +L P +V LH FQT + Y
Sbjct: 56 LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 61 YVSWNTP---LVVTLQ--TIIDDNLVVPFESDELSS-LAYLHHRKIAHLDIKPQNLVMMG 114
+V L LQ + F + E++S L YLH I + D+KP+N+++
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRAR-FYAAEIASALGYLHSLNIVYRDLKPENILL-- 172
Query: 115 DFPNCD----IKVCDFEIS-RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGV 169
D I + DF + I GTP+Y+APE+LH +P D W LG
Sbjct: 173 -----DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 170 TAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228
Y +L G PF +E + NI L + + A+ + +L K+ +R+
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI----TNSARHLLEGLLQKDRTKRLG 283
Query: 229 ---TAKEALKHPW--------LMNKK 243
E H + L+NKK
Sbjct: 284 AKDDFMEIKSHVFFSLINWDDLINKK 309
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 57/256 (22%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVS-- 63
ATG+++A K L ++ +L+ S IV L F+T V
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTI 266
Query: 64 -------WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
++ V + + + + +S L +LH R I + D+KP+N+++
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---- 322
Query: 117 PNCD----IKVCDFEIS-RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
D +++ D ++ + + + GTP ++APE+L E + D ++LGVT
Sbjct: 323 ---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTL 379
Query: 172 YVLLTGFSPFGGE----TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227
Y ++ PF + E + + + + +PD+ SP +KDF +L K+P +R
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKR 435
Query: 228 M-----TAKEALKHPW 238
+ + HP
Sbjct: 436 LGFRDGSCDGLRTHPL 451
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 41/249 (16%)
Query: 14 TGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+G +A K L+ V +E +L + P +VKL F+ Y V
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV---M 120
Query: 67 PLVV--TLQTIID-----DNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
V + + + F + ++ + YLH + + D+KP+NL++
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------ 174
Query: 119 CD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
D I+V DF ++ + L GTP+ +APEI+ + A D W+LGV Y +
Sbjct: 175 -DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-----T 229
G+ PF + + + I ++ FP S + KD + +L + +R
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 230 AKEALKHPW 238
+ H W
Sbjct: 288 VNDIKNHKW 296
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 33/250 (13%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
+T +V+A K L + + A +++ + SP +V+L FQ Y V
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEY 150
Query: 66 TP---LVVTLQTIIDDNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD- 120
P LV + F + E+ +L +H H D+KP N+++ D
Sbjct: 151 MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-------DK 203
Query: 121 ---IKVCDFEIS-RVILDGIEI-RELLGTPDYVAPEILHYEPI----TLAADMWSLGVTA 171
+K+ DF ++ +G+ +GTPDY++PE+L + D WS+GV
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 172 YVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT-- 229
Y +L G +PF ++ T+ I + DIS EAK+ I + + R+
Sbjct: 264 YEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRN 322
Query: 230 -AKEALKHPW 238
+E +H +
Sbjct: 323 GVEEIKRHLF 332
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 54/279 (19%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+ T ++A K ++ V +I + S P +V LH FQT +
Sbjct: 27 LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86
Query: 61 ----YVSWNTPLVVTLQ--TIIDDNLVVPFESDELSS-LAYLHHRKIAHLDIKPQNLVMM 113
YV+ L+ +Q + + F S E+S L YLH R I + D+K N+++
Sbjct: 87 FVIEYVN-GGDLMFHMQRQRKLPEEHAR-FYSAEISLALNYLHERGIIYRDLKLDNVLL- 143
Query: 114 GDFPNCD----IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLG 168
D IK+ D+ + + + G GTP+Y+APEIL E + D W+LG
Sbjct: 144 ------DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 197
Query: 169 VTAYVLLTGFSPFG---------GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219
V + ++ G SPF T+ F+ I + Q+ P L S +A +
Sbjct: 198 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKAASVLKSF 253
Query: 220 LIKNPMERM------TAKEALKHPW-------LMNKKQI 245
L K+P ER+ + HP+ +M +KQ+
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 74/255 (29%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
+VFA K L + E A +L S I LH FQ Y V
Sbjct: 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDY 155
Query: 66 TP---LVVTLQTIID--DNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
L+ L D + F E+ ++ +H H DIKP N++M
Sbjct: 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM------- 208
Query: 120 D----IKVCDFEIS-RVILDGIEIRELL-GTPDYVAPEILHYEPI-----TLAADMWSLG 168
D I++ DF +++ DG + GTPDY++PEIL D WSLG
Sbjct: 209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 169 VTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
V Y +L G +PF E+ ET+ I K + FP ++ D+S AKD I + LI +
Sbjct: 269 VCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV-TDVSENAKDLIRR-LICSREH 326
Query: 227 RMT---AKEALKHPW 238
R+ ++ KHP+
Sbjct: 327 RLGQNGIEDFKKHPF 341
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 67/257 (26%), Positives = 108/257 (42%), Gaps = 41/257 (15%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG+V+A K + + E++ +L I +LH FQ Y V
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYLVMEY 142
Query: 66 TP---LVVTLQ---TIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
L+ L I + + ++ + ++ +H H DIKP N+++
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL------- 195
Query: 120 D----IKVCDFEIS-RVILDGIEIRELL-GTPDYVAPEIL-------HYEPITLAADMWS 166
D I++ DF ++ DG + GTPDY++PEIL D W+
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 167 LGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDELFEDISPEAKDFIAKILIKNP 224
LGV AY + G +PF ++ +ET+ I K L P E + EA+DFI + L+ P
Sbjct: 256 LGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD-EGVPEEARDFIQR-LLCPP 313
Query: 225 MERMT---AKEALKHPW 238
R+ A + HP+
Sbjct: 314 ETRLGRGGAGDFRTHPF 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 54/247 (21%), Positives = 106/247 (42%), Gaps = 25/247 (10%)
Query: 14 TGEVFAAKFLESNPV------RIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNT 66
T A L+ + R E +L P IV+ +D ++ T +G + T
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVT 108
Query: 67 PLVV--TLQTII------DDNLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDF 116
L+ TL+T + ++ + L L +LH R I H D+K N+ + G
Sbjct: 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-- 166
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
P +K+ D ++ + + ++GTP+++APE+ E + D+++ G+ + T
Sbjct: 167 PTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT 224
Query: 177 GFSPFGGETD-SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
P+ + ++ +R ++ P + PE K+ I + +N ER + K+ L
Sbjct: 225 SEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
Query: 236 HPWLMNK 242
H + +
Sbjct: 283 HAFFQEE 289
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 61/259 (23%)
Query: 14 TGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
G +A K L+ V + E +LS+ + P I+++ FQ + + +
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI---- 84
Query: 67 PLVVTLQTIID-----------------DNLVVPFESDEL-SSLAYLHHRKIAHLDIKPQ 108
+D N V F + E+ +L YLH + I + D+KP+
Sbjct: 85 ---------MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135
Query: 109 NLVMMGDFPNCD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADM 164
N+++ D IK+ DF ++ + D L GTPDY+APE++ +P + D
Sbjct: 136 NILL-------DKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDW 186
Query: 165 WSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224
WS G+ Y +L G++PF +T+ I A+L FP + + KD +++++ ++
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF----NEDVKDLLSRLITRDL 242
Query: 225 MERM-----TAKEALKHPW 238
+R+ ++ HPW
Sbjct: 243 SQRLGNLQNGTEDVKNHPW 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 54/279 (19%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHEIA-------LLSLCSPSPRIVKLHDVFQTGEGAY 60
+ T ++A + ++ V +I + S P +V LH FQT +
Sbjct: 70 LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129
Query: 61 ----YVSWNTPLVVTLQT--IIDDNLVVPFESDELSS-LAYLHHRKIAHLDIKPQNLVMM 113
YV+ L+ +Q + + F S E+S L YLH R I + D+K N+++
Sbjct: 130 FVIEYVN-GGDLMFHMQRQRKLPEEHAR-FYSAEISLALNYLHERGIIYRDLKLDNVLL- 186
Query: 114 GDFPNCD----IKVCDFEISRV-ILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLG 168
D IK+ D+ + + + G GTP+Y+APEIL E + D W+LG
Sbjct: 187 ------DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 169 VTAYVLLTGFSPFG---------GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219
V + ++ G SPF T+ F+ I + Q+ P L S +A +
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKAASVLKSF 296
Query: 220 LIKNPMERM------TAKEALKHPW-------LMNKKQI 245
L K+P ER+ + HP+ +M +KQ+
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 62/281 (22%)
Query: 9 ADSIATGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
A +I E K L PV +I EI +L P I+ L D+ + VS
Sbjct: 55 AINITNNEKVVVKIL--KPVKKKKIKREIKILENLRGGPNIITLADIVKD-----PVSRT 107
Query: 66 TPLVVT------LQTIID---DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
LV + + D + + + L +L Y H I H D+KP N+ M D
Sbjct: 108 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV--MIDH 165
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAY 172
+ +++ D+ ++ G E + + + PE+L Y + DMWSLG
Sbjct: 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY---DYSLDMWSLGCMLA 222
Query: 173 VLLTGFSPF-----------------GGETDSETFRNI---------------SKAQLD- 199
++ PF G E + S+ + +
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 200 -FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
E +SPEA DF+ K+L + R+TA+EA++HP+
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 45/194 (23%), Positives = 78/194 (40%), Gaps = 32/194 (16%)
Query: 71 TLQTIIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
L+ ++ + ++ +LH + + H D+KP N+ D +
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVV 203
Query: 122 KVCDFEISRVILDGIEIRELL-------------GTPDYVAPEILHYEPITLAADMWSLG 168
KV DF + + E + +L GT Y++PE +H + D++SLG
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKA-QLDFPDELFEDISPEAKDFIAKILIKNPMER 227
+ + LL FS T E R I+ L FP LF P+ + +L +P ER
Sbjct: 264 LILFELLYSFS-----TQMERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTER 317
Query: 228 MTAKEALKHPWLMN 241
A + +++ N
Sbjct: 318 PEATDIIENAIFEN 331
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 40/263 (15%)
Query: 14 TGEVFAAKF--LESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS---W- 64
+G++ A K N R+ ++ + P V + GA + W
Sbjct: 31 SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY-------GALFREGDVWI 83
Query: 65 -----NTPLVVTLQTIIDDNLVVPFES-------DELSSLAYLHH-RKIAHLDIKPQNLV 111
+T L + +ID +P E + +L +LH + H D+KP N++
Sbjct: 84 CMELMDTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVL 142
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI----TLAADMWSL 167
+ +K+CDF IS ++D + G Y+APE ++ E ++ +D+WSL
Sbjct: 143 INA---LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199
Query: 168 GVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI-SPEAKDFIAKILIKNPME 226
G+T L P+ ++ F+ + + + +L D S E DF ++ L KN E
Sbjct: 200 GITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 227 RMTAKEALKHPWLMNKKQIMTRV 249
R T E ++HP+ + T V
Sbjct: 258 RPTYPELMQHPFFTLHESKGTDV 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 59/256 (23%), Positives = 103/256 (40%), Gaps = 23/256 (8%)
Query: 12 IATGEVFAAKF--LESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
TG V A K N RI ++ ++ P IV+ F T +
Sbjct: 47 RKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106
Query: 63 -SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCD 120
+ L +Q I + ++ + +L YL + H D+KP N+++
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE---RGQ 163
Query: 121 IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI-----TLAADMWSLGVTAYVLL 175
IK+CDF IS ++D G Y+APE + + AD+WSLG++ L
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDI--SPEAKDFIAKILIKNPMERMTAKEA 233
TG P+ + F ++K + P L + S + + F+ L K+ +R +
Sbjct: 224 TGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
Query: 234 LKHPWLMNKKQIMTRV 249
L+H ++ + + V
Sbjct: 282 LEHSFIKRYETLEVDV 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 62/266 (23%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 14 TGEVFAAKF--LESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS---W- 64
+G++ A K + ++ ++ ++ S P IV+ + GA + W
Sbjct: 46 SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY-------GALFREGDCWI 98
Query: 65 -----NTPLVVTLQTIIDDNLVVPFESDELSS--------LAYLHH-RKIAHLDIKPQNL 110
+T + + L + L L +L KI H DIKP N+
Sbjct: 99 CMELMSTSFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNI 157
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPI----TLAADMWS 166
++ + +IK+CDF IS ++D I G Y+APE + + +D+WS
Sbjct: 158 LLDR---SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214
Query: 167 LGVTAYVLLTGFSPFGG-ETDSETFRNISKAQL-DFPDELFEDISPEAKDFIAKILIKNP 224
LG+T Y L TG P+ + + + K + + SP +F+ L K+
Sbjct: 215 LGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274
Query: 225 MERMTAKEALKHPWLMNKKQIMTRVG 250
+R KE LKHP+++ ++ V
Sbjct: 275 SKRPKYKELLKHPFILMYEERAVEVA 300
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/260 (20%), Positives = 105/260 (40%), Gaps = 53/260 (20%)
Query: 13 ATGEVFAAKFLESNPVRIHHEIA-------LLSLCS--PSPRIVKLHDVFQTGEGAYYVS 63
TG+++A K L+ +++ +LSL S P IV + F T +
Sbjct: 212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS--- 268
Query: 64 WNTPLVVTL------------QTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLV 111
++ L + + + + ++ + L ++H+R + + D+KP N++
Sbjct: 269 ----FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 112 MMGDFPNCD----IKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY-EPITLAADMWS 166
+ D +++ D ++ + +GT Y+APE+L +AD +S
Sbjct: 325 L-------DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFS 376
Query: 167 LGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223
LG + LL G SPF E R ++ PD SPE + + +L ++
Sbjct: 377 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF----SPELRSLLEGLLQRD 432
Query: 224 PMERM-----TAKEALKHPW 238
R+ A+E + P+
Sbjct: 433 VNRRLGCLGRGAQEVKESPF 452
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 67/268 (25%)
Query: 14 TGEVFAAKFLESNPVRIHHEIA--------LLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG+++A K L+ + + +L SP +V LH FQT + +
Sbjct: 81 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI--- 137
Query: 66 TPLVVTLQTIID-----------------DNLVVPFESDELSS-LAYLHHRKIAHLDIKP 107
+D V E+ L +LH I + DIK
Sbjct: 138 ----------LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 187
Query: 108 QNLVMMGDFPNCD----IKVCDFEISRVILDGIEIRE--LLGTPDYVAPEILHYEPI--T 159
+N+++ D + + DF +S+ + R GT +Y+AP+I+
Sbjct: 188 ENILL-------DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 160 LAADMWSLGVTAYVLLTGFSPFGGE----TDSETFRNISKAQLDFPDELFEDISPEAKDF 215
A D WSLGV Y LLTG SPF + + +E R I K++ +P E+ S AKD
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM----SALAKDL 296
Query: 216 IAKILIKNPMERM-----TAKEALKHPW 238
I ++L+K+P +R+ A E +H +
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 17/245 (6%)
Query: 9 ADSIATGEVFAAKFLESNPVR-----IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY--- 60
T +V A K ++ I EI +LS C SP + K + + +
Sbjct: 41 GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIM 99
Query: 61 -YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
Y+ + L + +D+ + + L L YLH K H DIK N V++ + +
Sbjct: 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN-VLLSE--HG 156
Query: 120 DIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
++K+ DF ++ + D R +GTP ++APE++ AD+WSLG+TA L G
Sbjct: 157 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
P + I K P L + S K+F+ L K P R TAKE LKH +
Sbjct: 217 PPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273
Query: 239 LMNKK 243
++
Sbjct: 274 ILRNA 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 43/206 (20%)
Query: 44 PRIVKLHDVFQ----TGEGAYYVSWNTPLV------VTLQTIIDDNL----VVPFESDEL 89
P IV++ + + G+ Y +V +L+ L + + + L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGY------IVMEYVGGQSLKRSKGQKLPVAEAIAYLLEIL 192
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYV 148
+L+YLH + + D+KP+N+++ + +K+ D I G L GTP +
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRINSFGY----LYGTPGFQ 244
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE-D 207
APEI+ P T+A D++++G T L G P++
Sbjct: 245 APEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LPEDDPVLK 292
Query: 208 ISPEAKDFIAKILIKNPMER-MTAKE 232
+ + + +P +R TA+E
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEE 318
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 35/266 (13%)
Query: 9 ADSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV- 62
A E A K + +++ + EI +S C P IV + F + + V
Sbjct: 34 AYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVM 92
Query: 63 ------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNL 110
++D++ + + L L YLH H D+K N
Sbjct: 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN- 151
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELL------GTPDYVAPE-ILHYEPITLAAD 163
+++G+ + +++ DF +S + G +I GTP ++APE + AD
Sbjct: 152 ILLGE--DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKA---QLDFPDELFEDI---SPEAKDFIA 217
+WS G+TA L TG +P+ + + L+ + E + + I+
Sbjct: 210 IWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS 269
Query: 218 KILIKNPMERMTAKEALKHPWLMNKK 243
L K+P +R TA E L+H + K
Sbjct: 270 LCLQKDPEKRPTAAELLRHKFFQKAK 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 60/261 (22%), Positives = 109/261 (41%), Gaps = 35/261 (13%)
Query: 9 ADSIATGEVFAAKF--LESNPVR-IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS-- 63
+ TG++ A K + + I EI +L S I + F
Sbjct: 43 GRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102
Query: 64 WNTPLVV-------TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
W +V ++ +I + + + L L++LH K+ H DIK Q
Sbjct: 103 W----LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLA-----A 162
N V++ + N ++K+ DF +S + + R +GTP ++APE++ + A +
Sbjct: 159 N-VLLTE--NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 163 DMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222
D+WSLG+TA + G P I + P + S + + FI L+K
Sbjct: 216 DLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVK 273
Query: 223 NPMERMTAKEALKHPWLMNKK 243
N +R ++ +KHP++ ++
Sbjct: 274 NHSQRPATEQLMKHPFIRDQP 294
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 81/290 (27%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH-----------EIALLSLCSPSPRIVKLHDVFQTGE 57
A T E A K +R+ H E++LL I++L V
Sbjct: 53 AIDTVTNETVAIK-----RIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106
Query: 58 GAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDI 105
+ Y + L+ +D N ++ + + H R+ H D+
Sbjct: 107 RLHLIFEYAEND------LKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDL 158
Query: 106 KPQNLVMMGDFPNCD--IKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL----H 154
KPQNL++ + +K+ DF ++R GI IR+ T + Y PEIL H
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQF--THEIITLWYRPPEILLGSRH 214
Query: 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA------------------ 196
Y + D+WS+ +L F G+++ + I +
Sbjct: 215 YST---SVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 197 QLDFP--------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ FP L + E D + +L +P++R++AK AL+HP+
Sbjct: 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 74/309 (23%)
Query: 9 ADSIATGEVFAAK-FLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
+ TG++ A K FLES EI +L P +V L +VF+ +
Sbjct: 22 CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV 80
Query: 61 --YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNL 110
Y + +D L ++ + H H D+KP+N+
Sbjct: 81 FEYCDHT------VLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV------APEIL----HYEPITL 160
++ + IK+CDF +R++ D V +PE+L Y P
Sbjct: 134 LITK---HSVIKLCDFGFARLL--TGPSDYY--D-DEVATRWYRSPELLVGDTQYGP--- 182
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------------QLDFP 201
D+W++G LL+G + G++D + I K + P
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242
Query: 202 D--------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSS 253
D F +IS A + L +P ER+T ++ L HP+ N ++I
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302
Query: 254 CPSIIQNQQ 262
P+ Q
Sbjct: 303 KPAENLYFQ 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 59/252 (23%), Positives = 108/252 (42%), Gaps = 64/252 (25%)
Query: 33 EIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE 88
EI++L IVKL+DV T + ++ + L+ ++D ES
Sbjct: 50 EISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQD------LKKLLDVCEG-GLESVT 101
Query: 89 --------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140
L+ +AY H R++ H D+KPQNL++ ++K+ DF ++R GI +R+
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAF--GIPVRK 156
Query: 141 LLGTPD-----YVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFR 191
T + Y AP++L Y D+WS+G ++ G F G ++++
Sbjct: 157 Y--THEIVTLWYRAPDVLMGSKKYST---TIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 192 NISKA------------------QLDFP-------DELFEDISPEAKDFIAKILIKNPME 226
I + +F + + + D ++K+L +P +
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 227 RMTAKEALKHPW 238
R+TAK+AL+H +
Sbjct: 272 RITAKQALEHAY 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 46/252 (18%), Positives = 77/252 (30%), Gaps = 38/252 (15%)
Query: 14 TGEVFAAKFLE-SNPVRIHHEIALLSLCSPS--PRIVKLHDVFQTGEGAYYVSWNTPLVV 70
+ F K + +NP + L+ PS +K + G+ V L
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV---GELYS 150
Query: 71 --TLQTII-----------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
TL I LV+ F L + +H +I H DIKP N ++ F
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210
Query: 118 NCD--------IKVCDFEIS---RVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWS 166
D + + D S ++ G T + E+L +P D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 167 LGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226
+ T Y +L G E F D+ +F +L
Sbjct: 271 VAATVYCMLFGTYMKVKNEGGECKPEGL-----FRRLPHLDMW---NEFFHVMLNIPDCH 322
Query: 227 RMTAKEALKHPW 238
+ + + L+
Sbjct: 323 HLPSLDLLRQKL 334
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 9 ADSIATGEVFAAKF--LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
A TG++ A K +ES+ I EI+++ C SP +VK + + + V
Sbjct: 48 AIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 63 ---SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
S + ++ + ++ + L L YLH + H DIK N +++
Sbjct: 107 GAGSV-SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN-ILLNT--EG 162
Query: 120 DIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
K+ DF ++ + D + R ++GTP ++APE++ AD+WSLG+TA + G
Sbjct: 163 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 179 SPFGGETDSETFRNISKA---QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
P+ I P+ S DF+ + L+K+P +R TA + L+
Sbjct: 223 PPYADIHPMRAIFMIPTNPPPTFRKPELW----SDNFTDFVKQCLVKSPEQRATATQLLQ 278
Query: 236 HPWLMNKK 243
HP++ + K
Sbjct: 279 HPFVRSAK 286
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 69/255 (27%)
Query: 33 EIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE 88
EI+LL P IV L DV + ++ + L+ ++D+N + +
Sbjct: 69 EISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKT-GLQDSQ 120
Query: 89 --------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD--IKVCDFEISRVILDGIEI 138
L +A+ H +I H D+KPQNL++ N D +K+ DF ++R GI +
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI-----NSDGALKLADFGLARAF--GIPV 173
Query: 139 RELLGTPD-----YVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET 189
R T + Y AP++L Y + D+WS+G ++TG F G TD +
Sbjct: 174 RSY--THEVVTLWYRAPDVLMGSKKYST---SVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 190 FRNISKA-------------------QLDFPD-------ELFEDISPEAKDFIAKILIKN 223
I Q F + E D ++ +L +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288
Query: 224 PMERMTAKEALKHPW 238
P +R++A++A+ HP+
Sbjct: 289 PNKRISARDAMNHPY 303
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 74/285 (25%)
Query: 9 ADSIATGEVFAAK-FLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
+ TG + A K FLES+ EI LL +V L +V + + Y
Sbjct: 44 CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLV 102
Query: 61 --YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNL 110
+V + ++ + ++ + + H I H DIKP+N+
Sbjct: 103 FEFVDHT------ILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155
Query: 111 VMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV------APEIL----HYEPITL 160
++ + +K+CDF +R + D V APE+L Y
Sbjct: 156 LVSQ---SGVVKLCDFGFARTL--AAPGEVY--D-DEVATRWYRAPELLVGDVKYGK--- 204
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------------QLDFP 201
A D+W++G + G F G++D + +I + P
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 202 D--------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ + +S D K L +P +R E L H +
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-26
Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 81/288 (28%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH-----------EIALLSLCSPSPRIVKLHDVFQTGE 57
A + T E+ A K VR+ EI LL IV+LHDV + +
Sbjct: 21 AKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDK 74
Query: 58 GAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDI 105
+ + L+ D + + L L + H R + H D+
Sbjct: 75 KLTLVFEFCDQD------LKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 106 KPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL----HYE 156
KPQNL++ N ++K+ +F ++R GI +R + + Y P++L Y
Sbjct: 128 KPQNLLIN---RNGELKLANFGLARAF--GIPVRCY--SAEVVTLWYRPPDVLFGAKLYS 180
Query: 157 PITLAADMWSLGVTAYVLLTGFSP-FGGETDSETFRNISKA-------------QL---- 198
+ DMWS G L P F G + + I + +L
Sbjct: 181 T---SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 199 DFPD--------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+P + ++ +D + +L NP++R++A+EAL+HP+
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 57/247 (23%), Positives = 116/247 (46%), Gaps = 20/247 (8%)
Query: 9 ADSIATGEVFAAKF--LESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A +G A K L R + +E+ ++ +V+++ + GE +
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLME 122
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
++ + Q +++ + L +LAYLH + + H DIK ++++ D
Sbjct: 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GR 179
Query: 121 IKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF I + R+ L+GTP ++APE++ D+WSLG+ ++ G
Sbjct: 180 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 180 PFGGETDSETFRNISKA---QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ ++ + + + + +L ++ SP +DF+ ++L+++P ER TA+E L H
Sbjct: 240 PYFSDSPVQAMKRLRDSPPPKLKNSHKV----SPVLRDFLERMLVRDPQERATAQELLDH 295
Query: 237 PWLMNKK 243
P+L+
Sbjct: 296 PFLLQTG 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 68/297 (22%), Positives = 110/297 (37%), Gaps = 72/297 (24%)
Query: 12 IATGEVFAAKF--LESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+G V A K LE P +I E+ +L C+ SP IV + GA+Y
Sbjct: 55 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFY-------GAFYSDGEI 106
Query: 67 PLVV------TLQTIIDDNLVVPFES-------DELSSLAYLHH-RKIAHLDIKPQNLVM 112
+ + +L ++ +P E + L YL KI H D+KP N+++
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 165
Query: 113 MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+IK+CDF +S ++D + +GT Y++PE L ++ +D+WS+G++
Sbjct: 166 NS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPD---------------------------ELF 205
+ G P E EL
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 206 EDI-------------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRV 249
+ I S E +DF+ K LIKNP ER K+ + H ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 64/288 (22%), Positives = 103/288 (35%), Gaps = 80/288 (27%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHH----------EIALLSLCSPSPRIVKLHDVFQTGE 57
S T + A K +R+ H E++LL IV LHD+ T +
Sbjct: 20 KGKSKLTDNLVALK-----EIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEK 73
Query: 58 GAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDI 105
Y+ + L+ +DD L LAY H +K+ H D+
Sbjct: 74 SLTLVFEYLDKD------LKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126
Query: 106 KPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL----HYE 156
KPQNL++ ++K+ DF ++R I + + Y P+IL Y
Sbjct: 127 KPQNLLIN---ERGELKLADFGLARAK--SIPTKTY--DNEVVTLWYRPPDILLGSTDYS 179
Query: 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------------Q 197
DMW +G Y + TG F G T E I +
Sbjct: 180 T---QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 198 LDFPD-------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
++P + + D + K+L R++A++A+KHP+
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 35/240 (14%)
Query: 8 MADSIATGEVFAAKFL-ESNPV-RIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVS 63
M++++++ VF + E+ R+ P +V +HD GE G YV
Sbjct: 67 MSETLSSDPVFRTRMQREARTAGRLQE-----------PHVVPIHDF---GEIDGQLYVD 112
Query: 64 WNTPLV--VTLQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
L+ V L ++ V S+L H H D+KP+N +++
Sbjct: 113 --MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPEN-ILVS- 168
Query: 116 FPNCDIKVCDFEISRVILD-GI-EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
+ + DF I+ D + ++ +GT Y+APE T AD+++L Y
Sbjct: 169 -ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER-MTAKE 232
LTG P+ G+ S +I+ + P + I IA+ + KNP +R +T +
Sbjct: 228 CLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 65/247 (26%), Positives = 119/247 (48%), Gaps = 20/247 (8%)
Query: 9 ADSIATGEVFAAKF--LESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A +ATG+ A + L+ P + I +EI ++ +P IV D + G+ +
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVME 97
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
Y++ + V +T +D+ + + L +L +LH ++ H DIK N +++G +
Sbjct: 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN-ILLGM--DGS 154
Query: 121 IKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF I R ++GTP ++APE++ + D+WSLG+ A ++ G
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 180 PFGGETDSETFRNISKA---QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ E I+ +L P++L S +DF+ + L + +R +AKE L+H
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDFLNRCLEMDVEKRGSAKELLQH 270
Query: 237 PWLMNKK 243
+L K
Sbjct: 271 QFLKIAK 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 29/255 (11%)
Query: 9 ADSIATGEVFAAKF--LESNPVR--IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-- 62
A + TG + AAK +S EI +L+ C P IVKL + + +
Sbjct: 38 AKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIE 96
Query: 63 -----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
+ +++ L + + + L +L +LH ++I H D+K N V+M
Sbjct: 97 FCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN-VLMTL-- 152
Query: 118 NCDIKVCDFEISRVILDGIEIRE-LLGTPDYVAPEILHYEPITLA-----ADMWSLGVTA 171
DI++ DF +S L ++ R+ +GTP ++APE++ E + AD+WSLG+T
Sbjct: 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 172 YVLLTGFSPFGGETDSETFRNISKA---QLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
+ P I+K+ L P + S E +DF+ L KNP R
Sbjct: 213 IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW----SVEFRDFLKIALDKNPETRP 268
Query: 229 TAKEALKHPWLMNKK 243
+A + L+HP++ +
Sbjct: 269 SAAQLLEHPFVSSIT 283
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 67/295 (22%), Positives = 104/295 (35%), Gaps = 87/295 (29%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH----------EIALLSLCSPSPRIVKLHDVFQTGEG 58
+ TG A K V++ EI+L+ IV+L+DV T
Sbjct: 24 GLNKTTGVYVALK-----EVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENK 77
Query: 59 AY----YVSWNTPLVVTLQTIIDDNLVV----PFESDE--------LSSLAYLHHRKIAH 102
++ + L+ +D V E + L LA+ H KI H
Sbjct: 78 LTLVFEFMDND------LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL---- 153
D+KPQNL++ +K+ DF ++R GI + + + Y AP++L
Sbjct: 132 RDLKPQNLLIN---KRGQLKLGDFGLARAF--GIPVNTF--SSEVVTLWYRAPDVLMGSR 184
Query: 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE------------------------- 188
Y + D+WS G ++TG F G D E
Sbjct: 185 TYST---SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 189 ---TFRNISKAQLD--FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ L E + DF+ +L NP R++AK+AL HPW
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 37/242 (15%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHE---IALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
+ E +F E + LS IV + DV + + Y
Sbjct: 44 IFIPPREKEETLKRF--------EREVHNSSQLS----HQNIVSMIDVDEEDDCYYLVME 91
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFE------SDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
Y+ TL I+ + + + + L + + H +I H DIKPQN +++
Sbjct: 92 YIEG-----PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQN-ILID 145
Query: 115 DFPNCDIKVCDFEISRVILDG--IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
N +K+ DF I++ + + + +LGT Y +PE E D++S+G+ Y
Sbjct: 146 S--NKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 173 VLLTGFSPFGGETD-SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER-MTA 230
+L G PF GET S ++I + + ++ +DI + I + K+ R T
Sbjct: 204 EMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTI 263
Query: 231 KE 232
+E
Sbjct: 264 QE 265
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 71/269 (26%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPL------VVT------LQTII 76
EI ++ IVK+ ++ + +V L ++
Sbjct: 54 HALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL 112
Query: 77 DDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127
+ + +E L L Y+H + H D+KP NL + + + +K+ DF
Sbjct: 113 EQGPL----LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFG 166
Query: 128 ISRVILDGIEIRELLGTPDYV------APEIL----HYEPITLAADMWSLGVTAYVLLTG 177
++R++ + L + + +P +L +Y T A DMW+ G +LTG
Sbjct: 167 LARIMDPHYSHKGHL--SEGLVTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLTG 221
Query: 178 FSPFGGET---------------DSETFRNIS------------KAQLDFPDELFEDISP 210
+ F G E + + + +L IS
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISR 280
Query: 211 EAKDFIAKILIKNPMERMTAKEALKHPWL 239
EA DF+ +IL +PM+R+TA+EAL HP++
Sbjct: 281 EAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 62/290 (21%), Positives = 104/290 (35%), Gaps = 78/290 (26%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH--------------EIALLSLCSPS--PRIVKLHDV 52
A +G A K VR+ + E+ALL P +V+L DV
Sbjct: 28 ARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 53 FQTGEGAYYVSWNTPLV-----VTLQTIIDDNLVVPFESDE--------LSSLAYLHHRK 99
T + LV L+T +D ++ L L +LH
Sbjct: 83 CATSRTDREIKVT--LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 140
Query: 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL- 153
I H D+KP+N+++ +K+ DF ++R+ ++ TP Y APE+L
Sbjct: 141 IVHRDLKPENILVTS---GGTVKLADFGLARIY--SYQMAL---TPVVVTLWYRAPEVLL 192
Query: 154 --HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------QL 198
Y DMWS+G + F G ++++ I L
Sbjct: 193 QSTYAT---PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249
Query: 199 ---DFPD-------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
FP + ++ + ++L NP +R++A AL+H +
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 64/283 (22%), Positives = 98/283 (34%), Gaps = 69/283 (24%)
Query: 10 DSIATGEVFAAKFLESNPVRIHH-----------EIALLSLCSPS--PRIVKLHDVFQTG 56
D G A K VR+ E+A+L P +V+L DV
Sbjct: 32 DLKNGGRFVALK-----RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86
Query: 57 EGAYYVSWNTPLV-----VTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHL 103
LV L T +D ++ L L +LH ++ H
Sbjct: 87 RTDRETKLT--LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR 144
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEILHYEPI 158
D+KPQN+++ + IK+ DF ++R+ ++ T Y APE+L
Sbjct: 145 DLKPQNILVTS---SGQIKLADFGLARIY--SFQMAL---TSVVVTLWYRAPEVLLQSSY 196
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------QL---DFPD 202
D+WS+G + F G +D + I L F
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 256
Query: 203 -------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+ DI KD + K L NP +R++A AL HP+
Sbjct: 257 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 67/289 (23%), Positives = 101/289 (34%), Gaps = 82/289 (28%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH--------------EIALLSLCSPSPRIVKLHDVFQ 54
A T ++ A K +++ H EI LL S P I+ L D F
Sbjct: 29 ARDKNTNQIVAIK-----KIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG 82
Query: 55 TGEGAY----YVSWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAH 102
++ + L+ II DN + L L YLH I H
Sbjct: 83 HKSNISLVFDFMETD------LEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL---- 153
D+KP NL++ N +K+ DF +++ G R T Y APE+L
Sbjct: 136 RDLKPNNLLLD---ENGVLKLADFGLAKSF--GSPNRAY--THQVVTRWYRAPELLFGAR 188
Query: 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-------------QL-- 198
Y + DMW++G LL G++D + I + L
Sbjct: 189 MY---GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 199 --DFPD-------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
F +F + D I + + NP R+TA +ALK +
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-23
Identities = 46/205 (22%), Positives = 72/205 (35%), Gaps = 54/205 (26%)
Query: 89 LSSLAYLH-HRKIAHLDIKPQN-LVMMGDFPNCD--IKVCDFEISRVILDGIEIRELLGT 144
L L Y+H I H DIKP+N L+ + D P IK+ D + + T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQT 198
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL------ 198
+Y +PE+L P AD+WS + L+TG F + ++ +
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD--DDHIAQIIEL 256
Query: 199 --DFPDELF---------------------------EDISPEA-----------KDFIAK 218
+ P L ED+ E DF++
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316
Query: 219 ILIKNPMERMTAKEALKHPWLMNKK 243
+L +P +R A + HPWL +
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTL 341
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 65/259 (25%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVF------QTGEGAYYVSWNTPLVVT-LQTIIDDNLV 81
R + E+ LL ++ L DVF + Y V T L+ L I+ +
Sbjct: 74 RTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLV---THLMGADLNNIVKCQKL 129
Query: 82 VPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132
+D+ L L Y+H I H D+KP NL + +C++K+ DF ++R
Sbjct: 130 ----TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGLARHT 182
Query: 133 LDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET--- 185
D E+ + T Y APEI+ HY D+WS+G LLTG + F G
Sbjct: 183 AD--EMTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
Query: 186 ------------DSETFRNIS-------------KAQLDFPDELFEDISPEAKDFIAKIL 220
+E + IS +++F +F +P A D + K+L
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKML 296
Query: 221 IKNPMERMTAKEALKHPWL 239
+ + +R+TA +AL H +
Sbjct: 297 VLDSDKRITAAQALAHAYF 315
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 72/280 (25%)
Query: 14 TGEVFAAKFLE---SNPV---RIHHEIALLSLCSPSPRIVKLHDVF------QTGEGAYY 61
+GE A K L + + R + E+ LL ++ L DVF + Y
Sbjct: 48 SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYL 106
Query: 62 VSWNTPLVVT-LQTIIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLV 111
V P + T LQ I+ S+E L L Y+H + H D+KP NL
Sbjct: 107 V---MPFMQTDLQKIMGLKF-----SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSL 167
+ +C++K+ DF ++R E+ + T Y APE++ HY D+WS+
Sbjct: 159 VNE---DCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHY---NQTVDIWSV 210
Query: 168 GVTAYVLLTGFSPFGGET---------------DSETFRNIS-------------KAQLD 199
G +LTG + F G+ +E + ++ + D
Sbjct: 211 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 270
Query: 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
F +LF SP+A D + K+L + +R+TA +AL HP+
Sbjct: 271 F-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 8e-23
Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 78/289 (26%)
Query: 14 TGEVFAAKFLE---SNPV---RIHHEIALLSLCSPSPRIVKLHDVF------QTGEGAYY 61
A K L N R + E+ L+ + I+ L +VF + + Y
Sbjct: 49 LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYI 107
Query: 62 VSWNTPLVVT-LQTIIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLV 111
V L+ L +I L E L + +LH I H D+KP N+V
Sbjct: 108 V---MELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITLAADMWSLG 168
+ D C +K+ DF ++R + + T Y APE++ Y D+WS+G
Sbjct: 160 VKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVG 213
Query: 169 VTAYVLLTGFSPFGGET---------------DSETFRNIS------------------- 194
++ G F G E + +
Sbjct: 214 CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE 273
Query: 195 ----KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
E + + +A+D ++K+L+ + +R++ EAL+HP++
Sbjct: 274 KLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 50/253 (19%)
Query: 8 MADSIATGEVFAAKFLESNPVRIHHE---IALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
+ +A F +F E A L+ P IV ++D + A + +
Sbjct: 45 LRADLARDPSFYLRF--------RREAQNAAALN----HPAIVAVYDTGEAETPAGPLPY 92
Query: 65 NTPLV------VTLQTIIDDNLVVPFE------SDELSSLAYLHHRKIAHLDIKPQNLVM 112
+V VTL+ I+ + + +D +L + H I H D+KP N +M
Sbjct: 93 ---IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN-IM 148
Query: 113 MGDFPNCDIKVCDFEISRVILDGI----EIRELLGTPDYVAPEILHYEPITLAADMWSLG 168
+ +KV DF I+R I D + ++GT Y++PE + + +D++SLG
Sbjct: 149 IS--ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKA------QLDFPDELFEDISPEAKDFIAKILIK 222
Y +LTG PF G++ +S A P E +S + + K L K
Sbjct: 207 CVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260
Query: 223 NPMER-MTAKEAL 234
NP R TA E
Sbjct: 261 NPENRYQTAAEMR 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 55/352 (15%), Positives = 108/352 (30%), Gaps = 79/352 (22%)
Query: 9 ADSIATGEVFAAK--FLESNPVR----IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
A TGE + LE+ + E+ + L + P IV F + V
Sbjct: 46 ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVV 104
Query: 63 SWNTPLVV--TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVM 112
T + + + +I + + L +L Y+HH H +K ++++
Sbjct: 105 ---TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 161
Query: 113 MGDFPNCDIKVCDFEISRVILDGIEIR--------ELLGTPDYVAPEILHYEPI--TLAA 162
D + + + ++ + + + +++PE+L +
Sbjct: 162 SVD---GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218
Query: 163 DMWSLGVTAYVLLTGFSPF----------------------------------------- 181
D++S+G+TA L G PF
Sbjct: 219 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278
Query: 182 -GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240
G T SP F+ + L +NP R +A L H +
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338
Query: 241 NKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQEN 292
K R + P +++ N S+ +F V + +L+ ++
Sbjct: 339 QIK----RRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEVDD 386
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 68/278 (24%), Positives = 107/278 (38%), Gaps = 57/278 (20%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVF-QTGEGAYYVSWNTP 67
A +GE+ A K + + + E+ ++ IV+L F +GE V N
Sbjct: 73 AKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLN-- 129
Query: 68 LVV-----TLQTIIDDNLVV--PFESDE--------LSSLAYLHHRKIAHLDIKPQNLVM 112
LV+ T+ + SLAY+H I H DIKPQNL++
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 113 MGDFPNCDI-KVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSL 167
P+ + K+CDF ++ ++ G + + Y APE++ Y T + D+WS
Sbjct: 190 ---DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY---TSSIDVWSA 243
Query: 168 G-VTAYVLLTGFSPFGGET---------------DSETFRNIS--KAQLDFP-------- 201
G V A LL G F G++ E R ++ + FP
Sbjct: 244 GCVLAE-LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 302
Query: 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
PEA +++L P R+T EA H +
Sbjct: 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 62/258 (24%), Positives = 92/258 (35%), Gaps = 59/258 (22%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVF-----QTGEGAYYVSWNTPLVVT-LQTIIDDNLVV 82
R+ EI LL+ P I+ L D+F Y V T L+ T L +I D +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLV---TELMRTDLAQVIHDQRI- 129
Query: 83 PFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134
L L LH + H D+ P N+++ N DI +CDF ++R
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTA 186
Query: 135 GIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET----- 185
+ Y APE++ + T DMWS G + + F G T
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGF---TKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 186 ----------DSETFRNIS--------------KAQLDFPDELFEDISPEAKDFIAKILI 221
E S + + P A D IAK+L
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLE 302
Query: 222 KNPMERMTAKEALKHPWL 239
NP R++ ++AL+HP+
Sbjct: 303 FNPQRRISTEQALRHPYF 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 63/263 (23%), Positives = 105/263 (39%), Gaps = 68/263 (25%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVF-----QTGEGAYYVSWNTPLVVT-LQTIIDDNLVV 82
R EI +L I+ ++D+ + + Y V L+ T L ++
Sbjct: 71 RTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIV---QDLMETDLYKLLKTQ--- 123
Query: 83 PFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134
+D L L Y+H + H D+KP NL++ CD+K+CDF ++RV
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADP 180
Query: 135 GIEIRELLGTPDYV------APEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGE 184
+ L +YV APEI+ Y T + D+WS+G +L+ F G+
Sbjct: 181 DHDHTGFL--TEYVATRWYRAPEIMLNSKGY---TKSIDIWSVGCILAEMLSNRPIFPGK 235
Query: 185 T---------------DSETFRNIS-------------KAQLDFPDELFEDISPEAKDFI 216
E I K ++ + + LF + +A D +
Sbjct: 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLL 294
Query: 217 AKILIKNPMERMTAKEALKHPWL 239
K+L NP +R+ ++AL HP+L
Sbjct: 295 DKMLTFNPHKRIEVEQALAHPYL 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 63/258 (24%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVF------QTGEGAYYVSWNTPLVVT-LQTIIDDNLV 81
R + E+ LL ++ L DVF Y V P + T L ++
Sbjct: 70 RAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLV---MPFMGTDLGKLMKHE-- 123
Query: 82 VPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133
D L L Y+H I H D+KP NL + +C++K+ DF ++R
Sbjct: 124 -KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGLARQAD 179
Query: 134 DGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET---- 185
E+ + T Y APE++ Y T D+WS+G ++TG + F G
Sbjct: 180 S--EMTGYVVTRWYRAPEVILNWMRY---TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 186 -----------DSETFRNIS-------------KAQLDFPDELFEDISPEAKDFIAKILI 221
+E + + + DF + + SP A + + K+L+
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLV 293
Query: 222 KNPMERMTAKEALKHPWL 239
+ +R+TA EAL HP+
Sbjct: 294 LDAEQRVTAGEALAHPYF 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 65/281 (23%)
Query: 15 GEVFAAKFLESNPV----------RIHHEIALLSLCSPSPRIVKLHDVF-QTGEGAYYVS 63
G VF AK +ES+ V + E+ ++ + P +V L F G+ V
Sbjct: 54 GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVF 112
Query: 64 WNTPLV-----VTLQTIIDDNLVV--PFESDE--------LSSLAYLHHRKIAHLDIKPQ 108
N LV T+ + L SLAY+H I H DIKPQ
Sbjct: 113 LN--LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170
Query: 109 NLVMMGDFPNCD-IKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPITLAAD 163
NL++ P +K+ DF +++++ G + + Y APE++ +Y T D
Sbjct: 171 NLLLD---PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNY---TTNID 224
Query: 164 MWSLGVTAYVLLTGFSPFGGET---------------DSETFRNIS--KAQLDFP----- 201
+WS G L+ G F GE+ E + ++ + FP
Sbjct: 225 IWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284
Query: 202 --DELFE-DISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
++F P+A D I+++L P R+TA EAL HP+
Sbjct: 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-22
Identities = 32/235 (13%), Positives = 63/235 (26%), Gaps = 54/235 (22%)
Query: 7 EMADSIATGEVFAAKFL-ESNPV-RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSW 64
+ + + L + + RI P + ++ DV T G V+
Sbjct: 63 FVDPQGVLPDDVLQETLSRTLRLSRIDK-----------PGVARVLDVVHTRAGGLVVA- 110
Query: 65 NTPLV--VTLQTIIDDNL----VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
+ +LQ + D + + ++ H +A P V +
Sbjct: 111 --EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSR-VRVSI--- 164
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
DG +L P + D+ +G + Y LL
Sbjct: 165 ---------------DG---DVVLAYPATMPDA-------NPQDDIRGIGASLYALLVNR 199
Query: 179 SPFGGETDSETFRNISK---AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
P + Q P ++ DI + A+ + + R +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSAS 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 52/254 (20%), Positives = 100/254 (39%), Gaps = 58/254 (22%)
Query: 31 HHE--IALLSLCSPSPRIVKLHDVFQTGEGAYYVS--WNTPLVVTLQTIIDDNLVVPFES 86
+H+ I+LL++ +P + + DV Y V + L +Q +D +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDV-------YLVMELMDANLCQVIQMELDHERMSYLLY 171
Query: 87 DELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146
L + +LH I H D+KP N+V+ D C +K+ DF ++R + + T
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 147 YVAPEIL---HYEPITLAADMWSLGVTAYVLLTGFSPFGGET---------------DSE 188
Y APE++ Y D+WS+G ++ F G E
Sbjct: 229 YRAPEVILGMGY---KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 189 TFRNIS-----------------------KAQLDFPDELFEDISPEAKDFIAKILIKNPM 225
+ + + E + + +A+D ++K+L+ +P
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 226 ERMTAKEALKHPWL 239
+R++ +AL+HP++
Sbjct: 346 KRISVDDALQHPYI 359
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 61/279 (21%), Positives = 103/279 (36%), Gaps = 60/279 (21%)
Query: 14 TGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70
TG A K + +P R + L++ P IV+L F T +V+
Sbjct: 47 TGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVVM 105
Query: 71 -----TLQTIIDDNLVVPFESDE----------LSSLAYLHHR--KIAHLDIKPQNLVMM 113
TL + + S+ LH + H DIKP N+++
Sbjct: 106 EYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV- 164
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----HYEPITLAADMWSLG- 168
+ + +K+CDF ++ + + + Y APE++ HY T A D+WS+G
Sbjct: 165 -NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY---TTAVDIWSVGC 220
Query: 169 VTAYVLLTGFSPFGGET---------------DSETFRNIS--KAQLDFPD--------- 202
+ A ++ G F G+ E R ++ +D +
Sbjct: 221 IFAE-MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279
Query: 203 --ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ + EA D ++ +L P ERM EAL HP+
Sbjct: 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 36/181 (19%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
++ ++H I H DIKPQNL++ + + +K+CDF ++ ++ + + Y
Sbjct: 151 FRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR 208
Query: 149 APEIL----HYEPITLAADMWSLG-VTAYVLLTGFSPFGGET---------------DSE 188
APE++ Y T + D+WS+G V L+ G F GET E
Sbjct: 209 APELMLGATEY---TPSIDLWSIGCVFGE-LILGKPLFSGETSIDQLVRIIQIMGTPTKE 264
Query: 189 TFRNIS--KAQLDFP-------DELFEDISP-EAKDFIAKILIKNPMERMTAKEALKHPW 238
++ ++ FP ++ + +P A D + +IL P R+ EA+ HP+
Sbjct: 265 QMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
Query: 239 L 239
Sbjct: 325 F 325
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 79/290 (27%)
Query: 14 TGEVFAAKFLE--SNPV---RIHHEIALLSLCSPSPRIVKLHDVF-----QTGEGAYYVS 63
TGE+ A K +E P+ R EI +L I+ + ++ + Y +
Sbjct: 35 TGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYII- 92
Query: 64 WNTPLVVT-LQTIIDDNLVVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMM 113
L+ T L +I ++ SD+ L ++ LH + H D+KP NL++
Sbjct: 93 --QELMQTDLHRVISTQML----SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIRELLGTP-----DYV------APEIL----HYEPI 158
NCD+KVCDF ++R+I + ++V APE++ Y
Sbjct: 147 S---NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY--- 200
Query: 159 TLAADMWSLGVTAYVLLTGFSPFGGE----------------TDSETFRNIS-------- 194
+ A D+WS G L F G R I
Sbjct: 201 SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYI 260
Query: 195 -----KAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+++F ++P+ D + ++L+ +P +R+TAKEAL+HP+L
Sbjct: 261 KSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 52/252 (20%), Positives = 97/252 (38%), Gaps = 28/252 (11%)
Query: 9 ADSIATGEVFAAKF--LESNPVR-----IHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A + EV A K I E+ L P ++ + A+
Sbjct: 73 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL 131
Query: 62 V------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
V S + L+ + + + + L LAYLH + H D+K N +++ +
Sbjct: 132 VMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN-ILLSE 189
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE---PITLAADMWSLGVTAY 172
+K+ DF + ++ +GTP ++APE++ D+WSLG+T
Sbjct: 190 --PGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFE-DISPEAKDFIAKILIKNPMERMTAK 231
L P +I++ + L S ++F+ L K P +R T++
Sbjct: 245 ELAERKPPLFNMNAMSALYHIAQNE---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301
Query: 232 EALKHPWLMNKK 243
LKH +++ ++
Sbjct: 302 VLLKHRFVLRER 313
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 63/309 (20%), Positives = 107/309 (34%), Gaps = 89/309 (28%)
Query: 11 SIATGEVFAAKFLESN--PVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTP 67
+ +A K +E + EIALL P ++ L VF + + +
Sbjct: 44 DGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVW------ 96
Query: 68 LV-----VTLQTIID-------DNLVVPFESDE--------LSSLAYLHHRKIAHLDIKP 107
L+ L II + V L + YLH + H D+KP
Sbjct: 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156
Query: 108 QNLVMMGDFPNC-DIKVCDFEISRVILDGIEIRELLGTPDYV------APEIL----HYE 156
N+++MG+ P +K+ D +R+ ++ L V APE+L HY
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAPELLLGARHY- 213
Query: 157 PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA-QLD-------FPDE----- 203
T A D+W++G LLT F + N QLD FP +
Sbjct: 214 --TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWED 271
Query: 204 ------------------------------LFEDISPEAKDFIAKILIKNPMERMTAKEA 233
+A + K+L +P++R+T+++A
Sbjct: 272 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331
Query: 234 LKHPWLMNK 242
++ P+ +
Sbjct: 332 MQDPYFLED 340
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 61/292 (20%), Positives = 104/292 (35%), Gaps = 75/292 (25%)
Query: 9 ADSIATGEVFAAKFLESNPVRIHH-----------EIALLSLCSPSPRIVKLHDVFQTGE 57
A TG+ A K V + + EI +L L +V L ++ +T
Sbjct: 36 ARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKA 89
Query: 58 GAYYVSWNTPLVVT------LQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHL 103
Y + +V L ++ N++V F E L+ L Y+H KI H
Sbjct: 90 SPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 148
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD-----YVAPEIL----H 154
D+K N+++ + +K+ DF ++R + T Y PE+L
Sbjct: 149 DMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 205
Query: 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA------------------ 196
Y P D+W G + T G T+ IS+
Sbjct: 206 YGP---PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 262
Query: 197 -QLDFP-------DELFEDI--SPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+L+ + + P A D I K+L+ +P +R+ + +AL H +
Sbjct: 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 64/292 (21%), Positives = 98/292 (33%), Gaps = 94/292 (32%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQ--TGEGAYYVSWNTPLVVT-LQTIIDDNLVVPFE 85
R EI +L+ S IV L +V + Y V + T L +I N++
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV---FDYMETDLHAVIRANIL---- 106
Query: 86 SDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136
+ + YLH + H D+KP N+++ C +KV DF +SR ++
Sbjct: 107 EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIR 163
Query: 137 EIRELLGTP----------------DYV------APEIL----HYEPITLAADMWSLG-- 168
+ + DYV APEIL Y T DMWSLG
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY---TKGIDMWSLGCI 220
Query: 169 ----------------------------------------VTAYVLLTGFSPFGGETDSE 188
A ++ S
Sbjct: 221 LGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSN 280
Query: 189 TFRNISKAQLDFPDEL-FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+K + D + EA D + K+L NP +R++A +ALKHP++
Sbjct: 281 KRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 61/310 (19%), Positives = 105/310 (33%), Gaps = 114/310 (36%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQ-----TGEGAYYVSWNTPLVVT-LQTII--DDNL 80
RI EI +L+ S I++L+D+ + Y V + + L+ + L
Sbjct: 71 RILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIV---LEIADSDLKKLFKTPIFL 126
Query: 81 VVPFESDE---------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131
++E L ++H I H D+KP N ++ +C +KVCDF ++R
Sbjct: 127 -----TEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGLART 178
Query: 132 ILDGIEIRELLGTP-----------------DYV------APEIL----HYEPITLAADM 164
I + + +V APE++ +Y T + D+
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY---TKSIDI 235
Query: 165 WSLG-----------------VTAYVLLTGFSPFGGETDSETFRNISKAQLD-------- 199
WS G + L G S F D + + K+ D
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
Query: 200 -----------------------FP-------DELFEDISPEAKDFIAKILIKNPMERMT 229
FP + + IS + + + +L NP +R+T
Sbjct: 296 IGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT 355
Query: 230 AKEALKHPWL 239
+AL HP+L
Sbjct: 356 IDQALDHPYL 365
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 43/232 (18%), Positives = 76/232 (32%), Gaps = 74/232 (31%)
Query: 89 LSSLAYLHHRKIAHLDIKPQN-LVMMGDFP---------------NCDIKVCDF------ 126
+L +LH ++ H D+KP+N L + +F N I+V DF
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 127 --EISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE 184
+ ++ T Y PE++ D+WS+G + GF+ F
Sbjct: 193 HEHHTTIVA----------TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 185 TDSETFRNISKAQLDFPDEL----------------FEDISPEAK--------------- 213
+ E + K P + +++ S + +
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302
Query: 214 ---------DFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPS 256
D + ++L +P +R+T EAL HP+ S PS
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 66/317 (20%), Positives = 96/317 (30%), Gaps = 110/317 (34%)
Query: 31 HHEIALLS-LCSPSP------RIVKLHDVFQ-TG-EGAYYVSWNTPLVVTLQTIIDDNLV 81
EI LL + + P +V+L D F+ +G G + L L I +
Sbjct: 81 LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNY 140
Query: 82 VPFESDE--------LSSLAYLHHR-KIAHLDIKPQN-LVMMGDFP-------------- 117
L L YLH + +I H DIKP+N L+ + +
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 118 -------------------------------NCDIKVCDFEISRVILDGIEIRELLGTPD 146
+K+ D + E + T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQ 258
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTG---FSPFGGETDSET-------------- 189
Y + E+L AD+WS A+ L TG F P GE +
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318
Query: 190 ---FRNISKAQLDFPDE--------------LFE------DISPEAK----DFIAKILIK 222
K +F + LFE + S E DF+ +L
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378
Query: 223 NPMERMTAKEALKHPWL 239
P +R TA E L+HPWL
Sbjct: 379 IPEKRATAAECLRHPWL 395
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 49/220 (22%), Positives = 76/220 (34%), Gaps = 74/220 (33%)
Query: 89 LSSLAYLHHRKIAHLDIKPQN-LVMMGDFP---------------NCDIKVCDF------ 126
S+ +LH K+ H D+KP+N L + D+ N DIKV DF
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 127 --EISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE 184
S ++ T Y APE++ + D+WS+G GF+ F
Sbjct: 188 DEHHSTLVS----------TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 185 TDSETFRNISKAQLDFPDELFED-----------------------ISPEAK-------- 213
E + + P + + +S K
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297
Query: 214 ---------DFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244
D I K+L +P +R+T +EALKHP+ K+
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 61/315 (19%), Positives = 100/315 (31%), Gaps = 116/315 (36%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGA-----YYVSWNTPLVVT-LQTIIDDNLVV 82
RI EIA+L+ + +VK+ D+ + Y V + + + + V
Sbjct: 98 RILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVV---LEIADSDFKKLFRTP--V 151
Query: 83 PFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134
L + Y+H I H D+KP N ++ +C +KVCDF ++R +
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ---DCSVKVCDFGLARTVDY 208
Query: 135 GIEIRELLGTP----------------------DYV------APEIL----HYEPITLAA 162
L +V APE++ +Y T A
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY---TEAI 265
Query: 163 DMWSLG------VTAYV-----------LLTGFSPFGGETDSETFRNISKAQLDFPDELF 205
D+WS+G + L G S F D + + D+L
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN 325
Query: 206 -----------EDI------------------------------SPEAKDFIAKILIKNP 224
EDI S +A + ++L+ NP
Sbjct: 326 VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNP 385
Query: 225 MERMTAKEALKHPWL 239
+R+T E L HP+
Sbjct: 386 NKRITINECLAHPFF 400
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 6/186 (3%)
Query: 89 LSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146
++L +L + I H D+KP+N +++ + IK+ DF S G I + + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPEN-ILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE 206
Y +PE+L P LA DMWSLG + TG F G + + I + P + +
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283
Query: 207 DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKN 266
+P+A+ F K+ + T ++ +K + P + ++
Sbjct: 284 Q-APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342
Query: 267 LRKYLS 272
+ YL
Sbjct: 343 VADYLK 348
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 9/27 (33%), Positives = 15/27 (55%)
Query: 213 KDFIAKILIKNPMERMTAKEALKHPWL 239
KD I ++L +P R+ AL+H +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 46/215 (21%), Positives = 73/215 (33%), Gaps = 66/215 (30%)
Query: 89 LSSLAYLHHRKIAHLDIKPQN-LVMMGDFP---------------------NCDIKVCDF 126
L +L YL + H D+KP+N L+ F + IK+ DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 127 EISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE-- 184
+ ++ T Y APE++ +++DMWS G L TG F
Sbjct: 207 GCA--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264
Query: 185 ------------------------TDSETFRNISKAQLDFPDE---------------LF 205
T+ + N + +L +P+ L+
Sbjct: 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324
Query: 206 EDIS-PEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ I DF+ IL +P R + E LKH +L
Sbjct: 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 9/100 (9%)
Query: 92 LAYLHHRK---IAHLDIKPQNLVM-----MGDFPNCDIKVCDFEISRVILDGIEIRELLG 143
+ YLH I H D+K N+++ GD N +K+ DF ++R G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAG 176
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
++APE++ + +D+WS GV + LLTG PF G
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 4/154 (2%)
Query: 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI 138
LV F L L LH +I H D+KP+N +++ IKV DF S + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPEN-ILLKQQGRSGIKVIDFGSS--CYEHQRV 256
Query: 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL 198
+ + Y APE++ + DMWSLG LLTG+ GE + + + +
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 199 DFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+L + S AK+F++ T +
Sbjct: 317 MPSQKLLDA-SKRAKNFVSSKGYPRYCTVTTLSD 349
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 213 KDFIAKILIKNPMERMTAKEALKHPWL 239
DF+ + L +P RMT +AL+HPWL
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 32/144 (22%), Positives = 64/144 (44%), Gaps = 11/144 (7%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL---LGTPDYV 148
+ YLH + I H D+K N+ + D +K+ DF ++ + G+ ++
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDN---TVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 149 APEILHYE---PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--E 203
APE++ + P + +D+++ G+ Y L+TG P+ + + + PD +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 204 LFEDISPEAKDFIAKILIKNPMER 227
+ + K +A+ L K ER
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 92 LAYLHHRK---IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148
+AYLH + + H D+KP NL+++ K+CDF + I + G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVL--KICDFGTACDIQT--HMTNNKGSAAWM 170
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
APE+ + D++S G+ + ++T PF
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 92 LAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-LLGTPDYV 148
+ YLH+R I H ++K NL++ + +KVCDF +SR+ + GTP+++
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKY---TVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGG 183
APE+L EP +D++S GV + L T P+G
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 28/143 (19%), Positives = 56/143 (39%), Gaps = 18/143 (12%)
Query: 92 LAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149
+A+LH + I + +++++ D ++ ++ + P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGRM----YAPAWVA 176
Query: 150 PEIL---HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI--SKAQLDFPDEL 204
PE L + +ADMWS V + L+T PF ++ E + + P
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--- 233
Query: 205 FEDISPEAKDFIAKILIKNPMER 227
ISP + + ++P +R
Sbjct: 234 -PGISPHVSKLMKICMNEDPAKR 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 92 LAYLHHRK--IAHLDIKPQNLVMMGDFPNCD--IKVCDFEISRVILDGIEIRELLGTPDY 147
+ Y+ ++ I H D++ N+ + N KV DF +S+ + + LLG +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQW 192
Query: 148 VAPEILHYE--PITLAADMWSLGVTAYVLLTGFSPFGG 183
+APE + E T AD +S + Y +LTG PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 31/151 (20%), Positives = 53/151 (35%), Gaps = 21/151 (13%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL------LGTP 145
+ YLH + I H D+K +N+ D N + + DF + + R G
Sbjct: 143 MGYLHAKGILHKDLKSKNVFY--D--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 146 DYVAPEIL---------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA 196
++APEI+ P + +D+++LG Y L PF + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 197 QLDFPDELFEDISPEAKDFIAKILIKNPMER 227
P+ + E D + ER
Sbjct: 259 MK--PNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 23/105 (21%), Positives = 46/105 (43%), Gaps = 18/105 (17%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL--------- 142
+AYLH I H D+ N ++ + ++ V DF ++R+++D E L
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENK---NVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 143 ------GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF 181
G P ++APE+++ D++S G+ ++ +
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 33/138 (23%), Positives = 56/138 (40%), Gaps = 29/138 (21%)
Query: 92 LAYLHHR----------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEI 138
LAYLH I+H DIK +N+++ + + DF ++ G +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TA--CIADFGLALKFEAGKSAGDT 190
Query: 139 RELLGTPDYVAPEILHYEPI-----TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI 193
+GT Y+APE+L L DM+++G+ + L + + G D
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY----- 245
Query: 194 SKAQLDFPDELFEDISPE 211
L F +E+ + S E
Sbjct: 246 ---MLPFEEEIGQHPSLE 260
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 37/184 (20%), Positives = 72/184 (39%), Gaps = 46/184 (25%)
Query: 92 LAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL- 142
LA+LH IAH D+K +N+++ + C + D ++ + ++
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QC--CIADLGLAVMHSQSTNQLDVGN 174
Query: 143 ----GTPDYVAPEILHYEPI------TLAADMWSLGVTAYVLLTGFS----------PFG 182
GT Y+APE+L D+W+ G+ + + PF
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 183 GETDSE-TFRNISKA------QLDFPDELFEDISPEAKDFIAKILIK----NPMERMTAK 231
++ +F ++ K + + P+ F D + + +AK++ + NP R+TA
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS---LAKLMKECWYQNPSARLTAL 291
Query: 232 EALK 235
K
Sbjct: 292 RIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 24/131 (18%), Positives = 53/131 (40%), Gaps = 23/131 (17%)
Query: 92 LAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL- 142
L +LH IAH D+K +N+++ + C + D ++ + ++
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TC--CIADLGLAVKFISDTNEVDIPP 203
Query: 143 ----GTPDYVAPEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET-FR 191
GT Y+ PE+L ++ + ADM+S G+ + + G + + +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 192 NISKAQLDFPD 202
++ + + D
Sbjct: 264 DLVPSDPSYED 274
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 46/184 (25%)
Query: 92 LAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELL- 142
LA+LH IAH D+K +N+++ + + D ++ + ++
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG---TCCIADLGLAVRHDSATDTIDIAP 208
Query: 143 ----GTPDYVAPEIL------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE---- 188
GT Y+APE+L + AD++++G+ + + S G D +
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 189 -------TFRNISKA------QLDFPDELFEDISPEAKDFIAKILI----KNPMERMTAK 231
+ + K + + P+ + +AKI+ N R+TA
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV---MAKIMRECWYANGAARLTAL 325
Query: 232 EALK 235
K
Sbjct: 326 RIKK 329
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 34/145 (23%)
Query: 92 LAYLH---------HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE-- 140
LAYLH I+H D+ +N+++ D C + DF +S + +R
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TC--VISDFGLSMRLTGNRLVRPGE 180
Query: 141 -------LLGTPDYVAPEIL-------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETD 186
+GT Y+APE+L E DM++LG+ + + TD
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM------RCTD 234
Query: 187 SETFRNISKAQLDFPDELFEDISPE 211
++ + Q+ F E+ + E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY--VAP 150
YL + H ++ +N ++G+ N +KV DF +SR++ AP
Sbjct: 332 EYLEKKNFIHRNLAARN-CLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
E L Y ++ +D+W+ GV + + T G SP+ G S+ + + K
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP-DY 147
S +AY+ H D++ N +++G+ N KV DF ++R+I D R+ P +
Sbjct: 374 SGMAYVERMNYVHRDLRAAN-ILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE Y T+ +D+WS G+ L T G P+ G + E + +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP-DY 147
S +AY+ H D++ N +++G+ N KV DF ++R+I D R+ P +
Sbjct: 291 SGMAYVERMNYVHRDLRAAN-ILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE Y T+ +D+WS G+ L T G P+ G + E + +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 27/108 (25%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ YL + H D+ +N ++ + +K+ DF +SR DG+ V
Sbjct: 226 MEYLESKCCIHRDLAARN-CLVTE--KNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE L+Y + +D+WS G+ + + G SP+ ++ +T + K
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 14/110 (12%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG------TPD 146
A++ R H D++ N +++ C K+ DF ++RVI D T
Sbjct: 298 AFIEQRNYIHRDLRAAN-ILVSASLVC--KIADFGLARVIEDNEYTAREGAKFPIKWT-- 352
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE +++ T+ +D+WS G+ ++T G P+ G ++ E R + +
Sbjct: 353 --APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 34/172 (19%)
Query: 44 PRIVKLHDVFQTGEGAY-------------YVSWNTPLVVTLQTIIDDNLVVPFESDELS 90
R+V+L+ V T E Y ++ + + +T+ ++D +
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAE 120
Query: 91 SLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG------T 144
+A++ R H D++ N +++ D +C K+ DF ++R+I D T
Sbjct: 121 GMAFIEERNYIHRDLRAAN-ILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE ++Y T+ +D+WS G+ ++T G P+ G T+ E +N+ +
Sbjct: 178 ----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 2e-07
Identities = 26/113 (23%), Positives = 54/113 (47%), Gaps = 14/113 (12%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG------ 143
+A+L + H D+ +N ++ + +KV DF ++R +LD + +
Sbjct: 115 EGMAFLESHQFIHRDLAARN-CLVDR--DLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKW 171
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ APE+ HY + +D+W+ G+ + + + G P+ T+SE +S+
Sbjct: 172 S----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT--P-DYV 148
+ YL R++ H D+ +N V++ P +K+ DF +++++ + G P ++
Sbjct: 130 MNYLEDRRLVHRDLAARN-VLVKT-PQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
A E + + T +D+WS GVT + L+T G P+ G SE + K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 14/110 (12%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG------TPD 146
YL + H D+ +N ++G+ N +KV DF +SR++ T
Sbjct: 125 EYLEKKNFIHRDLAARN-CLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-- 179
Query: 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE L Y ++ +D+W+ GV + + T G SP+ G S+ + + K
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 31/118 (26%), Positives = 53/118 (44%), Gaps = 22/118 (18%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV- 148
+ + YL + H D+ +N +++ C KV DF +SRV+ D E Y
Sbjct: 158 AGMKYLANMNYVHRDLAARN-ILVNSNLVC--KVSDFGLSRVLEDDPE-------ATYTT 207
Query: 149 ----------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE + Y T A+D+WS G+ + ++T G P+ ++ E + I+
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 8e-07
Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG------ 143
+AYL + H D+ +N ++G+ N IKV DF ++R +LD
Sbjct: 115 EGMAYLEEACVIHRDLAARN-CLVGE--NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 171
Query: 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+PE+ + + +D+WS GV + + + G P+ ++SE +IS
Sbjct: 172 A----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 24/118 (20%), Positives = 42/118 (35%), Gaps = 24/118 (20%)
Query: 92 LAYLHHRKIAHLDIKPQN-LVMMGDF----PNCDIKVCDFEISRVILDGIEIRELLGTPD 146
+ +L + H ++ +N L++ + IK+ D IS +L D
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------D 175
Query: 147 Y-------VAPE-ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
V PE I + + + LA D WS G T + + + G P +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 35/143 (24%), Positives = 60/143 (41%), Gaps = 16/143 (11%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVM-MGDFPNCD-IKVCDFEISRVILDG-----IEIRE- 140
L+ + +H + + + DIKP N ++ + N + I V DF + + D I RE
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 141 --LLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPFGG---ETDSETFRNIS 194
L GT Y++ L E + D+ +LG L G P+ G T+ + + I
Sbjct: 176 KNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
Query: 195 KAQLDFP-DELFEDISPEAKDFI 216
+ + P EL E ++
Sbjct: 235 EKKQSTPLRELCAGFPEEFYKYM 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 64/224 (28%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV- 148
S + YL H D+ +N +++ N KV DF + RV+ D E Y
Sbjct: 158 SGMKYLSDMGYVHRDLAARN-ILINS--NLVCKVSDFGLGRVLEDDPE-------AAYTT 207
Query: 149 ----------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK-- 195
+PE + Y T A+D+WS G+ + +++ G P+ ++ + + + +
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267
Query: 196 ---AQLDFPDELFE------DISPEAK---DFIAKIL---IKNPMERMTAKEALKHP--- 237
+D P L++ + + I IL I+NP A P
Sbjct: 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL 327
Query: 238 -----------------WL----MNK-KQIMTRVGCSSCPSIIQ 259
WL K+I T V SSC +I +
Sbjct: 328 LLDQSNVDITTFRTTGDWLNGVWTAHCKEIFTGVEYSSCDTIAK 371
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 26/117 (22%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
LAYL ++ H DI +N V++ N +K+ DF +SR + D Y
Sbjct: 129 LAYLESKRFVHRDIAARN-VLVSS--NDCVKLGDFGLSRYMEDS----------TYYKAS 175
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE +++ T A+D+W GV + +L G PF G +++ I
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 26/116 (22%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL ++ H D+ +N ++ D +KV DF +SR +LD +Y
Sbjct: 134 EYLESKQFLHRDLAARN-CLVND--QGVVKVSDFGLSRYVLDD----------EYTSSVG 180
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
PE+L Y + +D+W+ GV + + + G P+ T+SET +I++
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT--P-DYV 148
+ YL R++ H D+ +N V++ P +K+ DF +++++ + G P ++
Sbjct: 130 MNYLEDRRLVHRDLAARN-VLVKT-PQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
A E + + T +D+WS GVT + L+T G P+ G SE + K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT--P-DYVA 149
YL + H ++ +N V++ P+ ++V DF ++ ++ + P ++A
Sbjct: 129 YYLEEHGMVHRNLAARN-VLLKS-PSQ-VQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
E +H+ T +D+WS GVT + L+T G P+ G +E + K
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 48/243 (19%), Positives = 84/243 (34%), Gaps = 51/243 (20%)
Query: 9 ADSIATGEVFAAKF--LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
+I T E A K +++ ++ +E + + I + G+ V
Sbjct: 26 GTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85
Query: 63 ---------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKP 107
S T L++ Q I + + ++H + H DIKP
Sbjct: 86 GPSLEDLFNFCSRKLSLKTVLMLADQMI--------------NRVEFVHSKSFLHRDIKP 131
Query: 108 QNLVMMGDFPNCD-IKVCDFEISRVILDG-----IEIRE---LLGTPDYVAPEI-LHYEP 157
N + MG + + + DF +++ D I RE L GT Y + L E
Sbjct: 132 DNFL-MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190
Query: 158 ITLAADMWSLGVTAYVLLTGFSPFGG---ETDSETFRNISKAQLDFP-DELFEDISPEAK 213
+ D+ SLG L G P+ G T + + IS+ ++ + L E
Sbjct: 191 -SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFA 249
Query: 214 DFI 216
+
Sbjct: 250 SYF 252
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 26/117 (22%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+AYL H DI +N +++ +K+ DF +SR I D DY
Sbjct: 126 MAYLESINCVHRDIAVRN-ILVAS--PECVKLGDFGLSRYIEDE----------DYYKAS 172
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+PE +++ T A+D+W V + +L+ G PF + + + K
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 29/118 (24%), Positives = 51/118 (43%), Gaps = 22/118 (18%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV- 148
+ + YL H D+ +N V++ C KV DF +SRV+ D + Y
Sbjct: 162 AGMRYLSDLGYVHRDLAARN-VLVDSNLVC--KVSDFGLSRVLEDDPD-------AAYTT 211
Query: 149 ----------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE + + + A+D+WS GV + +L G P+ T+ + ++ +
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 6/109 (5%)
Query: 90 SSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG-TP-DY 147
++LAYL ++ H DI +N V++ +C +K+ DF +SR + D + G P +
Sbjct: 502 TALAYLESKRFVHRDIAARN-VLVSS-NDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+APE +++ T A+D+W GV + +L G PF G +++ I
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 54/246 (21%), Positives = 89/246 (36%), Gaps = 57/246 (23%)
Query: 9 ADSIATGEVFAAKF--LESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
IA GE A K +++ ++H E + + I + G+ V
Sbjct: 28 GTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87
Query: 63 ---------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKP 107
S T L++ Q I S + Y+H + H D+KP
Sbjct: 88 GPSLEDLFNFCSRKFSLKTVLLLADQMI--------------SRIEYIHSKNFIHRDVKP 133
Query: 108 QNLVMMGDFPNCD-IKVCDFEISRVILDG-----IEIRE---LLGTPDYVAPEI-LHYEP 157
N +MG + + + DF +++ D I RE L GT Y + L E
Sbjct: 134 DN-FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192
Query: 158 ITLAADMWSLGVTAYVL---LTGFSPFGG---ETDSETFRNISKAQLDFP-DELFEDISP 210
+ D+ SLG YVL G P+ G T + + IS+ ++ P + L +
Sbjct: 193 -SRRDDLESLG---YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS 248
Query: 211 EAKDFI 216
E ++
Sbjct: 249 EFATYL 254
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 92 LAYLHHR---KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRELLGTP 145
LAYLH KI H D+K N+++ +F + V DF +++++ + + GT
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKDTHVTTA-VRGTI 199
Query: 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF 181
++APE L + D++ GV L+TG F
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 24/117 (20%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ YL H D+ +N V++ K+ DF +S+ + Y
Sbjct: 130 MKYLEESNFVHRDLAARN-VLLVT--QHYAKISDFGLSKALRADENY--------YKAQT 178
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE ++Y + +D+WS GV + + G P+ G SE + K
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 4e-06
Identities = 59/373 (15%), Positives = 113/373 (30%), Gaps = 110/373 (29%)
Query: 21 KFLESNPVRI--HHEI--ALLSLCSPSPRIVKLH------------DVFQTGE------- 57
F + N R+ + ++ ALL L P+ ++ + DV + +
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLEL-RPAKNVL-IDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 58 GAYYVS---WNTP--LVVTLQTI---IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQN 109
++++ N+P ++ LQ + ID N SD S++ H A L +
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS--RSDHSSNIKLRIHSIQAEL----RR 236
Query: 110 LVMMGDFPNC-----DIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADM 164
L+ + NC + V + + + + + LL T D
Sbjct: 237 LLKSKPYENCLLVLLN--VQNAKAWNA-FN-LSCKILLTTRF------------KQVTDF 280
Query: 165 WSLGVTAYVLLTGFSPFGGETDSET------FRNISKAQLDFPDELFEDISPEAKDFIAK 218
S T ++ L S T E + + L P E+ +P IA+
Sbjct: 281 LSAATTTHISLDHHSM--TLTPDEVKSLLLKYLDCRPQDL--PREV-LTTNPRRLSIIAE 335
Query: 219 ILIKNPME----RMTAKEALKH----------PWLMNKK-----------QIMTRVGC-- 251
+ + + L P K I T +
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 252 -----SSCPSIIQNQQNKKNL-RKYLSKSREAL----FEKVISASKLQQENLRKSALLKY 301
S ++ N+ +K +L K +S ++ E + L +S + Y
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA--LHRSIVDHY 453
Query: 302 NKTRRLCESQMSL 314
N + +
Sbjct: 454 NIPKTFDSDDLIP 466
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 52/377 (13%), Positives = 110/377 (29%), Gaps = 106/377 (28%)
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIK-VCDFEISRVILDGIEIRELL 142
FE+ E ++ I + + +F D K V D + IL EI ++
Sbjct: 9 FETGEHQ----YQYKDILSVFEDA----FVDNF---DCKDVQDMP--KSILSKEEIDHII 55
Query: 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYV--LLT---GF--SPFGGETDSETFRNISK 195
+ D V +V +L F SP E + +++
Sbjct: 56 MSKD---AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM--MTR 110
Query: 196 AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK----HPWL----MN--KKQI 245
++ D L+ D AK ++++ P ++ ++AL + + K
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRL---QPYLKL--RQALLELRPAKNVLIDGVLGSGKTW 165
Query: 246 MT--------------------RVGCSSCP-SIIQNQQNKKNLRKYLSKSREALFEKVIS 284
+ + + P ++++ Q L + + + + +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ---KLLYQIDPNWTSRSDHSSN 222
Query: 285 AS-KLQQENLRKSALLKYNKTRR-------LCESQ----MSLVSK----TREKSLGDMAI 328
++ LLK + ++ +L K TR K + D
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 329 SLGRSKEKL----YGF----------KCLSKSQEVLNLYKSMKDINNICIDEIIKNINDN 374
+ + L K L + +L + + N + I ++I D
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ--DLPREVLTTNPRRLSIIAESIRDG 340
Query: 375 K---------TKEKLKR 382
+KL
Sbjct: 341 LATWDNWKHVNCDKLTT 357
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 24/116 (20%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL ++ H D+ +N +++ + +K+ DF + R + + YV
Sbjct: 135 GYLESKRFIHRDLAARN-LLLAT-RDL-VKIGDFGLMRALPQNDDH--------YVMQEH 183
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE L + A+D W GVT + + T G P+ G S+ I K
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 25/147 (17%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC---DFEISRVILDG-----IEIRE 140
+S + Y+H + + + D+KP+N ++G N +V DF +++ +D I RE
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENF-LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 141 ---LLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVL---LTGFSPFGG---ETDSETF 190
L GT Y++ L E + D+ +LG ++ L G P+ G +T E +
Sbjct: 174 HKSLTGTARYMSINTHLGKEQ-SRRDDLEALG---HMFMYFLRGSLPWQGLKADTLKERY 229
Query: 191 RNISKAQLDFP-DELFEDISPEAKDFI 216
+ I + P + L E+ PE ++
Sbjct: 230 QKIGDTKRATPIEVLCENF-PEMATYL 255
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPDYV 148
L YLH R I H D+K N+++ +F K+ DF IS+ + + + GT Y+
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENF---VPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSP 180
PE +T +D++S GV + +L S
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 24/117 (20%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ YL + H ++ +N V++ + K+ DF +S+ + Y
Sbjct: 449 MKYLEEKNFVHRNLAARN-VLLVN--RHYAKISDFGLSKALGADDSY--------YTARS 497
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE +++ + +D+WS GVT + L+ G P+ E I +
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 16/109 (14%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLGTPDY 147
YL H D+ +N V++ + + KV DF +++ + ++ +
Sbjct: 303 EYLEGNNFVHRDLAARN-VLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVK-------W 352
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE L + + +D+WS G+ + + + G P+ + + K
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 25/117 (21%), Positives = 46/117 (39%), Gaps = 24/117 (20%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV--- 148
+ YL + H D+ +N V++ + K+ DF +S+ + Y
Sbjct: 123 MKYLEEKNFVHRDLAARN-VLLVN--RHYAKISDFGLSKALGADDSY--------YTARS 171
Query: 149 ---------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE +++ + +D+WS GVT + L+ G P+ E I +
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 9/109 (8%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL +K H D+ +N M+ + + +KV DF ++R ILD +
Sbjct: 138 EYLAEQKFVHRDLAARN-CMLDE--SFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 149 -APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
A E L T +D+WS GV + LLT G P+ + +++
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 9/116 (7%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---A 149
+L RK H D+ +N +++ + +K+CDF ++R I + + A
Sbjct: 207 EFLASRKCIHRDLAARN-ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 150 PEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKA--QLDFPD 202
PE + T+ +D+WS GV + + + G SP+ G E F K ++ PD
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----IEIRELLGTPDY 147
+ +LH H DIK N+++ F K+ DF ++R + R ++GT Y
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAF---TAKISDFGLARASEKFAQTVMTSR-IVGTTAY 201
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLTG 177
+APE L E IT +D++S GV ++TG
Sbjct: 202 MAPEALRGE-ITPKSDIYSFGVVLLEIITG 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 27/117 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL + H D+ +N ++G N +K+ DF +SR + DY
Sbjct: 147 VYLASQHFVHRDLATRN-CLVGA--NLLVKIGDFGMSRDVYST----------DYYRVGG 193
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ PE + Y T +D+WS GV + + T G P+ +++E I++
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 25/131 (19%), Positives = 45/131 (34%), Gaps = 39/131 (29%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL ++ H D+ +N +++ + +K+ DF +++V+ E +
Sbjct: 128 EYLGTKRYIHRDLATRN-ILVEN--ENRVKIGDFGLTKVLPQDKEF--------FKVKEP 176
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT----------------GFSPFGGE 184
APE L ++A+D+WS GV Y L T G G
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 185 TDSETFRNISK 195
+
Sbjct: 237 IVFHLIELLKN 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 26/131 (19%), Positives = 45/131 (34%), Gaps = 39/131 (29%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL ++ H D+ +N +++ + +K+ DF +++V+ E Y
Sbjct: 159 EYLGTKRYIHRDLATRN-ILVEN--ENRVKIGDFGLTKVLPQDKEY--------YKVKEP 207
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT----------------GFSPFGGE 184
APE L ++A+D+WS GV Y L T G G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 185 TDSETFRNISK 195
+
Sbjct: 268 IVFHLIELLKN 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 34/133 (25%), Positives = 58/133 (43%), Gaps = 32/133 (24%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
AYL+ K H D+ +N M+ + + +K+ DF ++R I + DY
Sbjct: 152 AYLNANKFVHRDLAARN-CMVAE--DFTVKIGDFGMTRDIYET----------DYYRKGG 198
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL 198
++PE L T +D+WS GV + + T P+ G ++ + R + + L
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 199 -----DFPDELFE 206
+ PD LFE
Sbjct: 259 LDKPDNCPDMLFE 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 24/115 (20%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL H DI +N ++ P K+ DF ++R I Y
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----------GYYRKGG 244
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNI 193
+ PE T D WS GV + + + G+ P+ +++ E +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 27/117 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL H D+ +N ++G +K+ DF +SR I DY
Sbjct: 172 VYLAGLHFVHRDLATRN-CLVGQ--GLVVKIGDFGMSRDIYST----------DYYRVGG 218
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+ PE + Y T +D+WS GV + + T G P+ +++E I++
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL +K H D+ +N M+ + +KV DF ++R + D T +
Sbjct: 142 KYLASKKFVHRDLAARN-CMLDE--KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 149 -APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
A E L + T +D+WS GV + L+T G P+ + + +
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
+L +K H D+ +N M+ + +KV DF ++R + D T +
Sbjct: 206 KFLASKKFVHRDLAARN-CMLDE--KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 149 -APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
A E L + T +D+WS GV + L+T G P+ + + +
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 16/109 (14%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----IEIRELLGTPDY 147
YL H D+ +N V++ + + KV DF +++ + ++ +
Sbjct: 131 EYLEGNNFVHRDLAARN-VLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVK-------W 180
Query: 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
APE L + + +D+WS G+ + + + G P+ + + K
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 24/119 (20%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL R+ H D+ +N +++ +K+ DF +++++ + YV
Sbjct: 141 EYLGSRRCVHRDLAARN-ILVES--EAHVKIADFGLAKLLPLDKDY--------YVVREP 189
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL 198
APE L + +D+WS GV Y L T + +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 25/133 (18%), Positives = 45/133 (33%), Gaps = 29/133 (21%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL H DI +N ++ P K+ DF ++R I Y
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----------SYYRKGG 203
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL 198
+ PE T D WS GV + + + G+ P+ +++ E ++
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 199 -----DFPDELFE 206
+ P ++
Sbjct: 264 MDPPKNCPGPVYR 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 30/118 (25%), Positives = 52/118 (44%), Gaps = 27/118 (22%)
Query: 92 LAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY---- 147
+ YL R H D+ +N M+ + + + V DF +SR I G DY
Sbjct: 150 MEYLSSRNFIHRDLAARN-CMLAE--DMTVCVADFGLSRKIYSG----------DYYRQG 196
Query: 148 ---------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+A E L T+ +D+W+ GVT + ++T G +P+ G ++E + +
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 27/117 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL +R H D+ +N M+ D + + V DF +S+ I G DY
Sbjct: 161 EYLSNRNFLHRDLAARN-CMLRD--DMTVCVADFGLSKKIYSG----------DYYRQGR 207
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISK 195
+A E L T +D+W+ GVT + + T G +P+ G + E + +
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 29/96 (30%), Positives = 45/96 (46%), Gaps = 23/96 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
AYLH + H D+ +N V++ + + +K+ DF +++ + +G E Y
Sbjct: 148 AYLHAQHYIHRDLAARN-VLLDN--DRLVKIGDFGLAKAVPEGHEY--------YRVRED 196
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT 176
APE L A+D+WS GVT Y LLT
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 28/133 (21%), Positives = 54/133 (40%), Gaps = 32/133 (24%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
YL + H D+ +N V++ D ++K+ D + R + DY
Sbjct: 142 EYLSSHHVVHKDLATRN-VLVYD--KLNVKISDLGLFREVYAA----------DYYKLLG 188
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQL 198
+APE + Y ++ +D+WS GV + + + G P+ G ++ + I Q+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248
Query: 199 -----DFPDELFE 206
D P ++
Sbjct: 249 LPCPDDCPAWVYA 261
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 18/98 (18%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD-IKVCDFEISRVILDG---IEIRE---- 140
L L Y+H + H DIK NL++ + N D + + D+ +S + +E
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLL--GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 141 -LLGTPDYVAPEILH--YEPITLAADMWSLGVTAYVLL 175
GT ++ H + +D+ LG Y +L
Sbjct: 219 GHNGTIEF-TSLDAHKGVAL-SRRSDVEILG---YCML 251
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 23/96 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV---- 148
YL R+ H D+ +N V++ +K+ DF +++ I E Y
Sbjct: 140 DYLGSRQYVHRDLAARN-VLVES--EHQVKIGDFGLTKAIETDKEY--------YTVKDD 188
Query: 149 --------APEILHYEPITLAADMWSLGVTAYVLLT 176
APE L +A+D+WS GVT + LLT
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 27/115 (23%)
Query: 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY----- 147
AYL RK H D+ +N ++G+ N +K+ DF +SR I DY
Sbjct: 188 AYLSERKFVHRDLATRN-CLVGE--NMVVKIADFGLSRNIYSA----------DYYKADG 234
Query: 148 --------VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNI 193
+ PE + Y T +D+W+ GV + + + G P+ G E +
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 15/98 (15%), Positives = 37/98 (37%), Gaps = 18/98 (18%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRE----- 140
L +L +LH + H ++ +N+ + + + + + + E
Sbjct: 169 LDALEFLHENEYVHGNVTAENI-FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 141 LLGTPDYVAPEI---LHYEPITLAADMWSLGVTAYVLL 175
G ++++ + P + +D+ SLG Y +L
Sbjct: 228 HEGDLEFIS--MDLHKGCGP-SRRSDLQSLG---YCML 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 20/97 (20%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD-IKVCDFEISRVILDG-----IEIRE-- 140
L L Y+H + H DIK NL++ ++ N D + + D+ ++
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLL--NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 141 -LLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVLL 175
GT ++ + + P + D+ LG Y ++
Sbjct: 220 CHDGTIEFTSIDAHNGVAP-SRRGDLEILG---YCMI 252
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 383 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.72 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.27 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.69 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.83 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.77 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=443.15 Aligned_cols=234 Identities=23% Similarity=0.392 Sum_probs=208.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|+++.||+.||||++.. ....+.+|+.+|+ .++|||||+++++|++++.+|+|||||+ ||+|.+++..
T Consensus 88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~ivmEy~~-gg~L~~~l~~~ 165 (346)
T 4fih_A 88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEFLE-GGALTDIVTHT 165 (346)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEECCCT-TEEHHHHHHHS
T ss_pred eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEeCCC-CCcHHHHHHcC
Confidence 3689999999999999999975 4677999999999 7799999999999999999999999999 9999997654
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l 153 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....+.+||+.|+|||++
T Consensus 166 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl 242 (346)
T 4fih_A 166 RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 242 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC---CCEEEecCcCceecCCCCCcccccccCcCcCCHHHH
Confidence 3456777999999999999999999999999999876 68999999999987544 345678999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+|+.++|||||||++|+|++|++||.+.+..+.+..|..... +....+..+|+++++||.+||.+||++|||++|+
T Consensus 243 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 243 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999999999999999999998888888876533 2334567899999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
|+||||+...
T Consensus 322 l~Hp~~~~~~ 331 (346)
T 4fih_A 322 LKHPFLAKAG 331 (346)
T ss_dssp TTCGGGGGCC
T ss_pred hcCHhhcCCC
Confidence 9999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=439.93 Aligned_cols=231 Identities=29% Similarity=0.498 Sum_probs=208.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.||+.||||++.+ ....+.+|+++|+ .++|||||+++++|++++.+|+||||+. ||+|.+++
T Consensus 46 g~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~yivmEy~~-gG~L~~~i 123 (311)
T 4aw0_A 46 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLYFGLSYAK-NGELLKYI 123 (311)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEEEecCC-CCCHHHHH
Confidence 3699999999999999999975 3467899999999 7799999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCc
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDY 147 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y 147 (383)
.+ ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...+.+|||.|
T Consensus 124 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~Y 200 (311)
T 4aw0_A 124 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQY 200 (311)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECCTTTTCCCBCCCCSCGGG
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC---CCEEEEEcCCceecCCCCCcccccCcccCccc
Confidence 43 3456777999999999999999999999999999766 689999999999875332 34567999999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+|||++.+.+|+.++||||+||++|+|++|++||.+.+..+++.+|..+.+.+|. .+|+++++||.+||.+||++|
T Consensus 201 mAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp CCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGS
T ss_pred CCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHC
Confidence 9999999999999999999999999999999999999999999999999888764 579999999999999999999
Q ss_pred CCHHH------HHcCcccCCcc
Q psy6377 228 MTAKE------ALKHPWLMNKK 243 (383)
Q Consensus 228 pt~~e------~L~hp~~~~~~ 243 (383)
||++| +++||||++..
T Consensus 277 ~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 277 LGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCC
T ss_pred cChHHHcCCHHHHCCCCcCCCC
Confidence 99988 58999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-57 Score=441.64 Aligned_cols=230 Identities=24% Similarity=0.382 Sum_probs=206.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+|+ .++|||||+++++|++++.+|+|||||+ ||+|.+++..
T Consensus 39 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~yiVmEy~~-gg~L~~~i~~ 116 (350)
T 4b9d_A 39 KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLA-NMKHPNIVQYRESFEENGSLYIVMDYCE-GGDLFKRINA 116 (350)
T ss_dssp CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHH-HCCCCCCCcEEEEEEECCEEEEEEeCCC-CCcHHHHHHH
Confidence 689999999999999999976 2457899999999 7789999999999999999999999999 9999997742
Q ss_pred --------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCC
Q psy6377 79 --------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVA 149 (383)
Q Consensus 79 --------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~a 149 (383)
..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... ..+.+||+.|+|
T Consensus 117 ~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmA 193 (350)
T 4b9d_A 117 QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNSTVELARACIGTPYYLS 193 (350)
T ss_dssp TTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT---CCEEECSTTEESCCCHHHHHHHHHHSCCTTCC
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CCEEEcccccceeecCCcccccccCCCccccC
Confidence 2345677999999999999999999999999999876 6899999999997654332 356789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+.+|+.++|||||||++|+|++|++||.+.+..+.+.+|..+.++. .+..+|+++++||.+||.+||++|||
T Consensus 194 PE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s 270 (350)
T 4b9d_A 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRSLVSQLFKRNPRDRPS 270 (350)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999998876543 34578999999999999999999999
Q ss_pred HHHHHcCcccCCc
Q psy6377 230 AKEALKHPWLMNK 242 (383)
Q Consensus 230 ~~e~L~hp~~~~~ 242 (383)
++|+|+||||+..
T Consensus 271 ~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 271 VNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTSHHHHTT
T ss_pred HHHHhcCHHhhcC
Confidence 9999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-57 Score=425.68 Aligned_cols=227 Identities=31% Similarity=0.505 Sum_probs=192.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.||+.||+|++.+ ....+.+|+.+++ .++|||||+++++|++++.+|+||||+. |+|.+.+.
T Consensus 28 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~ivmEy~~--g~L~~~l~ 104 (275)
T 3hyh_A 28 KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHPHIIKLYDVIKSKDEIIMVIEYAG--NELFDYIV 104 (275)
T ss_dssp CEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC--EEHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEEEEEeCCC--CCHHHHHH
Confidence 689999999999999999976 2356899999999 7789999999999999999999999985 68888654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.........+.+||+.|+|||
T Consensus 105 ~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 105 QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 181 (275)
T ss_dssp HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---CCEEECCSSCC---------------CTTSCHH
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC---CCEEEeecCCCeecCCCCccCCeeECcccCChh
Confidence 3 3456777999999999999999999999999999765 689999999999876666667789999999999
Q ss_pred ccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+.+| +.++||||+||++|+|++|++||.+.+..+.+..+..+.+.+|. .+|+++++||.+||++||++|||+
T Consensus 182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~s~ 257 (275)
T 3hyh_A 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIKRMLIVNPLNRISI 257 (275)
T ss_dssp HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccCChhHCcCH
Confidence 9998886 58999999999999999999999999999999999988877664 579999999999999999999999
Q ss_pred HHHHcCcccCC
Q psy6377 231 KEALKHPWLMN 241 (383)
Q Consensus 231 ~e~L~hp~~~~ 241 (383)
+|+|+||||+.
T Consensus 258 ~eil~hpw~k~ 268 (275)
T 3hyh_A 258 HEIMQDDWFKV 268 (275)
T ss_dssp HHHHHCHHHHT
T ss_pred HHHHcCccccc
Confidence 99999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=444.11 Aligned_cols=232 Identities=23% Similarity=0.404 Sum_probs=208.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|+++.||+.||||++.. ....+.+|+.+|+ .++|||||+++++|++++.+|+|||||. ||+|.+++..
T Consensus 166 ~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~iVmEy~~-gG~L~~~i~~~~ 243 (423)
T 4fie_A 166 IVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVMEFLE-GGALTDIVTHTR 243 (423)
T ss_dssp EEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TEEHHHHHHHSC
T ss_pred EEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHH-hCCCCCCCceEEEEEECCEEEEEEeCCC-CCcHHHHHhccC
Confidence 689999999999999999976 4567999999999 7799999999999999999999999999 9999997643
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~ 154 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+..... ....+.+||+.|||||++.
T Consensus 244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~ 320 (423)
T 4fie_A 244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS 320 (423)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT---CCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEecCccceECCCCCccccccccCcCcCCHHHHC
Confidence 3456777999999999999999999999999999876 68999999999987544 3456789999999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+.+|+.++|||||||++|+|++|++||.+.+..+.+..|..... +....+..+|+++++||.+||.+||++|||++|+|
T Consensus 321 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 321 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 99999999999999999999999999999999888888876532 23345578999999999999999999999999999
Q ss_pred cCcccCCc
Q psy6377 235 KHPWLMNK 242 (383)
Q Consensus 235 ~hp~~~~~ 242 (383)
+||||+..
T Consensus 400 ~Hp~~~~~ 407 (423)
T 4fie_A 400 KHPFLAKA 407 (423)
T ss_dssp TCGGGGGC
T ss_pred cCHHhcCC
Confidence 99999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=426.41 Aligned_cols=230 Identities=30% Similarity=0.442 Sum_probs=199.0
Q ss_pred eEEEEEEc---CCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++. .+|+.||+|++.+ ....+.+|+++|+ .++|||||+++++|++++.+|+||||++ ||+|.++
T Consensus 39 ~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~ivmEy~~-gg~L~~~ 116 (304)
T 3ubd_A 39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV-EVNHPFIVKLHYAFQTEGKLYLILDFLR-GGDLFTR 116 (304)
T ss_dssp EEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCC-CCCCTTEECEEEEEEETTEEEEEECCCT-TCEEHHH
T ss_pred EEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEEEEEEcCC-CCCHHHH
Confidence 68999884 4789999999976 3457889999999 7899999999999999999999999999 9999997
Q ss_pred hcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 76 IDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 76 l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
+.+ ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....+.+||+.|+
T Consensus 117 l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~~~~~~~~~GT~~Ym 193 (304)
T 3ubd_A 117 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 193 (304)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---SCEEEESSEEEEC-----CCCCSCCCCGGGC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC---CCEEecccccceeccCCCccccccccCcccC
Confidence 644 3456777999999999999999999999999999876 68999999999865433 3356689999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+.+|+.++||||+||++|+|++|++||.+.+..+.+..|..+.+.+|. .+|+++++||.+||++||++||
T Consensus 194 APE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~ 269 (304)
T 3ubd_A 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRMLFKRNPANRL 269 (304)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGST
T ss_pred CHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcccCHHHCC
Confidence 999999999999999999999999999999999999999999999988877764 6799999999999999999999
Q ss_pred C-----HHHHHcCcccCCcc
Q psy6377 229 T-----AKEALKHPWLMNKK 243 (383)
Q Consensus 229 t-----~~e~L~hp~~~~~~ 243 (383)
| ++|+++||||++..
T Consensus 270 ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 270 GAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp TCSTTTHHHHHTSGGGTTCC
T ss_pred CCCcCCHHHHHcCccccCCC
Confidence 8 48999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=416.82 Aligned_cols=229 Identities=21% Similarity=0.337 Sum_probs=194.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.+|+.||+|++.. ....+.+|+++++ .++|||||+++++|++ +..+|+|||||+ ||+|.+
T Consensus 41 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~-gg~L~~ 118 (290)
T 3fpq_A 41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLVTELMT-SGTLKT 118 (290)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEEETTEEEEEEEEECCC-SCBHHH
T ss_pred EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC-CCCHHH
Confidence 689999999999999999975 2456899999999 7799999999999976 345899999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
++.+ ..+..++.||+.||+|||++| |+||||||+|||+++. .+.+||+|||+|+... .....+.+|||.
T Consensus 119 ~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla~~~~-~~~~~~~~GTp~ 195 (290)
T 3fpq_A 119 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKR-ASFAKAVIGTPE 195 (290)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGGGGCC-TTSBEESCSSCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCCEeCC-CCccCCcccCcc
Confidence 7654 334567799999999999999 9999999999999753 2689999999998543 334567799999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE-TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|||||++.+ +|+.++|||||||++|+|++|++||.+.+... .+..+..+ ..|...+..+++++++||.+||.+||+
T Consensus 196 YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~ 272 (290)
T 3fpq_A 196 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKD 272 (290)
T ss_dssp CCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCGGGGGCCCHHHHHHHHHHSCSSGG
T ss_pred ccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--CCCCCCCccCCHHHHHHHHHHccCChh
Confidence 999999875 69999999999999999999999998766544 44444433 234455677899999999999999999
Q ss_pred CCCCHHHHHcCcccCC
Q psy6377 226 ERMTAKEALKHPWLMN 241 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~ 241 (383)
+|||++|+|+||||+.
T Consensus 273 ~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 273 ERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GSCCHHHHHTSGGGC-
T ss_pred HCcCHHHHhcCccccC
Confidence 9999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=424.54 Aligned_cols=234 Identities=24% Similarity=0.284 Sum_probs=201.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc------
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD------ 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~------ 78 (383)
.||+|+++.||+.||||++.... ...+|+.+++ .++|||||+++++|++++.+|+||||++ ||+|.+++..
T Consensus 73 ~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~-~l~HpnIV~l~~~~~~~~~~~ivmEy~~-gg~L~~~l~~~~~l~e 149 (336)
T 4g3f_A 73 EVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACA-GLSSPRIVPLYGAVREGPWVNIFMELLE-GGSLGQLIKQMGCLPE 149 (336)
T ss_dssp EEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTT-TCCCTTBCCEEEEEEETTEEEEEECCCT-TCBHHHHHHHHSSCCH
T ss_pred EEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEeccC-CCcHHHHHHHcCCCCH
Confidence 69999999999999999998632 3358999999 7899999999999999999999999999 9999997644
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc------cccccCCCCcCCCcc
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE------IRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~------~~~~~gt~~y~aPE~ 152 (383)
..+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+....... ....+||+.|||||+
T Consensus 150 ~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~ 227 (336)
T 4g3f_A 150 DRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--CCEEECCCTTCEEC------------CCCCCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHH
Confidence 34567779999999999999999999999999998762 2699999999997654321 123589999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+.+|+.++|||||||++|+|++|++||.+.+..+++..|.....++ ...++.+|+++++||.+||.+||.+|||+.|
T Consensus 228 ~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~e 306 (336)
T 4g3f_A 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAME 306 (336)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999999999999999999999999999999998888888887765432 3456789999999999999999999999999
Q ss_pred H-------------HcCcccCCcch
Q psy6377 233 A-------------LKHPWLMNKKQ 244 (383)
Q Consensus 233 ~-------------L~hp~~~~~~~ 244 (383)
+ |+|||+.....
T Consensus 307 l~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 307 LRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHHhhhhhccCCCcCCCCC
Confidence 7 57999976543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=420.51 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=203.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|+++.||+.||||++.+ ....+.+|+.+|+ .++|||||++++++.+. +.+|+||||+. |+|
T Consensus 69 ~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~--g~L 145 (398)
T 4b99_A 69 VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILK-HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME--SDL 145 (398)
T ss_dssp EEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS--EEH
T ss_pred EEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHH-hcCCCCcceEeeeeecccccccCCEEEEEEeCCC--CCH
Confidence 699999999999999999976 2356789999999 77899999999998643 67899999997 568
Q ss_pred HHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----cccccc
Q psy6377 73 QTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----IEIREL 141 (383)
Q Consensus 73 ~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-----~~~~~~ 141 (383)
.+++... .+..+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....+.
T Consensus 146 ~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~---~~~Ki~DFGla~~~~~~~~~~~~~~~~~ 222 (398)
T 4b99_A 146 HQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN---CELKIGDFGMARGLCTSPAEHQYFMTEY 222 (398)
T ss_dssp HHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTTCBCC-------CCCCCSS
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC---CCEEEeecceeeecccCccccccccccc
Confidence 8876443 356777999999999999999999999999999865 68999999999865332 234567
Q ss_pred cCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch----------------
Q psy6377 142 LGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL---------------- 204 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------- 204 (383)
+||+.|+|||++.+. .|+.++||||+|||+|+|++|++||.+.+..+++..|......++...
T Consensus 223 ~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~ 302 (398)
T 4b99_A 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSL 302 (398)
T ss_dssp CCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSS
T ss_pred eeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcC
Confidence 999999999998765 579999999999999999999999999999999998877655554322
Q ss_pred -----------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcccC
Q psy6377 205 -----------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVG 250 (383)
Q Consensus 205 -----------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~~ 250 (383)
++.+|+++++||.+||.+||++|||++|+|+||||+........+.
T Consensus 303 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~ 359 (398)
T 4b99_A 303 PPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD 359 (398)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC
T ss_pred CCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC
Confidence 3467899999999999999999999999999999997665444433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=437.89 Aligned_cols=237 Identities=33% Similarity=0.585 Sum_probs=218.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|+++.||+.||+|++.+ +...+.+|+.+|+ .++|||||+++++|++.+.+|+||||+. ||+|.+++..
T Consensus 172 ~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~iv~E~~~-gg~L~~~i~~~~ 249 (573)
T 3uto_A 172 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVMIYEFMS-GGELFEKVADEH 249 (573)
T ss_dssp EEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHH-HTCCTTBCCEEEEEECSSEEEEEEECCC-CCBHHHHHTCTT
T ss_pred EEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEeecC-CCcHHHHHHHhC
Confidence 689999999999999999976 3567889999999 7799999999999999999999999999 9999996643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
..+..+++||+.||+|||++||+||||||+|||++.+ ..+.+||+|||+|+.........+.+||+.|+|||++
T Consensus 250 ~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~ 328 (573)
T 3uto_A 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328 (573)
T ss_dssp SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEccCCCceeeeEECccccCHHHh
Confidence 2355777999999999999999999999999999764 2368999999999998777777888999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..|....+.++...+..+|+++++||.+||.+||.+|||++|+
T Consensus 329 ~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HcCcccCCcch
Q psy6377 234 LKHPWLMNKKQ 244 (383)
Q Consensus 234 L~hp~~~~~~~ 244 (383)
|+||||+....
T Consensus 409 l~Hpw~~~~~~ 419 (573)
T 3uto_A 409 LEHPWLTPGNA 419 (573)
T ss_dssp HHSTTTSCCCC
T ss_pred hcCcCcCCCCC
Confidence 99999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=412.22 Aligned_cols=235 Identities=27% Similarity=0.373 Sum_probs=191.8
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
.||+|+++ .+++.||+|.+.+ ...++.+|+++|+.+.+|||||+++++|++.+.+|+||||++ |++|.+++.
T Consensus 36 ~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~-g~~L~~~~~~l 114 (361)
T 4f9c_A 36 SVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE-HESFLDILNSL 114 (361)
T ss_dssp EEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC-CCCHHHHHTTC
T ss_pred EEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC-cccHHHHHcCC
Confidence 68999875 5788999998876 456788999999967789999999999999999999999999 999999764
Q ss_pred -cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---------------------
Q psy6377 78 -DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--------------------- 135 (383)
Q Consensus 78 -~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~--------------------- 135 (383)
+..+..+.+||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+...+.
T Consensus 115 ~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (361)
T 4f9c_A 115 SFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNK 192 (361)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEECTTCSCGGGGGC-------------
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCCCcccCCcccccccccccccccccccccc
Confidence 345667789999999999999999999999999998652 68999999999865332
Q ss_pred --------cccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhcc--------
Q psy6377 136 --------IEIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQ-------- 197 (383)
Q Consensus 136 --------~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~i~~~~-------- 197 (383)
....+.+||+.|+|||++.+. .|+.++||||+|||+|+|++|++||.+. +..+.+..|....
T Consensus 193 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~ 272 (361)
T 4f9c_A 193 CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQA 272 (361)
T ss_dssp -------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhh
Confidence 123456899999999999775 5899999999999999999999999644 4444444443210
Q ss_pred ------------------------------CCC------------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 198 ------------------------------LDF------------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 198 ------------------------------~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
... ....|..+|+++++||.+||++||++|+|++|+|+
T Consensus 273 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 273 AKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 11235678999999999999999999999999999
Q ss_pred CcccCCc
Q psy6377 236 HPWLMNK 242 (383)
Q Consensus 236 hp~~~~~ 242 (383)
||||++.
T Consensus 353 Hp~f~~i 359 (361)
T 4f9c_A 353 HPFFKDM 359 (361)
T ss_dssp SGGGTTC
T ss_pred CcccCCC
Confidence 9999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=400.15 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=182.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------------eEEEEEecCC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------------GAYYVSWNTP 67 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------------~~~lv~e~~~ 67 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+|+ .++|||||+++++|.+.+ .+|+|||||.
T Consensus 20 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~ 98 (299)
T 4g31_A 20 VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA-KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98 (299)
T ss_dssp EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred EEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence 689999999999999999975 2456889999999 779999999999998655 3799999999
Q ss_pred CcCcHHHhhccCC---------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 68 LVVTLQTIIDDNL---------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 68 ~g~~L~~~l~~~~---------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
||+|.+++.... ++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 99 -gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~---~~vKl~DFGla~~~~~~~~~ 174 (299)
T 4g31_A 99 -KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEE 174 (299)
T ss_dssp -SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCCCC---------
T ss_pred -CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---CcEEEccCccceecCCCccc
Confidence 999999875432 34577999999999999999999999999999876 6899999999987643321
Q ss_pred ------------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcch
Q psy6377 138 ------------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDEL 204 (383)
Q Consensus 138 ------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~ 204 (383)
..+.+||+.|||||++.+.+|+.++|||||||++|+|++ ||.+.... ..+..+. ...+| +.
T Consensus 175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~--~~~~p-~~ 248 (299)
T 4g31_A 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR--NLKFP-PL 248 (299)
T ss_dssp -----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH--TTCCC-HH
T ss_pred cccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh--cCCCC-CC
Confidence 234689999999999999999999999999999999996 77654321 2233333 23343 34
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+...++.+.+||.+||.+||++|||+.|+|+||||++..
T Consensus 249 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 249 FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 456688899999999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=394.43 Aligned_cols=238 Identities=38% Similarity=0.671 Sum_probs=215.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+++.+|+.||+|++.+. ...+.+|+.+++ .+.||||++++++|++...+|+|||++. |++|.
T Consensus 26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lv~e~~~-gg~L~ 103 (361)
T 2yab_A 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-QVLHPNIITLHDVYENRTDVVLILELVS-GGELF 103 (361)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHH
T ss_pred EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHH-hCCCcCCCcEEEEEEeCCEEEEEEEcCC-CCcHH
Confidence 36899999999999999999861 246889999999 7789999999999999999999999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-CCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-NCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
+++... .+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++.....+......+||+.
T Consensus 104 ~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~ 183 (361)
T 2yab_A 104 DFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183 (361)
T ss_dssp HHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCcc
Confidence 976543 34566799999999999999999999999999976531 23799999999998776666677889999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++...|..+++++++||.+||.+||.+
T Consensus 184 y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 263 (361)
T 2yab_A 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRK 263 (361)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTT
T ss_pred EECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||++|+|+||||....
T Consensus 264 R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 264 RLTIQEALRHPWITPVD 280 (361)
T ss_dssp SCCHHHHHTSTTTSCSS
T ss_pred CcCHHHHhcCcCcCCCc
Confidence 99999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=419.27 Aligned_cols=230 Identities=22% Similarity=0.343 Sum_probs=196.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHH---HHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHE---IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~E---i~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.||+.||||++.+ ....+.+| +.+++ ..+|||||+++++|++.+.+|+||||+. ||+|.+
T Consensus 204 ~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~-~~~HP~IV~l~~~f~~~~~lylVmEy~~-GGdL~~ 281 (689)
T 3v5w_A 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMN-GGDLHY 281 (689)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHS-SSCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHH
T ss_pred EEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHh-hCCCCCEeEEEEEEEECCEEEEEEecCC-CCcHHH
Confidence 689999999999999999976 22334455 44444 5689999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
++.. ..+.+++.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+..... ...+.+|||.|+
T Consensus 282 ~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~---G~vKL~DFGlA~~~~~~-~~~t~~GTp~Ym 357 (689)
T 3v5w_A 282 HLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-KPHASVGTHGYM 357 (689)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC-CCCSCCSCGGGC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC---CCEEecccceeeecCCC-CCCCccCCcCcc
Confidence 7643 4466778999999999999999999999999999876 79999999999986543 456689999999
Q ss_pred CCcccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 149 APEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 149 aPE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|||++. +.+|+.++|+|||||++|+|++|++||.+.+. .++...+......+| ..+|+++++||.+||.+||
T Consensus 358 APEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDV 433 (689)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCG
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHHHHHHHHHHccCCH
Confidence 999996 56899999999999999999999999987543 345555666655555 4689999999999999999
Q ss_pred CCCCC-----HHHHHcCcccCCcch
Q psy6377 225 MERMT-----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 225 ~~Rpt-----~~e~L~hp~~~~~~~ 244 (383)
.+|++ ++|+++||||++...
T Consensus 434 ~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 434 NRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp GGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred hHCCCCCCCCHHHHhcCccccCCCH
Confidence 99998 799999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=384.83 Aligned_cols=227 Identities=21% Similarity=0.275 Sum_probs=195.0
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++. .+|+.||||++.. ....+.+|+++|+ .++|||||++++++.+++.+|+||||++ +|+|.++
T Consensus 28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~~~~~~~~lV~Ey~~-~G~L~~~ 105 (299)
T 4asz_A 28 KVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT-NLQHEHIVKFYGVCVEGDPLIMVFEYMK-HGDLNKF 105 (299)
T ss_dssp CEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSEEEEEECCT-TCBHHHH
T ss_pred EEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHH-hCCCCCCccEEEEEeeCCEEEEEEEcCC-CCcHHHH
Confidence 68999865 4688999999986 2467899999999 7799999999999999999999999999 9999997
Q ss_pred hcc-------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 76 IDD-------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 76 l~~-------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
+.. ..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp HHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCSCHHHHTGGG
T ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC---CcEEECCcccceecCCCC
Confidence 743 2345677999999999999999999999999999876 689999999998654332
Q ss_pred c---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHH
Q psy6377 137 E---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212 (383)
Q Consensus 137 ~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 212 (383)
. ....+||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..+..+.... .+..+|+++
T Consensus 183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~ 259 (299)
T 4asz_A 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ---RPRTCPQEV 259 (299)
T ss_dssp CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC---CCTTCCHHH
T ss_pred ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHH
Confidence 2 223469999999999999999999999999999999998 999999999999999888776432 224689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 213 KDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
.+|+.+||..||++|||+.++ ++|+++
T Consensus 260 ~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 260 YELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 999999999999999999999 456654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=385.47 Aligned_cols=224 Identities=20% Similarity=0.271 Sum_probs=186.7
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+.+ .+|+.||||++.. ..+.+.+|+++|+ .++|||||++++++.+++.+|+||||++ +|+|.++
T Consensus 56 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~~~~~~~~lV~Ey~~-~G~L~~~ 133 (329)
T 4aoj_A 56 KVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT-MLQHQHIVRFFGVCTEGRPLLMVFEYMR-HGDLNRF 133 (329)
T ss_dssp EEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSEEEEEECCT-TCBHHHH
T ss_pred EEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEEcCC-CCcHHHH
Confidence 68999864 4789999999986 3467899999999 7799999999999999999999999999 9999997
Q ss_pred hccC---------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec
Q psy6377 76 IDDN---------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134 (383)
Q Consensus 76 l~~~---------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~ 134 (383)
+... .++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~---~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG---LVVKIGDFGMSRDIYS 210 (329)
T ss_dssp HHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC-------
T ss_pred HHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC---CcEEEcccccceeccC
Confidence 6432 245677999999999999999999999999999876 6899999999987643
Q ss_pred Ccc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 135 GIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 135 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
... ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+..+... +.+..+++
T Consensus 211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~---~~p~~~~~ 287 (329)
T 4aoj_A 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL---ERPRACPP 287 (329)
T ss_dssp ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC---CCCTTCCH
T ss_pred CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---CCcccccH
Confidence 322 234679999999999999999999999999999999998 99999999998988888776422 12346899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++.+|+.+||..||++|||++|++++
T Consensus 288 ~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 288 EVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=378.50 Aligned_cols=223 Identities=19% Similarity=0.290 Sum_probs=181.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+.+ ..||||+++. ....+.+|+.+++ .++|||||++++++. ++.+|+|||||+ ||+|.+++..
T Consensus 51 ~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~-~l~HpNIV~l~g~~~-~~~~~iVmEy~~-gGsL~~~l~~ 124 (307)
T 3omv_A 51 TVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLR-KTRHVNILLFMGYMT-KDNLAIVTQWCE-GSSLYKHLHV 124 (307)
T ss_dssp EEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSSCEEEEECCS-SCBHHHHHHT
T ss_pred EEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEE-CCeEEEEEEcCC-CCCHHHHHhh
Confidence 58999854 3589999875 2356889999999 789999999999875 567899999999 9999997643
Q ss_pred C-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---cccccccCCCCcC
Q psy6377 79 N-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYV 148 (383)
Q Consensus 79 ~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~y~ 148 (383)
. .+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....+.+||+.||
T Consensus 125 ~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ym 201 (307)
T 3omv_A 125 QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWM 201 (307)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC------------CCCCTTSC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC---CcEEEeeccCceecccCCcceeecccccCCCcc
Confidence 2 244666999999999999999999999999999876 68999999999865432 2345678999999
Q ss_pred CCccccc---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--cchhcCCCHHHHHHHHHhcccC
Q psy6377 149 APEILHY---EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--DELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 149 aPE~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~d 223 (383)
|||++.+ .+|+.++|||||||++|||+||+.||.+.+....+..+.......| ...+.++++++.+|+.+||..|
T Consensus 202 APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~d 281 (307)
T 3omv_A 202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKV 281 (307)
T ss_dssp CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSS
T ss_pred CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCC
Confidence 9999864 4699999999999999999999999998877666655554443333 3456788999999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|++|||+.|++++
T Consensus 282 P~~RPs~~ei~~~ 294 (307)
T 3omv_A 282 KEERPLFPQILSS 294 (307)
T ss_dssp STTSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=380.60 Aligned_cols=224 Identities=17% Similarity=0.255 Sum_probs=192.8
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+.. .+++.||||++.. ..+.+.+|+.+++ .++|||||++++++.+++.+++||||++ +|+|.+
T Consensus 41 ~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~-~l~HpNIV~l~g~~~~~~~~~lV~Ey~~-~G~L~~ 118 (308)
T 4gt4_A 41 KVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA-RLQHPNVVCLLGVVTKDQPLSMIFSYCS-HGDLHE 118 (308)
T ss_dssp EEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCS-SCBHHH
T ss_pred EEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHH-hCCCCCCCCcceEEEECCEEEEEEEcCC-CCcHHH
Confidence 58998853 5788999999976 2467899999999 7799999999999999999999999999 999999
Q ss_pred hhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 75 IIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 75 ~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
++... ....++.||+.||+|||+++||||||||+|||++++ +.+||+|||+|+..
T Consensus 119 ~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~---~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 119 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLFREV 195 (308)
T ss_dssp HHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCSCCBCGG
T ss_pred HHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC---CCEEECCcccceec
Confidence 77321 234577999999999999999999999999999876 68999999999875
Q ss_pred ecCc---ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCC
Q psy6377 133 LDGI---EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDI 208 (383)
Q Consensus 133 ~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 208 (383)
.... .....+||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+..+.... .+..+
T Consensus 196 ~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~ 272 (308)
T 4gt4_A 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP---CPDDC 272 (308)
T ss_dssp GGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred cCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---Ccccc
Confidence 4332 2345689999999999999999999999999999999998 899999999999888887765332 23578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 209 SPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 209 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++++.+|+.+||..||++|||+.|++++
T Consensus 273 ~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 273 PAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=382.52 Aligned_cols=238 Identities=30% Similarity=0.505 Sum_probs=215.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. |++|.+.+.
T Consensus 43 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~-gg~L~~~l~ 120 (362)
T 2bdw_A 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYLVFDLVT-GGELFEDIV 120 (362)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHT
T ss_pred eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEEEecCC-CCCHHHHHH
Confidence 3689999999999999999976 2356889999999 7789999999999999999999999999 999998664
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++............+||+.|+|||
T Consensus 121 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200 (362)
T ss_dssp TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHH
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHH
Confidence 32 345667999999999999999999999999999876555679999999998876655566678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+.+|+.++|||||||++|+|++|.+||.+.+..+....+..+.+.+|...|..+++++++||.+||..||++|||+.
T Consensus 201 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (362)
T 2bdw_A 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD 280 (362)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99999999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
++|+||||....
T Consensus 281 e~l~hp~~~~~~ 292 (362)
T 2bdw_A 281 QALKVPWICNRE 292 (362)
T ss_dssp HHTTSHHHHTHH
T ss_pred HHhcCcccCCCc
Confidence 999999997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=388.02 Aligned_cols=237 Identities=28% Similarity=0.503 Sum_probs=213.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+++..|+|||++. |++|.+.+..
T Consensus 26 ~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lv~E~~~-gg~L~~~i~~ 103 (444)
T 3soa_A 26 VVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVT-GGELFEDIVA 103 (444)
T ss_dssp EEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHH-HCCBTTBCCEEEEEECSSEEEEEECCCB-CCBHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCcCCCeEEEEEEECCEEEEEEEeCC-CCCHHHHHHH
Confidence 689999999999999999976 2356889999999 7799999999999999999999999999 9999986543
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..+..||+.||.|||++||+||||||+|||++.+...+.+||+|||+|....... .....+||+.|+|||
T Consensus 104 ~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE 183 (444)
T 3soa_A 104 REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183 (444)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHH
Confidence 3345677999999999999999999999999999876555789999999998765433 245678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+.+|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++...|..+++++++||.+||..||.+|||+.
T Consensus 184 ~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 263 (444)
T 3soa_A 184 VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAA 263 (444)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99999999999999999999999999999999999999999999999999988999999999999999999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
|+|+||||....
T Consensus 264 e~L~hp~~~~~~ 275 (444)
T 3soa_A 264 EALKHPWISHRS 275 (444)
T ss_dssp HHHHSCTTHHHH
T ss_pred HHhcCccccCCc
Confidence 999999997543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=370.03 Aligned_cols=232 Identities=25% Similarity=0.457 Sum_probs=207.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+.+..|+||||+. |++|.+++.
T Consensus 29 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 106 (328)
T 3fe3_A 29 AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKTLYLIMEYAS-GGEVFDYLV 106 (328)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCT-TCBHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEEEEEECCC-CCcHHHHHH
Confidence 3699999999999999999976 2356789999999 7789999999999999999999999999 999999753
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....+......+||+.|+|||
T Consensus 107 ~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 107 AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD---MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183 (328)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHH
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC---CCEEEeeccCceecCCCCccccccCCcceeCcc
Confidence 3 3455677999999999999999999999999999765 689999999998776666677789999999999
Q ss_pred ccccCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPIT-LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..++ .++||||+||++|+|++|.+||.+.+..+....+..+.+..|. .+++++.+||.+||..||.+|||+
T Consensus 184 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~ 259 (328)
T 3fe3_A 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTL 259 (328)
T ss_dssp HHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCH
T ss_pred cccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCH
Confidence 99888875 8999999999999999999999999999999999888877764 579999999999999999999999
Q ss_pred HHHHcCcccCCcch
Q psy6377 231 KEALKHPWLMNKKQ 244 (383)
Q Consensus 231 ~e~L~hp~~~~~~~ 244 (383)
+|+|+||||+....
T Consensus 260 ~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 260 EQIMKDRWINAGHE 273 (328)
T ss_dssp HHHTTCTTTTTTCT
T ss_pred HHHhcCHhhcCCCc
Confidence 99999999986543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=371.54 Aligned_cols=237 Identities=32% Similarity=0.569 Sum_probs=215.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++++.+..|+|||++. |++|.+.+...
T Consensus 19 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~-g~~L~~~l~~~~ 96 (321)
T 1tki_A 19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN-IARHRNILHLHESFESMEELVMIFEFIS-GLDIFERINTSA 96 (321)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEEEEECCCC-CCBHHHHHTSSS
T ss_pred eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHH-hCCCCCCCeEeEEEecCCEEEEEEEeCC-CCCHHHHHHhcC
Confidence 3689999999999999999876 3456789999999 7789999999999999999999999999 99999977543
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.++.+..||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++.....+.......||+.|+|||++
T Consensus 97 ~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 97 FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCccccccCChhhcCcHHh
Confidence 245666999999999999999999999999999863 2368999999999988766666677899999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..+...++...+..+|.++.+||.+||..||.+|||+.|+
T Consensus 176 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~ 255 (321)
T 1tki_A 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 98889999999999999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
|+||||+...
T Consensus 256 l~hp~~~~~~ 265 (321)
T 1tki_A 256 LQHPWLKQKI 265 (321)
T ss_dssp HHSHHHHSCG
T ss_pred hcChhhccCc
Confidence 9999998654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=365.08 Aligned_cols=238 Identities=37% Similarity=0.672 Sum_probs=214.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+++.+|+.||+|++.+. ...+.+|+.+++ .++||||++++++|.+....|+|||++. |++|.
T Consensus 25 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 102 (326)
T 2y0a_A 25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYENKTDVILILELVA-GGELF 102 (326)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHH
T ss_pred eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEEEEEcCC-CCCHH
Confidence 37899999999999999999761 345889999999 7789999999999999999999999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC-CCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF-PNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~-~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
+++... .+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++............+||+.
T Consensus 103 ~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~ 182 (326)
T 2y0a_A 103 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182 (326)
T ss_dssp HHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTT
T ss_pred HHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcC
Confidence 976543 3456679999999999999999999999999997653 234799999999998766555667789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+.+++.++|||||||++|+|++|.+||.+.+..+.+..+......++...+..++..+.+||.+||..||.+
T Consensus 183 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (326)
T 2y0a_A 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 262 (326)
T ss_dssp TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGG
T ss_pred cCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999999999999999999999888888888888999999999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||+.|+|+||||....
T Consensus 263 Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 263 RMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCCHHHHHHSTTTSCCS
T ss_pred CCCHHHHhcCCCccCCc
Confidence 99999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=370.25 Aligned_cols=237 Identities=27% Similarity=0.455 Sum_probs=208.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||++++++|.+.+.+|+||||+. |++|.+
T Consensus 38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~-g~~L~~ 115 (351)
T 3c0i_A 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-MLKHPHIVELLETYSSDGMLYMVFEFMD-GADLCF 115 (351)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCS-SCBHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEEEEeCCC-CCCHHH
Confidence 3699999999999999999864 2456889999999 7789999999999999999999999999 999987
Q ss_pred hhc----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccC
Q psy6377 75 IID----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLG 143 (383)
Q Consensus 75 ~l~----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~g 143 (383)
.+. +..+..++.||+.||+|||++||+||||||+|||++.++..+.+||+|||++........ ....+|
T Consensus 116 ~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g 195 (351)
T 3c0i_A 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195 (351)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCS
T ss_pred HHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcC
Confidence 542 233456679999999999999999999999999998765556799999999988755433 345689
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
|+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ..+.+..+..+...+++..|..+++++++||.+||..|
T Consensus 196 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 274 (351)
T 3c0i_A 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274 (351)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred CcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCC
Confidence 99999999999999999999999999999999999999875 45677778888888888888899999999999999999
Q ss_pred CCCCCCHHHHHcCcccCCcc
Q psy6377 224 PMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~~ 243 (383)
|++|||+.++|+||||+...
T Consensus 275 P~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 275 PAERITVYEALNHPWLKERD 294 (351)
T ss_dssp TTTSCCHHHHHTSHHHHTHH
T ss_pred hhHCcCHHHHhcChhhcCCc
Confidence 99999999999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=370.21 Aligned_cols=239 Identities=28% Similarity=0.469 Sum_probs=210.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc------
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD------ 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~------ 78 (383)
.||+|+++.+|+.||+|++.+......+|++++....+||||++++++|++++..|+||||+. |++|.+.+..
T Consensus 37 ~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~-gg~L~~~i~~~~~~~~ 115 (342)
T 2qr7_A 37 VCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK-GGELLDKILRQKFFSE 115 (342)
T ss_dssp EEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHHTCTTCCH
T ss_pred EEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC-CCcHHHHHHHcCCCCH
Confidence 699999999999999999988666788999999877799999999999999999999999999 9999996543
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC-CCCcEEEEeccceeEeecC-cccccccCCCCcCCCcccccC
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF-PNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~-~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 156 (383)
..+..+..||+.||+|||++||+||||||+|||+..+. ..+.+||+|||++...... ....+.+||+.|+|||++.+.
T Consensus 116 ~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC
Confidence 33456779999999999999999999999999985542 2246999999999976543 234567899999999999988
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCC---CCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFSPFGG---ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
+|+.++|||||||++|+|++|.+||.+ .+..+.+..+..+.+.++...|..+|+++++||.+||..||++|||+.++
T Consensus 196 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 899999999999999999999999986 45567788888888888888889999999999999999999999999999
Q ss_pred HcCcccCCcch
Q psy6377 234 LKHPWLMNKKQ 244 (383)
Q Consensus 234 L~hp~~~~~~~ 244 (383)
|+||||.+...
T Consensus 276 l~hp~~~~~~~ 286 (342)
T 2qr7_A 276 LRHPWIVHWDQ 286 (342)
T ss_dssp TTSHHHHTGGG
T ss_pred hcCCeecCccc
Confidence 99999976543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=372.33 Aligned_cols=233 Identities=27% Similarity=0.438 Sum_probs=203.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++...+||||++++++|++.+.+|+||||+. |++|..++
T Consensus 37 g~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l 115 (353)
T 3txo_A 37 GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN-GGDLMFHI 115 (353)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHH
T ss_pred EEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 3699999999999999999976 345678999999966689999999999999999999999999 99999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... .....+.+||+.|+|
T Consensus 116 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 192 (353)
T 3txo_A 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192 (353)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCC---------CCGGGCC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---CCEEEccccceeecccCCccccccCCCcCeEC
Confidence 43 3455677999999999999999999999999999766 6899999999986432 233556789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..|......+|. .+++++.+||.+||.+||.+||+
T Consensus 193 PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp HHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTT
T ss_pred hhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccC
Confidence 99999999999999999999999999999999999999999999998887764 47999999999999999999999
Q ss_pred H------HHHHcCcccCCcch
Q psy6377 230 A------KEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ~------~e~L~hp~~~~~~~ 244 (383)
+ +++++||||+....
T Consensus 269 ~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 269 SLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp SGGGTCTHHHHTSGGGTTCCH
T ss_pred CcccCCHHHHhhCCcccCCCH
Confidence 8 89999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=366.00 Aligned_cols=239 Identities=28% Similarity=0.443 Sum_probs=190.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC----
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN---- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~---- 79 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+++.+.+||||++++++|.++...|+|||++. |++|.+.+...
T Consensus 26 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~ 104 (325)
T 3kn6_A 26 ICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN-GGELFERIKKKKHFS 104 (325)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHHHCSCCC
T ss_pred EEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC-CCcHHHHHHhcCCCC
Confidence 689999999999999999987 456788999999966679999999999999999999999999 99999976543
Q ss_pred --CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCcccccC
Q psy6377 80 --LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEILHYE 156 (383)
Q Consensus 80 --~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 156 (383)
.+..+..||+.||+|||++||+||||||+|||++.++....+||+|||+++..... ......+||+.|+|||++.+.
T Consensus 105 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 184 (325)
T 3kn6_A 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------C
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC
Confidence 34567799999999999999999999999999987644458999999999875443 234567899999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFSPFGGETD-------SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
+|+.++|||||||++|+|++|.+||.+.+. .+.+..+..+.+.++...|..+++++++||.+||..||.+|||
T Consensus 185 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC
Confidence 999999999999999999999999987543 4677888888888888889999999999999999999999999
Q ss_pred HHHHHcCcccCCcch
Q psy6377 230 AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ~~e~L~hp~~~~~~~ 244 (383)
++++++||||++..+
T Consensus 265 ~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 265 MSGLRYNEWLQDGSQ 279 (325)
T ss_dssp TTTSTTCGGGCTTCC
T ss_pred HHHHhcChhhccCcc
Confidence 999999999987544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=375.90 Aligned_cols=225 Identities=21% Similarity=0.327 Sum_probs=186.4
Q ss_pred eEEEEEEcCC-----CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIAT-----GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~t-----g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+++.+ ++.||||.+.. ....+.+|+.+|..+..|||||++++++.+ ++.+|+|||||+ +|+|.
T Consensus 79 ~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~-~G~L~ 157 (353)
T 4ase_A 79 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK-FGNLS 157 (353)
T ss_dssp EEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCT-TEEHH
T ss_pred EEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCC-CCCHH
Confidence 5899987654 46899999976 245688999999966677999999999865 456899999999 99999
Q ss_pred HhhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 74 TIIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 74 ~~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+++... .+..++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.
T Consensus 158 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~---~~vKi~DFGlar~ 234 (353)
T 4ase_A 158 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARD 234 (353)
T ss_dssp HHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC---CCEEECcchhhhh
Confidence 987432 234566899999999999999999999999999876 6899999999987
Q ss_pred eecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHH-HHHHhccCCCCcchhc
Q psy6377 132 ILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETF-RNISKAQLDFPDELFE 206 (383)
Q Consensus 132 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 206 (383)
...... ..+.+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+.+ ..+..+.. ++ .+.
T Consensus 235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~--~p~ 311 (353)
T 4ase_A 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR--APD 311 (353)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC--CCT
T ss_pred cccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CC--CCc
Confidence 643322 234679999999999999999999999999999999998 99999987755444 44444432 21 224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+++++.+|+.+||..||++|||+.|+++|
T Consensus 312 ~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 312 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 679999999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.81 Aligned_cols=237 Identities=29% Similarity=0.477 Sum_probs=213.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||||++.+ ....+.+|+.+++ .++||||++++++|.+....|+|||++. |++|.+.+
T Consensus 40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~ 117 (484)
T 3nyv_A 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK-QLDHPNIMKLYEFFEDKGYFYLVGEVYT-GGELFDEI 117 (484)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEEEEecCC-CCCHHHHH
Confidence 3689999999999999999865 3456889999999 7799999999999999999999999999 99999865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||++............+||+.|+||
T Consensus 118 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 197 (484)
T 3nyv_A 118 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197 (484)
T ss_dssp HTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCc
Confidence 33 234567799999999999999999999999999976545579999999999877666666677899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.|..+|+++++||.+||.+||.+|||+
T Consensus 198 E~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 276 (484)
T 3nyv_A 198 EVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276 (484)
T ss_dssp HHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred eeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 99876 69999999999999999999999999999999999999999988888889999999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
.|+|+||||+...
T Consensus 277 ~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 277 RDALDHEWIQTYT 289 (484)
T ss_dssp HHHHTSHHHHHHT
T ss_pred HHHhhChhhcccc
Confidence 9999999997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=365.02 Aligned_cols=238 Identities=31% Similarity=0.519 Sum_probs=193.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+.+..++||||+. |++|.+.+...
T Consensus 67 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 144 (349)
T 2w4o_A 67 SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL-RLSHPNIIKLKEIFETPTEISLVLELVT-GGELFDRIVEKGY 144 (349)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC----------CHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHTTCSS
T ss_pred EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHH-hCCCCCCcceeeeEecCCeEEEEEEeCC-CCCHHHHHHhcCC
Confidence 3699999999999999999987 4567889999999 7789999999999999999999999999 99999976443
Q ss_pred ----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccccc
Q psy6377 80 ----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY 155 (383)
Q Consensus 80 ----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~ 155 (383)
.++.++.||+.||.|||++||+||||||+|||++.....+.+||+|||+++...........+||+.|+|||++.+
T Consensus 145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC
Confidence 3456669999999999999999999999999998644457899999999987655544566789999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 156 EPITLAADMWSLGVTAYVLLTGFSPFGGETDSE-TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 156 ~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
..++.++|||||||++|+|++|..||.+....+ .+..+......++...+..++.++.+||.+||..||++|||+.|+|
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 999999999999999999999999998776655 6677777777777778889999999999999999999999999999
Q ss_pred cCcccCCcc
Q psy6377 235 KHPWLMNKK 243 (383)
Q Consensus 235 ~hp~~~~~~ 243 (383)
+||||....
T Consensus 305 ~hp~~~~~~ 313 (349)
T 2w4o_A 305 QHPWVTGKA 313 (349)
T ss_dssp HSTTTTSTT
T ss_pred cCcccCCCc
Confidence 999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=363.94 Aligned_cols=231 Identities=30% Similarity=0.479 Sum_probs=206.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|++.+.+|+||||++ |++|...+
T Consensus 19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l 96 (337)
T 1o6l_A 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYAN-GGELFFHL 96 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH-hCCCCcCcceEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 3689999999999999999975 3456889999999 7789999999999999999999999999 99999866
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .+....+.+||+.|+|
T Consensus 97 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 173 (337)
T 1o6l_A 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173 (337)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTCCBCCCEECGGGCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC---CCEEEeeccchhhcccCCCcccccccChhhCC
Confidence 43 3455677999999999999999999999999999765 689999999998643 3334566789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+.+|+.++|+|||||++|+|++|.+||.+.+..+....+......+|. .+++++++||.+||..||.+||
T Consensus 174 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTT
T ss_pred hhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhcC
Confidence 99999999999999999999999999999999999988888888887777664 5799999999999999999999
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
+++|+++||||....
T Consensus 250 ~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp CSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=382.59 Aligned_cols=237 Identities=28% Similarity=0.499 Sum_probs=211.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||||++.+ ....+.+|+.+++ .++||||+++++++.+...+|+|||++. |++|.+.+.
T Consensus 36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 113 (486)
T 3mwu_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSFYIVGELYT-GGELFDEII 113 (486)
T ss_dssp SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHH-hCCCCCcCeEEEEEEcCCEEEEEEEcCC-CCcHHHHHH
Confidence 3689999999999999999865 4567889999999 6799999999999999999999999999 999988653
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
+..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||++............+||+.|+|||
T Consensus 114 ~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 193 (486)
T 3mwu_A 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193 (486)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGG
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHH
Confidence 33455677999999999999999999999999999766556789999999998766655566778999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.|..+|+++++||.+||.+||.+|||+.
T Consensus 194 ~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 194 VLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp GGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9976 599999999999999999999999999999999999999998888888899999999999999999999999999
Q ss_pred HHHcCcccCCcc
Q psy6377 232 EALKHPWLMNKK 243 (383)
Q Consensus 232 e~L~hp~~~~~~ 243 (383)
++|+||||+...
T Consensus 273 ~~l~hp~~~~~~ 284 (486)
T 3mwu_A 273 QCLEHPWIQKYS 284 (486)
T ss_dssp HHHHCHHHHHTC
T ss_pred HHhcCHhhccCc
Confidence 999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=367.77 Aligned_cols=240 Identities=29% Similarity=0.369 Sum_probs=197.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC--eEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++.+.+||||++++++|...+ .+|+||||+. ++|..++
T Consensus 24 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~--~~L~~~~ 101 (388)
T 3oz6_A 24 IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME--TDLHAVI 101 (388)
T ss_dssp CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS--EEHHHHH
T ss_pred EEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC--cCHHHHH
Confidence 689999999999999999865 34567899999996667999999999998654 6899999998 5888876
Q ss_pred ccC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-----------------
Q psy6377 77 DDN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD----------------- 134 (383)
Q Consensus 77 ~~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~----------------- 134 (383)
... ....++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 102 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 178 (388)
T 3oz6_A 102 RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE---CHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178 (388)
T ss_dssp HHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEESSSCCCCCCCGGGCCC----
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC---CCEEecCCccccccccccccccccccccccccc
Confidence 543 344667999999999999999999999999999765 6899999999987532
Q ss_pred -----CcccccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch----
Q psy6377 135 -----GIEIRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL---- 204 (383)
Q Consensus 135 -----~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 204 (383)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 258 (388)
T 3oz6_A 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESI 258 (388)
T ss_dssp -----------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTS
T ss_pred ccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhc
Confidence 112345689999999999876 6799999999999999999999999999998888887764332222111
Q ss_pred ---------------------------------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 205 ---------------------------------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 205 ---------------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
...+++++.+||.+||..||++|||++|+|+||||......
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 259 QSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp CCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred cCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence 12678999999999999999999999999999999876554
Q ss_pred hccc
Q psy6377 246 MTRV 249 (383)
Q Consensus 246 ~~~~ 249 (383)
...+
T Consensus 339 ~~~~ 342 (388)
T 3oz6_A 339 NEEP 342 (388)
T ss_dssp GGCC
T ss_pred ccCC
Confidence 4433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=369.51 Aligned_cols=237 Identities=33% Similarity=0.598 Sum_probs=213.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+....|+||||+. |++|.+.+...
T Consensus 65 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~~~ 142 (387)
T 1kob_A 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVLILEFLS-GGELFDRIAAE 142 (387)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEEEEECCC-CCBHHHHTTCT
T ss_pred EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHH-hCCCcCCCeEEEEEEeCCEEEEEEEcCC-CCcHHHHHHhh
Confidence 3699999999999999999976 3456889999999 7799999999999999999999999999 99999976532
Q ss_pred -------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 80 -------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 -------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
.++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||++............+||+.|+|||+
T Consensus 143 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 221 (387)
T 1kob_A 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221 (387)
T ss_dssp TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecCCCcceeeeccCCCccCchh
Confidence 345666999999999999999999999999999753 236799999999998766555566789999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...+..+++++++||.+||..||.+|||+.|
T Consensus 222 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp HTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999999999999999999999999988999999888888888888899999999999999999999999999
Q ss_pred HHcCcccCCcc
Q psy6377 233 ALKHPWLMNKK 243 (383)
Q Consensus 233 ~L~hp~~~~~~ 243 (383)
+|+||||....
T Consensus 302 ll~hp~~~~~~ 312 (387)
T 1kob_A 302 ALEHPWLKGDH 312 (387)
T ss_dssp HHTSTTTSSCC
T ss_pred HhhCccccCCc
Confidence 99999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=350.36 Aligned_cols=240 Identities=30% Similarity=0.510 Sum_probs=215.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|.++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||++. |++|.+.+.
T Consensus 20 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~l~~~~~ 97 (284)
T 3kk8_A 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYLVFDLVT-GGELFEDIV 97 (284)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEcCCEEEEEEecCC-CCCHHHHHH
Confidence 3689999999999999999876 2356789999999 6789999999999999999999999999 999988543
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
...+..+..|++.||.|||++||+||||||+||+++.++..+.+||+|||++.............||+.|+|||
T Consensus 98 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE 177 (284)
T 3kk8_A 98 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177 (284)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCch
Confidence 33455677999999999999999999999999999876555679999999998877666666678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+.+++.++||||||+++|+|++|..||.+.+..+....+..+...++...+..+++++.+||.+||..||++|||++
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 257 (284)
T 3kk8_A 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD 257 (284)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHH
Confidence 99999999999999999999999999999999999999999998888888888889999999999999999999999999
Q ss_pred HHHcCcccCCcchh
Q psy6377 232 EALKHPWLMNKKQI 245 (383)
Q Consensus 232 e~L~hp~~~~~~~~ 245 (383)
|+|+||||.+....
T Consensus 258 ~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 258 QALKVPWICNRERV 271 (284)
T ss_dssp HHTTSHHHHSCCCG
T ss_pred HHhcCccccCChhH
Confidence 99999999876544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=379.31 Aligned_cols=236 Identities=31% Similarity=0.513 Sum_probs=214.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+....|+||||+. |++|.+.+.
T Consensus 51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~g~L~~~~~ 128 (494)
T 3lij_A 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK-LLDHPNIMKLYDFFEDKRNYYLVMECYK-GGELFDEII 128 (494)
T ss_dssp -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEEEecCC-CCcHHHHHH
Confidence 3689999999999999999976 3467889999999 7899999999999999999999999999 999988553
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..+..+..||+.||.|||++||+||||||+|||++.....+.+||+|||+|............+||+.|+|||
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 208 (494)
T 3lij_A 129 HRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208 (494)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHH
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHH
Confidence 2 3345677999999999999999999999999999876555679999999999887666667788999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.|..+|+.+++||.+||.+||.+|||+.
T Consensus 209 ~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 209 VLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp HHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHH
Confidence 986 5699999999999999999999999999999999999999999999889999999999999999999999999999
Q ss_pred HHHcCcccCCc
Q psy6377 232 EALKHPWLMNK 242 (383)
Q Consensus 232 e~L~hp~~~~~ 242 (383)
++|+||||+..
T Consensus 288 e~l~hp~~~~~ 298 (494)
T 3lij_A 288 QALEHPWIKEM 298 (494)
T ss_dssp HHHTCHHHHHH
T ss_pred HHhcCcccccC
Confidence 99999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.11 Aligned_cols=237 Identities=31% Similarity=0.452 Sum_probs=200.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|+++.+|+.||||++.. ...+.+|+.++....+||||++++++|+. ...+|+||||+. |++|.+++...
T Consensus 76 g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~-gg~L~~~l~~~ 153 (400)
T 1nxk_A 76 GKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD-GGELFSRIQDR 153 (400)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC-SEEHHHHHHCC
T ss_pred eEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC-CCcHHHHHHHh
Confidence 3689999999999999999974 45688999998768899999999999986 567999999999 99999976442
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||+++.........+.+||+.|+|||
T Consensus 154 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 233 (400)
T 1nxk_A 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233 (400)
T ss_dssp ---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGG
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHh
Confidence 345667999999999999999999999999999875445789999999999876555566788999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
++.+..|+.++|||||||++|+|++|.+||.+.... .....+..+.+.++...|..++.++++||.+||..||++|
T Consensus 234 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 313 (400)
T 1nxk_A 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 313 (400)
T ss_dssp GSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred hcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHC
Confidence 999999999999999999999999999999876543 2566777788888888888999999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||+.|+|+||||...
T Consensus 314 pt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 314 MTITEFMNHPWIMQS 328 (400)
T ss_dssp CCHHHHHHSHHHHTT
T ss_pred cCHHHHhcCccccCC
Confidence 999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=357.62 Aligned_cols=230 Identities=25% Similarity=0.498 Sum_probs=205.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|++....|+||||+. |++|.+++
T Consensus 20 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~~lv~e~~~-gg~L~~~l 97 (318)
T 1fot_A 20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLL 97 (318)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh-hCCCCCCceEeEEEEeCCEEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999975 3456778999999 7899999999999999999999999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...+.+||+.|+||
T Consensus 98 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aP 172 (318)
T 1fot_A 98 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPD--VTYTLCGTPDYIAP 172 (318)
T ss_dssp HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSS--CBCCCCSCTTTCCH
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC---CCEEEeecCcceecCC--ccccccCCccccCH
Confidence 543 345667999999999999999999999999999765 6899999999987543 34467899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC--
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-- 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-- 228 (383)
|++.+.+|+.++|+|||||++|+|++|.+||.+.+..+.+..+......+|. .+++++.+||.+||..||.+||
T Consensus 173 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~ 248 (318)
T 1fot_A 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGN 248 (318)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTS
T ss_pred hHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCC
Confidence 9999999999999999999999999999999999988999999888777664 5799999999999999999999
Q ss_pred ---CHHHHHcCcccCCcch
Q psy6377 229 ---TAKEALKHPWLMNKKQ 244 (383)
Q Consensus 229 ---t~~e~L~hp~~~~~~~ 244 (383)
+++++++||||+....
T Consensus 249 ~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 249 LQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp STTTTHHHHTSGGGSSCCH
T ss_pred cCCCHHHHhcCccccCCCH
Confidence 9999999999987553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=359.04 Aligned_cols=239 Identities=41% Similarity=0.685 Sum_probs=209.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++.+..||||++++++|.+....|+|||++. |++|.+++..
T Consensus 44 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 122 (327)
T 3lm5_A 44 VVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA-GGEIFSLCLP 122 (327)
T ss_dssp EEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCT-TEEGGGGGSS
T ss_pred EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecC-CCcHHHHHHH
Confidence 689999999999999999986 246788999999977788999999999999999999999999 9999997633
Q ss_pred --------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 79 --------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 79 --------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
..++.++.|++.||+|||++||+||||||+|||++.....+.+||+|||++.............||+.|+||
T Consensus 123 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aP 202 (327)
T 3lm5_A 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202 (327)
T ss_dssp CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCH
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCC
Confidence 234566799999999999999999999999999987444578999999999987665556667899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+.+++.++|||||||++|+|++|..||.+.+..+....+......++...+..+++.+.+||.+||..||.+|||+
T Consensus 203 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 282 (327)
T 3lm5_A 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTA 282 (327)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred eeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCH
Confidence 99999999999999999999999999999999999999988888888888888888999999999999999999999999
Q ss_pred HHHHcCcccCCcch
Q psy6377 231 KEALKHPWLMNKKQ 244 (383)
Q Consensus 231 ~e~L~hp~~~~~~~ 244 (383)
+++|+||||+....
T Consensus 283 ~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 283 EICLSHSWLQQWDF 296 (327)
T ss_dssp HHHTTCGGGCCCCT
T ss_pred HHHhCCHhhccccc
Confidence 99999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=368.99 Aligned_cols=233 Identities=25% Similarity=0.397 Sum_probs=201.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|..++..+.+||||++++++|++.+.+|+||||+. |++|...+
T Consensus 66 G~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~-gg~L~~~l 144 (396)
T 4dc2_A 66 AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN-GGDLMFHM 144 (396)
T ss_dssp EEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC-CCcHHHHH
Confidence 3699999999999999999986 235588999999867799999999999999999999999999 99999865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe-ecCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI-LDGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~-~~~~~~~~~~gt~~y~a 149 (383)
.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.. .......+.+||+.|+|
T Consensus 145 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~a 221 (396)
T 4dc2_A 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221 (396)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---CCEEEeecceeeecccCCCccccccCCcccCC
Confidence 43 3455677999999999999999999999999999766 68999999999863 33444667899999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---------DSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
||++.+.+|+.++|+|||||++|+|++|++||.+.. .......+......+|. .+++++++||++||
T Consensus 222 PE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL 297 (396)
T 4dc2_A 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFL 297 (396)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHT
T ss_pred chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----cCCHHHHHHHHHHh
Confidence 999999999999999999999999999999996432 23355666767666664 57999999999999
Q ss_pred ccCCCCCCCH------HHHHcCcccCCcch
Q psy6377 221 IKNPMERMTA------KEALKHPWLMNKKQ 244 (383)
Q Consensus 221 ~~dP~~Rpt~------~e~L~hp~~~~~~~ 244 (383)
..||.+||++ +|+++||||++...
T Consensus 298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 298 NKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp CSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred cCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 9999999985 79999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=364.92 Aligned_cols=233 Identities=28% Similarity=0.428 Sum_probs=206.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|..++....+||||++++++|++.+.+|+||||+. |++|.+++
T Consensus 31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l 109 (345)
T 1xjd_A 31 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN-GGDLMYHI 109 (345)
T ss_dssp SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 3699999999999999999976 345678899999866799999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~a 149 (383)
.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......+||+.|+|
T Consensus 110 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 186 (345)
T 1xjd_A 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 186 (345)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC---CCEEEeEChhhhhcccCCCcccCCCCCcccCC
Confidence 43 3345677999999999999999999999999999765 6899999999986433 233556789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+.+|+.++|+|||||++|+|++|.+||.+.+..+.+..+......+|. .+++++++||.+||..||.+|||
T Consensus 187 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dp~~R~~ 262 (345)
T 1xjd_A 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLG 262 (345)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBT
T ss_pred hhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHHHHHHhcCCHhHcCC
Confidence 99999999999999999999999999999999999999999999888766653 57999999999999999999999
Q ss_pred HH-HHHcCcccCCcch
Q psy6377 230 AK-EALKHPWLMNKKQ 244 (383)
Q Consensus 230 ~~-e~L~hp~~~~~~~ 244 (383)
+. ++++||||.....
T Consensus 263 ~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 263 VRGDIRQHPLFREINW 278 (345)
T ss_dssp TBSCGGGSGGGTTCCH
T ss_pred ChHHHHcCccccCCCH
Confidence 98 9999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.65 Aligned_cols=237 Identities=35% Similarity=0.578 Sum_probs=212.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||++ |++|.+.+..
T Consensus 103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~E~~~-~~~L~~~l~~~ 180 (373)
T 2x4f_A 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN-QLDHANLIQLYDAFESKNDIVLVMEYVD-GGELFDRIIDE 180 (373)
T ss_dssp -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCT-TCEEHHHHHHT
T ss_pred EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEeCCC-CCcHHHHHHhc
Confidence 3689999999999999999986 3467889999999 7799999999999999999999999999 9999885532
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
..++.++.||+.||+|||++||+||||||+|||+..+ ..+.+||+|||+++...........+||+.|+|||+
T Consensus 181 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 259 (373)
T 2x4f_A 181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259 (373)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-TTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-CCCcEEEEeCCCceecCCccccccccCCCcEeChhh
Confidence 2344566899999999999999999999999999643 236899999999998776666666789999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++++||.+||..||.+|||++|
T Consensus 260 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e 339 (373)
T 2x4f_A 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASE 339 (373)
T ss_dssp HTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99999999999999999999999999999999999999999988888888888899999999999999999999999999
Q ss_pred HHcCcccCCcc
Q psy6377 233 ALKHPWLMNKK 243 (383)
Q Consensus 233 ~L~hp~~~~~~ 243 (383)
+|+||||....
T Consensus 340 ~l~hp~~~~~~ 350 (373)
T 2x4f_A 340 ALKHPWLSDHK 350 (373)
T ss_dssp HHHSHHHHCHH
T ss_pred HhcCcCcCCCc
Confidence 99999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.80 Aligned_cols=235 Identities=25% Similarity=0.374 Sum_probs=205.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ ..+||||++++++|++.+.+|+||||++ ||+|.+++
T Consensus 83 G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lV~E~~~-gg~L~~~l 160 (410)
T 3v8s_A 83 GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMP-GGDLVNLM 160 (410)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEeCCC-CCcHHHHH
Confidence 4699999999999999999975 3556889999999 7799999999999999999999999999 99999976
Q ss_pred ccC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCC
Q psy6377 77 DDN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVA 149 (383)
Q Consensus 77 ~~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~a 149 (383)
... .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... ..+.+||+.|+|
T Consensus 161 ~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~A 237 (410)
T 3v8s_A 161 SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237 (410)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSEEECCSCCSCGGGCC
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC---CCEEEeccceeEeeccCCcccccCCcCCccccC
Confidence 543 345677999999999999999999999999999765 6899999999987654432 346789999999
Q ss_pred CcccccCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 150 PEILHYEP----ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 150 PE~l~~~~----~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
||++.+.+ |+.++|||||||++|+|++|++||.+.+..+.+.+|......++.+.+..+|+++++||.+||..+|.
T Consensus 238 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~ 317 (410)
T 3v8s_A 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREV 317 (410)
T ss_dssp HHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGG
T ss_pred HHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhh
Confidence 99998765 88999999999999999999999999999999999887643222223457899999999999999998
Q ss_pred C--CCCHHHHHcCcccCCcc
Q psy6377 226 E--RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 226 ~--Rpt~~e~L~hp~~~~~~ 243 (383)
+ |++++|+++||||++..
T Consensus 318 rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 318 RLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CTTSSCHHHHHTSGGGCCSS
T ss_pred hCCCCCHHHHhcCccccCCC
Confidence 8 99999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=352.62 Aligned_cols=233 Identities=24% Similarity=0.354 Sum_probs=202.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+++..|+||||+. |++|.+++..
T Consensus 34 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 111 (297)
T 3fxz_A 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVMEYLA-GGSLTDVVTET 111 (297)
T ss_dssp EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHHS
T ss_pred eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHh-cCCCCCCCeEeEEEEECCEEEEEEECCC-CCCHHHHHhhc
Confidence 3689999999999999999865 4566889999999 7799999999999999999999999999 9999997654
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....+||+.|+|||++
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188 (297)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---CCEEEeeCCCceecCCcccccCCccCCcCccChhhh
Confidence 3455677999999999999999999999999999766 689999999998765433 24456899999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..|+.++|||||||++|+|++|..||.+.+.......+....... ......+++.+.+||.+||..||++|||++|+
T Consensus 189 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999888777666655443222 22345789999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
|+||||+..
T Consensus 268 l~h~~~~~~ 276 (297)
T 3fxz_A 268 LQHQFLKIA 276 (297)
T ss_dssp TTCGGGGGC
T ss_pred hhChhhccc
Confidence 999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=356.46 Aligned_cols=239 Identities=28% Similarity=0.525 Sum_probs=200.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|+++.+|+.||||++.. ....+.+|+.++..+.+||||+++++++.+++..|+|||++. |++|.+++..
T Consensus 27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 105 (316)
T 2ac3_A 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR-GGSILSHIHKR 105 (316)
T ss_dssp EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCC-CCcHHHHHhcc
Confidence 3689999999999999999976 346788999999866899999999999999999999999999 9999997643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC--------cccccccCCC
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG--------IEIRELLGTP 145 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~--------~~~~~~~gt~ 145 (383)
..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||++...... ......+||+
T Consensus 106 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 185 (316)
T 2ac3_A 106 RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185 (316)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCc
Confidence 334566799999999999999999999999999987654456999999998765321 1223456999
Q ss_pred CcCCCccccc-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHhccCCCCcchh
Q psy6377 146 DYVAPEILHY-----EPITLAADMWSLGVTAYVLLTGFSPFGGETD---------------SETFRNISKAQLDFPDELF 205 (383)
Q Consensus 146 ~y~aPE~l~~-----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~ 205 (383)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+... ......+..+...+|...+
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 265 (316)
T 2ac3_A 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW 265 (316)
T ss_dssp GGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHH
T ss_pred CccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhc
Confidence 9999999875 5588999999999999999999999987653 3456777788888888778
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..+++.+++||.+||..||.+|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 266 AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 88999999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=379.49 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=192.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||||++.+ ...++.+|+.+++ .++||||++++++|... ..+|+||||+. + .|
T Consensus 77 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~-~l 153 (464)
T 3ttj_A 77 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-A-NL 153 (464)
T ss_dssp EEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-E-EH
T ss_pred EEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHH-hCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-C-CH
Confidence 689999999999999999975 2467889999999 77999999999999755 45799999998 4 46
Q ss_pred HHhh----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTII----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.+.+ ....+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...........+||+.|+
T Consensus 154 ~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~ 230 (464)
T 3ttj_A 154 CQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYR 230 (464)
T ss_dssp HHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCCC-----CCCC----CCCTTC
T ss_pred HHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC---CCEEEEEEEeeeecCCCcccCCCccccccc
Confidence 6543 334456778999999999999999999999999999865 689999999999876665667789999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcC---------------------
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED--------------------- 207 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~--------------------- 207 (383)
|||++.+.+|+.++|||||||++|+|++|++||.+.+..+.+..|......+++..+..
T Consensus 231 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (464)
T 3ttj_A 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 310 (464)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHH
T ss_pred CHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChH
Confidence 99999999999999999999999999999999999998888887766544333222211
Q ss_pred -----------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 208 -----------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 208 -----------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.++++++||.+||.+||++|||++|+|+||||+....
T Consensus 311 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 1567999999999999999999999999999986543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=363.13 Aligned_cols=232 Identities=28% Similarity=0.491 Sum_probs=206.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|..++.....||||++++++|++.+..|+||||+. |++|.+++.
T Consensus 35 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 113 (353)
T 2i0e_A 35 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN-GGDLMYHIQ 113 (353)
T ss_dssp EEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999976 345678899999855589999999999999999999999999 999999764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~aP 150 (383)
. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .+......+||+.|+||
T Consensus 114 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190 (353)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC---CcEEEEeCCcccccccCCcccccccCCccccCh
Confidence 3 3455677999999999999999999999999999765 689999999998643 23345567899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.+.+|+.++|+|||||++|+|++|.+||.+.+..+.+..|......+|. .+++++++||.+||..||.+||+
T Consensus 191 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 9999999999999999999999999999999999999999999988877764 67999999999999999999994
Q ss_pred ----HHHHHcCcccCCcch
Q psy6377 230 ----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~ 244 (383)
++++++||||.....
T Consensus 267 ~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 267 GPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp STTHHHHHHTSGGGTTCCH
T ss_pred CCCCHHHHhcCccccCCCH
Confidence 699999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=347.19 Aligned_cols=236 Identities=31% Similarity=0.518 Sum_probs=212.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID-- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~-- 77 (383)
..||+|+++.++..+|+|.+.. ....+.+|+.+++ .++||||+++++++.+....|+|||++. |++|.+.+.
T Consensus 23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~ 100 (277)
T 3f3z_A 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK-SLDHPNIIRLYETFEDNTDIYLVMELCT-GGELFERVVHK 100 (277)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHHHHH
T ss_pred EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCeEEEEEeccC-CCcHHHHHHHc
Confidence 3689999999999999999876 4567889999999 7799999999999999999999999999 999988653
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
...++.++.|++.||.|||++||+||||||+|||+..+...+.++|+|||++.............||+.|+|||++
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~ 180 (277)
T 3f3z_A 101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180 (277)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHh
Confidence 3345567799999999999999999999999999955545578999999999987766666777899999999998
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+. ++.++||||||+++|+|++|..||.+.+..+....+..+...++...+..+++.+.+||.+||..||.+|||+.++
T Consensus 181 ~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 181 EGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp TTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 755 8999999999999999999999999999999999999999999888888999999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
|+||||++.
T Consensus 260 l~h~~~~~~ 268 (277)
T 3f3z_A 260 LEHEWFEKQ 268 (277)
T ss_dssp TTSHHHHHH
T ss_pred hcCHHHhcc
Confidence 999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=353.49 Aligned_cols=238 Identities=37% Similarity=0.658 Sum_probs=213.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .+.||||+++++++.+....|+|||++. |++|.
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 103 (321)
T 2a2a_A 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR-QVLHHNVITLHDVYENRTDVVLILELVS-GGELF 103 (321)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHH
T ss_pred EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCEEEEEEEcCC-CCcHH
Confidence 36899999999999999999761 345889999999 7789999999999999999999999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-CCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-NCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
+++... .++.++.|++.||+|||++||+||||||+|||++.++. ...++|+|||++.............||+.
T Consensus 104 ~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~ 183 (321)
T 2a2a_A 104 DFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183 (321)
T ss_dssp HHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCC
Confidence 976543 34566799999999999999999999999999976531 12799999999998766655666789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++...+..+++.+.+||.+||..||++
T Consensus 184 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 263 (321)
T 2a2a_A 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRK 263 (321)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTT
T ss_pred ccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhh
Confidence 99999999999999999999999999999999999999999999999988888888888899999999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||++|+|+||||....
T Consensus 264 Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 264 RLTIQEALRHPWITPVD 280 (321)
T ss_dssp SCCHHHHHHSTTTSCSS
T ss_pred CcCHHHHhcCccccCCC
Confidence 99999999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=359.66 Aligned_cols=232 Identities=27% Similarity=0.416 Sum_probs=199.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+. ...+.+|+.+++...+||||++++++|++.+..|+||||+. |++|.+++
T Consensus 23 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~-gg~L~~~l 101 (345)
T 3a8x_A 23 AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN-GGDLMFHM 101 (345)
T ss_dssp EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 36899999999999999999861 24578899999866699999999999999999999999999 99999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........+||+.|+|
T Consensus 102 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~a 178 (345)
T 3a8x_A 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178 (345)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCC
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEEeccccccccCCCCcccccCCCccccC
Confidence 43 3455677999999999999999999999999999765 689999999998643 3334566789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCC---------CcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE---------TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
||++.+..|+.++|+|||||++|+|++|.+||.+. ........+......+|. .++.++++||.+||
T Consensus 179 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL 254 (345)
T 3a8x_A 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFL 254 (345)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHT
T ss_pred ccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999752 333455666666666653 67999999999999
Q ss_pred ccCCCCCCCH------HHHHcCcccCCcc
Q psy6377 221 IKNPMERMTA------KEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rpt~------~e~L~hp~~~~~~ 243 (383)
..||.+|||+ +++++||||.+..
T Consensus 255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 255 NKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred cCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 9999999995 8999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.25 Aligned_cols=230 Identities=23% Similarity=0.394 Sum_probs=206.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+.+.+|+||||+. |++|.+++
T Consensus 55 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-gg~L~~~l 132 (350)
T 1rdq_E 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSNLYMVMEYVA-GGEMFSHL 132 (350)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHH
T ss_pred cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCEEEEEEcCCC-CCcHHHHH
Confidence 3699999999999999999975 3456888999999 7799999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...+.+||+.|+||
T Consensus 133 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFg~a~~~~~--~~~~~~gt~~y~aP 207 (350)
T 1rdq_E 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKG--RTWTLCGTPEALAP 207 (350)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSS--CBCCCEECGGGCCH
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC---CCEEEcccccceeccC--CcccccCCccccCH
Confidence 43 3355677999999999999999999999999999765 6899999999997643 23457899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+..+...+|. .+++++.+||.+||..||.+||+
T Consensus 208 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~ 283 (350)
T 1rdq_E 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred HHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCC
Confidence 9999999999999999999999999999999999999999999988877664 57999999999999999999998
Q ss_pred ----HHHHHcCcccCCcch
Q psy6377 230 ----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~~ 244 (383)
++++++||||.....
T Consensus 284 ~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 284 LKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp STTTTHHHHTSGGGTTCCH
T ss_pred ccCCHHHHHhCcCcCCCCH
Confidence 999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=374.84 Aligned_cols=236 Identities=31% Similarity=0.481 Sum_probs=213.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~ 66 (383)
..||+|+++.+|+.||+|++.+. ...+.+|+.+++ .++||||++++++|++...+|+||||+
T Consensus 50 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~ 128 (504)
T 3q5i_A 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK-SLDHPNIIKLFDVFEDKKYFYLVTEFY 128 (504)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCEEEEEEecC
Confidence 36899999999999999999751 245789999999 778999999999999999999999999
Q ss_pred CCcCcHHHhhc------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc
Q psy6377 67 PLVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140 (383)
Q Consensus 67 ~~g~~L~~~l~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~ 140 (383)
. |++|.+.+. +..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||++...........
T Consensus 129 ~-gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 207 (504)
T 3q5i_A 129 E-GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207 (504)
T ss_dssp T-TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCC
T ss_pred C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCcccc
Confidence 9 999988653 334556779999999999999999999999999998765445799999999998776666677
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++...|..+|+++++||.+||
T Consensus 208 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 286 (504)
T 3q5i_A 208 RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLML 286 (504)
T ss_dssp CCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHT
T ss_pred ccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHc
Confidence 88999999999987 46899999999999999999999999999999999999999999988889999999999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCc
Q psy6377 221 IKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+||.+|||++|+|+||||+..
T Consensus 287 ~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 287 TYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCChhHCCCHHHHhcCHhhhhc
Confidence 9999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=352.08 Aligned_cols=235 Identities=29% Similarity=0.355 Sum_probs=197.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..|+|||++. ++|.+++..
T Consensus 19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~ 95 (317)
T 2pmi_A 19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMK-ELKHENIVRLYDVIHTENKLTLVFEFMD--NDLKKYMDS 95 (317)
T ss_dssp CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHT-TCCBTTBCCEEEEECCTTEEEEEEECCC--CBHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHH-hcCCCCcceEEEEEEECCeEEEEEEecC--CCHHHHHHh
Confidence 3689999999999999999875 2356889999999 7789999999999999999999999998 588886532
Q ss_pred ------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCC
Q psy6377 79 ------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP 145 (383)
Q Consensus 79 ------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~ 145 (383)
..+..+..||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......||+
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~t~ 172 (317)
T 2pmi_A 96 RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARAFGIPVNTFSSEVVTL 172 (317)
T ss_dssp HHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCSSCEETTSCCCCCCCCCSCC
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---CCEEECcCccceecCCCcccCCCCcccc
Confidence 2234556899999999999999999999999999765 68999999999876432 2344568999
Q ss_pred CcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc---------------------
Q psy6377 146 DYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE--------------------- 203 (383)
Q Consensus 146 ~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------------- 203 (383)
.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T 2pmi_A 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPR 252 (317)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCC
T ss_pred cccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccch
Confidence 9999999876 468999999999999999999999999998888877775532222111
Q ss_pred ---------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 ---------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 ---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
....++.++.+||.+||..||++|||++|+|+||||.....
T Consensus 253 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 253 DLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11257889999999999999999999999999999987544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=360.63 Aligned_cols=229 Identities=29% Similarity=0.513 Sum_probs=199.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+.+..|+||||+. |+|.+.+
T Consensus 23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~E~~~--g~l~~~l 99 (336)
T 3h4j_B 23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHPHIIKLYDVITTPTDIVMVIEYAG--GELFDYI 99 (336)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEECCCC--EEHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEEEECCC--CcHHHHH
Confidence 3689999999999999999875 2457899999999 7889999999999999999999999995 7787754
Q ss_pred ------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 ------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
....+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....+......+||+.|+||
T Consensus 100 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aP 176 (336)
T 3h4j_B 100 VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN---LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176 (336)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT---CCEEECCSSCTBTTTTSBTTCCCTTSTTTSCG
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC---CCEEEEEeccceeccCCcccccccCCcCcCCH
Confidence 233456777999999999999999999999999999865 68999999999877666666778999999999
Q ss_pred cccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..+ +.++|||||||++|+|++|..||.+.........+..+...+| ..+|+++.+||.+||..||.+|||
T Consensus 177 E~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt 252 (336)
T 3h4j_B 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRIT 252 (336)
T ss_dssp GGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcC
Confidence 99988776 7899999999999999999999998776666555555544444 357999999999999999999999
Q ss_pred HHHHHcCcccCCc
Q psy6377 230 AKEALKHPWLMNK 242 (383)
Q Consensus 230 ~~e~L~hp~~~~~ 242 (383)
++|+++||||+..
T Consensus 253 ~~eil~hp~~~~~ 265 (336)
T 3h4j_B 253 IQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHTTCHHHHTT
T ss_pred HHHHHhChhhccC
Confidence 9999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=357.51 Aligned_cols=233 Identities=28% Similarity=0.445 Sum_probs=186.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID---- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~---- 77 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||+. |++|.+++.
T Consensus 35 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 112 (361)
T 3uc3_A 35 VARLMRDKLTKELVAVKYIERGAAIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIIMEYAS-GGELYERICNAGR 112 (361)
T ss_dssp SEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHHHHHSS
T ss_pred EEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHH-hCCCCCCCcEEEEEeeCCEEEEEEEeCC-CCCHHHHHHhcCC
Confidence 689999999999999999986 3567889999999 7789999999999999999999999999 999998753
Q ss_pred --cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccccc
Q psy6377 78 --DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY 155 (383)
Q Consensus 78 --~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~ 155 (383)
...++.+..|++.||+|||++||+||||||+|||++.+. .+.+||+|||+++...........+||+.|+|||++.+
T Consensus 113 ~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC---------------CTTSCHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC
Confidence 334567779999999999999999999999999997652 24699999999986544444556789999999999988
Q ss_pred CCCChh-hHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 156 EPITLA-ADMWSLGVTAYVLLTGFSPFGGETDS----ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 156 ~~~~~~-~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
..++.+ +|||||||++|+|++|++||.+.... .....+......+|. ...+++++.+||.+||..||.+|||+
T Consensus 192 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~ 269 (361)
T 3uc3_A 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRISI 269 (361)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCH
Confidence 888665 89999999999999999999876543 344445555555443 23679999999999999999999999
Q ss_pred HHHHcCcccCCc
Q psy6377 231 KEALKHPWLMNK 242 (383)
Q Consensus 231 ~e~L~hp~~~~~ 242 (383)
.|+++||||...
T Consensus 270 ~ell~hp~f~~~ 281 (361)
T 3uc3_A 270 PEIKTHSWFLKN 281 (361)
T ss_dssp HHHHTSHHHHTT
T ss_pred HHHHhCcchhcC
Confidence 999999999643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.23 Aligned_cols=236 Identities=30% Similarity=0.462 Sum_probs=205.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+.+..++||||++ |++|.++
T Consensus 41 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-gg~L~~~ 118 (345)
T 3hko_A 41 VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK-KLHHPNIARLYEVYEDEQYICLVMELCH-GGHLLDK 118 (345)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHH
T ss_pred EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHH-hCCCCCcceeehhhccCCeEEEEEeCCC-CCcHHHH
Confidence 689999999999999999865 2357889999999 6689999999999999999999999999 9999997
Q ss_pred hc----------------------------------------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCc
Q psy6377 76 ID----------------------------------------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQN 109 (383)
Q Consensus 76 l~----------------------------------------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~N 109 (383)
+. +..++.++.||+.||+|||++||+||||||+|
T Consensus 119 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 198 (345)
T 3hko_A 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198 (345)
T ss_dssp EEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 74 12234567999999999999999999999999
Q ss_pred EEEeccCCCCcEEEEeccceeEeecCc-----ccccccCCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCC
Q psy6377 110 LVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELLGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFG 182 (383)
Q Consensus 110 ILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~ 182 (383)
||++.+. .+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 199 Ill~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 277 (345)
T 3hko_A 199 FLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp EEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9997642 2479999999998754321 2345679999999999865 678999999999999999999999999
Q ss_pred CCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 183 GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 183 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
+.+..+....+......++...+..+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 278 GVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp CSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred CCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999988888888888888999999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=345.88 Aligned_cols=230 Identities=31% Similarity=0.455 Sum_probs=197.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------------------------cccHHHHHHHHHhcCCCCCcccceEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------------------------PVRIHHEIALLSLCSPSPRIVKLHDVF 53 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------------------------~~~~~~Ei~il~~~~~hpnIvkl~~~~ 53 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .++||||+++++++
T Consensus 27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~ 105 (298)
T 2zv2_A 27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK-KLDHPNVVKLVEVL 105 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH-TCCCTTBCCEEEEE
T ss_pred EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH-hCCCCCCCeEEEEE
Confidence 37899999999999999998752 246889999999 77999999999999
Q ss_pred Ee--CCeEEEEEecCCCcCcHHHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEec
Q psy6377 54 QT--GEGAYYVSWNTPLVVTLQTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDF 126 (383)
Q Consensus 54 ~~--~~~~~lv~e~~~~g~~L~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DF 126 (383)
.+ ....|+|||++. +++|.+++.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 106 ~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Df 181 (298)
T 2zv2_A 106 DDPNEDHLYMVFELVN-QGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKIADF 181 (298)
T ss_dssp ECSSSSEEEEEEECCT-TCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCC
T ss_pred EcCCCCEEEEEEecCC-CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CCEEEecC
Confidence 87 568999999999 8999886443 3455677999999999999999999999999999765 68999999
Q ss_pred cceeEeecCc-ccccccCCCCcCCCcccccCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc
Q psy6377 127 EISRVILDGI-EIRELLGTPDYVAPEILHYEP---ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD 202 (383)
Q Consensus 127 Gla~~~~~~~-~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 202 (383)
|++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......+|.
T Consensus 182 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 261 (298)
T 2zv2_A 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261 (298)
T ss_dssp TTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred CCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC
Confidence 9998765432 234568999999999997665 478999999999999999999999998877777777766655543
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
...+++++.+||.+||..||++|||+.|+|+||||.
T Consensus 262 --~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 262 --QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp --SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred --ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 357899999999999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=348.84 Aligned_cols=233 Identities=24% Similarity=0.379 Sum_probs=196.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcC--CCCCcccceEEEEeCC-----eEEEEEecCCC
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCS--PSPRIVKLHDVFQTGE-----GAYYVSWNTPL 68 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~~~~-----~~~lv~e~~~~ 68 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++.+. .||||+++++++.+.. ..+++||++.
T Consensus 24 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~- 102 (308)
T 3g33_A 24 TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD- 102 (308)
T ss_dssp CEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-
T ss_pred EEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-
Confidence 689999999999999999874 1346788999888443 4999999999998765 4899999997
Q ss_pred cCcHHHhhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc
Q psy6377 69 VVTLQTIIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140 (383)
Q Consensus 69 g~~L~~~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~ 140 (383)
++|.+++... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...........
T Consensus 103 -~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~ 178 (308)
T 3g33_A 103 -QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALTP 178 (308)
T ss_dssp -CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT---SCEEECSCSCTTTSTTCCCSGG
T ss_pred -cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEEeeCccccccCCCcccCC
Confidence 5998875432 345677999999999999999999999999999765 6899999999987655555666
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------------
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE----------------- 203 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----------------- 203 (383)
.+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (308)
T 3g33_A 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 258 (308)
T ss_dssp GGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCC
T ss_pred ccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCC
Confidence 789999999999999999999999999999999999999999999888888776543333222
Q ss_pred ------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 204 ------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 204 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..+.+++.+.+||.+||.+||++|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 259 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 224678999999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=345.29 Aligned_cols=233 Identities=26% Similarity=0.361 Sum_probs=192.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH-hh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT-II 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~-~l 76 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+++..|+|||++. + ++.+ +.
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~ 92 (292)
T 3o0g_A 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q-DLKKYFD 92 (292)
T ss_dssp SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEECCS-E-EHHHHHH
T ss_pred eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHh-cCCCCCEeeEEeEEEeCCEEEEEEecCC-C-CHHHHHH
Confidence 36899999999999999999751 256789999999 7789999999999999999999999998 5 5544 32
Q ss_pred c------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCC
Q psy6377 77 D------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~a 149 (383)
. ...+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+|
T Consensus 93 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~a 169 (292)
T 3o0g_A 93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169 (292)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCSCCSCCCSCCSCGGGCC
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecCCccccccCCccccCCcC
Confidence 2 23455677999999999999999999999999999866 68999999999876533 23445689999999
Q ss_pred CcccccCC-CChhhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHhccCCCCcc------------------------
Q psy6377 150 PEILHYEP-ITLAADMWSLGVTAYVLLTGFSP-FGGETDSETFRNISKAQLDFPDE------------------------ 203 (383)
Q Consensus 150 PE~l~~~~-~~~~~DiwSlGvilyelltg~~P-f~~~~~~~~~~~i~~~~~~~~~~------------------------ 203 (383)
||++.+.. ++.++||||+||++|+|++|..| |.+.+..+.+..+......++..
T Consensus 170 PE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T 3o0g_A 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCT
T ss_pred hHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchh
Confidence 99987765 89999999999999999987666 66666667776665533322221
Q ss_pred -hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 204 -LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 204 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..+.+++.+++||.+||..||++|||++|+|+||||++.
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 123578999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.89 Aligned_cols=232 Identities=25% Similarity=0.424 Sum_probs=201.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+.+..|+||||+. |++|..++
T Consensus 29 G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-gg~L~~~l 106 (384)
T 4fr4_A 29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ-GLEHPFLVNLWYSFQDEEDMFMVVDLLL-GGDLRYHL 106 (384)
T ss_dssp CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEEEEecCC-CCcHHHHH
Confidence 3689999999999999999975 3457889999999 7799999999999999999999999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
... .+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..........+.+||+.|+||
T Consensus 107 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aP 183 (384)
T 4fr4_A 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183 (384)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTCCBCCCCSCGGGCCG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC---CCEEEeccceeeeccCCCceeccCCCccccCC
Confidence 543 345677999999999999999999999999999765 68999999999987766667788999999999
Q ss_pred cccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 151 EILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGET---DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 151 E~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|++. +.+|+.++|||||||++|+|++|.+||.+.. ..+....+......+| ..+++.+.+||.+||..||
T Consensus 184 E~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp GGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSG
T ss_pred eeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCHHHHHHHHHHhcCCH
Confidence 9986 3568999999999999999999999997543 3445555555555555 3579999999999999999
Q ss_pred CCCCC-HHHHHcCcccCCcch
Q psy6377 225 MERMT-AKEALKHPWLMNKKQ 244 (383)
Q Consensus 225 ~~Rpt-~~e~L~hp~~~~~~~ 244 (383)
.+||+ ++++++||||.+...
T Consensus 260 ~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp GGSCCSHHHHHTSGGGTTCCH
T ss_pred hHhcccHHHHHcChhhhcCCH
Confidence 99998 899999999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.20 Aligned_cols=234 Identities=27% Similarity=0.480 Sum_probs=196.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
..||+|+++.+|+.+|+|++.. ....+.+|+.+++ .++||||+++++++.+....|+|||++. +++|.+.+.
T Consensus 36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 113 (285)
T 3is5_A 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK-SLDHPNIIKIFEVFEDYHNMYIVMETCE-GGELLERIVS 113 (285)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCS-CCBHHHHHHH
T ss_pred eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHH-hCCCchHHhHHHheecCCeEEEEEEeCC-CCcHHHHHHh
Confidence 3689999999999999999876 3467889999999 7799999999999999999999999999 999998652
Q ss_pred ---------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 78 ---------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 78 ---------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
...++.++.|++.||+|||++||+||||||+|||++.+...+.+||+|||++.............||+.|+
T Consensus 114 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~ 193 (285)
T 3is5_A 114 AQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193 (285)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGC
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcC
Confidence 22345677999999999999999999999999999765556789999999998766555556678999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++.. ...+++++.+||.+||..||++||
T Consensus 194 aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp CHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred ChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHHHHHHHHHHccCChhhCc
Confidence 999986 568999999999999999999999999988877777766655544332 245799999999999999999999
Q ss_pred CHHHHHcCcccCC
Q psy6377 229 TAKEALKHPWLMN 241 (383)
Q Consensus 229 t~~e~L~hp~~~~ 241 (383)
|+.|+|+||||++
T Consensus 272 s~~e~l~hp~f~~ 284 (285)
T 3is5_A 272 SAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHTSGGGGC
T ss_pred CHHHHhcCHHhhc
Confidence 9999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=345.81 Aligned_cols=236 Identities=35% Similarity=0.570 Sum_probs=208.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+....|+|||++. |++|.+.+..
T Consensus 23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 100 (304)
T 2jam_A 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK-KIKHENIVTLEDIYESTTHYYLVMQLVS-GGELFDRILER 100 (304)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHHHH
T ss_pred ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHH-hCCCCCeeehhhhcccCCEEEEEEEcCC-CccHHHHHHHc
Confidence 3699999999999999999976 3456889999999 7789999999999999999999999999 9999986533
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
..+..+..|++.||.|||++||+||||||+||++..++..+.++|+|||++...... ......||+.|+|||++
T Consensus 101 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~ 179 (304)
T 2jam_A 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVL 179 (304)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTB
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHh
Confidence 334567799999999999999999999999999954444578999999998764332 33456799999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+++.++|||||||++|+|++|..||.+.+..+....+..+...++...+..+++++.+||.+||..||++|||++++
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (304)
T 2jam_A 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259 (304)
T ss_dssp SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999999999999999999999888999998888888888888999999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
|+||||...
T Consensus 260 l~h~~~~~~ 268 (304)
T 2jam_A 260 LSHPWIDGN 268 (304)
T ss_dssp HTSHHHHSS
T ss_pred hcCccccCC
Confidence 999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=359.54 Aligned_cols=232 Identities=27% Similarity=0.405 Sum_probs=196.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|..++....+||||++++++|++.+.+|+||||+. |++|.+++
T Consensus 52 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l 130 (373)
T 2r5t_A 52 GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN-GGELFYHL 130 (373)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHH
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC-CCcHHHHH
Confidence 3699999999999999999976 234566777765437899999999999999999999999999 99999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........+||+.|+|
T Consensus 131 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 207 (373)
T 2r5t_A 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207 (373)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCBCGGGBCCCCCCCSBSCCCCCCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEeeCccccccccCCCccccccCCccccC
Confidence 43 3345677999999999999999999999999999765 699999999998633 2334556789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+..|+.++|+|||||++|+|++|.+||.+.+..+.+..|......++ ..++.++++||.+||..||.+||+
T Consensus 208 PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~ 283 (373)
T 2r5t_A 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLG 283 (373)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTT
T ss_pred HHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCC
Confidence 9999999999999999999999999999999999999999999988776665 367999999999999999999998
Q ss_pred H----HHHHcCcccCCcc
Q psy6377 230 A----KEALKHPWLMNKK 243 (383)
Q Consensus 230 ~----~e~L~hp~~~~~~ 243 (383)
+ +++++||||....
T Consensus 284 ~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 284 AKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp TTTTHHHHHTSGGGTTCC
T ss_pred CCCCHHHHhCCccccCCC
Confidence 6 6999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.35 Aligned_cols=233 Identities=29% Similarity=0.468 Sum_probs=208.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|+++.+|+.||||++... ...+.+|+.+++.+.+||||+++++++......|+||||+. |++
T Consensus 108 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~-g~~ 186 (365)
T 2y7j_A 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR-KGE 186 (365)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCT-TCB
T ss_pred EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCC-CCc
Confidence 36999999999999999998752 34578999999966689999999999999999999999999 999
Q ss_pred HHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 72 LQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 72 L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
|.+++.. ..+..++.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++............+||+
T Consensus 187 L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~---~~ikl~DfG~~~~~~~~~~~~~~~gt~ 263 (365)
T 2y7j_A 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN---MQIRLSDFGFSCHLEPGEKLRELCGTP 263 (365)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEEecCcccccCCCcccccCCCCC
Confidence 9997643 3345677999999999999999999999999999765 689999999999877666666788999
Q ss_pred CcCCCccccc------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 146 DYVAPEILHY------EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 146 ~y~aPE~l~~------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..+...++.+.|..++..+.+||.+|
T Consensus 264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 343 (365)
T 2y7j_A 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRL 343 (365)
T ss_dssp GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHH
T ss_pred CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHH
Confidence 9999999863 3588999999999999999999999999988888888888888888888889999999999999
Q ss_pred cccCCCCCCCHHHHHcCcccC
Q psy6377 220 LIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
|..||++|||++++|+||||+
T Consensus 344 L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 344 LQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCChhHCcCHHHHhcCcccC
Confidence 999999999999999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=348.22 Aligned_cols=233 Identities=25% Similarity=0.359 Sum_probs=192.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++. +|+.||+|++... ...+.+|+.+++ .++||||+++++++.+++..++|||++. ++|.+.+.
T Consensus 35 g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~ 110 (311)
T 3niz_A 35 GVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLK-ELHHPNIVSLIDVIHSERCLTLVFEFME--KDLKKVLD 110 (311)
T ss_dssp CEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHH-HCCCTTBCCEEEEECCSSCEEEEEECCS--EEHHHHHH
T ss_pred eEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHH-HcCCCCEeeeeeEEccCCEEEEEEcCCC--CCHHHHHH
Confidence 368999985 6999999999751 256789999999 6789999999999999999999999998 47777543
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~a 149 (383)
. ..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+|
T Consensus 111 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~a 187 (311)
T 3niz_A 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187 (311)
T ss_dssp TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEETTSCCC---CCCCCCTTCC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---CCEEEccCcCceecCCCcccccCCcccCCcCC
Confidence 2 2345667999999999999999999999999999866 68999999999876432 23445689999999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE------------------------- 203 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------- 203 (383)
||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......++.
T Consensus 188 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (311)
T 3niz_A 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267 (311)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHH
T ss_pred HHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHH
Confidence 999876 568999999999999999999999999988887777765533222211
Q ss_pred -hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 204 -LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 204 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..+.+++++.+||.+||.+||++|||++|+|+||||++..
T Consensus 268 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 2245788999999999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=366.86 Aligned_cols=230 Identities=29% Similarity=0.471 Sum_probs=195.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ .+.||||++++++|.+.+.+|+||||+. |++|.+.+.
T Consensus 163 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 240 (446)
T 4ejn_A 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLCFVMEYAN-GGELFFHLS 240 (446)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHC-------------CCC-CCSCTTSCCEEEEEEETTEEEEEECCCS-SCBHHHHHH
T ss_pred EEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHH-hCCCCeEeeEEEEEeeCCEEEEEEeeCC-CCcHHHHHH
Confidence 689999999999999999875 2456778999998 7789999999999999999999999999 999988764
Q ss_pred c------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
. ..+..+..||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+... ........+||+.|+|
T Consensus 241 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~a 317 (446)
T 4ejn_A 241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317 (446)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---SCEEECCCCCCCTTCC-----CCSSSCGGGCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---CCEEEccCCCceeccCCCcccccccCCccccC
Confidence 3 3345667999999999998 999999999999999865 689999999998632 2334556789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC-
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM- 228 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 228 (383)
||++.+..|+.++|||||||++|+|++|..||.+.+..+....+......+|. .+++++.+||.+||.+||.+||
T Consensus 318 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~ 393 (446)
T 4ejn_A 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLG 393 (446)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTT
T ss_pred HhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHHHhCC
Confidence 99999999999999999999999999999999999998899888888777664 5799999999999999999999
Q ss_pred ----CHHHHHcCcccCCcc
Q psy6377 229 ----TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 ----t~~e~L~hp~~~~~~ 243 (383)
|++|+|+||||.+..
T Consensus 394 ~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 394 GGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp CSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHhCccccCCC
Confidence 999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=367.64 Aligned_cols=229 Identities=28% Similarity=0.443 Sum_probs=206.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+++ .++||||+++++++.+.+..|+||||+. |++|.+++.
T Consensus 31 ~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~~~lv~E~~~-gg~L~~~l~ 108 (476)
T 2y94_A 31 KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHPHIIKLYQVISTPSDIFMVMEYVS-GGELFDYIC 108 (476)
T ss_dssp CEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCS-SEEHHHHTT
T ss_pred EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEeCCC-CCcHHHHHH
Confidence 689999999999999999975 2356889999999 7899999999999999999999999999 999999775
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....+....+.+||+.|+|||
T Consensus 109 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~---~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE 185 (476)
T 2y94_A 109 KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 185 (476)
T ss_dssp SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT---CCEEECCCSSCEECCTTCCBCCCCSCSTTCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC---CCeEEEeccchhhccccccccccCCCcCeEChh
Confidence 43 345667999999999999999999999999999765 689999999999877666667789999999999
Q ss_pred ccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..+ +.++|||||||++|+|++|.+||.+.+....+..+..+.+..|. .+++++.+||.+||..||.+|||+
T Consensus 186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~ 261 (476)
T 2y94_A 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLKHMLQVDPMKRATI 261 (476)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCHHHHHHHHHHcCCCchhCcCH
Confidence 9988776 78999999999999999999999999999999998888766653 578999999999999999999999
Q ss_pred HHHHcCcccCCc
Q psy6377 231 KEALKHPWLMNK 242 (383)
Q Consensus 231 ~e~L~hp~~~~~ 242 (383)
+++++||||...
T Consensus 262 ~eil~hp~~~~~ 273 (476)
T 2y94_A 262 KDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCHHHHTT
T ss_pred HHHHhCHHhhhc
Confidence 999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=357.93 Aligned_cols=234 Identities=18% Similarity=0.278 Sum_probs=191.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||++++++|.+++.+|+||||+. +++|.+++..
T Consensus 42 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 119 (389)
T 3gni_B 42 TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK-LFNHPNIVPYRATFIADNELWVVTSFMA-YGSAKDLICT 119 (389)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHH
T ss_pred EEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCCCcEeEEEEECCEEEEEEEccC-CCCHHHHHhh
Confidence 699999999999999999976 2356778999999 7789999999999999999999999999 9999997643
Q ss_pred C--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--------cccccc
Q psy6377 79 N--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------EIRELL 142 (383)
Q Consensus 79 ~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------~~~~~~ 142 (383)
. .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....+
T Consensus 120 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 196 (389)
T 3gni_B 120 HFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196 (389)
T ss_dssp TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCGGGCEECEETTEECSCBCCCCTTCT
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccccceeecccccccccccccccccc
Confidence 2 345667999999999999999999999999999765 689999999987653321 122347
Q ss_pred CCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC--------------------
Q psy6377 143 GTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-------------------- 200 (383)
Q Consensus 143 gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------- 200 (383)
||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+..+....
T Consensus 197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------
T ss_pred ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccc
Confidence 8999999999987 679999999999999999999999999877666655443322110
Q ss_pred ----------------------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 201 ----------------------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 201 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
....+..+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 1123456789999999999999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.55 Aligned_cols=236 Identities=30% Similarity=0.508 Sum_probs=194.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|.++.+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.. ...|+||||+. +++
T Consensus 149 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~-~~~~lv~e~~~-~g~ 225 (419)
T 3i6u_A 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFDA-EDYYIVLELME-GGE 225 (419)
T ss_dssp SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHH-HCCCTTBCCCCEEEES-SEEEEEEECCT-TCB
T ss_pred eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHH-hCCCCCEeeEEEEEec-CceEEEEEcCC-CCc
Confidence 3689999999999999999875 1235889999999 7799999999999864 56899999999 999
Q ss_pred HHHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 72 LQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 72 L~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
|.+.+... .+..++.|++.||+|||++||+||||||+|||++.++....+||+|||+|+...........+||+
T Consensus 226 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 305 (419)
T 3i6u_A 226 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305 (419)
T ss_dssp GGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------C
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCC
Confidence 99876443 345666999999999999999999999999999876545679999999998776555566778999
Q ss_pred CcCCCcccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 146 DYVAPEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 146 ~y~aPE~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.|+|||++. ...|+.++|||||||++|+|++|.+||.+.... .....+..+...+++..+..+++.+.+||.+||.
T Consensus 306 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 385 (419)
T 3i6u_A 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLV 385 (419)
T ss_dssp TTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred CccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHcc
Confidence 999999985 367889999999999999999999999876543 4556677777888888889999999999999999
Q ss_pred cCCCCCCCHHHHHcCcccCCc
Q psy6377 222 KNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.||.+|||++|+|+||||++.
T Consensus 386 ~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 386 VDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp SSTTTSCCHHHHHHSGGGCCH
T ss_pred CChhHCcCHHHHhCCcccCCh
Confidence 999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.60 Aligned_cols=232 Identities=29% Similarity=0.442 Sum_probs=195.0
Q ss_pred ceEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
..||+|++. .+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|.+.+..|+||||+. |++|
T Consensus 31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L 108 (327)
T 3a62_A 31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-EVKHPFIVDLIYAFQTGGKLYLILEYLS-GGEL 108 (327)
T ss_dssp EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHH-HCCCTTBCCEEEEEECSSCEEEEEECCT-TEEH
T ss_pred EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHH-hCCCCCccceeEEEEcCCEEEEEEeCCC-CCcH
Confidence 368999885 7899999999976 2345778999999 7789999999999999999999999999 9999
Q ss_pred HHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCC
Q psy6377 73 QTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTP 145 (383)
Q Consensus 73 ~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~ 145 (383)
.+.+.. ..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..... ......+||+
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 185 (327)
T 3a62_A 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFGLCKESIHDGTVTHTFCGTI 185 (327)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---SCEEECCCSCC----------CTTSSCC
T ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC---CcEEEEeCCcccccccCCccccccCCCc
Confidence 987643 2345667999999999999999999999999999765 68999999999864332 2345568999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+......+|. .++.++.+||.+||..||.
T Consensus 186 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dp~ 261 (327)
T 3a62_A 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKLLKRNAA 261 (327)
T ss_dssp TTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHSCSCGG
T ss_pred CccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHHhcCHh
Confidence 999999999999999999999999999999999999999988888888887776664 5799999999999999999
Q ss_pred CCC-----CHHHHHcCcccCCcch
Q psy6377 226 ERM-----TAKEALKHPWLMNKKQ 244 (383)
Q Consensus 226 ~Rp-----t~~e~L~hp~~~~~~~ 244 (383)
+|| +++++++||||.....
T Consensus 262 ~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 262 SRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp GSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred hccCCCCCCHHHHHcCCcccCCCH
Confidence 999 8899999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=347.53 Aligned_cols=232 Identities=25% Similarity=0.375 Sum_probs=194.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..|+||||+. |++|.+++..
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 98 (323)
T 3tki_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYLFLEYCS-GGELFDRIEP 98 (323)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCT-TEEGGGGSBT
T ss_pred EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEEEEEEcCC-CCcHHHHHhh
Confidence 3699999999999999999865 2467899999999 7799999999999999999999999999 9999998754
Q ss_pred C------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCcCC
Q psy6377 79 N------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDYVA 149 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y~a 149 (383)
. .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....+||+.|+|
T Consensus 99 ~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 175 (323)
T 3tki_A 99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (323)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEETTEECCBCSCCSCGGGSC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---CCEEEEEeeccceeccCCcccccCCCccCcCccC
Confidence 3 345667999999999999999999999999999765 689999999998754322 2345689999999
Q ss_pred CcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 150 PEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSET-FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 150 PE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
||++.+..+ +.++|||||||++|+|++|..||.+...... ........... ..+..+++.+.+||.+||..||++|
T Consensus 176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--CccccCCHHHHHHHHHHccCChhhC
Confidence 999987775 7899999999999999999999987665432 33333222222 2356789999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||++|+++||||+..
T Consensus 254 ~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 254 ITIPDIKKDRWYNKP 268 (323)
T ss_dssp CCHHHHTTCTTTTCC
T ss_pred cCHHHHhhChhhccc
Confidence 999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.45 Aligned_cols=231 Identities=26% Similarity=0.376 Sum_probs=189.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++ .+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. ++|.+++.
T Consensus 16 g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~ 91 (288)
T 1ob3_A 16 GVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVLVFEHLD--QDLKKLLD 91 (288)
T ss_dssp EEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEEEEECCS--EEHHHHHH
T ss_pred EEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHH-hcCCCCEeeeeeEEccCCeEEEEEEecC--CCHHHHHH
Confidence 36899998 7899999999865 2356889999999 7789999999999999999999999998 48888654
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVA 149 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~a 149 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~a 168 (288)
T 1ob3_A 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168 (288)
T ss_dssp TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---------CCCTTCC
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEeECccccccCccccccccccccccccC
Confidence 3 2345667999999999999999999999999999765 68999999999865432 22345679999999
Q ss_pred Cccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------c
Q psy6377 150 PEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD-------------------------E 203 (383)
Q Consensus 150 PE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------------------------~ 203 (383)
||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+. .
T Consensus 169 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
T 1ob3_A 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248 (288)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred chheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHH
Confidence 999875 45899999999999999999999999998887777766543211111 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
....+++++.+||.+||..||++|||++|+|+||||+.
T Consensus 249 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 22457899999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.34 Aligned_cols=238 Identities=38% Similarity=0.690 Sum_probs=207.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+....++|||++. +++|.+
T Consensus 20 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 97 (283)
T 3bhy_A 20 IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR-EIRHPNIITLHDIFENKTDVVLILELVS-GGELFD 97 (283)
T ss_dssp EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHH
T ss_pred EEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHH-hCCCCCeeehhheecCCCeEEEEEeecC-CCcHHH
Confidence 589999999999999999875 1356889999999 6789999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC-CCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF-PNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~-~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
++.. ..+..++.|++.||.|||++||+||||||+||+++.++ ..+.++|+|||++.............||+.|
T Consensus 98 ~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y 177 (283)
T 3bhy_A 98 FLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177 (283)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCc
Confidence 7643 33556779999999999999999999999999997653 2347999999999987655555667899999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++...+..+++.+.+||.+||..||++|
T Consensus 178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence 99999999999999999999999999999999999999888888888888888888888999999999999999999999
Q ss_pred CCHHHHHcCcccCCcch
Q psy6377 228 MTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~~ 244 (383)
||+.++|+||||+....
T Consensus 258 ps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 258 MTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp CCHHHHHHCHHHHHHHH
T ss_pred cCHHHHHhCHHHHHHHH
Confidence 99999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=365.75 Aligned_cols=235 Identities=27% Similarity=0.404 Sum_probs=203.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.++. ..+||||++++++|++.+.+|+||||+. ||+|.+++
T Consensus 88 G~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~-gg~L~~~l 165 (437)
T 4aw2_A 88 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDSKWITTLHYAFQDDNNLYLVMDYYV-GGDLLTLL 165 (437)
T ss_dssp EEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHH-HSCTTTBCCEEEEEECSSEEEEEECCCT-TCBHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCEEEEEEecCC-CCcHHHHH
Confidence 3689999999999999999976 3455899999998 7799999999999999999999999999 99999977
Q ss_pred cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCc
Q psy6377 77 DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDY 147 (383)
Q Consensus 77 ~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y 147 (383)
.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... ....+||+.|
T Consensus 166 ~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y 242 (437)
T 4aw2_A 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242 (437)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSCEECCSCCSCGGG
T ss_pred HHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC---CCEEEcchhhhhhcccCCCcccccccCCcCe
Confidence 54 2245667999999999999999999999999999765 6899999999987654333 2346899999
Q ss_pred CCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHHhc
Q psy6377 148 VAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 148 ~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L 220 (383)
+|||++. ...|+.++|||||||++|+|++|++||.+.+..+.+..|.... ..+|. .+..+|+++++||++||
T Consensus 243 ~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL 321 (437)
T 4aw2_A 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLI 321 (437)
T ss_dssp CCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTS
T ss_pred eChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-ccccCCHHHHHHHHHHh
Confidence 9999986 4568999999999999999999999999999999988887543 44443 33568999999999999
Q ss_pred ccCCCC--CCCHHHHHcCcccCCcch
Q psy6377 221 IKNPME--RMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 221 ~~dP~~--Rpt~~e~L~hp~~~~~~~ 244 (383)
..+|++ |++++|+++||||.+...
T Consensus 322 ~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 322 CSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp SCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred cccccccCCCCHHHHhCCCccCCCCH
Confidence 998888 999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=350.03 Aligned_cols=237 Identities=27% Similarity=0.356 Sum_probs=193.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||++. ++|.+.+..
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 92 (324)
T 3mtl_A 16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLTLVFEYLD--KDLKQYLDD 92 (324)
T ss_dssp EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHS-CCCCTTBCCEEEEEECSSCEEEEEECCS--EEHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHH-hcCCCCCCeeeeEEeeCCEEEEEecccc--cCHHHHHHh
Confidence 3689999999999999999976 2335668999999 7789999999999999999999999998 588876543
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+||
T Consensus 93 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 169 (324)
T 3mtl_A 93 CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169 (324)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---CCEEECSSSEEECC------------CGGGCCH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---CCEEEccCcccccccCCccccccccCcccccCh
Confidence 2345667999999999999999999999999999766 68999999999865432 234456789999999
Q ss_pred ccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch-------------------------
Q psy6377 151 EILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL------------------------- 204 (383)
Q Consensus 151 E~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------- 204 (383)
|++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......++...
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (324)
T 3mtl_A 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS 249 (324)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHH
T ss_pred hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhh
Confidence 99876 6689999999999999999999999999998888877766443333222
Q ss_pred -hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 205 -FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 205 -~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
++.+++++.+||.+||..||.+|||++|+|+||||.......
T Consensus 250 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 250 HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 235688999999999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=343.46 Aligned_cols=233 Identities=23% Similarity=0.418 Sum_probs=201.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||+++++++...+..|+||||+. |++|.+++...
T Consensus 59 g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 136 (321)
T 2c30_A 59 GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-DYQHFNVVEMYKSYLVGEELWVLMEFLQ-GGALTDIVSQV 136 (321)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEECCCC-SCBHHHHHTTC
T ss_pred eEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEEecCC-CCCHHHHHHhc
Confidence 3689999999999999999876 3456889999999 7799999999999999999999999999 99999976543
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
.+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++
T Consensus 137 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 137 RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CcEEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence 345667999999999999999999999999999765 689999999998765432 23456899999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++|||||||++|+|++|..||.+.+..+....+....... ......+++.+.+||.+||..||++|||+.++
T Consensus 214 ~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999999999999999999988877777766554322 12335689999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
++||||...
T Consensus 293 l~hp~~~~~ 301 (321)
T 2c30_A 293 LDHPFLLQT 301 (321)
T ss_dssp HTSGGGGGC
T ss_pred hcChhhccC
Confidence 999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=379.81 Aligned_cols=234 Identities=27% Similarity=0.478 Sum_probs=209.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||||++.+ ....+.+|..++.....||+|++++++|++.+.+|+||||+. |++|..++
T Consensus 355 G~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~-gg~L~~~l 433 (674)
T 3pfq_A 355 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN-GGDLMYHI 433 (674)
T ss_dssp BCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC-SCBHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC-CCcHHHHH
Confidence 3689999999999999999975 356688999999966689999999999999999999999999 99999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee-cCcccccccCCCCcCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~y~a 149 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+... .+....+.+||+.|+|
T Consensus 434 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~A 510 (674)
T 3pfq_A 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510 (674)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---SCEEECCCTTCEECCCTTCCBCCCCSCSSSCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---CcEEEeecceeeccccCCcccccccCCCcccC
Confidence 43 3456777999999999999999999999999999876 699999999998743 3344566789999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
||++.+.+|+.++|||||||++|+|++|++||.+.+..+++..|......+|. .+++++++||++||.+||.+||+
T Consensus 511 PE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~ 586 (674)
T 3pfq_A 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLG 586 (674)
T ss_dssp HHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTT
T ss_pred HhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCC
Confidence 99999999999999999999999999999999999999999999988887774 67999999999999999999999
Q ss_pred H-----HHHHcCcccCCcchh
Q psy6377 230 A-----KEALKHPWLMNKKQI 245 (383)
Q Consensus 230 ~-----~e~L~hp~~~~~~~~ 245 (383)
+ +|+++||||+.....
T Consensus 587 ~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 587 CGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp CSTTHHHHHHSSGGGSSCCHH
T ss_pred CCCCcHHHHhcCccccCCCHH
Confidence 7 999999999976543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=376.61 Aligned_cols=231 Identities=26% Similarity=0.413 Sum_probs=201.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+|+ .++||||++++++|++.+.+|+||||+. |++|.+++
T Consensus 198 G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~l~lVmEy~~-gg~L~~~l 275 (576)
T 2acx_A 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVLTLMN-GGDLKFHI 275 (576)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHH-HcCCCCEeeEEEEEeeCCEEEEEEEcCC-CCcHHHHH
Confidence 3699999999999999999965 3455789999999 7789999999999999999999999999 99999865
Q ss_pred cc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 77 DD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 77 ~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....+......+||+.|+
T Consensus 276 ~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~---g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~ 352 (576)
T 2acx_A 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVGYM 352 (576)
T ss_dssp HSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCTTCCEECCCSCGGGC
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC---CCeEEEecccceecccCccccccCCCcccc
Confidence 43 2345667999999999999999999999999999765 699999999999876665666779999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD----SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
|||++.+.+|+.++|||||||++|+|++|.+||.+.+. .+....+......++ ..+|+++++||.+||..||
T Consensus 353 APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDP 428 (576)
T ss_dssp CHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSG
T ss_pred CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCCH
Confidence 99999998999999999999999999999999987643 344555555444443 5689999999999999999
Q ss_pred CCCC-----CHHHHHcCcccCCcc
Q psy6377 225 MERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 225 ~~Rp-----t~~e~L~hp~~~~~~ 243 (383)
.+|| |++|+++||||+...
T Consensus 429 ~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHcCCCCCCCHHHHHhChhhccCC
Confidence 9999 799999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=339.04 Aligned_cols=236 Identities=29% Similarity=0.433 Sum_probs=210.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~ 70 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++.+.+||||+++++++.+....++|||++. ++
T Consensus 31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 109 (298)
T 1phk_A 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK-KG 109 (298)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT-TC
T ss_pred eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccC-CC
Confidence 36999999999999999998652 34577999999966679999999999999999999999999 99
Q ss_pred cHHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCC
Q psy6377 71 TLQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT 144 (383)
Q Consensus 71 ~L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt 144 (383)
+|.+++.. ..++.+..||+.||.|||++||+||||||+||+++.+ +.++|+|||++.............||
T Consensus 110 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~ 186 (298)
T 1phk_A 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGT 186 (298)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCCBCCCCSC
T ss_pred cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC---CcEEEecccchhhcCCCcccccccCC
Confidence 99997654 2345667999999999999999999999999999765 68999999999987666666677899
Q ss_pred CCcCCCcccc------cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHH
Q psy6377 145 PDYVAPEILH------YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 145 ~~y~aPE~l~------~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 218 (383)
+.|+|||++. ...++.++||||||+++|+|++|..||.+.+..+....+..+...++...+..++..+.+||.+
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 266 (298)
T 1phk_A 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 266 (298)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred ccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHH
Confidence 9999999985 4568899999999999999999999999998888888888888888777778899999999999
Q ss_pred hcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 219 ILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
||..||.+|||++++|+||||+...
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 267 FLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HccCCcccCCCHHHHHhChHhhhcc
Confidence 9999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.22 Aligned_cols=239 Identities=26% Similarity=0.329 Sum_probs=184.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe-----CCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-----GEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+.||||++.+ ...++.+|+.+|+ .++||||++++++|.. ...+|+|||++. ++|
T Consensus 67 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L 143 (458)
T 3rp9_A 67 GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN-RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDF 143 (458)
T ss_dssp -CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS--EEH
T ss_pred eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHH-hCCCCCCCceEEEEecCCcccCceEEEEEeccc--cch
Confidence 3689999999999999999876 2456889999999 6689999999999943 357999999875 789
Q ss_pred HHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----------
Q psy6377 73 QTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----------- 135 (383)
Q Consensus 73 ~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----------- 135 (383)
.+++... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 144 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~~~~~~~ 220 (458)
T 3rp9_A 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD---CSVKVCDFGLARTVDYPENGNSQLPISP 220 (458)
T ss_dssp HHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTTCBCTTSCTTCCCCCC---
T ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC---CCEeecccccchhccCccccccccccCc
Confidence 8876543 355677999999999999999999999999999766 68999999999865321
Q ss_pred -----------------cccccccCCCCcCCCccc-ccCCCChhhHHHHHHHHHHHHHh-----------CCCCCCCCCc
Q psy6377 136 -----------------IEIRELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYVLLT-----------GFSPFGGETD 186 (383)
Q Consensus 136 -----------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvilyellt-----------g~~Pf~~~~~ 186 (383)
......+||++|+|||++ ....|+.++||||||||+|+|++ |.++|.|.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~ 300 (458)
T 3rp9_A 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300 (458)
T ss_dssp ------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC----
T ss_pred cccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcc
Confidence 123456899999999986 56679999999999999999998 7888877542
Q ss_pred --------------------HHHHHHHHhccCCCC---------------------------cchhcCCCHHHHHHHHHh
Q psy6377 187 --------------------SETFRNISKAQLDFP---------------------------DELFEDISPEAKDFIAKI 219 (383)
Q Consensus 187 --------------------~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~ 219 (383)
.+.+..|......++ ...++.+++++.+||.+|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 380 (458)
T 3rp9_A 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM 380 (458)
T ss_dssp ----------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHH
T ss_pred ccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 223333322211111 123456799999999999
Q ss_pred cccCCCCCCCHHHHHcCcccCCcchhhcc
Q psy6377 220 LIKNPMERMTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~ 248 (383)
|.+||++|||++|+|+||||+........
T Consensus 381 L~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 381 LVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred hccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 99999999999999999999987654433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.37 Aligned_cols=235 Identities=26% Similarity=0.381 Sum_probs=200.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.++. ...||||++++++|++.+.+|+||||++ |++|.+++
T Consensus 75 G~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~~~lVmE~~~-gg~L~~~l 152 (412)
T 2vd5_A 75 SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV-NGDRRWITQLHFAFQDENYLYLVMEYYV-GGDLLTLL 152 (412)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHH-HSCTTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeCCEEEEEEcCCC-CCcHHHHH
Confidence 3689999999999999999975 3456889999998 7799999999999999999999999999 99999977
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCc
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDY 147 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y 147 (383)
... .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... ....+||+.|
T Consensus 153 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~---g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y 229 (412)
T 2vd5_A 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229 (412)
T ss_dssp HHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTTSCEECSSCCSCGGG
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC---CCEEEeechhheeccCCCccccceeccccCc
Confidence 542 245667999999999999999999999999999765 6999999999988654433 2346899999
Q ss_pred CCCcccc-------cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CCCCcchhcCCCHHHHHHHHH
Q psy6377 148 VAPEILH-------YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQ--LDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 148 ~aPE~l~-------~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~ 218 (383)
+|||++. ...|+.++|+|||||++|+|++|++||.+.+..+.+.+|.... ..+|. ....+|+++++||++
T Consensus 230 ~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~ 308 (412)
T 2vd5_A 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQR 308 (412)
T ss_dssp CCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHT
T ss_pred CCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHH
Confidence 9999987 3568999999999999999999999999999988888887643 33332 345789999999999
Q ss_pred hcccCCCCC---CCHHHHHcCcccCCcchh
Q psy6377 219 ILIKNPMER---MTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 219 ~L~~dP~~R---pt~~e~L~hp~~~~~~~~ 245 (383)
||. +|.+| ++++|+++||||......
T Consensus 309 lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 309 LLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp TSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred HcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999 99998 599999999999875443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.98 Aligned_cols=235 Identities=23% Similarity=0.338 Sum_probs=185.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~ 71 (383)
..||+|++..+|+.||||++.. ....+.+|+.+++ .++||||++++++|.... ..|+|||++. ++
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 115 (371)
T 2xrw_A 39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD--AN 115 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS--EE
T ss_pred EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHH-hcCCCCccceEEeeccccccccccceEEEEEcCC--CC
Confidence 3689999999999999999975 2356789999999 778999999999998765 7899999998 56
Q ss_pred HHHhhc----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 72 LQTIID----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 72 L~~~l~----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
|.+.+. ...+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...........+||+.|
T Consensus 116 l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 192 (371)
T 2xrw_A 116 LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYY 192 (371)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCC----------------CTT
T ss_pred HHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEEEeecccccccccccCCceecCCc
Confidence 777553 33455677999999999999999999999999999865 68999999999877655455667899999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc---------------------
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE--------------------- 206 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--------------------- 206 (383)
+|||++.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..+.......++..+.
T Consensus 193 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (371)
T 2xrw_A 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 272 (371)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCH
T ss_pred cCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccch
Confidence 99999999999999999999999999999999999998888777776543332222111
Q ss_pred -----------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 207 -----------------DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 207 -----------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
..+.++++||.+||..||.+|||++|+|+||||.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 273 EKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred hhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 12567999999999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.77 Aligned_cols=235 Identities=29% Similarity=0.399 Sum_probs=198.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||+++++++.... .+|+|||++ +++|
T Consensus 40 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~--~~~L 116 (367)
T 1cm8_A 40 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDL 116 (367)
T ss_dssp CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC--SEEH
T ss_pred EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH-hCCCcCCCCceeeEecCCccccCceEEEEEecC--CCCH
Confidence 689999999999999999965 2356789999999 778999999999998763 469999999 5899
Q ss_pred HHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.+++.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .....+||+.|
T Consensus 117 ~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~--~~~~~~~t~~y 191 (367)
T 1cm8_A 117 GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQADS--EMTGYVVTRWY 191 (367)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCS--SCCSSCSCGGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC---CCEEEEeeeccccccc--ccCcCcCCCCc
Confidence 997654 3345677999999999999999999999999999765 6899999999997543 34567899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE----------------------- 203 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----------------------- 203 (383)
+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..+.+..+......++..
T Consensus 192 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 1cm8_A 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271 (367)
T ss_dssp CCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred CCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC
Confidence 99999876 679999999999999999999999999999888887776654443322
Q ss_pred ----hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhc
Q psy6377 204 ----LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 204 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~ 247 (383)
.+..+++.+.+||.+||..||.+|||++|+|+||||+.......
T Consensus 272 ~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 272 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 23467899999999999999999999999999999987655443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.49 Aligned_cols=226 Identities=19% Similarity=0.197 Sum_probs=169.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHh-cCCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSL-CSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~-~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++ +|+.||||++.. ....+.+|.++... .++|||||++++++.+++ .+|+||||++ ||+|.+++..
T Consensus 18 ~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~-~gsL~~~l~~ 94 (303)
T 3hmm_A 18 EVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE-HGSLFDYLNR 94 (303)
T ss_dssp EEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT-TCBHHHHHHH
T ss_pred EEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC-CCcHHHHHHh
Confidence 5899986 699999999977 33344455554431 568999999999998654 5899999999 9999998765
Q ss_pred C-----CchhhHHHHHHHHHHHHhC--------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----ccc
Q psy6377 79 N-----LVVPFESDELSSLAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRE 140 (383)
Q Consensus 79 ~-----~~~~~~~qil~aL~yLHs~--------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~ 140 (383)
. ....+..|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+....... ...
T Consensus 95 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~~~~~~~~~~ 171 (303)
T 3hmm_A 95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDIAPNH 171 (303)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT---SCEEECCCTTCEEEETTTTEESCC---
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC---CCEEEEeCCCCccccCCCCceeeeccc
Confidence 3 3346669999999999987 99999999999999876 6899999999998755432 224
Q ss_pred ccCCCCcCCCcccccC------CCChhhHHHHHHHHHHHHHhCCCCCCCCC--------------c-HHHHHHHHhccC-
Q psy6377 141 LLGTPDYVAPEILHYE------PITLAADMWSLGVTAYVLLTGFSPFGGET--------------D-SETFRNISKAQL- 198 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvilyelltg~~Pf~~~~--------------~-~~~~~~i~~~~~- 198 (383)
.+||+.|+|||++.+. .|+.++|||||||++|||+||.+||.... . .+....+.....
T Consensus 172 ~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r 251 (303)
T 3hmm_A 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251 (303)
T ss_dssp --CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred ccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCC
Confidence 5899999999998754 36789999999999999999987664321 1 122222322222
Q ss_pred -CCCcchh-cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 199 -DFPDELF-EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 199 -~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+|.... ...+..+.+|+.+||..||++|||+.|+++.
T Consensus 252 p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2222211 1234578899999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=347.60 Aligned_cols=232 Identities=24% Similarity=0.323 Sum_probs=195.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--------CCeEEEEEecCCCcC
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--------GEGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--------~~~~~lv~e~~~~g~ 70 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+ .+..|+|||++. +
T Consensus 32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~- 108 (351)
T 3mi9_A 32 EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-H- 108 (351)
T ss_dssp SEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEEC--------CEEEEEEECCS-E-
T ss_pred EEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHH-hccCCCcccHhheeeccccccccCCceEEEEEeccC-C-
Confidence 699999999999999999865 2346789999999 7789999999999987 456899999998 4
Q ss_pred cHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----ccc
Q psy6377 71 TLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----IEI 138 (383)
Q Consensus 71 ~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-----~~~ 138 (383)
+|.+.+.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...... ...
T Consensus 109 ~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~ 185 (351)
T 3mi9_A 109 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRY 185 (351)
T ss_dssp EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCCCSSSSCCCC
T ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CCEEEccchhccccccccccccccc
Confidence 66664322 3355677999999999999999999999999999766 68999999999876422 223
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCC---------
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI--------- 208 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--------- 208 (383)
....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......+++..|+..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 265 (351)
T 3mi9_A 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 265 (351)
T ss_dssp CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSS
T ss_pred CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccc
Confidence 45678999999999876 55899999999999999999999999999988888888776666655544432
Q ss_pred -------------------CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 209 -------------------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 209 -------------------s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
++.+.+||.+||..||++|||++|+|+||||...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 266 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 6789999999999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.37 Aligned_cols=236 Identities=25% Similarity=0.348 Sum_probs=192.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..++|||++. +++|.+++.
T Consensus 17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~ 94 (311)
T 4agu_A 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLK-QLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDR 94 (311)
T ss_dssp EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHH-hCCCCCccchhheeecCCeEEEEEEeCC-CchHHHHHh
Confidence 36999999999999999988662 345778999999 7789999999999999999999999999 899988654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aP 150 (383)
. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... ......||+.|+||
T Consensus 95 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 171 (311)
T 4agu_A 95 YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH---SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171 (311)
T ss_dssp TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC------------GGGCCH
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC---CCEEEeeCCCchhccCcccccCCCcCCccccCh
Confidence 3 3345667999999999999999999999999999765 689999999998765332 24456899999999
Q ss_pred ccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------------
Q psy6377 151 EILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------- 202 (383)
Q Consensus 151 E~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------- 202 (383)
|++.+ ..++.++||||+||++|+|++|.+||.+.+..+....+.......++
T Consensus 172 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T 4agu_A 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE 251 (311)
T ss_dssp HHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH
T ss_pred HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhh
Confidence 99875 67899999999999999999999999998887776655443221111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
..++.++.++.+||.+||..||.+|||++|+|+||||++...
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 252 LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 123568999999999999999999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=346.09 Aligned_cols=235 Identities=26% Similarity=0.340 Sum_probs=197.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||++++++|.+.+..++|||++. + +|..
T Consensus 24 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~-~l~~ 100 (346)
T 1ua2_A 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKSNISLVFDFME-T-DLEV 100 (346)
T ss_dssp EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTTCCEEEEECCS-E-EHHH
T ss_pred EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHh-hCCCCCCCeEEEEEeeCCceEEEEEcCC-C-CHHH
Confidence 3699999999999999999975 1346789999999 6789999999999999999999999998 4 7877
Q ss_pred hhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 75 IIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 75 ~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
.+.. ..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ......+||+.
T Consensus 101 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~ 177 (346)
T 1ua2_A 101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAYTHQVVTRW 177 (346)
T ss_dssp HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCCCCCCSCCCCT
T ss_pred HHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC---CCEEEEecccceeccCCcccCCccccccc
Confidence 6543 3456777999999999999999999999999999765 68999999999865432 23455689999
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc----------------------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE---------------------- 203 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------- 203 (383)
|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 178 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (346)
T 1ua2_A 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 257 (346)
T ss_dssp TCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred ccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCCh
Confidence 999999865 458999999999999999999999999999888888776543322221
Q ss_pred --hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 --LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.+..+++++.+||.+||..||.+|||++|+|+||||.+...
T Consensus 258 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 258 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 22556899999999999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=358.14 Aligned_cols=235 Identities=26% Similarity=0.340 Sum_probs=194.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|+++.+|+.||||++..+.....+|+++++ .++||||++++++|... ..+++||||+. ++|.+.+.
T Consensus 69 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 145 (420)
T 1j1b_A 69 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARH 145 (420)
T ss_dssp EEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHH-TCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC--EEHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEecccchhHHHHHHHHH-HcCCCCccceeeEEeccCCCCcceeEEeehhccc--ccHHHHHHH
Confidence 6999999999999999999876666778999999 77999999999998542 23678999998 45655432
Q ss_pred ---------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 78 ---------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 78 ---------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
...++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+++...........+||+.|+
T Consensus 146 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~ 223 (420)
T 1j1b_A 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223 (420)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEEECCCTTCEECCTTCCCCSCCSCTTSC
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEEeccchhhhhcccCCCceeeeeCCCcC
Confidence 123456779999999999999999999999999998652 478999999999876665566778999999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC-----------------CCCc--------
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL-----------------DFPD-------- 202 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~-------- 202 (383)
|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+..... .+|.
T Consensus 224 aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~ 303 (420)
T 1j1b_A 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303 (420)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHH
T ss_pred CHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHH
Confidence 99998764 799999999999999999999999999988777766654211 1111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.+...+++++.+||.+||.+||.+|||+.|+|+||||.....
T Consensus 304 ~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 012356899999999999999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=341.59 Aligned_cols=236 Identities=30% Similarity=0.508 Sum_probs=201.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|+++.+|+.||||++... ...+.+|+.+++ .++||||+++++++..++ .|+|||++. +++
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~-~~lv~e~~~-~~~ 100 (322)
T 2ycf_A 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFDAED-YYIVLELME-GGE 100 (322)
T ss_dssp EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHH-HCCCTTBCCEEEEEESSS-EEEEEECCT-TEE
T ss_pred EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHH-hCCCCCCceEeeEEcCCc-eEEEEecCC-CCc
Confidence 36899999999999999998651 246889999999 679999999999997655 899999999 999
Q ss_pred HHHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 72 LQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 72 L~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
|.+.+... .++.+..||+.||.|||++||+||||||+|||++.++..+.+||+|||++.............||+
T Consensus 101 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~ 180 (322)
T 2ycf_A 101 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180 (322)
T ss_dssp THHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCC
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCc
Confidence 99866433 344566999999999999999999999999999876544569999999999876554455678999
Q ss_pred CcCCCcccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 146 DYVAPEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 146 ~y~aPE~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.|+|||++. ...++.++|||||||++|+|++|..||.+.... .....+..+...+.+..+..+++.+.+||.+||.
T Consensus 181 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 260 (322)
T 2ycf_A 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLV 260 (322)
T ss_dssp TTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred CccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcc
Confidence 999999974 567899999999999999999999999876544 4455566677777777788999999999999999
Q ss_pred cCCCCCCCHHHHHcCcccCCc
Q psy6377 222 KNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.||++|||++++|+||||...
T Consensus 261 ~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 261 VDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp SSTTTSCCHHHHHTSGGGCCH
T ss_pred cCHhhCCCHHHHhhCcCcCCH
Confidence 999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=345.47 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=190.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..|+|||++. ++|.+++.
T Consensus 48 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--~~L~~~~~ 124 (329)
T 3gbz_A 48 GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK-ELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMD 124 (329)
T ss_dssp SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGG-GCCCTTBCCEEEEEEETTEEEEEEECCS--EEHHHHHH
T ss_pred eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHH-HcCCCCcceEEEEEecCCEEEEEEecCC--CCHHHHHh
Confidence 3699999999999999999975 2346779999999 7799999999999999999999999998 58988764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
.. .++.++.||+.||+|||++||+||||||+|||++.++ ..+.+||+|||++...... ......+||+.|+
T Consensus 125 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~ 204 (329)
T 3gbz_A 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204 (329)
T ss_dssp HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCcccc
Confidence 43 3456679999999999999999999999999996432 2356999999999865432 2344567899999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh----------------------
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF---------------------- 205 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---------------------- 205 (383)
|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 205 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
T 3gbz_A 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK 284 (329)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHH
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHh
Confidence 99998764 5899999999999999999999999999888887777654332222211
Q ss_pred ----cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 206 ----EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 206 ----~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..+++++.+||.+||..||.+|||++|+|+||||++..
T Consensus 285 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 285 RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp HHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 12689999999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=348.15 Aligned_cols=233 Identities=24% Similarity=0.296 Sum_probs=196.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcC----CCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCS----PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~----~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||||++.. ......+|+.+++.+. .||||+++++++.+.+..++|||++ +++|.+++
T Consensus 49 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~--~~~L~~~~ 126 (360)
T 3llt_A 49 GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL--GPSLYEII 126 (360)
T ss_dssp EEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC--CCBHHHHH
T ss_pred eEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC--CCCHHHHH
Confidence 3689999999999999999976 3456778999998444 4999999999999999999999999 69999976
Q ss_pred ccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc----------------------CCCCcEEEEec
Q psy6377 77 DDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD----------------------FPNCDIKVCDF 126 (383)
Q Consensus 77 ~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~----------------------~~~~~ikL~DF 126 (383)
... .+..+..||+.||+|||++||+||||||+|||++.. ...+.+||+||
T Consensus 127 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DF 206 (360)
T 3llt_A 127 TRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206 (360)
T ss_dssp HHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCC
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEec
Confidence 542 245667999999999999999999999999999741 12468999999
Q ss_pred cceeEeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh-
Q psy6377 127 EISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF- 205 (383)
Q Consensus 127 Gla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~- 205 (383)
|+|..... ......||+.|+|||++.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..+......+|...+
T Consensus 207 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 284 (360)
T 3llt_A 207 GCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284 (360)
T ss_dssp TTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHH
T ss_pred cCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHh
Confidence 99986432 344568999999999999999999999999999999999999999999888887777666555543211
Q ss_pred -----------------------------------------cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 206 -----------------------------------------EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 206 -----------------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
...++.+.+||.+||.+||.+|||++|+|+||||+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 11247788999999999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=352.19 Aligned_cols=235 Identities=26% Similarity=0.352 Sum_probs=197.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----------------------------
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT---------------------------- 55 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~---------------------------- 55 (383)
..||+|+++.+|+.||+|++..+.....+|+.+++ .++||||++++++|..
T Consensus 21 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (383)
T 3eb0_A 21 GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMK-VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH 99 (383)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHT-TCCCTTBCCEEEEEEEC---------------------------
T ss_pred EEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHH-HcCCCCccchhheeeecCcccccccccccccccccccccccccc
Confidence 36899999999999999999886666779999999 7799999999999954
Q ss_pred ----------CCeEEEEEecCCCcCcHHHhhc----------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc
Q psy6377 56 ----------GEGAYYVSWNTPLVVTLQTIID----------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115 (383)
Q Consensus 56 ----------~~~~~lv~e~~~~g~~L~~~l~----------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~ 115 (383)
...+++||||++ ++|.+.+. ...+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~ 177 (383)
T 3eb0_A 100 HKSVIVNPSQNKYLNVIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177 (383)
T ss_dssp ----------CCEEEEEECCCS--EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETT
T ss_pred cccccccCCCceEEEEEEecCC--ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCC
Confidence 334889999998 47666442 22345667999999999999999999999999999743
Q ss_pred CCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q psy6377 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS 194 (383)
Q Consensus 116 ~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~ 194 (383)
.+.+||+|||+|+............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.
T Consensus 178 --~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 178 --DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII 255 (383)
T ss_dssp --TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 268999999999987766666778899999999998764 48999999999999999999999999998888877776
Q ss_pred hccCCCCc-------------------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 195 KAQLDFPD-------------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 195 ~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.....++. .....+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 256 QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 53222211 12235789999999999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.25 Aligned_cols=239 Identities=26% Similarity=0.365 Sum_probs=189.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+.||||++.. ...++.+|+.+|+ .++||||+++++++... ...|+|||++. ++|
T Consensus 40 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~--~~L 116 (432)
T 3n9x_A 40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN-RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--SDL 116 (432)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS--EEH
T ss_pred EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHH-HcCCCCcceEEEEEecCCCCcCCeEEEEEecCC--cCH
Confidence 3699999999999999999976 2467889999999 77899999999999876 57999999987 699
Q ss_pred HHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----------
Q psy6377 73 QTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---------- 136 (383)
Q Consensus 73 ~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---------- 136 (383)
.+++... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 117 ~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~ 193 (432)
T 3n9x_A 117 KKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD---CSVKVCDFGLARTINSEKDTNIVNDLEE 193 (432)
T ss_dssp HHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEEC--------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC---CCEEEccCCCcccccccccccccccccc
Confidence 9976543 345677999999999999999999999999999765 689999999999764332
Q ss_pred -------------ccccccCCCCcCCCccc-ccCCCChhhHHHHHHHHHHHHHh-----------CCCCCCCCCc-----
Q psy6377 137 -------------EIRELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYVLLT-----------GFSPFGGETD----- 186 (383)
Q Consensus 137 -------------~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvilyellt-----------g~~Pf~~~~~----- 186 (383)
.....+||++|+|||++ ....|+.++|||||||++|+|++ |.++|.+.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~ 273 (432)
T 3n9x_A 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273 (432)
T ss_dssp -----------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC---
T ss_pred cccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCc
Confidence 23567899999999986 56679999999999999999998 5556655431
Q ss_pred ------------HHHHHHHHhccCCCCc---------------------------chhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 187 ------------SETFRNISKAQLDFPD---------------------------ELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 187 ------------~~~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
.+.+..|......++. ..++.+++++.+||.+||.+||++|
T Consensus 274 ~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 353 (432)
T 3n9x_A 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR 353 (432)
T ss_dssp -------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccC
Confidence 2223222221111111 1235689999999999999999999
Q ss_pred CCHHHHHcCcccCCcchhhcc
Q psy6377 228 MTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~~~~~~ 248 (383)
||++|+|+||||+........
T Consensus 354 ~ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 354 ITIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp CCHHHHHTCGGGTTTCCTTTC
T ss_pred CCHHHHhcChhhhhccCcccC
Confidence 999999999999986654433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=355.03 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=185.0
Q ss_pred eEEEEEEc--CCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhhc-
Q psy6377 5 SEEMADSI--ATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
.||+|+++ .+++.||+|++.. ....+.+|+.+|+ .++||||++++++|.+ ...+|+||||+. ++|.+++.
T Consensus 36 ~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 112 (405)
T 3rgf_A 36 HVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR-ELKHPNVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIKF 112 (405)
T ss_dssp EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHH-HCCCTTBCCCCEEEEETTTTEEEEEEECCS--EEHHHHHHH
T ss_pred EEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHH-hcCCCCeeeEeeEEecCCCCeEEEEEeCCC--CCHHHHHHH
Confidence 68999976 6799999999987 3567889999999 7789999999999964 678999999997 57776542
Q ss_pred --------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc-CCCCcEEEEeccceeEeecC----ccc
Q psy6377 78 --------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD-FPNCDIKVCDFEISRVILDG----IEI 138 (383)
Q Consensus 78 --------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~-~~~~~ikL~DFGla~~~~~~----~~~ 138 (383)
...++.++.||+.||+|||++||+||||||+|||+..+ ...+.+||+|||+|+..... ...
T Consensus 113 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 192 (405)
T 3rgf_A 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192 (405)
T ss_dssp HHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC------------
T ss_pred hccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccC
Confidence 23355677999999999999999999999999999543 23478999999999876432 223
Q ss_pred ccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhccCCCCcchhcC-
Q psy6377 139 RELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETD---------SETFRNISKAQLDFPDELFED- 207 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~- 207 (383)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+... .+.+..+......++...|..
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~ 272 (405)
T 3rgf_A 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 272 (405)
T ss_dssp ----CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGG
T ss_pred CCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchh
Confidence 45689999999999887 4589999999999999999999999987654 245555544333333322222
Q ss_pred ---------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 208 ---------------------------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 208 ---------------------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.++.+.+||.+||.+||.+|||++|+|+||||.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp GGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 2778999999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=336.16 Aligned_cols=230 Identities=28% Similarity=0.502 Sum_probs=199.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+....++|||++. +++|.+.+
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~l 100 (279)
T 3fdn_A 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDATRVYLILEYAP-LGTVYREL 100 (279)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHH
T ss_pred eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-cCCCCCCcchhheEecCCEEEEEEecCC-CCcHHHHH
Confidence 3699999999999999999865 3456889999999 7789999999999999999999999999 99999865
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..+..+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++...... ......||+.|+||
T Consensus 101 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aP 176 (279)
T 3fdn_A 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS-RRTDLCGTLDYLPP 176 (279)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT---SCEEECSCCEESCC---------CCCCTTCCH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC---CCEEEEeccccccCCcc-cccccCCCCCccCH
Confidence 43 3355677999999999999999999999999999765 68999999998654332 23456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++||||||+++|+|++|..||.+.+..+....+......+|. .+++.+.+||.+||..||.+|||+
T Consensus 177 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~ 252 (279)
T 3fdn_A 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPML 252 (279)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHHHHHHhccChhhCCCH
Confidence 9999999999999999999999999999999999988888888877776654 578999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
.|+|+||||....
T Consensus 253 ~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 253 REVLEHPWITANS 265 (279)
T ss_dssp HHHHHCHHHHHHC
T ss_pred HHHhhCccccCCc
Confidence 9999999997643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.54 Aligned_cols=237 Identities=24% Similarity=0.365 Sum_probs=196.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhhc---
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTIID--- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l~--- 77 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++.+.+||||+++++++.+ ....++|||++. +++|.+++.
T Consensus 50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~ 128 (330)
T 3nsz_A 50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN-NTDFKQLYQTLT 128 (330)
T ss_dssp EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC-CCCHHHHGGGCC
T ss_pred eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC-chhHHHHHHhCC
Confidence 3699999999999999999986 567899999999966679999999999998 677999999999 999998754
Q ss_pred cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccccc-C
Q psy6377 78 DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY-E 156 (383)
Q Consensus 78 ~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~-~ 156 (383)
...+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++............||+.|+|||++.+ .
T Consensus 129 ~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (330)
T 3nsz_A 129 DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCC
Confidence 344567779999999999999999999999999998652 3899999999998776666667789999999999876 6
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHH-------------hccCCCCc--------------------
Q psy6377 157 PITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNIS-------------KAQLDFPD-------------------- 202 (383)
Q Consensus 157 ~~~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~i~-------------~~~~~~~~-------------------- 202 (383)
.++.++|||||||++|+|++|..||... ...+.+..+. ......++
T Consensus 207 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (330)
T 3nsz_A 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286 (330)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT
T ss_pred cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccc
Confidence 7899999999999999999999999543 3323322221 11111111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.....+++++.+||.+||.+||.+|||++|+|+||||+...
T Consensus 287 ~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11233799999999999999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=340.61 Aligned_cols=227 Identities=25% Similarity=0.308 Sum_probs=186.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||||++.. .......|+..+.....||||+++++++.+++..|+|||++. ++|.+.+.
T Consensus 71 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~--~~L~~~~~ 148 (311)
T 3p1a_A 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG--PSLQQHCE 148 (311)
T ss_dssp EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCC--CBHHHHHH
T ss_pred eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccC--CCHHHHHH
Confidence 4689999999999999999865 233456666666657799999999999999999999999995 68887543
Q ss_pred -------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 78 -------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 -------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
...++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.............||+.|+||
T Consensus 149 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aP 225 (311)
T 3p1a_A 149 AWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225 (311)
T ss_dssp HHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG---GCEEECCCTTCEECC------CCCCCGGGCCG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEccceeeeecccCCCCcccCCCccccCH
Confidence 23345677999999999999999999999999999876 68999999999887655555566799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+ .++.++|||||||++|+|++|..||.+.. ....+..+ ..+...+..+++++.+||.+||..||++|||+
T Consensus 226 E~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 299 (311)
T 3p1a_A 226 ELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQG--YLPPEFTAGLSSELRSVLVMMLEPDPKLRATA 299 (311)
T ss_dssp GGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTT--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred hHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhcc--CCCcccccCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99876 79999999999999999999977776543 23333332 34556677899999999999999999999999
Q ss_pred HHHHcCcccCC
Q psy6377 231 KEALKHPWLMN 241 (383)
Q Consensus 231 ~e~L~hp~~~~ 241 (383)
+|+|+||||+.
T Consensus 300 ~ell~hp~~~~ 310 (311)
T 3p1a_A 300 EALLALPVLRQ 310 (311)
T ss_dssp HHHHTSGGGSC
T ss_pred HHHHhCccccC
Confidence 99999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=337.01 Aligned_cols=236 Identities=28% Similarity=0.501 Sum_probs=208.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+.+.
T Consensus 36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 113 (287)
T 2wei_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSFYIVGELYT-GGELFDEII 113 (287)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHH-hccCCCccEEEEEEeCCCeEEEEEEccC-CCCHHHHHH
Confidence 3699999999999999999865 3457889999999 7799999999999999999999999999 999988543
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
...++.+..||+.||.|||++||+||||||+||+++.+...+.+||+|||++.............||+.|+|||
T Consensus 114 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE 193 (287)
T 2wei_A 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193 (287)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChH
Confidence 33455677999999999999999999999999999876555689999999998765554455567899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+. ++.++||||||+++|+|++|..||.+.+..+....+..+...++...+..+++++.+||.+||..||.+|||+.
T Consensus 194 ~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 272 (287)
T 2wei_A 194 VLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272 (287)
T ss_dssp HHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHH
Confidence 98754 89999999999999999999999999998888888888888777777788999999999999999999999999
Q ss_pred HHHcCcccCCc
Q psy6377 232 EALKHPWLMNK 242 (383)
Q Consensus 232 e~L~hp~~~~~ 242 (383)
++|+||||+..
T Consensus 273 ell~hp~~~~~ 283 (287)
T 2wei_A 273 QCLEHPWIQKY 283 (287)
T ss_dssp HHHHSHHHHHH
T ss_pred HHhcCHHHhcc
Confidence 99999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=341.43 Aligned_cols=228 Identities=20% Similarity=0.277 Sum_probs=187.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC---------------------
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--------------------- 57 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--------------------- 57 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||++++++|.+..
T Consensus 20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (332)
T 3qd2_B 20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA-KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98 (332)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHT-SCCCTTBCCEEEEEEECCSCHHHHHHHC-----------
T ss_pred eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHH-hCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccccccc
Confidence 3689999999999999999975 2356889999999 779999999999986654
Q ss_pred ------------------------------------eEEEEEecCCCcCcHHHhhccCC---------chhhHHHHHHHH
Q psy6377 58 ------------------------------------GAYYVSWNTPLVVTLQTIIDDNL---------VVPFESDELSSL 92 (383)
Q Consensus 58 ------------------------------------~~~lv~e~~~~g~~L~~~l~~~~---------~~~~~~qil~aL 92 (383)
..++|||++. |++|.+++.... ++.++.||+.||
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 177 (332)
T 3qd2_B 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCR-KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAV 177 (332)
T ss_dssp ---------------------------------CCCEEEEEEECCC-SSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHH
T ss_pred ccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecC-CCCHHHHHhcccCccchhhHHHHHHHHHHHHHH
Confidence 3899999999 999999875432 346779999999
Q ss_pred HHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-------------ccccccCCCCcCCCcccccCCCC
Q psy6377 93 AYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-------------EIRELLGTPDYVAPEILHYEPIT 159 (383)
Q Consensus 93 ~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-------------~~~~~~gt~~y~aPE~l~~~~~~ 159 (383)
+|||++||+||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||++.+..++
T Consensus 178 ~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 254 (332)
T 3qd2_B 178 EFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254 (332)
T ss_dssp HHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCC
T ss_pred HHHHhCCeeecCCCcccEEEeCC---CCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCc
Confidence 99999999999999999999765 689999999998765432 22345799999999999999999
Q ss_pred hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 160 LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 160 ~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
.++|||||||++|+|++|..|+... ......+... .+ +..+...++++.+||.+||..||.+|||++|+|+||||
T Consensus 255 ~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f 329 (332)
T 3qd2_B 255 HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNL--KF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329 (332)
T ss_dssp THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTT--CC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhcc--CC-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence 9999999999999999987775321 2222223222 22 23345668899999999999999999999999999999
Q ss_pred CC
Q psy6377 240 MN 241 (383)
Q Consensus 240 ~~ 241 (383)
++
T Consensus 330 ~~ 331 (332)
T 3qd2_B 330 EN 331 (332)
T ss_dssp CC
T ss_pred hc
Confidence 75
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.60 Aligned_cols=232 Identities=25% Similarity=0.375 Sum_probs=200.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++||||++++++|++.+.+|+||||+. |++|...+
T Consensus 199 G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~l~lVmE~~~-gg~L~~~l 276 (543)
T 3c4z_A 199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTDLCLVMTIMN-GGDIRYHI 276 (543)
T ss_dssp SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEECCCT-TCBHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHH-hcCCCCEeeEEEEEeeCCEEEEEEEecc-CCCHHHHH
Confidence 3699999999999999999975 2356889999999 7799999999999999999999999999 99999865
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCC
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTP 145 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~ 145 (383)
.. ..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....... ....+||+
T Consensus 277 ~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~---g~vkL~DFGla~~~~~~~~~~~~~~GT~ 353 (543)
T 3c4z_A 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTP 353 (543)
T ss_dssp HTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCTTCCCBCCCCSCT
T ss_pred HHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC---CCEEEeecceeeeccCCCcccccccCCc
Confidence 33 2344667999999999999999999999999999765 6899999999998755433 34468999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET----DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.|+|||++.+.+|+.++|+|||||++|+|++|.+||.+.+ ..+....+......+| ..+++++++||.+||.
T Consensus 354 ~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~ 429 (543)
T 3c4z_A 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQ 429 (543)
T ss_dssp TTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSC
T ss_pred cccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999998764 3456666666666555 4679999999999999
Q ss_pred cCCCCCCC-----HHHHHcCcccCCcch
Q psy6377 222 KNPMERMT-----AKEALKHPWLMNKKQ 244 (383)
Q Consensus 222 ~dP~~Rpt-----~~e~L~hp~~~~~~~ 244 (383)
+||.+||+ ++++++||||+....
T Consensus 430 ~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 430 KDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp SSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred CCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 99999996 589999999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=347.24 Aligned_cols=238 Identities=29% Similarity=0.388 Sum_probs=186.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||++++++|... ...|++++++ +++|
T Consensus 44 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~--~~~L 120 (367)
T 2fst_X 44 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADL 120 (367)
T ss_dssp CEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC--CEEC
T ss_pred EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEecCCccccCCeEEEEeccc--CCCH
Confidence 689999999999999999975 2356789999999 77899999999999764 5689999998 4888
Q ss_pred HHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
.+++.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .....+||+.|
T Consensus 121 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kL~DFG~a~~~~~--~~~~~~~t~~y 195 (367)
T 2fst_X 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTAD--EMTGYVATRWY 195 (367)
T ss_dssp C-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECC-----------------CCCTT
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC---CCEEEeeccccccccc--cCCCcCcCcCc
Confidence 887654 3345677999999999999999999999999999765 6899999999987543 34567899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------ 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 202 (383)
+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......++.
T Consensus 196 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (367)
T 2fst_X 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 275 (367)
T ss_dssp CCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCC
T ss_pred cChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCC
Confidence 99999876 67899999999999999999999999999888877777654332221
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcccC
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVG 250 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~~~ 250 (383)
..+...++.+.+||.+||..||.+|||++|+|+||||.........+.
T Consensus 276 ~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~ 326 (367)
T 2fst_X 276 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326 (367)
T ss_dssp CHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC
T ss_pred CHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC
Confidence 123457889999999999999999999999999999998765544433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.62 Aligned_cols=237 Identities=26% Similarity=0.328 Sum_probs=193.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeCCe------EEEEEecCCCcCcHHHhh-
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG------AYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~------~~lv~e~~~~g~~L~~~l- 76 (383)
..||+|++..+++ +|+|.+........+|+.+++ .++||||++++++|..... +++||||+. ++.+....
T Consensus 54 g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~ 130 (394)
T 4e7w_A 54 GVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRH 130 (394)
T ss_dssp EEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHH-TCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS-EEHHHHHHH
T ss_pred eEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHH-hCCCCCcceEEEEEEecCCCCCceEEEEEeeccC-ccHHHHHHH
Confidence 3689999988777 788877765556668999999 7799999999999965443 889999998 54433321
Q ss_pred --------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 77 --------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 77 --------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
....++.++.||+.||+|||++||+||||||+|||++.. .+.+||+|||+|+....+.......||+.|+
T Consensus 131 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~--~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~ 208 (394)
T 4e7w_A 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP--SGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208 (394)
T ss_dssp HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEECCTTCCCCSSCSCGGGC
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC--CCcEEEeeCCCcccccCCCCCcccccCcCcc
Confidence 223345677999999999999999999999999999832 2689999999999876666666788999999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------------
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------- 202 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------- 202 (383)
|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+......++.
T Consensus 209 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (394)
T 4e7w_A 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK 288 (394)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH
T ss_pred CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHH
Confidence 99998664 5899999999999999999999999999888777776553222111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
.+...+++++.+||.+||.+||.+|||+.|+|+||||+.....
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 1223588999999999999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=353.38 Aligned_cols=235 Identities=26% Similarity=0.328 Sum_probs=194.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcC-----CCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCS-----PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~-----~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++..+|+.||||++... ...+.+|+.+++.+. +||||+++++++.....+++|||++. ++|.++
T Consensus 111 g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~--~~L~~~ 188 (429)
T 3kvw_A 111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS--MNLYEL 188 (429)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC--CBHHHH
T ss_pred EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC--CCHHHH
Confidence 36899999999999999999873 356778888887432 68899999999999999999999997 688886
Q ss_pred hccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 76 IDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 76 l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
+... .+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+|.... ....+.+||+.|
T Consensus 189 l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~DFG~a~~~~--~~~~~~~gt~~y 265 (429)
T 3kvw_A 189 IKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSCYEH--QRVYTYIQSRFY 265 (429)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECCCTTCEETT--CCCCSSCSCGGG
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEeecccceecC--CcccccCCCCCc
Confidence 5432 24567799999999999999999999999999987531 239999999997643 334567899999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch-----------------------
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL----------------------- 204 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------- 204 (383)
+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 266 ~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (429)
T 3kvw_A 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVT 345 (429)
T ss_dssp CCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEE
T ss_pred cChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccc
Confidence 999999999999999999999999999999999999998888777665432222211
Q ss_pred --------------------------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 205 --------------------------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 205 --------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
....++.+.+||.+||.+||++|||++|+|+||||+...
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 346 TLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred ccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 112378899999999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=329.64 Aligned_cols=230 Identities=27% Similarity=0.427 Sum_probs=192.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||.|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 102 (276)
T 2h6d_A 25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHPHIIKLYQVISTPTDFFMVMEYVS-GGELFDYI 102 (276)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHH
T ss_pred eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHh-cCCCCCEeEEEEEEecCCeEEEEEeccC-CCcHHHHH
Confidence 3699999999999999999865 2357889999999 7789999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++.............||+.|+||
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aP 179 (276)
T 2h6d_A 103 CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179 (276)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---SCEEECCCCGGGCCCC-------------CCT
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---CCEEEeecccccccCCCcceecccCCccccCH
Confidence 43 3345667999999999999999999999999999765 68999999999876555445566899999999
Q ss_pred cccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..+ +.++||||||+++|+|++|..||.+.........+..+....| ..++..+.++|.+||..||.+|||
T Consensus 180 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp GGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCC
Confidence 99988776 6899999999999999999999999888888888877766554 356899999999999999999999
Q ss_pred HHHHHcCcccCCc
Q psy6377 230 AKEALKHPWLMNK 242 (383)
Q Consensus 230 ~~e~L~hp~~~~~ 242 (383)
+.++++||||+..
T Consensus 256 ~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 256 IKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHHhChhhccC
Confidence 9999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.83 Aligned_cols=231 Identities=28% Similarity=0.465 Sum_probs=173.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++
T Consensus 25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 102 (278)
T 3cok_A 25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC-QLKHPSILELYNYFEDSNYVYLVLEMCH-NGEMNRYL 102 (278)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TBCCTTBCCEEEEEECSSEEEEEEECCT-TEEHHHHH
T ss_pred eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH-hCCCCCeEeEEEEEccCCeEEEEEecCC-CCcHHHHH
Confidence 3699999999999999999975 2367889999999 7789999999999999999999999999 89999976
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcC
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYV 148 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~ 148 (383)
... .++.+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++...... .......||+.|+
T Consensus 103 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 179 (278)
T 3cok_A 103 KNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179 (278)
T ss_dssp HTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT---CCEEECCCTTCEECC----------------
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEEeecceeeccCCCCcceeccCCCCcC
Confidence 542 345667999999999999999999999999999765 68999999999876432 2234567999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+..++.++||||||+++|+|++|.+||.+.+..+....+.......| ..++.++.+||.+||..||++||
T Consensus 180 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rp 255 (278)
T 3cok_A 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKDLIHQLLRRNPADRL 255 (278)
T ss_dssp ------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHHHHHHHHcccCHhhCC
Confidence 99999988999999999999999999999999998877666665554444433 35789999999999999999999
Q ss_pred CHHHHHcCcccCCcc
Q psy6377 229 TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 t~~e~L~hp~~~~~~ 243 (383)
|++++|+||||....
T Consensus 256 s~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 256 SLSSVLDHPFMSRNS 270 (278)
T ss_dssp CHHHHTTSTTTC---
T ss_pred CHHHHhcCccccCCC
Confidence 999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=342.20 Aligned_cols=237 Identities=26% Similarity=0.372 Sum_probs=197.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~ 73 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++... ...|+|||++. ++|.
T Consensus 41 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~--~~L~ 117 (364)
T 3qyz_A 41 GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL-RFRHENIIGINDIIRAPTIEQMKDVYIVQDLME--TDLY 117 (364)
T ss_dssp EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS--EEHH
T ss_pred eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHH-hcCCCCCccceeEEecCCccccceEEEEEcccC--cCHH
Confidence 3689999999999999999975 2356889999999 77899999999999765 36899999997 5898
Q ss_pred Hhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCC
Q psy6377 74 TIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGT 144 (383)
Q Consensus 74 ~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt 144 (383)
+++.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........ ....+||
T Consensus 118 ~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 194 (364)
T 3qyz_A 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVAT 194 (364)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCGGGCBCCTTCCCCSC
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC---CCEEEEeCcceEecCCCCCccccccccccc
Confidence 87644 3355677999999999999999999999999999765 6899999999987654322 3446899
Q ss_pred CCcCCCcccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Q psy6377 145 PDYVAPEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------- 202 (383)
Q Consensus 145 ~~y~aPE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------- 202 (383)
+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 195 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T 3qyz_A 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274 (364)
T ss_dssp GGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred cCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCc
Confidence 9999999865 455899999999999999999999999999888887777543332221
Q ss_pred ------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 203 ------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 203 ------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
..+..+++++.+||.+||.+||++|||++|+|+||||.......
T Consensus 275 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 275 NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 12356789999999999999999999999999999999765443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.81 Aligned_cols=232 Identities=25% Similarity=0.381 Sum_probs=195.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..|+|||++. +++|.+++..
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 98 (276)
T 2yex_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYLFLEYCS-GGELFDRIEP 98 (276)
T ss_dssp SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCT-TEEGGGGSBT
T ss_pred cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHH-hcCCCCceeeeeEEEcCCEEEEEEEecC-CCcHHHHHhh
Confidence 3699999999999999999865 2356889999999 7799999999999999999999999999 9999998764
Q ss_pred C------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCcCC
Q psy6377 79 N------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDYVA 149 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y~a 149 (383)
. .++.+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......||+.|+|
T Consensus 99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (276)
T 2yex_A 99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (276)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEETTEECCBCCCCSCGGGCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC---CCEEEeeCCCccccCCCcchhcccCCccccCccC
Confidence 3 345666999999999999999999999999999765 689999999998754322 2345679999999
Q ss_pred CcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 150 PEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 150 PE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
||++.+..+ +.++||||||+++|+|++|..||.+.... ..+..+....... ..+..+++.+.+||.+||..||.+|
T Consensus 176 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 253 (276)
T 2yex_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPLALLHKILVENPSAR 253 (276)
T ss_dssp GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCHHHHHHHHHHCCCCchhC
Confidence 999987765 78999999999999999999999876654 2333333332222 2345789999999999999999999
Q ss_pred CCHHHHHcCcccCCc
Q psy6377 228 MTAKEALKHPWLMNK 242 (383)
Q Consensus 228 pt~~e~L~hp~~~~~ 242 (383)
||++|+++||||+..
T Consensus 254 ps~~~il~~~~~~~~ 268 (276)
T 2yex_A 254 ITIPDIKKDRWYNKP 268 (276)
T ss_dssp CCHHHHTTCTTTTCC
T ss_pred CCHHHHhcCccccCh
Confidence 999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=334.14 Aligned_cols=236 Identities=25% Similarity=0.373 Sum_probs=197.7
Q ss_pred ceEEEEEEc-CCCcEEEEEEccC------CcccHHHHHHHHHhcC--CCCCcccceEEEE-----eCCeEEEEEecCCCc
Q psy6377 4 LSEEMADSI-ATGEVFAAKFLES------NPVRIHHEIALLSLCS--PSPRIVKLHDVFQ-----TGEGAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~-~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~-----~~~~~~lv~e~~~~g 69 (383)
..||+|++. .+|+.||+|++.. ....+.+|+.+++.+. +||||+++++++. .....++|||++.
T Consensus 25 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-- 102 (326)
T 1blx_A 25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-- 102 (326)
T ss_dssp EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS--
T ss_pred EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC--
Confidence 368999995 7789999999875 2457889999888442 8999999999997 5567899999998
Q ss_pred CcHHHhhcc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccc
Q psy6377 70 VTLQTIIDD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 70 ~~L~~~l~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
++|.+++.. ..++.+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++............
T Consensus 103 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~ 179 (326)
T 1blx_A 103 QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSV 179 (326)
T ss_dssp CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCCSCCCCCGGGGGCCC
T ss_pred CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC---CCEEEecCcccccccCCCCcccc
Confidence 589886543 2345667999999999999999999999999999765 68999999999876555455667
Q ss_pred cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------
Q psy6377 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP-------------------- 201 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 201 (383)
.||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 1blx_A 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 259 (326)
T ss_dssp CCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCC
T ss_pred ccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCc
Confidence 899999999999999999999999999999999999999999988887777654322111
Q ss_pred ---cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 202 ---DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 202 ---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
...+..++..+.+||.+||..||.+|||+.++|+||||.....
T Consensus 260 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 260 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 1233568999999999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=339.05 Aligned_cols=224 Identities=28% Similarity=0.380 Sum_probs=192.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||+|+++.+|+.||||++... ...+.+|+.+++ .++||||++++++|.+.+..++|||++..|.+|
T Consensus 39 ~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l 117 (335)
T 3dls_A 39 FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS-RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL 117 (335)
T ss_dssp SEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCTTSCBH
T ss_pred EEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccH
Confidence 6999999999999999999762 246788999999 779999999999999999999999999845599
Q ss_pred HHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 73 QTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 73 ~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
.+++... .+..+..||+.||.|||++||+||||||+|||++.+ +.+||+|||++............+||+.
T Consensus 118 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~gt~~ 194 (335)
T 3dls_A 118 FAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED---FTIKLIDFGSAAYLERGKLFYTFCGTIE 194 (335)
T ss_dssp HHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECCTTCCBCEECSCGG
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC---CcEEEeecccceECCCCCceeccCCCcc
Confidence 9976543 345667999999999999999999999999999765 6899999999998776666667789999
Q ss_pred cCCCcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..+ +.++|||||||++|+|++|..||.+... ........| ..+++++.+||.+||.+||+
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~----~~~~~~l~~li~~~L~~dP~ 264 (335)
T 3dls_A 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP----YLVSKELMSLVSGLLQPVPE 264 (335)
T ss_dssp GCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS----SCCCHHHHHHHHHHTCSSGG
T ss_pred ccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC----cccCHHHHHHHHHHccCChh
Confidence 999999988876 8999999999999999999999976321 111222222 35799999999999999999
Q ss_pred CCCCHHHHHcCcccCCc
Q psy6377 226 ERMTAKEALKHPWLMNK 242 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~~ 242 (383)
+|||++++++||||...
T Consensus 265 ~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 265 RRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp GSCCHHHHHHCTTTTCC
T ss_pred hCcCHHHHhcCccccCC
Confidence 99999999999999763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=329.57 Aligned_cols=229 Identities=29% Similarity=0.463 Sum_probs=202.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+.+
T Consensus 28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 105 (284)
T 2vgo_A 28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS-HLRHPNILRMYNYFHDRKRIYLMLEFAP-RGELYKEL 105 (284)
T ss_dssp EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHH
T ss_pred eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHh-cCCCCCEeeEEEEEEcCCEEEEEEEeCC-CCcHHHHH
Confidence 3689999999999999999865 2356889999999 7789999999999999999999999999 89999876
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
.. ..+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++...... ......||+.|+||
T Consensus 106 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aP 181 (284)
T 2vgo_A 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSL-RRRTMCGTLDYLPP 181 (284)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---CCEEECCCTTCEECSSS-CBCCCCSCGGGCCH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---CCEEEecccccccCccc-ccccccCCCCcCCH
Confidence 43 3345677999999999999999999999999999765 68999999999765432 33456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++||||||+++|+|++|..||.+.+..+....+......+| ..++..+.+||.+||..||.+|||+
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~ 257 (284)
T 2vgo_A 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPL 257 (284)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCH
Confidence 999999999999999999999999999999999888888888877766655 3579999999999999999999999
Q ss_pred HHHHcCcccCCc
Q psy6377 231 KEALKHPWLMNK 242 (383)
Q Consensus 231 ~e~L~hp~~~~~ 242 (383)
+++++||||+..
T Consensus 258 ~~ll~h~~~~~~ 269 (284)
T 2vgo_A 258 KGVMEHPWVKAN 269 (284)
T ss_dssp HHHHTCHHHHHH
T ss_pred HHHhhCHHHHhh
Confidence 999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=342.83 Aligned_cols=234 Identities=29% Similarity=0.394 Sum_probs=194.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeE------EEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA------YYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~------~lv~e~~~~g~~ 71 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .++||||++++++|.+.+.. |+|||++. ++
T Consensus 56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 132 (371)
T 4exu_A 56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TD 132 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC--EE
T ss_pred eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHH-hcCCCCchhhhhheeccCCcccceeEEEEEcccc--cc
Confidence 36899999999999999999761 356789999999 77899999999999887765 99999998 68
Q ss_pred HHHhhc----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 72 LQTIID----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 72 L~~~l~----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
|.+.+. ...+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ......||+.|
T Consensus 133 l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~--~~~~~~~t~~y 207 (371)
T 4exu_A 133 LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADA--EMTGYVVTRWY 207 (371)
T ss_dssp HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSTTCC----------CTTCCCTT
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC---CCEEEEecCccccccc--CcCCcccCccc
Confidence 888654 34456777999999999999999999999999999765 6899999999986533 34556899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-----------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE----------------------- 203 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----------------------- 203 (383)
+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 208 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (371)
T 4exu_A 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 287 (371)
T ss_dssp SCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCC
T ss_pred cCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcch
Confidence 99999877 779999999999999999999999999998887777765533322221
Q ss_pred ----hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 204 ----LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 204 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
.+..+++.+.+||.+||..||++|||++|+|+||||......
T Consensus 288 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 288 DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp CHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 234679999999999999999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=340.59 Aligned_cols=234 Identities=22% Similarity=0.287 Sum_probs=191.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..|+|||++. ++.|.+++.
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~ 116 (331)
T 4aaa_A 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK-QLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLEL 116 (331)
T ss_dssp SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHh-hCCCCCEeeEEEEeecCCEEEEEEecCC-cchHHHHHh
Confidence 36899999999999999998651 344678999999 7789999999999999999999999999 888888643
Q ss_pred ------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 ------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
...+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+||
T Consensus 117 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 193 (331)
T 4aaa_A 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193 (331)
T ss_dssp STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCTTC------------CCCCCTTCCH
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---CcEEEEeCCCceeecCCccccCCCcCCccccCc
Confidence 23455677999999999999999999999999999765 68999999999865432 234456799999999
Q ss_pred cccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------------
Q psy6377 151 EILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD--------------------------- 202 (383)
Q Consensus 151 E~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------- 202 (383)
|++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......++
T Consensus 194 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
T 4aaa_A 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLE 273 (331)
T ss_dssp HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH
T ss_pred ccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhh
Confidence 998775 7899999999999999999999999998887776665443222111
Q ss_pred chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 203 ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 203 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..++.+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 274 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 274 RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1234679999999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=328.09 Aligned_cols=229 Identities=17% Similarity=0.194 Sum_probs=188.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||+|++.. ....+.+|+..+..+.+||||+++++++.+.+..++|||+++ |++|.+++.
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~ 103 (289)
T 1x8b_A 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN-GGSLADAIS 103 (289)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC-CCcHHHHHH
Confidence 3699999999999999999876 245678899999856699999999999999999999999999 999999764
Q ss_pred c----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC----------------CCCcEEEEeccceeE
Q psy6377 78 D----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF----------------PNCDIKVCDFEISRV 131 (383)
Q Consensus 78 ~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~----------------~~~~ikL~DFGla~~ 131 (383)
. ..++.++.||+.||+|||++||+||||||+|||++.++ ....++|+|||++..
T Consensus 104 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~ 183 (289)
T 1x8b_A 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183 (289)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEE
T ss_pred hhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccc
Confidence 3 33456779999999999999999999999999997543 335799999999987
Q ss_pred eecCcccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 132 ILDGIEIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 132 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
.... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.... ....+..+... .....+++
T Consensus 184 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~ 254 (289)
T 1x8b_A 184 ISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLP---RIPQVLSQ 254 (289)
T ss_dssp TTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCC---CCSSCCCH
T ss_pred cCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCC---CCCcccCH
Confidence 6432 234699999999999765 56789999999999999999998875543 34444444332 22356899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
++.+||.+||..||++|||+.++++||||...
T Consensus 255 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 255 EFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 99999999999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.26 Aligned_cols=237 Identities=29% Similarity=0.434 Sum_probs=173.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|+++.+|+.||+|++... ....+|+..+....+||||++++++|.. ....++||||+. |++|.+++...
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~-gg~L~~~l~~~ 120 (336)
T 3fhr_A 43 GKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME-GGELFSRIQER 120 (336)
T ss_dssp EEEEEEEETTTCCEEEEEEEESS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT-TEEHHHHHHTC
T ss_pred eEEEEEEECCCCCEEEEEEecCc-HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC-CCCHHHHHHhc
Confidence 36899999999999999999763 3445566555558899999999999987 455899999999 99999976543
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.++.+..||+.||.|||++||+||||||+|||++.++..+.+||+|||++..... ......+||+.|+|||
T Consensus 121 ~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPE 199 (336)
T ss_dssp -CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChh
Confidence 3456679999999999999999999999999998765557799999999987643 2345568899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET----FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
++.+..++.++|||||||++|+|++|..||.+...... ...+......++...+..+++++.+||.+||..||.+|
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 279 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHC
Confidence 99888899999999999999999999999987765443 33445556666777778899999999999999999999
Q ss_pred CCHHHHHcCcccCCcc
Q psy6377 228 MTAKEALKHPWLMNKK 243 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~ 243 (383)
||++|+|+||||+...
T Consensus 280 pt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 280 LTITQFMNHPWINQSM 295 (336)
T ss_dssp CCHHHHHHSHHHHTGG
T ss_pred cCHHHHhcCccccccc
Confidence 9999999999998643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=340.20 Aligned_cols=238 Identities=25% Similarity=0.297 Sum_probs=191.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-------EEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-------AYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-------~~lv~e~~~~g~~L~ 73 (383)
..||+|+++.+|+.||||++.. ......+|+..++ .++||||++++++|.+... .++||||+. + +|.
T Consensus 37 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~-~l~ 113 (360)
T 3e3p_A 37 GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLA-VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-D-TLH 113 (360)
T ss_dssp --CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHH-HHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS-C-BHH
T ss_pred eEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHH-hcCCCCcccHHHhhhccccccccceeEEEEeeccc-c-cHH
Confidence 3689999999999999999876 3445667777777 5689999999999976443 889999998 5 444
Q ss_pred Hhh----cc------CCchhhHHHHHHHHHHHH--hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccc
Q psy6377 74 TII----DD------NLVVPFESDELSSLAYLH--HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 74 ~~l----~~------~~~~~~~~qil~aL~yLH--s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
..+ .. ..+..+..|++.||.||| ++||+||||||+|||++.. .+.+||+|||++............
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~kl~Dfg~a~~~~~~~~~~~~ 191 (360)
T 3e3p_A 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSEPNVAY 191 (360)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEEECCCTTCBCCCTTSCCCST
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEEEeeCCCceecCCCCCcccc
Confidence 322 12 224466799999999999 9999999999999999852 268999999999987666556667
Q ss_pred cCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch----------------
Q psy6377 142 LGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL---------------- 204 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------- 204 (383)
.||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 192 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3e3p_A 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNS 271 (360)
T ss_dssp TSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCC
T ss_pred cCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcccccc
Confidence 899999999998654 489999999999999999999999999988888777765433322111
Q ss_pred ------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 205 ------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 205 ------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
....++++.+||.+||..||.+|||+.|+|+||||+......
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 272 KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 112567899999999999999999999999999998765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=329.98 Aligned_cols=230 Identities=26% Similarity=0.411 Sum_probs=202.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+.+..++|||++. +++|.+++.
T Consensus 30 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 107 (294)
T 2rku_A 30 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVVLELCR-RRSLLELHK 107 (294)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCEEEEEEecCC-CCCHHHHHH
Confidence 689999999999999999875 2356788999999 7799999999999999999999999999 999999754
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
. ..++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+||
T Consensus 108 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 184 (294)
T 2rku_A 108 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184 (294)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC---CCEEEEeccCceecccCccccccccCCCCcCCc
Confidence 3 3355677999999999999999999999999999765 68999999999876532 234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++||||||+++|+|++|..||.+....+....+.......|. .+++.+.++|.+||..||++|||+
T Consensus 185 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~ 260 (294)
T 2rku_A 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTI 260 (294)
T ss_dssp HHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred chhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHHHHHHHHcccChhhCcCH
Confidence 9999989999999999999999999999999999888888887777665553 578999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
+|+++||||....
T Consensus 261 ~~ll~~~~~~~~~ 273 (294)
T 2rku_A 261 NELLNDEFFTSGY 273 (294)
T ss_dssp GGGGGSHHHHTSC
T ss_pred HHHhhChheecCC
Confidence 9999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.87 Aligned_cols=234 Identities=25% Similarity=0.373 Sum_probs=195.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCe----EEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG----AYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~----~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .++||||+++++++..... .|+||||+. |++|
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~-g~~L 103 (311)
T 3ork_A 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTL 103 (311)
T ss_dssp EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCC-CCCCTTBCCEEEEEEEEETTEEEEEEEEECCC-EEEH
T ss_pred EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHH-cCCCCCcceEEEeeeccCCCCcccEEEEecCC-CCCH
Confidence 36999999999999999999762 235789999998 7799999999999986543 499999999 9999
Q ss_pred HHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----cccccc
Q psy6377 73 QTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI----EIRELL 142 (383)
Q Consensus 73 ~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~----~~~~~~ 142 (383)
.+++.. ..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... ......
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 180 (311)
T 3ork_A 104 RDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVI 180 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT---SCEEECCCSCC-----------------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC---CCEEEeeccCcccccccccccccccccC
Confidence 997643 3345677999999999999999999999999999876 689999999998654322 123457
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++...+..++.++.+||.+||..
T Consensus 181 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (311)
T 3ork_A 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260 (311)
T ss_dssp -CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred cCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999988888777777766666666778999999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCc
Q psy6377 223 NPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~ 242 (383)
||.+||++.++|.|+|++..
T Consensus 261 dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 261 NPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp SGGGSCSSHHHHHHHHHHHH
T ss_pred CHhhChhhHHHHHHHHHHHh
Confidence 99999999999999998743
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=336.69 Aligned_cols=230 Identities=26% Similarity=0.411 Sum_probs=203.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++..+|+.||+|++.+ ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++.
T Consensus 56 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~ 133 (335)
T 2owb_A 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVFVVLELCR-RRSLLELHK 133 (335)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCT-TCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEEEEEecCC-CCCHHHHHh
Confidence 699999999999999999875 2356889999999 7799999999999999999999999999 999999754
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
. ..++.+..||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......||+.|+||
T Consensus 134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 210 (335)
T 2owb_A 134 RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210 (335)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCH
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC---CCEEEeeccCceecccCcccccccCCCccccCH
Confidence 3 3455677999999999999999999999999999865 68999999999876532 234456799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+..++.++||||||+++|+|++|..||.+....+....+......++. .++..+.+||.+||..||++|||+
T Consensus 211 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~ 286 (335)
T 2owb_A 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTI 286 (335)
T ss_dssp HHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999999999999999999999999998888888888777666553 578999999999999999999999
Q ss_pred HHHHcCcccCCcc
Q psy6377 231 KEALKHPWLMNKK 243 (383)
Q Consensus 231 ~e~L~hp~~~~~~ 243 (383)
+|+|+||||....
T Consensus 287 ~ell~~~~~~~~~ 299 (335)
T 2owb_A 287 NELLNDEFFTSGY 299 (335)
T ss_dssp GGGGGSHHHHTSC
T ss_pred HHHhcCccccCCC
Confidence 9999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.84 Aligned_cols=233 Identities=25% Similarity=0.340 Sum_probs=192.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCC-----CcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSP-----RIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hp-----nIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+|+.||||++... ...+.+|+.+++.+..|+ +|+++++++...+..|+|||++. ++|.+++
T Consensus 69 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~--~~L~~~l 146 (382)
T 2vx3_A 69 QVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLL 146 (382)
T ss_dssp EEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC--CBHHHHH
T ss_pred EEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC--CCHHHHH
Confidence 6999999999999999999862 356678888888554455 49999999999999999999997 5999876
Q ss_pred ccC--------CchhhHHHHHHHHHHHH--hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 77 DDN--------LVVPFESDELSSLAYLH--HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 77 ~~~--------~~~~~~~qil~aL~yLH--s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
... .+..++.|++.||.||| ..||+||||||+|||++.+ ..+.+||+|||+|+.... .....+||+.
T Consensus 147 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~~kL~DFG~a~~~~~--~~~~~~~t~~ 223 (382)
T 2vx3_A 147 RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAIKIVDFGSSCQLGQ--RIYQYIQSRF 223 (382)
T ss_dssp HHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCCEEECCCTTCEETTC--CCCSSCSCGG
T ss_pred hhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCcEEEEeccCceeccc--ccccccCCcc
Confidence 432 24466699999999999 5799999999999999653 236899999999987633 3456789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCC------------------
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI------------------ 208 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~------------------ 208 (383)
|+|||++.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..+......+|...+...
T Consensus 224 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (382)
T 2vx3_A 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLK 303 (382)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEEC
T ss_pred ccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccc
Confidence 99999999999999999999999999999999999999988888877664433332211100
Q ss_pred ------------------------------------------CHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 209 ------------------------------------------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 209 ------------------------------------------s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
++++++||.+||.+||++|||++|+|+||||+..
T Consensus 304 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 304 KTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 1378999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.19 Aligned_cols=231 Identities=29% Similarity=0.423 Sum_probs=191.1
Q ss_pred eEEEEEEc---CCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++. .+|+.||||++.+ ....+.+|+.+++.+.+||||+++++++.+.+..|+||||+. +++|.
T Consensus 69 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 147 (355)
T 1vzo_A 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN-GGELF 147 (355)
T ss_dssp EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCC-SCBHH
T ss_pred EEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCC-CCCHH
Confidence 68999984 5899999999875 345677899999966589999999999999999999999999 99999
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTP 145 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~ 145 (383)
+++.. ..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... .....+||+
T Consensus 148 ~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 224 (355)
T 1vzo_A 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTI 224 (355)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECCGGGGGGGCGGGSCC
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CcEEEeeCCCCeecccCCCCcccCcccCc
Confidence 97643 2345666899999999999999999999999999765 689999999998764322 234468999
Q ss_pred CcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 146 DYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETD----SETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 146 ~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......+| ..++..+.+||.+|
T Consensus 225 ~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRL 300 (355)
T ss_dssp TTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHH
T ss_pred CccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHH
Confidence 9999999975 4578999999999999999999999976543 233344444443333 46799999999999
Q ss_pred cccCCCCCC-----CHHHHHcCcccCCcc
Q psy6377 220 LIKNPMERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 220 L~~dP~~Rp-----t~~e~L~hp~~~~~~ 243 (383)
|..||.+|| |++++++||||....
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred hhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 999999999 999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.10 Aligned_cols=233 Identities=21% Similarity=0.265 Sum_probs=190.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC--eEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||+++++++.+.. ..|+|||++. |++|.+++
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 100 (319)
T 4euu_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK-KLNHKNIVKLFAIEEETTTRHKVLIMEFCP-CGSLYTVL 100 (319)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECTTTCCEEEEEECCT-TCBHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHH-hcCCCCcceEEEEeecCCCceEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999976 3456789999999 678999999999998765 7899999999 99999976
Q ss_pred ccC---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEe-ccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 77 DDN---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMM-GDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 77 ~~~---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~-~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
... .++.++.||+.||+|||++||+||||||+|||+. .++..+.+||+|||+++............||+.
T Consensus 101 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~ 180 (319)
T 4euu_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180 (319)
T ss_dssp HSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGG
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCC
Confidence 542 3456669999999999999999999999999972 222336799999999998776666667789999
Q ss_pred cCCCcccc--------cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhccCCC--------------
Q psy6377 147 YVAPEILH--------YEPITLAADMWSLGVTAYVLLTGFSPFGGETD----SETFRNISKAQLDF-------------- 200 (383)
Q Consensus 147 y~aPE~l~--------~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~i~~~~~~~-------------- 200 (383)
|+|||++. +..++.++|||||||++|+|++|..||.+... .+.+..+..+....
T Consensus 181 y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 260 (319)
T 4euu_A 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260 (319)
T ss_dssp GCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEE
T ss_pred ccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccc
Confidence 99999986 57789999999999999999999999975433 44555555443211
Q ss_pred -------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6377 201 -------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238 (383)
Q Consensus 201 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~ 238 (383)
+......++..+.+||.+||..||++|||++|+|+||-
T Consensus 261 ~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11122334568999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=334.52 Aligned_cols=237 Identities=27% Similarity=0.428 Sum_probs=193.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~ 73 (383)
..||+|++..+|+.||||++.. ....+.+|+.+++ .++||||+++++++... ...|+|||++. ++|.
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--~~L~ 101 (353)
T 2b9h_A 25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ--TDLH 101 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS--EEHH
T ss_pred eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHH-hCcCCCcCCeeeeecccccCccceEEEEEeccC--ccHH
Confidence 3689999999999999999975 2345779999999 67899999999998764 67899999997 6888
Q ss_pred Hhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----------c
Q psy6377 74 TIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----------E 137 (383)
Q Consensus 74 ~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----------~ 137 (383)
+++.. ..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... .
T Consensus 102 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 178 (353)
T 2b9h_A 102 RVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN---CDLKVCDFGLARIIDESAADNSEPTGQQSG 178 (353)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECC---------------
T ss_pred HHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC---CcEEEEecccccccccccccccCccccccc
Confidence 86543 3455677999999999999999999999999999765 689999999998764321 1
Q ss_pred cccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------------
Q psy6377 138 IRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--------------- 201 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 201 (383)
....+||+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 2b9h_A 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRARE 258 (353)
T ss_dssp -CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHH
T ss_pred hhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhH
Confidence 223578999999998754 7789999999999999999999999999887666555433211111
Q ss_pred -------------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhh
Q psy6377 202 -------------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIM 246 (383)
Q Consensus 202 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~ 246 (383)
...++.+++++.+||.+||..||++|||++++|+||||+......
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 259 YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred HhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 123357899999999999999999999999999999998765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=323.12 Aligned_cols=230 Identities=21% Similarity=0.308 Sum_probs=190.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+..++..||+|++.. ....+.+|+.+++ .++||||++++++|.+ ...+++|||++. +++|.+
T Consensus 41 ~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 118 (290)
T 1t4h_A 41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLVTELMT-SGTLKT 118 (290)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEEEEEECCC-SCBHHH
T ss_pred EEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHH-hCCCCCeeeeeeeeccccCCCceEEEEEEecC-CCCHHH
Confidence 599999999999999999875 2456889999999 7789999999999976 356899999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
++.. ..++.+..|++.||.|||++| |+||||||+|||++.+ .+.+||+|||++..... .......||+.
T Consensus 119 ~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~--~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~ 195 (290)
T 1t4h_A 119 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRA-SFAKAVIGTPE 195 (290)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGGGCCT-TSBEESCSSCC
T ss_pred HHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC--CCCEEEeeCCCcccccc-cccccccCCcC
Confidence 7654 234566799999999999999 9999999999999733 26899999999975433 23445679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+ .++.++|||||||++|+|++|..||.+.............. ..+.......++++.+||.+||..||.+
T Consensus 196 y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 196 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp CCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGG
T ss_pred cCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCccccCCCCCHHHHHHHHHHccCChhh
Confidence 999998874 58999999999999999999999998865554443333222 2234455677899999999999999999
Q ss_pred CCCHHHHHcCcccCC
Q psy6377 227 RMTAKEALKHPWLMN 241 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~ 241 (383)
|||++++|+||||++
T Consensus 274 Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 274 RYSIKDLLNHAFFQE 288 (290)
T ss_dssp SCCHHHHHTSGGGC-
T ss_pred CCCHHHHhhCccccc
Confidence 999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.55 Aligned_cols=228 Identities=21% Similarity=0.314 Sum_probs=193.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||||++... ...+.+|+.+++ .++||||+++++++.+++..|+||||+. |+|.+.+
T Consensus 68 g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~--g~l~~~l 144 (348)
T 1u5q_A 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVMEYCL--GSASDLL 144 (348)
T ss_dssp EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCS--EEHHHHH
T ss_pred EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCeEEEEEecCC--CCHHHHH
Confidence 36899999999999999998751 246789999999 7789999999999999999999999998 5676654
Q ss_pred c-------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 77 D-------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 77 ~-------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
. ...+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ....+||+.|+|
T Consensus 145 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~---~~~~~gt~~y~a 218 (348)
T 1u5q_A 145 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP---ANSFVGTPYWMA 218 (348)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS---BCCCCSCGGGCC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEeeccCceecCC---CCcccCCcceeC
Confidence 2 23345677999999999999999999999999999865 6899999999986533 245689999999
Q ss_pred Ccccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 150 PEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 150 PE~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
||++. ...++.++|||||||++|+|++|.+||.+.+..+....+....... .....+++.+.+||.+||..||++
T Consensus 219 PE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~ 296 (348)
T 1u5q_A 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQD 296 (348)
T ss_dssp HHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhh
Confidence 99984 5678999999999999999999999999888777776666554322 223467999999999999999999
Q ss_pred CCCHHHHHcCcccCCc
Q psy6377 227 RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~ 242 (383)
|||++++|+|||+...
T Consensus 297 Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 297 RPTSEVLLKHRFVLRE 312 (348)
T ss_dssp SCCHHHHTTCHHHHSC
T ss_pred CcCHHHHhhChhhhcc
Confidence 9999999999999653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=326.57 Aligned_cols=234 Identities=26% Similarity=0.376 Sum_probs=199.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc----
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID---- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~---- 77 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++.
T Consensus 43 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~ 120 (314)
T 3com_A 43 GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQ-QCDSPHVVKYYGSYFKNTDLWIVMEYCG-AGSVSDIIRLRNK 120 (314)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCT-TEEHHHHHHHHTC
T ss_pred eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEEeecCC-CCCHHHHHHhcCC
Confidence 3699999999999999999976 4577899999999 7799999999999999999999999999 999999764
Q ss_pred ---cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCccc
Q psy6377 78 ---DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEIL 153 (383)
Q Consensus 78 ---~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l 153 (383)
...++.+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......||+.|+|||++
T Consensus 121 ~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (314)
T 3com_A 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197 (314)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---CCEEEeecccchhhhhhccccCccCCCCCccChhhc
Confidence 22345667999999999999999999999999999765 689999999998765432 23456799999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+..++.++||||||+++|+|++|..||.+.........+...... .......++..+.+||.+||..||.+|||+.++
T Consensus 198 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999999999999999999999988766655554433221 112234578999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
|+||||....
T Consensus 277 l~~~~~~~~~ 286 (314)
T 3com_A 277 LQHPFVRSAK 286 (314)
T ss_dssp TTSHHHHTCC
T ss_pred HhCHHHhcCC
Confidence 9999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.83 Aligned_cols=234 Identities=26% Similarity=0.331 Sum_probs=190.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||+++ +++|.+++...
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 113 (295)
T 2clq_A 36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK-HLKHKNIVQYLGSFSENGFIKIFMEQVP-GGSLSALLRSK 113 (295)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCS-EEEHHHHHHHT
T ss_pred EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHH-hCCCCCEeeEeeEEEeCCcEEEEEEeCC-CCCHHHHHHhh
Confidence 3689999999999999999876 2466889999999 7799999999999999999999999999 99999976532
Q ss_pred ---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCC
Q psy6377 80 ---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVA 149 (383)
Q Consensus 80 ---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~a 149 (383)
.+..+..|++.||.|||++||+||||||+||+++.. .+.++|+|||++....... ......||+.|+|
T Consensus 114 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~a 191 (295)
T 2clq_A 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191 (295)
T ss_dssp TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC-----CCCCCCGGGCC
T ss_pred ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCCCcccccCCCccccC
Confidence 233456899999999999999999999999999863 2689999999998764322 2345679999999
Q ss_pred CcccccCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 150 PEILHYEP--ITLAADMWSLGVTAYVLLTGFSPFGGETDSET-FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 150 PE~l~~~~--~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
||++.+.. ++.++||||||+++|+|++|..||.+...... ..... .....+.....+++++.+||.+||..||++
T Consensus 192 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--MFKVHPEIPESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--HHCCCCCCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--cccccccccccCCHHHHHHHHHHccCChhh
Confidence 99987654 89999999999999999999999976544332 11111 112222334578999999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||++++|+||||+...
T Consensus 270 Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 270 RACANDLLVDEFLKVSS 286 (295)
T ss_dssp SCCHHHHHTSGGGCC--
T ss_pred CCCHHHHhcChhhhhcc
Confidence 99999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=325.99 Aligned_cols=232 Identities=22% Similarity=0.347 Sum_probs=174.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
..||+|+++.+|+.||+|++... ......|...+....+||||+++++++.+++..|+|||++. ++|.+++.
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~--~~l~~~l~~ 98 (290)
T 3fme_A 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD--TSLDKFYKQ 98 (290)
T ss_dssp EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS--EEHHHHHHH
T ss_pred eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc--cchHHHHHH
Confidence 36899999999999999999761 22334444443348899999999999999999999999998 47766542
Q ss_pred ---------cCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 78 ---------DNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 78 ---------~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
...++.+..|++.||+|||++ ||+||||||+|||++.+ +.+||+|||++.............||+.|
T Consensus 99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y 175 (290)
T 3fme_A 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPY 175 (290)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT---CCEEBCCC---------------CCCCCC
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeecCCcccccccccccccCCCccc
Confidence 233456779999999999998 99999999999999765 68999999999877655555556899999
Q ss_pred CCCccc----ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 148 VAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGET-DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 148 ~aPE~l----~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
+|||++ .+..++.++||||+||++|+|++|..||.+.. ............. +......+++++.+||.+||..
T Consensus 176 ~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~ 253 (290)
T 3fme_A 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPADKFSAEFVDFTSQCLKK 253 (290)
T ss_dssp SCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHTCS
T ss_pred cChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCcccccCCHHHHHHHHHHhhc
Confidence 999996 56678999999999999999999999998643 3333443333322 1222346799999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCc
Q psy6377 223 NPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~ 242 (383)
||++|||+.|+++||||+..
T Consensus 254 ~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 254 NSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SGGGSCCHHHHTTSHHHHHH
T ss_pred ChhhCcCHHHHHhCcccccC
Confidence 99999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=335.84 Aligned_cols=236 Identities=29% Similarity=0.383 Sum_probs=192.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCe------EEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG------AYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~------~~lv~e~~~~g~~ 71 (383)
..||+|+++.+|+.||||++... ...+.+|+.+++ .++||||+++++++.+... +|+|||++. ++
T Consensus 38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 114 (353)
T 3coi_A 38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TD 114 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS--EE
T ss_pred eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCCcccHhheEecccccccceeEEEEecccc--CC
Confidence 36899999999999999999761 356789999999 7789999999999987654 499999997 68
Q ss_pred HHHhhc----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 72 LQTIID----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 72 L~~~l~----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
|.+.+. ...+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||++..... ......||+.|
T Consensus 115 l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~--~~~~~~~t~~y 189 (353)
T 3coi_A 115 LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGLARHADA--EMTGYVVTRWY 189 (353)
T ss_dssp GGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---CCEEECSTTCTTC----------CCSBCC
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC---CcEEEeecccccCCCC--CccccccCcCc
Confidence 887654 34456677999999999999999999999999999865 6899999999986532 24456899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------------- 201 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------------- 201 (383)
+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 190 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (353)
T 3coi_A 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269 (353)
T ss_dssp SCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC
T ss_pred CCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc
Confidence 99999876 6789999999999999999999999999887777666654322111
Q ss_pred --cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhc
Q psy6377 202 --DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 202 --~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~ 247 (383)
...+..+++++.+||.+||..||++|||++++|+||||........
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 270 DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence 1223467999999999999999999999999999999987654433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=323.83 Aligned_cols=231 Identities=26% Similarity=0.354 Sum_probs=200.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+....|+|||++. |++|.+++..
T Consensus 36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~ 113 (303)
T 3a7i_A 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWIIMEYLG-GGSALDLLEP 113 (303)
T ss_dssp SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TEEHHHHHTT
T ss_pred eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEEEeCC-CCcHHHHHhc
Confidence 3689999999999999999975 2467889999999 6799999999999999999999999999 9999998754
Q ss_pred C-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcc
Q psy6377 79 N-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~ 152 (383)
. .+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......||+.|+|||+
T Consensus 114 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 190 (303)
T 3a7i_A 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190 (303)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC---CCEEEeecccceecCccccccCccCCCcCccCHHH
Confidence 3 345666999999999999999999999999999765 689999999998765433 2345679999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
+.+..++.++||||||+++|+|++|.+||.+.........+..... ......++..+.+||.+||..||.+|||+.+
T Consensus 191 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 267 (303)
T 3a7i_A 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 267 (303)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9999999999999999999999999999998877776666654432 2334578999999999999999999999999
Q ss_pred HHcCcccCCc
Q psy6377 233 ALKHPWLMNK 242 (383)
Q Consensus 233 ~L~hp~~~~~ 242 (383)
+++||||...
T Consensus 268 ll~~~~~~~~ 277 (303)
T 3a7i_A 268 LLKHKFILRN 277 (303)
T ss_dssp HTTCHHHHHH
T ss_pred HhhChhhhcC
Confidence 9999999653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.08 Aligned_cols=230 Identities=21% Similarity=0.347 Sum_probs=185.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCC-CCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSP-SPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+.. |+.||||++.. ....+.+|+.+++.+.. ||||+++++++.+.+.+|+||| +. +++|.+++.
T Consensus 71 ~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~-~~~L~~~l~ 147 (390)
T 2zmd_A 71 KVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG-NIDLNSWLK 147 (390)
T ss_dssp EEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC-SEEHHHHHH
T ss_pred EEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC-CCCHHHHHH
Confidence 689998865 99999999975 23568899999996554 7999999999999999999999 55 799999765
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCcC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDYV 148 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y~ 148 (383)
.. .+..++.||+.||.|||++||+||||||+|||++. +.+||+|||+++...... .....+||+.|+
T Consensus 148 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 223 (390)
T 2zmd_A 148 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223 (390)
T ss_dssp HCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC---------CCSCCCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCCCccccCCCCCcCCCcc
Confidence 43 34456699999999999999999999999999953 589999999998764332 134568999999
Q ss_pred CCccccc-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHH
Q psy6377 149 APEILHY-----------EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 149 aPE~l~~-----------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li 216 (383)
|||++.+ ..|+.++|||||||++|+|++|.+||.+.... ..+..+......++ +....+.++.+||
T Consensus 224 aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 301 (390)
T 2zmd_A 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--FPDIPEKDLQDVL 301 (390)
T ss_dssp CHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC--CCCCSCHHHHHHH
T ss_pred ChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC--CCccchHHHHHHH
Confidence 9999865 46899999999999999999999999876443 44455544433322 2234588999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 217 AKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.+||..||.+|||+.|+|+||||+...
T Consensus 302 ~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 302 KCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHcccChhhCCCHHHHhhCcCccccC
Confidence 999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=328.07 Aligned_cols=235 Identities=27% Similarity=0.346 Sum_probs=193.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEE--------------eCCeEEEEEec
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQ--------------TGEGAYYVSWN 65 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~--------------~~~~~~lv~e~ 65 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++. +....|+|||+
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (320)
T 2i6l_A 25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR-RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY 103 (320)
T ss_dssp -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEEC
T ss_pred eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHH-hcCCCCeeEEEEeccccccccccccccccccCceeEEeec
Confidence 3689999999999999999876 2456789999999 779999999999984 34678999999
Q ss_pred CCCcCcHHHhhccC-----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC----c
Q psy6377 66 TPLVVTLQTIIDDN-----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----I 136 (383)
Q Consensus 66 ~~~g~~L~~~l~~~-----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----~ 136 (383)
+. ++|.+++... .++.++.|++.||+|||++||+||||||+|||++.++ +.+||+|||++...... .
T Consensus 104 ~~--~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~kl~Dfg~~~~~~~~~~~~~ 179 (320)
T 2i6l_A 104 ME--TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--LVLKIGDFGLARIMDPHYSHKG 179 (320)
T ss_dssp CS--EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--TEEEECCCTTCBCC--------
T ss_pred cC--CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CeEEEccCccccccCCCccccc
Confidence 98 5899977543 3456679999999999999999999999999997542 58999999999865432 1
Q ss_pred ccccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------
Q psy6377 137 EIRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP-------------- 201 (383)
Q Consensus 137 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 201 (383)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (320)
T 2i6l_A 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259 (320)
T ss_dssp CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHH
T ss_pred ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccc
Confidence 2344568999999998865 6789999999999999999999999999888777766654432211
Q ss_pred ------------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 202 ------------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 202 ------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+..++.++.+||.+||..||.+|||++|+|+||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 122356899999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=332.22 Aligned_cols=232 Identities=25% Similarity=0.461 Sum_probs=198.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---C-c-----------------ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---N-P-----------------VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~-~-----------------~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv 62 (383)
..||+|++ +|+.||+|++.. . . ..+.+|+.+++ .++||||+++++++.+.+..|+|
T Consensus 45 g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 121 (348)
T 2pml_X 45 NKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT-DIKNEYCLTCEGIITNYDEVYII 121 (348)
T ss_dssp CCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT-TCCCTTBCCCSEEEESSSEEEEE
T ss_pred eEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH-hCCCCCcceEEEEEeeCCeEEEE
Confidence 36899998 999999999976 1 1 77899999999 77899999999999999999999
Q ss_pred EecCCCcCcHHHh------hcc--------CCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEecc
Q psy6377 63 SWNTPLVVTLQTI------IDD--------NLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127 (383)
Q Consensus 63 ~e~~~~g~~L~~~------l~~--------~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFG 127 (383)
||++. +++|.++ +.. ..++.++.|++.||.|||+ +||+||||||+|||++.+ +.++|+|||
T Consensus 122 ~e~~~-~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~---~~~kl~dfg 197 (348)
T 2pml_X 122 YEYME-NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN---GRVKLSDFG 197 (348)
T ss_dssp EECCT-TCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT---SCEEECCCT
T ss_pred EeccC-CCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC---CcEEEeccc
Confidence 99999 8999987 543 2244566999999999999 999999999999999765 689999999
Q ss_pred ceeEeecCcccccccCCCCcCCCcccccC-CCCh-hhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCCCCcc-
Q psy6377 128 ISRVILDGIEIRELLGTPDYVAPEILHYE-PITL-AADMWSLGVTAYVLLTGFSPFGGETD-SETFRNISKAQLDFPDE- 203 (383)
Q Consensus 128 la~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~- 203 (383)
++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.+.+. .+....+..+...+|..
T Consensus 198 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 276 (348)
T 2pml_X 198 ESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276 (348)
T ss_dssp TCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS
T ss_pred cccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch
Confidence 99876543 44556899999999999877 6766 99999999999999999999998877 77777777776666532
Q ss_pred --------------hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 204 --------------LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 204 --------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
....++.++.+||.+||..||.+|||++|+|+||||....
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 1156899999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=326.57 Aligned_cols=234 Identities=27% Similarity=0.356 Sum_probs=193.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..++|||+++ +++|.+++..
T Consensus 33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~ 110 (302)
T 2j7t_A 33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWIMIEFCP-GGAVDAIMLEL 110 (302)
T ss_dssp CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHH-HCCCTTBCCEEEEEECC-CEEEEEECCT-TEEHHHHHHHH
T ss_pred eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHh-cCCCCCEeeeeeeeeeCCeEEEEEEeCC-CCcHHHHHHhh
Confidence 3689999999999999999876 3467889999999 6789999999999999999999999999 9999986532
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||.|||++|++||||||+|||++.+ +.+||+|||++...... .......||+.|+|||
T Consensus 111 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187 (302)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---SCEEECCCHHHHHHHHHHHC-----CCGGGCCHH
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---CCEEEEECCCCccccccccccccccCChhhcCCe
Confidence 3345667999999999999999999999999999765 68999999987643221 1233457999999999
Q ss_pred cc-----ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 152 IL-----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 152 ~l-----~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
++ ....++.++||||||+++|+|++|.+||.+.+.......+........ .....++..+.+||.+||..||.+
T Consensus 188 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~ 266 (302)
T 2j7t_A 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPET 266 (302)
T ss_dssp HHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTT
T ss_pred eeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhh
Confidence 98 467789999999999999999999999999887777776665543221 223567999999999999999999
Q ss_pred CCCHHHHHcCcccCCcc
Q psy6377 227 RMTAKEALKHPWLMNKK 243 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~~ 243 (383)
|||+.++++||||....
T Consensus 267 Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 267 RPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCCHHHHTTSTTTTTCC
T ss_pred CCCHHHHhcChHHhhhc
Confidence 99999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=329.90 Aligned_cols=234 Identities=25% Similarity=0.329 Sum_probs=192.2
Q ss_pred eEEEEEE-cCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCC------CcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADS-IATGEVFAAKFLES---NPVRIHHEIALLSLCSPSP------RIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~-~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hp------nIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+ +.+|+.||+|++.. ....+.+|+.+++ .+.|+ +|+++++++.+.+..++|||++ +++|.+
T Consensus 29 ~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~-~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~--~~~l~~ 105 (339)
T 1z57_A 29 KVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLE-HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL--GLSTYD 105 (339)
T ss_dssp EEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHH-HHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC--CCBHHH
T ss_pred EEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHH-HhhhcCCCCceeeEeeecccccCCcEEEEEcCC--CCCHHH
Confidence 6899998 56899999999976 2456888999888 44444 5999999999999999999999 488888
Q ss_pred hhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC----------------CCcEEEEecccee
Q psy6377 75 IIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP----------------NCDIKVCDFEISR 130 (383)
Q Consensus 75 ~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~----------------~~~ikL~DFGla~ 130 (383)
++... .+..+..||+.||+|||++||+||||||+|||++.++. .+.+||+|||++.
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 185 (339)
T 1z57_A 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185 (339)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCE
T ss_pred HHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccc
Confidence 66443 24456699999999999999999999999999976321 3579999999998
Q ss_pred EeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchh-----
Q psy6377 131 VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELF----- 205 (383)
Q Consensus 131 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 205 (383)
.... ......||+.|+|||++.+.+++.++|||||||++|+|++|.+||.+.+..+....+......+|...+
T Consensus 186 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 263 (339)
T 1z57_A 186 YDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263 (339)
T ss_dssp ETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSC
T ss_pred cCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccc
Confidence 7432 344568999999999999999999999999999999999999999998887776666554444443211
Q ss_pred -----------------------------------cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 206 -----------------------------------EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 206 -----------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 11246789999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.95 Aligned_cols=224 Identities=18% Similarity=0.243 Sum_probs=180.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHh--cCCCCCcccce-------EEEEeCCe---------
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSL--CSPSPRIVKLH-------DVFQTGEG--------- 58 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~--~~~hpnIvkl~-------~~~~~~~~--------- 58 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++. .+.||||++++ +++++.+.
T Consensus 87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (377)
T 3byv_A 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 166 (377)
T ss_dssp EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence 3689999999999999999874 23568899966553 33799999999 88876643
Q ss_pred --------EEEEEecCCCcCcHHHhhcc-------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC
Q psy6377 59 --------AYYVSWNTPLVVTLQTIIDD-------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 59 --------~~lv~e~~~~g~~L~~~l~~-------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~ 117 (383)
.|++||++. |+|.+++.. ..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 167 ~~~~~i~~~~lv~E~~~--g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-- 242 (377)
T 3byv_A 167 ERDMWVLSRFFLYPRMQ--SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-- 242 (377)
T ss_dssp ---CEEESEEEEEECCS--EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT--
T ss_pred CCceEEEEEEEEEeccC--CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--
Confidence 889999995 799997753 3344577999999999999999999999999999865
Q ss_pred CCcEEEEeccceeEeecCcccccccCCCCcCCCcccccC-----------CCChhhHHHHHHHHHHHHHhCCCCCCCCCc
Q psy6377 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE-----------PITLAADMWSLGVTAYVLLTGFSPFGGETD 186 (383)
Q Consensus 118 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DiwSlGvilyelltg~~Pf~~~~~ 186 (383)
+.+||+|||+|+.. +......+| +.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+.
T Consensus 243 -~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 243 -GGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318 (377)
T ss_dssp -CCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred -CCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc
Confidence 68999999999863 234456678 999999999887 899999999999999999999999987665
Q ss_pred HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 187 SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 187 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
......+.. .+..+++++.+||.+||..||++|||+.++|+||||+...
T Consensus 319 ~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 319 LGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp -CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred ccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 443333221 1246799999999999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=328.97 Aligned_cols=233 Identities=24% Similarity=0.387 Sum_probs=189.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEe------CCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQT------GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~------~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++.+.+||||+++++++.. ....|+|||++. +++|.+
T Consensus 38 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 116 (326)
T 2x7f_A 38 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG-AGSVTD 116 (326)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCT-TEEHHH
T ss_pred EEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCC-CCcHHH
Confidence 3699999999999999999876 456789999999966689999999999987 568999999999 899999
Q ss_pred hhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCC
Q psy6377 75 IIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP 145 (383)
Q Consensus 75 ~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~ 145 (383)
++... .++.+..||+.||.|||++||+||||||+|||++.+ +.+||+|||++....... ......||+
T Consensus 117 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 193 (326)
T 2x7f_A 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTP 193 (326)
T ss_dssp HHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCCTTTC-------------CCG
T ss_pred HHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC---CCEEEeeCcCceecCcCccccccccCCc
Confidence 76532 234566999999999999999999999999999765 689999999988754322 234467999
Q ss_pred CcCCCcccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 146 DYVAPEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 146 ~y~aPE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.|+|||++. ...++.++|||||||++|+|++|..||.+.........+..... +......++..+.+||.+||
T Consensus 194 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l 271 (326)
T 2x7f_A 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCL 271 (326)
T ss_dssp GGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHC
T ss_pred cccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHh
Confidence 999999986 56789999999999999999999999998877666665544332 22233567999999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCc
Q psy6377 221 IKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..||.+|||++++++||||...
T Consensus 272 ~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 272 VKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccChhhCCCHHHHhhChHHhhC
Confidence 9999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=342.38 Aligned_cols=233 Identities=27% Similarity=0.334 Sum_probs=184.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcC-------CCCCcccceEEEE----eCCeEEEEEecCCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCS-------PSPRIVKLHDVFQ----TGEGAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~-------~hpnIvkl~~~~~----~~~~~~lv~e~~~~g 69 (383)
..||+|++..+|+.||||++... ...+.+|+.+++.+. +||||++++++|. +....|+|||++.
T Consensus 51 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-- 128 (397)
T 1wak_A 51 STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-- 128 (397)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC--
T ss_pred eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC--
Confidence 36999999999999999999862 467889999998543 3899999999998 5568999999996
Q ss_pred CcHHH-hhcc-------CCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccC------------------------
Q psy6377 70 VTLQT-IIDD-------NLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDF------------------------ 116 (383)
Q Consensus 70 ~~L~~-~l~~-------~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~------------------------ 116 (383)
++|.+ +... ..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 129 ~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (397)
T 1wak_A 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208 (397)
T ss_dssp CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-------------
T ss_pred ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCC
Confidence 55555 4332 23456779999999999999 999999999999997542
Q ss_pred ----------------------CCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHH
Q psy6377 117 ----------------------PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174 (383)
Q Consensus 117 ----------------------~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyel 174 (383)
....+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 286 (397)
T 1wak_A 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFEL 286 (397)
T ss_dssp --------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHH
T ss_pred ccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHH
Confidence 113799999999987543 34556899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCc------HHHHHHHHhccCCCCcch--------------------------------------hcCCCH
Q psy6377 175 LTGFSPFGGETD------SETFRNISKAQLDFPDEL--------------------------------------FEDISP 210 (383)
Q Consensus 175 ltg~~Pf~~~~~------~~~~~~i~~~~~~~~~~~--------------------------------------~~~~s~ 210 (383)
++|.+||.+.+. ...+..+.......|... ....+.
T Consensus 287 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (397)
T 1wak_A 287 ATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA 366 (397)
T ss_dssp HHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHH
T ss_pred hhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHH
Confidence 999999987653 233333333222222111 122346
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKHPWLM 240 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~ 240 (383)
.+.+||.+||.+||++|||++|+|+||||+
T Consensus 367 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 367 GFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 789999999999999999999999999996
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=323.94 Aligned_cols=232 Identities=22% Similarity=0.336 Sum_probs=189.0
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEe-------------CCeEEEEEecCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-------------GEGAYYVSWNTP 67 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-------------~~~~~lv~e~~~ 67 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+ ....|+|||++.
T Consensus 20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (303)
T 1zy4_A 20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLA-SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCE 98 (303)
T ss_dssp EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCC
T ss_pred EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHH-hcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCC
Confidence 3689999999999999999976 3456889999999 7789999999999865 456899999999
Q ss_pred CcCcHHHhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----
Q psy6377 68 LVVTLQTIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG----- 135 (383)
Q Consensus 68 ~g~~L~~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~----- 135 (383)
|++|.+++... .++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 99 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~ 174 (303)
T 1zy4_A 99 -NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES---RNVKIGDFGLAKNVHRSLDILK 174 (303)
T ss_dssp -SCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCCCSCTTC------
T ss_pred -CCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC---CCEEEeeCcchhhcccccchhc
Confidence 99999987532 234566999999999999999999999999999765 68999999998764321
Q ss_pred ----------cccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHhccCCCCcc
Q psy6377 136 ----------IEIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFG-GETDSETFRNISKAQLDFPDE 203 (383)
Q Consensus 136 ----------~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~-~~~~~~~~~~i~~~~~~~~~~ 203 (383)
.......||+.|+|||++.+. .++.++|||||||++|+|++ ||. +....+....+......+|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 1zy4_A 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD 251 (303)
T ss_dssp -------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTT
T ss_pred cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcc
Confidence 223456799999999999764 68999999999999999998 554 333445566666667777777
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.....+..+.++|.+||..||.+|||+.++++||||....
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 7778889999999999999999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.73 Aligned_cols=234 Identities=24% Similarity=0.353 Sum_probs=178.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|++..+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+.+..++|||++. |++|.+++..
T Consensus 30 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 107 (303)
T 2vwi_A 30 VVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLS-GGSVLDIIKHI 107 (303)
T ss_dssp CEEEEEC----CEEEEECCC----------------CCC-CCCCTTBCCEEEEEESSSCEEEEEECCT-TCBHHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHh-hcCCCCEeeEEEEEeecCCcEEEehhcc-CCchHHHHHHH
Confidence 699999999999999999875 3456789999998 7789999999999999999999999999 9999997642
Q ss_pred -------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc------ccc
Q psy6377 79 -------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI------EIR 139 (383)
Q Consensus 79 -------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~------~~~ 139 (383)
..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++....... ...
T Consensus 108 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~ 184 (303)
T 2vwi_A 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRK 184 (303)
T ss_dssp HHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCCHHHHHCC------------
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC---CCEEEEeccchheeccCCCccchhhhc
Confidence 2345666999999999999999999999999999765 689999999987543321 123
Q ss_pred cccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------cchhcCCCHHH
Q psy6377 140 ELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------DELFEDISPEA 212 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~ 212 (383)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.................. ......++.++
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (303)
T 2vwi_A 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF 264 (303)
T ss_dssp ---CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHH
T ss_pred ccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHH
Confidence 4579999999999875 5689999999999999999999999998877666554443332211 12345688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 213 KDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.+||.+||..||.+|||+.++++||||+...
T Consensus 265 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 265 RKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=324.14 Aligned_cols=232 Identities=26% Similarity=0.399 Sum_probs=194.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEE--eCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQ--TGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~--~~~~~~lv~e~~~~g~~L~ 73 (383)
..||.|.+..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++. +....|+|||++. ++ |.
T Consensus 19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~-l~ 95 (305)
T 2wtk_C 19 GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-RLRHKNVIQLVDVLYNEEKQKMYMVMEYCV-CG-MQ 95 (305)
T ss_dssp CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECC---CEEEEEECCS-EE-HH
T ss_pred eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHH-hcCCCCeeEEEEEEEcCCCCeEEEEehhcc-CC-HH
Confidence 3689999999999999999975 2356889999999 778999999999984 4567999999998 55 65
Q ss_pred Hhhcc--------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---ccccccc
Q psy6377 74 TIIDD--------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRELL 142 (383)
Q Consensus 74 ~~l~~--------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~ 142 (383)
+.+.. ..+..+..||+.||.|||++||+||||||+|||++.+ +.++|+|||++...... .......
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~ 172 (305)
T 2wtk_C 96 EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTSQ 172 (305)
T ss_dssp HHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCSSCEECCCC
T ss_pred HHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---CcEEeeccccccccCccccccccccCC
Confidence 54432 2344566999999999999999999999999999765 68999999999876432 2234567
Q ss_pred CCCCcCCCcccccCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 143 GTPDYVAPEILHYEP--ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 143 gt~~y~aPE~l~~~~--~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+....+..+...++. .+++.+.+||.+||
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~l~~li~~~l 248 (305)
T 2wtk_C 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG----DCGPPLSDLLKGML 248 (305)
T ss_dssp SCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS----SSCHHHHHHHHHHT
T ss_pred CCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC----ccCHHHHHHHHHHc
Confidence 999999999987644 378999999999999999999999999888888888877766553 57899999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 221 IKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
..||.+|||+.++++||||+.....
T Consensus 249 ~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 249 EYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp CSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred cCChhhCCCHHHHhcCcccccCCCC
Confidence 9999999999999999999865443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=335.18 Aligned_cols=232 Identities=25% Similarity=0.371 Sum_probs=191.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+++..|+||||+. |++|.+++..
T Consensus 47 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 124 (360)
T 3eqc_A 47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEISICMEHMD-GGSLDQVLKK 124 (360)
T ss_dssp CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEETTEEEEEECCCT-TCBHHHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHH-HCCCCCEEEEeEEEEECCEEEEEEECCC-CCCHHHHHHH
Confidence 36999999999999999999762 456889999999 6799999999999999999999999999 9999997654
Q ss_pred C------CchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 79 N------LVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ~------~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. .+..+..|++.||.|||++ ||+||||||+|||++.+ +.++|+|||++..... .......||+.|+|||
T Consensus 125 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-SMANSFVGTRSYMSPE 200 (360)
T ss_dssp HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHHH-HC----CCCCTTCCHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC---CCEEEEECCCCccccc-ccccCCCCCCCeECHH
Confidence 2 3446679999999999996 99999999999999866 6899999999875432 2234568999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--------------------------------------
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI-------------------------------------- 193 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i-------------------------------------- 193 (383)
++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 201 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
T 3eqc_A 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280 (360)
T ss_dssp HHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHH
T ss_pred HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhh
Confidence 999999999999999999999999999999877654432221
Q ss_pred ----HhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 194 ----SKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 194 ----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.... .+......++.++.+||.+||..||.+|||++|+|+||||+...
T Consensus 281 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 281 LDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred hhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111 11111234789999999999999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=330.79 Aligned_cols=235 Identities=20% Similarity=0.287 Sum_probs=190.9
Q ss_pred eEEEEEEcCCC-cEEEEEEccC---CcccHHHHHHHHHhcCCCCC------cccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATG-EVFAAKFLES---NPVRIHHEIALLSLCSPSPR------IVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg-~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpn------Ivkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|++..+| +.||+|++.. ....+.+|+.+++ .+.|++ ++.+++++...+..++|||++. ++|.+
T Consensus 34 ~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~ 110 (355)
T 2eu9_A 34 KVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLK-KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG--KNTFE 110 (355)
T ss_dssp EEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHH-HHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC--CBHHH
T ss_pred EEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHH-HHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC--CChHH
Confidence 68999998887 6899999986 3456788999988 455554 9999999999999999999996 55555
Q ss_pred hh-cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEecc----------------CCCCcEEEEecccee
Q psy6377 75 II-DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD----------------FPNCDIKVCDFEISR 130 (383)
Q Consensus 75 ~l-~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~----------------~~~~~ikL~DFGla~ 130 (383)
.+ .. ..++.++.||+.||+|||++||+||||||+|||+..+ ...+.+||+|||++.
T Consensus 111 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 190 (355)
T 2eu9_A 111 FLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190 (355)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCE
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccc
Confidence 33 22 2345667999999999999999999999999999432 124689999999998
Q ss_pred EeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhc----
Q psy6377 131 VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE---- 206 (383)
Q Consensus 131 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 206 (383)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......+|...+.
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 268 (355)
T 2eu9_A 191 FDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK 268 (355)
T ss_dssp ETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC
T ss_pred ccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc
Confidence 643 23455689999999999999999999999999999999999999999988877776665554444432210
Q ss_pred ------------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 207 ------------------------------------DISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 207 ------------------------------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
..+.++.+||.+||..||.+|||+.|+|+||||.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 269 QKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred hhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 11357889999999999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.35 Aligned_cols=236 Identities=22% Similarity=0.304 Sum_probs=182.3
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
||++|+.+ ..+|+.||||++.. ....+.+|+.+|+.+.+|||||++++++.+....|+|||++. ++|.+++...
T Consensus 37 ~G~V~~~~--~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~--g~L~~~l~~~~ 112 (432)
T 3p23_A 37 EGTIVYRG--MFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA--ATLQEYVEQKD 112 (432)
T ss_dssp GGCEEEEE--ESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS--EEHHHHHHSSS
T ss_pred CEEEEEEE--EeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC--CCHHHHHHhcC
Confidence 67766544 46899999999876 456788999999966589999999999999999999999997 6999876432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC--CCcEEEEeccceeEeecCc----ccccccCCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP--NCDIKVCDFEISRVILDGI----EIRELLGTPDY 147 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~--~~~ikL~DFGla~~~~~~~----~~~~~~gt~~y 147 (383)
..+.++.||+.||+|||++||+||||||+|||++.++. ...+||+|||+|+...... .....+||+.|
T Consensus 113 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y 192 (432)
T 3p23_A 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192 (432)
T ss_dssp CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTS
T ss_pred CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCc
Confidence 34567799999999999999999999999999964322 2467899999998765432 23456799999
Q ss_pred CCCcccc---cCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 148 VAPEILH---YEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 148 ~aPE~l~---~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+|||++. ...++.++|||||||++|+|++ |.+||...........+........ ......+..+.+||.+||..|
T Consensus 193 ~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~d 271 (432)
T 3p23_A 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPEKHEDVIARELIEKMIAMD 271 (432)
T ss_dssp CCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTTCHHHHHHHHHHHHHSCSS
T ss_pred cChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-CccccccHHHHHHHHHHHhCC
Confidence 9999997 4667889999999999999999 9999976554433222211111111 111233567899999999999
Q ss_pred CCCCCCHHHHHcCcccCCc
Q psy6377 224 PMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~ 242 (383)
|.+|||++++|+||||...
T Consensus 272 P~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 272 PQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp GGGSCCHHHHHTSTTTCCH
T ss_pred HhhCCCHHHHHhCccccCh
Confidence 9999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.99 Aligned_cols=233 Identities=18% Similarity=0.180 Sum_probs=173.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcC-CCCCcccce-------EEEEeC------------
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCS-PSPRIVKLH-------DVFQTG------------ 56 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~-~hpnIvkl~-------~~~~~~------------ 56 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++.+. .||||++++ +++...
T Consensus 76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~ 155 (371)
T 3q60_A 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQ 155 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC-
T ss_pred EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCc
Confidence 36999999999999999999872 345667744443222 799977755 666544
Q ss_pred -----CeEEEEEecCCCcCcHHHhhcc------CCc-------hhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC
Q psy6377 57 -----EGAYYVSWNTPLVVTLQTIIDD------NLV-------VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118 (383)
Q Consensus 57 -----~~~~lv~e~~~~g~~L~~~l~~------~~~-------~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~ 118 (383)
..+|+||||+. ++|.+++.. ... ..++.||+.||+|||++||+||||||+|||++.+
T Consensus 156 ~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~--- 230 (371)
T 3q60_A 156 DDYAVANYLLLMPAAS--VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--- 230 (371)
T ss_dssp --CCEEEEEEEECCCS--EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT---
T ss_pred ccceeeeEEEEecCCC--CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC---
Confidence 33899999998 799997653 222 3455999999999999999999999999999865
Q ss_pred CcEEEEeccceeEeecCcccccccCCCCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH--
Q psy6377 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFGGETDSET--FRN-- 192 (383)
Q Consensus 119 ~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~-- 192 (383)
+.+||+|||+|+.... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+...... +..
T Consensus 231 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 308 (371)
T 3q60_A 231 GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308 (371)
T ss_dssp SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCC
T ss_pred CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhh
Confidence 6899999999997532 2224567799999999987 7799999999999999999999999987743211 110
Q ss_pred -HHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 193 -ISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 193 -i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.......+....+..+++.+.+||.+||..||++|||+.++|+||||+...
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 111112222233457899999999999999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=325.93 Aligned_cols=232 Identities=23% Similarity=0.319 Sum_probs=189.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..|+|||+++ |++|.+++
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-g~~L~~~l 102 (294)
T 4eqm_A 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS-QLSHQNIVSMIDVDEEDDCYYLVMEYIE-GPTLSEYI 102 (294)
T ss_dssp EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHT-TCCBTTBCCEEEEEECSSEEEEEEECCC-SCBHHHHH
T ss_pred EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHh-cCCCCCCceEEEeeeeCCeEEEEEeCCC-CCCHHHHH
Confidence 3689999999999999999854 1356889999999 7789999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYV 148 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~ 148 (383)
.. ..++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....+||+.|+
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 179 (294)
T 4eqm_A 103 ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179 (294)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCSSSTTC-------------CCSSC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEEeCCCccccccccccccCccccCcccc
Confidence 43 3345667999999999999999999999999999765 689999999998654332 233457999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDF-PDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+............ +......+++.+.++|.+||..||.+|
T Consensus 180 aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 259 (294)
T 4eqm_A 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259 (294)
T ss_dssp CHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHc
Confidence 9999999999999999999999999999999999988776655554443322 234456789999999999999999999
Q ss_pred CCHHHHHcCcccC
Q psy6377 228 MTAKEALKHPWLM 240 (383)
Q Consensus 228 pt~~e~L~hp~~~ 240 (383)
|+..+.+.+.|..
T Consensus 260 ~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 260 YKTIQEMKDDLSS 272 (294)
T ss_dssp CSSHHHHHHHHHT
T ss_pred cccHHHHHHHHHH
Confidence 9666666666644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=321.27 Aligned_cols=231 Identities=23% Similarity=0.366 Sum_probs=195.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+ ....|+|||++. |++|.+++
T Consensus 21 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 98 (279)
T 2w5a_A 21 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTLYIVMEYCE-GGDLASVI 98 (279)
T ss_dssp EEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEEGGGTEEEEEEECCT-TEEHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHH-hcCCCCCCeEEEEEecCCCceEEEEEeCCC-CCCHHHHH
Confidence 689999999999999999975 2356889999999 6689999999998854 578999999999 99999975
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-ccc
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRK-----IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRE 140 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~g-----ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~ 140 (383)
.. ..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||++........ ...
T Consensus 99 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~---~~~kl~dfg~~~~~~~~~~~~~~ 175 (279)
T 2w5a_A 99 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKT 175 (279)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS---SCEEECCCCHHHHC---CHHHHH
T ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC---CCEEEecCchheeeccccccccc
Confidence 43 235567799999999999999 9999999999999765 6899999999886543322 234
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
..||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..+.... ....++.++.++|.+||
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l 252 (279)
T 2w5a_A 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRML 252 (279)
T ss_dssp HHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHT
T ss_pred cCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CCcccCHHHHHHHHHHc
Confidence 579999999999999999999999999999999999999999988888887777765432 22467999999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCcc
Q psy6377 221 IKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..||.+|||++|+++|+|+....
T Consensus 253 ~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 253 NLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=332.44 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=183.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---C------------cccHHHHHHHHHhcCCCCCcccceEEEEe-----CCeEEEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---N------------PVRIHHEIALLSLCSPSPRIVKLHDVFQT-----GEGAYYVS 63 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-----~~~~~lv~ 63 (383)
..||+|++.. |+.||||++.. . ...+.+|+.+++ .++||||+++++++.. ...+|+||
T Consensus 36 g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 113 (362)
T 3pg1_A 36 GAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN-HFHHPNILGLRDIFVHFEEPAMHKLYLVT 113 (362)
T ss_dssp EEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEEEECCTTTCCEEEEEE
T ss_pred EEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH-hCCCcCccceeeeEEeccCCCcceEEEEE
Confidence 3689998854 99999999865 1 156889999999 7789999999999954 34689999
Q ss_pred ecCCCcCcHHHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 64 WNTPLVVTLQTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 64 e~~~~g~~L~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
|++. ++|.+.+.. ..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 114 e~~~--~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~ 188 (362)
T 3pg1_A 114 ELMR--TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---NDITICDFNLAREDTADA 188 (362)
T ss_dssp ECCS--EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCTTC--------
T ss_pred ccCC--CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC---CCEEEEecCccccccccc
Confidence 9998 577775432 2345667999999999999999999999999999765 689999999998765555
Q ss_pred ccccccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------
Q psy6377 137 EIRELLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------- 202 (383)
Q Consensus 137 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 202 (383)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 189 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 268 (362)
T 3pg1_A 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268 (362)
T ss_dssp -------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHH
T ss_pred ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhH
Confidence 5566789999999999876 67899999999999999999999999999887777766543222211
Q ss_pred ---------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 203 ---------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 203 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
...+.+++.+.+||.+||..||.+|||+.|+|+||||+.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 1234568899999999999999999999999999999876443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.47 Aligned_cols=234 Identities=25% Similarity=0.344 Sum_probs=184.7
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL 80 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~ 80 (383)
||++++. ...+|+.||||++.. ....+.+|+.+++.+.+||||+++++++.+++..|+|||++. ++|.+++....
T Consensus 28 ~g~V~~~--~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~--gsL~~~l~~~~ 103 (434)
T 2rio_A 28 SGTVVFQ--GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN--LNLQDLVESKN 103 (434)
T ss_dssp TTCEEEE--EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS--EEHHHHHHTC-
T ss_pred CeEEEEE--EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC--CCHHHHHhccC
Confidence 5666553 456899999999876 345678999999866799999999999999999999999997 59999775432
Q ss_pred -------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC----------CCCcEEEEeccceeEeecCcc
Q psy6377 81 -------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF----------PNCDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 81 -------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~----------~~~~ikL~DFGla~~~~~~~~ 137 (383)
++.++.||+.||+|||++||+||||||+|||++.++ ..+.+||+|||++........
T Consensus 104 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~ 183 (434)
T 2rio_A 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183 (434)
T ss_dssp -----------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---
T ss_pred CCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCc
Confidence 234779999999999999999999999999997541 345899999999998654322
Q ss_pred -----cccccCCCCcCCCccccc-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcch
Q psy6377 138 -----IRELLGTPDYVAPEILHY-------EPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDEL 204 (383)
Q Consensus 138 -----~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 204 (383)
....+||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+ ..+..+....+...
T Consensus 184 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~ 261 (434)
T 2rio_A 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMK 261 (434)
T ss_dssp -----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCT
T ss_pred cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccccc
Confidence 234579999999999865 678999999999999999999 999997765443 34444444433221
Q ss_pred ---hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 205 ---FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 205 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
...+++++.+||.+||..||.+|||+.++++||||..
T Consensus 262 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 262 CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1234688999999999999999999999999999965
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=337.39 Aligned_cols=232 Identities=16% Similarity=0.181 Sum_probs=195.3
Q ss_pred eEEEEE-----EcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMAD-----SIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~-----~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+ +..+++.||||++.. ....+.+|+.+++ .++||||+++++++.+....|+|||++. |++|.+
T Consensus 86 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~~-~g~L~~ 163 (367)
T 3l9p_A 86 EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILLELMA-GGDLKS 163 (367)
T ss_dssp CEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHH
T ss_pred EEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCCCEEEEEeCC-CCCHHH
Confidence 689998 567888999999975 2446889999999 6689999999999999999999999999 999999
Q ss_pred hhccC-------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---ccc
Q psy6377 75 IIDDN-------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEI 138 (383)
Q Consensus 75 ~l~~~-------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~~ 138 (383)
++... .++.++.||+.||+|||++||+||||||+|||++.++....+||+|||+++..... ...
T Consensus 164 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~ 243 (367)
T 3l9p_A 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243 (367)
T ss_dssp HHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTC
T ss_pred HHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccC
Confidence 77542 23456799999999999999999999999999986654457999999999754322 223
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+....+ ...++..+.+||.
T Consensus 244 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~ 320 (367)
T 3l9p_A 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMT 320 (367)
T ss_dssp CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred CCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHH
Confidence 34568999999999999999999999999999999998 9999999998888888776653322 2467999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCC
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
+||..||.+|||+.+++++.|...
T Consensus 321 ~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 321 QCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHh
Confidence 999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.79 Aligned_cols=229 Identities=22% Similarity=0.354 Sum_probs=180.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCC-CCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPS-PRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~h-pnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.+ .+|+.||||++.. ....+.+|+.+++.+..| |||+++++++.++...|+||| +. +++|.+++.
T Consensus 24 ~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~-~~~L~~~l~ 100 (343)
T 3dbq_A 24 KVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG-NIDLNSWLK 100 (343)
T ss_dssp EEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CC-SEEHHHHHH
T ss_pred EEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CC-CCCHHHHHH
Confidence 5899987 5799999999875 125678999999955433 999999999999999999999 45 689999765
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYV 148 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~ 148 (383)
.. .+..++.||+.||+|||++||+||||||+|||++. +.+||+|||+++....... ....+||+.|+
T Consensus 101 ~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 176 (343)
T 3dbq_A 101 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176 (343)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC------------CCCCSSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccCcccccccCCCCcCCcCcC
Confidence 43 34566799999999999999999999999999963 4799999999987643322 23567999999
Q ss_pred CCccccc-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHH
Q psy6377 149 APEILHY-----------EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 149 aPE~l~~-----------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li 216 (383)
|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+...... ..+....+.++.+||
T Consensus 177 aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li 254 (343)
T 3dbq_A 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--IEFPDIPEKDLQDVL 254 (343)
T ss_dssp CHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--CCCCCCSCHHHHHHH
T ss_pred CHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--cCCcccCCHHHHHHH
Confidence 9999865 67899999999999999999999999875443 333333322221 223345678999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 217 AKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+||..||.+|||+.|+|+||||+..
T Consensus 255 ~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 255 KCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHcCCChhHCCCHHHHHhCcccccc
Confidence 99999999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=324.59 Aligned_cols=229 Identities=18% Similarity=0.216 Sum_probs=190.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+++.+.+||||+++++++.+++..|+|||++ +++|.+++..
T Consensus 24 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~--~~~L~~~~~~~~~~ 101 (330)
T 2izr_A 24 ELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT 101 (330)
T ss_dssp SEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTTC
T ss_pred eEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC--CCCHHHHHHHcCCC
Confidence 699999999999999999976 45679999999996659999999999999999999999999 6999997653
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC--CCcEEEEeccceeEeecCcc--------cccccCCC
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP--NCDIKVCDFEISRVILDGIE--------IRELLGTP 145 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~--~~~ikL~DFGla~~~~~~~~--------~~~~~gt~ 145 (383)
..++.++.|++.||+|||++||+||||||+|||++.+.. ...+||+|||+++....... ....+||+
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~ 181 (330)
T 2izr_A 102 FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181 (330)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCc
Confidence 234566799999999999999999999999999987631 11299999999997654322 24568999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+.......+........+++.++|..||..
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~ 261 (330)
T 2izr_A 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRL 261 (330)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHC
T ss_pred cccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhC
Confidence 99999999999999999999999999999999999988543 344555555554444433333333999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||.+||+++++++
T Consensus 262 ~p~~RP~~~~l~~ 274 (330)
T 2izr_A 262 DFFEKPDYDYLRK 274 (330)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999998875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=323.64 Aligned_cols=233 Identities=21% Similarity=0.255 Sum_probs=176.9
Q ss_pred ceEEEEEEcCCCc---EEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeE------EEEEecCCC
Q psy6377 4 LSEEMADSIATGE---VFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA------YYVSWNTPL 68 (383)
Q Consensus 4 ~~V~~~~~~~tg~---~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~------~lv~e~~~~ 68 (383)
..||+|+++.+++ .||+|++.. ....+.+|+.+++ .++||||+++++++.+.... ++|||++.
T Consensus 37 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~- 114 (323)
T 3qup_A 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK-EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK- 114 (323)
T ss_dssp EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHT-TCCCTTBCCCCEEEECC-------CEEEEEECCT-
T ss_pred eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHH-HCCCCceehhhceeeccccccCCCccEEEEEecc-
Confidence 4689999888876 899999976 2456889999999 67999999999999887665 99999999
Q ss_pred cCcHHHhhcc------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 69 VVTLQTIIDD------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 69 g~~L~~~l~~------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
+++|.+++.. ..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~---~~~kl~Dfg~a~~~~~~~ 191 (323)
T 3qup_A 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLSRKIYSGD 191 (323)
T ss_dssp TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC--------
T ss_pred CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC---CCEEEeeccccccccccc
Confidence 9999986532 2345677999999999999999999999999999765 689999999998764432
Q ss_pred c---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHH
Q psy6377 137 E---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEA 212 (383)
Q Consensus 137 ~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 212 (383)
. .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+.... ....+++++
T Consensus 192 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 268 (323)
T 3qup_A 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK---QPPECMEEV 268 (323)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHH
T ss_pred cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC---CCCccCHHH
Confidence 2 223456789999999999999999999999999999999 999999998888888776654322 224679999
Q ss_pred HHHHHHhcccCCCCCCC-------HHHHHcCcccCCcch
Q psy6377 213 KDFIAKILIKNPMERMT-------AKEALKHPWLMNKKQ 244 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt-------~~e~L~hp~~~~~~~ 244 (383)
.+||.+||..||.+||| +++++.|||+....+
T Consensus 269 ~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 269 YDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 99999999999999999 777889999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=330.44 Aligned_cols=226 Identities=19% Similarity=0.263 Sum_probs=190.7
Q ss_pred ceEEEEEEc-------CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSI-------ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~-------~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|++. .++..||+|++.. ....+.+|+.+++.+.+||||+++++++.+.+.+|+||||+. |++
T Consensus 95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~-~g~ 173 (370)
T 2psq_A 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGN 173 (370)
T ss_dssp SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCT-TCB
T ss_pred eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCC-CCC
Confidence 368999875 4567899999976 235688999999955589999999999999999999999999 999
Q ss_pred HHHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 72 LQTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 72 L~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
|.+++.... ++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 174 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a 250 (370)
T 2psq_A 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 250 (370)
T ss_dssp HHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCSSC
T ss_pred HHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC---CCEEEccccCC
Confidence 999775421 23466899999999999999999999999999765 68999999999
Q ss_pred eEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchh
Q psy6377 130 RVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELF 205 (383)
Q Consensus 130 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 205 (383)
+....... .....+|+.|+|||++.+..|+.++|||||||++|+|++ |..||.+.+..+.+..+..+... ...
T Consensus 251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 327 (370)
T 2psq_A 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKP 327 (370)
T ss_dssp EETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCC
T ss_pred cccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCC
Confidence 87644322 233467889999999999999999999999999999999 99999999888888777665422 223
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..++.++.+||.+||..||.+|||+.|++++
T Consensus 328 ~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 328 ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4679999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=313.42 Aligned_cols=224 Identities=18% Similarity=0.250 Sum_probs=191.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
..||+|++. +++.||+|++.. ....+.+|+.+++ .++||||+++++++.+....|+|||+++ +++|.+++...
T Consensus 24 g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~ 100 (269)
T 4hcu_A 24 GLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPICLVFEFME-HGCLSDYLRTQR 100 (269)
T ss_dssp CEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEEEEEECCT-TCBHHHHHHTTT
T ss_pred cEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCceEEEEEeCC-CCcHHHHHHhcC
Confidence 368999986 577899999987 4567899999999 7789999999999999999999999999 99999976432
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~aPE 151 (383)
.++.+..|++.||+|||++||+||||||+||+++.+ +.++|+|||++....... ......+|+.|+|||
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (269)
T 4hcu_A 101 GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 177 (269)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC---CCEEeccccccccccccccccccCcccccccCCHH
Confidence 244566999999999999999999999999999766 689999999998654322 123345778899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..++.++||||+|+++|+|++ |.+||.+.+..+....+..+..... ...+++.+.+++.+||..||.+|||+
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~ 254 (269)
T 4hcu_A 178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAF 254 (269)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHHHHHHHHccCCcccCcCH
Confidence 9999999999999999999999999 9999999998888888776543322 24569999999999999999999999
Q ss_pred HHHHcC
Q psy6377 231 KEALKH 236 (383)
Q Consensus 231 ~e~L~h 236 (383)
.++++|
T Consensus 255 ~~ll~~ 260 (269)
T 4hcu_A 255 SRLLRQ 260 (269)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.58 Aligned_cols=231 Identities=17% Similarity=0.137 Sum_probs=192.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++.+.+||||+++++++.+....++|||++ +++|.+++..
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~--~~~L~~~l~~~~~ 101 (298)
T 1csn_A 24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR 101 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTT
T ss_pred EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec--CCCHHHHHHHhcc
Confidence 3799999999999999999976 56789999999996669999999999999999999999999 6999997653
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecCcc--------cccccCC
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDGIE--------IRELLGT 144 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~~~--------~~~~~gt 144 (383)
..+..++.||+.||+|||++||+||||||+|||++.++ ..+.+||+|||++........ .....||
T Consensus 102 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt 181 (298)
T 1csn_A 102 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCC
Confidence 23456679999999999999999999999999997652 123499999999997654322 3446799
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCC-CcchhcCCCHHHHHHHHHhc
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---DSETFRNISKAQLDF-PDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L 220 (383)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+....... .......+++++.++|.+||
T Consensus 182 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 261 (298)
T 1csn_A 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 261 (298)
T ss_dssp TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred cccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHh
Confidence 99999999999999999999999999999999999998853 334444444433222 23445678999999999999
Q ss_pred ccCCCCCCCHHHHHcC
Q psy6377 221 IKNPMERMTAKEALKH 236 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~h 236 (383)
..||++|||++++++.
T Consensus 262 ~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 262 NLAFDATPDYDYLQGL 277 (298)
T ss_dssp HCCTTCCCCHHHHHHH
T ss_pred cCCcccCCCHHHHHHH
Confidence 9999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.04 Aligned_cols=237 Identities=26% Similarity=0.336 Sum_probs=186.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcC----------CCCCcccceEEEEeCC----eEEEEEecC
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCS----------PSPRIVKLHDVFQTGE----GAYYVSWNT 66 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~----------~hpnIvkl~~~~~~~~----~~~lv~e~~ 66 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++.+. +||||+++++++...+ ..+++||++
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~ 112 (373)
T 1q8y_A 33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL 112 (373)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence 3699999999999999999986 2456788999888433 2899999999998654 788999998
Q ss_pred CCcCcHHHhhcc--------CCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccC---CCCcEEEEeccceeEeec
Q psy6377 67 PLVVTLQTIIDD--------NLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDF---PNCDIKVCDFEISRVILD 134 (383)
Q Consensus 67 ~~g~~L~~~l~~--------~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~---~~~~ikL~DFGla~~~~~ 134 (383)
+++|.+++.. ..+..++.||+.||+|||++ ||+||||||+|||++.++ ..+.+||+|||++.....
T Consensus 113 --~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 113 --GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp --CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred --CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence 5899987643 22456669999999999998 999999999999996432 234799999999987543
Q ss_pred CcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhccCCCCcch----
Q psy6377 135 GIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD------SETFRNISKAQLDFPDEL---- 204 (383)
Q Consensus 135 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~i~~~~~~~~~~~---- 204 (383)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+......+|...
T Consensus 191 --~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 268 (373)
T 1q8y_A 191 --HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268 (373)
T ss_dssp --CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred --CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhcc
Confidence 34456899999999999999999999999999999999999999987652 233333333222222211
Q ss_pred ----------------------------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 205 ----------------------------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 205 ----------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
...+++++.+||.+||..||++|||++|+|+||||++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred chhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 1234678999999999999999999999999999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=320.27 Aligned_cols=227 Identities=23% Similarity=0.371 Sum_probs=182.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++ +|+.||||++... ...+.+|+.+++ .++||||+++++++.+....++||||+. +++|.+++..
T Consensus 52 ~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~ 127 (309)
T 3p86_A 52 TVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMK-RLRHPNIVLFMGAVTQPPNLSIVTEYLS-RGSLYRLLHK 127 (309)
T ss_dssp EEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSTTCCEEEEECCT-TCBHHHHHHS
T ss_pred EEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCceEEEEecCC-CCcHHHHHhh
Confidence 5899976 6899999998762 246789999999 6789999999999999999999999999 9999997654
Q ss_pred C---------CchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCC
Q psy6377 79 N---------LVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPD 146 (383)
Q Consensus 79 ~---------~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~ 146 (383)
. .++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+++...... ......||+.
T Consensus 128 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~ 204 (309)
T 3p86_A 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK---YTVKVCDFGLSRLKASTFLSSKSAAGTPE 204 (309)
T ss_dssp TTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT---CCEEECCCC-----------------CCT
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC---CcEEECCCCCCccccccccccccCCCCcc
Confidence 3 23456699999999999999 9999999999999765 689999999998654332 2345679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....+++++.+||.+||..||.+
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~ 282 (309)
T 3p86_A 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNLNPQVAAIIEGCWTNEPWK 282 (309)
T ss_dssp TSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHccCChhh
Confidence 999999999999999999999999999999999999988877777664333222 233568999999999999999999
Q ss_pred CCCHHHHHc--CcccC
Q psy6377 227 RMTAKEALK--HPWLM 240 (383)
Q Consensus 227 Rpt~~e~L~--hp~~~ 240 (383)
|||+.++++ .+++.
T Consensus 283 Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 283 RPSFATIMDLLRPLIK 298 (309)
T ss_dssp SCCHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHH
Confidence 999999987 34544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=328.36 Aligned_cols=227 Identities=22% Similarity=0.298 Sum_probs=186.9
Q ss_pred ceEEEEE-----EcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-EEEEEecCCCcCcH
Q psy6377 4 LSEEMAD-----SIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-AYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~-----~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-~~lv~e~~~~g~~L 72 (383)
..||+|+ +..+|+.||||++.. ....+.+|+.+++.+.+||||+++++++.+.+. .++||||+. |++|
T Consensus 36 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~-~g~L 114 (359)
T 3vhe_A 36 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK-FGNL 114 (359)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCT-TEEH
T ss_pred ceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecC-CCcH
Confidence 3689998 667889999999976 234688999999966689999999999987655 899999999 9999
Q ss_pred HHhhccCC------------------------------------------------------------------------
Q psy6377 73 QTIIDDNL------------------------------------------------------------------------ 80 (383)
Q Consensus 73 ~~~l~~~~------------------------------------------------------------------------ 80 (383)
.+++....
T Consensus 115 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 194 (359)
T 3vhe_A 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194 (359)
T ss_dssp HHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHH
T ss_pred HHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHH
Confidence 99765422
Q ss_pred chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCcCCCcccccCC
Q psy6377 81 VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDYVAPEILHYEP 157 (383)
Q Consensus 81 ~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~ 157 (383)
++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|+|||++.+..
T Consensus 195 ~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 271 (359)
T 3vhe_A 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 271 (359)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC
Confidence 23456899999999999999999999999999876 589999999998653322 233457899999999999999
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 158 ITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 158 ~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++.++|||||||++|+|++ |.+||.+....+.+..........+ ....+++++.++|.+||..||.+|||+.++++|
T Consensus 272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999998 9999998876555444433332221 224679999999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=325.94 Aligned_cols=235 Identities=24% Similarity=0.390 Sum_probs=168.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID- 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~- 77 (383)
..||+|.++.+|+.||||++... ...+.+|+..+....+||||+++++++.+.+..|+|||++. ++|.+++.
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~ 113 (327)
T 3aln_A 36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS--TSFDKFYKY 113 (327)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS--EEHHHHHHH
T ss_pred EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC--CChHHHHHH
Confidence 36899999999999999999762 34566777744448899999999999999999999999998 47766543
Q ss_pred ----------cCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 78 ----------DNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 78 ----------~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
...+..+..|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++.............||+.
T Consensus 114 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~gt~~ 190 (327)
T 3aln_A 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKTRDAGCRP 190 (327)
T ss_dssp HHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT---TEEEECCCSSSCC---------------
T ss_pred HHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC---CCEEEccCCCceecccccccccCCCCcc
Confidence 223446679999999999999 99999999999999865 6899999999987655444455689999
Q ss_pred cCCCccc----ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhcc-CCCCcchhcCCCHHHHHHHHHhc
Q psy6377 147 YVAPEIL----HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQ-LDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 147 y~aPE~l----~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L 220 (383)
|+|||++ .+..++.++|||||||++|+|++|..||.+.... +.+..+..+. ..++...+..+++.+.+||.+||
T Consensus 191 y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 270 (327)
T 3aln_A 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCL 270 (327)
T ss_dssp ---------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHT
T ss_pred ccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHh
Confidence 9999998 5667899999999999999999999999875432 2222222222 22333344568999999999999
Q ss_pred ccCCCCCCCHHHHHcCcccCCcc
Q psy6377 221 IKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
..||.+|||+.++++||||....
T Consensus 271 ~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 271 TKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSSGGGSCCHHHHTTSHHHHHHH
T ss_pred hCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999999999997544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.52 Aligned_cols=232 Identities=23% Similarity=0.347 Sum_probs=177.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHH-HHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIA-LLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~-il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|+++.+|+.||||++... ......|+. +++ ..+||||+++++++.+.+..|+|||++. +.+..+..
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~--~~~~~l~~ 115 (318)
T 2dyl_A 39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK-SHDCPYIVQCFGTFITNTDVFIAMELMG--TCAEKLKK 115 (318)
T ss_dssp -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSEEEEEECCCS--EEHHHHHH
T ss_pred eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHH-hcCCCceeeEEEEEecCCcEEEEEeccC--CcHHHHHH
Confidence 36899999999999999999762 223444444 455 7899999999999999999999999994 55655432
Q ss_pred -------cCCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 78 -------DNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 78 -------~~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
...+..+..|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++.............||+.|+|
T Consensus 116 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~a 192 (318)
T 2dyl_A 116 RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192 (318)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT---SCEEECCCTTC--------------CCTTCC
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC---CCEEEEECCCchhccCCccccccCCCccccC
Confidence 233456779999999999996 99999999999999765 6899999999987655545556689999999
Q ss_pred Ccccc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 150 PEILH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGE-TDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 150 PE~l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
||++. ...++.++|||||||++|+|++|..||.+. ...+.+..+........ .....+++++.+||.+||..|
T Consensus 193 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~d 271 (318)
T 2dyl_A 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMGFSGDFQSFVKDCLTKD 271 (318)
T ss_dssp HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSCCCHHHHHHHHHHTCSC
T ss_pred hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCCCCHHHHHHHHHHccCC
Confidence 99984 566899999999999999999999999874 44455566555443322 123468999999999999999
Q ss_pred CCCCCCHHHHHcCcccCCc
Q psy6377 224 PMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~~~~ 242 (383)
|.+|||++++++||||+..
T Consensus 272 p~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 272 HRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp TTTSCCHHHHTTSHHHHHH
T ss_pred hhHCcCHHHHhhCHHHHhc
Confidence 9999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.34 Aligned_cols=223 Identities=19% Similarity=0.258 Sum_probs=191.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|+++ ++..||+|++.. ....+.+|+.+++ .+.||||+++++++.+....++|||+++ +++|.+++..
T Consensus 23 ~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 99 (268)
T 3sxs_A 23 VVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMM-KLSHPKLVKFYGVCSKEYPIYIVTEYIS-NGCLLNYLRSHGK 99 (268)
T ss_dssp EEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSEEEEEECCT-TCBHHHHHHHHGG
T ss_pred eEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCceEEEEEccC-CCcHHHHHHHcCC
Confidence 68999775 677899999987 4567899999999 6789999999999999999999999999 9999997543
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~ 152 (383)
..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++........ .....+|+.|+|||+
T Consensus 100 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (268)
T 3sxs_A 100 GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD---LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176 (268)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT---CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC---CCEEEccCccceecchhhhhcccCCCcCcccCCHHH
Confidence 3345667999999999999999999999999999765 6899999999987654432 223456778999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+.....+ ..+++.+.++|.+||..||.+|||+.
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (268)
T 3sxs_A 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQ 253 (268)
T ss_dssp HHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred HhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHH
Confidence 998889999999999999999999 99999999888888777766544333 34689999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
+++++
T Consensus 254 ~ll~~ 258 (268)
T 3sxs_A 254 QLLSS 258 (268)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=320.30 Aligned_cols=226 Identities=20% Similarity=0.259 Sum_probs=189.6
Q ss_pred ceEEEEEEcCCCcEE--EEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVF--AAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~v--AvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|..+ |+|.+.. ....+.+|+.+++.+.+||||+++++++.+.+..|+|||+++ +++|.+++
T Consensus 39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 117 (327)
T 1fvr_A 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP-HGNLLDFL 117 (327)
T ss_dssp CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT-TCBHHHHH
T ss_pred ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC-CCCHHHHH
Confidence 379999999999866 9998875 356789999999955499999999999999999999999999 99999976
Q ss_pred ccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec
Q psy6377 77 DDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134 (383)
Q Consensus 77 ~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~ 134 (383)
... .++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kL~Dfg~~~~~~~ 194 (327)
T 1fvr_A 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEV 194 (327)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEESSCE
T ss_pred HhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC---CeEEEcccCcCccccc
Confidence 543 234566999999999999999999999999999876 6899999999985433
Q ss_pred CcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHH
Q psy6377 135 GIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213 (383)
Q Consensus 135 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 213 (383)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+... .....+++.+.
T Consensus 195 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 271 (327)
T 1fvr_A 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EKPLNCDDEVY 271 (327)
T ss_dssp ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC---CCCTTBCHHHH
T ss_pred cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC---CCCCCCCHHHH
Confidence 333344567889999999998889999999999999999998 99999999888887777655321 22246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6377 214 DFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+||.+||..||.+|||+++++++
T Consensus 272 ~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 272 DLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.36 Aligned_cols=223 Identities=19% Similarity=0.243 Sum_probs=191.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|.+. ++..||+|++.. ....+.+|+.+++ .+.||||+++++++.+.+..|+|||++. +++|.+++..
T Consensus 39 ~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 115 (283)
T 3gen_A 39 VVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMM-NLSHEKLVQLYGVCTKQRPIFIITEYMA-NGCLLNYLREMRH 115 (283)
T ss_dssp EEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEEEEECCCT-TCBHHHHHHCGGG
T ss_pred eEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHh-cCCCCCEeeEEEEEecCCCeEEEEeccC-CCcHHHHHHHhcc
Confidence 68999875 677899999987 4567889999999 7789999999999999999999999999 9999997644
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~ 152 (383)
..++.++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++........ .....+|+.|+|||+
T Consensus 116 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 192 (283)
T 3gen_A 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192 (283)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT---SCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC---CCEEEccccccccccccccccccCCccCcccCCHHH
Confidence 2345667999999999999999999999999999765 6899999999986543221 223456788999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+.....+ ..+++.+.++|.+||..||.+|||+.
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (283)
T 3gen_A 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFK 269 (283)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999999999999999999998 99999999888888887766433332 45689999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
++++|
T Consensus 270 ~ll~~ 274 (283)
T 3gen_A 270 ILLSN 274 (283)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.89 Aligned_cols=224 Identities=19% Similarity=0.243 Sum_probs=188.3
Q ss_pred ceEEEEEEcCCCcE---EEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEV---FAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~---vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|+++.+|+. ||||++.. ....+.+|+.+++ .++||||+++++++.+++..|+||||+. |++|.++
T Consensus 63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 140 (325)
T 3kul_A 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG-QFDHPNIIRLEGVVTRGRLAMIVTEYME-NGSLDTF 140 (325)
T ss_dssp EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECGGGCCEEEEECCT-TCBHHHH
T ss_pred cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCccEEEeeCCC-CCcHHHH
Confidence 36899999876664 99999976 2456889999999 7789999999999999999999999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGT 144 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt 144 (383)
+... .++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|
T Consensus 141 l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t 217 (325)
T 3kul_A 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN---LVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217 (325)
T ss_dssp HHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCSSCEECC----CCEECC---CC
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC---CCEEECCCCcccccccCccceeeccCCCCc
Confidence 7432 345666999999999999999999999999999765 6899999999987644321 2223567
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....+++.+.+||.+||..|
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d 294 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APMGCPHALHQLMLDCWHKD 294 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSS
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCCCcCHHHHHHHHHHccCC
Confidence 88999999998999999999999999999999 999999999888888777653222 22468999999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|.+|||+.++++
T Consensus 295 p~~Rps~~eil~ 306 (325)
T 3kul_A 295 RAQRPRFSQIVS 306 (325)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.87 Aligned_cols=225 Identities=20% Similarity=0.249 Sum_probs=191.0
Q ss_pred ceEEEEEE-----cCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADS-----IATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~-----~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|.+ +.+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..|+|||++. |++|.
T Consensus 37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 114 (314)
T 2ivs_A 37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK-QVNHPHVIKLYGACSQDGPLLLIVEYAK-YGSLR 114 (314)
T ss_dssp SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHH
T ss_pred eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHh-hCCCCceeeEEEEEecCCceEEEEeecC-CCCHH
Confidence 36899987 456689999999762 356889999999 7799999999999999999999999999 99999
Q ss_pred HhhccC------------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEE
Q psy6377 74 TIIDDN------------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123 (383)
Q Consensus 74 ~~l~~~------------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL 123 (383)
+++... .++.+..||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 115 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~---~~~kl 191 (314)
T 2ivs_A 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG---RKMKI 191 (314)
T ss_dssp HHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT---TEEEE
T ss_pred HHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCC---CCEEE
Confidence 976542 234566999999999999999999999999999865 68999
Q ss_pred EeccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCC
Q psy6377 124 CDFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLD 199 (383)
Q Consensus 124 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~ 199 (383)
+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+...
T Consensus 192 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 271 (314)
T 2ivs_A 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM 271 (314)
T ss_dssp CCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC
Confidence 99999987644322 223457889999999998899999999999999999999 99999998888777776655422
Q ss_pred CCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 200 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.....+++.+.++|.+||..||.+|||+.+++++
T Consensus 272 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 272 ---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2335789999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=321.72 Aligned_cols=221 Identities=20% Similarity=0.282 Sum_probs=183.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.++...++|||++. |++|.+++..
T Consensus 24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 101 (310)
T 3s95_A 24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR-CLEHPNVLKFIGVLYKDKRLNFITEYIK-GGTLRGIIKSM 101 (310)
T ss_dssp EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHHC
T ss_pred EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHH-hCCCcCcccEEEEEecCCeeEEEEEecC-CCcHHHHHHhc
Confidence 3689999999999999998865 3567889999999 7789999999999999999999999999 9999997754
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--------------
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-------------- 138 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~-------------- 138 (383)
..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.........
T Consensus 102 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (310)
T 3s95_A 102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN---KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178 (310)
T ss_dssp CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT---SCEEECCCTTCEECC-------------------
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC---CCEEEeecccceeccccccccccccccccccccc
Confidence 2344566999999999999999999999999999765 68999999999876432211
Q ss_pred -ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHhccCCCCcchhcCCCHHH
Q psy6377 139 -RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE-----TFRNISKAQLDFPDELFEDISPEA 212 (383)
Q Consensus 139 -~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~s~~~ 212 (383)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .....+++.+
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l 252 (310)
T 3s95_A 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR------YCPPNCPPSF 252 (310)
T ss_dssp -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH------TCCTTCCTTH
T ss_pred ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc------cCCCCCCHHH
Confidence 14579999999999999999999999999999999999999987643211 11111111 1124678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6377 213 KDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.++|.+||..||++|||+.++++
T Consensus 253 ~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 253 FPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=323.03 Aligned_cols=225 Identities=20% Similarity=0.261 Sum_probs=191.1
Q ss_pred ceEEEEEEc-----CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSI-----ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~-----~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|++. .+++.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..|+||||+. +++|.
T Consensus 61 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~ 138 (343)
T 1luf_A 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA-EFDNPNIVKLLGVCAVGKPMCLLFEYMA-YGDLN 138 (343)
T ss_dssp CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHH
T ss_pred eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEccCCceEEEEecCC-CCcHH
Confidence 368999987 45689999999862 356889999999 6799999999999999999999999999 99999
Q ss_pred HhhccC------------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEE
Q psy6377 74 TIIDDN------------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123 (383)
Q Consensus 74 ~~l~~~------------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL 123 (383)
+++... .++.++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 139 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl 215 (343)
T 1luf_A 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVVKI 215 (343)
T ss_dssp HHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEE
T ss_pred HHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCC---CeEEE
Confidence 977542 234467999999999999999999999999999876 68999
Q ss_pred EeccceeEeecCc---ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCC
Q psy6377 124 CDFEISRVILDGI---EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLD 199 (383)
Q Consensus 124 ~DFGla~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~ 199 (383)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+...
T Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 295 (343)
T 1luf_A 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 295 (343)
T ss_dssp CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC
Confidence 9999997653322 1234568899999999999999999999999999999999 99999999888888877766543
Q ss_pred CCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 200 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
. ....++..+.++|.+||..||.+|||+.+++++
T Consensus 296 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 296 A---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 2 224679999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=322.18 Aligned_cols=233 Identities=16% Similarity=0.187 Sum_probs=193.5
Q ss_pred eEEEEE-----EcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMAD-----SIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~-----~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+ +..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+....|+|||+++ |++|.+
T Consensus 45 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 122 (327)
T 2yfx_A 45 EVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS-KFNHQNIVRCIGVSLQSLPRFILMELMA-GGDLKS 122 (327)
T ss_dssp CEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHH
T ss_pred eEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHh-hCCCCCCCeEEEEEcCCCCcEEEEecCC-CCcHHH
Confidence 689998 667899999999975 2456889999999 6699999999999999999999999999 999999
Q ss_pred hhccCC-------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---cc
Q psy6377 75 IIDDNL-------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EI 138 (383)
Q Consensus 75 ~l~~~~-------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~ 138 (383)
++.... ++.++.|++.||.|||++||+||||||+|||++.++....++|+|||++....... ..
T Consensus 123 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 202 (327)
T 2yfx_A 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202 (327)
T ss_dssp HHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------C
T ss_pred HHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccC
Confidence 875432 34566999999999999999999999999999865445679999999987543222 12
Q ss_pred ccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 139 RELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 139 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+....+ ...++..+.++|.
T Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 279 (327)
T 2yfx_A 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMT 279 (327)
T ss_dssp CGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred CCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC---CCCCCHHHHHHHH
Confidence 34568999999999998999999999999999999998 9999999888887777766543322 2467999999999
Q ss_pred HhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 218 KILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
+||..||.+|||+.+++++.|....
T Consensus 280 ~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 280 QCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999999999887543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.34 Aligned_cols=228 Identities=16% Similarity=0.223 Sum_probs=190.9
Q ss_pred ceEEEEEE-----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADS-----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~-----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|++ ..++..||+|++.. ....+.+|+.+++.+.+||||+++++++.+.+..|+|||+++ +++|.
T Consensus 59 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~-~g~L~ 137 (344)
T 1rjb_A 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC-YGDLL 137 (344)
T ss_dssp EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHH
T ss_pred ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCC-CCcHH
Confidence 36899987 35677899999975 356789999999955599999999999999999999999999 99999
Q ss_pred HhhccCC-----------------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEE
Q psy6377 74 TIIDDNL-----------------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124 (383)
Q Consensus 74 ~~l~~~~-----------------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~ 124 (383)
+++.... ++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 138 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kL~ 214 (344)
T 1rjb_A 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKIC 214 (344)
T ss_dssp HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT---TEEEEC
T ss_pred HHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCC---CcEEeC
Confidence 9775432 23466999999999999999999999999999866 689999
Q ss_pred eccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCC
Q psy6377 125 DFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 125 DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..+.......
T Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (344)
T 1rjb_A 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294 (344)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred CCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC
Confidence 9999986644322 233567889999999999999999999999999999998 999999887766665555444333
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHP 237 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 237 (383)
+ ....+++++.+||.+||..||.+|||+.++++|.
T Consensus 295 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 295 D--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 2 2346799999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.35 Aligned_cols=227 Identities=26% Similarity=0.369 Sum_probs=190.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcC-CCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCS-PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~-~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+.||||++.. ....+.+|+.+++.+. +||||+++++++.+.+..++|||++..+++|
T Consensus 57 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L 136 (320)
T 3a99_A 57 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136 (320)
T ss_dssp CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccH
Confidence 3689999999999999999976 1256788999999555 4799999999999999999999999834899
Q ss_pred HHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 73 QTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 73 ~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
.+++.. ..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++...... ......||+.
T Consensus 137 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~ 213 (320)
T 3a99_A 137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKDT-VYTDFDGTRV 213 (320)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TTEEEECCCTTCEECCSS-CBCCCCSCGG
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC--CCCEEEeeCccccccccc-cccCCCCCcc
Confidence 987643 2345667999999999999999999999999999843 268999999999876543 3445679999
Q ss_pred cCCCcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .+......++ ..+++++.+||.+||..||.
T Consensus 214 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVSSECQHLIRWCLALRPS 283 (320)
T ss_dssp GSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCCHHHHHHHHHHTCSSGG
T ss_pred CCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----ccCCHHHHHHHHHHccCChh
Confidence 999999987776 688999999999999999999997542 2333333333 46799999999999999999
Q ss_pred CCCCHHHHHcCcccCCcc
Q psy6377 226 ERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~~~~ 243 (383)
+|||++++++||||+...
T Consensus 284 ~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 284 DRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp GSCCHHHHHTSGGGSSCC
T ss_pred hCcCHHHHhcCHhhcCcc
Confidence 999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=307.76 Aligned_cols=226 Identities=21% Similarity=0.305 Sum_probs=181.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++. |+.||+|++.. ....+.+|+.+++ .++||||+++++++.+++..++|||++. |++|.++
T Consensus 21 g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 96 (271)
T 3dtc_A 21 GKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA-MLKHPNIIALRGVCLKEPNLCLVMEFAR-GGPLNRV 96 (271)
T ss_dssp EEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHH-HCCCTTBCCEEEEECCC--CEEEEECCT-TEEHHHH
T ss_pred eEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHH-hcCCCCEeeEEEEEecCCceEEEEEcCC-CCCHHHH
Confidence 368999874 89999999875 1356889999999 7789999999999999999999999999 9999998
Q ss_pred hccC-----CchhhHHHHHHHHHHHHhCC---ceecCCCCCcEEEeccC-----CCCcEEEEeccceeEeecCccccccc
Q psy6377 76 IDDN-----LVVPFESDELSSLAYLHHRK---IAHLDIKPQNLVMMGDF-----PNCDIKVCDFEISRVILDGIEIRELL 142 (383)
Q Consensus 76 l~~~-----~~~~~~~qil~aL~yLHs~g---ivHrDLKp~NILl~~~~-----~~~~ikL~DFGla~~~~~~~~~~~~~ 142 (383)
+... .++.+..|++.||.|||++| |+||||||+|||++.+. ..+.++|+|||++....... .....
T Consensus 97 ~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 175 (271)
T 3dtc_A 97 LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAA 175 (271)
T ss_dssp HTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCC
Confidence 7543 34566699999999999999 89999999999997532 14689999999998754432 23467
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+ ....+++.+.++|.+||..
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~ 253 (271)
T 3dtc_A 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPSTCPEPFAKLMEDCWNP 253 (271)
T ss_dssp CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCS
T ss_pred CccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCcccCHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999999999887777766665544332 3356799999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||.+|||+.|++++
T Consensus 254 ~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 254 DPHSRPSFTNILDQ 267 (271)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=310.47 Aligned_cols=225 Identities=19% Similarity=0.257 Sum_probs=190.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----------------CCeEEEEEecCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----------------GEGAYYVSWNTP 67 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----------------~~~~~lv~e~~~ 67 (383)
..||+|++..+|+.||+|++......+.+|+.+++ .+.||||+++++++.. ....|+|||+++
T Consensus 25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (284)
T 2a19_B 25 GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALA-KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103 (284)
T ss_dssp CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHH-HCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCC
T ss_pred eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHH-hCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccC
Confidence 36999999999999999999887788999999999 7789999999999865 445899999999
Q ss_pred CcCcHHHhhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccc
Q psy6377 68 LVVTLQTIIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR 139 (383)
Q Consensus 68 ~g~~L~~~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~ 139 (383)
+++|.+++... .++.+..|++.||.|||++||+||||||+|||++.+ +.++|+|||++..........
T Consensus 104 -~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~ 179 (284)
T 2a19_B 104 -KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT---KQVKIGDFGLVTSLKNDGKRT 179 (284)
T ss_dssp -SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEESSCCSCCC
T ss_pred -CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC---CCEEECcchhheecccccccc
Confidence 99999977432 234566999999999999999999999999999876 689999999999876655556
Q ss_pred cccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHh
Q psy6377 140 ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 219 (383)
...||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+.... . ...++..+.++|.+|
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~----~~~~~~~~~~li~~~ 251 (284)
T 2a19_B 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--I----SDIFDKKEKTLLQKL 251 (284)
T ss_dssp CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--C----CTTSCHHHHHHHHHH
T ss_pred ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--c----cccCCHHHHHHHHHH
Confidence 678999999999999999999999999999999999999988532 22333333322 1 235789999999999
Q ss_pred cccCCCCCCCHHHHHcCcccCC
Q psy6377 220 LIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 220 L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
|..||.+|||+.++++|+|.-.
T Consensus 252 l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 252 LSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999987643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=314.49 Aligned_cols=218 Identities=30% Similarity=0.450 Sum_probs=180.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHhhccC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
..||+|.++.+|+.||+|++.. .....+|+.++....+||||++++++|.+ ....|+|||++. |++|.+++...
T Consensus 32 g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 109 (299)
T 3m2w_A 32 GKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD-GGELFSRIQDR 109 (299)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC-SCBHHHHHHHC
T ss_pred eEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC-CCcHHHHHHhc
Confidence 3689999999999999999974 56788999999668899999999999987 678999999999 99999976442
Q ss_pred --------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 80 --------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 80 --------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.++.+..|++.||+|||++||+||||||+|||++.+...+.++|+|||++....
T Consensus 110 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------ 171 (299)
T 3m2w_A 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------ 171 (299)
T ss_dssp TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------
Confidence 345666999999999999999999999999999875445789999999987542
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF----RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+..++.++|||||||++|+|++|.+||.+....... ..+......++...+..+++++.+||.+||..||.+|
T Consensus 172 ---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 172 ---GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp ---TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred ---cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhC
Confidence 234788999999999999999999999876654332 2233344555666667899999999999999999999
Q ss_pred CCHHHHHcCcccCCcch
Q psy6377 228 MTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~~ 244 (383)
||+.|+|+||||.....
T Consensus 249 ps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 249 MTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CCHHHHHTSHHHHTGGG
T ss_pred CCHHHHhcChhhccccc
Confidence 99999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=309.55 Aligned_cols=224 Identities=23% Similarity=0.287 Sum_probs=182.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.. ++|||++. +++|
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~--~lv~e~~~-~~~L 108 (287)
T 4f0f_A 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS-NLNHPNIVKLYGLMHNPP--RMVMEFVP-CGDL 108 (287)
T ss_dssp SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT-TCCCTTBCCEEEEETTTT--EEEEECCT-TCBH
T ss_pred eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH-hCCCCCchhhheeecCCC--eEEEEecC-CCCH
Confidence 3699999999999999999865 1157889999999 778999999999997655 79999999 9999
Q ss_pred HHhhcc-------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCC--CCcEEEEeccceeEeecCcccccc
Q psy6377 73 QTIIDD-------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFP--NCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 73 ~~~l~~-------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~--~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
.+.+.. ..++.+..|++.||+|||++| |+||||||+|||++.++. ...+||+|||+++.... .....
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~ 186 (287)
T 4f0f_A 109 YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGL 186 (287)
T ss_dssp HHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECC
T ss_pred HHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--ccccc
Confidence 885532 223466799999999999999 999999999999976521 12399999999985432 34556
Q ss_pred cCCCCcCCCccc--ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhccCCCCcchhcCCCHHHHHHHH
Q psy6377 142 LGTPDYVAPEIL--HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSET--FRNISKAQLDFPDELFEDISPEAKDFIA 217 (383)
Q Consensus 142 ~gt~~y~aPE~l--~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~s~~~~~li~ 217 (383)
.||+.|+|||++ ....++.++|||||||++|+|++|..||.+.+.... ...+... ..+......+++.+.+||.
T Consensus 187 ~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~ 264 (287)
T 4f0f_A 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--GLRPTIPEDCPPRLRNVIE 264 (287)
T ss_dssp CCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--CCCCCCCTTSCHHHHHHHH
T ss_pred CCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--CCCCCCCcccCHHHHHHHH
Confidence 899999999998 445678999999999999999999999987765444 3333322 2233444678999999999
Q ss_pred HhcccCCCCCCCHHHHHc
Q psy6377 218 KILIKNPMERMTAKEALK 235 (383)
Q Consensus 218 ~~L~~dP~~Rpt~~e~L~ 235 (383)
+||..||.+|||++++++
T Consensus 265 ~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 265 LCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.62 Aligned_cols=224 Identities=19% Similarity=0.232 Sum_probs=189.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
..||+|+++.+|+.||||++... ...+.+|+.+++ .++||||+++++++.+.+..|+|||+++ +++|.+++..
T Consensus 128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~ 205 (377)
T 3cbl_A 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIVMELVQ-GGDFLTFLRT 205 (377)
T ss_dssp EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHT-TCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHHHHH
T ss_pred CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEecCCCcEEEEEcCC-CCCHHHHHHh
Confidence 36899999999999999998762 357889999999 7799999999999999999999999999 9999997643
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc---ccccCCCCcC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI---RELLGTPDYV 148 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~---~~~~gt~~y~ 148 (383)
..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........ ....+++.|+
T Consensus 206 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~---~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~ 282 (377)
T 3cbl_A 206 EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282 (377)
T ss_dssp HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCGGGCEECTTSEEECCSSCCEEEGGGS
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC---CcEEECcCCCceecCCCceeecCCCCCCCcCcC
Confidence 2344566999999999999999999999999999765 68999999999875433211 1123567899
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....+++++.+||.+||..||++|
T Consensus 283 aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELCPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCchhC
Confidence 9999998899999999999999999998 999999988877776665543221 224578999999999999999999
Q ss_pred CCHHHHHc
Q psy6377 228 MTAKEALK 235 (383)
Q Consensus 228 pt~~e~L~ 235 (383)
||+.++++
T Consensus 360 ps~~~i~~ 367 (377)
T 3cbl_A 360 PSFSTIYQ 367 (377)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=323.74 Aligned_cols=226 Identities=20% Similarity=0.258 Sum_probs=191.6
Q ss_pred ceEEEEEEcCC-------CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIAT-------GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~t-------g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|++..+ +..||+|++.. ....+.+|+++++.+.+||||+++++++.+.+..|+|||++. +++
T Consensus 83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~-~g~ 161 (382)
T 3tt0_A 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGN 161 (382)
T ss_dssp EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TCB
T ss_pred eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecC-CCc
Confidence 36899987644 35799999976 235688999999966599999999999999999999999999 999
Q ss_pred HHHhhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 72 LQTIIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 72 L~~~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
|.+++... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 162 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DFG~a 238 (382)
T 3tt0_A 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLA 238 (382)
T ss_dssp HHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSCSCC
T ss_pred HHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC---CcEEEcccCcc
Confidence 99976432 245666999999999999999999999999999765 68999999999
Q ss_pred eEeecCc---ccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchh
Q psy6377 130 RVILDGI---EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELF 205 (383)
Q Consensus 130 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 205 (383)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ..
T Consensus 239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 315 (382)
T 3tt0_A 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KP 315 (382)
T ss_dssp CCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CC
T ss_pred cccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 8654332 2334467889999999999999999999999999999999 999999998888877776654322 22
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..+++++.+||.+||..||++|||+.+++++
T Consensus 316 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=308.31 Aligned_cols=230 Identities=18% Similarity=0.192 Sum_probs=185.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++.+..|+++..+..++.++...++|||++ +++|.+++..
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~--~~~L~~~~~~~~~ 100 (296)
T 3uzp_A 23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR 100 (296)
T ss_dssp EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTT
T ss_pred eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec--CCCHHHHHHhhcc
Confidence 3699999999999999999876 45678999999994444444555555557788899999999 5899997642
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccccCCCC
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IRELLGTPD 146 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~~gt~~ 146 (383)
..++.++.|++.||+|||++||+||||||+|||++.+...+.+||+|||++........ .....||+.
T Consensus 101 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (296)
T 3uzp_A 101 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccc
Confidence 23456679999999999999999999999999996333347899999999987654322 245679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCCC-cchhcCCCHHHHHHHHHhccc
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET---DSETFRNISKAQLDFP-DELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+..+.......+ +.....+++++.+||.+||..
T Consensus 181 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 3uzp_A 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred cCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhc
Confidence 999999999999999999999999999999999998743 3344555544443333 234467899999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||++|||++++++
T Consensus 261 dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 261 RFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CcCcCCCHHHHHH
Confidence 9999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=316.88 Aligned_cols=225 Identities=18% Similarity=0.227 Sum_probs=191.3
Q ss_pred ceEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+++ .+++.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||++. +++|.
T Consensus 39 g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~ 116 (322)
T 1p4o_A 39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPTLVIMELMT-RGDLK 116 (322)
T ss_dssp SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGG-GCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHH
T ss_pred eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHH-hcCCCCEeeeEEEEccCCccEEEEEeCC-CCcHH
Confidence 368999877 5788999999976 2345789999999 7799999999999999999999999999 99999
Q ss_pred Hhhcc----------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc
Q psy6377 74 TIIDD----------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 74 ~~l~~----------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~ 137 (383)
+++.. ..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 117 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~ 193 (322)
T 1p4o_A 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDY 193 (322)
T ss_dssp HHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT---CCEEECCTTCCCGGGGGGC
T ss_pred HHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC---CeEEECcCccccccccccc
Confidence 97643 2334566999999999999999999999999999865 6899999999986543321
Q ss_pred ---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHH
Q psy6377 138 ---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAK 213 (383)
Q Consensus 138 ---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 213 (383)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+..... ...++..+.
T Consensus 194 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 270 (322)
T 1p4o_A 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLF 270 (322)
T ss_dssp EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCC---CCCCCHHHH
Confidence 223457889999999999999999999999999999999 8999999888888877766543222 246799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6377 214 DFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 214 ~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+||.+||..||.+|||+.+++++
T Consensus 271 ~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 271 ELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.08 Aligned_cols=226 Identities=20% Similarity=0.292 Sum_probs=189.3
Q ss_pred eEEEEEE-----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADS-----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~-----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|++ ..+++.||+|++.. ....+.+|+.+++.+.+||||+++++++.+++..++|||+++ +++|.+
T Consensus 38 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~ 116 (313)
T 1t46_A 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC-YGDLLN 116 (313)
T ss_dssp EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHH
T ss_pred ceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCC-CCCHHH
Confidence 6889984 56889999999976 246688999999955599999999999999999999999999 999999
Q ss_pred hhccC------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 75 IIDDN------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 75 ~l~~~------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
++... .++.+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~ 193 (313)
T 1t46_A 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLAR 193 (313)
T ss_dssp HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT---TEEEECCCGGGS
T ss_pred HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC---CCEEEccccccc
Confidence 76432 234566999999999999999999999999999865 689999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.......+ ...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 271 (313)
T 1t46_A 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPE 271 (313)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCT
T ss_pred cccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC--Ccc
Confidence 7644322 223457889999999999999999999999999999998 9999998876665555544433322 234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++..+.++|.+||..||.+|||+.+++++
T Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 679999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=313.93 Aligned_cols=227 Identities=26% Similarity=0.401 Sum_probs=183.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcC---CCCCcccceEEEEeCCeEEEEEec-CCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCS---PSPRIVKLHDVFQTGEGAYYVSWN-TPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~---~hpnIvkl~~~~~~~~~~~lv~e~-~~~g 69 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++.+. +||||+++++++.+.+..++|||+ +. +
T Consensus 45 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~-~ 123 (312)
T 2iwi_A 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP-A 123 (312)
T ss_dssp EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSS-E
T ss_pred EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCC-C
Confidence 3689999999999999999975 2345678999988443 899999999999999999999999 56 9
Q ss_pred CcHHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 70 VTLQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 70 ~~L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
++|.+++.. ..++.+..||+.||+|||++||+||||||+||+++.+ .+.++|+|||++...... ......|
T Consensus 124 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--~~~~kl~dfg~~~~~~~~-~~~~~~~ 200 (312)
T 2iwi_A 124 QDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR--RGCAKLIDFGSGALLHDE-PYTDFDG 200 (312)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT--TTEEEECCCSSCEECCSS-CBCCCCS
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC--CCeEEEEEcchhhhcccC-cccccCC
Confidence 999997643 3345677999999999999999999999999999832 268999999999876543 3455679
Q ss_pred CCCcCCCcccccCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPIT-LAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.. .+......++ ..++..+.+||.+||..
T Consensus 201 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~----~~~~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP----AHVSPDCCALIRRCLAP 270 (312)
T ss_dssp CTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC----TTSCHHHHHHHHHHTCS
T ss_pred cccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc----ccCCHHHHHHHHHHccC
Confidence 9999999998877664 58999999999999999999997542 2333444443 46799999999999999
Q ss_pred CCCCCCCHHHHHcCcccCCcch
Q psy6377 223 NPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 223 dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
||++|||++|+++||||+....
T Consensus 271 ~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 271 KPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp STTTSCCHHHHHHSTTTCC---
T ss_pred ChhhCcCHHHHhcChhhcCchh
Confidence 9999999999999999987554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=305.13 Aligned_cols=223 Identities=18% Similarity=0.264 Sum_probs=190.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|++. +++.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..|+|||+++ +++|.+++...
T Consensus 23 ~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~ 99 (267)
T 3t9t_A 23 LVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPICLVTEFME-HGCLSDYLRTQRG 99 (267)
T ss_dssp EEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSCEEEECCCT-TCBHHHHHHHTTT
T ss_pred eEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCeEEEEeCCC-CCcHHHHHhhCcc
Confidence 68999986 778999999987 3467899999999 7789999999999999999999999999 99999976542
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~ 152 (383)
.+..+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......||+.|+|||+
T Consensus 100 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 100 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176 (267)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG---GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC---CCEEEcccccccccccccccccccccccccccChhh
Confidence 244566999999999999999999999999999766 689999999988653321 1233467889999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+..... ...++..+.+++.+||..||.+|||+.
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (267)
T 3t9t_A 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFS 253 (267)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHHHHHHHHccCChhhCcCHH
Confidence 998999999999999999999999 9999999888888887776543322 235789999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
+++++
T Consensus 254 ~ll~~ 258 (267)
T 3t9t_A 254 RLLRQ 258 (267)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=309.69 Aligned_cols=224 Identities=20% Similarity=0.257 Sum_probs=191.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
..||+|+++.+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+....|+|||++. |++|.+++..
T Consensus 27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~~~ 104 (288)
T 3kfa_A 27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYIITEFMT-YGNLLDYLRECN 104 (288)
T ss_dssp CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSEEEEEECCT-TEEHHHHHHHCC
T ss_pred eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCEEEEEEcCC-CCcHHHHHHhcc
Confidence 36899999999999999999873 466889999999 7789999999999999999999999999 9999997653
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++........ .....+|+.|+||
T Consensus 105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 105 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181 (288)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG---GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCH
T ss_pred cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC---CCEEEccCccceeccCCccccccCCccccCcCCh
Confidence 2234566899999999999999999999999999776 5899999999986543321 2334578899999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++||||||+++|+|++ |.+||.+.+.......+...... .....+++.+.+||.+||..||.+|||
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps 258 (288)
T 3kfa_A 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPS 258 (288)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHhCCChhhCcC
Confidence 99999999999999999999999999 99999998877777766554222 223567999999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
++++++
T Consensus 259 ~~~~~~ 264 (288)
T 3kfa_A 259 FAEIHQ 264 (288)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=316.06 Aligned_cols=224 Identities=19% Similarity=0.277 Sum_probs=185.9
Q ss_pred ceEEEEEEcCCCcE----EEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEV----FAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~----vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|+++.+|+. ||+|.+.. ....+.+|+.+++ .++||||+++++++. +...++||||+. +++|.+
T Consensus 27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~~~~~v~e~~~-~~~L~~ 103 (325)
T 3kex_A 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG-SLDHAHIVRLLGLCP-GSSLQLVTQYLP-LGSLLD 103 (325)
T ss_dssp CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHH-TCCCTTBCCEEEEEC-BSSEEEEEECCT-TCBSHH
T ss_pred ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEc-CCccEEEEEeCC-CCCHHH
Confidence 36999999999987 77777654 3467889999998 779999999999986 567999999999 999998
Q ss_pred hhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCC
Q psy6377 75 IIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGT 144 (383)
Q Consensus 75 ~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt 144 (383)
.+.. ..++.+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....||
T Consensus 104 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 180 (325)
T 3kex_A 104 HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP---SQVQVADFGVADLLPPDDKQLLYSEAKTP 180 (325)
T ss_dssp HHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS---SCEEECSCSGGGGSCCCTTCCC-----CC
T ss_pred HHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC---CeEEECCCCcccccCcccccccccCCCCc
Confidence 6543 3355677999999999999999999999999999765 6899999999987643322 2345688
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+..+.....+ ..++.++.++|.+||..|
T Consensus 181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~d 257 (325)
T 3kex_A 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QICTIDVYMVMVKCWMID 257 (325)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TTBCTTTTHHHHHHTCSC
T ss_pred ccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---CcCcHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999 99999998888877777665432222 346888999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|.+|||+.+++++
T Consensus 258 p~~Rps~~el~~~ 270 (325)
T 3kex_A 258 ENIRPTFKELANE 270 (325)
T ss_dssp TTTSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.78 Aligned_cols=231 Identities=22% Similarity=0.275 Sum_probs=187.3
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC--eEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|+++.+|+.||+|++.. ....+.+|+++++ .++||||+++++++.+.. ..|+||||+. |++|.+++
T Consensus 23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l 100 (396)
T 4eut_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK-KLNHKNIVKLFAIEEETTTRHKVLIMEFCP-CGSLYTVL 100 (396)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECTTTCCEEEEECCCT-TEEHHHHT
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHH-hcCCCCCCeEEEeeccCCCCeeEEEEecCC-CCCHHHHH
Confidence 3689999999999999999976 3456789999999 778999999999998765 7899999999 99999976
Q ss_pred ccC---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEe-ccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 77 DDN---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMM-GDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 77 ~~~---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~-~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
... .++.++.||+.||+|||++||+||||||+|||+. .++..+.+||+|||+++............||+.
T Consensus 101 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~ 180 (396)
T 4eut_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180 (396)
T ss_dssp TSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCT
T ss_pred HhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCcc
Confidence 542 2455669999999999999999999999999972 222336799999999998766666667789999
Q ss_pred cCCCccccc--------CCCChhhHHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhccCCC--------------
Q psy6377 147 YVAPEILHY--------EPITLAADMWSLGVTAYVLLTGFSPFGGE----TDSETFRNISKAQLDF-------------- 200 (383)
Q Consensus 147 y~aPE~l~~--------~~~~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~i~~~~~~~-------------- 200 (383)
|+|||++.+ ..++.++|||||||++|+|++|..||.+. ...+.+..+..+....
T Consensus 181 y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 260 (396)
T 4eut_A 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260 (396)
T ss_dssp TCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEE
T ss_pred ccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcc
Confidence 999999865 56788999999999999999999999753 3345555555543211
Q ss_pred -------CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 201 -------PDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 201 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+......++..+.++|.+||..||++|||+++++++
T Consensus 261 ~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111112345678999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=308.76 Aligned_cols=224 Identities=20% Similarity=0.292 Sum_probs=178.0
Q ss_pred ceEEEEEEcCC---CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIAT---GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~t---g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++..+ +..||+|++.. ....+.+|+.+++ .++||||+++++++. ++..|+|||++. +++|.++
T Consensus 29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~~~~lv~e~~~-~~~L~~~ 105 (281)
T 1mp8_A 29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-ENPVWIIMELCT-LGELRSF 105 (281)
T ss_dssp SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-SSSCEEEEECCT-TEEHHHH
T ss_pred eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCccceEEEEEc-cCccEEEEecCC-CCCHHHH
Confidence 36899998764 45799999876 2456889999999 778999999999984 567899999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPD 146 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~ 146 (383)
+... .++.+..|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.
T Consensus 106 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 182 (281)
T 1mp8_A 106 LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182 (281)
T ss_dssp HHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECC-------------------CCGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC---CCEEECccccccccCcccccccccCCCccc
Confidence 6532 244566999999999999999999999999999876 6899999999987644322 223457789
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+..+... .....+++.+.++|.+||..||+
T Consensus 183 y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~ 259 (281)
T 1mp8_A 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPS 259 (281)
T ss_dssp GCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999996 99999999888888877665432 22357899999999999999999
Q ss_pred CCCCHHHHHcC
Q psy6377 226 ERMTAKEALKH 236 (383)
Q Consensus 226 ~Rpt~~e~L~h 236 (383)
+|||+.+++++
T Consensus 260 ~Rps~~~l~~~ 270 (281)
T 1mp8_A 260 RRPRFTELKAQ 270 (281)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=313.15 Aligned_cols=226 Identities=23% Similarity=0.279 Sum_probs=181.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+++..|+|||++. |++|.+++
T Consensus 48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 125 (309)
T 2h34_A 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG-RLQEPHVVPIHDFGEIDGQLYVDMRLIN-GVDLAAML 125 (309)
T ss_dssp SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEECCC-CEEHHHHH
T ss_pred eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHh-hcCCCCeeEEEEEEeeCCeEEEEEEecC-CCCHHHHH
Confidence 36999999999999999999761 256889999999 7799999999999999999999999999 99999976
Q ss_pred cc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCCCcC
Q psy6377 77 DD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTPDYV 148 (383)
Q Consensus 77 ~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~y~ 148 (383)
.. ..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|+
T Consensus 126 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~ 202 (309)
T 2h34_A 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202 (309)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSCCC----------------CCGGGC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---CCEEEecCccCccccccccccccccCCCcCcc
Confidence 53 2345677999999999999999999999999999765 689999999998764432 233567999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+..++.++||||||+++|+|++|..||.+.+.... ..........+......++.++.++|.+||..||++||
T Consensus 203 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp CGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred CHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHH
Confidence 99999989999999999999999999999999988765533 33344444445556678999999999999999999999
Q ss_pred -CHHHHHc
Q psy6377 229 -TAKEALK 235 (383)
Q Consensus 229 -t~~e~L~ 235 (383)
|++++++
T Consensus 282 ~s~~~l~~ 289 (309)
T 2h34_A 282 VTCGDLSA 289 (309)
T ss_dssp SSHHHHHH
T ss_pred HhHHHHHH
Confidence 7888765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.23 Aligned_cols=226 Identities=23% Similarity=0.322 Sum_probs=177.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|.+..+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||++. +++|.+++
T Consensus 46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l 123 (310)
T 2wqm_A 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNELNIVLELAD-AGDLSRMI 123 (310)
T ss_dssp CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCC-SCBHHHHH
T ss_pred ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCcEEEEEecCC-CCCHHHHH
Confidence 3689999999999999999875 2356789999999 7789999999999999999999999999 99999876
Q ss_pred cc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCC
Q psy6377 77 DD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTP 145 (383)
Q Consensus 77 ~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~ 145 (383)
.. ..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++....... ......||+
T Consensus 124 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 200 (310)
T 2wqm_A 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTP 200 (310)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCC------------------CC
T ss_pred HHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC---CCEEEEeccceeeecCCCccccccCCCe
Confidence 42 2345667999999999999999999999999999765 689999999998754332 233457999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD--SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
.|+|||++.+..++.++||||||+++|+|++|..||.+... ......+.... ++......+++++.+||.+||..|
T Consensus 201 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~d 278 (310)
T 2wqm_A 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPD 278 (310)
T ss_dssp SSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTTSCHHHHHHHHHHTCSS
T ss_pred eEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcccccCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999999976543 23444444333 333334578999999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|.+|||+.+++++
T Consensus 279 p~~Rps~~~il~~ 291 (310)
T 2wqm_A 279 PEKRPDVTYVYDV 291 (310)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=311.12 Aligned_cols=230 Identities=22% Similarity=0.359 Sum_probs=180.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCC-CCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSP-SPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++. +|+.||+|++.. ....+.+|+.+++.+.. ||||+++++++.+.+..|+||| +. +++|.+++.
T Consensus 43 ~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~-~~~L~~~l~ 119 (313)
T 3cek_A 43 KVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG-NIDLNSWLK 119 (313)
T ss_dssp EEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC-SEEHHHHHH
T ss_pred EEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC-CCcHHHHHH
Confidence 68999885 599999999865 23567899999985543 7999999999999999999999 55 789999765
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCCCcC
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYV 148 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~y~ 148 (383)
.. .++.++.|++.||.|||++||+||||||+|||+++ +.+||+|||++........ .....||+.|+
T Consensus 120 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 195 (313)
T 3cek_A 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195 (313)
T ss_dssp HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCC--------------CCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccccccCccccccccCCCCCCCcC
Confidence 43 34456699999999999999999999999999964 5899999999987543321 23457999999
Q ss_pred CCccccc-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCCcchhcCCCHHHHHHH
Q psy6377 149 APEILHY-----------EPITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKAQLDFPDELFEDISPEAKDFI 216 (383)
Q Consensus 149 aPE~l~~-----------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li 216 (383)
|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+....... ......+.++.+||
T Consensus 196 aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 273 (313)
T 3cek_A 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDVL 273 (313)
T ss_dssp CHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC--CCCCCSCHHHHHHH
T ss_pred CHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc--CCcccchHHHHHHH
Confidence 9999865 47899999999999999999999999876443 3333333322221 22345688999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 217 AKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 217 ~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
.+||..||.+|||+.|+|+||||+...
T Consensus 274 ~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 274 KCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHccCCcccCcCHHHHhcCccccCCC
Confidence 999999999999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=316.32 Aligned_cols=226 Identities=18% Similarity=0.271 Sum_probs=189.3
Q ss_pred eEEEEEEcCCCc-----EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGE-----VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~-----~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|.+..+|+ .||+|++.. ....+.+|+.+++.+.+||||+++++++.+.+..|+|||+++ +++|.+
T Consensus 61 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~ 139 (333)
T 2i1m_A 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC-YGDLLN 139 (333)
T ss_dssp EEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHH
T ss_pred ceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCC-CCcHHH
Confidence 689999987775 799999976 235688999999955589999999999999999999999999 999999
Q ss_pred hhccC--------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec
Q psy6377 75 IIDDN--------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD 134 (383)
Q Consensus 75 ~l~~~--------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~ 134 (383)
++... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~ 216 (333)
T 2i1m_A 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMN 216 (333)
T ss_dssp HHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG---GEEEBCCCGGGCCGGG
T ss_pred HHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC---CeEEECcccccccccc
Confidence 76432 234566999999999999999999999999999876 6899999999986543
Q ss_pred Ccc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 135 GIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 135 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
... .....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+......+..+.......+ ....+++
T Consensus 217 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 294 (333)
T 2i1m_A 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA--QPAFAPK 294 (333)
T ss_dssp CTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC--CCTTCCH
T ss_pred ccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC--CCCCCCH
Confidence 322 223457889999999999999999999999999999998 9999998877666665555443332 2245689
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+.++|.+||..||.+|||+.+++++
T Consensus 295 ~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 295 NIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=305.19 Aligned_cols=230 Identities=18% Similarity=0.193 Sum_probs=184.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
..||+|++..+|+.||+|++.. ....+.+|+.+++.+..|++|..+..++.+.+..++|||++ +++|.+++..
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~--~~~L~~~~~~~~~ 100 (296)
T 4hgt_A 23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR 100 (296)
T ss_dssp SEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTS
T ss_pred eEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc--CCCHHHHHHHhcC
Confidence 4699999999999999998765 56789999999995544445555555567888899999999 5999997642
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccccCCCC
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IRELLGTPD 146 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~~gt~~ 146 (383)
..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++........ .....||+.
T Consensus 101 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (296)
T 4hgt_A 101 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCcc
Confidence 23456669999999999999999999999999994333347899999999997654322 234679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCCCC-cchhcCCCHHHHHHHHHhccc
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---ETFRNISKAQLDFP-DELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+ ......+++++.+||.+||..
T Consensus 181 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 4hgt_A 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred ccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999875432 33444444433333 233467899999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||++|||++++++
T Consensus 261 ~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 261 RFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=309.42 Aligned_cols=223 Identities=17% Similarity=0.229 Sum_probs=181.5
Q ss_pred ceEEEEEEcCCCc-------EEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIATGE-------VFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~tg~-------~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
..||+|+++.+|+ .||+|++.. ....+.+|+.+++ .++||||+++++++.+++..++|||++. |++|
T Consensus 22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L 99 (289)
T 4fvq_A 22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS-KLSHKHLVLNYGVCVCGDENILVQEFVK-FGSL 99 (289)
T ss_dssp EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHH-TSCCTTBCCEEEEECCTTCCEEEEECCT-TCBH
T ss_pred ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEEeCCCCEEEEECCC-CCCH
Confidence 3689999998884 799999876 3467889999999 7789999999999999999999999999 9999
Q ss_pred HHhhccCC-------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC-----CcEEEEeccceeEeecCccccc
Q psy6377 73 QTIIDDNL-------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN-----CDIKVCDFEISRVILDGIEIRE 140 (383)
Q Consensus 73 ~~~l~~~~-------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~-----~~ikL~DFGla~~~~~~~~~~~ 140 (383)
.+++.... ++.++.||+.||.|||++||+||||||+|||++.+... +.+||+|||++..... ...
T Consensus 100 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~ 176 (289)
T 4fvq_A 100 DTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDI 176 (289)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHH
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccc
Confidence 99765432 34566999999999999999999999999999876311 1299999999875432 233
Q ss_pred ccCCCCcCCCccccc-CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHH
Q psy6377 141 LLGTPDYVAPEILHY-EPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 218 (383)
..||+.|+|||++.+ ..++.++|||||||++|+|++| .+||.+..... ...+.......+ ...++++.+||.+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~l~~li~~ 251 (289)
T 4fvq_A 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQLP----APKAAELANLINN 251 (289)
T ss_dssp HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCC----CCSSCTTHHHHHH
T ss_pred cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCCCC----CCCCHHHHHHHHH
Confidence 568999999999987 7799999999999999999995 45555544433 333333433333 3457889999999
Q ss_pred hcccCCCCCCCHHHHHcC
Q psy6377 219 ILIKNPMERMTAKEALKH 236 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~h 236 (383)
||..||.+|||+.++++|
T Consensus 252 ~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 252 CMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HSCSSGGGSCCHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.38 Aligned_cols=224 Identities=19% Similarity=0.234 Sum_probs=181.7
Q ss_pred ceEEEEEEcCCCcEE----EEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVF----AAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~v----AvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|++..+|+.+ |+|.+.. ....+.+|+.+++ .++||||+++++++.++. .++|++++. +++|.+
T Consensus 29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~-~~~v~e~~~-~g~L~~ 105 (327)
T 3poz_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTST-VQLITQLMP-FGCLLD 105 (327)
T ss_dssp EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHH-HCCBTTBCCEEEEEESSS-EEEEEECCT-TCBHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCC-eEEEEEecC-CCcHHH
Confidence 369999999888765 7777754 3457889999999 778999999999998754 788999999 999999
Q ss_pred hhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCC
Q psy6377 75 IIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGT 144 (383)
Q Consensus 75 ~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt 144 (383)
++.. ..++.+..||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||
T Consensus 106 ~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3poz_A 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCTTHHHHHTTTCC-------CCC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC---CCEEEccCcceeEccCCcccccccCCCcc
Confidence 7644 2345677999999999999999999999999999876 6899999999987543322 2234568
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....++..+.+++.+||..|
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~ 259 (327)
T 3poz_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTIDVYMIMVKCWMID 259 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSC
T ss_pred ccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999 999999988877776665544222 22457899999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|.+|||+.+++++
T Consensus 260 p~~Rps~~ell~~ 272 (327)
T 3poz_A 260 ADSRPKFRELIIE 272 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCCCHHHHHHH
Confidence 9999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=313.53 Aligned_cols=226 Identities=19% Similarity=0.252 Sum_probs=189.5
Q ss_pred ceEEEEEEc-------CCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSI-------ATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~-------~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
..||+|++. .+++.||+|++... ...+.+|+.+++.+.+||||+++++++.+.+..|+|||++. +++
T Consensus 49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~ 127 (334)
T 2pvf_A 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGN 127 (334)
T ss_dssp CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCT-TCB
T ss_pred eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCC-CCc
Confidence 368999876 56789999999762 35688999999966599999999999999999999999999 999
Q ss_pred HHHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccce
Q psy6377 72 LQTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEIS 129 (383)
Q Consensus 72 L~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla 129 (383)
|.+++.... ++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~ 204 (334)
T 2pvf_A 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 204 (334)
T ss_dssp HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTC
T ss_pred HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC---CCEEEcccccc
Confidence 999765432 24566899999999999999999999999999765 68999999999
Q ss_pred eEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchh
Q psy6377 130 RVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELF 205 (383)
Q Consensus 130 ~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 205 (383)
........ .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 281 (334)
T 2pvf_A 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD---KP 281 (334)
T ss_dssp EECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---CC
T ss_pred ccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC---CC
Confidence 87654322 223457889999999988889999999999999999999 999999998888777776654222 23
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..++.++.++|.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 282 ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4679999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.07 Aligned_cols=225 Identities=19% Similarity=0.220 Sum_probs=189.1
Q ss_pred eEEEEEEc--CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSI--ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++ .+++.||+|++.. ....+.+|+.+++ .++||||+++++++ ..+..++|||++. +++|.+++.
T Consensus 25 ~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~-~~~~~~lv~e~~~-~~~L~~~l~ 101 (287)
T 1u59_A 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH-QLDNPYIVRLIGVC-QAEALMLVMEMAG-GGPLHKFLV 101 (287)
T ss_dssp EEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEE-ESSSEEEEEECCT-TEEHHHHHT
T ss_pred eEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHH-hCCCCCEeEEEEEe-cCCCcEEEEEeCC-CCCHHHHHH
Confidence 58999754 5788999999986 2456889999999 66899999999999 4567999999999 999999764
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPD 146 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~ 146 (383)
. ..++.+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++........ .....||+.
T Consensus 102 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 178 (287)
T 1u59_A 102 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPLK 178 (287)
T ss_dssp TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred hCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC---CCEEECcccceeeeccCcceeecccccccccc
Confidence 3 2345666999999999999999999999999999876 6899999999987643322 123356889
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..+... .....+++++.++|.+||..||.
T Consensus 179 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWE 255 (287)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGG
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChh
Confidence 999999998889999999999999999998 99999998888888777665422 22357899999999999999999
Q ss_pred CCCCHHHHHcCcc
Q psy6377 226 ERMTAKEALKHPW 238 (383)
Q Consensus 226 ~Rpt~~e~L~hp~ 238 (383)
+|||+.+++++.+
T Consensus 256 ~Rps~~~l~~~l~ 268 (287)
T 1u59_A 256 DRPDFLTVEQRMR 268 (287)
T ss_dssp GSCCHHHHHHHHH
T ss_pred hCcCHHHHHHHHH
Confidence 9999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.81 Aligned_cols=224 Identities=21% Similarity=0.260 Sum_probs=177.4
Q ss_pred ceEEEEE----EcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMAD----SIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~----~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+ +..+|+.||||++... ...+.+|+.+++ .++||||+++++++.+ ...+++|||+++ +++|.
T Consensus 24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~ 101 (295)
T 3ugc_A 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK-SLQHDNIVKYKGVCYSAGRRNLKLIMEYLP-YGSLR 101 (295)
T ss_dssp EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECHHHHTSCEEEEECCT-TCBHH
T ss_pred EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCCCceEEEEEeCC-CCCHH
Confidence 3689998 6789999999999762 356889999999 7789999999999864 356899999999 99999
Q ss_pred HhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----ccccc
Q psy6377 74 TIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELL 142 (383)
Q Consensus 74 ~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~ 142 (383)
+++... .++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++........ .....
T Consensus 102 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (295)
T 3ugc_A 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFGLTKVLPQDKEFFKVKEPGE 178 (295)
T ss_dssp HHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCCSCC-------------CTT
T ss_pred HHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC---CeEEEccCcccccccCCcceeeeccCCC
Confidence 976442 244566999999999999999999999999999876 6899999999987644322 22345
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCcchhc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS----------------ETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~ 206 (383)
+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+... ... ....
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~ 255 (295)
T 3ugc_A 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRL--PRPD 255 (295)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT-CCC--CCCT
T ss_pred CccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc-CcC--CCCc
Confidence 777899999999999999999999999999999999998653211 111112211 111 2235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+++++.+||.+||..||++|||+.|+++
T Consensus 256 ~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 256 GCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 68999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=316.15 Aligned_cols=227 Identities=20% Similarity=0.184 Sum_probs=182.7
Q ss_pred eEEEEEEcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC-
Q psy6377 5 SEEMADSIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~- 79 (383)
.||+|++ .+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..|+|||++. +++|.+++...
T Consensus 54 ~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~ 130 (321)
T 2qkw_B 54 KVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLS-FCRHPHLVSLIGFCDERNEMILIYKYME-NGNLKRHLYGSD 130 (321)
T ss_dssp EEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGG-SCCCTTBCCEEEECCCTTCCEEEEECCT-TCBTGGGSSSSC
T ss_pred eEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEEEEEEcCC-CCcHHHHHhccC
Confidence 6899986 47999999998762 356889999998 7789999999999999999999999999 99999976432
Q ss_pred ---------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCc
Q psy6377 80 ---------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDY 147 (383)
Q Consensus 80 ---------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y 147 (383)
.++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... ......||+.|
T Consensus 131 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 207 (321)
T 2qkw_B 131 LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN---FVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207 (321)
T ss_dssp CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT---CCEEECCCTTCEECSSSSCCCCBCCCEEETTT
T ss_pred CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC---CCEEEeecccccccccccccccccccCCCccc
Confidence 234566999999999999999999999999999765 689999999998754322 12345689999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-------HHhcc------CCCCcchhcCCCHHHHH
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN-------ISKAQ------LDFPDELFEDISPEAKD 214 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~-------i~~~~------~~~~~~~~~~~s~~~~~ 214 (383)
+|||++.+..++.++|||||||++|+|++|+.||.+....+.... ...+. ...+.......+..+.+
T Consensus 208 ~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 287 (321)
T 2qkw_B 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287 (321)
T ss_dssp CCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHH
T ss_pred cCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHH
Confidence 999999888999999999999999999999999987554322111 11111 01111222344678999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCc
Q psy6377 215 FIAKILIKNPMERMTAKEALKHP 237 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~hp 237 (383)
++.+||..||++|||+.|++++.
T Consensus 288 li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 288 TAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999999999999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.21 Aligned_cols=229 Identities=16% Similarity=0.114 Sum_probs=178.3
Q ss_pred ceEEEEEEcCC-----CcEEEEEEccCCcccHHHHHHHHHh--------------cCCCCCcccceEEEEeC----CeEE
Q psy6377 4 LSEEMADSIAT-----GEVFAAKFLESNPVRIHHEIALLSL--------------CSPSPRIVKLHDVFQTG----EGAY 60 (383)
Q Consensus 4 ~~V~~~~~~~t-----g~~vAvK~i~~~~~~~~~Ei~il~~--------------~~~hpnIvkl~~~~~~~----~~~~ 60 (383)
..||+|.++.+ ++.||+|++......+.+|+.+++. .+.||||+++++++.+. ...|
T Consensus 49 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~ 128 (364)
T 3op5_A 49 GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF 128 (364)
T ss_dssp CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEE
T ss_pred eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEE
Confidence 35899998765 6899999998755566666665553 34599999999999875 4589
Q ss_pred EEEecCCCcCcHHHhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee
Q psy6377 61 YVSWNTPLVVTLQTIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133 (383)
Q Consensus 61 lv~e~~~~g~~L~~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~ 133 (383)
+||||+ |++|.+++... .++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||+++...
T Consensus 129 lv~e~~--g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 129 MIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205 (364)
T ss_dssp EEEECE--EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-CTTCEEECCCTTCEESS
T ss_pred EEEeCC--CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-CCCeEEEEECCcceecc
Confidence 999999 79999976442 345667999999999999999999999999999832 23689999999998764
Q ss_pred cCcc--------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC-CCCcc-
Q psy6377 134 DGIE--------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQL-DFPDE- 203 (383)
Q Consensus 134 ~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~- 203 (383)
.... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+............... .....
T Consensus 206 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 285 (364)
T 3op5_A 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASL 285 (364)
T ss_dssp GGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHH
T ss_pred cCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHH
Confidence 3322 1334599999999999999999999999999999999999999986443332222111111 00011
Q ss_pred ---h--hcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 204 ---L--FEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 204 ---~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
. ...+++++.+|+..||..||.+|||+.++++
T Consensus 286 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 286 MDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1 1467999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=311.73 Aligned_cols=226 Identities=21% Similarity=0.303 Sum_probs=185.2
Q ss_pred ceEEEEEE-----cCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-eEEEEEecCCCcCcH
Q psy6377 4 LSEEMADS-----IATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-GAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~-----~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-~~~lv~e~~~~g~~L 72 (383)
..||+|++ ..+|+.||+|++.. ....+.+|+.+++.+.+||||+++++++.+.+ .+++|||++. |++|
T Consensus 41 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~-~~~L 119 (316)
T 2xir_A 41 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK-FGNL 119 (316)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCT-TEEH
T ss_pred eeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCC-CCcH
Confidence 36899984 46789999999976 23468899999996668999999999988755 4899999999 9999
Q ss_pred HHhhccCC----------------------chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDNL----------------------VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~~----------------------~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++.... ++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 120 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~ 196 (316)
T 2xir_A 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLAR 196 (316)
T ss_dssp HHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGS
T ss_pred HHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEECCCcccc
Confidence 99765432 34566899999999999999999999999999865 689999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH-HHHhccCCCCcchh
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFR-NISKAQLDFPDELF 205 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~ 205 (383)
....... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+. .+..+.. . ...
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~ 273 (316)
T 2xir_A 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-M--RAP 273 (316)
T ss_dssp CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-C--CCC
T ss_pred ccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-C--CCC
Confidence 6543322 234568899999999999999999999999999999998 999998877554443 3333322 1 122
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..+++.+.++|.+||..||.+|||+.++++|
T Consensus 274 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4579999999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=311.11 Aligned_cols=224 Identities=19% Similarity=0.235 Sum_probs=180.6
Q ss_pred ceEEEEEEcCCCcEE----EEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGEVF----AAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~~v----AvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|+++.+|+.+ |+|.+.. ....+.+|+.+++ .++||||+++++++.++. .++|++++. +++|.+
T Consensus 29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~-~~~v~~~~~-~g~L~~ 105 (327)
T 3lzb_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTST-VQLITQLMP-FGCLLD 105 (327)
T ss_dssp EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHT-TCCBTTBCCCCEEEESSS-EEEEECCCS-SCBHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHH-hCCCCCeeEEEEEEecCC-ceEEEEecC-CCcHHH
Confidence 369999999999876 5665543 3467889999999 778999999999998754 888999999 999999
Q ss_pred hhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCC
Q psy6377 75 IIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGT 144 (383)
Q Consensus 75 ~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt 144 (383)
++.. ..++.+..||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....... .....||
T Consensus 106 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3lzb_A 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCTTC----------------CCC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC---CCEEEccCcceeEccCccccccccCCCcc
Confidence 7643 2345677999999999999999999999999999876 6899999999987643322 2234568
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+..+..... ...++.++.+||.+||..|
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~d 259 (327)
T 3lzb_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICTIDVYMIMRKCWMID 259 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTBCHHHHHHHHHHTCSS
T ss_pred ccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999 9999999888877776665542222 2457899999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|.+|||+.|+++.
T Consensus 260 p~~Rps~~ell~~ 272 (327)
T 3lzb_A 260 ADSRPKFRELIIE 272 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.18 Aligned_cols=223 Identities=20% Similarity=0.267 Sum_probs=191.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|+++.+|..||||++.. ....+.+|+.+++ .++||||+++++++.+...+|+|||++. +++|.+++...
T Consensus 235 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~ 312 (495)
T 1opk_A 235 EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYIITEFMT-YGNLLDYLRECNR 312 (495)
T ss_dssp SEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHHHHHSCT
T ss_pred EEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHH-hcCCCCEeeEEEEEecCCcEEEEEEccC-CCCHHHHHHhcCc
Confidence 689999999999999999986 4567889999999 7789999999999999999999999999 99999977532
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||
T Consensus 313 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE 389 (495)
T 1opk_A 313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389 (495)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC---CcEEEeecccceeccCCceeecCCCcCCcceeCHh
Confidence 234566899999999999999999999999999766 6899999999987643221 22345678899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.. . .....+++.+.+||.+||..||.+|||+
T Consensus 390 ~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~ 466 (495)
T 1opk_A 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-M--ERPEGCPEKVYELMRACWQWNPSDRPSF 466 (495)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHHHcCcChhHCcCH
Confidence 9998999999999999999999999 9999999888777776654422 1 2235689999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
.++++
T Consensus 467 ~el~~ 471 (495)
T 1opk_A 467 AEIHQ 471 (495)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=306.87 Aligned_cols=224 Identities=20% Similarity=0.260 Sum_probs=181.1
Q ss_pred ceEEEEE----EcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcH
Q psy6377 4 LSEEMAD----SIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~----~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L 72 (383)
..||+|+ +..+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+. ..+++|||++. +++|
T Consensus 35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~L 112 (302)
T 4e5w_A 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR-NLYHENIVKYKGICTEDGGNGIKLIMEFLP-SGSL 112 (302)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHH-TCCCTTBCCEEEEEEC---CCEEEEEECCT-TCBH
T ss_pred eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHH-hCCCCCeeeeeeEEecCCCceEEEEEEeCC-CCcH
Confidence 3689998 678999999999975 2367889999999 77899999999999877 67899999999 9999
Q ss_pred HHhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccc
Q psy6377 73 QTIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IREL 141 (383)
Q Consensus 73 ~~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~ 141 (383)
.+++.. ..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++........ ....
T Consensus 113 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 189 (302)
T 4e5w_A 113 KEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEYYTVKDDR 189 (302)
T ss_dssp HHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCCEEECCCCT
T ss_pred HHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC---CCEEECcccccccccCCCcceeccCCC
Confidence 997632 2345667999999999999999999999999999876 6899999999988654432 2345
Q ss_pred cCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------------cHH-HHHHHHhccCCCCcchhc
Q psy6377 142 LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET--------------DSE-TFRNISKAQLDFPDELFE 206 (383)
Q Consensus 142 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~--------------~~~-~~~~i~~~~~~~~~~~~~ 206 (383)
.||+.|+|||++.+..++.++||||||+++|+|++|..|+.... ... ....+..+. ......
T Consensus 190 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 266 (302)
T 4e5w_A 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK---RLPCPP 266 (302)
T ss_dssp TCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC---CCCCCT
T ss_pred CCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC---CCCCCC
Confidence 68888999999999999999999999999999999998864221 111 122222221 122335
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+++.+.+||.+||..||.+|||+.++++
T Consensus 267 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 267 NCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 78999999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.70 Aligned_cols=223 Identities=18% Similarity=0.252 Sum_probs=177.5
Q ss_pred eEEEEEEc---CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSI---ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~---~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++ .++..||||++.. ....+.+|+.+++ .++||||+++++++.+.+..|+||||++ +++|.+++
T Consensus 60 ~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~sL~~~l 137 (373)
T 2qol_A 60 EVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG-QFDHPNIIRLEGVVTKSKPVMIVTEYME-NGSLDSFL 137 (373)
T ss_dssp EEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHHH
T ss_pred EEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCceEEEEeCCC-CCcHHHHH
Confidence 68999887 5788899999976 2356889999999 7799999999999999999999999999 99999987
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCC
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTP 145 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~ 145 (383)
... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+
T Consensus 138 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 214 (373)
T 2qol_A 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN---LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214 (373)
T ss_dssp HTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC----------------------C
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC---CCEEECcCccccccccCCccceeccCCCcCC
Confidence 543 244566999999999999999999999999999765 6899999999987643321 11234577
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+....+ ...++..+.++|.+||..||
T Consensus 215 ~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMDCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTTCBHHHHHHHHHHTCSSG
T ss_pred CccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccccHHHHHHHHHHhCcCh
Confidence 8999999999999999999999999999998 9999999888887777765532221 23678999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
.+|||+.++++
T Consensus 292 ~~RPs~~~i~~ 302 (373)
T 2qol_A 292 NNRPKFEQIVS 302 (373)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=308.77 Aligned_cols=224 Identities=21% Similarity=0.236 Sum_probs=178.9
Q ss_pred eEEEEEEcC---CCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCe-----EEEEEecCCCcC
Q psy6377 5 SEEMADSIA---TGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-----AYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~---tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-----~~lv~e~~~~g~ 70 (383)
.||+|+... +++.||+|++... ...+.+|+.+++ .++||||+++++++.+.+. .++|||++. ++
T Consensus 49 ~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~-~~ 126 (313)
T 3brb_A 49 SVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK-DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK-YG 126 (313)
T ss_dssp CEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEC-------CEEEEEECCT-TC
T ss_pred EEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHh-cCCCCCeeeeeEEEeeccccCCcccEEEEeccc-CC
Confidence 588887765 5668999999751 345889999999 7789999999999987653 599999999 99
Q ss_pred cHHHhhc------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-
Q psy6377 71 TLQTIID------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE- 137 (383)
Q Consensus 71 ~L~~~l~------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~- 137 (383)
+|.+++. ...++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 127 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~~ 203 (313)
T 3brb_A 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLSKKIYSGDYY 203 (313)
T ss_dssp BHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---SCEEECSCSCC---------
T ss_pred CHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcEEEeecCcceeccccccc
Confidence 9999762 12345667999999999999999999999999999765 6899999999987644321
Q ss_pred --cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 138 --IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.....+++.|+|||++.+..++.++||||||+++|+|++ |.+||.+....+....+..+... .....+++.+.+
T Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 280 (313)
T 3brb_A 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL---KQPEDCLDELYE 280 (313)
T ss_dssp -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCBTTCCHHHHH
T ss_pred CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---CCCccccHHHHH
Confidence 223457889999999999999999999999999999999 99999998888888777665432 223578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+|.+||..||.+|||+.+++++
T Consensus 281 li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 281 IMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=305.03 Aligned_cols=223 Identities=17% Similarity=0.229 Sum_probs=186.7
Q ss_pred ceEEEE--EEcCCCcEEEEEEccCC------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMA--DSIATGEVFAAKFLESN------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~--~~~~tg~~vAvK~i~~~------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+| .+..+++.||||++... ...+.+|+.+++ .++||||+++++++ ..+..|+|||++. +++|.++
T Consensus 31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~-~~~~~~lv~e~~~-~~~L~~~ 107 (291)
T 1xbb_A 31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGIC-EAESWMLVMEMAE-LGPLNKY 107 (291)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH-TCCCTTBCCEEEEE-ESSSEEEEEECCT-TEEHHHH
T ss_pred eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEE-CCCCcEEEEEeCC-CCCHHHH
Confidence 368999 55678899999999762 456889999999 77899999999999 5678899999999 9999997
Q ss_pred hccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc----ccccCCC
Q psy6377 76 IDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI----RELLGTP 145 (383)
Q Consensus 76 l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~----~~~~gt~ 145 (383)
+... .++.+..|++.||+|||++||+||||||+|||++.+ +.++|+|||++......... ....+|+
T Consensus 108 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 184 (291)
T 1xbb_A 108 LQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPV 184 (291)
T ss_dssp HHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCSEEEC----CCCG
T ss_pred HHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC---CcEEEccCCcceeeccCCCcccccccCCCCc
Confidence 6543 345667999999999999999999999999999876 58999999999876543321 2234678
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+..+... .....+++.+.++|.+||..||
T Consensus 185 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSST
T ss_pred eeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCh
Confidence 8999999998889999999999999999999 99999998888777776655422 2235689999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
.+|||+.++++
T Consensus 262 ~~Rps~~~l~~ 272 (291)
T 1xbb_A 262 ENRPGFAAVEL 272 (291)
T ss_dssp TTSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=311.54 Aligned_cols=228 Identities=15% Similarity=0.062 Sum_probs=181.6
Q ss_pred eEEEEEEcC---CCcEEEEEEccCCcc---------------cHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEE
Q psy6377 5 SEEMADSIA---TGEVFAAKFLESNPV---------------RIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYV 62 (383)
Q Consensus 5 ~V~~~~~~~---tg~~vAvK~i~~~~~---------------~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv 62 (383)
.||+|++.. ++..+|+|++..... .+.+|+.+++ .++||||+++++++.+ ....|+|
T Consensus 52 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~-~l~h~ni~~~~~~~~~~~~~~~~~~lv 130 (345)
T 2v62_A 52 LIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK-QLDYLGIPLFYGSGLTEFKGRSYRFMV 130 (345)
T ss_dssp CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH-TCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc-cccccCcceeecccccccCCCcEEEEE
Confidence 699999987 899999999876332 2445666666 6689999999999988 7789999
Q ss_pred EecCCCcCcHHHhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc
Q psy6377 63 SWNTPLVVTLQTIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI 136 (383)
Q Consensus 63 ~e~~~~g~~L~~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~ 136 (383)
||++ |++|.+++... .++.++.||+.||+|||++||+||||||+|||++.++ .+.+||+|||+++......
T Consensus 131 ~e~~--~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kL~Dfg~a~~~~~~~ 207 (345)
T 2v62_A 131 MERL--GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNG 207 (345)
T ss_dssp EECE--EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTSEEECCCTTCEESSGGG
T ss_pred Eecc--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCcEEEEeCCCceeccccc
Confidence 9999 69999977543 3456679999999999999999999999999998763 2489999999998764322
Q ss_pred c--------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCCcchh-
Q psy6377 137 E--------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET--DSETFRNISKAQLDFPDELF- 205 (383)
Q Consensus 137 ~--------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~- 205 (383)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ...............|....
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (345)
T 2v62_A 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLK 287 (345)
T ss_dssp CCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHH
T ss_pred ccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHh
Confidence 1 244579999999999999999999999999999999999999996532 22222222222223333221
Q ss_pred ----cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 206 ----EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 206 ----~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..+++++.++|.+||..||++|||++++++.
T Consensus 288 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 288 WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1789999999999999999999999998763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=303.92 Aligned_cols=224 Identities=20% Similarity=0.226 Sum_probs=183.4
Q ss_pred ceEEEEEEcC---CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIA---TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~---tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++.. ++..||+|++.. ....+.+|+.+++ .++||||+++++++.+ +..|+|||++. +++|.++
T Consensus 26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~-~~~~~v~e~~~-~~~L~~~ 102 (281)
T 3cc6_A 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK-NLDHPHIVKLIGIIEE-EPTWIIMELYP-YGELGHY 102 (281)
T ss_dssp SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHH-HHCCTTBCCEEEEECS-SSCEEEEECCT-TCBHHHH
T ss_pred eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHH-hCCCCCcceEEEEEcC-CCCEEEEecCC-CCCHHHH
Confidence 3689998653 445699999986 2466889999999 6689999999999875 45789999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPD 146 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~ 146 (383)
+... .+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....+|+.
T Consensus 103 l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 179 (281)
T 3cc6_A 103 LERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP---ECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179 (281)
T ss_dssp HHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET---TEEEECCCCGGGCC---------CCCCCGG
T ss_pred HHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC---CcEEeCccCCCcccccccccccccCCCCcc
Confidence 6432 244566899999999999999999999999999876 5899999999986543321 233457889
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+..+..... ...+++.+.++|.+||..||+
T Consensus 180 y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGG
T ss_pred eeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHccCCch
Confidence 999999999999999999999999999998 9999998887777776665543222 245789999999999999999
Q ss_pred CCCCHHHHHcC
Q psy6377 226 ERMTAKEALKH 236 (383)
Q Consensus 226 ~Rpt~~e~L~h 236 (383)
+|||+.+++++
T Consensus 257 ~Rps~~ell~~ 267 (281)
T 3cc6_A 257 DRPRFTELVCS 267 (281)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.27 Aligned_cols=219 Identities=18% Similarity=0.260 Sum_probs=185.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCC-eEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE-GAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~-~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|... |+.||||++.. ....+.+|+.+++ .++||||+++++++.+.. ..|+||||+. +++|.+++...
T Consensus 208 ~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~iv~e~~~-~g~L~~~l~~~~~ 283 (450)
T 1k9a_A 208 DVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTEYMA-KGSLVDYLRSRGR 283 (450)
T ss_dssp EEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHH-TCCCTTBCCEEEEEECTTSCEEEEEECCT-TCBHHHHHHHHCT
T ss_pred eEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHH-hccCCCEEEEEEEEEcCCCceEEEEEecC-CCcHHHHHHhcCC
Confidence 68899874 88999999987 4567899999999 779999999999987665 7999999999 99999976542
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .....+++.|+|||++
T Consensus 284 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~ 358 (450)
T 1k9a_A 284 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEAL 358 (450)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---SCEEECCCTTCEECC--------CCCTTTSCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC---CCEEEeeCCCccccccc--ccCCCCCcceeCHHHh
Confidence 234566999999999999999999999999999765 68999999999865332 2334678999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
.+..++.++|||||||++|+|++ |..||.+.+..+....+..+... .....+++.+.+||.+||..||.+|||+.+
T Consensus 359 ~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~ 435 (450)
T 1k9a_A 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQ 435 (450)
T ss_dssp HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999999999999998 99999998888888777665321 123468999999999999999999999999
Q ss_pred HHc
Q psy6377 233 ALK 235 (383)
Q Consensus 233 ~L~ 235 (383)
+++
T Consensus 436 l~~ 438 (450)
T 1k9a_A 436 LRE 438 (450)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.83 Aligned_cols=224 Identities=21% Similarity=0.203 Sum_probs=184.4
Q ss_pred ceEEEEEEcCCCc---EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeE-EEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATGE---VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGA-YYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg~---~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~-~lv~e~~~~g~~L~~ 74 (383)
..||+|++..+++ .||+|++.. ....+.+|+.+++ .++||||+++++++.+.+.. +++|+++. +++|.+
T Consensus 35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~v~e~~~-~~~L~~ 112 (298)
T 3pls_A 35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR-GLNHPNVLALIGIMLPPEGLPHVLLPYMC-HGDLLQ 112 (298)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEECCSSSCCEEEECCCT-TCBHHH
T ss_pred ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEecCCCCcEEEEeccc-CCCHHH
Confidence 3689998766655 899999876 2356789999999 77899999999999877665 99999999 999999
Q ss_pred hhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-----cccccc
Q psy6377 75 IIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-----EIRELL 142 (383)
Q Consensus 75 ~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-----~~~~~~ 142 (383)
++... .++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ......
T Consensus 113 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 189 (298)
T 3pls_A 113 FIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLARDILDREYYSVQQHRHAR 189 (298)
T ss_dssp HHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECCTTSSCTTTTGGGGCSCCSSCTT
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcEEeCcCCCcccccCCcccccccCcCCC
Confidence 77542 234566899999999999999999999999999765 689999999998543321 223456
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+.... ....+++.+.++|.+||.
T Consensus 190 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~ 266 (298)
T 3pls_A 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVMQQCWE 266 (298)
T ss_dssp CGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTC
T ss_pred CCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCccchHHHHHHHHHHcc
Confidence 8899999999999999999999999999999999 666677777666666665554322 224678999999999999
Q ss_pred cCCCCCCCHHHHHc
Q psy6377 222 KNPMERMTAKEALK 235 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~ 235 (383)
.||.+|||+.++++
T Consensus 267 ~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 267 ADPAVRPTFRVLVG 280 (298)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.68 Aligned_cols=222 Identities=21% Similarity=0.284 Sum_probs=187.4
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
..||+|++. +++.||+|++.. ....+.+|+.+++ .++||||+++++++. .+..++|||++. +++|.+++..
T Consensus 27 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~v~e~~~-~~~L~~~l~~~~ 102 (279)
T 1qpc_A 27 GEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMK-QLQHQRLVRLYAVVT-QEPIYIITEYME-NGSLVDFLKTPS 102 (279)
T ss_dssp EEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSCEEEEECCT-TCBHHHHTTSHH
T ss_pred eEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHH-hCCCcCcceEEEEEc-CCCcEEEEecCC-CCCHHHHHhcCC
Confidence 368999875 677899999976 4567889999999 678999999999986 456899999999 9999997653
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++........ .....+++.|+||
T Consensus 103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179 (279)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC---CCEEECCCcccccccCcccccccCCCCccCccCh
Confidence 2345666999999999999999999999999999765 6899999999987654322 2234578899999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++||||||+++|+|++ |..||.+.+..+....+..+... .....+++++.++|.+||..||++|||
T Consensus 180 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps 256 (279)
T 1qpc_A 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPEELYQLMRLCWKERPEDRPT 256 (279)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccccHHHHHHHHHHhccChhhCCC
Confidence 99998889999999999999999999 99999998888887777655322 223467999999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
++++++
T Consensus 257 ~~~l~~ 262 (279)
T 1qpc_A 257 FDYLRS 262 (279)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.53 Aligned_cols=225 Identities=18% Similarity=0.223 Sum_probs=182.3
Q ss_pred ceEEEEEEcCCC----cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATG----EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg----~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|+++.++ ..||+|++.. ....+.+|+.+++ .+.||||+++++++.+.+..++|||++. +++|.+
T Consensus 58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~ 135 (333)
T 1mqb_A 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG-QFSHHNIIRLEGVISKYKPMMIITEYME-NGALDK 135 (333)
T ss_dssp SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEEEEEECCT-TEEHHH
T ss_pred eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEecCCCcEEEEeCCC-CCcHHH
Confidence 368999887664 3599999976 2346789999999 7799999999999999999999999999 999999
Q ss_pred hhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccC
Q psy6377 75 IIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLG 143 (383)
Q Consensus 75 ~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~g 143 (383)
++... .++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....+
T Consensus 136 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (333)
T 1mqb_A 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEATYTTSGGKI 212 (333)
T ss_dssp HHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC-----------------CC
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC---CcEEECCCCcchhhccccccccccCCCCc
Confidence 76542 345666999999999999999999999999999765 6899999999987643321 122346
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....++..+.++|.+||..
T Consensus 213 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~ 289 (333)
T 1mqb_A 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQ 289 (333)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCS
T ss_pred cccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC---CcccCCHHHHHHHHHHcCC
Confidence 788999999999999999999999999999998 999999988888877776653221 2246789999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||.+|||+.+++++
T Consensus 290 ~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 290 ERARRPKFADIVSI 303 (333)
T ss_dssp STTTSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=323.59 Aligned_cols=221 Identities=21% Similarity=0.333 Sum_probs=187.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|++. ++..||||++.. ....+.+|+.+++ .++||||+++++++. ....|+|||++. +++|.+++...
T Consensus 203 ~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~-~~~~~lv~e~~~-~g~L~~~l~~~~~ 278 (454)
T 1qcf_A 203 EVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMK-TLQHDKLVKLHAVVT-KEPIYIITEFMA-KGSLLDFLKSDEG 278 (454)
T ss_dssp EEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSSCEEEECCCT-TCBHHHHHHSHHH
T ss_pred EEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHh-hCCCCCEeeEEEEEe-CCccEEEEeecC-CCcHHHHHHhccC
Confidence 68999875 577899999986 4567899999999 779999999999986 667999999999 99999977532
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
.+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+|||
T Consensus 279 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE 355 (454)
T 1qcf_A 279 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355 (454)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT---CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC---CcEEEeeCCCceEcCCCceeccCCCcccccccCHH
Confidence 234566999999999999999999999999999765 6899999999987543221 22345678899999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++....++.++|||||||++|+|++ |..||.+.+..+....+..+.. .+ ....+++++.+||.+||..||++|||+
T Consensus 356 ~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dp~~RPt~ 432 (454)
T 1qcf_A 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPENCPEELYNIMMRCWKNRPEERPTF 432 (454)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CC--CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999999999999999999999999 9999999988888887766532 22 124689999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
+++++
T Consensus 433 ~~i~~ 437 (454)
T 1qcf_A 433 EYIQS 437 (454)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=300.42 Aligned_cols=219 Identities=17% Similarity=0.255 Sum_probs=178.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeC-CeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|.+ +|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+. +..|+|||++. +++|.+++..
T Consensus 36 ~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~ 111 (278)
T 1byg_A 36 DVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTEYMA-KGSLVDYLRSRGR 111 (278)
T ss_dssp EEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CCEEEECCCT-TEEHHHHHHHHHH
T ss_pred eEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCCceEEEEecCC-CCCHHHHHHhccc
Confidence 6899986 489999999987 4567889999999 77899999999997544 47899999999 8999997643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
..++.+..|++.||.|||++||+||||||+||+++.+ +.++|+|||++...... .....+++.|+|||++
T Consensus 112 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~ 186 (278)
T 1byg_A 112 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEAL 186 (278)
T ss_dssp HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC--------------CCTTTSCHHHH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC---CcEEEeecccccccccc--ccCCCccccccCHHHh
Confidence 2345667999999999999999999999999999765 68999999999865432 2334688999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+.. ......+++.+.++|.+||..||.+|||+.+
T Consensus 187 ~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 263 (278)
T 1byg_A 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ 263 (278)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 99999999999999999999998 9999999888777777655432 2233578999999999999999999999999
Q ss_pred HHc
Q psy6377 233 ALK 235 (383)
Q Consensus 233 ~L~ 235 (383)
+++
T Consensus 264 l~~ 266 (278)
T 1byg_A 264 LRE 266 (278)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=310.65 Aligned_cols=224 Identities=18% Similarity=0.240 Sum_probs=175.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|++. |+.||||++.. ......+|+.+++ .++||||+++++++.+.. .+|+||||++ +++|.+++.
T Consensus 39 ~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 114 (322)
T 3soc_A 39 CVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLP-GMKHENILQFIGAEKRGTSVDVDLWLITAFHE-KGSLSDFLK 114 (322)
T ss_dssp EEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTST-TCCCTTBCCEEEEEEEECSSSEEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHh-cCCCCCchhhcceeccCCCCCceEEEEEecCC-CCCHHHHHH
Confidence 58999875 89999999976 2345667888888 778999999999998754 3799999999 999999875
Q ss_pred cC-----CchhhHHHHHHHHHHHHhC----------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cc
Q psy6377 78 DN-----LVVPFESDELSSLAYLHHR----------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IR 139 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLHs~----------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~ 139 (383)
.. .++.++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||+++....... ..
T Consensus 115 ~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~---~~~kL~DFg~a~~~~~~~~~~~~~ 191 (322)
T 3soc_A 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN---LTACIADFGLALKFEAGKSAGDTH 191 (322)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT---CCEEECCCTTCEEECTTSCCCCCT
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC---CeEEEccCCcccccccccCccccc
Confidence 43 3456679999999999999 99999999999999765 6899999999987654332 33
Q ss_pred cccCCCCcCCCccccc-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccC
Q psy6377 140 ELLGTPDYVAPEILHY-----EPITLAADMWSLGVTAYVLLTGFSPFGGETDS----------------ETFRNISKAQL 198 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~----------------~~~~~i~~~~~ 198 (383)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.....
T Consensus 192 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (322)
T 3soc_A 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271 (322)
T ss_dssp TCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred cCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC
Confidence 4679999999999876 34667899999999999999999999765321 11122221111
Q ss_pred C-CCcchhc--CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 199 D-FPDELFE--DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 199 ~-~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
. .....+. ..++++.+||.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1111221 12456999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=307.08 Aligned_cols=229 Identities=20% Similarity=0.239 Sum_probs=182.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|++ .+|+.||+|++.. ....+.+|+.+++ .+.||||+++++++.+.+..++|||++. +++|.+++...
T Consensus 45 ~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 121 (326)
T 3uim_A 45 KVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERLLVYPYMA-NGSVASCLRER 121 (326)
T ss_dssp EEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGG-TCCCTTBCCCCEEECCSSCCEEEEECCT-TCBHHHHHHCC
T ss_pred EEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHH-hccCCCccceEEEEecCCceEEEEEecc-CCCHHHHHHhc
Confidence 6899974 5799999999976 3346899999998 7789999999999999999999999999 99999976542
Q ss_pred ----------CchhhHHHHHHHHHHHHhC---CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCC
Q psy6377 80 ----------LVVPFESDELSSLAYLHHR---KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGT 144 (383)
Q Consensus 80 ----------~~~~~~~qil~aL~yLHs~---givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt 144 (383)
.+..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||++........ .....||
T Consensus 122 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 198 (326)
T 3uim_A 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDFGLAKLMDYKDTHVTTAVRGT 198 (326)
T ss_dssp STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT---CCEEECCCSSCEECCSSSSCEECCCCSC
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC---CCEEeccCccccccCcccccccccccCC
Confidence 2346679999999999999 99999999999999765 6899999999987643322 3345699
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHhccC-----------CCCcchhcCCC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGE----TDSETFRNISKAQL-----------DFPDELFEDIS 209 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~i~~~~~-----------~~~~~~~~~~s 209 (383)
+.|+|||++.+..++.++|||||||++|+|++|..||... .............. ..+.......+
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 3uim_A 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278 (326)
T ss_dssp GGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHH
T ss_pred cCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHH
Confidence 9999999998888999999999999999999999999521 11111111111100 01111222335
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6377 210 PEAKDFIAKILIKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 210 ~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~ 239 (383)
..+.+++.+||..||.+|||+.++++|.+-
T Consensus 279 ~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 279 EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 789999999999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=302.70 Aligned_cols=224 Identities=17% Similarity=0.196 Sum_probs=183.2
Q ss_pred ceEEEEEEcCCC---cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEE-EeCCeEEEEEecCCCcCcHHH
Q psy6377 4 LSEEMADSIATG---EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVF-QTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 4 ~~V~~~~~~~tg---~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~-~~~~~~~lv~e~~~~g~~L~~ 74 (383)
..||+|++..++ ..+|+|.+.. ....+.+|+.+++ .++||||+++++++ .+++..++|||++. +++|.+
T Consensus 39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~v~e~~~-~~~L~~ 116 (298)
T 3f66_A 39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGSPLVVLPYMK-HGDLRN 116 (298)
T ss_dssp EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEECCSSSCCEEEEECCT-TCBHHH
T ss_pred ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHH-hCCCCCEeeeeeEEEcCCCceEEEEeCCC-CCCHHH
Confidence 368999865443 4689999876 2356889999999 77899999999985 55668899999999 999999
Q ss_pred hhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----ccccc
Q psy6377 75 IIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELL 142 (383)
Q Consensus 75 ~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~ 142 (383)
++... .++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++........ .....
T Consensus 117 ~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 193 (298)
T 3f66_A 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEYYSVHNKTGAK 193 (298)
T ss_dssp HHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECSCGGGCCCSCGGGCBC-----CC
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC---CCEEECcccccccccccchhccccccCCC
Confidence 77442 234566899999999999999999999999999765 6899999999986543221 23346
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+..+.....+ ..+++.+.++|.+||.
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~ 270 (298)
T 3f66_A 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWH 270 (298)
T ss_dssp BCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTC
T ss_pred CCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 7889999999999999999999999999999999 77888888877777777666544332 4578999999999999
Q ss_pred cCCCCCCCHHHHHc
Q psy6377 222 KNPMERMTAKEALK 235 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~ 235 (383)
.||.+|||+.++++
T Consensus 271 ~~p~~Rps~~ell~ 284 (298)
T 3f66_A 271 PKAEMRPSFSELVS 284 (298)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=299.53 Aligned_cols=219 Identities=19% Similarity=0.266 Sum_probs=183.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|++. |+.||+|++.. ....+.+|+.+++ .++||||+++++++.+. ...++|||+++ |++|.++
T Consensus 24 g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 99 (271)
T 3kmu_A 24 GELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLR-IFSHPNVLPVLGACQSPPAPHPTLITHWMP-YGSLYNV 99 (271)
T ss_dssp EEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGC-CCSCTTEECEEEEECTTTSSSCEEEEECCT-TCBHHHH
T ss_pred ceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHH-hcCCCchhheEEEEccCCCCCeEeeecccC-CCcHHHH
Confidence 368999974 89999999976 2346889999998 77999999999999887 78899999999 9999997
Q ss_pred hccC--------CchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCC
Q psy6377 76 IDDN--------LVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTP 145 (383)
Q Consensus 76 l~~~--------~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 145 (383)
+... .++.+..|++.||+|||++| |+||||||+|||++.+ +.++|+|||++... ......||+
T Consensus 100 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~---~~~~l~~~~~~~~~----~~~~~~~t~ 172 (271)
T 3kmu_A 100 LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED---MTARISMADVKFSF----QSPGRMYAP 172 (271)
T ss_dssp HHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT---SCEEEEGGGSCCTT----SCTTCBSCG
T ss_pred HhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC---cceeEEeccceeee----cccCccCCc
Confidence 7543 23456699999999999999 9999999999999765 68899998886542 223457899
Q ss_pred CcCCCcccccCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 146 DYVAPEILHYEPI---TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 146 ~y~aPE~l~~~~~---~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....... .....+++++.++|.+||..
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 250 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPGISPHVSKLMKICMNE 250 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTTCCHHHHHHHHHHTCS
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcCC
Confidence 9999999986554 348999999999999999999999988877777666544332 23457899999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||++|||++++++
T Consensus 251 ~p~~Rps~~~il~ 263 (271)
T 3kmu_A 251 DPAKRPKFDMIVP 263 (271)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.08 Aligned_cols=225 Identities=19% Similarity=0.248 Sum_probs=176.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhc-CCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLC-SPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~-~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++ +|+.||||++.. ......+|.+++... ++||||+++++++.+ ....|+||||+. +++|.+++..
T Consensus 23 ~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~ 99 (301)
T 3q4u_A 23 EVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE-MGSLYDYLQL 99 (301)
T ss_dssp EEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT-TCBHHHHHTT
T ss_pred EEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc-CCCHHHHHhh
Confidence 5899986 799999999976 455667788887743 689999999999654 345899999999 9999998754
Q ss_pred C-----CchhhHHHHHHHHHHHH--------hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----ccc
Q psy6377 79 N-----LVVPFESDELSSLAYLH--------HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRE 140 (383)
Q Consensus 79 ~-----~~~~~~~qil~aL~yLH--------s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~ 140 (383)
. .++.++.|++.||+||| ++||+||||||+|||++.+ +.+||+|||+|+....... ...
T Consensus 100 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 176 (301)
T 3q4u_A 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---GQCCIADLGLAVMHSQSTNQLDVGNNP 176 (301)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT---SCEEECCCTTCEEEETTTTEEECCCCC
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC---CCEEEeeCCCeeecccccccccccccc
Confidence 3 34566699999999999 9999999999999999865 6899999999987654332 223
Q ss_pred ccCCCCcCCCcccccC------CCChhhHHHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHHHhcc---
Q psy6377 141 LLGTPDYVAPEILHYE------PITLAADMWSLGVTAYVLLTG----------FSPFGGETD----SETFRNISKAQ--- 197 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvilyelltg----------~~Pf~~~~~----~~~~~~i~~~~--- 197 (383)
..||+.|+|||++.+. .++.++|||||||++|+|++| .+||.+... ...........
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~ 256 (301)
T 3q4u_A 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR 256 (301)
T ss_dssp CCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred cccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC
Confidence 4799999999999876 455799999999999999999 889865432 23333332222
Q ss_pred CCCCcch-hcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 198 LDFPDEL-FEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 198 ~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
...|... ....++.+.+||.+||..||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 257 PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 1222211 1235678999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=300.04 Aligned_cols=222 Identities=19% Similarity=0.299 Sum_probs=172.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|++. ..+|+|++.. ....+.+|+.+++ .+.||||++++++ ......++|||++. |++|.+.+..
T Consensus 39 ~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~-~~~~~~~lv~e~~~-~~~L~~~l~~ 112 (289)
T 3og7_A 39 TVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLR-KTRHVNILLFMGY-STAPQLAIVTQWCE-GSSLYHHLHA 112 (289)
T ss_dssp EEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEE-ECSSSCEEEEECCC-EEEHHHHHTT
T ss_pred EEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHH-hCCCCcEEEEEee-ccCCccEEEEEecC-CCcHHHHHhh
Confidence 58888754 3599999875 2356889999999 7889999999995 46677899999999 9999997643
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec---CcccccccCCCCcC
Q psy6377 79 -------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD---GIEIRELLGTPDYV 148 (383)
Q Consensus 79 -------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~---~~~~~~~~gt~~y~ 148 (383)
..++.+..|++.||.|||++||+||||||+|||++.+ +.++|+|||++..... ........||+.|+
T Consensus 113 ~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 189 (289)
T 3og7_A 113 SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED---NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189 (289)
T ss_dssp C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC------------------CCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEEccceeccccccccccccccccCCCcccc
Confidence 2344667999999999999999999999999999876 6899999999986543 22234567999999
Q ss_pred CCcccc---cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-hccCCCC-cchhcCCCHHHHHHHHHhcccC
Q psy6377 149 APEILH---YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS-KAQLDFP-DELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 149 aPE~l~---~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~-~~~~~~~-~~~~~~~s~~~~~li~~~L~~d 223 (383)
|||++. +.+++.++||||||+++|+|++|..||.+....+....+. .+....+ ......+++.+.+||.+||..|
T Consensus 190 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 269 (289)
T 3og7_A 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKK 269 (289)
T ss_dssp CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSS
T ss_pred CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCC
Confidence 999986 6678999999999999999999999998876665554443 3333222 2344578999999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|.+|||+.++++
T Consensus 270 p~~Rps~~ell~ 281 (289)
T 3og7_A 270 RDERPSFPRILA 281 (289)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=309.26 Aligned_cols=224 Identities=23% Similarity=0.319 Sum_probs=163.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEE--------eCCeEEEEEecCCCcCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQ--------TGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~--------~~~~~~lv~e~~~~g~~ 71 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++.+.+||||+++++++. ....++++||++. ++
T Consensus 42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~--g~ 119 (337)
T 3ll6_A 42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK--GQ 119 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS--EE
T ss_pred eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC--CC
Confidence 3699999999999999998865 34568899999996667999999999994 3345899999997 68
Q ss_pred HHHhhcc---------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc--
Q psy6377 72 LQTIIDD---------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-- 138 (383)
Q Consensus 72 L~~~l~~---------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~-- 138 (383)
|.+++.. ..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.........
T Consensus 120 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~ 196 (337)
T 3ll6_A 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTISHYPDYSW 196 (337)
T ss_dssp HHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT---SCEEBCCCTTCBCCSSCC----
T ss_pred HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC---CCEEEecCccceeccccCcccc
Confidence 8775432 234567799999999999999 9999999999999865 68999999999875432221
Q ss_pred -----------ccccCCCCcCCCccc---ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch
Q psy6377 139 -----------RELLGTPDYVAPEIL---HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL 204 (383)
Q Consensus 139 -----------~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 204 (383)
....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+........ .....+.
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~-- 270 (337)
T 3ll6_A 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYSIPP-- 270 (337)
T ss_dssp ---------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCT--
T ss_pred cccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----CcccCCc--
Confidence 145699999999998 56778999999999999999999999998765443332 2222222
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~ 238 (383)
....+..+.+||.+||..||.+|||+.|+++|.+
T Consensus 271 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 271 HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2456788999999999999999999999998743
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=307.80 Aligned_cols=225 Identities=20% Similarity=0.248 Sum_probs=183.2
Q ss_pred ceEEEEE----EcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEE--eCCeEEEEEecCCCcCcHH
Q psy6377 4 LSEEMAD----SIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQ--TGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~----~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~--~~~~~~lv~e~~~~g~~L~ 73 (383)
..||+|+ +..+|+.||+|++... ...+.+|+.+++ .++||||+++++++. +....|+|||+++ +++|.
T Consensus 37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~L~ 114 (327)
T 3lxl_A 37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK-ALHSDFIVKYRGVSYGPGRQSLRLVMEYLP-SGCLR 114 (327)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSSCEEEEEEECCT-TCBHH
T ss_pred eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHH-hcCCCceeEEEEEEecCCCceEEEEEeecC-CCCHH
Confidence 4689998 6789999999999762 355889999999 779999999999987 4567999999999 99999
Q ss_pred Hhhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----ccccc
Q psy6377 74 TIIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELL 142 (383)
Q Consensus 74 ~~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~ 142 (383)
+++.. ..++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||++........ .....
T Consensus 115 ~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 191 (327)
T 3lxl_A 115 DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLAKLLPLDKDYYVVREPGQ 191 (327)
T ss_dssp HHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCGGGCEECCTTCSEEECSSCCC
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC---CCEEEcccccceecccCCccceeeccCC
Confidence 97643 2345666999999999999999999999999999876 6899999999997654332 22346
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCcchhcC
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---------------ETFRNISKAQLDFPDELFED 207 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~ 207 (383)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+..+. .......
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 268 (327)
T 3lxl_A 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ---RLPAPPA 268 (327)
T ss_dssp SCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC---CCCCCTT
T ss_pred ccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc---CCCCCCc
Confidence 888899999999999999999999999999999999999654322 1122222221 1222357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 208 ISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 208 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 269 CPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=307.96 Aligned_cols=225 Identities=19% Similarity=0.243 Sum_probs=179.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|+++.+|+.||+|++.. ....+.+|+.+++ .++||||+++++++.. ....|+|||++. +++|.++
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 120 (317)
T 2buj_A 43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR-LFNHPNILRLVAYCLRERGAKHEAWLLLPFFK-RGTLWNE 120 (317)
T ss_dssp EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEEEETTEEEEEEEEECCT-TCBHHHH
T ss_pred eEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHh-hcCCCCeeeEEEEEEeccCCCceeEEEEEeCC-CCcHHHH
Confidence 3689999999999999998865 3567889999999 7799999999999973 347899999999 9999986
Q ss_pred hcc----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------
Q psy6377 76 IDD----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-------- 137 (383)
Q Consensus 76 l~~----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-------- 137 (383)
+.. ..++.++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++........
T Consensus 121 l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~ 197 (317)
T 2buj_A 121 IERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGSMNQACIHVEGSRQALTL 197 (317)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCSSCEESCEEEESHHHHHHH
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC---CCEEEEecCcchhcccccccccccccc
Confidence 543 2345667999999999999999999999999999765 6899999999886432111
Q ss_pred --cccccCCCCcCCCcccccCC---CChhhHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCCcchhcCCCH
Q psy6377 138 --IRELLGTPDYVAPEILHYEP---ITLAADMWSLGVTAYVLLTGFSPFGGET--DSETFRNISKAQLDFPDELFEDISP 210 (383)
Q Consensus 138 --~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 210 (383)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. .......+ .....+|. ...++.
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~ 274 (317)
T 2buj_A 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQLSIPQ--SPRHSS 274 (317)
T ss_dssp HHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC--CCC--CTTSCH
T ss_pred cccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-hccCCCCc--cccCCH
Confidence 12346899999999987554 6899999999999999999999995421 11112222 22222222 346799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 211 EAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 211 ~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
++.++|.+||..||.+|||+.+++++
T Consensus 275 ~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 275 ALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 99999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.47 Aligned_cols=226 Identities=14% Similarity=0.141 Sum_probs=179.4
Q ss_pred eEEEEEEcCC--------CcEEEEEEccCCcccHHHHHHHHHhcCCCCCccc---------------ceEEEEe-CCeEE
Q psy6377 5 SEEMADSIAT--------GEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVK---------------LHDVFQT-GEGAY 60 (383)
Q Consensus 5 ~V~~~~~~~t--------g~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvk---------------l~~~~~~-~~~~~ 60 (383)
.||+|+++.| |+.||+|++... ..+.+|+.+++ .+.||||++ +++++.. +...|
T Consensus 57 ~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 134 (352)
T 2jii_A 57 ILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQ-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF 134 (352)
T ss_dssp EEEEEEECC-----------CEEEEEEETT-STHHHHHHHHH-HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEE
T ss_pred EEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHH-HhcccchhhhhhhhccCCccCccchhhccccCCcEEE
Confidence 6999999884 899999998754 67999999999 668999998 6777776 77899
Q ss_pred EEEecCCCcCcHHHhhccC--------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 61 YVSWNTPLVVTLQTIIDDN--------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 61 lv~e~~~~g~~L~~~l~~~--------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+|||++ +++|.+++... .++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus 135 lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~-~~~~kl~Dfg~a~~~ 211 (352)
T 2jii_A 135 LVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED-QSQVTLAGYGFAFRY 211 (352)
T ss_dssp EEEECC--CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE-EEEEEECCGGGCBCS
T ss_pred EEecCC--CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC-CceEEEecCcceeec
Confidence 999998 69999976542 3456669999999999999999999999999998651 127999999999875
Q ss_pred ecCcc--------cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHh----ccCC
Q psy6377 133 LDGIE--------IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGET-DSETFRNISK----AQLD 199 (383)
Q Consensus 133 ~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~i~~----~~~~ 199 (383)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..... ....
T Consensus 212 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 291 (352)
T 2jii_A 212 CPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291 (352)
T ss_dssp SGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC
T ss_pred cCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh
Confidence 43221 133479999999999999999999999999999999999999998764 3332222221 1111
Q ss_pred CC--cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 200 FP--DELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 200 ~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
++ ...+..+++++.+||.+||..||++|||++++++
T Consensus 292 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 292 FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 11 1223467999999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.94 Aligned_cols=222 Identities=22% Similarity=0.264 Sum_probs=182.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
..||+|++.. +..||||++.. ....+.+|+.+++ .++||||+++++++.+ +..|+|||++. +++|.+++..
T Consensus 198 g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~-~~~~iv~e~~~-~gsL~~~l~~~~ 273 (452)
T 1fmk_A 198 GEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYIVTEYMS-KGSLLDFLKGET 273 (452)
T ss_dssp CEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEEECCCT-TCBHHHHHSHHH
T ss_pred eEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHH-hCCCCCEeeEEEEEcC-CceEEEehhhc-CCCHHHHHHhcC
Confidence 3689999864 46799999986 3467899999999 7789999999999876 77899999999 9999997753
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.|+||
T Consensus 274 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350 (452)
T ss_dssp HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC--------------CCGGGSCH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC---CCEEECCCccceecCCCceecccCCcccccccCH
Confidence 2344666999999999999999999999999999866 6899999999987643321 2234577899999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++|||||||++|+|++ |..||.+....+....+..+.... ....+++.+.+||.+||..||++|||
T Consensus 351 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPESLHDLMCQCWRKEPEERPT 427 (452)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999999999999 999999998888888776553221 22467999999999999999999999
Q ss_pred HHHHHc
Q psy6377 230 AKEALK 235 (383)
Q Consensus 230 ~~e~L~ 235 (383)
++++++
T Consensus 428 ~~~l~~ 433 (452)
T 1fmk_A 428 FEYLQA 433 (452)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.42 Aligned_cols=221 Identities=21% Similarity=0.260 Sum_probs=177.5
Q ss_pred EEEEEcCCCcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHhhccC
Q psy6377 7 EMADSIATGEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 7 ~~~~~~~tg~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
|.+.+..+|+.||+|++... ...+.+|+.+++ .+.||||+++++++.+. ..+++|||++. +++|.+++...
T Consensus 52 ~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~ 129 (318)
T 3lxp_A 52 YDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR-TLYHEHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRH 129 (318)
T ss_dssp ECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTTTEEEEEECCCT-TCBHHHHGGGS
T ss_pred EccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHH-hCCCcchhhEEEEEecCCCceEEEEEeccc-CCcHHHHHhhC
Confidence 33456678999999999862 356889999999 77899999999999984 67899999999 99999987653
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCCcCCC
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPDYVAP 150 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~y~aP 150 (383)
.++.+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....||+.|+||
T Consensus 130 ~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP 206 (318)
T 3lxp_A 130 SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC---CCEEECCccccccccccccccccccCCCCCceeeCh
Confidence 345666999999999999999999999999999765 6899999999998754432 2335688899999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHhccCCCCcchhcCCCHHHHHH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---------------ETFRNISKAQLDFPDELFEDISPEAKDF 215 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~l 215 (383)
|++.+..++.++|||||||++|+|++|..||...... .....+... . .......++.++.+|
T Consensus 207 E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~l 283 (318)
T 3lxp_A 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-E--RLPRPDKCPAEVYHL 283 (318)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-C--CCCCCTTCCHHHHHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-c--CCCCCccccHHHHHH
Confidence 9999989999999999999999999999999754321 111111111 1 122335689999999
Q ss_pred HHHhcccCCCCCCCHHHHHc
Q psy6377 216 IAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 216 i~~~L~~dP~~Rpt~~e~L~ 235 (383)
|.+||..||.+|||+.++++
T Consensus 284 i~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 284 MKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.10 Aligned_cols=239 Identities=23% Similarity=0.287 Sum_probs=193.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEe------CCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT------GEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~------~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+++.+|+.||||++.. ....+.+|+.+++ .++||||+++++++.+ ++..|+||||+. |++|.
T Consensus 29 ~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~-ggsL~ 106 (676)
T 3qa8_A 29 YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK-KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE-GGDLR 106 (676)
T ss_dssp BCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHH-HCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCS-SCBHH
T ss_pred EEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHH-hCCCCCCCceeeeecccccccCCCeEEEEEEeCC-CCCHH
Confidence 689999999999999999876 2456889999999 6789999999999765 677899999999 99999
Q ss_pred Hhhcc---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCC
Q psy6377 74 TIIDD---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT 144 (383)
Q Consensus 74 ~~l~~---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt 144 (383)
+++.. ..++.++.|++.||+|||++||+||||||+|||++.++....++|+|||++.............||
T Consensus 107 ~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt 186 (676)
T 3qa8_A 107 KYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186 (676)
T ss_dssp HHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSC
T ss_pred HHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCC
Confidence 97643 335567799999999999999999999999999987654456999999999987665556667899
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--------------HHhccC------CCCcch
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRN--------------ISKAQL------DFPDEL 204 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~--------------i~~~~~------~~~~~~ 204 (383)
+.|+|||++.+..++.++|||||||++|+|++|..||.+......+.. ...+.. +.|...
T Consensus 187 ~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l 266 (676)
T 3qa8_A 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHL 266 (676)
T ss_dssp CTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCC
T ss_pred cccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhh
Confidence 999999999999999999999999999999999999976533221100 001111 112233
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
...+++.+.+||.+||.+||++|||+.++++||||......
T Consensus 267 ~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 267 SGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred chhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 44567899999999999999999999999999999765543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.43 Aligned_cols=224 Identities=20% Similarity=0.286 Sum_probs=183.0
Q ss_pred eEEEEEEcC-CCc--EEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIA-TGE--VFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~-tg~--~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|++.. +++ .||+|++.. ....+.+|+.+++ .++||||+++++++.+.. .++|||++. +++|.+
T Consensus 33 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~-~~~v~e~~~-~~~L~~ 109 (291)
T 1u46_A 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVLTPP-MKMVTELAP-LGSLLD 109 (291)
T ss_dssp CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSS-CEEEEECCT-TCBHHH
T ss_pred eEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHH-hCCCCCcccEEEEEccCC-ceeeEeccc-CCCHHH
Confidence 588998643 343 699999875 1356789999999 668999999999998755 899999999 999998
Q ss_pred hhcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccC
Q psy6377 75 IIDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLG 143 (383)
Q Consensus 75 ~l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~g 143 (383)
.+.. ..+..+..|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....+
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 186 (291)
T 1u46_A 110 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKV 186 (291)
T ss_dssp HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred HHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC---CCEEEccccccccccccccchhhhccCCC
Confidence 6543 2345666999999999999999999999999999876 5899999999987644322 223467
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+......++ ....++.++.++|.+||..
T Consensus 187 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAH 264 (291)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCS
T ss_pred CceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCcCcCHHHHHHHHHHccC
Confidence 889999999998889999999999999999999 9999999988888887766554433 2357899999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||.+|||+.+++++
T Consensus 265 ~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 265 KPEDRPTFVALRDF 278 (291)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=316.89 Aligned_cols=223 Identities=13% Similarity=0.107 Sum_probs=171.3
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc------------ccHHHHHHHHHhcC--------CCCCcccceEE------------
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP------------VRIHHEIALLSLCS--------PSPRIVKLHDV------------ 52 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~------------~~~~~Ei~il~~~~--------~hpnIvkl~~~------------ 52 (383)
.||+|++ +|+.||||++.... ..+.+|+.+++.+. .||||++++++
T Consensus 35 ~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv 112 (336)
T 2vuw_A 35 EVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112 (336)
T ss_dssp EEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHH
T ss_pred EEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHH
Confidence 6899997 78999999998621 66889999988443 35555555554
Q ss_pred -----EEe-------------CCeEEEEEecCCCcCcHHHhh-----ccCCchhhHHHHHHHHHHHH-hCCceecCCCCC
Q psy6377 53 -----FQT-------------GEGAYYVSWNTPLVVTLQTII-----DDNLVVPFESDELSSLAYLH-HRKIAHLDIKPQ 108 (383)
Q Consensus 53 -----~~~-------------~~~~~lv~e~~~~g~~L~~~l-----~~~~~~~~~~qil~aL~yLH-s~givHrDLKp~ 108 (383)
|.+ .+..|+||||+. +|++.+.+ .+..++.++.||+.||+||| ++||+||||||+
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~-~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~ 191 (336)
T 2vuw_A 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF-GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191 (336)
T ss_dssp HHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEEC-CCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGG
T ss_pred HHHHHHhhhccccccCccccccCeEEEEEEecC-CCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHH
Confidence 443 788999999999 77655533 33446677799999999999 999999999999
Q ss_pred cEEEeccCC-----------------CCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHH-
Q psy6377 109 NLVMMGDFP-----------------NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVT- 170 (383)
Q Consensus 109 NILl~~~~~-----------------~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi- 170 (383)
|||++.++. ...+||+|||+|+..... ..+||+.|+|||++.+.. +.++||||+|++
T Consensus 192 NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~ 266 (336)
T 2vuw_A 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKE 266 (336)
T ss_dssp GEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHH
T ss_pred HEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCC
Confidence 999987631 128999999999987543 358999999999998776 999999998776
Q ss_pred HHHHHhCCCCCCCCCc-HHHHHHHHh---ccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH-cCcccC
Q psy6377 171 AYVLLTGFSPFGGETD-SETFRNISK---AQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL-KHPWLM 240 (383)
Q Consensus 171 lyelltg~~Pf~~~~~-~~~~~~i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L-~hp~~~ 240 (383)
.+++++|..||.+... ......+.. .....+...+..+++++++||++||.+| |++|+| +||||+
T Consensus 267 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 267 NNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred CcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 7788999999954211 112222221 2223334456678999999999999987 999999 999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.22 Aligned_cols=224 Identities=17% Similarity=0.193 Sum_probs=176.9
Q ss_pred eEEEEEEcCCC---cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEE-eCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATG---EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg---~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~-~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+...++ ..||+|.+.. ....+.+|+.+++ .++||||+++++++. .++..|+||||+. +++|.++
T Consensus 104 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~~lv~e~~~-~g~L~~~ 181 (373)
T 3c1x_A 104 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGSPLVVLPYMK-HGDLRNF 181 (373)
T ss_dssp EEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTST-TCCCTTBCCCCEEECCCSSCCEEEEECCT-TCBHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCCCeEEEEECCC-CCCHHHH
Confidence 58999876443 4689999876 2356889999999 778999999999864 4567899999999 9999998
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cccccC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLG 143 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~g 143 (383)
+... .++.+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+
T Consensus 182 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~ 258 (373)
T 3c1x_A 182 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEFDSVHNKTGAKL 258 (373)
T ss_dssp HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC---------------------C
T ss_pred HhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC---CCEEEeeccccccccccccccccccCCCCC
Confidence 7542 234566899999999999999999999999999765 6899999999986543221 233457
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+.....+ ..++..+.++|.+||..
T Consensus 259 ~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~ 335 (373)
T 3c1x_A 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHP 335 (373)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCS
T ss_pred cccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCC
Confidence 889999999999999999999999999999999 78999888777777776665533322 46789999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||++|||+.+++++
T Consensus 336 dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 336 KAEMRPSFSELVSR 349 (373)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=317.56 Aligned_cols=230 Identities=17% Similarity=0.167 Sum_probs=189.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
..||+|++..+|+.||||++.. ....+.+|+.+++.+..|++|+.+..++.+.+..++|||++ +++|.+++..
T Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~--g~sL~~ll~~~~~ 98 (483)
T 3sv0_A 21 GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98 (483)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTT
T ss_pred EEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC--CCCHHHHHHhhcC
Confidence 3699999999999999999876 45679999999996666688888888888889999999999 6999997642
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccccCCCC
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IRELLGTPD 146 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~~gt~~ 146 (383)
..++.++.||+.||+|||++||+||||||+|||++.+...+.+||+|||+++....... ....+||+.
T Consensus 99 ~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 178 (483)
T 3sv0_A 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178 (483)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcc
Confidence 33556779999999999999999999999999995333347899999999998654332 125679999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHhccC-CCCcchhcCCCHHHHHHHHHhccc
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD---SETFRNISKAQL-DFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+..... .........++.++.+||..||..
T Consensus 179 Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~ 258 (483)
T 3sv0_A 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSL 258 (483)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTC
T ss_pred ccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999987554 333444433322 222344467899999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||++||+++++++
T Consensus 259 dP~~RPs~~el~~ 271 (483)
T 3sv0_A 259 RFDDKPDYSYLKR 271 (483)
T ss_dssp CTTCCCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.44 Aligned_cols=223 Identities=18% Similarity=0.210 Sum_probs=184.5
Q ss_pred ceEEEEEEc--CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSI--ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~--~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|..+ .++..||||++.. ....+.+|+.+++ .++|||||++++++.+ +..|+||||+. +++|.+++
T Consensus 350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~-~~~~lv~E~~~-~g~L~~~l 426 (613)
T 2ozo_A 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-EALMLVMEMAG-GGPLHKFL 426 (613)
T ss_dssp SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHT-TCCCTTBCCEEEEEES-SSEEEEEECCT-TCBHHHHH
T ss_pred cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHH-hCCCCCEeeEEEEecc-CCeEEEEEeCC-CCcHHHHH
Confidence 368888775 4567899999976 3467899999999 7799999999999976 56999999999 99999976
Q ss_pred cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCC
Q psy6377 77 DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTP 145 (383)
Q Consensus 77 ~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~ 145 (383)
.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+
T Consensus 427 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 503 (613)
T 2ozo_A 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPL 503 (613)
T ss_dssp TTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCSTTTTCC--------------CC
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC---CcEEEeeccCcccccCCCceeeeccCCCCcc
Confidence 43 2345666999999999999999999999999999876 6899999999986543221 12234668
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.... ....+++++.+||.+||..||
T Consensus 504 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP 580 (613)
T 2ozo_A 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPELYALMSDCWIYKW 580 (613)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSST
T ss_pred ceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999998 999999999988888887664221 224689999999999999999
Q ss_pred CCCCCHHHHHc
Q psy6377 225 MERMTAKEALK 235 (383)
Q Consensus 225 ~~Rpt~~e~L~ 235 (383)
++|||+.++++
T Consensus 581 ~~RPs~~~l~~ 591 (613)
T 2ozo_A 581 EDRPDFLTVEQ 591 (613)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=301.22 Aligned_cols=219 Identities=21% Similarity=0.299 Sum_probs=173.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNL-- 80 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~-- 80 (383)
.||+|++. |+.||+|++.. ....+.+|+.+++ .++||||+++++++. +..++||||++ |++|.+++....
T Consensus 23 ~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~--~~~~lv~e~~~-~~~L~~~l~~~~~~ 96 (307)
T 2eva_A 23 VVCKAKWR--AKDVAIKQIESESERKAFIVELRQLS-RVNHPNIVKLYGACL--NPVCLVMEYAE-GGSLYNVLHGAEPL 96 (307)
T ss_dssp EEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHH-HCCCTTBCCEEEBCT--TTTEEEEECCT-TCBHHHHHHCSSSE
T ss_pred eEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHh-cCCCCCcCeEEEEEc--CCcEEEEEcCC-CCCHHHHHhccCCC
Confidence 68999864 88999999976 3467889999999 678999999999886 45899999999 999999875432
Q ss_pred -------chhhHHHHHHHHHHHHh---CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCC
Q psy6377 81 -------VVPFESDELSSLAYLHH---RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAP 150 (383)
Q Consensus 81 -------~~~~~~qil~aL~yLHs---~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aP 150 (383)
++.+..|++.||+|||+ +||+||||||+|||++.++ ..+||+|||++..... ......||+.|+||
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aP 172 (307)
T 2eva_A 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACDIQT--HMTNNKGSAAWMAP 172 (307)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT--TEEEECCCCC--------------CCTTSSCH
T ss_pred CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC--CEEEEccccccccccc--ccccCCCCCceECh
Confidence 34555899999999999 8999999999999998652 2489999999986533 23345799999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS--ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|++.+..++.++|||||||++|+|++|+.||...... .....+..+. .......++..+.++|.+||..||.+||
T Consensus 173 E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rp 249 (307)
T 2eva_A 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRP 249 (307)
T ss_dssp HHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCc
Confidence 9999999999999999999999999999999865432 2222333222 2233467899999999999999999999
Q ss_pred CHHHHHcC
Q psy6377 229 TAKEALKH 236 (383)
Q Consensus 229 t~~e~L~h 236 (383)
|+++++++
T Consensus 250 s~~ell~~ 257 (307)
T 2eva_A 250 SMEEIVKI 257 (307)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.63 Aligned_cols=222 Identities=17% Similarity=0.225 Sum_probs=184.8
Q ss_pred eEEEE--EEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMA--DSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~--~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+| ..+.+++.||||++.. ....+.+|+.+++ .++|||||++++++++ +..++||||+. +++|.+++
T Consensus 384 ~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~-~~~~lv~E~~~-~g~L~~~l 460 (635)
T 4fl3_A 384 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGICEA-ESWMLVMEMAE-LGPLNKYL 460 (635)
T ss_dssp EEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHH-HCCCTTBCCEEEEEES-SSEEEEEECCT-TEEHHHHH
T ss_pred EEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEec-CCEEEEEEccC-CCCHHHHH
Confidence 58888 4457789999999976 1357889999999 7789999999999975 56899999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPD 146 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~ 146 (383)
... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.
T Consensus 461 ~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~ 537 (635)
T 4fl3_A 461 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVK 537 (635)
T ss_dssp HHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCTTHHHHTTC-------------CGG
T ss_pred hhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---CCEEEEEcCCccccccCccccccccCCCCcee
Confidence 543 345677999999999999999999999999999876 5899999999986543321 223456789
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..|+.++|||||||++|+|++ |..||.+.+..+....+..+.... ....+++++.+||.+||..||+
T Consensus 538 y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~ 614 (635)
T 4fl3_A 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLMNLCWTYDVE 614 (635)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTT
T ss_pred eeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHh
Confidence 999999999999999999999999999998 999999999888888777664322 2246899999999999999999
Q ss_pred CCCCHHHHHc
Q psy6377 226 ERMTAKEALK 235 (383)
Q Consensus 226 ~Rpt~~e~L~ 235 (383)
+|||++++++
T Consensus 615 ~RPs~~~l~~ 624 (635)
T 4fl3_A 615 NRPGFAAVEL 624 (635)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.18 Aligned_cols=225 Identities=18% Similarity=0.248 Sum_probs=179.1
Q ss_pred ceEEEEEEcCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 4 LSEEMADSIATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
..||+|.+ +|+.||+|++.. ....+.+|+.+++ .++||||+++++++.+.+..++|||+++ +++|.++
T Consensus 45 g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~ 120 (307)
T 2nru_A 45 GVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA-KCQHENLVELLGFSSDGDDLCLVYVYMP-NGSLLDR 120 (307)
T ss_dssp EEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHH
T ss_pred eEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHH-hcCCCCeEEEEEEEecCCceEEEEEecC-CCcHHHH
Confidence 36899985 689999999875 1356889999999 7789999999999999999999999999 9999997
Q ss_pred hcc---------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccC
Q psy6377 76 IDD---------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLG 143 (383)
Q Consensus 76 l~~---------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~g 143 (383)
+.. ..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++........ .....|
T Consensus 121 l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 197 (307)
T 2nru_A 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLARASEKFAQTVMTSRIVG 197 (307)
T ss_dssp HHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCSCSSCEECSSCCS
T ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC---CcEEEeecccccccccccccccccccCC
Confidence 642 2234566999999999999999999999999999765 6899999999987643221 234579
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----hccCCCC-------cchhcCCCHHH
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNIS----KAQLDFP-------DELFEDISPEA 212 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~----~~~~~~~-------~~~~~~~s~~~ 212 (383)
|+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.........+. .....++ .......+..+
T Consensus 198 ~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (307)
T 2nru_A 198 TTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276 (307)
T ss_dssp CGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHH
T ss_pred CcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHH
Confidence 999999999875 47899999999999999999999998765443322221 1111100 11112345779
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 213 KDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 213 ~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+++.+||..||.+|||+.+++++
T Consensus 277 ~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 277 YSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=312.29 Aligned_cols=224 Identities=19% Similarity=0.192 Sum_probs=176.1
Q ss_pred eEEEE-----EEcCCCcEEEEEEccC-CcccHHHHHHHHHhcC--CCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMA-----DSIATGEVFAAKFLES-NPVRIHHEIALLSLCS--PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~-----~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~--~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+| .+..+|+.||+|++.. ....+.+|+.+++.+. .|+||+++++++.+.+..|+||||+. |++|.+++
T Consensus 80 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~g~L~~~l 158 (365)
T 3e7e_A 80 QVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS-YGTLLNAI 158 (365)
T ss_dssp EEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCC-SCBHHHHH
T ss_pred EEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccC-CCcHHHHH
Confidence 68999 5788999999999987 4567888888888433 29999999999999999999999999 99999977
Q ss_pred cc-----------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEec--------cCCCCcEEEEeccceeEee---c
Q psy6377 77 DD-----------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG--------DFPNCDIKVCDFEISRVIL---D 134 (383)
Q Consensus 77 ~~-----------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~--------~~~~~~ikL~DFGla~~~~---~ 134 (383)
.. ..++.++.||+.||+|||++||+||||||+|||++. +...+.+||+|||+|+... .
T Consensus 159 ~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~ 238 (365)
T 3e7e_A 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238 (365)
T ss_dssp HHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCT
T ss_pred HHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCC
Confidence 42 125567799999999999999999999999999976 1224789999999997653 2
Q ss_pred CcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 135 GIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 135 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ .....++. ...++.+.+
T Consensus 239 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~---~~~~~~~~~ 310 (365)
T 3e7e_A 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFRR---LPHLDMWNE 310 (365)
T ss_dssp TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCTT---CSSHHHHHH
T ss_pred CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----eechhccc---cCcHHHHHH
Confidence 3345567899999999999999999999999999999999999999965432110 01111111 123678899
Q ss_pred HHHHhcccCCCCCCCHHHHHcCc
Q psy6377 215 FIAKILIKNPMERMTAKEALKHP 237 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~hp 237 (383)
++..||..+|.+|++..+.+.+.
T Consensus 311 ~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 311 FFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp HHHHHHCCCCTTCCCCHHHHHHH
T ss_pred HHHHHcCCCCCCcchHHHHHHHH
Confidence 99999999999997665555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.52 Aligned_cols=226 Identities=19% Similarity=0.267 Sum_probs=175.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhc-CCCCCcccceEEEEeC----CeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLC-SPSPRIVKLHDVFQTG----EGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~-~~hpnIvkl~~~~~~~----~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++ |+.||||++.. ......+|.+++... .+||||+++++++.+. ...|+||||+. +++|.+++..
T Consensus 52 ~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~ 128 (337)
T 3mdy_A 52 EVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE-NGSLYDYLKS 128 (337)
T ss_dssp EEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT-TCBHHHHHHH
T ss_pred EEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC-CCcHHHHhhc
Confidence 68999875 99999999876 445566777777633 3899999999999987 78999999999 9999998754
Q ss_pred C-----CchhhHHHHHHHHHHHHhC--------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----ccc
Q psy6377 79 N-----LVVPFESDELSSLAYLHHR--------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRE 140 (383)
Q Consensus 79 ~-----~~~~~~~qil~aL~yLHs~--------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~ 140 (383)
. .++.+..|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++........ ...
T Consensus 129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 205 (337)
T 3mdy_A 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVKFISDTNEVDIPPNT 205 (337)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT---SCEEECCCTTCEECC---------CCS
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC---CCEEEEeCCCceeeccccccccCCCCC
Confidence 3 3456679999999999999 99999999999999765 6899999999987643322 124
Q ss_pred ccCCCCcCCCcccccCCCChh------hHHHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHHHhc---c
Q psy6377 141 LLGTPDYVAPEILHYEPITLA------ADMWSLGVTAYVLLTG----------FSPFGGETD----SETFRNISKA---Q 197 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~------~DiwSlGvilyelltg----------~~Pf~~~~~----~~~~~~i~~~---~ 197 (383)
..||+.|+|||++.+..++.. +|||||||++|+|++| ..||..... .......... .
T Consensus 206 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
T 3mdy_A 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285 (337)
T ss_dssp SCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred CccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC
Confidence 579999999999987766554 9999999999999999 777765322 2222222221 1
Q ss_pred CCCCcch-hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 198 LDFPDEL-FEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 198 ~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
..+|... ...+++++.+||.+||..||.+|||+.++++|
T Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222211 12456789999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.34 Aligned_cols=222 Identities=16% Similarity=0.148 Sum_probs=182.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++.. .+|+|++.. ....+.+|+.+++ .++||||+++++++.+....++|||++. |++|.+++.
T Consensus 47 g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~iv~e~~~-~~~L~~~l~ 121 (319)
T 2y4i_B 47 GQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYR-QTRHENVVLFMGACMSPPHLAIITSLCK-GRTLYSVVR 121 (319)
T ss_dssp SEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGT-TCCCTTBCCCCEEEECSSCEEEECBCCC-SEEHHHHTT
T ss_pred eEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHh-cCCCCCEeEEEEEEecCCceEEEeeccc-CCcHHHHHH
Confidence 3689998753 499999875 2466889999998 7799999999999999999999999999 999999875
Q ss_pred cC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec------CcccccccCC
Q psy6377 78 DN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD------GIEIRELLGT 144 (383)
Q Consensus 78 ~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~------~~~~~~~~gt 144 (383)
.. .++.+..||+.||+|||++||+||||||+|||+++ +.++|+|||++..... ........||
T Consensus 122 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~ 197 (319)
T 2y4i_B 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN----GKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197 (319)
T ss_dssp SSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----------CCSCBCCSGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC----CCEEEeecCCccccccccccccccccccCCCc
Confidence 43 24566699999999999999999999999999973 5899999999875432 1223345689
Q ss_pred CCcCCCccccc---------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHH
Q psy6377 145 PDYVAPEILHY---------EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215 (383)
Q Consensus 145 ~~y~aPE~l~~---------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 215 (383)
+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.... .....++.++.++
T Consensus 198 ~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 275 (319)
T 2y4i_B 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--LSQIGMGKEISDI 275 (319)
T ss_dssp GGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--CCCSSCCTTHHHH
T ss_pred ccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--CCcCCCCHHHHHH
Confidence 99999999864 458999999999999999999999999988887777766554332 2224678999999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q psy6377 216 IAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 216 i~~~L~~dP~~Rpt~~e~L~h 236 (383)
|.+||..||.+|||+.++++.
T Consensus 276 i~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 276 LLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHHCSSTTTSCCHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=301.09 Aligned_cols=227 Identities=18% Similarity=0.194 Sum_probs=180.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhc-CCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHhhc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLC-SPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~-~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~l~ 77 (383)
..||+|++ +|+.||+|++.. ....+.+|++++... ++||||+++++++.+.. ..|+|||++. +++|.+++.
T Consensus 56 g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 132 (342)
T 1b6c_B 56 GEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE-HGSLFDYLN 132 (342)
T ss_dssp EEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT-TCBHHHHHH
T ss_pred cEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC-CCcHHHHHh
Confidence 36899987 599999999976 456678899999843 68999999999999876 7999999999 999999875
Q ss_pred cC-----CchhhHHHHHHHHHHHH--------hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cc
Q psy6377 78 DN-----LVVPFESDELSSLAYLH--------HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IR 139 (383)
Q Consensus 78 ~~-----~~~~~~~qil~aL~yLH--------s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~ 139 (383)
.. .++.++.|++.||.||| ++||+||||||+|||++.+ +.+||+|||++........ ..
T Consensus 133 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~ 209 (342)
T 1b6c_B 133 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDIAPN 209 (342)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT---SCEEECCCTTCEEEETTTTEEEECCC
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC---CCEEEEECCCceeccccccccccccc
Confidence 43 34567799999999999 8999999999999999765 6899999999988765432 24
Q ss_pred cccCCCCcCCCcccccCC------CChhhHHHHHHHHHHHHHhC----------CCCCCCCCc-----HHHHHHHHhccC
Q psy6377 140 ELLGTPDYVAPEILHYEP------ITLAADMWSLGVTAYVLLTG----------FSPFGGETD-----SETFRNISKAQL 198 (383)
Q Consensus 140 ~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvilyelltg----------~~Pf~~~~~-----~~~~~~i~~~~~ 198 (383)
...||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.+... ......+.....
T Consensus 210 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (342)
T 1b6c_B 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289 (342)
T ss_dssp SCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred cCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHh
Confidence 457999999999987652 34789999999999999999 789876532 223333332222
Q ss_pred --CCCcch-hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 199 --DFPDEL-FEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 199 --~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.++..+ ....+..+.+||.+||..||++|||+.++++|
T Consensus 290 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 222211 12344679999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.27 Aligned_cols=221 Identities=18% Similarity=0.185 Sum_probs=171.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCC-CCcc---------c------------ceEEEEe
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPS-PRIV---------K------------LHDVFQT 55 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~h-pnIv---------k------------l~~~~~~ 55 (383)
.||+|++..+|+.||||++.. ....+.+|+.+++ .+.| +|.. . +.+++..
T Consensus 93 ~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (413)
T 3dzo_A 93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR-LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 171 (413)
T ss_dssp EEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGG-GSTTCCSHHHHHHHTCBCCCCEEEECCC----------
T ss_pred EEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHH-hhccCCCHHHHHHhcccccchhhcccCCCCccccccCC
Confidence 689999999999999999984 3567889999998 5555 3221 1 1122222
Q ss_pred -----CCeEEEEEecCCCcCcHHHhhc-------------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC
Q psy6377 56 -----GEGAYYVSWNTPLVVTLQTIID-------------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 56 -----~~~~~lv~e~~~~g~~L~~~l~-------------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~ 117 (383)
...++++|+.+ +++|.++++ ....+.++.||+.||+|||++||+||||||+|||++.+
T Consensus 172 ~~~~~~~~~~~~~~~~--~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~-- 247 (413)
T 3dzo_A 172 ERDMWVLSRFFLYPRM--QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-- 247 (413)
T ss_dssp -----CCSEEEEEECC--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT--
T ss_pred CccccccceEEEeehh--cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecC--
Confidence 22456777766 489998763 12344556999999999999999999999999999876
Q ss_pred CCcEEEEeccceeEeecCcccccccCCCCcCCCccc----------ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH
Q psy6377 118 NCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL----------HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS 187 (383)
Q Consensus 118 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~ 187 (383)
+.+||+|||+++.... .....+| +.|+|||++ ....|+.++|||||||++|+|++|+.||.+.+..
T Consensus 248 -~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 248 -GGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp -CCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGG
T ss_pred -CeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 5799999999987533 3456678 999999999 5566889999999999999999999999887654
Q ss_pred HHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 188 ETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 188 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
+....+.. .+..+++++.+||.+||..||++|||+.++++||||+..
T Consensus 324 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 324 GGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 44333322 123678999999999999999999999999999999754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=321.24 Aligned_cols=223 Identities=22% Similarity=0.280 Sum_probs=187.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 4 LSEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
..||+|++.. +..||||++.. ....+.+|+.+++ .++||||+++++++.+ ...|+||||+. +++|.+++..
T Consensus 281 g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~-~~~~lv~e~~~-~gsL~~~l~~~~ 356 (535)
T 2h8h_A 281 GEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EPIYIVTEYMS-KGSLLDFLKGET 356 (535)
T ss_dssp EEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEEECCCT-TEEHHHHHSHHH
T ss_pred eEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHH-hCCCCCEeeEEEEEee-ccceEeeehhc-CCcHHHHHhhcC
Confidence 3689999865 46799999986 3467899999999 7789999999999876 77999999999 9999997753
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCC
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAP 150 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aP 150 (383)
..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... .....+++.|+||
T Consensus 357 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 357 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433 (535)
T ss_dssp HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC---CcEEEcccccceecCCCceecccCCcCcccccCH
Confidence 2344666999999999999999999999999999766 5899999999986543211 2234567889999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+..++.++|||||||++|+|++ |..||.+....+....+..+... + ....++..+.+||.+||..||++|||
T Consensus 434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPPECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 99999999999999999999999999 99999999888888877655321 1 22467999999999999999999999
Q ss_pred HHHHHcC
Q psy6377 230 AKEALKH 236 (383)
Q Consensus 230 ~~e~L~h 236 (383)
++++++.
T Consensus 511 ~~~l~~~ 517 (535)
T 2h8h_A 511 FEYLQAF 517 (535)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.76 Aligned_cols=224 Identities=21% Similarity=0.260 Sum_probs=179.2
Q ss_pred ceEEEEE----EcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCCCCcccceEEEEeCC--eEEEEEecCCCcCcHH
Q psy6377 4 LSEEMAD----SIATGEVFAAKFLESN----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGE--GAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 4 ~~V~~~~----~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~--~~~lv~e~~~~g~~L~ 73 (383)
..||+|+ +..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+ ..++|||+++ +++|.
T Consensus 55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~-~~~L~ 132 (326)
T 2w1i_A 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK-SLQHDNIVKYKGVCYSAGRRNLKLIMEYLP-YGSLR 132 (326)
T ss_dssp EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHH-TCCCTTBCCEEEEECC----CCEEEECCCT-TCBHH
T ss_pred eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEecCCCceEEEEECCC-CCCHH
Confidence 3689998 5779999999999762 356889999999 778999999999987654 7899999999 99999
Q ss_pred HhhccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----ccccc
Q psy6377 74 TIIDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELL 142 (383)
Q Consensus 74 ~~l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~ 142 (383)
+++... .++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ .....
T Consensus 133 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 209 (326)
T 2w1i_A 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFGLTKVLPQDKEYYKVKEPGE 209 (326)
T ss_dssp HHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECCSSCSEEECSSCCS
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC---CcEEEecCcchhhccccccccccccCCC
Confidence 976543 244566999999999999999999999999999876 6899999999988654332 12345
Q ss_pred CCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCc------------H----HHHHHHHhccCCCCcchhc
Q psy6377 143 GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETD------------S----ETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 143 gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~------------~----~~~~~i~~~~~~~~~~~~~ 206 (383)
+++.|+|||++.+..++.++||||||+++|+|++|..||..... . .....+... ... ....
T Consensus 210 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~ 286 (326)
T 2w1i_A 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRL--PRPD 286 (326)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT-CCC--CCCT
T ss_pred CceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC-CCC--CCCC
Confidence 77889999999988899999999999999999999999864311 0 111111111 111 1235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+++++.++|.+||..||++|||+.++++
T Consensus 287 ~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 287 GCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.08 Aligned_cols=234 Identities=20% Similarity=0.217 Sum_probs=170.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHh-cCCCCCcccceEEEEe-----CCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSL-CSPSPRIVKLHDVFQT-----GEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~-~~~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+. +|+.||||++.. ....+..|.+++.. ...||||+++++.+.. ...+|+||||++ +++|.+++.
T Consensus 28 ~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~g~L~~~l~ 104 (336)
T 3g2f_A 28 AVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP-NGSLXKYLS 104 (336)
T ss_dssp EEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT-TCBHHHHHH
T ss_pred EEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC-CCcHHHHHh
Confidence 5899975 799999999976 34455556665542 4789999999986653 235789999999 999999875
Q ss_pred cCC-----chhhHHHHHHHHHHHHhC---------CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-------
Q psy6377 78 DNL-----VVPFESDELSSLAYLHHR---------KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI------- 136 (383)
Q Consensus 78 ~~~-----~~~~~~qil~aL~yLHs~---------givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~------- 136 (383)
... ...++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||++.......
T Consensus 105 ~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~---~~~kL~DFG~a~~~~~~~~~~~~~~ 181 (336)
T 3g2f_A 105 LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND---GTCVISDFGLSMRLTGNRLVRPGEE 181 (336)
T ss_dssp HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT---SCEEECCCTTCEECSSSSCC-----
T ss_pred hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC---CcEEEeeccceeecccccccCcccc
Confidence 432 345669999999999999 99999999999999865 689999999998764321
Q ss_pred --ccccccCCCCcCCCccccc-------CCCChhhHHHHHHHHHHHHHhCCCCCCC-CCcH----------------HHH
Q psy6377 137 --EIRELLGTPDYVAPEILHY-------EPITLAADMWSLGVTAYVLLTGFSPFGG-ETDS----------------ETF 190 (383)
Q Consensus 137 --~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvilyelltg~~Pf~~-~~~~----------------~~~ 190 (383)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .... +..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3g2f_A 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM 261 (336)
T ss_dssp ----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH
Confidence 1234579999999999976 4567899999999999999999666533 2211 111
Q ss_pred HHHHhc---cCCCCcch--hcCCCHHHHHHHHHhcccCCCCCCCHHHHH------cCcccCCcch
Q psy6377 191 RNISKA---QLDFPDEL--FEDISPEAKDFIAKILIKNPMERMTAKEAL------KHPWLMNKKQ 244 (383)
Q Consensus 191 ~~i~~~---~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L------~hp~~~~~~~ 244 (383)
...... ...+|... ...+++.+.+||.+||..||++|||+.|++ .++|-++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 262 QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp HHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred HhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 111111 11222111 112345799999999999999999999995 4678776544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=320.86 Aligned_cols=222 Identities=20% Similarity=0.296 Sum_probs=184.6
Q ss_pred eEEEEEEcCC---CcEEEEEEccCC-----cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIAT---GEVFAAKFLESN-----PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~t---g~~vAvK~i~~~-----~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+ +..||+|.+... ...+.+|+.+++ .++||||+++++++. ++..|+||||+. +++|.+++
T Consensus 405 ~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~-~~~~~lv~E~~~-~g~L~~~l 481 (656)
T 2j0j_A 405 DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-ENPVWIIMELCT-LGELRSFL 481 (656)
T ss_dssp CEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSCEEEEECCT-TCBHHHHH
T ss_pred EEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEe-cCceEEEEEcCC-CCcHHHHH
Confidence 6899998754 467999998762 367889999999 778999999999985 567899999999 99999977
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCc
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDY 147 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y 147 (383)
... .++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....... .....+|+.|
T Consensus 482 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~---~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y 558 (656)
T 2j0j_A 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558 (656)
T ss_dssp HHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCCCCCSCCC----------CCGGG
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC---CCEEEEecCCCeecCCCcceeccCCCCCcce
Confidence 533 234566999999999999999999999999999876 6899999999987644322 2234577899
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+.... ....+++.+.+||.+||..||.+
T Consensus 559 ~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred eCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999997 999999998888888877654322 23468999999999999999999
Q ss_pred CCCHHHHHc
Q psy6377 227 RMTAKEALK 235 (383)
Q Consensus 227 Rpt~~e~L~ 235 (383)
|||+.++++
T Consensus 636 RPs~~el~~ 644 (656)
T 2j0j_A 636 RPRFTELKA 644 (656)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=284.74 Aligned_cols=201 Identities=17% Similarity=0.114 Sum_probs=167.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
..||+|++..+|+.||+|++... ...+.+|+.+++ .++||||+++++++.+.+..|+||||+. |++|.+++
T Consensus 45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~-g~~L~~~l 122 (286)
T 3uqc_A 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS-RIDKPGVARVLDVVHTRAGGLVVAEWIR-GGSLQEVA 122 (286)
T ss_dssp CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCC-EEEHHHHH
T ss_pred eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHh-cCCCCCcceeeEEEEECCcEEEEEEecC-CCCHHHHH
Confidence 36899999999999999999862 156889999998 7799999999999999999999999999 99999988
Q ss_pred ccCC----chhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 77 DDNL----VVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 77 ~~~~----~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
.... ...+..|++.||+|||++||+||||||+|||++.+ +.+||+++| |++
T Consensus 123 ~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~---g~~kl~~~~-------------------~~~--- 177 (286)
T 3uqc_A 123 DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPA-------------------TMP--- 177 (286)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT---SCEEECSCC-------------------CCT---
T ss_pred hcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC---CCEEEEecc-------------------ccC---
Confidence 6532 34566999999999999999999999999999876 678887443 333
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFR---NISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
+++.++|||||||++|+|++|+.||.+.+..+.+. ....+....+......+++++.+||.+||..||++| |
T Consensus 178 ----~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s 252 (286)
T 3uqc_A 178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S 252 (286)
T ss_dssp ----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C
T ss_pred ----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-C
Confidence 37899999999999999999999999876543221 112233333345567899999999999999999999 9
Q ss_pred HHHHHcC
Q psy6377 230 AKEALKH 236 (383)
Q Consensus 230 ~~e~L~h 236 (383)
+.++++.
T Consensus 253 ~~el~~~ 259 (286)
T 3uqc_A 253 ASTLLNL 259 (286)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.37 Aligned_cols=218 Identities=21% Similarity=0.259 Sum_probs=177.6
Q ss_pred ceEEEEEEcC-CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe-----EEEEEecCCCcCcH
Q psy6377 4 LSEEMADSIA-TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG-----AYYVSWNTPLVVTL 72 (383)
Q Consensus 4 ~~V~~~~~~~-tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~-----~~lv~e~~~~g~~L 72 (383)
..||+|+++. +|+.||||++.. ....+.+|+.+++ .++||||+++++++.+.+. .|+||||+. |++|
T Consensus 94 g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~-g~~L 171 (681)
T 2pzi_A 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLA-EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSL 171 (681)
T ss_dssp EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEEECTTSCEEEEEEEECCC-CEEC
T ss_pred eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHH-hcCCCCcCeEeeeEeecCCCCCceeEEEEEeCC-CCcH
Confidence 3689999986 799999999865 2345789999999 7789999999999997765 799999999 9999
Q ss_pred HHhhcc----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 73 QTIIDD----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 73 ~~~l~~----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
.+.+.. ..++.+..||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... ...+||+.|+
T Consensus 172 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG~a~~~~~~---~~~~gt~~y~ 244 (681)
T 2pzi_A 172 KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLGAVSRINSF---GYLYGTPGFQ 244 (681)
T ss_dssp C----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCTTCEETTCC---SCCCCCTTTS
T ss_pred HHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecccchhcccC---CccCCCcccc
Confidence 886543 4455677999999999999999999999999999763 7999999999876433 4567999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+.. +.++|||||||++|+|++|.+||.+..... .. ........++.+.+||.+||.+||.+||
T Consensus 245 aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~ 313 (681)
T 2pzi_A 245 APEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP-EDDPVLKTYDSYGRLLRRAIDPDPRQRF 313 (681)
T ss_dssp CTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC-TTCHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred CHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------cc-ccccccccCHHHHHHHhhhccCChhhCC
Confidence 999987654 899999999999999999999987642111 00 1111223578899999999999999999
Q ss_pred CHHHHHcCcccCC
Q psy6377 229 TAKEALKHPWLMN 241 (383)
Q Consensus 229 t~~e~L~hp~~~~ 241 (383)
+..+.+.|+|...
T Consensus 314 ~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 314 TTAEEMSAQLTGV 326 (681)
T ss_dssp SSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999888753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-33 Score=290.67 Aligned_cols=214 Identities=16% Similarity=0.134 Sum_probs=149.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC--------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcC
Q psy6377 5 SEEMADSIATGEVFAAKFLES--------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~ 70 (383)
.+..++...+|+.||||++.+ ....+.+|+++|+++..|+||++++++++++...||||||++ |+
T Consensus 249 ~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~-G~ 327 (569)
T 4azs_A 249 AHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLP-GR 327 (569)
T ss_dssp ---CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCC-SE
T ss_pred cccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCC-CC
Confidence 345667778999999999976 235689999999977689999999999999999999999999 99
Q ss_pred cHHHhhccCCc---hhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCC
Q psy6377 71 TLQTIIDDNLV---VPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPD 146 (383)
Q Consensus 71 ~L~~~l~~~~~---~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~ 146 (383)
+|.+++..... ..++.||+.||+|||++|||||||||+|||++.+ |.+||+|||+|+..... ....+.+||+.
T Consensus 328 ~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---g~vKL~DFGlAr~~~~~~~~~~t~vGTp~ 404 (569)
T 4azs_A 328 LLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---QHARLIDFGSIVTTPQDCSWPTNLVQSFF 404 (569)
T ss_dssp EHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---SCEEECCCTTEESCC---CCSHHHHHHHH
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCC---CCEEEeecccCeeCCCCCccccCceechh
Confidence 99998765432 3566999999999999999999999999999876 68999999999876433 33556789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
|+|||++.+. +..++|+||+|+++|++.++..|+. ..+ +..+... ..+..+...++..+|..
T Consensus 405 YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l----~~~~~~~-----~~~~~l~~~l~~~~~~~ 466 (569)
T 4azs_A 405 VFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWL--------YAV----WQEPVER-----WNFVLLLALFEKKAKLP 466 (569)
T ss_dssp HHHHHHC------------------CCCCTTHHHHH--------HHH----HTSCGGG-----CSHHHHHHHHHTGGGSC
T ss_pred hccHHHhCCC-CCCcccccccccchhhhccccchhH--------HHh----hcCCCCC-----CcHHHHHHHHhCCCCCC
Confidence 9999999865 5778999999999988876654431 111 1111111 12445666666777777
Q ss_pred CCCHHHHHcCcccC
Q psy6377 227 RMTAKEALKHPWLM 240 (383)
Q Consensus 227 Rpt~~e~L~hp~~~ 240 (383)
|+.......++|..
T Consensus 467 ~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 467 SAEQQRGATEQWII 480 (569)
T ss_dssp CGGGSSCCHHHHHH
T ss_pred CCChhhhccchhHH
Confidence 77666555555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=229.49 Aligned_cols=167 Identities=13% Similarity=0.043 Sum_probs=140.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC------------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||+| ...++.+|+|.... ...++.+|+++++ .++||||+++..++.+.+..|+||||++ |++|
T Consensus 351 ~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~lVmE~~~-ggsL 426 (540)
T 3en9_A 351 DIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLA-LVKDFGIPAPYIFDVDLDNKRIMMSYIN-GKLA 426 (540)
T ss_dssp EEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHH-HGGGGTCCCCCEEEEETTTTEEEEECCC-SEEH
T ss_pred EEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHH-hcCCCCcCceEEEEEeCCccEEEEECCC-CCCH
Confidence 58888 35688899997643 1234789999999 6699999966666667788899999999 9999
Q ss_pred HHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--------cccccCC
Q psy6377 73 QTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--------IRELLGT 144 (383)
Q Consensus 73 ~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--------~~~~~gt 144 (383)
.+++.. ...+..|++.||+|||++||+||||||+|||++. .+||+|||+|+....... ....+||
T Consensus 427 ~~~l~~--~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT 499 (540)
T 3en9_A 427 KDVIED--NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLST 499 (540)
T ss_dssp HHHSTT--CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHH--HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCccccccchhhhhhhhcCC
Confidence 999887 5688999999999999999999999999999975 799999999998754322 2356899
Q ss_pred CCcCCCccccc--CCCChhhHHHHHHHHHHHHHhCCCCCC
Q psy6377 145 PDYVAPEILHY--EPITLAADMWSLGVTAYVLLTGFSPFG 182 (383)
Q Consensus 145 ~~y~aPE~l~~--~~~~~~~DiwSlGvilyelltg~~Pf~ 182 (383)
+.|+|||++.. ..|+..+|+|+.++-..+...++.+|.
T Consensus 500 ~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 500 HHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999999986 678889999999988888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=184.29 Aligned_cols=127 Identities=19% Similarity=0.077 Sum_probs=105.6
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----------------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----------------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----------------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~l 61 (383)
..||+|++ .+|+.||+|++... ...+.+|+.+++.+. | +++++++.. +..|+
T Consensus 104 g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v~~~~~~-~~~~l 177 (282)
T 1zar_A 104 SAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAVPKVYAW-EGNAV 177 (282)
T ss_dssp EEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSSCCEEEE-ETTEE
T ss_pred ceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCcCeEEec-cceEE
Confidence 36999999 89999999999641 234789999999544 5 667776654 55699
Q ss_pred EEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccc
Q psy6377 62 VSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 62 v~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
||||++ |++|.+ +.......+..|++.||.|||++||+||||||+|||++ + +.+||+|||+|+.
T Consensus 178 vmE~~~-g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~---~~vkl~DFG~a~~---------- 241 (282)
T 1zar_A 178 LMELID-AKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E---EGIWIIDFPQSVE---------- 241 (282)
T ss_dssp EEECCC-CEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T---TEEEECCCTTCEE----------
T ss_pred EEEecC-CCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C---CcEEEEECCCCeE----------
Confidence 999999 999999 66666778889999999999999999999999999998 4 6899999999874
Q ss_pred cCCCCcCCCcccc
Q psy6377 142 LGTPDYVAPEILH 154 (383)
Q Consensus 142 ~gt~~y~aPE~l~ 154 (383)
+..+.|||.+.
T Consensus 242 --~~~~~a~e~l~ 252 (282)
T 1zar_A 242 --VGEEGWREILE 252 (282)
T ss_dssp --TTSTTHHHHHH
T ss_pred --CCCCCHHHHHH
Confidence 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.7e-16 Score=145.49 Aligned_cols=119 Identities=13% Similarity=0.087 Sum_probs=91.7
Q ss_pred ceEEEEEEcCCCcE--EEEEEccCC----c------------------------ccHHHHHHHHHhcCCCCCc--ccceE
Q psy6377 4 LSEEMADSIATGEV--FAAKFLESN----P------------------------VRIHHEIALLSLCSPSPRI--VKLHD 51 (383)
Q Consensus 4 ~~V~~~~~~~tg~~--vAvK~i~~~----~------------------------~~~~~Ei~il~~~~~hpnI--vkl~~ 51 (383)
..||+|.+..+|+. ||||++... . ..+.+|+.+++ .+.|++| +.+++
T Consensus 61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~ 139 (258)
T 1zth_A 61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE-RAKEAGVSVPQPYT 139 (258)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH-HHHHTTCCCCCEEE
T ss_pred EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH-HHHhCCCCCCeEEE
Confidence 36999999889999 999987541 0 15788999998 5556654 44443
Q ss_pred EEEeCCeEEEEEecCCCcC----cHHHhhc---cCCchhhHHHHHHHHHHHH-hCCceecCCCCCcEEEeccCCCCcEEE
Q psy6377 52 VFQTGEGAYYVSWNTPLVV----TLQTIID---DNLVVPFESDELSSLAYLH-HRKIAHLDIKPQNLVMMGDFPNCDIKV 123 (383)
Q Consensus 52 ~~~~~~~~~lv~e~~~~g~----~L~~~l~---~~~~~~~~~qil~aL~yLH-s~givHrDLKp~NILl~~~~~~~~ikL 123 (383)
. +..++||||+...| .|.+... ......+..|++.||.||| +.||+||||||+|||++. .++|
T Consensus 140 ~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-----~~~l 210 (258)
T 1zth_A 140 Y----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-----KVYF 210 (258)
T ss_dssp E----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-----SEEE
T ss_pred c----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-----cEEE
Confidence 2 35789999995113 7777543 3356678899999999999 999999999999999964 6999
Q ss_pred EeccceeEe
Q psy6377 124 CDFEISRVI 132 (383)
Q Consensus 124 ~DFGla~~~ 132 (383)
+|||+|...
T Consensus 211 iDFG~a~~~ 219 (258)
T 1zth_A 211 IDMGQAVTL 219 (258)
T ss_dssp CCCTTCEET
T ss_pred EECcccccC
Confidence 999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=5.7e-15 Score=145.13 Aligned_cols=123 Identities=9% Similarity=0.016 Sum_probs=85.2
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC------------------cccH--------HHHHHHHHhcCCCCCcccceEEEEeCC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN------------------PVRI--------HHEIALLSLCSPSPRIVKLHDVFQTGE 57 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~------------------~~~~--------~~Ei~il~~~~~hpnIvkl~~~~~~~~ 57 (383)
..||.|.+ .+|+.||||+++.. .... .+|...|.++ |++.+.+...+...
T Consensus 109 a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL--~~~gv~vp~p~~~~- 184 (397)
T 4gyi_A 109 SDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL--YEEGFPVPEPIAQS- 184 (397)
T ss_dssp EEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH--HHTTCSCCCEEEEE-
T ss_pred eEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--HhcCCCCCeeeecc-
Confidence 36999987 47999999997540 0011 2344444422 11112222222222
Q ss_pred eEEEEEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC-------CcEEEEecccee
Q psy6377 58 GAYYVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN-------CDIKVCDFEISR 130 (383)
Q Consensus 58 ~~~lv~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~-------~~ikL~DFGla~ 130 (383)
..++||||+. |.+|..+........+..|++.+|.|||..|||||||||.|||++.++.. ..+.|+||+-+.
T Consensus 185 ~~~LVME~i~-G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 185 RHTIVMSLVD-ALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTEEEEECCS-CEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CceEEEEecC-CccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 2379999999 99999887766667788999999999999999999999999999876310 137899999765
Q ss_pred E
Q psy6377 131 V 131 (383)
Q Consensus 131 ~ 131 (383)
.
T Consensus 264 ~ 264 (397)
T 4gyi_A 264 S 264 (397)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=8.6e-11 Score=108.52 Aligned_cols=123 Identities=11% Similarity=-0.008 Sum_probs=99.7
Q ss_pred ceEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-cc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII-DD 78 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l-~~ 78 (383)
..||.+.. .|+.+++|+... ....+.+|+.+++.+..+..++++++++.+.+..|+|||+++ |.+|.+.+ ..
T Consensus 28 ~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~-G~~l~~~~~~~ 104 (263)
T 3tm0_A 28 AKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD-GVLCSEEYEDE 104 (263)
T ss_dssp SEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS-SEEHHHHCCTT
T ss_pred CeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC-CeehhhccCCc
Confidence 35788763 478999999874 456799999999976678889999999999999999999999 99998854 22
Q ss_pred CCchhhHHHHHHHHHHHHh-----------------------------------------------------------CC
Q psy6377 79 NLVVPFESDELSSLAYLHH-----------------------------------------------------------RK 99 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs-----------------------------------------------------------~g 99 (383)
.....+..++..+|..||+ .+
T Consensus 105 ~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 184 (263)
T 3tm0_A 105 QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV 184 (263)
T ss_dssp TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE
T ss_pred ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce
Confidence 2333567899999999999 45
Q ss_pred ceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 100 ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
++|+|++|.|||++.+ +.+.|+||+.+...
T Consensus 185 l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 185 FSHGDLGDSNIFVKDG---KVSGFIDLGRSGRA 214 (263)
T ss_dssp EECSSCCTTSEEEETT---EEEEECCCTTCEEE
T ss_pred EECCCCCcCcEEEECC---cEEEEEEchhcccC
Confidence 8999999999999753 34579999987753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=2.9e-10 Score=104.07 Aligned_cols=122 Identities=16% Similarity=0.003 Sum_probs=93.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCC-CcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSP-RIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLV 81 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hp-nIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~ 81 (383)
-.||.+. ..+|+.+++|+... ....+.+|+.+++.+..+. .+++++.+..+++..++|||+++ |.+|. ......
T Consensus 34 ~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~-G~~l~--~~~~~~ 109 (264)
T 1nd4_A 34 AAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP-GQDLL--SSHLAP 109 (264)
T ss_dssp CEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS-SEETT--TSCCCH
T ss_pred ceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC-CcccC--cCcCCH
Confidence 4678875 45678899999765 3467889999998555552 26779999888888999999999 98884 333333
Q ss_pred hhhHHHHHHHHHHHHhCC----------------------------------------------------------ceec
Q psy6377 82 VPFESDELSSLAYLHHRK----------------------------------------------------------IAHL 103 (383)
Q Consensus 82 ~~~~~qil~aL~yLHs~g----------------------------------------------------------ivHr 103 (383)
.....++...|..||+.. ++|+
T Consensus 110 ~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Hg 189 (264)
T 1nd4_A 110 AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG 189 (264)
T ss_dssp HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECC
Confidence 356688888888888754 9999
Q ss_pred CCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 104 DLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
|++|.|||++.+ +.+.|+|||.+...
T Consensus 190 Dl~~~Nil~~~~---~~~~liD~~~a~~g 215 (264)
T 1nd4_A 190 DACLPNIMVENG---RFSGFIDCGRLGVA 215 (264)
T ss_dssp SCCGGGEEEETT---EEEEECCCTTCEEE
T ss_pred CCCCCcEEEECC---cEEEEEcchhcccC
Confidence 999999999754 34569999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.72 E-value=3.8e-08 Score=95.09 Aligned_cols=124 Identities=15% Similarity=0.164 Sum_probs=91.1
Q ss_pred eEEEEEEcCCCcEEEEEEcc--C-----CcccHHHHHHHHHhcCC-CCCcccceEEEEeC---CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLE--S-----NPVRIHHEIALLSLCSP-SPRIVKLHDVFQTG---EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~--~-----~~~~~~~Ei~il~~~~~-hpnIvkl~~~~~~~---~~~~lv~e~~~~g~~L~ 73 (383)
.||.+.. .+..+++|+.. . ....+.+|..+++.+.. +..+++++.++.+. ...|+|||+++ |..+.
T Consensus 53 ~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~-G~~l~ 129 (359)
T 3dxp_A 53 PTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVS-GRVLW 129 (359)
T ss_dssp CEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCC-CBCCC
T ss_pred eEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecC-CeecC
Confidence 4677764 35689999887 3 24688999999985543 45689999988776 34899999999 88875
Q ss_pred H-hh---ccCCchhhHHHHHHHHHHHHh----------------------------------------------------
Q psy6377 74 T-II---DDNLVVPFESDELSSLAYLHH---------------------------------------------------- 97 (383)
Q Consensus 74 ~-~l---~~~~~~~~~~qil~aL~yLHs---------------------------------------------------- 97 (383)
+ .+ .......+..++..+|..||+
T Consensus 130 ~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 209 (359)
T 3dxp_A 130 DQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIP 209 (359)
T ss_dssp CTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCC
T ss_pred CCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCC
Confidence 4 22 222233556899999999997
Q ss_pred ------CCceecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 98 ------RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 98 ------~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
.+++|+|++|.|||++.+.. ..+.|+||+.+...
T Consensus 210 ~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g 249 (359)
T 3dxp_A 210 QEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG 249 (359)
T ss_dssp STTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred CccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence 36899999999999986532 24689999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=3.7e-08 Score=93.07 Aligned_cols=165 Identities=15% Similarity=0.128 Sum_probs=103.1
Q ss_pred cEEEEEEccCC--cccHHHHHHHHHhcCCCCC--cccceEEEEeCC---eEEEEEecCCCcCcHHHh-h---ccCCchhh
Q psy6377 16 EVFAAKFLESN--PVRIHHEIALLSLCSPSPR--IVKLHDVFQTGE---GAYYVSWNTPLVVTLQTI-I---DDNLVVPF 84 (383)
Q Consensus 16 ~~vAvK~i~~~--~~~~~~Ei~il~~~~~hpn--Ivkl~~~~~~~~---~~~lv~e~~~~g~~L~~~-l---~~~~~~~~ 84 (383)
..+++|+.... ...+.+|.++++.+..+.. +++++....+.. ..|+||++++ |..+... . .......+
T Consensus 41 ~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~-G~~l~~~~~~~l~~~~~~~~ 119 (304)
T 3sg8_A 41 RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK-GVPLTPLLLNNLPKQSQNQA 119 (304)
T ss_dssp TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC-CEECCHHHHHTSCHHHHHHH
T ss_pred CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC-CeECCccccccCCHHHHHHH
Confidence 46889986642 4678999999985545443 344544433333 3488999999 9888752 2 11222345
Q ss_pred HHHHHHHHHHHHh----------------------------------------------------------CCceecCCC
Q psy6377 85 ESDELSSLAYLHH----------------------------------------------------------RKIAHLDIK 106 (383)
Q Consensus 85 ~~qil~aL~yLHs----------------------------------------------------------~givHrDLK 106 (383)
..|+...|..||+ ..++|+|++
T Consensus 120 ~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~ 199 (304)
T 3sg8_A 120 AKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFS 199 (304)
T ss_dssp HHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCC
T ss_pred HHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCC
Confidence 5677777777775 247999999
Q ss_pred CCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc----c-CCC---------ChhhHHHHHHHHHH
Q psy6377 107 PQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH----Y-EPI---------TLAADMWSLGVTAY 172 (383)
Q Consensus 107 p~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~---------~~~~DiwSlGvily 172 (383)
|.||+++.+. ...+.++||+.+....+..++........-..|+... . ... ....+.|++|.++|
T Consensus 200 ~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~ 278 (304)
T 3sg8_A 200 SDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIY 278 (304)
T ss_dssp GGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998641 2467899999988754332221111110002333221 0 111 12368999999999
Q ss_pred HHHhCCCCCC
Q psy6377 173 VLLTGFSPFG 182 (383)
Q Consensus 173 elltg~~Pf~ 182 (383)
.+.+|.++|.
T Consensus 279 ~~~~g~~~~~ 288 (304)
T 3sg8_A 279 GKEYGYMDWY 288 (304)
T ss_dssp HHHTTCHHHH
T ss_pred HHHcCCHHHH
Confidence 9999988874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-06 Score=79.63 Aligned_cols=124 Identities=13% Similarity=0.070 Sum_probs=90.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--CCc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--NLV 81 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--~~~ 81 (383)
.||.......+..+++|+-+. ....+.+|..+|+.+..+-.+++++.+.++.+..|+||++++ |.++.+.... ...
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~-G~~~~~~~~~~~~~~ 118 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP-GKTAFQVLEEYPDSG 118 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC-SEEHHHHHHHCGGGH
T ss_pred eEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC-CccccccccCCHHHH
Confidence 578777777788899998765 345688999999876666668899999999999999999999 8887764321 111
Q ss_pred hhhHHHHHHHHHHHHhC----------------------------------------------------------Cceec
Q psy6377 82 VPFESDELSSLAYLHHR----------------------------------------------------------KIAHL 103 (383)
Q Consensus 82 ~~~~~qil~aL~yLHs~----------------------------------------------------------givHr 103 (383)
..+..++...|.-||+. .++|+
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 12334444445555431 16899
Q ss_pred CCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 104 DLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
|+.|.|||++.+ +.+-|+||+.+...
T Consensus 199 Dl~~~Nil~~~~---~~~~viDwe~a~~g 224 (272)
T 4gkh_A 199 DFSLDNLIFDEG---KLIGCIDVGRVGIA 224 (272)
T ss_dssp CCCTTSEEEETT---EEEEECCCTTCEEE
T ss_pred CCCCCeEEEECC---eEEEEEECcccccC
Confidence 999999999754 45669999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=2.1e-05 Score=74.26 Aligned_cols=118 Identities=14% Similarity=0.116 Sum_probs=75.8
Q ss_pred CcEEEEEEccC--CcccHHHHHHHHHhcCCC-C-CcccceEEEE-eCCeEEEEEecCCCcCcHHHh-hc---cCCchhhH
Q psy6377 15 GEVFAAKFLES--NPVRIHHEIALLSLCSPS-P-RIVKLHDVFQ-TGEGAYYVSWNTPLVVTLQTI-ID---DNLVVPFE 85 (383)
Q Consensus 15 g~~vAvK~i~~--~~~~~~~Ei~il~~~~~h-p-nIvkl~~~~~-~~~~~~lv~e~~~~g~~L~~~-l~---~~~~~~~~ 85 (383)
|..+++|+-.. ....+.+|.++|+.+..| + .+++++.+.. ..+..|++|++++ |..+... +. ......+.
T Consensus 39 g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~-G~~l~~~~~~~l~~~~~~~~~ 117 (306)
T 3tdw_A 39 NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ-GQILGEDGMAVLPDDAKDRLA 117 (306)
T ss_dssp TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC-SEECHHHHHTTSCHHHHHHHH
T ss_pred CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC-CeECchhhhhhCCHHHHHHHH
Confidence 57789998543 245788999999955544 2 3667777764 3455789999999 8888752 11 11111222
Q ss_pred HHHHHHHHHHHh------------------------------------------------------------CCceecCC
Q psy6377 86 SDELSSLAYLHH------------------------------------------------------------RKIAHLDI 105 (383)
Q Consensus 86 ~qil~aL~yLHs------------------------------------------------------------~givHrDL 105 (383)
.++...|..||+ ..++|+|+
T Consensus 118 ~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~ 197 (306)
T 3tdw_A 118 LQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDL 197 (306)
T ss_dssp HHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCC
T ss_pred HHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCC
Confidence 333333333332 24699999
Q ss_pred CCCcEEEeccCCCCc-EEEEeccceeEee
Q psy6377 106 KPQNLVMMGDFPNCD-IKVCDFEISRVIL 133 (383)
Q Consensus 106 Kp~NILl~~~~~~~~-ikL~DFGla~~~~ 133 (383)
+|.|||++.+...+. +.|+||+.+....
T Consensus 198 ~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 198 SPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp SGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred CcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 999999986212234 4899999888653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00023 Score=69.41 Aligned_cols=63 Identities=13% Similarity=-0.100 Sum_probs=39.9
Q ss_pred ceEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCCC-C-CcccceEEEEeCCeEEEEEecCCCc
Q psy6377 4 LSEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSPS-P-RIVKLHDVFQTGEGAYYVSWNTPLV 69 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~h-p-nIvkl~~~~~~~~~~~lv~e~~~~g 69 (383)
-.||++....+|+.+++|.... ...++.+|.++++.+..+ | .+++++.+ +.+..++|||++. |
T Consensus 44 n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~-g 119 (397)
T 2olc_A 44 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS-H 119 (397)
T ss_dssp EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT-T
T ss_pred EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCC-C
Confidence 4578887666788999997542 124567899998854332 3 34566643 4556789999997 5
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=4.8e-05 Score=72.97 Aligned_cols=58 Identities=12% Similarity=0.194 Sum_probs=42.6
Q ss_pred CcEEEEEEccCC-------cccHHHHHHHHHhcCCC--CCcccceEEEEeC---CeEEEEEecCCCcCcHH
Q psy6377 15 GEVFAAKFLESN-------PVRIHHEIALLSLCSPS--PRIVKLHDVFQTG---EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 15 g~~vAvK~i~~~-------~~~~~~Ei~il~~~~~h--pnIvkl~~~~~~~---~~~~lv~e~~~~g~~L~ 73 (383)
|+.+++|+.... ...+.+|..+++.+..+ -.+++++.+..+. ...|+|||+++ |..+.
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~-G~~l~ 121 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVE-GVVPP 121 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCC-CBCCC
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecC-CCChh
Confidence 678999987652 25789999999865554 3578888887655 34689999998 76654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00016 Score=71.23 Aligned_cols=33 Identities=21% Similarity=0.208 Sum_probs=28.0
Q ss_pred hCCceecCCCCCcEEEeccCCCCcEEEEeccceeEee
Q psy6377 97 HRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133 (383)
Q Consensus 97 s~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~ 133 (383)
...++|+|++|.|||++.+ .+.++||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~----~~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD----STQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSS----CEEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCC----CCEEEeCcccccCc
Confidence 5679999999999999754 38999999988754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00082 Score=63.32 Aligned_cols=31 Identities=19% Similarity=0.249 Sum_probs=26.6
Q ss_pred CCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
.+++|+|++|.|||++.+ +.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~---~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN---EQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGG---GCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCC---CcEEEEehhhccc
Confidence 679999999999999654 4789999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0022 Score=60.68 Aligned_cols=117 Identities=12% Similarity=0.064 Sum_probs=69.2
Q ss_pred CCcEEEEEEccCCc-ccHHHHHHHHHhcCCCC-CcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCc----------
Q psy6377 14 TGEVFAAKFLESNP-VRIHHEIALLSLCSPSP-RIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLV---------- 81 (383)
Q Consensus 14 tg~~vAvK~i~~~~-~~~~~Ei~il~~~~~hp-nIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~---------- 81 (383)
+|+.+++|...... ..+..|+.+++.+..+. .+++++.+ ....+ +++||.+. +..+.+.+.....
T Consensus 42 ~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~-d~~~g-~ll~e~l~-~~~l~~~l~~~~~~~~~~~~~~~ 118 (333)
T 3csv_A 42 TGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAE-EHARG-LLLIEDLG-DALFTEVINNDPAQEMPLYRAAV 118 (333)
T ss_dssp TCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEE-ETTTT-EEEECCCC-SCBHHHHHHHCGGGHHHHHHHHH
T ss_pred CCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeee-cCCCC-EEEEeeCC-CcchHHHhcCCCccHHHHHHHHH
Confidence 36778888766543 67888998888554442 35666665 22333 78999987 6555432211000
Q ss_pred --------------h---------------hhH-------------HHHHHHHHHH------HhCCceecCCCCCcEEEe
Q psy6377 82 --------------V---------------PFE-------------SDELSSLAYL------HHRKIAHLDIKPQNLVMM 113 (383)
Q Consensus 82 --------------~---------------~~~-------------~qil~aL~yL------Hs~givHrDLKp~NILl~ 113 (383)
. .+. ..+...+..+ +...++|+|+.|.|||++
T Consensus 119 ~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~~Nil~~ 198 (333)
T 3csv_A 119 DLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHAQNLLWL 198 (333)
T ss_dssp HHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSGGGEEEC
T ss_pred HHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCcccEEec
Confidence 0 000 0011112222 124699999999999997
Q ss_pred ccCC-CCcEEEEeccceeEee
Q psy6377 114 GDFP-NCDIKVCDFEISRVIL 133 (383)
Q Consensus 114 ~~~~-~~~ikL~DFGla~~~~ 133 (383)
.+.. .+.+.|+||+.+....
T Consensus 199 ~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 199 PEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp TTSCGGGGEEECCCTTCEEEC
T ss_pred cCcCCCCCeEEEeCCCcCcCC
Confidence 5311 1468999999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0022 Score=62.48 Aligned_cols=114 Identities=15% Similarity=0.182 Sum_probs=69.1
Q ss_pred CCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH-hhc------------
Q psy6377 14 TGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT-IID------------ 77 (383)
Q Consensus 14 tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~-~l~------------ 77 (383)
+++.|++|+... ......+|.++++.+..+.-.++++.++.+ . +|||+++ |..|.. -+.
T Consensus 81 ~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e~i~-G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQYIP-SRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEECCS-EEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEEEec-CccCChhHhCCHHHHHHHHHHH
Confidence 357899998644 345567899998866555555778777643 2 8999998 766542 110
Q ss_pred -----------cCC------chhhHHHH-------------------HHHHHHHH----h----CCceecCCCCCcEEEe
Q psy6377 78 -----------DNL------VVPFESDE-------------------LSSLAYLH----H----RKIAHLDIKPQNLVMM 113 (383)
Q Consensus 78 -----------~~~------~~~~~~qi-------------------l~aL~yLH----s----~givHrDLKp~NILl~ 113 (383)
... +..+..++ -..+..|. . ..++|+|+.+.|||++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 000 00111111 11223332 2 2489999999999997
Q ss_pred cc-CCCCcEEEEeccceeEe
Q psy6377 114 GD-FPNCDIKVCDFEISRVI 132 (383)
Q Consensus 114 ~~-~~~~~ikL~DFGla~~~ 132 (383)
.+ ...+.+.++||..|...
T Consensus 236 ~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp SCC---CCEEECCCTTCEEE
T ss_pred CCCCccCcEEEEecccCCcC
Confidence 64 12357899999988763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.005 Score=58.30 Aligned_cols=64 Identities=9% Similarity=-0.040 Sum_probs=48.9
Q ss_pred EEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCC--CCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 6 EEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSP--SPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 6 V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~--hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
+|... .+++.+++|+... ....+.+|.+.|+.+.. ...+++++.+..+.+..|+|||+++ |..+
T Consensus 52 ~y~v~--~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~-G~~~ 118 (312)
T 3jr1_A 52 IWLIN--DEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN-KSKN 118 (312)
T ss_dssp EEEEE--SSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC-CCCC
T ss_pred eeEEE--ECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc-CCCC
Confidence 56655 3577899998765 34568899888885543 3778999999888889999999999 7654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.003 Score=58.95 Aligned_cols=108 Identities=11% Similarity=0.032 Sum_probs=64.4
Q ss_pred cEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecC-CCcCcHHH-hhccCCchhhHHHHHH
Q psy6377 16 EVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT-PLVVTLQT-IIDDNLVVPFESDELS 90 (383)
Q Consensus 16 ~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~-~~g~~L~~-~l~~~~~~~~~~qil~ 90 (383)
+.+++|+.... .....+|..+++.+..+.-.++++.+ +.+.-+++++++ + |.++.. .+... .....++..
T Consensus 38 ~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~-g~~l~~~~~~~~--~~~~~~~~~ 112 (301)
T 3dxq_A 38 GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG-AQTMSPEKFKTR--PGSPARAGE 112 (301)
T ss_dssp TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT-CEECCHHHHHHS--TTHHHHHHH
T ss_pred eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC-CccCCHhhHhhh--HHHHHHHHH
Confidence 45788877652 23457888888755444333566654 344457899999 6 666543 11100 012233333
Q ss_pred HHHHHHhC-----------------------------------------------------CceecCCCCCcEEEeccCC
Q psy6377 91 SLAYLHHR-----------------------------------------------------KIAHLDIKPQNLVMMGDFP 117 (383)
Q Consensus 91 aL~yLHs~-----------------------------------------------------givHrDLKp~NILl~~~~~ 117 (383)
.|.-||+. .++|+|+.|.||+.. +
T Consensus 113 ~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil~~-~-- 189 (301)
T 3dxq_A 113 AFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACHCDPLCENFLDT-G-- 189 (301)
T ss_dssp HHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEECSCCCGGGEEEC-S--
T ss_pred HHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeeccCCCcCCEEEC-C--
Confidence 33333321 279999999999943 2
Q ss_pred CCcEEEEeccceeEe
Q psy6377 118 NCDIKVCDFEISRVI 132 (383)
Q Consensus 118 ~~~ikL~DFGla~~~ 132 (383)
+.+.++||..+...
T Consensus 190 -~~~~lID~e~a~~g 203 (301)
T 3dxq_A 190 -ERMWIVDWEYSGMN 203 (301)
T ss_dssp -SCEEECCCTTCEEE
T ss_pred -CCEEEEecccccCC
Confidence 46899999988763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0039 Score=58.46 Aligned_cols=121 Identities=12% Similarity=0.063 Sum_probs=70.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCC-CcccceEE------EEeCCeEEEEEecCCCcCcHHH-
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSP-RIVKLHDV------FQTGEGAYYVSWNTPLVVTLQT- 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hp-nIvkl~~~------~~~~~~~~lv~e~~~~g~~L~~- 74 (383)
.+|.+.. ++..+++|+... ....+..|+.+++.+..+. .+++++.. ....+..++++++++ |..+..
T Consensus 37 ~~~~v~~--~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~-G~~~~~~ 113 (322)
T 2ppq_A 37 SNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE-GMWLRKP 113 (322)
T ss_dssp EEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC-CBCCSSC
T ss_pred ceEEEEe--CCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC-CcCCCCC
Confidence 3555543 233688999876 4567888988887544331 13333321 223456789999998 654321
Q ss_pred -----------------hhc---cC-----CchhhH------------------HHHHHHHHHHHh-------CCceecC
Q psy6377 75 -----------------IID---DN-----LVVPFE------------------SDELSSLAYLHH-------RKIAHLD 104 (383)
Q Consensus 75 -----------------~l~---~~-----~~~~~~------------------~qil~aL~yLHs-------~givHrD 104 (383)
... .. ....+. ..+...+++++. .+++|+|
T Consensus 114 ~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgD 193 (322)
T 2ppq_A 114 EAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHAD 193 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSC
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCC
Confidence 000 00 000000 123445555553 3699999
Q ss_pred CCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 105 IKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 105 LKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+.|.|||++.+ +.+.++||+.+..
T Consensus 194 l~~~Nil~~~~---~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 194 LFQDNVFFLGD---ELSGLIDFYFACN 217 (322)
T ss_dssp CCGGGEEEETT---EEEEECCCTTCEE
T ss_pred CCccCEEEeCC---ceEEEecchhccC
Confidence 99999999764 3457999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0052 Score=60.72 Aligned_cols=63 Identities=13% Similarity=0.015 Sum_probs=42.1
Q ss_pred eEEEEEEcC-------CCcEEEEEEccC-Cc-ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIA-------TGEVFAAKFLES-NP-VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~-------tg~~vAvK~i~~-~~-~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.+|.+.... .++.+++|+... .. ..+.+|..+++.+..+.-.+++++.+. + .+|+++++ |.++
T Consensus 88 ~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~-G~~l 159 (429)
T 1nw1_A 88 MLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIP-SRPL 159 (429)
T ss_dssp EEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCC-EEEC
T ss_pred ceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeC-Cccc
Confidence 466666432 357899999854 33 567789999885555544577777654 2 28899998 6444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0071 Score=58.08 Aligned_cols=52 Identities=10% Similarity=-0.072 Sum_probs=34.5
Q ss_pred cEEEEEEccCCc---ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 16 EVFAAKFLESNP---VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 16 ~~vAvK~i~~~~---~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
..+++|+..... .....|..+++.+..+.-.++++..+ . -++||++++ |..+
T Consensus 67 ~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~i~-G~~l 121 (369)
T 3c5i_A 67 TRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEWLY-GDPL 121 (369)
T ss_dssp CEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECCC-SEEC
T ss_pred ceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEEec-CCcC
Confidence 689999876522 23478888888554443355777654 2 368999998 7544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.032 Score=55.61 Aligned_cols=63 Identities=8% Similarity=0.039 Sum_probs=41.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCCc---ccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLESNP---VRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~---~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.+|++.....+..+++|+..... ....+|..+++.+..+.-.++++.++. +. +||++++ |..|
T Consensus 123 ~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~-G~~l 188 (458)
T 2qg7_A 123 ILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD-GYAL 188 (458)
T ss_dssp EEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC-SEEC
T ss_pred EEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC-CccC
Confidence 46777654445789999875522 223689999986655555577888773 32 4999998 6554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.05 E-value=0.021 Score=53.48 Aligned_cols=66 Identities=9% Similarity=-0.044 Sum_probs=41.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCC-CcccceEE-----EEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSP-RIVKLHDV-----FQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hp-nIvkl~~~-----~~~~~~~~lv~e~~~~g~~L 72 (383)
.||.+.. .+|+.+++|+... ....+..|..+++.+..+. .+++++.. ...++..+++|++++ |..+
T Consensus 40 ~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~-G~~~ 114 (328)
T 1zyl_A 40 RVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG-GRQF 114 (328)
T ss_dssp EEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC-CEEC
T ss_pred ceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC-CCCC
Confidence 4666542 4567899999863 3456788888887443321 24444442 223456688999998 6543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.066 Score=47.91 Aligned_cols=117 Identities=16% Similarity=0.190 Sum_probs=70.0
Q ss_pred cCcHHHhh-------ccCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccccc
Q psy6377 69 VVTLQTII-------DDNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRE 140 (383)
Q Consensus 69 g~~L~~~l-------~~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~ 140 (383)
..+|.+++ ++.++|.+..|.+.+|.-+-. +.-..+=+.|..|++..+ |.|-+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d---G~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD---GAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT---SCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC---Cceeccc-cccc----------
Confidence 34677654 556777777888888776521 221233345688888766 5555443 1111
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.....+.|||... .+.+.+.=|||||+++|.-+- +..++..-..+|+.+..||..|.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD---------------------ygL~e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD---------------------YGLKENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT---------------------TTCCTTEEECCCHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh---------------------cCCCcccchhhCHHHHHHHHHHH
Confidence 1233466888764 345788999999999998764 33333334578999999999997
Q ss_pred cc
Q psy6377 221 IK 222 (383)
Q Consensus 221 ~~ 222 (383)
.-
T Consensus 155 ~~ 156 (229)
T 2yle_A 155 NT 156 (229)
T ss_dssp TC
T ss_pred hc
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.61 E-value=0.13 Score=47.34 Aligned_cols=61 Identities=11% Similarity=-0.037 Sum_probs=40.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC----cccHHHHHHHHHhcCCC--CCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN----PVRIHHEIALLSLCSPS--PRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~----~~~~~~Ei~il~~~~~h--pnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
.||+.+ ..+|+.|++|+-+.. ...+..|.+.|+.+... -.+++++.+ + .-++|||++. ++.
T Consensus 30 ~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~-~~~ 96 (288)
T 3f7w_A 30 HLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVD-ERP 96 (288)
T ss_dssp EEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCC-CCC
T ss_pred EEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeec-ccC
Confidence 567775 468999999987652 23578899999855443 234555554 2 3478899987 443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.19 Score=47.54 Aligned_cols=33 Identities=18% Similarity=0.284 Sum_probs=27.5
Q ss_pred CCceecCCCCCcEEEeccCCCCcEEEEeccceeEee
Q psy6377 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVIL 133 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~ 133 (383)
.+++|+|+.|.||+++.+ +.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~---~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE---ESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGG---GCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCC---CeEEEEECCCCeeCC
Confidence 368999999999999754 468999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.092 Score=51.75 Aligned_cols=53 Identities=8% Similarity=-0.098 Sum_probs=36.5
Q ss_pred CcEEEEEEccCC---cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 15 GEVFAAKFLESN---PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 15 g~~vAvK~i~~~---~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
++.|++++.... .....+|..+++.+..+.-.+++++.+. -++|+++++ |..|
T Consensus 102 ~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI~-G~~l 157 (424)
T 3mes_A 102 HPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFID-GEPL 157 (424)
T ss_dssp CSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECCC-SEEC
T ss_pred CCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEeC-CccC
Confidence 678999987552 2345789998886555555667776442 278899999 7664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.77 E-value=0.82 Score=40.56 Aligned_cols=121 Identities=14% Similarity=0.061 Sum_probs=74.3
Q ss_pred HHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--CCchhhHHHHHHHHHHHHhCCceecCCCCCc
Q psy6377 32 HEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--NLVVPFESDELSSLAYLHHRKIAHLDIKPQN 109 (383)
Q Consensus 32 ~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--~~~~~~~~qil~aL~yLHs~givHrDLKp~N 109 (383)
+|+.+|. ..||+++.. .+-++++.+.+.++.-..+.++..+-.. ...+.++.+|+....++ ..=+|--|+|+|
T Consensus 35 ~el~LL~--~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~N 109 (215)
T 4ann_A 35 HLMYLLE--QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDE 109 (215)
T ss_dssp GGGGGGG--SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGG
T ss_pred HHHHHHh--ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecce
Confidence 4444554 569999987 6777777777777666534555553222 22334445555555333 334788899999
Q ss_pred EEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCC
Q psy6377 110 LVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF 181 (383)
Q Consensus 110 ILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf 181 (383)
|+++.+ +.++++-.|+-.. ++|. .++...=.-..=|++..+++++..|
T Consensus 110 L~f~~~---~~p~i~~RGik~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 110 LFFTRD---GLPIAKTRGLQNV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEECTT---SCEEESCCEETTT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEcCC---CCEEEEEccCccC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999876 5788887775322 2222 1233333334557778888888877
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 383 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-32 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-04 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (463), Expect = 5e-55
Identities = 84/308 (27%), Positives = 141/308 (45%), Gaps = 14/308 (4%)
Query: 9 ADSIATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
ATG FAAKF+ ES+ + EI +S+ P +V LHD F+
Sbjct: 45 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYE 103
Query: 61 YVSWNT--PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
++S V + ++ V + L ++H HLD+KP+N++ +
Sbjct: 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-S 162
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
++K+ DF ++ + ++ GT ++ APE+ +P+ DMWS+GV +Y+LL+G
Sbjct: 163 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
SPFGGE D ET RN+ + D F IS + KDFI K+L+ +P RMT +AL+HPW
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 239 LMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKSAL 298
L S ++ + ++ + S L++ ++ ++
Sbjct: 283 L--TPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSI 340
Query: 299 LKYNKTRR 306
R
Sbjct: 341 RDAFWDRS 348
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-54
Identities = 83/278 (29%), Positives = 144/278 (51%), Gaps = 14/278 (5%)
Query: 9 ADSIATGEVFAAKFL---ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS-- 63
++ + + AKF+ ++ V + EI++L++ I+ LH+ F++ E +
Sbjct: 24 CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEF 82
Query: 64 -WNTPLVVTLQT---IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
+ + T +++ +V + +L +LH I H DI+P+N++ +
Sbjct: 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSS 141
Query: 120 DIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
IK+ +F +R + G R L P+Y APE+ ++ ++ A DMWSLG YVLL+G +
Sbjct: 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 180 PFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
PF ET+ + NI A+ F +E F++IS EA DF+ ++L+K RMTA EAL+HPWL
Sbjct: 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
Query: 240 MNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREA 277
KQ + RV ++ + ++K L+ A
Sbjct: 262 ---KQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (455), Expect = 9e-54
Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 12/298 (4%)
Query: 9 ADSIATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
ATG VF AKF+ + + +EI++++ P+++ LHD F+
Sbjct: 48 CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILE 106
Query: 61 YVSWNT--PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
++S + + + V+ + L ++H I HLDIKP+N +M
Sbjct: 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN-IMCETKKA 165
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
+K+ DF ++ + ++ T ++ APEI+ EP+ DMW++GV YVLL+G
Sbjct: 166 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
SPF GE D ET +N+ + +F ++ F +SPEAKDFI +L K P +R+T +AL+HPW
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285
Query: 239 LMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLRKS 296
L +T SS + I+ + +K + S K + + +
Sbjct: 286 LKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 343
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-52
Identities = 65/238 (27%), Positives = 111/238 (46%), Gaps = 21/238 (8%)
Query: 14 TGEVFAAKFL-------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNT 66
+ + A K L ++ E+ + S P I++L+ F Y +
Sbjct: 30 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYA 88
Query: 67 PLVVTLQTI-----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
PL + + D+ + ++ ++L+Y H +++ H DIKP+NL++ ++
Sbjct: 89 PLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---EL 145
Query: 122 KVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPF 181
K+ DF S L GT DY+ PE++ D+WSLGV Y L G PF
Sbjct: 146 KIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 182 GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
T ET++ IS+ + FPD ++ A+D I+++L NP +R +E L+HPW+
Sbjct: 205 EANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 1e-51
Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 11/267 (4%)
Query: 9 ADSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY--- 60
A+ T ++ A K + E + +EIA+L P IV L D++++G Y
Sbjct: 28 AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGHLYLIM 86
Query: 61 -YVSWNTPL-VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
VS + + + L ++ YLH I H D+KP+NL+ +
Sbjct: 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
I + DF +S++ G + GTP YVAPE+L +P + A D WS+GV AY+LL G+
Sbjct: 147 SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
PF E D++ F I KA+ +F ++DIS AKDFI ++ K+P +R T ++AL+HPW
Sbjct: 207 PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266
Query: 239 LMNKKQIMTRVGCSSCPSIIQNQQNKK 265
+ + + S I +N K
Sbjct: 267 IAGDTALDKNIHQSVSEQIKKNFAKSK 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 86/250 (34%), Positives = 139/250 (55%), Gaps = 17/250 (6%)
Query: 9 ADSIATGEVFAAKFLESNPV----------RIHHEIALLSLCSPSPRIVKLHDVFQTGEG 58
+TG +AAKF++ I E+++L P ++ LH+V++
Sbjct: 29 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTD 87
Query: 59 AYYV-----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQN-LVM 112
+ + + + + F L+ + YLH +IAH D+KP+N +++
Sbjct: 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 147
Query: 113 MGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+ P IK+ DF ++ I G E + + GTP++VAPEI++YEP+ L ADMWS+GV Y
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+LL+G SPF G+T ET N+S +F DE F + S AKDFI ++L+K+P +RMT ++
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267
Query: 233 ALKHPWLMNK 242
+L+HPW+ K
Sbjct: 268 SLQHPWIKPK 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-50
Identities = 84/306 (27%), Positives = 135/306 (44%), Gaps = 25/306 (8%)
Query: 14 TGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV--- 70
T E FA K L+ P + E+ L S P IV++ DV++ Y L+V
Sbjct: 36 TQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYEN----LYAGRKCLLIVMEC 90
Query: 71 ----TLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
L + I D F E ++ YLH IAH D+KP+NL+ PN
Sbjct: 91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGF 178
+K+ DF ++ + TP YVAPE+L E + DMWSLGV Y+LL G+
Sbjct: 151 AILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
Query: 179 SPFGGETDSET----FRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
PF I Q +FP+ + ++S E K I +L P +RMT E +
Sbjct: 211 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
Query: 235 KHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEKVISASKLQQENLR 294
HPW+M ++ +S + ++++ +++++ ++ + + + E+
Sbjct: 271 NHPWIMQSTKVPQTPLHTS-RVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDAS 329
Query: 295 KSALLK 300
LLK
Sbjct: 330 NPLLLK 335
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-47
Identities = 65/248 (26%), Positives = 115/248 (46%), Gaps = 23/248 (9%)
Query: 9 ADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A +AT +A K LE + + E ++S P VKL+ FQ E Y+
Sbjct: 27 ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF 85
Query: 62 V-----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+ + D+ + ++ +S+L YLH + I H D+KP+N+++ D
Sbjct: 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED- 144
Query: 117 PNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
I++ DF ++V+ + +GT YV+PE+L + ++D+W+LG Y
Sbjct: 145 --MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
L+ G PF + F+ I K + DFP E P+A+D + K+L+ + +R+ +E
Sbjct: 203 LVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEM 258
Query: 234 LKHPWLMN 241
+ L
Sbjct: 259 EGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 4e-47
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 33/258 (12%)
Query: 9 ADSIATGEVFAAKFLESNPV-------------RIHHEIALLSLCSPSPRIVKLHDVFQT 55
T + +A K ++ E+ +L S P I++L D ++T
Sbjct: 22 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81
Query: 56 GEGAYYVSWNTPLVV--TLQTIIDDNLVVPFE------SDELSSLAYLHHRKIAHLDIKP 107
+ V L+ L + + + + + L + LH I H D+KP
Sbjct: 82 NTFFFLV---FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKP 138
Query: 108 QNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL------HYEPITLA 161
+N+++ D +IK+ DF S + G ++RE+ GTP Y+APEI+ ++
Sbjct: 139 ENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 195
Query: 162 ADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221
DMWS GV Y LL G PF R I F ++D S KD +++ L+
Sbjct: 196 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 255
Query: 222 KNPMERMTAKEALKHPWL 239
P +R TA+EAL HP+
Sbjct: 256 VQPQKRYTAEEALAHPFF 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-47
Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 14/244 (5%)
Query: 9 ADSIATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---- 60
A +ATG+ A + + + I +EI ++ +P IV D + G+ +
Sbjct: 39 AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVME 97
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
Y++ + V +T +D+ + + L +L +LH ++ H DIK N+++ +
Sbjct: 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGS 154
Query: 121 IKVCDFEISRVIL-DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFS 179
+K+ DF I + + ++GTP ++APE++ + D+WSLG+ A ++ G
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 180 PFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P+ E I+ + E +S +DF+ + L + +R +AKE L+H +L
Sbjct: 215 PYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 240 MNKK 243
K
Sbjct: 274 KIAK 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-47
Identities = 68/247 (27%), Positives = 108/247 (43%), Gaps = 21/247 (8%)
Query: 9 ADSIATGEVFAAKFL----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-- 62
A + T + AAK + E EI +L+ C P IVKL D F + +
Sbjct: 31 AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIE 89
Query: 63 ----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
+++ L+ + ++ + L +L YLH KI H D+K N++ +
Sbjct: 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLD 146
Query: 119 CDIKVCDFEISRVILDGIEIR-ELLGTPDYVAPEILHYE-----PITLAADMWSLGVTAY 172
DIK+ DF +S I+ R +GTP ++APE++ E P AD+WSLG+T
Sbjct: 147 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 206
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232
+ P I+K++ + S KDF+ K L KN R T +
Sbjct: 207 EMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRWSSNFKDFLKKCLEKNVDARWTTSQ 265
Query: 233 ALKHPWL 239
L+HP++
Sbjct: 266 LLQHPFV 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 8e-45
Identities = 59/288 (20%), Positives = 108/288 (37%), Gaps = 28/288 (9%)
Query: 9 ADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A + EV A K + + I E+ L P ++ + A+
Sbjct: 34 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL 92
Query: 62 V-----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
V + L+ + + + + L LAYLH + H D+K N+++
Sbjct: 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL---HYEPITLAADMWSLGVTAYV 173
+K+ DF + ++ +GTP ++APE++ D+WSLG+T
Sbjct: 153 ---LVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 174 LLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233
L P +I AQ + P S ++F+ L K P +R T++
Sbjct: 207 LAERKPPLFNMNAMSALYHI--AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
Query: 234 LKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKYLSKSREALFEK 281
LKH ++ ++ V + NL+ K ++ LF++
Sbjct: 265 LKHRFV--LRERPPTVIMDLIQRTKDAVRELDNLQY--RKMKKILFQE 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-44
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 19/245 (7%)
Query: 9 ADSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY--- 60
A + T E A K + P I EI + + + +VK + + G Y
Sbjct: 24 AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFL 82
Query: 61 -YVSWNTPL-VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
Y S + + + F ++ + YLH I H DIKP+NL++
Sbjct: 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--- 139
Query: 119 CDIKVCDFEISRVILDGIEIREL---LGTPDYVAPEILHYEPI-TLAADMWSLGVTAYVL 174
++K+ DF ++ V R L GT YVAPE+L D+WS G+ +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234
L G P+ +DS + K + + + ++ I + KIL++NP R+T +
Sbjct: 200 LAGELPWDQPSDSCQEYSDWKEKKTYLNP-WKKIDSAPLALLHKILVENPSARITIPDIK 258
Query: 235 KHPWL 239
K W
Sbjct: 259 KDRWY 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (383), Expect = 1e-43
Identities = 65/283 (22%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 8 MADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY 60
+ S G +A K L+ V + E +LS+ + P I+++ FQ + +
Sbjct: 22 LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIF 80
Query: 61 YVS-----WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGD 115
+ ++ + + + ++ +L YLH + I + D+KP+N+++ +
Sbjct: 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN 140
Query: 116 FPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
IK+ DF ++ + D L GTPDY+APE++ +P + D WS G+ Y +L
Sbjct: 141 ---GHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TA 230
G++PF +T+ I A+L FP + + KD +++++ ++ +R+
Sbjct: 196 AGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGT 251
Query: 231 KEALKHPWL--MNKKQIMTR-VGCSSCPSIIQNQQNKKNLRKY 270
++ HPW + +++++R + P I Q Q + KY
Sbjct: 252 EDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-42
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 40/259 (15%)
Query: 9 ADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
+ G++ K L E+ + E+ LL P IV+ +D
Sbjct: 23 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81
Query: 63 SWNTPLVV------TLQTIIDDNLVVPFESDE----------LSSLAYLHHR-----KIA 101
+V+ L ++I DE +L H R +
Sbjct: 82 -----IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136
Query: 102 HLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI-RELLGTPDYVAPEILHYEPITL 160
H D+KP N+ + G ++K+ DF ++R++ + +GTP Y++PE ++
Sbjct: 137 HRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE 193
Query: 161 AADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220
+D+WSLG Y L PF + E I + + + S E + I ++L
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIPYRYSDELNEIITRML 250
Query: 221 IKNPMERMTAKEALKHPWL 239
R + +E L++P +
Sbjct: 251 NLKDYHRPSVEEILENPLI 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 21/245 (8%)
Query: 9 ADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A+ T + FA K L+ + V E +LSL P + + FQT E ++
Sbjct: 21 AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80
Query: 62 V---SWNTPLVVTLQT--IIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
V L+ +Q+ D + + ++ + L +LH + I + D+K N+++ D
Sbjct: 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 140
Query: 117 PNCDIKVCDFEISR-VILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
K+ DF + + +L + GTPDY+APEIL + + D WS GV Y +L
Sbjct: 141 HI---KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK-EAL 234
G SPF G+ + E F +I +P + EAKD + K+ ++ P +R+ + +
Sbjct: 198 IGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
Query: 235 KHPWL 239
+HP
Sbjct: 254 QHPLF 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 63/277 (22%), Positives = 107/277 (38%), Gaps = 56/277 (20%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS---WN 65
+G V A K + + +I E+ +L C+ SP IV + F +
Sbjct: 30 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDG 88
Query: 66 TPLVVTLQT--IIDDNLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIK 122
L L+ I + ++ + L YL + KI H D+KP N+++ +IK
Sbjct: 89 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIK 145
Query: 123 VCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFG 182
+CDF +S ++D +GT Y++PE L ++ +D+WS+G++ + G P
Sbjct: 146 LCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 183 GETDSE---------------------------------------TFRNISKAQLDFPDE 203
E F + + P +
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 204 LFED-ISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
L S E +DF+ K LIKNP ER K+ + H ++
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 4e-41
Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 23/243 (9%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNT 66
T A L +S R E +L P IV+ +D +++ +G + T
Sbjct: 33 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVT 91
Query: 67 PLVV--TLQTIIDDNLVVPFE------SDELSSLAYLHHRK--IAHLDIKPQNLVMMGDF 116
L+ TL+T + V+ + L L +LH R I H D+K N+ + G
Sbjct: 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP- 150
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
+K+ D ++ + + ++GTP+++APE+ E + D+++ G+ + T
Sbjct: 151 -TGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT 207
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
P+ ++ + + P + PE K+ I + +N ER + K+ L H
Sbjct: 208 SEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266
Query: 237 PWL 239
+
Sbjct: 267 AFF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-40
Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 31/251 (12%)
Query: 9 ADSIATGEVFAAKFLE----------SNPVRIHHEIALLS-LCSPSPRIVKLHDVFQTGE 57
++ A K +E N R+ E+ LL + S +++L D F+ +
Sbjct: 23 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82
Query: 58 GAYYVSWNTPLVVTLQTII------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLV 111
+ V L I + L F L ++ + H+ + H DIK +N++
Sbjct: 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142
Query: 112 MMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEP-ITLAADMWSLGVT 170
+ + ++K+ DF +L + GT Y PE + Y +A +WSLG+
Sbjct: 143 IDLN--RGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 171 AYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230
Y ++ G PF + I + Q+ F + +S E + I L P +R T
Sbjct: 200 LYDMVCGDIPFEHDE------EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTF 249
Query: 231 KEALKHPWLMN 241
+E HPW+ +
Sbjct: 250 EEIQNHPWMQD 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-40
Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 26/249 (10%)
Query: 9 ADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
ATG +A K L + E +L P + L FQT + +
Sbjct: 24 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF 82
Query: 62 VSWNTP-----LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
V ++ + + + + ++ +S+L YLH R + + DIK +NL++
Sbjct: 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---D 139
Query: 117 PNCDIKVCDFEISRVIL-DGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLL 175
+ IK+ DF + + + DG ++ GTP+Y+APE+L A D W LGV Y ++
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TA 230
G PF + F I ++ FP +SPEAK +A +L K+P +R+ A
Sbjct: 200 CGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 231 KEALKHPWL 239
KE ++H +
Sbjct: 256 KEVMEHRFF 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-39
Identities = 58/269 (21%), Positives = 97/269 (36%), Gaps = 44/269 (16%)
Query: 14 TGEVFAAKFL---------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-- 62
T ++ A K + + EI LL S P I+ L D F V
Sbjct: 22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80
Query: 63 ---SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
+ ++ ++ + + + L L YLH I H D+KP NL++ N
Sbjct: 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENG 137
Query: 120 DIKVCDFEISRVILDGIE-IRELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYVLLTG 177
+K+ DF +++ + T Y APE+L + DMW++G LL
Sbjct: 138 VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197
Query: 178 FSPFGGETDSETFRNISKAQLDFPDE------------------------LFEDISPEAK 213
G++D + I + +E +F +
Sbjct: 198 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 257
Query: 214 DFIAKILIKNPMERMTAKEALKHPWLMNK 242
D I + + NP R+TA +ALK + N+
Sbjct: 258 DLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-38
Identities = 59/274 (21%), Positives = 99/274 (36%), Gaps = 45/274 (16%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPS--PRIVKLHDVFQTGEGAYYV--- 62
G A K + E P+ E+A+L P +V+L DV
Sbjct: 32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91
Query: 63 --------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
T L + + + L L +LH ++ H D+KPQN+++
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
+ IK+ DF ++R+ + + ++ T Y APE+L D+WS+G +
Sbjct: 152 ---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDE-----------------------LFEDISPE 211
F G +D + I +E DI
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 212 AKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245
KD + K L NP +R++A AL HP+ + ++
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 135 bits (341), Expect = 6e-38
Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 24/251 (9%)
Query: 9 ADSIATGEVFAAKFL-------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
A + A K L S +R E + + P IV ++D + A
Sbjct: 26 ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGP 84
Query: 62 VSW-------NTPLVVTLQTI--IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVM 112
+ + L + T + + +D +L + H I H D+KP N+++
Sbjct: 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144
Query: 113 MGDFPNCDIKVCDFEISRVILDGIEIRE----LLGTPDYVAPEILHYEPITLAADMWSLG 168
+KV DF I+R I D ++GT Y++PE + + +D++SLG
Sbjct: 145 S---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
Y +LTG PF G++ + P E +S + + K L KNP R
Sbjct: 202 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261
Query: 229 TAKEALKHPWL 239
++ +
Sbjct: 262 QTAAEMRADLV 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 60/266 (22%), Positives = 94/266 (35%), Gaps = 43/266 (16%)
Query: 14 TGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----------YVS 63
+GE+ A K + + + E+ ++ IV+L F + YV
Sbjct: 44 SGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102
Query: 64 WNTPLVV----TLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
V + + V + SLAY+H I H DIKPQNL++ D
Sbjct: 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--TA 160
Query: 120 DIKVCDFEISRVILDGIEIRELLGTPDYVAP-EILHYEPITLAADMWSLGVTAYVLLTGF 178
+K+CDF ++ ++ G + + Y AP I T + D+WS G LL G
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
Query: 179 SPFGGETDSETFRNISKAQLDFPDE-------------------------LFEDISPEAK 213
F G++ + I K E PEA
Sbjct: 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 214 DFIAKILIKNPMERMTAKEALKHPWL 239
+++L P R+T EA H +
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFF 306
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (332), Expect = 2e-36
Identities = 58/264 (21%), Positives = 106/264 (40%), Gaps = 42/264 (15%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV----- 62
GE FA K + E P EI++L IVKL+DV T + V
Sbjct: 25 YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLD 83
Query: 63 SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIK 122
L+ + ++ F L+ +AY H R++ H D+KPQ + ++K
Sbjct: 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ---NLLINREGELK 140
Query: 123 VCDFEISRVI-LDGIEIRELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYVLLTGFSP 180
+ DF ++R + + + T Y AP++L + + D+WS+G ++ G
Sbjct: 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 181 FGGETDSETFRNISKAQLDFPDE-------------------------LFEDISPEAKDF 215
F G ++++ I + + + + D
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 216 IAKILIKNPMERMTAKEALKHPWL 239
++K+L +P +R+TAK+AL+H +
Sbjct: 261 LSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 43/272 (15%)
Query: 9 ADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
A + TGEV A K + E P EI+LL + P IVKL DV T Y V
Sbjct: 21 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79
Query: 63 SWNTP------LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
+ + T I L+ + L LA+ H ++ H D+KPQNL++
Sbjct: 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN--- 136
Query: 117 PNCDIKVCDFEISRVILDGIEIR-ELLGTPDYVAPEIL-HYEPITLAADMWSLGVTAYVL 174
IK+ DF ++R + + T Y APEIL + + A D+WSLG +
Sbjct: 137 TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPD-------------------------ELFEDIS 209
+T + F G+++ + I + + ++ +
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 210 PEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241
+ + ++++L +P +R++AK AL HP+ +
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 7e-36
Identities = 52/247 (21%), Positives = 105/247 (42%), Gaps = 27/247 (10%)
Query: 14 TGEVFAAKFL----------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS 63
TG+++A K L E+ + ++L+S P IV + F T + ++
Sbjct: 28 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFIL 86
Query: 64 ---WNTPLVVTL--QTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
L L + + + + ++ + L ++H+R + + D+KP N+++ +
Sbjct: 87 DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EH 143
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPE-ILHYEPITLAADMWSLGVTAYVLLTG 177
+++ D ++ + +GT Y+APE + +AD +SLG + LL G
Sbjct: 144 GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 178 FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT-----AKE 232
SPF + I + L EL + SPE + + +L ++ R+ A+E
Sbjct: 203 HSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 261
Query: 233 ALKHPWL 239
+ P+
Sbjct: 262 VKESPFF 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-36
Identities = 65/316 (20%), Positives = 118/316 (37%), Gaps = 54/316 (17%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-------- 60
A K + ++ R EI +L I+ ++D+ +
Sbjct: 32 NKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVT 90
Query: 61 YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD 120
++ + + ++ + F L L Y+H + H D+KP NL++ CD
Sbjct: 91 HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCD 147
Query: 121 IKVCDFEISRVILDGIE----IRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLL 175
+K+CDF ++RV + + E + T Y APEI+ T + D+WS+G +L
Sbjct: 148 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 207
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDE---------------------------LFEDI 208
+ F G+ + +I E LF +
Sbjct: 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267
Query: 209 SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLR 268
+A D + K+L NP +R+ ++AL HP+L +Q + + +L
Sbjct: 268 DSKALDLLDKMLTFNPHKRIEVEQALAHPYL---EQYYDPSDEPIAEAPFKFDMELDDLP 324
Query: 269 KYLSKSREALFEKVIS 284
K K +E +FE+
Sbjct: 325 K--EKLKELIFEETAR 338
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-35
Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 27/249 (10%)
Query: 14 TGEVFAAKFLESNPV--------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWN 65
TG+++A K L+ + E +L SP +V LH FQT E ++ +
Sbjct: 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLILD 109
Query: 66 TPLVVTLQTIIDDNLVVPFESDE------LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNC 119
L T + + + +L +LH I + DIK +N+++ N
Sbjct: 110 YINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNG 166
Query: 120 DIKVCDFEISRVILD--GIEIRELLGTPDYVAPEIL--HYEPITLAADMWSLGVTAYVLL 175
+ + DF +S+ + + GT +Y+AP+I+ A D WSLGV Y LL
Sbjct: 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226
Query: 176 TGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TA 230
TG SPF + + + IS+ L +++S AKD I ++L+K+P +R+ A
Sbjct: 227 TGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286
Query: 231 KEALKHPWL 239
E +H +
Sbjct: 287 DEIKEHLFF 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 2e-35
Identities = 54/250 (21%), Positives = 96/250 (38%), Gaps = 27/250 (10%)
Query: 9 ADSIATGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
+G +A K L+ V +E +L + P +VKL F+ Y
Sbjct: 60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM 118
Query: 62 VSWNTPLVVTLQTI-----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF 116
V + + + + + + YLH + + D+KP+NL++
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID--- 175
Query: 117 PNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT 176
I+V DF ++ + L GTP+ +APEI+ + A D W+LGV Y +
Sbjct: 176 QQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM-----TAK 231
G+ PF + + + I ++ FP S + KD + +L + +R
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 232 EALKHPWLMN 241
+ H W
Sbjct: 290 DIKNHKWFAT 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-35
Identities = 55/279 (19%), Positives = 97/279 (34%), Gaps = 57/279 (20%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP 67
TG+ A K + E P+ EI +L L +V L ++ +T Y +
Sbjct: 34 TGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSI 92
Query: 68 LVVT-------------LQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+V + + + L+ L Y+H KI H D+K N+++
Sbjct: 93 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI-- 150
Query: 115 DFPNCDIKVCDFEISRVILDGIE-----IRELLGTPDYVAPEILHYE-PITLAADMWSLG 168
+ +K+ DF ++R + T Y PE+L E D+W G
Sbjct: 151 -TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209
Query: 169 VTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDI-------------------- 208
+ T G T+ IS+ E++ ++
Sbjct: 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269
Query: 209 --------SPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
P A D I K+L+ +P +R+ + +AL H +
Sbjct: 270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-35
Identities = 41/228 (17%), Positives = 91/228 (39%), Gaps = 19/228 (8%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNT--PLVVTLQTIIDDNLVV 82
+E+ +L I+ + T + ++ + ++T + ++
Sbjct: 50 AFKNEVGVLRKTR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI 107
Query: 83 PFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIR 139
+ YLH + I H D+K N+ + D +K+ DF ++ V +
Sbjct: 108 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---TVKIGDFGLATVKSRWSGSHQFE 164
Query: 140 ELLGTPDYVAPEILHYE---PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKA 196
+L G+ ++APE++ + P + +D+++ G+ Y L+TG P+ + + +
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 197 QLDFPD--ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242
PD ++ + K +A+ L K ER + L L+ +
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 1e-34
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 44/271 (16%)
Query: 9 ADSIATGEVFAAKFLESNPV-RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV----- 62
A +I E K L+ +I EI +L P I+ L D+ +
Sbjct: 54 AINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113
Query: 63 SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIK 122
NT QT+ D + + + L +L Y H I H D+KP N+++ D + ++
Sbjct: 114 VNNTDFKQLYQTL-TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLR 170
Query: 123 VCDFEISRVILDGIEIRELLGTPDYVAPEI-LHYEPITLAADMWSLGVTAYVLLTGFSPF 181
+ D+ ++ G E + + + PE+ + Y+ + DMWSLG ++ PF
Sbjct: 171 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
Query: 182 -GGETDSETFRNISKA---------------------------------QLDFPDELFED 207
G + + I+K + E
Sbjct: 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290
Query: 208 ISPEAKDFIAKILIKNPMERMTAKEALKHPW 238
+SPEA DF+ K+L + R+TA+EA++HP+
Sbjct: 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 3e-34
Identities = 41/256 (16%), Positives = 82/256 (32%), Gaps = 22/256 (8%)
Query: 9 ADSIATGEVFAAKFL--ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
IA GE A K ++ ++H E + + I + G+ V
Sbjct: 26 GTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85
Query: 63 -SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
L V+ +S + Y+H + H D+KP N +M +
Sbjct: 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV 145
Query: 122 KVCDFEISRVILDG--------IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYV 173
+ DF +++ D E + L GT Y + + D+ SLG
Sbjct: 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 205
Query: 174 LLTG---FSPFGGETDSETFRNISKAQLDFP-DELFEDISPEAKDFIAKILIKNPMERMT 229
G + T + + IS+ ++ P + L + E ++ ++
Sbjct: 206 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265
Query: 230 A---KEALKHPWLMNK 242
++ ++ +
Sbjct: 266 YSYLRQLFRNLFHRQG 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-34
Identities = 36/234 (15%), Positives = 88/234 (37%), Gaps = 20/234 (8%)
Query: 14 TGEVFAAKFLESNPV--RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV--------S 63
G A K ++++ E ++++ +V+L V +G Y+ S
Sbjct: 29 RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87
Query: 64 WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
L ++++ + ++ F D ++ YL H D+ +N+++ D KV
Sbjct: 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKV 144
Query: 124 CDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFG 182
DF +++ + + + APE L + + +D+WS G+ + + + G P+
Sbjct: 145 SDFGLTKEASSTQDTGK--LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202
Query: 183 GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
+ + K + + + P + + + R + + +
Sbjct: 203 RIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 70/319 (21%), Positives = 117/319 (36%), Gaps = 55/319 (17%)
Query: 9 ADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY-- 60
A TG A K L + R + E+ LL ++ L DVF
Sbjct: 37 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEF 95
Query: 61 -------YVSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMM 113
++ + + D+ V L L Y+H I H D+KP NL +
Sbjct: 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 155
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI-LHYEPITLAADMWSLGVTAY 172
+C++K+ DF ++R E+ + T Y APEI L++ D+WS+G
Sbjct: 156 ---EDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 173 VLLTGFSPFGGETDSETFRNISKAQLDFPDEL---------------------------F 205
LLTG + F G + + I + EL F
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 270
Query: 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKK 265
+P A D + K+L+ + +R+TA +AL H + P Q+ +
Sbjct: 271 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP------DDEPVADPYDQSFE 324
Query: 266 NLRKYLSKSREALFEKVIS 284
+ + + + +++VIS
Sbjct: 325 SRDLLIDEWKSLTYDEVIS 343
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 55/314 (17%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVS---- 63
TG A K L E R + E+ LL ++ L DVF E +
Sbjct: 42 TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYL 100
Query: 64 -----WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPN 118
+ + ++ + L L Y+H I H D+KP NL + +
Sbjct: 101 VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---ED 157
Query: 119 CDIKVCDFEISRVILDGIEIRELLGTPDYVAPE-ILHYEPITLAADMWSLGVTAYVLLTG 177
C++K+ DF ++R E+ + T Y APE IL++ T D+WS+G ++TG
Sbjct: 158 CELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 178 FSPFGGETDSETFRNISKAQLDFPDE---------------------------LFEDISP 210
+ F G + + I K P E + + SP
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 211 EAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPSIIQNQQNKKNLRKY 270
A + + K+L+ + +R+TA EAL HP+ + P + + + ++ +
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE------PQVQKYDDSFDDVDRT 329
Query: 271 LSKSREALFEKVIS 284
L + + +++V+S
Sbjct: 330 LDEWKRVTYKEVLS 343
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-33
Identities = 37/243 (15%), Positives = 78/243 (32%), Gaps = 25/243 (10%)
Query: 14 TGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---YVSW 64
+ A K L + + E ++ +P IV++ + +
Sbjct: 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEAESWMLVMEMAEL 91
Query: 65 NTPLVVTLQTI-IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
Q + D ++ + YL H D+ +N++++ K+
Sbjct: 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKI 148
Query: 124 CDFEISRVILDGIEIRE----LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GF 178
DF +S+ + + + APE ++Y + +D+WS GV + + G
Sbjct: 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE---ALK 235
P+ G SE + K + E D + + R L+
Sbjct: 209 KPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
Query: 236 HPW 238
+ +
Sbjct: 266 NYY 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (307), Expect = 7e-33
Identities = 40/248 (16%), Positives = 73/248 (29%), Gaps = 21/248 (8%)
Query: 9 ADSIATGEVFAAKFL--ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV---- 62
++ + A KF S+ ++ E L + I ++ Q G V
Sbjct: 24 GTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83
Query: 63 -SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCD- 120
L+ V L+ + +H + + + DIKP N ++
Sbjct: 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 121 -IKVCDFEISRVILDGI--------EIRELLGTPDYVAPEILHYEPITLAADMWSLGVTA 171
I V DF + + D + E + L GT Y++ + D+ +LG
Sbjct: 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203
Query: 172 YVLLTGFSPFGGETDSETFRNISKA----QLDFPDELFEDISPEAKDFIAKILIKNPMER 227
L G P+ G + + + Q EL E ++
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
Query: 228 MTAKEALK 235
Sbjct: 264 PDYDYLQG 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-33
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 43/270 (15%)
Query: 9 ADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
A + T E+ A K + E P EI LL IV+LHDV + + V
Sbjct: 21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79
Query: 63 -----SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP 117
+ +D +V F L L + H R + H D+KPQNL++
Sbjct: 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NR 136
Query: 118 NCDIKVCDFEISRVILDGIEIRELLG-TPDYVAPEILHYEPI-TLAADMWSLGVTAYVLL 175
N ++K+ +F ++R + T Y P++L + + + DMWS G L
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 176 TGFSP-FGGETDSETFRNISKAQLDFPDE-------------------------LFEDIS 209
P F G + + I + +E + ++
Sbjct: 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN 256
Query: 210 PEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+D + +L NP++R++A+EAL+HP+
Sbjct: 257 ATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-33
Identities = 55/328 (16%), Positives = 119/328 (36%), Gaps = 60/328 (18%)
Query: 9 ADSIATGEVFAAKFL------ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV 62
A A K L +++ R + E+ L+ + I+ L +VF +
Sbjct: 36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEF 94
Query: 63 S--------WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMG 114
+ L +Q +D + L + +LH I H D+KP N+V+
Sbjct: 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVL 174
D C +K+ DF ++R + + T Y APE++ D+WS+G +
Sbjct: 155 D---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 175 LTGFSPFGGETDSETFRNISKAQLDFPDELFEDI-------------------------- 208
+ F G + + + + E + +
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 209 ------------SPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTRVGCSSCPS 256
+ +A+D ++K+L+ +P +R++ +AL+HP++
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331
Query: 257 IIQNQQNKKNLRKYLSKSREALFEKVIS 284
Q + + + ++ +E ++++V++
Sbjct: 332 DKQLDEREHTIEEW----KELIYKEVMN 355
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-32
Identities = 43/235 (18%), Positives = 90/235 (38%), Gaps = 19/235 (8%)
Query: 14 TGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP--- 67
A K ++ + E ++ S ++V+L+ V + ++
Sbjct: 27 GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGC 85
Query: 68 ---LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
+ ++ ++ D ++ YL ++ H D+ +N ++ +KV
Sbjct: 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVS 142
Query: 125 DFEISRVILDGIEIRE--LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPF 181
DF +SR +LD + PE+L Y + +D+W+ GV + + + G P+
Sbjct: 143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202
Query: 182 GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
T+SET +I++ + L S + + + ER T K L +
Sbjct: 203 ERFTNSETAEHIAQGLRLYRPHL---ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-32
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 19/235 (8%)
Query: 14 TGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP--- 67
+ A K + + E ++ S P++V+L+ V V
Sbjct: 28 NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 68 ---LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124
+ T + + ++ D +AYL + H D+ +N ++ + IKV
Sbjct: 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ---VIKVS 143
Query: 125 DFEISRVILDG--IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPF 181
DF ++R +LD + +PE+ + + +D+WS GV + + + G P+
Sbjct: 144 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203
Query: 182 GGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
++SE +IS + L S + + P +R L+
Sbjct: 204 ENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 5e-31
Identities = 41/250 (16%), Positives = 85/250 (34%), Gaps = 25/250 (10%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---YVSWN 65
A K L +++ + E ++ +P IV+L V Q
Sbjct: 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAEALMLVMEMAGGG 93
Query: 66 T--PLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
+V + I + V + YL + H D+ +N++++ K+
Sbjct: 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKI 150
Query: 124 CDFEISRVILDGIEIRELL----GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GF 178
DF +S+ + + APE +++ + +D+WS GVT + L+ G
Sbjct: 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
Query: 179 SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE---ALK 235
P+ E I + + E + PE ++ I +R ++
Sbjct: 211 KPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 236 HPWLMNKKQI 245
+ ++
Sbjct: 268 ACYYSLASKV 277
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 47/235 (20%), Positives = 89/235 (37%), Gaps = 21/235 (8%)
Query: 14 TGEVFAAKFL---ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-------S 63
A K L +P E L+ R+V+L+ V T E Y + S
Sbjct: 36 GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVV-TQEPIYIITEYMENGS 93
Query: 64 WNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
L + N ++ + +A++ R H D++ N+++ K+
Sbjct: 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKI 150
Query: 124 CDFEISRVILDGIEIRE--LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSP 180
DF ++R+I D + APE ++Y T+ +D+WS G+ ++T G P
Sbjct: 151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
+ G T+ E +N+ + + ++ E + + P +R T
Sbjct: 211 YPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-30
Identities = 41/230 (17%), Positives = 87/230 (37%), Gaps = 28/230 (12%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP--------------------- 67
E+ +L P I+ L + Y P
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 68 LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFE 127
+ + + + ++ F +D + YL ++ H D+ +N+++ + K+ DF
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFG 172
Query: 128 ISRVILDGIEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETD 186
+SR ++ ++A E L+Y T +D+WS GV + +++ G +P+ G T
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 187 SETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
+E + + + + E + E D + + + P ER + + L
Sbjct: 233 AELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 7e-30
Identities = 46/252 (18%), Positives = 86/252 (34%), Gaps = 33/252 (13%)
Query: 15 GEVFAAKFLESNPV-------------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
GEV+ + + V E ++ ++V+L+ V + E Y
Sbjct: 31 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPIYI 88
Query: 62 VSWNTPLVVTLQTIIDDNLVVPFESDE-------LSSLAYLHHRKIAHLDIKPQNLVMMG 114
V+ L + + S +AY+ H D++ N+++
Sbjct: 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 148
Query: 115 DFPNCDIKVCDFEISRVILDGIEIRE--LLGTPDYVAPEILHYEPITLAADMWSLGVTAY 172
+ KV DF ++R+I D + APE Y T+ +D+WS G+
Sbjct: 149 NL---VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 205
Query: 173 VLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231
L T G P+ G + E + + + + D + + K P ER T +
Sbjct: 206 ELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 262
Query: 232 EALK--HPWLMN 241
+ +
Sbjct: 263 YLQAFLEDYFTS 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-29
Identities = 33/252 (13%), Positives = 76/252 (30%), Gaps = 37/252 (14%)
Query: 17 VFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-------------- 62
+ K S + E+ +++ IV L Y +
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 63 --------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQ 108
+ ++ ++ F + +L + H D+ +
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193
Query: 109 NLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMW 165
N+++ +K+CDF ++R I+ ++APE L T+ +D+W
Sbjct: 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 166 SLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224
S G+ + + + G +P+ G F + + + E + +
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDS 308
Query: 225 MERMTAKEALKH 236
+R +
Sbjct: 309 RKRPSFPNLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-28
Identities = 37/223 (16%), Positives = 82/223 (36%), Gaps = 16/223 (7%)
Query: 29 RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP-----LVVTLQTIIDDNLVVP 83
I E +++ +P + +L + T V + I ++
Sbjct: 57 EILDEAYVMASVD-NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 115
Query: 84 FESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL-- 141
+ + YL R++ H D+ +N+++ +K+ DF +++++ +
Sbjct: 116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEG 172
Query: 142 -LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLD 199
++A E + + T +D+WS GVT + L+T G P+ G SE + K
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---G 229
Query: 200 FPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242
+ + + K + + R +E + M +
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 43/254 (16%), Positives = 84/254 (33%), Gaps = 37/254 (14%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV------ 62
A K L + + E+ +LS IV L G +
Sbjct: 52 AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 63 -----------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDI 105
+ ++ + +D ++ F +A+L + H D+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171
Query: 106 KPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPDYVAPEILHYEPITLAA 162
+N+++ K+CDF ++R I + ++APE + T +
Sbjct: 172 AARNILLTHGR---ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 163 DMWSLGVTAYVLLTGFSP-FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILI 221
D+WS G+ + L + S + G F + K E E D +
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWD 286
Query: 222 KNPMERMTAKEALK 235
+P++R T K+ ++
Sbjct: 287 ADPLKRPTFKQIVQ 300
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-28
Identities = 42/240 (17%), Positives = 80/240 (33%), Gaps = 23/240 (9%)
Query: 14 TGEVFAAKFLESNPV-------RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY---YVS 63
A K L+ + + E+ + +++L+ V T
Sbjct: 35 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPPMKMVTELAP 93
Query: 64 WNTPL--VVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDI 121
+ L + Q + + + YL ++ H D+ +NL++ +
Sbjct: 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLV 150
Query: 122 KVCDFEISRVILDGIEIREL----LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT- 176
K+ DF + R + + + + APE L + A+D W GVT + + T
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 177 GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
G P+ G S+ I K P ED + + + + P +R T
Sbjct: 211 GQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (267), Expect = 3e-27
Identities = 46/235 (19%), Positives = 92/235 (39%), Gaps = 20/235 (8%)
Query: 14 TGEVFAAKFLESNPV---RIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70
A K L+ + + E A++ P +V+L V Y ++
Sbjct: 41 YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGN 99
Query: 71 TLQTI-------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
L + + +++ + S++ YL + H D+ +N ++ + +KV
Sbjct: 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH---LVKV 156
Query: 124 CDFEISRVILDGIEIRE--LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSP 180
DF +SR++ + APE L Y ++ +D+W+ GV + + T G SP
Sbjct: 157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
+ G S+ + + K D+ E E + + + NP +R + E +
Sbjct: 217 YPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-27
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 20/236 (8%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTP- 67
A K +S + E + P IVKL V + T
Sbjct: 34 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITENPVWIIMELCTLG 92
Query: 68 ----LVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKV 123
+ + +D ++ + ++LAYL ++ H DI +N+++ + +K+
Sbjct: 93 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKL 149
Query: 124 CDFEISRVILDGIEIR--ELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSP 180
DF +SR + D + + ++APE +++ T A+D+W GV + +L G P
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209
Query: 181 FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
F G +++ I + + + P + K +P R E
Sbjct: 210 FQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 5e-27
Identities = 36/233 (15%), Positives = 76/233 (32%), Gaps = 20/233 (8%)
Query: 17 VFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAY----YVSWNT--PLVV 70
+ + E E +++ P ++ L V ++ + +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 119
Query: 71 TLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130
+V + + YL H D+ +N+++ + KV DF +SR
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL---VCKVSDFGLSR 176
Query: 131 VILDGIEIREL------LGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGG 183
+ D + APE + Y T A+D+WS G+ + +++ G P+
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 184 ETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236
T+ + I + D+ D + K+ R + +
Sbjct: 237 MTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-26
Identities = 41/230 (17%), Positives = 79/230 (34%), Gaps = 18/230 (7%)
Query: 17 VFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV------SWNTPLVV 70
A + E V E ++ S I++L V + + +
Sbjct: 43 TLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 101
Query: 71 TLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130
+V + + YL + H D+ +N+++ + KV DF +SR
Sbjct: 102 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL---VCKVSDFGLSR 158
Query: 131 VILDGIEIRELL----GTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGET 185
V+ D E + APE + Y T A+D+WS G+ + ++T G P+ +
Sbjct: 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218
Query: 186 DSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235
+ E + I+ F D + + + R + +
Sbjct: 219 NHEVMKAIND---GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 36/257 (14%)
Query: 10 DSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-- 62
D A K L E + + E+ ++ + I+ L Y +
Sbjct: 40 DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99
Query: 63 -------------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHL 103
++ + + +V + YL +K H
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159
Query: 104 DIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL---LGTPDYVAPEILHYEPITL 160
D+ +N+++ D K+ DF ++R I ++ ++APE L T
Sbjct: 160 DLAARNVLVTEDNVM---KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 161 AADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKI 219
+D+WS GV + + T G SP+ G E F+ + + + + + E +
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDC 273
Query: 220 LIKNPMERMTAKEALKH 236
P +R T K+ ++
Sbjct: 274 WHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-26
Identities = 43/248 (17%), Positives = 82/248 (33%), Gaps = 25/248 (10%)
Query: 7 EMADSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61
+ D+ A K L + E ++ S P ++ L + EG+
Sbjct: 47 TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL 105
Query: 62 VSWNTPLVVTLQTIIDDNLVVPFESDEL-------SSLAYLHHRKIAHLDIKPQNLVMMG 114
V L+ I + P D + + +L +K H D+ +N ++
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165
Query: 115 DFPNCDIKVCDFEISRVILDGIEIREL-----LGTPDYVAPEILHYEPITLAADMWSLGV 169
+KV DF ++R + D ++A E L + T +D+WS GV
Sbjct: 166 K---FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222
Query: 170 TAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228
+ L+T G P+ + + + + E + + K R
Sbjct: 223 LLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRP 279
Query: 229 TAKEALKH 236
+ E +
Sbjct: 280 SFSELVSR 287
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 5e-26
Identities = 58/302 (19%), Positives = 93/302 (30%), Gaps = 69/302 (22%)
Query: 9 ADSIATGEVFAAKFLESNPV-------------RIHHEIALLSLCSPSPRIVKLHDVFQT 55
A + A K + + V R++ + I+KL D F
Sbjct: 32 AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91
Query: 56 GEGAYYVSWNTPLVVTLQTIIDDNLVVPFESDE----------LSSLAYLH-HRKIAHLD 104
V+ + L L Y+H I H D
Sbjct: 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 151
Query: 105 IKPQN-LVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYEPITLAAD 163
IKP+N L+ + D P I++ ++ + T +Y +PE+L P AD
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 211
Query: 164 MWSLGVTAYVLLTGFSPFG---------------------GETDSETFRNISKAQLDFPD 202
+WS + L+TG F GE S RN + F
Sbjct: 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 271
Query: 203 -----------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWL 239
+ +D + E DF++ +L +P +R A + HPWL
Sbjct: 272 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
Query: 240 MN 241
+
Sbjct: 332 KD 333
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 2e-25
Identities = 45/260 (17%), Positives = 82/260 (31%), Gaps = 45/260 (17%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV------ 62
+ A K L E AL++ +P IVKL V G+ +
Sbjct: 42 PFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAY 100
Query: 63 -----------------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRK 99
S + + + + +AYL RK
Sbjct: 101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160
Query: 100 IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL---LGTPDYVAPEILHYE 156
H D+ +N ++ + +K+ DF +SR I + ++ PE + Y
Sbjct: 161 FVHRDLATRNCLVGENM---VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 217
Query: 157 PITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDF 215
T +D+W+ GV + + + G P+ G E + E+ E +
Sbjct: 218 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN---ILACPENCPLELYNL 274
Query: 216 IAKILIKNPMERMTAKEALK 235
+ K P +R + +
Sbjct: 275 MRLCWSKLPADRPSFCSIHR 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 5e-25
Identities = 48/258 (18%), Positives = 87/258 (33%), Gaps = 36/258 (13%)
Query: 10 DSIATGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV-- 62
D AT A K L S + E+ +L +V L G V
Sbjct: 38 DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97
Query: 63 --------------------SWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAH 102
+ + + ++ + + +L RK H
Sbjct: 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 157
Query: 103 LDIKPQNLVMMGDFPNCDIKVCDFEISRVIL---DGIEIRELLGTPDYVAPEILHYEPIT 159
D+ +N+++ +K+CDF ++R I D + + ++APE + T
Sbjct: 158 RDLAARNILLSEKN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 160 LAADMWSLGVTAYVLLTGF-SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218
+ +D+WS GV + + + SP+ G E F K + +PE +
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLD 272
Query: 219 ILIKNPMERMTAKEALKH 236
P +R T E ++H
Sbjct: 273 CWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 1e-23
Identities = 43/247 (17%), Positives = 93/247 (37%), Gaps = 31/247 (12%)
Query: 14 TGEVFAAKFL-----ESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYV------ 62
A K + + +E +++ + +V+L V G+ +
Sbjct: 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTR 107
Query: 63 -SWNTPLVVTLQTIIDDNLVVPFESDE--------LSSLAYLHHRKIAHLDIKPQNLVMM 113
+ L + ++ ++ P + +AYL+ K H D+ +N ++
Sbjct: 108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167
Query: 114 GDFPNCDIKVCDFEISRVILDGIEIR---ELLGTPDYVAPEILHYEPITLAADMWSLGVT 170
DF +K+ DF ++R I + R + L +++PE L T +D+WS GV
Sbjct: 168 EDF---TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
Query: 171 AYVLLTGF-SPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229
+ + T P+ G ++ + R + + L + ++ + + NP R +
Sbjct: 225 LWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPS 281
Query: 230 AKEALKH 236
E +
Sbjct: 282 FLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 9e-20
Identities = 43/270 (15%), Positives = 82/270 (30%), Gaps = 52/270 (19%)
Query: 14 TGEVFAAKFLESNPVRIHH---EIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70
GE A K S R EI + I+ G + W
Sbjct: 25 RGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 71 ---TLQTII-----DDNLVVPFESDELSSLAYLHH--------RKIAHLDIKPQNLVMMG 114
+L + ++ S LA+LH IAH D+K +N+++
Sbjct: 84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 115 DFPNCDIKVCDFEISRVILDGIEIREL-----LGTPDYVAPEIL------HYEPITLAAD 163
+ + D ++ + ++ +GT Y+APE+L + AD
Sbjct: 144 NG---TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 164 MWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFE----------------- 206
++++G+ + + S G D + +E+ +
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260
Query: 207 -DISPEAKDFIAKILIKNPMERMTAKEALK 235
+ + + N R+TA K
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 39.0 bits (90), Expect = 3e-04
Identities = 12/44 (27%), Positives = 20/44 (45%), Gaps = 4/44 (9%)
Query: 89 LSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132
L +A +HR I H D+ N+++ I + DF S +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 383 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.34 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-56 Score=424.19 Aligned_cols=236 Identities=34% Similarity=0.566 Sum_probs=198.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|+++.||+.||||++.+ ....+.+|+.+|+ .++|||||+++++|++++.+|+||||++ |++|.+++...
T Consensus 24 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lvmE~~~-gg~L~~~l~~~ 101 (307)
T d1a06a_ 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH-KIKHPNIVALDDIYESGGHLYLIMQLVS-GGELFDRIVEK 101 (307)
T ss_dssp GEEEEEETTTCCEEEEEEEEC----------CHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHHTC
T ss_pred EEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEeccC-CCcHHHhhhcc
Confidence 689999999999999999976 3456789999999 7799999999999999999999999999 99999976443
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
.+..++.||+.||+|||++||+||||||+|||+......+.+||+|||+|+.........+.+||+.|+|||++
T Consensus 102 ~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~ 181 (307)
T d1a06a_ 102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHH
Confidence 34567799999999999999999999999999976555689999999999987666666778999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+|+.++|||||||++|+|++|.+||.+.+..+....+..+...++.+.+..+|+++++||.+||.+||++|||++|+
T Consensus 182 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 99999999999999999999999999999999999999999999888888888999999999999999999999999999
Q ss_pred HcCcccCCc
Q psy6377 234 LKHPWLMNK 242 (383)
Q Consensus 234 L~hp~~~~~ 242 (383)
|+||||++.
T Consensus 262 l~hp~~~~~ 270 (307)
T d1a06a_ 262 LQHPWIAGD 270 (307)
T ss_dssp HHSTTTTSS
T ss_pred hcCHhhCCC
Confidence 999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-55 Score=414.88 Aligned_cols=237 Identities=36% Similarity=0.664 Sum_probs=214.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.||+.||||++.+ ..+.+.+|+.+|+ .++|||||+++++|++.+.+|+||||++ ||+|.+
T Consensus 25 ~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~iv~E~~~-gg~L~~ 102 (293)
T d1jksa_ 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYENKTDVILILELVA-GGELFD 102 (293)
T ss_dssp EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEEEECCC-SCBHHH
T ss_pred EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEEcCC-Cccccc
Confidence 699999999999999999975 1346889999999 7789999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCC-CCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFP-NCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~-~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
++.. ..++.++.|++.||+|||++||+||||||+|||++.++. ...+||+|||+|.....+....+..||+.|
T Consensus 103 ~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y 182 (293)
T d1jksa_ 103 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182 (293)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGG
T ss_pred hhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcc
Confidence 7644 335567799999999999999999999999999976542 246999999999988766667778999999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+|||++.+..|+.++||||+||++|+|++|.+||.+.+..+.+.++..+...++...+..+|+++++||++||.+||++|
T Consensus 183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (293)
T d1jksa_ 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262 (293)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHC
Confidence 99999999999999999999999999999999999999999999999999999988889999999999999999999999
Q ss_pred CCHHHHHcCcccCCcc
Q psy6377 228 MTAKEALKHPWLMNKK 243 (383)
Q Consensus 228 pt~~e~L~hp~~~~~~ 243 (383)
||++|+|+||||+...
T Consensus 263 ~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 263 MTIQDSLQHPWIKPKD 278 (293)
T ss_dssp CCHHHHHHSTTTCC--
T ss_pred cCHHHHhcCcccCCCC
Confidence 9999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=410.85 Aligned_cols=227 Identities=29% Similarity=0.509 Sum_probs=204.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||+|++.+ ....+.+|+.+++ .++|||||+++++|.+++.+|+||||++ ||+|.+++.
T Consensus 21 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~ivmEy~~-~g~L~~~l~ 98 (263)
T d2j4za1 21 NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDATRVYLILEYAP-LGTVYRELQ 98 (263)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH-hcCCCCCCeEEEEEEECCEEEEEEeecC-CCcHHHHHh
Confidence 699999999999999999875 3466889999999 7799999999999999999999999999 999998764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...... .....+||+.|+|||
T Consensus 99 ~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE 174 (263)
T d2j4za1 99 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS-RRTTLCGTLDYLPPE 174 (263)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCSCSCCCCC-CCEETTEEGGGCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---CCEeecccceeeecCCC-cccccCCCCcccCHH
Confidence 3 3355677999999999999999999999999999876 68999999999875433 345678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
++.+.+|+.++|||||||++|+|++|++||.+.+..+.+..+....+.+|+ .+|+++++||.+||.+||++|||++
T Consensus 175 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~ 250 (263)
T d2j4za1 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLR 250 (263)
T ss_dssp HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999999999999999999999999888877664 5799999999999999999999999
Q ss_pred HHHcCcccCC
Q psy6377 232 EALKHPWLMN 241 (383)
Q Consensus 232 e~L~hp~~~~ 241 (383)
|+|+||||..
T Consensus 251 eil~hp~~~~ 260 (263)
T d2j4za1 251 EVLEHPWITA 260 (263)
T ss_dssp HHHTCHHHHH
T ss_pred HHHcCcCcCC
Confidence 9999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=413.84 Aligned_cols=231 Identities=25% Similarity=0.368 Sum_probs=204.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|+++.||+.||||++.. ..+.+.+|+.+++ .++|||||+++++|.+++.+|+||||++ ||+|.+++..
T Consensus 35 ~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~ivmEy~~-gg~L~~~~~~~~ 112 (293)
T d1yhwa1 35 TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVVMEYLA-GGSLTDVVTETC 112 (293)
T ss_dssp EEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TCBHHHHHHHSC
T ss_pred EEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHH-hCCCCCEeeEeEEEEECCEEEEEEEecC-CCcHHHHhhccC
Confidence 699999999999999999876 4456899999999 7899999999999999999999999999 9999997543
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCcccc
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPEILH 154 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE~l~ 154 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... .....+||+.|+|||++.
T Consensus 113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~ 189 (293)
T d1yhwa1 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---CcEeeccchhheeeccccccccccccCCCccChhhhc
Confidence 3456777999999999999999999999999999765 689999999999875433 345678999999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+.+|+.++||||+||++|+|++|++||.+.+..+.+..+...... +...+..+|+++++||.+||.+||++|||++|+|
T Consensus 190 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 999999999999999999999999999998888777776655432 2234567899999999999999999999999999
Q ss_pred cCcccCC
Q psy6377 235 KHPWLMN 241 (383)
Q Consensus 235 ~hp~~~~ 241 (383)
+||||+.
T Consensus 269 ~Hp~~~~ 275 (293)
T d1yhwa1 269 QHQFLKI 275 (293)
T ss_dssp TCGGGGG
T ss_pred cCHhhCC
Confidence 9999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-54 Score=422.47 Aligned_cols=236 Identities=33% Similarity=0.584 Sum_probs=215.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|+++.||+.||||++.+ ..+.+.+|+.+|+ .++|||||+++++|++++.+|+||||++ ||+|.+.+..
T Consensus 41 ~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~ivmE~~~-gg~L~~~l~~~~ 118 (350)
T d1koaa2 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVMIYEFMS-GGELFEKVADEH 118 (350)
T ss_dssp EEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHH-HTCCTTBCCEEEEEEETTEEEEEECCCC-SCBHHHHHTCTT
T ss_pred EEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEEcCC-CCCHHHHHHhhc
Confidence 699999999999999999976 3466889999999 7789999999999999999999999999 9999997632
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
..+..++.||+.||+|||++||+||||||+|||++.+. .+.+||+|||+|+.........+.+||+.|+|||++
T Consensus 119 ~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~ 197 (350)
T d1koaa2 119 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197 (350)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheecccccccceecCcccccCHHHH
Confidence 23456679999999999999999999999999997542 368999999999988776667778999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..|......++...+..+|+++++||.+||.+||++|||++|+
T Consensus 198 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999999999999999999998888889999999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
|+||||....
T Consensus 278 l~hp~~~~~~ 287 (350)
T d1koaa2 278 LEHPWLTPGN 287 (350)
T ss_dssp HHSTTTSCTT
T ss_pred hcCcccCCCC
Confidence 9999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.2e-55 Score=424.08 Aligned_cols=236 Identities=33% Similarity=0.609 Sum_probs=216.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID--- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~--- 77 (383)
.||+|+++.||+.||||++.+ +...+.+|+.+|+ .++|||||+++++|++++.+|+||||++ ||+|.+.+.
T Consensus 44 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~ivmE~~~-gg~L~~~~~~~~ 121 (352)
T d1koba_ 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVLILEFLS-GGELFDRIAAED 121 (352)
T ss_dssp EEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEEEEECCC-CCBHHHHTTCTT
T ss_pred EEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEEcCC-CChHHHHHHhcC
Confidence 689999999999999999976 3457889999999 7799999999999999999999999999 999988543
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
+..++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+|..........+..||+.|+|||++
T Consensus 122 ~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 200 (352)
T d1koba_ 122 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200 (352)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCCCCceeeccCcccccCHHHH
Confidence 33456677999999999999999999999999999753 2378999999999998776667778999999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEA 233 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 233 (383)
.+.+|+.++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++...+..+|+++++||.+||.+||.+|||++|+
T Consensus 201 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999999999999999999999988889999999999999999999999999999
Q ss_pred HcCcccCCcc
Q psy6377 234 LKHPWLMNKK 243 (383)
Q Consensus 234 L~hp~~~~~~ 243 (383)
|+||||+...
T Consensus 281 l~Hp~~~~~~ 290 (352)
T d1koba_ 281 LEHPWLKGDH 290 (352)
T ss_dssp HTSTTTSSCC
T ss_pred hcCHhhCCCc
Confidence 9999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=407.10 Aligned_cols=231 Identities=26% Similarity=0.363 Sum_probs=195.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~ 79 (383)
.||+|+++.||+.||||++.. ..+.+.+|+.+++ .++|||||++++++.+++.+|+||||+. ||+|.+++...
T Consensus 20 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~~~~~~~~~~~~~ivmEy~~-gg~L~~~l~~~ 97 (271)
T d1nvra_ 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYLFLEYCS-GGELFDRIEPD 97 (271)
T ss_dssp EEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEEEEECCT-TEEGGGGSBTT
T ss_pred EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHH-hCCCCCEeeEeeeeccCceeEEEEeccC-CCcHHHHHhcC
Confidence 699999999999999999876 3467899999999 7899999999999999999999999999 99999987543
Q ss_pred ------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc---ccccccCCCCcCCC
Q psy6377 80 ------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI---EIRELLGTPDYVAP 150 (383)
Q Consensus 80 ------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~y~aP 150 (383)
.+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...+.+||+.|+||
T Consensus 98 ~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174 (271)
T ss_dssp TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---CCEEEccchhheeeccCCccccccceeeCcCccCH
Confidence 345677999999999999999999999999999865 689999999999765432 24557899999999
Q ss_pred cccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC
Q psy6377 151 EILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT 229 (383)
Q Consensus 151 E~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 229 (383)
|++.+.++ +.++||||+||++|+|++|++||.+.+............... ...+..+|+++++||.+||..||++|||
T Consensus 175 E~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred hHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCccccCCHHHHHHHHHHcCCChhHCcC
Confidence 99988876 578999999999999999999998766544333333332222 2335678999999999999999999999
Q ss_pred HHHHHcCcccCC
Q psy6377 230 AKEALKHPWLMN 241 (383)
Q Consensus 230 ~~e~L~hp~~~~ 241 (383)
++|+|+||||+.
T Consensus 254 ~~eil~hpwf~~ 265 (271)
T d1nvra_ 254 IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHTTCTTTTC
T ss_pred HHHHhcCHhhCc
Confidence 999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=406.33 Aligned_cols=231 Identities=27% Similarity=0.353 Sum_probs=202.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID--- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~--- 77 (383)
.||+|+++.||+.||||++.+ ..+.+.+|+++|+ .++|||||+++++|.+++.+|+||||++ ||+|.+++.
T Consensus 27 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lvmEy~~-~g~L~~~~~~~~ 104 (288)
T d2jfla1 27 KVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWILIEFCA-GGAVDAVMLELE 104 (288)
T ss_dssp EEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEEEECCT-TEEHHHHHHHHT
T ss_pred EEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCeEEEEEecCC-CCcHHHHHHhcC
Confidence 699999999999999999976 3567899999999 7789999999999999999999999999 999998643
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCCcc
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAPEI 152 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~ 152 (383)
+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....+.+||+.|+|||+
T Consensus 105 ~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~ 181 (288)
T d2jfla1 105 RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181 (288)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---CCEEEEechhhhccCCCcccccccccccccCCHHH
Confidence 23355677999999999999999999999999999876 68999999999876433 22446789999999999
Q ss_pred cc-----cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 153 LH-----YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 153 l~-----~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
+. ..+|+.++|||||||++|+|++|++||.+.+..+.+.++..+..+.. ..+..+|+++++||.+||++||++|
T Consensus 182 l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp HTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHHHHHHHHHccCChhHC
Confidence 83 56689999999999999999999999999999999888887764332 2345789999999999999999999
Q ss_pred CCHHHHHcCcccCC
Q psy6377 228 MTAKEALKHPWLMN 241 (383)
Q Consensus 228 pt~~e~L~hp~~~~ 241 (383)
||++|+|+||||+.
T Consensus 261 ~t~~ell~hp~~~~ 274 (288)
T d2jfla1 261 WTTSQLLQHPFVTV 274 (288)
T ss_dssp CCHHHHTTSGGGCC
T ss_pred cCHHHHhcCcccCC
Confidence 99999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=407.31 Aligned_cols=230 Identities=29% Similarity=0.505 Sum_probs=203.0
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.||+.||||++.+ ....+.+|+++++ .++|||||+++++|++++.+|+||||++ ||+|.+++.
T Consensus 23 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~ivmEy~~-gg~L~~~~~ 100 (288)
T d1uu3a_ 23 TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLYFGLSYAK-NGELLKYIR 100 (288)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCSTTBCCEEEEEECSSEEEEEECCCT-TEEHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHH-HcCCCCeeEEEEEEEECCEEEEEEEccC-CCCHHHhhh
Confidence 699999999999999999975 3456899999999 7799999999999999999999999999 999998654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---cccccccCCCCcC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYV 148 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~y~ 148 (383)
. ..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....+.+||+.|+
T Consensus 101 ~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 177 (288)
T d1uu3a_ 101 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177 (288)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECC----------CCCCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC---ceEEecccccceecccCCcccccccccCCcccc
Confidence 3 3456677999999999999999999999999999876 68999999999976432 2234568999999
Q ss_pred CCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 149 APEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 149 aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
|||++.+.+|+.++||||+||++|+|++|++||.+.+..+.+.+|..+.+.+|. .+|+++++||++||.+||++||
T Consensus 178 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~ 253 (288)
T d1uu3a_ 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRL 253 (288)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSSGGGST
T ss_pred CceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999999999999999999999999988877764 6799999999999999999999
Q ss_pred CHHH------HHcCcccCCcc
Q psy6377 229 TAKE------ALKHPWLMNKK 243 (383)
Q Consensus 229 t~~e------~L~hp~~~~~~ 243 (383)
|++| +++||||++..
T Consensus 254 t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 254 GCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp TSGGGTCHHHHHTSGGGTTCC
T ss_pred CHHHHcCCHHHHcCCccCCCC
Confidence 9987 58899998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=411.34 Aligned_cols=230 Identities=30% Similarity=0.479 Sum_probs=208.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.||+.||||++.+ ....+.+|+.+|+ .++||||++++++|++.+.+|+||||++ ||+|.+++.
T Consensus 20 ~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~iv~ey~~-gg~L~~~~~ 97 (337)
T d1o6la_ 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYAN-GGELFFHLS 97 (337)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hCCCCCEEEEEeeeccccccccceeccC-CCchhhhhh
Confidence 699999999999999999976 3466889999999 7789999999999999999999999999 999998654
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeec-CcccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILD-GIEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~-~~~~~~~~gt~~y~aP 150 (383)
. ..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+.... .....+.+||+.|+||
T Consensus 98 ~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aP 174 (337)
T d1o6la_ 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174 (337)
T ss_dssp HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTCCBCCCEECGGGCCG
T ss_pred cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---CCEEEeecccccccccCCcccccceeCHHHhhh
Confidence 3 3456777999999999999999999999999999876 6999999999987543 3445668999999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCC-
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMT- 229 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt- 229 (383)
|++.+.+|+.++||||+||++|+|++|++||.+.+..+.+..+..+.+.+|. .+|+++++||++||++||.+|++
T Consensus 175 E~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp GGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred hhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHhhccCCchhhccc
Confidence 9999999999999999999999999999999999999999999988877764 67999999999999999999994
Q ss_pred ----HHHHHcCcccCCcc
Q psy6377 230 ----AKEALKHPWLMNKK 243 (383)
Q Consensus 230 ----~~e~L~hp~~~~~~ 243 (383)
++|+++||||.+..
T Consensus 251 ~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 251 GPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp STTTHHHHHTSGGGTTCC
T ss_pred ccccHHHHHcCcccccCC
Confidence 89999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=413.33 Aligned_cols=235 Identities=33% Similarity=0.580 Sum_probs=215.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|+++.||+.||||++.+ +...+.+|+++|+ .++|||||+++++|++++.+|+|||||. |++|.+.+...
T Consensus 20 ~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~lvmE~~~-gg~L~~~i~~~~~ 97 (321)
T d1tkia_ 20 IVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN-IARHRNILHLHESFESMEELVMIFEFIS-GLDIFERINTSAF 97 (321)
T ss_dssp EEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEEEEECCCC-CCBHHHHHTSSSC
T ss_pred EEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEecCC-CCcHHHHHHhcCC
Confidence 599999999999999999987 3456889999999 7889999999999999999999999999 99999977543
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILH 154 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~ 154 (383)
.+..++.||+.||+|||++||+||||||+|||++.+. ...+||+|||+++.........+.+||+.|+|||.+.
T Consensus 98 ~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~ 176 (321)
T d1tkia_ 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccccCCcccccccccccccchhcc
Confidence 2456669999999999999999999999999997642 3689999999999877666667788999999999999
Q ss_pred cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6377 155 YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEAL 234 (383)
Q Consensus 155 ~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 234 (383)
+..|+.++||||+||++|+|++|.+||.+.+..+.+.+|..+.+.++...+..+|+++++||.+||.+||++|||++|+|
T Consensus 177 ~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCc
Q psy6377 235 KHPWLMNK 242 (383)
Q Consensus 235 ~hp~~~~~ 242 (383)
+||||...
T Consensus 257 ~hp~~~~~ 264 (321)
T d1tkia_ 257 QHPWLKQK 264 (321)
T ss_dssp HSHHHHSC
T ss_pred cCHhhccC
Confidence 99999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=417.11 Aligned_cols=236 Identities=31% Similarity=0.462 Sum_probs=206.6
Q ss_pred eEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHHhhcc--
Q psy6377 5 SEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQTIIDD-- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~~l~~-- 78 (383)
.||+|+++.||+.||||++.+ ...+.+|+.++.++.+|||||+++++|++ +..+|+|||||+ ||+|.+++..
T Consensus 27 ~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~-gg~L~~~i~~~~ 104 (335)
T d2ozaa1 27 KVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD-GGELFSRIQDRG 104 (335)
T ss_dssp EEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC-SEEHHHHHHSCS
T ss_pred EEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC-CCcHHHHHHhcC
Confidence 599999999999999999974 56788999997668899999999999986 466899999999 9999997643
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
..++.++.||+.||+|||++||+||||||+|||++.+...+.+||+|||+|+...........+||+.|+|||+
T Consensus 105 ~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 184 (335)
T d2ozaa1 105 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184 (335)
T ss_dssp CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCC
T ss_pred CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHH
Confidence 23456669999999999999999999999999998766667899999999998877666777899999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETF----RNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
+.+.+|+.++|||||||++|+|++|++||.+.+..+.. ..+..+.+.+|...+..+|+++++||++||++||++||
T Consensus 185 ~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 264 (335)
T d2ozaa1 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 264 (335)
T ss_dssp CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC
T ss_pred HcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc
Confidence 99999999999999999999999999999887655443 34455667778778888999999999999999999999
Q ss_pred CHHHHHcCcccCCc
Q psy6377 229 TAKEALKHPWLMNK 242 (383)
Q Consensus 229 t~~e~L~hp~~~~~ 242 (383)
|+.|+|+||||...
T Consensus 265 s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 265 TITEFMNHPWIMQS 278 (335)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHHcCHHhhCC
Confidence 99999999999653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=396.92 Aligned_cols=228 Identities=21% Similarity=0.336 Sum_probs=193.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe----CCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT----GEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~----~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.||+.||+|.+.. ....+.+|+++++ .++|||||+++++|++ +..+|+||||++ ||+|.+
T Consensus 24 ~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~-~g~L~~ 101 (270)
T d1t4ha_ 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIVLVTELMT-SGTLKT 101 (270)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEEEEEECCC-SCBHHH
T ss_pred EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeccccCCEEEEEEeCCC-CCcHHH
Confidence 599999999999999999875 2356889999999 7789999999999976 356899999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRK--IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~g--ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
++.+ ..+..+..||+.||+|||++| |+||||||+|||++++ .+.+||+|||+|+.... ....+.+||+.
T Consensus 102 ~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla~~~~~-~~~~~~~GT~~ 178 (270)
T d1t4ha_ 102 YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRA-SFAKAVIGTPE 178 (270)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGGGCCT-TSBEESCSSCC
T ss_pred HHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcceeccC-CccCCcccCcc
Confidence 7654 234567799999999999999 9999999999999643 26899999999986432 33456789999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSE-TFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+ +|+.++|||||||++|+|++|++||.+..... ....+..+ ..|......+++++++||.+||.+||+
T Consensus 179 Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~ 255 (270)
T d1t4ha_ 179 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKD 255 (270)
T ss_dssp CCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCGGGGGCCCHHHHHHHHHHSCSSGG
T ss_pred ccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--CCCcccCccCCHHHHHHHHHHccCCHh
Confidence 999999875 69999999999999999999999998765544 44444433 234456677899999999999999999
Q ss_pred CCCCHHHHHcCcccC
Q psy6377 226 ERMTAKEALKHPWLM 240 (383)
Q Consensus 226 ~Rpt~~e~L~hp~~~ 240 (383)
+|||++|+|+||||+
T Consensus 256 ~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 256 ERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GSCCHHHHHTSGGGC
T ss_pred HCcCHHHHhCCcccC
Confidence 999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=401.51 Aligned_cols=227 Identities=23% Similarity=0.362 Sum_probs=188.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--CCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--GEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.||+.||+|++.. ..+.+.+|+++++ .++|||||++++++.+ ++.+|+||||++ ||+|.+++
T Consensus 19 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~-~g~L~~~i 96 (269)
T d2java1 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTLYIVMEYCE-GGDLASVI 96 (269)
T ss_dssp EEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTT-SCCCTTBCCEEEEEEC----CEEEEEECCT-TEEHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEeCCCCEEEEEEecCC-CCcHHHHH
Confidence 699999999999999999876 2345889999999 7899999999999965 456899999999 99999975
Q ss_pred c----------cCCchhhHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-cccc
Q psy6377 77 D----------DNLVVPFESDELSSLAYLHHRK-----IAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRE 140 (383)
Q Consensus 77 ~----------~~~~~~~~~qil~aL~yLHs~g-----ivHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~ 140 (383)
. +..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+...... ...+
T Consensus 97 ~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~~~~~~ 173 (269)
T d2java1 97 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKA 173 (269)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEECCHHHHHHC---------
T ss_pred HhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEEeeccceeecccCCCcccc
Confidence 3 2346677799999999999976 9999999999999876 689999999998765433 3456
Q ss_pred ccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhc
Q psy6377 141 LLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKIL 220 (383)
Q Consensus 141 ~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 220 (383)
.+||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+..+....+..+.... .+..+|+++++||.+||
T Consensus 174 ~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~li~~~L 250 (269)
T d2java1 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRML 250 (269)
T ss_dssp --CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHT
T ss_pred CCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHHc
Confidence 789999999999999999999999999999999999999999999988888888776543 23468999999999999
Q ss_pred ccCCCCCCCHHHHHcCccc
Q psy6377 221 IKNPMERMTAKEALKHPWL 239 (383)
Q Consensus 221 ~~dP~~Rpt~~e~L~hp~~ 239 (383)
..||++|||++|+|+|||+
T Consensus 251 ~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 251 NLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CSSGGGSCCHHHHHTSTTC
T ss_pred CCChhHCcCHHHHHhCCcC
Confidence 9999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-52 Score=401.62 Aligned_cols=228 Identities=25% Similarity=0.513 Sum_probs=205.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+++ .++|||||+++++|.+++.+|+||||+. |++|..++.
T Consensus 19 ~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~ivmE~~~-gg~l~~~~~ 96 (316)
T d1fota_ 19 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLR 96 (316)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEEEEEECCCC-SCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-hccCcChhheeeeEeeCCeeeeEeeecC-Ccccccccc
Confidence 689999999999999999975 3467889999999 7899999999999999999999999999 999999764
Q ss_pred cC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 DN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.. .+..+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... ...+.+||+.|+|||
T Consensus 97 ~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~---g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE 171 (316)
T d1fota_ 97 KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPD--VTYTLCGTPDYIAPE 171 (316)
T ss_dssp HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSS--CBCCCCSCTTTCCHH
T ss_pred ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC---CCEEEecCccceEecc--ccccccCcccccCHH
Confidence 43 334566999999999999999999999999999865 6899999999998643 345678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC---
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM--- 228 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--- 228 (383)
++.+.+|+.++|||||||++|+|++|+.||.+.+..+...++..+...+|+ .+|++++++|.+||.+||.+|+
T Consensus 172 ~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~~~~ 247 (316)
T d1fota_ 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNL 247 (316)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSS
T ss_pred HHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHhccccc
Confidence 999999999999999999999999999999999999999999988877664 5799999999999999999996
Q ss_pred --CHHHHHcCcccCCcc
Q psy6377 229 --TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 --t~~e~L~hp~~~~~~ 243 (383)
|++++|+||||++..
T Consensus 248 r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 248 QNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TTTTHHHHTSGGGSSCC
T ss_pred hhhHHHHHcCcccccCC
Confidence 999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=400.32 Aligned_cols=235 Identities=24% Similarity=0.299 Sum_probs=199.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGEVFAAKFLES---------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+++.+|+.||||+++. ....+.+|+.+++ .++|||||+++++|.+++.+|+||||+. |+.+..+
T Consensus 13 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~~~~~~~~~ivmE~~~-~~~~~~~ 90 (299)
T d1ua2a_ 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII 90 (299)
T ss_dssp EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHH-hCCCCCEeEEEeeeccCCceeehhhhhc-chHHhhh
Confidence 599999999999999999975 1346889999999 7789999999999999999999999999 8877765
Q ss_pred h------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcC
Q psy6377 76 I------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYV 148 (383)
Q Consensus 76 l------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~ 148 (383)
. .+..+..+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...+.+||+.|+
T Consensus 91 ~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~---~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~ 167 (299)
T d1ua2a_ 91 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 167 (299)
T ss_dssp TTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCCCCCCSCCCCTTC
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---CccccccCccccccCCCcccccceecChhhc
Confidence 4 334566778999999999999999999999999999865 689999999998654432 345578999999
Q ss_pred CCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------c
Q psy6377 149 APEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------E 203 (383)
Q Consensus 149 aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------~ 203 (383)
|||++.. ..|+.++||||+||++|+|++|.+||.+.+..+.+.+|......++. .
T Consensus 168 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
T d1ua2a_ 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH 247 (299)
T ss_dssp CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH
T ss_pred cHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHH
Confidence 9999864 56899999999999999999999999999999888887654332221 1
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
.+..+++++++||.+||++||++||||+|+|+||||++...
T Consensus 248 ~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 248 IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 23467899999999999999999999999999999986543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-52 Score=395.51 Aligned_cols=234 Identities=29% Similarity=0.445 Sum_probs=210.8
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC-------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcC
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN-------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVV 70 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~-------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~ 70 (383)
..||+|+++.+|+.||||++.+. ...+.+|+.+++.+..||||++++++|++++.+|+||||++ ||
T Consensus 17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~-~g 95 (277)
T d1phka_ 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK-KG 95 (277)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT-TC
T ss_pred eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCC-Cc
Confidence 35999999999999999999761 13588999999966679999999999999999999999999 99
Q ss_pred cHHHhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCC
Q psy6377 71 TLQTIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGT 144 (383)
Q Consensus 71 ~L~~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt 144 (383)
+|.+++.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....+......+||
T Consensus 96 ~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~---~~~kl~DFG~a~~~~~~~~~~~~~gt 172 (277)
T d1phka_ 96 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGT 172 (277)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECCTTCCBCCCCSC
T ss_pred hHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC---CCeEEccchheeEccCCCceeeeecc
Confidence 99997643 3456777999999999999999999999999999765 68999999999988766666778899
Q ss_pred CCcCCCccccc------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHH
Q psy6377 145 PDYVAPEILHY------EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAK 218 (383)
Q Consensus 145 ~~y~aPE~l~~------~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 218 (383)
+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+..+...++...+.++|+++++||.+
T Consensus 173 ~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 252 (277)
T d1phka_ 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252 (277)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred CCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHH
Confidence 99999999853 357899999999999999999999999999999999999998888888888999999999999
Q ss_pred hcccCCCCCCCHHHHHcCcccCC
Q psy6377 219 ILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 219 ~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
||.+||++|||++|+|+||||+.
T Consensus 253 ~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 253 FLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=408.00 Aligned_cols=232 Identities=25% Similarity=0.367 Sum_probs=190.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc-
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~- 78 (383)
.||+|+++.||+.||+|++.+ ....+.+|+.+|+ .++|||||+++++|.+++.+|+||||++ ||+|.+++.+
T Consensus 21 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~iVmEy~~-gg~L~~~l~~~ 98 (322)
T d1s9ja_ 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEISICMEHMD-GGSLDQVLKKA 98 (322)
T ss_dssp CEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGG-GCCCTTBCCEEEEEECSSEEEEEEECCT-TEEHHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEEEEcCC-CCcHHHHHhhc
Confidence 499999999999999999976 2356889999999 7799999999999999999999999999 9999997643
Q ss_pred -----CCchhhHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHR-KIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEI 152 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~-givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 152 (383)
..+..+..|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+.... ....+.+||+.|+|||+
T Consensus 99 ~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~-~~~~~~~GT~~Y~APEv 174 (322)
T d1s9ja_ 99 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-SMANSFVGTRSYMSPER 174 (322)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHHH-HTC---CCSSCCCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC---CCEEEeeCCCccccCC-CccccccCCccccCchH
Confidence 33456679999999999984 99999999999999766 6899999999987543 23456799999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---c---------------------------------
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISK---A--------------------------------- 196 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~---~--------------------------------- 196 (383)
+.+.+|+.++||||+||++|+|++|+.||.+.+..+....... +
T Consensus 175 l~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (322)
T d1s9ja_ 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254 (322)
T ss_dssp HHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHH
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHH
Confidence 9999999999999999999999999999987654332111000 0
Q ss_pred ----cCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 197 ----QLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 197 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
...+|......+|.++++||.+||.+||.+|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 255 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred hhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000111112368899999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-52 Score=401.37 Aligned_cols=227 Identities=22% Similarity=0.310 Sum_probs=198.5
Q ss_pred eEEEEEEcCCCcEEEEEEccCC-------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-
Q psy6377 5 SEEMADSIATGEVFAAKFLESN-------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII- 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~-------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l- 76 (383)
.||+|+++.||+.||||++.+. ...+.+|+.+++ .++|||||+++++|.+++.+|+|||||. ||+|..++
T Consensus 30 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~iv~E~~~-~g~l~~~~~ 107 (309)
T d1u5ra_ 30 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV 107 (309)
T ss_dssp EEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEECCEEEEEEEecC-CCchHHHHH
Confidence 6999999999999999999761 245889999999 7789999999999999999999999999 89887653
Q ss_pred -----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 77 -----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 77 -----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
.+..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|..... ....+||+.|+|||
T Consensus 108 ~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 108 HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP---ANSFVGTPYWMAPE 181 (309)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS---BCCCCSCGGGCCHH
T ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---CCEEEeecccccccCC---CCccccCccccCHH
Confidence 333456777999999999999999999999999999876 6899999999986533 34568999999999
Q ss_pred cccc---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC
Q psy6377 152 ILHY---EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM 228 (383)
Q Consensus 152 ~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 228 (383)
++.+ .+|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+. ...+|+++++||.+||.+||++||
T Consensus 182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rp 259 (309)
T d1u5ra_ 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRP 259 (309)
T ss_dssp HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHCcCChhHCc
Confidence 9854 46899999999999999999999999999888888887766544332 346899999999999999999999
Q ss_pred CHHHHHcCcccCC
Q psy6377 229 TAKEALKHPWLMN 241 (383)
Q Consensus 229 t~~e~L~hp~~~~ 241 (383)
|++|+|+||||..
T Consensus 260 t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 260 TSEVLLKHRFVLR 272 (309)
T ss_dssp CHHHHTTCHHHHS
T ss_pred CHHHHHhCHHhcC
Confidence 9999999999965
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-51 Score=401.97 Aligned_cols=228 Identities=23% Similarity=0.408 Sum_probs=205.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.||+.||||++.+ ....+.+|+.+|+ .++|||||+++++|.+....|+|||++. ||+|...+.
T Consensus 56 ~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~~v~e~~~-~g~l~~~l~ 133 (350)
T d1rdqe_ 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSNLYMVMEYVA-GGEMFSHLR 133 (350)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-HcCCCcEeeccccccccccccccccccc-ccchhhhHh
Confidence 699999999999999999875 3456889999999 7799999999999999999999999999 999998653
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCc
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPE 151 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE 151 (383)
. ..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.... ...+.+||+.|+|||
T Consensus 134 ~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~---g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKG--RTWTLCGTPEALAPE 208 (350)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSS--CBCCCEECGGGCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC---CCEEeeeceeeeeccc--ccccccCccccCCHH
Confidence 3 4456777999999999999999999999999999765 6899999999998643 345678999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCC---
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERM--- 228 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--- 228 (383)
++.+.+|+.++|||||||++|+|++|++||.+.+....+..|..+...+|. .+|+++.+||++||.+||.+|+
T Consensus 209 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~kR~~~~ 284 (350)
T d1rdqe_ 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNL 284 (350)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSS
T ss_pred HHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHhhhCHHhccccc
Confidence 999999999999999999999999999999999999999999888776653 6799999999999999999995
Q ss_pred --CHHHHHcCcccCCcc
Q psy6377 229 --TAKEALKHPWLMNKK 243 (383)
Q Consensus 229 --t~~e~L~hp~~~~~~ 243 (383)
|++++++||||+...
T Consensus 285 r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 285 KNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TTTTHHHHTSGGGTTCC
T ss_pred cccHHHHHcCccccCCC
Confidence 999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=398.20 Aligned_cols=231 Identities=29% Similarity=0.452 Sum_probs=205.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.||+.||||++.+ ....+.+|+.++...++|||||+++++|++++.+|+||||++ ||+|.+++.
T Consensus 17 ~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~-~g~L~~~i~ 95 (320)
T d1xjda_ 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN-GGDLMYHIQ 95 (320)
T ss_dssp EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT-TCBHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC-CCcHHHHhh
Confidence 599999999999999999975 334678888888767899999999999999999999999999 999999764
Q ss_pred c------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 78 D------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 78 ~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ......+||+.|+||
T Consensus 96 ~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~---~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172 (320)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCH
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC---CceeccccchhhhcccccccccccCCCCCcCCH
Confidence 3 3356777999999999999999999999999999865 68999999999875443 334557899999999
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 151 EILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 151 E~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
|++.+.+|+.++||||+||++|+|++|+.||.+.+..+++..+..+.+.+| ..+|+++++||++||.+||.+|||+
T Consensus 173 E~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~ 248 (320)
T d1xjda_ 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKLFVREPEKRLGV 248 (320)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSBTT
T ss_pred HHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHhcccCCCCCcCH
Confidence 999999999999999999999999999999999999999999988877665 3679999999999999999999999
Q ss_pred H-HHHcCcccCCcc
Q psy6377 231 K-EALKHPWLMNKK 243 (383)
Q Consensus 231 ~-e~L~hp~~~~~~ 243 (383)
. ++++||||++..
T Consensus 249 ~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 249 RGDIRQHPLFREIN 262 (320)
T ss_dssp BSCGGGSGGGTTCC
T ss_pred HHHHHhCchhccCC
Confidence 5 899999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-50 Score=396.38 Aligned_cols=232 Identities=22% Similarity=0.351 Sum_probs=194.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHH---HHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHE---IALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~E---i~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.||+.||||++.+ ....+.+| +++++ ..+|||||+++++|++.+.+|+||||++ ||+|.+
T Consensus 19 ~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~-~~~hpnIv~l~~~~~~~~~~~ivmE~~~-gg~L~~ 96 (364)
T d1omwa3 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMN-GGDLHY 96 (364)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHS-SSCCTTBCCEEEEEECSSEEEEEECCCC-SCBHHH
T ss_pred EEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHh-cCCCCcEEEEEEEEEECCEEEEEEEecC-CCcHHH
Confidence 589999999999999999875 22334455 55555 6689999999999999999999999999 999999
Q ss_pred hhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 75 IIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 75 ~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
++.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... .....+||+.|+
T Consensus 97 ~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~---g~iKl~DFGla~~~~~~-~~~~~~GT~~y~ 172 (364)
T d1omwa3 97 HLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-KPHASVGTHGYM 172 (364)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---SCEEECCCTTCEECSSS-CCCSCCSCGGGC
T ss_pred HHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC---CcEEEeeeceeeecCCC-cccccccccccc
Confidence 7643 3455677999999999999999999999999999765 68999999999976543 345678999999
Q ss_pred CCcccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCC
Q psy6377 149 APEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMER 227 (383)
Q Consensus 149 aPE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 227 (383)
|||++. +..|+.++|||||||++|+|++|++||.+.+..+... +.......+...+..+|+++++||.+||.+||++|
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred hhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHh
Confidence 999986 4679999999999999999999999998766544332 23333344444556789999999999999999999
Q ss_pred CC-----HHHHHcCcccCCcc
Q psy6377 228 MT-----AKEALKHPWLMNKK 243 (383)
Q Consensus 228 pt-----~~e~L~hp~~~~~~ 243 (383)
|| |+|+++||||++..
T Consensus 252 ~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 252 LGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp TTTSSSTHHHHHTSGGGTTCC
T ss_pred CCCcccCHHHHHcCccccCCC
Confidence 99 79999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=385.13 Aligned_cols=236 Identities=28% Similarity=0.349 Sum_probs=198.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh---
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI--- 75 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~--- 75 (383)
.||+|+++.+|+.||||++.. ...++.+|+++++ .++|||||+++++|++++.+|+|||++. ++.+...
T Consensus 17 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~ 94 (298)
T d1gz8a_ 17 VVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS 94 (298)
T ss_dssp EEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHT
T ss_pred EEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEEeccccccccceeEEEeecC-Cchhhhhhhh
Confidence 789999999999999999965 3567899999999 7899999999999999999999999998 5544433
Q ss_pred ----hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-cccccccCCCCcCCC
Q psy6377 76 ----IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-IEIRELLGTPDYVAP 150 (383)
Q Consensus 76 ----l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~y~aP 150 (383)
+.+..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ......+||+.|+||
T Consensus 95 ~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~---~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~ap 171 (298)
T d1gz8a_ 95 ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171 (298)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCH
T ss_pred cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc---CcceeccCCcceeccCCcccceeecccceeeeh
Confidence 2334566777999999999999999999999999999765 68999999999876443 334556899999999
Q ss_pred cccccCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------h
Q psy6377 151 EILHYEP-ITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE-------------------------L 204 (383)
Q Consensus 151 E~l~~~~-~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------------~ 204 (383)
|++.... ++.++||||+||++|+|++|++||.+.+..+.+.++......+... .
T Consensus 172 E~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T d1gz8a_ 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251 (298)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHH
T ss_pred hhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhh
Confidence 9987665 4799999999999999999999999998888777765433222211 2
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchh
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQI 245 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~ 245 (383)
...+|+++++||++||.+||++|||++|+|+||||++..++
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 24578999999999999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=383.53 Aligned_cols=235 Identities=24% Similarity=0.354 Sum_probs=197.2
Q ss_pred eEEEEEEcCC-CcEEEEEEccC------CcccHHHHHHHHHhc--CCCCCcccceEEEEe-----CCeEEEEEecCCCcC
Q psy6377 5 SEEMADSIAT-GEVFAAKFLES------NPVRIHHEIALLSLC--SPSPRIVKLHDVFQT-----GEGAYYVSWNTPLVV 70 (383)
Q Consensus 5 ~V~~~~~~~t-g~~vAvK~i~~------~~~~~~~Ei~il~~~--~~hpnIvkl~~~~~~-----~~~~~lv~e~~~~g~ 70 (383)
.||+|+++.+ |+.||||++.. ....+.+|+.+++.+ .+||||++++++|.. ...+|++||++. ++
T Consensus 22 ~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~-~~ 100 (305)
T d1blxa_ 22 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD 100 (305)
T ss_dssp EEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CB
T ss_pred EEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEecc-CC
Confidence 5999999766 67799999865 345688999988744 379999999999964 346899999999 77
Q ss_pred cHHHh-------hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccC
Q psy6377 71 TLQTI-------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLG 143 (383)
Q Consensus 71 ~L~~~-------l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~g 143 (383)
.+... +.+..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...........+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~---~~~kl~dfg~~~~~~~~~~~~~~~g 177 (305)
T d1blxa_ 101 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVVV 177 (305)
T ss_dssp HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCCSCCCCCGGGGGCCCCC
T ss_pred chhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC---CCeeecchhhhhhhcccccCCCccc
Confidence 66543 2233455777999999999999999999999999999765 6899999999987766666677899
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP---------------------- 201 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 201 (383)
|+.|+|||++.+.+|+.++||||+||++|+|++|++||.+.+..+.+..+......++
T Consensus 178 T~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (305)
T d1blxa_ 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQP 257 (305)
T ss_dssp CCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCC
T ss_pred ChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccc
Confidence 9999999999999999999999999999999999999999998888887765322211
Q ss_pred -cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 202 -DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 202 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
...+..+++.+++||.+||.+||++|||++|+|+||||++..
T Consensus 258 ~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 258 IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 123456789999999999999999999999999999998653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=376.29 Aligned_cols=225 Identities=26% Similarity=0.378 Sum_probs=191.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC----------CcccHHHHHHHHHhcC-CCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES----------NPVRIHHEIALLSLCS-PSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----------~~~~~~~Ei~il~~~~-~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+++.||+.||||++.+ ...++.+|+.+++.+. .|||||+++++|++.+..|+|||++..++++.
T Consensus 19 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~ 98 (273)
T d1xwsa_ 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 98 (273)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH
T ss_pred EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHH
Confidence 699999999999999999875 2345789999998554 49999999999999999999999997346777
Q ss_pred Hhhc------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 74 TIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 74 ~~l~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
+++. +..++.+..||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.... ....+.+||+.|
T Consensus 99 ~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~--~~vkl~DFG~a~~~~~-~~~~~~~GT~~y 175 (273)
T d1xwsa_ 99 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD-TVYTDFDGTRVY 175 (273)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEECCS-SCBCCCCSCGGG
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC--CeEEECccccceeccc-ccccccccCCCc
Confidence 7643 344567779999999999999999999999999998542 5899999999987543 345667899999
Q ss_pred CCCcccccCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 148 VAPEILHYEPI-TLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 148 ~aPE~l~~~~~-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+|||++.+..+ +.++||||+||++|+|++|++||.+. ..+..+...++ ..+|+++++||++||.+||++
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGG
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCCHHHHHHHHHHccCCHhH
Confidence 99999987765 57799999999999999999999764 23555665554 468999999999999999999
Q ss_pred CCCHHHHHcCcccCCc
Q psy6377 227 RMTAKEALKHPWLMNK 242 (383)
Q Consensus 227 Rpt~~e~L~hp~~~~~ 242 (383)
|||++|+|+||||++.
T Consensus 246 R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 246 RPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCHHHHHTSGGGSSC
T ss_pred CcCHHHHhcCHhhCCC
Confidence 9999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=387.32 Aligned_cols=238 Identities=25% Similarity=0.317 Sum_probs=198.6
Q ss_pred ccceEEEEEEcCCCcEEEEEEccCCcccHHHHHHHHHhcCCCCCcccceEEEEeC------CeEEEEEecCCCcCcHHHh
Q psy6377 2 FALSEEMADSIATGEVFAAKFLESNPVRIHHEIALLSLCSPSPRIVKLHDVFQTG------EGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~------~~~~lv~e~~~~g~~L~~~ 75 (383)
|| .||+|+++.+|+.||||++.++.....+|+++|+ .++||||++++++|... ..+|+||||++ ++.+..+
T Consensus 33 fg-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~-~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~-~~~~~~l 109 (350)
T d1q5ka_ 33 FG-VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVA 109 (350)
T ss_dssp TE-EEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHH-HCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS-EEHHHHH
T ss_pred Ce-EEEEEEECCCCCEEEEEEECccchHHHHHHHHHH-hcCCCCCCcEEEEEEecCccCCceEEEEEEeccC-CccHHHH
Confidence 44 4999999999999999999887667779999999 77999999999999543 35799999998 6543333
Q ss_pred ---------hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCC
Q psy6377 76 ---------IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPD 146 (383)
Q Consensus 76 ---------l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 146 (383)
+.+..++.+++||+.||+|||++||+||||||+|||++.+. ..+||+|||++..........+.+||+.
T Consensus 110 ~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 187 (350)
T d1q5ka_ 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYICSRY 187 (350)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECCCTTCEECCTTSCCCSCCSCTT
T ss_pred HhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEecccchhhccCCccccccccccc
Confidence 23334567789999999999999999999999999998653 4799999999998877666777899999
Q ss_pred cCCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------------------------
Q psy6377 147 YVAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP------------------------ 201 (383)
Q Consensus 147 y~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~------------------------ 201 (383)
|+|||++.+ ..|+.++||||+||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 188 y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (350)
T d1q5ka_ 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 267 (350)
T ss_dssp SCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCG
T ss_pred ccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCch
Confidence 999998764 5789999999999999999999999999988887777654322111
Q ss_pred -cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 202 -DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 202 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
......+++++.+||.+||.+||++|||+.|+|+||||+....
T Consensus 268 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 268 TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0112457899999999999999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-49 Score=372.08 Aligned_cols=230 Identities=25% Similarity=0.378 Sum_probs=192.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCe----EEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEG----AYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~----~~lv~e~~~~g~~L~ 73 (383)
.||+|+++.+|+.||||++.+ ....+.+|+.+++ ..+|||||++++++.+.+. .|+||||++ |++|.
T Consensus 22 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~-~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~-g~~L~ 99 (277)
T d1o6ya_ 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD-GVTLR 99 (277)
T ss_dssp EEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEECSSSEEEEEEEECCC-EEEHH
T ss_pred EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hcCCCCCCcccceeeeccCCCceEEEEEECCC-CCEeh
Confidence 699999999999999999976 1346889999999 8899999999999987543 899999999 99999
Q ss_pred Hhhcc------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc----ccccccC
Q psy6377 74 TIIDD------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI----EIRELLG 143 (383)
Q Consensus 74 ~~l~~------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~----~~~~~~g 143 (383)
+.+.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.++++|||.+....... .....+|
T Consensus 100 ~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~G 176 (277)
T d1o6ya_ 100 DIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIG 176 (277)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT---SCEEECCCTTCEECC--------------
T ss_pred hhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc---ccceeehhhhhhhhccccccccccccccC
Confidence 86533 3456777999999999999999999999999999876 589999999987653322 2445689
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
|+.|+|||++.+.+|+.++||||+||++|+|++|++||.+.+..+.+.++......++...+.++|+++.+||.+||.+|
T Consensus 177 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 256 (277)
T d1o6ya_ 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256 (277)
T ss_dssp --TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSS
T ss_pred cccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999999998888888888877777788899999999999999999
Q ss_pred CCCCCCHHHHHcCccc
Q psy6377 224 PMERMTAKEALKHPWL 239 (383)
Q Consensus 224 P~~Rpt~~e~L~hp~~ 239 (383)
|++||+..+.|.|+|.
T Consensus 257 p~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 257 PENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGSCSSHHHHHHHHH
T ss_pred HhHCHhHHHHHHHHHH
Confidence 9999954444556665
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=380.26 Aligned_cols=232 Identities=28% Similarity=0.405 Sum_probs=196.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCC------eEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE------GAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~------~~~lv~e~~~~g~~L 72 (383)
.||+|+++.||+.||||++.+ ....+.+|+.+|+ .++|||||+++++|.+.+ .+|+||||+. .+|
T Consensus 33 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~--~~l 109 (346)
T d1cm8a_ 33 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG--TDL 109 (346)
T ss_dssp CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCS--EEH
T ss_pred EEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHH-hcCCCCeeEEEEEeccCccccccceEEEEEeccc--ccH
Confidence 489999999999999999986 2356889999999 678999999999998655 5799999995 778
Q ss_pred HHhh-----ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCc
Q psy6377 73 QTII-----DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDY 147 (383)
Q Consensus 73 ~~~l-----~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y 147 (383)
..++ ++..++.+++||+.||+|||++||+||||||+|||++.+ +.+|++|||+|+... ......+||+.|
T Consensus 110 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~---~~~kl~Dfg~a~~~~--~~~~~~~~t~~y 184 (346)
T d1cm8a_ 110 GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGLARQAD--SEMTGYVVTRWY 184 (346)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECC--SSCCSSCSCGGG
T ss_pred HHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc---cccccccccceeccC--Cccccccccccc
Confidence 7764 344566777999999999999999999999999999876 689999999998764 345667899999
Q ss_pred CCCccccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------------------------
Q psy6377 148 VAPEILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPD------------------------ 202 (383)
Q Consensus 148 ~aPE~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 202 (383)
+|||++.+ ..++.++||||+||++|+|++|.+||.+.+....+..+......+|.
T Consensus 185 ~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (346)
T d1cm8a_ 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 264 (346)
T ss_dssp CCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred cCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccccc
Confidence 99999876 45789999999999999999999999999887777666554433332
Q ss_pred ---chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcch
Q psy6377 203 ---ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQ 244 (383)
Q Consensus 203 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~ 244 (383)
....++++++.+||.+||.+||++|||++|+|+||||+....
T Consensus 265 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 265 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred chHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 123467899999999999999999999999999999987554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=373.25 Aligned_cols=235 Identities=24% Similarity=0.299 Sum_probs=193.7
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe--------CCeEEEEEecCC
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT--------GEGAYYVSWNTP 67 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~--------~~~~~lv~e~~~ 67 (383)
|| .||+|+++.+|+.||||++.. ...++.+|+.+|+ .++||||+++++++.+ .+.+|+|||++.
T Consensus 23 fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~ 100 (318)
T d3blha1 23 FG-EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE 100 (318)
T ss_dssp SS-EEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEC----------CEEEEEECCC
T ss_pred Ce-EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHH-HhcCCCccceEeeeecccccccccCceEEEEEeccC
Confidence 44 599999999999999999865 3456889999999 7789999999999865 346899999998
Q ss_pred CcCcHHHhhc------cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC-----c
Q psy6377 68 LVVTLQTIID------DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG-----I 136 (383)
Q Consensus 68 ~g~~L~~~l~------~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~-----~ 136 (383)
++.+..... ...++.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... .
T Consensus 101 -~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~---~~~kl~dfg~~~~~~~~~~~~~~ 176 (318)
T d3blha1 101 -HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPN 176 (318)
T ss_dssp -EEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEECCC-----CC
T ss_pred -CCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC---CcEEeeecceeeecccccccccc
Confidence 666665432 23455677999999999999999999999999999876 68999999999865432 1
Q ss_pred ccccccCCCCcCCCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcC--------
Q psy6377 137 EIRELLGTPDYVAPEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFED-------- 207 (383)
Q Consensus 137 ~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------- 207 (383)
...+.+||+.|+|||++.+. +|+.++||||+||++|+|++|++||.+.+..+....+......+++..+..
T Consensus 177 ~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T d3blha1 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256 (318)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC----
T ss_pred cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh
Confidence 23346799999999998754 689999999999999999999999999998888888777655554433222
Q ss_pred --------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 208 --------------------ISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 208 --------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.++++++||.+||++||++|||++|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp ---CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 36788999999999999999999999999999853
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=373.74 Aligned_cols=235 Identities=25% Similarity=0.377 Sum_probs=196.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCCCCcccceEEEEeC--CeEEEEEecCCCcCcHHHh---hcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG--EGAYYVSWNTPLVVTLQTI---IDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~--~~~~lv~e~~~~g~~L~~~---l~~ 78 (383)
.||+|+++.+|+.||||++++ ...++.+|+.+|+.+.+||||++++++|... ..+++||||+. +++|... +++
T Consensus 50 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~-~~~L~~~~~~l~e 128 (328)
T d3bqca1 50 EVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN-NTDFKQLYQTLTD 128 (328)
T ss_dssp EEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC-SCBGGGTTTSCCH
T ss_pred EEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC-CCcHHHHhcCCCH
Confidence 699999999999999999987 5678899999999666799999999999854 56999999999 9999885 445
Q ss_pred CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCcccccC-C
Q psy6377 79 NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEILHYE-P 157 (383)
Q Consensus 79 ~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~ 157 (383)
..+..++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+|+...........+||+.|+|||++.+. .
T Consensus 129 ~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 206 (328)
T d3bqca1 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccCCCcccccccCccccCcccccCCCC
Confidence 66778889999999999999999999999999998653 46999999999988777677778999999999997764 5
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhc-------------cCC--------------------CCcc
Q psy6377 158 ITLAADMWSLGVTAYVLLTGFSPFGGETDS-ETFRNISKA-------------QLD--------------------FPDE 203 (383)
Q Consensus 158 ~~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~i~~~-------------~~~--------------------~~~~ 203 (383)
|+.++||||+||++|+|++|..||...... .....+... ... ++..
T Consensus 207 ~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (328)
T d3bqca1 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 286 (328)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTT
T ss_pred CCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccccc
Confidence 899999999999999999999999765432 222222110 000 1111
Q ss_pred hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 204 LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 204 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
.+..+|+++++||++||.+||++|||++|+|+||||+..
T Consensus 287 ~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 287 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 234578999999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-48 Score=367.80 Aligned_cols=231 Identities=26% Similarity=0.352 Sum_probs=191.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++ +|+.||||++.. ...++.+|+.+|+ .++|||||+++++|.+++..|++|+++. ++.+..+...
T Consensus 17 ~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~i~~e~~~-~~~~~~~~~~ 93 (286)
T d1ob3a_ 17 VVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVC 93 (286)
T ss_dssp EEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTS
T ss_pred EEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHH-hCCCCcEEeeeeecccCCceeEEEEeeh-hhhHHHHHhh
Confidence 58999985 899999999976 2567899999999 7789999999999999999999999998 7777766443
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc-ccccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI-EIRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~y~aPE 151 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|....... ......|++.|+|||
T Consensus 94 ~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 94 EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170 (286)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---------CCCTTCCHH
T ss_pred cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---CCEEecccccceecccCccccceecccchhhhHH
Confidence 3456777999999999999999999999999999776 689999999998754332 234457999999999
Q ss_pred cccc-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------cchh
Q psy6377 152 ILHY-EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP-------------------------DELF 205 (383)
Q Consensus 152 ~l~~-~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~ 205 (383)
.+.+ ..++.++||||+||++|+|++|++||.+.+..+.+.++......++ ....
T Consensus 171 ~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T d1ob3a_ 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (286)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred HHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence 9865 4579999999999999999999999999988888777654332221 1223
Q ss_pred cCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCC
Q psy6377 206 EDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMN 241 (383)
Q Consensus 206 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~ 241 (383)
..+++.+.+||++||++||++|||++|+|+||||+.
T Consensus 251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 567899999999999999999999999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=374.13 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=195.2
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCC----eEEEEEecCCCcCcH
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTL 72 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L 72 (383)
|| .||+|+++.||+.||||++.+ ...++.+|+.+|+ .++||||+++++++.... ..+++++++. |++|
T Consensus 21 fg-~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~-~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~-~g~L 97 (345)
T d1pmea_ 21 YG-MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL-RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADL 97 (345)
T ss_dssp CC-CEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECCSSTTTCCCEEEEEECC-CEEH
T ss_pred Ce-EEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHH-HcCCCCCCcEEEEEeeccccccceEEEEEeec-CCch
Confidence 44 599999999999999999976 2346789999999 779999999999997653 2345556666 8999
Q ss_pred HHhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccC
Q psy6377 73 QTIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLG 143 (383)
Q Consensus 73 ~~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~g 143 (383)
.+++.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|........ ....+|
T Consensus 98 ~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~~g 174 (345)
T d1pmea_ 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 174 (345)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCGGGCBCCTTCCCCS
T ss_pred hhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC---CCEEEcccCceeeccCCCccceeeccccc
Confidence 997643 3455677999999999999999999999999999865 6899999999987644322 345679
Q ss_pred CCCcCCCcccc-cCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------------------
Q psy6377 144 TPDYVAPEILH-YEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--------------------- 201 (383)
Q Consensus 144 t~~y~aPE~l~-~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 201 (383)
|+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+...........+.
T Consensus 175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (345)
T d1pmea_ 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254 (345)
T ss_dssp CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCc
Confidence 99999999984 45679999999999999999999999998877666555433221111
Q ss_pred ------cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhcc
Q psy6377 202 ------DELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMTR 248 (383)
Q Consensus 202 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~~ 248 (383)
...++.+|+++++||.+||.+||.+|||++|+|+||||+........
T Consensus 255 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~ 307 (345)
T d1pmea_ 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307 (345)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence 12345788999999999999999999999999999999876554433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=378.03 Aligned_cols=234 Identities=24% Similarity=0.331 Sum_probs=186.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEe------CCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQT------GEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~------~~~~~lv~e~~~~g~~L 72 (383)
.||+|+++.||+.||||++.+ ...++.+|+.+|+ .++|||||+++++|.. ...+|+||||+. |+.+
T Consensus 32 ~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~-~~l~ 109 (355)
T d2b1pa1 32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC 109 (355)
T ss_dssp EEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHH
T ss_pred EEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHH-hcCCCCeeEEEEEEecccccccCceeEEEEeccc-hHHH
Confidence 599999999999999999976 2346889999999 6789999999999964 468999999998 6655
Q ss_pred HHh---hccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCC
Q psy6377 73 QTI---IDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVA 149 (383)
Q Consensus 73 ~~~---l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~a 149 (383)
... +....++.++.||+.||+|||++||+||||||+|||++.+ +.++++|||+++...........+||+.|+|
T Consensus 110 ~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~t~~y~a 186 (355)
T d2b1pa1 110 QVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186 (355)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC---------------CCTTCC
T ss_pred HhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---cceeeechhhhhccccccccccccccccccC
Confidence 554 3445567788999999999999999999999999999876 6899999999998776666677889999999
Q ss_pred CcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcch-------------------------
Q psy6377 150 PEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDEL------------------------- 204 (383)
Q Consensus 150 PE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------------------- 204 (383)
||++.+..++.++||||+||++|+|++|++||.+.+.......+......+++..
T Consensus 187 PE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (355)
T d2b1pa1 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266 (355)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHH
T ss_pred hhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccc
Confidence 9999999999999999999999999999999999887777666654333222211
Q ss_pred -------------hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcc
Q psy6377 205 -------------FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKK 243 (383)
Q Consensus 205 -------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~ 243 (383)
....|+++.+||++||.+||++||||+|+|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 112467899999999999999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=373.69 Aligned_cols=226 Identities=16% Similarity=0.237 Sum_probs=193.3
Q ss_pred eEEEEEEcCCCc-----EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIATGE-----VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~tg~-----~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+++.+++ .||+|.+.. ....+.+|+.++..+.+|||||++++++.+.+.+|+||||++ ||+|.+
T Consensus 52 ~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~-~g~L~~ 130 (325)
T d1rjba_ 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC-YGDLLN 130 (325)
T ss_dssp EEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHH
T ss_pred EEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCC-CCcHHH
Confidence 489999887665 699999865 356788999999867799999999999999999999999999 999999
Q ss_pred hhccC-----------------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEe
Q psy6377 75 IIDDN-----------------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCD 125 (383)
Q Consensus 75 ~l~~~-----------------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~D 125 (383)
++... .++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~---~~~Kl~D 207 (325)
T d1rjba_ 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKICD 207 (325)
T ss_dssp HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETT---TEEEECC
T ss_pred HHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccC---CeEEEee
Confidence 76432 244567999999999999999999999999999876 6999999
Q ss_pred ccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCC
Q psy6377 126 FEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFP 201 (383)
Q Consensus 126 FGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 201 (383)
||+|+....... ..+..||+.|+|||++.+..|+.++|||||||++|+|++ |.+||.+.+..+.+.++......++
T Consensus 208 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (325)
T d1rjba_ 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD 287 (325)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC
T ss_pred ccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999987654332 234578999999999999999999999999999999997 8999999887777776665554433
Q ss_pred cchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 202 DELFEDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 202 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.+..+|+++++||.+||..||++|||++|+++|
T Consensus 288 --~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 288 --QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 235789999999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=360.60 Aligned_cols=223 Identities=18% Similarity=0.254 Sum_probs=182.8
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccC--
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDN-- 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~-- 79 (383)
.||+|+++ +++.||||+++. ..+.+.+|+.+++ .++|||||++++++.+++..|+||||++ +|+|.+++...
T Consensus 20 ~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~ 96 (263)
T d1sm2a_ 20 LVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPICLVFEFME-HGCLSDYLRTQRG 96 (263)
T ss_dssp CEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHHHHTTTT
T ss_pred EEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHH-hcCCCCcccccceeccCCceEEEEEecC-CCcHHHHhhcccc
Confidence 58999875 678899999987 4567899999999 7789999999999999999999999999 99999975432
Q ss_pred -----CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcc
Q psy6377 80 -----LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEI 152 (383)
Q Consensus 80 -----~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~ 152 (383)
....++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||+
T Consensus 97 ~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 173 (263)
T d1sm2a_ 97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173 (263)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---GCEEECSCC------------------CTTSCCHHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---CCeEecccchheeccCCCceeecceecCcccCChHH
Confidence 234566999999999999999999999999999876 6899999999987654332 234578999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..|+.++|||||||++|||++ |.+||.+.+..+....+..+..... +..+++++.+||.+||..||++|||++
T Consensus 174 l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999998 6788888888888888877643322 246789999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
|+++|
T Consensus 251 ~il~~ 255 (263)
T d1sm2a_ 251 RLLRQ 255 (263)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-48 Score=366.05 Aligned_cols=223 Identities=19% Similarity=0.226 Sum_probs=187.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|+++.+|+.||||++.. ..+.+.+|+++++ .++|||||+++++|.+++.+|+||||++ +|+|.+++..
T Consensus 32 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~iv~E~~~-~g~l~~~l~~~~~ 109 (287)
T d1opja_ 32 EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPFYIITEFMT-YGNLLDYLRECNR 109 (287)
T ss_dssp SEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHHHHHHSCT
T ss_pred EEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHH-hCCCCCEecCCccEeeCCeeEEEeeccc-CcchHHHhhhccc
Confidence 689999999999999999987 4567899999999 7789999999999999999999999999 9999997643
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||
T Consensus 110 ~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186 (287)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC---CcEEEccccceeecCCCCceeeccccccccccChH
Confidence 2234566899999999999999999999999999876 6899999999987644322 23345889999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLTGFSP-FGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyelltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+.+|+.++|||||||++|+|++|..| |.+.+..+....+..+ .. ...+..+|+++.+||.+||..||++|||+
T Consensus 187 ~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 263 (287)
T d1opja_ 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGCPEKVYELMRACWQWNPSDRPSF 263 (287)
T ss_dssp HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC--CCCCccchHHHHHHHHHHcCCCHhHCcCH
Confidence 99999999999999999999999996555 5555555555544433 22 23345789999999999999999999999
Q ss_pred HHHHc
Q psy6377 231 KEALK 235 (383)
Q Consensus 231 ~e~L~ 235 (383)
+|+++
T Consensus 264 ~ei~~ 268 (287)
T d1opja_ 264 AEIHQ 268 (287)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=357.08 Aligned_cols=223 Identities=19% Similarity=0.238 Sum_probs=194.3
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|+++ +++.||||++.+ ....+.+|+.+++ .++||||+++++++.+++.+++||||+. +|+|..++..
T Consensus 19 ~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~-~l~HpnIv~~~g~~~~~~~~~iv~Ey~~-~g~l~~~~~~~~~ 95 (258)
T d1k2pa_ 19 VVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMM-NLSHEKLVQLYGVCTKQRPIFIITEYMA-NGCLLNYLREMRH 95 (258)
T ss_dssp EEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHH-TCCCTTBCCEEEEECCSSSEEEEEECCT-TEEHHHHHHSGGG
T ss_pred EEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHH-hcCCCceeeEEEEEeeCCceEEEEEccC-CCcHHHhhhcccc
Confidence 58999984 788999999987 5678999999999 7789999999999999999999999999 9999886432
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCcc
Q psy6377 79 ----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPEI 152 (383)
Q Consensus 79 ----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE~ 152 (383)
..++.+..|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||+
T Consensus 96 ~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~---~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~ 172 (258)
T d1k2pa_ 96 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172 (258)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT---CCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC---CcEEECcchhheeccCCCceeecccCCCCCcCCcHH
Confidence 2345667999999999999999999999999999865 6899999999987544322 234678999999999
Q ss_pred cccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHH
Q psy6377 153 LHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAK 231 (383)
Q Consensus 153 l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 231 (383)
+.+..|+.++|||||||++|||+| |+.||.+.+..+....+..+....+ +...++++.+||.+||+.||++|||++
T Consensus 173 ~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred hcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999998 8999999999998888877643332 246789999999999999999999999
Q ss_pred HHHcC
Q psy6377 232 EALKH 236 (383)
Q Consensus 232 e~L~h 236 (383)
++++|
T Consensus 250 eil~~ 254 (258)
T d1k2pa_ 250 ILLSN 254 (258)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=362.58 Aligned_cols=226 Identities=17% Similarity=0.242 Sum_probs=188.9
Q ss_pred eEEEEEEc--CCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSI--ATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~--~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|..+ .+++.||||++.. ....+.+|+++++ .++|||||++++++++ +..|+||||++ +|+|.+++
T Consensus 22 ~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~g~~~~-~~~~lvmE~~~-~g~L~~~l 98 (277)
T d1xbba_ 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ-QLDNPYIVRMIGICEA-ESWMLVMEMAE-LGPLNKYL 98 (277)
T ss_dssp EEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHH-TCCCTTBCCEEEEEES-SSEEEEEECCT-TEEHHHHH
T ss_pred EEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHH-hCCCCCCceEEEEecc-CCEEEEEEcCC-CCcHHHHH
Confidence 58999754 5668899999975 1356889999999 7799999999999965 56789999999 99999976
Q ss_pred ccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCC
Q psy6377 77 DDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPD 146 (383)
Q Consensus 77 ~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~ 146 (383)
... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.
T Consensus 99 ~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~---~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 175 (277)
T d1xbba_ 99 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVK 175 (277)
T ss_dssp HHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTCSEEEC----CCCGG
T ss_pred hhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---CcccccchhhhhhccccccccccccccCCCce
Confidence 543 355677999999999999999999999999999876 6899999999997654322 223578999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+....+..+... +.+..+|+++.+||.+||..||+
T Consensus 176 y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dp~ 252 (277)
T d1xbba_ 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVE 252 (277)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTT
T ss_pred ecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHHHHHcCCCHh
Confidence 999999999999999999999999999998 89999999988888888765432 22357899999999999999999
Q ss_pred CCCCHHHH---HcCccc
Q psy6377 226 ERMTAKEA---LKHPWL 239 (383)
Q Consensus 226 ~Rpt~~e~---L~hp~~ 239 (383)
+|||++++ |+|+|+
T Consensus 253 ~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 253 NRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHhhCHHh
Confidence 99999998 456654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=363.05 Aligned_cols=227 Identities=19% Similarity=0.224 Sum_probs=190.8
Q ss_pred eEEEEEEcCC--CcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIAT--GEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~t--g~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|.++.+ +..||||++.. ....+.+|+++++ .++|||||++++++++ +.+|+||||++ ||+|.+++.
T Consensus 24 ~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~-~~~~lvmE~~~-~g~L~~~l~ 100 (285)
T d1u59a_ 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-EALMLVMEMAG-GGPLHKFLV 100 (285)
T ss_dssp EEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEES-SSEEEEEECCT-TEEHHHHHT
T ss_pred EEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHH-hCCCCCEeeEeeeecc-CeEEEEEEeCC-CCcHHHHhh
Confidence 5899987644 55899999976 2456889999999 6789999999999975 56899999999 999999753
Q ss_pred c-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCCCC
Q psy6377 78 D-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGTPD 146 (383)
Q Consensus 78 ~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt~~ 146 (383)
. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.
T Consensus 101 ~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 177 (285)
T d1u59a_ 101 GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPLK 177 (285)
T ss_dssp TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC---CceeeccchhhhcccccccccccccccccCcc
Confidence 2 2345667999999999999999999999999999876 6899999999998654322 234568999
Q ss_pred cCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCC
Q psy6377 147 YVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPM 225 (383)
Q Consensus 147 y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 225 (383)
|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+..+.... .++.+|+++.+||.+||..||+
T Consensus 178 y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPELYALMSDCWIYKWE 254 (285)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGG
T ss_pred ccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCCHh
Confidence 999999999999999999999999999998 999999999888888887765322 2357899999999999999999
Q ss_pred CCCCHHHH---HcCcccC
Q psy6377 226 ERMTAKEA---LKHPWLM 240 (383)
Q Consensus 226 ~Rpt~~e~---L~hp~~~ 240 (383)
+|||+.++ |+|+|+.
T Consensus 255 ~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 255 DRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 99999887 5677763
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=370.83 Aligned_cols=236 Identities=28% Similarity=0.367 Sum_probs=194.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeC-----CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-----EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-----~~~~lv~e~~~~g~~L~ 73 (383)
.||+|+++.+|+.||||++.+ ...++.+|+.+|+ .++|||||+++++|... ...+++|+++. |++|.
T Consensus 33 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~-~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~-gg~L~ 110 (348)
T d2gfsa1 33 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN 110 (348)
T ss_dssp SEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred EEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeccccccCceEEEEEeec-CCchh
Confidence 599999999999999999986 2346789999999 77899999999999743 34466677787 89999
Q ss_pred Hhhcc-----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcC
Q psy6377 74 TIIDD-----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYV 148 (383)
Q Consensus 74 ~~l~~-----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~ 148 (383)
+++.. ..+..++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+|.... ....+..||+.|+
T Consensus 111 ~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~---~~~kl~dfg~a~~~~--~~~~~~~g~~~y~ 185 (348)
T d2gfsa1 111 NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARHTD--DEMTGYVATRWYR 185 (348)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCC----CCT--GGGSSSCHHHHTS
T ss_pred hhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc---ccccccccchhcccC--ccccccccccccc
Confidence 97643 3456777999999999999999999999999999876 689999999998653 3455678999999
Q ss_pred CCcccccC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc------------------------
Q psy6377 149 APEILHYE-PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDE------------------------ 203 (383)
Q Consensus 149 aPE~l~~~-~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------------------ 203 (383)
|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+.......+..
T Consensus 186 apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (348)
T d2gfsa1 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 265 (348)
T ss_dssp CHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCC
T ss_pred CchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcc
Confidence 99987665 46899999999999999999999999998888877776654443322
Q ss_pred ---hhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCcchhhc
Q psy6377 204 ---LFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNKKQIMT 247 (383)
Q Consensus 204 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~~~~~~ 247 (383)
.+.++++++++||.+||.+||.+|||++|+|+||||+.......
T Consensus 266 ~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 266 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 23467999999999999999999999999999999987654433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=367.73 Aligned_cols=235 Identities=28% Similarity=0.374 Sum_probs=197.0
Q ss_pred eEEEEEE---cCCCcEEEEEEccC--------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADS---IATGEVFAAKFLES--------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~---~~tg~~vAvK~i~~--------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++ +.+|+.||||++.+ ....+.+|+++++++.+||||+++++++++...++++||++. |++|.
T Consensus 39 ~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~-~~~L~ 117 (322)
T d1vzoa_ 39 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN-GGELF 117 (322)
T ss_dssp EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCC-SCBHH
T ss_pred EEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeeccc-ccHHH
Confidence 4899987 45799999999875 346788999999966566999999999999999999999999 99999
Q ss_pred HhhccC------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--ccccccCCC
Q psy6377 74 TIIDDN------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--EIRELLGTP 145 (383)
Q Consensus 74 ~~l~~~------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~ 145 (383)
+.+... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...+..|++
T Consensus 118 ~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~vkL~DFG~a~~~~~~~~~~~~~~~g~~ 194 (322)
T d1vzoa_ 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTI 194 (322)
T ss_dssp HHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECCGGGGGGGCGGGSCC
T ss_pred HHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---CCEEEeeccchhhhccccccccccccccc
Confidence 976443 344566999999999999999999999999999876 689999999998764332 245578999
Q ss_pred CcCCCcccccC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 146 DYVAPEILHYE--PITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 146 ~y~aPE~l~~~--~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
.|+|||.+.+. .++.++|||||||+||+|++|..||.+.+..+....+.......+...+..+|+++.+||.+||.+|
T Consensus 195 ~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 274 (322)
T d1vzoa_ 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274 (322)
T ss_dssp TTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccC
Confidence 99999998654 4688999999999999999999999988777666666555444444445678999999999999999
Q ss_pred CCCCC-----CHHHHHcCcccCCcc
Q psy6377 224 PMERM-----TAKEALKHPWLMNKK 243 (383)
Q Consensus 224 P~~Rp-----t~~e~L~hp~~~~~~ 243 (383)
|++|| |++|+|+||||+...
T Consensus 275 P~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 275 PKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp GGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999 589999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=358.86 Aligned_cols=225 Identities=20% Similarity=0.291 Sum_probs=190.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID---- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~---- 77 (383)
.||+|+++ +++.||||++.. ....+.+|+.+++ .++|||||++++++. ++..|+||||++ +|+|.+++.
T Consensus 28 ~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~-~~~~~iv~Ey~~-~g~L~~~~~~~~~ 103 (272)
T d1qpca_ 28 EVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMK-QLQHQRLVRLYAVVT-QEPIYIITEYME-NGSLVDFLKTPSG 103 (272)
T ss_dssp EEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSCEEEEECCT-TCBHHHHTTSHHH
T ss_pred EEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHH-hCCCCCEeEEEeeec-cCCeEEEEEeCC-CCcHHHHHhhcCC
Confidence 58999975 678899999986 4567899999999 669999999999875 467899999999 999998543
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
...++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||
T Consensus 104 ~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 104 IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT---LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180 (272)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc---cceeeccccceEEccCCccccccccCCcccccChH
Confidence 23455777999999999999999999999999999876 6899999999998754432 33457899999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++.+..|+.++|||||||++|||+| |.+||.+.+..+.+..+..+.... ....+++++.+||.+||..||++|||+
T Consensus 181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~ 257 (272)
T d1qpca_ 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTF 257 (272)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCH
Confidence 9998999999999999999999999 567777777778888777654322 235689999999999999999999999
Q ss_pred HHHHc--Cccc
Q psy6377 231 KEALK--HPWL 239 (383)
Q Consensus 231 ~e~L~--hp~~ 239 (383)
+++++ |+||
T Consensus 258 ~ei~~~L~~~f 268 (272)
T d1qpca_ 258 DYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHhhhhh
Confidence 99987 6666
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-47 Score=363.32 Aligned_cols=224 Identities=18% Similarity=0.241 Sum_probs=180.2
Q ss_pred eEEEEEEcCCCc---EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATGE---VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg~---~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|+++.+|+ .||||.+.. ....+.+|+.+|+ .++|||||++++++.+++.+|+||||++ ||+|.+++
T Consensus 41 ~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~iv~Ey~~-~g~L~~~~ 118 (299)
T d1jpaa_ 41 EVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG-QFDHPNVIHLEGVVTKSTPVMIITEFME-NGSLDSFL 118 (299)
T ss_dssp EEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHHHH
T ss_pred EEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHH-hCCCCCCccEEEEEeeCCEEEEEEEecC-CCcceeee
Confidence 689999988775 589998876 2356899999999 7799999999999999999999999999 99999965
Q ss_pred ccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCccc------ccccC
Q psy6377 77 DDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEI------RELLG 143 (383)
Q Consensus 77 ~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~------~~~~g 143 (383)
... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+........ ....|
T Consensus 119 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~ 195 (299)
T d1jpaa_ 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195 (299)
T ss_dssp HTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCC-----------------------
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC---CcEEECCcccceEccCCCCcceeeecccccC
Confidence 432 244566999999999999999999999999999876 68999999999876543221 12457
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+..+.... .+..+++++.+||.+||..
T Consensus 196 t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---PPMDCPSALHQLMLDCWQK 272 (299)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCS
T ss_pred CccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCC
Confidence 899999999999999999999999999999998 899999999888888877654322 2346899999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||++|||+.|++++
T Consensus 273 ~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 273 DRNHRPKFGQIVNT 286 (299)
T ss_dssp STTTSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=359.78 Aligned_cols=223 Identities=19% Similarity=0.271 Sum_probs=180.9
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+.+ ..||||++.. ....+.+|+.+++ .++|||||++++++ +++.+|+||||++ ||+|.+++..
T Consensus 23 ~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~-~~~~~~lv~Ey~~-~g~L~~~l~~ 96 (276)
T d1uwha_ 23 TVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLR-KTRHVNILLFMGYS-TAPQLAIVTQWCE-GSSLYHHLHI 96 (276)
T ss_dssp EEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHT-TCCCTTBCCEEEEE-CSSSCEEEEECCC-EEEHHHHHHT
T ss_pred EEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHH-hCCCCCEeeeeEEE-eccEEEEEEecCC-CCCHHHHHhh
Confidence 58999753 4699999975 2356889999999 77999999999986 4567899999999 9999997643
Q ss_pred C-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC---cccccccCCCCcC
Q psy6377 79 N-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG---IEIRELLGTPDYV 148 (383)
Q Consensus 79 ~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~y~ 148 (383)
. .+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....+..||+.|+
T Consensus 97 ~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 173 (276)
T d1uwha_ 97 IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173 (276)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---SSEEECCCCCSCC------------CCCCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC---CCEEEccccceeeccccCCcccccccccCcccC
Confidence 2 234566999999999999999999999999999876 68999999999865432 2244568999999
Q ss_pred CCccccc---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--cchhcCCCHHHHHHHHHhcccC
Q psy6377 149 APEILHY---EPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNISKAQLDFP--DELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 149 aPE~l~~---~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~d 223 (383)
|||++.+ .+|+.++|||||||++|||++|+.||.+.+....+..+.......| .....++++++.+||.+||..|
T Consensus 174 APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~d 253 (276)
T d1uwha_ 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253 (276)
T ss_dssp CHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSS
T ss_pred CHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCC
Confidence 9999864 3589999999999999999999999998877666555544433333 3445678999999999999999
Q ss_pred CCCCCCHHHHHcC
Q psy6377 224 PMERMTAKEALKH 236 (383)
Q Consensus 224 P~~Rpt~~e~L~h 236 (383)
|++|||++|++++
T Consensus 254 p~~RPt~~~il~~ 266 (276)
T d1uwha_ 254 RDERPLFPQILAS 266 (276)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=354.88 Aligned_cols=233 Identities=24% Similarity=0.334 Sum_probs=194.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc
Q psy6377 5 SEEMADSIATGEVFAAKFLES------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~ 78 (383)
.||+|+++.+|+.||||+++. ...++.+|+.+++ .++||||++++++|.+....+++++++. |++|..++..
T Consensus 17 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~iv~~~~~-~~~l~~~~~~ 94 (292)
T d1unla_ 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSC 94 (292)
T ss_dssp EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEECCS-EEHHHHHHHT
T ss_pred EEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHH-hcCcCCEEeeccccccccceeEEeeecc-cccccccccc
Confidence 699999999999999999865 1357789999999 7899999999999999999999999999 8888886543
Q ss_pred ------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-cccccCCCCcCCCc
Q psy6377 79 ------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-IRELLGTPDYVAPE 151 (383)
Q Consensus 79 ------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~y~aPE 151 (383)
..+..+..|++.||+|||++||+||||||+|||++.+ +.+||+|||.|+....... .....+++.|+|||
T Consensus 95 ~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe 171 (292)
T d1unla_ 95 NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171 (292)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHH
T ss_pred ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---CceeeeecchhhcccCCCccceeeccccchhhhh
Confidence 3345677999999999999999999999999999765 5899999999998754433 34456788999999
Q ss_pred ccccCC-CChhhHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHhccCCCC-------------------------cch
Q psy6377 152 ILHYEP-ITLAADMWSLGVTAYVLLTGFSPF-GGETDSETFRNISKAQLDFP-------------------------DEL 204 (383)
Q Consensus 152 ~l~~~~-~~~~~DiwSlGvilyelltg~~Pf-~~~~~~~~~~~i~~~~~~~~-------------------------~~~ 204 (383)
++.... ++.++||||+||++|+|++|+.|| .+.+..+.+..+.......+ ...
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence 987655 699999999999999999998875 55555666666544322221 112
Q ss_pred hcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 205 FEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 205 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
...+++.+.+||++||++||.+||||+|+|+||||++.
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 34568899999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=349.66 Aligned_cols=223 Identities=20% Similarity=0.297 Sum_probs=179.6
Q ss_pred eEEEEEEcCCC---cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh
Q psy6377 5 SEEMADSIATG---EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII 76 (383)
Q Consensus 5 ~V~~~~~~~tg---~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l 76 (383)
.||+|++..++ ..||||.+.. ....+.+|+.+++ .++|||||++++++. ++.+|+||||+. +|+|.+++
T Consensus 22 ~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~-~~~~~iv~E~~~-~g~l~~~~ 98 (273)
T d1mp8a_ 22 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-ENPVWIIMELCT-LGELRSFL 98 (273)
T ss_dssp EEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-SSSCEEEEECCT-TEEHHHHH
T ss_pred EEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEe-cCeEEEEEEecc-CCcHHhhh
Confidence 58999987654 4689999875 2456889999999 779999999999995 567899999999 99998864
Q ss_pred cc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCc
Q psy6377 77 DD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDY 147 (383)
Q Consensus 77 ~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y 147 (383)
.. ..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+|+....... .....||+.|
T Consensus 99 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~---~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y 175 (273)
T d1mp8a_ 99 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175 (273)
T ss_dssp HHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECC-------------------CCGGG
T ss_pred hccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC---CcEEEccchhheeccCCcceeccceecCccc
Confidence 32 2345666999999999999999999999999999876 5899999999987643322 3345789999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPME 226 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 226 (383)
+|||++.+.+|+.++|||||||++|+|++ |.+||.+.+..+....+..+... +.++++|+++.+||.+||..||++
T Consensus 176 ~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp CCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred chhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhH
Confidence 99999999999999999999999999998 89999999999998888776532 234678999999999999999999
Q ss_pred CCCHHHHHcC
Q psy6377 227 RMTAKEALKH 236 (383)
Q Consensus 227 Rpt~~e~L~h 236 (383)
|||+.|+++|
T Consensus 253 Rps~~ei~~~ 262 (273)
T d1mp8a_ 253 RPRFTELKAQ 262 (273)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=349.60 Aligned_cols=223 Identities=18% Similarity=0.235 Sum_probs=178.9
Q ss_pred eEEEEEEcCCC----cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATG----EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg----~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|..+.++ ..||||++.. ....+.+|+.+++ .++|||||++++++.+.+..++|||++. ++++.+.
T Consensus 22 ~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~-~l~H~nIv~~~g~~~~~~~~~~v~e~~~-~~~l~~~ 99 (283)
T d1mqba_ 22 EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG-QFSHHNIIRLEGVISKYKPMMIITEYME-NGALDKF 99 (283)
T ss_dssp EEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSEEEEEECCT-TEEHHHH
T ss_pred EEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHH-hcCCCCEeeeeEEEecCCceEEEEEecc-cCcchhh
Confidence 59999988766 4799999876 2346889999999 7789999999999999999999999999 8998885
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccCC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLGT 144 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~gt 144 (383)
+... .+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||
T Consensus 100 ~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 176 (283)
T d1mqba_ 100 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176 (283)
T ss_dssp HHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC-----------------CCC
T ss_pred hhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC---CeEEEcccchhhcccCCCccceEeccCCCC
Confidence 4332 244666999999999999999999999999999876 6899999999987644321 2235689
Q ss_pred CCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccC
Q psy6377 145 PDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 145 ~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+..+.... ....++.++.+||.+||..|
T Consensus 177 ~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQE 253 (283)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCSS
T ss_pred ccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC---CchhhHHHHHHHHHHHCcCC
Confidence 99999999999999999999999999999998 456666677777777766553222 23468999999999999999
Q ss_pred CCCCCCHHHHHc
Q psy6377 224 PMERMTAKEALK 235 (383)
Q Consensus 224 P~~Rpt~~e~L~ 235 (383)
|++|||+.|+++
T Consensus 254 p~~RPt~~eil~ 265 (283)
T d1mqba_ 254 RARRPKFADIVS 265 (283)
T ss_dssp TTTSCCHHHHHH
T ss_pred HhHCcCHHHHHH
Confidence 999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=353.65 Aligned_cols=225 Identities=20% Similarity=0.245 Sum_probs=190.3
Q ss_pred eEEEEEEcCCCcE--EEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc
Q psy6377 5 SEEMADSIATGEV--FAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~--vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~ 77 (383)
.||+|+++.+|.. ||||.+.. ..+.+.+|+++|+.+.+|||||++++++.+++..|+||||++ ||+|.+++.
T Consensus 25 ~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~-~g~L~~~l~ 103 (309)
T d1fvra_ 25 QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP-HGNLLDFLR 103 (309)
T ss_dssp EEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT-TCBHHHHHH
T ss_pred EEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC-CCcHHHHHh
Confidence 5899999999875 67777754 356789999999955589999999999999999999999999 999999774
Q ss_pred cC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 78 DN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 78 ~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
.. .++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~---~~~kl~DfG~a~~~~~~ 180 (309)
T d1fvra_ 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVY 180 (309)
T ss_dssp TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEESSCEE
T ss_pred hccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC---CceEEcccccccccccc
Confidence 32 234566999999999999999999999999999876 68999999999876544
Q ss_pred cccccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHH
Q psy6377 136 IEIRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKD 214 (383)
Q Consensus 136 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 214 (383)
.......||+.|+|||.+.+..|+.++|||||||++|+|++| .+||.+.+..+....+..+.. .+.+..+++++++
T Consensus 181 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~ 257 (309)
T d1fvra_ 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCDDEVYD 257 (309)
T ss_dssp CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---CCCCTTBCHHHHH
T ss_pred ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CCCCccCCHHHHH
Confidence 444556799999999999999999999999999999999996 578999988888888776532 2233578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHcC
Q psy6377 215 FIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 215 li~~~L~~dP~~Rpt~~e~L~h 236 (383)
||.+||..||++|||++++++|
T Consensus 258 li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 258 LMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=348.72 Aligned_cols=228 Identities=21% Similarity=0.276 Sum_probs=186.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIID---- 77 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~---- 77 (383)
.||+|+++.+ +.||||++.. ..+.+.+|+.+++ .++|||||++++++. ++..|+||||++ +|+|..++.
T Consensus 32 ~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~g~~~-~~~~~lv~Ey~~-~g~l~~~~~~~~~ 107 (285)
T d1fmka3 32 EVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQLYAVVS-EEPIYIVTEYMS-KGSLLDFLKGETG 107 (285)
T ss_dssp EEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSCEEEECCCT-TCBHHHHHSHHHH
T ss_pred EEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHH-hcccCCEeEEEEEEe-cCCeEEEEEecC-CCchhhhhhhccc
Confidence 5899998755 5699999977 4567999999999 789999999999985 466899999999 999888543
Q ss_pred ----cCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc--cccccCCCCcCCCc
Q psy6377 78 ----DNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE--IRELLGTPDYVAPE 151 (383)
Q Consensus 78 ----~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~y~aPE 151 (383)
...++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+.|+|||
T Consensus 108 ~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~---~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 108 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184 (285)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC--------------CCGGGSCHH
T ss_pred ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC---CcEEEcccchhhhccCCCceeeccccccccccChH
Confidence 33456777999999999999999999999999999876 6899999999987644332 33467999999999
Q ss_pred ccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCH
Q psy6377 152 ILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTA 230 (383)
Q Consensus 152 ~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 230 (383)
++....++.++|||||||++|+|++ |.+||.+....+.+..+..+... +....+++++++||.+||..||++|||+
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~ 261 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTF 261 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCcccCHHHHHHHHHHcccCHhHCcCH
Confidence 9999999999999999999999999 56667777777777777655321 2345789999999999999999999999
Q ss_pred HHHHc--CcccCCc
Q psy6377 231 KEALK--HPWLMNK 242 (383)
Q Consensus 231 ~e~L~--hp~~~~~ 242 (383)
+++++ ++||...
T Consensus 262 ~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 262 EYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTTTSCS
T ss_pred HHHHHHHhhhhcCC
Confidence 99987 8888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=351.81 Aligned_cols=226 Identities=20% Similarity=0.284 Sum_probs=178.6
Q ss_pred eEEEEEEcC-----CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeC-CeEEEEEecCCCcCcHH
Q psy6377 5 SEEMADSIA-----TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTG-EGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 5 ~V~~~~~~~-----tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~-~~~~lv~e~~~~g~~L~ 73 (383)
.||+|++.. +++.||||++.. ....+.+|+.++.++..||||+.+++++.+. ..+++||||++ +|+|.
T Consensus 28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~-~g~L~ 106 (299)
T d1ywna1 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK-FGNLS 106 (299)
T ss_dssp EEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCT-TCBHH
T ss_pred EEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecC-CCcHH
Confidence 589998754 457899999976 2456778888888788899999999998654 46899999999 99999
Q ss_pred Hhhcc----------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 74 TIIDD----------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 74 ~~l~~----------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
+++.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 107 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~---~~~Kl~DFGla~~ 183 (299)
T d1ywna1 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARD 183 (299)
T ss_dssp HHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECC------
T ss_pred HHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC---CcEEEccCcchhh
Confidence 97643 2245667999999999999999999999999999876 6899999999987
Q ss_pred eecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcC
Q psy6377 132 ILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFED 207 (383)
Q Consensus 132 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 207 (383)
...... ....+||+.|+|||++.+..|+.++|||||||++|+|++| .+||.+....+.+..+......+ ..+..
T Consensus 184 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 261 (299)
T d1ywna1 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDY 261 (299)
T ss_dssp CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTT
T ss_pred ccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--CCCcc
Confidence 544322 3346799999999999999999999999999999999986 67898877655554443332222 23356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 208 ISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 208 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
+++++.+||.+||..||++|||++|+++|
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 262 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=351.31 Aligned_cols=224 Identities=19% Similarity=0.233 Sum_probs=183.8
Q ss_pred eEEEEEEcCCCc----EEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATGE----VFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg~----~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+++.+|+ .||+|.+.. ....+.+|+.+++ .++|||||++++++.++ ..+++++++. +++|.+.
T Consensus 24 ~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~-~~~~v~e~~~-~~~l~~~ 100 (317)
T d1xkka_ 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTS-TVQLITQLMP-FGCLLDY 100 (317)
T ss_dssp EEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHH-HCCCTTBCCEEEEEESS-SEEEEEECCT-TCBHHHH
T ss_pred EEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecC-CeeEEEEecc-CCccccc
Confidence 689999999987 578887765 3457899999999 67899999999999864 5678889998 8888885
Q ss_pred hcc-------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc---cccccCCC
Q psy6377 76 IDD-------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE---IRELLGTP 145 (383)
Q Consensus 76 l~~-------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~ 145 (383)
+.. ..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....... .....||+
T Consensus 101 ~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177 (317)
T ss_dssp HHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCCSHHHHTTTTCC--------CCT
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC---CCeEeeccccceecccccccccccccccCc
Confidence 432 2345677999999999999999999999999999876 6899999999987644322 23346899
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCC
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNP 224 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 224 (383)
.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+..+.... .+..+++++.+||.+||..||
T Consensus 178 ~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP 254 (317)
T d1xkka_ 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDA 254 (317)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBCHHHHHHHHHHTCSSG
T ss_pred cccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHhCCCCh
Confidence 9999999999999999999999999999998 899999988888877777654322 224679999999999999999
Q ss_pred CCCCCHHHHHcCc
Q psy6377 225 MERMTAKEALKHP 237 (383)
Q Consensus 225 ~~Rpt~~e~L~hp 237 (383)
++|||+.|++.|.
T Consensus 255 ~~RPs~~eil~~l 267 (317)
T d1xkka_ 255 DSRPKFRELIIEF 267 (317)
T ss_dssp GGSCCHHHHHHHH
T ss_pred hhCcCHHHHHHHH
Confidence 9999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-45 Score=346.05 Aligned_cols=223 Identities=20% Similarity=0.252 Sum_probs=191.1
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+.+ .+++.||||++.. ....+.+|+.+++ .++||||+++++++.+.+..+++||++. +|+|.+
T Consensus 28 ~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~~v~e~~~-~g~L~~ 105 (301)
T d1lufa_ 28 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA-EFDNPNIVKLLGVCAVGKPMCLLFEYMA-YGDLNE 105 (301)
T ss_dssp EEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSCEEEEECCT-TCBHHH
T ss_pred EEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHH-hcCCCCcccceeeeccCCceEEEEEecC-CCcHHH
Confidence 58999876 4678999999976 2456899999999 7799999999999999999999999999 999999
Q ss_pred hhcc------------------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEE
Q psy6377 75 IIDD------------------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVC 124 (383)
Q Consensus 75 ~l~~------------------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~ 124 (383)
++.. ..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~---~~~Kl~ 182 (301)
T d1lufa_ 106 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN---MVVKIA 182 (301)
T ss_dssp HHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEEC
T ss_pred HHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCC---CcEEEc
Confidence 7632 1245667999999999999999999999999999876 689999
Q ss_pred eccceeEeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCC
Q psy6377 125 DFEISRVILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDF 200 (383)
Q Consensus 125 DFGla~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~ 200 (383)
|||+|+...+... ..+..||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+....+..+....
T Consensus 183 DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~ 262 (301)
T d1lufa_ 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 262 (301)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999986543322 3346789999999999999999999999999999999998 47899999999988888766432
Q ss_pred CcchhcCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 201 PDELFEDISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 201 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+..+++++.+||.+||..||++|||+.|+++
T Consensus 263 ---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 263 ---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33578999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=343.92 Aligned_cols=224 Identities=21% Similarity=0.276 Sum_probs=191.2
Q ss_pred eEEEEEEcCCC-------cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATG-------EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg-------~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||+|++..++ ..||||++.+ ....+.+|...+.++.+|||||++++++.+++..|+||||+. +|+|
T Consensus 28 ~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~-~g~l 106 (299)
T d1fgka_ 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS-KGNL 106 (299)
T ss_dssp CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCT-TCBH
T ss_pred EEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccC-CCcH
Confidence 68999987665 4799999977 235677888888867799999999999999999999999999 9999
Q ss_pred HHhhccC----------------------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 73 QTIIDDN----------------------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 73 ~~~l~~~----------------------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
.+++... .++.+..||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~---~~~kl~dfg~~~ 183 (299)
T d1fgka_ 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLAR 183 (299)
T ss_dssp HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECSTTCCC
T ss_pred HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC---CCeEeccchhhc
Confidence 9976322 245677999999999999999999999999999876 689999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... .....||+.|+|||++.+.+|+.++|||||||++|+|++ |.+||.+.+..+.+..+..+... ..+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~p~ 260 (299)
T d1fgka_ 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKPS 260 (299)
T ss_dssp CGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC---CCCS
T ss_pred cccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCC---CCCc
Confidence 7654322 234678999999999999999999999999999999998 79999999888888777665322 2235
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+++++.+||.+||..||++|||+.|+++
T Consensus 261 ~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 261 NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=337.81 Aligned_cols=220 Identities=17% Similarity=0.257 Sum_probs=180.7
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEE-eCCeEEEEEecCCCcCcHHHhhcc---
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQ-TGEGAYYVSWNTPLVVTLQTIIDD--- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~-~~~~~~lv~e~~~~g~~L~~~l~~--- 78 (383)
.||+|+. +|+.||||++++ ..+.+.+|+++++ .++||||+++++++. +.+.+|+||||++ +|+|.+++..
T Consensus 22 ~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~~lv~ey~~-~g~L~~~l~~~~~ 97 (262)
T d1byga_ 22 DVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGGLYIVTEYMA-KGSLVDYLRSRGR 97 (262)
T ss_dssp EEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHT-TCCCTTBCCEEEEECCC--CCEEEECCCT-TEEHHHHHHHHHH
T ss_pred EEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEecCCcEEEEEeccC-CCCHHHHHHhcCC
Confidence 5899987 478999999987 4677999999999 679999999999885 4566899999999 9999997633
Q ss_pred -----CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccccCCCCcCCCccc
Q psy6377 79 -----NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIRELLGTPDYVAPEIL 153 (383)
Q Consensus 79 -----~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~y~aPE~l 153 (383)
..++.++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+++.... ......+|+.|+|||++
T Consensus 98 ~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~---~~~kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEAL 172 (262)
T ss_dssp HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC--------------CCTTTSCHHHH
T ss_pred CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC---CCEeecccccceecCC--CCccccccccCCChHHH
Confidence 3355677999999999999999999999999999876 6899999999987543 23445789999999999
Q ss_pred ccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6377 154 HYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIKNPMERMTAKE 232 (383)
Q Consensus 154 ~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 232 (383)
.+..++.++|||||||++|||++ |.+||.+.+..+....+..+... +....+++++.+||++||..||.+|||+.+
T Consensus 173 ~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999999999999999999998 89999999888888888765322 223467999999999999999999999999
Q ss_pred HHcC
Q psy6377 233 ALKH 236 (383)
Q Consensus 233 ~L~h 236 (383)
++++
T Consensus 250 l~~~ 253 (262)
T d1byga_ 250 LREQ 253 (262)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=340.21 Aligned_cols=223 Identities=20% Similarity=0.268 Sum_probs=183.5
Q ss_pred eEEEEEEcCC-C--cEEEEEEccC-------CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSIAT-G--EVFAAKFLES-------NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~~t-g--~~vAvK~i~~-------~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+...+ + ..||||++.+ ....+.+|+.+++ .++|||||++++++.+ ...++||||+. ++++.+
T Consensus 23 ~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~~~g~~~~-~~~~lv~e~~~-~~~l~~ 99 (273)
T d1u46a_ 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVLT-PPMKMVTELAP-LGSLLD 99 (273)
T ss_dssp CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SSCEEEEECCT-TCBHHH
T ss_pred EEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEee-cchheeeeeec-Ccchhh
Confidence 4899986533 3 3689999876 1356899999999 6799999999999975 57889999999 889887
Q ss_pred hh-------ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc----cccccC
Q psy6377 75 II-------DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----IRELLG 143 (383)
Q Consensus 75 ~l-------~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----~~~~~g 143 (383)
.+ +...++.+..||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....... .....|
T Consensus 100 ~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~---~~vkl~DfGl~~~~~~~~~~~~~~~~~~~ 176 (273)
T d1u46a_ 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKV 176 (273)
T ss_dssp HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred hhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc---cceeeccchhhhhcccCCCcceecCcccc
Confidence 43 233455677999999999999999999999999999886 5899999999998644322 223467
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......++ .+..+|+++.+||.+||..
T Consensus 177 ~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAH 254 (273)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCS
T ss_pred CcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCC
Confidence 889999999999999999999999999999998 8999999999999888877655443 3467899999999999999
Q ss_pred CCCCCCCHHHHHc
Q psy6377 223 NPMERMTAKEALK 235 (383)
Q Consensus 223 dP~~Rpt~~e~L~ 235 (383)
||++|||++++++
T Consensus 255 dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 255 KPEDRPTFVALRD 267 (273)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-44 Score=338.51 Aligned_cols=234 Identities=17% Similarity=0.175 Sum_probs=185.4
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh------
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII------ 76 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l------ 76 (383)
.||+|+++.+|+.||||++.. ....+.+|+++++.+..|++|+.+++++.+++..++|||++. ++|...+
T Consensus 22 ~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~--~~l~~~~~~~~~~ 99 (299)
T d1ckia_ 22 DIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG--PSLEDLFNFCSRK 99 (299)
T ss_dssp EEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC--CBHHHHHHHTTTC
T ss_pred EEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC--CchhhhhhhccCC
Confidence 689999999999999999876 567899999999955556667777788889999999999996 5565532
Q ss_pred -ccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCc--------ccccccCCCCc
Q psy6377 77 -DDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGI--------EIRELLGTPDY 147 (383)
Q Consensus 77 -~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~--------~~~~~~gt~~y 147 (383)
+...+..++.|++.||+|||++||+||||||+|||++..+....++|+|||+|+...... .....+||+.|
T Consensus 100 ~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y 179 (299)
T d1ckia_ 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSS
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccc
Confidence 223455677999999999999999999999999998765555689999999999875432 12345799999
Q ss_pred CCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCC-CcchhcCCCHHHHHHHHHhcccC
Q psy6377 148 VAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDSETFRNI---SKAQLDF-PDELFEDISPEAKDFIAKILIKN 223 (383)
Q Consensus 148 ~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~i---~~~~~~~-~~~~~~~~s~~~~~li~~~L~~d 223 (383)
+|||++.+.+|+.++|||||||++|+|++|.+||.+.........+ ....... ++....++|+++.+||.+||..|
T Consensus 180 ~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~ 259 (299)
T d1ckia_ 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259 (299)
T ss_dssp CCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSC
T ss_pred cCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999999999999876654433322 2222222 23455688999999999999999
Q ss_pred CCCCCCHHH---HHcCcccC
Q psy6377 224 PMERMTAKE---ALKHPWLM 240 (383)
Q Consensus 224 P~~Rpt~~e---~L~hp~~~ 240 (383)
|++||++++ +|+|+|..
T Consensus 260 p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 260 FDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTCCCCHHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHHHH
Confidence 999999874 56777653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=342.95 Aligned_cols=225 Identities=20% Similarity=0.298 Sum_probs=189.5
Q ss_pred eEEEEEEc-----CCCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHH
Q psy6377 5 SEEMADSI-----ATGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQT 74 (383)
Q Consensus 5 ~V~~~~~~-----~tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~ 74 (383)
.||+|+.+ .+++.||||++.. ....+.+|+.+++.+.+|||||++++++.+.+..|+||||++ +|+|.+
T Consensus 38 ~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~-~g~l~~ 116 (311)
T d1t46a_ 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC-YGDLLN 116 (311)
T ss_dssp EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT-TEEHHH
T ss_pred EEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCC-CCCHHH
Confidence 58999863 5778999999976 344688999999966689999999999999999999999999 999999
Q ss_pred hhcc------------------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEecccee
Q psy6377 75 IIDD------------------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISR 130 (383)
Q Consensus 75 ~l~~------------------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~ 130 (383)
++.. ..+..+..||+.||+|||++||+||||||+|||++.+ +.++++|||+++
T Consensus 117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~---~~~ki~DfG~~~ 193 (311)
T d1t46a_ 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLAR 193 (311)
T ss_dssp HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT---TEEEECCCGGGS
T ss_pred HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc---Ccccccccchhe
Confidence 7643 2344566999999999999999999999999999865 689999999998
Q ss_pred EeecCcc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCcchhc
Q psy6377 131 VILDGIE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLT-GFSPFGGETDSETFRNISKAQLDFPDELFE 206 (383)
Q Consensus 131 ~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 206 (383)
....... ....+||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+.++......++ ...
T Consensus 194 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~--~~~ 271 (311)
T d1t46a_ 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPE 271 (311)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC--CCT
T ss_pred eccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--Ccc
Confidence 7643322 234578999999999999999999999999999999998 7788888777777666655443332 234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 207 DISPEAKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 207 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
.+++++.+||.+||.+||++|||++++++
T Consensus 272 ~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67999999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=341.98 Aligned_cols=225 Identities=18% Similarity=0.238 Sum_probs=192.0
Q ss_pred ccceEEEEEEcC-----CCcEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 2 FALSEEMADSIA-----TGEVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 2 f~~~V~~~~~~~-----tg~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
|| .||+|.++. +++.||||++.. ....+.+|+.+++ .++|||||++++++..+...++|||++. +|+
T Consensus 33 fG-~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~lv~e~~~-~g~ 109 (308)
T d1p4oa_ 33 FG-MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQGQPTLVIMELMT-RGD 109 (308)
T ss_dssp SS-EEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGG-GCCCTTBCCEEEEECSSSSCEEEEECCT-TCB
T ss_pred Ce-EEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHH-HcCCCCEeeeeeEEecCCceeEEEeecC-CCC
Confidence 45 489998863 467899999976 2345789999999 7789999999999999999999999999 999
Q ss_pred HHHhhcc----------------CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecC
Q psy6377 72 LQTIIDD----------------NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDG 135 (383)
Q Consensus 72 L~~~l~~----------------~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~ 135 (383)
|.+++.. ..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 110 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~---~~~Kl~DFGla~~~~~~ 186 (308)
T d1p4oa_ 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYET 186 (308)
T ss_dssp HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT---CCEEECCTTCCCGGGGG
T ss_pred HHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC---ceEEEeecccceeccCC
Confidence 9997532 1244677999999999999999999999999999866 68999999999865443
Q ss_pred cc---cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCCCCcchhcCCCHH
Q psy6377 136 IE---IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTG-FSPFGGETDSETFRNISKAQLDFPDELFEDISPE 211 (383)
Q Consensus 136 ~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 211 (383)
.. .....||+.|+|||.+.+..++.++|||||||++|+|++| .+||.+.+..+.+..+..+..... ...+++.
T Consensus 187 ~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~ 263 (308)
T d1p4oa_ 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK---PDNCPDM 263 (308)
T ss_dssp GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred cceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC---cccchHH
Confidence 22 2334689999999999999999999999999999999997 689999999998888877654322 2467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6377 212 AKDFIAKILIKNPMERMTAKEALK 235 (383)
Q Consensus 212 ~~~li~~~L~~dP~~Rpt~~e~L~ 235 (383)
+.++|.+||..||++|||++++++
T Consensus 264 l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 264 LFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=332.34 Aligned_cols=224 Identities=17% Similarity=0.153 Sum_probs=180.3
Q ss_pred eEEEEEEcCCC---cEEEEEEccC-----CcccHHHHHHHHHhcCCCCCcccceEEEEe-CCeEEEEEecCCCcCcHHHh
Q psy6377 5 SEEMADSIATG---EVFAAKFLES-----NPVRIHHEIALLSLCSPSPRIVKLHDVFQT-GEGAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 5 ~V~~~~~~~tg---~~vAvK~i~~-----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~-~~~~~lv~e~~~~g~~L~~~ 75 (383)
.||+|+...++ ..||||.+.+ ....+.+|+++++ .++||||+++++++.+ +...++||||+. +++|.++
T Consensus 42 ~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~~lv~E~~~-~g~l~~~ 119 (311)
T d1r0pa_ 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGSPLVVLPYMK-HGDLRNF 119 (311)
T ss_dssp EEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEETTTEEEEEEECCT-TCBHHHH
T ss_pred EEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHH-hCCCCCEeEEeEEEEecCCceEEEEEEee-cCchhhh
Confidence 58999987654 3699999975 3467899999999 7789999999999765 568999999999 9999997
Q ss_pred hccC-------CchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----cccccC
Q psy6377 76 IDDN-------LVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE-----IRELLG 143 (383)
Q Consensus 76 l~~~-------~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~-----~~~~~g 143 (383)
+... .++.++.|++.||.|||+.||+||||||+|||++++ +.+||+|||+++....... .....|
T Consensus 120 ~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~---~~~kL~DFG~~~~~~~~~~~~~~~~~~~~g 196 (311)
T d1r0pa_ 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196 (311)
T ss_dssp HHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECSSGGGCCTTTTTCCCTTCTTCSSC
T ss_pred hccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC---CCEEEecccchhhccccccccceecccccc
Confidence 6532 234667999999999999999999999999999765 6899999999987543322 223568
Q ss_pred CCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHhccCCCCcchhcCCCHHHHHHHHHhccc
Q psy6377 144 TPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFG-GETDSETFRNISKAQLDFPDELFEDISPEAKDFIAKILIK 222 (383)
Q Consensus 144 t~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 222 (383)
|+.|+|||.+....++.++||||||+++|||++|..||. ..+..+....+..+.... ....+++++.+||.+||..
T Consensus 197 t~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~~~l~~li~~cl~~ 273 (311)
T d1r0pa_ 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHP 273 (311)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCS
T ss_pred cccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccCcHHHHHHHHHHcCC
Confidence 999999999999999999999999999999999666654 444455666666554332 2246799999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6377 223 NPMERMTAKEALKH 236 (383)
Q Consensus 223 dP~~Rpt~~e~L~h 236 (383)
||++|||+.|+++|
T Consensus 274 dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 274 KAEMRPSFSELVSR 287 (311)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-42 Score=324.68 Aligned_cols=229 Identities=17% Similarity=0.147 Sum_probs=188.5
Q ss_pred eEEEEEEcCCCcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhhcc----
Q psy6377 5 SEEMADSIATGEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDD---- 78 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~---- 78 (383)
.||+|+++.+|+.||||+++. +...+.+|+++++.+.+|+||+.+++++.++...|+|||++ |++|.+++..
T Consensus 20 ~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~--~~~l~~~~~~~~~~ 97 (293)
T d1csna_ 20 VIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK 97 (293)
T ss_dssp EEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC--CCBHHHHHHHTTTC
T ss_pred EEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec--CCCHHHHHHhhccc
Confidence 699999999999999999876 56778999999996667799999999999999999999998 4888886543
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccC--CCCcEEEEeccceeEeecCc--------ccccccCCC
Q psy6377 79 ---NLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDF--PNCDIKVCDFEISRVILDGI--------EIRELLGTP 145 (383)
Q Consensus 79 ---~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~--~~~~ikL~DFGla~~~~~~~--------~~~~~~gt~ 145 (383)
.....++.|++.||+|||++||+||||||+|||++.+. ..+.+||+|||+|+...... .....+||+
T Consensus 98 ~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred hhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence 22445669999999999999999999999999997532 24689999999999864321 233467999
Q ss_pred CcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccC-CCCcchhcCCCHHHHHHHHHhcc
Q psy6377 146 DYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS---ETFRNISKAQL-DFPDELFEDISPEAKDFIAKILI 221 (383)
Q Consensus 146 ~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~ 221 (383)
.|+|||++.+.+++.++|||||||++|+|++|..||.+.... +....+..... ..+.....++|+++.+++..|+.
T Consensus 178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~ 257 (293)
T d1csna_ 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN 257 (293)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred hhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhc
Confidence 999999999999999999999999999999999999876543 33333333322 23344557789999999999999
Q ss_pred cCCCCCCCHHHHHc
Q psy6377 222 KNPMERMTAKEALK 235 (383)
Q Consensus 222 ~dP~~Rpt~~e~L~ 235 (383)
.+|++||+++.+.+
T Consensus 258 ~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 258 LAFDATPDYDYLQG 271 (293)
T ss_dssp CCTTCCCCHHHHHH
T ss_pred CCcccCcCHHHHHH
Confidence 99999999876643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=322.65 Aligned_cols=228 Identities=19% Similarity=0.219 Sum_probs=172.0
Q ss_pred ccceEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHh-cCCCCCcccceEEEEeCC----eEEEEEecCCCcCcHHHh
Q psy6377 2 FALSEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSL-CSPSPRIVKLHDVFQTGE----GAYYVSWNTPLVVTLQTI 75 (383)
Q Consensus 2 f~~~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~-~~~hpnIvkl~~~~~~~~----~~~lv~e~~~~g~~L~~~ 75 (383)
|| .||+|+. +|+.||||++.. ......+|.+++.. ..+|||||++++++.+.+ .+|+||||++ +|+|.++
T Consensus 16 fg-~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~-~g~L~~~ 91 (303)
T d1vjya_ 16 FG-EVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE-HGSLFDY 91 (303)
T ss_dssp SS-EEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT-TCBHHHH
T ss_pred Ce-EEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc-CCCHHHH
Confidence 45 6899985 699999999976 33445556665542 468999999999998654 5899999999 9999998
Q ss_pred hccCC-----chhhHHHHHHHHHHHHh--------CCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcc-----
Q psy6377 76 IDDNL-----VVPFESDELSSLAYLHH--------RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIE----- 137 (383)
Q Consensus 76 l~~~~-----~~~~~~qil~aL~yLHs--------~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~----- 137 (383)
+.+.. .+.+..|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 92 l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~---~~~Kl~DFGl~~~~~~~~~~~~~~ 168 (303)
T d1vjya_ 92 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDIA 168 (303)
T ss_dssp HHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT---SCEEECCCTTCEEEETTTTEECC-
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC---CCeEEEecCccccccCCCcceecc
Confidence 86543 34677999999999996 599999999999999766 6999999999998765432
Q ss_pred cccccCCCCcCCCcccccCC------CChhhHHHHHHHHHHHHHhCCCCCCCCC--------------cHHHHHH-HHhc
Q psy6377 138 IRELLGTPDYVAPEILHYEP------ITLAADMWSLGVTAYVLLTGFSPFGGET--------------DSETFRN-ISKA 196 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvilyelltg~~Pf~~~~--------------~~~~~~~-i~~~ 196 (383)
....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.... ..+.... +...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T d1vjya_ 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248 (303)
T ss_dssp ---CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS
T ss_pred ccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcc
Confidence 23468999999999987543 5788999999999999999988874322 1122222 2222
Q ss_pred cC--CCCcchh-cCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6377 197 QL--DFPDELF-EDISPEAKDFIAKILIKNPMERMTAKEALKH 236 (383)
Q Consensus 197 ~~--~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 236 (383)
.. .+|.... ......+.+|+.+||..||++|||+.|++++
T Consensus 249 ~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22 2222211 1123468999999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-41 Score=327.53 Aligned_cols=236 Identities=26% Similarity=0.357 Sum_probs=175.8
Q ss_pred eEEEEEEcCCCcEEEEEEccCC---cccHHHHHHHHHhcC----------CCCCcccceEEEEe--CCeEEEEEecCCCc
Q psy6377 5 SEEMADSIATGEVFAAKFLESN---PVRIHHEIALLSLCS----------PSPRIVKLHDVFQT--GEGAYYVSWNTPLV 69 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~~---~~~~~~Ei~il~~~~----------~hpnIvkl~~~~~~--~~~~~lv~e~~~~g 69 (383)
.||+|+++.+|+.||||++.++ ...+.+|+.+++.+. +||||+++++++.. ....+++++++..+
T Consensus 28 ~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 107 (362)
T d1q8ya_ 28 TVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG 107 (362)
T ss_dssp EEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCC
T ss_pred EEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccc
Confidence 5999999999999999999873 356788998887432 47899999999864 45667777776633
Q ss_pred CcHHHhh--------ccCCchhhHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCC---CcEEEEeccceeEeecCcc
Q psy6377 70 VTLQTII--------DDNLVVPFESDELSSLAYLHH-RKIAHLDIKPQNLVMMGDFPN---CDIKVCDFEISRVILDGIE 137 (383)
Q Consensus 70 ~~L~~~l--------~~~~~~~~~~qil~aL~yLHs-~givHrDLKp~NILl~~~~~~---~~ikL~DFGla~~~~~~~~ 137 (383)
+...... ....+..+..||+.||+|||+ .||+||||||+|||++.++.. ..++++|||.|..... .
T Consensus 108 ~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~ 185 (362)
T d1q8ya_ 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--H 185 (362)
T ss_dssp EEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--C
T ss_pred cccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--c
Confidence 3333321 122345677999999999998 899999999999999765321 2589999999986532 3
Q ss_pred cccccCCCCcCCCcccccCCCChhhHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCc---------
Q psy6377 138 IRELLGTPDYVAPEILHYEPITLAADMWSLGVTAYVLLTGFSPFGGETDS------ETFRNISKAQLDFPD--------- 202 (383)
Q Consensus 138 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~i~~~~~~~~~--------- 202 (383)
....+||+.|+|||++.+.+|+.++|+||+||++++|++|+.||.+.... +............|.
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~ 265 (362)
T d1q8ya_ 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT 265 (362)
T ss_dssp CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH
T ss_pred cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccc
Confidence 45578999999999999999999999999999999999999999765421 111111111111110
Q ss_pred -----------------------------chhcCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccCCc
Q psy6377 203 -----------------------------ELFEDISPEAKDFIAKILIKNPMERMTAKEALKHPWLMNK 242 (383)
Q Consensus 203 -----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp~~~~~ 242 (383)
..+...++++++||.+||.+||.+||||+|+|+||||++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 266 RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 0112346789999999999999999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=2.7e-20 Score=163.63 Aligned_cols=147 Identities=15% Similarity=0.008 Sum_probs=106.5
Q ss_pred ceEEEEEEcCCCcEEEEEEccCC----------------------cccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEE
Q psy6377 4 LSEEMADSIATGEVFAAKFLESN----------------------PVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYY 61 (383)
Q Consensus 4 ~~V~~~~~~~tg~~vAvK~i~~~----------------------~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~l 61 (383)
..||+|++ .+|+.||||++... .....+|...+. .+.|++++..+++. ..++
T Consensus 14 g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~v~~~~~~~----~~~l 87 (191)
T d1zara2 14 SAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ-KLQGLAVPKVYAWE----GNAV 87 (191)
T ss_dssp EEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH-HTTTSSSCCEEEEE----TTEE
T ss_pred eEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHH-HccCCCcceEEEec----CCEE
Confidence 36899988 47999999987530 122346777887 66799999988763 2378
Q ss_pred EEecCCCcCcHHHhhccCCchhhHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCcEEEEeccceeEeecCcccccc
Q psy6377 62 VSWNTPLVVTLQTIIDDNLVVPFESDELSSLAYLHHRKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRVILDGIEIREL 141 (383)
Q Consensus 62 v~e~~~~g~~L~~~l~~~~~~~~~~qil~aL~yLHs~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~~~~~~~~~~~ 141 (383)
+||++. +..+.+ +.......+..|++.||.|||++||+||||||+|||++.+ .++|+|||+|.....+...
T Consensus 88 vme~~~-~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~liDFG~a~~~~~~~~~--- 158 (191)
T d1zara2 88 LMELID-AKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWIIDFPQSVEVGEEGWR--- 158 (191)
T ss_dssp EEECCC-CEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEECCCTTCEETTSTTHH---
T ss_pred EEEeec-cccccc-hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEEECCCcccCCCCCcH---
Confidence 999999 666554 4555566888999999999999999999999999999854 5899999999875432211
Q ss_pred cCCCCcCCCcc-----cccCCCChhhHHHHHHH
Q psy6377 142 LGTPDYVAPEI-----LHYEPITLAADMWSLGV 169 (383)
Q Consensus 142 ~gt~~y~aPE~-----l~~~~~~~~~DiwSlGv 169 (383)
.|....+ .....|+.++|+||+.-
T Consensus 159 ----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 159 ----EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp ----HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred ----HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 0111000 11356788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=4.4e-06 Score=74.26 Aligned_cols=122 Identities=11% Similarity=0.002 Sum_probs=86.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC----CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHHHhh-ccC
Q psy6377 5 SEEMADSIATGEVFAAKFLES----NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTII-DDN 79 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~----~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l-~~~ 79 (383)
.||... ..++.+++|+... ....+.+|...++.+.++-.+++++.+.++++..|+||++++ |..+.+.. ...
T Consensus 29 ~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~-G~~~~~~~~~~~ 105 (263)
T d1j7la_ 29 KVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD-GVLCSEEYEDEQ 105 (263)
T ss_dssp EEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS-SEEHHHHTTTCS
T ss_pred cEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc-cccccccccccc
Confidence 577764 5677788998865 355788999998866666667889999999999999999999 88886632 222
Q ss_pred CchhhHHHHHHHHHHHHh-----------------------------------------------------C------Cc
Q psy6377 80 LVVPFESDELSSLAYLHH-----------------------------------------------------R------KI 100 (383)
Q Consensus 80 ~~~~~~~qil~aL~yLHs-----------------------------------------------------~------gi 100 (383)
.......++...+..||+ . .+
T Consensus 106 ~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l 185 (263)
T d1j7la_ 106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF 185 (263)
T ss_dssp CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEE
T ss_pred cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEE
Confidence 211222333333333332 1 26
Q ss_pred eecCCCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 101 AHLDIKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 101 vHrDLKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+|+|+.|.|||++.+ +.+-|+||+.+...
T Consensus 186 ~HgD~~~~Nil~~~~---~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 186 SHGDLGDSNIFVKDG---KVSGFIDLGRSGRA 214 (263)
T ss_dssp ECSCCCTTSEEEETT---EEEEECCCTTCEEE
T ss_pred EEeeccCcceeecCC---ceEEEeechhcccC
Confidence 899999999999754 34569999988764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=4.1e-05 Score=67.35 Aligned_cols=121 Identities=17% Similarity=0.016 Sum_probs=80.6
Q ss_pred eEEEEEEcCCCcEEEEEEccC-CcccHHHHHHHHHhcCCC-CCcccceEEEEeCCeEEEEEecCCCcCcHHHhhccCCch
Q psy6377 5 SEEMADSIATGEVFAAKFLES-NPVRIHHEIALLSLCSPS-PRIVKLHDVFQTGEGAYYVSWNTPLVVTLQTIIDDNLVV 82 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-~~~~~~~Ei~il~~~~~h-pnIvkl~~~~~~~~~~~lv~e~~~~g~~L~~~l~~~~~~ 82 (383)
.||+... .+|..+++|.... ....+..|...++.+..+ -.+++++.+..+++..++||++++ |.++.+..... .
T Consensus 26 ~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~-G~~~~~~~~~~--~ 101 (255)
T d1nd4a_ 26 AVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP-GQDLLSSHLAP--A 101 (255)
T ss_dssp EEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS-SEETTTSCCCH--H
T ss_pred eEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee-ccccccccccH--H
Confidence 5777763 5677799998776 455688999988744433 337788888888889999999998 77665421000 0
Q ss_pred hhHH---------------------------------------------------HHHHHHHHHHhC-------CceecC
Q psy6377 83 PFES---------------------------------------------------DELSSLAYLHHR-------KIAHLD 104 (383)
Q Consensus 83 ~~~~---------------------------------------------------qil~aL~yLHs~-------givHrD 104 (383)
.... .....+..+... .++|+|
T Consensus 102 ~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD 181 (255)
T d1nd4a_ 102 EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGD 181 (255)
T ss_dssp HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSS
T ss_pred HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCC
Confidence 0000 112233344332 279999
Q ss_pred CCCCcEEEeccCCCCcEEEEeccceeEe
Q psy6377 105 IKPQNLVMMGDFPNCDIKVCDFEISRVI 132 (383)
Q Consensus 105 LKp~NILl~~~~~~~~ikL~DFGla~~~ 132 (383)
+.|.|||++.+ ..+-|+||+.+...
T Consensus 182 ~~~~Nvl~~~~---~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 182 ACLPNIMVENG---RFSGFIDCGRLGVA 206 (255)
T ss_dssp CCGGGEEEETT---EEEEECCCTTCEEE
T ss_pred CCCcceEEeCC---ceEEEEEchhcccC
Confidence 99999999864 34679999987763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.75 E-value=6.9e-05 Score=71.07 Aligned_cols=64 Identities=11% Similarity=-0.118 Sum_probs=40.2
Q ss_pred eEEEEEEcCCCcEEEEEEccC-----------CcccHHHHHHHHHhcCCC--CCcccceEEEEeCCeEEEEEecCCCcCc
Q psy6377 5 SEEMADSIATGEVFAAKFLES-----------NPVRIHHEIALLSLCSPS--PRIVKLHDVFQTGEGAYYVSWNTPLVVT 71 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~-----------~~~~~~~Ei~il~~~~~h--pnIvkl~~~~~~~~~~~lv~e~~~~g~~ 71 (383)
.||++....+|+.++||.-.. ...+..+|.+.|+.+..+ ..+++++.+ +....++|||++. +..
T Consensus 41 ~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~-~~~ 117 (392)
T d2pula1 41 YVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS-HLK 117 (392)
T ss_dssp EEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT-TSE
T ss_pred eEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccC-Ccc
Confidence 477787777788999996432 223567799888855444 345666654 5666788999997 543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.42 E-value=0.0038 Score=58.43 Aligned_cols=54 Identities=15% Similarity=0.066 Sum_probs=37.5
Q ss_pred CcEEEEEEccC--CcccHHHHHHHHHhcCCCCCcccceEEEEeCCeEEEEEecCCCcCcHH
Q psy6377 15 GEVFAAKFLES--NPVRIHHEIALLSLCSPSPRIVKLHDVFQTGEGAYYVSWNTPLVVTLQ 73 (383)
Q Consensus 15 g~~vAvK~i~~--~~~~~~~Ei~il~~~~~hpnIvkl~~~~~~~~~~~lv~e~~~~g~~L~ 73 (383)
++.|.+++... ......+|..+++.+..+.-.++++.++.+ .+|+++++ |..+.
T Consensus 74 ~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~-g~~l~ 129 (395)
T d1nw1a_ 74 PNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP-SRPLS 129 (395)
T ss_dssp CSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC-EEECC
T ss_pred CCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEec-cccCC
Confidence 45677777654 234466889999866666656788888743 67899998 76554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.87 E-value=0.012 Score=53.28 Aligned_cols=66 Identities=9% Similarity=-0.034 Sum_probs=41.1
Q ss_pred eEEEEEEcCCCcEEEEEEccC---CcccHHHHHHHHHhcCCCC-Ccccce-----EEEEeCCeEEEEEecCCCcCcH
Q psy6377 5 SEEMADSIATGEVFAAKFLES---NPVRIHHEIALLSLCSPSP-RIVKLH-----DVFQTGEGAYYVSWNTPLVVTL 72 (383)
Q Consensus 5 ~V~~~~~~~tg~~vAvK~i~~---~~~~~~~Ei~il~~~~~hp-nIvkl~-----~~~~~~~~~~lv~e~~~~g~~L 72 (383)
.||.+.. .+|+.|++|+.+. ...++..|+..+..+..+. .++... ..+..+...+.+++++. |..+
T Consensus 37 ~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~-G~~~ 111 (325)
T d1zyla1 37 RVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG-GRQF 111 (325)
T ss_dssp EEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC-CEEC
T ss_pred eeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC-CcCC
Confidence 3777764 6889999999875 3466888988777443221 111111 22345566788888887 5443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.34 E-value=0.021 Score=51.02 Aligned_cols=31 Identities=23% Similarity=0.315 Sum_probs=26.1
Q ss_pred CCceecCCCCCcEEEeccCCCCcEEEEeccceeE
Q psy6377 98 RKIAHLDIKPQNLVMMGDFPNCDIKVCDFEISRV 131 (383)
Q Consensus 98 ~givHrDLKp~NILl~~~~~~~~ikL~DFGla~~ 131 (383)
.|++|+|+.++||+++++ ...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~---~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD---ELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccc---cceeEeccccccc
Confidence 479999999999999875 3457999998875
|